PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Vanden Berghe, T; Kalai, M; van Loo, G; Declercq, W; Vandenabeele, P				Vanden Berghe, T; Kalai, M; van Loo, G; Declercq, W; Vandenabeele, P			Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEATH DOMAIN KINASE; CYTOCHROME-C RELEASE; NECROTIC CELL-DEATH; FAS RECEPTOR; PROTEIN; ACTIVATION; COMPLEX; RIP; MITOCHONDRIA	Triggering tumor necrosis factor receptor-1 (TNFR1) induces apoptosis in various cell lines. In contrast, stimulation of TNFR1 in L929sA leads to necrosis. Inhibition of HSP90, a chaperone for many kinases, by geldanamycin or radicicol shifted the response of L929sA cells to TNF from necrosis to apoptosis. This shift was blocked by CrmA but not by BCL-2 overexpression, suggesting that it occurred through activation of procaspase-8. Geldanamycin pretreatment led to a proteasome-dependent decrease in the levels of several TNFR1-interacting proteins including the kinases receptor-interacting protein, inhibitor of kappaB kinase-alpha, inhibitor of kappaB kinase-beta, and to a lesser extent the adaptors NF-kappaB essential modulator and tumor necrosis factor receptor-associated factor 2. As a consequence, NF-kappaB, p38MAPK, and JNK activation were abolished. No significant decrease in the levels of mitogen-activated protein kinases, adaptor proteins TNFR-associated death domain and Fas-associated death domain, or caspase-3, -8, and -9 could be detected. These results suggest that HSP90 client proteins play a crucial role in necrotic signaling. We conclude that inhibition of HSP90 may alter the composition of the TNFR1 complex, favoring the caspase-8-dependent apoptotic pathway. In the absence of geldanamycin, certain HSP90 client proteins may be preferentially recruited to the TNFR1 complex, promoting necrosis. Thus, the availability of proteins such as receptor-interacting protein, Fas-associated death domain, and caspase-8 can determine whether TNFR1 activation will lead to apoptosis or to necrosis.	State Univ Ghent VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Lab, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), KL Ledgeanckstraat 35, B-9000 Ghent, Belgium.	peter.vandenabeele@dmb.rug.ac.be	van Loo, Geert/C-1505-2009; Vandenabeele, Peter/C-8597-2009; Vanden Berghe, Tom/C-4916-2009; , van Loo Geert/AAD-1220-2019; Vandenabeele, Peter/AAD-5793-2022; Berghe, Tom Vanden/N-2902-2019	Vanden Berghe, Tom/0000-0002-1633-0974; , van Loo Geert/0000-0002-8427-4775; Vandenabeele, Peter/0000-0002-6669-8822; Berghe, Tom Vanden/0000-0002-1633-0974				BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Denecker G, 2001, CELL DEATH DIFFER, V8, P829, DOI 10.1038/sj.cdd.4400883; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Juo P, 1999, CELL GROWTH DIFFER, V10, P797; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim JW, 2000, ONCOGENE, V19, P4491, DOI 10.1038/sj.onc.1203796; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Lin H, 2002, EXP CELL RES, V272, P192, DOI 10.1006/excr.2001.5417; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; O'Reilly LA, 2002, CELL DEATH DIFFER, V9, P832, DOI 10.1038/sj.cdd.4401033; POUPART P, 1987, EMBO J, V6, P1219, DOI 10.1002/j.1460-2075.1987.tb02357.x; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Todryk S, 1999, J IMMUNOL, V163, P1398; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wang CY, 1999, MOL CELL BIOL, V19, P5923; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681	53	132	134	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					5622	5629		10.1074/jbc.M208925200	http://dx.doi.org/10.1074/jbc.M208925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12441346	hybrid			2022-12-27	WOS:000181129400019
J	Bohmer, FD; Karagyozov, L; Uecker, A; Serve, H; Botzki, A; Mahboobi, S; Dove, S				Bohmer, FD; Karagyozov, L; Uecker, A; Serve, H; Botzki, A; Mahboobi, S; Dove, S			A single amino acid exchange inverts susceptibility of related receptor tyrosine kinases for the ATP site inhibitor STI-571	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PHENYLAMINO-PYRIMIDINE PAP; CRYSTAL-STRUCTURE; SELECTIVE INHIBITORS; SIGNAL-TRANSDUCTION; HEMATOPOIETIC-CELLS; INSULIN-RECEPTOR; PROTEIN-KINASES; DOMAIN; PHOSPHORYLATION	The tyrosine kinase inhibitor STI-571 potently blocks BCR-Abl, platelet-derived growth factor (PDGF) alpha- and beta-receptors, and c-Kit kinase activity. Flt3, a receptor tyrosine kinase closely related to PDGF receptors and c-Kit is, however, not inhibited by STI-571. Sequence alignments of different kinases and indications from the crystal structure of the STI-571 Abl kinase complex revealed amino acid residues that are probably crucial for this activity profile. It was predicted that Flt3 Phe-691 in the 135 strand may sterically prevent interaction with STI-571. The point mutants Flt3 F691T and PDGFbeta-receptor T681F were constructed, and kinase assays showed that the Flt3 mutant but not the PDGFbeta-receptor mutant is inhibited by STI-571. Docking of STI-571 into computer models of the PDGFbeta-receptor and Flt3 kinase domains and comparison with the crystal structure of the STI-571 Abl kinase complex indicated very similar binding sites among the three nonphosphorylated kinases, suggesting corresponding courses of their Asp-Phe-Gly motifs and activation loops. Accordingly, we observed reduced sensitivity of preactivated compared with nonactivated PDGFR-beta for the inhibition by STI-571. Courses of the activation loop that collide with STI-571 binding explain its inactivity at other kinases as the insulin receptor. The binding site models of PDGFR-beta and Flt3 were applied to predict structural approaches for more selective PDGFbeta-receptor inhibitors.	Univ Jena, Fac Med, Res Unit Mol Cell Biol, D-07747 Jena, Germany; Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria; Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany; Univ Regensburg, Inst Pharm, D-93040 Regensburg, Germany	Friedrich Schiller University of Jena; Bulgarian Academy of Sciences; University of Munster; University of Regensburg	Bohmer, FD (corresponding author), Univ Jena, Fac Med, Res Unit Mol Cell Biol, Drackendorfer Str 1, D-07747 Jena, Germany.			Botzki, Alexander/0000-0001-6691-4233				Bishop AC, 1999, PHARMACOL THERAPEUT, V82, P337, DOI 10.1016/S0163-7258(98)00060-6; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; BLUNDELL T, 1988, EUR J BIOCHEM, V172, P513, DOI 10.1111/j.1432-1033.1988.tb13917.x; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; CAROW CE, 1996, GENE, V169, P197; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Gazit A, 1996, J MED CHEM, V39, P2170, DOI 10.1021/jm950727b; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; KOVALENKO M, 1994, CANCER RES, V54, P6106; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; MAGUIRE MP, 1994, J MED CHEM, V37, P2129, DOI 10.1021/jm00040a003; Mahboobi S, 2002, J MED CHEM, V45, P1002, DOI 10.1021/jm010988n; Mauro MJ, 2002, J CLIN ONCOL, V20, P325, DOI 10.1200/JCO.20.1.325; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Nagar B, 2002, CANCER RES, V62, P4236; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Palmer BD, 1998, J MED CHEM, V41, P5457, DOI 10.1021/jm9804681; Palmer BD, 1999, J MED CHEM, V42, P2373, DOI 10.1021/jm980658b; Rosnet O, 1996, LEUKEMIA, V10, P238; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Teller S, 2002, LEUKEMIA, V16, P1528, DOI 10.1038/sj.leu.2402630; Turner AM, 1996, BLOOD, V88, P3383, DOI 10.1182/blood.V88.9.3383.bloodjournal8893383; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4; Zimmermann J, 1996, BIOORG MED CHEM LETT, V6, P1221, DOI 10.1016/0960-894X(96)00197-7	36	58	59	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5148	5155		10.1074/jbc.M209861200	http://dx.doi.org/10.1074/jbc.M209861200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435730	hybrid			2022-12-27	WOS:000180968900102
J	Iyer, SPN; Akimoto, Y; Hart, GW				Iyer, SPN; Akimoto, Y; Hart, GW			Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; RNA-POLYMERASE-II; EIF-2 ALPHA-SUBUNIT; TETRATRICOPEPTIDE REPEATS; TRANSCRIPTION FACTORS; RETICULOCYTE LYSATE; CYTOSOLIC PROTEINS; TERMINAL DOMAIN; C-MYC; GLYCOSYLATION	The abundant and dynamic post-translational modification of nuclear and cytosolic proteins by beta-O-linked N-acetylglucosamine (O-GlcNAc) is catalyzed by O-GlcNAc transferase (OGT). Here we used the yeast two-hybrid approach to identify and isolate GABA(A) receptor-associated protein, GRIF-1 (Beck, M., Brickley, K., Wilkinson, H. L., Sharma, S., Smith, M., Chazot, P. L., Pollard, S., and Stephenson, F. A. (2002) J. Biol. Chem. 277, 30079-30090), and its novel homolog, OIP106 (KIAA1042), as novel OGT-interacting proteins. The proteins are highly similar to each other but are encoded by two separate genes. Both GRIF-1 and OIP106 contain coiled-coil domains and interact with the tetratricopeptide repeats of OGT. GRIF-1 and OIP106 are modified by O-GlcNAc and therefore are substrates for OGT. However, unlike another high affinity protein substrate, such as nucleoporin p62, OIP106 and GRIF-1 co-immunoprecipitate with OGT, exhibiting stable in vitro and in vivo associations. Whereas GRIF-1 has been reported to be expressed only in excitable tissue, OIP106 is expressed in all human cell lines that were examined. Confocal and electron microscopy show that OIP106 localizes to nuclear punctae in HeLa cells and co-localizes with RNA polymerase II. Co-immunoprecipitation experiments confirm the presence of an in vivo RNA polymerase II-OIP106-OGT complex, suggesting that OIP106 may target OGT to transcriptional complexes for glycosylation of transcriptional proteins, such as RNA polymerase II, and transcription factors. Similarly, GRIF-1 may serve to target OGT to GABA(A) receptor complexes for mediating GABA signaling cascades.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Univ Alabama, Dept Biochem & Mol Genet, Grad Program, Birmingham, AL 35294 USA; Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 1818611, Japan	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Kyorin University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Hart, Gerald/0000-0001-7812-4351				Akimoto Y, 1999, DIABETES, V48, P2407, DOI 10.2337/diabetes.48.12.2407; Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Brandon NJ, 2002, PHARMACOL THERAPEUT, V94, P113, DOI 10.1016/S0163-7258(02)00175-4; CHAKRABORTY A, 1994, BIOCHEMISTRY-US, V33, P6700, DOI 10.1021/bi00187a041; Cheng XG, 2001, J BIOL CHEM, V276, P10570, DOI 10.1074/jbc.M010411200; CHOU TY, 1995, P NATL ACAD SCI USA, V92, P4417, DOI 10.1073/pnas.92.10.4417; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; *CLONT LAB INC, 1999, CLONT YEAST PROT HDB; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; COMER FI, 2000, THESIS U ALABAMA BIR; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DATTA B, 1989, J BIOL CHEM, V264, P20620; DONG DLY, 1993, J BIOL CHEM, V268, P16679; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GREIS K, 1994, J VIROL, V68, P9339; Hadano S, 2001, GENOMICS, V71, P200, DOI 10.1006/geno.2000.6392; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Harlow E., 1988, ANTIBODIES LAB MANUA; HART GW, 1995, ADV EXP MED BIOL, V376, P115; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; HOLT GD, 1987, J BIOL CHEM, V262, P14847; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; MEIKRANTZ W, 1991, J CELL SCI, V98, P303; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; REASON AJ, 1992, J BIOL CHEM, V267, P16911; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shaw P, 1996, ONCOGENE, V12, P921; STARR CM, 1990, J BIOL CHEM, V265, P6868; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TZAMARIAS D, 1995, GENE DEV, V9, P821, DOI 10.1101/gad.9.7.821; von Mikecz A, 2000, J CELL BIOL, V150, P265, DOI 10.1083/jcb.150.1.265; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998	49	120	139	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5399	5409		10.1074/jbc.M209384200	http://dx.doi.org/10.1074/jbc.M209384200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435728	hybrid			2022-12-27	WOS:000180968900132
J	Miao, H; Seiler, JA; Burhans, WC				Miao, H; Seiler, JA; Burhans, WC			Regulation of cellular and SV40 virus origins of replication by Chk1-dependent intrinsic and UVC radiation-induced checkpoints	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; DNA-DAMAGE CHECKPOINT; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; RADIOSENSITIZING AGENT; ULTRAVIOLET-LIGHT; HUMAN-FIBROBLASTS; IRRADIATED-CELLS; FISSION YEAST; INHIBITION	DNA replication is inhibited by DNA damage through cis effects on replication fork progression and trans effects associated with checkpoints. In this study, we employed a combined pulse labeling and neutral-neutral two-dimensional gel-based approach to compare the effects of a DNA damaging agent frequently employed to invoke checkpoints; UVC radiation, on the replication of cellular and simian virus 40 (SV40) chromosomes in intact cells. UVC radiation induced similar inhibitory effects on the initiation and elongation phases of cellular and SV40 DNA replication. The initiation-inhibitory effects occurred independently of p53 and were abrogated by the ATM and ATR kinase inhibitor caffeine, or the Chk1 kinase inhibitor UCN-01. Inhibition of cellular origins was also abrogated by the expression of a dominant-negative Chk1 mutant. These results indicate that UVC induces a Chk1- and ATR or ATM-dependent checkpoint that targets both cellular and SV40 viral replication origins. Loss of Chk1 and ATR or ATM function also stimulated initiation of cellular and viral DNA replication in the absence of UVC radiation, revealing the existence of a novel intrinsic checkpoint that targets both cellular and SV40 viral origins of replication in the absence of DNA damage or stalled DNA replication forks. This checkpoint inhibits the replication in early S phase cells of a region of the repetitive rDNA locus that replicates in late S phase. The ability to detect these checkpoints using the well characterized SV40 model system should facilitate analysis of the molecular basis for these effects.	New York State Dept Hlth, Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Burhans, WC (corresponding author), New York State Dept Hlth, Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA.				NCI NIH HHS [CA 84086, P30 CA16056] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084086, P30CA016056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43; BERGER CA, 1986, MOL CELL BIOL, V6, P3443, DOI 10.1128/MCB.6.10.3443; BOWDEN GT, 1983, CHEM-BIOL INTERACT, V47, P57, DOI 10.1016/0009-2797(83)90147-3; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Bullock SK, 2001, CARCINOGENESIS, V22, P233, DOI 10.1093/carcin/22.2.233; Bunch RT, 1997, CELL GROWTH DIFFER, V8, P779; Busby EC, 2000, CANCER RES, V60, P2108; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CLEAVER JE, 1990, RADIAT RES, V124, P294, DOI 10.2307/3577842; Cobuzzi RJ, 1996, J BIOL CHEM, V271, P19852, DOI 10.1074/jbc.271.33.19852; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guo N, 2002, CELL GROWTH DIFFER, V13, P77; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Huberman JA, 1999, PROG NUCLEIC ACID RE, V62, P369; Iliakis G, 1999, METH MOL B, V113, P543; KAUFMANN WK, 1981, J MOL BIOL, V149, P171, DOI 10.1016/0022-2836(81)90297-7; KAUFMANN WK, 1991, MOL CELL BIOL, V11, P3711, DOI 10.1128/MCB.11.7.3711; KAUFMANN WK, 1985, BIOCHIM BIOPHYS ACTA, V824, P146, DOI 10.1016/0167-4781(85)90091-0; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; LAMB JR, 1989, INT J RADIAT BIOL, V56, P125, DOI 10.1080/09553008914551271; LEHMANN AR, 1972, BIOPHYS J, V12, P1316, DOI 10.1016/S0006-3495(72)86165-4; LITTLE RD, 1993, MOL CELL BIOL, V13, P6600, DOI 10.1128/MCB.13.10.6600; Liu PK, 1996, ONCOGENE, V12, P2267; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; MAKINO F, 1975, RADIAT RES, V62, P37, DOI 10.2307/3574182; McHugh MM, 1997, BIOCHEMISTRY-US, V36, P1003, DOI 10.1021/bi962121a; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAINTER RB, 1980, J MOL BIOL, V143, P289, DOI 10.1016/0022-2836(80)90191-6; PAINTER RB, 1985, MUTAT RES, V145, P63, DOI 10.1016/0167-8817(85)90041-0; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shao RG, 1997, CANCER RES, V57, P4029; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; TATSUMI K, 1979, J MOL BIOL, V135, P435, DOI 10.1016/0022-2836(79)90445-5; WANG Y, 1995, RADIAT RES, V142, P169, DOI 10.2307/3579025; Weinberger M, 1999, J BIOL CHEM, V274, P35975, DOI 10.1074/jbc.274.50.35975; ZHUKOVSKAYA N, 1994, CARCINOGENESIS, V15, P2189, DOI 10.1093/carcin/15.10.2189	48	50	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4295	4304		10.1074/jbc.M204264200	http://dx.doi.org/10.1074/jbc.M204264200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12424256	hybrid			2022-12-27	WOS:000180869700097
J	Sun, AQ; Salkar, R; Sachchidanand; Xu, SH; Zeng, L; Zhou, MM; Suchy, FJ				Sun, AQ; Salkar, R; Sachchidanand; Xu, SH; Zeng, L; Zhou, MM; Suchy, FJ			A 14-amino acid sequence with a beta-turn structure is required for apical membrane sorting of the rat ileal bile acid transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PHOSPHOTYROSINE BINDING DOMAIN; AMYLOID PRECURSOR PROTEIN; CANINE KIDNEY-CELLS; INTERNALIZATION SIGNAL; EPITHELIAL-CELLS; CYTOPLASMIC TAIL; PLASMA-MEMBRANE; PTB DOMAIN; TERMINAL DOMAIN	The rat ileal sodium-dependent bile acid transporter (Asbt) is a polytopic membrane glycoprotein, which is specifically expressed on the apical domain of the ileal brush-border membrane. In the present study, an essential 14-amino acid (aa 335-348) sorting signal was defined on the cytoplasmic tail of Asbt with two potential phosphorylation sites motifs for casein kinase II ((335)SFQE) and protein kinase C (PKC) ((TNK)-T-339). Two-dimension NMR spectra analysis demonstrated that a tetramer, (340)NKGF, which overlaps with the potential PKC site within the 14-mer signal sequence, adopts a type I beta-turn conformation. Replacement of the potential phosphorylation residue Ser(335) and Thr(339) with alanine or deletion of either the 4 ((335)SFQE) or 10 as (338-348, containing (339)TNKGF) from the C terminus of Asbt resulted in a significantly decreased initial bile acid transport activity and increased the basolateral distribution of the mutants by 2-3-fold compared with that of wild type Asbt. Deletion of the entire last 14 amino acids (335-348) from the C terminus of Asbt abolished the apical expression of the truncated Asbt. Moreover, replacement of the cytoplasmic tail of the liver basolateral membrane protein, Na+/taurocholate cotransporting polypeptide, with the 14-mer peptide tail of Asbt redirected the chimera to the apical domain. In contrast, a chimera consisting of the 14-mer peptide of Asbt fused with green fluorescent protein was expressed in an intracellular transport vesicle-like distribution in transfected Madin-Darby canine kidney and COS 7 cells. This suggests that the apical localization of the 14-mer peptide requires a membrane anchor to support proper targeting. The results from biological reagent treatment and low temperature shift (20 degreesC) suggests that Asbt follows a transport vesicle-mediated apical sorting pathway that is brefeldin A-sensitive and insensitive to protein glycosylation, monensin treatment, and low temperature shift.	Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Struct Biol Program, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University	Sun, AQ (corresponding author), Mt Sinai Sch Med, Dept Pediat, Box 1664,1 Gustave L Levy Pl, New York, NY 10029 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020632, R01HD020632] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20632] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALONSO FV, 1981, J CELL BIOL, V89, P700, DOI 10.1083/jcb.89.3.700; AROETI B, 1993, J CELL BIOL, V123, P1149, DOI 10.1083/jcb.123.5.1149; ARREAZA G, 1995, J BIOL CHEM, V270, P23641, DOI 10.1074/jbc.270.40.23641; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; DARGEMONT C, 1993, EMBO J, V12, P1713, DOI 10.1002/j.1460-2075.1993.tb05816.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; GRUNE S, 1993, J BIOL CHEM, V268, P17734; INOUE M, 1984, J CLIN INVEST, V73, P659, DOI 10.1172/JCI111257; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jolimay N, 2000, J NEUROSCI, V20, P9111; Kibbey RG, 1998, J CELL BIOL, V142, P59, DOI 10.1083/jcb.142.1.59; Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734; LOW SH, 1991, J BIOL CHEM, V266, P17729; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Matter K, 2000, CURR BIOL, V10, pR39, DOI 10.1016/S0960-9822(99)00256-0; Milewski MI, 2001, J CELL SCI, V114, P719; Muth TR, 1998, J BIOL CHEM, V273, P25616, DOI 10.1074/jbc.273.40.25616; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Puertollano R, 1999, BIOCHEM BIOPH RES CO, V254, P689, DOI 10.1006/bbrc.1998.0122; Puertollano R, 1999, MOL BIOL CELL, V10, P3435, DOI 10.1091/mbc.10.10.3435; Riento K, 2000, J BIOL CHEM, V275, P13476, DOI 10.1074/jbc.275.18.13476; SARASTE J, 1991, J CELL SCI, V100, P415; Shneider B L, 1995, J Pediatr Gastroenterol Nutr, V20, P233, DOI 10.1097/00005176-199502000-00016; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun AQ, 1998, AM J PHYSIOL-GASTR L, V275, pG1045, DOI 10.1152/ajpgi.1998.275.5.G1045; Sun AQ, 2001, J BIOL CHEM, V276, P6825, DOI 10.1074/jbc.M008797200; Sun AQ, 2001, AM J PHYSIOL-GASTR L, V280, pG1305, DOI 10.1152/ajpgi.2001.280.6.G1305; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tugizov S, 1998, J VIROL, V72, P7374, DOI 10.1128/JVI.72.9.7374-7386.1998; VAUX D, 1992, Trends in Cell Biology, V2, P189, DOI 10.1016/0962-8924(92)90232-C; Vleurick L, 1999, MOL ENDOCRINOL, V13, P1823, DOI 10.1210/me.13.11.1823; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; WILMOT CM, 1988, J MOL BIOL, V203, P222; WONG MH, 1994, J BIOL CHEM, V269, P1340; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	45	49	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4000	4009		10.1074/jbc.M207163200	http://dx.doi.org/10.1074/jbc.M207163200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12435749	hybrid			2022-12-27	WOS:000180869700062
J	Brokx, RD; Bolewska-Pedyczak, E; Gariepy, J				Brokx, RD; Bolewska-Pedyczak, E; Gariepy, J			A stable human p53 heterotetramer based on constructive charge interactions within the tetramerization domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; OLIGOMERIZATION DOMAIN; TRANSFORMING DOMAIN; MECHANISM; SPECIFICITY; STABILITY; MUTANTS; CLONING; MODEL; CDNA	The human p53 tetramerization domain (called p53tet; residues 325-355) spontaneously forms a dimer of dimers in solution. Hydrophobic interactions play a major role in stabilizing the p53 tetramer. However, the distinctive arrangement of charged residues at the dimer-dimer interface suggests that they also contribute to tetramer stability. Charge-reversal mutations at positions 343,346, and 351 within the dimer-dimer interface were thus introduced into p53tet constructs and shown to result in the selective formation of a stable heterotetramer composed of homodimers. More precisely, mutants p53tet-E343K/E346K and p53tet-K351E preferentially associated with each other, but not with wild-type p53tet, to form a heterodimeric tetramer with enhanced thermal stability relative to either of the two components in isolation. The p53tet-E343K/E346K mutant alone assembled into a weakly stable tetramer in solution, whereas p53tet-K351E existed only as a dimer. Moreover, these mutants did not form heterocomplexes with wild-type p53tet, illustrating the specificity of the ionic interactions that form the novel heterotetramer. This study demonstrates the dramatic importance of ionic interactions in altering the stability of the p53 tetramer and in selectively creating heterotetramers of this protein scaffold.	Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto	Gariepy, J (corresponding author), Univ Toronto, Dept Med Biophys, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	gariepy@uhnres.utoronto.ca						Arrowsmith CH, 1996, ONCOGENE, V12, P1379; Bargonetti J, 2002, CURR OPIN ONCOL, V14, P86, DOI 10.1097/00001622-200201000-00015; Chene P, 1999, J MOL BIOL, V286, P1269, DOI 10.1006/jmbi.1999.2563; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Davison TS, 2001, J MOL BIOL, V307, P605, DOI 10.1006/jmbi.2001.4450; DEFROMENTEL CC, 1992, GENE, V112, P241, DOI 10.1016/0378-1119(92)90383-Z; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Fairman R, 1996, BIOCHEMISTRY-US, V35, P2824, DOI 10.1021/bi952784c; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; Mateu MG, 1999, P NATL ACAD SCI USA, V96, P3595, DOI 10.1073/pnas.96.7.3595; McCoy M, 1997, EMBO J, V16, P6230, DOI 10.1093/emboj/16.20.6230; Noolandi J, 2000, P NATL ACAD SCI USA, V97, P9955, DOI 10.1073/pnas.160075697; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SAKAMOTO H, 1994, P NATL ACAD SCI USA, V91, P8974, DOI 10.1073/pnas.91.19.8974; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Somasundaram K, 2000, FRONT BIOSCI, V5, pD424, DOI 10.2741/Somasund; SOUSSI T, 1987, ONCOGENE, V1, P71; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	36	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2327	2332		10.1074/jbc.M208528200	http://dx.doi.org/10.1074/jbc.M208528200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433927	hybrid			2022-12-27	WOS:000180562000035
J	Dreyfuss, BW; Hamel, PP; Nakamoto, SS; Merchant, S				Dreyfuss, BW; Hamel, PP; Nakamoto, SS; Merchant, S			Functional analysis of a divergent system II protein, Ccs1, involved in c-type cytochrome biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME CHAPERONE CCME; CHLAMYDOMONAS-REINHARDTII; PARACOCCUS-DENITRIFICANS; ESCHERICHIA-COLI; COPROPORPHYRINOGEN OXIDASE; PERIPLASMIC THIOREDOXIN; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; MEMBRANE-PROTEIN	The Ccs1 gene, encoding a highly divergent novel component of a system II type c-type cytochrome biogenesis pathway, is encoded by the previously defined CCS1 locus in Chlamydomonas reinhardtii. phoA and lacZalpha bacterial topological reporters were used to deduce a topological model of the Synechocystis sp. 6803 Ccs1 homologue, CcsB. CcsB, and therefore by analogy Ccs1, possesses a large soluble lumenal domain at its C terminus that is tethered in the thylakoid membrane by three closely spaced transmembrane domains in the N-terminal portion of the protein. Molecular analysis of ccs1 alleles reveals that the entire C-terminal soluble domain is essential for Ccs1 function and that a stromal loop appears to be important in vivo, at least for maintenance of Ccs1. Site-directed mutational analysis reveals that a single histidine (His(274)) within the last transmembrane domain, preceding the large lumenal domain, is required for c-type cytochrome assembly, whereas an invariant cysteine residue (Cys(199)) is shown to be nonessential. Ccs1 is proposed to interact with other Ccs components based on its reduced accumulation in ccs2, ccs3, ccs4, and ccsA strains.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Merchant, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Box 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu			NIGMS NIH HHS [GM07185, GM17483, GM48350] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CM, 1991, PLANT PHYSIOL, V96, P584, DOI 10.1104/pp.96.2.584; Auchincloss AH, 1999, MOL GEN GENET, V261, P21, DOI 10.1007/s004380050937; Beckett CS, 2000, MOL MICROBIOL, V38, P465, DOI 10.1046/j.1365-2958.2000.02174.x; BECKMAN DL, 1992, GENE DEV, V6, P268, DOI 10.1101/gad.6.2.268; BECKMAN DL, 1993, P NATL ACAD SCI USA, V90, P2179, DOI 10.1073/pnas.90.6.2179; Cahoon AB, 2000, PLANT CELL, V12, P559, DOI 10.1105/tpc.12.4.559; Cervera AM, 1998, MOL MICROBIOL, V30, P67, DOI 10.1046/j.1365-2958.1998.01039.x; CHEN XM, 1995, PLANT CELL, V7, P1295; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DEHEIJ HT, 1984, EUR J BIOCHEM, V138, P161; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Dreyfuss BW, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P3139; DRYGAS ME, 1989, J BIOL CHEM, V264, P17897; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Fabianek RA, 1997, J BIOL CHEM, V272, P4467, DOI 10.1074/jbc.272.7.4467; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; FENTON JM, 1990, PHOTOSYNTH RES, V26, P59, DOI 10.1007/BF00048977; Funke RP, 1997, PLANT PHYSIOL, V114, P237, DOI 10.1104/pp.114.1.237; Gaballa A, 1998, MOL MICROBIOL, V30, P547, DOI 10.1046/j.1365-2958.1998.01085.x; Goldman BS, 1997, J MOL BIOL, V268, P724, DOI 10.1006/jmbi.1997.0992; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Goldman BS, 2001, RES MICROBIOL, V152, P323, DOI 10.1016/S0923-2508(01)01203-7; GORMAN DS, 1966, PLANT PHYSIOL, V41, P1648, DOI 10.1104/pp.41.10.1648; GUMPEL NJ, 1994, CURR GENET, V26, P438, DOI 10.1007/BF00309931; Hamel PP, 2003, J BIOL CHEM, V278, P2593, DOI 10.1074/jbc.M208651200; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; HILL KL, 1995, EMBO J, V14, P857, DOI 10.1002/j.1460-2075.1995.tb07067.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; Katzen F, 2002, EMBO J, V21, P3960, DOI 10.1093/emboj/cdf405; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; KRANZ RG, 1989, J BACTERIOL, V171, P456, DOI 10.1128/jb.171.1.456-464.1989; Kranz RG, 2002, RES MICROBIOL, V153, P1, DOI 10.1016/S0923-2508(01)01278-5; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Le Brun NE, 2000, MOL MICROBIOL, V36, P638, DOI 10.1046/j.1365-2958.2000.01883.x; LEMAIRE C, 1986, BIOCHIM BIOPHYS ACTA, V851, P229, DOI 10.1016/0005-2728(86)90130-1; Lennartz K, 2001, PLANT CELL, V13, P2539, DOI 10.1105/tpc.13.11.2539; Li HH, 1996, J BIOL CHEM, V271, P31283, DOI 10.1074/jbc.271.49.31283; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; MALNOE P, 1988, J CELL BIOL, V106, P609, DOI 10.1083/jcb.106.3.609; Maquat LE, 2002, SCIENCE, V295, P2221, DOI 10.1126/science.1071285; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1990, J BIOL CHEM, V265, P12372; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; Ohad I, 1974, Methods Enzymol, V32, P865; Page MD, 1997, MICROBIOL-SGM, V143, P563, DOI 10.1099/00221287-143-2-563; PAGE MD, 1995, MOL MICROBIOL, V15, P307, DOI 10.1111/j.1365-2958.1995.tb02245.x; Page MD, 1997, MICROBIOL-SGM, V143, P3111, DOI 10.1099/00221287-143-10-3111; Page MD, 1997, MOL MICROBIOL, V24, P977, DOI 10.1046/j.1365-2958.1997.4061775.x; Page MD, 1998, TRENDS BIOCHEM SCI, V23, P103, DOI 10.1016/S0968-0004(98)01173-6; Page MD, 1999, MICROBIOL-UK, V145, P3047, DOI 10.1099/00221287-145-11-3047; Pisa R, 2002, MOL MICROBIOL, V43, P763, DOI 10.1046/j.1365-2958.2002.02784.x; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quinn JM, 1999, J BIOL CHEM, V274, P14444, DOI 10.1074/jbc.274.20.14444; RAMSEIER TM, 1991, J BIOL CHEM, V266, P7793; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Reid E, 1998, FEMS MICROBIOL LETT, V166, P369, DOI 10.1016/S0378-1097(98)00357-7; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; RITZ D, 1995, MOL GEN GENET, V247, P27, DOI 10.1007/BF00425818; RITZ D, 1993, MOL MICROBIOL, V9, P729, DOI 10.1111/j.1365-2958.1993.tb01733.x; ROST B, 1995, PROTEIN SCI, V4, P521; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schiott T, 1997, J BACTERIOL, V179, P1962, DOI 10.1128/jb.179.6.1962-1973.1997; SCHULDINER S, 1969, BIOCHIM BIOPHYS ACTA, V180, P165, DOI 10.1016/0005-2728(69)90203-5; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; SCHUSTER G, 1988, EUR J BIOCHEM, V177, P411, DOI 10.1111/j.1432-1033.1988.tb14390.x; STEINER H, 1995, J BIOL CHEM, V270, P22842, DOI 10.1074/jbc.270.39.22842; Sun GF, 1996, J BACTERIOL, V178, P1374, DOI 10.1128/jb.178.5.1374-1385.1996; TAUTZ D, 1983, ANAL BIOCHEM, V132, P14, DOI 10.1016/0003-2697(83)90419-0; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tichy M, 1999, J BIOL CHEM, V274, P32396, DOI 10.1074/jbc.274.45.32396; VARGAS C, 1994, J BACTERIOL, V176, P4117, DOI 10.1128/JB.176.13.4117-4123.1994; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Xie ZY, 1998, BBA-BIOENERGETICS, V1365, P309, DOI 10.1016/S0005-2728(98)00085-1; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Xie ZY, 1998, GENETICS, V148, P681; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x	88	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2604	2613		10.1074/jbc.M208652200	http://dx.doi.org/10.1074/jbc.M208652200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427747	hybrid			2022-12-27	WOS:000180562000071
J	Fu, TF; Scarsdale, JN; Kazanina, G; Schirch, V; Wright, HT				Fu, TF; Scarsdale, JN; Kazanina, G; Schirch, V; Wright, HT			Location of the pteroylpolyglutamate-binding site on rabbit cytosolic serine hydroxymethyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; THYMIDYLATE SYNTHASE; DIRECTED MUTAGENESIS; ANGSTROM RESOLUTION; SUBSTRATE; COMPLEX; DOMAIN; FOLYLPOLYGLUTAMATES; TETRAHYDROFOLATE; PURIFICATION	Serine hydroxymethyltransferase (SHMT; EC 2.1.2.1) catalyzes the reversible interconversion of serine and glycine with transfer of the serine side chain one-carbon group to tetrahydropteroylglutamate (H,PteGlu), and also the conversion of 5,10-methenyl-H(4)PteGlu to 5-formyl-H(4)pteGlu. In the cell, H(4)PteGlu carries a poly-gamma-glutamyl tail of at least 3 glutamyl residues that is required for physiological activity. This study combines solution binding and mutagenesis studies with crystal-lographic structure determination to identify the extended binding site for tetrahydropteroylpolyglutamate on rabbit cytosolic SHMT. Equilibrium binding and kinetic measurements of B(4)PteGlu(3), and H(4)PteGlu, with wild-type and Lys --> Gln or Glu site mutant homotetrameric rabbit cytosolic SHMTs identified lysine residues that contribute to the binding of the polyglutamate tail. The crystal structure of the enzyme in complex with 5-formyl-H(4)PteGlu(3) confirms the solution data and indicates that the conformation of the pteridine ring and its interactions with the enzyme differ slightly from those observed in complexes of the monoglutamate cofactor. The polyglutamate chain, which does not contribute to catalysis, exists in multiple conformations in each of the two occupied binding sites and appears to be bound by the electrostatic field created by the cationic residues, with only limited interactions with specific individual residues.	Virginia Commonwealth Univ, Inst Struct Biol & Drug Dis, Richmond, VA 23219 USA; Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23219 USA	Virginia Commonwealth University; Virginia Commonwealth University	Wright, HT (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol & Drug Dis, 800 E Leigh St,Suite 212, Richmond, VA 23219 USA.	xrdproc@hsc.vcu.edu	Fu, Tzu-Fun/G-7820-2011		NIDDK NIH HHS [DK55648] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1998, COMPREHENSIVE BIOL C; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; Birdsall DL, 1996, J MOL BIOL, V255, P522, DOI 10.1006/jmbi.1996.0043; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; di Salvo ML, 1998, PROTEIN EXPRES PURIF, V13, P177, DOI 10.1006/prep.1998.0890; FEENEY J, 1980, J CHEM SOC PERK T 2, P176, DOI 10.1039/p29800000176; FERONE R, 1986, J BIOL CHEM, V261, P6356; FINERMOORE JS, 1994, BIOCHEMISTRY-US, V33, P15459, DOI 10.1021/bi00255a028; Girgis S, 1997, J BIOL CHEM, V272, P4729, DOI 10.1074/jbc.272.8.4729; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang T, 1998, BIOCHEMISTRY-US, V37, P13536, DOI 10.1021/bi980827u; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Iurescia S, 1996, PROTEIN EXPRES PURIF, V7, P323, DOI 10.1006/prep.1996.0046; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KAMB A, 1992, BIOCHEMISTRY-US, V31, P9883, DOI 10.1021/bi00156a005; Kazanina G, 1998, J STRUCT BIOL, V123, P169, DOI 10.1006/jsbi.1998.4020; Kim DW, 1996, BIOCHEMISTRY-US, V35, P15772, DOI 10.1021/bi9619684; KLEIN C, 1995, J MOL BIOL, V249, P153, DOI 10.1006/jmbi.1995.0286; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; KNIGHTON DR, 1994, NAT STRUCT BIOL, V1, P186, DOI 10.1038/nsb0394-186; Kohls D, 2000, STRUCT FOLD DES, V8, P35, DOI 10.1016/S0969-2126(00)00078-2; Liang PH, 1998, BIOCHEMISTRY-US, V37, P12195, DOI 10.1021/bi9803168; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MATTHEWS RG, 1982, BIOCHEMISTRY-US, V21, P1230, DOI 10.1021/bi00535a019; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ovadi J, 2000, INT REV CYTOL, V192, P255; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PASCARELLA S, 1993, FEBS LETT, V331, P145, DOI 10.1016/0014-5793(93)80314-K; Pawelek PD, 2000, BBA-PROTEIN STRUCT M, V1479, P59, DOI 10.1016/S0167-4838(00)00058-3; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; POE M, 1980, BIOCHEMISTRY-US, V19, P4576, DOI 10.1021/bi00561a006; POE M, 1978, J BIOL CHEM, V253, P543; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Renwick SB, 1998, STRUCTURE, V6, P1105, DOI 10.1016/S0969-2126(98)00112-9; Sanghani PC, 2000, PROTEIN EXPRES PURIF, V18, P36, DOI 10.1006/prep.1999.1173; Sayre PH, 2001, J MOL BIOL, V313, P813, DOI 10.1006/jmbi.2001.5074; Scarsdale JN, 2000, J MOL BIOL, V296, P155, DOI 10.1006/jmbi.1999.3453; Scarsdale JN, 1999, BIOCHEMISTRY-US, V38, P8347, DOI 10.1021/bi9904151; Schirch L. V., 1984, FOLATES PTERINS CHEM, V1, P399; SCHIRCH V, 1991, J BIOL CHEM, V266, P759; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; Shen BW, 1999, PROTEIN SCI, V8, P1342, DOI 10.1110/ps.8.6.1342; STOVER P, 1992, ANAL BIOCHEM, V202, P82, DOI 10.1016/0003-2697(92)90210-X; STOVER P, 1990, J BIOL CHEM, V265, P14227; STOVER P, 1991, J BIOL CHEM, V266, P1543; STRONG WB, 1989, BIOCHEMISTRY-US, V28, P9430, DOI 10.1021/bi00450a028; STROUD RM, 1994, NAT STRUCT BIOL, V1, P131, DOI 10.1038/nsb0394-131; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; Trivedi V, 2002, J BIOL CHEM, V277, P17161, DOI 10.1074/jbc.M111976200; Trujillo M, 1996, BIOCHEMISTRY-US, V35, P6366, DOI 10.1021/bi952923q; Trujillo M, 1997, PROTEIN ENG, V10, P567, DOI 10.1093/protein/10.5.567; USHA R, 1992, J BIOL CHEM, V267, P9289; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zeng H, 2001, CANCER RES, V61, P7225	59	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2645	2653		10.1074/jbc.M210649200	http://dx.doi.org/10.1074/jbc.M210649200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12438316	hybrid			2022-12-27	WOS:000180562000076
J	Pietsch, EC; Chan, JY; Torti, FM; Torti, SV				Pietsch, EC; Chan, JY; Torti, FM; Torti, SV			Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; YA-SUBUNIT GENE; TRANSCRIPTION FACTOR NRF2; CONTROLLING INDUCIBLE EXPRESSION; SUPEROXIDE-DISMUTASE GENE; PLANAR AROMATIC-COMPOUNDS; HEME OXYGENASE-1 GENE; AH RECEPTOR COMPLEX; OXIDATIVE STRESS; CONSTITUTIVE EXPRESSION	Ferritin is a ubiquitous intracellular iron storage protein that consists of 24 subunits of the H and L type. The ability to sequester iron from participation in oxygen free radical formation is consistent with a cytoprotective role for ferritin. Here we demonstrate that ferritins H and L are induced in cells treated with beta-napthoflavone (beta-NF) and chemopreventive dithiolethiones. Induction of ferritin H by beta-NF and the dithiolethiones oltipraz and 1,2-dithiole-3-thione (D3T) occurs via a transcriptional mechanism that is mediated by the ferritin H electrophile/antioxidant-responsive element (EpRE/ARE). The murine ferritin H gene contains five potential xenobiotic-responsive element (XRE) sequences in its 5'-promoter region. However, deletion analysis demonstrates that these XRE sequences are not functional in inducing ferritin H in response to beta-NF. Electrophoretic mobility shift assays demonstrate that the ferritin H EpRE/ARE binds Nrf2. Transfection of chimeric ferritin H reporter genes with Nrf2 expression vectors and Nrf2 dominant-negative mutants indicate that Nrf2 functions at the EpRE/ARE to mediate transcriptional activation of ferritin H. Induction of ferritin H and L was not seen in Nrf2 knockout cells, demonstrating that this transcription factor is required for the induction of ferritin in response to polycyclic aromatic xenobiotics and chemopreventive agents. Nrf2 may also play a role in basal transcription of both ferritin H and L. These results provide a mechanistic link between regulation of the iron storage protein ferritin and the cancer chemopreventive response.	Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA	Wake Forest University; Wake Forest University; Wake Forest University; University of California System; University of California Irvine	Torti, SV (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042412, R01DK042412] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK17282, DK42412] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; BERGELSON S, 1994, BIOCHEM BIOPH RES CO, V200, P290, DOI 10.1006/bbrc.1994.1447; BERGELSON S, 1994, ONCOGENE, V9, P565; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bosio A, 2002, CARCINOGENESIS, V23, P741, DOI 10.1093/carcin/23.5.741; BOYD D, 1985, J BIOL CHEM, V260, P1755; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Chan JY, 2000, BBA-GENE STRUCT EXPR, V1517, P19, DOI 10.1016/S0167-4781(00)00238-4; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cho HY, 2002, AM J RESP CELL MOL, V26, P42, DOI 10.1165/ajrcmb.26.1.4536; Cho JS, 2001, MOL GENET GENOMICS, V266, P133; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; DENISON MS, 1989, J BIOL CHEM, V264, P16478; DENISON MS, 1988, J BIOL CHEM, V263, P17221; Dhakshinamoorthy S, 2002, ONCOGENE, V21, P5301, DOI 10.1038/sj.onc.1205642; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Emi Y, 1996, J BIOL CHEM, V271, P3952, DOI 10.1074/jbc.271.7.3952; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; FRILING RS, 1992, P NATL ACAD SCI USA, V89, P668, DOI 10.1073/pnas.89.2.668; FUJISAWASEHARA A, 1986, NUCLEIC ACIDS RES, V14, P1465; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kensler TW, 1999, CHEM RES TOXICOL, V12, P113, DOI 10.1021/tx980185b; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; KWAK EL, 1995, J BIOL CHEM, V270, P15285, DOI 10.1074/jbc.270.25.15285; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LEE TC, 1995, ARCH TOXICOL, V69, P498, DOI 10.1007/s002040050204; LI Y, 1992, J BIOL CHEM, V267, P15097; LI Y, 1992, BIOCHEM BIOPH RES CO, V188, P992, DOI 10.1016/0006-291X(92)91329-O; McMahon M, 2001, CANCER RES, V61, P3299; Moinova HR, 1998, J BIOL CHEM, V273, P14683, DOI 10.1074/jbc.273.24.14683; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; Munzel PA, 1998, ARCH BIOCHEM BIOPHYS, V350, P72, DOI 10.1006/abbi.1997.0485; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; OKUDA A, 1989, J BIOL CHEM, V264, P16919; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Orino K, 1999, FEBS LETT, V461, P334, DOI 10.1016/S0014-5793(99)01443-X; PRESTERA T, 1993, P NATL ACAD SCI USA, V90, P2965, DOI 10.1073/pnas.90.7.2965; PRESTERA T, 1995, MOL MED, V1, P827, DOI 10.1007/BF03401897; Primiano T, 1996, CARCINOGENESIS, V17, P2291, DOI 10.1093/carcin/17.11.2291; PROCHASKA HJ, 1988, CANCER RES, V48, P4776; PROCHASKA HJ, 1985, P NATL ACAD SCI USA, V82, P8232, DOI 10.1073/pnas.82.23.8232; QUATTROCHI LC, 1994, J BIOL CHEM, V269, P6949; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; Schiaffonati L, 1997, LIVER, V17, P183; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TORTI SV, 1988, J BIOL CHEM, V263, P12638; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; TSUJI Y, 1995, MOL CELL BIOL, V15, P5152; Tsuji Y, 1998, J BIOL CHEM, V273, P2984, DOI 10.1074/jbc.273.5.2984; Tsuji Y, 1999, J BIOL CHEM, V274, P7501, DOI 10.1074/jbc.274.11.7501; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wattenberg LW, 1997, P SOC EXP BIOL MED, V216, P133; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yoo HY, 1999, BIOCHEM BIOPH RES CO, V256, P133, DOI 10.1006/bbrc.1999.0299; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	80	181	187	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2361	2369		10.1074/jbc.M210664200	http://dx.doi.org/10.1074/jbc.M210664200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435735	hybrid			2022-12-27	WOS:000180562000040
J	An, WJ; Roeder, RG				An, WJ; Roeder, RG			Direct association of p300 with unmodified H3 and H4N termini modulates p300-dependent acetylation and transcription of nucleosomal templates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLATION; LYSINE 9; IN-VITRO; BROMODOMAIN; CHROMATIN; ACETYLTRANSFERASE; RECOGNITION; METHYLATION; PROTEINS; TAILS	The nature of histone acetylation events in active chromatin is an important issue in transcriptional regulation. We have systematically analyzed the ability of p300, either alone or in response to an interacting activator, to acetylate specific recombinant histones in the context of free histones, histone octamers, or nucleosomal arrays. Our results indicate that p300 has an intrinsic ability to acetylate all core histones but that the level and specificity of histone acetylation is indeed context-dependent. Thus, H3 and H4 are preferentially acetylated in free octamers, whereas all histones are nearly equally acetylated, in an activator-dependent manner, in chromatin. Moreover, H3 and H4 show H2A and H2B tail-independent acetylation in chromatin, whereas maximal H2A and 11213 acetylation in this context is dependent upon H3 and H4 tails (but not their acetylation). In further support of an apparent intrinsic preference of p300 for the H3 and 114 tails, as well as an important role for direct interactions of p300 with unacetylated H3 and H4 tails in both acetylation and transcription, we have shown that p300 selectively acetylates isolated 113 and H4 tails, that p300 strongly and selectively binds to free unacetylated H3 and H4 tails, and that p300-mediated acetylation of nucleosomal histones and transcriptional activation are selectively inhibited by isolated (unacetylated) H3 and H4 tails.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.				NCI NIH HHS [CA42567] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042567] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Goodman RH, 2000, GENE DEV, V14, P1553; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hayes JJ, 2001, CURR OPIN GENET DEV, V11, P124, DOI 10.1016/S0959-437X(00)00168-4; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Holde K.E., 1988, CHROMATIN; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	43	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1504	1510		10.1074/jbc.M209355200	http://dx.doi.org/10.1074/jbc.M209355200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421817	hybrid			2022-12-27	WOS:000180462200019
J	Birrane, G; Chung, J; Ladias, JAA				Birrane, G; Chung, J; Ladias, JAA			Novel mode of ligand recognition by the Erbin PDZ domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB2/HER2 RECEPTOR; PROTEIN; INTERACTS; REFINEMENT	Erbin contains a class I PDZ domain that binds to the C-terminal region of the receptor tyrosine kinase ErbB2, a class II ligand. The crystal structure of the human Erbin PDZ bound to the peptide EYLGLDVPV corresponding to the C-terminal residues 1247-1255 of human ErbB2 has been determined at 1.25-Angstrom resolution. The Erbin PDZ deviates from the canonical PDZ fold in that it contains a single alpha-helix. The isopropyl group of valine at position -2 of the ErbB2 peptide interacts with the Erbin Val(1351) and displaces the peptide backbone away from the alpha-helix, elucidating the molecular basis of class II ligand recognition by a class I PDZ domain. Strikingly, the phenolic ring of tyrosine -7 enters into a pocket formed by the extended beta2-beta3 loop of the Erbin PDZ. Phosphorylation of tyrosine -7 abolishes this interaction but does not affect the binding of the four C-terminal peptidic residues to PDZ, as revealed by the crystal structure of the Erbin PDZ complexed with a phosphotyrosine-containing ErbB2 peptide. Since phosphorylation of tyrosine -7 plays a critical role in ErbB2 function, the selective binding and sequestration of this residue in its unphosphorylated state by the Erbin PDZ provides a novel mechanism for regulation of the ErbB2-mediated signaling and oncogenicity.	Harvard Univ, Sch Med, Inst Med, Mol Med Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Med, Macromol Crystallog Unit,Div Expt Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ladias, JAA (corresponding author), Harvard Univ, Sch Med, Inst Med, Mol Med Lab, Rm 354,4 Blackfan Circle, Boston, MA 02115 USA.			Birrane, Gabriel/0000-0002-1759-5499				BENLEVY R, 1994, EMBO J, V13, P3302, DOI 10.1002/j.1460-2075.1994.tb06632.x; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bryant PJ, 2000, NAT CELL BIOL, V2, pE141, DOI 10.1038/35019616; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dillon C, 2002, MOL CELL BIOL, V22, P6553, DOI 10.1128/MCB.22.18.6553-6563.2002; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Erdmann KS, 2000, ONCOGENE, V19, P3894, DOI 10.1038/sj.onc.1203725; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Harris BZ, 2001, J CELL SCI, V114, P3219; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; Jaulin-Bastard F, 2001, J BIOL CHEM, V276, P15256, DOI 10.1074/jbc.M010032200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Piserchio A, 2002, J BIOL CHEM, V277, P6967, DOI 10.1074/jbc.M109453200; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walma T, 2002, J MOL BIOL, V316, P1101, DOI 10.1006/jmbi.2002.5402	32	86	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1399	1402		10.1074/jbc.C200571200	http://dx.doi.org/10.1074/jbc.C200571200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12444095	hybrid			2022-12-27	WOS:000180462200004
J	Burke, JR; Pattoli, MA; Gregor, KR; Brassil, PJ; MacMaster, JF; McIntyre, KW; Yang, XX; Iotzova, VS; Clarke, W; Strnad, J; Qiu, YP; Zusi, FC				Burke, JR; Pattoli, MA; Gregor, KR; Brassil, PJ; MacMaster, JF; McIntyre, KW; Yang, XX; Iotzova, VS; Clarke, W; Strnad, J; Qiu, YP; Zusi, FC			BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-ALPHA; ACTIVATION; BETA; PHOSPHORYLATION; COMPLEX; UBIQUITINATION; PROTEOLYSIS; SUBUNITS; EPSILON	The signal-inducible phosphorylation of serines 32 and 36 of IkappaBalpha is critical in regulating the subsequent ubiquitination and proteolysis of IkappaBalpha, which then releases NF-kappaB to promote gene transcription. The multi-subunit licB kinase responsible for this phosphorylation contains two catalytic subunits, termed licB kinase (IKK)-1 and IKK-2. BMS-345541 (4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline) was identified as a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50 = 0.3 muM, IKK-1 IC50 = 4 muM). The compound failed to inhibit a panel of 15 other kinases and selectively inhibited the stimulated phosphorylation Of IkappaBalpha in cells (IC50 = 4 muM) while failing to affect c-Jun and STAT3 phosphorylation, as well as mitogen-activated protein kinase-activated protein kinase 2 activation in cells. Consistent with the role of IKK/NF-kappaB in the regulation of cytokine transcription, BMS-345541 inhibited lipopolysaccharide-stimulated tumor necrosis factor a, interleukin-1beta, interleukin-8, and interleukin-6 in THP-1 cells with IC50 values in the 1- to 5-muM range. Although a Dixon plot of the inhibition of IKK-2 by BMS-345541 showed a non-linear relationship indicating non-Michaelis-Menten kinetic binding, the use of multiple inhibition analyses indicated that BMS-345541 binds in a mutually exclusive manner with respect to a peptide inhibitor corresponding to amino acids 26-42 of IkappaBalpha with Ser-32 and Ser-36 changed to aspartates and in a non-mutually exclusive manner with respect to ADP. The opposite results were obtained when studying the binding to IKK-1. A binding model is proposed in which BMS-345541 binds to similar allosteric sites on IKK-1 and IKK-2, which then affects the active sites of the subunits differently. BMS-345541 was also shown to have excellent pharmacokinetics in mice, and peroral administration showed the compound to dose-dependently inhibit the production of serum tumor necrosis factor a following intraperitoneal challenge with lipopolysaccharide. Thus, the compound is effective against NF-kappaB activation in mice and represents an important tool for investigating the role of IKK in disease models.	Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Immunol Inflammat & Pulm Drug Discovery, Princeton, NJ 08543 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Preclin Candidate Optimizat, Wallingford, CT 06492 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Discovery Chem, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Burke, JR (corresponding author), Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Immunol Inflammat & Pulm Drug Discovery, POB 4000, Princeton, NJ 08543 USA.							Baldi L, 1996, J BIOL CHEM, V271, P376, DOI 10.1074/jbc.271.1.376; Bauerle PA, 1996, CELL, V87, P13; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Burke JR, 1998, J BIOL CHEM, V273, P12041, DOI 10.1074/jbc.273.20.12041; Burke JR, 2002, BIOCHEM BIOPH RES CO, V293, P1508, DOI 10.1016/S0006-291X(02)00417-5; Burke JR, 1999, J BIOL CHEM, V274, P36146, DOI 10.1074/jbc.274.51.36146; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; Ghezzi P, 2000, CYTOKINE, V12, P1205, DOI 10.1006/cyto.2000.0697; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huynh QK, 2000, J BIOL CHEM, V275, P25883, DOI 10.1074/jbc.M000296200; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li J, 1998, J BIOL CHEM, V273, P30736, DOI 10.1074/jbc.273.46.30736; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; SEGEL IH, 1975, ENZYME KINETICS, P474; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; TREIBER HJ, 1994, Patent No. 4329970; Weil R, 1997, J BIOL CHEM, V272, P9942; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	28	432	459	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1450	1456		10.1074/jbc.M209677200	http://dx.doi.org/10.1074/jbc.M209677200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12403772	hybrid			2022-12-27	WOS:000180462200012
J	Luchetti, MM; Paroncini, P; Majlingova, P; Frampton, J; Mucenski, M; Baroni, SS; Sambo, P; Golay, J; Introna, M; Gabrielli, A				Luchetti, MM; Paroncini, P; Majlingova, P; Frampton, J; Mucenski, M; Baroni, SS; Sambo, P; Golay, J; Introna, M; Gabrielli, A			Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; B-MYB; TRANSCRIPTIONAL ACTIVATION; EXTRACELLULAR-MATRIX; HEMATOPOIETIC-CELLS; FUNCTIONAL-ANALYSIS; DERMAL FIBROBLASTS; PROCOLLAGEN GENE; EXPRESSION; GROWTH	We have characterized the role of c-Myb and B-Myb in the regulation of human type I collagen alpha2 chain gene expression in fibroblastic cells. We have identified four Myb-binding sites (MBSs) in the promoter. Transactivation assays on wild type and mutant promoter-reporter constructs demonstrated that c-Myb, but not B-Myb, can transactivate the human type I collagen alpha2 chain gene promoter via the MBS-containing region. Electrophoretic mobility shift assay experiments showed that c-Myb specifically binds to each of the four MBS; however, the mutagenesis of site MBS-4 completely inhibited transactivation by c-Myb, at least in the full-length promoter. In agreement with these results, c-myb(-/-)mouse embryo fibroblasts (MEFs) showed a selective lack of expression of type I collagen alpha2 chain gene but maintained the expression of fibronectin and type III collagen. Furthermore, transforming growth factor-beta induced type I collagen alpha2 chain gene expression in c-myb(-/-) MEFs, implying that the transforming growth factor-beta signaling pathway is maintained and that the absence of COL1A2 gene expression in c-myb(-/-) MEFs is a direct consequence of the lack of c-Myb. The demonstration of the importance of c-Myb in the regulation of the type I collagen alpha2 chain gene suggests that uncontrolled expression of c-Myb could be an underlying mechanism in the pathogenesis of several fibrotic disorders.	Univ Ancona, Mol Med Lab, Ist Clin Med Ematol & Immunol Clin, I-60020 Ancona, Italy; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England; Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Ist Ric Farmacol Mario Negri, Dipartimento Immunol & Biol Cellulare, I-20154 Milan, Italy	Marche Polytechnic University; University of Birmingham; Cincinnati Children's Hospital Medical Center; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Luchetti, MM (corresponding author), Univ Ancona, Inst Internal Med Haematol & Clin Immunol, Via Tronto 10-A, I-60020 Ancona, Italy.	mickey@deanovell.unian.it	Golay, Josee/AAA-4085-2022; Svegliati, Silvia/L-2614-2016; Introna, Martino/AAA-5823-2019; Luchetti, Michele Maria/J-6955-2019	Golay, Josee/0000-0002-7932-909X; Svegliati, Silvia/0000-0001-6863-2600; Introna, Martino/0000-0001-6216-0892; Luchetti, Michele Maria/0000-0001-9132-7401	Telethon [E.0822] Funding Source: Medline	Telethon(Fondazione Telethon)		Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; Bein K, 1997, J CELL PHYSIOL, V173, P319, DOI 10.1002/(SICI)1097-4652(199712)173:3<319::AID-JCP3>3.0.CO;2-Q; Birko Z, 2001, FEMS MICROBIOL LETT, V196, P223, DOI 10.1111/j.1574-6968.2001.tb10568.x; BOISE LH, 1992, CELL GROWTH DIFFER, V3, P53; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; BOSSELUT R, 1992, VIROLOGY, V186, P764, DOI 10.1016/0042-6822(92)90044-P; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Dabrowski S, 2000, PROTEIN EXPRES PURIF, V19, P107, DOI 10.1006/prep.2000.1231; Deng QL, 1996, NUCLEIC ACIDS RES, V24, P766, DOI 10.1093/nar/24.4.766; DEWET W, 1987, J BIOL CHEM, V262, P16032; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; FOOS G, 1992, EMBO J, V11, P4619, DOI 10.1002/j.1460-2075.1992.tb05564.x; FRAMPTON J, 1991, PROTEIN ENG, V4, P891, DOI 10.1093/protein/4.8.891; Ghayor C, 2000, J BIOL CHEM, V275, P27421; GOLAY J, 1991, BLOOD, V77, P149; GRASSER FA, 1992, ONCOGENE, V7, P1005; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; GUEHMANN S, 1992, NUCLEIC ACIDS RES, V20, P2279, DOI 10.1093/nar/20.9.2279; Hasegawa T, 1996, NUCLEIC ACIDS RES, V24, P3253, DOI 10.1093/nar/24.16.3253; Hitraya EG, 1996, ARTHRITIS RHEUM-US, V39, P1347, DOI 10.1002/art.1780390812; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; Hu QH, 2000, J BIOL CHEM, V275, P4435, DOI 10.1074/jbc.275.6.4435; IHN H, 1996, J BIOL CHEM, V15, P359; INTRONA M, 1994, SEMIN CANCER BIOL, V5, P113; JIMENEZ SA, 1994, J BIOL CHEM, V269, P12684; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; KIKUCHI K, 1992, BIOCHEM BIOPH RES CO, V187, P45, DOI 10.1016/S0006-291X(05)81456-1; Kouba DJ, 1999, J IMMUNOL, V162, P4226; KU DH, 1993, J BIOL CHEM, V268, P2255; Kypreos KE, 1998, CELL GROWTH DIFFER, V9, P723; LIPSICK JS, 1993, P NATL ACAD SCI USA, V90, P9320; Littlejohn TK, 2000, PROTEIN EXPRES PURIF, V19, P22, DOI 10.1006/prep.2000.1214; Marhamati DJ, 1996, J BIOL CHEM, V271, P3359; MIZUGUCHI G, 1990, J BIOL CHEM, V265, P9280; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Neidhardt Edie A., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P183; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pawelczyk T, 2000, PROTEIN EXPRES PURIF, V18, P320, DOI 10.1006/prep.1999.1199; Peterkofsky B, 1999, J CELL BIOCHEM, V73, P408, DOI 10.1002/(SICI)1097-4644(19990601)73:3<408::AID-JCB12>3.3.CO;2-4; Piccinini G, 1996, J INVEST DERMATOL, V106, P1281, DOI 10.1111/1523-1747.ep12348998; Piccinini G, 1999, J INVEST DERMATOL, V112, P191, DOI 10.1046/j.1523-1747.1999.00485.x; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RAMSAY RG, 1992, J BIOL CHEM, V267, P5656; REISS K, 1991, CANCER RES, V51, P5997; REISS K, 1991, J CELL PHYSIOL, V148, P338, DOI 10.1002/jcp.1041480303; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; Ruiz IG, 2000, DNA CELL BIOL, V19, P167, DOI 10.1089/104454900314555; Sheibani N, 1999, PREP BIOCHEM BIOTECH, V29, P77, DOI 10.1080/10826069908544695; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; Sun W, 2001, MATRIX BIOL, V20, P527, DOI 10.1016/S0945-053X(01)00163-9; TAMAKI T, 1995, J BIOL CHEM, V270, P4299, DOI 10.1074/jbc.270.9.4299; TRAVALI S, 1991, ONCOGENE, V6, P887; Trojanowska M, 2000, ONCOGENE, V19, P6464, DOI 10.1038/sj.onc.1204043; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; Widom RL, 1997, GENE, V198, P407, DOI 10.1016/S0378-1119(97)00360-0; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; ZOBEL A, 1992, BIOCHEM BIOPH RES CO, V186, P715, DOI 10.1016/0006-291X(92)90805-U; Zorbas M, 1999, ONCOGENE, V18, P5821, DOI 10.1038/sj.onc.1202971	64	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1533	1541		10.1074/jbc.M204392200	http://dx.doi.org/10.1074/jbc.M204392200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424255	hybrid			2022-12-27	WOS:000180462200023
J	Friday, RP; Pietropaolo, SL; Profozich, J; Trucco, M; Pietropaolo, M				Friday, RP; Pietropaolo, SL; Profozich, J; Trucco, M; Pietropaolo, M			Alternative core promoters regulate tissue-specific transcription from the autoimmune diabetes-related ICA1 (ICA69) gene locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-CELL ANTIGEN; DNA METHYLATION; T-CELL; HUMAN THYMUS; REPRESSES TRANSCRIPTION; EXPRESSION; CREB; ACTIVATION; AUTOANTIGEN; TOLERANCE	Islet cell autoantigen 69-kDa (ICA69), protein product of the human ICA1 gene, is one target of the immune processes defining the pathogenesis of Type 1 diabetes. We have characterized the genomic structure and functional promoters within the 5'-regulatory region of ICA1 5'-RNA ligase-mediated rapid amplification of cDNA ends evaluation of ICA1 transcripts expressed in human islets, testis, heart, and cultured neuroblastoma cells reveals that three 5'-untranslated region exons are variably expressed from the ICA1 gene in a tissue-specific manner. Surrounding the transcription initiation sites are motifs characteristic of non-TATA, non-CAAT, GC-rich promoters, including consensus Sp1/GC boxes, an initiator element, cAMP-responsive element-binding protein (CREB) sites, and clusters of other putative transcription factor sites within a genomic CpG island. Luciferase reporter constructs demonstrate that the first two ICA1 exon promoters reciprocally stimulate luciferase expression within islet- (RIN 1046-38 cells) and brain-derived (NMB7) cells in culture; the exon A promoter exhibits greater activity in islet cells, whereas the exon B promoter more efficiently activates transcription in neuronal cells. Mutation of a CREB site within the ICA1 exon B promoter significantly enhances transcriptional activity in both cell lines. Our basic understanding of expression from the functional core promoter elements of ICA1 is an important advance that will not only add to our knowledge of the ICA69 autoantigen but will also facilitate a rational approach to discover the function of ICA69 and to identify relevant ICA1 promoter polymorphisms and their potential associations with disease.	Univ Pittsburgh, Sch Med, Childrens Hosp, Div Immunogenet,Diabet Inst,Rangos Res Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pietropaolo, M (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp, Div Immunogenet,Diabet Inst,Rangos Res Ctr, 3460 5th Ave, Pittsburgh, PA 15213 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053456, R01DK056200] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK56200, R01 DK53456] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beohar N, 1998, J BIOL CHEM, V273, P9168, DOI 10.1074/jbc.273.15.9168; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Cao YX, 2000, BIOCHEM J, V350, P883, DOI 10.1042/0264-6021:3500883; Carey M, 2000, TRANSCRIPTIONAL REGU; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; CHAPLIN DD, 1992, CURRENT PROTOCOLS MO; Choi RCY, 2001, MOL CELL NEUROSCI, V17, P732, DOI 10.1006/mcne.2001.0968; Cibelli G, 1996, EUR J BIOCHEM, V236, P171, DOI 10.1111/j.1432-1033.1996.00171.x; Comeron JM, 2000, GENETICS, V156, P1175; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DellaFazia MA, 1997, FEBS LETT, V410, P22, DOI 10.1016/S0014-5793(97)00445-6; DeLuca P, 1996, J BIOL CHEM, V271, P8533, DOI 10.1074/jbc.271.15.8533; DIBB NJ, 1993, FEBS LETT, V325, P135, DOI 10.1016/0014-5793(93)81429-4; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Duret L, 2001, TRENDS GENET, V17, P172, DOI 10.1016/S0168-9525(01)02236-3; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; GAEDIGK R, 1994, CYTOGENET CELL GENET, V66, P274, DOI 10.1159/000133711; Gaedigk R, 1996, GENOMICS, V38, P382, DOI 10.1006/geno.1996.0641; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GERMAN M, 2000, DIABETES MELLITUS FU, P11; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hurst LD, 1999, TRENDS GENET, V15, P437, DOI 10.1016/S0168-9525(99)01832-6; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Karges W, 1997, DIABETES, V46, P1548, DOI 10.2337/diabetes.46.10.1548; Karges W, 1997, BBA-MOL BASIS DIS, V1360, P97, DOI 10.1016/S0925-4439(97)00002-1; Karges W, 1996, DIABETES, V45, P513, DOI 10.2337/diabetes.45.4.513; KENNEDY GC, 1995, NAT GENET, V9, P292; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAMPASONA V, 1994, J AUTOIMMUN, V7, P665, DOI 10.1006/jaut.1994.1051; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Lubbert M, 1999, LEUKEMIA, V13, P1420, DOI 10.1038/sj.leu.2401486; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; MARTIN S, 1995, DIABETOLOGIA, V38, P351, DOI 10.1007/s001250050292; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MIYAZAKI I, 1994, BBA-MOL BASIS DIS, V1227, P101, DOI 10.1016/0925-4439(94)90113-9; MIYAZAKI I, 1995, J IMMUNOL, V154, P1461; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Paulsen M, 2001, J PATHOL, V195, P97, DOI 10.1002/path.890; Persengiev SP, 1996, NEUROREPORT, V8, P227, DOI 10.1097/00001756-199612200-00046; Pfeifer K, 2000, AM J HUM GENET, V67, P777, DOI 10.1086/303101; PIETROPAOLO M, 1993, J CLIN INVEST, V92, P359, DOI 10.1172/JCI116574; Pietropaolo M, 2002, NAT IMMUNOL, V3, P335, DOI 10.1038/ni0402-335a; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Roep BO, 1996, EUR J IMMUNOL, V26, P1285, DOI 10.1002/eji.1830260616; Roep BO, 1996, DIABETES, V45, P1147, DOI 10.2337/diabetes.45.9.1147; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schwab J, 2001, INT IMMUNOL, V13, P705, DOI 10.1093/intimm/13.5.705; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; SOLIMENA M, 2002, DIABETES METAB RE S4, V18, P32; Sospedra M, 1998, J IMMUNOL, V161, P5918; Stassi G, 1997, DIABETOLOGIA, V40, P120; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Werdelin O, 1998, SCAND J IMMUNOL, V47, P95; Winer S, 2000, J IMMUNOL, V165, P4086, DOI 10.4049/jimmunol.165.7.4086; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	67	14	14	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					853	863		10.1074/jbc.M210175200	http://dx.doi.org/10.1074/jbc.M210175200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409289	hybrid			2022-12-27	WOS:000180321900023
J	Ramirez, R; Carracedo, J; Jimenez, R; Canela, A; Herrera, E; Aljama, P; Blasco, MA				Ramirez, R; Carracedo, J; Jimenez, R; Canela, A; Herrera, E; Aljama, P; Blasco, MA			Massive telomere loss is an early event of DNA damage-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TELOMERES; CELLS; DYSFUNCTION; INHIBITION; INVOLVEMENT; RADIATION; FUSIONS; RESCUES; LENGTH; MICE	Chromosomal stability and cell viability require a proficient telomeric end-capping function. In particular, telomere dysfunction because of either critical telomere shortening or because of mutation of telomere-binding proteins results in increased apoptosis and/or cell arrest. Here, we show that, in turn, DNA damage-induced apoptosis results in a dramatic telomere loss. In particular, using flow cytometry for simultaneous detection of telomere length and apoptosis, we show that cells undergoing apoptosis upon DNA damage also exhibit a rapid and dramatic loss of telomeric sequences. This telomere loss occurs at early stages of apoptosis, because it does not require caspase-3 activation, and it is induced by loss of the mitochondrial membrane potential (Deltapsi(m)) and production of reactive oxygen species. These observations suggest a direct effect of mitochondrial dysfunction on telomeres.	Hosp Univ Reina Sofia, Unidad Invest, Cordoba 14004, Spain; Natl Ctr Biotechnol, Dept Immunol & Oncol, Madrid 28049, Spain	Hospital Universitario Reina Sofia - Cordoba	Ramirez, R (corresponding author), Hosp Univ Reina Sofia, Unidad Invest, Avda Menendez Pidal S-N, Cordoba 14004, Spain.	rramirez@hrs.sas.junta-andalucia.es	Carracedo, Julia/L-2012-2015; Ramirez, Rafael/B-3249-2019; Carracedo, Julia/ABG-2464-2020; Herrera, Eloísa/A-5377-2008; Blasco, Maria A./M-1694-2014	Carracedo, Julia/0000-0002-8422-812X; Carracedo, Julia/0000-0002-8422-812X; Herrera, Eloísa/0000-0001-9525-5441; Blasco, Maria A./0000-0002-4211-233X; Rafael, Ramirez/0000-0003-4598-339X				Andoh T, 2000, CELL BIOCHEM BIOPHYS, V33, P181, DOI 10.1385/CBB:33:2:181; Barkle A., 2000, DNA DAMAGE STRESS SI, P80; BLACKBURN EH, 1990, J BIOL CHEM, V265, P5919; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; de Lange T, 2001, SCIENCE, V292, P1075; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Henderson LO, 1998, CYTOMETRY, V33, P97, DOI 10.1002/(SICI)1097-0320(19981001)33:2<97::AID-CYTO3>3.0.CO;2-H; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.0.CO;2-9; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Lee KH, 2001, P NATL ACAD SCI USA, V98, P3381, DOI 10.1073/pnas.051629198; Mattson MP, 2001, MECH AGEING DEV, V122, P659, DOI 10.1016/S0047-6374(01)00221-4; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Muller H.J., 1938, COLLECTING NET, V13, P181; Ren JG, 2001, FEBS LETT, V488, P123, DOI 10.1016/S0014-5793(00)02377-2; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shimizu T, 1997, LEUKEMIA, V11, P1238, DOI 10.1038/sj.leu.2400734; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wang B, 2001, J RADIAT RES, V42, P1, DOI 10.1269/jrr.42.1; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	32	85	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					836	842		10.1074/jbc.M206818200	http://dx.doi.org/10.1074/jbc.M206818200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409303				2022-12-27	WOS:000180321900021
J	Hiriart, E; Farjot, G; Gruffat, H; Nguyen, MVC; Sergean, A; Manet, E				Hiriart, E; Farjot, G; Gruffat, H; Nguyen, MVC; Sergean, A; Manet, E			A novel nuclear export signal and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; EXON-EXON JUNCTIONS; SM PROTEIN; HUMAN HOMOLOG; TYPE-1; ICP27; TRANSCRIPTION; TRANSPORT; PATHWAY; MOTIF	A striking characteristic of mRNA export factors is that they shuttle continuously between the cytoplasm and the nucleus. This shuttling is mediated by specific factors interacting with peptide motifs called nuclear export signals (NES) and nuclear localization signals. We have identified a novel CRM-1-independent transferable NES and two nuclear localization signals in the Epstein-Barr virus mRNA export factor EB2 (also called BMLF1, Mta, or SM) localized at the N terminus of the protein between amino acids 61 and 146. We have also found that a previously described double NES (amino acids 213-236) does not mediate the nuclear shuttling of EB2, but is an interaction domain with the cellular export factor REF in vitro. This newly characterized REF interaction domain is essential for EB2-mediated mRNA export. Accordingly, in vivo, EB2 is found in complexes containing REF as well as the cellular factor TAP. However, these interactions are RNase-sensitive, suggesting that the RNA is an essential component of these complexes.	Ecole Normale Super Lyon, INSERM, U412, Unite Virol Humaine, F-69364 Lyon 07, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Manet, E (corresponding author), Ecole Normale Super Lyon, INSERM, U412, Unite Virol Humaine, 46 Allee Italie, F-69364 Lyon 07, France.		Gruffat, Henri/I-2407-2016; MANET, Evelyne/G-5644-2019	Gruffat, Henri/0000-0002-4735-6894; MANET, Evelyne/0000-0001-7619-9982				Boyle SM, 1999, J VIROL, V73, P6872, DOI 10.1128/JVI.73.8.6872-6881.1999; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Buisson M, 1999, J VIROL, V73, P4090, DOI 10.1128/JVI.73.5.4090-4100.1999; BUISSON M, 1989, J VIROL, V63, P5276, DOI 10.1128/JVI.63.12.5276-5284.1989; Chen L, 2001, VIROLOGY, V288, P119, DOI 10.1006/viro.2001.1057; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; COOK ID, 1994, VIROLOGY, V205, P217, DOI 10.1006/viro.1994.1637; CORBO L, 1994, ONCOGENE, V9, P3299; Farjot G, 2000, J VIROL, V74, P6068, DOI 10.1128/JVI.74.13.6068-6076.2000; Farjot G, 1999, J BIOL CHEM, V274, P17309, DOI 10.1074/jbc.274.24.17309; FIXMAN ED, 1992, J VIROL, V66, P5030, DOI 10.1128/JVI.66.8.5030-5039.1992; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruffat H, 2002, J VIROL, V76, P9635, DOI 10.1128/JVI.76.19.9635-9644.2002; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; HOPE TJ, 1991, J VIROL, V65, P6001, DOI 10.1128/JVI.65.11.6001-6007.1991; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Key SCS, 1998, J VIROL, V72, P8485, DOI 10.1128/JVI.72.11.8485-8492.1998; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Koffa MD, 2001, EMBO J, V20, P5769, DOI 10.1093/emboj/20.20.5769; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Moore MJ, 2001, SCIENCE, V294, P1841, DOI 10.1126/science.1067676; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Ruvolo V, 2001, J VIROL, V75, P6033, DOI 10.1128/JVI.75.13.6033-6041.2001; Sandri-Goldin RM, 1998, GENE DEV, V12, P868, DOI 10.1101/gad.12.6.868; Semmes OJ, 1998, J VIROL, V72, P9526, DOI 10.1128/JVI.72.12.9526-9534.1998; Soliman TM, 2000, J VIROL, V74, P7600, DOI 10.1128/JVI.74.16.7600-7609.2000; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3; Zolotukhin AS, 2002, J BIOL CHEM, V277, P3935, DOI 10.1074/jbc.M107598200	39	74	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					335	342		10.1074/jbc.M208656200	http://dx.doi.org/10.1074/jbc.M208656200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403791	Green Published, hybrid			2022-12-27	WOS:000180255700045
J	Lova, P; Paganini, S; Hirsch, E; Barberis, L; Wymann, M; Sinigaglia, F; Balduini, C; Torti, M				Lova, P; Paganini, S; Hirsch, E; Barberis, L; Wymann, M; Sinigaglia, F; Balduini, C; Torti, M			A selective role for phosphatidylinositol 3,4,5-trisphosphate in the G(i)-dependent activation of platelet Rap1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; THROMBIN-RECEPTOR; LIPID PRODUCTS; AGGREGATION; PROTEIN; INTEGRIN; GAMMA; BETA; CYTOSKELETON; SUBUNITS	The small GTP-binding protein Rap1B is activated in human platelets upon stimulation of a G(i)-dependent signaling pathway. In this work, we found that inhibition of platelet adenylyl cyclase by dideoxyadenosine or SQ22536 did not cause activation of Rap1B and did not restore Rap1B activation in platelets stimulated by cross-linking of Fcgamma receptor IIA (FcgammaRIIA) in the presence of ADP scavengers. Moreover, elevation of the intracellular cAMP concentration did not impair the G(i)-dependent activation of Rap1B. Two unrelated inhibitors of phosphatidylinositol 3-kinase (PI3K), wortmannin and LY294002, totally prevented Rap1B activation in platelets stimulated by cross-linking of FcgammaRIIA by stimulation of the P2Y(12) receptor for ADP, or by epinephrine. However, in platelets from PI3Kgamma-deficient mice, both ADP and epinephrine were still able to normally stimulate Rap1B activation through a PI3K-dependent mechanism, suggesting the involvement of a different isoform of the enzyme. Moreover, the lack of PI3Kgamma did not prevent the ability of epinephrine to potentiate platelet aggregation through a G(i)-dependent pathway. The inhibitory effect of wortmannin on Rap1B activation was overcome by addition of phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3), but not PtdIns(3,4)P-2, although both lipids were found to support phosphorylation of Akt. Moreover, PtdIns (3,4,5)P3 was able to relieve the inhibitory effect of apyrase on Fc-gammaRIIA-mediated platelet aggregation. We conclude that stimulation of a Gi-dependent signaling pathway causes activation of the small GTPase Rap1B through the action of the PI3K product PtdIns(3,4,5)P-3, but not PtdIns(3,4)P-2, and that this process may contribute to potentiation of platelet aggregation.	Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; Univ A Avogadro, Dept Med Sci, I-28100 Novara, Italy; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; Univ Fribourg, Inst Biochem, Dept Med, CH-1700 Fribourg, Switzerland	University of Pavia; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Fribourg	Torti, M (corresponding author), Univ Pavia, Dept Biochem, Via Bassi 21, I-27100 Pavia, Italy.		Wymann, Matthias P/C-3227-2008; Hirsch, Emilio/F-4848-2013	Wymann, Matthias P/0000-0003-3349-4281; Hirsch, Emilio/0000-0002-9073-6024				Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bodin S, 2001, BIOCHEMISTRY-US, V40, P15290, DOI 10.1021/bi0109313; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; FISCHER TH, 1990, J BIOL CHEM, V265, P19405; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gratacap MP, 2000, BLOOD, V96, P3439, DOI 10.1182/blood.V96.10.3439.h8003439_3439_3446; Heraud JM, 1998, J BIOL CHEM, V273, P17817, DOI 10.1074/jbc.273.28.17817; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; KOVACSOVICS TJ, 1995, J BIOL CHEM, V270, P11358, DOI 10.1074/jbc.270.19.11358; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; LAPETINA EG, 1989, P NATL ACAD SCI USA, V86, P3131, DOI 10.1073/pnas.86.9.3131; LAU LF, 1994, BIOCHEM J, V303, P391, DOI 10.1042/bj3030391; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Lu PJ, 1998, BIOCHEMISTRY-US, V37, P9776, DOI 10.1021/bi980163o; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; SORISKY A, 1992, BIOCHEM J, V286, P581, DOI 10.1042/bj2860581; SULTAN C, 1991, J BIOL CHEM, V266, P23554; TORTI M, 1992, P NATL ACAD SCI USA, V89, P7796, DOI 10.1073/pnas.89.16.7796; TORTI M, 1994, THROMB HAEMOSTASIS, V71, P533; TORTI M, 1993, P NATL ACAD SCI USA, V90, P7553, DOI 10.1073/pnas.90.16.7553; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; WINEGAR DA, 1991, J BIOL CHEM, V266, P4375; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Yart A, 2002, J BIOL CHEM, V277, P21167, DOI 10.1074/jbc.M110411200; Zhang J, 1996, J BIOL CHEM, V271, P6265, DOI 10.1074/jbc.271.11.6265	33	78	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					131	138		10.1074/jbc.M204821200	http://dx.doi.org/10.1074/jbc.M204821200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407113	hybrid			2022-12-27	WOS:000180255700018
J	Zheng, ZL; Wang, ZM; Delbono, O				Zheng, ZL; Wang, ZM; Delbono, O			Insulin-like growth factor-1 increases skeletal muscle dihydropyridine receptor alpha(1s) transcriptional activity by acting on the cAMP-response element-binding protein element of the promoter region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; CHARGE MOVEMENT; CALCIUM-CHANNEL; CA2+ CHANNEL; GENE-EXPRESSION; RAT; FIBERS; CELLS; ALPHA-1; DIFFERENTIATION	Previous work from our laboratory has shown that insulin-like growth factor 1 (IGF-1) increases the expression of the skeletal muscle dihydropyridine receptor (DHPR) a, subunit by regulating DHPR alpha(1S) nuclear transcription. In this study, we investigated the mechanism by which IGF-1 enhances expression of the DHPR alpha(1S) gene. To this end, the promoter region of the mouse DHPR alpha(1S) gene was recently cloned and sequenced and various promoter deletion-luciferase reporter constructs were used. These constructs were transfected into C2C12 cells and IGF-1 effects were measured by recording luciferase activity. IGF-1 significantly enhanced DHPR a,, transcription in those constructs carrying cAMP-response element-binding protein (CREB) binding site but not in CREB core binding site mutants. Gel mobility shift assay using a double stranded oligonucleotide for the CREB site in the promoter region, and competition experiments with excess unlabeled or mutated promoter oligonucleotide, and unlabeled consensus CREB oligonucleotide demonstrated that IGF-1 induces CREB binding to the DHPR alpha(1S) promoter. IGF-1-mediated enhancement in charge movement was prevented by incubating the cells with antisense but not with sense oligonucleotides against CREB. These results support the conclusion that IGF-1 regulates DHPR alpha(1S) transcription in muscle cells by acting on the CREB element of the promoter.	Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Program Neurosci, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Delbono, O (corresponding author), Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	odelbono@wfubmc.edu			NIA NIH HHS [AG18775, AG13934, AG15820] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015820, R29AG013934, R01AG013934] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Blum G, 2000, BIOCHEMISTRY-US, V39, P15705, DOI 10.1021/bi001516y; CHAUDHARI N, 1993, DEV BIOL, V155, P507, DOI 10.1006/dbio.1993.1048; Cheng ZQ, 2000, J ENDOCRINOL, V167, P175, DOI 10.1677/joe.0.1670175; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; Delbono O, 1997, J NEUROSCI, V17, P6918; DELBONO O, 1992, J PHYSIOL-LONDON, V451, P187, DOI 10.1113/jphysiol.1992.sp019160; DELBONO O, 1993, J PHYSIOL-LONDON, V460, P173, DOI 10.1113/jphysiol.1993.sp019465; DULHUNTY AF, 1983, J PHYSIOL-LONDON, V341, P213, DOI 10.1113/jphysiol.1983.sp014802; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FLEIG A, 1995, J PHYSIOL-LONDON, V489, P41, DOI 10.1113/jphysiol.1995.sp021028; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLINGWORTH S, 1981, J PHYSIOL-LONDON, V321, P583, DOI 10.1113/jphysiol.1981.sp014004; Imagawa S, 1997, BLOOD, V89, P1430, DOI 10.1182/blood.V89.4.1430; Kim JG, 2001, ARCH ORAL BIOL, V46, P495, DOI 10.1016/S0003-9969(01)00013-9; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; MORTON ME, 1989, NEURON, V2, P1499, DOI 10.1016/0896-6273(89)90196-7; Pereon Y, 1997, BIOCHEM BIOPH RES CO, V240, P612, DOI 10.1006/bbrc.1997.7712; Renganathan M, 1997, J MEMBRANE BIOL, V157, P247, DOI 10.1007/s002329900233; Renganathan M, 1998, J BIOL CHEM, V273, P28845, DOI 10.1074/jbc.273.44.28845; Renganathan M, 1997, FEBS LETT, V417, P13, DOI 10.1016/S0014-5793(97)01225-8; Renganathan M, 1999, PFLUG ARCH EUR J PHY, V438, P649, DOI 10.1007/s004240051089; Renganathan M, 1997, BIOCHEM BIOPH RES CO, V235, P784, DOI 10.1006/bbrc.1997.6881; RIOS E, 1991, J MUSCLE RES CELL M, V12, P127, DOI 10.1007/BF01774031; ROTMAN EI, 1995, J BIOL CHEM, V270, P16371, DOI 10.1074/jbc.270.27.16371; SABORIDO A, 1995, PFLUG ARCH EUR J PHY, V429, P364, DOI 10.1007/BF00374151; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; SIMON BJ, 1985, J GEN PHYSIOL, V85, P1, DOI 10.1085/jgp.85.1.1; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Wang ZM, 1999, J PHYSIOL-LONDON, V516, P331, DOI 10.1111/j.1469-7793.1999.0331v.x; Wang ZM, 1999, BIOPHYS J, V77, P2709, DOI 10.1016/S0006-3495(99)77104-3; Wang ZM, 2002, BIOPHYS J, V82, P1338, DOI 10.1016/S0006-3495(02)75489-1; ZHENG Z, 2001, 31 ANN M SAN DIEG CA, P266; Zheng ZL, 2002, J PHYSIOL-LONDON, V540, P397, DOI 10.1113/jphysiol.2001.013464; Zheng ZL, 2001, MECH AGEING DEV, V122, P373, DOI 10.1016/S0047-6374(00)00236-0	43	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50535	50542		10.1074/jbc.M210526200	http://dx.doi.org/10.1074/jbc.M210526200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12407098	hybrid			2022-12-27	WOS:000180177700046
J	Nedrelow, JH; Cianci, CD; Morrow, JS				Nedrelow, JH; Cianci, CD; Morrow, JS			C-src binds alpha II spectrin's Src homology 3 (SH3) domain and blocks calpain susceptibility by phosphorylating Tyr(1176)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE-I; TYROSINE PHOSPHORYLATION; MOLECULAR MECHANISMS; MEDIATED TRUNCATION; BRAIN SPECTRIN; CELL-DEATH; PROTEOLYSIS; FODRIN; CALMODULIN; CALCIUM	Spectrin is a ubiquitous heterodimeric scaffolding protein that stabilizes membranes and organizes protein and lipid microdomains on both the plasma membrane and intracellular organelles. Phosphorylation of beta-spectrin on Ser/Thr is well recognized. Less clear is whether a-spectrin is phosphorylated in vivo and whether spectrin is phosphorylated on tyrosine (pTyr). We affirmatively answer both questions. In cultured Madin-Darby canine kidney cells, all spectrin undergoes in vivo tyrosine phosphorylation. Enhancement of the steady state level of pTyr-modified all spectrin by vanadate, a phosphatase inhibitor, implies a dynamic balance between all spectrin phosphorylation and dephosphorylation. Recombinant peptides containing the Src homology 3 domain of all spectrin (but not the Src homology 3 domain of alphaI spectrin) bind specifically to phosphorylated c-Src in Madin-Darby canine kidney cell lysates, suggesting that this kinase is responsible for its in vivo phosphorylation. pTyr-modified all spectrin is resistant to maitotoxin-induced cleavage by mu-calpain in vivo. In vitro studies of recombinant all spectrin peptides representing repeats 9-12 identify two sites of pTyr modification. The first site is at Tyr(1073), a residue immediately adjacent to a region encoded by alternative exon usage (insert 1). The second site is at Tyr(1176). This residue flanks the major site of cleavage by the calcium-dependent protease calpain, and phosphorylation of Tyr(1176) by c-Src reduces the susceptibility of all spectrin to cleavage by mu-calpain. Calpain cleavage of spectrin, activated by Ca2+ and calmodulin, contributes to diverse cellular processes including synaptic remodeling, receptor-mediated endocytosis, apoptosis, and the response of the renal epithelial cell to ischemic injury. Tyrosine phosphorylation of all spectrin now would appear to also mediate these events. The spectrin skeleton thus forms a point of convergence between kinase/phosphatase and Ca2+-mediated signaling cascades.	Yale Univ, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Dept Pediat, New Haven, CT 06510 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Morrow, JS (corresponding author), Yale Univ, Dept Pathol, 310 Cedar St, New Haven, CT 06510 USA.							Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Bi RF, 2000, J BIOL CHEM, V275, P26477, DOI 10.1074/jbc.M003763200; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Buday L, 1999, BBA-REV BIOMEMBRANES, V1422, P187, DOI 10.1016/S0304-4157(99)00005-2; Cianci CD, 1999, BIOCHEMISTRY-US, V38, P15721, DOI 10.1021/bi991458k; De Matteis MA, 2000, J CELL SCI, V113, P2331; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; DOCTOR RB, 1993, AM J PHYSIOL, V264, pC1003, DOI 10.1152/ajpcell.1993.264.4.C1003; DOSEMECI A, 1995, SYNAPSE, V20, P91, DOI 10.1002/syn.890200113; Dutta S, 2002, BIOL CHEM, V383, P785, DOI 10.1515/BC.2002.082; Faddis BT, 1997, J NEUROSCI, V17, P951; FOWLER VM, 1992, J CELL BIOL, V119, P1559, DOI 10.1083/jcb.119.6.1559; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; GLANTZ SB, 1996, TISSUE OXYGEN DEPRIV, P153; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; GOODMAN SR, 1984, AM J PHYSIOL, V247, pC61, DOI 10.1152/ajpcell.1984.247.1.C61; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HARRIS AS, 1989, J BIOL CHEM, V264, P17401; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; HARRIS WH, 1980, J BIOL CHEM, V255, P11512; HU RJ, 1991, J BIOL CHEM, V266, P18200; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; KADOWAKI T, 1985, BIOCHEM BIOPH RES CO, V127, P493, DOI 10.1016/S0006-291X(85)80187-X; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; MCMAHON AP, 1987, DIFFERENTIATION, V34, P68, DOI 10.1111/j.1432-0436.1987.tb00052.x; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Perrin BJ, 2002, INT J BIOCHEM CELL B, V34, P722, DOI 10.1016/S1357-2725(02)00009-2; Perrotta S, 2001, LEUKEMIA, V15, P440, DOI 10.1038/sj.leu.2402047; PINDER JC, 1977, NATURE, V270, P752, DOI 10.1038/270752a0; Sambrook J., 2002, MOL CLONING LAB MANU; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; SIDDHANTA A, 2003, IN PRESS J BIOL CHEM, V278; Sihag RK, 1998, J NEUROCHEM, V71, P2220; Stabach PR, 2000, J BIOL CHEM, V275, P21385, DOI 10.1074/jbc.C000159200; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Takahashi K, 1990, INTRACELLULAR CALCIU, P55; TRAVE G, 1995, EUR J BIOCHEM, V227, P35, DOI 10.1111/j.1432-1033.1995.tb20357.x; TRUSCOTT RJW, 1990, INVEST OPHTH VIS SCI, V31, P2405; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; WANG CY, 1988, BIOCHEMISTRY-US, V27, P1254, DOI 10.1021/bi00404a027; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Zhao X, 1999, NEUROCHEM RES, V24, P371, DOI 10.1023/A:1020933616351; ZIMMERMAN UJP, 1992, BIOCHIM BIOPHYS ACTA, V1137, P127, DOI 10.1016/0167-4889(92)90193-F	52	52	53	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 28	2003	278	9					7735	7741		10.1074/jbc.M210988200	http://dx.doi.org/10.1074/jbc.M210988200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649EZ	12446661	hybrid			2022-12-27	WOS:000181195100139
J	Strong, RK; Holmes, MA; Li, PW; Braun, L; Lee, N; Geraghty, DE				Strong, RK; Holmes, MA; Li, PW; Braun, L; Lee, N; Geraghty, DE			HLA-E allelic variants - Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-KP43 MONOCLONAL-ANTIBODY; NATURAL-KILLER-CELLS; FREE R-VALUE; SURFACE EXPRESSION; ESCHERICHIA-COLI; LYMPHOCYTES-T; MHC MOLECULE; ANTIGEN; BINDING; RECOGNITION	Previous studies of HLA-E allelic polymorphism have indicated that balancing selection may be acting to maintain two major alleles in most populations, indicating that a functional difference may exist between the alleles. The alleles differ at only one amino acid position, where an arginine at position 107 in HL-E*0101 (E-R) is replaced by a glycine in HLA-E*0103 (E-G). To investigate possible functional differences, we have undertaken a study of the physical and biochemical properties of these two proteins. By comparing expression levels, we found that whereas steady-state protein levels were similar, the two alleles did in fact differ with respect to cell surface levels. To help explain this difference, we undertook studies of the relative differences in peptide affinity, complex stability, and three-dimensional structure between the alleles. The crystal structures for HLA-E-G complexed with two distinct peptides were determined, and both were compared with the HLA-E-R structure. No significant differences in the structure of HLA-E were induced as a result of binding different peptides or by the allelic substitution at position 107. However, there were clear differences in the relative affinity for peptide of each heavy chain, which correlated with and may be explained by differences between their thermal stabilities. These differences were completely consistent with the relative levels of the HLA-E alleles on the cell sur face and may indeed correlate with functional differences. This in turn may help explain the apparent balancing selection acting on this locus.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Geraghty, DE (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,A3-023, Seattle, WA 98109 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048675, R01AI038508] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49213, R01 AI48675, R01 AI38508] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARAMBURU J, 1991, J IMMUNOL, V147, P714; ARAMBURU J, 1990, J IMMUNOL, V144, P3238; Bellon T, 1999, J IMMUNOL, V162, P3996; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; FUJII T, 1994, J IMMUNOL, V153, P5516; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GERAGHTY DE, 1992, J IMMUNOL, V149, P1934; GERAGHTY DE, 1990, J EXP MED, V171, P1, DOI 10.1084/jem.171.1.1; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; Griffin TA, 1997, J IMMUNOL, V159, P4887; Grimsley C, 2002, TISSUE ANTIGENS, V60, P206, DOI 10.1034/j.1399-0039.2002.600302.x; Grimsley C, 1997, HUM IMMUNOL, V52, P33, DOI 10.1016/S0198-8859(96)00241-8; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; ISHITANI A, 2003, IN PRESS J IMMUNOL; King A, 1998, HUM REPROD UPDATE, V4, P480, DOI 10.1093/humupd/4.5.480; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, J IMMUNOL, V160, P4951; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Little A M, 1999, Rev Immunogenet, V1, P105; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; MACFERRIN KD, 1990, P NATL ACAD SCI USA, V87, P1937, DOI 10.1073/pnas.87.5.1937; Matte C, 2000, HUM IMMUNOL, V61, P1150, DOI 10.1016/S0198-8859(00)00200-7; Mazda O, 1997, SCAND J IMMUNOL, V46, P262, DOI 10.1046/j.1365-3083.1997.d01-125.x; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Morgan CS, 1997, PROTEIN SCI, V6, P1771, DOI 10.1002/pro.5560060819; O'Callaghan CA, 1998, PROTEIN SCI, V7, P1264, DOI 10.1002/pro.5560070525; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEREZVILLAR JJ, 1995, J IMMUNOL, V154, P5779; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Ulbrecht M, 1998, J IMMUNOL, V160, P4375; Ulbrecht M, 1999, EUR J IMMUNOL, V29, P537, DOI 10.1002/(SICI)1521-4141(199902)29:02<537::AID-IMMU537>3.0.CO;2-6; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117	49	220	224	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5082	5090		10.1074/jbc.M208268200	http://dx.doi.org/10.1074/jbc.M208268200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12411439	hybrid			2022-12-27	WOS:000180968900094
J	Palmieri, D; Poggi, S; Ulivi, V; Casartelli, G; Manduca, P				Palmieri, D; Poggi, S; Ulivi, V; Casartelli, G; Manduca, P			Pro-collagen ICOOH-terminal trimer induces directional migration and metalloproteinases in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; UROKINASE RECEPTOR; CYTOSKELETON REORGANIZATION; ALPHA-6-BETA-4 INTEGRIN; MAMMARY-CARCINOMA; EPITHELIAL-CELLS; SIGNALING EVENTS; MELANOMA-CELLS	Breast and prostatic carcinomas, melanoma, and endothelial cell lines are chemoattracted by medium conditioned by mature osteoblasts. The chemoattractant for endothelial cells was identified with C3, carboxyl-terminal trimer of pro-collagen type I. We report that C3 induces directional migration and proliferation, the expression of tissue inhibitor of metalloproteinases-2, prometalloproteinase-2 and -9, and their activation in MDA MB231 cells, without changing the expression of tissue inhibitor of metalloproteinases-1 and of metalloproteinase-14. Antiserum against metalloproteinase-2 or -9 or -14, tissue inhibitor of metalloproteinases-1, or GM6001 inhibits the C3-induced migration. Urokinase and its receptor are detected and unchanged upon exposure to C3. The antibody against urokinase or addition of plasminogen activator inhibitor inhibits migration. Blocking antibodies to integrins alpha(2), alpha(6), beta(1), and beta(3) inhibit chemotaxis and do not change urokinase and urokinase receptor expression. Blockage of alpha(2), alpha(6), beta(1), and beta(3) integrins affect differently the induction by C3 of pro-metalloproteinase-2 and -9 and of tissue inhibitor of metalloproteinases-2. Chemotaxis to C3 is also inhibited by genistein, by pertussis toxin, which also inhibits C3-induced pro-metalloproteinase -2 and -9, but not urokinase expression. Wortmannin partially inhibits C3-induced cell migration. Other, but not all, breast carcinoma lines tested responded to C3 with migration and pro-metalloproteinase-2 induction. Presently C3 is the only agent known to induce migration specifically of both endothelial and breast carcinoma cells. The mitogenic and motogenic role of C3 in vitro might prefigure a role in in vivo carcinogenesis and in the establishment of metastasis.	Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy; Ist Nazl Ric Canc, I-16132 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Palmieri, D (corresponding author), Univ Genoa, Dipartimento Oncol Biol & Genet, 26 C Europa, I-16132 Genoa, Italy.							Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; BIANCHI E, 1994, CANCER RES, V54, P861; Bourhis XFDL, 1997, INT J CANCER, V71, P42, DOI 10.1002/(SICI)1097-0215(19970328)71:1<42::AID-IJC9>3.0.CO;2-3; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Davies D, 1997, EUR J BIOCHEM, V246, P274, DOI 10.1111/j.1432-1033.1997.t01-1-00274.x; de Witte JH, 2001, BRIT J CANCER, V85, P85, DOI 10.1054/bjoc.2001.1867; Degryse B, 2001, ONCOGENE, V20, P2032, DOI 10.1038/sj.onc.1204261; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; DUFFY MJ, 1990, CANCER RES, V50, P6827; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fassina G, 2000, CLIN EXP METASTAS, V18, P111, DOI 10.1023/A:1006797522521; Festuccia C, 1999, ONCOL RES, V11, P17; Giancotti FG, 2000, NAT CELL BIOL, V2, pE13, DOI 10.1038/71397; GIUNCIUGLIO D, 1995, CANCER LETT, V97, P69, DOI 10.1016/0304-3835(95)03955-V; Gruvberger S, 2001, CANCER RES, V61, P5979; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanemaaijer R, 2000, INT J CANCER, V86, P204, DOI 10.1002/(SICI)1097-0215(20000415)86:2<204::AID-IJC9>3.0.CO;2-6; Hofmann UB, 2000, INT J CANCER, V87, P12, DOI 10.1002/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A; Hua J, 1996, CANCER RES, V56, P5279; ITO A, 1995, BRIT J CANCER, V71, P1039, DOI 10.1038/bjc.1995.200; Jukkola A, 1997, CANCER RES, V57, P5517; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; KAWAMATA H, 1995, INT J CANCER, V63, P568, DOI 10.1002/ijc.2910630418; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Khatib AM, 2001, INT J CANCER, V91, P300, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1055>3.3.CO;2-E; Koolwijk P, 2001, BLOOD, V97, P3123, DOI 10.1182/blood.V97.10.3123; KOYOMA H, 1996, CELL, V87, P1069; Kubota S, 1997, INT J CANCER, V70, P106; Liu EB, 2000, CANCER RES, V60, P2361; Maghazachi AA, 2000, INT J BIOCHEM CELL B, V32, P931, DOI 10.1016/S1357-2725(00)00035-2; Manduca P, 1997, BONE, V21, P31, DOI 10.1016/S8756-3282(97)00037-9; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Mignatti P, 1996, ENZYME PROTEIN, V49, P117, DOI 10.1159/000468621; Moinfar F, 2000, CANCER RES, V60, P2562; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Okumura Y, 1997, FEBS LETT, V402, P181, DOI 10.1016/S0014-5793(96)01523-2; Olumi AF, 1998, CANCER RES, V58, P4525; Olumi AF, 1999, CANCER RES, V59, P5002; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Palmieri D, 2000, J BIOL CHEM, V275, P32658, DOI 10.1074/jbc.M002698200; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Pedersen AN, 2000, CANCER RES, V60, P6927; PICARD O, 1986, CANCER RES, V46, P3290; RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548; Shaw LM, 1999, J MAMMARY GLAND BIOL, V4, P367, DOI 10.1023/A:1018766317055; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; STRINGA E, 1995, BONE, V16, P663, DOI 10.1016/8756-3282(95)00100-R; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tsunezuka Y, 1996, CANCER RES, V56, P5678; Varner JA, 1996, CURR OPIN CELL BIOL, V8, P724, DOI 10.1016/S0955-0674(96)80115-3; Wang Y, 2001, MED RES REV, V21, P146, DOI 10.1002/1098-1128(200103)21:2<146::AID-MED1004>3.0.CO;2-B; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; WESTON SA, 1994, J BIOL CHEM, V269, P20982; Yebra M, 1999, EXP CELL RES, V250, P231, DOI 10.1006/excr.1999.4510	61	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3639	3647		10.1074/jbc.M207483200	http://dx.doi.org/10.1074/jbc.M207483200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12441353	hybrid			2022-12-27	WOS:000180869700017
J	Shibukawa, Y; Takahashi, M; Laffont, I; Honke, K; Taniguchi, N				Shibukawa, Y; Takahashi, M; Laffont, I; Honke, K; Taniguchi, N			Down-regulation of hydrogen peroxide-induced PKC delta activation in N-acetylglucosaminyltransferase III-transfected HeLaS3 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; OXIDATIVE STRESS; KAPPA-B; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; PROTEIN-KINASES; GROWTH-FACTOR; APOPTOSIS; PATHWAY; TRANSLOCATION	N-acetylglucosaminyltransferase III (GnT-III) is a key enzyme that inhibits the extension of N-glycans by introducing a bisecting N-acetylglucosamine residue. Our previous studies have shown that modification of N-glycans by GnT-III affects a number of intracellular signaling pathways, In this study, the effects of GnT-III on the cellular response to reactive oxygen species (ROS) were examined. We found that an overexpression of GnT-III suppresses H2O2-induced apoptosis in HeLaS3 cells. In the case of GnT-III transfectants, activation of Jun N-terminal kinase (JNK) following H2O2 treatment was markedly reduced compared with control cells. Either the depletion of protein kinase C (PKC) by prolonged treatment with phorbol 12-myristate 13-acetate or the inhibition of PKC by the specific inhibitor 117 attenuated the H2O2-induced activation of JNK1 and apoptosis in control cells but not in the GnT-III transfectants. Furthermore, we found that H2O2-induced phosphorylation of PKCdelta was markedly suppressed in GnT-III transfectants. Rottlerin, a specific inhibitor of PKCdelta, significantly inhibited H2O2-induced activation of JNK1 in control cells, indicating that PKCdelta is involved in the pathway. These findings suggest that the overexpression of GnT-III suppresses H2O2-induced activation of PKCdelta-JNK1 pathway, resulting in inhibition of apoptosis.	Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan	Osaka University	Taniguchi, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Biochem, 2-2 Yamadaoka,B1, Suita, Osaka 5650871, Japan.		Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014; Takahashi, Motoko/I-3154-2013	Taniguchi, Naoyuki/0000-0001-5889-5968; Takahashi, Motoko/0000-0002-2112-6142				Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Chen NY, 1999, J BIOL CHEM, V274, P15389, DOI 10.1074/jbc.274.22.15389; Ihara Y, 1997, J BIOL CHEM, V272, P9629; Ito Y, 2001, CELL DEATH DIFFER, V8, P794, DOI 10.1038/sj.cdd.4400886; Kang YJ, 2000, J BIOL CHEM, V275, P13690, DOI 10.1074/jbc.275.18.13690; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Li YC, 1997, J BIOL CHEM, V272, P20646, DOI 10.1074/jbc.272.33.20646; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Mitsutake N, 2001, ONCOGENE, V20, P989, DOI 10.1038/sj.onc.1204179; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; SARIH M, 1993, BIOCHEM BIOPH RES CO, V191, P503, DOI 10.1006/bbrc.1993.1246; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; SCHMIDT KN, 1995, J BIOL CHEM, V270, P27136, DOI 10.1074/jbc.270.45.27136; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Taniguchi N, 1999, BBA-MOL BASIS DIS, V1455, P287, DOI 10.1016/S0925-4439(99)00066-6; TANIGUCHI N, 1995, GLYCOCONJUGATE J, V12, P733, DOI 10.1007/BF00731232; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754	37	29	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3197	3203		10.1074/jbc.M207870200	http://dx.doi.org/10.1074/jbc.M207870200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427758	hybrid			2022-12-27	WOS:000180915000055
J	Woetmann, A; Brockdorff, J; Lovato, P; Nielsen, M; Leick, V; Rieneck, K; Svejgaard, A; Geisler, C; Odum, N				Woetmann, A; Brockdorff, J; Lovato, P; Nielsen, M; Leick, V; Rieneck, K; Svejgaard, A; Geisler, C; Odum, N			Protein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PHOSPHORYLATION; ACTIVATION; PATHWAYS; CELLS; IL-4; DIFFERENTIATION; TRANSCRIPTION; ASSOCIATION; LYMPHOCYTES; EXPRESSION	Interleukin-4 (IL-4) plays a pivotal role in the induction and maintenance of allergy by promoting Th2 differentiation and B cell isotype switching to IgE. Studies on STAT6-deficient mice have demonstrated the essential role of STAT6 in mediating the biological functions of IL-4. IL-4 induces tyrosine phosphorylation of STAT6, which in turn leads to transcription of IL-4-specific genes. In addition, serine phosphorylation of STAT6 has recently been reported. Here we study the functional role of STAT6 serine phosphorylation and the kinases and phosphatases involved. We show that inhibition of protein phosphatase 2A (PP2A) induces serine phosphorylation of STAT6 and severely inhibits DNA binding of STAT6. In contrast, IL-4-induced tyrosine phosphorylation of Janus kinase-1 and STAT6 is not affected, suggesting that PP2A acts downstream of Janus kinases in IL-4 signaling. In conclusion, we provide the first evidence that PP2A plays a crucial role in the regulation of STAT6 function.	Univ Copenhagen, Inst Med Microbiol & Immunol, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Inst Med Biochem & Genet, DK-2200 Copenhagen, Denmark; Rigshosp, Inst Inflammat Res, DK-2200 Copenhagen, Denmark; Natl Univ Hosp, Dept Clin Immunol, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Odum, N (corresponding author), Univ Copenhagen, Inst Med Microbiol & Immunol, Panum 22-5-34,Blegdamsvej 3C, DK-2200 Copenhagen, Denmark.		Geisler, Carsten/A-7056-2012; Woetmann, Anders/AAJ-3171-2020	Geisler, Carsten/0000-0002-8472-0771; Woetmann, Anders/0000-0002-3008-735X; Lovato, Paola/0000-0002-4097-9634				Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Brender C, 2001, BLOOD, V97, P1056, DOI 10.1182/blood.V97.4.1056; Brockdorff J, 1997, TISSUE ANTIGENS, V49, P228, DOI 10.1111/j.1399-0039.1997.tb02743.x; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; EILERS A, 1995, MOL CELL BIOL, V15, P3579; Eriksen KW, 2001, EXP CLIN IMMUNOGENET, V18, P233, DOI 10.1159/000049202; GEISLER C, 1990, J IMMUNOL, V145, P1761; Harris William, 1993, Drugs of the Future, V18, P727; Jain N, 1998, ONCOGENE, V17, P3157, DOI 10.1038/sj.onc.1202238; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lim CP, 2001, J BIOL CHEM, V276, P21004, DOI 10.1074/jbc.M007592200; LIU J, 1991, CELL, V267, P13115; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nielsen M, 1997, P NATL ACAD SCI USA, V94, P6764, DOI 10.1073/pnas.94.13.6764; Nielsen M, 1998, CYTOKINE, V10, P735, DOI 10.1006/cyto.1998.0356; NIELSEN M, 1994, EXP CLIN IMMUNOGENET, V11, P23; Paul WE, 1997, CIBA F SYMP, V204, P208; Pesu M, 2000, BLOOD, V95, P494, DOI 10.1182/blood.V95.2.494; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Shen CH, 1998, MOL CELL BIOL, V18, P3395, DOI 10.1128/MCB.18.6.3395; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wick KR, 2000, MOL IMMUNOL, V37, P641, DOI 10.1016/S0161-5890(00)00088-2; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	30	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2787	2791		10.1074/jbc.M210196200	http://dx.doi.org/10.1074/jbc.M210196200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12426308	hybrid			2022-12-27	WOS:000180915000004
J	Overgaard, MT; Sorensen, ES; Stachowiak, D; Boldt, HB; Kristensen, L; Sottrup-Jensen, L; Oxvig, C				Overgaard, MT; Sorensen, ES; Stachowiak, D; Boldt, HB; Kristensen, L; Sottrup-Jensen, L; Oxvig, C			Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein - Disulfide structure and carbohydrate attachment sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPP-A; CRYSTAL-STRUCTURE; ACTIVATION; MECHANISM; DOMAIN; CELLS; IGF; CHROMATOGRAPHY; LOCALIZATION; SERRALYSINS	Pregnancy-associated plasma protein-A (PAPP-A) is a metzincin superfamily metalloproteinase responsible for cleavage of insulin-like growth factor-binding protein-4, thus causing release of bound insulin-like growth factor. PAPP-A is secreted as a dimer of 400 kDa but circulates in pregnancy as a disulfide-bound 500-kDa 2:2 complex with the proform of eosinophil major basic protein (pro-MBP), recently shown to function as a proteinase inhibitor of PAPP-A. Except for PAPP-A2, PAPP-A does not share global similarity with other proteins. Three lin-notch (LNR or LIN-12) modules and five complement control protein modules (also known as SCR modules) have been identified in PAPP-A by sequence similarity with other proteins, but no data are available that allow unambiguous prediction of disulfide bonds of these modules. To establish the connectivities of cysteine residues of the PAPP-A-pro-MBP complex, biochemical analyses of peptides derived from purified protein were performed. The PAPP-A subunit contains a total of 82 cysteine residues, of which 81 have been accounted for. The pro-MBP subunit contains 12 cysteine residues, of which 10 have been accounted for. Within the 2:2 complex, PAPP-A is dimerized by a single disulfide bond; pro-MBP is dimerized by two disulfides, and each PAPP-A subunit is connected to a pro-MBP subunit by two disulfide bonds. All other disulfides are intrachain bridges. We also show that of 13 potential sites for N-linked carbohydrate substitution of the PAPP-A subunit, 11 are occupied. The large number of disulfide bonds of the PAPP-A-pro-MBP complex imposes many restraints on polypeptide folding, and knowledge of the disulfide pattern of PAPP-A will facilitate structural studies based on recombinant expression of individual, putative PAPP-A domains. Furthermore, it will allow rational experimental design of functional studies aimed at understanding the formation of the PAPP-A-pro-MBP complex, as well as the inhibitory mechanism of pro-MBP.	Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University	Oxvig, C (corresponding author), Univ Aarhus, Dept Mol Biol, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	co@mb.au.dk	Overgaard, Michael Toft/E-1354-2011	Overgaard, Michael Toft/0000-0002-1423-2481; Sorensen, Esben Skipper/0000-0002-7050-3354; Oxvig, Claus/0000-0002-4715-9719				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1999, BIOCHEMISTRY-US, V38, P4736, DOI 10.1021/bi982713o; BARKER RL, 1988, J EXP MED, V168, P1493, DOI 10.1084/jem.168.4.1493; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bayes-Genis A, 2001, ARTERIOSCL THROM VAS, V21, P335, DOI 10.1161/01.ATV.21.3.335; BENDIXEN E, 1992, BIOCHEMISTRY-US, V31, P3611, DOI 10.1021/bi00129a009; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Chen BK, 2002, ENDOCRINOLOGY, V143, P1199, DOI 10.1210/en.143.4.1199; Conover CA, 2001, ENDOCRINOLOGY, V142, P2155, DOI 10.1210/en.142.5.2155; CRIMMINS DL, 1989, ANAL BIOCHEM, V176, P255, DOI 10.1016/0003-2697(89)90305-9; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fortini ME, 2001, CURR OPIN CELL BIOL, V13, P627, DOI 10.1016/S0955-0674(00)00261-1; Giudice LC, 2002, J CLIN ENDOCR METAB, V87, P2359, DOI 10.1210/jc.87.5.2359; Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504; Hourvitz A, 2002, ENDOCRINOLOGY, V143, P1833, DOI 10.1210/en.143.5.1833; JAUREGUIADELL J, 1975, ANAL BIOCHEM, V69, P468, DOI 10.1016/0003-2697(75)90148-7; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; KRISTENSEN T, 1994, BIOCHEMISTRY-US, V33, P1592, DOI 10.1021/bi00172a040; Laursen LS, 2002, J BIOL CHEM, V277, P47225, DOI 10.1074/jbc.M209155200; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223, DOI 10.1016/0002-9378(74)90553-5; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mazerbourg S, 2001, ENDOCRINOLOGY, V142, P5243, DOI 10.1210/en.142.12.5243; MONGET P, 2003, IN PRESS BIOL REPROD, V68; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; NAKANO Y, 1992, BIOCHIM BIOPHYS ACTA, V1116, P235, DOI 10.1016/0304-4165(92)90016-N; Overgaard MT, 2000, J BIOL CHEM, V275, P31128, DOI 10.1074/jbc.M001384200; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; OXVIG C, 1994, FEBS LETT, V341, P213, DOI 10.1016/0014-5793(94)80459-1; OXVIG C, 1994, BIOCHEM MOL BIOL INT, V33, P329; OXVIG C, 1993, J BIOL CHEM, V268, P12243; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Popken-Harris P, 1998, BLOOD, V92, P623, DOI 10.1182/blood.V92.2.623.414k32_623_631; Smith GCS, 2002, NATURE, V417, P916, DOI 10.1038/417916a; SOTTRUPJENSEN L, 1993, BIOCHEM MOL BIOL INT, V30, P789; SOTTRUPJENSEN L, 1995, ANAL BIOCHEM, V225, P187, DOI 10.1006/abio.1995.1137; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STOCKER W, 1995, PROTEIN SCI, V4, P823; Swaminathan GJ, 2001, J BIOL CHEM, V276, P26197, DOI 10.1074/jbc.M100848200; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701	46	65	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2106	2117		10.1074/jbc.M208777200	http://dx.doi.org/10.1074/jbc.M208777200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12421832	hybrid			2022-12-27	WOS:000180562000006
J	Razandi, M; Pedram, A; Park, ST; Levin, ER				Razandi, M; Pedram, A; Park, ST; Levin, ER			Proximal events in signaling by plasma membrane estrogen receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; BREAST-CANCER CELLS; COUPLED RECEPTORS; TYROSINE KINASE; BINDING-SITES; ESTRADIOL; PATHWAY; ALPHA	Estradiol (E2) rapidly stimulates signal transduction from plasma membrane estrogen receptors (ER) that are G protein-coupled. This is reported to occur through the transactivation of the epidermal growth factor receptor (EGFR) or insulin-like growth factor-1 receptor, similar to other G protein-coupled receptors. Here, we define the signaling events that result in EGFR and ERK activation. E2-stimulated ERKC required ER in breast cancer and endothelial cells and was substantially prevented by expression of a dominant negative EGFR or by tyrphostin AG1478, a specific inhibitor for EGFR tyrosine kinase activity. Transactivation/phosphorylation of EGFR by E2 was dependent on the rapid liberation of heparin-binding EGF (HB-EGF) from cultured MCF-7 cells and was blocked by antibodies to this ligand for EGFR. Expression of dominant negative mini-genes for Galpha(q) and Galpha(i) blocked E2-induced, EGFR-dependent ERK activation, and Gbetagamma also contributed. G protein activation led to activation of matrix metalloproteinases (MMP)-2 and -9. This resulted from Src-induced MMP activation, implicated using PP2 (Src family kinase inhibitor) or the expression of a dominant negative Src protein. Antisense oligonucleotides to MMP-2 and MMP-9 or ICI 182780 (E-R antagonist) each prevented E2-induced HB-EGF liberation and ERK activation. E2 also induced AKT up-regulation in MCF-7 cells and p38beta MAP kinase activity in endothelial cells, blocked by an MMP inhibitor, GM6001,and tyrphostin AG1478. Targeting of only the E domain of ERalpha to the plasma membrane resulted in MMP activation and EGFR transactivation. Thus, specific G proteins; mediate the ability of E2 to activate MMP-2 and MMP-9 via Src. This leads to HB-EGF transactivation of EGFR and signaling to multiple kinase cascades in several target cells for E2. The E domain is sufficient to enact these events, defining additional details of the important cross-talk between membrane ER and EGFR. in breast cancer.	Univ Calif Irvine, Med Serv 111 1, Vet Adm Med Ctr, Div Endocrinol, Long Beach, CA 90822 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; University of California System; University of California Irvine; University of California System; University of California Irvine	Levin, ER (corresponding author), Univ Calif Irvine, Med Serv 111 1, Vet Adm Med Ctr, Div Endocrinol, 5901 E 7th St, Long Beach, CA 90822 USA.	ellis.levin@med.va.gov	Levin, Ellis/J-5402-2013		NHLBI NIH HHS [HL-59890] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059890] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Ansonoff MA, 1998, ENDOCRINOLOGY, V139, P3050, DOI 10.1210/en.139.7.3050; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; COUSE JF, 1995, MOL ENDOCRINOL, V9, P1441, DOI 10.1210/me.9.11.1441; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Falkenstein E, 2000, EUR J CLIN INVEST, V30, P51, DOI 10.1046/j.1365-2362.2000.0300s3051.x; Ferret S, 2001, MOL CELL ENDOCRINOL, V176, P77, DOI 10.1016/S0303-7207(01)00464-6; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Gilchrist A, 2002, METHOD ENZYMOL, V344, P58; Guccione M, 2002, AM J PHYSIOL-RENAL, V282, pF164, DOI 10.1152/ajprenal.0318.2000; Guo ZY, 2002, J BIOL CHEM, V277, P7044, DOI 10.1074/jbc.M109808200; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hua J, 1996, CANCER RES, V56, P5279; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kelly MJ, 1999, TRENDS ENDOCRIN MET, V10, P369, DOI 10.1016/S1043-2760(99)00190-3; Kim HP, 1999, BIOCHEM BIOPH RES CO, V263, P257; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LeMellay V, 1997, J BIOL CHEM, V272, P11902, DOI 10.1074/jbc.272.18.11902; Levin ER, 2001, J APPL PHYSIOL, V91, P1860, DOI 10.1152/jappl.2001.91.4.1860; LIEBERHERR M, 1993, J BONE MINER RES, V8, P1365; Liu J, 1997, J BIOL CHEM, V272, P7211, DOI 10.1074/jbc.272.11.7211; Lopez GN, 2001, J BIOL CHEM, V276, P22177, DOI 10.1074/jbc.M010718200; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Morey AK, 1997, ENDOCRINOLOGY, V138, P3330, DOI 10.1210/en.138.8.3330; Norfleet AM, 1999, ENDOCRINOLOGY, V140, P3805, DOI 10.1210/en.140.8.3805; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RAY JM, 1994, EUR RESPIR J, V7, P2062; Razandi M, 2000, MOL ENDOCRINOL, V14, P1434, DOI 10.1210/me.14.9.1434; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; Rubio-Gayosso I, 2000, J CARDIOVASC PHARM, V36, P196, DOI 10.1097/00005344-200008000-00009; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Schmidt M, 2000, J BIOL CHEM, V275, P32603, DOI 10.1074/jbc.M004784200; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Sumitomo M, 2001, CANCER RES, V61, P3294; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Sylvia VL, 2001, J CELL BIOCHEM, V81, P413, DOI 10.1002/1097-4644(20010601)81:3<413::AID-JCB1055>3.0.CO;2-M; Tang XW, 2002, J BIOL CHEM, V277, P338, DOI 10.1074/jbc.M108927200; TEIXEIRA C, 1995, CANCER RES, V55, P3902; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Umata T, 2001, J BIOL CHEM, V276, P30475, DOI 10.1074/jbc.M103673200; Ushio-Fukai M, 2001, J BIOL CHEM, V276, P48269, DOI 10.1074/jbc.M105901200; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wyckoff MH, 2001, J BIOL CHEM, V276, P27071, DOI 10.1074/jbc.M100312200; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	72	385	404	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2701	2712		10.1074/jbc.M205692200	http://dx.doi.org/10.1074/jbc.M205692200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12421825	hybrid			2022-12-27	WOS:000180562000083
J	Saito, H; Kusano, K; Kinosaki, M; Ito, H; Hirata, M; Segawa, H; Miyamoto, K; Fukushima, N				Saito, H; Kusano, K; Kinosaki, M; Ito, H; Hirata, M; Segawa, H; Miyamoto, K; Fukushima, N			Human fibroblast growth factor-23 mutants suppress Na+ -dependent phosphate co-transport activity and 1 alpha,25-dihydroxyvitamin D-3 production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN D-3; INDUCED OSTEOMALACIA; TRANSGENIC MICE; GENE; FGF-23; PHEX; HYPOPHOSPHATEMIA; ELECTROPORATION; IDENTIFICATION; EFFICIENT	The human fibroblast growth factor 23 (hFGF23) and its autosomal dominant hypophosphatemic rickets (ADHR) mutant genes were incorporated into animals by naked DNA injection to investigate the action on phosphate homeostasis in vivo. The hFGF23 mutants (R176Q, R179Q and R179W) markedly reduced serum phosphorus (6.2-6.9 mg/dl) compared with the plasmid MOCK (8.5 mg/dl). However, native hFGF23 did not affect serum phosphorus (8.6 mg/dl). Both hFGF23 and hFGF23R179Q mRNAs were expressed more than 100-fold in the liver 4 days after injection, however, the C-terminal portion of hFGF23 was detected only in the serum from hFGF23R179Q-injected animals (1109 pg/ml). hFGF23R179Q mutant was secreted as a 32-kDa protein, whereas, native hFGF23 was detected as a 20-kDa protein in the cell-conditioned media. These results suggest the hFGF23R179Q protein is resistant to intracellular proteolytic processing. The hFGF23R179Q suppressed Na/P-i co-transport activities both in kidney and in small intestine by 45 and 30%, respectively, as well as serum lalpha,25-dihydroxyvitamin D-3 to less than 15 pg/ml. However, it had little effect on serum parathyroid hormone (PTH). Infusion of hFGF23R179Q protein normalized serum phosphorus in thyroparathyroidectomized rats without affecting serum calcium. Taken together, the FGF23 mutants reduce both phosphate uptake in intestine and phosphate reabsorption in kidney, independent of PTH action.	Chugai Pharmaceut Co Ltd, Pharmaceut Lab 2, Shizuoka 4128513, Japan; Chugai Pharmaceut Co Ltd, Technol Lab, Shizuoka 4128513, Japan; Univ Tokushima, Sch Med, Dept Nutr, Tokushima 7708503, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Tokushima University	Saito, H (corresponding author), Chugai Pharmaceut Co Ltd, Pharmaceut Lab 2, Shizuoka 4128513, Japan.		Saito, Hitoshi/A-5844-2016	Saito, Hitoshi/0000-0001-5316-2079				Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Drezner MK, 2000, KIDNEY INT, V57, P9, DOI 10.1046/j.1523-1755.2000.00807.x; Econs MJ, 1997, J CLIN ENDOCR METAB, V82, P674, DOI 10.1210/jc.82.2.674; Fulgham DL, 1999, ENDOTHELIUM-NEW YORK, V6, P185, DOI 10.3109/10623329909053409; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HORIUCHI N, 1987, AM J PHYSIOL, V253, pE187, DOI 10.1152/ajpendo.1987.253.2.E187; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; John MR, 2001, BONE, V29, P393, DOI 10.1016/S8756-3282(01)00586-5; Katai K, 1999, BIOCHEM J, V343, P705, DOI 10.1042/0264-6021:3430705; Katai K, 1997, J BIOCHEM-TOKYO, V121, P50, DOI 10.1093/oxfordjournals.jbchem.a021569; Maruyama H, 2000, HUM GENE THER, V11, P429, DOI 10.1089/10430340050015897; Maruyama H, 2002, J GENE MED, V4, P333, DOI 10.1002/jgm.281; MIYAUCHI A, 1988, J CLIN ENDOCR METAB, V67, P46, DOI 10.1210/jcem-67-1-46; MIYAZAKI J, 1989, GENE, V79, P269; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Taketani Y, 1998, J BIOL CHEM, V273, P14575, DOI 10.1074/jbc.273.23.14575; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamaoka T, 2002, BIOCHEM BIOPH RES CO, V292, P138, DOI 10.1006/bbrc.2002.6601; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992	27	310	337	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2206	2211		10.1074/jbc.M207872200	http://dx.doi.org/10.1074/jbc.M207872200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12419819	hybrid			2022-12-27	WOS:000180562000019
J	Pagani, F; Stuani, C; Zuccato, E; Kornblihtt, AR; Baralle, FE				Pagani, F; Stuani, C; Zuccato, E; Kornblihtt, AR; Baralle, FE			Promoter architecture modulates CFTR exon 9 skipping	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PRE-MESSENGER-RNA; C-TERMINAL DOMAIN; SPLICING FACTORS; IN-VIVO; TRANSCRIPTION; PROTEINS; MUTATIONS; ENHANCER; ABSENCE	Using hybrid minigene experiments, we have investigated the role of the promoter architecture on the regulation of two alternative spliced exons, cystic fibrosis transmembrane regulator (CFTR) exon 9 and fibronectin extra domain-A (EDB). A specific alternative splicing pattern corresponded to each analyzed promoter. Promoter-dependent sensitivity to cotransfected regulatory splicing factor SF2/ASF was observed only for the CFTR exon 9, whereas that of the EDB was refractory to promoter-mediated regulation. Deletion in the CFTR minigene of the downstream intronic splicing silencer element binding SF2/ASF abolished the specific promoter-mediated response to this splicing factor. A systematic analysis of the regulatory cis-acting elements showed that in the presence of suboptimal splice sites or by deletion of exonic enhancer elements the promoter-dependent sensitivity to splicing factor-mediated inhibition was lost. However, the basal regulatory effect of each promoter was preserved. The complex relationships between the promoter-dependent sensitivity to SF2 modulated by the exon 9 definition suggest a kinetic model of promoter-dependent alternative splicing regulation that possibly involves differential RNA polymerase 11 elongation.	Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Fisiol & Biol Mol, Dept Fisiol Biol Mol & Celular, RA-1053 Buenos Aires, DF, Argentina	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Buenos Aires	Baralle, FE (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.			Kornblihtt, Alberto/0000-0003-4322-0831; Pagani, Franco/0000-0002-2678-3459	Telethon [GGP02453] Funding Source: Medline	Telethon(Fondazione Telethon)		Alonso CR, 1996, J BIOL CHEM, V271, P22271, DOI 10.1074/jbc.271.36.22271; Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Kadener S, 2001, EMBO J, V20, P5759, DOI 10.1093/emboj/20.20.5759; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Lim LP, 1998, MOL CELL BIOL, V18, P3900, DOI 10.1128/MCB.18.7.3900; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Morris DP, 2000, J BIOL CHEM, V275, P39935, DOI 10.1074/jbc.M004118200; Mortillaro MJ, 1996, P NATL ACAD SCI USA, V93, P8253, DOI 10.1073/pnas.93.16.8253; Muro AF, 1999, MOL CELL BIOL, V19, P2657; Niksic M, 1999, HUM MOL GENET, V8, P2339, DOI 10.1093/hmg/8.13.2339; Nissim-Rafinia M, 2000, HUM MOL GENET, V9, P1771, DOI 10.1093/hmg/9.12.1771; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; PAGANI F, 2000, J BIOL CHEM, V13, P13; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	29	63	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1511	1517		10.1074/jbc.M209676200	http://dx.doi.org/10.1074/jbc.M209676200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421814	hybrid			2022-12-27	WOS:000180462200020
J	Wojcikiewicz, RJH; Xu, Q; Webster, JM; Alzayady, K; Gao, C				Wojcikiewicz, RJH; Xu, Q; Webster, JM; Alzayady, K; Gao, C			Ubiquitination and proteasomal degradation of endogenous and exogenous inositol 1,4,5-trisphosphate receptors in alpha T3-1 anterior pituitary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED DOWN-REGULATION; ENDOPLASMIC-RETICULUM; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; TRISPHOSPHATE RECEPTORS; CA2+ MOBILIZATION; PROTEIN LIGASE; PATHWAY; BINDING; STIMULATION; MECHANISMS	In alphaT3-1 mouse anterior pituitary gonadotropes, chronic activation of gonadotropin-releasing hormone (GnRH) receptors causes inositol 1,4,5-trisphosphate (InsP.) receptor down-regulation (Willars, G. B., Royall, J. E., Nahorski, S. R., El-Gehani, F., Everest, H. and McArdle, C. A. (2001) J. Biol. Chem. 276, 3123-3129). In the current study, we sought to define the mechanism behind this adaptive response. We show that GnRH induces a rapid and dramatic increase in InsP(3) receptor polyubiquitination and that proteasome inhibitors block InsP(3) receptor down-regulation and cause the accumulation of polyubiquitinated receptors. Thus, the ubiquitin/proteasome pathway is active in alphaT3-1 cells, and GnRH regulates the levels of InsP(3) receptors via this mechanism. Given these findings and further characterization of this system, we also examined the possibility that alphaT3-1 cells could be used to examine the ubiquitination of exogenous InsP(3) receptors introduced by cDNA transfection. This was found to be the case, since exogenous wild-type InsP(3) receptors, but not binding-defective mutant receptors, were polyubiquitinated in a GnRH-dependent manner, and agents that inhibited the polyubiquitination of endogenous receptors also inhibited the polyubiquitination of exogenous receptors. Further, we used this system to determine whether phosphorylation was involved in triggering InsP(3) receptor polyubiquitination. This was not the case, since mutation of serine residues 1588 and 1755 (the predominant phosphorylation sites in the type I receptor) did not inhibit polyubiquitination. In total, these data show that the ubiquitin/proteasome pathway is active in anterior pituitary cells, that this pathway targets both endogenous and exogenous InsP(3) receptors in GnRH-stimulated alphaT3-1 cells, and that, in contrast to the situation for many other substrates, phosphorylation does not trigger InsP(3) receptor polyubiquitination.	SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wojcikiewicz, RJH (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@mail.upstate.edu		Webster, Jack/0000-0003-2586-473X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049194] Funding Source: NIH RePORTER; NIDDK NIH HHS [5R01DK49194] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARBIERI RL, 1992, TRENDS ENDOCRIN MET, V3, P30, DOI 10.1016/1043-2760(92)90089-J; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; Brind S, 2000, DEV BIOL, V223, P251, DOI 10.1006/dbio.2000.9728; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; Hirota J, 1999, J BIOL CHEM, V274, P34433, DOI 10.1074/jbc.274.48.34433; INOUE S, 1992, J BIOL CHEM, V267, P9080; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; McArdle CA, 1996, J BIOL CHEM, V271, P23711, DOI 10.1074/jbc.271.39.23711; McArdle CA, 2002, J ENDOCRINOL, V173, P1, DOI 10.1677/joe.0.1730001; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Oberdorf J, 1999, BIOCHEM J, V339, P453, DOI 10.1042/0264-6021:3390453; Paschen W, 2001, CELL CALCIUM, V29, P1, DOI 10.1054/ceca.2000.0162; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Penela P, 1998, J BIOL CHEM, V273, P35238, DOI 10.1074/jbc.273.52.35238; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Rajapurohitam V, 2002, AM J PHYSIOL-ENDOC M, V282, pE739, DOI 10.1152/ajpendo.00511.2001; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Shacham S, 2001, VITAM HORM, V63, P63, DOI 10.1016/S0083-6729(01)63003-6; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Sipma H, 1998, CELL CALCIUM, V23, P11, DOI 10.1016/S0143-4160(98)90070-7; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Thrower EC, 2001, TRENDS PHARMACOL SCI, V22, P580, DOI 10.1016/S0165-6147(00)01809-5; Tovey SC, 2001, J CELL SCI, V114, P3979; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Wojcikiewicz RJH, 1999, GASTROENTEROLOGY, V116, P1194, DOI 10.1016/S0016-5085(99)70023-5; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wojcikiewicz RJH, 1998, J BIOL CHEM, V273, P5670, DOI 10.1074/jbc.273.10.5670; Wojcikiewicz RJH, 1996, J BIOL CHEM, V271, P16652, DOI 10.1074/jbc.271.28.16652; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; WOJCIKIEWICZ RJH, 1991, J BIOL CHEM, V266, P22234; Yoo SH, 2000, J BIOL CHEM, V275, P30293, DOI 10.1074/jbc.M001204200; Zhu CC, 1999, J BIOL CHEM, V274, P3476, DOI 10.1074/jbc.274.6.3476; Zhu CC, 2000, BIOCHEM J, V348, P551, DOI 10.1042/0264-6021:3480551	49	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					940	947		10.1074/jbc.M206607200	http://dx.doi.org/10.1074/jbc.M206607200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12421829	hybrid			2022-12-27	WOS:000180321900033
J	Cherepanov, P; Maertens, G; Proost, P; Devreese, B; Van Beeumen, J; Engelborghs, Y; De Clercq, E; Debyser, Z				Cherepanov, P; Maertens, G; Proost, P; Devreese, B; Van Beeumen, J; Engelborghs, Y; De Clercq, E; Debyser, Z			HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 INTEGRASE; GROWTH-FACTOR LEDGF/P75; PREINTEGRATION COMPLEXES; SELF-ASSOCIATION; IN-VITRO; DNA; P52; ORGANIZATION; EXPRESSION; DOMAINS	We studied human immunodeficiency virus, type 1 (HIV-1) integrase (IN) complexes derived from nuclei of human cells stably expressing the viral protein from a synthetic gene. We show that in the nuclear extracts IN exists as part of a large distinct complex with an apparent Stokes radius of 61 Angstrom, which dissociates upon dilution yielding a core molecule of 41 Angstrom. We isolated the IN complexes from cells expressing FLAG-tagged IN and demonstrated that the 41 Angstrom core is a tetramer of IN, whereas 61 Angstrom molecules are composed of IN tetramers associated with a cellular protein with an apparent molecular mass of 76 kDa. This novel integrase interacting protein was found to be identical to lens epithelium-derived growth factor (LEDGF/p75), a protein implicated in regulation of gene expression and cellular stress response. HIV-1 IN and LEDGF co-localized in the nuclei of human cells stably expressing IN. Furthermore, recombinant LEDGF robustly enhanced strand transfer activity of HIV-1 IN in vitro. Our findings indicate that the minimal IN molecule in human cells is a homotetramer, suggesting that at least an octamer of IN is required to accomplish coordinated integration of both retroviral long terminal repeats and that LEDGF is a cellular factor involved in this process.	Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Lab Biomol Dynam, B-3001 Heverlee, Belgium; State Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium	KU Leuven; KU Leuven; Ghent University	Debyser, Z (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Louvain, Belgium.		Maertens, Goedele/D-8628-2015; Devreese, Bart/B-2011-2009; Devreese, Bart/K-2841-2019; Proost, Paul/V-3052-2017; Cherepanov, Peter P/F-6859-2010	Maertens, Goedele/0000-0002-1963-8026; Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Proost, Paul/0000-0002-0133-5545; Cherepanov, Peter P/0000-0002-0634-538X; De Clercq, Erik/0000-0002-2985-8890				Asante-Appiah E, 1997, ANTIVIR RES, V36, P139, DOI 10.1016/S0166-3542(97)00046-6; BAKER TA, 1992, GENE DEV, V6, P2221, DOI 10.1101/gad.6.11.2221; Bhasin A, 2000, J MOL BIOL, V302, P49, DOI 10.1006/jmbi.2000.4048; Brown P. O., 1997, P161; Chen HM, 2001, MOL CELL BIOL, V21, P6758, DOI 10.1128/MCB.21.20.6758-6767.2001; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Cherepanov P, 1999, NUCLEIC ACIDS RES, V27, P2202, DOI 10.1093/nar/27.10.2202; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Coleman J, 1999, J BIOL CHEM, V274, P32842, DOI 10.1074/jbc.274.46.32842; Craigie R, 2001, J BIOL CHEM, V276, P23213, DOI 10.1074/jbc.R100027200; Debyser Zeger, 2002, Antiviral Chemistry & Chemotherapy, V13, P1; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Dietz F, 2002, BIOCHEM J, V366, P491, DOI 10.1042/BJ20011811; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Fatma N, 2001, J BIOL CHEM, V276, P48899, DOI 10.1074/jbc.M100733200; Friedman DI, 1992, CURR OPIN GENET DEV, V2, P727, DOI 10.1016/S0959-437X(05)80133-9; Fujita M, 1997, J BIOL CHEM, V272, P10928; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7; Henikoff S, 1999, BIOINFORMATICS, V15, P471, DOI 10.1093/bioinformatics/15.6.471; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; JI TH, 1983, METHOD ENZYMOL, V91, P580; JONES KS, 1992, J BIOL CHEM, V267, P16037; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Miller MD, 2001, CURR OPIN MICROBIOL, V4, P535, DOI 10.1016/S1369-5274(00)00247-2; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Nishizawa Y, 2001, CELL TISSUE RES, V305, P107, DOI 10.1007/s004410100398; Ochs RL, 2000, J ALLERGY CLIN IMMUN, V105, P1211, DOI 10.1067/mai.2000.107039; Petit C, 1999, J VIROL, V73, P5079, DOI 10.1128/JVI.73.6.5079-5088.1999; Pommier Y, 2000, ANTIVIR RES, V47, P139, DOI 10.1016/S0166-3542(00)00112-1; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; SCHULTE D, 1995, J CELL SCI, V108, P1381; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2000, GENE, V242, P265, DOI 10.1016/S0378-1119(99)00506-5; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wilkins MR, 1996, CURR BIOL, V6, P1543, DOI 10.1016/S0960-9822(02)70764-1; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yung E, 2001, NAT MED, V7, P920, DOI 10.1038/90959	56	533	560	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					372	381		10.1074/jbc.M209278200	http://dx.doi.org/10.1074/jbc.M209278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407101	hybrid			2022-12-27	WOS:000180255700050
J	Garcia-Ocana, A; Takane, KK; Reddy, VT; Lopez-Talavera, JC; Vasavada, RC; Stewart, AF				Garcia-Ocana, A; Takane, KK; Reddy, VT; Lopez-Talavera, JC; Vasavada, RC; Stewart, AF			Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; FACTOR SCATTER FACTOR; FACTOR/SCATTER FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; ACTIVATION; INSULIN; OVEREXPRESSION; PROLIFERATION; MASS; HYPERPLASIA	Hepatocyte growth factor (HGF) increases beta cell proliferation and function in rat insulin promoter (RIP)targeted transgenic mice. RIP-HGF mouse islets also function superiorly to normal islets in a transplant setting. Here, we aimed to determine whether viral gene transfer of the HGF gene into mouse islets ex vivo could enhance the performance of normal islets in a streptozotocin-diabetic severe combined immunodeficient mouse marginal islet mass model in which 300 uninfected or adenovirus (Adv) LacZ-transduced islet equivalents were insufficient to correct hyperglycemia. In dramatic contrast, 300 AdvHGF-transduced islet equivalents promptly (day 1) and significantly (p < 0.01) decreased random non-fasting blood glucose levels, from 351 +/- 20 mg/dl to an average of 191 +/- 7 mg/dl over 8 weeks. At day 1 post-transplant, beta cell death was significantly (p < 0.05) decreased, and the total insulin content was significantly (p < 0.05) increased in Adv-HGF-transduced islets containing grafts. This anti-beta cell death action of HGF was independently confirmed in RIP-HGF mice and in INS-1 cells, both treated with streptozotocin. Activation of the phosphatidylinositol 3-kinase/Akt intracellular-signaling pathway appeared to be involved in this beta cell protective effect of HGF in vitro. In summary, adenoviral delivery of HGF to murine islets ex vivo improves islet transplant survival and blood glucose control in a subcapsular renal graft model in immuno-incompetent diabetic mice.	Univ Pittsburgh, Sch Med, Div Endocrinol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garcia-Ocana, A (corresponding author), Univ Pittsburgh, Sch Med, Div Endocrinol, 3550 Terrace St, Pittsburgh, PA 15213 USA.	ocana@msx.dept-med.pitt.edu			NIDDK NIH HHS [DK 55023, DK 47168] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047168, R01DK055023] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Cebrian A, 2002, DIABETES, V51, P3003, DOI 10.2337/diabetes.51.10.3003; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Fan SJ, 2000, ONCOGENE, V19, P2212, DOI 10.1038/sj.onc.1203566; Gahr S, 2002, J MOL ENDOCRINOL, V28, P99, DOI 10.1677/jme.0.0280099; Garcia-Ocana A, 2001, DIABETES, V50, P2752, DOI 10.2337/diabetes.50.12.2752; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; George M, 2002, J CLIN INVEST, V109, P1153, DOI 10.1172/JCI200212969; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; KRISTENSEN P, 1987, ENDOCRINOLOGY, V121, P2238, DOI 10.1210/endo-121-6-2238; Leibowitz G, 1999, DIABETES, V48, P745, DOI 10.2337/diabetes.48.4.745; Liu YH, 1999, AM J PHYSIOL-RENAL, V277, pF624, DOI 10.1152/ajprenal.1999.277.4.F624; MARS WM, 1993, AM J PATHOL, V143, P949; Mildner M, 2002, J BIOL CHEM, V277, P14146, DOI 10.1074/jbc.M110687200; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MIYAZAWA K, 1994, J BIOL CHEM, V269, P8966; Muruve DA, 1997, TRANSPLANTATION, V64, P542, DOI 10.1097/00007890-199708150-00031; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Newgard CB, 1997, DIABETOLOGIA, V40, pS42, DOI 10.1007/s001250051398; Otonkoski T, 1996, ENDOCRINOLOGY, V137, P3131, DOI 10.1210/en.137.7.3131; OTONKOSKI T, 1994, DIABETES, V43, P947, DOI 10.2337/diabetes.43.7.947; Porter SE, 1998, ENDOCRINOLOGY, V139, P3743, DOI 10.1210/en.139.9.3743; Ptasznik A, 1997, J CELL BIOL, V137, P1127, DOI 10.1083/jcb.137.5.1127; Ramiya VK, 2000, NAT MED, V6, P278; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Vasavada RC, 1996, J BIOL CHEM, V271, P1200, DOI 10.1074/jbc.271.2.1200; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Weber M, 1997, J SURG RES, V69, P23, DOI 10.1006/jsre.1997.4995; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	42	99	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					343	351		10.1074/jbc.M207848200	http://dx.doi.org/10.1074/jbc.M207848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403787	hybrid			2022-12-27	WOS:000180255700046
J	Vertegaal, ACO; Kuiperij, HB; Houweling, A; Verlaan, M; van der Eb, AJ; Zantema, A				Vertegaal, ACO; Kuiperij, HB; Houweling, A; Verlaan, M; van der Eb, AJ; Zantema, A			Differential expression of tapasin and immunoproteasome subunits in adenovirus type 5-versus type 12-transformed cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; NF-KAPPA-B; HIGHLY ONCOGENIC ADENOVIRUS-12; TRANSFORMED RAT-CELLS; BETA-INTERFERON GENE; ANTIGEN PRESENTATION; PROTEASOME SUBUNITS; DOWN-REGULATION; TARGETED DISRUPTION	Adenovirus type 12 (Ad12)-transformed baby rat kidney (BRK) cells are oncogenic in syngeneic immunocompetent rats in contrast to adenovirus type 5 (Ad5)-transformed BRK cells, which are not oncogenic in these animals. A significant factor contributing to the difference in oncogenicity may be the low levels of major histocompatibility complex (MHC) class I membrane expression in Ad12-transformed BRK cells as compared with those in Ad5-transformed BRK cells, which presumably results in escape from killing by cytotoxic T lymphocytes. Here we show that, in addition to the decreased levels of expression of the MHC class I heavy chain and the peptide transporter Tap-2, the expression levels of the chaperone Tapasin and the immunoproteasome components MECL-1, PA28-alpha, and PA28-beta also are much lower in Ad12- than in Ad5-transformed BRK cells. The low expression levels of these proteins may contribute to the escape from killing by cytotoxic T lymphocytes, because the generation of optimal peptides and loading of these peptides on MHC class I require these components. Increased levels of phosphorylated signal transducer and activator of transcription-1 protein and expression of IFN regulatory factor-7 were found in Ad5-versus Ad12-transformed BRK cells. Therefore, the critical alteration leading to the plethora of differences may be an interferon (-related) effect.	Leiden Univ, Med Ctr, Ctr Med Genet, Dept Mol Cell Biol, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zantema, A (corresponding author), Leiden Univ, Med Ctr, Ctr Med Genet, Dept Mol Cell Biol, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.		Vertegaal, Alfred CO/Y-3875-2018; Vertegaal, Alfred/ABG-8141-2021; Kuiperij, Bea/A-4737-2013	Vertegaal, Alfred CO/0000-0002-7989-0493; Vertegaal, Alfred/0000-0002-7989-0493; Kuiperij, Bea/0000-0002-0635-7428				Abele R, 1999, BBA-BIOMEMBRANES, V1461, P405, DOI 10.1016/S0005-2736(99)00171-6; ACKRILL AM, 1988, ONCOGENE, V3, P483; ADAMI GR, 1990, J VIROL, V64, P3427, DOI 10.1128/JVI.64.7.3427-3436.1990; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; BERNARDS R, 1983, NATURE, V305, P776, DOI 10.1038/305776a0; BERNARDS R, 1984, BIOCHIM BIOPHYS ACTA, V783, P187, DOI 10.1016/0167-4781(84)90029-0; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chatterjee-Kishore M, 1998, J BIOL CHEM, V273, P16177, DOI 10.1074/jbc.273.26.16177; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; DIJKEMA R, 1984, NUCLEIC ACIDS RES, V12, P1227, DOI 10.1093/nar/12.2.1227; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Foss GS, 1998, BBA-MOL CELL RES, V1402, P17, DOI 10.1016/S0167-4889(97)00152-3; FRIEDMAN DJ, 1988, VIROLOGY, V165, P303, DOI 10.1016/0042-6822(88)90689-7; Fruh K, 1999, CURR OPIN IMMUNOL, V11, P76, DOI 10.1016/S0952-7915(99)80014-4; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; GRAHAM FL, 1974, NATURE, V251, P687, DOI 10.1038/251687a0; Grandea AG, 1998, IMMUNOGENETICS, V48, P260, DOI 10.1007/s002510050430; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Groettrup M, 1996, EUR J IMMUNOL, V26, P863, DOI 10.1002/eji.1830260421; Herberg JA, 1998, EUR J IMMUNOL, V28, P459, DOI 10.1002/(SICI)1521-4141(199802)28:02<459::AID-IMMU459>3.3.CO;2-Q; HOWARD JC, 1995, CURR OPIN IMMUNOL, V7, P69, DOI 10.1016/0952-7915(95)80031-X; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; ISRAEL A, 1989, NUCLEIC ACIDS RES, V17, P5245, DOI 10.1093/nar/17.13.5245; Kohda K, 1998, J IMMUNOL, V160, P4923; Kushner DB, 1999, MOL CELL BIOL, V19, P2169; Lee CK, 1999, J EXP MED, V190, P1451, DOI 10.1084/jem.190.10.1451; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Li YH, 1999, IMMUNOGENETICS, V49, P149, DOI 10.1007/s002510050476; Liu XH, 1996, MOL CELL BIOL, V16, P398; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; MAUXION F, 1989, IMMUNOGENETICS, V29, P397, DOI 10.1007/BF00375868; MEIJER I, 1992, CELL IMMUNOL, V145, P56, DOI 10.1016/0008-8749(92)90312-D; MEIJER I, 1991, ONCOGENE, V6, P911; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Min W, 1996, J IMMUNOL, V156, P3174; MOMBURG F, 1992, NATURE, V360, P174, DOI 10.1038/360174a0; Nandi D, 1996, J IMMUNOL, V156, P2361; Niedermann G, 1999, IMMUNOL REV, V172, P29, DOI 10.1111/j.1600-065X.1999.tb01354.x; NIELSCH U, 1991, EMBO J, V10, P4169, DOI 10.1002/j.1460-2075.1991.tb04995.x; Pereira DS, 1996, ONCOGENE, V13, P445; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Proffitt JA, 1997, FEBS LETT, V400, P141, DOI 10.1016/S0014-5793(96)01375-0; ROTEMYEHUDAR R, 1994, J EXP MED, V180, P477, DOI 10.1084/jem.180.2.477; RotemYehudar R, 1996, J EXP MED, V183, P499, DOI 10.1084/jem.183.2.499; Ruuls SR, 1996, J IMMUNOL, V157, P5721; SCHOUTEN GJ, 1995, EMBO J, V14, P1498, DOI 10.1002/j.1460-2075.1995.tb07136.x; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SCHRIER PI, 1979, VIROLOGY, V99, P372, DOI 10.1016/0042-6822(79)90016-3; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Solheim JC, 1999, IMMUNOL REV, V172, P11, DOI 10.1111/j.1600-065X.1999.tb01352.x; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; STET RJM, 1987, TRANSPLANT P, V19, P3004; Stohwasser R, 1997, EUR J IMMUNOL, V27, P1182, DOI 10.1002/eji.1830270520; Stoltze L, 2000, IMMUNOL TODAY, V21, P317, DOI 10.1016/S0167-5699(00)01665-0; Suh WK, 1999, J IMMUNOL, V162, P1530; Tanaka K, 1998, IMMUNOL REV, V163, P161; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; van der Eb A J, 1980, Methods Enzymol, V65, P826; van Hall T, 2000, J EXP MED, V192, P483, DOI 10.1084/jem.192.4.483; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; YANO O, 1987, EMBO J, V6, P3317, DOI 10.1002/j.1460-2075.1987.tb02652.x; York IA, 1999, IMMUNOL REV, V172, P49, DOI 10.1111/j.1600-065X.1999.tb01355.x	76	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					139	146		10.1074/jbc.M206267200	http://dx.doi.org/10.1074/jbc.M206267200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407112	hybrid			2022-12-27	WOS:000180255700019
J	Sterne-Marr, R; Tesmer, JJG; Day, PW; Stracquatanio, RP; Cilente, JAE; O'Connor, KE; Pronin, AN; Benovic, JL; Wedegaertner, PB				Sterne-Marr, R; Tesmer, JJG; Day, PW; Stracquatanio, RP; Cilente, JAE; O'Connor, KE; Pronin, AN; Benovic, JL; Wedegaertner, PB			G protein-coupled receptor kinase 2/G alpha(q/11) interaction - A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; GTPASE-ACTIVATING PROTEIN; ADENOMATOUS POLYPOSIS-COLI; LEUKEMIA-ASSOCIATED RHO; KINASE 2; SELECTIVE REGULATION; MUTATIONAL ANALYSIS; POINT MUTATION; AMINO-TERMINUS; BETA-ARRESTIN	G protein-coupled receptors (GPCRs) transduce cellular signals from hormones, neurotransmitters, light, and odorants by activating heterotrimeric guanine nucleotide-binding (G) proteins. For many GPCRs, short term regulation is initiated by agonist-dependent phosphorylation by GPCR kinases (GRKs), such as GRK2, resulting in G protein/receptor uncoupling. GRK2 also regulates signaling by binding Galpha(q/11) and inhibiting Galpha(q) stimulation of the effector phospholipase Cbeta. The binding site for Galpha(q/11) resides within the amino-terminal domain of GRK2, which is homologous to the regulator of G protein signaling (RGS) family of proteins. To map the Galpha(q/11) binding site on GRK2, we carried out site-directed mutagenesis of the RGS homology (RH) domain and identified eight residues, which when mutated, alter binding to Gaq/11. These mutations do not alter the ability of full-length GRK2 to phosphorylate rhodopsin, an activity that also requires the amino-terminal domain. Mutations causing Gaq/11 binding defects impair recruitment to the plasma membrane by activated Galpha(q) and regulation of Galpha(q)-stimulated phospholipase Cbeta activity when introduced into full-length GRK2. Two different protein interaction sites have previously been identified on RH domains. The Galpha binding sites on RGS4 and RGS9, called the "A' site, is localized to the loops between helices alpha3 and alpha4, alpha5 and alpha6, and alpha7 and alpha8. The adenomatous polyposis coli (APQ binding site of axin involves residues on a helices 3, 4, and 5 (the "B" site) of its RH domain. We demonstrate that the Gaq/11 binding site on the GRK2 RH domain is distinct from the "A" and "B" sites and maps primarily to the COOH terminus of its alpha5 helix. We suggest that this novel protein interaction site on an RH domain be designated the "C" site.	Siena Coll, Dept Biol, Morrell Sci Ctr 123, Loudonville, NY 12211 USA; Univ Texas, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Senomyx Inc, La Jolla, CA 92037 USA	University of Texas System; University of Texas Austin; Jefferson University	Sterne-Marr, R (corresponding author), Siena Coll, Dept Biol, Morrell Sci Ctr 123, 515 Loudon Rd, Loudonville, NY 12211 USA.	sternemarr@siena.edu		Tesmer, John/0000-0003-1125-3727	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047417, R56GM056444, R37GM047417, R55GM056444, R01GM056444, R01GM044944] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47417, GM44944, GM56444, GM628884] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; Bohm SK, 1997, BIOCHEM J, V322, P1; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chen Z, 2001, NAT STRUCT BIOL, V8, P805, DOI 10.1038/nsb0901-805; CORMACK B, 1991, CURRENT PROTOCOLS MO; Dale LB, 2000, J BIOL CHEM, V275, P38213, DOI 10.1074/jbc.M006075200; de Alba E, 1999, J MOL BIOL, V291, P927, DOI 10.1006/jmbi.1999.2989; DEBBURMAN SK, 1995, J BIOL CHEM, V270, P5742, DOI 10.1074/jbc.270.11.5742; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Druey KM, 1997, P NATL ACAD SCI USA, V94, P12851, DOI 10.1073/pnas.94.24.12851; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Freedman NJ, 1997, J BIOL CHEM, V272, P17734, DOI 10.1074/jbc.272.28.17734; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Ingi T, 1998, J NEUROSCI, V18, P7178; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jones TA, 1994, 1 MAP FINAL MODEL, P1; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Levay K, 1998, BIOCHEMISTRY-US, V37, P13650, DOI 10.1021/bi980998z; Longenecker KL, 2001, STRUCTURE, V9, P559, DOI 10.1016/S0969-2126(01)00620-7; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P7063, DOI 10.1021/bi992760w; Nagata Y, 2001, BLOOD, V97, P3051, DOI 10.1182/blood.V97.10.3051; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Scheschonka A, 2000, MOL PHARMACOL, V58, P719, DOI 10.1124/mol.58.4.719; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Srinivasa SP, 1998, J BIOL CHEM, V273, P1529, DOI 10.1074/jbc.273.3.1529; SterneMarr R, 1995, VITAM HORM, V51, P193, DOI 10.1016/S0083-6729(08)61039-0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; Usui K, 2000, INT J MOL MED, V5, P335; Wang L, 2001, P NATL ACAD SCI USA, V98, P3220, DOI 10.1073/pnas.051633398; Weiss E R, 1998, Mol Vis, V4, P27; Wieland T, 2000, J BIOL CHEM, V275, P28500, DOI 10.1074/jbc.M004187200; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	74	103	103	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					6050	6058		10.1074/jbc.M208787200	http://dx.doi.org/10.1074/jbc.M208787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12427730	hybrid			2022-12-27	WOS:000181129400071
J	Vignols, F; Mouaheb, N; Thomas, D; Meyer, Y				Vignols, F; Mouaheb, N; Thomas, D; Meyer, Y			Redox control of Hsp70-Co-chaperone interaction revealed by expression of a thioredoxin-like Arabidopsis protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; CHAPERONE ACTIVITY; TETRATRICOPEPTIDE REPEAT; MOLECULAR CHAPERONES; PLANT THIOREDOXINS; DIRECT ASSOCIATION; OXIDATIVE STRESS; HSP70; MOTIF; DNAJ	By using a yeast functional complementation assay, we have identified AtTDX, a new Arabidopsis thaliana gene, encoding a two-domain 42-kDa protein. The amino-terminal domain of AtTDX is closely related to the co-chaperone Hsp70-interacting protein HIP, whereas its carboxyl-terminal part contains a thioredoxin domain. Both in vivo and in vitro assays showed that AtTDX is a protein-disulfide reductase. We next found that the HIP domain of AtTDX is capable of interacting with the ATPase domain of Ssb2, a yeast heat-shock protein 70 chaperone. Strikingly, the AtTDX-Ssb2 interaction can be released under oxidative stress, a redox-dependent regulation involving the thioredoxin activity of AtTDX. A mutation inactivating the cysteine 20 of the ATPase domain of Ssb2 was found to stabilize the AtTDX-Ssb2 interaction that becomes redox-insensitive. As cysteine 20 is conserved in virtually all the Hsp70 chaperones, our results suggest that this residue might be more generally the target of redox regulations of chaperone binding activity.	Univ Perpignan, CNRS, UMR 5096, Lab Genome & Dev Plantes, F-66860 Perpignan, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Vignols, F (corresponding author), Univ Perpignan, CNRS, UMR 5096, Lab Genome & Dev Plantes, 52 Ave Villeneuve, F-66860 Perpignan, France.	vignols@univ-perp.fr	VIGNOLS, Florence/ABD-3603-2020; Vignols, Florence/X-6276-2019	VIGNOLS, Florence/0000-0002-2031-0407; 				Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Benaroudj N, 1996, J BIOL CHEM, V271, P18471, DOI 10.1074/jbc.271.31.18471; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Brehelin C, 2000, J BIOL CHEM, V275, P31641, DOI 10.1074/jbc.M002916200; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Callahan MK, 2002, J BIOL CHEM, V277, P33604, DOI 10.1074/jbc.M202890200; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; FERNANDO MR, 1992, EUR J BIOCHEM, V209, P917, DOI 10.1111/j.1432-1033.1992.tb17363.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GutierrezMarcos JF, 1996, P NATL ACAD SCI USA, V93, P13377, DOI 10.1073/pnas.93.23.13377; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOHFELD J, 1995, CELL, V83, P589; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1981, TRENDS BIOCHEM SCI, V6, P26, DOI 10.1016/0968-0004(81)90010-4; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; Martin EA, 2000, BIOCHEM BIOPH RES CO, V275, P764, DOI 10.1006/bbrc.2000.3383; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Meyer Y, 1999, TRENDS PLANT SCI, V4, P388, DOI 10.1016/S1360-1385(99)01475-2; Meyer Y, 2002, METHOD ENZYMOL, V347, P394; MEYER Y, 2002, ANN PLANT REV, P1; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MINET M, 1992, PLANT J, V2, P417; Mouaheb N, 1998, P NATL ACAD SCI USA, V95, P3312, DOI 10.1073/pnas.95.6.3312; MULLER EGD, 1991, J BIOL CHEM, V266, P9194; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200; Pfund C, 2001, MOL BIOL CELL, V12, P3773, DOI 10.1091/mbc.12.12.3773; PIGIET VP, 1986, P NATL ACAD SCI USA, V83, P7643, DOI 10.1073/pnas.83.20.7643; Pilon M, 1999, CELL, V97, P679, DOI 10.1016/S0092-8674(00)80780-1; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; RIVERAMADRID R, 1995, P NATL ACAD SCI USA, V92, P5620, DOI 10.1073/pnas.92.12.5620; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SALZ HK, 1994, GENETICS, V136, P1075; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; STUART RA, 1994, TRENDS BIOCHEM SCI, V19, P87, DOI 10.1016/0968-0004(94)90041-8; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Witte S, 2000, J BIOL CHEM, V275, P1902, DOI 10.1074/jbc.275.3.1902; WU SH, 1994, PLANT MOL BIOL, V25, P577, DOI 10.1007/BF00043887; WYNN R, 1995, BIOCHEMISTRY-US, V34, P11807, DOI 10.1021/bi00037a019; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809; Zavialov AV, 1998, BBA-PROTEIN STRUCT M, V1388, P123, DOI 10.1016/S0167-4838(98)00172-1	59	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4516	4523		10.1074/jbc.M210080200	http://dx.doi.org/10.1074/jbc.M210080200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12433921	hybrid			2022-12-27	WOS:000180968900022
J	Ganeshan, R; Di, A; Nelson, DJ; Quick, MW; Kirk, KL				Ganeshan, R; Di, A; Nelson, DJ; Quick, MW; Kirk, KL			The interaction between syntaxin 1A and cystic fibrosis transmembrane conductance regulator Cl- channels is mechanistically distinct from syntaxin 1A-SNARE interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CFTR CHLORIDE CHANNELS; FUNCTIONAL IMPACT; CALCIUM CHANNELS; XENOPUS-OOCYTES; N-TYPE; COMPLEX; DOMAIN; SPECIFICITY; TRAFFICKING	Syntaxin 1A binds to and inhibits epithelial cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels and synaptic Ca2+ channels in addition to participating in SNARE complex assembly and membrane fusion. We exploited the isoform-specific nature of the interaction between syntaxin 1A and CFTR to identify residues in the H3 domain of this SNARE (SNARE motif) that influence CFTR binding and regulation. Mutating isoform-specific residues that map to the surface of syntaxin 1A in the SNARE complex led to the identification of two sets of hydrophilic residues that are important for binding to and regulating CFTR channels or for binding to the syntaxin regulatory protein Munc-18a. None of these mutations affected syntaxin 1A binding to other SNAREs or the assembly and stability of SNARE complexes in vitro. Conversely, the syntaxin 1A-CFTR interaction was unaffected by mutating hydrophobic residues in the H3 domain that influence SNARE complex stability and Ca2+ channel regulation. Thus, CFTR channel regulation by syntaxin 1A involves hydrophilic interactions that are mechanistically distinct from the hydrophobic interactions that mediate SNARE complex formation and Ca2+ channel regulation by this t-SNARE.	Univ Alabama, Dept Physiol & Biophys, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Alabama System; University of Alabama Birmingham; University of Chicago; University of Southern California	Kirk, KL (corresponding author), Univ Alabama, Dept Physiol & Biophys, Gregory Fleming James Cyst Fibrosis Res Ctr, MCLM 985,1918 Univ Blvd, Birmingham, AL 35294 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058341] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL58341] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; Bezprozvanny I, 2000, P NATL ACAD SCI USA, V97, P13943, DOI 10.1073/pnas.220389697; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chang SY, 2002, J CELL SCI, V115, P783; COREY JL, 1994, J BIOL CHEM, V269, P14759; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Deken SL, 2000, NAT NEUROSCI, V3, P998, DOI 10.1038/79939; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fergestad T, 2001, J NEUROSCI, V21, P9142, DOI 10.1523/JNEUROSCI.21-23-09142.2001; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Foster LJ, 1998, BIOCHEMISTRY-US, V37, P11089, DOI 10.1021/bi980253t; Hao JC, 1997, J NEUROSCI, V17, P1596; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Naren AP, 2000, J CLIN INVEST, V105, P377, DOI 10.1172/JCI8631; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Peters KW, 1999, AM J PHYSIOL-CELL PH, V277, pC174, DOI 10.1152/ajpcell.1999.277.1.C174; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rettig J, 1996, P NATL ACAD SCI USA, V93, P7363, DOI 10.1073/pnas.93.14.7363; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sheng ZH, 1998, J BIOENERG BIOMEMBR, V30, P335, DOI 10.1023/A:1021985521748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Zhu T, 1999, J BIOL CHEM, V274, P29102, DOI 10.1074/jbc.274.41.29102	29	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2876	2885		10.1074/jbc.M211790200	http://dx.doi.org/10.1074/jbc.M211790200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12446681	hybrid			2022-12-27	WOS:000180915000016
J	Knipp, M; Braun, O; Gehrig, PM; Sack, R; Vasak, M				Knipp, M; Braun, O; Gehrig, PM; Sack, R; Vasak, M			Zn(II)-free dimethylargininase-1 (DDAH-1) is inhibited upon specific Cys-S-nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ZINC-SULFUR CLUSTERS; BOVINE BRAIN; N-G,N-G-DIMETHYLARGININE DIMETHYLAMINOHYDROLASE; ENDOTHELIAL DYSFUNCTION; MASS-SPECTROMETRY; RAT-KIDNEY; RELEASE; PROTEINS; ENZYME	The endogenous nitric oxide synthase inhibitors L-N-omega-methylarginine and L-N-omega-,N-omega-dimethylarginine are catabolized by the enzyme dimethylargininase. Dimethyl-argininase-1 from bovine brain contains one tightly bound Zn(II) coordinated by two cysteine sulfur and two lighter ligands. Activity measurements showed that only the apo-enzyme is active and that the holo-enzyme is activated by zinc removal. In this work, the effect of NO on dimethylargininase-1 structure and its activity was investigated using 2-(N,N-dimethylamino)-diazenolate-2-oxide as an NO source. The results showed that whereas the holo-form was resistant to S-nitrosylation, the apo-form could be modified. The results of absorption spectroscopy, mass spectrometry, and fluorometric S-NO quantification revealed that two of five cysteine residues reacted with NO yielding cysteine-S-NO. The modification reaction is specific, because by liquid chromatography/mass spectrometry experiments of digested S-NO-dimethylargininase-1, cysteines 221 and 273 could be identified as cysteine-NO. Because Zn(II) protects the enzyme against nitrosation, it is suggested that both cysteines are involved in metal binding. However, specific cysteine-S-NO formation occurred in the absence of a characteristic sequence motif. Based on a structural model of dimethylargininase-1, the activation of both cysteines may be accomplished by the close proximity of charged residues in the tertiary structure of the enzyme.	Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Vasak, M (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Sack, Ragna/0000-0003-0963-8089				Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; AULD DS, 1988, METHOD ENZYMOL, V158, P13, DOI 10.1016/0076-6879(88)58043-6; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Bogumil R, 1998, BIOCHEMISTRY-US, V37, P4791, DOI 10.1021/bi972312t; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Broillet MC, 1999, CELL MOL LIFE SCI, V55, P1036, DOI 10.1007/s000180050354; Brune B, 2001, CURR PROTEIN PEPT SC, V2, P61, DOI 10.2174/1389203013381206; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Choi YB, 2000, CELL MOL LIFE SCI, V57, P1535, DOI 10.1007/PL00000638; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Das I, 1996, NEUROSCI LETT, V215, P209; Dawson TM, 1996, ANNU REV MED, V47, P219, DOI 10.1146/annurev.med.47.1.219; Feelisch M., 1996, METHODS NITRIC OXIDE, P71; Ferranti P, 1997, FEBS LETT, V400, P19, DOI 10.1016/S0014-5793(96)01258-6; Fundel SM, 1996, FEBS LETT, V395, P33, DOI 10.1016/0014-5793(96)00997-0; Gergel D, 1996, BIOCHEMISTRY-US, V35, P16186, DOI 10.1021/bi962043r; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kimoto M, 1997, BBA-PROTEIN STRUCT M, V1337, P6, DOI 10.1016/S0167-4838(96)00196-3; Kimoto M, 1998, EUR J BIOCHEM, V258, P863, DOI 10.1046/j.1432-1327.1998.2580863.x; Knipp M, 2000, ANAL BIOCHEM, V286, P257, DOI 10.1006/abio.2000.4805; Knipp M, 2001, J BIOL CHEM, V276, P40449, DOI 10.1074/jbc.M104056200; Kroncke KD, 1996, METHOD ENZYMOL, V269, P279; KRONCKE KD, 1994, BIOCHEM BIOPH RES CO, V200, P1105, DOI 10.1006/bbrc.1994.1564; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Lipton SA, 1998, BIOFACTORS, V8, P33, DOI 10.1002/biof.5520080107; Lundell N, 1999, ANAL BIOCHEM, V266, P31, DOI 10.1006/abio.1998.2919; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; MIRZA UA, 1995, J BIOL CHEM, V270, P17185, DOI 10.1074/jbc.270.29.17185; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Nakagomi S, 1999, EUR J NEUROSCI, V11, P2160, DOI 10.1046/j.1460-9568.1999.00634.x; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Park JKJ, 1997, ANAL BIOCHEM, V249, P61, DOI 10.1006/abio.1997.2159; Patel RP, 1999, BBA-BIOENERGETICS, V1411, P385, DOI 10.1016/S0005-2728(99)00028-6; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Prevot V, 2000, BRAIN RES REV, V34, P27, DOI 10.1016/S0165-0173(00)00035-7; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; STRICKLER SJ, 1963, J AM CHEM SOC, V85, P2899, DOI 10.1021/ja00902a007; Strijbos PJLM, 2000, EUR J NEUROSCI, V12, P470; Thomsen LL, 1998, CLIN NEUROSCI, V5, P28; Tsao PS, 1998, J CARDIOVASC PHARM, V32, pS48; Wilcox CS, 1998, CURR OPIN NEPHROL HY, V7, P443; WILLIAMS DLH, 1996, CHEM COMMUN, V10, P1085; Zangger K, 2001, FASEB J, V15, P1303, DOI 10.1096/fj.00-0641fje	57	50	53	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3410	3416		10.1074/jbc.M209088200	http://dx.doi.org/10.1074/jbc.M209088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441345	hybrid			2022-12-27	WOS:000180915000082
J	Sigoillot, FD; Berkowski, JA; Sigoillot, SM; Kotsis, DH; Guy, HI				Sigoillot, FD; Berkowski, JA; Sigoillot, SM; Kotsis, DH; Guy, HI			Cell cycle-dependent regulation of pyrimidine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; MULTIFUNCTIONAL PROTEIN; NUCLEOTIDE BIOSYNTHESIS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; HAMSTER-CELLS; CAD; PHOSPHORYLATION; ENZYMES; KINASE	De novo pyrimidine biosynthesis is activated in proliferating cells in response to an increased demand for nucleotides needed for DNA synthesis. The pyrimidine biosynthetic pathway in baby hamster kidney cells, synchronized by serum deprivation, was found to be upregulated 1.9-fold during S phase and subsequently down-regulated as the cells progressed through the cycle. The nucleotide pools were depleted by serum starvation and were not replenished during the first round of cell division, suggesting that the rate of utilization of the newly synthesized nucleotides closely matched their rate of formation. The activation and subsequent down-regulation of the pathway can be attributed to altered allosteric regulation of the carbamoyl-phosphate synthetase activity of CAD (carbamoyl-phosphate synthetase-aspartate carbamoyltransferase-dihydroorotase), a multifunctional protein that initiates mammalian pyrimidine biosynthesis. As the culture approached S-phase there was an increased sensitivity to the allosteric activator, 5-phosphoribosyl-1-pyrophosphate, and a loss of UTP inhibition, changes that were reversed when cells emerged from S phase. The allosteric regulation of CAD is known to be modulated by MAP kinase (MAPK) and protein kinase A (PKA)-mediated phosphorylations as well as by autophosphorylation. CAD was found to be fully autophosphorylated in the synchronized cells, but the level remained invariant throughout the cycle. Although the MAPK activity increased early in G, the phosphorylation of the CAD MAPK site was delayed until just before the onset of S phase, probably due to antagonistic phosphorylation by PKA that persisted until late G,. Once activated, pyrimidine biosynthesis remained elevated until rephosphorylation. of CAD by PKA and dephosphorylation of the CAD MAPK site late in S phase. Thus, the cell cycle-dependent regulation of pyrimidine biosynthesis results from the sequential phosphorylation and dephosphorylation of CAD under the control of two important signaling cascades.	Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Guy, HI (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.			Sigoillot, Frederic/0000-0002-8695-4838	NIGMS NIH HHS [R01 GM060371, GM/CA60371] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060371] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOKI T, 1981, SCIENCE, V212, P463, DOI 10.1126/science.7209543; CALVA E, 1959, CANCER RES, V19, P101; CALVA E, 1959, CANCER RES, V19, P679; CARREY EA, 1986, BIOCHEM J, V236, P327, DOI 10.1042/bj2360327; CARREY EA, 1985, EMBO J, V4, P3735, DOI 10.1002/j.1460-2075.1985.tb04142.x; CARREY EA, 1993, BIOCHEM SOC T, V21, P191, DOI 10.1042/bst0210191; CARREY EA, 1988, EUR J BIOCHEM, V171, P583, DOI 10.1111/j.1432-1033.1988.tb13828.x; CHEN JJ, 1979, J BIOL CHEM, V254, P4908; CHEN JJ, 1979, J BIOL CHEM, V254, P2697; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; DUTTA A, 1995, P NATL ACAD SCI USA, V92, P5386, DOI 10.1073/pnas.92.12.5386; Fairbanks LD, 1999, J CHROMATOGR B, V732, P487, DOI 10.1016/S0378-4347(99)00303-5; Feliciello A, 2000, J BIOL CHEM, V275, P303, DOI 10.1074/jbc.275.1.303; FERRELL JE, 1989, J BIOL CHEM, V264, P20723; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; GRAYSON DR, 1985, J BIOL CHEM, V260, P5840; Guo N, 2000, J BIOL CHEM, V275, P1715, DOI 10.1074/jbc.275.3.1715; GUY HI, 1994, J BIOL CHEM, V269, P23808; HAGER SE, 1967, J BIOL CHEM, V242, P5667; HUISMAN WH, 1979, J BIOL CHEM, V254, P2595; ITO K, 1972, J BIOL CHEM, V248, P389; JACKSON RC, 1980, CANCER RES, V40, P1286; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; Jung EJ, 2001, BIOTECHNIQUES, V31, P1026, DOI 10.2144/01315st02; KIM S, 1965, ARCH BIOCHEM BIOPHYS, V109, P421, DOI 10.1016/0003-9861(65)90385-1; LEVINE EM, 1965, P NATL ACAD SCI USA, V53, P350, DOI 10.1073/pnas.53.2.350; LEVINE RL, 1971, BIOCHEMISTRY-US, V10, P3694; LIAO WSL, 1986, J BIOL CHEM, V261, P5577; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MITCHELL AD, 1975, EXP CELL RES, V93, P105, DOI 10.1016/0014-4827(75)90428-0; MORI M, 1975, BIOCHEMISTRY-US, V14, P2622, DOI 10.1021/bi00683a010; NORDMANN Y, 1964, NATURE, V201, P616, DOI 10.1038/201616a0; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; ROUX JM, 1973, J BIOL CHEM, V248, P1196; Sahay N, 1998, J BIOL CHEM, V273, P31195, DOI 10.1074/jbc.273.47.31195; SHAMBAUGH GE, 1974, DEV BIOL, V37, P171, DOI 10.1016/0012-1606(74)90177-8; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SHOAF WT, 1973, BIOCHEMISTRY-US, V12, P4039, DOI 10.1021/bi00745a004; Sigoillot FD, 2002, J BIOL CHEM, V277, P15745, DOI 10.1074/jbc.M201112200; Sigoillot FD, 2002, J BIOL CHEM, V277, P24809, DOI 10.1074/jbc.M203512200; SMITH ML, 1979, J CELL PHYSIOL, V101, P293, DOI 10.1002/jcp.1041010210; SMITH ML, 1979, HORMONES CELL CULTUR, V6, P789; TATIBANA M, 1969, J BIOL CHEM, V244, P5903; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; WAHL GM, 1979, J BIOL CHEM, V254, P8679; WARD GA, 1973, J CELL PHYSL, V73, P213; WEBER G, 1983, CANCER RES, V43, P3466	49	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3403	3409		10.1074/jbc.M211078200	http://dx.doi.org/10.1074/jbc.M211078200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12438317	hybrid			2022-12-27	WOS:000180915000081
J	Shoeb, F; Malykhina, AP; Akbarali, HI				Shoeb, F; Malykhina, AP; Akbarali, HI			Cloning and functional characterization of the smooth muscle ether-a-go-go-related gene K+ channel - Potential role of a conserved amino acid substitution in the S4 region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; I-KR CHANNELS; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; HUMAN HEART; TERMINAL DOMAIN; XENOPUS OOCYTES; MOLECULAR-BASIS; ERG PROTEINS; HERG	The human ether-a-go-go-related gene (HERG) product forms the pore-forming subunit of the delayed rectifier K+ channel in the heart. Unlike the cardiac isoform, the erg K+ channels in native smooth muscle demonstrate gating properties consistent with a role in maintaining resting potential. We have cloned the smooth muscle isoform of HERG, denoted as erg1-sm, from human and rabbit colon. erg1-sm is truncated by 101 amino acids in the C terminus due to a single nucleotide deletion in the 14th exon. Sequence alignment against HERG showed a substitution of alanine for valine in the S4 domain. When expressed in Xenopus oocytes, erg1-sm currents had much faster activation and deactivation kinetics compared with HERG. Step depolarization positive to -20 mV consistently produced a transient outward component. The threshold for activation of erg1-sm was -60 mV and steady-state conductance was similar to10-fold greater than HERG near the resting potential of smooth muscle. Site-directed mutagenesis of alanine to valine in the S4 region of erg1-sm converted many of the properties to that of the cardiac HERG, including shifts in the voltage dependence of activation and slowing of deactivation. These studies define the functional role of a novel isoform of the ether-a-go-go-related gene K+ channel in smooth muscle.	Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73194 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Akbarali, HI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, 940 Stanton L Young Blvd, Oklahoma City, OK 73194 USA.	hamid-akbarali@ouhsc.edu	Akbarali, Hamid/Q-9344-2019	Akbarali, Hamid/0000-0003-1423-0774	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046367, R01DK059777, R29DK046367] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46367, DK59777] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Akbarali HI, 1999, AM J PHYSIOL-CELL PH, V277, pC1284, DOI 10.1152/ajpcell.1999.277.6.C1284; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Bauer CK, 1998, RECEPTOR CHANNEL, V6, P19; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Gomez-Varela D, 2002, J MEMBRANE BIOL, V187, P117, DOI 10.1007/s00232-001-0156-4; Itoh T, 1998, HUM GENET, V102, P435, DOI 10.1007/s004390050717; January CT, 2000, J CARDIOVASC ELECTR, V11, P1413, DOI 10.1046/j.1540-8167.2000.01413.x; Kiehn J, 1999, AM J PHYSIOL-HEART C, V277, pH199, DOI 10.1152/ajpheart.1999.277.1.H199; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; LeesMiller JP, 1997, CIRC RES, V81, P719; Liu SG, 1996, BIOPHYS J, V70, P2704, DOI 10.1016/S0006-3495(96)79840-5; London B, 1997, CIRC RES, V81, P870; Lu Y, 2001, J PHYSIOL-LONDON, V537, P843, DOI 10.1113/jphysiol.2001.012690; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Ohya S, 2002, AM J PHYSIOL-CELL PH, V283, pC866, DOI 10.1152/ajpcell.00099.2002; Ohya S, 2002, AM J PHYSIOL-GASTR L, V282, pG277, DOI 10.1152/ajpgi.00200.2001; Overholt JL, 2000, J NEUROPHYSIOL, V83, P1150, DOI 10.1152/jn.2000.83.3.1150; Pond AL, 2001, TRENDS CARDIOVAS MED, V11, P286, DOI 10.1016/S1050-1738(01)00127-X; Pond AL, 2000, J BIOL CHEM, V275, P5997, DOI 10.1074/jbc.275.8.5997; SANDERS KM, 1992, ANNU REV PHYSIOL, V54, P439; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SANGUINETTI MC, 1991, AM J PHYSIOL, V260, pH393, DOI 10.1152/ajpheart.1991.260.2.H393; Sanguinetti MC, 1999, J PHYSIOL-LONDON, V514, P667, DOI 10.1111/j.1469-7793.1999.667ad.x; Schafer R, 1999, J PHYSIOL-LONDON, V518, P401, DOI 10.1111/j.1469-7793.1999.0401p.x; Shi WM, 1997, J NEUROSCI, V17, P9423; SHIBASAKI T, 1987, J PHYSIOL-LONDON, V387, P227, DOI 10.1113/jphysiol.1987.sp016571; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Snyders DJ, 1996, MOL PHARMACOL, V49, P949; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 1998, GENOMICS, V51, P86, DOI 10.1006/geno.1998.5361; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wymore RS, 1997, CIRC RES, V80, P261, DOI 10.1161/01.RES.80.2.261; Zhou W, 1998, J GEN PHYSIOL, V111, P781, DOI 10.1085/jgp.111.6.781; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x	47	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2503	2514		10.1074/jbc.M208525200	http://dx.doi.org/10.1074/jbc.M208525200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427763	hybrid			2022-12-27	WOS:000180562000059
J	Andl, CD; Mizushima, T; Nakagawa, H; Oyama, K; Harada, H; Chruma, K; Herlyn, M; Rustgi, AK				Andl, CD; Mizushima, T; Nakagawa, H; Oyama, K; Harada, H; Chruma, K; Herlyn, M; Rustgi, AK			Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal Keratinocytes in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; E-CADHERIN; GENE-EXPRESSION; CARCINOMA; ADHESION; HEAD; NECK; RHO; MATRIX-METALLOPROTEINASE-9; GTPASES	Epidermal growth factor receptor (EGFR) overexpression is observed in a number of malignancies, especially those of esophageal squamous cell origin. However, little is known about the biological functions of EGFR in primary esophageal squamous epithelial cells. Using newly established primary human esophageal squamous epithelial cells as a platform, we overexpressed EGFR through retroviral transduction and established novel three-dimensional organotypic cultures. Additionally, EGFR was targeted in a cell type- and tissue-specific fashion to the esophageal epithelium in transgenic mice. EGFR overexpression in primary esophageal keratinocytes resulted in the biochemical activation of Akt and STAT pathways and induced enhanced cell migration and cell aggregation. When established in organotypic culture, EGFR-overexpressing cells had evidence of epithelial cell hyperproliferation and hyperplasia. These effects were also observed in EGFR-overexpressing transgenic mice and the esophageal cell lines established thereof. In particular, EGFR-induced effects upon aggregation appear to be mediated through the relocalization of p120 from the cytoplasm to the membrane and increased interaction with E-cadherin. EGFR modulates cell migration through the up-regulation of matrix metalloproteinase 1. Taken together, the functional effects of EGFR overexpression help to explain its role in the initiating steps of esophageal squamous carcinogenesis.	Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; The Wistar Institute; University of Pennsylvania	Rustgi, AK (corresponding author), Univ Penn, Div Gastroenterol, 600 CRB,415 Curie Blvd, Philadelphia, PA 19104 USA.	anil2@mail.med.upenn.edu			NATIONAL CANCER INSTITUTE [P01CA025874, P01CA098101, R01CA080999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NCI NIH HHS [CA 80999, CA 25874, P01 CA098101] Funding Source: Medline; NIDCR NIH HHS [P01 DE12467] Funding Source: Medline; NIDDK NIH HHS [P30 DK50306] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alper O, 2000, INT J CANCER, V88, P566, DOI 10.1002/1097-0215(20001115)88:4<566::AID-IJC8>3.0.CO;2-D; Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Charous SJ, 1997, ANN OTO RHINOL LARYN, V106, P271, DOI 10.1177/000348949710600402; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Dossenbach C, 2001, DEVELOPMENT, V128, P4563; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200; GRAY ST, 1992, AM J PATHOL, V141, P301; Hanakawa Y, 2000, J CELL SCI, V113, P1803; HOSCHUETZKY H, 1994, J CELL BIOL, V127, P1375, DOI 10.1083/jcb.127.5.1375; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Kheradmand F, 2002, J CELL SCI, V115, P839; Kitagawa Y, 1996, CLIN CANCER RES, V2, P909; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; MANDARD AM, 2000, MUTAT RES, V62, P343; Manes S, 1999, J BIOL CHEM, V274, P6935, DOI 10.1074/jbc.274.11.6935; Manes S, 1997, J BIOL CHEM, V272, P25706, DOI 10.1074/jbc.272.41.25706; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Mohler WA, 1996, BIOTECHNIQUES, V21, P260; MULLER D, 1993, CANCER RES, V53, P165; Nakagawa H, 1997, ONCOGENE, V14, P1185, DOI 10.1038/sj.onc.1200937; Nakagawa M, 2001, J CELL SCI, V114, P1829; O-charoenrat P, 2000, CANCER RES, V60, P1121; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickett KL, 1999, J DENT RES, V78, P1354, DOI 10.1177/00220345990780071001; POLETTE M, 1991, INVAS METAST, V11, P76; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shimada Y, 1999, BRIT J CANCER, V80, P1281, DOI 10.1038/sj.bjc.6690499; StetlerStevenson WG, 1996, SEMIN CANCER BIOL, V7, P147, DOI 10.1006/scbi.1996.0020; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779	38	208	213	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1824	1830		10.1074/jbc.M209148200	http://dx.doi.org/10.1074/jbc.M209148200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12435727	hybrid			2022-12-27	WOS:000180462200061
J	Cui, S; Klima, R; Ochem, A; Arosio, D; Falaschi, A; Vindigni, A				Cui, S; Klima, R; Ochem, A; Arosio, D; Falaschi, A; Vindigni, A			Characterization of the DNA-unwinding activity of human RECQ1, a helicase specifically stimulated by human replication protein A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; SYNDROME GENE-PRODUCT; ROTHMUND-THOMSON-SYNDROME; BLOOMS-SYNDROME HELICASE; ESCHERICHIA-COLI; BINDING PROTEIN; HELA-CELLS; FUNCTIONAL INTERACTION; MOLECULAR-CLONING; DROSOPHILA	The RecQ helicases are involved in several aspects of DNA metabolism. Five members of the RecQ family have been found in humans, but only two of them have been carefully characterized, BLM and WRN. In this work, we describe the enzymatic characterization of RECQ1. The helicase has 3' to 5' polarity, cannot start the unwinding from a blunt-ended terminus, and needs a 3'-single-stranded DNA tail longer than 10 nucleotides to open the substrate. However, it was also able to unwind a blunt-ended duplex DNA with a "bubble" of 25 nucleotides in the middle, as previously observed for WRN and BLM. We show that only short DNA duplexes (<30 bp) can be unwound by RECQ1 alone, but the addition of human replication protein A (hRPA) increases the processivity of the enzyme (>100 bp). Our studies done with Escherichia coli single-strand binding protein (SSB) indicate that the helicase activity of RECQ1 is specifically stimulated by hRPA. This finding suggests that RECQ1 and hRPA may interact also in vivo and function together in DNA metabolism. Comparison of the present results with previous studies on WRN and BLM provides novel insight into the role of the N- and C-terminal domains of these helicases in determining their substrate specificity and in their interaction with hRPA.	Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Vindigni, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	vindigni@icgeb.org	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020; arosio, daniele/B-3160-2012	Sheng, CUI/0000-0001-6329-3582; 				Arosio D, 2002, J BIOL CHEM, V277, P9741, DOI 10.1074/jbc.M111916200; Blander G, 1999, J BIOL CHEM, V274, P29463, DOI 10.1074/jbc.274.41.29463; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 2002, J BIOL CHEM, V277, P23236, DOI 10.1074/jbc.M111446200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Cooper MP, 2000, GENE DEV, V14, P907; Costa M, 1999, NUCLEIC ACIDS RES, V27, P817, DOI 10.1093/nar/27.3.817; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; Hickson ID, 2001, BIOCHEM SOC T, V29, P201, DOI 10.1042/0300-5127:0290201; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; KOZMIK Z, 1990, NUCLEIC ACIDS RES, V18, P2198, DOI 10.1093/nar/18.8.2198; Kusano K, 1999, GENETICS, V151, P1027; Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795; Li BM, 2000, J BIOL CHEM, V275, P39800; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; NAKAYAMA K, 1985, MOL GEN GENET, V200, P266, DOI 10.1007/BF00425434; Ozsoy AZ, 2001, NUCLEIC ACIDS RES, V29, P2986, DOI 10.1093/nar/29.14.2986; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Sekelsky JJ, 1999, NUCLEIC ACIDS RES, V27, P3762, DOI 10.1093/nar/27.18.3762; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; SEKI M, 1994, J BIOCHEM-TOKYO, V115, P523, DOI 10.1093/oxfordjournals.jbchem.a124369; Shen JC, 1998, NUCLEIC ACIDS RES, V26, P2879, DOI 10.1093/nar/26.12.2879; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; TUTEJA N, 1990, NUCLEIC ACIDS RES, V18, P6785, DOI 10.1093/nar/18.23.6785; TUTEJA N, 1995, NUCLEIC ACIDS RES, V23, P2457, DOI 10.1093/nar/23.13.2457; TUTEJA N, 1993, NUCLEIC ACIDS RES, V21, P2323, DOI 10.1093/nar/21.10.2323; TUTEJA N, 1991, NUCLEIC ACIDS RES, V19, P3613, DOI 10.1093/nar/19.13.3613; TUTEJA N, 1992, NUCLEIC ACIDS RES, V20, P5329, DOI 10.1093/nar/20.20.5329; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; Vindigni A, 2001, NUCLEIC ACIDS RES, V29, P1061, DOI 10.1093/nar/29.5.1061; von Kobbe C, 2002, J BIOL CHEM, V277, P22035, DOI 10.1074/jbc.M200914200; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2001, SCIENCE, V292, P229, DOI 10.1126/science.1060832; Yang Q, 2002, J BIOL CHEM, V277, P31980, DOI 10.1074/jbc.M204111200; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	56	63	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1424	1432		10.1074/jbc.M209407200	http://dx.doi.org/10.1074/jbc.M209407200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419808	hybrid			2022-12-27	WOS:000180462200009
J	Geiben-Lynn, R; Kursar, M; Brown, NV; Addo, MM; Shau, H; Lieberman, J; Luster, AD; Walker, BD				Geiben-Lynn, R; Kursar, M; Brown, NV; Addo, MM; Shau, H; Lieberman, J; Luster, AD; Walker, BD			HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; NONCYTOLYTIC INHIBITION; THIOREDOXIN PEROXIDASE; ANTIOXIDANT PROPERTIES; REVERSE TRANSCRIPTION; CHEMOKINE RECEPTORS; PRIMARY MACROPHAGES	CD8(+) T-cells are a major source for the production of non-cytolytic factors that inhibit HIV-1 replication. In order to characterize further these factors, we analyzed gene expression profiles of activated CD8(+) T-cells using a human cDNA expression array containing 588 human cDNAs. mRNA for the chemokine I-309 (CCL1), the cytokines granulocyte-macrophage colony-stimulating factor and interleukin-13, and natural killer cell enhancing factors (NKEF) -A and -B were up-regulated in bulk CD8(+) T-cells from HIV-1 seropositive individuals compared with seronegative individuals. Recombinant NKEF-A and NKEF-B inhibited HIV-1 replication when exogenously added to acutely infected T-cells at an ID50 (dose inhibiting HIV-1 replication by 50%) of similar to130 nm (3 mug/ml). Additionally, inhibition against dual-tropic simian immunodeficiency virus and dual-tropic simian-human immunodeficiency virus was found. T-cells transfected with NKEF-A or NKEF-B cDNA were able to inhibit 80-98% HIV-1 replication in vitro. Elevated plasma levels of both NKEF-A and NKEF-B proteins were detected in 23% of HIV-infected non-treated individuals but not in persons treated with highly active antiviral therapy or uninfected persons. These results indicate that the peroxiredoxin family members NKEF-A and NKEF-B are up-regulated in activated CD8(+) T-cells in HIV infection, and suggest that these antioxidant proteins contribute to the antiviral activity of CD8(+) T-cells.	Massachusetts Gen Hosp, Partners AIDS Res Ctr, Hillsborough 02129, North Ireland; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Hillsborough 02129, North Ireland; Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Hillsborough 02129, North Ireland; Harvard Univ, Sch Med, Hillsborough 02129, North Ireland; Univ Calif Los Angeles, Sch Med, Div Surg Oncol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Geiben-Lynn, R (corresponding author), Massachusetts Gen Hosp, Partners AIDS Res Ctr, Bldg 149,13th St, Hillsborough 02129, North Ireland.		Luster, Andrew/ABE-6504-2020; Lieberman, Judy/A-2717-2015; Addo, Marylyn M./GNP-2548-2022	Luster, Andrew/0000-0001-9679-7912; Addo, Marylyn/0000-0003-2836-9224	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046999, R01AI028568, R37AI028568, R01AI030914] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28568, AI30914, AI46999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allard JP, 1998, AM J CLIN NUTR, V67, P143, DOI 10.1093/ajcn/67.1.143; Bailer RT, 2000, EUR J IMMUNOL, V30, P1340, DOI 10.1002/(SICI)1521-4141(200005)30:5<1340::AID-IMMU1340>3.0.CO;2-L; BARKER E, 1995, P NATL ACAD SCI USA, V92, P11135, DOI 10.1073/pnas.92.24.11135; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Butterfield LH, 1999, ANTIOXID REDOX SIGN, V1, P385, DOI 10.1089/ars.1999.1.4-385; CASTRO BA, 1991, CELL IMMUNOL, V132, P246, DOI 10.1016/0008-8749(91)90023-5; CHEN CH, 1993, AIDS RES HUM RETROV, V9, P1079, DOI 10.1089/aid.1993.9.1079; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Crowe SM, 1997, J LEUKOCYTE BIOL, V62, P41, DOI 10.1002/jlb.62.1.41; de Martino M, 2001, CLIN IMMUNOL, V100, P82, DOI 10.1006/clim.2001.5042; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; Elbim C, 1999, J VIROL, V73, P4561, DOI 10.1128/JVI.73.6.4561-4566.1999; Fowke KR, 2000, IMMUNOL CELL BIOL, V78, P586, DOI 10.1046/j.1440-1711.2000.00944.x; Furci L, 1997, J EXP MED, V186, P455, DOI 10.1084/jem.186.3.455; Geiben-Lynn R, 2002, J BIOL CHEM, V277, P42352, DOI 10.1074/jbc.M207079200; Geiben-Lynn R, 2001, J VIROL, V75, P8306, DOI 10.1128/JVI.75.17.8306-8316.2001; Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Kim AT, 1997, TOXICOL APPL PHARM, V147, P135, DOI 10.1006/taap.1997.8270; Lachgar A, 1999, J VIROL, V73, P1447, DOI 10.1128/JVI.73.2.1447-1452.1999; Le Borgne S, 2000, J VIROL, V74, P4456, DOI 10.1128/JVI.74.10.4456-4464.2000; Letvin NL, 1998, J CLIN INVEST, V102, P1643, DOI 10.1172/JCI5440; Locher CP, 1999, IMMUNOL LETT, V66, P151, DOI 10.1016/S0165-2478(98)00175-8; Mackewicz CE, 2000, J GEN VIROL, V81, P1261, DOI 10.1099/0022-1317-81-5-1261; MACKEWICZ CE, 1995, P NATL ACAD SCI USA, V92, P2308, DOI 10.1073/pnas.92.6.2308; Malorni W, 1998, AIDS RES HUM RETROV, V14, P1589, DOI 10.1089/aid.1998.14.1589; MASUTANI H, 1992, AIDS RES HUM RETROV, V8, P1707, DOI 10.1089/aid.1992.8.1707; McMichael A, 1998, CELL, V93, P673, DOI 10.1016/S0092-8674(00)81428-2; McMichael AJ, 2000, PHILOS T R SOC B, V355, P363, DOI 10.1098/rstb.2000.0575; Moriuchi H, 1996, P NATL ACAD SCI USA, V93, P15341, DOI 10.1073/pnas.93.26.15341; Nagai S, 2001, INT IMMUNOL, V13, P367, DOI 10.1093/intimm/13.3.367; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; OKAMOTO T, 1992, INT IMMUNOL, V4, P811, DOI 10.1093/intimm/4.7.811; Pal R, 1997, SCIENCE, V278, P695, DOI 10.1126/science.278.5338.695; Perl A, 2000, ANTIOXID REDOX SIGN, V2, P551, DOI 10.1089/15230860050192323; Rana S, 1997, J VIROL, V71, P3219, DOI 10.1128/JVI.71.4.3219-3227.1997; Rizzardi GP, 1998, CLIN EXP IMMUNOL, V114, P61; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Sarafian TA, 1997, FREE RADICAL RES, V26, P281, DOI 10.3109/10715769709097806; Sarafian TA, 1998, MOL CHEM NEUROPATHOL, V34, P39, DOI 10.1007/BF02815135; Sauri H, 1996, J LEUKOCYTE BIOL, V59, P925, DOI 10.1002/jlb.59.6.925; Seve M, 1999, ARCH BIOCHEM BIOPHYS, V361, P165, DOI 10.1006/abbi.1998.0942; Shau H, 1998, BIOCHEM BIOPH RES CO, V249, P683, DOI 10.1006/bbrc.1998.9129; SHAU HG, 1994, IMMUNOGENETICS, V40, P129; Shau HY, 1997, FREE RADICAL BIO MED, V22, P497, DOI 10.1016/S0891-5849(96)00372-3; SHAU HY, 1993, CELL IMMUNOL, V147, P1, DOI 10.1006/cimm.1993.1043; SHAU HY, 1994, BIOCHEM BIOPH RES CO, V199, P83, DOI 10.1006/bbrc.1994.1197; Tomaras GD, 2000, P NATL ACAD SCI USA, V97, P3503, DOI 10.1073/pnas.070521097; Walker BD, 1998, ADV EXP MED BIOL, V452, P159; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WALKER CM, 1991, J VIROL, V65, P5921, DOI 10.1128/JVI.65.11.5921-5927.1991; Yang OO, 1997, ADV IMMUNOL, V66, P273, DOI 10.1016/S0065-2776(08)60600-8; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	61	74	81	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1569	1574		10.1074/jbc.M209964200	http://dx.doi.org/10.1074/jbc.M209964200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421812	hybrid			2022-12-27	WOS:000180462200027
J	Andoh, T; Chiueh, CC; Chock, PB				Andoh, T; Chiueh, CC; Chock, PB			Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; CELL-DEATH; SUPEROXIDE-DISMUTASE; PC12 CELLS; INHIBITION; REDUCTASE; BCL-2; DISTINCT; 1-CHLORO-2,4-DINITROBENZENE; PHOSPHORYLATION	Human neuroblastoma cells, SH-SY5Y, contain relatively low levels of thioredoxin (Trx); thus, they serve favorably as a model for studying oxidative stress-induced apoptosis (Andoh, T., Chock, P. B., and Chiueh, C. C. (2001) J. BioL Chem. 277, 9655-9660). When these neurotrophic cells were subjected to nonlethal 2-h serum deprivation, their neuronal nitric oxide synthase and Trx were up-regulated, and the cells became more tolerant of oxidative stress, indicating that NO may protect cells from serum deprivation-induced apoptosis. Here, the mechanism by which NO exerts its protective effects was investigated. Our results reveal that in SH-SY5Y cells, NO inhibits apoptosis through its ability to activate guanylate cyclase, which in turn activates the cGMP-dependent protein kinase (PKG). The activated PKG is required to protect cells from lipid peroxidation and apoptosis, to inhibit caspase-9 and caspase-3 activation, and to elevate the levels of Trx peroxidase-1 and Trx, which subsequently induces the expression of Bcl-2. Furthermore, active PKG promotes the elevation of c-Jun, phosphorylated MAPK/ERK1/2, and c-Myc, consistent with the notion that PKG enhances the expression of Trx through its c-Myc-, AP-1-, and PEA3-binding motifs. Elevation of Trx and Trx peroxidase-1 and Mn(II)-superoxide dismutase would reduce H2O2 and O-2(.-), respectively. Thus, the cytoprotective effect of NO in SH-SY5Y cells appears to proceed via the PKG-mediated pathway, and S-nitrosylation of caspases plays a minimal role.	NHLBI, LB, NIH, Bethesda, MD 20892 USA; NIMH, Clin Sci Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Chock, PB (corresponding author), NHLBI, LB, NIH, Bldg 50,Rm 2134,50 S Dr,MSC-8012, Bethesda, MD 20892 USA.	pbc@helix.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000202, ZIAHL000202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002648] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Andoh T, 2000, FASEB J, V14, P2144; Andoh T, 2002, J BIOL CHEM, V277, P9655, DOI 10.1074/jbc.M110701200; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; BARGER SW, 1995, J NEUROCHEM, V64, P2087; Basuyaux JP, 1997, J BIOL CHEM, V272, P26188, DOI 10.1074/jbc.272.42.26188; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; CHIUEH CC, 1994, ANN NY ACAD SCI, V738, P25; Chung HT, 2001, BIOCHEM BIOPH RES CO, V282, P1075, DOI 10.1006/bbrc.2001.4670; deLaunoit Y, 1997, BIOCHEM MOL MED, V61, P127, DOI 10.1006/bmme.1997.2605; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; GAMM DM, 1995, J BIOL CHEM, V270, P27380, DOI 10.1074/jbc.270.45.27380; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Heneka MT, 1998, J NEUROCHEM, V71, P88; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ishikawa A, 1999, NEUROSCI LETT, V277, P99, DOI 10.1016/S0304-3940(99)00850-2; KAGHAD M, 1994, GENE, V140, P273, DOI 10.1016/0378-1119(94)90557-6; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim YM, 1998, J BIOL CHEM, V273, P31437, DOI 10.1074/jbc.273.47.31437; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; Messmer UK, 1996, FEBS LETT, V384, P162; Moskovitz J, 1999, METHOD ENZYMOL, V300, P239; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Satoh T, 1996, BRAIN RES, V733, P9, DOI 10.1016/0006-8993(96)00527-6; SETH A, 1991, J BIOL CHEM, V266, P23521; Sheehan JP, 1997, J NEUROSCI RES, V48, P226, DOI 10.1002/(SICI)1097-4547(19970501)48:3<226::AID-JNR5>3.0.CO;2-H; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Thippeswamy T, 1997, BRAIN RES, V774, P116, DOI 10.1016/S0006-8993(97)81694-0; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; Wiesel P, 2000, J BIOL CHEM, V275, P24840, DOI 10.1074/jbc.M000835200; Wirtz-Brugger F, 2000, NEUROSCIENCE, V99, P737, DOI 10.1016/S0306-4522(00)00243-8; Yim HS, 1997, J BIOL CHEM, V272, P8861	45	70	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					885	890		10.1074/jbc.M209914200	http://dx.doi.org/10.1074/jbc.M209914200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414792	hybrid			2022-12-27	WOS:000180321900026
J	French, SW; Malone, CS; Shen, RR; Renard, M; Henson, SE; Miner, MD; Wall, R; Teitell, MA				French, SW; Malone, CS; Shen, RR; Renard, M; Henson, SE; Miner, MD; Wall, R; Teitell, MA			Sp1 transactivation of the TCL1 oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER TRANSCRIPTION FACTORS; CENTER B-CELLS; GENE-EXPRESSION; BINDING-SITES; CYTOSINE METHYLATION; ANTISILENCER ELEMENT; SILENCER ELEMENTS; LYMPHOID-TISSUES; VIMENTIN GENE; CPG ISLAND	Cis-regions and trans-factors controlling TCL1 oncogene expression are not known. We identified the functional TCL1 promoter by mapping four transcriptional start sites 24-30 bp downstream of a TATA box. A 424-bp fragment upstream of the major start site showed robust promoter activity comparable with SV40 in both TCL1 expressing and non-expressing cell lines. Additional constructs spanning 10 kb upstream and 20 kb downstream of the start site showed only modest increases in reporter activity indicating that TCL1 expression is primarily controlled by the promoter. Ten putative Sp1-binding sites were identified within 300 bp of the start site, and three of these specifically bound Sp1. A dose-dependent transactivation of the TCL1 promoter with Sp1 addition in Sp1-negative Drosophila SL2 cells was observed, and mutation of the three identified Sp1-binding sites significantly repressed reporter gene expression in 293T cells, confirming a key role for Sp1 in activating the TCL1 promoter in vivo. In TCL1 silent cell lines, CpG DNA methylation was rarely observed at functional Sp1 sites, and methylation of a previously reported NotI restriction site was associated with dense CpG methylation rather than endogenous TCL1 gene silencing. Together, these results indicate that Sp1 mediates transactivation of the TCL1 core promoter and that TCL1 gene silencing is not dependent on mechanisms involving Sp1 and Not1 site methylation.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, MacDonald Res Labs 4 760,Ctr Hlth Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Hlth Sci Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Hlth Sci Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Hlth Sci Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Hlth Sci Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, AIDS Inst, Hlth Sci Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Teitell, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, MacDonald Res Labs 4 760,Ctr Hlth Sci, 675 Charles Young Dr S, Los Angeles, CA 90095 USA.			Miner, Maurine/0000-0002-4637-1283	NATIONAL CANCER INSTITUTE [R01CA085841, T32CA009056, T32CA009120, R01CA090571, K08CA074929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040185] Funding Source: NIH RePORTER; NCI NIH HHS [CA90571, CA85841, T32CA009120, T32CA009056, CA74929] Funding Source: Medline; NIGMS NIH HHS [GM07185, GM40185] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arvand A, 2001, CANCER RES, V61, P5311; BENHATTAR J, 1989, NUCLEIC ACIDS RES, V17, P10179, DOI 10.1093/nar/17.24.10179; BERG JM, 1992, P NATL ACAD SCI USA, V89, P11109, DOI 10.1073/pnas.89.23.11109; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; CHEN JH, 1993, ONCOGENE, V8, P133; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Dennig J, 1996, EMBO J, V15, P5659, DOI 10.1002/j.1460-2075.1996.tb00950.x; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Dobretsova A, 1999, J NEUROCHEM, V72, P2227, DOI 10.1046/j.1471-4159.1999.0722227.x; Drexler HG, 1998, LEUKEMIA, V12, P1507, DOI 10.1038/sj.leu.2401160; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Ferradini L, 1994, Semin Immunol, V6, P165, DOI 10.1006/smim.1994.1022; French SW, 2002, BIOCHEMISTRY-US, V41, P6376, DOI 10.1021/bi016068o; Gaidano G, 2001, ADV CANCER RES, V80, P115, DOI 10.1016/S0065-230X(01)80014-2; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; Grayson J, 1998, J CELL BIOCHEM, V70, P366, DOI 10.1002/(SICI)1097-4644(19980901)70:3<366::AID-JCB10>3.3.CO;2-T; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Hoyer KK, 2002, P NATL ACAD SCI USA, V99, P14392, DOI 10.1073/pnas.212410199; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Izmailova ES, 1999, GENE, V230, P111, DOI 10.1016/S0378-1119(99)00046-3; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; KOLLMAR R, 1993, P SOC EXP BIOL MED, V203, P127; Korswagen HC, 1999, COLD SPRING HARB SYM, V64, P141, DOI 10.1101/sqb.1999.64.141; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Kwon HS, 1999, J BIOL CHEM, V274, P20, DOI 10.1074/jbc.274.1.20; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Malone CS, 1997, P NATL ACAD SCI USA, V94, P12314, DOI 10.1073/pnas.94.23.12314; Malone CS, 2001, GENE, V268, P9, DOI 10.1016/S0378-1119(01)00430-9; MARTENSSON IL, 1994, INT IMMUNOL, V6, P863, DOI 10.1093/intimm/6.6.863; Matolcsy A, 1998, AM J PATHOL, V153, P1609, DOI 10.1016/S0002-9440(10)65749-5; Nakayama I, 2000, PATHOL INT, V50, P191, DOI 10.1046/j.1440-1827.2000.01023.x; Narducci MG, 2000, CANCER RES, V60, P2095; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; OMORI SA, 1993, P NATL ACAD SCI USA, V90, P11723, DOI 10.1073/pnas.90.24.11723; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Radtke F, 1996, BIOL CHEM H-S, V377, P47, DOI 10.1515/bchm3.1996.377.1.47; Said JW, 2001, LAB INVEST, V81, P555, DOI 10.1038/labinvest.3780264; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; STOVER DM, 1992, MOL CELL BIOL, V12, P2230, DOI 10.1128/MCB.12.5.2230; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki Y, 1999, BLOOD, V93, P4264, DOI 10.1182/blood.V93.12.4264.412k27_4264_4276; Teitell M, 1999, P NATL ACAD SCI USA, V96, P9809, DOI 10.1073/pnas.96.17.9809; TEITELL M, 2002, WILEYS ENCY MOL MED, P3106; THIESEN HJ, 1990, NUCLEIC ACIDS RES, V18, P3203, DOI 10.1093/nar/18.11.3203; Tretiakova A, 1999, J CELL PHYSIOL, V181, P160, DOI 10.1002/(SICI)1097-4652(199910)181:1<160::AID-JCP17>3.0.CO;2-H; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Yuille MR, 2001, GENE CHROMOSOME CANC, V30, P336, DOI 10.1002/gcc.1099	71	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					948	955		10.1074/jbc.M207166200	http://dx.doi.org/10.1074/jbc.M207166200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12421830	hybrid			2022-12-27	WOS:000180321900034
J	Waetzig, V; Herdegen, T				Waetzig, V; Herdegen, T			A single c-Jun N-terminal kinase isoform (JNK3-p54) is an effector in both neuronal differentiation and cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; RAT PC12 CELLS; GROWTH-FACTOR; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; IN-VIVO; DEPENDENT REGULATION; SYMPATHETIC NEURONS; NEURITE OUTGROWTH	The c-Jun N-terminal kinases (JNKs) mediate degeneration and apoptosis in the brain. Particularly, JNK3 is considered to be a degenerative enzyme with c-Jun as a relevant substrate. The contribution of individual JNK isoforms, however, to pathological as well as to physiological processes remains to be defined. To analyze the effects of a single JNK isoform on neuronal cell death and differentiation, we transfected PC12 cells, which normally express only JNK1 and JNK2, with JNK3-p54. Transfected JNK3 significantly enhanced cell death after UV irradiation (0.5-6 J/cm(2)) and paclitaxel/taxol treatment (1-10 mum). In contrast, in the context of nerve growth factor-induced (10 or 50 ng/ml) differentiation of PC12 cells, JNK3 expression significantly increased the number and length of neurites. This functional dichotomy of JNK3 was mirrored by differential activation and induction of nuclear JNK substrates; although activating transcription factor-2 phosphorylation was enhanced by death signaling in response to UV and taxol, c-Jun protein expression and N-terminal phosphorylation were increased during nerve growth factor-induced differentiation. The absence of significant JNK activation or target phosphorylation in response to H2O2 (60 mum) further supports the hypothesis that JNK isoforms are not merely injury- or stress-specific kinases but also have context-specific physiological functions.	Univ Kiel, Med Ctr, Inst Pharmacol, D-24105 Kiel, Germany	University of Kiel	Herdegen, T (corresponding author), Univ Kiel, Med Ctr, Inst Pharmacol, Hosp Str 4, D-24105 Kiel, Germany.	t.herdegen@pharmakologie.uni-kiel.de	herdegen, thomas/E-5135-2010					Bruckner SR, 2001, J NEUROCHEM, V78, P298, DOI 10.1046/j.1471-4159.2001.00400.x; Butterfield L, 1999, BIOCHEM J, V338, P681, DOI 10.1042/0264-6021:3380681; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Chihab R, 1998, MOL BRAIN RES, V63, P105, DOI 10.1016/S0169-328X(98)00266-6; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Crocker SJ, 2001, P NATL ACAD SCI USA, V98, P13385, DOI 10.1073/pnas.231177098; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Figueroa-Masot XA, 2001, J NEUROSCI, V21, P4657, DOI 10.1523/JNEUROSCI.21-13-04657.2001; Fritz G, 1999, MOL CELL BIOL, V19, P1768; Ghahremani MH, 2002, J BIOL CHEM, V277, P35586, DOI 10.1074/jbc.M204362200; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Giasson BI, 1999, J NEUROCHEM, V72, P1081, DOI 10.1046/j.1471-4159.1999.0721081.x; Goodman MN, 1998, J NEUROBIOL, V36, P537, DOI 10.1002/(SICI)1097-4695(19980915)36:4<537::AID-NEU7>3.0.CO;2-X; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Heasley LE, 1996, MOL CELL BIOL, V16, P648; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Herdegen T, 1998, J NEUROSCI, V18, P5124, DOI 10.1523/JNEUROSCI.18-14-05124.1998; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ivanov VN, 1999, J BIOL CHEM, V274, P14079, DOI 10.1074/jbc.274.20.14079; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kita Y, 1998, J CELL SCI, V111, P907; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Ladiwala U, 1998, J NEUROSCI, V18, P1297; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Mc Gee MM, 2002, J BIOL CHEM, V277, P18383, DOI 10.1074/jbc.M112058200; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mielke K, 2000, MOL BRAIN RES, V75, P128, DOI 10.1016/S0169-328X(99)00308-3; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Minden A., 1997, BIOCHIM BIOPHYS ACTA, V1333, P85, DOI DOI 10.1016/S0304-419X(97)00018-8; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Namgung U, 2000, J NEUROSCI, V20, P6442, DOI 10.1523/JNEUROSCI.20-17-06442.2000; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Saporito MS, 2000, J NEUROCHEM, V75, P1200, DOI 10.1046/j.1471-4159.2000.0751200.x; Savage MJ, 2002, J NEUROSCI, V22, P3376; Shackelford DA, 2001, MOL BRAIN RES, V94, P178, DOI 10.1016/S0169-328X(01)00245-5; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Stone AA, 2000, EXP CELL RES, V254, P110, DOI 10.1006/excr.1999.4731; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILHELM D, 1995, IMMUNOBIOLOGY, V193, P143, DOI 10.1016/S0171-2985(11)80537-1; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yao RJ, 1997, J BIOL CHEM, V272, P18261, DOI 10.1074/jbc.272.29.18261; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605	65	62	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					567	572		10.1074/jbc.M207391200	http://dx.doi.org/10.1074/jbc.M207391200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12401814	hybrid			2022-12-27	WOS:000180255700074
J	Swamynathan, SK; Piatigorsky, J				Swamynathan, SK; Piatigorsky, J			Orientation-dependent influence of an intergenic enhancer on the promoter activity of the divergently transcribed mouse Shsp/alpha B-crystallin and Mkbp/HspB2 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; NON-LENTICULAR TISSUES; ALPHA-A-CRYSTALLIN; BETA-GLOBIN; TRANSGENIC MICE; CORE PROMOTERS; SHARED ENHANCER; SKELETAL-MUSCLE; 3RD INTRON; LENS	The mouse Shsp/alphaB-crystallin and Mkbp/HspB2 genes are closely linked and divergently transcribed. In this study, we have analyzed the contribution of the intergenic enhancer to Sitsp/alphaB-crystallin and Mkbp/HspB2 promoter activity using dual-reporter vectors in transient transfection and transgenic mouse experiments. Deletion of the enhancer reduced Shsp/alphaB-crystallin promoter activity by 30- and 93-fold and Mkbp/HspB2 promoter activity by 6- and 10-fold in transiently transfected mouse lens alpha-TN4 and myoblast C2C12 cells, respectively. Surprisingly, inversion of the enhancer reduced Shsp/alphaB-crystallin promoter activity by 17-fold, but did not affect Mkbp/HspB2 promoter activity in the transfected cells. In contrast, enhancer activity was orientation-independent in combination with a heterologous promoter in transfected cells. Transgenic mouse experiments established the orientation dependence and Shsp/alphaB-crystallin promoter preference of the intergenic enhancer in its native context. The orientation dependence and preferential effect of the Shsp/alphaB-crystallin enhancer on the Shsp/alphaB-crystallin promoter provide an example of adaptive changes in gene regulation accompanying the functional diversification of duplicated genes during evolution.	NEI, Mol & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Piatigorsky, J (corresponding author), NEI, Mol & Dev Biol Lab, NIH, Bldg 6,Rm 201,6 Ctr Dr, Bethesda, MD 20892 USA.			Swamynathan, Shivalingappa/0000-0002-9158-1511				Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Angulo A, 2000, J VIROL, V74, P2826, DOI 10.1128/JVI.74.6.2826-2839.2000; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; BURBELO PD, 1988, P NATL ACAD SCI USA, V85, P9679, DOI 10.1073/pnas.85.24.9679; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; Connelly MA, 1998, GENOMICS, V47, P71, DOI 10.1006/geno.1997.5076; Coughlin BC, 2000, J BIOL CHEM, V275, P12051, DOI 10.1074/jbc.275.16.12051; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DUBIN RA, 1991, MOL CELL BIOL, V11, P4340, DOI 10.1128/MCB.11.9.4340; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; DUNCAN MK, 1995, GENE, V162, P189, DOI 10.1016/0378-1119(95)00363-B; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; FOLEY KP, 1992, GENE DEV, V6, P730, DOI 10.1101/gad.6.5.730; Gemel J, 1999, J BIOL CHEM, V274, P6020, DOI 10.1074/jbc.274.9.6020; Gopal-Srivastava R, 1998, J BIOL CHEM, V273, P17954, DOI 10.1074/jbc.273.28.17954; Gopal-Srivastava R, 2000, MECH DEVELOP, V92, P125, DOI 10.1016/S0925-4773(99)00341-X; GopalSrivastava R, 1996, J BIOL CHEM, V271, P23029, DOI 10.1074/jbc.271.38.23029; GOPALSRIVASTAVA R, 1994, NUCLEIC ACIDS RES, V22, P1281, DOI 10.1093/nar/22.7.1281; GOPALSRIVASTAVA R, 1993, MOL CELL BIOL, V13, P7144, DOI 10.1128/MCB.13.11.7144; GOPALSRIVASTAVA R, 1995, MOL CELL BIOL, V15, P7081; HAYASHI S, 1987, GENE DEV, V1, P818, DOI 10.1101/gad.1.8.818; Haynes JI, 1996, DEV DYNAM, V207, P75, DOI 10.1002/(SICI)1097-0177(199609)207:1<75::AID-AJA8>3.3.CO;2-O; Herault Y, 1997, DEVELOPMENT, V124, P3493; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hough RB, 2002, P NATL ACAD SCI USA, V99, P8145, DOI 10.1073/pnas.122231099; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; JONSSON JJ, 1994, GENE, V140, P187, DOI 10.1016/0378-1119(94)90543-6; Kappe G, 2001, BBA-GENE STRUCT EXPR, V1520, P1, DOI 10.1016/S0167-4781(01)00237-8; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; NICKOL JM, 1988, P NATL ACAD SCI USA, V85, P2548, DOI 10.1073/pnas.85.8.2548; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; Nolan EM, 1996, MOL CELL ENDOCRINOL, V124, P51, DOI 10.1016/S0303-7207(96)03927-5; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; PARMACEK MS, 1994, MOL CELL BIOL, V14, P1870, DOI 10.1128/MCB.14.3.1870; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; Piatigorsky J, 1998, PROG RETIN EYE RES, V17, P145, DOI 10.1016/S1350-9462(97)00004-9; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; REDDAN JR, 1986, DIFFERENTIATION, V33, P168, DOI 10.1111/j.1432-0436.1986.tb00422.x; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Scohy S, 2000, NUCLEIC ACIDS RES, V28, P3743, DOI 10.1093/nar/28.19.3743; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Surinya KH, 1998, J BIOL CHEM, V273, P16798, DOI 10.1074/jbc.273.27.16798; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; WAWROUSEK EF, 1990, DEV BIOL, V137, P68, DOI 10.1016/0012-1606(90)90008-7; Wei W, 2000, P NATL ACAD SCI USA, V97, P14518, DOI 10.1073/pnas.011529598; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; YAMADA T, 1990, CURR EYE RES, V9, P31, DOI 10.3109/02713689009000052; Zhang XH, 1997, J BIOL CHEM, V272, P29272, DOI 10.1074/jbc.272.46.29272	63	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 20	2002	277	51					49700	49706		10.1074/jbc.M209700200	http://dx.doi.org/10.1074/jbc.M209700200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	629AU	12403771	hybrid			2022-12-27	WOS:000180028900080
J	Skelton, NJ; Koehler, MFT; Zobel, K; Wong, WL; Yeh, S; Pisabarro, MT; Yin, JP; Lasky, LA; Sidhu, SS				Skelton, NJ; Koehler, MFT; Zobel, K; Wong, WL; Yeh, S; Pisabarro, MT; Yin, JP; Lasky, LA; Sidhu, SS			Origins of PDZ domain ligand specificity - Structure determination and mutagenesis of the erbin PDZ domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR-SUPPRESSOR PROTEIN; NMDA RECEPTOR SUBUNITS; PEPTIDE RECOGNITION; GUANYLATE KINASES; EPITHELIAL-CELLS; BINDING DOMAIN; BETA-HAIRPINS; PHAGE DISPLAY; GROWTH-FACTOR	The LAP (leucine-rich repeat and PDZ-containing) family of proteins play a role in maintaining epithelial and neuronal cell size, and mutation of these proteins can have oncogenic consequences. The LAP protein Erbin has been implicated previously in a number of cellular activities by virtue of its PDZ domain-dependent association with the C termini of both ERB-B2 and the p120-catenins. The present work describes the NMR structure of Erbin PDZ in complex with a high affinity peptide ligand and includes a comprehensive energetic analysis of both the ligand and PDZ domain side chains responsible for binding. C-terminal phage display has been used to identify preferred ligands, whereas binding affinity measurements provide precise details of the energetic importance of each ligand side chain to binding. Alanine and homolog scanning mutagenesis (in a combinatorial phage display format) identifies Erbin side chains that make energetically important contacts with the ligand. The structure of a phage-optimized peptide (Ac-TGW(-4)ETW(-1)V, IC50 = similar to0.15 mum) in complex with Erbin PDZ provides a structural context to understand the binding energetics. In particular, the very favorable interactions with Trp(-1) are not Erbin side chain-mediated (and therefore may be generally applicable to many PDZ domains), whereas the beta2-beta3 loop provides a binding site for the Trp(-4) side chain (specific to Erbin because it has an unusually long loop). These results contribute to a growing appreciation for the importance of at least five ligand C-terminal side chains in determining PDZ domain binding energy and highlight the mechanisms of ligand discrimination among the several hundred PDZ domains present in the human genome.	Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Sidhu, SS (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	sidhu@gene.com	Pisabarro, M. Teresa/D-4270-2012	Koehler, Michael/0000-0003-0967-8304				Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038; Bryant PJ, 2000, NAT CELL BIOL, V2, pE141, DOI 10.1038/35019616; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Cavanagh J., 1995, PROTEIN NMR SPECTROS; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cochran AG, 2002, P NATL ACAD SCI USA, V99, P9081, DOI 10.1073/pnas.132249099; Cochran AG, 2001, J AM CHEM SOC, V123, P625, DOI 10.1021/ja003369x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cowburn D, 1996, STRUCTURE, V4, P1005, DOI 10.1016/S0969-2126(96)00106-2; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Harris BZ, 2001, J CELL SCI, V114, P3219; Hazbun TR, 2001, P NATL ACAD SCI USA, V98, P4277, DOI 10.1073/pnas.091096398; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Izawa I, 2002, GENES CELLS, V7, P475, DOI 10.1046/j.1365-2443.2002.00533.x; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee CH, 1998, METH MOL B, V84, P3; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Niethammer M, 1996, J NEUROSCI, V16, P2157; Pan B, 2002, J MOL BIOL, V316, P769, DOI 10.1006/jmbi.2001.5370; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Russell SJ, 2000, J AM CHEM SOC, V122, P12600, DOI 10.1021/ja002085+; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Starovasnik MA, 1999, J MOL BIOL, V293, P531, DOI 10.1006/jmbi.1999.3134; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WOODS DF, 1993, MECH DEVELOP, V44, P889; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Xenarios L, 2001, CURR OPIN BIOTECH, V12, P334, DOI 10.1016/S0958-1669(00)00224-X	54	121	128	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2003	278	9					7645	7654		10.1074/jbc.M209751200	http://dx.doi.org/10.1074/jbc.M209751200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649EZ	12446668	hybrid			2022-12-27	WOS:000181195100129
J	Xia, Y; Pao, GM; Chen, HW; Verma, IM; Hunter, T				Xia, Y; Pao, GM; Chen, HW; Verma, IM; Hunter, T			Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-PREDISPOSING MUTATIONS; CONJUGATING ENZYME COMPLEX; RING FINGER PROTEINS; RNA-POLYMERASE-II; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; CRYSTAL-STRUCTURE; PRIMARY BREAST; GENE BRCA1; DOMAIN	The breast and ovarian cancer-specific tumor suppressor RING finger protein BRCA1 has been identified as an E3 ubiquitin (Ub) ligase through in vitro studies, which demonstrated that its RING finger domain can autoubiquitylate and monoubiquitylate histone H2A when supplied with Ub, E1, and UBC4 (E2). Here we report that the E3 ligase activity of the N-terminal 110 amino acid residues of BRCA1, which encodes a stable domain containing the RING finger, as well as that of the full-length BRCA1, was significantly enhanced by the BARD1 protein (residues 8-142), whose RING finger domain itself lacked Uh ligase activity in vitro. The results of mutagenesis studies indicate that the enhancement of BRCA1 E3 ligase activity by BARD1 depends on direct interaction between the two proteins. Using K48A and K63A Ub mutants, we found that BARD1 stimulated the formation of both LYS48- and LyS(63)-linked poly-Ub chains. However, the enhancement of BRCA1 autoubiquitylation by BARD1 mostly resulted in poly-Ub chains linked through LyS(63), which could potentially activate biological pathways other than BRCA1 degradation. We also found that co-expression of BRCA1 and BARD1 in living cells increased the abundance and stability of both proteins and that this depended on their ability to heterodimerize.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif Davis, Ctr Canc, Dept Biol Chem, Sacramento, CA 95817 USA	Salk Institute; Salk Institute; University of California System; University of California Davis	Hunter, T (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu			NATIONAL CANCER INSTITUTE [R01CA082683, R01CA080100, P30CA014195] Funding Source: NIH RePORTER; NCI NIH HHS [CA82683, CA80100, CA14195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberg Anthony J., 1997, Current Opinion in Oncology, V9, P505, DOI 10.1097/00001622-199711000-00003; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bhattacharyya A, 2000, J BIOL CHEM, V275, P23899, DOI 10.1074/jbc.C000276200; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brzovic PS, 1998, J BIOL CHEM, V273, P7795, DOI 10.1074/jbc.273.14.7795; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Deng CX, 2000, BIOESSAYS, V22, P728; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Deng CX, 2002, ONCOGENE, V21, P6222, DOI 10.1038/sj.onc.1205713; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Irminger-Finger I, 1998, J CELL BIOL, V143, P1329, DOI 10.1083/jcb.143.5.1329; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miyake T, 2000, J BIOL CHEM, V275, P40169, DOI 10.1074/jbc.M007138200; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Morris JR, 2002, J BIOL CHEM, V277, P9382, DOI 10.1074/jbc.M109249200; Parvin JD, 2001, P NATL ACAD SCI USA, V98, P5952, DOI 10.1073/pnas.121184998; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2002, NATURE, V419, P120, DOI 10.1038/419120a; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yu X, 2000, J BIOL CHEM, V275, P18541, DOI 10.1074/jbc.M909494199; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	69	169	174	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5255	5263		10.1074/jbc.M204591200	http://dx.doi.org/10.1074/jbc.M204591200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12431996	hybrid			2022-12-27	WOS:000180968900115
J	Hecht, A; Stemmler, MP				Hecht, A; Stemmler, MP			Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; EMBRYONIC INTESTINE; SIGNALING PATHWAYS; GENE-EXPRESSION; IN-VITRO; LEF-1; ENHANCER; INTERACT; COMPLEX; XENOPUS	Wnt growth factors control numerous cell fate decisions in development by altering specific gene expression patterns through the activity of heterodimeric transcriptional activators. These consist of beta-catenin and one of the four members of the T-cell factor (TCF) family of DNA-binding proteins. How can the Wnt/beta-catenin pathway control various sets of target genes in distinct cellular settings with such a limited number of nuclear effectors? Here we asked whether different TCF proteins could perform specific, nonredundant functions at natural beta-catenin/TCF-regulated promoters. We found that TCF4E but not LEFT supported beta-catenin-dependent activation of the Cdx1 promoter, whereas LEFT specifically activated the Siamois promoter. Deletion of a C-terminal domain of TCF4E prevented Cdx1 promoter induction. A chimeric protein consisting of LEFT and the C terminus of TCF4E was fully functional. Therefore, the TCF4E C terminus harbors a promoter-specific transactivation domain. This domain influences the DNA binding properties of TCF4 and additionally mediates an interaction with the transcriptional coactivator p300. Apparently, the C terminus of TCF4E cooperates with beta-catenin and p300 to form a specialized transcription factor complex that specifically supports the activation of the Cdx1 promoter.	Max Planck Inst Immunbiol, D-79108 Freiburg, Germany	Max Planck Society	Hecht, A (corresponding author), Univ Freiburg, Inst Mol Med & Zellforsch, Hugstetter Str 55, D-79106 Freiburg, Germany.			Hecht, Andreas/0000-0003-2262-2575				Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; DUPREY P, 1988, GENE DEV, V2, P1647, DOI 10.1101/gad.2.12a.1647; Galceran J, 2001, P NATL ACAD SCI USA, V98, P8668, DOI 10.1073/pnas.151258098; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Ghazi A, 2000, NATURE, V408, P419, DOI 10.1038/35044174; Goodman RH, 2000, GENE DEV, V14, P1553; Gradl D, 2002, J BIOL CHEM, V277, P14159, DOI 10.1074/jbc.M107055200; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Lickert H, 2000, DEVELOPMENT, V127, P3805; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; MEYER BI, 1993, DEVELOPMENT, V117, P191; Miyagishi M, 2000, J BIOL CHEM, V275, P35170, DOI 10.1074/jbc.C000258200; Molenaar M, 1998, MECH DEVELOP, V75, P151, DOI 10.1016/S0925-4773(98)00085-9; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Palaparti A, 1997, J BIOL CHEM, V272, P26604, DOI 10.1074/jbc.272.42.26604; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Pukrop T, 2001, J BIOL CHEM, V276, P8968, DOI 10.1074/jbc.M007533200; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sambrook J., 2002, MOL CLONING LAB MANU; See RH, 2001, J BIOL CHEM, V276, P16310, DOI 10.1074/jbc.M008113200; SHERIDAN PL, 1995, GENE DEV, V9, P2090, DOI 10.1101/gad.9.17.2090; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Subramanian V, 1998, DIFFERENTIATION, V64, P11, DOI 10.1046/j.1432-0436.1998.6410011.x; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wong MH, 2002, J BIOL CHEM, V277, P15843, DOI 10.1074/jbc.M200184200; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703	58	77	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3776	3785		10.1074/jbc.M210081200	http://dx.doi.org/10.1074/jbc.M210081200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446687	hybrid			2022-12-27	WOS:000180869700034
J	Key, TA; Foutz, TD; Gurevich, VV; Sklar, LA; Prossnitz, ER				Key, TA; Foutz, TD; Gurevich, VV; Sklar, LA; Prossnitz, ER			N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTOR; REAL-TIME ANALYSIS; ARRESTIN/CLATHRIN INTERACTION; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; INDEPENDENT MECHANISMS; CRYSTAL-STRUCTURE; 48-KDA PROTEIN	Arrestins regulate the signaling and endocytosis of many G protein-coupled receptors (GPCRs). It has been suggested that the functions of arrestins are dependent upon both the number and pattern of phosphorylation sites present in an activated GPCR. However, little is currently known about the relationships between the sites of receptor phosphorylation, the resulting affinities of arrestin binding, and the ensuing mechanisms of receptor regulation for any given GPCR. To investigate these interactions, we used an active truncated mutant of arrestin (amino acids 1-382) and phosphorylation-deficient mutants of the N-formyl peptide receptor (FPR). In contrast to results with wild type arrestins, the truncated arrestin-2 protein bound to the unphosphorylated wild type FPR, although with lower affinity and a low affinity for the agonist as revealed by competition studies with heterotrimeric G proteins. Using FPR mutants, we further demonstrated that the phosphorylation status of serines and threonines between residues 328-332 is a key determinant that regulates the affinity of the FPR for arrestins. Furthermore, we found that the phosphorylation status of serine and threonine residues between amino acids 334 and 339 regulates the affinity of the receptor for agonist when arrestin is bound. These results suggest that the agonist affinity state of the receptor is principally regulated by phosphorylation at specific sites and is not simply a consequence of arrestin binding as has previously been proposed. Furthermore, this is the first demonstration that agonist affinity of a GPCR and the affinity of arrestin binding to the phosphorylated receptor are regulated by distinct receptor phosphodomains.	Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Vanderbilt University	Prossnitz, ER (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA.		Prossnitz, Eric/I-4599-2019; Gurevich, Vsevolod/A-3236-2008; Prossnitz, Eric R./B-4543-2008	Prossnitz, Eric/0000-0001-9190-8302; Gurevich, Vsevolod/0000-0002-3950-5351; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001315] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036357, R01AI043932, R29AI036357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB000265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063097, R24GM060799] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01315] Funding Source: Medline; NEI NIH HHS [EY11500] Funding Source: Medline; NIAID NIH HHS [AI43932, AI36357] Funding Source: Medline; NIBIB NIH HHS [EB00265] Funding Source: Medline; NIGMS NIH HHS [GM60799, GM63097] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bennett TA, 2000, J BIOL CHEM, V275, P24590, DOI 10.1074/jbc.C000314200; Bennett TA, 2001, J BIOL CHEM, V276, P49195, DOI 10.1074/jbc.M106414200; Bennett TA, 2001, J BIOL CHEM, V276, P22453, DOI 10.1074/jbc.M009679200; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; FAY SP, 1991, BIOCHEMISTRY-US, V30, P5066, DOI 10.1021/bi00234a033; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004, DOI 10.1074/jbc.270.48.29004; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Potter RM, 2002, J BIOL CHEM, V277, P8970, DOI 10.1074/jbc.M111086200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; SKLAR LA, 1984, J BIOL CHEM, V259, P5661; SKLAR LA, 1989, J BIOL CHEM, V264, P8483; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	41	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4041	4047		10.1074/jbc.M204687200	http://dx.doi.org/10.1074/jbc.M204687200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12424254	hybrid			2022-12-27	WOS:000180869700068
J	Babcock, GJ; Farzan, M; Sodroski, J				Babcock, GJ; Farzan, M; Sodroski, J			Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTORS; CHEMOKINE RECEPTORS; PARAMAGNETIC PROTEOLIPOSOMES; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; PRIMARY INFECTION; FACTOR-I; TYPE-1; BINDING	CXCR4, a member of the G protein-coupled receptor family of proteins, is the receptor for stromal cell-derived factor (SDF-1alpha) and is a principal coreceptor for human immunodeficiency virus type 1 (HIV-1). CXCR4 has also been implicated in breast cancer metastasis. We examined the ability of CXCR4 to homomultimerize in detergent-solubilized cell lysates and in the membranes of intact cells. CXCR4 was found to multimerize in cell lysates containing the detergents CHAPSO or Cymal-7 but not other detergents that have been shown to disrupt the native conformation of CXCR4. CXCR4 expression levels did not affect the observed multimerization and differentially tagged CXCR4 molecules associated only when coexpressed in the same cell. CXCR4 did not interact with CCR5, the other principal HIV-1 coreceptor, when the two proteins were coexpressed. Using bioluminescence resonance energy transfer (BRET2), we demonstrated that CXCR4 multimers are found naturally in the intact cell membrane, in both the presence and absence of multiple CXCR4 ligands. Ligand binding did not significantly alter the observed BRET2 signal, suggesting that CXCR4 exists as a constitutive oligomer. In cell lysates prepared with non-denaturing detergents, CXCR4 sedimented in a manner consistent with a dimer, whereas CCR5 sedimented as a monomer under these conditions. The stable, constitutive dimerization of CXCR4 may contribute to its biological functions in chemokine binding, signaling, and HIV-1 entry.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Div Aids, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St,JFB824, Boston, MA 02115 USA.			Farzan, Michael/0000-0002-2990-5319	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028691, U01AI046725, R01AI041851] Funding Source: NIH RePORTER; NIAID NIH HHS [AI46725, AI41851, AI28691] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ASJO B, 1986, LANCET, V2, P660; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Drews J, 1996, NAT BIOTECHNOL, V14, P1516, DOI 10.1038/nbt1196-1516; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gouldson PR, 2000, NEUROPSYCHOPHARMACOL, V23, pS60, DOI 10.1016/S0893-133X(00)00153-6; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hebert TE, 1998, BIOCHEM J, V330, P287; Hoffman TL, 2000, P NATL ACAD SCI USA, V97, P11215, DOI 10.1073/pnas.190274097; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Stadel JM, 1997, TRENDS PHARMACOL SCI, V18, P430, DOI 10.1016/S0165-6147(97)01117-6; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7; TERSMETTE M, 1988, J VIROL, V62, P2026, DOI 10.1128/JVI.62.6.2026-2032.1988; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; TURNER S, 1992, P NATL ACAD SCI USA, V89, P1335, DOI 10.1073/pnas.89.4.1335; VALENTIN A, 1994, J VIROL, V68, P6684, DOI 10.1128/JVI.68.10.6684-6689.1994; Vila-Coro AJ, 2000, P NATL ACAD SCI USA, V97, P3388, DOI 10.1073/pnas.050457797; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; WRIN T, 1995, J VIROL, V69, P39, DOI 10.1128/JVI.69.1.39-48.1995; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	186	195	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3378	3385		10.1074/jbc.M210140200	http://dx.doi.org/10.1074/jbc.M210140200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433920	hybrid			2022-12-27	WOS:000180915000078
J	Cai, DM; Leem, JY; Greenfield, JP; Wang, P; Kim, BS; Wang, RS; Lopes, KO; Kim, SH; Zheng, H; Greengard, P; Sisodia, SS; Thinakaran, G; Xu, HX				Cai, DM; Leem, JY; Greenfield, JP; Wang, P; Kim, BS; Wang, RS; Lopes, KO; Kim, SH; Zheng, H; Greengard, P; Sisodia, SS; Thinakaran, G; Xu, HX			Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; TRANS-GOLGI NETWORK; GAMMA-SECRETASE ACTIVITY; AXONAL-TRANSPORT; ENDOPLASMIC-RETICULUM; PERMEABILIZED CELLS; IN-VIVO; MEMBRANE; NOTCH; PEPTIDES	Presenilins (PS1/PS2) play a critical role in proteolysis of beta-amyloid precursor protein (betaAPP) to generate beta-amyloid, a peptide important in the pathogenesis of Alzheimer's disease. Nevertheless, several regulatory functions of PSI have also been reported. Here we demonstrate, in neuroblastoma cells, that PSI regulates the biogenesis of betaAPP-containing vesicles from the trans-Golgi network and the endoplasmic reticulum. PSI deficiency or the expression of loss-of-function variants leads to robust vesicle formation, concomitant with increased maturation and/or cell surface accumulation of PAPP. In contrast, release of vesicles containing PAPP is impaired in familial Alzheimer's disease (FAD)-linked PSI mutant cells, resulting in reduced betaAPP delivery to the cell surface. Moreover, diminution of surface betaAPP is profound at axonal terminals in neurons expressing a PSI FAD variant. These results suggest that PSI regulation of betaAPP trafficking may represent an alternative mechanism by which FAD-linked PS1 variants modulate betaAPP processing.	Rockefeller Univ, Fisher Ctr Res Alzheimers Dis, New York, NY 10021 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Human Genet, Houston, TX 77030 USA	Rockefeller University; Rockefeller University; University of Chicago; Baylor College of Medicine	Xu, HX (corresponding author), Rockefeller Univ, Fisher Ctr Res Alzheimers Dis, 1230 York Ave, New York, NY 10021 USA.		Xu, Huaxi/AAV-7177-2021	Wang, Pei/0000-0003-2373-7315; Greenfield, Jeffrey/0000-0003-1904-1040; Radomski, Kryslaine/0000-0001-9624-623X	NIA NIH HHS [AG21495, AG021494, AG19070, AG09464] Funding Source: Medline; NINDS NIH HHS [NS40039] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495, P01AG009464, R01AG021494] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; Berechid BE, 1999, CURR BIOL, V9, P1493, DOI 10.1016/S0960-9822(00)80121-9; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Capell A, 2000, NAT CELL BIOL, V2, P205, DOI 10.1038/35008626; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chen FS, 2000, J BIOL CHEM, V275, P36794, DOI 10.1074/jbc.M006986200; De Strooper B, 1999, NATURE, V402, P471, DOI 10.1038/44973; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Edbauer D, 2002, P NATL ACAD SCI USA, V99, P8666, DOI 10.1073/pnas.132277899; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Greenfield JP, 2000, FRONT BIOSCI, V5, pD72, DOI 10.2741/Greenfield; Greenfield JP, 2002, J BIOL CHEM, V277, P12128, DOI 10.1074/jbc.M110009200; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li HL, 1997, J NEUROBIOL, V32, P469, DOI 10.1002/(SICI)1097-4695(199705)32:5<469::AID-NEU3>3.3.CO;2-5; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Ling WLW, 1998, METHODS, V16, P141, DOI 10.1006/meth.1998.0661; MORIN PJ, 1993, J NEUROCHEM, V61, P464; Musch A, 1996, J CELL BIOL, V133, P543, DOI 10.1083/jcb.133.3.543; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Scheper W, 2000, HUM MOL GENET, V9, P303, DOI 10.1093/hmg/9.2.303; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2001, P NATL ACAD SCI USA, V98, P11039, DOI 10.1073/pnas.211352598; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sisodia SS, 1999, AM J HUM GENET, V65, P7, DOI 10.1086/302475; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5172; Wilson CA, 2002, NAT NEUROSCI, V5, P849, DOI 10.1038/nn898; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; XU HX, 1993, J CELL BIOL, V122, P1169, DOI 10.1083/jcb.122.6.1169; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	57	117	117	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3446	3454		10.1074/jbc.M209065200	http://dx.doi.org/10.1074/jbc.M209065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12435726	hybrid			2022-12-27	WOS:000180915000086
J	Haynes, MP; Li, L; Sinha, D; Russell, KS; Hisamoto, K; Baron, R; Collinge, M; Sessa, WC; Bender, JR				Haynes, MP; Li, L; Sinha, D; Russell, KS; Hisamoto, K; Baron, R; Collinge, M; Sessa, WC; Bender, JR			Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BINDING-SITES; TYROSINE PHOSPHORYLATION; MCF-7 CELLS; POSTMENOPAUSAL WOMEN; SIGNAL-TRANSDUCTION; REGULATORY SUBUNIT; RECEPTOR-ALPHA; 3-KINASE; PROTEIN; ESTRADIOL	17beta-Estradiol activates endothelial nitric oxide synthase (eNOS), enhancing nitric oxide (NO) release from endothelial cells via the phosphatidylinositol 3-kinase (PI3-kinase)/Akt pathway. The upstream regulators of this pathway are unknown. We now demonstrate that 17beta-estradiol rapidly activates eNOS through Src kinase in human endothelial cells. The Src family kinase specific-inhibitor 4-amino-5-(4- chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) abrogates 17beta-estradiol- but not ionomycin-stimulated NO release. Consistent with these results, PP2 blocked 17beta-estradiol-induced Akt phosphorylation but did not inhibit NO release from cells transduced with a constitutively active Akt. PP2 abrogated 17beta-estradiol-induced activation of PI3-kinase, indicating that the PP2-inhibitable kinase is upstream of PI3-kinase and Akt. A 17beta-estradiol-induced estrogen receptor/c-Src association correlated with rapid c-Src phosphorylation. Moreover, transfection of kinase-dead c-Src inhibited 17beta-estradiol-induced Akt phosphorylation, whereas constitutively active c-Src increased basal Akt phosphorylation. Estrogen stimulation of murine embryonic fibroblasts with homozygous deletions of the c-src, fyn, and yes genes failed to induce Akt phosphorylation, whereas cells maintaining c-Src expression demonstrated estrogen-induced Akt activation. Estrogen rapidly activated c-Src inducing an estrogen receptor, c-Src, and P85 (regulatory subunit of PI3-kinase) complex formation. This complex formation results in the successive activation of PI3-kinase, Akt, and eNOS with consequent enhanced NO release, implicating c-Src as a critical upstream regulator of the estrogen-stimulated PI3-kinase/Akt/eNOS pathway.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Vasc Biol & Transplantat Program, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cell Biol & Orthoped, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pharmacol, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Cardiovasc Med, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Immunobiol Sect, New Haven, CT 06536 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Bender, JR (corresponding author), 295 Congress Ave, New Haven, CT 06536 USA.	jeffrey.bender@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938	NHLBI NIH HHS [HL61782] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL061782, R01HL061782] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Best PJM, 1998, ANN INTERN MED, V128, P285, DOI 10.7326/0003-4819-128-4-199802150-00006; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Brubaker KD, 1999, CALCIFIED TISSUE INT, V64, P459, DOI 10.1007/s002239900633; Brubaker KD, 2000, J CELL BIOCHEM, V76, P206; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CaulinGlaser T, 1997, CIRC RES, V81, P885; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Falkenstein E, 1999, ENDOCRINOLOGY, V140, P5999, DOI 10.1210/en.140.12.5999; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GERMAIN PS, 1993, ANTICANCER RES, V13, P2347; Grey A, 2000, ENDOCRINOLOGY, V141, P2129, DOI 10.1210/en.141.6.2129; Guetta V, 1997, CIRCULATION, V96, P2795, DOI 10.1161/01.CIR.96.9.2795; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; HerreraVelit P, 1996, J IMMUNOL, V156, P1157; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kirsch EA, 1999, AM J RESP CELL MOL, V20, P658, DOI 10.1165/ajrcmb.20.4.3241; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; LantinHermoso RL, 1997, AM J PHYSIOL-LUNG C, V273, pL119, DOI 10.1152/ajplung.1997.273.1.L119; Lee AWM, 2000, MOL CELL BIOL, V20, P6779, DOI 10.1128/MCB.20.18.6779-6798.2000; Mak P, 1996, FEBS LETT, V397, P183, DOI 10.1016/S0014-5793(96)01179-9; Marquez DC, 2001, ONCOGENE, V20, P5420, DOI 10.1038/sj.onc.1204729; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MIGLIACCIO A, 1993, ONCOGENE, V8, P2183; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; Pendaries C, 2002, P NATL ACAD SCI USA, V99, P2205, DOI 10.1073/pnas.042688499; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; PIETRAS RJ, 1977, NATURE, V265, P69, DOI 10.1038/265069a0; PRASAD KVS, 1993, PHILOS T ROY SOC B, V342, P35, DOI 10.1098/rstb.1993.0132; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Rubanyi GM, 1997, J CLIN INVEST, V99, P2429, DOI 10.1172/JCI119426; Russell KS, 2000, J BIOL CHEM, V275, P5026, DOI 10.1074/jbc.275.7.5026; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; Salazar EP, 1999, J BIOL CHEM, V274, P28371, DOI 10.1074/jbc.274.40.28371; Shinohara M, 2001, J BIOL CHEM, V276, P18941, DOI 10.1074/jbc.M100909200; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Susa M, 1996, BIOCHEM BIOPH RES CO, V220, P729, DOI 10.1006/bbrc.1996.0472; von Willebrand M, 1998, J BIOL CHEM, V273, P3994, DOI 10.1074/jbc.273.7.3994; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Watters JJ, 1997, ENDOCRINOLOGY, V138, P4030, DOI 10.1210/en.138.9.4030	55	254	270	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2118	2123		10.1074/jbc.M210828200	http://dx.doi.org/10.1074/jbc.M210828200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431978	hybrid			2022-12-27	WOS:000180562000007
J	Youn, H; Kerby, RL; Roberts, GP				Youn, H; Kerby, RL; Roberts, GP			The role of the hydrophobic distal heme pocket of CooA in ligand sensing and response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; RHODOSPIRILLUM-RUBRUM; ESCHERICHIA-COLI; GENE-EXPRESSION; PROTEIN; RESIDUES; BINDING; CAMP; DNA; MUTATIONS	CooA from Rhodospirillum rubrum is a heme-containing transcriptional activator that becomes activated only upon binding CO. The basis for this specificity has been probed in a CooA variant, termed DeltaP3R4 CooA, lacking two residues adjacent to the Pro(2) heme ligand, which weakens that ligand. DeltaP3R4 CooA can bind imidazole and CN-, as well as CO, and form a 6-coordinate low spin adduct with each. However, in contrast to the case with CO, imidazole and CN- do not stimulate the DNA binding activity of DeltaP3R4 CooA. This result indicates that the CO-specific activation of CooA is not merely the result of creation of a 6-coordinate CooA adduct but that there must be another element to this response. One feature of CooA activation is modest repositioning of the C-helices upon CO binding, so we altered a portion of the C-helix (residues IIe(113) and Leu(116)) located near the heme-bound CO in wild type CooA, and we investigated the effect on CO-specific activation. Surprisingly, the sizes of IIe(113) and/or Leu(116) positions are not critical,for CooA activation by CO, disproving a precise interaction between these residues and the CO-bound heme as a basis for the CO activation mechanism and CO ligand specificity. In contrast, hydrophobic residues at these positions contribute to the activation. Some CooA variants altered at these positions in the background of DeltaP3R4 were also found to show low but reproducible activation in response to imidazole binding to the heme. A model for the role of hydrophobicity in CooA activation and specificity is suggested.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Roberts, GP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	groberts@bact.wisc.edu			NIGMS NIH HHS [GM53228] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053228] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; Ausubel F. M., 1995, SHORT PROTOCOLS MOL, P21; Cheng XD, 1998, J BIOL CHEM, V273, P705, DOI 10.1074/jbc.273.2.705; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Chiang L W, 1993, PCR Methods Appl, V2, P210; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; He YP, 1996, J BIOL CHEM, V271, P120, DOI 10.1074/jbc.271.1.120; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Karplus PA, 1997, PROTEIN SCI, V6, P1302; KERBY RL, 1995, J BACTERIOL, V177, P2241, DOI 10.1128/jb.177.8.2241-2244.1995; KERBY RL, IN PRESS J MOL BIOL; KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; SHELVER D, 1995, J BACTERIOL, V177, P2157, DOI 10.1128/jb.177.8.2157-2163.1995; Shelver D, 1999, BIOCHEMISTRY-US, V38, P2669, DOI 10.1021/bi982658j; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Thorsteinsson MV, 2000, J BIOL CHEM, V275, P39332, DOI 10.1074/jbc.M007691200; Yamamoto K, 2001, J BIOL CHEM, V276, P11473, DOI 10.1074/jbc.C100047200; Youn H, 2002, J BIOL CHEM, V277, P33616, DOI 10.1074/jbc.M203684200; Youn H, 2001, J BIOL CHEM, V276, P41603, DOI 10.1074/jbc.M106165200	27	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2333	2340		10.1074/jbc.M210825200	http://dx.doi.org/10.1074/jbc.M210825200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433917	hybrid			2022-12-27	WOS:000180562000036
J	Aggarwal, S; Ghilardi, N; Xie, MH; de Sauvage, FJ; Gurney, AL				Aggarwal, S; Ghilardi, N; Xie, MH; de Sauvage, FJ; Gurney, AL			Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID-ARTHRITIS; ALLOGRAFT-REJECTION; HUMAN KERATINOCYTES; CYTOKINE PRODUCTION; IL-17; EXPRESSION; RECEPTOR; LYMPHOCYTES; IL-12P40; BINDING	Interleukin (IL)-17 is a pro-inflammatory cytokine that is produced by activated T cells. Despite increasing evidence that high levels of IL-17 are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis, and multiple sclerosis, the regulation of its expression is not well characterized. We observe that IL-17 production is increased in response to the recently described cytokine IL-23. We present evidence that murine IL-23, which is produced by activated dendritic cells, acts on memory T cells, resulting in elevated IL-17 secretion. IL-23 also induced expression of the related cytokine IL-17F. IL-23 is a heterodimeric cytokine and shares a subunit, p40, with IL-12. In contrast to IL-23, IL-12 had only marginal effects on IL-17 production. These data suggest that during a secondary immune response, IL-23 can promote an activation state with features distinct from the well characterized Th1 and Th2 profiles.	Genentech Inc, Dept Biol Mol, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Gurney, AL (corresponding author), Genentech Inc, Dept Biol Mol, 1 DNA Way,MS 37, San Francisco, CA 94080 USA.		de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Ghilardi, Nico/0000-0003-4945-3097				Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Albanesi C, 2000, J INVEST DERMATOL, V115, P81, DOI 10.1046/j.1523-1747.2000.00041.x; Antonysamy MA, 1999, J IMMUNOL, V162, P577; ANTONYSAMY MA, 1999, TRANSPLANT P, V31, P1; BUDD RC, 1987, J IMMUNOL, V138, P3120; Cai XY, 1998, IMMUNOL LETT, V62, P51, DOI 10.1016/S0165-2478(98)00027-3; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; CHUA AO, 1995, J IMMUNOL, V155, P4286; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; FRUCHT DM, 2002, SCI STKE, V8; Holscher C, 2001, J IMMUNOL, V167, P6957, DOI 10.4049/jimmunol.167.12.6957; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hsieh HG, 2001, TRANSPL INT, V14, P287; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; JUNG TM, 1988, J IMMUNOL, V141, P4110; Kennedy J, 1996, J INTERF CYTOK RES, V16, P611, DOI 10.1089/jir.1996.16.611; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Laan M, 1999, J IMMUNOL, V162, P2347; Linden A, 2000, EUR RESPIR J, V15, P973, DOI 10.1034/j.1399-3003.2000.15e28.x; LOONG CC, 2000, TRANSPLANT PROC, V32; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5	33	1378	1542	2	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1910	1914		10.1074/jbc.M207577200	http://dx.doi.org/10.1074/jbc.M207577200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12417590	hybrid			2022-12-27	WOS:000180462200073
J	Kitada, S; Yamasaki, E; Kojima, K; Ito, A				Kitada, S; Yamasaki, E; Kojima, K; Ito, A			Determination of the cleavage site of the presequence by mitochondrial processing peptidase on the substrate binding scaffold and the multiple subsites inside a molecular cavity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SUBUNIT; BETA-SUBUNIT; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; PROXIMAL ARGININE; SYNTHETIC PEPTIDE; AMINO-ACIDS; RECOGNITION; IMPORT; RESIDUES	Mitochondrial processing peptidase (MPP) recognizes a large variety of basic presequences of mitochondrial preproteins and cleaves the single site, often including arginine, at the -2 position (P-2). To elucidate the recognition and specific processing of the preproteins by MPP, we mutated to alanines at acidic residues conserved in a large internal cavity formed by the MPP subunits, alpha-MPP and beta-MPP, and analyzed the processing efficiencies for various preproteins. We report here that alanine mutations at a subsite in rat beta-MPP interacting with the P-2 arginine cause a shift in the processing site to the C-terminal side of the preprotein. Because of reduced interactions with the P-2 arginine, the mutated enzymes recognize not only the N-terminal authentic cleavage site with P-2 arginine but also the potential C-terminal cleavage site without a P-2 arginine. In fact, it competitively cleaves the two sites of the preprotein. Moreover, the acidified site of alpha-MPP, which binds to the distal basic site in the long presequence, recognized the authentic P-2 arginine as the distal site in compensation for ionic interaction at the proximal site in the mutant MPP. Thus, MPP seems to scan the presequence from beta- to alpha-MPP on the substrate binding scaffold inside the MPP cavity and finds the distal and P-2 arginines on the multiple subsites on both MPP subunits. A possible mechanism for substrate recognition and cleavage is discussed here based on the notable character of a subsite-deficient mutant of MPP in which the substrate specificity is altered.	Kyushu Univ, Fac Sci, Dept Chem, Fukuoka 8128581, Japan	Kyushu University	Kitada, S (corresponding author), Kyushu Univ, Fac Sci, Dept Chem, Fukuoka 8128581, Japan.	s.kitscc@mbox.nc.kyushu-u.ac.jp						ARRETZ M, 1994, J BIOL CHEM, V269, P4959; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; Boteva R, 1996, ARCH BIOCHEM BIOPHYS, V332, P329, DOI 10.1006/abbi.1996.0349; BRAUN HP, 1992, EMBO J, V11, P3219, DOI 10.1002/j.1460-2075.1992.tb05399.x; Deng K, 2001, J BIOL CHEM, V276, P6499, DOI 10.1074/jbc.M007128200; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GELI V, 1993, P NATL ACAD SCI USA, V90, P6247, DOI 10.1073/pnas.90.13.6247; GLASER E, 1994, FEBS LETT, V346, P83, DOI 10.1016/0014-5793(94)00312-2; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; KITADA S, 1995, J BIOCHEM-TOKYO, V117, P1148, DOI 10.1093/oxfordjournals.jbchem.a124836; Kitada S, 1998, J BIOL CHEM, V273, P32547, DOI 10.1074/jbc.273.49.32547; Kitada S, 2001, BIOCHEM BIOPH RES CO, V287, P594, DOI 10.1006/bbrc.2001.5641; Kitada S, 2001, J BIOCHEM, V129, P155, DOI 10.1093/oxfordjournals.jbchem.a002827; Kojima K, 1998, J BIOL CHEM, V273, P32542, DOI 10.1074/jbc.273.49.32542; Kojima K, 2001, J BIOCHEM-TOKYO, V130, P497, DOI 10.1093/oxfordjournals.jbchem.a003012; Kojima K, 2001, J BIOL CHEM, V276, P2115, DOI 10.1074/jbc.M003111200; Luciano P, 1997, J MOL BIOL, V272, P213, DOI 10.1006/jmbi.1997.1231; Luciano P, 1996, EXPERIENTIA, V52, P1077, DOI 10.1007/BF01952105; Moriwaki K, 1999, J BIOCHEM, V126, P874, DOI 10.1093/oxfordjournals.jbchem.a022529; Nagao Y, 2000, J BIOL CHEM, V275, P34552, DOI 10.1074/jbc.M003110200; NIIDOME T, 1994, J BIOL CHEM, V269, P24719; Ogishima T, 1995, J BIOL CHEM, V270, P30322, DOI 10.1074/jbc.270.51.30322; OU WJ, 1989, EMBO J, V8, P2605, DOI 10.1002/j.1460-2075.1989.tb08400.x; SAAVEDRAALANIS VM, 1994, J BIOL CHEM, V269, P9284; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shimokata K, 1998, J BIOL CHEM, V273, P25158, DOI 10.1074/jbc.273.39.25158; Shimokata K, 1997, J BIOCHEM-TOKYO, V122, P1019; Song MC, 1996, J BIOCHEM-TOKYO, V120, P1163; Song MC, 1998, J BIOCHEM, V124, P1045, DOI 10.1093/oxfordjournals.jbchem.a022198; Striebel HM, 1996, ARCH BIOCHEM BIOPHYS, V335, P211, DOI 10.1006/abbi.1996.0500; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x; Zhang XP, 2001, PLANT J, V27, P427, DOI 10.1046/j.1365-313X.2001.01108.x	34	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1879	1885		10.1074/jbc.M209263200	http://dx.doi.org/10.1074/jbc.M209263200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12433926	hybrid			2022-12-27	WOS:000180462200069
J	Claeysen, S; Joubert, L; Sebben, M; Bockaert, J; Dumuis, A				Claeysen, S; Joubert, L; Sebben, M; Bockaert, J; Dumuis, A			A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a G(s)-coupled receptor activated exclusively by synthetic ligands (RASSL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BENZIMIDAZOLE DERIVATIVES; G(I)-COUPLED RECEPTOR; ADENYLATE-CYCLASE; POTENT AGONISTS; GUINEA-PIG; BINDING; ANTAGONISTS; DESIGN; ASSAY	To better understand G-protein-coupled receptor (GPCRs) signaling, cellular and animal physiology, as well as gene therapy, a new tool has recently been proposed. It consists of GPCR mutants that are insensitive to endogenous ligands but sensitive to synthetic ligands. These GPCRs are called receptor activated solely by synthetic ligands (RASSL). Only two examples of such engineered receptors have been described so far: one G(i)-coupled (opioid receptors) and one G(s)-coupled (beta(2)-adrenergic receptors). Here, we describe the first RASSL related to serotonin receptors (D100)(3.32A G(s)-coupled 5-HT4 receptor or 5-HT4-RASSL). 5-HT4-RASSL is generated by a single mutation, is totally insensitive to serotonin (5-HT), and still responds to synthetic ligands. These ligands have affinities in the range of nanomolar concentrations for the mutant receptor and exhibit full efficacy. More interestingly, two synthetic ligands behave as antagonists on the wild type but as agonists on the 5-HT4-RASSL.	CNRS, UPR 9023, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS)	Bockaert, J (corresponding author), CNRS, UPR 9023, 141 Rue Cardonille, F-34094 Montpellier, France.		Claeysen, Sylvie/C-8599-2014	Claeysen, Sylvie/0000-0002-0576-5518				Ansanay H, 1996, EUR J PHARMACOL, V298, P165, DOI 10.1016/0014-2999(95)00786-5; Blondel O, 1998, BRIT J PHARMACOL, V125, P595, DOI 10.1038/sj.bjp.0702163; Bockaert J, 2002, INT REV CYTOL, V212, P63; Bockaert J, 1997, HANDB EXP PHARM, V129, P439; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BUCHHEIT KH, 1995, J MED CHEM, V38, P2326, DOI 10.1021/jm00013a009; BUCHHEIT KH, 1995, J MED CHEM, V38, P2331, DOI 10.1021/jm00013a010; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clark R. D., 1998, 5 HT4 RECEPTORS BRAI, P1; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; DUMUIS A, 1991, N-S ARCH PHARMACOL, V343, P245; GROSSMAN CJ, 1993, BRIT J PHARMACOL, V109, P618, DOI 10.1111/j.1476-5381.1993.tb13617.x; Joubert L, 2002, J BIOL CHEM, V277, P25502, DOI 10.1074/jbc.M202539200; Kaumann AJ, 1996, N-S ARCH PHARMACOL, V353, P592; Kii Y, 1997, J CARDIOVASC PHARM, V29, P670, DOI 10.1097/00005344-199705000-00016; LANGLOIS M, 1994, BIOORG MED CHEM LETT, V4, P1433, DOI 10.1016/S0960-894X(01)80508-4; Lopez-Rodriguez ML, 1999, BIOORGAN MED CHEM, V7, P2271, DOI 10.1016/S0968-0896(99)00172-8; Lopez-Rodriguez ML, 2001, BIOORG MED CHEM LETT, V11, P2807, DOI 10.1016/S0960-894X(01)00517-0; Mialet J, 2000, BRIT J PHARMACOL, V130, P527, DOI 10.1038/sj.bjp.0703356; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Scearce-Levie K, 2002, METHOD ENZYMOL, V343, P232; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; Small KM, 2001, J BIOL CHEM, V276, P31596, DOI 10.1074/jbc.M102734200; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Yang DL, 1997, J MED CHEM, V40, P608, DOI 10.1021/jm960320m	30	57	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					699	702		10.1074/jbc.C200588200	http://dx.doi.org/10.1074/jbc.C200588200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12441358	Green Published, hybrid			2022-12-27	WOS:000180321900002
J	Cunnea, PM; Miranda-Vizuete, A; Bertoli, G; Simmen, T; Damdimopoulos, AE; Hermann, S; Leinonen, S; Huikko, MP; Gustafsson, JA; Sitia, R; Spyrou, G				Cunnea, PM; Miranda-Vizuete, A; Bertoli, G; Simmen, T; Damdimopoulos, AE; Hermann, S; Leinonen, S; Huikko, MP; Gustafsson, JA; Sitia, R; Spyrou, G			ERdJ5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; GLUCOSE-REGULATED PROTEINS; DISULFIDE-ISOMERASE; MOLECULAR CHAPERONES; UNFOLDED PROTEINS; ATPASE ACTIVITY; QUALITY-CONTROL; DEGRADATION; DISEASE; PATHWAY	A complex array of chaperones and enzymes reside in the endoplasmic reticulum (ER) to assist the folding and assembly of and the disulfide bond formation in nascent secretory proteins. Here we characterize a novel human putative ER co-chaperone (ERdJ5) containing domains resembling DnaJ, protein-disulfide isomerase, and thioredoxin domains. Homologs of ERdJ5 have been found in Caenorhabditis elegans and Mus musculus. In vitro experiments demonstrated that ERdj5 interacts via its DnaJ domain with BiP in an ATP-dependent manner. ERdj5 is a ubiquitous protein localized in the ER and is particularly abundant in secretory cells. Its transcription is induced during ER stress, suggesting potential roles for ERdj5 in protein folding and translocation across the ER membrane.	Karolinska Inst, Novum, Ctr Biotechnol, Dept Biosci, S-14157 Huddinge, Sweden; Sodertorns Hogskola, Steroid Grp, S-14157 Huddinge, Sweden; Ist Sci San Raffaele, Dept Biol & Technol Res, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy; Tampere Univ, Sch Med, Dept Dev Biol, FIN-33101 Tampere, Finland; Tampere Univ Hosp, Dept Pathol, FIN-33101 Tampere, Finland	Karolinska Institutet; Sodertorn University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Tampere University; Tampere University; Tampere University Hospital	Spyrou, G (corresponding author), Karolinska Inst, Novum, Ctr Biotechnol, Dept Biosci, S-14157 Huddinge, Sweden.	giannis.spyrou@cbt.ki.se	IBIS, REDOX/J-7473-2017; Cunnea, Paula/L-5824-2019; Miranda-Vizuete, Antonio/D-6927-2012; Sitia, Roberto/AAB-5005-2019; Bertoli, Gloria/J-6559-2016	Cunnea, Paula/0000-0002-3699-4911; Miranda-Vizuete, Antonio/0000-0002-6856-5396; Sitia, Roberto/0000-0001-7086-4152; Bertoli, Gloria/0000-0002-5901-4269; Damdimopoulos, Anastasios/0000-0003-4425-1189	Telethon [GP0117Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Benedetti C, 2000, BIOCHEM BIOPH RES CO, V278, P530, DOI 10.1006/bbrc.2000.3838; Brooks DA, 1999, SEMIN CELL DEV BIOL, V10, P441, DOI 10.1006/scdb.1999.0314; Cabibbo A, 1998, ONCOGENE, V16, P2935, DOI 10.1038/sj.onc.1201825; Chai YH, 1999, J NEUROSCI, V19, P10338; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fagerstam L G, 1990, J Mol Recognit, V3, P208, DOI 10.1002/jmr.300030507; Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200; Fassio A, 2002, HISTOCHEM CELL BIOL, V117, P151, DOI 10.1007/s00418-001-0364-0; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gething MJ, 2000, NAT CELL BIOL, V2, pE21, DOI 10.1038/35000090; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Holstein SEH, 1996, J CELL BIOL, V135, P925, DOI 10.1083/jcb.135.4.925; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; KONENEN J, 1997, TECHNICAL TIPS ONLIN; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mossner E, 1998, PROTEIN SCI, V7, P1233; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Sun XX, 2000, BBA-PROTEIN STRUCT M, V1481, P45, DOI 10.1016/S0167-4838(00)00122-9; Taguchi J, 2000, ACTA NEUROPATHOL, V100, P153, DOI 10.1007/s004019900165; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; Xiong XM, 1999, J BIOL CHEM, V274, P2616, DOI 10.1074/jbc.274.5.2616; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200	56	149	165	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1059	1066		10.1074/jbc.M206995200	http://dx.doi.org/10.1074/jbc.M206995200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411443	hybrid			2022-12-27	WOS:000180321900049
J	Di, YP; Harper, R; Zhao, YH; Pahlavan, N; Finkbeiner, W; Wu, R				Di, YP; Harper, R; Zhao, YH; Pahlavan, N; Finkbeiner, W; Wu, R			Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACHEOBRONCHIAL EPITHELIAL-CELLS; CASEIN KINASE-II; MESSENGER-RNA; VITAMIN-A; MUCIN GENES; PLUNC GENE; IN-VITRO; EXPRESSION; IDENTIFICATION; BPI	Retinoids, such as all-trans-retinoic acid, play an essential role in the regulation of airway epithelial cell growth, differentiation, and gene expression. Using cDNA microarray, we identified a clone, DD4, that contains the cDNA of a novel gene, spurt (secretory protein in upper respiratory tracts) that was significantly induced by all-trans-retinoic acid in primary cultured human tracheobroncheal epithelia. Two alternatively spliced spurt transcripts of 1090 and 1035 base pairs exist that contain the same open reading frame expressing a 256-amino acid peptide. The full-length spurt cDNA sequence spans a genomic DNA fragment of 7,313 bp, and the gene is located on chromosome 20q11.21. spurt mRNA is notably expressed at high levels in human nasal, tracheal, and lung tissues. In situ hybridization demonstrated that spurt message is often present in secretory cell types. The human spurt gene product is a secretory protein that contains a distinct signal peptide sequence in its first 19 amino acids. Mono-specific antibodies were generated to characterize spurt expression. Our data demonstrate that spurt is secreted onto the apical side of primary human airway epithelial cultures and is present in clinical sputum samples. spurt gene expression is higher in sputum and tissue samples obtained from patients with chronic obstructive lung disease. Our results provide the cloning and characterization of this tissue-specific novel gene and its possible relationship with airway diseases.	Univ Calif Davis, Med Ctr, Ctr Comparat Resp Biol & Med, Div Pulm & Crit Care Med,Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Med Ctr, Dept Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Di, YP (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, 3343 Forbes Ave, Pittsburgh, PA 15260 USA.		Di, Yuanpu Peter/H-4191-2016; Harper, Richart W/F-9359-2013	Di, Yuanpu Peter/0000-0003-2028-2087; Harper, Richart W/0000-0001-8097-6465	NHLBI NIH HHS [5F32HL09573, HL35635, HL04404, F32 HL009573] Funding Source: Medline; NIEHS NIH HHS [ES06230, ES09701] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009573, R37HL035635, R01HL035635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009701, R01ES006230] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aust MR, 1997, AM J RHINOL, V11, P293, DOI 10.2500/105065897781446685; BASBAUM CB, 1984, CIBA F SYMP, V109, P4, DOI 10.1002/9780470720905.ch2; BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bingle CD, 2000, BBA-GENE STRUCT EXPR, V1493, P363, DOI 10.1016/S0167-4781(00)00196-2; Calafat J, 1998, BLOOD, V91, P4770, DOI 10.1182/blood.V91.12.4770.412k33_4770_4775; Chen JJW, 1998, GENOMICS, V51, P313, DOI 10.1006/geno.1998.5354; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chytil F, 1996, FASEB J, V10, P986, DOI 10.1096/fasebj.10.9.8801181; Cui HM, 1996, TRENDS GENET, V12, P506, DOI 10.1016/S0168-9525(96)90048-7; ELSBACH P, 1993, IMMUNOBIOLOGY, V187, P417, DOI 10.1016/S0171-2985(11)80354-2; ELSBACH P, 1995, INFECT AGENT DIS, V4, P102; EMURA M, 1988, IN VITRO CELL DEV B, V24, P639; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; FILHOL O, 1992, J BIOL CHEM, V267, P20577; Finkbeiner WE, 1999, RESP PHYSIOL, V118, P77, DOI 10.1016/S0034-5687(99)00080-8; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Horton Paul, 1997, INTELLIGENT SYSTEMS, V5, P147; HUANG TH, 1989, DIFFERENTIATION, V41, P78, DOI 10.1111/j.1432-0436.1989.tb00735.x; HUANG TH, 1994, AM J RESP CELL MOL, V10, P192, DOI 10.1165/ajrcmb.10.2.7509163; Iwao K, 2001, INT J CANCER, V91, P433, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1059>3.0.CO;2-B; Jeffery PK, 1997, EUR RESPIR J, V10, P1655, DOI 10.1183/09031936.97.10071655; Kim KC, 1997, EUR RESPIR J, V10, P2644, DOI 10.1183/09031936.97.10112644; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; KOMMINOTH P, 1995, LAB INVEST, V72, P424; Komminoth P, 1992, Diagn Mol Pathol, V1, P142, DOI 10.1097/00019606-199206000-00008; Koo JS, 1999, AM J RESP CELL MOL, V20, P43, DOI 10.1165/ajrcmb.20.1.3310; KORDIYAK GJ, 1994, BIOCHEMISTRY-US, V33, P13484, DOI 10.1021/bi00249a037; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeClair EE, 2001, BIOCHEM BIOPH RES CO, V284, P792, DOI 10.1006/bbrc.2001.5024; MADSEN HO, 1985, NUCLEIC ACIDS RES, V13, P1, DOI 10.1093/nar/13.1.1; MIRELS L, 1992, J BIOL CHEM, V267, P2679; MORO I, 1984, J ORAL PATHOL MED, V13, P97, DOI 10.1111/j.1600-0714.1984.tb01405.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229; REES DD, 1995, AM J PHYSIOL-LUNG C, V269, pL195, DOI 10.1152/ajplung.1995.269.2.L195; Reid CJ, 1997, AM J RESP CELL MOL, V17, P592, DOI 10.1165/ajrcmb.17.5.2798; Rogers D F, 2000, Monaldi Arch Chest Dis, V55, P324; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seregni E, 1997, TUMORI J, V83, P625, DOI 10.1177/030089169708300301; SMITH TF, 1985, NUCLEIC ACIDS RES, V13, P645, DOI 10.1093/nar/13.2.645; SMITH TF, 1983, NUCLEIC ACIDS RES, V11, P2205, DOI 10.1093/nar/11.7.2205; Thornton DJ, 2000, AM J PHYSIOL-LUNG C, V278, pL1118, DOI 10.1152/ajplung.2000.278.6.L1118; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Weston WM, 1999, J BIOL CHEM, V274, P13698, DOI 10.1074/jbc.274.19.13698; Wiese A, 1997, BIOCHEMISTRY-US, V36, P10301, DOI 10.1021/bi970176m; Wu R, 1999, AM J RESP CRIT CARE, V159, pA507; Wu R, 1997, EUR RESPIR J, V10, P2398, DOI 10.1183/09031936.97.10102398; WU R, 1990, AM J RESP CELL MOL, V3, P467, DOI 10.1165/ajrcmb/3.5.467; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Yoon Joo-Heon, 1998, Rhinology (Utrecht), V36, P146	58	76	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1165	1173		10.1074/jbc.M210523200	http://dx.doi.org/10.1074/jbc.M210523200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409287	hybrid			2022-12-27	WOS:000180321900062
J	Endo, M; Shirouzu, M; Yokoyama, S				Endo, M; Shirouzu, M; Yokoyama, S			The Cdc42 binding and scaffolding activities of the fission yeast adaptor protein Scd2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; SH3 DOMAIN; EFFECTOR PROTEINS; PC MOTIF; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; SCHIZOSACCHAROMYCES-POMBE; PAK ACTIVATION; POTENTIAL ROLE; CELL-ADHESION; NADPH OXIDASE	The small GTP-binding protein Cdc42, the guanine nucleotide exchange factor Scd1, the p21-activated kinase Shk1, and the adaptor protein Scd2 are involved in the Cdc42-dependent signaling cascade in fission yeast. In the present study, we analyzed the Cdc42 binding and scaffolding activities of Scd2 by co-precipitation assays. We found that two SH3-containing regions, amino acid residues 1-87 (CB1 (Cdc42-binding region 1)) and 110266 (CB2), of Scd2 can bind to the GTP-bound form of Cdc42. CB2 is cryptic because of the intramolecular binding between the SH3 domain in CB2 (SH3(C)) and the PX domain and binds to Cdc42 only when the Scd2 PB1 domain binds to the PC motif-containing region (residues 760-872) of Scdl. This CB2.Cdc42 association, which would stabilize the open configuration of Scd2, enables the SH3(C) domain to bind to the polyproline motif of Shk1. We also found that the GTP-bound form of Cdc42 binds to the CRIB motif of Shk1 more strongly than to Scd2. Thus, Scd2 functions as a scaffold to form a protein complex, and the GTP-bound Cdc42 might be transferred effectively from the upstream activator Scdl to the downstream effector Shk1 via Scd2.	RIKEN, Genomic Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; RIKEN, Harima Inst Spring 8, Cellular Signaling Lab, Hyogo 6795143, Japan	RIKEN; University of Tokyo; RIKEN	Yokoyama, S (corresponding author), RIKEN, Genomic Sci Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; Endo, Makoto/0000-0002-2055-5471				Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chang E, 1999, MOL CELL BIOL, V19, P8066; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Gladfelter AS, 2001, MOL BIOL CELL, V12, P1239, DOI 10.1091/mbc.12.5.1239; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Han JS, 1998, BIOCHEM MOL BIOL INT, V45, P1089; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; HUGHES DA, 1995, SEMIN CELL BIOL, V6, P89, DOI 10.1016/1043-4682(95)90005-5; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Isshiki T, 1994, Tanpakushitsu Kakusan Koso, V39, P429; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V262, P1, DOI 10.1006/bbrc.1999.1122; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; MARCUS S, 1995, P NATL ACAD SCI USA, V92, P6180, DOI 10.1073/pnas.92.13.6180; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; POLAKIS P, 1993, J BIOL CHEM, V268, P9157; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; Ponting CP, 2002, TRENDS BIOCHEM SCI, V27, P10, DOI 10.1016/S0968-0004(01)02006-0; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Shirouzu M, 1998, J BIOL CHEM, V273, P7737, DOI 10.1074/jbc.273.13.7737; Song X, 2001, BIOCHEMISTRY-US, V40, P8940, DOI 10.1021/bi0155100; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Terasawa H, 2001, EMBO J, V20, P3947, DOI 10.1093/emboj/20.15.3947; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tu H, 1999, MOL CELL BIOL, V19, P602; Wang BC, 2000, J BIOL CHEM, V275, P5222, DOI 10.1074/jbc.275.7.5222; Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	52	50	50	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					843	852		10.1074/jbc.M209714200	http://dx.doi.org/10.1074/jbc.M209714200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409291	hybrid			2022-12-27	WOS:000180321900022
J	Ramstrom, H; Sanglier, S; Leize-Wagner, E; Philippe, C; Van Dorsselaer, A; Haiech, J				Ramstrom, H; Sanglier, S; Leize-Wagner, E; Philippe, C; Van Dorsselaer, A; Haiech, J			Properties and regulation of the bifunctional enzyme HPr kinase/phosphatase in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON CATABOLITE REPRESSION; IONIZATION MASS-SPECTROMETRY; TYROSINE KINASE INHIBITORS; DEPENDENT PROTEIN-KINASE; GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-MUTANS; STAPHYLOCOCCUS-XYLOSUS; ACETYL PHOSPHATE; GENE; OPERON	The bifunctional allosteric enzyme HPr kinase/phosphatase (HPrK/P) from Bacillus subtilis is a key enzyme in the main mechanism of carbon catabolite repression/activation (i.e. a means for the bacteria to adapt rapidly to environmental changes in carbon sources). In this regulation system, the enzyme can phosphorylate and dephosphorylate two proteins, HPr/HPr(Ser(P)) and Crh/Crh(Ser(P)), sensing the metabolic state of the cell. To acquire further insight into the properties of HPrK/P, electrospray ionization mass spectrometry, dynamic light scattering, and BILACORE were used to determine the oligomeric state of the protein under native conditions, revealing that the enzyme exists as a hexamer at pH 6.8 and as a monomer and dimer at pH 9.5. Using an in vitro radioactive assay, the influence of divalent cations, pH, temperature, and different glycolytic intermediates on the activity as well as kinetic parameters were investigated. The presence of divalent cations was found to be essential for both opposing activities of the enzyme. Furthermore, pH values equal to the internal pH of vegetative cells seem to favor the kinase activity, whereas lower pH values increased the phosphatase activity. Among the glycolytic intermediates evaluated, fructose 1,6-diphosphate and fructose 2,6-diphosphate were found to be allosteric activators in the kinase assay, whereas high concentrations inhibited the phosphatase activity, except for fructose 1,6-diphosphate in the case of HPr(Ser(P)). Phosphatase activity was induced by inorganic phosphate as well as acetyl phosphate and glyceraldehyde 3-phosphate. Kinetic parameters indicate a preference for binding of HPr compared with Crh to the enzyme and supported a strong positive cooperativity. This work suggests that the oligomeric state of the enzyme is influenced by several effectors and is correlated to the kinase or phosphatase activity. The phosphatase activity is mainly supported by the hexameric form.	Univ Louis Pasteur Strasbourg 1, Fac Pharm, UMR CNRS 7034, F-67401 Illkirch Graffenstaden, France; Univ Strasbourg, UMR CNRS 7509, ECPM, Lab Spectrometrie Masse Bioorgan, F-67087 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Haiech, J (corresponding author), Univ Louis Pasteur Strasbourg 1, Fac Pharm, UMR CNRS 7034, 74 Route Rhin,BP 24, F-67401 Illkirch Graffenstaden, France.	haiech@pharma.u-strasbg.fr	haiech, jacques J/F-2890-2010	Cianferani, Sarah/0000-0003-4013-4129; haiech, jacques/0000-0003-2908-8053				Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Asanuma N, 2000, APPL ENVIRON MICROB, V66, P3773, DOI 10.1128/AEM.66.9.3773-3777.2000; BARTON JK, 1980, P NATL ACAD SCI-BIOL, V77, P2470, DOI 10.1073/pnas.77.5.2470; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Brochu D, 1999, J BACTERIOL, V181, P709, DOI 10.1128/JB.181.3.709-717.1999; CORNISHBOWDEN A, 1995, FUNDAMENTALS ENZYME, P69; DAHL MK, 1995, FEMS MICROBIOL LETT, V132, P79, DOI 10.1111/j.1574-6968.1995.tb07814.x; Darbon E, 2001, J MOL MICROB BIOTECH, V3, P439; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Dossonnet V, 2000, J BACTERIOL, V182, P2582, DOI 10.1128/JB.182.9.2582-2590.2000; FERRARI S, 1991, METHOD ENZYMOL, V200, P159; Fieulaine S, 2001, EMBO J, V20, P3917, DOI 10.1093/emboj/20.15.3917; FUJITA Y, 1979, J BIOL CHEM, V254, P5340; FUJITA Y, 1995, MOL MICROBIOL, V17, P953, DOI 10.1111/j.1365-2958.1995.mmi_17050953.x; Galinier A, 2002, J BIOL CHEM, V277, P11362, DOI 10.1074/jbc.M109527200; Galinier A, 1998, P NATL ACAD SCI USA, V95, P1823, DOI 10.1073/pnas.95.4.1823; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; GRUNDY FJ, 1994, J BACTERIOL, V176, P4527, DOI 10.1128/JB.176.15.4527-4533.1994; GRUNDY FJ, 1993, J BACTERIOL, V175, P7348, DOI 10.1128/JB.175.22.7348-7355.1993; GUEFFROY DE, 1993, BUFFERS GUIDE PREPAR, P13; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Huynh PL, 2000, J BACTERIOL, V182, P1895, DOI 10.1128/JB.182.7.1895-1902.2000; IWAMI Y, 1975, ARCH ORAL BIOL, V20, P695, DOI 10.1016/0003-9969(75)90140-5; JACOB S, 1991, MOL GEN GENET, V229, P189, DOI 10.1007/BF00272155; Jault JM, 2000, J BIOL CHEM, V275, P1773, DOI 10.1074/jbc.275.3.1773; Kim SB, 2001, FEMS MICROBIOL LETT, V195, P179, DOI 10.1111/j.1574-6968.2001.tb10518.x; KOUNTZ PD, 1985, ARCH BIOCHEM BIOPHYS, V238, P531, DOI 10.1016/0003-9861(85)90197-3; Kravanja M, 1999, MOL MICROBIOL, V31, P59, DOI 10.1046/j.1365-2958.1999.01146.x; KRULWICH TA, 1985, J BACTERIOL, V162, P768, DOI 10.1128/JB.162.2.768-772.1985; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Last AM, 1999, CURR OPIN CHEM BIOL, V3, P564, DOI 10.1016/S1367-5931(99)00009-5; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; Ludwig H, 2001, MOL MICROBIOL, V41, P409, DOI 10.1046/j.1365-2958.2001.02523.x; Marquez JA, 2002, P NATL ACAD SCI USA, V99, P3458, DOI 10.1073/pnas.052461499; MARTINVERSTRAETE I, 1995, J BACTERIOL, V177, P6919, DOI 10.1128/jb.177.23.6919-6927.1995; MASON PW, 1981, J BIOL CHEM, V256, P1861; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; MIMURA CS, 1987, J CELL BIOCHEM, V33, P161, DOI 10.1002/jcb.240330303; MIWA Y, 1990, NUCLEIC ACIDS RES, V18, P7049, DOI 10.1093/nar/18.23.7049; Monedero V, 2001, EMBO J, V20, P3928, DOI 10.1093/emboj/20.15.3928; Noonberg SB, 2000, DRUGS, V59, P753, DOI 10.2165/00003495-200059040-00003; NYSTROM T, 1994, MOL MICROBIOL, V12, P833, DOI 10.1111/j.1365-2958.1994.tb01069.x; ODA M, 1992, MOL MICROBIOL, V6, P2573, DOI 10.1111/j.1365-2958.1992.tb01434.x; Penin F, 2001, J MOL MICROB BIOTECH, V3, P429; PERRIN DD, 1974, BUFFERS PH METAL ION, P24; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889, DOI 10.1128/JB.181.22.6889-6897.1999; REIZER J, 1988, P NATL ACAD SCI USA, V85, P2041, DOI 10.1073/pnas.85.7.2041; REIZER J, 1984, J BACTERIOL, V160, P333, DOI 10.1128/JB.160.1.333-340.1984; Reizer J, 1998, MOL MICROBIOL, V27, P1157, DOI 10.1046/j.1365-2958.1998.00747.x; Rostom AA, 1999, J AM CHEM SOC, V121, P4718, DOI 10.1021/ja990238r; Sedlacek HH, 2000, DRUGS, V59, P435, DOI 10.2165/00003495-200059030-00004; SEGEL IH, 1993, ENZYME KINETICS BEHA, P884; Steinhauer K, 2002, ACTA CRYSTALLOGR D, V58, P515, DOI 10.1107/S090744490102145X; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; THEVENOT T, 1995, J BACTERIOL, V177, P2751, DOI 10.1128/jb.177.10.2751-2759.1995; Tito MA, 2000, J AM CHEM SOC, V122, P3550, DOI 10.1021/ja993740k; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Turinsky AJ, 2000, J BACTERIOL, V182, P5611, DOI 10.1128/JB.182.19.5611-5614.2000; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wendisch VF, 1997, ARCH MICROBIOL, V168, P262, DOI 10.1007/s002030050497; WRAY LV, 1994, J BACTERIOL, V176, P1894, DOI 10.1128/jb.176.7.1894-1902.1994; Zal F, 2002, BIOMACROMOLECULES, V3, P229, DOI 10.1021/bm0101668	69	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1174	1185		10.1074/jbc.M209052200	http://dx.doi.org/10.1074/jbc.M209052200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411438	hybrid			2022-12-27	WOS:000180321900063
J	Bernimoulin, MP; Zeng, XL; Abbal, C; Giraud, S; Martinez, M; Michielin, O; Schapira, M; Spertini, O				Bernimoulin, MP; Zeng, XL; Abbal, C; Giraud, S; Martinez, M; Michielin, O; Schapira, M; Spertini, O			Molecular basis of leukocyte rolling on PSGL-1 - Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; P-SELECTIN; IN-VIVO; ENDOTHELIAL-CELLS; AMINO-TERMINUS; SIDE-CHAINS; FUCT-VII; ADHESION; BINDING; PROTEINS	Interactions between the leukocyte adhesion receptor L-selectin and P-selectin glycoprotein ligand-1 play an important role in regulating the inflammatory response by mediating leukocyte tethering and rolling on adherent leukocytes. In this study, we have examined the effect of post-translational modifications of PSGL-1 including Tyr sulfation and presentation of sialylated and fucosylated O-glycans for L-selectin binding. The functional importance of these modifications was determined by analyzing soluble L-selectin binding and leukocyte rolling on CHO cells expressing various glycoforms of PSGL-1 or mutant PSGL-1 targeted at N-terminal Thr or Tyr residues. Simultaneous expression of core-2 beta1,6-N-acetylglucosaminyltransferase and fucosyltransferase VII was required for optimal L-selectin binding to PSGL-1. Substitution of Thr-57 by Ala but not of Thr-44, strongly decreased L-selectin binding and leukocyte rolling on PSGL-1. Substitution of Tyr by Phe revealed that PSGL-1 Tyr-51 plays a predominant role in mediating L-selectin binding and leukocyte rolling whereas Tyr-48 has a minor role, an observation that contrasts with the pattern seen for the interactions between PSGL-1 and P-selectin where Tyr-48 plays a key role. Molecular modeling analysis of L-selectin and P-selectin interactions with PSGL-1 further supported these observations. Additional experiments showed that core-2 O-glycans attached to Thr-57 were also of critical importance in regulating the velocity and stability of leukocyte rolling. These observations pinpoint the structural characteristics of PSGL-1 that are required for optimal interactions with L-selectin and may be responsible for the specific kinetic and mechanical bond properties of the L-selectin-PSGL-1 adhesion receptor-counterreceptor pair.	CHU Vaudois, Div Hematol, CH-1011 Lausanne, Switzerland; CHU Vaudois, Cent Hematol Lab, CH-1011 Lausanne, Switzerland; Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; Swiss Inst Bioinformat, Epalinges, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics	Spertini, O (corresponding author), Univ Lausanne, CHU Vaudois, Div Hematol, BH 18-544, CH-1011 Lausanne, Switzerland.	Olivier.Spertini@chuv.hospvd.ch	Michielin, Olivier/ABE-7924-2020	Giraud, Sylvain/0000-0002-3437-0849				Alon R, 1997, J CELL BIOL, V138, P1169, DOI 10.1083/jcb.138.5.1169; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Giuffre L, 1997, J CELL BIOL, V136, P945, DOI 10.1083/jcb.136.4.945; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Jung U, 1996, AM J PHYSIOL-HEART C, V271, pH2740, DOI 10.1152/ajpheart.1996.271.6.H2740; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kunkel EJ, 1998, CIRC RES, V82, P30; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; LEY K, 1993, BLOOD, V82, P1632; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Ma YQ, 2002, J IMMUNOL, V168, P1690, DOI 10.4049/jimmunol.168.4.1690; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Martin ACR, 1997, PROTEINS, P14; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCDONALD IK, 1995, PROTEIN ENG, V8, P217, DOI 10.1093/protein/8.3.217; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Moore KL, 1998, LEUKEMIA LYMPHOMA, V29, P1, DOI 10.3109/10428199809058377; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOULT J, 2001, PROTEIN-STRUCT FUNCT, V45, P2; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; Norman KE, 2000, BLOOD, V96, P3585; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Rees S, 1996, BIOTECHNIQUES, V20, P102; Rodgers SD, 2001, BIOPHYS J, V81, P2001, DOI 10.1016/S0006-3495(01)75850-X; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2001, BLOOD, V97, P3812, DOI 10.1182/blood.V97.12.3812; SPERTINI O, 1991, J IMMUNOL, V147, P942; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; TINGBEALL HP, 1993, BLOOD, V81, P2774; Tu L, 1999, J EXP MED, V189, P241, DOI 10.1084/jem.189.2.241; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769	69	49	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					37	47		10.1074/jbc.M204360200	http://dx.doi.org/10.1074/jbc.M204360200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403782	hybrid			2022-12-27	WOS:000180255700005
J	Furusawa, M; Taira, T; Iguchi-Ariga, SMM; Ariga, H				Furusawa, M; Taira, T; Iguchi-Ariga, SMM; Ariga, H			AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SPERM CAPACITATION; TYROSINE PHOSPHORYLATION; CONDENSATION; SPERMATOZOA	We have reported that a novel c-Myc-binding protein, AMY-1, binds to cAMP-dependent protein kinase-anchoring protein 149 (AKAP149) and its splicing variant, AKAP84 and is localized in the mitochondria in a complex with RII, a regulatory subunit of cAMP-dependent protein kinase (PKA) (Furusawa, M., Ohnishi, T., Taira, T., Iguchi-Ariga, S. M. M., and Axiga, H. (2001) J. Biol. Chem. 276, 36647-36651). In this study, we further found that AMY-1 competitively bound to either AKAP95 or AKAP84 in the nucleus and the cytoplasm, respectively, in a concentration-dependent manner of either AKAP. Like AKAP84, AMY-1 was found to bind to the RII-binding region of AKAP95 in vivo and in vitro and to make a ternary complex with RII. It was also found that the formation of the complex of AMY-1 with AKAP84/95 and RII prevented a catalytic subunit from binding to this AKAP complex, leading to suppression of PKA activity. These findings suggest that AMY-1 is an important modulator of PKA.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Hokkaido Univ, Coll Med Technol, Kita Ku, Sapporo, Hokkaido 0600812, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Ariga, Sanae/H-9647-2013	Ariga, Hiroyoshi/0000-0001-7384-2143; 				AITKEN RJ, 1995, J CELL SCI, V108, P2017; Akileswaran L, 2001, J BIOL CHEM, V276, P17448, DOI 10.1074/jbc.M101171200; Collas P, 1999, J CELL BIOL, V147, P1167, DOI 10.1083/jcb.147.6.1167; Eide T, 2002, EMBO REP, V3, P426, DOI 10.1093/embo-reports/kvf089; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Furusawa M, 2000, INT J ONCOL, V16, P339; Furusawa M, 2001, J BIOL CHEM, V276, P36647, DOI 10.1074/jbc.M103885200; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Han I, 2002, MOL CELL BIOL, V22, P2136, DOI 10.1128/MCB.22.7.2136-2146.2002; Landsverk HB, 2001, J CELL SCI, V114, P3255; Leclerc P, 1997, FREE RADICAL BIO MED, V22, P643, DOI 10.1016/S0891-5849(96)00379-6; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; NAZ RK, 1991, J CELL SCI, V99, P157; Ono T, 2000, J BIOL CHEM, V275, P31145, DOI 10.1074/jbc.M003031200; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Trendelenburg G, 1996, BIOCHEM BIOPH RES CO, V225, P313, DOI 10.1006/bbrc.1996.1172; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129	21	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50885	50892		10.1074/jbc.M206387200	http://dx.doi.org/10.1074/jbc.M206387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12414807	hybrid			2022-12-27	WOS:000180177700090
J	Robertson, AS; Belorgey, D; Lilley, KS; Lomas, DA; Gubb, D; Dafforn, TR				Robertson, AS; Belorgey, D; Lilley, KS; Lomas, DA; Gubb, D; Dafforn, TR			Characterization of the necrotic protein that regulates the toll-mediated immune response in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SERINE PROTEASES; SUBSTRATE-SPECIFICITY; DORSOVENTRAL POLARITY; REACTIVE LOOP; INHIBITION; ALPHA(1)-ANTITRYPSIN; ANTITHROMBIN; ACTIVATION; MECHANISM	Necrotic (Nec) is an important component of the proteolytic cascade that activates the Toll-mediated immune response in Drosophila. The Nec protein is a member of the serpin (SERine Protease INhibitor) superfamily and is thought to regulate the cascade by inhibiting the serine protease Persephone. Nec was expressed in Escherichia coli, and the purified protein folded to the active native conformation required for protease inhibitory activity. Biochemical analysis showed that Nec had a broad inhibitory specificity and inhibited elastase, thrombin, and chymotrypsin-like proteases. It did not inhibit trypsin or kallikrein. These data show that Necrotic is likely to inhibit a wide range of proteases in Drosophila and that Nec has the specificity requirements to act as the physiological inhibitor of Persephone in vivo.	Univ Cambridge, Med Res Inst, Cambridge CB2 2XY, England; Univ Cambridge, Dept Biochem, Cambridge Ctr Proteom, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge		tim.dafforn@man.ac.uk	Lilley, Kathryn/ABF-5787-2020; Gubb, David/F-9793-2011; Dafforn, Tim/A-9072-2015	Lilley, Kathryn/0000-0003-0594-6543; Dafforn, Tim/0000-0003-2257-6679	Biotechnology and Biological Sciences Research Council [G18877] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; Belorgey D, 1996, BIOCHEM J, V313, P555, DOI 10.1042/bj3130555; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BIETH JG, 1984, ADV EXP MED BIOL, V167, P97; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chang WSW, 1998, J BIOL CHEM, V273, P3695, DOI 10.1074/jbc.273.6.3695; Czapinska H, 1999, EUR J BIOCHEM, V260, P571, DOI 10.1046/j.1432-1327.1999.00160.x; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676; Green C, 2000, GENETICS, V156, P1117; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; LETSOU A, 1991, P NATL ACAD SCI USA, V88, P810, DOI 10.1073/pnas.88.3.810; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Mansell A, 2001, FEBS LETT, V508, P313, DOI 10.1016/S0014-5793(01)03077-0; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Oelschlager C, 2002, BLOOD, V99, P4015, DOI 10.1182/blood.V99.11.4015; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sivasothy P, 2000, J BIOL CHEM, V275, P33663, DOI 10.1074/jbc.M004054200; Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798; Solivan S, 2002, FEBS LETT, V512, P133, DOI 10.1016/S0014-5793(02)02242-1; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200	35	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					6175	6180		10.1074/jbc.M209277200	http://dx.doi.org/10.1074/jbc.M209277200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12414799	hybrid			2022-12-27	WOS:000181129400086
J	Weinreb, GE; Mukhopadhyay, K; Majumder, R; Lentz, BR				Weinreb, GE; Mukhopadhyay, K; Majumder, R; Lentz, BR			Cooperative roles of factor V-a and phosphatidylserine-containing membranes as cofactors in prothrombin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELETS; MEIZOTHROMBIN; COMPLEX	Activation of prothrombin, as catalyzed by the prothrombinase complex (factor X-a enzyme; factor V-a and phosphatidylserine (PS)-containing membranes, cofactors), involves production and subsequent proteolysis of two possible intermediates, meizothrombin (MZll(a)) and prethrombin 2 plus fragment 1.2 (Pre2 & F1.2). V-max, K-m, or V-max/K-m for all four proteolytic steps was determined as a function of membrane-phospholipid concentration. Proteolysis was monitored using a fluorescent thrombin inhibitor, a chromogenic substrate, and SDS-PAGE. The kinetic constants for the conversion of MZlla and Pre2 & F1.2 to thrombin were determined directly. Pre2 & F1.2 conversion was linear in substrate concentration up to 4 pm, whereas MZII(a) proteolysis was saturable. First order rate constants for formation of MzII(a) and Pre2 & F1.2 could not be determined directly and were determined from global fitting of the data to a parallel, sequential model, each step of which was treated by the Michaelis-Menten formalism. The rate of direct conversion to thrombin without release of intermediates from the membrane-V-a-X-a complex (i.e. "channeling") also was adjusted because both the membranes and factor V-a have been shown to cause channeling. k(cat), K-m, or k(cat)/K-m values were reported for one lipid concentration, for which all X-a was likely incorporated into a X-a-V-a complex on a PS membrane. Comparing previous results, which were obtained either with factor V. (Boskovic, D. S., Bvijzar, L. S., and Nesheim, M. E. (2001) J. Biol. Chem. 276, 28686 -28693) or with membranes individually (Wu, J. R., Zhou, C., Majumder, R., Powers, D. D., Weinreb, G., and Lentz, B. R. (2002) Biochemistry 41, 935-949), with results presented here we conclude that both factor V-a and PS-containing membranes induce similar rate increases and pathway changes. Moreover, we have determined: 1) factor V-a has the greatest effect in enhancing rates of individual proteolytic events; 2) PS-containing membranes have the greatest role in increasing the preference for the MZII(a) versus Pre2 pathway; and 3) PS membranes cause similar to50% of the substrate to be activated via channeling at 50 mum membrane concentration, but factor V. extends the range of efficient channeling to much lower or higher membrane concentrations.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lentz, BR (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.		Majumder, Rinku/J-7512-2019	majumder, Rinku/0000-0002-1727-7220	NHLBI NIH HHS [HL45916] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045916] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banerjee M, 2002, BIOCHEMISTRY-US, V41, P7751, DOI 10.1021/bi020017p; Banerjee M, 2002, BIOCHEMISTRY-US, V41, P950, DOI 10.1021/bi0116902; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; Boskovic DS, 2001, J BIOL CHEM, V276, P28686, DOI 10.1074/jbc.M101813200; CARLISLE TL, 1990, J BIOL CHEM, V265, P22044; CUTSFORTH GA, 1989, BIOCHEMISTRY-US, V28, P7453, DOI 10.1021/bi00444a045; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu YF, 1996, BIOCHEMISTRY-US, V35, P8201, DOI 10.1021/bi960281g; Majumder R, 2002, J BIOL CHEM, V277, P29765, DOI 10.1074/jbc.M200893200; MITRA P, 1994, ANAL BIOCHEM, V223, P327, DOI 10.1006/abio.1994.1594; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; NESHEIM ME, 1983, J BIOL CHEM, V258, P5386; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; PEI G, 1993, J BIOL CHEM, V268, P3226; PEI G, 1991, BLOOD COAGUL FIBRIN, V2, P309, DOI 10.1097/00001721-199104000-00014; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SANDBERG H, 1982, BIOCHEM J, V203, P303, DOI 10.1042/bj2030303; SANDBERG H, 1985, THROMB RES, V39, P63, DOI 10.1016/0049-3848(85)90122-7; Wu JR, 2002, BIOCHEMISTRY-US, V41, P935, DOI 10.1021/bi0116893; YE J, 1995, BIOCHEMISTRY-US, V34, P6448, DOI 10.1021/bi00019a026	22	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					5679	5684		10.1074/jbc.M208423200	http://dx.doi.org/10.1074/jbc.M208423200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12438309	hybrid			2022-12-27	WOS:000181129400026
J	Chang, CS; Magracheva, E; Kozlov, S; Fong, S; Tobin, G; Kotenko, S; Wlodawer, A; Zdanov, A				Chang, CS; Magracheva, E; Kozlov, S; Fong, S; Tobin, G; Kotenko, S; Wlodawer, A; Zdanov, A			Crystal structure of interleukin-19 defines a new subfamily of helical cytokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-GAMMA; RECEPTOR COMPLEXES; HOMOLOG; REVEALS; IDENTIFICATION; IL-19; CHAIN	Interleukin-19 (IL-19) is a novel cytokine that was initially identified during a sequence data base search aimed at finding potential IL-10 homologs. IL-19 shares a receptor complex with IL-20, indicating that the biological activities of these two cytokines overlap and that both may play an important role in regulating development and proper functioning of the skin. We determined the crystal structure of human recombinant IL-19 and refined it at 1.95-Angstrom resolution to an R-factor of 0.157. Unlike IL-10, which forms an intercalated dimer, the molecule of IL-19 is a monomer made of seven amphipathic helices, A-G, creating a unique helical bundle. On the basis of the observed structure, we propose that IL-19, IL-20, and other putative members of the proposed IL-10 family together form a distinct subfamily of helical cytokines.	NCI, Ctr Canc Res, Macromol Crystallog Lab, Prot Struct Sect,NIH, Frederick, MD 21702 USA; SAIC Frederick Inc, Intramural Res Support Program, Frederick, MD 21702 USA; NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21702 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center	Zdanov, A (corresponding author), NCI, Ctr Canc Res, Macromol Crystallog Lab, Prot Struct Sect,NIH, POB B, Frederick, MD 21702 USA.		Chang, Changsoo/X-3271-2018	Chang, Changsoo/0000-0003-1860-2969	NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010348] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5; EALICK SE, 1991, SCIENCE, V252, P698, DOI 10.1126/science.1902591; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Josephson K, 2002, STRUCTURE, V10, P981, DOI 10.1016/S0969-2126(02)00791-8; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Knappe A, 2000, J VIROL, V74, P3881, DOI 10.1128/JVI.74.8.3881-3887.2000; Kotenko SV, 2002, CYTOKINE GROWTH F R, V13, P223, DOI 10.1016/S1359-6101(02)00012-6; Kotenko SV, 2000, ONCOGENE, V19, P2557, DOI 10.1038/sj.onc.1203524; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P80; PRESNELL SR, 1989, P NATL ACAD SCI USA, V86, P6592, DOI 10.1073/pnas.86.17.6592; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOREAU E, 1991, FEBS LETT, V282, P26, DOI 10.1016/0014-5793(91)80437-8; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Zdanov A, 1997, J MOL BIOL, V268, P460, DOI 10.1006/jmbi.1997.0990; Zdanov A, 1996, PROTEIN SCI, V5, P1955, DOI 10.1002/pro.5560051001; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9; [No title captured]	30	67	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3308	3313		10.1074/jbc.M208602200	http://dx.doi.org/10.1074/jbc.M208602200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12403790	hybrid			2022-12-27	WOS:000180915000069
J	Sato, T; Gotoh, M; Kiyohara, K; Akashima, T; Iwasaki, H; Kameyama, A; Mochizuki, H; Yada, T; Inaba, N; Togayachi, A; Kudo, T; Asada, M; Watanabe, H; Imamura, T; Kimata, K; Narimatsu, H				Sato, T; Gotoh, M; Kiyohara, K; Akashima, T; Iwasaki, H; Kameyama, A; Mochizuki, H; Yada, T; Inaba, N; Togayachi, A; Kudo, T; Asada, M; Watanabe, H; Imamura, T; Kimata, K; Narimatsu, H			Differential roles of two N-acetylgalactosaminyltransferases, CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2 - Initiation and elongation in synthesis of chondroitin sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; BETA-D-XYLOSYLTRANSFERASE; UDP-D-XYLOSE; BETA-4-GALACTOSYLTRANSFERASE GENE FAMILY; FIBROBLAST GROWTH-FACTOR; MOLECULAR-CLONING; HEPARAN-SULFATE; EXPRESSION; PROTEOGLYCANS; BIOSYNTHESIS	By a tblastn search with beta1,4-galactosyltransferases as query sequences, we found an expressed sequence tag that showed similarity in beta1,4-glycosyltransferase motifs. The full-length complementary DNA was obtained by a method of 5'-rapid amplification of complementary DNA ends. The predicted open reading frame encodes a typical type H membrane protein comprising 543 amino acids, the sequence of which was highly homologous to chondroitin sulfate N-acetylgalactosaminyltransferase CSGalNAcT-1), and we designated this novel enzyme CSGalNAcT-2. CSGalNAcT-2 showed much stronger N-acetylgalactosaminyltransferase activity toward glucuronic acid of chondroitin poly- and oligosaccharides, and chondroitin sulfate poly- and oligosaccharides with a beta1-4 linkage, i.e. elongation activity for chondroitin and chondroitin sulfate, but showed much weaker activity toward a tetrasaccharide of the glycosaminoglycan linkage structure (GlcA-Gal-Gal-Xyl-0-methoxyphenyl), i.e. initiation activity, than CSGalNAcT-1. Transfection of the CSGalNAcT-1 gene into Chinese hamster ovary cells yielded a change of glycosaminoglycan composition, i.e. the replacement of heparan sulfate on a syndecan-4/fibroblast growth factor-1 chimera protein by chondroitin sulfate, however, transfection of the CSGalNAcT-2 gene did not. The above results indicated that CSGalNAcT-1 is involved in the initiation of chondroitin sulfate synthesis, whereas CSGalNAcT-2 participates mainly in the elongation, not initiation. Quantitative real-time PCR analysis revealed that CSGalNAcT-2 tran-scripts were highly expressed in the small intestine, leukocytes, and spleen, however, both CSGalNAcTs were ubiquitously expressed in various tissues.	Natl Inst Adv Ind Sci & Technol, AIST, RCG, Glycogene Funct Team, Tsukuba, Ibaraki 3058568, Japan; Amersham Biosci KK, Shinjuku Ku, Tokyo 1690073, Japan; Seikagaku corp, Higashiyamato, Tokyo 2070021, Japan; Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; JGS Japan Genome Solut Inc, Hachioji, Tokyo 1920031, Japan; AIST, Age Dimens Res Ctr, Cell Regulat Team, Tsukuba, Ibaraki 3058566, Japan; New Energy & Ind Technol Dev Org, NEDO, Toshima Ku, Tokyo 1706028, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Seikagaku Corporation; Aichi Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, AIST, RCG, Glycogene Funct Team, Cent 2 C-2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.		Sato, Takashi/M-2577-2018; Narimatsu, Hisashi/M-4757-2018; Kameyama, Akihiko/A-9641-2008; ASADA, MASAHIRO/M-4086-2018; Togayachi, Akira/M-4144-2018	Sato, Takashi/0000-0002-9973-8923; Narimatsu, Hisashi/0000-0002-8402-133X; Kameyama, Akihiko/0000-0002-8229-4449; ASADA, MASAHIRO/0000-0001-6092-2080; Togayachi, Akira/0000-0003-3600-9149; Watanabe, Hideto/0000-0001-5291-0696				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892; Brinkmann T, 1997, J BIOL CHEM, V272, P11171; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GUNDLACH MW, 1985, BIOCHEM J, V226, P705, DOI 10.1042/bj2260705; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; IMAMURA T, 1994, EXP CELL RES, V215, P363, DOI 10.1006/excr.1994.1353; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Kang HG, 2002, J BIOL CHEM, V277, P34766, DOI 10.1074/jbc.M204907200; Kawar ZS, 2002, J BIOL CHEM, V277, P34924, DOI 10.1074/jbc.M206112200; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Schwientek T, 1998, J BIOL CHEM, V273, P29331, DOI 10.1074/jbc.273.45.29331; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Tanaka Y, 1998, P ASSOC AM PHYSICIAN, V110, P118; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Yamauchi S, 2000, J BIOL CHEM, V275, P8975, DOI 10.1074/jbc.275.12.8975; Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487; Zou K, 2000, EUR J BIOCHEM, V267, P4046, DOI 10.1046/j.1432-1327.2000.01440.x	46	79	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3063	3071		10.1074/jbc.M208886200	http://dx.doi.org/10.1074/jbc.M208886200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12446672	hybrid			2022-12-27	WOS:000180915000039
J	Heidenfelder, BL; Makhov, AM; Topal, MD				Heidenfelder, BL; Makhov, AM; Topal, MD			Hairpin formation in Friedreich's ataxia triplet repeat expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA SECONDARY STRUCTURE; REPLICATION IN-VITRO; TRINUCLEOTIDE REPEATS; ESCHERICHIA-COLI; LAGGING-STRAND; POLYMERASE-I; BASE-PAIRS; DISEASES; GAA; INSTABILITY	Triplet repeat tracts occur throughout the human genome. Expansions of a (GAA)(n)/(TTQ)(n) repeat tract during its transmission from parent to child are tightly associated with the occurrence of Friedreich's ataxia. Evidence supports DNA slippage during DNA replication as the cause of the expansions. DNA slippage results in single-stranded expansion intermediates. Evidence has accumulated that predicts that hairpin structures protect from DNA repair the expansion intermediates of all of the disease-associated repeats except for those of Friedreich's ataxia. How the latter repeat expansions avoid repair remains a mystery because (GAA)(n) and (TTQ)(n). repeats are reported not to self-anneal. To characterize the Friedreich's ataxia intermediates, we generated massive expansions of (GAA)(n) and (TTQ)(n) during DNA replication in vitro using human polymerase beta and the Klenow fragment of Escherichia coli polymerase I. Electron microscopy, endonuclease cleavage, and DNA sequencing of the expansion products demonstrate, for the first time, the occurrence of large and growing (GAA)(n) and (TTQ)(n) hairpins during DNA synthesis. The results provide unifying evidence that predicts that hairpin formation during DNA synthesis mediates all of the disease-associated, triplet repeat expansions.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Topal, MD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.							Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Beard WA, 1995, METHOD ENZYMOL, V262, P98; CHEN XA, 1995, P NATL ACAD SCI USA, V92, P5199, DOI 10.1073/pnas.92.11.5199; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Freudenreich CH, 1997, MOL CELL BIOL, V17, P2090, DOI 10.1128/MCB.17.4.2090; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; GACY AM, 1995, CELL, V81, P533; Gao YG, 1999, BIOCHEMISTRY-US, V38, P16452, DOI 10.1021/bi9914614; Gordenin DA, 1997, NAT GENET, V16, P116, DOI 10.1038/ng0697-116; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; HUERTAS D, 1993, EMBO J, V12, P4029, DOI 10.1002/j.1460-2075.1993.tb06081.x; HUNTER WN, 1986, J BIOMOL STRUCT DYN, V4, P173, DOI 10.1080/07391102.1986.10506338; JAISHREE TN, 1994, FEBS LETT, V337, P139, DOI 10.1016/0014-5793(94)80261-0; Ji JP, 1996, NUCLEIC ACIDS RES, V24, P2835, DOI 10.1093/nar/24.14.2835; Kang S, 1996, J MOL BIOL, V258, P543, DOI 10.1006/jmbi.1996.0266; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LeProust EM, 2000, J MOL BIOL, V302, P1063, DOI 10.1006/jmbi.2000.4073; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; Lyons-Darden T, 1999, NUCLEIC ACIDS RES, V27, P2235, DOI 10.1093/nar/27.11.2235; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; MITAS M, 1995, NUCLEIC ACIDS RES, V23, P1050, DOI 10.1093/nar/23.6.1050; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; NADEL Y, 1995, J BIOL CHEM, V270, P28970, DOI 10.1074/jbc.270.48.28970; Nakayabu M, 1998, NUCLEIC ACIDS RES, V26, P1980, DOI 10.1093/nar/26.8.1980; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; PazElizur T, 1997, BIOCHEMISTRY-US, V36, P1766, DOI 10.1021/bi9621324; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; PRIVE GG, 1987, SCIENCE, V238, P498, DOI 10.1126/science.3310237; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; Roberts RJ, 2000, NUCLEIC ACIDS RES, V28, P306, DOI 10.1093/nar/28.1.306; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schweitzer JK, 1998, HUM MOL GENET, V7, P69, DOI 10.1093/hmg/7.1.69; Shiber MC, 1996, NUCLEIC ACIDS RES, V24, P5004, DOI 10.1093/nar/24.24.5004; Sinden RR, 2001, NATURE, V411, P757, DOI 10.1038/35081234; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Suen IS, 1999, BBA-GENE STRUCT EXPR, V1444, P14, DOI 10.1016/S0167-4781(98)00267-X; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Tuntiwechapikul W, 2002, BIOCHEMISTRY-US, V41, P854, DOI 10.1021/bi0110950; Usdin K, 1998, NUCLEIC ACIDS RES, V26, P4078, DOI 10.1093/nar/26.17.4078; VEAUTE X, 1993, SCIENCE, V261, P598, DOI 10.1126/science.8342022; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; White PJ, 1999, MOL CELL BIOL, V19, P5675	53	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2425	2431		10.1074/jbc.M210643200	http://dx.doi.org/10.1074/jbc.M210643200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441336	Green Published, hybrid			2022-12-27	WOS:000180562000049
J	Ketteler, R; Moghraby, CS; Hsiao, JG; Sandra, O; Lodish, HF; Klingmuller, U				Ketteler, R; Moghraby, CS; Hsiao, JG; Sandra, O; Lodish, HF; Klingmuller, U			The cytokine-inducible Scr homology domain-containing protein negatively regulates signaling by promoting apoptosis in erythroid progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROPOIETIN RECEPTOR; STAT5 ACTIVATION; TYROSINE PHOSPHORYLATION; STAT5A(-/-)5B(-/-) MICE; HEMATOPOIETIC-CELLS; T-CELLS; PROLIFERATION; SURVIVAL; CIS; DIFFERENTIATION	The small cytokine-inducible SH2 domain-containing protein (CIS) has been implicated in the negative regulation of signaling through cytokine receptors. CIS reduces growth of erythropoietin receptor (EpoR)-dependent cell lines, but its role in proliferation, differentiation, and survival of erythroid progenitor cells has not been resolved. To dissect the function of CIS in cell lines and erythroid progenitor cells, we generated green fluorescent protein (GFP)-tagged versions of wild type CIS, a mutant harboring an inactivated SH2 domain (CIS R107K), and a mutant with a deletion of the SOCS Box (CISDeltaBox). Retroviral expression of the GFP fusion proteins in BaF3-EpoR cells revealed that both Tyr-401 in the EpoR and an intact SH2 domain within CIS are prerequisites for receptor recruitment. As a consequence, both are essential for the growth inhibitory effect of CIS, whereas the CIS SOCS box is dispensable. Accordingly, the retroviral expression of GFP-CIS but not GFP-CIS R107K impaired proliferation of erythroid progenitor cells in colony assays. Erythroid differentiation was unaffected by either protein. Interestingly, apoptosis of erythroid progenitor cells was increased upon GFP-CIS expression and this required the presence both of an intact SH2 domain and the SOCS box. Thus, CIS negatively regulates signaling at two levels, apoptosis and proliferation, and thereby sets a threshold for signal transduction.	Max Planck Inst Immunbiol, Hans Spemann Lab, D-79108 Freiburg, Germany; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Max Planck Society; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Klingmuller, U (corresponding author), Max Planck Inst Immunbiol, Hans Spemann Lab, D-79108 Freiburg, Germany.		Klingmüller, Ursula/G-8477-2013	Klingmüller, Ursula/0000-0001-9845-3099; Ketteler, Robin/0000-0002-2786-7291	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 32262] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bittorf T, 2001, CELL SIGNAL, V13, P673, DOI 10.1016/S0898-6568(01)00189-9; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Gobert S, 1996, EMBO J, V15, P2434, DOI 10.1002/j.1460-2075.1996.tb00601.x; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Hortner M, 2002, EUR J BIOCHEM, V269, P2516, DOI 10.1046/j.1432-1033.2002.02916.x; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jegalian AG, 2002, J INTERF CYTOK RES, V22, P853, DOI 10.1089/107999002760274863; Kapur R, 2001, J BIOL CHEM, V276, P1099, DOI 10.1074/jbc.M007442200; Ketteler R, 2002, J BIOL CHEM, V277, P26547, DOI 10.1074/jbc.M202287200; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Klingmuller U, 1996, P NATL ACAD SCI USA, V93, P8324, DOI 10.1073/pnas.93.16.8324; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Klingmuller U, 1997, EUR J BIOCHEM, V249, P637, DOI 10.1111/j.1432-1033.1997.t01-1-00637.x; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Marine JC, 1999, CELL, V98, P617, DOI 10.1016/S0092-8674(00)80049-5; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Motoyama N, 1999, J EXP MED, V189, P1691, DOI 10.1084/jem.189.11.1691; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Tauchi T, 1996, BLOOD, V87, P4495, DOI 10.1182/blood.V87.11.4495.bloodjournal87114495; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	32	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2654	2660		10.1074/jbc.M211236200	http://dx.doi.org/10.1074/jbc.M211236200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441334	Green Published, hybrid			2022-12-27	WOS:000180562000077
J	Kroj, T; Rudd, JJ; Nurnberger, T; Gabler, Y; Lee, J; Scheel, D				Kroj, T; Rudd, JJ; Nurnberger, T; Gabler, Y; Lee, J; Scheel, D			Mitogen-activated protein kinases play an essential role in oxidative burst-independent expression of pathogenesis-related genes in parsley	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ACTIVATION; TOBACCO CELL-SUSPENSIONS; MAP KINASE; OLIGOPEPTIDE ELICITOR; DEFENSE RESPONSES; NONHOST RESISTANCE; EXTRACELLULAR GLYCOPROTEIN; PHYTOALEXIN SYNTHESIS; FUNGAL ELICITOR; ARABIDOPSIS	Plants are continuously exposed to attack by potential phytopathogens. Disease prevention requires pathogen recognition and the induction of a multifaceted defense response. We are studying the non-host disease resistance response of parsley to the oomycete, Phytophthora sojae using a cell culture-based system. Receptor-mediated recognition of P. sojae may be achieved through a thirteen amino acid peptide sequence (Pep-13) present within an abundant cell wall transglutaminase. Following recognition of this elicitor molecule, parsley cells mount a defense response, which includes the generation of reactive oxygen species (ROS) and transcriptional activation of genes encoding pathogenesis-related (PR) proteins or enzymes involved in the synthesis of antimicrobial phytoalexins. Treatment of parsley cells with the NADPH oxidase inhibitor, diphenylene iodonium (DPI), blocked both Pep-13-induced phytoalexin production and the accumulation of transcripts encoding enzymes involved in their synthesis. In contrast, DPI treatment had no effect upon Pep-13-induced PR gene expression, suggesting the existence of an oxidative burst-independent mechanism for the transcriptional activation of PR genes. The use of specific antibodies enabled the identification of three parsley mitogen-activated protein kinases (MAPKs) that are activated within the signal transduction pathway(s) triggered following recognition of Pep-13. Other environmental challenges failed to activate these kinases in parsley cells, suggesting that their activation plays a key role in defense signal transduction. Moreover, by making use of a protoplast co-transfection system over-expressing wild-type and loss-of-function MAPK mutants, we show an essential role for post-translational phosphorylation and activation of MAPKs for oxidative burst-independent PR promoter activation.	Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle An Der Saale, Germany		Scheel, D (corresponding author), Inst Plant Biochem, Dept Stress & Dev Biol, Weinberg 3, D-06120 Halle An Der Saale, Germany.	dscheel@ipb-halle.de	Kroj, Thomas/ABG-3249-2020; Lee, Justin/B-6096-2012	Lee, Justin/0000-0001-8269-7494; Rudd, Jason/0000-0002-4743-1401; kroj, thomas/0000-0002-3752-1788				Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Batz O, 1998, BIOL CHEM, V379, P1127, DOI 10.1515/bchm.1998.379.8-9.1127; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bogre L, 1997, PLANT CELL, V9, P75, DOI 10.1105/tpc.9.1.75; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Cazale AC, 1999, PLANT J, V19, P297, DOI 10.1046/j.1365-313X.1999.00528.x; Cormack RS, 2002, BBA-GENE STRUCT EXPR, V1576, P92, DOI 10.1016/S0167-4781(02)00298-1; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DANGL JL, 1987, EMBO J, V6, P2551, DOI 10.1002/j.1460-2075.1987.tb02543.x; Desikan R, 1999, PLANTA, V210, P97, DOI 10.1007/s004250050658; DIETRICH A, 1990, J BIOL CHEM, V265, P6360; Droillard MJ, 2000, FEBS LETT, V474, P217, DOI 10.1016/S0014-5793(00)01611-2; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; FELIX G, 1991, P NATL ACAD SCI USA, V88, P8831, DOI 10.1073/pnas.88.19.8831; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; HAHLBROCK K, 1995, P NATL ACAD SCI USA, V92, P4150, DOI 10.1073/pnas.92.10.4150; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; Hoyos ME, 2000, PLANT PHYSIOL, V122, P1355, DOI 10.1104/pp.122.4.1355; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; JAHNEN W, 1988, PLANTA, V173, P197, DOI 10.1007/BF00958957; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; JONAK C, 1993, PLANT J, V3, P611, DOI 10.1046/j.1365-313X.1993.03040611.x; JONAK C, 1995, MOL GEN GENET, V248, P686, DOI 10.1007/BF02191708; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; KORFHAGE U, 1994, PLANT CELL, V6, P695, DOI 10.1105/tpc.6.5.695; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Munnik T, 1999, PLANT J, V20, P381, DOI 10.1046/j.1365-313x.1999.00610.x; Nennstiel D, 1998, FEBS LETT, V431, P405, DOI 10.1016/S0014-5793(98)00800-X; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; NURNBERGER T, 1994, CELL, V78, P449, DOI 10.1016/0092-8674(94)90423-5; NURNBERGER T, 1995, P NATL ACAD SCI USA, V92, P2338, DOI 10.1073/pnas.92.6.2338; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; NURNBERGER T, 1994, BIOCHEM SOC SYMP, P173; Nurnberger T, 2002, CURR OPIN PLANT BIOL, V5, P318, DOI 10.1016/S1369-5266(02)00265-0; PARKER JE, 1991, MOL PLANT MICROBE IN, V4, P19, DOI 10.1094/MPMI-4-019; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; SACKS W, 1995, MOL GEN GENET, V246, P45, DOI 10.1007/BF00290132; Samuel MA, 2000, PLANT J, V22, P367, DOI 10.1046/j.1365-313x.2000.00741.x; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; SOMSSICH IE, 1989, PLANT MOL BIOL, V12, P227, DOI 10.1007/BF00020507; Sprenger-Haussels M, 2000, PLANT J, V22, P1, DOI 10.1046/j.1365-313x.2000.00687.x; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; USAMI S, 1995, P NATL ACAD SCI USA, V92, P8660, DOI 10.1073/pnas.92.19.8660; VANDELOCHT U, 1990, EMBO J, V9, P2945, DOI 10.1002/j.1460-2075.1990.tb07486.x; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xiang CB, 1998, PLANT CELL, V10, P1539, DOI 10.1105/tpc.10.9.1539; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Yuasa T, 2001, PLANT CELL PHYSIOL, V42, P1012, DOI 10.1093/pcp/pce123; ZHANG S, 2000, PLANT J, V23, P1; Zhang SQ, 1998, PLANT CELL, V10, P435, DOI 10.1105/tpc.10.3.435; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7225, DOI 10.1073/pnas.95.12.7225; Zhang SQ, 2001, PLANT CELL, V13, P1877, DOI 10.1105/tpc.13.8.1877; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809; Zimmermann S, 1997, P NATL ACAD SCI USA, V94, P2751, DOI 10.1073/pnas.94.6.2751	72	84	91	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2256	2264		10.1074/jbc.M208200200	http://dx.doi.org/10.1074/jbc.M208200200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12426314	hybrid, Green Published			2022-12-27	WOS:000180562000026
J	Lio, YC; Mazin, AV; Kowalczykowski, SC; Chen, DJ				Lio, YC; Mazin, AV; Kowalczykowski, SC; Chen, DJ			Complex formation by the human Rad51B and Rad51C DNA repair proteins and their activities in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RECA PROTEIN; HOMOLOGOUS RECOMBINATION; STRAND EXCHANGE; MOUSE GENES; XRCC3; PURIFICATION; MEMBER; IDENTIFICATION; PROMOTES; DAMAGE		Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Drexel Univ, Coll Med, Dept Biochem, Philadelphia, PA 19102 USA; Univ Calif Davis, Div Biol Sci, Sect Microbiol & Mol & Cellular Biol, Ctr Genet & Dev, Davis, CA 95616 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Drexel University; University of California System; University of California Davis	Lio, YC (corresponding author), Lawrence Berkeley Natl Lab, Div Life Sci, MS74-157,1 Cyclotron Rd, Berkeley, CA 94720 USA.	YLio@lbl.gov	Classen, Scott/AAY-8176-2020		NCI NIH HHS [CA-092584, CA 74046] Funding Source: Medline; NIGMS NIH HHS [GM-62653] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074046, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062653, R01GM062653] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aihara H, 1999, J MOL BIOL, V290, P495, DOI 10.1006/jmbi.1999.2904; Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; Baumann P, 1997, MUTAT RES-DNA REPAIR, V384, P65, DOI 10.1016/S0921-8777(97)00028-1; Baumann P, 1997, EMBO J, V16, P5198, DOI 10.1093/emboj/16.17.5198; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Braybrooke JP, 2000, J BIOL CHEM, V275, P29100, DOI 10.1074/jbc.M002075200; Brenneman MA, 2000, MUTAT RES-DNA REPAIR, V459, P89, DOI 10.1016/S0921-8777(00)00002-1; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P3084, DOI 10.1093/nar/26.13.3084; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Godthelp BC, 2002, NUCLEIC ACIDS RES, V30, P2172, DOI 10.1093/nar/30.10.2172; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Kawabata M, 1999, BIOCHEM BIOPH RES CO, V257, P156, DOI 10.1006/bbrc.1999.0413; KOWALCZYKOWSKI SC, 1989, J MOL BIOL, V207, P735, DOI 10.1016/0022-2836(89)90240-4; KOWALCZYKOWSKI SC, 1989, J MOL BIOL, V207, P719, DOI 10.1016/0022-2836(89)90239-8; Kurumizaka H, 2002, J BIOL CHEM, V277, P14315, DOI 10.1074/jbc.M105719200; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; Liu N, 1998, MOL CELL, V1, P783, DOI 10.1016/S1097-2765(00)80078-7; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; MENETSKI JP, 1990, J MOL BIOL, V211, P845, DOI 10.1016/0022-2836(90)90078-Z; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; O'Regan P, 2001, J BIOL CHEM, V276, P22148, DOI 10.1074/jbc.M102396200; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pittman DL, 1998, GENOMICS, V49, P103, DOI 10.1006/geno.1998.5226; Rice MC, 1997, P NATL ACAD SCI USA, V94, P7417, DOI 10.1073/pnas.94.14.7417; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Shao XG, 2000, NUCLEIC ACIDS RES, V28, P2643, DOI 10.1093/nar/28.14.2643; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Takata M, 2001, MOL CELL BIOL, V21, P2858, DOI 10.1128/MCB.21.8.2858-2866.2001; TEBBS RS, 1995, P NATL ACAD SCI USA, V92, P6354, DOI 10.1073/pnas.92.14.6354; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; Thompson LH, 1999, BIOCHIMIE, V81, P87, DOI 10.1016/S0300-9084(99)80042-X; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Vispe S, 1997, BIOCHIMIE, V79, P587, DOI 10.1016/S0300-9084(97)82007-X; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001	50	99	106	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2469	2478		10.1074/jbc.M211038200	http://dx.doi.org/10.1074/jbc.M211038200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427746	Green Submitted, hybrid			2022-12-27	WOS:000180562000055
J	Winter, AD; Myllyharju, J; Page, AP				Winter, AD; Myllyharju, J; Page, AP			A hypodermally expressed prolyl 4-hydroxylase from the filarial nematode Brugia malayi is soluble and active in the absence of protein disulfide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC CAENORHABDITIS-ELEGANS; SITE-DIRECTED MUTAGENESIS; ALPHA-SUBUNIT ISOFORM; BETA-SUBUNIT; BACULOVIRUS EXPRESSION; ENDOPLASMIC-RETICULUM; ONCHOCERCA-VOLVULUS; MOLECULAR-CLONING; UNIQUE PROPERTIES; ENZYME TETRAMER	The collagen prolyl 4-hydroxylase (P4H) class of enzymes catalyze the hydroxylation of prolines in the XPro-Gly repeats of collagen chains. This modification is central to the synthesis of all collagens. Most P4Hs are alpha(2)beta(2) tetramers with the catalytic activity residing in the a subunits. The beta subunits are identical to the enzyme protein disuffide isomerase. The nematode cuticle is a collagenous extracellular matrix required for maintenance of the worm body shape. Examination of the model nematode Caenorhabditis elegans has demonstrated that its unique P4Hs are essential for viability and body morphology. The filarial parasite Brugia malayi is a causative agent of lymphatic filariasis in humans. We report here on the cloning and characterization of a B. malayi P4H with unusual properties. The recombinant B. malayi a subunit, PHY-1, is a soluble and active P4H by itself, and it does not become associated with protein disulfide isomerase. The active enzyme form is a homotetramer with catalytic and inhibition properties similar to those of the C. elegans P4Hs. High levels of B. malayi phy-1 transcript expression were observed in all developmental stages examined, and its expression was localized to the cuticle-synthesizing hypodermal tissue in the heterologous host C. elegans. Although active by itself, the B. malayi PRY-1 was not able to replace enzyme function in a C. elegans P4H mutant.	Univ Glasgow, Wellcome Ctr Mol Parasitol, Anderson Coll, Glasgow G11 6NU, Lanark, Scotland; Univ Oulu, Bioctr Oulu, Collagen Res Unit, FIN-90014 Oulu, Finland; Univ Oulu, Dept Med Biochem, FIN-90014 Oulu, Finland	University of Glasgow; University of Oulu; University of Oulu	Page, AP (corresponding author), Univ Glasgow, Wellcome Ctr Mol Parasitol, Anderson Coll, 56 Dumbarton Rd, Glasgow G11 6NU, Lanark, Scotland.	a.page@udcf.gla.ac.uk						Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Annunen P, 1999, J BIOL CHEM, V274, P6790, DOI 10.1074/jbc.274.10.6790; BLUMENTHAL T, 1997, C ELEGANS, V2, P117; BRENNER S, 1974, GENETICS, V77, P71; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Britton C, 1999, MOL BIOCHEM PARASIT, V103, P171, DOI 10.1016/S0166-6851(99)00121-8; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P4395, DOI 10.1128/MCB.8.10.4395; COX GN, 1981, DEV BIOL, V86, P456, DOI 10.1016/0012-1606(81)90204-9; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Eriksson M, 1999, J BIOL CHEM, V274, P22131, DOI 10.1074/jbc.274.32.22131; FIRE A, 1992, GENET ANAL-BIOMOL E, V9, P151, DOI 10.1016/1050-3862(92)90042-4; Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hill KL, 2000, GENETICS, V155, P1139; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; JOHN DCA, 1994, BIOCHEMISTRY-US, V33, P14018, DOI 10.1021/bi00251a009; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; KASKA DD, 1988, BIOCHEM J, V256, P257, DOI 10.1042/bj2560257; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Krause S, 2001, MOL BIOCHEM PARASIT, V117, P145, DOI 10.1016/S0166-6851(01)00342-5; LAMBERG A, 1995, J BIOL CHEM, V270, P9926, DOI 10.1074/jbc.270.17.9926; Merriweather A, 2001, MOL BIOCHEM PARASIT, V116, P185, DOI 10.1016/S0166-6851(01)00317-6; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2002, J BIOL CHEM, V277, P29187, DOI 10.1074/jbc.M203824200; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Page Antony P., 2001, P167, DOI 10.1079/9780851994239.0167; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Qin L, 1998, MOL BIOCHEM PARASIT, V96, P59, DOI 10.1016/S0166-6851(98)00108-X; Riihimaa P, 2002, J BIOL CHEM, V277, P18238, DOI 10.1074/jbc.M200895200; SCOTT AL, 1995, MOL BIOCHEM PARASIT, V70, P221, DOI 10.1016/0166-6851(95)00017-U; THACKER C, 1995, GENE DEV, V9, P956, DOI 10.1101/gad.9.8.956; TUDERMAN L, 1975, EUR J BIOCHEM, V52, P9, DOI 10.1111/j.1432-1033.1975.tb03967.x; Veijola J, 1996, BIOCHEM J, V317, P721, DOI 10.1042/bj3170721; VEIJOLA J, 1994, J BIOL CHEM, V269, P26746; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; *WHO, 2000, WHO MON SER, V102; WILSON WR, 1994, MOL BIOCHEM PARASIT, V68, P103, DOI 10.1016/0166-6851(94)00161-8; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000	49	20	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2554	2562		10.1074/jbc.M210381200	http://dx.doi.org/10.1074/jbc.M210381200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12417582	hybrid			2022-12-27	WOS:000180562000065
J	Calkins, CC; Hoepner, BL; Law, CM; Novak, MR; Setzer, SV; Hatzfeld, M; Kowalczyk, AP				Calkins, CC; Hoepner, BL; Law, CM; Novak, MR; Setzer, SV; Hatzfeld, M; Kowalczyk, AP			The armadillo family protein p0071 is a VE-cadherin- and desmoplakin-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CADHERIN; INTERMEDIATE FILAMENT NETWORKS; DESMOSOMAL PLAQUE; EMBRYONIC HEART; COMPLEXUS ADHAERENTES; CONTAINING JUNCTIONS; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; PLAKOGLOBIN; CATENIN	p0071, a member of the armadillo protein family, localizes to both adherens junctions and desmosomes in epithelial cells and exhibits homology to the adherens junction protein p120 and the desmosomal protein plakophilin-1. p0071 is also present at dermal microvascular endothelial intercellular junctions and colocalizes with VE-cadherin, an endothelium-specific cadherin that associates with both actin and intermediate filament networks. To define the role of p0071 in junction assembly, p0071 was tested for interactions with other components of the endothelial junctional complex. In transient expression assays, p0071 colocalized with and formed complexes with both VE-cadherin and desmoplakin. Deletion analysis using the yeast two-hybrid system revealed that the armadillo repeat domain of p0071 bound directly to VE-cadherin. Site-directed mutagenesis experiments demonstrated that p0071 and p120 bound to the same region on the cytoplasmic tail of VE-cadherin and that overexpression of p0071 could displace p120 from intercellular junctions. In contrast to VE-cadherin, desmoplakin was found to associate with the non-armadillo head domain of p0071. Cotransfections and triple-label immunofluorescence analysis revealed that VE-cadherin colocalization with desmoplakin in transfected COS cells required p0071, suggesting that p0071 may couple VE-cadherin to desmoplakin. Based on previous findings that both VE-cadherin and desmoplakin play central roles in vasculogenesis, these new results suggest that p0071 may play an important role in endothelial junction assembly and in the morphogenic events associated with vascular remodeling.	Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Skin Dis Res Ctr, Atlanta, GA 30322 USA; Univ Halle Wittenberg, Fac Med, Dept Biochem & Pathobiol, D-06097 Halle Saale, Germany	Emory University; Emory University; Emory University; Martin Luther University Halle Wittenberg	Kowalczyk, AP (corresponding author), Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA.				NIAMS NIH HHS [R01 AR48266-01, T32 AR007587, R03 AR47147, HP30 AR042687, K01 AR002039] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR047147, K01AR002039, P30AR042687, T32AR007587, R01AR048266] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; ANGST BD, 1990, J CELL SCI, V97, P247; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bonne S, 1999, J CELL SCI, V112, P2265; Bornslaeger EA, 2001, J CELL SCI, V114, P727; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; COWIN P, 1994, MOL BIOL DESMOSOMES, P53; Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; Gallicano GI, 2001, DEVELOPMENT, V128, P929; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; Hatsell S, 2001, NAT CELL BIOL, V3, pE270, DOI 10.1038/ncb1201-e270; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Jaulin-Bastard F, 2002, J BIOL CHEM, V277, P2869, DOI 10.1074/jbc.M109652200; KLYMKOWSKY MW, 1995, CELL, V83, P5, DOI 10.1016/0092-8674(95)90226-0; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145; Kowalczyk AP, 1998, J CELL SCI, V111, P3045; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Leung CL, 2002, TRENDS CELL BIOL, V12, P37, DOI 10.1016/S0962-8924(01)02180-8; Leung CL, 2001, J CELL SCI, V114, P3409; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Liao F, 2000, CANCER RES, V60, P6805; Lum H, 1996, CAN J PHYSIOL PHARM, V74, P787, DOI 10.1139/cjpp-74-7-787; Mariner DJ, 2000, J CELL SCI, V113, P1481; Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; MULLER WA, 1986, J CELL BIOL, V103, P2389, DOI 10.1083/jcb.103.6.2389; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Paulson AF, 2000, J BIOL CHEM, V275, P30124, DOI 10.1074/jbc.M003048200; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; SCHMELZ M, 1994, DIFFERENTIATION, V57, P97, DOI 10.1046/j.1432-0436.1994.5720097.x; SCHMELZ M, 1993, EUR J CELL BIOL, V61, P274; Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956; Schroder R, 2000, J MUSCLE RES CELL M, V21, P577, DOI 10.1023/A:1026587530656; Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001; Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Valiron O, 1996, J CELL SCI, V109, P2141; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Venkiteswaran K, 2002, AM J PHYSIOL-CELL PH, V283, pC811, DOI 10.1152/ajpcell.00417.2001; Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273	59	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1774	1783		10.1074/jbc.M205693200	http://dx.doi.org/10.1074/jbc.M205693200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426320	hybrid			2022-12-27	WOS:000180462200055
J	Canela, N; Rodriguez-Vilarrupla, A; Estanyol, JM; Diaz, C; Pujol, MJ; Agell, N; Bachs, O				Canela, N; Rodriguez-Vilarrupla, A; Estanyol, JM; Diaz, C; Pujol, MJ; Agell, N; Bachs, O			The SET protein regulates G(2)/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE UNDIFFERENTIATED LEUKEMIA; DNA-REPLICATION; MYELOID LEUKEMOGENESIS; PUTATIVE ONCOGENE; RAN/TC4 GTPASE; IDENTIFICATION; GENE; TRANSCRIPTION; GADD45; PCNA	The SET protein and the cell cycle inhibitor p21(Cip1) interact in vivo and in vitro. We identified here the domain (LIF159)-L-157 of p21(Cip1) as essential for the binding of SET. We also found that SET contains at least two domains of interaction with p21(Cip1), one located in the fragment amino acids 81-180 and the other one in the fragment including amino acids 181-277. SET and p21(Cip1) co-localize in the cell nucleus in a temporal manner. Overexpression of SET blocks the cell cycle at the G(2)/M transition in COS and HCT116 cells. Moreover, SET inhibits cyclin B-CDK1 activity both in vivo and in vitro in both cell types. This effect is specific for these complexes since SET did not inhibit either cyclin A-CDK2 or cyclin E-CDK2 complexes. SET and p21(Cip1) cooperate in the inhibition of cyclin B-CDK1 activity. The inhibitory effect of SET resides in its acidic C terminus, as demonstrated by the ability of this domain to inhibit cyclin B-CDK1 activity and by the lack of blocking G(2)/M transition when a mutated form of SET lacking this C terminus domain was overexpressed in COS cells. These results indicate that SET might regulate G(2)/M transition by modulating cyclin B-CDK1 activity.	Univ Barcelona, Inst Invest Biomed August Pi Sunyer, Dept Biol Cellular & Anat Patol, Fac Med, Barcelona 08036, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Bachs, O (corresponding author), Univ Barcelona, Fac Med, Dept Cell Biol & Pathol, Casanova 143, Barcelona 08036, Spain.	bachs@medicina.ub.es	Estanyol, Josep M/I-1039-2015; Agell, Neus/E-9640-2016; Canela, Núria/I-5401-2015	Estanyol, Josep M/0000-0001-8621-0057; Agell, Neus/0000-0002-1205-6074; Canela, Núria/0000-0003-0261-2396				ADACHI Y, 1994, FEBS LETT, V340, P231, DOI 10.1016/0014-5793(94)80144-4; ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; CHEN IT, 1995, ONCOGENE, V11, P1931; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; Fan ZS, 2002, MOL CELL BIOL, V22, P2810, DOI 10.1128/MCB.22.8.2810-2820.2002; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Ozbun LL, 2001, GENOMICS, V73, P179, DOI 10.1006/geno.2001.6505; Qu DB, 2002, J BIOL CHEM, V277, P7324, DOI 10.1074/jbc.M107270200; REN MD, 1994, MOL CELL BIOL, V14, P4216, DOI 10.1128/MCB.14.6.4216; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shen HH, 2001, GENOMICS, V71, P21, DOI 10.1006/geno.2000.6397; Taules M, 1999, J BIOL CHEM, V274, P24445, DOI 10.1074/jbc.274.35.24445; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vairapandi M, 1996, ONCOGENE, V12, P2579; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wen CH, 2000, P NATL ACAD SCI USA, V97, P14524, DOI 10.1073/pnas.011446498; Yang Q, 2000, J BIOL CHEM, V275, P36892, DOI 10.1074/jbc.M005319200; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667	31	121	130	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1158	1164		10.1074/jbc.M207497200	http://dx.doi.org/10.1074/jbc.M207497200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12407107	hybrid			2022-12-27	WOS:000180321900061
J	Cao, ZH; Warfel, P; Newton, SMC; Klebba, PE				Cao, ZH; Warfel, P; Newton, SMC; Klebba, PE			Spectroscopic observations of ferric enterobactin transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL CHANGE; BACTERIAL OUTER-MEMBRANE; MEDIATED IRON TRANSPORT; ESCHERICHIA-COLI K-12; CRYSTAL-STRUCTURE; BINDING-SITES; CELL-ENVELOPE; FHUA PROTEIN; TONB PROTEIN; LIGAND	We characterized the uptake of ferric enterobactin (FeEnt), the native Escherichia coli ferric siderophore, through its cognate outer membrane receptor protein, FepA, using a site-directed fluorescence methodology. The experiments first defined locations in FepA that were accessible to covalent modification with fluorescein maleimide (FM) in vivo; among 10 sites that we tested by substituting single Cys residues, FM labeled W101C, S271C, F329C, and S397C, and all these exist within surface-exposed loops of the outer membrane protein. FeEnt normally adsorbed to the fluoresceinated S271C and S397C mutant FepA proteins in vivo, which we observed as quenching of fluorescence intensity, but the ferric siderophore did not bind to the FM-modified derivatives of W101C or F329C. These in vivo fluorescence determinations showed, for the first time, consistency with radioisotopic measurements of the affinity of the FeEnt-FepA interaction; K-d was 0.2 nm by both methods. Analysis of the FepA mutants with AlexaFluor(680), a fluorescein derivative with red-shifted absorption and emission spectra that do not overlap the absorbance spectrum of FeEnt, refuted the possibility that the fluorescence quenching resulted from resonance energy transfer. These and other data instead indicated that the quenching originated from changes in the environment of the fluor as a result of loop conformational changes during ligand binding and transport. We used the fluorescence system to monitor FeEnt uptake by live bacteria and determined its dependence on ligand concentration, temperature, pH, and carbon sources and its susceptibility to inhibition by the metabolic poisons. Unlike cyanocobalamin transport through the outer membrane, FeEnt uptake was sensitive to inhibitors of electron transport and phosphorylation, in addition to its sensitivity to proton motive force depletion.	Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Klebba, PE (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	peklebba@ou.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053836, R01 GM053836-08] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG SK, 1990, J BIOL CHEM, V265, P14536; Bos C, 1998, J BACTERIOL, V180, P605; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; CAO Z, 1999, THESIS U OKLAHOMA; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; DIMASI DR, 1973, J BACTERIOL, V115, P506, DOI 10.1128/JB.115.2.506-513.1973; ECKER DJ, 1986, J BACTERIOL, V167, P666, DOI 10.1128/jb.167.2.666-673.1986; Einstein A, 1906, ANN PHYS-BERLIN, V19, P371; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; FISS EH, 1982, BIOCHEMISTRY-US, V21, P4517, DOI 10.1021/bi00261a050; GIBSON F, 1977, BIOCHEM J, V162, P665, DOI 10.1042/bj1620665; GUTERMAN SK, 1973, J BACTERIOL, V114, P1217, DOI 10.1128/JB.114.3.1217-1224.1973; GUTERMAN SK, 1973, J BACTERIOL, V114, P1225, DOI 10.1128/JB.114.3.1225-1230.1973; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; Klebba PE, 1998, CURR OPIN MICROBIOL, V1, P238, DOI 10.1016/S1369-5274(98)80017-9; KLUG CS, 1995, BIOCHEMISTRY-US, V34, P14230, DOI 10.1021/bi00043a030; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Langevin P, 1908, CR HEBD ACAD SCI, V146, P530; LEONG J, 1976, J BACTERIOL, V126, P823, DOI 10.1128/JB.126.2.823-830.1976; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; LIU J, 1994, BIOCHEMISTRY-US, V33, P13274, DOI 10.1021/bi00249a014; Locher KP, 1997, EUR J BIOCHEM, V247, P770, DOI 10.1111/j.1432-1033.1997.t01-1-00770.x; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEILANDS JB, 1982, ANNU REV MICROBIOL, V36, P285, DOI 10.1146/annurev.mi.36.100182.001441; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Newton SMC, 1997, P NATL ACAD SCI USA, V94, P4560, DOI 10.1073/pnas.94.9.4560; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; POSTLE K, 1993, J BIOENERG BIOMEMBR, V25, P591; PUGSLEY AP, 1976, J BACTERIOL, V127, P218, DOI 10.1128/JB.127.1.218-228.1976; PUGSLEY AP, 1977, J BACTERIOL, V130, P26, DOI 10.1128/JB.130.1.26-36.1977; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; Schalk IJ, 1999, BIOCHEMISTRY-US, V38, P9357, DOI 10.1021/bi990421x; Schalk IJ, 2002, BIOCHEMISTRY-US, V41, P1663, DOI 10.1021/bi0157767; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Scott DC, 2002, J BACTERIOL, V184, P4906, DOI 10.1128/JB.184.17.4906-4911.2002; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Sprencel C, 2000, J BACTERIOL, V182, P5359, DOI 10.1128/JB.182.19.5359-5364.2000; Thulasiraman P, 1998, J BACTERIOL, V180, P6689, DOI 10.1128/JB.180.24.6689-6696.1998; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; WANG CC, 1971, J BIOL CHEM, V246, P2147; WANG CC, 1969, J BACTERIOL, V98, P1142, DOI 10.1128/JB.98.3.1142-1150.1969; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976	56	27	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1022	1028		10.1074/jbc.M210360200	http://dx.doi.org/10.1074/jbc.M210360200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409288	hybrid			2022-12-27	WOS:000180321900044
J	Chang, HK; Shieh, RC				Chang, HK; Shieh, RC			Conformational changes in Kir2.1 channels during NH4+-induced inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER K+ CHANNEL; POTASSIUM CHANNEL; XENOPUS OOCYTES; INWARD RECTIFICATION; IONS; PORE; SELECTIVITY; PERMEATION; MECHANISM; RESIDUES	We have shown previously that NH4+ binding to the external pore of a Kir2.1 channel induces channel inactivation possibly through conformational changes. In this study, we performed further biophysical analyses of the NH4+-induced inactivation modeled by a refined kinetic scheme. Also, we investigated the conformational change hypothesis by examining whether the chemical modification of single-cysteine substitution of amino acids located at the internal pore alters the kinetics of the NH4+-induced inactivation. In addition, we examined whether the mutation of amino acids located at various parts of a Kir2.1 channel influences the N-H-4(+)-induced inactivation. Kir2.1 channels were expressed in Xenopus oocytes and studied using patch-clamp techniques. The gating of the NH4+-induced inactivation was affected by mutation of several amino acids located at various regions of the Mr2.1 channel. These results suggest that amino acids from different parts of a Kir2.1 channel are involved in the channel closure. Furthermore, internal chemical modification of several cysteine mutants resulted in the block of inward currents and changes in the on and off rate for the NH4+-induced inactivation, suggesting that the internal pore mouth is involved in the closure of a Kir2.1 channel. Taken together these results provide new evidence for conformational changes affecting the NH4+-induced inactivation in the Kir2.1 channel.	Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Shieh, RC (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Yen Chiu Yuan Rd,Sect 2, Taipei 11529, Taiwan.							Alagem N, 2001, J PHYSIOL-LONDON, V534, P381, DOI 10.1111/j.1469-7793.2001.00381.x; ASHCROFT FM, 1983, J PHYSIOL-LONDON, V343, P407, DOI 10.1113/jphysiol.1983.sp014900; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; CHEPILKO S, 1995, AM J PHYSIOL-CELL PH, V268, pC389, DOI 10.1152/ajpcell.1995.268.2.C389; CHERVITZ SA, 1995, J BIOL CHEM, V270, P24043, DOI 10.1074/jbc.270.41.24043; Colquhoun David, 1995, P397; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hilgemann Donald W., 1995, P307; Hille B., 1992, IONIC CHANNELS EXCIT; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Lauger P., 1995, SINGLE CHANNEL RECOR, P651; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Shieh RC, 2000, J PHYSIOL-LONDON, V526, P241, DOI 10.1111/j.1469-7793.2000.00241.x; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; Shieh RC, 1999, J BIOL CHEM, V274, P17424, DOI 10.1074/jbc.274.25.17424; Shieh RC, 2001, J PHYSIOL-LONDON, V535, P359, DOI 10.1111/j.1469-7793.2001.00359.x; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Xie LH, 2002, J GEN PHYSIOL, V120, P53, DOI 10.1085/jgp.20028576; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Zhou H, 1996, AM J PHYSIOL-CELL PH, V271, pC1949, DOI 10.1152/ajpcell.1996.271.6.C1949	29	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					908	918		10.1074/jbc.M208839200	http://dx.doi.org/10.1074/jbc.M208839200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12419816	hybrid			2022-12-27	WOS:000180321900029
J	Coco, S; Calegari, F; Pravettoni, E; Pozzi, D; Taverna, E; Rosa, P; Matteoli, M; Verderio, C				Coco, S; Calegari, F; Pravettoni, E; Pozzi, D; Taverna, E; Rosa, P; Matteoli, M; Verderio, C			Storage and release of ATP from Astrocytes in culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT GLUTAMATE RELEASE; H+-ATPASE; NEUROTRANSMITTER RELEASE; CALCIUM OSCILLATIONS; CHROMAFFIN GRANULES; WAVE-PROPAGATION; GLIAL-CELLS; NEURONS; MODULATION; SYNAPTOPHYSIN	ATP is released from astrocytes and is involved in the propagation of calcium waves among them. Neuronal ATP secretion is quantal and calcium-dependent, but it has been suggested that ATP release from astrocytes may not be vesicular. Here we report that, besides the described basal ATP release facilitated by exposure to calcium-free medium, astrocytes release purine under conditions of elevated calcium. The evoked release was not affected by the gap-junction blockers anandamide and flufenamic acid, thus excluding purine efflux through connexin hemichannels. Sucrose-gradient analysis revealed that a fraction of ATP is stored in secretory granules, where it is accumulated down an electrochemical proton gradient sensitive to the v-ATPase inhibitor bafilomycin A, ATP release was partially sensitive to tetanus neurotoxin, whereas glutamate release from the same intoxicated astrocytes was almost completely impaired. Finally, the activation of metabotropic glutamate receptors, which strongly evokes glutamate release, was only slightly effective in promoting purine secretion. These data indicate that astrocytes concentrate ATP in granules and may release it via a regulated secretion pathway. They also suggest that ATP-storing vesicles may be distinct from glutamate-containing vesicles, thus opening up the possibility that their exocytosis is regulated differently.	Univ Milan, Dept Med Pharmacol, CNR, Inst Neurosci Cellular & Mol Pharmacol, I-20129 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan	Verderio, C (corresponding author), Univ Milan, Dept Med Pharmacol, CNR, Inst Neurosci Cellular & Mol Pharmacol, Via Vanvitelli 32, I-20129 Milan, Italy.	C.Verderio@csfic.mi.cnr.it	Pozzi, Davide/A-7021-2016; Taverna, Elena/AFW-4935-2022; Coco, Silvia/AAD-6719-2022; Matteoli, Michela/K-4526-2018; taverna, elena/O-8180-2014; verderio, claudia/K-4415-2016	Pozzi, Davide/0000-0001-6436-0556; Matteoli, Michela/0000-0002-3569-7843; Rosa, Patrizia/0000-0002-2590-6955; taverna, elena/0000-0002-2430-4725; verderio, claudia/0000-0001-7216-5873; calegari, federico/0000-0002-3703-2802; COCO, SILVIA/0000-0002-3883-9472	Telethon [1042] Funding Source: Medline	Telethon(Fondazione Telethon)		ABERER W, 1978, BIOCHEM J, V172, P353, DOI 10.1042/bj1720353b; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Belai A, 2000, NEUROREPORT, V11, P5, DOI 10.1097/00001756-200001170-00002; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Bruzzone S, 2001, FASEB J, V15, P10; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151; CHILCOTE TJ, 1995, J CELL BIOL, V129, P219, DOI 10.1083/jcb.129.1.219; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Fam SR, 2000, J NEUROSCI, V20, P2800; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grafstein B, 2000, ANN NEUROL, V47, P18, DOI 10.1002/1531-8249(200001)47:1<18::AID-ANA6>3.3.CO;2-E; Gualix J, 1996, J BIOL CHEM, V271, P1957, DOI 10.1074/jbc.271.4.1957; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; HANADA H, 1990, BIOCHEM BIOPH RES CO, V170, P873, DOI 10.1016/0006-291X(90)92172-V; Hassinger TD, 1996, P NATL ACAD SCI USA, V93, P13268, DOI 10.1073/pnas.93.23.13268; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Jeftinija SD, 1997, BRAIN RES, V750, P41, DOI 10.1016/S0006-8993(96)00610-5; John GR, 1999, P NATL ACAD SCI USA, V96, P11613, DOI 10.1073/pnas.96.20.11613; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; LINSTEDT AD, 1991, NEURON, V7, P309, DOI 10.1016/0896-6273(91)90269-6; LUNDBERG JM, 1986, PROG BRAIN RES, V68, P241, DOI 10.1016/S0079-6123(08)60242-3; Maienschein V, 1999, GLIA, V26, P233, DOI 10.1002/(SICI)1098-1136(199905)26:3<233::AID-GLIA5>3.0.CO;2-2; MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366, DOI 10.1073/pnas.85.19.7366; MORIYAMA Y, 1990, J BIOL CHEM, V265, P9165; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 1998, J NEUROSCI, V18, P4022; Nicholls DG, 1998, PROG BRAIN RES, V116, P15, DOI 10.1016/S0079-6123(08)60427-6; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parpura V, 1995, FEBS LETT, V377, P489, DOI 10.1016/0014-5793(95)01401-2; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Queiroz G, 1997, NEUROSCIENCE, V78, P1203, DOI 10.1016/S0306-4522(96)00637-9; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; ROSA P, 1985, J CELL BIOL, V101, P1999, DOI 10.1083/jcb.101.5.1999; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; VENANCE L, 1995, EUR J NEUROSCI, V7, P451, DOI 10.1111/j.1460-9568.1995.tb00341.x; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; VERDERIO C, 1995, P NATL ACAD SCI USA, V92, P6449, DOI 10.1073/pnas.92.14.6449; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Waters J, 2000, J NEUROSCI, V20, P7863; WIEDENMANN B, 1988, FEBS LETT, V240, P71, DOI 10.1016/0014-5793(88)80342-9; Willmott NJ, 2000, J NEUROSCI, V20, P1767; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang Y, 1998, J PHYSIOL-LONDON, V508, P763, DOI 10.1111/j.1469-7793.1998.763bp.x; ZIMMERMANN H, 1994, TRENDS NEUROSCI, V17, P420, DOI 10.1016/0166-2236(94)90016-7	58	389	400	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1354	1362		10.1074/jbc.M209454200	http://dx.doi.org/10.1074/jbc.M209454200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414798	hybrid			2022-12-27	WOS:000180321900085
J	Decatur, WA; Fournier, MJ				Decatur, WA; Fournier, MJ			RNA-guided nucleotide modification of ribosomal and other RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMALL NUCLEOLAR RNAS; U6 SPLICEOSOMAL RNA; BOX-C/D MOTIF; SACCHAROMYCES-CEREVISIAE; 2'-O-RIBOSE METHYLATION; PSEUDOURIDINE SYNTHASE; PRERIBOSOMAL RNA; U2 SNRNA; SNORNA; DATABASE		Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Fournier, MJ (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Lederle Grad Res Tower, Amherst, MA 01003 USA.			Decatur, Wayne/0000-0002-6961-7514	NIGMS NIH HHS [GM19351] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019351] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHELLERIE JP, 1995, TRENDS BIOCHEM SCI, V20, P261, DOI 10.1016/S0968-0004(00)89039-8; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dennis PP, 2001, MOL MICROBIOL, V40, P509, DOI 10.1046/j.1365-2958.2001.02381.x; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Ganot P, 1999, MOL CELL BIOL, V19, P6906; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; Gu J, 1998, NUCLEIC ACIDS RES, V26, P160, DOI 10.1093/nar/26.1.160; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Hansen MA, 2002, RNA, V8, P202, DOI 10.1017/S1355838202013365; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541; KING TH, 2003, IN PRESS MOL CELL; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Liang XH, 2002, RNA, V8, P237, DOI 10.1017/S1355838202018290; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lukowiak AA, 2001, RNA, V7, P1833; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Narayanan A, 1999, MOL BIOL CELL, V10, P2131, DOI 10.1091/mbc.10.7.2131; Newby MI, 2001, RNA, V7, P833, DOI 10.1017/S1355838201002308; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ofengand J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P175; Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Peculis BA, 2001, RNA, V7, P207, DOI 10.1017/S1355838201001625; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; SALIM M, 1973, NATURE, V244, P334, DOI 10.1038/244334a0; Samarsky DA, 1999, NUCLEIC ACIDS RES, V27, P161, DOI 10.1093/nar/27.1.161; Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Terns MP, 2002, GENE EXPRESSION, V10, P17; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Watanabe Y, 2000, NUCLEIC ACIDS RES, V28, P2342, DOI 10.1093/nar/28.12.2342; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 1998, RNA, V4, P1549, DOI 10.1017/S1355838298980761; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	59	168	189	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					695	698		10.1074/jbc.R200023200	http://dx.doi.org/10.1074/jbc.R200023200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12431975	hybrid			2022-12-27	WOS:000180321900001
J	Marie, H; Pratt, SJ; Betson, M; Epple, H; Kittler, JT; Meek, L; Moss, SJ; Troyanovsky, S; Attwell, D; Longmore, GD; Braga, VMM				Marie, H; Pratt, SJ; Betson, M; Epple, H; Kittler, JT; Meek, L; Moss, SJ; Troyanovsky, S; Attwell, D; Longmore, GD; Braga, VMM			The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DISSECTION; HUMAN KERATINOCYTES; ADHERENS JUNCTIONS; ADHESION MOLECULES; ZYXIN; ACTIN; PHOSPHORYLATION; EXPRESSION; NUCLEUS; BINDING	Cell-cell adhesive events affect cell growth and fate decisions and provide spatial clues for cell polarity within tissues. The complete molecular determinants required for adhesive junction formation and their function are not completely understood. LIM domain-containing proteins have been shown to be present at cell-cell contact sites and are known to shuttle into the nucleus where they can affect cell fate and growth; however, their precise localization at cell-cell contacts, how they localize to these sites, and what their functions are at these sites is unknown. Here we show that, in primary keratinocytes, the LIM domain protein Ajuba is recruited to cadherin-dependent cell-cell adhesive complexes in a regulated manner. At cadherin adhesive complexes Ajuba interacts with a-catenin, and a-catenin is required for efficient recruitment of Ajuba to cell junctions. Ajuba also interacts directly with F-actin. Keratinocytes from Ajuba null mice exhibit abnormal cell-cell junction formation and/or stability and function. These data reveal Ajuba as a new component at cadherin-mediated cell-cell junctions and suggest that Ajuba may contribute to the bridging of the cadherin adhesive complexes to the actin cytoskeleton and as such contribute to the formation or strengthening of cadherin-mediated cell-cell adhesion.	Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA; UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; University of London; University College London	Braga, VMM (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	v.braga@ic.ac.uk	Braga, Vania MM/C-7345-2008; Kittler, Josef T/E-9113-2010; Attwell, David/ABE-6750-2020; Betson, Martha/D-3818-2014; Marie, Hélène/F-1404-2011; Kittler, Josef/N-7589-2019	Kittler, Josef T/0000-0002-3437-9456; Betson, Martha/0000-0002-4220-3290; Marie, Hélène/0000-0003-2310-6097; Kittler, Josef/0000-0002-3437-9456; Braga, Vania/0000-0003-0546-7163	NCI NIH HHS [CA85839] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085839] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; BRAGA VMM, 1995, CELL ADHES COMMUN, V3, P201, DOI 10.3109/15419069509081287; Braga VMM, 1998, CELL ADHES COMMUN, V5, P137, DOI 10.3109/15419069809040287; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; DITTEL BN, 1993, BLOOD, V81, P2272; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Hashimoto S, 2001, J BIOL CHEM, V276, P6037, DOI 10.1074/jbc.M005854200; HIRAI Y, 1989, DEVELOPMENT, V105, P271; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kiss H, 1999, HUM GENET, V105, P552, DOI 10.1007/s004390051144; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; Macalma T, 1996, J BIOL CHEM, V271, P31470, DOI 10.1074/jbc.271.49.31470; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; Pradhan D, 2001, J BIOL CHEM, V276, P4175, DOI 10.1074/jbc.M009259200; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Schmeichel KL, 1997, MOL BIOL CELL, V8, P219, DOI 10.1091/mbc.8.2.219; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yi JS, 2002, J BIOL CHEM, V277, P9580, DOI 10.1074/jbc.M106922200; Yi JS, 1998, GENOMICS, V49, P314, DOI 10.1006/geno.1998.5248	37	114	117	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1220	1228		10.1074/jbc.M205391200	http://dx.doi.org/10.1074/jbc.M205391200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417594	hybrid			2022-12-27	WOS:000180321900069
J	Golab, J; Nowis, D; Skrzycki, M; Czeczot, H; Baranczyk-Kuzma, A; Wilczynski, GM; Makowski, M; Mroz, P; Kozar, K; Kaminski, R; Jalili, A; Kopec, M; Grzela, T; Jakobisiak, M				Golab, J; Nowis, D; Skrzycki, M; Czeczot, H; Baranczyk-Kuzma, A; Wilczynski, GM; Makowski, M; Mroz, P; Kozar, K; Kaminski, R; Jalili, A; Kopec, M; Grzela, T; Jakobisiak, M			Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol - A superoxide dismutase inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN METABOLITE; AMINOLEVULINIC ACID; HYDROGEN-PEROXIDE; BREAST-CANCER; FREE-RADICALS; GAMMA-RAYS; IN-VITRO; CARCINOMA; RADIATION; APOPTOSIS	Photodynamic therapy (PDT), a promising therapeutic modality for the management of solid tumors, is a two-phase treatment consisting of a photosensitizer and visible light. Increasing evidence indicates that tumor cells in regions exposed to sublethal doses of PDT can respond by rescue responses that lead to insufficient cell death. We decided to examine the role of superoxide dismutases (SODs) in the effectiveness of PDT and to investigate whether 2-methoxyestradiol (2-McOE(2)), an inhibitor of SODs, is capable of potentiating the antitumor effects of this treatment regimen. In the initial experiment we observed that PDT induced the expression of MnSOD but not Cu,Zn-SOD in cancer cells. Pretreatment of cancer cells with a cell-permeable SOD mimetic, Mn(II)-tetrakis(4-benzoic acid)porphyrin chloride, and transient transfection with the MnSOD gene resulted in a decreased effectiveness of PDT. Inhibition of SOD activity in tumor cells by preincubation with 2-MeOE2 produced synergistic antitumor effects when combined with PDT in 3 murine and 5 human tumor cell lines. The combination treatment was also effective in vivo producing retardation of the tumor growth and prolongation of the survival of tumor-bearing mice. We conclude that inhibition of MnSOD activity by 2-MeOE2 is an effective treatment modality capable of potentiating the antitumor effectiveness of PDT.	Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, PL-02004 Warsaw, Poland; Med Univ Warsaw, Dept Biochem, Ctr Biostruct Res, PL-02004 Warsaw, Poland; Med Univ Warsaw, Dept Pathol, Ctr Biostruct Res, PL-02004 Warsaw, Poland; Med Univ Warsaw, Dept Histol & Embryol, Ctr Biostruct Res, PL-02004 Warsaw, Poland; Med Univ Warsaw, Dept Gen & Vasc Surg & Transplantat, PL-02004 Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Golab, J (corresponding author), Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, Chalubinskiego 5, PL-02004 Warsaw, Poland.	jgolab@ib.amwaw.edu.pl	Mroz, Pawel/P-1258-2019; Golab, Jakub/K-6974-2013; Skrzycki, Michał/X-3743-2018; Nowis, Dominika/P-6866-2019; Nowis, Dominika/P-1213-2017; CZECZOT, HANNA/ABB-6415-2020	Golab, Jakub/0000-0002-2830-5100; Skrzycki, Michał/0000-0001-7087-1037; Nowis, Dominika/0000-0003-2748-9523; Nowis, Dominika/0000-0003-2748-9523; Kaminski, Rafal/0000-0003-4552-3596; Mroz, Pawel/0000-0003-3838-4743; CZECZOT, HANNA/0000-0001-8541-6619; Wilczynski, Grzegorz/0000-0001-6667-0291; Kozar-Kaminska, Katarzyna/0000-0002-2397-2975				ALLARDICE JT, 1994, SURG ONCOL, V3, P1, DOI 10.1016/0960-7404(94)90018-3; Allison R, 2001, CANCER, V91, P1, DOI 10.1002/1097-0142(20010101)91:1<1::AID-CNCR1>3.0.CO;2-P; Amorino GP, 2000, RADIAT RES, V153, P384, DOI 10.1667/0033-7587(2000)153[0384:EOREIV]2.0.CO;2; ATHAR M, 1988, BIOCHEM BIOPH RES CO, V151, P1054, DOI 10.1016/S0006-291X(88)80472-8; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Berr F, 2000, HEPATOLOGY, V31, P291, DOI 10.1002/hep.510310205; Bown SG, 2002, GUT, V50, P549, DOI 10.1136/gut.50.4.549; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; Das Hiranmoy, 2000, International Journal of Clinical Oncology, V5, P97, DOI 10.1007/s101470050098; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Gilaberte Y, 1997, PHOTODERMATOL PHOTO, V13, P43, DOI 10.1111/j.1600-0781.1997.tb00107.x; Golab J, 2000, BRIT J CANCER, V82, P1485; Golab J, 2002, CLIN CANCER RES, V8, P1265; Golab J, 2001, LEUKEMIA, V15, P613; Goodell T T, 2001, J Neurosci Nurs, V33, P296; Hadjur C, 1997, J PHOTOCH PHOTOBIO B, V38, P196, DOI 10.1016/S1011-1344(96)07440-4; HENDERSON BW, 1987, CANCER RES, V47, P3110; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Kachadourian R, 2001, ARCH BIOCHEM BIOPHYS, V392, P349, DOI 10.1006/abbi.2001.2455; Kashtan H, 1999, GASTROINTEST ENDOSC, V49, P760, DOI 10.1016/S0016-5107(99)70297-X; Kinuya S, 2001, EUR J NUCL MED, V28, P1306, DOI 10.1007/s002590100585; Klauber N, 1997, CANCER RES, V57, P81; Korbelik M, 2000, BRIT J CANCER, V82, P1835, DOI 10.1054/bjoc.2000.1157; Kuninaka S, 2000, BRIT J CANCER, V83, P928, DOI 10.1054/bjoc.2000.1367; Kuroda M, 2000, ANTICANCER RES, V20, P7; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; MARTINEZCAYUELA M, 1995, BIOCHIMIE, V77, P147, DOI 10.1016/0300-9084(96)88119-3; Mimura S, 1996, LASER SURG MED, V19, P168; Moor ACE, 2000, J PHOTOCH PHOTOBIO B, V57, P1, DOI 10.1016/S1011-1344(00)00065-8; Morgan J, 2000, PHOTOCHEM PHOTOBIOL, V71, P747, DOI 10.1562/0031-8655(2000)071<0747:COPTIA>2.0.CO;2; Nakano T, 1996, CANCER RES, V56, P2771; RIGO A, 1975, BIOCHEM BIOPH RES CO, V63, P1013, DOI 10.1016/0006-291X(75)90670-1; Salet C, 1997, FREE RADICAL RES, V26, P201, DOI 10.3109/10715769709097800; Schumacher G, 1999, CLIN CANCER RES, V5, P493; Seegers JC, 1997, J STEROID BIOCHEM, V62, P253, DOI 10.1016/S0960-0760(97)00043-5; Sharman WM, 2000, METHOD ENZYMOL, V319, P376; Ueta E, 1999, JPN J CANCER RES, V90, P555, DOI 10.1111/j.1349-7006.1999.tb00783.x; Ueta E, 2001, INT J CANCER, V94, P545, DOI 10.1002/ijc.1513; WEISHAUPT KR, 1976, CANCER RES, V36, P2326; Wenk J, 1999, J BIOL CHEM, V274, P25869, DOI 10.1074/jbc.274.36.25869; WHITE L, 1988, BRIT J CANCER, V57, P455, DOI 10.1038/bjc.1988.106; Wilson BC, 1997, PHOTOCHEM PHOTOBIOL, V65, P166, DOI 10.1111/j.1751-1097.1997.tb01894.x; Wood L, 2001, ANTI-CANCER DRUG DES, V16, P209; Wyss P, 2001, INT J CANCER, V93, P720, DOI 10.1002/ijc.1400; Zhang Y, 2002, CANCER RES, V62, P1205	46	103	110	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					407	414		10.1074/jbc.M209125200	http://dx.doi.org/10.1074/jbc.M209125200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409296	hybrid			2022-12-27	WOS:000180255700054
J	Richard, JP; Melikov, K; Vives, E; Ramos, C; Verbeure, B; Gait, MJ; Chernomordik, LV; Lebleu, B				Richard, JP; Melikov, K; Vives, E; Ramos, C; Verbeure, B; Gait, MJ; Chernomordik, LV; Lebleu, B			Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS; IN-VIVO; ANTENNAPEDIA HOMEODOMAIN; BASIC DOMAIN; 3RD HELIX; DELIVERY; TRANSDUCTION; OLIGONUCLEOTIDES; INTERNALIZATION	Cellular uptake of a family of cationic cell-penetrating peptides (examples include Tat peptides and penetratin) have been ascribed in the literature to a mechanism that does not involve endocytosis. In this work we reevaluate the mechanisms of cellular uptake of Tat 48-60 and (Arg)(9). We demonstrate here that cell fixation, even in mild conditions, leads to the artifactual uptake of these peptides. Moreover, we show that flow cytometry analysis cannot be used validly to evaluate cellular uptake unless a step of trypsin digestion of the cell membrane-adsorbed peptide is included in the protocol. Fluorescence microscopy on live unfixed cells shows characteristic endosomal distribution of peptides. Flow cytometry analysis indicates that the kinetics of uptake are similar to the kinetics of endocytosis. Peptide uptake is inhibited by incubation at low temperature and cellular ATP pool depletion. Similar data were obtained for Tat-conjugated peptide nucleic acids. These data are consistent with the involvement of endocytosis in the cellular internalization of cell-penetrating peptides and their conjugates to peptide nucleic acids.	NICHD, Sect Membrane Biol, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; Univ Montpellier 2, CNRS, Unite Mixte Rech 5124, Montpellier, France; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; MRC Laboratory Molecular Biology	Melikov, K (corresponding author), NICHD, Sect Membrane Biol, Lab Cellular & Mol Biophys, NIH, 10 Ctr Dr,Bldg 10,Rm 10D05, Bethesda, MD 20892 USA.	melikovk@mail.nih.gov	Melikov, Kamran/A-6604-2009; VIVES, Eric/AAG-6569-2020	VIVES, Eric/0000-0001-5391-9641; Richard, Jean-Philippe/0000-0003-2890-2316	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001501] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arzumanov A, 2001, NUCLEOS NUCLEOT NUCL, V20, P471, DOI 10.1081/NCN-100002321; Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329; Braasch D., 2002, J WILEY SONS NY, V14, P11; Chan WC, 2000, FMOC SOLID PHASE PEP; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Drin G, 2001, EUR J BIOCHEM, V268, P1304, DOI 10.1046/j.1432-1327.2001.01997.x; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gewirtz AM, 1998, BLOOD, V92, P712, DOI 10.1182/blood.V92.3.712.415a32_712_736; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4; Ho A, 2001, CANCER RES, V61, P474; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Juliano RL, 1999, PHARM RES-DORDR, V16, P494, DOI 10.1023/A:1011958726518; Koppelhus U, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P359; Langel U., 2002, CELL PENETRATING PEP, V1st ed; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450; Mitchell A, 2000, NAT REV MOL CELL BIO, V1, P7, DOI 10.1038/35036020; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pichon C, 1999, ANTISENSE NUCLEIC A, V9, P89, DOI 10.1089/oli.1.1999.9.89; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	36	1421	1492	8	378	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					585	590		10.1074/jbc.M209548200	http://dx.doi.org/10.1074/jbc.M209548200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12411431	hybrid			2022-12-27	WOS:000180255700076
J	Waldron, RT; Rozengurt, E				Waldron, RT; Rozengurt, E			Protein kinase C phosphorylates protein kinase D activation loop Ser(744) and Ser(748) and releases autoinhibition by the pleckstrin homology domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; SIGNAL-TRANSDUCTION PATHWAY; D PKD ACTIVATION; PHORBOL ESTERS; RAPID ACTIVATION; INTACT-CELLS; MOLECULAR-CLONING; CATALYTIC DOMAIN; PHOSPHOLIPASE-C; ALPHA-SUBUNIT	Persistent activation of protein kinase D (PKD) via protein kinase C (PKC)-mediated signal transduction is accompanied by phosphorylation at Ser(774) and Ser(748) located in the catalytic domain activation loop, but whether PKC isoforms directly phosphorylate these residues, induce PKD autophosphorylation, or recruit intermediate upstream kinase(s) is unclear. Here, we explore the mechanism whereby PKC activates PKD in response to cellular stimuli. We first assessed in vitro PKC-PKD transphosphorylation and PKD activation. A PKD738-753 activation loop peptide was well phosphorylated by immunoprecipitated PKC isoforms, consistent with similarities between the loop and their known substrate specificities. A similar peptide with glutamic acid replacing Ser(748) was preferentially phosphorylated by PKCepsilon, suggesting that PKD containing phosphate at Ser(748). is rapidly targeted by this isoform at Ser(744). When incubated in the presence of phosphatidylserine, phorbol 12,13-dibutyrate and ATP, intact PKD slowly auto-phosphorylated in the activation loop but only at Ser(748). In contrast, addition of purified PKCepsilon to the incubation mixture induced rapid Ser(744) and Ser(748) phosphorylation, concomitant with persistent 2-3-fold increases in PKD activity, measured using reimmunoprecipitated PKD to phosphorylate an exogenous peptide, syntide-2. We also further examined pleckstrin homology domain-mediated PKD regulation to determine its relationship with activation loop phosphorylation. The high constitutive activity of the pleckstrin homology (PH) domain deletion mutant PKD-DeltaPH was not abrogated by mutation of Ser(744) and Ser(748) to alanines, suggesting that one function of activation loop phosphorylation in the PKD activation mechanism is to relieve autoinhibition by the PH domain. These studies provide evidence of a direct PKCepsilon-PKD phosphorylation cascade and provide additional insight into the activation mechanism.	Univ Calif Los Angeles, David Geffen Sch Med,Dept Med, Unit Signal Transduct & Gastrointestinal, Div Digest Dis,CURE,Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med,Dept Med, Unit Signal Transduct & Gastrointestinal, Div Digest Dis,CURE,Digest Dis Res Ctr, 900 Vet Ave,Warren Hall Rm 11-124, Los Angeles, CA 90095 USA.		Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002	NATIONAL CANCER INSTITUTE [P50CA090388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002834, R01DK056930] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA90388] Funding Source: Medline; NIDDK NIH HHS [K01 DK 02834, DK 56930, DK 55003] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Bagowski CP, 1999, EMBO J, V18, P5567, DOI 10.1093/emboj/18.20.5567; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2273, DOI 10.1006/jmcc.1997.0466; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Hausser A, 2001, FEBS LETT, V492, P39, DOI 10.1016/S0014-5793(01)02219-0; Haworth RS, 1999, AM J PHYSIOL-CELL PH, V277, pC1202, DOI 10.1152/ajpcell.1999.277.6.C1202; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Hurd C, 2001, BIOCHEM BIOPH RES CO, V282, P404, DOI 10.1006/bbrc.2001.4591; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Klein IK, 2000, CANCER RES, V60, P2077; Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mochly-Rosen D, 1998, FASEB J, V12, P35; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Paolucci L, 1999, CANCER RES, V59, P572; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; REY O, 2001, J BIOL CHEM, V15, P15; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Yeo EJ, 1997, BBA-MOL CELL RES, V1356, P308, DOI 10.1016/S0167-4889(97)00006-2; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	64	153	157	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					154	163		10.1074/jbc.M208075200	http://dx.doi.org/10.1074/jbc.M208075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407104	hybrid			2022-12-27	WOS:000180255700021
J	Jiang, YF; Zhang, ZX; Kifor, O; Lane, CR; Quinn, SJ; Bai, M				Jiang, YF; Zhang, ZX; Kifor, O; Lane, CR; Quinn, SJ; Bai, M			Protein kinase C (PKC) phosphorylation of the Ca2+-sensing receptor (CaR) modulates functional interaction of g proteins with the CaR cytoplasmic tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PARATHYROID CELLS; CALCIUM-SENSING RECEPTOR; HORMONE RELEASE; EXTRACELLULAR CALCIUM; CA-0(2+)-SENSING RECEPTOR; HYPERPARATHYROIDISM; SECRETION; EXPRESSION; ACTIVATION; CA-2+	The extracellular calcium (Ca-o(2+))-sensing receptor (CaR) activates Ca2+ influx independent of the release of intracellular Ca2+ stores. The latter can be negatively regulated by protein kinase C (PKC) through phosphorylation of Thr-888 of the CaR. In this study, we substituted Thr-888 with various amino acid residues or a stop codon to understand how PKC phosphorylation of the CaR inhibits receptor-mediated release of intracellular Ca2+ stores. Substitutions of Thr-888 with hydrophobic and hydrophilic amino acid residues had various effects on CaR-mediated release of intracellular Ca2+ stores as well as activation of Ca2+ influx. Several point mutations, such as T888D, had marked negative effects on CaR-mediated release of intracellular Ca2+ stores but not on phorbol myristate acetate-insensitive activation of Ca2+ influx. Presumably, the negatively charged aspartate mimics phospho-threonine. Interestingly, truncating the receptor at 888 had an even more pronounced negative effect on CaR-elicited release of intracellular Ca2+ stores without significantly affecting CaR-mediated activation of Ca2+ influx. Therefore, truncation at position 888 of the CaR affects the activity of the receptor in a manner that resembles PKC phosphorylation of the CaR. This in turn suggests that PKC phosphorylation of the CaR prevents G protein subtypes from interacting with the region of the receptor critical for releasing Ca2+ stores, which is missing in the truncated receptor.	Brigham & Womens Hosp, Div Endocrine Hypertens, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bai, M (corresponding author), Brigham & Womens Hosp, Div Endocrine Hypertens, Dept Med, 221 Longwood Ave, Boston, MA 02115 USA.				NIDDK NIH HHS [DK54934] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054934] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bai M, 1997, J CLIN INVEST, V99, P1917, DOI 10.1172/JCI119359; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Bai M, 1998, J BIOL CHEM, V273, P21267, DOI 10.1074/jbc.273.33.21267; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; CLARKE BL, 1993, ENDOCRINOLOGY, V132, P1168, DOI 10.1210/en.132.3.1168; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; FAJTOVA VT, 1991, AM J PHYSIOL, V261, pE151, DOI 10.1152/ajpendo.1991.261.1.E151; Gogusev J, 1997, KIDNEY INT, V51, P328, DOI 10.1038/ki.1997.41; ISHIZUKA T, 1987, ENDOCRINOL JAPON, V34, P965; KIFOR O, 1992, J BONE MINER RES, V7, P1327; Kifor O, 1996, J CLIN ENDOCR METAB, V81, P1598, DOI 10.1210/jc.81.4.1598; KIFOR O, 1990, J BONE MINER RES, V5, P1003; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MEMBRENO L, 1989, ENDOCRINOLOGY, V124, P789, DOI 10.1210/endo-124-2-789; MORRISSEY JJ, 1988, AM J PHYSIOL, V254, pE63, DOI 10.1152/ajpendo.1988.254.1.E63; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P141, DOI 10.1113/jphysiol.1993.sp019764; RACKE FK, 1993, J PHYSIOL-LONDON, V468, P163, DOI 10.1113/jphysiol.1993.sp019765; RACKE FK, 1994, AM J PHYSIOL, V267, pE429, DOI 10.1152/ajpendo.1994.267.3.E429; RIDEFELT P, 1992, ACTA ENDOCRINOL-COP, V126, P505, DOI 10.1530/acta.0.1260505; SHOBACK DM, 1990, ENDOCRINOLOGY, V127, P141, DOI 10.1210/endo-127-1-141; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; WATSON PH, 1992, J BONE MINER RES, V7, P667; WONGSURAWAT N, 1987, EXP GERONTOL, V22, P263, DOI 10.1016/0531-5565(87)90005-2	24	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50543	50549		10.1074/jbc.M205798200	http://dx.doi.org/10.1074/jbc.M205798200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12409307	hybrid			2022-12-27	WOS:000180177700047
J	Lee, TH; Avraham, HK; Jiang, SX; Avraham, S				Lee, TH; Avraham, HK; Jiang, SX; Avraham, S			Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-CELLS; TUMOR-GROWTH; E-SELECTIN; FACTOR VEGF; METASTASIS; EXPRESSION; INVASION; ADHESION; CALCIUM; INHIBITION	Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), has been shown to increase potently the permeability of endothelium and is highly expressed in breast cancer cells. In this study, we investigated the role of VEGF/VPF in breast cancer metastasis to the brain. Very little is known about the role of endothelial integrity in the extravasation of breast cancer cells to the brain. We hypothesized that VEGF/VPF, having potent vascular permeability activity, may support tumor cell penetration across blood vessels by inducing vascular leakage. To examine this role of VEGF/VPF, we used a Transwell culture system of the human brain microvascular endothelial cell (HBMEC) monolayer as an in vitro model for the blood vessels. We observed that VEGF/VPF significantly increased the penetration of the highly metastatic MDA-MB-231 breast cancer cells across the HBMEC monolayer. We found that the increased transendothelial migration (TM) of MDA-MB-231 cells resulted from the increased adhesion of tumor cells onto the HBMEC monolayer. These effects (TM and adhesion of tumor cells) were inhibited by the pre-treatment of the HBMEC monolayer with the VEGF/VPF receptor (KDR/Flk-1) inhibitor, SU-1498, and the calcium chelator 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (acetoxymethyl)ester. These treatments of the HB-MEC monolayer also inhibited VEGF/VPF-induced permeability and the cytoskeletal rearrangement of the monolayer. These data suggest that VEGF/VPF can modulate the TM of tumor cells by regulating the integrity of the HBMEC monolayer. Taken together, these findings indicate that VEGF/VPF might contribute to breast cancer metastasis by enhancing the TM of tumor cells through the down-regulation of endothelial integrity.	Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Div Expt Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Avraham, S (corresponding author), Harvard Univ, Inst Med, Beth Israel Deaconess Med Ctr, Div Expt Med, 4 Blackfan Circle, Boston, MA 02115 USA.			Avraham, Hava/0000-0002-7545-3640	NCI NIH HHS [CA76226, CA87200] Funding Source: Medline; NHLBI NIH HHS [HL55445] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055445] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Bachelder RE, 2001, CANCER RES, V61, P5736; Bates DO, 1997, AM J PHYSIOL-HEART C, V273, pH687, DOI 10.1152/ajpheart.1997.273.2.H687; BERKMAN RA, 1993, J CLIN INVEST, V91, P153, DOI 10.1172/JCI116165; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Brekken RA, 2000, CANCER RES, V60, P5117; Brodt P, 1997, INT J CANCER, V71, P612, DOI 10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D; BROWN LF, 1995, HUM PATHOL, V26, P86, DOI 10.1016/0046-8177(95)90119-1; CURRY FE, 1992, FASEB J, V6, P2456, DOI 10.1096/fasebj.6.7.1563597; De Jong JS, 1998, J PATHOL, V184, P53, DOI 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; FUJITA S, 1992, JPN J CANCER RES, V83, P1317, DOI 10.1111/j.1349-7006.1992.tb02764.x; GEHLSEN KR, 1988, J CELL BIOL, V106, P925, DOI 10.1083/jcb.106.3.925; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; GLEADLE JM, 1995, AM J PHYSIOL-CELL PH, V268, pC1362, DOI 10.1152/ajpcell.1995.268.6.C1362; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V127, P121, DOI 10.1002/jcp.1041270116; HONN KV, 1989, FASEB J, V3, P2285, DOI 10.1096/fasebj.3.11.2673900; HUANG AJ, 1993, J CELL BIOL, V120, P1371, DOI 10.1083/jcb.120.6.1371; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Kevil CG, 1998, J BIOL CHEM, V273, P15099, DOI 10.1074/jbc.273.24.15099; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KRAMER RH, 1980, INT J CANCER, V26, P639, DOI 10.1002/ijc.2910260516; KUSAMA T, 1995, INT J CANCER, V63, P112, DOI 10.1002/ijc.2910630120; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Lee TH, 2002, J BIOL CHEM, V277, P10445, DOI 10.1074/jbc.M107348200; Lewalle JM, 1998, CLIN EXP METASTAS, V16, P21; Melnyk O, 1996, CANCER RES, V56, P921; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; MOREL NML, 1990, INFLAMMATION, V14, P571, DOI 10.1007/BF00914277; Nagayasu H, 1998, BRIT J CANCER, V77, P1371, DOI 10.1038/bjc.1998.229; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; NICOLSON GL, 1994, CRIT REV ONCOGENESIS, V5, P451, DOI 10.1615/CritRevOncog.v5.i5.20; OLESEN SP, 1986, BRAIN RES, V368, P24, DOI 10.1016/0006-8993(86)91038-3; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; PFAU S, 1995, J CELL BIOL, V128, P969, DOI 10.1083/jcb.128.5.969; Price DJ, 2001, CELL GROWTH DIFFER, V12, P129; SENGER DR, 1986, CANCER RES, V46, P5629; Shibata T, 2000, TUMOR BIOL, V21, P299, DOI 10.1159/000030135; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; ZIEGELSTEIN RC, 1994, CIRCULATION, V90, P1899, DOI 10.1161/01.CIR.90.4.1899	50	164	174	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5277	5284		10.1074/jbc.M210063200	http://dx.doi.org/10.1074/jbc.M210063200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12446667	hybrid			2022-12-27	WOS:000180968900118
J	Antony, T; Hoyer, W; Cherny, D; Heim, G; Jovin, TM; Subramaniam, V				Antony, T; Hoyer, W; Cherny, D; Heim, G; Jovin, TM; Subramaniam, V			Cellular polyamines promote the aggregation of alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID PEPTIDE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; LEWY BODIES; SUBCELLULAR-LOCALIZATION; ORNITHINE-DECARBOXYLASE; FIBRIL FORMATION; HUMAN BRAIN; IN-VITRO; PROTEIN	The cellular polyamines putrescine, spermidine, and spermine accelerate the aggregation and fibrillization of alpha-synuclein, the major protein component of Lewy bodies associated with Parkinson's disease. Circular dichroism and fluorometric thioflavin T kinetic studies showed a transition of alpha-synuclein from unaggregated to highly aggregated states, characterized by lag and transition phases. In the presence of polyamines, both the lag and transition times were significantly shorter. All three polyamines accelerated the aggregation and fibrillization of alpha-synuclein to a degree that increased with the total charge, length, and concentration of the polyamine. Electron and scanning force microscopy of the reaction products after the lag phase revealed the presence of aggregated particles (protofibrils) and small fibrils. At the end of the transition phase, alpha-synuclein formed long fibrils in all cases, although some morphological variations were apparent. In the presence of polyamines, fibrils formed large networks leading ultimately to condensed aggregates. In the absence of polyamines, fibrils were mostly isolated. We conclude that the polyamines at physiological concentrations can modulate the propensity of alpha-synuclein to form fibrils and may hence play a role in the formation of cytosolic alpha-synuclein aggregates.	Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Max Planck Society; Russian Academy of Sciences	Subramaniam, V (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fasserg 11, D-37077 Gottingen, Germany.	tjovin@gwdg.de; vinod.subramaniam@astrazeneca.com	Hoyer, Wolfgang/H-6193-2013; Subramaniam, Vinod/B-4197-2010	Hoyer, Wolfgang/0000-0003-4301-5416; Subramaniam, Vinod/0000-0001-6712-7266				ABRAHAM AK, 1981, MED BIOL, V59, P368; Ahlskog JE, 2001, NEUROL CLIN, V19, P579, DOI 10.1016/S0733-8619(05)70036-0; Bachrach U, 2001, NEWS PHYSIOL SCI, V16, P106, DOI 10.1152/physiologyonline.2001.16.3.106; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield DA, 2001, MECH AGEING DEV, V122, P945, DOI 10.1016/S0047-6374(01)00249-4; BUXBAUM J, 1992, HEMATOL ONCOL CLIN N, V6, P323, DOI 10.1016/S0889-8588(18)30347-2; Chamberlain AK, 2000, BIOPHYS J, V79, P3282, DOI 10.1016/S0006-3495(00)76560-X; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DUBOCHET J, 1971, J ULTRA MOL STRUCT R, V35, P147, DOI 10.1016/S0022-5320(71)80148-X; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gai WP, 1998, LANCET, V352, P547, DOI 10.1016/S0140-6736(05)79256-4; Gerlach M, 1996, J NEURAL TRANSM-SUPP, P7; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; GILAD GM, 1986, INT J DEV NEUROSCI, V4, P195, DOI 10.1016/0736-5748(86)90059-6; Gilad GM, 1999, NEUROSCI LETT, V268, P33, DOI 10.1016/S0304-3940(99)00375-4; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kim YS, 2001, BRAIN RES, V908, P93, DOI 10.1016/S0006-8993(01)02575-6; Kruger R, 2000, J NEURAL TRANSM, V107, P31, DOI 10.1007/s007020050002; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; McGowan DP, 2000, NEUROSCIENCE, V100, P677, DOI 10.1016/S0306-4522(00)00391-2; McLean PJ, 2000, J NEURAL TRANSM-SUPP, P53; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Morrison LD, 1998, J NEUROCHEM, V71, P288; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Paik SR, 1997, ARCH BIOCHEM BIOPHYS, V344, P325, DOI 10.1006/abbi.1997.0207; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROCK DM, 1995, ANNU REV PHARMACOL, V35, P463; SARHAN S, 1989, BIOL CHEM H-S, V370, P1279, DOI 10.1515/bchm3.1989.370.2.1279; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SLOTKIN TA, 1986, BRAIN RES BULL, V17, P307, DOI 10.1016/0361-9230(86)90236-4; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2001, FEBS LETT, V500, P105, DOI 10.1016/S0014-5793(01)02597-2; Vivo M, 2001, NEUROSCI LETT, V304, P107, DOI 10.1016/S0304-3940(01)01776-1; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Weller RO, 2001, J PATHOL, V194, P1, DOI 10.1002/1096-9896(200105)194:1<1::AID-PATH871>3.0.CO;2-M; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yatin SM, 2001, J NEUROSCI RES, V63, P395, DOI 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q	63	141	145	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3235	3240		10.1074/jbc.M208249200	http://dx.doi.org/10.1074/jbc.M208249200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12435752	hybrid, Green Published			2022-12-27	WOS:000180915000060
J	Gourley, BL; Parker, SB; Jones, BJ; Zumbrennen, KB; Leibold, EA				Gourley, BL; Parker, SB; Jones, BJ; Zumbrennen, KB; Leibold, EA			Cytosolic aconitase and ferritin are regulated by iron in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; RESPONSIVE-ELEMENT; GLYOXYLATE CYCLE; MESSENGER-RNA; LIFE-SPAN; DROSOPHILA-MELANOGASTER; TRANSLATIONAL REGULATION; DIFFERENTIAL EXPRESSION; MOLECULAR CONTROL; NITRIC-OXIDE	Iron regulatory protein-1 (IRP-1) is a cytosolic RNA-binding protein that is a regulator of iron homeostasis in mammalian cells. IRP-1 binds to RNA structures, known as iron-responsive elements, located in the untranslated regions of specific mRNAs, and it regulates the translation or stability of these mRNAs. Iron regulates IRP-1 activity by converting it from an RNA-binding apoprotein into a [4Fe-4S] cluster protein exhibiting aconitase activity. IRP-1 is widely found in prokaryotes and eukaryotes. Here, we report the biochemical characterization and regulation of an IRP-1 homolog in Caenorhabditis elegans (GEI-22/ACO-1). GEI-22/ACO-1 is expressed in the cytosol of cells of the hypodermis and the intestine. Like mammalian IRP-1/aconitases, GEI-22/ACO-1 exhibits aconitase activity and is post-translationally regulated by iron. Although GEI-22/ACO-1 shares striking resemblance to mammalian IRP-1, it fails to bind RNA. This is consistent with the lack of iron-responsive elements in the C. elegans ferritin genes, ftn-1 and ftn-2. While mammalian ferritin H and L mRNAs are translationally regulated by iron, the amounts of C. elegans ftn-1 and ftn-2 mRNAs are increased by iron and decreased by iron chelation. Excess iron did not significantly alter worm development but did shorten their life span. These studies indicated that iron homeostasis in C. elegans shares some similarities with those of vertebrates.	Univ Utah, Eccles Program Human Mol Biol & Genet, HMBG, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med, Div Hematol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med, Div Oncol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Eccles Program Human Mol Biol & Genet, HMBG, 15 N 2030 E Rm 3240, Salt Lake City, UT 84112 USA.	betty.leibold@hmbg.utah.edu			NIGMS NIH HHS [GM45201] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alen C, 1999, P NATL ACAD SCI USA, V96, P10412, DOI 10.1073/pnas.96.18.10412; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; BLUMENTHAL T, 1997, C ELEGANS, V2, P117; Broeks A, 1996, EMBO J, V15, P6132, DOI 10.1002/j.1460-2075.1996.tb01001.x; COURTOISVERNIQUET F, 1993, BIOCHEM J, V294, P103, DOI 10.1042/bj2940103; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fleming RE, 2002, ANNU REV PHYSIOL, V64, P663, DOI 10.1146/annurev.physiol.64.081501.155838; FOBISLOISY I, 1995, EUR J BIOCHEM, V231, P609, DOI 10.1111/j.1432-1033.1995.0609d.x; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gray NK, 1996, P NATL ACAD SCI USA, V93, P4925, DOI 10.1073/pnas.93.10.4925; Gruer MJ, 1997, TRENDS BIOCHEM SCI, V22, P3, DOI 10.1016/S0968-0004(96)10069-4; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HAYASHI M, 1995, PLANT CELL PHYSIOL, V36, P669; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KHAN FR, 1980, FEBS LETT, V115, P312, DOI 10.1016/0014-5793(80)81195-1; Koga M, 2000, EMBO J, V19, P5148, DOI 10.1093/emboj/19.19.5148; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; KOVAVEC A, 2002, MED HYPOTHESES, V58, P411; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; LEIBOLD EA, 1987, J BIOL CHEM, V262, P7335; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Liao VHC, 1998, J BIOL CHEM, V273, P31962, DOI 10.1074/jbc.273.48.31962; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Liu FZ, 1997, BIOCHEMISTRY-US, V36, P255, DOI 10.1021/bi9623800; LIU FZ, 1995, DEV BIOL, V169, P399, DOI 10.1006/dbio.1995.1156; Loyevsky M, 2001, BLOOD, V98, P2555, DOI 10.1182/blood.V98.8.2555; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; MENGAUD JM, 1993, J BACTERIOL, V175, P5666, DOI 10.1128/JB.175.17.5666-5676.1993; Muckenthaler M, 1998, EUR J BIOCHEM, V254, P230, DOI 10.1046/j.1432-1327.1998.2540230.x; Narahari J, 2000, J BIOL CHEM, V275, P16227, DOI 10.1074/jbc.M910450199; Navarre DA, 2000, PLANT PHYSIOL, V122, P573, DOI 10.1104/pp.122.2.573; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; PATEL TR, 1977, ARCH BIOCHEM BIOPHYS, V183, P24, DOI 10.1016/0003-9861(77)90414-3; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; PEYRET P, 1995, J BIOL CHEM, V270, P8131, DOI 10.1074/jbc.270.14.8131; Popov VN, 1998, FEBS LETT, V440, P55, DOI 10.1016/S0014-5793(98)01422-7; PRODROMOU C, 1992, EUR J BIOCHEM, V204, P599, DOI 10.1111/j.1432-1033.1992.tb16673.x; ROBBINS AH, 1989, P NATL ACAD SCI USA, V86, P3639, DOI 10.1073/pnas.86.10.3639; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; ROTHENBERGER S, 1990, NUCLEIC ACIDS RES, V18, P1175, DOI 10.1093/nar/18.5.1175; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Savino G, 1997, J BIOL CHEM, V272, P33319, DOI 10.1074/jbc.272.52.33319; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schneider B D, 2000, Curr Opin Clin Nutr Metab Care, V3, P267, DOI 10.1097/00075197-200007000-00005; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Sulston J., 1988, NEMATODE CAENORHABDI, P603; SULSTON JE, 1974, GENETICS, V77, P95; Sun JT, 1999, MOL CELL BIOL, V19, P216; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Tsuboi D, 2002, BIOCHEM BIOPH RES CO, V292, P697, DOI 10.1006/bbrc.2002.6717; Villanueva A, 2001, EMBO J, V20, P5114, DOI 10.1093/emboj/20.18.5114; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; WHITE K, 1988, J BIOL CHEM, V263, P8938; YU Y, 1992, J BIOL CHEM, V267, P19005; Zhang D, 2001, INSECT MOL BIOL, V10, P531, DOI 10.1046/j.0962-1075.2001.00293.x; ZHENG LM, 1992, ARCH BIOCHEM BIOPHYS, V299, P356, DOI 10.1016/0003-9861(92)90287-7; ZHENG LM, 1990, J BIOL CHEM, V265, P2814	71	59	66	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3227	3234		10.1074/jbc.M210333200	http://dx.doi.org/10.1074/jbc.M210333200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12438312	hybrid			2022-12-27	WOS:000180915000059
J	Inui, T; Ohkubo, T; Emi, M; Irikura, D; Hayaishi, O; Urade, Y				Inui, T; Ohkubo, T; Emi, M; Irikura, D; Hayaishi, O; Urade, Y			Characterization of the unfolding process of lipocalin-type prostaglandin D synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER DIHYDROFOLATE-REDUCTASE; RETINOL-BINDING-PROTEIN; BETA-TRACE; CONFORMATIONAL FLEXIBILITY; EQUILIBRIUM INTERMEDIATE; IDENTIFICATION; LACTOGLOBULIN; ACTIVATION; BILIRUBIN; FORM	We found that low concentrations of guanidine hydrochloride (GdnHCl, <0.75 m) or urea (<1.5 m) enhanced the enzyme activity of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) maximally 2.5- and 1.6-fold at 0.5 m GdnHCl and 1 m urea, respectively. The catalytic constants in the absence of denaturant and in the presence of 0.5 m GdnHCl or 1 m urea were 22, 57, and 30 min(-1), respectively, and the K-m values for the substrate, PGH(2), were 2.8, 8.3, and 2.3 mum, respectively, suggesting that the increase in the catalytic constant was mainly responsible for the activation of L-PGDS. The intensity of the circular dichroism. (CD) spectrum at 218 nm, reflecting the beta-sheet content, was also increased by either denaturant in a concentration-dependent manner, with the maximum at 0.5 m GdnHCl or 1 m urea. By plotting the enzyme activities against the ellipticities at 218 nm of the CD spectra of L-PGDS in the presence or absence of GdnHCl or urea, we found two states in the reversible folding process of L-PGDS: one is an activity-enhanced state and the other, an inactive state. The NMR analysis of L-PGDS revealed that the hydrogen-bond network was reorganized to be increased in the activity-enhanced state formed in the presence of 0.5 m GdnHCl or 1 m urea and to be decreased but still remain in the inactive intermediate observed in the presence of 2 m GdnHCl or 4 m urea. Furthermore, binding of the nonsubstrate ligands, bilirubin or 13-cis-retinal, to L-PGDS changed from a multistate mode in the native form of L-PGDS to a simple two-state mode in the activity-enhanced form, as monitored by CD spectra of the bound ligands. Therefore, L-PGDS is a unique protein whose enzyme activity and ligand-binding property are bi-phasically altered during the unfolding process by denaturants.	Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 5650874, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650874, Japan; Osaka Univ, Fac Pharmaceut Sci, Suita, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); Osaka University	Urade, Y (corresponding author), Osaka Biosci Inst, Dept Mol Behav Biol, 6-2-4 Furuedai, Suita, Osaka 5650874, Japan.	uradey@obi.or.jp	Inui, Takashi/G-1069-2011					Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; BAX A, 1983, J MAGN RESON, V55, P301, DOI 10.1016/0022-2364(83)90241-X; Beuckmann CT, 2000, J COMP NEUROL, V428, P62, DOI 10.1002/1096-9861(20001204)428:1<62::AID-CNE6>3.0.CO;2-E; Beuckmann CT, 1999, BIOCHEMISTRY-US, V38, P8006, DOI 10.1021/bi990261p; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Burns LL, 1998, PROTEINS, V33, P107, DOI 10.1002/(SICI)1097-0134(19981001)33:1<107::AID-PROT10>3.3.CO;2-N; Capaldi AP, 1998, CURR OPIN STRUC BIOL, V8, P86, DOI 10.1016/S0959-440X(98)80014-6; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; FAN YX, 1995, BBA-PROTEIN STRUCT M, V1252, P151, DOI 10.1016/0167-4838(95)00125-E; Fan YX, 1996, BIOCHEM J, V315, P97, DOI 10.1042/bj3150097; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Hamada D, 1997, J MOL BIOL, V269, P479, DOI 10.1006/jmbi.1997.1055; Hoffmann A, 1996, DEV DYNAM, V207, P332, DOI 10.1002/(SICI)1097-0177(199611)207:3<332::AID-AJA10>3.0.CO;2-6; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Inui T, 2002, INT CONGR SER, V1233, P447, DOI 10.1016/S0531-5131(02)00528-9; Inui T, 1999, BIOCHEM BIOPH RES CO, V266, P641, DOI 10.1006/bbrc.1999.1881; JENG MF, 1991, J MOL BIOL, V221, P1045, DOI 10.1016/0022-2836(91)80191-V; Kuwajima K, 1996, J MOL BIOL, V264, P806, DOI 10.1006/jmbi.1996.0678; LEVINE RL, 1977, CLIN CHEM, V23, P2292; Mase M, 1999, NEUROSCI LETT, V270, P188, DOI 10.1016/S0304-3940(99)00494-2; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; MCDONAGH AF, 1971, FEBS LETT, V18, P315, DOI 10.1016/0014-5793(71)80475-1; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1; NEWCOMER ME, 1993, P NATL ACAD SCI USA, V90, P9223, DOI 10.1073/pnas.90.19.9223; Oda H, 1996, P JPN ACAD B-PHYS, V72, P108, DOI 10.2183/pjab.72.108; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; Ptitsyn Oleg B., 1992, P243; ROBERT SH, 1982, METHOD ENZYMOL, V88, P506; Samuel D, 2000, J BIOL CHEM, V275, P34968, DOI 10.1074/jbc.M005147200; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Toh H, 1996, PROTEIN ENG, V9, P1067, DOI 10.1093/protein/9.12.1067; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; URADE Y, 1985, J BIOL CHEM, V260, P2410; URADE Y, 1995, J BIOL CHEM, V270, P1422, DOI 10.1074/jbc.270.3.1422; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Weichsel A, 1998, NAT STRUCT BIOL, V5, P304, DOI 10.1038/nsb0498-304; Zhang HJ, 1997, BIOCHEM BIOPH RES CO, V238, P382, DOI 10.1006/bbrc.1997.7301	43	40	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2845	2852		10.1074/jbc.M209934200	http://dx.doi.org/10.1074/jbc.M209934200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441340	hybrid			2022-12-27	WOS:000180915000012
J	Martin, JL; Weenink, SM; Baxter, RC				Martin, JL; Weenink, SM; Baxter, RC			Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells - Involvement of p44/42 and p38 mitogen-activated protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; IGF-I ACTION; FACTOR BINDING-PROTEIN-3; SURFACE BINDING; CARCINOMA-CELLS; RECEPTOR; EXPRESSION; INHIBITION; APOPTOSIS; IGFBP-3	Insulin-like growth factor-binding protein-3 (IGFBP-3) is inhibitory to the growth of many breast cancer cells in vitro; however, a high level of expression of IGFBP-3 in breast tumors correlates with poor prognosis, suggesting that IGFBP-3 may be associated with growth stimulation in some breast cancers. We have shown previously in MCF-10A breast epithelial cells that chronic activation of Ras-p44/42 mitogen-activated protein (MAP) kinase confers resistance to the growth-inhibitory effects of IGFBP-3 (Martin, J. L., and Baxter, R. C. (1999) J. Biol Chem. 274, 16407-16411). Here we show that, in the same cell line, IGFBP-3 potentiates DNA synthesis and cell proliferation stimulated by epidermal growth factor (EGF), a potent activator of Ras. A mutant of IGFBP-3, which fails to translocate to the nucleus and has reduced ability to cell-associate, similarly enhanced EGF action in these cells. By contrast, the structurally related IGFBP-5, which shares many functional features with IGFBP-3, was slightly inhibitory to DNA synthesis in the presence of EGF. IGFBP-3 primes MCF-10A cells to respond to EGF because pre-incubation caused a similar degree of EGF potentiation as co-incubation. In IGFBP-3-primed cells, EGF-stimulated EGF receptor phosphorylation at Tyr-1068 was increased relative to unprimed cells, as was phosphorylation and activity of p44/42 and p38 AMY kinases, but not Akt/PKB. Partial blockade of the p44/42 and p38 MAP kinase pathways abolished the potentiation by IGFBP-3 of EGF-stimulated DNA synthesis. Collectively, these findings indicate that IGFBP-3 enhances EGF signaling and proliferative effects in breast epithelial cells via increased EGF receptor phosphorylation and activation of p44/42 and p38 MAP kinase signaling pathways.	Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Martin, JL (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia.		Baxter, Robert C/F-3927-2012	Baxter, Robert C/0000-0001-5061-2142				Baxter RC, 1997, ADV MOL CELL ENDOCRI, V1, P123, DOI [10.1016/S1569-2566(97)80036-1, DOI 10.1016/S1569-2566(97)80036-1]; Bernard L, 2002, BIOCHEM BIOPH RES CO, V293, P55, DOI 10.1016/S0006-291X(02)00181-X; Butt AJ, 2002, ENDOCRINOLOGY, V143, P2693, DOI 10.1210/en.143.7.2693; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; CHEN JC, 1994, J CELL PHYSIOL, V158, P69, DOI 10.1002/jcp.1041580110; Cohen P, 2000, AM J PHYSIOL-LUNG C, V278, pL545, DOI 10.1152/ajplung.2000.278.3.L545; Colston KW, 1998, J MOL ENDOCRINOL, V20, P157, DOI 10.1677/jme.0.0200157; CONOVER CA, 1991, ENDOCRINOLOGY, V129, P3259, DOI 10.1210/endo-129-6-3259; Conover CA, 2000, ENDOCRINOLOGY, V141, P3098, DOI 10.1210/en.141.9.3098; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Fanayan S, 2000, J BIOL CHEM, V275, P39146, DOI 10.1074/jbc.M006964200; Firth SM, 1998, BIOCHEM BIOPH RES CO, V246, P325, DOI 10.1006/bbrc.1998.8615; Firth SM, 1999, PROTEIN EXPRES PURIF, V16, P202, DOI 10.1006/prep.1999.1075; Firth SM, 1998, J BIOL CHEM, V273, P2631, DOI 10.1074/jbc.273.5.2631; Firth SM, 2001, ENDOCRINOLOGY, V142, P2147, DOI 10.1210/en.142.5.2147; FONTANA JA, 1991, ENDOCRINOLOGY, V128, P1115, DOI 10.1210/endo-128-2-1115; Grill CJ, 2000, J CELL PHYSIOL, V183, P273, DOI 10.1002/(SICI)1097-4652(200005)183:2<273::AID-JCP14>3.3.CO;2-A; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Jaques G, 1997, ENDOCRINOLOGY, V138, P1767, DOI 10.1210/en.138.4.1767; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Lange CA, 1998, J BIOL CHEM, V273, P31308, DOI 10.1074/jbc.273.47.31308; Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200; Martin JL, 2000, ENDOCRINOLOGY, V141, P2401, DOI 10.1210/en.141.7.2401; Martin JL, 1999, J BIOL CHEM, V274, P16407, DOI 10.1074/jbc.274.23.16407; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; MARTIN JL, 1995, ENDOCRINOLOGY, V136, P1219, DOI 10.1210/en.136.3.1219; MARTIN JL, 1992, ENDOCRINOLOGY, V131, P1703, DOI 10.1210/en.131.4.1703; MARTIN JL, 1999, IGF SYSTEM MOL BIOL, P227; Nickerson T, 1997, BIOCHEM BIOPH RES CO, V237, P690, DOI 10.1006/bbrc.1997.7089; OH Y, 1995, J BIOL CHEM, V270, P13589, DOI 10.1074/jbc.270.23.13589; OH YM, 1993, J BIOL CHEM, V268, P14964; Perks CM, 1999, J CELL BIOCHEM, V75, P652, DOI 10.1002/(SICI)1097-4644(19991215)75:4<652::AID-JCB11>3.0.CO;2-0; Porfiri E, 1996, J BIOL CHEM, V271, P5871, DOI 10.1074/jbc.271.10.5871; Richer JK, 1998, J BIOL CHEM, V273, P31317, DOI 10.1074/jbc.273.47.31317; Ricort JM, 2002, J BIOL CHEM, V277, P19448, DOI 10.1074/jbc.M200439200; Rocha RL, 1997, CLIN CANCER RES, V3, P103; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Salahifar H, 2000, GROWTH HORM IGF RES, V10, P367, DOI 10.1054/ghir.2000.0180; Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347; SOULE HD, 1990, CANCER RES, V50, P6075; Spagnoli A, 2001, J BIOL CHEM, V276, P5533, DOI 10.1074/jbc.M005088200; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; Yu H, 1996, BRIT J CANCER, V74, P1242, DOI 10.1038/bjc.1996.523; Yu H, 1998, INT J CANCER, V79, P624, DOI 10.1002/(SICI)1097-0215(19981218)79:6<624::AID-IJC12>3.0.CO;2-9; Zadeh SM, 1997, ENDOCRINOLOGY, V138, P3069, DOI 10.1210/en.138.7.3069	47	68	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2969	2976		10.1074/jbc.M210739200	http://dx.doi.org/10.1074/jbc.M210739200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433918	hybrid			2022-12-27	WOS:000180915000027
J	Traidej, M; Marquart, ME; Caballero, AR; Thibodeaux, BA; O'Callaghan, RJ				Traidej, M; Marquart, ME; Caballero, AR; Thibodeaux, BA; O'Callaghan, RJ			Identification of the active site residues of Pseudomonas aeruginosa protease IV - Importance of enzyme activity in autoprocessing and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTACT-LENS WEAR; ACHROMOBACTER-LYTICUS; LYSOBACTER-ENZYMOGENES; CORNEAL VIRULENCE; CYSTIC-FIBROSIS; SERINE-PROTEASE; KERATITIS; GENE; RESOLUTION; SEQUENCE	Protease IV is a lysine-specific endoprotease produced by Pseudomonas aeruginosa whose activity has been correlated with corneal virulence. Comparison of the protease IV amino acid sequence to other bacterial proteases suggested that amino acids His-72, Asp-122, and Ser-198 could form a catalytic triad that is critical for protease rV activity. To test this possibility, site-directed mutations by alanine substitution were introduced into six selected residues including the predicted triad and identical residues located close to the triad. Mutations at any of the amino acids of the predicted catalytic triad or Ser-197 caused a loss of enzymatic activity and absence of the mature form of protease IV. In contrast, mutations at His-116 or Ser-200 resulted in normal processing into the enzymatically active mature form. A purified proenzyme that accumulated in the His-72 mutant was shown in vitro to be susceptible to cleavage by protease IV purified from P. aeruginosa. Furthermore, similarities of protease IV to the lysine-specific endoprotease of Achromobacter lyticus suggested three possible disulfide bonds in protease W. These results identify the catalytic triad of protease IV, demonstrate that autodigestion is essential for the processing of protease IV into a mature protease, and predict sites essential to enzyme conformation.	Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; Louisiana State Univ, Ctr Eye, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System	O'Callaghan, RJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, 1901 Perdido St, New Orleans, LA 70112 USA.	rocall@lsuhsc.edu		Chomnawang, Mullika/0000-0002-3200-9259	NEI NIH HHS [EYI 12961] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012961] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALFONSO E, 1986, AM J OPHTHALMOL, V101, P429, DOI 10.1016/0002-9394(86)90641-0; ARFFA RC, 1991, INT OPHTHALMOL CLIN, V31, P89, DOI 10.1097/00004397-199103130-00009; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bodey GP, 2001, CURR OPIN INFECT DIS, V14, P403, DOI 10.1097/00001432-200108000-00001; Caballero A, 2001, INVEST OPHTH VIS SCI, V42, pS739; DART JKG, 1988, BRIT J OPHTHALMOL, V72, P926, DOI 10.1136/bjo.72.12.926; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Doring G, 1997, Monaldi Arch Chest Dis, V52, P363; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Engel LS, 1997, INVEST OPHTH VIS SCI, V38, P1535; Engel LS, 1998, INVEST OPHTH VIS SCI, V39, P662; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JEKEL PA, 1983, ANAL BIOCHEM, V134, P347, DOI 10.1016/0003-2697(83)90308-1; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; Koch C, 2000, RESPIRATION, V67, P239, DOI 10.1159/000029503; KOCH C, 1993, LANCET, V341, P1065, DOI 10.1016/0140-6736(93)92422-P; LI SL, 1990, J BACTERIOL, V172, P6506, DOI 10.1128/jb.172.11.6506-6511.1990; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; MENDELSON MH, 1994, CLIN INFECT DIS, V18, P886, DOI 10.1093/clinids/18.6.886; NORIOKA S, 1994, J BIOL CHEM, V269, P17025; OCallaghan RJ, 1996, INVEST OPHTH VIS SCI, V37, P534; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; STEPLETON F, 1995, EPIDEMIOL INFECT, V114, P395, DOI 10.1017/S0950268800052109; STROUD RM, 1974, J MOL BIOL, V83, P185, DOI 10.1016/0022-2836(74)90387-8; Sweeney DF, 2001, OPTOMETRY VISION SCI, V78, P100, DOI 10.1097/00006324-200102000-00010; TODER DS, 1992, ASM M NEW ORL LA MAY, P104; TRAIDEJ M, 2002, IN PRESS INVEST OPHT; TSUNASAWA S, 1989, J BIOL CHEM, V264, P3832; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Wilderman PJ, 2001, INFECT IMMUN, V69, P5385, DOI 10.1128/IAI.69.9.5385-5394.2001; Wright DS, 1998, BBA-GENE STRUCT EXPR, V1443, P369, DOI 10.1016/S0167-4781(98)00228-0	33	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2549	2553		10.1074/jbc.M208973200	http://dx.doi.org/10.1074/jbc.M208973200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12419815	hybrid			2022-12-27	WOS:000180562000064
J	Wong, I; Bernards, AS; Miller, JK; Wirz, JA				Wong, I; Bernards, AS; Miller, JK; Wirz, JA			A dimeric mechanism for contextual target recognition by MutY glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI MUTY; OXIDATIVE DNA-DAMAGE; MISMATCH REPAIR ENZYME; MITOCHONDRIAL DECAY; OGG1 GENE; MUTAGENIC SUBSTRATE; CIGARETTE-SMOKING; HUMAN HOMOLOG; PROTEIN; CLONING	MutY, an adenine glycosylase, initiates the critical repair of an adenine:8-oxo-guanine base pair in DNA arising from polymerase error at the oxidatively damaged guanine. Here we demonstrate for the first time, using presteady-state active site titrations, that MutY assembles into a dimer upon binding substrate DNA and that the dimer is the functionally active form of the enzyme. Additionally, we observed allosteric inhibition of glycosylase activity in the dimer by the concurrent binding of two lesion mispairs. Active site titration results were independently verified by gel mobility shift assays and quantitative DNA footprint titrations. A model is proposed for the potential functional role of the observed polysteric and allosteric regulation in recruiting and coordinating interactions with the methyl-directed mismatch repair system.	Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Wong, I (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	wongis@onid.orst.edu		Wirz, Jacqueline/0000-0003-2046-610X	NIGMS NIH HHS [GM58771] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058771] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aburatani H, 1997, CANCER RES, V57, P2151; AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139; Asami S, 1996, CANCER RES, V56, P2546; AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; Baik SC, 1996, CANCER RES, V56, P1279; Ballinger SW, 1996, CANCER RES, V56, P5692; Bao KK, 2002, J BIOL CHEM, V277, P12089, DOI 10.1074/jbc.M111315200; Beckman KB, 2000, FREE RADICAL BIO MED, V29, P357, DOI 10.1016/S0891-5849(00)00316-6; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bernards AS, 2002, J BIOL CHEM, V277, P20960, DOI 10.1074/jbc.C200181200; Bohr V, 1998, TOXICOL LETT, V103, P47; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; BRENOWITZ M, 1986, P NATL ACAD SCI USA, V83, P8462, DOI 10.1073/pnas.83.22.8462; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; Bulychev NV, 1996, BIOCHEMISTRY-US, V35, P13147, DOI 10.1021/bi960694h; CABRERA M, 1988, J BACTERIOL, V170, P5405, DOI 10.1128/jb.170.11.5405-5407.1988; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Chepanoske CL, 1999, NUCLEIC ACIDS RES, V27, P3197, DOI 10.1093/nar/27.15.3197; DENNIS JE, 1981, ACM T MATH SOFTWARE, V7, P348, DOI 10.1145/355958.355965; Engler LE, 1997, J MOL BIOL, V269, P82, DOI 10.1006/jmbi.1997.1027; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P159; Gogos A, 1996, BIOCHEMISTRY-US, V35, P16665, DOI 10.1021/bi960843w; Gu YS, 2002, J BIOL CHEM, V277, P11135, DOI 10.1074/jbc.M108618200; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Ichinose T, 1997, CARCINOGENESIS, V18, P185, DOI 10.1093/carcin/18.1.185; JOHNSON MD, 1992, PHYSICIAN SPORTSMED, V20, P60, DOI 10.1080/00913847.1992.11947449; KAKUMA T, 1995, J BIOL CHEM, V270, P25942, DOI 10.1074/jbc.270.43.25942; Li XH, 2000, J BIOL CHEM, V275, P8448, DOI 10.1074/jbc.275.12.8448; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu L, 1996, MUTAT RES-GENET TOX, V370, P145, DOI 10.1016/S0165-1218(96)00048-1; LU AL, 1995, J BIOL CHEM, V270, P23582, DOI 10.1074/jbc.270.40.23582; Lu AL, 2000, METH MOL B, V152, P3; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Manuel RC, 1996, J BIOL CHEM, V271, P16218, DOI 10.1074/jbc.271.27.16218; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; MCGOLDRICK JP, 1995, MOL CELL BIOL, V15, P989; MICHAELS ML, 1992, BIOCHEMISTRY-US, V31, P10964, DOI 10.1021/bi00160a004; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Monden Y, 1999, BIOCHEM BIOPH RES CO, V258, P605, DOI 10.1006/bbrc.1999.0649; Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Porello SL, 1996, J AM CHEM SOC, V118, P10684, DOI 10.1021/ja9602206; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Shinmura A, 2000, NUCLEIC ACIDS RES, V28, P4912, DOI 10.1093/nar/28.24.4912; Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; TULLIUS TD, 1989, ANNU REV BIOPHYS BIO, V18, P213, DOI 10.1146/annurev.bb.18.060189.001241; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; VANHOLDE KE, 1998, PRINCIPLES PHYSICAL, P216; Verdine GL, 1997, CHEM BIOL, V4, P329, DOI 10.1016/S1074-5521(97)90123-X; VIDMAR JJ, 1993, CAN J MICROBIOL, V39, P892, DOI 10.1139/m93-133; WANG I, 2002, J BIOL CHEM, V277, P19424; Wong I, 1995, METHOD ENZYMOL, V259, P95; WONG I, 1992, J BIOL CHEM, V267, P7596; Zhang QM, 1998, NUCLEIC ACIDS RES, V26, P4669, DOI 10.1093/nar/26.20.4669	64	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2411	2418		10.1074/jbc.M209802200	http://dx.doi.org/10.1074/jbc.M209802200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441341	hybrid			2022-12-27	WOS:000180562000047
J	Dziembowski, A; Piwowarski, J; Hoser, R; Minczuk, M; Dmochowska, A; Siep, M; van der Spek, H; Grivell, L; Stepien, PP				Dziembowski, A; Piwowarski, J; Hoser, R; Minczuk, M; Dmochowska, A; Siep, M; van der Spek, H; Grivell, L; Stepien, PP			The yeast mitochondrial degradosome - Its composition, interplay between RNA helicase and RNase activities and the role in mitochondrial RNA metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED DODECAMER SEQUENCE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; ESCHERICHIA-COLI; GENE-EXPRESSION; POSTTRANSCRIPTIONAL PROCESSES; BINDING-PROTEIN; IN-VIVO; NUCLEASE; TURNOVER	The yeast mitochondrial degradosome (mtEXO) is an NTP-dependent exoribonuclease involved in mitochondrial RNA metabolism. Previous purifications suggested that it was composed of three subunits. Our results suggest that the degradosome is composed of only two large subunits: an RNase and a RNA helicase encoded by nuclear genes DSS1 and SUV3, respectively, and that it co-purifies with mitochondrial ribosomes. We have found that the purified degradosome has RNA helicase activity that precedes and is essential for exoribonuclease activity of this complex. The degradosome RNase activity is necessary for mitochondrial biogenesis but in vitro the degradosome without RNase activity is still able to unwind RNA. In yeast strains lacking degradosome components there is a strong accumulation of mitochondrial mRNA and rRNA precursors not processed at 3'- and 5'-ends. The observed accumulation of precursors is probably the result of lack of degradation rather than direct inhibition of processing. We suggest that the degradosome is a central part of a mitochondrial RNA surveillance system responsible for degradation of aberrant and unprocessed RNAs.	Warsaw Univ, Dept Genet, PL-02106 Warsaw, Poland; Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; Univ Amsterdam, Swammerdam Inst Life Sci, Mol Biol Sect, NL-1098 SM Amsterdam, Netherlands	University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Amsterdam	Stepien, PP (corresponding author), Warsaw Univ, Dept Genet, Pawinskiego 5A, PL-02106 Warsaw, Poland.	siep@endov.fgg.eur.nl; grivell@embl-heidelberg.de; stepien@ibb.waw.pl	Siep, Michel/AAE-3770-2020; Minczuk, Michal/G-1638-2014	Minczuk, Michal/0000-0001-8242-1420; Dziembowski, Andrzej/0000-0001-8492-7572				BERK AJ, 1989, METHOD ENZYMOL, V180, P334; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; BUTOW RA, 1989, GENOME, V31, P757, DOI 10.1139/g89-134; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; Chacinska A, 2000, MOL CELL BIOL, V20, P7220, DOI 10.1128/MCB.20.19.7220-7229.2000; Chen W, 1999, GENETICS, V151, P1315; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; DAUM G, 1988, BIOCHIM BIOPHYS ACTA, V939, P277, DOI 10.1016/0005-2736(88)90071-5; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dmochowska A, 1998, CYTOGENET CELL GENET, V83, P84, DOI 10.1159/000015135; Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; Dziembowski A, 2001, ANAL BIOCHEM, V294, P87, DOI 10.1006/abio.2001.5126; Dziembowski A, 2001, METHOD ENZYMOL, V342, P367, DOI 10.1016/S0076-6879(01)42559-6; Fox TD, 1996, EXPERIENTIA, V52, P1130, DOI 10.1007/BF01952112; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; GAGLIARDI D, 2001, J BIOL CHEM, V13, P1803; Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Graack HR, 1998, BIOCHEM J, V329, P433, DOI 10.1042/bj3290433; GRIVELL LA, 1995, CRIT REV BIOCHEM MOL, V30, P121, DOI 10.3109/10409239509085141; GROOT GSP, 1974, NATURE, V252, P167, DOI 10.1038/252167a0; Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418; HENDLER FJ, 1975, NATURE, V258, P357, DOI 10.1038/258357a0; HOFMANN TJ, 1993, YEAST, V9, P1319, DOI 10.1002/yea.320091205; Li HL, 1999, BIOCHEM BIOPH RES CO, V261, P740, DOI 10.1006/bbrc.1999.1085; Li HL, 2000, CURR GENET, V37, P356, DOI 10.1007/s002940000117; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Lupold DS, 1999, PLANT CELL, V11, P1565, DOI 10.1105/tpc.11.8.1565; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Margossian SP, 1996, TRENDS BIOCHEM SCI, V21, P392, DOI 10.1016/S0968-0004(96)90129-2; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Marujo PE, 2000, RNA, V6, P1185, DOI 10.1017/S135583820000073X; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Min J J, 1991, SAAS Bull Biochem Biotechnol, V4, P1; MIN JJ, 1993, J BACTERIOL, V175, P6245, DOI 10.1128/JB.175.19.6245-6253.1993; MIN JJ, 1993, J BIOL CHEM, V268, P7350; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Reichert AS, 2000, NUCLEIC ACIDS RES, V28, P2043, DOI 10.1093/nar/28.10.2043; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; STEPIEN PP, 1995, CURR GENET, V27, P234, DOI 10.1007/BF00326154; VINCENT RD, 1988, NUCLEIC ACIDS RES, V16, P3297, DOI 10.1093/nar/16.8.3297; Wegierski T, 1998, ACTA BIOCHIM POL, V45, P935, DOI 10.18388/abp.1998_4352; Wiesenberger G, 1997, MOL CELL BIOL, V17, P2816, DOI 10.1128/MCB.17.5.2816; ZASSENHAUS HP, 1988, NUCLEIC ACIDS RES, V16, P3283, DOI 10.1093/nar/16.8.3283	51	122	135	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1603	1611		10.1074/jbc.M208287200	http://dx.doi.org/10.1074/jbc.M208287200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426313	hybrid			2022-12-27	WOS:000180462200032
J	Guo, ZH; Su, W; Ma, ZM; Smith, GM; Gong, MC				Guo, ZH; Su, W; Ma, ZM; Smith, GM; Gong, MC			Ca2+-independent phospholipase A(2) is required for agonist-induced Ca2+ sensitization of contraction in vascular smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN LIGHT-CHAIN; ARACHIDONIC-ACID RELEASE; TRANSFECTED INSULINOMA CELLS; CORONARY-ARTERY SPASM; PROTEIN-KINASE; RHO-KINASE; P388D(1) MACROPHAGES; SIGNAL-TRANSDUCTION; OVEREXPRESS GROUP; CALCIUM	Excitatory agonists can induce significant smooth muscle contraction under constant free Ca2+ through a mechanism called Ca2+ sensitization. Considerable evidence suggests that free arachidonic acid plays an important role in mediating agonist-induced Ca2+-sensitization; however, the molecular mechanisms responsible for maintaining and regulating free arachidonic acid level are not completely understood. In the current study, we demonstrated that Ca2+-independent phospholipase A(2) (iPLA(2)) is expressed in vascular smooth muscle tissues. Inhibition of the endogenous iPLA(2) activity by bromoenol lactone (BEL) decreases basal free arachidonic acid levels and reduces the final free arachidonic acid level after phenylephrine stimulation, without significant effect on the net increase in free arachidonic acid stimulated by phenylephrine. Importantly, BEL treatment diminishes agonist-induced Ca2+ sensitization of contraction from 49 +/- 3.6 to 12 +/- 1.0% (p < 0.01). In contrast, BEL does not affect agonist-induced diacylglycerol production or contraction induced by Ca2+, phorbol 12,13-dibutyrate (a protein kinase C activator), or exogenous arachidonic acid. Further, we demonstrate that adenovirus-mediated overexpression of exogenous iPIA(2) in mouse portal vein tissue significantly potentiates serotonin-induced contraction. Our data provide the first evidence that iPLA(2) is required for maintaining basal free arachidonic acid levels and thus is essential for agonist-induced Ca2+-sensitization of contraction in vascular smooth muscle.	Univ Kentucky, Med Ctr, Dept Physiol, Lexington, KY 40536 USA; Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Div Expt Diabet & Aging, New York, NY USA	University of Kentucky; Icahn School of Medicine at Mount Sinai	Gong, MC (corresponding author), Univ Kentucky, Med Ctr, Dept Physiol, Lexington, KY 40536 USA.				NHLBI NIH HHS [HL67284] Funding Source: Medline; NINDS NIH HHS [NS38126] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038126] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKERMANN EJ, 1995, BBA-LIPID LIPID MET, V1259, P125, DOI 10.1016/0005-2760(95)00143-Z; Akiba S, 1999, J BIOL CHEM, V274, P19906, DOI 10.1074/jbc.274.28.19906; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Araki S, 2001, PFLUG ARCH EUR J PHY, V441, P596, DOI 10.1007/s004240000462; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Balsinde J, 1996, J BIOL CHEM, V271, P31937, DOI 10.1074/jbc.271.50.31937; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Chiu CH, 2001, BIOCHEM BIOPH RES CO, V287, P600, DOI 10.1006/bbrc.2001.5632; de Figueiredo P, 2000, TRAFFIC, V1, P504, DOI 10.1034/j.1600-0854.2000.010608.x; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Eto M, 2001, J BIOL CHEM, V276, P29072, DOI 10.1074/jbc.M103206200; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479; Forsell PKAL, 1999, EUR J BIOCHEM, V262, P575, DOI 10.1046/j.1432-1327.1999.00418.x; Fu XH, 1998, FEBS LETT, V440, P183, DOI 10.1016/S0014-5793(98)01455-0; Gailly P, 1997, J PHYSIOL-LONDON, V500, P95, DOI 10.1113/jphysiol.1997.sp022002; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; GONG MC, 1995, J PHYSIOL-LONDON, V486, P113, DOI 10.1113/jphysiol.1995.sp020795; GONG MC, 1992, J BIOL CHEM, V267, P21492; Gong MC, 1997, J BIOL CHEM, V272, P10704; GRAMHAM FL, 1991, METHODS MOL BIOL GEN, P109; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIRATA K, 1992, J BIOL CHEM, V267, P8719; Hoozemans JJM, 2001, EXP GERONTOL, V36, P559, DOI 10.1016/S0531-5565(00)00226-6; Jensen PE, 1996, BIOCHEM J, V318, P469, DOI 10.1042/bj3180469; Kandabashi T, 2000, CIRCULATION, V101, P1319, DOI 10.1161/01.CIR.101.11.1319; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kitazawa T, 1999, J PHYSIOL-LONDON, V520, P139, DOI 10.1111/j.1469-7793.1999.00139.x; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; LEHMAN JJ, 1993, J BIOL CHEM, V268, P20713; Ma ZM, 2001, LIPIDS, V36, P689, DOI 10.1007/s11745-001-0774-9; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Ma ZM, 1997, J BIOL CHEM, V272, P11118; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Maillard L, 1998, GENE THER, V5, P1023, DOI 10.1038/sj.gt.3300682; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; MIYAKE R, 1992, BIOCHIM BIOPHYS ACTA, V1165, P167, DOI 10.1016/0005-2760(92)90183-V; Muthalif MM, 1996, J BIOL CHEM, V271, P30149, DOI 10.1074/jbc.271.47.30149; Niiro N, 2001, J BIOL CHEM, V276, P29567, DOI 10.1074/jbc.M102753200; Pages C, 1999, BIOCHEM BIOPH RES CO, V265, P572, DOI 10.1006/bbrc.1999.1726; RESINK TJ, 1989, BIOCHEM BIOPH RES CO, V158, P279, DOI 10.1016/S0006-291X(89)80209-8; Roshak AK, 2000, J BIOL CHEM, V275, P35692, DOI 10.1074/jbc.M002273200; Sanchez T, 2001, BIOCHEM PHARMACOL, V61, P811, DOI 10.1016/S0006-2952(01)00555-X; Sato M, 2000, CIRC RES, V87, P195, DOI 10.1161/01.RES.87.3.195; Seasholtz TM, 2001, CIRC RES, V89, P488, DOI 10.1161/hh1801.096337; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; Shin HM, 2002, CIRC RES, V90, P546, DOI 10.1161/01.RES.0000012822.23273.EC; Shin KJ, 2002, TOXICOL APPL PHARM, V178, P37, DOI 10.1006/taap.2001.9317; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith GM, 1997, J NEUROPHYSIOL, V77, P3115, DOI 10.1152/jn.1997.77.6.3115; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Tanaka H, 2000, BIOCHEM BIOPH RES CO, V272, P320, DOI 10.1006/bbrc.2000.2776; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Yang HC, 1999, ANAL BIOCHEM, V269, P278, DOI 10.1006/abio.1999.4053; Zablocki K, 2000, ACTA BIOCHIM POL, V47, P591	69	47	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1856	1863		10.1074/jbc.M211075200	http://dx.doi.org/10.1074/jbc.M211075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421808	hybrid			2022-12-27	WOS:000180462200066
J	Li, L; Li, ZA; Sacks, DB				Li, L; Li, ZA; Sacks, DB			Calmodulin regulates the transcriptional activity of estrogen receptors - Selective inhibition of calmodulin function in subcellular compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ANTIESTROGENS; ASSOCIATION; ANTAGONIST; MECHANISMS	The steroid hormone estrogen elicits biological effects in cells by binding to and activating the estrogen receptor (ER). Estrogen binding induces a conformational change in the receptor, inducing nuclear translocation and transcriptional activation of ER. The ubiquitous Ca2+-binding protein calmodulin has been shown to interact directly with ER and enhance its stability. To further elucidate the functional sequelae of the association between calmodulin and ER, we examined the effect on ER transcriptional activation of specifically inhibiting calmodulin. The cell-permeable calmodulin antagonist CGS9343B prevented estrogen-induced transcriptional activation by ER, without altering basal transcription. The inhibition was dose-dependent and independent of the time of estrogen stimulation. To validate these findings, calmodulin function was also neutralized by targeted expression of a specific inhibitor peptide. By inserting localization signals, the inhibitor peptide was selectively targeted to different subcellular domains. Inactivation of calmodulin function in the nucleus virtually eliminated estrogen-stimulated ER transcriptional activation. By contrast, when membrane calmodulin was specifically neutralized, estrogen-stimulated transcriptional activation by ER was only slightly attenuated. Importantly, the inhibitor peptides did not significantly reduce the amount of ER in the cells. Together, these data demonstrate that calmodulin is a fundamental component of ER transcriptional activation.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St,Thorn 530, Boston, MA 02115 USA.	dsacks@rics.bwh.harvard.edu		Sacks, David/0000-0003-3100-0735	NATIONAL CANCER INSTITUTE [R01CA093645] Funding Source: NIH RePORTER; NCI NIH HHS [CA93645] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biswas DK, 1998, J BIOL CHEM, V273, P33817, DOI 10.1074/jbc.273.50.33817; BOUHOUTE A, 1995, BIOCHEM BIOPH RES CO, V208, P748, DOI 10.1006/bbrc.1995.1401; BOUHOUTE A, 1992, BIOCHEM BIOPH RES CO, V184, P1432, DOI 10.1016/S0006-291X(05)80043-9; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; BROUCHE N, 2002, J BIOL CHEM, V277, P21851; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chun KY, 2000, CALCIUM: THE MOLECULAR BASIS OF CALCIUM ACTION IN BIOLOGY AND MEDICINE, P541; Cohen P, 1988, CALMODULIN; Corcoran EE, 2001, J BIOL CHEM, V276, P2975, DOI 10.1074/jbc.R000027200; Dickson R B, 2000, J Natl Cancer Inst Monogr, P135; FLANDROY L, 1983, CELL TISSUE RES, V233, P639; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Levin ER, 1999, TRENDS ENDOCRIN MET, V10, P374, DOI 10.1016/S1043-2760(99)00192-7; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; MacGregor JI, 1998, PHARMACOL REV, V50, P151; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MIGLIACCIO A, 1984, P NATL ACAD SCI-BIOL, V81, P5921, DOI 10.1073/pnas.81.19.5921; Newton CJ, 2000, J STEROID BIOCHEM, V73, P29, DOI 10.1016/S0960-0760(00)00047-9; NORMAN JA, 1987, MOL PHARMACOL, V31, P535; Onions J, 1997, J BIOL CHEM, V272, P23930, DOI 10.1074/jbc.272.38.23930; Pedrero JMG, 2002, MOL ENDOCRINOL, V16, P947; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; STROBL JS, 1992, J PHARMACOL EXP THER, V263, P186; Sugimura M, 1997, EUR J PHARMACOL, V336, P99, DOI 10.1016/S0014-2999(97)01251-X; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; WEI JW, 1983, CANCER CHEMOTH PHARM, V11, P86; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	30	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1195	1200		10.1074/jbc.M210708200	http://dx.doi.org/10.1074/jbc.M210708200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12419798	hybrid			2022-12-27	WOS:000180321900065
J	Gao, BC; Tsan, MF				Gao, BC; Tsan, MF			Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor a release by murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TOLL-LIKE RECEPTOR-4; MOLECULAR CHAPERONES; COATED VESICLES; CUTTING EDGE; INNATE; SIGNAL; LIPOPOLYSACCHARIDE; CLATHRIN; PATHWAY	Using commercially available recombinant human heat shock protein 70 (rhHsp70), recent studies have shown that rhHsp70 could induce the production of tumor necrosis factor alpha (TNFalpha) by macrophages and monocytes in a manner similar to lipopolysaccharide (LPS) e.g. via CD14 and Toll-like receptor 4-mediated signal transduction pathway. In the current study, we demonstrated that a highly purified rhHsp70 preparation (designated as rhHsp70-1) with a LPS content of 1.4 pg/mug was unable to induce TNFalpha release by RAW264.7 murine macrophages at concentrations up to 5 mug/ml. In contrast, a less purified rhHsp70 preparation (designated as rhHsp70-2) at 1 mug/ml with a LPS content of 0.2 ng/mug was able to induce TNFalpha release to the same extent as that induced by 0.2 ng/ml LPS. Failure of rhHsp70-1 to induce TNFalpha release was not because of defective physical properties since rhHsp70-1 and rhHsp70-2 contained identical hsp70 content as determined by SDS gels stained with Coomassie Blue and Western blots probed with an anti-rhHsp70 antibody. Both rhHsp70 preparations also had similar enzymatic activities as judged by their ability to remove clathrin from clathrin-coated vesicles. Removal of LPS from rhHsp70-2 by polymyxin B-agarose column or direct addition of polymyxin B to the incubation medium essentially eliminated the TNFalpha-inducing activity of rhHsp70-2. The addition of LPS at the concentration found in rhHsp70-2 to rhHsp70-1 resulted in the same TNFalpha-inducing activity as observed with rhHsp70-2. The TNFalpha-inducing activities of rhHsp-2, LPS alone, and LPS plus rhHsp70-1 were all equally sensitive to heat inactivation. These results suggest that rhHsp-70 does not induce TNFa release from murine macrophages and that the observed TNFa-inducing activity in the rhHsp70-2 preparation is entirely due to the contaminating LPS.	Vet Affairs Med Ctr, Washington, DC 20422 USA; Inst Clin Res, Washington, DC 20422 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gao, BC (corresponding author), Vet Affairs Med Ctr, 10R,50 Irving St NW, Washington, DC 20422 USA.	baochong.gao@med.va.gov						Antal-Szalmas P, 2000, EUR J CLIN INVEST, V30, P167; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Fisher R.A., 1963, STAT TABLES BIOL AGR, V6th; GAO BC, 1991, J BIOL CHEM, V266, P19565; Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jiang RF, 2000, J BIOL CHEM, V275, P8439, DOI 10.1074/jbc.275.12.8439; JONES BW, 2001, ANN RHEUM DIS     S3, V60, P6; Kol A, 1998, CIRCULATION, V98, P300, DOI 10.1161/01.CIR.98.4.300; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; NG DTW, 1994, CURR OPIN CELL BIOL, V6, P510, DOI 10.1016/0955-0674(94)90069-8; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stelter F, 2000, CHEM IMMUNOL, V74, P25; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; TSAN MF, 2001, AM J PHYSIOL-CELL PH, V280, P1422; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vikstrom EV, 2002, IMMUNOL LETT, V80, P15, DOI 10.1016/S0165-2478(01)00298-X; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8	33	317	332	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					174	179		10.1074/jbc.M208742200	http://dx.doi.org/10.1074/jbc.M208742200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403778	hybrid			2022-12-27	WOS:000180255700023
J	Hinkle, A; Tobacman, LS				Hinkle, A; Tobacman, LS			Folding and function of the troponin tail domain - Effects of cardiomyopathic troponin T mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; RABBIT SKELETAL-MUSCLE; MYOSIN SUBFRAGMENT 1; PROTEIN-C GENE; THIN FILAMENT; ALPHA-TROPOMYOSIN; CRYSTAL-STRUCTURE; CA2+ SENSITIVITY; TERMINAL REGION; ATPASE ACTIVITY	Troponin contains a globular Ca2+-binding domain and an elongated tail domain composed of the N terminus of subunit troponin T (TnT). The tail domain anchors troponin to tropomyosin and actin, modulates myosin function, and is a site of cardiomyopathy-inducing mutations. Critical interactions between tropomyosin and troponin are proposed to depend on tail domain residues 112-136, which are highly conserved across phyla. Most cardiomyopathy mutations in TnT flank this region. Three such mutations were examined and had contrasting effects on peptide TnT-(1-156), promoting folding and thermal stability assessed by circular dichroism (F110I) or weakening folding and stability (T104V and to a small extent R92Q). Folding of both TnT-(1-156) and whole troponin was promoted by replacing bovine TnT Thr-104 with human TnT Ala-104, further indicating the importance of this cardiomyopathy site residue for protein folding. Mutation F110I markedly stabilized the troponin tail but weakened binding of holo-troponin to actin-tropomyosin 8-fold, suggesting that loss of flexibility impairs troponin tail function. The effect of the F110I mutation on troponin-tropomyosin binding to actin was much less, indicating this flexibility is particularly important for the interactions of troponin with tropomyosin. We suggest that most cardiomyopathic mutations in the troponin tail alter muscle function indirectly, by perturbing interactions between troponin and tropomyosin requisite for the complex effects of these proteins on myosin.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Tobacman, LS (corresponding author), Univ Iowa, Dept Internal Med, 200 Hawkins Dr,SE-610-GH, Iowa City, IA 52242 USA.	tobacman@uiowa.edu						BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Bottinelli R, 1998, CIRC RES, V82, P106; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; BYERS DM, 1979, FEBS LETT, V104, P106, DOI 10.1016/0014-5793(79)81093-5; CabralLilly D, 1997, BIOPHYS J, V73, P1763, DOI 10.1016/S0006-3495(97)78206-7; Chandra M, 1999, J MOL CELL CARDIOL, V31, P867, DOI 10.1006/jmcc.1999.0928; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; DAHIYA R, 1994, J BIOL CHEM, V269, P29457; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; FISHER D, 1995, J BIOL CHEM, V270, P25455, DOI 10.1074/jbc.270.43.25455; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Golitsina N, 1997, BIOCHEMISTRY-US, V36, P4637, DOI 10.1021/bi962970y; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; HILL LE, 1992, J BIOL CHEM, V267, P16106; HILL TL, 1981, BIOPHYS CHEM, V14, P31, DOI 10.1016/0301-4622(81)87004-4; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; HOLMES KC, 1995, BIOPHYS J, V68, pS2; Homsher E, 2000, J PHYSIOL-LONDON, V524, P233, DOI 10.1111/j.1469-7793.2000.00233.x; Huynh Q, 1996, BIOPHYS J, V70, P1447, DOI 10.1016/S0006-3495(96)79704-7; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; Karibe A, 2001, CIRCULATION, V103, P65; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Maytum R, 2002, J BIOL CHEM, V277, P29774, DOI 10.1074/jbc.M201761200; MESNARD L, 1993, FEBS LETT, V328, P139, DOI 10.1016/0014-5793(93)80981-Y; Michele DE, 1999, NAT MED, V5, P1413; Miller T, 2001, J BIOL CHEM, V276, P3743, DOI 10.1074/jbc.M006746200; Morimoto S, 1998, AM J PHYSIOL-CELL PH, V275, pC200, DOI 10.1152/ajpcell.1998.275.1.C200; NakajimaTaniguchi C, 1997, J MOL CELL CARDIOL, V29, P839, DOI 10.1006/jmcc.1996.0322; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; PEARLSTONE JR, 1977, CAN J BIOCHEM CELL B, V55, P1032, DOI 10.1139/o77-154; PHILLIPS GN, 1979, NATURE, V278, P413, DOI 10.1038/278413a0; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Rust EM, 1999, J CLIN INVEST, V103, P1459, DOI 10.1172/JCI6377; Smith DA, 2001, J PHYS A-MATH GEN, V34, P4507, DOI 10.1088/0305-4470/34/21/307; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strand J, 2001, J BIOL CHEM, V276, P34832, DOI 10.1074/jbc.M104750200; Sweeney HL, 1998, P NATL ACAD SCI USA, V95, P14406, DOI 10.1073/pnas.95.24.14406; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2002, BIOPHYS J, V82, p170A; TANOKURA M, 1983, J BIOCHEM, V93, P331, DOI 10.1093/oxfordjournals.jbchem.a134185; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; TOBACMAN LS, 1988, J BIOL CHEM, V263, P2668; TOBACMAN LS, 1986, BIOCHEMISTRY-US, V25, P798, DOI 10.1021/bi00352a010; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; Tobacman LS, 1999, J BIOL CHEM, V274, P28363, DOI 10.1074/jbc.274.40.28363; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Torrealba JR, 2002, J MOL CELL CARDIOL, V34, P797, DOI 10.1006/jmcc.2002.2016; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Yanaga F, 1999, J BIOL CHEM, V274, P8806, DOI 10.1074/jbc.274.13.8806	64	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					506	513		10.1074/jbc.M209194200	http://dx.doi.org/10.1074/jbc.M209194200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409295	hybrid			2022-12-27	WOS:000180255700067
J	Kim, HJ; Kim, JH; Bae, SC; Choi, JY; Kim, HJ; Ryoo, HM				Kim, HJ; Kim, JH; Bae, SC; Choi, JY; Kim, HJ; Ryoo, HM			The protein kinase c pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; OSTEOBLAST DIFFERENTIATION; CROUZON-SYNDROME; CLEIDOCRANIAL DYSPLASIA; SIGNALING PATHWAYS; FACTOR RECEPTOR-2; OSTEOCALCIN GENE; DOWN-REGULATION; NEURONAL CELLS; FACTOR BETA-1	Fibroblast growth factor (FGF)/FGF receptor (FGFR) signaling induces the expression of Runx2, a key transcription factor in osteoblast differentiation, but little is known about the molecular signaling mechanisms that mediate this. Here we examined the role of the protein kinase C (PKC) pathway in regulating Runx2 gene expression and its transactivation function. Treatment with FGF2 or FGF4, or transfection with a vector expressing a mutant FGFR2 that is constitutively activated in the absence of ligand, strongly stimulates Runx2 expression. Electrophoretic mobility shift assays also showed that FGF2 treatment increases the specific binding of Runx2 to the cognate response element in the osteocalcin gene promoter. Blocking PKC completely inhibited FGF2-induced Runx2 expression, whereas mitogen-activate protein kinase inhibitors had no effect. The FGF/FGFR-stimulated 6xOSE2 promoter activity was also blocked by inhibiting PKC, as was the FGF2 stimulation of the DNA-binding activity of Runx2. Experiments with PKC isoform-specific inhibitors and dominant negative isoforms of PKC indicate that PKCS is one of key isoforms involved in the FGF2-stimulated Runx2 expression. In addition, experiments with Runx2-knockout cells showed that, although the PKC pathway largely regulates FGF2-stimulated Runx2 activity by upregulating Runx2 expression, it also modifies Runx2 protein post-translationally and thereby increases its transcriptional activity. Thus, we show for the first time that FGF/FGFR signaling stimulates the DNA-binding and transcriptional activities of Runx2 as well as its expression, and these are largely regulated by the PKC pathway.	Kyungpook Natl Univ, Sch Dent, Dept Biochem, Jung Gu, Taegu 700422, South Korea; Kyungpook Natl Univ, Biomol Engn Ctr, Taegu 700422, South Korea; Kyungpook Natl Univ, Sch Med, Dept Biochem, Taegu 700422, South Korea; Kyungpook Natl Univ, Dept Pediat Dent, Taegu 700422, South Korea; Chungbuk Natl Univ, Sch Med, Dept Biochem, Chungju 361373, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Chungbuk National University	Ryoo, HM (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Biochem, Jung Gu, 101 Dong In Dong, Taegu 700422, South Korea.		Ryoo, Hyun-Mo/D-5839-2012	Ryoo, Hyun-Mo/0000-0001-6769-8341				Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; CANNALIS E, 1988, J CLIN INVEST, V81, P1572; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539, DOI 10.1210/endo-124-3-1539; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Iseki S, 1999, DEVELOPMENT, V126, P5611; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; Jackson TA, 2001, MOL ENDOCRINOL, V15, P1517, DOI 10.1210/me.15.9.1517; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kim HJ, 2002, J CELL BIOCHEM, V87, P93, DOI 10.1002/jcb.10280; KLINT P, 1999, FRONT BIOSCI, V4, P165; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kozawa O, 1999, J CELL BIOCHEM, V74, P479, DOI 10.1002/(SICI)1097-4644(19990901)74:3<479::AID-JCB15>3.3.CO;2-0; Kuo WL, 1997, MOL CELL BIOL, V17, P4633, DOI 10.1128/MCB.17.8.4633; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Li BJ, 2002, J BIOL CHEM, V277, P12418, DOI 10.1074/jbc.M111443200; LONG MW, 1995, J CLIN INVEST, V95, P881, DOI 10.1172/JCI117738; Maher P, 1999, J BIOL CHEM, V274, P17491, DOI 10.1074/jbc.274.25.17491; Moerlooze L. D., 1997, CURR OPIN GENE DEV, V7, P378, DOI 10.1016/S0959-437X(97)80152-9; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; OHMICHI M, 1993, BIOCHEM J, V295, P767, DOI 10.1042/bj2950767; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; PITARU S, 1993, J BONE MINER RES, V8, P919; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; RODAN SB, 1989, CONNECT TISSUE RES, V20, P283, DOI 10.3109/03008208909023898; Ryoo HM, 1997, J CELL BIOCHEM, V64, P106, DOI 10.1002/(SICI)1097-4644(199701)64:1<106::AID-JCB13>3.0.CO;2-J; Sanders JL, 1996, J BONE MINER RES, V11, P1862; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Soh JW, 1999, MOL CELL BIOL, V19, P1313; Suzuki A, 2000, J BONE MINER RES, V15, P95, DOI 10.1359/jbmr.2000.15.1.95; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tsuji K, 2001, J BONE MINER METAB, V19, P213, DOI 10.1007/s007740170023; Wert MM, 2000, BIOCHEM J, V352, P175, DOI 10.1042/0264-6021:3520175; Wooten MW, 1997, J NEUROSCI RES, V49, P393, DOI 10.1002/(SICI)1097-4547(19970815)49:4<393::AID-JNR1>3.0.CO;2-3; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	56	197	205	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					319	326		10.1074/jbc.M203750200	http://dx.doi.org/10.1074/jbc.M203750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403780	hybrid			2022-12-27	WOS:000180255700043
J	Smith, WJ; Nassar, N; Bretscher, A; Cerione, RA; Karplus, PA				Smith, WJ; Nassar, N; Bretscher, A; Cerione, RA; Karplus, PA			Structure of the active n-terminal domain of ezrin - Conformational and mobility changes identify keystone interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERM DOMAIN; CRYSTAL-STRUCTURE; ERM PROTEINS; BINDING-SITE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EZRIN/RADIXIN/MOESIN PROTEINS; NEUROFIBROMATOSIS TYPE-2; ACTIVATION MECHANISMS; DIFFRACTION DATA; TAIL DOMAIN	Ezrin is a member of the ERM (ezrin, radixin, moesin) family of proteins that cross-link the actin cytoskeleton to the plasma membrane and also may function in signaling cascades that regulate the assembly of actin stress fibers. Here, we report a crystal structure for the free (activated) FERM domain (residues 2-297) of recombinant human ezrin at 2.3 Angstrom resolution. Structural comparison among the dormant moesin FERM domain structure and the three known active FERM domain structures (radixin, moesin, and now ezrin) allows the clear definition of regions that undergo structural changes during activation. The key regions affected are residues 135-150 and 155-180 in lobe F2 and residues 210-214 and 235-267 in lobe F3. Furthermore, we show that a large increase in the mobilities of lobes F2 and F3 accompanies activation, suggesting that their integrity is compromised. This leads us to propose a new concept that we refer to as keystone interactions. Keystone interactions occur when one protein (or protein part) contributes residues that allow another protein to complete folding, meaning that it becomes an integral part of the structure and would rarely dissociate. Such interactions are well suited for long-lived cytoskeletal protein interactions. The keystone interactions concept leads us to predict two specific docking sites within lobes F2 and F3 that are likely to bind target proteins.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Cornell University; Cornell University; Cornell University; Oregon State University	Bretscher, A (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	apb5@cornell.edu; karplusp@ucs.orst.edu		Karplus, Paul/0000-0001-8725-6292	NIGMS NIH HHS [GM07273, GM36652, 2 R01 GM40654] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM036652] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Edwards SD, 2001, BIOCHEMISTRY-US, V40, P7061, DOI 10.1021/bi010419h; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Jensen LH, 1997, METHOD ENZYMOL, V277, P353, DOI 10.1016/S0076-6879(97)77020-4; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; KARPLUS PA, 1987, J MOL BIOL, V195, P701, DOI 10.1016/0022-2836(87)90191-4; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KREIG J, 1992, J BIOL CHEM, V267, P19258; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; Lu GA, 1996, PROTEIN DATA BANK Q, V78, P10; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Smith WJ, 2002, ACTA CRYSTALLOGR D, V58, P1359, DOI [10.1107/S0907444902010004, 10.1107/S0907444902009162]; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; STERNBERG MJE, 1979, J MOL BIOL, V130, P231, DOI 10.1016/0022-2836(79)90539-4; TSUKITA S, 1989, J CELL BIOL, V108, P2369, DOI 10.1083/jcb.108.6.2369; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Yonemura S, 2002, J CELL SCI, V115, P2569; Zhang FX, 1997, DEV BRAIN RES, V99, P216, DOI 10.1016/S0165-3806(96)00218-0; ZHOU MM, 1995, NATURE, V378, P582	52	89	100	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4949	4956		10.1074/jbc.M210601200	http://dx.doi.org/10.1074/jbc.M210601200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12429733	hybrid			2022-12-27	WOS:000180968900079
J	Dresios, J; Panopoulos, P; Suzuki, K; Synetos, D				Dresios, J; Panopoulos, P; Suzuki, K; Synetos, D			A dispensable yeast ribosomal protein optimizes peptidyltransferase activity and affects translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL TRANSFERASE CENTER; TRANSFER-RNA BINDING; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; ACCURACY CENTER; P-SITE; SUBUNIT; MUTATIONS; CYCLOHEXIMIDE	Yeast ribosomal protein L41 is dispensable in the yeast. Its absence had no effect on polyphenylalanine synthesis activity, and a limited effect on growth, translational accuracy, or the resistance toward the antibiotic paromomycin. Removal of L41 did not affect the 60:40 S ratio, but it reduced the amount of 80 S, suggesting that L41 is involved in ribosomal subunit association. However, the two most important effects of L41 were on peptidyltransferase activity and translocation. Peptidyltransferase activity was measured as a second-order rate constant (k(cat)/K-s) corresponding to the rate of peptide bond formation; this k(cat)/K-s was lowered 3-fold to 1.15 min(-1) mM(-1) in the L41 mutant compared with 3.46 min(-1) mM(-1) in the wild type. Translocation was also affected by L41. Elongation factor 2 (EF2)-dependent (enzymatic) translocation of Ac-Phe-tRNA from the A- to P-site was more efficient in the absence of L41, because 50% translocation was achieved at only 0.004 muM EF2 compared with 0.02 muM for the wild type. Furthermore, the EF2-dependent translocation was inhibited by 50% at 2.5 muM of the translocation inhibitor cycloheximide in the L41 mutant compared with 1.2 muM in the wild type. Finally, the rate of EF2-independent (spontaneous) translocation was increased in the absence of L41.	Univ Patras, Sch Med, Biochem Lab, GR-26110 Patras, Greece; Kinki Univ, Dept Environm & Toxicol Chem, Hiroshima 7392116, Japan	University of Patras; Kindai University (Kinki University)	Synetos, D (corresponding author), Univ Patras, Sch Med, Biochem Lab, GR-26110 Patras, Greece.							ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; ALKSNE LE, 1993, P NATL ACAD SCI USA, V90, P9538, DOI 10.1073/pnas.90.20.9538; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; Bayfield MA, 2001, P NATL ACAD SCI USA, V98, P10096, DOI 10.1073/pnas.171319598; BILGIN N, 1988, FEBS LETT, V233, P95, DOI 10.1016/0014-5793(88)81362-0; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; CHOLI T, 1993, BIOL CHEM H-S, V374, P377, DOI 10.1515/bchm3.1993.374.1-6.377; Diedrich G, 2000, EMBO J, V19, P5241, DOI 10.1093/emboj/19.19.5241; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; Dresios J, 2001, BIOCHEMISTRY-US, V40, P8101, DOI 10.1021/bi0025722; EBERHARDT I, 1995, CURR GENET, V27, P306, DOI 10.1007/BF00352097; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; EUSTICE DC, 1986, J MOL BIOL, V188, P207, DOI 10.1016/0022-2836(86)90305-0; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; KAWAI S, 1992, J BACTERIOL, V174, P254, DOI 10.1128/jb.174.1.254-262.1992; Koosha H, 2000, RNA, V6, P1166, DOI 10.1017/S1355838200000534; Lee JH, 1997, BIOCHEM BIOPH RES CO, V238, P462, DOI 10.1006/bbrc.1997.7317; Liebman SW, 1995, BIOCHEM CELL BIOL, V73, P1141, DOI 10.1139/o95-123; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; MERRICK WC, 1975, J BIOL CHEM, V250, P2620; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; O'Connor M, 2001, NUCLEIC ACIDS RES, V29, P710, DOI 10.1093/nar/29.3.710; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; SACHS AB, 1990, SCIENCE, V247, P1077, DOI 10.1126/science.2408148; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schmeing TM, 2002, NAT STRUCT BIOL, V9, P225, DOI 10.1038/nsb758; SIKORSKI RS, 1989, GENETICS, V122, P19; Spahn CMT, 1996, J BIOL CHEM, V271, P32857, DOI 10.1074/jbc.271.51.32857; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Stevens DR, 2001, MOL GEN GENET, V264, P790, DOI 10.1007/s004380000368; SUZUKI K, 1990, CURR GENET, V17, P185, DOI 10.1007/BF00312608; Synetos D, 1996, BBA-GENE STRUCT EXPR, V1309, P156, DOI 10.1016/S0167-4781(96)00128-5; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; VINCENT A, 1992, GENETICS, V132, P375; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wower IK, 1998, J BIOL CHEM, V273, P19847, DOI 10.1074/jbc.273.31.19847; Xiong LQ, 2001, RNA, V7, P1365; Yu X, 2001, J BIOL CHEM, V276, P33821, DOI 10.1074/jbc.M103772200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	47	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3314	3322		10.1074/jbc.M207533200	http://dx.doi.org/10.1074/jbc.M207533200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433929	hybrid			2022-12-27	WOS:000180915000070
J	Nakano, H; Yoshida, T; Uchiyama, S; Kawachi, M; Matsuo, H; Kato, T; Ohshima, A; Yamaichi, Y; Honda, T; Kato, H; Yamagata, Y; Ohkubo, T; Kobayashi, Y				Nakano, H; Yoshida, T; Uchiyama, S; Kawachi, M; Matsuo, H; Kato, T; Ohshima, A; Yamaichi, Y; Honda, T; Kato, H; Yamagata, Y; Ohkubo, T; Kobayashi, Y			Structure and binding mode of a ribosome recycling factor (RRF) from mesophilic bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOMES; RELEASE FACTOR RF3; TRANSFER-RNA; CRYSTAL-STRUCTURE; VIBRIO-PARAHAEMOLYTICUS; PROTEIN-BIOSYNTHESIS; TERMINATION COMPLEX; PROGRAM; TRANSLATION; RESOLUTION	X-ray and NAIR analyses on ribosome recycling factors (RRFs) from thermophilic bacteria showed that they display a tRNA-like L-shaped conformation consisting of two domains. Since then, it has been accepted that domain I, consisting of a three-helix bundle, corresponds to the anticodon arm of tRNA and domain II and a beta/alpha/beta sandwich structure, corresponds to the acceptor arm. In this study, we obtained a RRF from a mesophilic bacterium, Vibrio parahaemolyticus, by gene. cloning and carried out an x-ray analysis on it at 2.2 Angstrom resolution. This RRF was shown to be active in an in vitro assay system using Escherichia coli polysomes and elongation factor G (EF-G). In contrast, the above-mentioned RRFs from thermophilic bacteria were inactive in such a system. Analysis of the relative orientations between the two domains in the structures of various RRFs, including this RRF from mesophilic bacterium, revealed that domain II rotates about the long axis of the helix bundle of domain I. To elucidate the ribosome binding site of RRF, the peptide fragment (RRF-DI) corresponding to domain I of RRF was expressed and characterized. RRF-DI is bound to 70 S ribosome and the 50 S subunit with an affinity similar to that of wild-type RRF. But it does not bind to the 30 S subunit. These findings caused us to reinvestigate the concept of the mimicry of RRF to tRNA and to propose a new model where domain I corresponds to the acceptor arm of tRNA and domain II corresponds to the anticodon arm. This is just the reverse of a model that is now widely accepted. However, the new model is in better agreement with published biological findings.	Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; RIKEN, Membrane Dynam Res Grp, Harima Inst, Sayo, Hyogo 6795148, Japan; Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan	Osaka University; Osaka University; RIKEN; Kumamoto University	Kobayashi, Y (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.		UCHIYAMA, Susumu/F-9590-2017; Yamagata, Yoshiki/T-6489-2019; Yamaichi, Yoshiharu/E-1776-2019	UCHIYAMA, Susumu/0000-0002-5181-179X; Yamaichi, Yoshiharu/0000-0003-0835-5407; Yoshida, Takuya/0000-0002-3491-9344; Kato, Hiroaki/0000-0002-5993-4532				Atarashi K, 2000, J BACTERIOL, V182, P6154, DOI 10.1128/JB.182.21.6154-6160.2000; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; BRUNGER AT, 1994, ACTA CRYSTALLOGR D, V50, P760; CAMBILLAU C, 1984, J MOL GRAPHICS, V2, P53, DOI 10.1016/0263-7855(84)80036-3; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Fujiwara T, 2001, RNA, V7, P64, DOI 10.1017/S1355838201001704; GARRETT RA, 2000, RIBOSOME STRUCTURE F, P1; HIRASHIM.A, 1970, BIOCHEM BIOPH RES CO, V41, P877, DOI 10.1016/0006-291X(70)90165-8; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; HIRASHIMA A, 1972, BIOCHEMISTRY-US, V11, P4037, DOI 10.1021/bi00772a005; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hirokawa G, 2002, EMBO J, V21, P2272, DOI 10.1093/emboj/21.9.2272; Iida T, 1997, J MED MICROBIOL, V46, P639, DOI 10.1099/00222615-46-8-639; Ishino T, 2000, GENES CELLS, V5, P953, DOI 10.1046/j.1365-2443.2000.00382.x; Ito K, 2002, MOL CELL, V9, P1263, DOI 10.1016/S1097-2765(02)00547-6; JACK A, 1976, J MOL BIOL, V108, P619, DOI 10.1016/S0022-2836(76)80109-X; Janosi L, 2000, J MOL BIOL, V295, P815, DOI 10.1006/jmbi.1999.3401; Janosi L, 1996, BIOCHIMIE, V78, P959, DOI 10.1016/S0300-9084(97)86718-1; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Kaji A, 1998, BIOCHEM BIOPH RES CO, V250, P1, DOI 10.1006/bbrc.1998.9168; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Karlsson M, 1999, BIOCHIMIE, V81, P995, DOI 10.1016/S0300-9084(99)00220-5; Kim KK, 2000, EMBO J, V19, P2362, DOI 10.1093/emboj/19.10.2362; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUROKAWA K, 1998, GENOME INFORMATICS, V9, P164; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Nakano H, 2002, ACTA CRYSTALLOGR D, V58, P124, DOI 10.1107/S0907444901019941; Nasu H, 2000, J CLIN MICROBIOL, V38, P2156; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ohnishi M, 1999, J BACTERIOL, V181, P1281, DOI 10.1128/JB.181.4.1281-1291.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Pavlov MY, 1997, J MOL BIOL, V273, P389, DOI 10.1006/jmbi.1997.1324; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; RYOJI M, 1981, P NATL ACAD SCI-BIOL, V78, P5973, DOI 10.1073/pnas.78.10.5973; SAKABE N, 1991, NUCL INSTRUM METH A, V303, P448, DOI 10.1016/0168-9002(91)90282-U; Sambrook J., 2002, MOL CLONING LAB MANU; Selmer M, 1999, SCIENCE, V286, P2349, DOI 10.1126/science.286.5448.2349; Toyoda T, 2000, RNA, V6, P1432, DOI 10.1017/S1355838200001060; Yoshida T, 2001, BIOCHEMISTRY-US, V40, P2387, DOI 10.1021/bi002474g; Yun J, 2000, ACTA CRYSTALLOGR D, V56, P84, DOI 10.1107/S0907444999013906; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	45	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3427	3436		10.1074/jbc.M208098200	http://dx.doi.org/10.1074/jbc.M208098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12411440	hybrid			2022-12-27	WOS:000180915000084
J	Wang, YM; Guo, HC				Wang, YM; Guo, HC			Two-step dimerization for autoproteolysis to activate glycosylasparaginase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL NUCLEOPHILE; HUMAN LYSOSOMAL ASPARTYLGLUCOSAMINIDASE; CRYSTAL-STRUCTURE; FLAVOBACTERIUM GLYCOSYLASPARAGINASE; INTRAMOLECULAR PROTEOLYSIS; MOLECULAR-CLONING; HYDROLASE; MECHANISM; MENINGOSEPTICUM; PURIFICATION	Glycosylasparaginase (GA) is an amidase and belongs to a novel family of N-terminal nucleophile hydrolases that use a similar autoproteolytic processing mechanism to generate a mature/active enzyme from a single chain protein precursor. From bacteria to eukaryotes, GAs are conserved in primary sequences, tertiary structures, and activation of amidase activity by intramolecular autoproteolysis. An evolutionarily conserved HisAsp-Thr sequence is cleaved to generate a newly exposed N-terminal threonine, which plays a central role in both autoproteolysis and in its amidase activity. We have recently determined the crystal structure of the bacterial GA precursor at 1.9-Angstrom resolution, which reveals a highly distorted and energetically unfavorable conformation at the scissile peptide bond. A mechanism of autoproteolysis via an N-O acyl shift was proposed to relieve these conformational strains. However, it is not understood how the polypeptide chain distortion was generated and preserved during the folding of GA to trigger autoproteolysis. An obstacle to our understanding of GA autoproteolysis is the uncertainty concerning its quaternary structure in solution. Here we have revisited this question and show that GA forms dimers in solution. Mutants with alterations at the dimer interface cannot form dimers and are impaired in the autoproteolytic activation. This suggests that dimerization of GA plays an essential role in autoproteolysis to activate the amidase activity. Comparison of the melting temperatures of GA dimers before and after autoproteolysis suggests two states of dimerization in the process of enzyme maturation. A two-step dimerization mechanism to trigger autoproteolysis is proposed to accommodate the data presented here as well as those in the literature.	Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Guo, HC (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 715 Albany St, Boston, MA 02118 USA.		Wang, Yeming/C-9082-2013		NIDDK NIH HHS [DK53893] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053893] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARONSON NN, 1989, FASEB J, V3, P2615, DOI 10.1096/fasebj.3.14.2531691; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cui T, 1999, ACTA CRYSTALLOGR D, V55, P1961, DOI 10.1107/S0907444999011798; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; KAARTINEN V, 1991, J BIOL CHEM, V266, P5860; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Liu Y, 1996, GLYCOBIOLOGY, V6, P527, DOI 10.1093/glycob/6.5.527; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MONONEN I, 1993, FASEB J, V7, P1247, DOI 10.1096/fasebj.7.13.8405810; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 2000, CURR OPIN BIOTECH, V11, P377, DOI 10.1016/S0958-1669(00)00113-0; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Riikonen A, 1996, J BIOL CHEM, V271, P21340, DOI 10.1074/jbc.271.35.21340; RIIKONEN A, 1995, J BIOL CHEM, V270, P4903, DOI 10.1074/jbc.270.9.4903; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; TARENTINO AL, 1995, ARCH BIOCHEM BIOPHYS, V316, P399, DOI 10.1006/abbi.1995.1053; TARENTINO AL, 1993, BIOCHEM BIOPH RES CO, V197, P179, DOI 10.1006/bbrc.1993.2457; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; TOLLERSRUD OK, 1992, BIOCHEM J, V282, P891, DOI 10.1042/bj2820891; TOLLERSRUD OK, 1994, BIOCHEM J, V300, P541, DOI 10.1042/bj3000541; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Xuan JC, 1998, PROTEIN SCI, V7, P774, DOI 10.1002/pro.5560070327	31	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3210	3219		10.1074/jbc.M210431200	http://dx.doi.org/10.1074/jbc.M210431200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433919	hybrid			2022-12-27	WOS:000180915000057
J	Song, JL; Li, J; Huang, YS; Chuang, DT				Song, JL; Li, J; Huang, YS; Chuang, DT			Encapsulation of an 86-kDa assembly intermediate inside the cavities of GroEL and its single-ring variant SR1 by GroES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOACID DEHYDROGENASE; SYRUP-URINE-DISEASE; HETERODIMERIC INTERMEDIATE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CHAPERONIN GROEL; GROEL/GROES; ALPHA(2)BETA(2); DECARBOXYLASE; POLYPEPTIDE	We described previously that during the assembly of the alpha(2)beta(2) heterotetramer of human mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD), chaperonins GroEL/GroES interact with the kinetically trapped heterodimeric (alphabeta) intermediate to facilitate conversion of the latter to the native BCKD heterotetramer. Here, we show that the 86-kDa heterodimeric intermediate possesses a native-like conformation as judged by its binding to a fluorescent probe 1-anilino-8-naphthalenesulfonate. This large heterodimeric intermediate is accommodated as an entity inside cavities of GroEL and its single-ring variant SR1 and is encapsulated by GroES as indicated by the resistance of the heterodimer to tryptic digestion. The SR1-alphabeta-GroES complex is isolated as a stable single species by gel filtration in the presence of Mg-ATP. In contrast, an unfolded BCKD fusion protein of similar size, which also resides in the GroEL or SR1 cavity, is too large to be capped by GroES. The cis-capping mechanism is consistent with the high level of BCKD activity recovered with the GroEL-alphabeta complex, GroES, and Mg-ATP. The 86-kDa native-like heterodimeric intermediate in the BCKD assembly pathway represents the largest protein substrate known to fit inside the GroEL cis cavity underneath GroES, which significantly exceeds the current size limit of 57 kDa established for unfolded proteins.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Huang, Yi-Shuian/P-2824-2018	Huang, Yi-Shuian/0000-0001-9000-7748	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK26758] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AEvarsson A, 2000, STRUCTURE, V8, P277, DOI 10.1016/S0969-2126(00)00105-2; Bhattacharyya AM, 2002, BIOCHEMISTRY-US, V41, P422, DOI 10.1021/bi011726q; BURNS DM, 1990, J BIOL CHEM, V265, P2060; Chalikian TV, 1996, BIOPOLYMERS, V39, P619, DOI 10.1002/(SICI)1097-0282(199611)39:5<619::AID-BIP1>3.0.CO;2-Z; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; Clark AC, 1998, METHOD ENZYMOL, V290, P100; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; GORDON CL, 1994, J BIOL CHEM, V269, P27941; Grallert H, 1998, J BIOL CHEM, V273, P33305, DOI 10.1074/jbc.273.50.33305; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Horwich AL, 1998, METHOD ENZYMOL, V290, P141, DOI 10.1016/S0076-6879(98)90013-1; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; MURAI N, 1995, J BIOL CHEM, V270, P19957, DOI 10.1074/jbc.270.34.19957; Sakikawa C, 1999, J BIOL CHEM, V274, P21251, DOI 10.1074/jbc.274.30.21251; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Song JL, 2000, J BIOL CHEM, V275, P22305, DOI 10.1074/jbc.M002038200; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; WYNN RM, 1992, J BIOL CHEM, V267, P12400; Wynn RM, 1998, J BIOL CHEM, V273, P13110, DOI 10.1074/jbc.273.21.13110; Wynn RM, 2000, J BIOL CHEM, V275, P2786, DOI 10.1074/jbc.275.4.2786; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	24	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2515	2521		10.1074/jbc.M209705200	http://dx.doi.org/10.1074/jbc.M209705200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431983	hybrid			2022-12-27	WOS:000180562000060
J	Yamauchi, T; Kamon, J; Waki, H; Imai, Y; Shimozawa, N; Hioki, K; Uchida, S; Ito, Y; Takakuwa, K; Matsui, J; Takata, M; Eto, K; Terauchi, Y; Komeda, K; Tsunoda, M; Murakami, K; Ohnishi, Y; Naitoh, T; Yamamura, K; Ueyama, Y; Froguel, P; Kimura, S; Nagai, R; Kadowaki, T				Yamauchi, T; Kamon, J; Waki, H; Imai, Y; Shimozawa, N; Hioki, K; Uchida, S; Ito, Y; Takakuwa, K; Matsui, J; Takata, M; Eto, K; Terauchi, Y; Komeda, K; Tsunoda, M; Murakami, K; Ohnishi, Y; Naitoh, T; Yamamura, K; Ueyama, Y; Froguel, P; Kimura, S; Nagai, R; Kadowaki, T			Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR EXPRESSION; REVERSES INSULIN-RESISTANCE; ADIPOSE-TISSUE; OBESITY; PROTEIN; MACROPHAGES; MECHANISM; LEPTIN	The adipocyte-derived hormone adiponectin has been shown to play important roles in the regulation of energy homeostasis and insulin sensitivity. In this study, we analyzed globular domain adiponectin (gAd) transgenic (Tg) mice crossed with leptin-deficient ob/ob or apoE-deficient mice. Interestingly, despite an unexpected similar body weight, gAd Tg ob/ob mice showed amelioration of insulin resistance and beta-cell degranulation as well as diabetes, indicating that globular adiponectin and leptin appeared to have both distinct and overlapping functions. Amelioration of diabetes and insulin resistance was associated with increased expression of molecules involved. in fatty acid oxidation such as acyl-CoA oxidase, and molecules involved in energy dissipation such as uncoupling proteins 2 and 3 and increased fatty acid oxidation in skeletal muscle of gAd Tg ob/ob mice. Moreover, despite similar plasma glucose and lipid levels on an apoE-deficient background, gAd Tg apoE-deficient mice showed amelioration of atherosclerosis, which was associated with decreased expression of class A scavenger receptor and tumor necrosis factor alpha. This is the first demonstration that globular adiponectin can protect against atherosclerosis in vivo. In conclusion, replenishment of globular adiponectin may provide a novel treatment modality for both type 2 diabetes and atherosclerosis.	Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1138655, Japan; Cent Inst Expt Anim, Kanagawa 2160001, Japan; Tokyo Med Univ, Div Lab Anim Sci, Anim Res Ctr, Tokyo 1608402, Japan; Kyorin Pharmaceut, Cent Res Labs, Nogi, Tochigi 3290114, Japan; Kumamoto Univ, Dept Dev Genet, Inst Mol Embryol & Genet, Kumamoto 8620976, Japan; Inst Pasteur, CNRS, Inst Biol, UPRES A8090, F-59000 Lille, France; Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; Tokyo Medical University; Kyorin Pharmaceutical Co Ltd; Kumamoto University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Japan Science & Technology Agency (JST)	Kadowaki, T (corresponding author), Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowak-3im@h.u-tokyo.ac.jp	Terauchi, Yasuo/AAO-4347-2020; Waki, Hironori/AAE-3942-2020; FROGUEL, Philippe/O-6799-2017	Waki, Hironori/0000-0002-5302-9793; FROGUEL, Philippe/0000-0003-2972-0784	MRC [G0000477] Funding Source: UKRI; Medical Research Council [G0000477] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Imai Y, 2002, ARTERIOSCL THROM VAS, V22, P1310, DOI 10.1161/01.ATV.0000024685.92243.E7; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P802; Ogawa Y, 1999, DIABETES, V48, P1822, DOI 10.2337/diabetes.48.9.1822; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; REAVEN GM, 1995, DIABETOLOGIA, V38, P3, DOI 10.1007/BF02369347; Sakamoto H, 2001, CIRCULATION, V104, P109, DOI 10.1161/hc2701.091070; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	33	732	811	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2461	2468		10.1074/jbc.M209033200	http://dx.doi.org/10.1074/jbc.M209033200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431986	hybrid			2022-12-27	WOS:000180562000054
J	Gowen, LC; Petersen, DN; Mansolf, AL; Qi, H; Stock, JL; Tkalcevic, GT; Simmons, HA; Crawford, DT; Chidsey-Frink, KL; Ke, HZ; McNeish, JD; Brown, TA				Gowen, LC; Petersen, DN; Mansolf, AL; Qi, H; Stock, JL; Tkalcevic, GT; Simmons, HA; Crawford, DT; Chidsey-Frink, KL; Ke, HZ; McNeish, JD; Brown, TA			Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MICE; EXTRACELLULAR-MATRIX; CELL-LINE; IN-VITRO; OSTEOPONTIN; PROTEIN; DIFFERENTIATION; OSTEOMALACIA; LACKING; MARROW	We have previously described osteoblast/osteocyte factor 45 (OF45), a novel bone-specific extracellular matrix protein, and demonstrated that its expression is tightly linked to mineralization and bone formation. In this report, we have cloned and characterized the mouse OF45 cDNA and genomic region. Mouse OF45 (also called MEPE) was similar to its rat orthologue in that its expression was increased during mineralization in osteoblast cultures and the protein was highly expressed within the osteocytes that are imbedded within bone. To further determine the role of OF45 in bone metabolism, we generated a targeted mouse line deficient in this protein. Ablation of OF45 resulted in increased bone mass. In fact, disruption of only a single allele of OF45 caused significantly increased bone mass. In addition, knockout mice were resistant to aging-associated trabecular bone loss. Cancellous bone histomorphometry revealed that the increased bone mass was the result of increased osteoblast number and osteoblast activity with unaltered osteoclast number and osteoclast surface in knockout animals. Consistent with the bone histomorphometric results, we also determined that OF45 knockout osteoblasts produced significantly more mineralized nodules in ex vivo cell cultures than did wild type osteoblasts. Osteoclastogenesis and bone resorption in ex vivo cultures was unaffected by OF45 mutation. We conclude that OF45 plays an inhibitory role in bone formation in mouse.	Pfizer Global Res & Dev, Groton Labs, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Cardiovasc & Metabol Dis, Groton, CT 06340 USA; Pfizer Global Res & Dev, Dept Genet Technol, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Brown, TA (corresponding author), Pfizer Global Res & Dev, Groton Labs, Eastern Point Rd, Groton, CT 06340 USA.			Morton, Lori/0000-0002-5214-5784				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6553; Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y; Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Erdmann J, 1999, MECH AGEING DEV, V110, P73, DOI 10.1016/S0047-6374(99)00043-3; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Grasser WA, 1997, J CELL BIOCHEM, V65, P159, DOI 10.1002/(SICI)1097-4644(199705)65:2<159::AID-JCB3>3.0.CO;2-T; Guo R, 2002, BIOCHEM BIOPH RES CO, V297, P38, DOI 10.1016/S0006-291X(02)02125-3; Harlow E., 1988, ANTIBODIES LAB MANUA; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jee WSS, 1997, HDB BONE MORPHOLOGY, P87; Ke H. Z., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P479; Ke HZ, 2001, J BONE MINER RES, V16, P765, DOI 10.1359/jbmr.2001.16.4.765; Lanyon L.E., 1993, CALCIFIED TISSUE INT, V53, P102; Liaw L, 1998, J CLIN INVEST, V101, P1468; Lozupone E, 1996, CLIN RHEUMATOL, V15, P563, DOI 10.1007/BF02238545; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; MacDougall M, 2002, CONNECT TISSUE RES, V43, P320, DOI 10.1080/03008200290000556; MCGEOCH DJ, 1985, VIRUS RES, V3, P271, DOI 10.1016/0168-1702(85)90051-6; McKee MD, 1996, ANAT RECORD, V245, P293, DOI 10.1002/(SICI)1097-0185(199606)245:2<293::AID-AR13>3.0.CO;2-K; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Noble BS, 2000, MOL CELL ENDOCRINOL, V159, P7, DOI 10.1016/S0303-7207(99)00174-4; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; PALUMBO C, 1990, ACTA ANAT, V137, P350; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Petersen DN, 2000, J BIOL CHEM, V275, P36172, DOI 10.1074/jbc.M003622200; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; ROACH ML, 1995, EXP CELL RES, V221, P520, DOI 10.1006/excr.1995.1403; Robey PG, 1996, CONNECT TISSUE RES, V35, P131, DOI 10.3109/03008209609029183; Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C; ROHOLL PJM, 1994, J BONE MINER RES, V9, P355; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Sambrook J., 2002, MOL CLONING LAB MANU; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Schinke T, 1998, ANN MED, V30, P538, DOI 10.3109/07853899809002601; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; von Kossa J, 1901, BEITR PATHOL ANAT AL, V29, P163; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	51	206	221	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1998	2007		10.1074/jbc.M203250200	http://dx.doi.org/10.1074/jbc.M203250200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421822	hybrid			2022-12-27	WOS:000180462200084
J	Miller, YI; Viriyakosol, S; Binder, CJ; Feramisco, JR; Kirkland, TN; Witztum, JL				Miller, YI; Viriyakosol, S; Binder, CJ; Feramisco, JR; Kirkland, TN; Witztum, JL			Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; NF-KAPPA-B; BACTERIAL LIPOPOLYSACCHARIDE; OVEREXPRESS 15-LIPOXYGENASE; PROTEIN-KINASE; ATHEROSCLEROSIS; ACTIVATION; MICE; GENE; FIBROBLASTS	Minimally modified low density lipoprotein (mmLDL) is a pro-inflammatory and pro-atherogenic lipoprotein that, unlike profoundly oxidized LDL (OxLDL), is not recognized by scavenger receptors and thus does not have enhanced uptake by macrophages. However, here we demonstrate that mmLDL (as well as OxLDL) induces actin polymerization and spreading of macrophages, which results in such pro-atherogenic consequences as inhibition of phagocytosis of apoptotic cells but enhancement of OxLDL uptake. We also demonstrate for the first time that the lipopolysaccharide receptor, CD14, and toll-like receptor-4/MD-2 are involved in these mmLDL effects. Macrophages of the J774 cell line exhibited higher mmLDL binding and F-actin response than its CD14-deficient mutant, LR-9 cells. Similarly, Chinese hamster ovary cells transfected with human CD14 specifically bound mmLDL and responded with higher F-actin compared with control cells. Macrophages from C3H/HeJ mice, which have a point mutation in the Tlr4 gene, responded with lower F-actin to mmLDL and did not spread as well as macrophages from control animals. A significantly higher F-actin response was also observed in Chinese hamster ovary cells transfected with human toll-like receptor-4/MD-2 but not with TLR4 alone or TLR2. Thus, in addition to inhibition of phagocytosis, the recognition of mmLDL by macrophage lipopolysaccharide receptors results in convergence of cellular immune responses to products of microorganisms and to oxidation-specific self-antigens, which could both influence macrophage function and atherogenesis.	Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Vet Adm San Diego Healthcare Syst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol & Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Miller, YI (corresponding author), Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, 1080 Basic Sci Bldg,9500 Gilman Dr, La Jolla, CA 92093 USA.		Kirkland, Theo/ADK-9674-2022; Eckhardt, Erik/G-1567-2010	Binder, Christoph J./0000-0001-8313-7050	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL056989, P01HL066941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM037696] Funding Source: NIH RePORTER; NHLBI NIH HHS [1 P01 HL66941, HL56989] Funding Source: Medline; NIGMS NIH HHS [P01GM37696] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abate A, 1998, LIFE SCI, V62, P1081, DOI 10.1016/S0024-3205(98)00031-9; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; BENZ DJ, 1995, J BIOL CHEM, V270, P5191, DOI 10.1074/jbc.270.10.5191; Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; EZAKI M, 1995, J LIPID RES, V36, P1996; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; Huh HY, 1996, BLOOD, V87, P2020; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kawasaki K, 2000, J BIOL CHEM, V275, P2251, DOI 10.1074/jbc.275.4.2251; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee C, 1999, ARTERIOSCL THROM VAS, V19, P1437, DOI 10.1161/01.ATV.19.6.1437; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; LIAO F, 1993, J CLIN INVEST, V91, P2572, DOI 10.1172/JCI116495; LIAO F, 1991, J CLIN INVEST, V87, P2253, DOI 10.1172/JCI115261; Libby P, 2001, AM J CARDIOL, V88, p3J; Lougheed M, 1996, J BIOL CHEM, V271, P11798, DOI 10.1074/jbc.271.20.11798; Martinet W, 2001, CURR OPIN LIPIDOL, V12, P535, DOI 10.1097/00041433-200110000-00009; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Mine S, 2002, ATHEROSCLEROSIS, V160, P281, DOI 10.1016/S0021-9150(01)00582-2; Nakamura I, 2001, J CELL BIOL, V152, P361, DOI 10.1083/jcb.152.2.361; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; NISHIJIMA M, 1994, J BIOCHEM-TOKYO, V116, P1082, DOI 10.1093/oxfordjournals.jbchem.a124631; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Patino R, 2000, AM J CARDIOL, V85, P1288, DOI 10.1016/S0002-9149(00)00757-8; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Ropert C, 2001, J IMMUNOL, V166, P3423, DOI 10.4049/jimmunol.166.5.3423; Schissel SL, 1996, J CLIN INVEST, V98, P1455, DOI 10.1172/JCI118934; Schlegel RA, 1999, CELL DEATH DIFFER, V6, P583, DOI 10.1038/sj.cdd.4400529; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Shi WB, 2000, CIRCULATION, V102, P75, DOI 10.1161/01.CIR.102.1.75; Sigari F, 1997, ARTERIOSCL THROM VAS, V17, P3639, DOI 10.1161/01.ATV.17.12.3639; Sugiyama T, 2001, J IMMUNOL, V166, P826, DOI 10.4049/jimmunol.166.2.826; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VIRIYAKOSOL S, 1995, J BIOL CHEM, V270, P361, DOI 10.1074/jbc.270.1.361; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631	57	313	339	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1561	1568		10.1074/jbc.M209634200	http://dx.doi.org/10.1074/jbc.M209634200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424240	hybrid			2022-12-27	WOS:000180462200026
J	Duan, S; Hajek, P; Lin, C; Shin, SK; Attardi, G; Chomyn, A				Duan, S; Hajek, P; Lin, C; Shin, SK; Attardi, G; Chomyn, A			Mitochondrial outer membrane permeability change and hypersensitivity to digitonin early in staurosporine-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; THYMIDINE KINASE; CYCLOSPORINE-A; IN-VIVO; PROTEIN; CELLS; GALACTOKINASE; RESPIRATION; INHIBITION; TRANSITION	We have shown here that the apoptosis inducer staurosporine causes an early decrease in the endogenous respiration rate in intact 143B.TK- cells. On the other hand, the activity of cytochrome c oxidase is unchanged for the first 8 h after staurosporine treatment, as determined by oxygen consumption measurements in intact cells. The decrease in the endogenous respiration rate precedes the release of cytochrome c from mitochondria. Moreover, we have ruled out caspases, permeability transition, and protein kinase C inhibition as being responsible for the decrease in respiration rate. Furthermore, overexpression of the gene for Bcl-2 does not prevent the decrease in respiration rate. The last finding suggests that Bcl-2 acts downstream of the perturbation in respiration. The evidence of normal enzymatic activities of complex I and complex III in staurosporine-treated 143B.TK- osteosarcoma cells indicates that the cause of the respiration decrease is probably an alteration in the permeability of the outer mitochondrial membrane. Presumably, the voltage-dependent anion channel closes, thereby preventing ADP and oxidizable substrates from being taken up into mitochondria. This interpretation was confirmed by another surprising finding, namely that, in staurosporine-treated 143B.TK- cells permeabilized with digitonin at a concentration not affecting the mitochondrial membranes in naive cells, the outer mitochondrial membrane loses its integrity; this leads to a reversal of its impermeability to exogenous substrates. The loss of outer membrane integrity leads also to a massive premature release of cytochrome c from mitochondria. Most significantly, Bcl-2 overexpression prevents the staurosporine-induced hypersensitivity of the outer membrane to digitonin. Our experiments have thus revealed early changes in the outer mitochondrial membrane, which take place long before cytochrome c is released from mitochondria in intact cells.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Chomyn, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	chomyn@caltech.edu			NIGMS NIH HHS [GM-11726] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Colombini M, 1980, Ann N Y Acad Sci, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; COLOMBINI M, 1987, J BIOENERG BIOMEMBR, V19, P309, DOI 10.1007/BF00768534; CROMPTON M, 1988, BIOCHEM J, V255, P357; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GRANGER DL, 1982, J CELL BIOL, V95, P527, DOI 10.1083/jcb.95.2.527; Hajek P, 2001, J BIOL CHEM, V276, P606, DOI 10.1074/jbc.M007871200; Han Z, 2000, CELL DEATH DIFFER, V7, P521, DOI 10.1038/sj.cdd.4400681; Harkin ST, 1998, MOL PHARMACOL, V54, P663; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hirsch T, 1997, BIOSCIENCE REP, V17, P67, DOI 10.1023/A:1027339418683; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; HOFHAUS G, 1993, EMBO J, V12, P3043, DOI 10.1002/j.1460-2075.1993.tb05973.x; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luetjens CM, 2001, MOL PHARMACOL, V60, P1008, DOI 10.1124/mol.60.5.1008; MCBREEN P, 1977, CYTOGENET CELL GENET, V19, P7, DOI 10.1159/000130789; ORKWISZEWSKI KG, 1976, SOMAT CELL GENET, V2, P21, DOI 10.1007/BF01539239; ORKWISZEWSKI KG, 1976, CYTOGENET CELL GENET, V16, P427, DOI 10.1159/000130650; Ruiz-Vela A, 2002, FEBS LETT, V517, P133, DOI 10.1016/S0014-5793(02)02607-8; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vander Heiden MG, 1999, MOL CELL, V3, P159; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; ZIZI M, 1994, J BIOL CHEM, V269, P1614	46	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1346	1353		10.1074/jbc.M209269200	http://dx.doi.org/10.1074/jbc.M209269200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12403774	Green Accepted, hybrid			2022-12-27	WOS:000180321900084
J	Garcia-Nogales, P; Almeida, A; Bolanos, JP				Garcia-Nogales, P; Almeida, A; Bolanos, JP			Peroxynitrite protects neurons against nitric oxide-mediated apoptosis - A key role for glucose-6-phosphate dehydrogenase activity in neuroprotection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; CELLULAR-ENERGY DEPLETION; DNA STRAND BREAKAGE; METHYL-D-ASPARTATE; SEA-URCHIN EGGS; OXIDATIVE STRESS; S-NITROSOGLUTATHIONE; HYDROGEN-PEROXIDE; POLY(ADP-RIBOSE) SYNTHETASE; CULTURED ASTROCYTES	Peroxynitrite is thought to be a nitric oxide-derived neurotoxic effector molecule involved in the disruption of key energy-related metabolic targets. To assess the consequences of such interference in cellular glucose metabolism and viability, we studied the possible modulatory role played by peroxynitrite in glucose oxidation in neurons and astrocytes in primary culture. Here, we report that peroxynitrite triggered rapid stimulation of pentose phosphate pathway (PPP) activity and the accumulation of NADPH, an essential cofactor for glutathione regeneration. In contrast to peroxynitrite, nitric oxide elicited NADPH depletion, glutathione oxidation, and apoptotic cell death in neurons, but not in astrocytes. These events were noticeably counteracted by pretreatment of neurons with peroxynitrite. In an attempt to elucidate the mechanism responsible for this PPP stimulation and neuroprotection, we found evidence consistent with both exogenous and endogenous peroxynitrite-mediated activation of glucose-6-phosphate dehydrogenase (G6PD), an enzyme that catalyzes the first rate-limiting step in the PPP. Moreover, functional overexpression of the G6PD gene in stably transformed PC12 cells induced NADPH accumulation and offered remarkable resistance against nitric oxide-mediated apoptosis, whereas G6PD gene-targeted antisense inhibition depleted NADPH levels and exacerbated cellular vulnerability. In light of these results, we suggest that G6PD activation represents a novel role for peroxynitrite in neuroprotection against nitric oxide-mediated apoptosis.	Univ Salamanca, Dept Bioquim & Biol Mol, Salamanca 37007, Spain; Hosp Univ Salamanca, Unidad Invest, Salamanca 37007, Spain	University of Salamanca; University of Salamanca	Bolanos, JP (corresponding author), Univ Salamanca, Dept Bioquim & Biol Mol, Edifico Dept,Plaza Doctores Reina S-N, Salamanca 37007, Spain.		ALMEIDA, ANGELES/B-4727-2017; Bolaños, Juan Pedro/M-9518-2019	ALMEIDA, ANGELES/0000-0003-0485-8904; Bolaños, Juan Pedro/0000-0002-3949-6862				AGULLO L, 1992, BIOCHEM BIOPH RES CO, V182, P1362, DOI 10.1016/0006-291X(92)91883-R; Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Almeida A, 1998, BRAIN RES PROTOC, V2, P209, DOI 10.1016/S1385-299X(97)00044-5; Bal-Price A, 2000, J NEUROCHEM, V75, P1455, DOI 10.1046/j.1471-4159.2000.0751455.x; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BenYoseph O, 1996, J NEUROCHEM, V66, P2329; Bolanos JP, 1997, J NEUROCHEM, V68, P2227; BOLANOS JP, 1994, J NEUROCHEM, V63, P910; Bolanos JP, 1997, BRAIN RES PROTOC, V1, P258, DOI 10.1016/S1385-299X(96)00039-6; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; Bolanos JP, 1996, FREE RADICAL BIO MED, V21, P995, DOI 10.1016/S0891-5849(96)00240-7; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Chang J, 1996, AM J PHYSIOL-LUNG C, V270, pL931, DOI 10.1152/ajplung.1996.270.6.L931; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; DEUTSCH J, 1983, METHOD ENZYMAT AN, V3, P190; Dringen R, 1998, DEV NEUROSCI-BASEL, V20, P401, DOI 10.1159/000017337; Dringen R, 1996, J NEUROCHEM, V67, P1375, DOI 10.1046/j.1471-4159.1996.67041375.x; Dringen R, 2002, METHOD ENZYMOL, V348, P281, DOI 10.1016/S0076-6879(02)48646-6; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; DUGAN LL, 1995, J NEUROSCI, V15, P6377; EPEL D, 1981, CELL, V23, P543, DOI 10.1016/0092-8674(81)90150-1; ESTEVEZ AG, 1995, J NEUROCHEM, V65, P1543; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Feelisch M., 1989, J CARDIOVASC PHARM, V14, P13; Garcia-Nogales P, 1999, J NEUROCHEM, V72, P1750, DOI 10.1046/j.1471-4159.1999.721750.x; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; HOTHERSALL JS, 1979, ARCH BIOCHEM BIOPHYS, V198, P478, DOI 10.1016/0003-9861(79)90522-8; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; IZANT JG, 1985, SCIENCE, V229, P345, DOI 10.1126/science.2990048; Kirsch M, 1999, J BIOL CHEM, V274, P24664, DOI 10.1074/jbc.274.35.24664; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; KLINGENBERG M, 1985, METHOD ENZYMAT AN, V7, P251; Kussmaul L, 1999, J NEUROCHEM, V73, P1246, DOI 10.1046/j.1471-4159.1999.0731246.x; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lizasoain I, 1996, BIOCHEM J, V314, P877, DOI 10.1042/bj3140877; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKAR TK, 1994, J NEUROCHEM, V62, P45; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Merrill JE, 1997, J NEUROSCI RES, V48, P372, DOI 10.1002/(SICI)1097-4547(19970515)48:4<372::AID-JNR9>3.0.CO;2-8; MICHAL G, 1984, METHOD ENZYMAT AN, V6, P191; Mohanakumar KP, 2002, ANN NY ACAD SCI, V962, P389, DOI 10.1111/j.1749-6632.2002.tb04083.x; MOLLERING H, 1985, METHOD ENZYMAT AN, V6, P220; MONCADA S, 1991, PHARMACOL REV, V43, P109; MURPHY S, 1990, J NEUROCHEM, V55, P349, DOI 10.1111/j.1471-4159.1990.tb08860.x; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Perez MJ, 2001, FREE RADICAL BIO MED, V30, P734, DOI 10.1016/S0891-5849(01)00461-0; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; RADONS J, 1994, BIOCHEM BIOPH RES CO, V199, P1270, DOI 10.1006/bbrc.1994.1368; Rauhala P, 1998, FASEB J, V12, P165, DOI 10.1096/fasebj.12.2.165; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750; Sastry PS, 2000, J NEUROCHEM, V74, P1, DOI 10.1046/j.1471-4159.2000.0740001.x; Schomer B, 1998, DEV BIOL, V203, P1, DOI 10.1006/dbio.1998.9044; Schrammel A, 1998, MOL PHARMACOL, V54, P207, DOI 10.1124/mol.54.1.207; SCOTT MD, 1991, BLOOD, V77, P2059; Spolarics Z, 1996, HEPATOLOGY, V24, P691, DOI 10.1053/jhep.1996.v24.pm0008781344; STANTON RC, 1991, J BIOL CHEM, V266, P12442; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; SWEZEY RR, 1986, J CELL BIOL, V103, P1509, DOI 10.1083/jcb.103.4.1509; Szabo C, 1996, CIRC RES, V78, P1051, DOI 10.1161/01.RES.78.6.1051; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; Vega-Agapito V, 2002, J BIOL CHEM, V277, P29753, DOI 10.1074/jbc.M203728200; WALZ W, 1988, GLIA, V1, P366, DOI 10.1002/glia.440010603; Wink DA, 1996, ARCH BIOCHEM BIOPHYS, V331, P241, DOI 10.1006/abbi.1996.0304; WULFF K, 1985, METHOD ENZYMAT AN, V7, P280; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; Zingarelli B, 1996, J IMMUNOL, V156, P350	82	123	124	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					864	874		10.1074/jbc.M206835200	http://dx.doi.org/10.1074/jbc.M206835200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414804	hybrid			2022-12-27	WOS:000180321900024
J	Namkung, W; Lee, JA; Ahn, WI; Han, WS; Kwon, SW; Ahn, DS; Kim, KH; Lee, MG				Namkung, W; Lee, JA; Ahn, WI; Han, WS; Kwon, SW; Ahn, DS; Kim, KH; Lee, MG			Ca2+ activates cystic fibrosis transmembrane conductance regulator- and Cl--dependent HCO3- transport in pancreatic duct cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUID SECRETION; CFTR; RECEPTORS; PROTEIN; ION; H+; LOCALIZATION; BICARBONATE; MECHANISMS; EPITHELIUM	Pancreatic duct cells secrete bicarbonate-rich fluids, which are important for maintaining the patency of pancreatic ductal trees as well as intestinal digestive function. The bulk of bicarbonate secretion in the luminal membrane of duct cells is mediated by a Cl-dependent mechanism (Cl-/HCO3- exchange), and we previously reported that the mechanism is CFTR-dependent and cAMP-activated (Lee, M. G., Choi, J. Y., Luo, X., Strickland, E., Thomas, P. J., and Muallem, S. (1999) J. Biol. Chem. 274,14670-14677). In the present study, we provide comprehensive evidence that calcium signaling also activates the same CFTR- and Cl--dependent HCO3- transport. ATP and trypsin evoked intracellular calcium signaling in pancreatic duct-derived cells through the activation of purinergic and protease-activated receptors, respectively. Cl-/HCO3- exchange activity was measured by recording pH(i) in response to [Cl-](0) changes of the perfusate. In perfusate containing high concentrations of K+, which blocks Cl- movement through electrogenic or K+-coupled pathways, ATP and trypsin highly stimulated luminal Cl-/HCO3- exchange activity in CAPAN-1 cells expressing wild-type CFTR, but not in CFPAC-1 cells that have defective (AF508) CFTR. Notably, adenoviral transfection of wild-type CFTR in CFPAC-1 cells completely restored the stimulatory effect of ATP on luminal Cl-/HCO3- exchange. In addition, the chelation of intracellular calcium by 1,2-bis(2-aminophenoxy)ethane-N,N,N,N'-tetraacetic acid N'-tetraacetic acid (BAPTA) treatment abolished the effect of calcium agonists on luminal Cl-/HCO3- exchange. These results provide a molecular basis for calcium-induced bicarbonate secretion in pancreatic duct cells and highlight the importance of CFTR in epithelial bicarbonate secretion induced by various stimuli.	Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, MG (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.		Lee, Min Goo/AAS-4636-2020; Lee, Min Goo/D-5635-2012; Kwon, Sung Won/C-5362-2018	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Kwon, Sung Won/0000-0002-1610-5726				Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Argent B. E., 1994, P1473; BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; BIJMAN J, 1984, AM J PHYSIOL, V247, pC10, DOI 10.1152/ajpcell.1984.247.1.C10; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Hitt M. M., 1994, CELL BIOL LAB HDB, V1, P479; Hogan DL, 1997, AM J PHYSIOL-GASTR L, V272, pG872, DOI 10.1152/ajpgi.1997.272.4.G872; Ishiguro H, 1998, J PHYSIOL-LONDON, V511, P407, DOI 10.1111/j.1469-7793.1998.407bh.x; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; JOHANSEN PG, 1968, LANCET, V1, P455; Kawabata A, 2000, BRIT J PHARMACOL, V129, P1808, DOI 10.1038/sj.bjp.0703274; Ko WH, 1999, J MEMBRANE BIOL, V170, P205, DOI 10.1007/s002329900550; KOPELMAN H, 1985, NEW ENGL J MED, V312, P329, DOI 10.1056/NEJM198502073120601; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 1997, J BIOL CHEM, V272, P32951, DOI 10.1074/jbc.272.52.32951; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Luo X, 1999, AM J PHYSIOL-CELL PH, V277, pC205, DOI 10.1152/ajpcell.1999.277.2.C205; MUALLEM S, 1990, J BIOL CHEM, V265, P12813; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; QUINTON PM, 1982, PEDIATR RES, V16, P533, DOI 10.1203/00006450-198207000-00008; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; QUINTON PM, 1994, 2 J LEV MEM LECT CYS; Reddy MM, 2001, J MEMBRANE BIOL, V179, P51, DOI 10.1007/s002320010036; Roussa E, 2002, HISTOCHEM CELL BIOL, V117, P335, DOI 10.1007/s00418-002-0393-3; SATO K, 1990, J LAB CLIN MED, V115, P504; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; SMITH BF, 1989, GASTROENTEROLOGY, V97, P179, DOI 10.1016/0016-5085(89)91433-9; Sohma Y, 2000, J MEMBRANE BIOL, V176, P77, DOI 10.1007/s002320001077; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Szalmay G, 2001, J PHYSIOL-LONDON, V535, P795, DOI 10.1111/j.1469-7793.2001.00795.x; Vergnolle N, 2000, ALIMENT PHARM THER, V14, P257; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57; Zsembery A, 2000, FASEB J, V14, P2345, DOI 10.1096/fj.99-0509com	35	54	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					200	207		10.1074/jbc.M207199200	http://dx.doi.org/10.1074/jbc.M207199200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409301	hybrid			2022-12-27	WOS:000180255700027
J	Ren, H; Honse, Y; Karp, BJ; Lipsky, RH; Peoples, RW				Ren, H; Honse, Y; Karp, BJ; Lipsky, RH; Peoples, RW			A site in the fourth membrane-associated domain of the N-methyl-D-aspartate receptor regulates desensitization and ion channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; GLYCINE-BINDING-SITE; NMDA RECEPTOR; GLUTAMATE-RECEPTOR; EXTRACELLULAR VESTIBULE; MOLECULAR DETERMINANTS; SINGLE-CHANNEL; TIME COURSE; SUBUNIT; IDENTIFICATION	The N-methyl-D-aspartate (NMDA) receptor has four membrane-associated domains, three of which are membrane-spanning (M1, M3, and M4) and one of which is a re-entrant pore loop (M2). The M2-M3 domains have been demonstrated to influence the function of the ion channel, but a similar role for the M4 domain has not been reported. We have identified a methionine residue (Met(823)) in the M4 domain of the NR2A subunit that regulates desensitization and ion channel gating. A tryptophan substitution at this site did not alter the EC50 for glycine or the peak NMDA EC50 but decreased the steady-state NMDA EC50 and markedly increased apparent desensitization, mean open time, and peak current density. Results of rapid solution exchange experiments revealed that changes in microscopic desensitization rates and closing rates could account for the changes in macroscopic desensitization, steady-state NMDA EC50, and current density. Other amino acid substitutions at this site could increase or decrease the rate of desensitization and mean open time of the ion channel. Both mean open time and desensitization were dependent primarily upon the hydrophobic character of the amino acid at the position. These results demonstrate an important role for hydrophobic interactions at Met(823) in regulation of NMDA receptor function.	NIAAA, Unit Cellular Neuropharmacol, LMCN, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Peoples, RW (corresponding author), NIAAA, Unit Cellular Neuropharmacol, LMCN, Pk 2 Bldg,Rm 150,12420 Parklawn Dr,MSC 8115, Bethesda, MD 20892 USA.	bpeoples@helix.nih.gov		Lipsky, Robert/0000-0001-7753-1473	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000448] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Anson LC, 1998, J NEUROSCI, V18, P581; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; Buck DP, 2000, BIOPHYS J, V79, P2454, DOI 10.1016/S0006-3495(00)76488-5; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dingledine R, 1999, PHARMACOL REV, V51, P7; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Koltchine VV, 1999, MOL PHARMACOL, V56, P1087, DOI 10.1124/mol.56.5.1087; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Li B, 2002, NAT NEUROSCI, V5, P833, DOI 10.1038/nn912; Lieberman DN, 1999, NAT NEUROSCI, V2, P125, DOI 10.1038/5680; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LIMALANDMAN MTR, 1989, FEBS LETT, V247, P61, DOI 10.1016/0014-5793(89)81241-4; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Price CJ, 1999, J NEUROCHEM, V72, P634, DOI 10.1046/j.1471-4159.1999.0720634.x; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; Wick MJ, 1998, P NATL ACAD SCI USA, V95, P6504, DOI 10.1073/pnas.95.11.6504; Wright JM, 1996, BRAIN RES, V738, P249, DOI 10.1016/S0006-8993(96)00780-9; Yamakura T, 1999, J BIOL CHEM, V274, P23006, DOI 10.1074/jbc.274.33.23006; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; Zhu YL, 2001, J GEN PHYSIOL, V117, P275, DOI 10.1085/jgp.117.3.275; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	52	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					276	283		10.1074/jbc.M209486200	http://dx.doi.org/10.1074/jbc.M209486200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414797	hybrid			2022-12-27	WOS:000180255700037
J	Shibata, K; Katsuma, S; Koshimizu, T; Shinoura, H; Hirasawa, A; Tanoue, A; Tsujimoto, G				Shibata, K; Katsuma, S; Koshimizu, T; Shinoura, H; Hirasawa, A; Tanoue, A; Tsujimoto, G			alpha(1)-adrenergic receptor subtypes differentially control the cell cycle of transfected CHO cells through a cAMP-dependent mechanism involving p27(KiP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOGEN-ACTIVATED PROTEIN; HAMSTER OVARY CELLS; ALPHA(1B)-ADRENERGIC RECEPTOR; ALPHA-1-ADRENERGIC RECEPTOR; MOLECULAR-CLONING; SIGNAL-TRANSDUCTION; RAT HEPATOCYTES; HEPG2 CELLS; EXPRESSION; PATHWAYS	Three distinct subtypes of alpha(1)-adrenergic receptors (alpha(1)A-, a(1)B-, and alpha(1)D-AR) play a prominent role in cell growth. However, little is known about subtype-specific effects on cell proliferation. The activation of alpha(1)A- or alpha(1)B-AR inhibits serum-promoted cell proliferation, whereas a,D-AR activation does not show such an inhibitory effect. Notably, cell-cycle progression was blocked at G(1)/S transition after activation of alpha(1)A/alpha(1)B-AR but not of a,D-AR. In agreement with the differential cell proliferation effect, cAMP production was increased after activation of alpha(1)A/alpha(1)B-AR but not alpha(1)D-AR, whereas all alpha(1)-AR subtypes are associated with inositol 1,4,5-trisphosphate production and mitogen-activated protein kinase activation in a similar fashion. Furthermore, the serum-induced reduction in the levels of the cyclindependent kinase inhibitor, p27(Kip1), was blocked after activation of alpha(1)A/alpha(1)B-AR but not alpha(1)D-AR. These results show that alpha(1)-AR subtypes differentially activate the cAMP/p27(Kip1) pathway and thereby have differential inhibitory effects on cell proliferation. Subtype-dependent effects should be taken into consideration when assessing the physiological response of native cells where alpha(1)-AR subtypes are generally co-expressed.	Natl Ctr Child Hlth, Dept Mol & Cellular Pharmacol, Setagaya Ku, Tokyo 1548567, Japan; Inst Dev Res, Setagaya Ku, Tokyo 1548567, Japan		Tsujimoto, G (corresponding author), Natl Ctr Child Hlth, Dept Mol & Cellular Pharmacol, Setagaya Ku, Tokyo 1548567, Japan.		Koshimizu, Taka-aki/G-2740-2015	Koshimizu, Taka-aki/0000-0001-5292-7535				Auer KL, 1998, FEBS LETT, V436, P131, DOI 10.1016/S0014-5793(98)01074-6; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; CRUISE JL, 1985, SCIENCE, V227, P749, DOI 10.1126/science.2982212; ESBENSHADE TA, 1995, MOL PHARMACOL, V47, P977; FEIGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI DOI 10.1073/PNAS.84.21.7413; Feinstein DL, 1997, NEUROSCI LETT, V223, P37, DOI 10.1016/S0304-3940(97)13402-4; HIRASAWA A, 1993, BIOCHEM BIOPH RES CO, V195, P902, DOI 10.1006/bbrc.1993.2130; HOFMANN B, 1993, P NATL ACAD SCI USA, V90, P6676, DOI 10.1073/pnas.90.14.6676; HORIE K, 1995, MOL PHARMACOL, V48, P392; Hu ZW, 1996, J BIOL CHEM, V271, P8977, DOI 10.1074/jbc.271.15.8977; JACKSON CL, 1992, HYPERTENSION, V20, P713, DOI 10.1161/01.HYP.20.6.713; JOHNSON RD, 1987, MOL PHARMACOL, V31, P239; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Keffel S, 2000, BIOCHEM BIOPH RES CO, V272, P906, DOI 10.1006/bbrc.2000.2850; LLAHI S, 1992, J BIOL CHEM, V267, P3679; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; MINNEMAN KP, 1994, ANNU REV PHARMACOL, V34, P117; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MORGAN NG, 1983, J BIOL CHEM, V258, P5103; MULLER S, 1995, BIOCHEM SOC T, V23, P141; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; PEREZ DM, 1993, MOL PHARMACOL, V44, P784; SCHWINN DA, 1995, J PHARMACOL EXP THER, V272, P134; SCHWINN DA, 1990, J BIOL CHEM, V265, P8183; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHIBATA K, 1995, MOL PHARMACOL, V48, P250; Spector M, 2000, EXP CELL RES, V258, P109, DOI 10.1006/excr.2000.4907; Spector MS, 1997, MOL CELL BIOL, V17, P3556, DOI 10.1128/MCB.17.7.3556; THONBERG H, 1994, J BIOL CHEM, V269, P33179; THORBURN J, 1994, J CELL BIOL, V126, P1565, DOI 10.1083/jcb.126.6.1565; VAIRO G, 1990, J BIOL CHEM, V265, P2692; WEINBERG DH, 1994, BIOCHEM BIOPH RES CO, V201, P1296, DOI 10.1006/bbrc.1994.1845; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	40	22	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					672	678		10.1074/jbc.M201375200	http://dx.doi.org/10.1074/jbc.M201375200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409310	hybrid			2022-12-27	WOS:000180255700085
J	Wang, XD; He, K; Gerhart, M; Huang, Y; Jiang, J; Paxton, RJ; Yang, SS; Lu, CS; Menon, RK; Black, RA; Baumann, G; Frank, SJ				Wang, XD; He, K; Gerhart, M; Huang, Y; Jiang, J; Paxton, RJ; Yang, SS; Lu, CS; Menon, RK; Black, RA; Baumann, G; Frank, SJ			Metalloprotease-mediated GH receptor proteolysis and GHBP shedding - Determination of extracellular domain stem region cleavage site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE RECEPTOR; NECROSIS-FACTOR-ALPHA; CONVERTING-ENZYME TACE; BINDING-PROTEIN; CYTOPLASMIC DOMAIN; TYROSINE PHOSPHORYLATION; IDENTIFICATION; JAK2; SERUM; INTERNALIZATION	Growth hormone-binding protein (GHBP) is complexed to a substantial fraction of circulating GH. In humans, rabbits, and other species, GHBP derives from proteolytic shedding of the GH receptor (GHR) extracellular domain. In cell culture studies, stimuli such as phorbol ester, platelet-derived growth factor, or serum induce GHR proteolysis, which concomitantly yields shed GHBP in cell supernatants and a cell-associated cytoplasmic domain-containing GHR remnant. This process is sensitive to metalloprotease inhibition, and genetic reconstitution studies identify tumor necrosis factor-a converting enzyme (TACE/ADAM-17), a transmembrane metalloprotease, as a GHR sheddase. Stimuli that induce GHR proteolysis render cells less responsive to GH, but the mechanism(s) of this desensitization is not yet understood. In this study, we mapped the rabbit (rb) GHR cleavage site. We adenovirally expressed a C-terminal epitope-tagged rbGHR lacking most of its cytoplasmic domain, purified the remnant protein induced by the phorbol ester, PMA, and derived the cleavage site by N-terminal sequencing of the purified remnant. The N-terminal sequence, (FTCEEDFR246)-F-239, matched perfectly the rbGHR and suggests that cleavage occurs eight residues from the membrane in the proximal extracellular domain stem region. Deletion and alanine substitution mutagenesis indicated that, similar to other TACE substrates, the spacing of residues in this region, more than their identity, influences GHR cleavage susceptibility. Further, we determined that PMA pretreatment desensitized a cleavage-sensitive GHR mutant, but not a cleavage-insensitive mutant, to GH-induced JAK2 activation. These results suggest that inducible GHR proteolysis can regulate GH signaling.	Univ Alabama Birmingham, Dept Med, Div Endocrinol & Metab, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Immunex Corp, Seattle, WA 98101 USA; Univ Pittsburgh, Dept Pediat, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Northwestern Univ, Sch Med, Ctr Endocrinol Metab & Mol Med, Dept Med, Chicago, IL 60611 USA; Vet Adm Chicago Hlth Syst, Lakeside Div, Chicago, IL 60611 USA; Vet Adm Med Ctr, Med Serv, Endocrinol Sect, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Immunex Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Frank, SJ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol & Metab, 1530 3rd Ave S,BDB 861, Birmingham, AL 35294 USA.	frank@endo.dom.uab.edu	He, Kai/AHB-3118-2022	He, Kai/0000-0002-4378-9297	NIDDK NIH HHS [DK46395, DK58259] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046395, R01DK046395, R56DK058259, R56DK046395, R01DK058259] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alele J, 1998, ENDOCRINOLOGY, V139, P1927, DOI 10.1210/en.139.4.1927; ALLEVATO G, 1995, J BIOL CHEM, V270, P17210, DOI 10.1074/jbc.270.29.17210; Amit T, 2001, J ENDOCRINOL, V169, P397, DOI 10.1677/joe.0.1690397; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baumann G, 2002, J ENDOCRINOL, V174, P361, DOI 10.1677/joe.0.1740361; Baumann G, 2001, J PEDIATR ENDOCR MET, V14, P355; BAUMANN G, 1989, METABOLISM, V38, P683, DOI 10.1016/0026-0495(89)90108-X; BAUMANN G, 1988, ENDOCRINOLOGY, V122, P976, DOI 10.1210/endo-122-3-976; BAUMBACH WR, 1989, GENE DEV, V3, P1199, DOI 10.1101/gad.3.8.1199; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Conte F, 2002, BIOCHEM BIOPH RES CO, V290, P851, DOI 10.1006/bbrc.2001.6261; Dastot F, 1996, P NATL ACAD SCI USA, V93, P10723, DOI 10.1073/pnas.93.20.10723; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FRANK SJ, 1994, ENDOCRINOLOGY, V135, P2228, DOI 10.1210/en.135.5.2228; Frank SJ, 2002, CYTOKINE REFERENCE O, P1; Goldsmith JF, 1997, AM J PHYSIOL-ENDOC M, V273, pE932, DOI 10.1152/ajpendo.1997.273.5.E932; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Guan R, 2001, ENDOCRINOLOGY, V142, P1137, DOI 10.1210/en.142.3.1137; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; Jiang J, 1998, BIOCHEM BIOPH RES CO, V253, P774, DOI 10.1006/bbrc.1998.9793; Kovanen PE, 2000, BLOOD, V95, P1626, DOI 10.1182/blood.V95.5.1626.005k21_1626_1632; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LOBIE PE, 1994, J BIOL CHEM, V269, P31735; Lu CX, 2001, J BIOL CHEM, V276, P22892, DOI 10.1074/jbc.M011647200; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mohan MJ, 2002, BIOCHEMISTRY-US, V41, P9462, DOI 10.1021/bi0260132; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; SADEGHI H, 1990, MOL ENDOCRINOL, V4, P1799, DOI 10.1210/mend-4-12-1799; Schlondorff J, 1999, J CELL SCI, V112, P3603; SILVA CM, 1993, ENDOCRINOLOGY, V133, P2307, DOI 10.1210/en.133.5.2307; SMITH WC, 1989, MOL ENDOCRINOL, V3, P984, DOI 10.1210/mend-3-6-984; SOTIROPOULOS A, 1993, ENDOCRINOLOGY, V132, P1863, DOI 10.1210/en.132.4.1863; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; Yi WS, 1996, MOL ENDOCRINOL, V10, P1425, DOI 10.1210/me.10.11.1425; Zhang Y, 2001, J BIOL CHEM, V276, P24565, DOI 10.1074/jbc.M101281200; Zhang Y, 1999, J BIOL CHEM, V274, P33072, DOI 10.1074/jbc.274.46.33072; Zhang Y, 2000, ENDOCRINOLOGY, V141, P4342, DOI 10.1210/en.141.12.4342	44	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50510	50519		10.1074/jbc.M208738200	http://dx.doi.org/10.1074/jbc.M208738200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12403792	hybrid			2022-12-27	WOS:000180177700043
J	Horecker, BL				Horecker, BL			The pentose phosphate pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Horecker, BL (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.							HORECKER BL, 1953, J AM CHEM SOC, V75, P1009, DOI 10.1021/ja01100a525; HORECKER BL, 1953, J AM CHEM SOC, V75, P2021, DOI 10.1021/ja01104a532; HORECKER BL, 1956, J BIOL CHEM, V223, P1009; HORECKER BL, 1956, J BIOL CHEM, V218, P785; HORECKER BL, 1955, J BIOL CHEM, V212, P811; HORECKER BL, 1951, J BIOL CHEM, V193, P383; HORECKER BL, 1948, J BIOL CHEM, V175, P385; HORECKER BL, 1955, J BIOL CHEM, V205, P661; HORECKER BL, 1955, J BIOL CHEM, V218, P827; HURWITZ J, 1956, J BIOL CHEM, V218, P769; VISHNIAC W, 1957, ADV ENZYMOL REL S BI, V19, P1; WEISSBACH A, 1956, J BIOL CHEM, V218, P795; WEISSBACH A, 1954, J AM CHEM SOC, V76, P3611, DOI 10.1021/ja01642a090	13	101	105	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 13	2002	277	50					47965	47971		10.1074/jbc.X200007200	http://dx.doi.org/10.1074/jbc.X200007200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	624YK	12403765	hybrid			2022-12-27	WOS:000179789600001
J	Borgatti, M; Lampronti, I; Romanelli, A; Pedone, C; Saviano, M; Bianchi, N; Mischiati, C; Gambari, R				Borgatti, M; Lampronti, I; Romanelli, A; Pedone, C; Saviano, M; Bianchi, N; Mischiati, C; Gambari, R			Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; KRUPPEL-LIKE FACTOR; PNA-DNA CHIMERAS; HUMAN K562 CELLS; GENE-EXPRESSION; IN-VIVO; ERYTHROID-DIFFERENTIATION; OLIGONUCLEOTIDE-INHIBITION; GLOBIN PROMOTER	Peptide nucleic acids (PNAs) are DNA-mimicking molecules in which the sugar-phosphate backbone is replaced by a pseudopeptide backbone composed of N-(2aminoethyl)glycine units. We determined whether double-stranded molecules based on PNAs and PNA-DNA-PNA (PDP) chimeras could be capable of stable interactions with nuclear proteins belonging to the Sp1 transcription factor family and, therefore, could act as decoy reagents able to inhibit molecular interactions between Sp1 and DNA. Since the structure of PNA/PNA hybrids is very different from that of the DNA/DNA double helix, they could theoretically alter the molecular structure of the double-stranded PNA-DNA-PNA chimeras, perturbing interactions with specific transcription factors. We found that PNA-based hybrids do not inhibit Sp1/DNA interactions. In contrast, hybrid molecules based on PNA-DNA-PNA chimeras are very effective decoy molecules, encouraging further experiments focused on the possible use of these molecules for the development of potential agents for a decoy approach in gene therapy. In this respect, the finding that PDP-based decoy molecules are more resistant than DNA/DNA hybrids to enzymatic degradation appears to be of great interest. Furthermore, their resistance can even be improved after complexation with cationic liposomes to which PDP/PDP chimeras are able to bind by virtue of their internal DNA structure.	Univ Ferrara, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy; CNR, Inst Biostruct & Bioimaging, I-80134 Naples, Italy; Univ Ferrara, Ctr Biotechnol, I-44100 Ferrara, Italy	University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Ferrara	Gambari, R (corresponding author), Univ Ferrara, Dept Biochem & Mol Biol, Via L Borsari 46, I-44100 Ferrara, Italy.		Saviano, Michele/R-1693-2016; Mischiati, Carlo/AAF-2016-2020; Borgatti, Monica/G-2611-2015; Gambari, Roberto/F-9555-2015; Bianchi, Nicoletta/H-1902-2015; Lampronti, Ilaria/F-5522-2016	Saviano, Michele/0000-0001-5086-2459; Borgatti, Monica/0000-0001-8470-2496; Gambari, Roberto/0000-0001-9205-6033; Bianchi, Nicoletta/0000-0001-9280-6017; Mischiati, Carlo/0000-0002-0029-2205; ROMANELLI, Alessandra/0000-0002-7609-4061; Lampronti, Ilaria/0000-0002-1972-7766				BACON ER, 1995, MOL MED, V1, P297, DOI 10.1007/BF03401554; BETTS L, 1995, SCIENCE, V270, P1838, DOI 10.1126/science.270.5243.1838; Bianchi N, 2001, BRIT J HAEMATOL, V113, P951, DOI 10.1046/j.1365-2141.2001.02843.x; Bianchi N, 2000, BIOCHEM PHARMACOL, V60, P31, DOI 10.1016/S0006-2952(00)00297-5; Bianchi N, 1999, BRIT J HAEMATOL, V104, P258, DOI 10.1046/j.1365-2141.1999.01173.x; Borgatti M, 2002, BIOCHEM PHARMACOL, V64, P609, DOI 10.1016/S0006-2952(02)01188-7; Cho-Chung YS, 2000, MOL CELL BIOCHEM, V212, P29, DOI 10.1023/A:1007144618589; CLUSEL C, 1994, GENE EXPRESSION, V4, P301; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062; FERIOTTO G, 1994, BIOCHEM J, V299, P451, DOI 10.1042/bj2990451; GAMBARI R, 1984, CELL DIFFER DEV, V14, P87, DOI 10.1016/0045-6039(84)90033-2; Gambari R, 2001, CURR PHARM DESIGN, V7, P1839, DOI 10.2174/1381612013397087; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; Goodwin AJ, 2001, J BIOL CHEM, V276, P26883, DOI 10.1074/jbc.M008410200; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; HANVEY JC, 1992, SCIENCE, V258, P1481, DOI 10.1126/science.1279811; Hata Y, 1998, J BIOL CHEM, V273, P19294, DOI 10.1074/jbc.273.30.19294; Hosoya T, 1999, FEBS LETT, V461, P136, DOI 10.1016/S0014-5793(99)01450-7; Ishibashi H, 2000, CANCER RES, V60, P6531; Iwase R, 1997, Nucleic Acids Symp Ser, P203; Kawauchi M, 2000, CIRC RES, V87, P1063, DOI 10.1161/01.RES.87.11.1063; Kozlov IA, 1997, ANTISENSE NUCLEIC A, V7, P279, DOI 10.1089/oli.1.1997.7.279; Larsen HJ, 1996, NUCLEIC ACIDS RES, V24, P458, DOI 10.1093/nar/24.3.458; Lee YN, 2000, BIOCHEMISTRY-US, V39, P4863, DOI 10.1021/bi992272o; Liang FQ, 1999, ENDOCRINOLOGY, V140, P1695, DOI 10.1210/en.140.4.1695; Lim CS, 1997, NUCLEIC ACIDS RES, V25, P575, DOI 10.1093/nar/25.3.575; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Mischiati C, 1999, J BIOL CHEM, V274, P33114, DOI 10.1074/jbc.274.46.33114; Misra HS, 1998, BIOCHEMISTRY-US, V37, P1917, DOI 10.1021/bi971524n; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; MORISHITA R, 1995, P NATL ACAD SCI USA, V92, P5855, DOI 10.1073/pnas.92.13.5855; Motojima M, 2000, BIOCHEM J, V349, P435, DOI 10.1042/0264-6021:3490435; Nastruzzi C, 2000, J CONTROL RELEASE, V68, P237, DOI 10.1016/S0168-3659(00)00273-X; NASTRUZZI C, 1990, J PHARM SCI, V79, P672, DOI 10.1002/jps.2600790804; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Ono S, 1998, HUM GENE THER, V9, P1003, DOI 10.1089/hum.1998.9.7-1003; PONDEL MD, 1995, P NATL ACAD SCI USA, V92, P7237, DOI 10.1073/pnas.92.16.7237; ROMANELLI E, 2001, EUR J BIOCHEM, V268, P1; Sabath DE, 1998, BLOOD CELL MOL DIS, V24, P183, DOI 10.1006/bcmd.1998.0185; Saviano M, 2000, J BIOMOL STRUCT DYN, V18, P353, DOI 10.1080/07391102.2000.10506672; Sharma HW, 1996, ANTICANCER RES, V16, P61; Suzuki J, 2000, GENE THER, V7, P1847, DOI 10.1038/sj.gt.3301316; THOMSON SA, 1995, TETRAHEDRON, V51, P6179, DOI 10.1016/0040-4020(95)00286-H; Tomita N, 2000, J AM SOC NEPHROL, V11, P1244, DOI 10.1681/ASN.V1171244; Tomita N, 1998, J HYPERTENS, V16, P993, DOI 10.1097/00004872-199816070-00013; Tomita N, 2000, GENE THER, V7, P1326, DOI 10.1038/sj.gt.3301243; Uhlmann E, 1998, BIOL CHEM, V379, P1045; van der Laan AC, 1998, BIOORG MED CHEM LETT, V8, P663, DOI 10.1016/S0960-894X(98)00088-2; VANDERLAAN AC, 1995, RECL TRAV CHIM PAY B, V114, P295; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Vos IHC, 2000, FASEB J, V14, P815, DOI 10.1096/fasebj.14.5.815; Yamashita J, 1998, J BIOL CHEM, V273, P15993, DOI 10.1074/jbc.273.26.15993; Yu JH, 1999, J BIOL CHEM, V274, P34327, DOI 10.1074/jbc.274.48.34327	56	87	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 28	2003	278	9					7500	7509		10.1074/jbc.M206780200	http://dx.doi.org/10.1074/jbc.M206780200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649EZ	12446679	Green Published, hybrid			2022-12-27	WOS:000181195100112
J	Liao, GQ; Chen, LY; Zhang, AH; Godavarthy, A; Xia, F; Ghosh, JC; Li, H; Chen, JD				Liao, GQ; Chen, LY; Zhang, AH; Godavarthy, A; Xia, F; Ghosh, JC; Li, H; Chen, JD			Regulation of androgen receptor activity by the nuclear receptor corepressor SMRT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES TRANSCRIPTIONAL ACTIVITY; AMINO-TERMINAL DOMAIN; LIGAND-BINDING DOMAIN; N-COR; HORMONE-RECEPTOR; SILENCING MEDIATOR; IN-VIVO; ACTIVATION; REPRESSION; COACTIVATOR	Androgen receptor (AR) is a hormone-regulated transcription factor that mediates a wide array of biological processes including sexual differentiation, spermatogenesis, and prostate cancer progression. The transcriptional activity of AR and other members of the nuclear receptor superfamily are modulated by coregulatory proteins. In this study, we have investigated the regulation of AR transcriptional activity by the silencing mediator for retinoid and thyroid hormone receptors (SMRT). We found that AR possesses an intrinsic transcriptional repression activity, and AR interacts directly with SMRT. One interacting surface on AR is mapped to the ligand-binding domain, and the presence of a DNA binding/hinge region enhances this interaction. The binding surface on SMRT is mapped to the C-terminal ID2 region, and mutation in the ID2 corepressor motif inhibits the interaction. Overexpression of SMRT inhibits dihydrotestosterone-dependent transactivation by AR and further suppresses the antiandrogen flutamide-mediated inhibition of AR activity. We provide evidence to suggest that the mechanisms of SMRT-mediated inhibition of AR activity involves inhibition of AR N/C interaction and competition with the p160 coactivator. Our data establish a significant role of SMRT in modulating AR transcriptional activity.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Liao, GQ (corresponding author), Univ Med & Dent New Jersey, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.		Chen, Liuh-Yow/AAA-3963-2021	Chen, Liuh-Yow/0000-0002-9857-068X	NIDDK NIH HHS [DK52542, R01 DK052542-02, DK52888] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052888, R01DK052542] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmed SF, 2000, J CLIN ENDOCR METAB, V85, P658, DOI 10.1210/jc.85.2.658; Alen P, 1999, MOL CELL BIOL, V19, P6085; Bentel JM, 1996, J ENDOCRINOL, V151, P1, DOI 10.1677/joe.0.1510001; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Bubulya A, 2001, J BIOL CHEM, V276, P44704, DOI 10.1074/jbc.M107346200; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Doesburg P, 1997, BIOCHEMISTRY-US, V36, P1052, DOI 10.1021/bi961775g; Dotzlaw H, 2002, MOL ENDOCRINOL, V16, P661, DOI 10.1210/me.16.4.661; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Ghosh JC, 2002, P NATL ACAD SCI USA, V99, P5842, DOI 10.1073/pnas.092043399; Gottlieb B, 1999, HUM MUTAT, V14, P527, DOI 10.1002/(SICI)1098-1004(199912)14:6<527::AID-HUMU12>3.0.CO;2-X; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hiort O, 2000, J CLIN ENDOCR METAB, V85, P2810, DOI 10.1210/jc.85.8.2810; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Ikonen T, 1997, J BIOL CHEM, V272, P29821, DOI 10.1074/jbc.272.47.29821; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2002, J CELL SCI, V115, P689; Krogsdam AM, 2002, BIOCHEM J, V363, P157, DOI 10.1042/0264-6021:3630157; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; MARIVOET S, 1992, MOL CELL ENDOCRINOL, V88, P165, DOI 10.1016/0303-7207(92)90021-W; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Ordentlich P, 2001, CURR TOP MICROBIOL, V254, P101; Park EJ, 1999, P NATL ACAD SCI USA, V96, P3519, DOI 10.1073/pnas.96.7.3519; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Roy AK, 1999, VITAM HORM, V55, P309; Roy AK, 2001, ANN NY ACAD SCI, V949, P44; Sack JS, 2001, P NATL ACAD SCI USA, V98, P4904, DOI 10.1073/pnas.081565498; Saitoh M, 2002, MOL ENDOCRINOL, V16, P694, DOI 10.1210/me.16.4.694; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P742, DOI 10.1021/bi00147a029; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513	62	136	137	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5052	5061		10.1074/jbc.M206374200	http://dx.doi.org/10.1074/jbc.M206374200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12441355	hybrid			2022-12-27	WOS:000180968900091
J	Eschenlauer, SCP; Page, AP				Eschenlauer, SCP; Page, AP			The Caenorhabditis elegans ERp60 homolog protein disulfide isomerase-3 has disulfide isomerase and transglutaminase-like cross-linking activity and is involved in the maintenance of body morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL 4-HYDROXYLASE; DIROFILARIA-IMMITIS; COLLAGEN GENES; TRIPLE-HELIX; NEMATODE; MORPHOGENESIS; CALRETICULIN; LOCALIZATION; EXPRESSION; MUTANTS	A novel protein disulfide isomerase gene, pdi-3, was isolated from the nematode Caenorhabditis elegans. This gene encodes an enzyme related to the ERp60 class of thioredoxin proteins and was found to exhibit unusual enzymatic properties. Recombinant protein displayed both disulfide bond isomerase activity and calcium-dependent transglutaminase-like cross-linking activity. The pdi-3 transcript was developmentally constitutively expressed, and the encoded protein is present in many tissues including the gut and the hypodermis. The nematode hypodermis synthesizes the essential collagenous extracellular matrix (ECM) called the cuticle. Transcript disruption via double-stranded RNA interference resulted in dramatic and specific synthetic phenotypes in several C. elegans mutant alleles with weakened cuticles: sqt-3(e2117), dpy-18(e364, ok162, and bx26). These nematodes displayed severe dumpy phenotypes and disrupted lateral alae, a destabilized cuticle and abnormal male and hermaphrodite tail morphologies. These defects were confirmed to be consistent with hypodermal seam cell abnormalities and corresponded with the severe disruption of a cuticle collagen. Wild type nematodes did not exhibit observable morphological defects; however, cuticle collagen localization was mildly disrupted following pdi-3 RNA interference. The unusual thioredoxin enzyme, protein disulfide isomerase-3, may therefore play a role in ECM assembly. This enzyme is required for the proper maintenance of postembryonic body shape in strains with a weakened cuticle, perhaps through ECM stabilization via cross-linking activity, disulfide isomerase protein folding activity, protein disulfide isomerase-chaperone activity, or via multifunctional events.	Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	Page, AP (corresponding author), Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland.	a.page@udcf.gla.ac.uk						ANDRES DA, 1990, J BIOL CHEM, V265, P5952; BAIRD SE, 1991, DEVELOPMENT, V113, P515; Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chandrashekar R, 1998, P NATL ACAD SCI USA, V95, P531, DOI 10.1073/pnas.95.2.531; Chandrashekar R, 2002, PARASITOL RES, V88, P185, DOI 10.1007/s00436-001-0520-4; Chandrashekar R, 2000, PARASITOL TODAY, V16, P11, DOI 10.1016/S0169-4758(99)01587-2; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; EMMONS SW, 1997, C ELEGANS, V2, P295; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hill KL, 2000, GENETICS, V155, P1139; Hirabayashi J, 1999, TRENDS GLYCOSCI GLYC, V11, P211, DOI 10.4052/tigg.11.211; Johnstone IL, 2000, TRENDS GENET, V16, P21, DOI 10.1016/S0168-9525(99)01857-0; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Ko FCF, 2002, DEVELOPMENT, V129, P1185; Koivunen P, 1996, BIOCHEM J, V316, P599, DOI 10.1042/bj3160599; KRAMER JM, 1997, C ELEGANS, V2, P471; LEVY AD, 1993, MOL BIOL CELL, V4, P803, DOI 10.1091/mbc.4.8.803; LUSTIGMAN S, 1995, ANTIMICROB AGENTS CH, V39, P1913, DOI 10.1128/AAC.39.9.1913; Madi A, 1998, EUR J BIOCHEM, V253, P583, DOI 10.1046/j.1432-1327.1998.2530583.x; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Myllyharju J, 2002, J BIOL CHEM, V277, P29187, DOI 10.1074/jbc.M203824200; Natsuka S, 2001, J BIOCHEM-TOKYO, V130, P731, DOI 10.1093/oxfordjournals.jbchem.a003042; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliverio S, 1999, J BIOL CHEM, V274, P34123, DOI 10.1074/jbc.274.48.34123; Page Antony P., 2001, P167, DOI 10.1079/9780851994239.0167; Page AP, 1999, GENE, V230, P267, DOI 10.1016/S0378-1119(99)00102-X; Page AP, 1997, DNA CELL BIOL, V16, P1335, DOI 10.1089/dna.1997.16.1335; Picken NC, 2002, J MOL BIOL, V322, P15, DOI 10.1016/S0022-2836(02)00712-X; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; SLAUGHTER TF, 1992, ANAL BIOCHEM, V205, P166, DOI 10.1016/0003-2697(92)90594-W; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; VANDERKEYL H, 1994, DEV DYNAM, V201, P86, DOI 10.1002/aja.1002010109; VanderWaal RP, 2002, J CELL BIOCHEM, V85, P689, DOI 10.1002/jcb.10169; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; Winter AD, 2000, MOL CELL BIOL, V20, P4084, DOI 10.1128/MCB.20.11.4084-4093.2000	47	39	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4227	4237		10.1074/jbc.M210510200	http://dx.doi.org/10.1074/jbc.M210510200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12424233	hybrid			2022-12-27	WOS:000180869700090
J	Cogswell, PC; Kashatus, DF; Keifer, JA; Guttridge, DC; Reuther, JY; Bristow, C; Roy, S; Nicholson, DW; Baldwin, AS				Cogswell, PC; Kashatus, DF; Keifer, JA; Guttridge, DC; Reuther, JY; Bristow, C; Roy, S; Nicholson, DW; Baldwin, AS			NF-kappa B and I kappa B alpha are found in the mitochondria - Evidence for regulation of mitochondrial gene expression by NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REL PROTEINS; APOPTOSIS; KINASE; LOCALIZATION; INHIBITION; SEQUENCE; SUBUNIT; DOMAIN; RNA	The transcription factor NF-kappaB has been shown to be predominantly cytoplasmically localized in the absence of an inductive signal. Stimulation of cells with inflammatory cytokines such as tumor necrosis factor alpha or interleukin-1 induces the degradation of IkappaB, the inhibitor of NF-kappaB, allowing nuclear accumulation of NF-kappaB and regulation of specific gene expression. The degradation of IkappaB is controlled initially by phosphorylation induced by the IkappaB kinase, which leads to ubiquitination and subsequent proteolysis of the inhibitor by the proteasome. We report here that NF-kappaB and IkappaBalpha but not IkappaBbeta are also localized in the mitochondria. Stimulation of cells with tumor necrosis factor a leads to the phosphorylation, of mitochondrial IkappaBalpha and its subsequent degradation by a nonproteasome-dependent pathway. Interestingly, expression of the mitochondrially encoded cytochrome c oxidase III and cytochrome b mRNAs were reduced by cytokine treatment of cells. Inhibition of activation of mitochondrial NF-kappaB by expression of the superrepressor form of IkappaBalpha inhibited the loss of expression of both cytochrome c oxidase III and cytochrome b mRNA. These data indicate that the NF-kappaB regulatory pathway exists in mitochondria and that NF-kappaB can negatively regulate mitochondrial mRNA expression.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Merck Frosst Ctr Therapeut Res, Dept Pharmacol Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Merck & Company	Baldwin, AS (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, CB 7295, Chapel Hill, NC 27599 USA.	jhall@med.unc.edu	Kashatus, David F/D-8299-2012; Ariel, Pablo/AGJ-4118-2022	Kashatus, David F/0000-0001-8007-0612; Guttridge, Denis/0000-0002-7276-6609	NATIONAL CANCER INSTITUTE [R01CA073756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035098, R37AI035098] Funding Source: NIH RePORTER; NCI NIH HHS [CA73756] Funding Source: Medline; NIAID NIH HHS [AI35098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Keifer JA, 2001, J BIOL CHEM, V276, P22382, DOI 10.1074/jbc.M100938200; Kingsbury DJ, 2000, J BIOL CHEM, V275, P24156, DOI 10.1074/jbc.M001742200; MADDEN VJ, 1998, MICROSC MICROANAL, V4, P854; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; SCHEFFLER I, 1999, MITOCHONDRIA, P367; Scheller K, 2000, EUR J CELL BIOL, V79, P299, DOI 10.1078/S0171-9335(04)70033-3; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tao YX, 2001, J BIOL CHEM, V276, P2329, DOI 10.1074/jbc.C000526200; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zandi E, 1999, MOL CELL BIOL, V19, P4547	26	154	166	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2963	2968		10.1074/jbc.M209995200	http://dx.doi.org/10.1074/jbc.M209995200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433922	hybrid			2022-12-27	WOS:000180915000026
J	Ennifar, E; Paillart, JC; Marquet, R; Ehresmann, B; Ehresmann, C; Dumas, P; Walter, P				Ennifar, E; Paillart, JC; Marquet, R; Ehresmann, B; Ehresmann, C; Dumas, P; Walter, P			HIV-1 RNA dimerization initiation site is structurally similar to the ribosomal A site and binds aminoglycoside antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GENOMIC RNA; VIRAL INFECTIVITY; CRYSTAL-STRUCTURE; LOOP COMPLEX; SEQUENCE; REGION; NEOMYCIN; HAIRPIN; PROTEIN	Human immunodeficiency virus (HIV) genomic RNA is packaged into virions as a dimer. The first step of dimerization is the formation of a kissing-loop complex at the so-called dimerization initiation site (DIS). We found an unexpected and fortuitous resemblance between the HIV-1 DIS kissing-loop complex and the eu-bacterial 16 S ribosomal aminoacyl-tRNA site (A site), which is the target of aminoglycoside antibiotics. Similarities exist not only at the primary and secondary structure level but also at the tertiary structure level, as revealed by comparison of the respective DIS and A site crystal structures. Gel shift, inhibition of lead-induced cleavage, and footprinting experiments showed that paromomycin and neomycin specifically bind to the kissing-loop complex formed by the DIS, with an affinity and a geometry similar to that observed for the A site. Modeling of the aminoglycoside-DIS complex allowed us to identify antibiotic modifications likely to increase the affinity and/or the specificity for the DIS. This could be a starting point for designing antiviral drugs against HIV-1 RNA dimerization.	CNRS, UPR9002, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Walter, P (corresponding author), CNRS, UPR9002, Inst Biol Mol & Cellulaire, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	p.walter@ibmc.u-strasbg.fr	Paillart, Jean-Christophe/A-4171-2010	Paillart, Jean-Christophe/0000-0003-1647-8917; Marquet, Roland/0000-0002-4209-3976				Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Clever JL, 1997, J VIROL, V71, P3407, DOI 10.1128/JVI.71.5.3407-3414.1997; Clever JL, 1996, J VIROL, V70, P5902, DOI 10.1128/JVI.70.9.5902-5908.1996; De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703; Ennifar E, 1999, STRUCTURE, V7, P1439, DOI 10.1016/S0969-2126(00)80033-7; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; FU W, 1994, J VIROL, V68, P5013, DOI 10.1128/JVI.68.8.5013-5018.1994; Girard F, 1999, J BIOMOL STRUCT DYN, V16, P1145, DOI 10.1080/07391102.1999.10508323; Haddad J, 2002, J AM CHEM SOC, V124, P3229, DOI 10.1021/ja011695m; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jossinet F, 1999, RNA, V5, P1222, DOI 10.1017/S1355838299990982; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; LEVITT M, 1978, J AM CHEM SOC, V100, P2607, DOI 10.1021/ja00477a004; McPike MP, 2002, NUCLEIC ACIDS RES, V30, P2825, DOI 10.1093/nar/gkf402; Mikkelsen NE, 2001, NAT STRUCT BIOL, V8, P510, DOI 10.1038/88569; Miyaguchi H, 1996, NUCLEIC ACIDS RES, V24, P3700, DOI 10.1093/nar/24.19.3700; Mujeeb A, 1998, NAT STRUCT BIOL, V5, P432, DOI 10.1038/nsb0698-432; Muriaux D, 1996, J BIOL CHEM, V271, P33686, DOI 10.1074/jbc.271.52.33686; MURIAUX D, 1995, J BIOL CHEM, V270, P8209, DOI 10.1074/jbc.270.14.8209; Paillart JC, 2002, J BIOL CHEM, V277, P5995, DOI 10.1074/jbc.M108972200; Paillart JC, 1997, J MOL BIOL, V270, P36, DOI 10.1006/jmbi.1997.1096; Paillart JC, 1996, J VIROL, V70, P8348, DOI 10.1128/JVI.70.12.8348-8354.1996; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; PUROHIT P, 1994, NATURE, V370, P659, DOI 10.1038/370659a0; Recht MI, 1999, EMBO J, V18, P3133, DOI 10.1093/emboj/18.11.3133; Recht MI, 1999, J MOL BIOL, V286, P33, DOI 10.1006/jmbi.1998.2446; Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526; Shen N, 2000, J VIROL, V74, P5729, DOI 10.1128/JVI.74.12.5729-5735.2000; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Walter F, 1999, CURR OPIN CHEM BIOL, V3, P694, DOI 10.1016/S1367-5931(99)00028-9; Wang SH, 1998, BIOCHEMISTRY-US, V37, P5549, DOI 10.1021/bi972808a; Wong CH, 1998, CHEM BIOL, V5, P397, DOI 10.1016/S1074-5521(98)90073-4; Yoshizawa S, 1998, EMBO J, V17, P6437, DOI 10.1093/emboj/17.22.6437; ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B	40	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2723	2730		10.1074/jbc.M205726200	http://dx.doi.org/10.1074/jbc.M205726200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435744	hybrid			2022-12-27	WOS:000180562000085
J	Kageyama, H; Kondo, T; Iwasaki, H				Kageyama, H; Kondo, T; Iwasaki, H			Circadian formation of clock protein complexes by KaiA, KaiB, KaiC, and SasA in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; RHYTHMS	Physical interactions among clock-related proteins KaiA, KaiB, KaiC, and SasA are proposed to be important for circadian function in the cyanobacterium Synechococcus elongatus PCC 7942. Here we show that the Kai proteins and SasA form heteromultimeric protein complexes dynamically in a circadian fashion. KaiC forms protein complexes of similar to350 and 400-600 kDa during the subjective day and night, respectively, and serves as a core of the circadian protein complexes. This change in the size of the KaiC-containing complex is accompanied by nighttime-specific interaction of KaiA and KaiB with KaiC. In various arrhythmic mutants that lack each functional Kai protein or SasA circadian rhythms in formation of the clock protein complex are abolished, and the size of the protein complexes is dramatically affected. Thus, circadian-regulated formation of the clock protein complexes is probably a critical process in the generation of circadian rhythm in cyanobacteria.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST)	Iwasaki, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Furo Cho, Nagoya, Aichi 4648602, Japan.	iwasaki@bio.nagoya-u.ac.jp	Kageyama, Hakuto/AAX-1682-2020; Kageyama, Hakuto/L-6890-2019; Kageyama, Hakuto/M-7302-2019	Kageyama, Hakuto/0000-0002-7741-7408; Iwasaki, Hideo/0000-0002-3754-4955				Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, PLANT CELL PHYSIOL, V41, P1013, DOI 10.1093/pcp/pcd024; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; Leipe DD, 2000, GENOME RES, V10, P5; Mori T, 2001, SEMIN CELL DEV BIOL, V12, P271, DOI 10.1006/scdb.2001.0254; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Xu Y, 2000, EMBO J, V19, P3349, DOI 10.1093/emboj/19.13.3349; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	13	100	111	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2388	2395		10.1074/jbc.M208899200	http://dx.doi.org/10.1074/jbc.M208899200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441347	hybrid			2022-12-27	WOS:000180562000044
J	Hsieh-Wilson, LC; Benfenati, F; Snyder, GL; Allen, PB; Nairn, AC; Greengard, P				Hsieh-Wilson, LC; Benfenati, F; Snyder, GL; Allen, PB; Nairn, AC; Greengard, P			Phosphorylation of spinophilin modulates its interaction with actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA1 PYRAMIDAL CELLS; DENDRITIC SPINES; PHOSPHATASE 1; BINDING-PROTEIN; CYCLIC-AMP; CATALYTIC SUBUNIT; RECEPTOR; DOPAMINE; PLASTICITY	Spinophilin is a protein phosphatase 1 (PP1)- and actin-binding protein that modulates excitatory synaptic transmission and dendritic spine morphology. We report that spinophilin is phosphorylated in vitro by protein kinase A (PKA). Phosphorylation of spinophilin was stimulated by treatment of neostriatal neurons with a dopamine D1 receptor agonist or with forskolin, consistent with spinophilin being a substrate for PKA in intact cells. Using tryptic phosphopeptide mapping, site-directed mutagenesis, and microsequencing analysis, we identified two major sites of phosphorylation, Ser-94 and Ser-177, that are located within the actin-binding domain of spinophilin. Phosphorylation of spinophilin by PKA modulated the association between spinophilin and the actin cytoskeleton. Following subcellular fractionation, unphosphorylated spinophilin was enriched in the postsynaptic density, whereas a pool of phosphorylated spinophilin was found in the cytosol. F-actin co-sedimentation and overlay analysis revealed that phosphorylation of spinophilin reduced the stoichiometry of the spinophilin-actin interaction. In contrast, the ability of spinophilin to bind to PP1 remained unchanged. Taken together, our studies suggest that phosphorylation of spinophilin by PKA modulates the anchoring of the spinophilin-PP1 complex within dendritic spines, thereby likely contributing to the efficacy and plasticity of synaptic transmission.	Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10021 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Univ Genoa, Sect Human Physiol, Dept Expt Med, I-16132 Genoa, Italy; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; California Institute of Technology; University of Genoa; Yale University	Nairn, AC (corresponding author), Rockefeller Univ, Lab Mol & Cellular Neurosci, 1230 York Ave, New York, NY 10021 USA.	nairn@mail.rockefeller.edu		Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044, DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; CARR DW, 1992, J BIOL CHEM, V267, P16816; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Czernik A. J., 1997, REGULATORY PROTEIN M, V30, P219; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; FERNANDEZ A, 1990, J CELL BIOL, V111, P103, DOI 10.1083/jcb.111.1.103; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Gouras GK, 1998, J NEUROCHEM, V71, P1920; GRAY EG, 1959, J ANAT, V93, P420; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hartshorne DJ, 1998, ACTA PHYSIOL SCAND, V164, P483; HORN G, 1985, J NEUROSCI, V5, P3161; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Huff RM, 1996, CELL SIGNAL, V8, P453, DOI 10.1016/S0898-6568(96)00074-5; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAvoy T, 1999, BIOCHEMISTRY-US, V38, P12943, DOI 10.1021/bi991227d; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MOLLOY SS, 1991, P NATL ACAD SCI USA, V88, P4756, DOI 10.1073/pnas.88.11.4756; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; Nakanishi H, 1997, J CELL BIOL, V139, P951, DOI 10.1083/jcb.139.4.951; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; OCORR KA, 1991, NEURON, V6, P907, DOI 10.1016/0896-6273(91)90231-N; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Richman JG, 2001, J BIOL CHEM, V276, P15003, DOI 10.1074/jbc.M011679200; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Smith FD, 1999, J BIOL CHEM, V274, P19894, DOI 10.1074/jbc.274.28.19894; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Snyder GL, 1998, J NEUROSCI, V18, P10297; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stoof JC, 1981, NATURE, V294, P366, DOI 10.1038/294366a0; VANDERKERCKHOVE J, 1992, CURR OPIN CELL BIOL, V4, P34; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Woolley CS, 1997, J NEUROSCI, V17, P1848; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	60	67	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1186	1194		10.1074/jbc.M205754200	http://dx.doi.org/10.1074/jbc.M205754200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417592	hybrid, Green Accepted			2022-12-27	WOS:000180321900064
J	Suzuki, A; Kusakai, G; Kishimoto, A; Lu, J; Ogura, T; Lavin, MF; Esumi, H				Suzuki, A; Kusakai, G; Kishimoto, A; Lu, J; Ogura, T; Lavin, MF; Esumi, H			Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CHECKPOINT; ATAXIA-TELANGIECTASIA; NUTRIENT DEPRIVATION; GLUCOSE STARVATION; PHOSPHORYLATION; TOLERANCE; ACTIVATION; CLONING; GENE; SUBFAMILY	We identified a novel human AMP-activated protein kinase (AMPK) family member, designated ARK5, encoding 661 amino acids with an estimated molecular mass of 74 kDa. The putative amino acid sequence reveals 47, 45.8, 42.4, and 55% homology to AMPK-alpha1, AMPK-alpha2, MELK and SNARE respectively, suggesting that it is a new member of the AMPK family. It has a putative Akt phosphorylation motif at amino acids 595600, and Ser(600) was found to be phosphorylated by active Akt resulting in the activation of kinase activity toward the SAMS peptide, a consensus AMPK substrate. During nutrient starvation, ARK5 supported the survival of cells in an Akt-dependent manner. In addition, we also demonstrated that ARK5, when activated by Akt, phosphorylated the ATM protein that is mutated in the human genetic disorder ataxia-telangiectasia and also induced the phosphorylation of p53. On the basis of our current findings, we propose that a novel AMPK family member, ARK5, is the tumor cell survival factor activated by Akt and acts as an ATM kinase under the conditions of nutrient starvation.	Natl Canc Ctr, Res Inst E, Invest Treatment Div, Kashiwa, Chiba 2778577, Japan; Univ Queensland, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Dept Surg, Brisbane, Qld 4029, Australia	National Cancer Center - Japan; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Esumi, H (corresponding author), Natl Canc Ctr, Res Inst E, Invest Treatment Div, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hesumi@east.ncc.go.jp	Lavin, Martin F/F-5961-2014	Lavin, Martin F/0000-0002-5940-4769				AGUAN K, 1994, GENE, V149, P345, DOI 10.1016/0378-1119(94)90174-0; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Becker W, 1996, EUR J BIOCHEM, V235, P736, DOI 10.1111/j.1432-1033.1996.00736.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Esumi H, 2002, J BIOL CHEM, V277, P32791, DOI 10.1074/jbc.M112270200; Gardner HP, 2000, GENOMICS, V63, P46, DOI 10.1006/geno.1999.6078; Gatei M, 2001, ONCOGENE, V20, P289, DOI 10.1038/sj.onc.1204111; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hashimoto K, 2002, BIOCHEM BIOPH RES CO, V290, P263, DOI 10.1006/bbrc.2001.6193; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; INGLIS JD, 1993, MAMM GENOME, V4, P401, DOI 10.1007/BF00360595; Izuishi K, 2000, CANCER RES, V60, P6201; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Lavin MF, 2000, NAT CELL BIOL, V2, pE215, DOI 10.1038/35046628; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lefebvre DL, 2001, BIOCHEM J, V355, P297, DOI 10.1042/0264-6021:3550297; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Rotman G, 1997, CANCER SURV, V29, P285; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; SULLIVAN JE, 1994, BIOCHEM BIOPH RES CO, V200, P1551, DOI 10.1006/bbrc.1994.1627; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021	35	110	126	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					48	53		10.1074/jbc.M206025200	http://dx.doi.org/10.1074/jbc.M206025200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409306	hybrid			2022-12-27	WOS:000180255700006
J	Park, M; Ko, SBH; Choi, JY; Muallem, G; Thomas, PJ; Pushkin, A; Lee, MS; Kim, JY; Lee, MG; Muallem, S; Kurtz, I				Park, M; Ko, SBH; Choi, JY; Muallem, G; Thomas, PJ; Pushkin, A; Lee, MS; Kim, JY; Lee, MG; Muallem, S; Kurtz, I			The cystic fibrosis transmembrane conductance regulator interacts with and regulates the activity of the HCO3- salvage transporter human Na+-HCO3- cotransport isoform 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; TISSUE DISTRIBUTION; CL-/HCO3-EXCHANGE; CFTR; EXPRESSION; MEMBRANE; NBC3; DUCT; H+; COLOCALIZATION	Cystic fibrosis transmembrane conductance regulator (CFTR) regulates both HCO3- secretion and HCO3- salvage in secretory epithelia. At least two luminal transporters mediate HCO3- salvage, the Na+/H+ exchanger (NHE3) and the Na+-HCO3- cotransport (NBC3). In a previous work, we show that CFTR interacts with NHE3 to regulate its activity (Ahn, W., Kim, K.W., Lee, J.A., Kim, J.Y., Choi, J.Y., Moe, O.M., Milgram, S.L., Muallem, S., and Lee, M. G. (2001) J. Biol. Chem. 276,17236-17243). In this work, we report that transient or stable expression of human NBC3 (hNBC3) in HEK cells resulted in a Na+-dependent, DIDS (4,4'-diisothiocyanostilbene-2,2'-disulfonic acid)- and 5-ethylisopropylamiloride-insensitive HCO3- transport. Stimulation of CFTR with forskolin markedly inhibited NBC3 activity. This inhibition was prevented by the inhibition of protein kinase A. NBC3 and CFTR could be reciprocally coimmunoprecipitated from transfected HEK cells and from the native pancreas and submandibular and parotid glands. Precipitation of NBC3 or CFTR from transfected HEK293 cells and from the pancreas and submandibular gland also coimmunoprecipitated EBP50. Glutathione S-transferase-EBP50 pulled down CFTR and hNBC3 from cell lysates when expressed individually and as a complex when expressed together. Notably, the deletion of the C-terminal PDZ binding motifs of CFTR or hNBC3 prevented coimmunoprecipitation of the proteins and inhibition of hNBC3 activity by CFTR. We conclude that CFTR and NBC3 reside in the same HCO3--transporting complex with the aid of PDZ domain-containing scaffolds, and this interaction is essential for regulation of NBC3 activity by CFTR. Furthermore, these findings add additional evidence for the suggestion that CFTR regulates the overall trans-cellular HCO3- transport by regulating the activity of all luminal HCO3- secretion and salvage mechanisms of secretory epithelial cells.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Univ Calif Los Angeles, Dept Med, Div Nephrol, Los Angeles, CA 90095 USA; Sookmyung Womens Univ, Dept Sci Biol, Seoul 140742, South Korea; Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Seoul 120752, South Korea	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles; Sookmyung Women's University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Muallem, S (corresponding author), Univ Texas, SW Med Ctr, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	SHMUEL.MUALLEM@utsouthwestern.edu	Lee, Min Goo/AAS-4636-2020; Thomas, Philip J/F-7115-2012; Ko, Shigeru/H-3450-2012; Lee, Min Goo/D-5635-2012; Kim, Joo Young/X-7562-2019	Lee, Min Goo/0000-0001-7436-012X; Ko, Shigeru/0000-0003-1913-6357; Lee, Min Goo/0000-0001-7436-012X; Kim, Joo Young/0000-0003-2623-1491	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE12309] Funding Source: Medline; NIDDK NIH HHS [DK58563] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; ARGENT BE, 1994, PHYSL GASTROINTESTIN, P1478; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Ishiguro H, 1996, J PHYSIOL-LONDON, V495, P169, DOI 10.1113/jphysiol.1996.sp021582; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; Kwon TH, 2002, AM J PHYSIOL-RENAL, V282, pF341, DOI 10.1152/ajprenal.00104.2001; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lee MG, 2000, J CLIN INVEST, V105, P1651, DOI 10.1172/JCI9207; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; Luo X, 2001, J BIOL CHEM, V276, P9808, DOI 10.1074/jbc.M008548200; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Praetorius J, 2001, AM J PHYSIOL-GASTR L, V280, pG332, DOI 10.1152/ajpgi.2001.280.3.G332; Pushkin A, 2000, J ANDROL, V21, P708; Pushkin A, 1999, AM J PHYSIOL-RENAL, V277, pF974, DOI 10.1152/ajprenal.1999.277.6.F974; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; QUINTON PM, 1999, PHYSIOL REV, V79, P3; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; TIZZANO EF, 1995, ANN INTERN MED, V123, P305, DOI 10.7326/0003-4819-123-4-199508150-00009; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57	29	77	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50503	50509		10.1074/jbc.M201862200	http://dx.doi.org/10.1074/jbc.M201862200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12403779	hybrid			2022-12-27	WOS:000180177700042
J	Croci, C; Brandstatter, JH; Enz, R				Croci, C; Brandstatter, JH; Enz, R			ZIP3, a new splice variant of the PKC-zeta-interacting protein family, binds to GABAc receptors, PKC-zeta, and Kv beta 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL BIPOLAR CELLS; KAPPA-B ACTIVATION; HIGH-EFFICIENCY TRANSFORMATION; KINASE-C-ZETA; RHO-SUBUNITS; SUPERIOR COLLICULUS; MAMMALIAN RETINA; RAT-BRAIN; PHOSPHORYLATION; P62	The correct targeting of modifying enzymes to ion channels and neurotransmitter receptors represents an important biological mechanism to control neuronal excitability. The recent cloning of protein kinase C-zeta interacting proteins (ZIP1, ZIP2) identified new scaffolds linking the atypical protein kinase PKC-zeta to target proteins. GABA(C) receptors are composed of three p subunits (rho1-3) that are highly expressed in the retina, where they are clustered at synaptic terminals of bipolar cells. A yeast two-hybrid screen for the GABAc receptor rho3 subunit identified ZIP3, a new C-terminal splice variant of the ZIP protein family. ZIP3 was ubiquitously expressed in non-neuronal and neuronal tissues, including the retina. The rho3-binding region of ZIP3 contained a ZZ-zinc finger domain, which interacted with 10 amino acids conserved in rho1-3 but not in GABA(A) receptors. Consistently, only rho1-3 subunits bound to ZIP3. ZIP3 formed dimers with ZIP1-3 and interacted with PKC-zeta and the shaker-type potassium channel subunit Kvbeta2. Different domains of ZIP3 interacted with PKC-zeta and the rho3 subunit, and simultaneous assembly of ZIP3, PKC-zeta and rho3 was demonstrated in vitro. Subcellular co-expression of ZIP3 binding partners in the retina supported the proposed protein interactions. Our results indicate the formation of a ternary postsynaptic complex containing PKC-zeta ZIP3, and GABA(C) receptors.	Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; Max Planck Inst Hirnforsch, Abt Neuroanat, D-60528 Frankfurt, Germany	University of Erlangen Nuremberg; Max Planck Society	Enz, R (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.							ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Billups D, 2000, J NEUROSCI, V20, P8643; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; Boue-Grabot E, 1998, J NEUROCHEM, V70, P899; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cherubini E, 1998, PERSPECT DEV NEUROBI, V5, P289; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cohen PTW, 2002, J CELL SCI, V115, P241; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Delaney AJ, 2001, J NEUROPHYSIOL, V86, P717, DOI 10.1152/jn.2001.86.2.717; DREW CA, 1992, J NEUROCHEM, V58, P1087, DOI 10.1111/j.1471-4159.1992.tb09366.x; Enz R, 2001, BIOL CHEM, V382, P1111, DOI 10.1515/BC.2001.141; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; FEIGENSPAN A, 1994, EUR J PHARM-MOLEC PH, V288, P97, DOI 10.1016/0922-4106(94)90014-0; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Filippova N, 2000, MOL PHARMACOL, V57, P847; Filippova N, 1999, J PHYSIOL-LONDON, V518, P385, DOI 10.1111/j.1469-7793.1999.0385p.x; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; GOMEZ J, 1995, EUR J IMMUNOL, V25, P2673, DOI 10.1002/eji.1830250941; Gong JP, 1999, SCIENCE, V285, P1565, DOI 10.1126/science.285.5433.1565; Hackam AS, 1997, J BIOL CHEM, V272, P13750, DOI 10.1074/jbc.272.21.13750; Hanley JG, 2000, J BIOL CHEM, V275, P840, DOI 10.1074/jbc.275.2.840; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; KOISTINAHO J, 1994, NEUROSCI LETT, V177, P15, DOI 10.1016/0304-3940(94)90033-7; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Kusama T, 1998, NEUROSCI LETT, V255, P17, DOI 10.1016/S0304-3940(98)00696-X; Kusama T, 1995, EUR J PHARM-MOLEC PH, V291, P431, DOI 10.1016/0922-4106(95)90086-1; Kusama T, 2000, JPN J PHYSIOL, V50, P429, DOI 10.2170/jjphysiol.50.429; Martina M, 1996, EUR J NEUROSCI, V8, P2168, DOI 10.1111/j.1460-9568.1996.tb00738.x; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; OSBORNE NN, 1994, BRAIN RES, V637, P156, DOI 10.1016/0006-8993(94)91228-9; Pasternack M, 1999, J NEUROPHYSIOL, V82, P2020, DOI 10.1152/jn.1999.82.4.2020; Pattnaik B, 2000, J NEUROSCI, V20, P6789, DOI 10.1523/JNEUROSCI.20-18-06789.2000; Platt B, 1998, NEUROPHARMACOLOGY, V37, P1111, DOI 10.1016/S0028-3908(98)00100-2; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P11, DOI 10.1016/0968-0004(96)80878-4; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt M, 2001, J NEUROSCI, V21, P691, DOI 10.1523/JNEUROSCI.21-02-00691.2001; Sedelnikova A, 2002, INT J DEV NEUROSCI, V20, P237, DOI 10.1016/S0736-5748(02)00037-0; Seibenhener M L, 1999, Mol Cell Biol Res Commun, V2, P28, DOI 10.1006/mcbr.1999.0140; Shields CR, 2000, J NEUROSCI, V20, P2673; STRATA F, 1994, J PHYSIOL-LONDON, V480, P493, DOI 10.1113/jphysiol.1994.sp020378; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Vadlamudi RK, 1998, FEBS LETT, V435, P138, DOI 10.1016/S0014-5793(98)01021-7; Wegelius K, 1998, EUR J NEUROSCI, V10, P350, DOI 10.1046/j.1460-9568.1998.00023.x; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Zhang DX, 2001, TRENDS PHARMACOL SCI, V22, P121, DOI 10.1016/S0165-6147(00)01625-4; Zhu JJ, 1999, J NEUROSCI, V19, P5721, DOI 10.1523/JNEUROSCI.19-14-05721.1999	59	48	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					6128	6135		10.1074/jbc.M205162200	http://dx.doi.org/10.1074/jbc.M205162200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12431995	hybrid			2022-12-27	WOS:000181129400080
J	Leys, D; Mowat, CG; McLean, KJ; Richmond, A; Chapman, SK; Walkinshaw, MD; Munro, AW				Leys, D; Mowat, CG; McLean, KJ; Richmond, A; Chapman, SK; Walkinshaw, MD; Munro, AW			Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; HEMOPROTEIN DOMAIN; HEME DOMAIN; SUBSTRATE; SUPERFAMILY; REFINEMENT; PROTOTYPE; ENZYMES; BINDING	The first structure of a P450 to an atomic resolution of 1.06 Angstrom has been solved for CYP121 from Mycobacterium tuberculosis. A comparison with P450 EryF (CYP107A1) reveals a remarkable overall similarity in fold with major differences residing in active site structural elements. The high resolution obtained allows visualization of several unusual aspects. The heme cofactor is bound in two distinct conformations while being notably kinked in one pyrrole group due to close interaction with the proline residue (Pro(346)) immediately following the heme iron-ligating cysteine (Cys(345)). The active site is remarkably rigid in comparison with the remainder of the structure, notwithstanding the large cavity volume of 1350 Angstrom(3). The region immediately surrounding the distal water ligand is remarkable in several aspects. Unlike other bacterial P450s, the I helix shows no deformation, similar to mammalian CYP2C5. In addition, the positively charged Arg(386) is located immediately above the heme plane, dominating the local structure. Putative proton relay pathways from protein surface to heme (converging at Ser(279)) are identified. Most interestingly, the electron density indicates weak binding of a dioxygen molecule to the P450. This structure provides a basis for rational design of putative antimycobacterial agents.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Edinburgh, Inst Cellular & Mol Biol, Struct Biochem Grp, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Strathclyde, Royal Coll, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland; Univ Edinburgh, Dept Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Leicester; University of Edinburgh; University of Strathclyde; University of Edinburgh	Leys, D (corresponding author), Univ Leicester, Dept Biochem, Adrian Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.	dl37@le.ac.uk	McLean, Kirsty J/GXI-2853-2022; walkinshaw, malcolm/AAB-7497-2019; Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; walkinshaw, malcolm/0000-0001-5955-9325				ANDERSEN JF, 1993, BIOCHEMISTRY-US, V32, P1905, DOI 10.1021/bi00059a004; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bille J, 2000, INT J ANTIMICROB AG, V16, P331, DOI 10.1016/S0924-8579(00)00260-0; BODDUPALLI SS, 1992, P NATL ACAD SCI USA, V89, P5567, DOI 10.1073/pnas.89.12.5567; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; CuppVickery JR, 1996, NAT STRUCT BIOL, V3, P632, DOI 10.1038/nsb0796-632; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Gunsalus I C, 1978, Methods Enzymol, V52, P166; IMAI T, 1993, J BIOL CHEM, V268, P19681; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; Lamb DC, 2002, BIOCHEM J, V364, P555, DOI 10.1042/BJ20011380; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Miles CS, 2000, BBA-PROTEIN STRUCT M, V1543, P383, DOI 10.1016/S0167-4838(00)00236-3; MODI S, 1995, BIOCHEM J, V310, P939, DOI 10.1042/bj3100939; Mortuza GB, 1997, FEBS LETT, V412, P610, DOI 10.1016/S0014-5793(97)00870-3; Mowat CG, 2002, ACTA CRYSTALLOGR D, V58, P704, DOI 10.1107/S0907444902002676; Munro AW, 1996, MOL MICROBIOL, V20, P1115, DOI 10.1111/j.1365-2958.1996.tb02632.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muskett FW, 1996, J MOL BIOL, V258, P172, DOI 10.1006/jmbi.1996.0241; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Unno M, 2002, J BIOL CHEM, V277, P2547, DOI 10.1074/jbc.M108917200; VOIECHOVSKY J, 1999, BIOPHYS J, V77, P2153; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014	40	124	131	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5141	5147		10.1074/jbc.M209928200	http://dx.doi.org/10.1074/jbc.M209928200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435731	Green Published, hybrid			2022-12-27	WOS:000180968900101
J	Sichler, K; Kopetzki, E; Huber, R; Bode, W; Hopfner, KP; Brandstetter, H				Sichler, K; Kopetzki, E; Huber, R; Bode, W; Hopfner, KP; Brandstetter, H			Physiological fIXa activation involves a cooperative conformational rearrangement of the 99-loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR IXA; PLASMA THROMBOPLASTIN ANTECEDENT; X-RAY STRUCTURE; ACTIVE-SITE; CHRISTMAS FACTOR; HEMOPHILIA-B; CATALYTIC ACTIVITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; FACTOR-XIA	Coagulation factor IXa (fIXa) plays a central role in the coagulation cascade. Enzymatically, fIXa is characterized by its very low amidolytic activity that is not improved in the presence of cofactor, factor VIIIa (fVIIIa), distinguishing fIXa from all other coagulation factors. Activation of the fIXa-fVIIIa complex requires its macromolecular substrate, factor X (fX). The 99-loop positioned near the active site partly accounts for the poor activity of fIXa because it adopts a conformation that interferes with canonical substrate binding in S2-S4. Here we show that residues Lys-98 and Tyr-99 are critically linked to the amidolytic properties of fIXa. Exchange of Tyr-99 with smaller residues resulted not only in an overall decreased activity but also in impaired binding in S1. Replacement of Lys-98 with smaller and uncharged residues increased activity. Simultaneous mutagenesis of Lys-98, Tyr-177, and Tyr-94 produced an enzyme with 7000-fold increased activity and altered specificity. This triple mutant probably mimics the conformational changes that are physiologically induced by cofactor and substrate binding. It therefore provides a cooperative two-step activation model for fIXa. Tyr-177 locks the 99-loop in an inactive conformation which, in the physiologic complex, is released by cofactor fVIIIa. FX is then able to rearrange the unlocked 99-loop and subsequently binds to the active site cleft.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Roche Diagnost GmbH, D-82372 Penzberg, Germany; Univ Munich, Geozentrum, D-81377 Munich, Germany	Max Planck Society; Roche Holding; University of Munich	Sichler, K (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hopfner, Karl-Peter/B-6864-2014; Brandstetter, Hans/E-6754-2011	Hopfner, Karl-Peter/0000-0002-4528-8357; Brandstetter, Hans/0000-0002-6089-3045				Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BODE W, 1979, J MOL BIOL, V127, P357, DOI 10.1016/0022-2836(79)90227-4; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; Brandstetter H, 1996, J BIOL CHEM, V271, P29988, DOI 10.1074/jbc.271.47.29988; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; ESMON CT, 1973, THESIS WASHINGTON U; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; Giannelli F, 1998, NUCLEIC ACIDS RES, V26, P265, DOI 10.1093/nar/26.1.265; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Hopfner KP, 1999, STRUCTURE, V7, P989, DOI 10.1016/S0969-2126(99)80125-7; Kolkman JA, 2000, BIOCHEMISTRY-US, V39, P7398, DOI 10.1021/bi992735q; Kopetzki E., 1996, Patent, Patent No. [US 5489528, 5489528]; KOPETZKI E, 1992, Patent No. 612325; Krishnan R, 2000, ACTA CRYSTALLOGR D, V56, P406, DOI 10.1107/S0907444900001487; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; LOZIER JN, 1990, BLOOD, V75, P1097; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MCRAE BJ, 1981, BIOCHEMISTRY-US, V20, P7196, DOI 10.1021/bi00528a022; NEUENSCHWANDER PF, 1994, J BIOL CHEM, V270, P970; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; PEDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P9331, DOI 10.1021/bi00450a013; ROSING J, 1980, J BIOL CHEM, V255, P274; Sambrook J., 2002, MOL CLONING LAB MANU; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Stone SR, 1997, J MOL BIOL, V265, P344, DOI 10.1006/jmbi.1996.0727; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9	30	36	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4121	4126		10.1074/jbc.M210722200	http://dx.doi.org/10.1074/jbc.M210722200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12444082	hybrid			2022-12-27	WOS:000180869700078
J	Villa, H; Marcos, ARO; Reguera, RM; Balana-Fouce, R; Garcia-Estrada, C; Perez-Pertejo, Y; Tekwani, BL; Myler, PJ; Stuart, KD; Bjornsti, MA; Ordonez, D				Villa, H; Marcos, ARO; Reguera, RM; Balana-Fouce, R; Garcia-Estrada, C; Perez-Pertejo, Y; Tekwani, BL; Myler, PJ; Stuart, KD; Bjornsti, MA; Ordonez, D			A novel active DNA topoisomerase I in Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE; PROTEIN; DOMAIN; FORMS	A common feature shared by type I DNA topoisomerases is the presence of a "serine, lysine, X, X, tyrosine" motif as conventional enzyme active site. Preliminary data have shown that Leishmania donovani DNA topoisomerase I gene (LdTOP1A) lacked this conserved motif, giving rise to different theories about the reconstitution of an active DNA topoisomerase I in this parasite. We, herein, describe the molecular cloning of a new DNA topoisomerase I gene from L. donovani (LdTOP1B) containing the highly conserved serine, lysine, X, X, tyrosine motif. DNA topoisomerase I activity was detected only when both genes (LdTOP1A and LdTOP1B) were co-expressed in a yeast expression system, suggesting the existence of a dimeric DNA topoisomerase I in Leishmania parasites.	Univ Leon, Dept Farmacol & Toxicol, INTOXCAL, E-24071 Leon, Spain; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Seattle Biomed Res Inst, Seattle, WA 98195 USA; Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA	Universidad de Leon; St Jude Children's Research Hospital; Center for Infectious Disease Research; University of Mississippi	Ordonez, D (corresponding author), Univ Leon, Dept Farmacol & Toxicol, INTOXCAL, Campus Vegazana S-N, E-24071 Leon, Spain.	dftrbf@unileon.es	Balana-Fouce, Rafael/K-4890-2014; Pérez-Pertejo, Yolanda/K-6609-2017; Garcia-Estrada, Carlos/F-7932-2014; Balana-Fouce, Rafael/AAK-9485-2021; Reguera, Rosa M/K-6027-2017; Myler, Peter John/AAR-9535-2021	Balana-Fouce, Rafael/0000-0003-0418-6116; Pérez-Pertejo, Yolanda/0000-0003-2361-3785; Garcia-Estrada, Carlos/0000-0001-5617-9669; Balana-Fouce, Rafael/0000-0003-0418-6116; Reguera, Rosa M/0000-0001-9148-2997; Myler, Peter/0000-0002-0056-0513	NCI NIH HHS [R01 CA058755, CA 58755] Funding Source: Medline; NIAID NIH HHS [U01 AI040599] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI040599] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BRAHMS S, 1989, EUR J BIOCHEM, V184, P297, DOI 10.1111/j.1432-1033.1989.tb15019.x; Broccoli S, 1999, NUCLEIC ACIDS RES, V27, P2745, DOI 10.1093/nar/27.13.2745; Burke D, 2000, METHODS YEAST GENETI, P103; CHAKRABORTY AK, 1993, INDIAN J BIOCHEM BIO, V30, P257; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheesman SJ, 2000, PARASITOL TODAY, V16, P277, DOI 10.1016/S0169-4758(00)01697-5; Cheng CH, 1998, J BIOL CHEM, V273, P11589, DOI 10.1074/jbc.273.19.11589; Das A, 2002, NUCLEIC ACIDS RES, V30, P794, DOI 10.1093/nar/30.3.794; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GOTO T, 1984, J BIOL CHEM, V259, P422; Ivens AC, 1998, GENOME RES, V8, P135, DOI 10.1101/gr.8.2.135; JAXEL C, 1989, EMBO J, V8, P3135, DOI 10.1002/j.1460-2075.1989.tb08466.x; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; LYNN RM, 1989, P NATL ACAD SCI USA, V86, P3559, DOI 10.1073/pnas.86.10.3559; MEADE JC, 1987, MOL CELL BIOL, V7, P3937, DOI 10.1128/MCB.7.11.3937; Quijada L, 1997, J BIOL CHEM, V272, P4493, DOI 10.1074/jbc.272.7.4493; SAMBROOK J, 1989, MOL CLONING, V9, P14; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Stewart L, 1996, J BIOL CHEM, V271, P7593, DOI 10.1074/jbc.271.13.7593; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Woo MH, 2000, METH MOL B, V95, P303; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	26	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3521	3526		10.1074/jbc.M203991200	http://dx.doi.org/10.1074/jbc.M203991200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12444094	hybrid			2022-12-27	WOS:000180869700004
J	Zhao, WQ; Chen, GH; Chen, H; Pascale, A; Ravindranath, L; Quon, MJ; Alkon, DL				Zhao, WQ; Chen, GH; Chen, H; Pascale, A; Ravindranath, L; Quon, MJ; Alkon, DL			Secretion of annexin II via activation of insulin receptor and insulin-like growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; TETRAMER; IDENTIFICATION; PARTICIPATION; ASSOCIATION; AGGREGATION; EXOCYTOSIS; SUBSTRATE	Annexin II is secreted into the extracellular environment, where, via interactions with specific proteases and extracellular matrix proteins, it participates in plasminogen activation, cell adhesion, and tumor metastasis and invasion. However,; mechanisms regulating annexin II transport across the cellular membrane are unknown. In this study, we used coimmunoprecipitation to show that Annexin-II was bound to insulin and insulin-like growth factor-1 (IGF-1) receptors in PC12 cells and NIH-3T3 cells overexpressing insulin (NIH-3T3(IR)) or IGF-1 receptor (NIH-3T3(IGF-IR)). Stimulation of insulin and IGF-1 receptors, by insulin caused a temporary dissociation of annexin II from these receptors, which was accompanied by;an increased amount of extracellular annexin II detected in the media of PC12, NIH-3T3(IR), and NIH-3T3(IGF-IR) cells but not in that of untransfected NIH-3T3 cells. Activation of a different growth factor receptor, the platelet-derived growth factor receptor, did not produce such results. Tyrphostin AG1024, a tyrosine kinase inhibitor of insulin and IGF-1 receptor, was shown to inhibit annexin II secretion along with reduced receptor phosphorylation. Inhibitors of a few downstream signaling enzymes including phosphatidylinositol 3-kinase, pp60c-Src, and protein kinase C had no effect on insulin-induced annexin II secretion, suggesting a possible direct link between receptor activation and annex in II secretion. Immunocytochemistry revealed that insulin also induced transport of the membrane-bound form of annexin II to the outside layer of the cell membrane and appeared to promote cell aggregation. These results suggest that the insulin receptor and its signaling pathways may participate in molecular mechanisms mediating annexin II secretion.	Blanchette Rockefeller Neurosci Inst, Rockville, MD 20850 USA; NINDS, Lab Adapt Syst, NIH, Bethesda, MD 20892 USA; NCCAM, LCI, Diabet Unit, NIH, Bethesda, MD 20892 USA; Univ Pavia, Dept Expt & Appl Pharmacol, I-27100 Pavia, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine; University of Pavia	Zhao, WQ (corresponding author), Blanchette Rockefeller Neurosci Inst, 9601 Med Ctr Dr,Acad & Res Bldg,3rd Fl, Rockville, MD 20850 USA.		Quon, Michael/B-1970-2008	Quon, Michael/0000-0002-9601-9915; QUON, MICHAEL/0000-0002-5289-3707	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [ZIAAT000002, Z01AT000002] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		ALI SM, 1990, CELL SIGNAL, V2, P265, DOI 10.1016/0898-6568(90)90054-E; Benz J, 1997, BIOL CHEM, V378, P177; Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Burger A, 1996, J MOL BIOL, V257, P839, DOI 10.1006/jmbi.1996.0205; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Chung CY, 1996, MOL BIOL CELL, V7, P883, DOI 10.1091/mbc.7.6.883; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; DURONIO V, 1988, J BIOL CHEM, V263, P5436; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; Hajjar KA, 1999, TRENDS CARDIOVAS MED, V9, P128, DOI 10.1016/S1050-1738(99)00020-1; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; JACOBS S, 1983, P NATL ACAD SCI-BIOL, V80, P1228, DOI 10.1073/pnas.80.5.1228; Jiang YX, 1996, J BIOL CHEM, V271, P160, DOI 10.1074/jbc.271.1.160; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; Jost M, 1997, J CELL SCI, V110, P221; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; KATO H, 1993, J BIOL CHEM, V268, P2655; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kristoffersen EK, 1996, AM J REPROD IMMUNOL, V36, P141; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Nystrom FH, 1999, CELL SIGNAL, V11, P563, DOI 10.1016/S0898-6568(99)00025-X; POOLE AR, 1978, NATURE, V273, P545, DOI 10.1038/273545a0; QUON MJ, 1992, BIOCHEMISTRY-US, V31, P9947, DOI 10.1021/bi00156a013; RECKLIES AD, 1980, CANCER RES, V40, P550; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Rothhut B, 1997, CELL MOL LIFE SCI, V53, P522, DOI 10.1007/s000180050066; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; Siever DA, 1997, INT J BIOCHEM CELL B, V29, P1219, DOI 10.1016/S1357-2725(97)00057-5; TRESSLER RJ, 1993, J CELL BIOCHEM, V53, P265, DOI 10.1002/jcb.240530311; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; WEBER K, 1992, ANNEXINS, P61; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520	37	47	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4205	4215		10.1074/jbc.M210545200	http://dx.doi.org/10.1074/jbc.M210545200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12431980	hybrid			2022-12-27	WOS:000180869700088
J	Percherancier, Y; Lagane, B; Planchenault, T; Staropoli, I; Altmeyer, R; Virelizier, JL; Arenzana-Seisdedos, F; Hoessli, DC; Bachelerie, F				Percherancier, Y; Lagane, B; Planchenault, T; Staropoli, I; Altmeyer, R; Virelizier, JL; Arenzana-Seisdedos, F; Hoessli, DC; Bachelerie, F			HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PLASMA-MEMBRANE; LIPID RAFTS; CYTOPLASMIC DOMAIN; ANCHORED PROTEINS; RAPID METHOD; CHOLESTEROL; FUSION; RECEPTOR; PALMITOYLATION	The contribution of raft domains to human immunodeficiency virus (HIV) 1 entry was assessed. In particular, we asked whether the CD4 and CCR5 HIV-1 receptors need to associate with sphingolipid-enriched, detergent-resistant membrane domains (rafts) to allow viral entry into primary and T-cell lines. Based on Triton X-100 solubilization and confocal microscopy, CD4 was shown to distribute partially to rafts. In contrast, CCR5 did not associate with rafts and localized in nonraft plasma membrane domains. HIV-1-receptor partitioning remained unchanged upon viral adsorption, suggesting that viral entry probably takes place outside rafts. To directly investigate this possibility, we targeted CD4 to nonraft domains of the membrane by preventing CD4 palmitoylation and interaction with p56(lck). Directed mutagenesis of both targeting signals significantly prevented association of CD4 with rafts, but did not suppress the HIV-1 receptor function of CD4. Collectively, these results strongly suggest that the presence of HIV-1 receptors in rafts is not required for viral infection. We show, however, that depleting plasma membrane cholesterol inhibits HIV-1 entry. We therefore propose that cholesterol modulates the HIV-1 entry process independently of its ability to promote raft formation.	Inst Pasteur, Unite Immunol Virale, F-75724 Paris 15, France; Univ Geneva, Ctr Med, Dept Pathol, CH-1211 Geneva 4, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva	Bachelerie, F (corresponding author), Inst Pasteur, Unite Immunol Virale, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	fbachele@pasteur.fr	Lagane, Bernard/K-8446-2016; Lagane, Bernard/AAA-2205-2019; BACHELERIE, FRANCOISE/F-8823-2013; Arenzana-Seisdedos, Fernando/E-5835-2016	Lagane, Bernard/0000-0002-3459-7867; BACHELERIE, FRANCOISE/0000-0002-0399-3277; percherancier, yann/0000-0002-2410-5806				Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; BEDINGER P, 1988, NATURE, V334, P162, DOI 10.1038/334162a0; Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOHUSLAV J, 1993, EUR J IMMUNOL, V23, P825, DOI 10.1002/eji.1830230409; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; BUTTKE TM, 1992, J BIOL CHEM, V267, P8819; Chanel C, 2002, AIDS, V16, P2337, DOI 10.1097/00002030-200211220-00016; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; CHERNOMORDIK L, 1995, BIOPHYS J, V69, P922, DOI 10.1016/S0006-3495(95)79966-0; Christian AE, 1997, J LIPID RES, V38, P2264; CINEK T, 1995, IMMUNOGENETICS, V41, P110, DOI 10.1007/BF00182321; CRISE B, 1992, J BIOL CHEM, V267, P13593; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dimitrov DS, 2000, CELL, V101, P697, DOI 10.1016/S0092-8674(00)80882-X; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Dunphy JT, 2001, J BIOL CHEM, V276, P43300, DOI 10.1074/jbc.M104275200; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Foti M, 2002, P NATL ACAD SCI USA, V99, P2008, DOI 10.1073/pnas.042689099; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Ge MT, 1999, BIOPHYS J, V77, P925, DOI 10.1016/S0006-3495(99)76943-2; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Haque ME, 2001, BIOCHEMISTRY-US, V40, P4340, DOI 10.1021/bi002030k; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Ilangumaran S, 2000, IMMUNOL TODAY, V21, P2, DOI 10.1016/S0167-5699(99)01494-2; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Ilangumaran S, 1997, BBA-BIOMEMBRANES, V1328, P227, DOI 10.1016/S0005-2736(97)00099-0; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769; Kozak SL, 2002, J VIROL, V76, P1802, DOI 10.1128/JVI.76.4.1802-1815.2002; Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200; Lagane B, 2002, BIOPHYS CHEM, V95, P7, DOI 10.1016/S0301-4622(01)00235-6; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; MAEDA T, 1983, BIOCHIM BIOPHYS ACTA, V731, P115, DOI 10.1016/0005-2736(83)90404-2; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; MCCLARE CWF, 1971, ANAL BIOCHEM, V39, P527, DOI 10.1016/0003-2697(71)90443-X; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Millan J, 1999, TISSUE ANTIGENS, V53, P33, DOI 10.1034/j.1399-0039.1999.530104.x; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Nguyen DH, 2002, BLOOD, V99, P4298, DOI 10.1182/blood-2001-11-0087; Nguyen DH, 2002, J IMMUNOL, V168, P4121, DOI 10.4049/jimmunol.168.8.4121; Ostermeyer AG, 1999, J BIOL CHEM, V274, P34459, DOI 10.1074/jbc.274.48.34459; Parolini I, 1996, BLOOD, V87, P3783, DOI 10.1182/blood.V87.9.3783.bloodjournal8793783; Patra SK, 1998, BBA-BIOMEMBRANES, V1373, P112, DOI 10.1016/S0005-2736(98)00095-9; Peisajovich SG, 2000, BIOCHEMISTRY-US, V39, P1826, DOI 10.1021/bi991887i; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Pereira FB, 1997, BIOPHYS J, V73, P1977, DOI 10.1016/S0006-3495(97)78228-6; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Prior IA, 2001, J CELL SCI, V114, P1603; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Solomon KR, 1998, BIOCHEM J, V334, P325, DOI 10.1042/bj3340325; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Stegmann T, 2000, TRAFFIC, V1, P598, DOI 10.1034/j.1600-0854.2000.010803.x; TREMBLAY M, 1994, EMBO J, V13, P774, DOI 10.1002/j.1460-2075.1994.tb06320.x; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Ugolini S, 1997, J IMMUNOL, V159, P3000; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xiao XD, 2000, EXP MOL PATHOL, V68, P133, DOI 10.1006/exmp.1999.2300; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	82	94	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3153	3161		10.1074/jbc.M207371200	http://dx.doi.org/10.1074/jbc.M207371200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431990	hybrid			2022-12-27	WOS:000180915000050
J	Petrat, F; Pindiur, S; Kirsch, M; de Groot, H				Petrat, F; Pindiur, S; Kirsch, M; de Groot, H			NAD(P)H, a primary target of O-1(2) in mitochondria of intact cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLET OXYGEN; PERMEABILITY TRANSITION; CHELATABLE IRON; RAT HEPATOCYTES; PHOTODYNAMIC THERAPY; CULTURED-HEPATOCYTES; ELECTRON-TRANSFER; IN-VIVO; APOPTOSIS; ANTIOXIDANT	Direct reaction of NAD(P)H with oxidants like singlet oxygen (O-1(2)) has not yet been demonstrated in biological systems. We therefore chose different rhodamine derivatives (tetramethylrhodamine methyl ester, TMRM; 2',4',5',7'-tetrabromorhodamine 123 bromide; and rhodamine 123; Rho 123) to selectively generate singlet oxygen within the NAD(P)H-rich mitochondrial matrix of cultured hepatocytes. In a cell-free system, photoactivation of all of these dyes led to the formation of O-1(2), which readily oxidized NAD(P)H to NAD(P)(+). In hepatocytes loaded with the various dyes only TMRM and Rho 123 proved suited to generating O-1(2) within the mitochondrial matrix space. Photoactivation of the intracellular dyes (TMRM for 5-10 s, Rho 123 for 60 s) led to a significant (29.6 +/- 8.2 and 30.2 +/- 5.2%) and rapid decrease in mitochondrial NAD(P)H fluorescence followed by a slow reincrease. Prolonged photoactivation. (greater than or equal to15 s) of TMRM-loaded cells resulted in even stronger NAD(P)H oxidation, the rapid onset of mitochondrial permeability transition, and apoptotic cell death. These results demonstrate that NAD (P)H is the primary target for O-1(2) in hepatocyte mitochondria. Thus NAD(P)H may operate directly as an intracellular antioxidant, as long as it is regenerated. At cell-injurious concentrations of the oxidant, however, NAD(P)H depletion may be the event that triggers cell death.	Univ Essen Gesamthsch Klinikum, Inst Physiol Chem, D-45122 Essen, Germany	University of Duisburg Essen	de Groot, H (corresponding author), Univ Essen Gesamthsch Klinikum, Inst Physiol Chem, Hufelandstr 55, D-45122 Essen, Germany.	h.de.groot@uni-essen.de						Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2; ADAMSON GM, 1993, BIOCHEM PHARMACOL, V45, P2289, DOI 10.1016/0006-2952(93)90201-7; Atamna H, 2001, FASEB J, V15, P2196, DOI 10.1096/fj.01-0134com; BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; BODANESS RS, 1977, J BIOL CHEM, V252, P8554; BODANESS RS, 1982, BIOCHEM BIOPH RES CO, V108, P1709, DOI 10.1016/S0006-291X(82)80108-3; COREY EJ, 1987, BIOCHEM BIOPH RES CO, V145, P842, DOI 10.1016/0006-291X(87)91041-2; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; DEGROOT H, 1991, BIOL CHEM H-S, V372, P35, DOI 10.1515/bchm3.1991.372.1.35; Diaz G, 2000, FEBS LETT, V475, P218, DOI 10.1016/S0014-5793(00)01683-5; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; EVANS PJ, 1994, METHOD ENZYMOL, V233, P82; Ferreira FML, 1999, LIFE SCI, V65, P1013, DOI 10.1016/S0024-3205(99)00332-X; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; HAUGLAND RP, 1996, HDB FLUORESCENT PROB, P479; HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x; HOEK JB, 1988, BIOCHEM J, V254, P1; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Huser J, 1998, BIOPHYS J, V74, P2129, DOI 10.1016/S0006-3495(98)77920-2; Kessel D, 1999, CELL DEATH DIFFER, V6, P28, DOI 10.1038/sj.cdd.4400446; Kessel D, 1998, J PHOTOCH PHOTOBIO B, V42, P89, DOI 10.1016/S1011-1344(97)00127-9; Kessel D, 1997, PHOTOCHEM PHOTOBIOL, V65, P422, DOI 10.1111/j.1751-1097.1997.tb08581.x; Kirsch M, 1999, J BIOL CHEM, V274, P24664, DOI 10.1074/jbc.274.35.24664; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; KOPPENOL WH, 1976, NATURE, V262, P420, DOI 10.1038/262420a0; Lass A, 2000, FASEB J, V14, P87, DOI 10.1096/fasebj.14.1.87; LEE CP, 1964, BIOCHIM BIOPHYS ACTA, V81, P187, DOI 10.1016/0926-6569(64)90353-0; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Leopold JA, 2001, FASEB J, V15, P1771, DOI 10.1096/fj.00-0893fje; Li X, 2001, ARCH BIOCHEM BIOPHYS, V387, P143, DOI 10.1006/abbi.2000.2245; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; MOAN J, 1990, J PHOTOCH PHOTOBIO B, V6, P343, DOI 10.1016/1011-1344(90)85104-5; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; MODICANAPOLITANO JS, 1987, CANCER RES, V47, P4361; Moor ACE, 2000, J PHOTOCH PHOTOBIO B, V57, P1, DOI 10.1016/S1011-1344(00)00065-8; NADAKAVUKAREN KK, 1985, CANCER RES, V45, P6093; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; OGILBY PR, 1982, J AM CHEM SOC, V104, P2069, DOI 10.1021/ja00371a067; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; PARKER JG, 1984, J PHOTOCHEM, V25, P545, DOI 10.1016/0047-2670(84)87054-9; Peng Q, 1996, ULTRASTRUCT PATHOL, V20, P109, DOI 10.3109/01913129609016306; PETERS G, 1981, BIOCHIM BIOPHYS ACTA, V637, P43, DOI 10.1016/0005-2728(81)90208-5; PETERS G, 1980, BIOCHEM BIOPH RES CO, V96, P770, DOI 10.1016/0006-291X(80)91421-7; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Petrat F, 2001, BIOCHEM J, V356, P61, DOI 10.1042/0264-6021:3560061; Pierce RH, 2000, AM J PATHOL, V157, P221, DOI 10.1016/S0002-9440(10)64533-6; Pogue BW, 2001, PHOTOCHEM PHOTOBIOL, V74, P817, DOI 10.1562/0031-8655(2001)074<0817:IVNFMA>2.0.CO;2; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; ROSS AB, 1998, NDRL NIST SOLUTION K; SCHELLENBERG KA, 1958, J BIOL CHEM, V231, P547; SHEA CR, 1989, CANCER RES, V49, P3961; SHEA CR, 1990, CANCER RES, V50, P4167; SHEA CR, 1989, LASER SURG MED, V9, P83, DOI 10.1002/lsm.1900090202; SNYDER JW, 1993, CHEM-BIOL INTERACT, V88, P209, DOI 10.1016/0009-2797(93)90092-D; TYLER DD, 1992, MITOCHONDRIAN HLTH D; ZAHREBELSKI G, 1995, HEPATOLOGY, V21, P1361, DOI 10.1002/hep.1840210521; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	60	62	66	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3298	3307		10.1074/jbc.M204230200	http://dx.doi.org/10.1074/jbc.M204230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433931	hybrid			2022-12-27	WOS:000180915000068
J	Stohl, EA; Brockman, JP; Burkle, KL; Morimatsu, K; Kowalczykowski, SC; Siefert, HS				Stohl, EA; Brockman, JP; Burkle, KL; Morimatsu, K; Kowalczykowski, SC; Siefert, HS			Escherichia coli RecX inhibits RecA recombinase and coprotease activities in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA STRAND EXCHANGE; LEXA REPRESSOR; NEISSERIA-GONORRHOEAE; REGULATORY GENE; SOS INDUCTION; PROTEIN; EXPRESSION; STRAINS; BINDING; K-12	In Escherichia coli the RecA protein plays a pivotal role in homologous recombination, DNA repair, and SOS repair and mutagenesis. A gene designated recX (or oraA) is present directly downstream of recA in E. coli; however, the function of RecX is unknown. In this work we demonstrated interaction of RecX and RecA in a yeast two-hybrid assay. In vitro, substoichiometric amounts of RecX strongly inhibited both RecA-mediated DNA strand exchange and RecA ATPase activity. In vivo, we showed that recX is under control of the LexA repressor and is up-regulated in response to DNA damage. A loss-of-function mutation in recX resulted in decreased resistance to UV irradiation; however, overexpression of RecX in trans resulted in a greater decrease in UV resistance. Overexpression of RecX inhibited induction of two din (damage-inducible) genes and cleavage of the UmuD and LexA repressor proteins; however, recX inactivation had no effect on any of these processes. Cells overexpressing RecX showed decreased levels of P1 transduction, whereas recX mutation had no effect on P1 transduction frequency. Our combined in vitro and in vivo data indicate that RecX can inhibit both RecA recombinase and coprotease activities.	Northwestern Univ, Feinberg Sch Med, Dept Immunol & Microbiol, Chicago, IL 60611 USA; Univ Calif Davis, Ctr Genet & Dev, Sect Microbiol & Mol & Cellular Biol, Div Biol Sci, Davis, CA 95616 USA	Northwestern University; Feinberg School of Medicine; University of California System; University of California Davis	Siefert, HS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Immunol & Microbiol, 303 E Chicago Ave, Chicago, IL 60611 USA.		Morimatsu, Katsumi/G-5029-2013		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R37AI033493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044239, R01-AI44239, R37 AI033493] Funding Source: Medline; NIGMS NIH HHS [R01-GM-62653] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; BAGDASARIAN M, 1986, P NATL ACAD SCI USA, V83, P5723, DOI 10.1073/pnas.83.15.5723; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; BAILONE A, 1988, MOL GEN GENET, V214, P389, DOI 10.1007/BF00330471; Bebenek A, 1996, MOL GEN GENET, V250, P674; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; Courcelle J, 2001, GENETICS, V158, P41; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEMOT R, 1994, NUCLEIC ACIDS RES, V22, P1313, DOI 10.1093/nar/22.7.1313; DEWITT SK, 1962, GENETICS, V47, P577; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Frank EG, 1996, J BACTERIOL, V178, P3550, DOI 10.1128/jb.178.12.3550-3556.1996; Frank EG, 2000, J MOL BIOL, V297, P585, DOI 10.1006/jmbi.2000.3591; Harmon FG, 1996, J BIOL CHEM, V271, P23874, DOI 10.1074/jbc.271.39.23874; HEITMAN J, 1987, J BACTERIOL, V169, P3243, DOI 10.1128/jb.169.7.3243-3250.1987; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; LAVERY PE, 1990, J BIOL CHEM, V265, P4004; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Mehr IJ, 2000, GENETICS, V154, P523; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Papavinasasundaram KG, 1998, MOL MICROBIOL, V30, P525, DOI 10.1046/j.1365-2958.1998.01083.x; Papavinasasundaram KG, 1997, MOL MICROBIOL, V24, P141, DOI 10.1046/j.1365-2958.1997.3441697.x; Rehrauer WM, 1996, J BIOL CHEM, V271, P23865, DOI 10.1074/jbc.271.39.23865; Rehrauer WM, 1998, J BIOL CHEM, V273, P32384, DOI 10.1074/jbc.273.49.32384; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; Sambrook J., 2002, MOL CLONING LAB MANU; SANO Y, 1993, J BACTERIOL, V175, P2451, DOI 10.1128/JB.175.8.2451-2454.1993; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Stohl EA, 2002, MICROBIOL-SGM, V148, P1821, DOI 10.1099/00221287-148-6-1821; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Sukchawalit R, 2001, FEMS MICROBIOL LETT, V205, P83, DOI 10.1111/j.1574-6968.2001.tb10929.x; Van Dyk TK, 2001, J BACTERIOL, V183, P5496, DOI 10.1128/JB.183.19.5496-5505.2001; Venkatesh R, 2002, P NATL ACAD SCI USA, V99, P12091, DOI 10.1073/pnas.192178999; Vierling S, 2000, J BACTERIOL, V182, P4005, DOI 10.1128/JB.182.14.4005-4011.2000; Voloshin ON, 2001, GENE DEV, V15, P415, DOI 10.1101/gad.862901; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Yang MK, 2001, CURR MICROBIOL, V42, P257, DOI 10.1007/s002840010214; Yasuda T, 1998, EMBO J, V17, P3207, DOI 10.1093/emboj/17.11.3207; Yasuda T, 2001, EMBO J, V20, P1192, DOI 10.1093/emboj/20.5.1192; YU X, 1993, J MOL BIOL, V231, P29, DOI 10.1006/jmbi.1993.1254; ZAITSEV E, 1994, MUTAT RES, V323, P173, DOI 10.1016/0165-7992(94)90030-2	44	133	138	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2278	2285		10.1074/jbc.M210496200	http://dx.doi.org/10.1074/jbc.M210496200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427742	hybrid			2022-12-27	WOS:000180562000029
J	Miyoshi, T; Sadaie, M; Kanoh, J; Ishikawa, F				Miyoshi, T; Sadaie, M; Kanoh, J; Ishikawa, F			Telomeric DNA ends are essential for the localization of Ku at telomeres in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; HOMOLOGOUS RECOMBINATION; LENGTH MAINTENANCE; BINDING PROTEIN; MAMMALIAN-CELLS; REPAIR; IDENTIFICATION; FUSIONS	The Ku70-Ku80 heterodimer is a conserved protein complex essential for the non-homologous end-joining pathway. Ku proteins are also involved in telomere maintenance, although their precise roles remain to be elucidated. In fission yeast, pku70(+), the gene encoding the Ku70 homologue, has been reported. Here we report the identification and characterization of pku80(+), the gene encoding Ku80. Both pku70+(_) andp ku80(+) are essential for efficient non-homologous end-joining. We also found that the pku70 and pku 80 mutants are sensitive to methyl methanesulfonate and hydroxyurea, suggesting their roles in the S phase. The pku80 mutant shows telomere shortening and tandem amplification of a subtelomeric sequence but no defects in the telomere position effect, as was previously reported for the pku70 mutant. By using the chromatin immunoprecipitation assay, we demonstrated that Pku70 and Pku80 physically interact with telomeric repeats and subtelomeric sequences. Interestingly, this telomere association of Pku proteins is independent of Taz1, a telomeric DNA-binding protein. We also showed that the Pku proteins do not associate with ectopically integrated telomeric repeats in the internal region of circular chromosomes. These results indicate that the physical end of DNA is necessary for the localization of Pku80 at telomeres.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Tokyo Institute of Technology; Kyoto University	Ishikawa, F (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.		Ishikawa, Fuyuki/AAU-4056-2021; Kanoh, Junko/AGM-9632-2022	Ishikawa, Fuyuki/0000-0002-5580-2305; Miyoshi, Tomoichiro/0000-0002-5319-7877				Alfa C., 1993, EXPT FISSION YEAST; Arosio D, 2002, J BIOL CHEM, V277, P9741, DOI 10.1074/jbc.M111916200; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; Bliss TM, 1997, J BIOL CHEM, V272, P5765, DOI 10.1074/jbc.272.9.5765; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; CHLEBOWICZ E, 1979, MOL GEN GENET, V167, P279, DOI 10.1007/BF00267420; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Dahlen M, 1998, MOL BIOL CELL, V9, P611, DOI 10.1091/mbc.9.3.611; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Kaiser C, 1994, METHODS YEAST GENETI, P137; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Manolis KG, 2001, EMBO J, V20, P210, DOI 10.1093/emboj/20.1.210; Milne GT, 1996, MOL CELL BIOL, V16, P4189; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHWARTZ JL, 1989, MUTAT RES, V216, P111, DOI 10.1016/0165-1161(89)90011-3; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sugawara N., 1988, THESIS HARVARD U CAM; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wilson S, 1999, NUCLEIC ACIDS RES, V27, P2655, DOI 10.1093/nar/27.13.2655	57	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1924	1931		10.1074/jbc.M208813200	http://dx.doi.org/10.1074/jbc.M208813200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424244	hybrid			2022-12-27	WOS:000180462200075
J	Zhu, XY; Larsen, NA; Basran, A; Bruce, NC; Wilson, IA				Zhu, XY; Larsen, NA; Basran, A; Bruce, NC; Wilson, IA			Observation of an arsenic adduct in an acetyl esterase crystal structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; SUBSTRATE-SPECIFICITY; HIGH-LEVEL; SERINE; ACETYLCHOLINESTERASE; CARBOXYLESTERASE; HEROIN; DOMAIN	The crystal structures of an acetyl esterase, HerE, and its complex with an inhibitor dimethylarsinic acid have been determined at 1.30- and 1.45-Angstrom resolution, respectively. Although the natural substrate for the enzyme is unknown, HerE hydrolyzes the acetyl groups from heroin to yield morphine and from phenyl acetate to yield phenol. Recently, the activity of the enzyme toward heroin has been exploited to develop a heroin biosensor, which affords higher sensitivity than other currently available detection methods. The crystal structure reveals a single domain with the canonical alp hydrolase fold with an acyl binding pocket that snugly accommodates the acetyl substituent of the substrate and three backbone amides that form a tripartite oxyanion hole. In addition, a covalent adduct was observed between the active site serine and dimethylarsinic acid, which inhibits the enzyme. This crystal structure provides the first example of an As-containing compound in a serine esterase active site and the first example of covalent modification of serine by arsenic. Thus, the HerE complex reveals the structural basis for the broad scope inhibition of serine hydrolases by As(V)-containing organic compounds.	Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ York, Dept Biol, Ctr Novel Agr Prod,Dept Biol Area 8, York YO10 5YW, N Yorkshire, England	Scripps Research Institute; Scripps Research Institute; University of York - UK	Wilson, IA (corresponding author), Scripps Res Inst, Dept Biol Mol, 10550 N Torrey Pines Rd,BCC206, La Jolla, CA 92037 USA.	wilson@scripps.edu		Bruce, Neil Charles/0000-0003-0398-2997	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038273, R29GM038273] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38273] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen F.H., 1993, CHEM DESIGN AUTOMATI, V8, P31; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMERON GWW, 1994, APPL ENVIRON MICROB, V60, P3881, DOI 10.1128/AEM.60.10.3881-3883.1994; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; De Simone G, 2000, J MOL BIOL, V303, P761, DOI 10.1006/jmbi.2000.4195; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FREEDMAN LD, 1955, J AM CHEM SOC, V77, P6374, DOI 10.1021/ja01628a094; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; GLAZER AN, 1968, J BIOL CHEM, V243, P3693; Harel M, 1996, J AM CHEM SOC, V118, P2340, DOI 10.1021/ja952232h; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holt PJ, 1996, ANAL CHEM, V68, P1877, DOI 10.1021/ac951207r; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Longhi S, 1996, PROTEINS, V26, P442, DOI [10.1002/(SICI)1097-0134(199612)26:4<442::AID-PROT5>3.3.CO;2-H, 10.1002/(SICI)1097-0134(199612)26:4&lt;442::AID-PROT5&gt;3.0.CO;2-D]; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pindel EV, 1997, J BIOL CHEM, V272, P14769, DOI 10.1074/jbc.272.23.14769; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Westhead DR, 1999, PROTEIN SCI, V8, P897	35	55	56	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2008	2014		10.1074/jbc.M210103200	http://dx.doi.org/10.1074/jbc.M210103200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421810	hybrid			2022-12-27	WOS:000180462200085
J	Brzeski, J; Jerzmanowski, A				Brzeski, J; Jerzmanowski, A			Deficient in DNA methylation 1 (DDM1) defines a novel family of chromatin-remodeling factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; N-TERMINAL DOMAINS; HISTONE MODIFICATIONS; SNF2 FAMILY; IN-VITRO; ARABIDOPSIS; ISWI; TRANSCRIPTION; COMPLEXES; THALIANA	Deficient in DNA Methylation 1 (DDM1) protein is required to maintain the DNA methylation status of Arabidopsis thaliana. DDMI is a member of the broad SW12/SNF2 protein family. Because of its phylogenetic position, DDMI has been speculated to act as a chromatin-remodeling factor. Here we used a purified recombinant DDM1 protein to investigate whether it can remodel chromatin in vitro. We show that DDMI is an ATPase stimulated by both naked and nucleosomal DNA. DDM1 binds to the nucleosome and promotes chromatin remodeling in an ATP-dependent manner. Specifically, it induces nucleosome repositioning on a short DNA fragment. The enzymatic activity of DDM1 is not affected by DNA methylation. The relevance of these findings to the in vivo role of DDM1 is discussed.	Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; Warsaw Univ, Lab Plant Mol Biol, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Brzeski, J (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5A, PL-02106 Warsaw, Poland.	jbrzeski@ibb.waw.pl						Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; DePamphilis ML, 1999, BIOESSAYS, V21, P5, DOI 10.1002/(SICI)1521-1878(199901)21:1<5::AID-BIES2>3.0.CO;2-6; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Imhof A, 2001, MOL BIOTECHNOL, V17, P1, DOI 10.1385/MB:17:1:01; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAKUTANI T, 1995, NUCLEIC ACIDS RES, V23, P130, DOI 10.1093/nar/23.1.130; Kishimoto N, 2001, PLANT MOL BIOL, V46, P171, DOI 10.1023/A:1010636222327; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Moggs JG, 1999, BIOCHIMIE, V81, P45, DOI 10.1016/S0300-9084(99)80037-6; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Schlissel MS, 2000, SCIENCE, V287, P438, DOI 10.1126/science.287.5452.438; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Smerdon MJ, 1999, PROG NUCLEIC ACID RE, V62, P227; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Verbsky ML, 2001, CURR OPIN PLANT BIOL, V4, P494, DOI 10.1016/S1369-5266(00)00206-5; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; VONHOLT C, 1989, METHOD ENZYMOL, V170, P431; Wade PA, 1996, MOL CELL BIOL, V16, P1641; Wang HB, 2001, NUCLEIC ACIDS RES, V29, P2517, DOI 10.1093/nar/29.12.2517; Yoo EJ, 2000, NUCLEIC ACIDS RES, V28, P2004, DOI 10.1093/nar/28.9.2004; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	52	138	151	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					823	828		10.1074/jbc.M209260200	http://dx.doi.org/10.1074/jbc.M209260200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12403775	hybrid			2022-12-27	WOS:000180321900019
J	Cissell, MA; Zhao, L; Sussel, L; Henderson, E; Stein, R				Cissell, MA; Zhao, L; Sussel, L; Henderson, E; Stein, R			Transcription factor occupancy of the insulin gene in vivo - Evidence for direct regulation by Nkx2.2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN PROTEIN; TRANSACTIVE FACTORS; CHROMATIN STRUCTURE; BETA-CELLS; EXPRESSION; DIFFERENTIATION; PDX-1; IDENTIFICATION; SEQUENCES; PROMOTER	Consensus-binding sites for many transcription factors are relatively non-selective and found at high frequency within the genome. This raises the possibility that factors that are capable of binding to a cis-acting element in vitro and regulating transcription from a transiently transfected plasmid, which would not have higher order chromatin structure, may not occupy this site within the endogenous gene. Closed chromatin structure and competition from another DNA-binding protein with similar nucleotide specificity are two possible mechanisms by which a transcription factor may be excluded from a potential binding site in vivo. Multiple transcription factors, including Pdx-1, BETA-2, and Pax6, have been implicated in expression of the insulin gene in pancreatic beta cells. In this study, the chromatin immunoprecipitation assay has been used to show that these factors do, in fact, bind to insulin control region sequences in intact beta cells. In addition, another key islet-enriched transcription factor, Nkx2.2, was found to occupy this region using the chromatin immunoprecipitation assay. In vitro DNA-binding and transient transfection assays defined how Nkx2.2 affected insulin gene expression. Pdx-1 was also shown to bind within a region of the endogenous islet amyloid polypeptide, pax-4, and glucokinase genes that were associated with control in vitro. Because Pdx-1 does not regulate gene transcription in isolation, these sequences were examined for occupancy by the other insulin transcriptional regulators. BETA-2, Pax6, and Nkx2.2 were also found to bind to amyloid polypeptide, glucokinase, and pax-4 control sequences in vivo. These studies reveal the broad application of the Pdx-1, BETA-2, Pax6, and Nkx2.2 transcription factors in regulating expression of genes selectively expressed in islet beta cells.	Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA	Vanderbilt University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Stein, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37232 USA.	roland.stein@mcmail.vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK055091, R01DK050203] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK-50203, P60 DK20593, DK-55091] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Crane-Robinson C, 1998, TRENDS GENET, V14, P477, DOI 10.1016/S0168-9525(98)01621-7; CROWE DT, 1989, MOL CELL BIOL, V9, P1784, DOI 10.1128/MCB.9.4.1784; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Edlund H, 2001, DIABETES, V50, pS5, DOI 10.2337/diabetes.50.2007.S5; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; MOATES JM, 2002, IN PRESS DIABETES; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; ROBINSON GLWG, 1994, J BIOL CHEM, V269, P2452; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; STEIN R, 2001, HDB PHYSL 7, V2, P25; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; WHELAN J, 1990, MOL CELL BIOL, V10, P1564, DOI 10.1128/MCB.10.4.1564; Xu WZ, 2000, MOL CELL ENDOCRINOL, V170, P79, DOI 10.1016/S0303-7207(00)00329-4; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532	42	77	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					751	756		10.1074/jbc.M205905200	http://dx.doi.org/10.1074/jbc.M205905200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12426319	hybrid			2022-12-27	WOS:000180321900010
J	Ikeda, K; Brown, JA; Yagi, T; Norrander, JM; Hirono, M; Eccleston, E; Kamiya, R; Linck, RW				Ikeda, K; Brown, JA; Yagi, T; Norrander, JM; Hirono, M; Eccleston, E; Kamiya, R; Linck, RW			Rib72, a conserved protein associated with the ribbon compartment of flagellar A-microtubules and potentially involved in the linkage between outer doublet microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER DYNEIN ARMS; SEA-URCHIN; CHLAMYDOMONAS-REINHARDTII; RADIAL SPOKES; SPERM FLAGELLA; NEXIN LINKS; CILIA; DIGESTION; SEQUENCE; TEKTINS	Ciliary and flagellar axonemes are basically composed of nine outer doublet microtubules and several functional components, e.g. dynein arms, radial spokes, and interdoublet links. Each A-tubule of the doublet contains a specialized "ribbon" of three protofilaments composed of tubulin and other proteins postulated to specify the three-dimensional arrangement of the various axonemal components. The interdoublet links hold the doublet microtubules together and limit their sliding during the flagellar beat. In this study on Chlamydomonas reinhardtii, we cloned a cDNA encoding a 71,985-Da polypeptide with three DM10 repeats, two C-terminal EF-hand motifs, and homologs extending to humans. This polypeptide, designated as Rib72, is a novel component of the ribbon compartment of flagellar microtubules. It remained associated with 9-fold arrays of doublet tubules following extraction under high and low ionic conditions, and anti-Rib72 antibodies revealed an -96-nm periodicity along axonemes, consistent with Rib,72 associating with interdoublet links. Following proteolysis- and ATP-dependent disintegration of axonemes, the rate of cleavage of Rib72 correlated closely with the rate of sliding disintegration. These observations identify a ribbon-associated protein that may function in the structural assembly of the axoneme and in the mechanism and regulation of ciliary and flagellar motility.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Tokyo; University of Minnesota System; University of Minnesota Twin Cities	Linck, RW (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.	kamiyar@biol.s.u-tokyo.acjp; linck@mail.ahc.umn.edu	HIRONO, MASAFUMI/G-4948-2014; Hirono, Masafumi/G-5140-2013	HIRONO, MASAFUMI/0000-0002-2497-4227; Hirono, Masafumi/0000-0002-2497-4227; Brown, Jennifer/0000-0002-6699-2933	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035648] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35648] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS WB, 1986, J CELL SCI, P55; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOZKURT HH, 1993, CELL MOTIL CYTOSKEL, V24, P109; BROKAW CJ, 1991, J CELL BIOL, V114, P1201, DOI 10.1083/jcb.114.6.1201; BROKAW CJ, 1980, SCIENCE, V207, P1365, DOI 10.1126/science.6898364; CHEN R, 1993, J CELL SCI, V106, P909; Cibert C, 2001, CELL MOTIL CYTOSKEL, V49, P161, DOI 10.1002/cm.1030; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GIBBONS IR, 1963, P NATL ACAD SCI USA, V50, P1002, DOI 10.1073/pnas.50.5.1002; GOODENOUGH UW, 1985, J CELL BIOL, V100, P2008, DOI 10.1083/jcb.100.6.2008; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; JAMES SW, 1993, J CELL SCI, V106, P209; JOHNSON KA, 1995, METHOD CELL BIOL, V47, P153, DOI 10.1016/S0091-679X(08)60804-3; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; KING SM, 1986, METHOD ENZYMOL, V134, P291; KINTER M, 2000, PROTEIN SEQUENCING I, P153; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINCK RW, 1985, J CELL BIOL, V100, P126, DOI 10.1083/jcb.100.1.126; LINCK RW, 1990, ADV CELL BIOL, V3, P35; LINCK RW, 2000, ENCY LIFE SCI; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; MEZA I, 1972, EXP CELL RES, V74, P535, DOI 10.1016/0014-4827(72)90413-2; Minoura I, 1999, CELL STRUCT FUNCT, V24, P27, DOI 10.1247/csf.24.27; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; NOJIMA D, 1995, CURR BIOL, V5, P158, DOI 10.1016/S0960-9822(95)00037-6; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Norrander J, 1998, J NEUROSCI, V18, P8912; NORRANDER JM, 1992, P NATL ACAD SCI USA, V89, P8567, DOI 10.1073/pnas.89.18.8567; Norrander JM, 1996, J MOL BIOL, V257, P385, DOI 10.1006/jmbi.1996.0170; Norrander JM, 2000, MOL BIOL CELL, V11, P201, DOI 10.1091/mbc.11.1.201; OKAGAKI T, 1986, J CELL BIOL, V103, P1895, DOI 10.1083/jcb.103.5.1895; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; Omoto CK, 1996, CELL MOTIL CYTOSKEL, V33, P88; Patel-King RS, 2002, J BIOL CHEM, V277, P34271, DOI 10.1074/jbc.M204137200; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennarun G, 2002, AM J RESP CELL MOL, V26, P362, DOI 10.1165/ajrcmb.26.3.4738; PIPERNO G, 1981, J CELL BIOL, V88, P73, DOI 10.1083/jcb.88.1.73; PIRNER MA, 1994, J BIOL CHEM, V269, P31800; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; SALE WS, 1977, P NATL ACAD SCI USA, V74, P2045, DOI 10.1073/pnas.74.5.2045; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANDERS MA, 1995, METHOD CELL BIOL, V47, P163, DOI 10.1016/S0091-679X(08)60805-5; SCHLOSS JA, 1984, MOL CELL BIOL, V4, P424, DOI 10.1128/MCB.4.3.424; SILFLOW CD, 1985, MOL CELL BIOL, V5, P2389, DOI 10.1128/MCB.5.9.2389; STEPHENS R E, 1970, Journal of Molecular Biology, V47, P353, DOI 10.1016/0022-2836(70)90307-4; Stephens RE, 2000, CELL MOTIL CYTOSKEL, V47, P130, DOI 10.1002/1097-0169(200010)47:2<130::AID-CM4>3.0.CO;2-0; STEPHENS RE, 1989, J CELL SCI, V92, P391; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; SUMMERS KE, 1973, J CELL BIOL, V58, P618, DOI 10.1083/jcb.58.3.618; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WARNER FD, 1976, J CELL SCI, V20, P101; WARNER FD, 1983, CELL MOTIL CYTOSKEL, V3, P321, DOI 10.1002/cm.970030404; WARNER FD, 1980, J CELL BIOL, V86, P436, DOI 10.1083/jcb.86.2.436; WITMAN GB, 1986, METHOD ENZYMOL, V134, P280; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; WITMAN GB, 1972, J CELL BIOL, V54, P540, DOI 10.1083/jcb.54.3.540; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Woolley DM, 1997, J CELL SCI, V110, P85; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; YAGI T, 1995, CELL MOTIL CYTOSKEL, V31, P207, DOI 10.1002/cm.970310304; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	66	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2003	278	9					7725	7734		10.1074/jbc.M210751200	http://dx.doi.org/10.1074/jbc.M210751200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649EZ	12435737	hybrid			2022-12-27	WOS:000181195100138
J	Manfredi, G; Kwong, JQ; Oca-Cossio, JA; Woischnik, M; Gajewski, CD; Martushova, K; D'Aurelio, M; Friedlich, AL; Moraes, CT				Manfredi, G; Kwong, JQ; Oca-Cossio, JA; Woischnik, M; Gajewski, CD; Martushova, K; D'Aurelio, M; Friedlich, AL; Moraes, CT			BCL-2 improves oxidative phosphorylation and modulates adenine nucleotide translocation in mitochondria of cells harboring mutant mtDNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X(L) PREVENTS; ATP; APOPTOSIS; DECREASE; PROTEIN; GENE; INHIBITORS; MUTATION; SURVIVAL; CALCIUM	Members of the BCL-2-related antiapoptotic family of proteins have been shown previously to regulate ATP/ ADP exchange across the mitochondrial membranes and to prevent the loss of coupled mitochondrial respiration during apoptosis. We have found that BCL-2/ BCL-x(L) can also improve mitochondrial oxidative phosphorylation in cells harboring pathogenic mutations in mitochondrial tRNA genes. The effect of BCL-2 overexpression in mutated cells was independent from apoptosis and was presumably associated with a modulation of adenine nucleotide exchange between mitochondria and cytosol. These results suggest that BCL-2 can regulate respiratory functions in response to mitochondrial distress by regulating the levels of adenine nucleotides.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Univ Miami, Sch Med, Dept Neurol, Miami, FL 33136 USA; Massachusetts Gen Hosp, Lab Oxidat Biol Genet, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Psychiat, Charlestown, MA USA	Cornell University; University of Miami; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Manfredi, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 525 E 68th St,A-505, New York, NY 10021 USA.	gim2004@mail.med.cornell.edu	Kwong, Jennifer/L-4348-2019; Moraes, Carlos/AAT-3818-2021		NCI NIH HHS [CA085700] Funding Source: Medline; NINDS NIH HHS [NS02179] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085700] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; DEGLIESPOSTI M, 1999, J BIOL CHEM, V274, P29831; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; MONAGHAN P, 1992, J HISTOCHEM CYTOCHEM, V40, P1819, DOI 10.1177/40.12.1453000; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Porcelli AM, 2001, METHOD CELL BIOL, V65, P353, DOI 10.1016/S0091-679X(01)65021-0; Seaton TA, 1997, BRAIN RES, V777, P110; Shimizu S, 1996, ONCOGENE, V13, P21; Single B, 2001, EXP CELL RES, V262, P8, DOI 10.1006/excr.2000.5059; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Vander Heiden MG, 1999, MOL CELL, V3, P159; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8	26	36	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					5639	5645		10.1074/jbc.M203080200	http://dx.doi.org/10.1074/jbc.M203080200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12431997	hybrid			2022-12-27	WOS:000181129400021
J	Kovanen, PE; Rosenwald, A; Fu, J; Hurt, EM; Lam, LT; Giltnane, JM; Wright, G; Staudt, LM; Leonard, WJ				Kovanen, PE; Rosenwald, A; Fu, J; Hurt, EM; Lam, LT; Giltnane, JM; Wright, G; Staudt, LM; Leonard, WJ			Analysis of gamma(c)-family cytokine target genes - Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL PROLIFERATION; RECEPTOR-ALPHA GENE; IL-2 RECEPTOR; ERYTHROPOIETIN RECEPTORS; GROWTH-FACTOR; IN-VIVO; CHAIN; EXPRESSION; TRANSDUCTION; LYMPHOCYTES	Interleukin (IL)-2, IL-4, IL-7, IL-99 IL-15, and IL-21 form a family of cytokines based on their sharing the common cytokine receptor gamma chain, gamma(c), which is mutated in X-linked severe combined immunodeficiency (SCID). As a step toward further elucidating the mechanism of action of these cytokines in T-cell biology, we compared the gene expression profiles of IL-2, IL-4, IL-7, and IL-15 in T cells using cDNA microarrays. IL-2, IL-7, and IL-15 each induced a highly similar set of genes, whereas IL-4 induced distinct genes correlating with differential STAT protein activation by this cytokine. One gene induced by IL-2, IL-7, and IL-15 but not IL-4 was dual-specificity phosphatase 5 (DUSP5). In IL-2-dependent CTLL-2 cells, we show that IL-2-induced ERK-1/2 activity was inhibited by wild type DUSP5 but markedly increased by an inactive form of DUSP5, suggesting a negative feedback role for DUSP5 in IL-2 signaling. Our findings provide insights into the shared versus distinctive actions by different members of the yc family of cytokines. Moreover, we have identified a DUSP5-dependent negative regulatory pathway for MAPK activity in T cells.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; NCI, Metab Branch, Ctr Canc Res, Bethesda, MD 20892 USA; NCI, Biometr Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.	wjl@helix.nih.gov	Wright, George W/M-1660-2017; Giltnane, Jennifer/D-2584-2013; Leonard, Warren/AAA-1397-2022; Staudt, Louis/AAC-5324-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005402, ZIAHL005402, ZIAHL005401, Z01HL005401] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BEADLING C, 1993, P NATL ACAD SCI USA, V90, P2719, DOI 10.1073/pnas.90.7.2719; Bulanova E, 2001, J IMMUNOL, V167, P6292, DOI 10.4049/jimmunol.167.11.6292; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; CHAZEN GD, 1989, P NATL ACAD SCI USA, V86, P5923, DOI 10.1073/pnas.86.15.5923; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Gaffen SL, 1996, J BIOL CHEM, V271, P21381, DOI 10.1074/jbc.271.35.21381; Goldsmith MA, 1998, P NATL ACAD SCI USA, V95, P7006, DOI 10.1073/pnas.95.12.7006; Gonzalez J, 2001, BLOOD CELL MOL DIS, V27, P572, DOI 10.1006/bcmd.2001.0420; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Herblot S, 1999, J IMMUNOL, V162, P3280; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; John S, 1996, EMBO J, V15, P5627, DOI 10.1002/j.1460-2075.1996.tb00947.x; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; Kotanides H, 1996, J BIOL CHEM, V271, P25555, DOI 10.1074/jbc.271.41.25555; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; Lecine P, 1996, MOL CELL BIOL, V16, P6829; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Moon JJ, 2001, J IMMUNOL, V167, P2714, DOI 10.4049/jimmunol.167.5.2714; Nakajima H, 2000, IMMUNOL TODAY, V21, P88, DOI 10.1016/S0167-5699(99)01555-8; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; OHARA J, 1988, P NATL ACAD SCI USA, V85, P8221, DOI 10.1073/pnas.85.21.8221; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; RENAULD JC, 1994, ONCOGENE, V9, P1327; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Socolovsky M, 1997, J BIOL CHEM, V272, P14009, DOI 10.1074/jbc.272.22.14009; SPERISEN P, 1995, J BIOL CHEM, V270, P10743, DOI 10.1074/jbc.270.18.10743; Sporri B, 2001, BLOOD, V97, P221, DOI 10.1182/blood.V97.1.221; Stoffel R, 1999, P NATL ACAD SCI USA, V96, P698, DOI 10.1073/pnas.96.2.698; Tagaya Y, 1996, EMBO J, V15, P4928, DOI 10.1002/j.1460-2075.1996.tb00873.x; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; TURNER B, 1991, P NATL ACAD SCI USA, V88, P1227, DOI 10.1073/pnas.88.4.1227; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Van Parijs L, 1998, SCIENCE, V280, P243; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yeh JH, 2001, MOL CELL BIOL, V21, P4515, DOI 10.1128/MCB.21.14.4515-4527.2001; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	54	81	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5205	5213		10.1074/jbc.M209015200	http://dx.doi.org/10.1074/jbc.M209015200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435740	hybrid			2022-12-27	WOS:000180968900109
J	Paris, S; Viemon, C; Curien, G; Dumas, R				Paris, S; Viemon, C; Curien, G; Dumas, R			Mechanism of control of Arabidopsis thaliana aspartate kinase-homoserine dehydrogenase by threonine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ASPARTOKINASE-I; NUCLEOTIDE-SEQUENCE; THRA GENE; FAMILY; DEAMINASE; PROTEIN; BINDING	The regulatory domain of the bifunctional threonine-sensitive aspartate kinase homoserine dehydrogenase contains two homologous subdomains defined by a common loop-alpha helix-loop-beta strand-loop-beta strand motif. This motif is homologous with that found in the two subdomains of the biosynthetic threonine-deaminase regulatory domain. Comparisons of the primary and secondary structures of the two enzymes allowed us to predict the location and identity of the amino acid residues potentially involved in two threonine-binding sites of Arabidopsis thaliana aspartate kinase-homoserine dehydrogenase. These amino acids were then mutated and activity measurements were carried out to test this hypothesis. Steady-state kinetic experiments on the wildtype and mutant enzymes demonstrated that each regulatory domain of the monomers of aspartate kinase-homoserine dehydrogenase possesses two nonequivalent threonine-binding sites constituted in part by Gln(443) and Gln(524). Our results also demonstrated that threonine interaction with Gln(443) leads to inhibition of aspartate kinase activity and facilitates the binding of a second threonine on Gln(524). Interaction of this second threonine with Gln(524) leads to inhibition of homoserine dehydrogenase activity.	INRA, Bayer Cropsci, CNRS, UMR 1932,Lab Mixte, F-69263 Lyon, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); INRAE	Dumas, R (corresponding author), CEA, UJF, CNRS, UMR 5019,Lab Physiol Cellulaire Vegetale, Ave Martyrs, F-38054 Grenoble 9, France.		Dumas, Renaud/E-1835-2011					Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BEARER CF, 1978, BIOCHEMISTRY-US, V17, P3512, DOI 10.1021/bi00610a014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYAN PA, 1970, BIOCHEM BIOPH RES CO, V41, P1211, DOI 10.1016/0006-291X(70)90215-9; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; COHEN GN, 1985, METHOD ENZYMOL, V113, P596; FALCOZKELLY F, 1972, EUR J BIOCHEM, V28, P507, DOI 10.1111/j.1432-1033.1972.tb01938.x; FAZEL A, 1983, J BIOL CHEM, V258, P3570; FAZEL A, 1983, BIOCHEMISTRY-US, V22, P158, DOI 10.1021/bi00270a023; FERRARA P, 1984, P NATL ACAD SCI-BIOL, V81, P3019, DOI 10.1073/pnas.81.10.3019; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Gebhardt J. S., 1999, Plant Physiology, V120, P339, DOI 10.1104/pp.120.1.339; GHISLAIN M, 1994, PLANT MOL BIOL, V24, P835, DOI 10.1007/BF00014439; GOURGEON C, 1994, PROTEIN ENG, V7, P157; KATINKA M, 1980, P NATL ACAD SCI-BIOL, V77, P5730, DOI 10.1073/pnas.77.10.5730; MUEHLBAUER GJ, 1994, PLANT PHYSIOL, V106, P1303, DOI 10.1104/pp.106.4.1303; OMORI K, 1993, J BACTERIOL, V175, P959, DOI 10.1128/JB.175.4.959-965.1993; OMORI K, 1993, J BACTERIOL, V175, P785, DOI 10.1128/JB.175.3.785-794.1993; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P99, DOI 10.1006/prep.2001.1538; Paris S, 2002, PROTEIN EXPRES PURIF, V24, P105, DOI 10.1006/prep.2001.1539; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; WEISEMANN JM, 1993, PLANT MOL BIOL, V22, P301, DOI 10.1007/BF00014937; Wessel PM, 2000, BIOCHEMISTRY-US, V39, P15136, DOI 10.1021/bi001625c; ZAKIN MM, 1983, J BIOL CHEM, V258, P3028	26	36	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5361	5366		10.1074/jbc.M207379200	http://dx.doi.org/10.1074/jbc.M207379200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435751	Green Published, hybrid			2022-12-27	WOS:000180968900128
J	Pasciak, M; Holst, O; Lindner, B; Mordarska, H; Gamian, A				Pasciak, M; Holst, O; Lindner, B; Mordarska, H; Gamian, A			Novel bacterial polar lipids containing ether-linked alkyl chains, the structures and biological properties of the four major glycolipids from Propionibacterium propionicum PCM 2431 (ATCC 14157(T))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOBACTERIUM-THERMOAUTOTROPHICUM; HALOALKALIPHILIC ARCHAEBACTERIA; MYCOBACTERIUM-TUBERCULOSIS; HALOPHILIC BACTERIA; CELL-MEMBRANE; FATTY-ACID; ACNES; CLASSIFICATION; ENDOCARDITIS; ENDOPHTHALMITIS	Propionibacterium propionicum belongs to the "acnes group" of propionibacteria, which is currently considered as clinically important because of its growing potential in infections, in particular with those connected with immune system dysfunctions. Propionibacteria are thought to be actinomycete-like microorganisms and may still cause diagnostic difficulties. The chloroform-methanol extracts of the cell mass of P. propionicum (type strain) gave in TLC analysis the characteristic glycolipid profile containing four major glycolipids, labeled G(1) through G(4). These polar lipids were found to be useful chemotaxonomic markers to differentiate P. propionicum from other cutaneous propionibacteria, in particular from strains of the acnes group. Glycolipids G(1)-G(4) were isolated and purified using gel-permeation chromatography, TLC, and high performance liquid chromatography, and their structures were elucidated by compositional and methylation analyses, specific chemical degradations, MALDI-TOF mass spectrometry, and H-1 NMR and C-13 NMR spectroscopy, including HMBC, TOCSY, HMQC, and NOESY experiments. Glycolipids G(2) and G(3) possess as backbone alpha-D-Glcp-(1-->3)-alpha-D-Glcp-(1-->1)-Gro (Gro, glycerol), in which position O-2 of the glycerol residue is acylated by a fatty acid (mainly C-15:0) while O-3 is substituted by an alkyl ether chain. In glycolipid G(3), an additional fatty acyl chain was linked to O-6 of the terminal glucose residue. Glycolipid G(4) was structurally related to G(2) but devoid of one glucose residue. Glycolipid G(3) was isolated in small amounts, and its structure was therefore deduced from MALDI-TOF-MS experiments alone, which revealed that it possessed the structure of G(2) but was lacking one fatty acid residue. In studies on the biological properties of P. propionicum glycolipids, the anti-P. propionicum rabbit antisera reacted in dot enzyme-immunoblotting test with G(2) and G(3). Glycolipid G(3) was able to induce the delayed type of hypersensitivity. The results indicated that these novel ether linkage-containing polar glycolipids are immunogenic and possibly active in hypersensitivity, and thus, in pathogenesis.	Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland; Borstel Res Ctr, Div Struct Biochem, D-23845 Borstel, Germany; Borstel Res Ctr, Div Biophys, D-23845 Borstel, Germany	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Forschungszentrum Borstel; Forschungszentrum Borstel	Gamian, A (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Weigla 12, PL-53114 Wroclaw, Poland.		Lindner, Buko/G-9731-2014	Pasciak, Mariola/0000-0002-2603-4634; Gamian, Andrzej/0000-0002-2206-6591				Albers SV, 2000, FRONT BIOSCI, V5, pD813; Armstrong RW, 1996, CLIN INFECT DIS, V23, P1178, DOI 10.1093/clinids/23.5.1178; BANNISTER AB, 1989, ARCH DIS CHILD, V64, P397; BERGMEYER HU, 1974, METHODEN ENZYMATISCH, V2, P1250; BRANGER C, 1987, J CLIN MICROBIOL, V25, P2405, DOI 10.1128/JCM.25.12.2405-2406.1987; BROOK I, 1991, REV INFECT DIS, V13, P819; CHATTERJEE D, 1987, J BIOL CHEM, V262, P3528; CLAEYS G, 1994, EUR J CLIN MICROBIOL, V13, P747, DOI 10.1007/BF02276058; Clark WL, 1999, OPHTHALMOLOGY, V106, P1665, DOI 10.1016/S0161-6420(99)90348-2; COLLINS MD, 1980, J GEN MICROBIOL, V118, P29; Collins MD, 1985, METHODS MICROBIOLOGY, P329, DOI 10.1016/S0580-9517(08)70480-X; Csukas Zsuzsanna, 1993, Acta Microbiologica Hungarica, V40, P107; Delyle LG, 2000, ARTHRITIS RHEUM, V43, P2843, DOI 10.1002/1529-0131(200012)43:12<2843::AID-ANR26>3.0.CO;2-2; DEROSA M, 1988, J GEN MICROBIOL, V134, P205; DEROSA M, 1983, J GEN MICROBIOL, V129, P2333; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Durupt S, 1998, PRESSE MED, V27, P1839; EKIEL I, 1986, J BACTERIOL, V166, P559, DOI 10.1128/jb.166.2.559-564.1986; Embley TM., 1994, CHEM METHODS PROKARY, P121; FOX GE, 1987, METHOD MICROBIOL, V19, P405; GAMIAN A, 1992, FEMS MICROBIOL IMMUN, V89, P323, DOI 10.1016/0378-1097(92)90272-P; Gamian A, 1996, CARBOHYD RES, V296, P55, DOI 10.1016/S0008-6215(96)00246-7; Gamian Andrzej, 1996, Archivum Immunologiae et Therapiae Experimentalis, V44, P249; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Johnson J. L., 1985, METHOD MICROBIOL, V18, P1; Jones C. W., 1985, METHOD MICROBIOL, V18, P285; Kamekura M, 1999, BIOSCI BIOTECH BIOCH, V63, P969, DOI 10.1271/bbb.63.969; Kamekura M., 1988, HALOPHILIC BACTERIA, P25; Kamekura Masahiro, 1993, P135; KATES M, 1978, Progress in the Chemistry of Fats and Other Lipids, V15, P301; Kates M., 1990, HDB LIPID RES, V6, P1; KATES M, 1986, LAB TECHNIQUES BIOCH, V3, P186; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; KUSHWAHA SC, 1982, CAN J MICROBIOL, V28, P1365, DOI 10.1139/m82-203; LECHEVALIER MP, 1977, CRC CR REV MICROBIOL, V5, P109, DOI 10.3109/10408417709102311; MEISLER DM, 1989, OPHTHALMOLOGY, V96, P54; MINNIKIN DE, 1979, J APPL BACTERIOL, V47, P87, DOI 10.1111/j.1365-2672.1979.tb01172.x; MINNIKIN DE, 1977, INT J SYST BACTERIOL, V27, P104, DOI 10.1099/00207713-27-2-104; MORDARSKA H, 1994, FEMS MICROBIOL LETT, V123, P325, DOI 10.1016/0378-1097(94)90213-5; Mordarska H., 1992, Actinomycetes, V3, P31; Mordarska H., 1995, Actinomycetes, V6, P1; MORDARSKA H, 1985, Actinomycetes, V19, P11; Mordarska H, 1998, FEMS IMMUNOL MED MIC, V21, P47, DOI 10.1111/j.1574-695X.1998.tb01148.x; Moreira AL, 2000, CLIN INFECT DIS, V30, P224, DOI 10.1086/313627; NISHIHARA M, 1989, BIOCHEMISTRY-US, V28, P95, DOI 10.1021/bi00427a014; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P1007, DOI 10.1093/oxfordjournals.jbchem.a121942; Nishijima S, 2000, J Dermatol, V27, P318; ODONNELL AG, 1985, CHEM METHODS BACTERI, P131; PAPA F, 1993, RES MICROBIOL, V144, P91, DOI 10.1016/0923-2508(93)90021-S; PAPA F, 1992, RES MICROBIOL, V143, P327, DOI 10.1016/0923-2508(92)90024-I; PASCIAK M, 1998, THESIS L HIRSZFELD I; PREHM P, 1980, CARBOHYD RES, V78, P372, DOI 10.1016/0008-6215(80)90018-X; PUZO G, 1990, CRIT REV MICROBIOL, V17, P305, DOI 10.3109/10408419009105730; Riedel KHJ, 1998, SYST APPL MICROBIOL, V21, P419; RILEY TV, 1981, BRIT MED J, V282, P1035, DOI 10.1136/bmj.282.6269.1035; Ross H. N. M., 1985, CHEM METHODS BACTERI, P289; ROSS HNM, 1981, J GEN MICROBIOL, V123, P75; SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048; Schleifer K. H., 1985, CHEM METHODS BACTERI, P201; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Templeton N S, 1992, Diagn Mol Pathol, V1, P58, DOI 10.1097/00019606-199203000-00008; TINDALL BJ, 1985, SYST APPL MICROBIOL, V6, P243, DOI 10.1016/S0723-2020(85)80025-4; Tornabene T. G., 1985, METHOD MICROBIOL, V18, P209; TRINCONE A, 1980, J GEN MICROBIOL, V136, P2327; WAEGHE TJ, 1983, CARBOHYD RES, V123, P281, DOI 10.1016/0008-6215(83)88484-5; Wagner F, 2000, EUR J BIOCHEM, V267, P6276, DOI 10.1046/j.1432-1327.2000.01709.x; Woese CR, 1996, CURR BIOL, V6, P1060, DOI 10.1016/S0960-9822(02)70664-7; WOLLENWEBER HW, 1990, J MICROBIOL METH, V11, P195, DOI 10.1016/0167-7012(90)90056-C; [No title captured]	70	29	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3948	3956		10.1074/jbc.M206013200	http://dx.doi.org/10.1074/jbc.M206013200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12427753	hybrid			2022-12-27	WOS:000180869700056
J	Song, CC; Wang, Q; Li, CCH				Song, CC; Wang, Q; Li, CCH			ATPase activity of p97-valosin-containing protein (VCP) - D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; SENSITIVE FUSION PROTEIN; SACCHAROMYCES-CEREVISIAE; TYROSINE PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTOR; MEMBRANE-FUSION; AAA ATPASE; PROTEASOME; BINDING	The 97-kDa valosin-containing protein (p97-VCP) plays a role in a wide variety of cellular activities, many of which are regulated by the ubiquitin-proteasome (Ub-Pr)-mediated degradation pathway. We previously demonstrated that VCP binds to multi-ubiquitin chains and may act as a molecular chaperone that targets the ubiquitinated substrates to the proteasome for degradation. In this report, we show that although the ubiquitin chain-binding activity, carried out by the N-terminal 200 residues (N domain), is necessary for the degradation of proteasome substrates, it is not sufficient. Using in vitro degradation assays, we demonstrated that the entire VCP molecule, consisting of the N domain and two ATPase domains D1 and D2, is required for mediating the Ub-Pr degradation. The ATPase activity of VCP requires Mg2+, and is stimulated by high temperature. Under optimal conditions, VCP hydrolyzes ATP with a K-m of similar to0.33 mm and a V-max of similar to0.52 nmol P-i min(-1) mug(-1). At a physiological temperature, mutation in D2 significantly inhibits the ATPase activity, while that in D1 has little effect. Interestingly, mutations in D1, but not D2, abolish the heat-stimulated ATPase activity. Thus, we provide the first demonstration that the ATPase activity of VCP is required for mediating the Ub-Pr degradation, that D2 accounts for the major ATPase activity, and that D1 contributes to the heat-induced activity.	NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA; NCI, Basic Res Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Li, CCH (corresponding author), NCI, SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA.	licc@ncifcrf.gov			DIVISION OF BASIC SCIENCES - NCI [Z01BC010029] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-56000] Funding Source: Medline	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; EGERTON M, 1994, J BIOL CHEM, V269, P11435; FROHLICH KU, 1995, BBA-PROTEIN STRUCT M, V1253, P25, DOI 10.1016/0167-4838(95)00136-I; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hanninen AL, 1999, MOL BIOL CELL, V10, P3623, DOI 10.1091/mbc.10.11.3623; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lavoie C, 2000, P NATL ACAD SCI USA, V97, P13637, DOI 10.1073/pnas.240278097; Madeo F, 1997, GENE, V204, P145, DOI 10.1016/S0378-1119(97)00535-0; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; OCONNOR PM, 1993, CANCER RES, V53, P4776; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Pamnani V, 1997, FEBS LETT, V404, P263, DOI 10.1016/S0014-5793(97)00138-5; PARSELL DA, 1994, J BIOL CHEM, V269, P4480; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; PETERS JM, 1992, J MOL BIOL, V223, P557, DOI 10.1016/0022-2836(92)90670-F; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Swaffield JC, 1997, J MOL EVOL, V45, P549, DOI 10.1007/PL00006259; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	47	166	169	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3648	3655		10.1074/jbc.M208422200	http://dx.doi.org/10.1074/jbc.M208422200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446676	hybrid			2022-12-27	WOS:000180869700018
J	Heck, M; Schadel, SA; Maretzki, D; Bartl, FJ; Ritter, E; Palczewski, K; Hofmann, KP				Heck, M; Schadel, SA; Maretzki, D; Bartl, FJ; Ritter, E; Palczewski, K; Hofmann, KP			Signaling states of rhodopsin - Formation of the storage form, metarhodopsin III, from active metarhodopsin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENT; G-PROTEIN; VISUAL PIGMENT; CRYSTAL-STRUCTURE; BINDING PROTEIN; ACTIVATION; OPSIN; BOVINE; KINETICS; DECAY	Vertebrate rhodopsin consists of the apoprotein opsin and the chromophore 11-cis-retinal covalently linked via a protonated Schiff base. Upon photoisomerization of the chromophore to all-trans-retinal, the retinylidene linkage hydrolyzes, and all-trans-retinal dissociates from opsin. The pigment is eventually restored by recombining with enzymatically produced 11-cis-retinal. All-trans-retinal release occurs in parallel with decay of the active form, metarhodopsin (Meta) II, in which the original Schiff base is intact but deprotonated. The intermediates formed during Meta II decay include Meta III, with the original Schiff base reprotonated, and Meta III-like pseudo-photoproducts. Using an intrinsic fluorescence assay, Fourier transform infrared spectroscopy, and UV-visible spectroscopy, we investigated Meta II decay in native rod disk membranes. Up to 40% of Meta III is formed without changes in the intrinsic Trp fluorescence and thus without all-trans-retinal release. NADPH, a cofactor for the reduction of all-trans-retinal to all-trans-retinol, does not accelerate Meta II decay nor does it change the amount of Meta III formed. However, Meta III can be photoconverted back to the Meta II signaling state. The data are described by two quasi-irreversible pathways, leading in parallel into Meta III or into release of all-trans-retinal. Therefore, Meta III could be a form of rhodopsin that is storaged away, thus regulating photoreceptor regeneration.	Humboldt Univ, Univ Klinikum charite, Inst Med Phys & Biophys, D-10098 Berlin, Germany; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Heck, M (corresponding author), Humboldt Univ, Univ Klinikum charite, Inst Med Phys & Biophys, Schumannstr 20-21, D-10098 Berlin, Germany.	martin.heck@charite.de			NATIONAL EYE INSTITUTE [R01EY009339] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY009339, EY09339] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; BAUMANN C, 1972, J PHYSIOL-LONDON, V222, P643, DOI 10.1113/jphysiol.1972.sp009819; BLAZYNSKI C, 1984, VISION RES, V24, P459, DOI 10.1016/0042-6989(84)90043-9; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; CHABRE M, 1979, VISION RES, V19, P1005, DOI 10.1016/0042-6989(79)90226-8; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; DEGRIP WJ, 2000, MOL MECH VISUAL TRAN, P1, DOI DOI 10.1016/S1383-8121(00)80004-4; DONNER KO, 1975, VISION RES, V15, P985, DOI 10.1016/0042-6989(75)90241-2; EBREY TG, 1968, VISION RES, V8, P965, DOI 10.1016/0042-6989(68)90071-0; EBREY TG, 1971, P NATL ACAD SCI USA, V68, P713, DOI 10.1073/pnas.68.4.713; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; FUKADA Y, 1981, BIOCHIM BIOPHYS ACTA, V675, P195, DOI 10.1016/0304-4165(81)90226-9; GUTFREUND H, 1995, KINETICS LIFE SCI, P57; Hofmann K. P., 2000, HDB BIOL PHYSICS, P91, DOI 10.1016/s1383-8121(00)80006-8; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; HOFMANN KP, 1983, BIOCHIM BIOPHYS ACTA, V725, P60, DOI 10.1016/0005-2728(83)90224-4; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; JAGER F, 1994, BIOCHEMISTRY-US, V33, P7389; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jang GF, 2001, J BIOL CHEM, V276, P26148, DOI 10.1074/jbc.M102212200; Janz JM, 2001, BIOCHEMISTRY-US, V40, P7219, DOI 10.1021/bi002937i; KIBELBEK J, 1991, BIOCHEMISTRY-US, V30, P6761, DOI 10.1021/bi00241a019; Kisselev OG, 1999, P NATL ACAD SCI USA, V96, P4898, DOI 10.1073/pnas.96.9.4898; KLINGER AL, 1992, BIOPHYS J, V63, P1244, DOI 10.1016/S0006-3495(92)81700-9; KROFP A, 1967, VISION RES, V7, P811, DOI 10.1016/0042-6989(67)90001-6; KUHN H, 1982, METHOD ENZYMOL, V81, P556; Lewis JW, 1997, VISION RES, V37, P1, DOI 10.1016/S0042-6989(96)00138-1; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Rohrig UF, 2002, BIOCHEMISTRY-US, V41, P10799, DOI 10.1021/bi026011h; ROTHSCHILD KJ, 1987, BIOPHYS J, V51, P345, DOI 10.1016/S0006-3495(87)83341-6; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sachs K, 2000, METHOD ENZYMOL, V315, P238; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Szundi I, 2000, VISION RES, V40, P3039, DOI 10.1016/S0042-6989(00)00148-6; Tachibanaki S, 1998, FEBS LETT, V425, P126, DOI 10.1016/S0014-5793(98)00216-6; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; VANBREUGEL PJGM, 1979, BIOCHIM BIOPHYS ACTA, V557, P188, DOI 10.1016/0005-2736(79)90101-9; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Vogel R, 2001, BIOCHEMISTRY-US, V40, P13342, DOI 10.1021/bi0113667; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	56	100	101	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3162	3169		10.1074/jbc.M209675200	http://dx.doi.org/10.1074/jbc.M209675200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427735	Green Accepted, hybrid			2022-12-27	WOS:000180915000051
J	Idelman, G; Glaser, T; Roberts, CT; Werner, H				Idelman, G; Glaser, T; Roberts, CT; Werner, H			WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSOR GENE; WILMS-TUMOR; IGF-I; INCREASED EXPRESSION; PROMOTER ACTIVITY; P53; WT1; APOPTOSIS; CELLS; TRANSCRIPTION	The insulin-like growth factor-I receptor (IGF-IR) plays a critical role in transformation. The expression of the IGF-IR gene is negatively regulated by a number of transcription factors, including the V,1171 and p53 tumor suppressors. Previous studies have suggested both physical and functional interactions between the WT1 and p53 proteins. The potential functional interactions between WT1 and p53 in control of IGF-IR promoter activity were addressed by transient coexpression of vectors encoding different isoforms of WT1, together with IGF-IR promoter-luciferase reporter constructs, in p53-null osteosarcoma-derived Saos-2 cells, wild-type p53-expressing kidney tumor-derived G401 cells, and mutant p53-expressing, rhabdomyosarcoma-derived RD cells. Similar studies were also performed to compare p53-expressing Balb/c-3T3 and clonally derived p53-null, (10)l fibroblasts and the colorectal cancer cell line HCT116 +/+, which expresses a wild-type p53 gene, and its HCT116-/- derivative, in which the p53 gene has been disrupted by homologous recombination. WT1 splice variants lacking a KTS insert between zinc fingers 3 and 4 suppressed IGF-IR promoter activity in the absence of p53 or in the presence of wild-type p53. WT1 variants that contain the KTS insert are impaired in their ability to bind to the IGF-IR promoter and are unable to suppress IGF-IR promoter. In the presence of mutant p53, WT1 cannot repress the IGF-IR promoter. Coilmmunoprecipitation experiments showed that p53 and WT1 physically interact, whereas electrophoretic mobility shift assay studies revealed that p53 modulates the ability of WT1 to bind to the IGF-IR promoter. In summary, the transcriptional activity of WT1 proteins and their ability to function as tumor suppressors or oncogenes depends on the cellular status of p53.	Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA	Tel Aviv University; Sackler Faculty of Medicine; Oregon Health & Science University	Werner, H (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel.	hwerner@post.tau.ac.il	Roberts, Charles/K-6953-2017	Roberts, Charles/0000-0003-1756-5772	FIC NIH HHS [TW00997-03] Funding Source: Medline; NIDDK NIH HHS [DK50810] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050810] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARDEESY N, 1995, CANCER RES, V55, P215; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; BEITNERJOHNSON D, 1995, MOL ENDOCRINOL, V9, P1147, DOI 10.1210/me.9.9.1147; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Duarte A, 1998, BRIT J CANCER, V77, P253, DOI 10.1038/bjc.1998.41; GANSLER T, 1989, AM J PATHOL, V135, P961; Girnita L, 2000, CANCER RES, V60, P5278; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; LEMOINE NR, 1992, J PATHOL, V168, P237, DOI 10.1002/path.1711680213; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; MAHESWARAN S, 1995, GENE DEV, V9, P2143, DOI 10.1101/gad.9.17.2143; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; MORRIS JF, 1991, ONCOGENE, V6, P2339; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Prisco M, 1997, MOL CELL BIOL, V17, P1084, DOI 10.1128/MCB.17.3.1084; RESNICOFF M, 1995, CANCER RES, V55, P2463; SELL C, 1995, CANCER RES, V55, P303; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Silberstein GB, 1997, P NATL ACAD SCI USA, V94, P8132, DOI 10.1073/pnas.94.15.8132; Tajinda K, 1999, ENDOCRINOLOGY, V140, P4713, DOI 10.1210/en.140.10.4713; Webster NJG, 1997, BIOCHEM MOL MED, V62, P139, DOI 10.1006/bmme.1997.2648; Werner H, 2000, CELL MOL LIFE SCI, V57, P932, DOI 10.1007/PL00000735; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1995, MOL CELL BIOL, V15, P3516; WERNER H, 1992, MOL ENDOCRINOL, V6, P1545, DOI 10.1210/me.6.10.1545; Werner H, 1997, CRIT REV ONCOGENESIS, V8, P71, DOI 10.1615/CritRevOncog.v8.i1.40; WERNER H, 1993, P NATL ACAD SCI USA, V90, P5828, DOI 10.1073/pnas.90.12.5828; Werner H, 1996, ADV CANCER RES, V68, P183, DOI 10.1016/S0065-230X(08)60354-1; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; WERNER H, 1999, IGF SYSTEM MOL BIOL, P63; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768	36	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3474	3482		10.1074/jbc.M211606200	http://dx.doi.org/10.1074/jbc.M211606200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12444079	hybrid			2022-12-27	WOS:000180915000089
J	Nour, N; Basak, A; Chretien, M; Seidah, NG				Nour, N; Basak, A; Chretien, M; Seidah, NG			Structure-function analysis of the prosegment of the proprotein convertase PC5A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-BINDING INHIBITORS; PROHORMONE CONVERTASES; IN-VITRO; INTRAMOLECULAR CHAPERONE; SECRETORY PATHWAY; ENZYMATIC CHARACTERIZATION; PROTEOLYTIC ACTIVATION; PROCESSING ENZYME; POTENT INHIBITORS; CDNA STRUCTURE	To investigate if some residues within the prosegment of PC5A are important for its optimal proteolytic function, various PC5A mutants were cellularly expressed, and their processing activities were compared using pro-vascular endothelial growth factor C (pro-VEGF-C) as a substrate. Although wild type PC5A almost completely processes pro-VEGF-C, a prosegment deletion as well as both P1 mutants of the primary (R116A) and secondary (R84A) autocatalytic cleavage sites are inactive. The in vitro inhibitory potency of various decapeptides mimicking the C-terminal sequence of PC5 prosegment (pPC5) revealed that the native (107)QQVVVKKRTKR(116) peptide is a nanomolar inhibitor, whereas its P6 mutant K111H is more selective toward PC5A than Furin. In vitro activity assays using the bacterially expressed pPC5 and its mutants revealed them to be very potent nanomolar inhibitors (IC50) and only similar to 6-fold more selective inhibitors of PC5A versus Furin. Expression of the preprosegment of PC5 (ppPC5) and its mutants in Chinese hamster ovary FD11 cells overexpressing pro-VEGF-C with either PC5A or Furin showed them to be as good inhibitors of PC5A as the serpin alpha1-antitrypsin Portland (alpha1-PDX), ppFurin, or ppPACE4 but less potent toward overexpressed Furin. In conclusion, cleavages of the prosegment of PC5A at both Arg(116) and Are are required for PC5A cellular activity, and ppPC5 is a very potent but modestly selective cellular inhibitor of PC5A.	Ottawa Hlth Res Inst, Reg Prot Chem Ctr, Dis Aging Unit, Ottawa, ON K1Y 4E9, Canada; Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada	University of Ottawa; Ottawa Hospital Research Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Chretien, M (corresponding author), Ottawa Hlth Res Inst, Reg Prot Chem Ctr, Dis Aging Unit, Loeb Bldg,725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.		Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342				Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; ANGLIKER H, 1995, J MED CHEM, V38, P4014, DOI 10.1021/jm00020a016; Barbero P, 1998, J BIOL CHEM, V273, P25339, DOI 10.1074/jbc.273.39.25339; Basak A, 1999, BIOCHEM J, V343, P29, DOI 10.1042/0264-6021:3430029; Basak A, 1999, BIOCHEM J, V338, P107, DOI 10.1042/0264-6021:3380107; BASAK A, 1995, INT J PEPT PROT RES, V46, P228; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; BEAUBIEN G, 1995, CELL TISSUE RES, V279, P539; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bhattacharjya S, 2000, BIOCHEMISTRY-US, V39, P2868, DOI 10.1021/bi9923961; Boudreault A, 1998, J BIOL CHEM, V273, P31574, DOI 10.1074/jbc.273.47.31574; Cain BM, 2001, PEPTIDES, V22, P1271, DOI 10.1016/S0196-9781(01)00451-X; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Campan M, 1996, BIOCHEMISTRY-US, V35, P3797, DOI 10.1021/bi952552d; CHRETIEN M, 1995, P ASSOC AM PHYSICIAN, V107, P47; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; DONG W, 1995, J NEUROSCI, V15, P1778, DOI 10.1523/JNEUROSCI.15-03-01778.1995; Dufour EK, 2001, J BIOL CHEM, V276, P38971, DOI 10.1074/jbc.M102959200; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; GU ML, 1995, FEBS LETT, V365, P95, DOI 10.1016/0014-5793(95)00447-H; JEAN F, 1995, BIOCHEM J, V307, P689, DOI 10.1042/bj3070689; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; Lesage G, 2001, FEBS LETT, V508, P332, DOI 10.1016/S0014-5793(01)03096-4; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Lissitzky JC, 2000, BIOCHEM J, V346, P133, DOI 10.1042/0264-6021:3460133; LU WY, 1993, J BIOL CHEM, V268, P14583; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Mercure C, 1996, HYPERTENSION, V28, P840, DOI 10.1161/01.HYP.28.5.840; Miranda L, 1996, P NATL ACAD SCI USA, V93, P7695, DOI 10.1073/pnas.93.15.7695; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nachtigal MW, 1996, P NATL ACAD SCI USA, V93, P7711, DOI 10.1073/pnas.93.15.7711; Nagahama M, 1998, FEBS LETT, V434, P155, DOI 10.1016/S0014-5793(98)00970-3; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; SEIDAH NG, 2002, CO POST TRANSLATIONA, P237; SHINDE U, 1993, P NATL ACAD SCI USA, V90, P6924, DOI 10.1073/pnas.90.15.6924; Stawowy P, 2001, J HISTOCHEM CYTOCHEM, V49, P323, DOI 10.1177/002215540104900306; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Taylor NA, 1997, BIOCHEM J, V321, P367, DOI 10.1042/bj3210367; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; Tsuji A, 2002, PROTEIN ENG, V15, P123, DOI 10.1093/protein/15.2.123; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; VanRompaey L, 1997, BIOCHEM J, V326, P507; Wong BSY, 2002, MOL REPROD DEV, V61, P453, DOI 10.1002/mrd.10113; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Yabuta Y, 2001, J BIOL CHEM, V276, P44427, DOI 10.1074/jbc.M107573200; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	69	44	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2886	2895		10.1074/jbc.M208009200	http://dx.doi.org/10.1074/jbc.M208009200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12414802	hybrid			2022-12-27	WOS:000180915000017
J	Pandey, AV; Mellon, SH; Miller, WL				Pandey, AV; Mellon, SH; Miller, WL			Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; NEONATAL PIG TESTIS; ACTIVATING FACTOR-I; 17,20-LYASE ACTIVITY; MICROSOMAL CYTOCHROME-P-450; OKADAIC ACID; ADRENARCHE; EXPRESSION; GIRLS; CELLS	Cytochrome P450c17 catalyzes 17alpha-hydroxylation needed for cortisol synthesis and 17,20 lyase activity needed to produce sex steroids. Serine phosphorylation of P450c17 specifically increases 17,20 lyase activity, but the physiological factors regulating this effect remain unknown. Treating human adrenal NCI-H295A cells with the phosphatase inhibitors okadaic acid, fostriecin, and cantharidin increased 17,20 lyase activity, suggesting involvement of protein phosphatase 2A (PP2A) or 4 (PP4). PP2A but not PP4 inhibited 17,20 lyase activity in microsomes from cultured cells, but neither affected 17alpha-hydroxylation. Inhibition of 17,20 lyase activity by PP2A was concentration-dependent, could be inhibited by okadaic acid, and was restored by endogenous protein kinases. PP2A but not PP4 coinimunoprecipitated with P450c17, and suppression of PP2A by small interfering RNA increased 17,20 lyase activity. Phosphoprotein SET found in adrenals inhibited PP2A, but not PP4, and fostered 17,20 lyase activity. The identification of PP2A and SET as post-translational regulators of androgen biosynthesis suggests potential additional mechanisms contributing to adrenarche and hyperandrogenic disorders such as polycystic ovary syndrome.	Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Miller, WL (corresponding author), Univ Calif San Francisco, Dept Pediat, Bldg MR4,Rm 209, San Francisco, CA 94143 USA.	wlmlab@itsa.ucsf.edu	Miller, Walter L/J-3696-2012; Pandey, Amit V/A-7223-2008; Pandey, Amit V/AAO-6442-2020	Pandey, Amit V/0000-0001-8331-5902; Pandey, Amit V/0000-0001-8331-5902	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041958, R01HD027970] Funding Source: NIH RePORTER; NICHD NIH HHS [HD34449, HD27970, HD41958] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		APTER D, 1979, ACTA PAEDIATR SCAND, V68, P599, DOI 10.1111/j.1651-2227.1979.tb05062.x; Arlt W, 2002, ENDOCRINOLOGY, V143, P4665, DOI 10.1210/en.2002-220456; Arlt W, 2001, J BIOL CHEM, V276, P16767, DOI 10.1074/jbc.M100040200; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; CUTLER GB, 1978, ENDOCRINOLOGY, V103, P2112, DOI 10.1210/endo-103-6-2112; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Estanyol JM, 1999, J BIOL CHEM, V274, P33161, DOI 10.1074/jbc.274.46.33161; GAZDAR AF, 1990, CANCER RES, V50, P5488; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; HARDIE DG, 1999, PROTEIN PHOSPHORYLAT, P109; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; HAYSTEAD CMM, 1993, EUR J BIOCHEM, V214, P459, DOI 10.1111/j.1432-1033.1993.tb17942.x; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Ibanez L, 1999, J CLIN ENDOCR METAB, V84, P4739, DOI 10.1210/jc.84.12.4739; IBANEZ L, 1993, J CLIN ENDOCR METAB, V76, P1599, DOI 10.1210/jc.76.6.1599; ISSINGER OG, 1988, EMBO J, V7, P1621, DOI 10.1002/j.1460-2075.1988.tb02988.x; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KIM EG, 1994, AM J PHYSIOL, V266, pF155, DOI 10.1152/ajprenal.1994.266.1.F155; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; LIN D, 1991, J BIOL CHEM, V266, P15992; LIN D, 1993, ENDOCRINOLOGY, V132, P2498, DOI 10.1210/en.132.6.2498; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; NAKAJIN S, 1981, BIOCHEMISTRY-US, V20, P4037, DOI 10.1021/bi00517a014; OPPENHEIMER E, 1995, J CLIN ENDOCR METAB, V80, P614, DOI 10.1210/jc.80.2.614; ORENTREICH N, 1984, J CLIN ENDOCR METAB, V59, P551, DOI 10.1210/jcem-59-3-551; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; Rodriguez H, 1997, J CLIN ENDOCR METAB, V82, P365, DOI 10.1210/jc.82.2.365; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; SMAIL PJ, 1982, ENDOCRINOLOGY, V111, P844, DOI 10.1210/endo-111-3-844; STAELS B, 1993, MOL ENDOCRINOL, V7, P423, DOI 10.1210/me.7.3.423; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; ZHANG LH, 1995, P NATL ACAD SCI USA, V92, P10619, DOI 10.1073/pnas.92.23.10619; Zhang PL, 2001, DNA CELL BIOL, V20, P613, DOI 10.1089/104454901753340604; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	50	109	113	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2837	2844		10.1074/jbc.M209527200	http://dx.doi.org/10.1074/jbc.M209527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12444089	hybrid			2022-12-27	WOS:000180915000011
J	Kufel, J; Allmang, C; Petfalski, E; Beggs, J; Tollervey, D				Kufel, J; Allmang, C; Petfalski, E; Beggs, J; Tollervey, D			Lsm proteins are required for normal processing and stability of ribosomal RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SM-LIKE PROTEINS; SMALL NUCLEAR RIBONUCLEOPROTEINS; YEAST MESSENGER-RNAS; HUMAN PM-SCL; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; U6 SNRNA; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; PRERIBOSOMAL RNA	Depletion of any of the essential Lsm proteins, Lsm2-5p or Lsm8p, delayed pre-rRNA processing and led to the accumulation cif many aberrant processing intermediates, indicating that an Lsm complex is required to maintain the normally strict order of processing events. In addition, high levels of degradation products derived from both precursors and mature rRNAs accumulated in Lsm-depleted strains. Depletion of the essential Lsm proteins reduced the apparent processivity of both 5' and 3' exonuclease activities involved in 5.8S rRNA processing, and the degradation intermediates that accumulated were consistent with inefficient 5' and 3' degradation. Many, but not all, pre-rRNA species could be coprecipitated with tagged Lsm3p, but not with tagged Lsm1p or non-tagged control strains, suggesting their direct interaction with an Lsm2-8p complex. We propose that Lsm. proteins facilitate RNA protein interactions and structural changes required during ribosomal subunit assembly.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Swann Bldg,Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Beggs, Jean/H-4861-2011; , jbeggs/N-9551-2019; Kufel, Joanna/AAK-2108-2020; Tollervey, David/AAR-6662-2020	Beggs, Jean/0000-0002-8179-6519; Kufel, Joanna/0000-0001-6810-2749; Tollervey, David/0000-0003-2894-2772; Allmang, Christine/0000-0001-8883-0874				AbouElela S, 1996, CELL, V85, P115, DOI 10.1016/S0092-8674(00)81087-9; Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; ALBERS A, 2002, IN PRESS RNA NY, V8; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; Bonnerot C, 2000, MOL CELL BIOL, V20, P5939, DOI 10.1128/MCB.20.16.5939-5946.2000; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; BRAND RC, 1977, EUR J BIOCHEM, V75, P311, DOI 10.1111/j.1432-1033.1977.tb11531.x; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; BROMLEY S, 1982, MOL CELL BIOL, V2, P1205, DOI 10.1128/MCB.2.10.1205; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Chanfreau G, 1998, EMBO J, V17, P3726, DOI 10.1093/emboj/17.13.3726; Collins BM, 2001, J MOL BIOL, V309, P915, DOI 10.1006/jmbi.2001.4693; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Elela SA, 1998, EMBO J, V17, P3738, DOI 10.1093/emboj/17.13.3738; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Geerlings TH, 2000, RNA, V6, P1698, DOI 10.1017/S1355838200001540; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gottschalk A, 1999, EMBO J, V18, P4535, DOI 10.1093/emboj/18.16.4535; He WH, 2001, GENETICS, V158, P1445; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; HUTCHISON HT, 1969, J BACTERIOL, V99, P807, DOI 10.1128/JB.99.3.807-814.1969; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Kufel J, 2002, MOL CELL BIOL, V22, P5248, DOI 10.1128/MCB.22.14.5248-5256.2002; Kufel J, 1999, RNA, V5, P909, DOI 10.1017/S135583829999026X; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mitchell P, 1996, GENE DEV, V10, P502, DOI 10.1101/gad.10.4.502; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; ROSBASH M, 1981, CELL, V24, P679, DOI 10.1016/0092-8674(81)90094-5; Russell CS, 2000, RNA, V6, P1565, DOI 10.1017/S1355838200000984; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; VANDERSANDE CAFM, 1992, J MOL BIOL, V223, P899, DOI 10.1016/0022-2836(92)90251-E; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Venema J, 1996, EMBO J, V15, P5701, DOI 10.1002/j.1460-2075.1996.tb00954.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; YEH LCC, 1990, BIOCHEMISTRY-US, V29, P5911, DOI 10.1021/bi00477a005; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	73	63	70	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2147	2156		10.1074/jbc.M208856200	http://dx.doi.org/10.1074/jbc.M208856200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12438310	hybrid			2022-12-27	WOS:000180562000012
J	Lee, JR; Shin, H; Ko, JW; Choi, J; Lee, H; Kim, E				Lee, JR; Shin, H; Ko, JW; Choi, J; Lee, H; Kim, E			Characterization of the movement of the kinesin motor KIF1A in living cultured neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERFAMILY PROTEIN KIF1A; HIPPOCAMPAL-NEURONS; AXONAL-TRANSPORT; SYNAPTIC VESICLE; C-ELEGANS; CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEINS; MONOMERIC MOTOR; GENE; UNC-104	KIF1A is a kinesin motor known to transport synaptic vesicle precursors in neuronal axons, but little is known about whether KIF1A mediates fast and processive axonal transport in vivo. By monitoring movements of EGFP-labeled KIF1A in living cultured hippocampal neurons, we determined the characteristics of KIF1A movements. KIF1A particles moved anterogradely along the neurites with an average velocity of 1.0 mum/s. The movements of KIF1A were highly processive, with an average duration of persistent anterograde movement of 11 s. Some KIF1A particles (17%) exhibited retrograde movements of 0.72 mum/s, although overall particle movement was in the anterograde direction. The anterograde movement of KIF1A, however, did not lead to a detectable accumulation of KIF1A in the periphery of neurons, suggesting that there are mechanisms inhibiting the peripheral accumulation of KIF1A. These results suggest that KIF1A mediates neuronal transport at a high velocity and processivity in vivo.	Korea Adv Inst Sci & Technol, Dept Sci Biol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Sci Biol, Taejon 305701, South Korea.		Kim, Eunjoon/C-1566-2011					BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; Banker G., 1991, CULTURING NERVE CELL; Bloom GS, 2001, CURR OPIN CELL BIOL, V13, P36, DOI 10.1016/S0955-0674(00)00171-X; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HIROKAWA N, 1991, J CELL BIOL, V114, P295, DOI 10.1083/jcb.114.2.295; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Koushika SP, 2000, CURR OPIN CELL BIOL, V12, P517, DOI 10.1016/S0955-0674(00)00125-3; Mok H, 2002, J NEUROSCI, V22, P5253; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Prekeris R, 1999, J NEUROSCI, V19, P10324; Rogers KR, 1997, MOL BRAIN RES, V51, P161, DOI 10.1016/S0169-328X(97)00234-9; Scholey JM, 2002, DEV CELL, V2, P515, DOI 10.1016/S1534-5807(02)00177-6; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Xia ZG, 1996, J NEUROSCI, V16, P5425; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZQ, 1998, CHINESE CHEM LETT, V9, P261; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	37	51	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2624	2629		10.1074/jbc.M211152200	http://dx.doi.org/10.1074/jbc.M211152200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435738	hybrid			2022-12-27	WOS:000180562000073
J	Varin, A; Manna, SK; Quivy, V; Decrion, AZ; Van Lint, C; Herbein, G; Aggarwal, BB				Varin, A; Manna, SK; Quivy, V; Decrion, AZ; Van Lint, C; Herbein, G; Aggarwal, BB			Exogenous Nef protein activates NF-kappa B, AP-1, and c-jun N-terminal kinase and stimulates HIV transcription in promonocytic cells - Role in aids pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 NEF; TAT PROTEIN; T-CELL; VIRAL REPLICATION; GENE-EXPRESSION; SH3 DOMAINS; INFECTION; INDUCTION; CD4	The human immunodeficiency virus (HIV) Nef protein plays a critical role in AIDS pathogenesis by enhancing replication and survival of the virus within infected cells and by facilitating its spread in vivo. Most of the data obtained so far have been in experiments with endogenous Nef protein, so far overlooking the effects of exogenous soluble Nef protein. We used recombinant exogenous Nef proteins to activate nuclear transcription factors NF-B-K and A-P-1 in the promonocytic cell line U937. Exogenous SIV and HIV-1 Nef proteins activated NF-kappaB and AP-1 in a dose- and time-dependent manner. Activation of NF-B-K by exogenous Nef was concomitant to the degradation of the inhibitor of NF-kappaB, IkappaBalpha. In agreement with increased AP-1 activation, a time- and dose-dependent increase in JNK activation was observed following treatment of U937 cells with exogenous Nef. Since exogenous Nef activates the transcription factors NF-B-K and AP-1, which bind to the HIV-1 long terminal repeat (LTR), we investigated the effect of exogenous Nef on HIV-1 replication. We observed that exogenous Nef stimulated HIV-1 LTR via NF-KB activation in U937 cells and enhanced viral replication in the chronically infected promonocytic cells U1. Therefore, our results suggest that exogenous Nef could fuel the progression of the disease via stimulation of HIV-1 provirus present in such cellular reservoirs as mononuclear phagocytes in HIV-infected patients.	Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Cytokine Res Sect, Houston, TX 77030 USA; Free Univ Brussels, IBMM, B-6041 Gosselies, Belgium; Univ Franche Comte, Dept Virol, F-25030 Besancon, France; Univ Franche Comte, Inst Etud & Transfert Genes, F-25030 Besancon, France	University of Texas System; UTMD Anderson Cancer Center; Universite Libre de Bruxelles; Universite de Franche-Comte; Universite de Franche-Comte	Aggarwal, BB (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Cytokine Res Sect, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013	Varin, Audrey/0000-0002-9182-9193				AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Alessandrini L, 2000, J GEN VIROL, V81, P2905, DOI 10.1099/0022-1317-81-12-2905; AMEISEN JC, 1989, AIDS RES HUM RETROV, V5, P279, DOI 10.1089/aid.1989.5.279; Arold S, 1998, BIOCHEMISTRY-US, V37, P14683, DOI 10.1021/bi980989q; Asin S, 2001, J VIROL, V75, P11408, DOI 10.1128/JVI.75.23.11408-11416.2001; Asin S, 1999, J VIROL, V73, P3893, DOI 10.1128/JVI.73.5.3893-3903.1999; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; BAHRAOUI E, 1990, AIDS RES HUM RETROV, V6, P1087, DOI 10.1089/aid.1990.6.1087; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Biggs TE, 1999, J MOL BIOL, V290, P21, DOI 10.1006/jmbi.1999.2849; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; CANONNEHERGAUX F, 1995, J VIROL, V69, P6634, DOI 10.1128/JVI.69.11.6634-6642.1995; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Cheng H, 1999, VIROLOGY, V264, P5, DOI 10.1006/viro.1999.9937; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; CULLEN BR, 1991, FASEB J, V5, P2361, DOI 10.1096/fasebj.5.10.1712325; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Demarchi F, 1996, J VIROL, V70, P4427, DOI 10.1128/JVI.70.7.4427-4437.1996; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1988, J IMMUNOL, V140, P1117; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Gibellini D, 1997, BLOOD, V89, P1654, DOI 10.1182/blood.V89.5.1654.1654_1654_1664; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Harris M, 1999, CURR BIOL, V9, pR459, DOI 10.1016/S0960-9822(99)80282-6; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Herbein G, 1997, J VIROL, V71, P4150, DOI 10.1128/JVI.71.5.4150-4156.1997; Hodge DR, 1998, J BIOL CHEM, V273, P15727, DOI 10.1074/jbc.273.25.15727; Jacque JM, 1996, J VIROL, V70, P2930; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; Kumar A, 1998, J IMMUNOL, V161, P776; Lafrenie RM, 1997, J IMMUNOL, V159, P4077; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lu XB, 1996, CURR BIOL, V6, P1677, DOI 10.1016/S0960-9822(02)70792-6; Luo TC, 1996, J VIROL, V70, P6493, DOI 10.1128/JVI.70.9.6493-6496.1996; Mahlknecht U, 2000, J IMMUNOL, V165, P6437, DOI 10.4049/jimmunol.165.11.6437; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Manna SK, 1999, J IMMUNOL, V163, P6800; Manna SK, 1999, J IMMUNOL, V162, P2095; McCloskey TW, 1997, J IMMUNOL, V158, P1014; MCELHINNY JA, 1995, J VIROL, V69, P1500, DOI 10.1128/JVI.69.3.1500-1509.1995; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NIEDERMAN TMJ, 1992, J VIROL, V66, P6213, DOI 10.1128/JVI.66.10.6213-6219.1992; Nunn MF, 1996, J VIROL, V70, P6157, DOI 10.1128/JVI.70.9.6157-6161.1996; Okada H, 1997, FEBS LETT, V414, P603, DOI 10.1016/S0014-5793(97)01080-6; Ott M, 1998, J IMMUNOL, V160, P2872; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; SALGHETTI S, 1995, P NATL ACAD SCI USA, V92, P349, DOI 10.1073/pnas.92.2.349; Sawai ET, 1996, CURR BIOL, V6, P1519, DOI 10.1016/S0960-9822(96)00757-9; SCHUITEMAKER H, 1992, J CLIN INVEST, V89, P1154, DOI 10.1172/JCI115697; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Smith BL, 1996, J BIOL CHEM, V271, P16753, DOI 10.1074/jbc.271.28.16753; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; THOMAS CA, 1994, J IMMUNOL, V153, P3831; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VANLINT C, 1994, J VIROL, V68, P2632, DOI 10.1128/JVI.68.4.2632-2648.1994; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Yang XY, 1999, J BIOL CHEM, V274, P27981, DOI 10.1074/jbc.274.39.27981	84	92	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2219	2227		10.1074/jbc.M209622200	http://dx.doi.org/10.1074/jbc.M209622200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12419805	hybrid			2022-12-27	WOS:000180562000021
J	Xia, L; Nordman, T; Olsson, JM; Damdimopoulos, A; Bjorkhem-Bergman, L; Nalvarte, I; Eriksson, LC; Arner, ESJ; Spyrou, G; Bjornstedt, M				Xia, L; Nordman, T; Olsson, JM; Damdimopoulos, A; Bjorkhem-Bergman, L; Nalvarte, I; Eriksson, LC; Arner, ESJ; Spyrou, G; Bjornstedt, M			The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone - A novel mechanism for defense against oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELENOCYSTEINE INSERTION-SEQUENCE; RAT-LIVER NODULES; LIPOAMIDE DEHYDROGENASE; FUNCTIONAL EXPRESSION; MESSENGER-RNA; COENZYME-Q; SELENIUM; ANTIOXIDANT; EVOLUTION; ASCORBATE	The selenoprotein thioredoxin reductase (TrxR1) is an essential antioxidant enzyme known to reduce many compounds in addition to thioredoxin, its principle protein substrate. Here we found that TrxR1 reduced ubiquinone-10 and thereby regenerated the antioxidant ubiquinol-10 (Q10), which is important for protection against lipid and protein peroxidation. The reduction was time-and dose-dependent, with an apparent K-m of 22 muM and a maximal rate of about 12 nmol of reduced Q10 per milligram of TrxR1 per minute. TrxR1 reduced ubiquinone maximally at a physiological pH of 7.5 at similar rates using either NADPH or NADH as cofactors. The reduction of Q10 by mammalian TrxR1 was selenium dependent as revealed by comparison with Escherichia coli TrxR or selenium-deprived mutant; and truncated mammalian TrxR forms. In addition, the rate of reduction of ubiquinone was significantly higher in homogenates from human embryo kidney 293 cells stably overexpressing thioredoxin reductase and was induced along with increasing cytosolic TrxR activity after the addition of selenite to the culture medium. These data demonstrate that the selenoenzyme thioredoxin reductase is an important selenium-dependent ubiquinone reductase and can explain how selenium and ubiquinone, by a combined action, may protect the cell from oxidative damage.	Huddinge Univ Hosp, Div Pathol, Karolinska Inst, Dept Microbiol Pathol & Immunol, SE-14186 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; Karolinska Inst, Ctr Biotechnol, Novum, Dept Biosci, SE-14157 Huddinge, Sweden; Univ Coll, Sodertorns Hogskola, SE-14104 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Sodertorn University	Bjornstedt, M (corresponding author), Huddinge Univ Hosp, Div Pathol, Karolinska Inst, Dept Microbiol Pathol & Immunol, F46, SE-14186 Stockholm, Sweden.		Arnér, Elias/K-6737-2019; Nalvarte, Ivan/V-3849-2019; Arnér, Elias S.J./J-5832-2012	Arnér, Elias/0000-0002-4807-6114; Nalvarte, Ivan/0000-0001-6828-2583; Arnér, Elias S.J./0000-0002-4807-6114; Damdimopoulos, Anastasios/0000-0003-4425-1189				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Bjorkhem L, 2001, J HEPATOL, V35, P259, DOI 10.1016/S0168-8278(01)00113-1; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; ERNSTER L, 1969, EUR J BIOCHEM, V9, P299, DOI 10.1111/j.1432-1033.1969.tb00609.x; ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Fujiwara N, 1999, BIOCHEM J, V340, P439, DOI 10.1042/0264-6021:3400439; Gasdaska JR, 1999, J BIOL CHEM, V274, P25379, DOI 10.1074/jbc.274.36.25379; Gasdaska PY, 1999, FEBS LETT, V442, P105, DOI 10.1016/S0014-5793(98)01638-X; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Gladyshev VN, 2001, BIOFACTORS, V14, P87, DOI 10.1002/biof.5520140112; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1998, OXIDATIVE STRESS CAN, P229; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Li X, 2001, FEBS LETT, V508, P489, DOI 10.1016/S0014-5793(01)03129-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma XR, 2002, J BIOL CHEM, V277, P22460, DOI 10.1074/jbc.M202286200; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; OLSSON JM, 1991, CANCER RES, V51, P3774; Olsson JM, 1999, FEBS LETT, V448, P190, DOI 10.1016/S0014-5793(99)00363-4; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Stal P, 1997, J HEPATOL, V27, P562, DOI 10.1016/S0168-8278(97)80362-5; VADHANAVIKIT S, 1994, MOL ASPECTS MED, V15, P103, DOI 10.1016/0098-2997(94)90019-1; VADHANAVIKIT S, 1993, BIOCHEM BIOPH RES CO, V190, P921, DOI 10.1006/bbrc.1993.1137; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; Xia L, 2001, EUR J BIOCHEM, V268, P1486, DOI 10.1046/j.1432-1327.2001.02013.x; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	35	158	170	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2141	2146		10.1074/jbc.M210456200	http://dx.doi.org/10.1074/jbc.M210456200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435734	hybrid			2022-12-27	WOS:000180562000011
J	Dayem, MA; Basquin, C; Pourcher, T; Cordat, E; Leblanc, G				Dayem, MA; Basquin, C; Pourcher, T; Cordat, E; Leblanc, G			Cytoplasmic loop connecting helices IV and V of the melibiose permease from Escherichia coli is involved in the process of Na+-coupled sugar translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-SPANNING SEGMENTS; CATION SPECIFICITY; BINDING-PROPERTIES; ACIDIC RESIDUES; TRANSPORT; CARRIER; MUTAGENESIS; RECOGNITION; SITE; H+	Previous photolabeling and limited proteolysis studies suggested that one of the four basic residues (Arg-141) of the N-terminal cytoplasmic loop connecting helices IV and V (loop 4-5) of the melibiose permease (MelB) from Escherichia coli has a potential role in its symport function (Ambroise, Y., Leblanc, G., and Rousseau, B. (2000) Biochemistry 39, 1338-1345). A mutagenesis study of Arg-141 and of the other three basic residues of loop 4-5 was undertaken to further examine this hypothesis. Cys replacement analysis indicated that Arg-141 and Arg-149, but not Lys-138 and Arg-139, are essential for MelB transport activity. Replacement of Arg-141 by neutral residues (Cys or Gln) inactivated transport and energy-independent carrier-mediated flows of substrates (counterflow, efflux), whereas it had a limited effect on co-substrate binding. R141C sugar transport was partially rescued on reintroducing a positive charge with a charged and permeant thiol reagent. Whereas R149C was completely inactive, R149K and R149Q remained functional. Strikingly, introduction of an additional mutation in the C-terminal helix X (Gly for Val-343) of R149C restored sugar transport. Impermeant thiol reagents inhibited R149C/V343G transport activity in right-side-out membrane vesicles and prevented sugar binding in a sugar-protected manner. All these data suggest that MelB loop 4-5 is close to the sugar binding site and that the charged residue Arg-141 is involved in the reaction of co-substrate translocation or substrate release in the inner compartment.	Univ Nice Sophia Antipolis, Lab Physiol Membranes Cellulaires, F-06230 Villefranche Sur Mer, France; CNRS, UMR 6078, Commissariat Energie Atom, LRC,CEA 16V, F-06230 Villefranche Sur Mer, France	UDICE-French Research Universities; Universite Cote d'Azur; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Leblanc, G (corresponding author), Univ Nice Sophia Antipolis, Lab Physiol Membranes Cellulaires, F-06230 Villefranche Sur Mer, France.			Pourcher, Thierry/0000-0003-2839-4622				Ambroise Y, 2000, BIOCHEMISTRY-US, V39, P1338, DOI 10.1021/bi9916224; BASSILANA M, 1985, BIOCHEM BIOPH RES CO, V129, P626, DOI 10.1016/0006-291X(85)91937-0; BASSILANA M, 1988, J BIOL CHEM, V263, P9663; BOTFIELD MC, 1988, J BIOL CHEM, V263, P12909; BOTFIELD MC, 1992, J BIOL CHEM, V267, P1818; Cordat E, 2000, BIOCHEMISTRY-US, V39, P4493, DOI 10.1021/bi991852i; DAMIANOFORANO E, 1986, J BIOL CHEM, V261, P6893; Dave N, 2000, BIOPHYS J, V79, P747, DOI 10.1016/S0006-3495(00)76332-6; Ding PZ, 2000, BIOCHEM BIOPH RES CO, V268, P409, DOI 10.1006/bbrc.2000.2149; Ding PZ, 2000, BBA-BIOMEMBRANES, V1509, P123, DOI 10.1016/S0005-2736(00)00286-8; Ding PZ, 2001, BIOCHEMISTRY-US, V40, P5506, DOI 10.1021/bi002761k; Dumas F, 2000, BIOCHEMISTRY-US, V39, P4846, DOI 10.1021/bi992634s; Franco PJ, 1999, J BACTERIOL, V181, P6377, DOI 10.1128/JB.181.20.6377-6386.1999; Gwizdek C, 1997, BIOCHEMISTRY-US, V36, P8522, DOI 10.1021/bi970312n; Hacksell I, 2002, EMBO J, V21, P3569, DOI 10.1093/emboj/cdf378; HAMA H, 1993, J BIOL CHEM, V268, P10060; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Maehrel C, 1998, J BIOL CHEM, V273, P33192, DOI 10.1074/jbc.273.50.33192; MUSVETEAU I, 1995, BIOCHEMISTRY-US, V34, P6775, DOI 10.1021/bi00020a024; Olami Y, 1997, J BIOL CHEM, V272, P1761, DOI 10.1074/jbc.272.3.1761; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POURCHER T, 1990, PHILOS T ROY SOC B, V326, P411, DOI 10.1098/rstb.1990.0021; POURCHER T, 1993, J BIOL CHEM, V268, P3209; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Pourcher T, 1996, BIOCHEMISTRY-US, V35, P4161, DOI 10.1021/bi9527496; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; ROSSI B, 1980, J BIOL CHEM, V255, P9936; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; TSUCHIYA T, 1978, J MEMBRANE BIOL, V42, P45, DOI 10.1007/BF01870393; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Weissborn AC, 1997, BBA-BIOMEMBRANES, V1329, P237, DOI 10.1016/S0005-2736(97)00116-8; WILSON DM, 1992, J BACTERIOL, V174, P3083, DOI 10.1128/JB.174.9.3083-3086.1992; WILSON DM, 1987, BIOCHIM BIOPHYS ACTA, V904, P191, DOI 10.1016/0005-2736(87)90368-3; ZANI ML, 1993, J BIOL CHEM, V268, P3216; ZANI ML, 1994, J BIOL CHEM, V269, P24883	37	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1518	1524		10.1074/jbc.M210053200	http://dx.doi.org/10.1074/jbc.M210053200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421811	hybrid			2022-12-27	WOS:000180462200021
J	Cao, GQ; Liang, Y; Broderick, CL; Oldham, BA; Beyer, TP; Schmidt, RJ; Zhang, YY; Stayrook, KR; Suen, C; Otto, KA; Miller, AR; Dai, JN; Foxworthy, P; Gao, H; Ryan, TP; Jiang, XC; Burris, TP; Eacho, PI; Etgen, GJ				Cao, GQ; Liang, Y; Broderick, CL; Oldham, BA; Beyer, TP; Schmidt, RJ; Zhang, YY; Stayrook, KR; Suen, C; Otto, KA; Miller, AR; Dai, JN; Foxworthy, P; Gao, H; Ryan, TP; Jiang, XC; Burris, TP; Eacho, PI; Etgen, GJ			Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTORS; LIPOPROTEIN-LIPASE; ACID BIOSYNTHESIS; LXR-ALPHA; PATHWAY; GAMMA; PROMOTER; PROTEIN; ELEMENT; INSULIN	The oxysterol receptors LXR (liver X receptor)-alpha and LXRbeta are nuclear receptors that play a key role in regulation of cholesterol and fatty acid metabolism. We found that LXRs also play a significant role in glucose metabolism. Treatment of diabetic rodents with the LXR agonist, T0901317, resulted in dramatic reduction of plasma glucose. In insulin-resistant Zucker (fa/fa) rats, T0901317 significantly improved insulin sensitivity. Activation of LXR did not induce robust adipogenesis but rather inhibited the expression of several genes involved in hepatic gluconeogenesis, including phosphoenolpyruvate carboxykinase (PEPCK). Hepatic glucose output was dramatically reduced as a result of this regulation. Nuclear run-on studies indicated that transcriptional repression was primarily responsible for the inhibition of PEPCK by the LXR agonist. In addition, we show that the regulation of the liver gluconeogenic pathway by LXR agonists was a direct effect on hepatocytes. These data not only suggest that LXRs are novel targets for diabetes but also reveal an unanticipated role for these receptors, further linking lipid and glucose metabolism.	Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA; Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Eli Lilly; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Cao, GQ (corresponding author), Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA.		Burris, Thomas/H-5078-2011; Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Beyer, Thomas/0000-0002-8308-3918				Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Burris TP, 1999, MOL ENDOCRINOL, V13, P410, DOI 10.1210/me.13.3.410; Cao GQ, 2002, J BIOL CHEM, V277, P39561, DOI 10.1074/jbc.M207187200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Costet P, 2000, J BIOL CHEM, V275, P28240; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; DeFronzo RA, 2000, ANN INTERN MED, V133, P73, DOI 10.7326/0003-4819-133-1-200007040-00016; Edwards PA, 2002, J LIPID RES, V43, P2; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; REPA JJ, 2002, J BIOL CHEM, V18, P18; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	26	238	264	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1131	1136		10.1074/jbc.M210208200	http://dx.doi.org/10.1074/jbc.M210208200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414791	hybrid			2022-12-27	WOS:000180321900058
J	Patel, NA; Eichler, DC; Chappell, DS; Illingworth, PA; Chalfant, CE; Yamamoto, M; Dean, NM; Wyatt, JR; Mebert, K; Watson, JE; Cooper, DR				Patel, NA; Eichler, DC; Chappell, DS; Illingworth, PA; Chalfant, CE; Yamamoto, M; Dean, NM; Wyatt, JR; Mebert, K; Watson, JE; Cooper, DR			The protein kinase C beta II exon confers mRNA instability in the presence of high glucose concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; MESSENGER-RNA STABILITY; GROWTH-FACTOR; 3'-UNTRANSLATED REGION; BINDING-PROTEIN; INSULIN-LIKE; PROLIFERATION; IDENTIFICATION; EXPRESSION; ELEMENT	Previous studies showed that short term exposure of cells to high glucose destabilized protein kinase C (PKC) betaII mRNA, whereas PKCbetaI mRNA levels remained unaltered. Because PKCbeta mRNAs share common sequences other than the PKCbetaII exon encoding a different carboxyl terminus, we examined PKCbetaII mRNA for a cis-acting region that could confer glucose-induced destabilization. A beta-globin/growth hormone reporter con struct containing the PKCbetaII exon was transfected into human aorta and rat vascular smooth muscle cells (A10) to follow glucose-induced destabilization. Glucose (25 mm) exposure destabilized PKCbetaII chimeric mRNA but not control mRNA. Deletion analysis and electrophoretic mobility shift assays followed by UV cross-linking experiments demonstrated that a region introduced by inclusion of the betaII exon was required to confer destabilization. Although a cis-acting element mapped to 38 nucleotides within the betaII exon was necessary to bestow destabilization, it was not sufficient by itself to confer complete mRNA destabilization. Yet, in intact cells antisense oligonucleotides complementary to this region blocked glucose-induced destabilization. These results suggest that this region must function in context with other sequence elements created by exon inclusion involved in affecting mRNA stability. In summary, inclusion of an exon that encodes PKCbetaII mRNA introduces a cis-acting region that confers destabilization to the mRNA in response to glucose.	James A Haley Vet Hosp, Res Serv, Tampa, FL 33612 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA; Univ S Florida, Coll Med, Dept Biochem, Tampa, FL 33612 USA; Univ S Florida, Coll Med, Dept Biol Mol, Tampa, FL 33612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Isis Pharmaceuticals Inc; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cooper, DR (corresponding author), James A Haley Vet Hosp, Res Serv, VAR 151,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.		Eichler, Duane/A-1906-2012; Cooper, Denise R./A-4740-2012; Patel, Niketa/A-1392-2012	Patel, Niketa A./0000-0003-4811-8596	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054393] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54393] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amara FM, 1996, BIOCHEM BIOPH RES CO, V228, P347, DOI 10.1006/bbrc.1996.1664; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BONINI J, 1992, BIOTECHNIQUES, V11, P708; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREWER G, 1988, MOL CELL BIOL, V8, P1687; Canete-Soler R, 1998, J BIOL CHEM, V273, P12650, DOI 10.1074/jbc.273.20.12650; CHALFANT CE, 1995, J BIOL CHEM, V270, P13326, DOI 10.1074/jbc.270.22.13326; Chalfant CE, 1998, J BIOL CHEM, V273, P910, DOI 10.1074/jbc.273.2.910; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; COOPER DR, 1993, ARCH BIOCHEM BIOPHYS, V302, P490, DOI 10.1006/abbi.1993.1244; COOPER DR, 1993, ENDOCRINOLOGY, V133, P2241, DOI 10.1210/en.133.5.2241; CORREAROTTER R, 1992, BIOTECHNIQUES, V12, P154; Dean NM, 1997, ANTISENSE NUCLEIC A, V7, P229, DOI 10.1089/oli.1.1997.7.229; HALLER H, 1995, KIDNEY INT, V47, P1057, DOI 10.1038/ki.1995.152; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; KOSTURA M, 1986, BIOCHEMISTRY-US, V25, P6384, DOI 10.1021/bi00369a007; Kulkarni RD, 1997, MOL MICROBIOL, V24, P1131, DOI 10.1046/j.1365-2958.1997.4201768.x; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PALMER LA, 2001, MOL CELL BIOL, V21, P2070; Patel NA, 1999, FASEB J, V13, P103, DOI 10.1096/fasebj.13.1.103; Patel NA, 2002, ARCH BIOCHEM BIOPHYS, V403, P111, DOI 10.1016/S0003-9861(02)00208-4; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; ROSS R, 1978, J CELL PHYSIOL, V97, P497, DOI 10.1002/jcp.1040970325; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCHEPER W, 1995, MOL CELL BIOL, V15, P235, DOI 10.1128/MCB.15.1.235; Shetty S, 1997, MOL CELL BIOL, V17, P1075, DOI 10.1128/MCB.17.3.1075; STEINBERG RA, 1975, CELL, V5, P29, DOI 10.1016/0092-8674(75)90088-4; Yamamoto M, 1998, EXP CELL RES, V240, P349, DOI 10.1006/excr.1998.3999; Yamamoto M, 1999, INT J CANCER, V83, P98, DOI 10.1002/(SICI)1097-0215(19990924)83:1<98::AID-IJC18>3.0.CO;2-V; Yamamoto M, 2000, AM J PHYSIOL-CELL PH, V279, pC587, DOI 10.1152/ajpcell.2000.279.3.C587; YAMAMOTO M, 1998, J ANTI-AGING MED, V1, P207	34	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1149	1157		10.1074/jbc.M206797200	http://dx.doi.org/10.1074/jbc.M206797200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12407109	hybrid			2022-12-27	WOS:000180321900060
J	Garcia, A; Sekowski, A; Subramanian, V; Brasaemle, DL				Garcia, A; Sekowski, A; Subramanian, V; Brasaemle, DL			The central domain is required to target and anchor perilipin A to lipid droplets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEINS; STORAGE; TIP47; EXPRESSION; LIPOLYSIS; CAVEOLIN; BODIES; GOLGI; ADRP	The perilipins are the most abundant proteins coating the surfaces of lipid droplets in adipocytes and are found at lower levels surrounding lipid droplets in steroidogenic cells. Perilipins drive triacylglycerol storage in adipocytes by regulating the rate of basal lipolysis and are also required to maximize hormonally stimulated lipolysis. To map the domains that target and anchor perilipin A to lipid droplets, we stably expressed fragments of perilipin A in 3T3-L1 fibroblasts. Immunofluorescence microscopy and immunoblotting of proteins from isolated lipid droplets revealed that neither the amino nor the carboxyl terminus is required to target perilipin A to lipid droplets; however, there are multiple, partially redundant targeting signals within a central domain including 25% of the primary amino acid sequence. A peptide composed of the central domain of perilipin A directed a fused green fluorescent protein to the surfaces of lipid droplets. Full-length perilipin A associates with lipid droplets via hydrophobic interactions, as shown by the persistence of perilipins on lipid droplets after centrifugation through an alkaline carbonate solution. Results of the mutagenesis studies indicate that the sequences responsible for anchoring perilipin A to lipid droplets are most likely domains of moderately hydrophobic amino acids located within the central 25% of the protein. Thus, we conclude that the central 25% of the perilipin A sequence contains all of the amino acids necessary to target and anchor the protein to lipid droplets.	Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Brasaemle, DL (corresponding author), Rutgers State Univ, Dept Nutr Sci, 96 Lipman Dr, New Brunswick, NJ 08901 USA.	brasaemle@aesop.rutgers.edu		Brasaemle, Dawn/0000-0002-8553-8285	NIDDK NIH HHS [DK54797] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054797] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barbero P, 2001, J BIOL CHEM, V276, P24348, DOI 10.1074/jbc.M102468200; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; EGAN JJ, 1990, J BIOL CHEM, V265, P18769; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; Hanna J, 2002, P NATL ACAD SCI USA, V99, P7450, DOI 10.1073/pnas.112198799; Heid HW, 1996, BIOCHEM J, V320, P1025, DOI 10.1042/bj3201025; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Lu XY, 2001, MAMM GENOME, V12, P741, DOI 10.1007/s00335-01-2055-5; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; PELHAM HRB, 1992, P ROY SOC B-BIOL SCI, V250, P1, DOI 10.1098/rspb.1992.0123; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Souza SC, 1998, J BIOL CHEM, V273, P24665, DOI 10.1074/jbc.273.38.24665; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200	34	86	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					625	635		10.1074/jbc.M206602200	http://dx.doi.org/10.1074/jbc.M206602200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407111	hybrid			2022-12-27	WOS:000180255700080
J	Yigzaw, Y; Poppleton, HM; Sreejayan, B; Hassid, A; Patel, TB				Yigzaw, Y; Poppleton, HM; Sreejayan, B; Hassid, A; Patel, TB			Protein-tyrosine phosphatase-1B (PTP1B) mediates the anti-migratory actions of sprouty	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; DROSOPHILA SPROUTY; CELL-MIGRATION; SRC; 1B; PHOSPHORYLATION; INACTIVATION; RECOGNITION; EXPRESSION; P130(CAS)	Mammalian Sprouty proteins have been shown to inhibit the proliferation and migration of cells in response to growth factors and serum. In this communication, using HeLa cells, we have examined the possibility that human Sprouty 2 (hSPRY2) mediates its anti-migratory actions by modulating the activity or intracellular localization of protein-tyrosine phosphatases. In HeLa cells, overexpression of hSPRY2 resulted in an increase in protein-tyrosine phosphatase (PTP1B) amount and activity in the soluble (100,000 x g) fraction of cells without an increase in total amount of cellular PTP1B. This increase in the soluble form of PTP1B was accompanied by a decrease in the amount of the enzyme in the particulate fraction. The amounts of PTP-PEST or PTP1D in the soluble fractions were not altered. Consistent with an increase in soluble PTP1B amount and activity, the tyrosine phosphorylation of cellular proteins and p130Cas was decreased in hSPRY2-expressing cells. In control cells, overexpression of wild-type (WT) PTP1B, but not its C215S catalytically inactive mutant mimicked the actions of hSPRY2 on tyrosine phosphorylation of cellular proteins and migration. On the other hand, in hSPRY2-expressing cells, the C215S mutant, but not WT PTP1B, increased tyrosine phosphorylation of cellular proteins and attenuated the anti-migratory actions of hSPRY2. Interestingly, neither WT nor C215S mutant forms of PTP1B modulated the anti-mitogenic actions of hSPRY2. Therefore, we conclude that an increase in soluble PTP1B activity contributes to the anti-migratory, but not anti-mitogenic, actions of hSPRY2.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Patel, TB (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.				NHLBI NIH HHS [HL48308, HL063886] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048308, R01HL063886] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Minowada G, 1999, DEVELOPMENT, V126, P4465; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; RASHED HM, 1993, HEPATOLOGY, V17, P677, DOI 10.1002/hep.1840170423; Reich A, 1999, DEVELOPMENT, V126, P4139; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tao JC, 2001, J BIOL CHEM, V276, P29520, DOI 10.1074/jbc.M103721200; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	27	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					284	288		10.1074/jbc.M210359200	http://dx.doi.org/10.1074/jbc.M210359200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414790	hybrid			2022-12-27	WOS:000180255700038
J	Yu, YH; Zhang, YY; Oelkers, P; Sturley, SL; Rader, DJ; Ginsberg, HN				Yu, YH; Zhang, YY; Oelkers, P; Sturley, SL; Rader, DJ; Ginsberg, HN			Posttranscriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; MESSENGER-RNA TRANSLATION; B-CONTAINING LIPOPROTEINS; TRIACYLGLYCEROL SYNTHESIS; APOLIPOPROTEIN-E; GENE-EXPRESSION; 5'-UNTRANSLATED REGION; CELLS; BIOSYNTHESIS; CHOLESTEROL	Acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) catalyzes the final step of triglyceride synthesis in mammalian cells. Data obtained from DGAT1-knockout mice have indicated that this enzyme plays an important role in energy homeostasis. We investigated the regulation of the expression and function of DGAT1 in mouse 3T3-L1 cell as a model for mammalian adipocytes. We demonstrated that the DGAT1 protein level increased by similar to90-fold following differentiation of 3T3-L1 into mature adipocytes, a change that was accompanied by similar to7-fold increase in DGAT1 mRNA. On the other hand, forced overexpression of DGAT1 mRNA by >20-fold via a recombinant adenovirus only resulted in similar to2-fold increase in DGAT1 protein in mature adipocytes and little increase in preadipocytes. These results indicated that gene expression of DGAT1 in adipocytes is subjected to rigorous posttranscriptional regulation, which is modulated significantly by the differentiation status of 3T3-L1 cells. Protein stability is not a significant factor in the control of DGAT1 expression. The steady-state levels of DGAT1 were unaffected by blockage of proteolytic pathways by ALLN. However, translational control was suggested by sequence analysis of the 5'-untranslated region of human DGAT1. (hDGAT1) mRNA. We found that the level of DGAT1 activity was predominantly a function of the steady-state level of DGAT1 protein. No significant functional changes were observed when the conserved tyrosine phosphorylation site in hDGAT1 was mutated by a single base pair substitution. Despite only a similar to2-fold increase in DGAT1 protein caused by recombinant viral transduction, a proportionate increase in cellular triglyceride synthesis resulted without affecting the triglyceride lipolysis rate, leading to >2-fold increase in intracellular triglyceride accumulation. No change in adipocyte morphology or in the expression levels of lipoprotein lipase, proxisomal proliferation-activating receptor-gamma, and aP2 was evident secondary to DGAT1 overexpression at different stages in 3T3-L1 differentiation. These data suggest that dysregulation of DGAT1 may play a role in the development of obesity, and manipulation of the steady-state level of DGAT1 protein may offer a potential means to treat or prevent obesity.	Columbia Univ Coll Phys & Surg, Dept Med, Div Prevent Med & Nutr, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Columbia University; University of Pennsylvania	Yu, YH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Div Prevent Med & Nutr, 630 W 168th St, New York, NY 10032 USA.			Yu, Yi-Hao/0000-0003-2696-1486	NHLBI NIH HHS [HL55638, T32 HL07343] Funding Source: Medline; NIDDK NIH HHS [K08 DK60530-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL055638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060530] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADELI K, 1995, CLIN BIOCHEM, V28, P123, DOI 10.1016/0009-9120(95)00007-V; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2002, J CLIN INVEST, V109, P175, DOI 10.1172/JCI0213880; Chen HC, 2002, J CLIN INVEST, V109, P1049, DOI [10.1172/JCI200214672, 10.1172/JCI0214672]; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Fu Q, 1998, J NEUROCHEM, V71, P549; Ginsberg HN, 1997, CLIN EXP PHARMACOL P, V24, pA29, DOI 10.1111/j.1440-1681.1997.tb03051.x; GIRON MD, 1993, ARCH BIOCHEM BIOPHYS, V302, P265, DOI 10.1006/abbi.1993.1209; HAAGSMAN HP, 1982, J BIOL CHEM, V257, P593; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; IMATAKA H, 1994, J BIOL CHEM, V269, P20668; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; KIM SJ, 1992, J BIOL CHEM, V267, P13702; Kirchgessner TG, 1997, J CLIN INVEST, V100, P2777, DOI 10.1172/JCI119824; Kopelman PG, 1998, CLINICAL OBESITY-BOOK, P158; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lau TE, 1996, LIPIDS, V31, P277, DOI 10.1007/BF02529874; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Ludwig EH, 2002, CLIN GENET, V62, P68, DOI 10.1034/j.1399-0004.2002.620109.x; MANZELLA JM, 1990, J BIOL CHEM, V265, P11817; MAZIERE C, 1986, LIPIDS, V21, P525, DOI 10.1007/BF02535641; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Nykiforuk CL, 2002, BBA-MOL CELL BIOL L, V1580, P95, DOI 10.1016/S1388-1981(01)00200-1; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Orlicky DJ, 2001, J LIPID RES, V42, P460; Paludan SR, 2001, J IMMUNOL, V167, P2202, DOI 10.4049/jimmunol.167.4.2202; Pan MH, 2002, J BIOL CHEM, V277, P4413, DOI 10.1074/jbc.M107460200; PANDURO A, 1990, BIOCHEMISTRY-US, V29, P8430, DOI 10.1021/bi00488a033; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; PEFFLEY DM, 1992, SOMAT CELL MOLEC GEN, V18, P19, DOI 10.1007/BF01233446; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; PRECIOUS B, 1985, VIROLOGY PRACTICAL A, P35; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; SAMBROOK J, 1989, MOL CLONING LAB MANU, V3; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Shatkin A J, 1982, Biochem Soc Symp, V47, P129; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; SOLING HD, 1989, J BIOL CHEM, V264, P10643; SPARKS JD, 1992, J CLIN INVEST, V89, P1418, DOI 10.1172/JCI115731; SRIVASTAVA RAK, 1994, BIOCHEM MOL BIOL INT, V34, P393; Srivastava RAK, 1997, MOL CELL BIOCHEM, V173, P161, DOI 10.1023/A:1006896131186; STRAKA MS, 1995, ARCH BIOCHEM BIOPHYS, V317, P235, DOI 10.1006/abbi.1995.1158; SUGIMOTO T, 1993, ANAL BIOCHEM, V211, P170, DOI 10.1006/abio.1993.1249; Tsukamoto K, 1997, J LIPID RES, V38, P1869; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Webb NR, 1997, J LIPID RES, V38, P1583; Wenner C, 2001, BIOCHEM BIOPH RES CO, V282, P608, DOI 10.1006/bbrc.2001.4611; Wu XJ, 1996, J LIPID RES, V37, P1198; Zhang YY, 1997, BIOCHEM BIOPH RES CO, V240, P492, DOI 10.1006/bbrc.1997.7622	63	51	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50876	50884		10.1074/jbc.M207353200	http://dx.doi.org/10.1074/jbc.M207353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12407108	hybrid			2022-12-27	WOS:000180177700089
J	de Haij, S; Adcock, IM; Bakker, AC; Gobin, SJP; Daha, MR; van Kooten, C				de Haij, S; Adcock, IM; Bakker, AC; Gobin, SJP; Daha, MR; van Kooten, C			Steroid responsiveness of renal epithelial cells - Dissociation of transrepression and transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CREB-BINDING-PROTEIN; GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ANGIOTENSINOGEN; MECHANISMS; IMMUNOSUPPRESSION; ACTIVATION; REPRESSION	Glucocorticoids modulate cellular and inflammatory responses via stimulation or inhibition of gene transcription. Inhibition of cytokine gene expression is mediated via repression of transcription factors, including NF-kappaB. Previously we have shown that cytokine production by renal epithelial cells is insensitive to the inhibitory action of dexamethasone. In this study we demonstrate that dexamethasone is unable to inhibit NF-kappaB activation in the renal epithelial cell line HK-2, as measured by IkappaB-alpha degradation and DNA binding activity. Transfection of an NF-kappaB-inducible reporter gene demonstrated that non-stimulated HK-2 cells contain a high level of constitutively active NF-kappaB compared with the steroid-sensitive airway epithelial cell line A549, which was not blocked by dexamethasone. Expression and nuclear translocation of the glucocorticoid receptor (GR) was comparable in both cell types. In HK-2 cells, dexamethasone stimulated expression of two glucocorticoid-responsive genes, beta(2)-adrenoreceptors and angiotensinogen. The capacity of GR to transactivate the native angiotensinogen glucocorticoid-responsive element (GRE) using chromatin-IP was not impaired. Moreover, dexamethasone activation of a GRE-driven reporter construct appeared to be equally effective, although less sensitive compared with A549 cells. In conclusion, we provide evidence that glucocorticoids are unable to repress the activity of NF-kappaB in renal epithelial cells in the presence of an intact stimulatory pathway.	Leiden Univ, Ctr Med, Dept Nephrol, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Ctr Med, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands; Univ London Imperial Coll Sci Technol & Med, Sch Med, Natl Heart & Lung Inst, Dept Thorac Med, London SW3 6LY, England	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Imperial College London	van Kooten, C (corresponding author), Leiden Univ, Ctr Med, Dept Nephrol, Bldg 1,C3P,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	Kooten@LUMC.nl	van Kooten, Cees/E-5694-2018; Adcock, Ian/L-3217-2019	van Kooten, Cees/0000-0002-6257-0899; Adcock, Ian/0000-0003-2101-8843				Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Auwardt RB, 1998, J AM SOC NEPHROL, V9, P1620; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Brasier AR, 1996, HYPERTENSION, V27, P465, DOI 10.1161/01.HYP.27.3.465; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; de Haij S, 2002, BRIT J PHARMACOL, V137, P197, DOI 10.1038/sj.bjp.0704866; Gobin SJP, 1998, J IMMUNOL, V161, P2276; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Imhof A, 1998, CURR BIOL, V8, pR422, DOI 10.1016/S0960-9822(98)70268-4; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; John M, 1997, J IMMUNOL, V158, P1841; Lee JI, 1998, J CLIN PHARMACOL, V38, P981, DOI 10.1177/009127009803801101; MAK JCW, 1995, AM J PHYSIOL-LUNG C, V268, pL41, DOI 10.1152/ajplung.1995.268.1.L41; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; McKay LI, 2000, MOL ENDOCRINOL, V14, P1222, DOI 10.1210/me.14.8.1222; Miyazawa K, 1998, J BIOCHEM, V124, P1130, DOI 10.1093/oxfordjournals.jbchem.a022231; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Shimada M, 2002, J IMMUNOL, V168, P861, DOI 10.4049/jimmunol.168.2.861; Sporn LA, 1997, INFECT IMMUN, V65, P2786, DOI 10.1128/IAI.65.7.2786-2791.1997; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; van Kooten C, 2001, CURR OPIN NEPHROL HY, V10, P55, DOI 10.1097/00041552-200101000-00009; van Kooten C, 1999, KIDNEY INT, V56, P41, DOI 10.1046/j.1523-1755.1999.00514.x; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; vanKooten C, 1997, KIDNEY INT, V51, P711, DOI 10.1038/ki.1997.102; Wang LS, 1998, KIDNEY INT, V53, P287, DOI 10.1046/j.1523-1755.1998.00759.x; Woltman AM, 2000, J AM SOC NEPHROL, V11, P2044, DOI 10.1681/ASN.V11112044	36	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5091	5098		10.1074/jbc.M209836200	http://dx.doi.org/10.1074/jbc.M209836200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12414793	hybrid			2022-12-27	WOS:000180968900095
J	Sato, T; Shimada, Y; Nagasawa, N; Nakanishi, S; Jingami, H				Sato, T; Shimada, Y; Nagasawa, N; Nakanishi, S; Jingami, H			Amino acid mutagenesis of the ligand binding site and the dimer interface of the metabotropic glutamate receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-BINDING; TERMINAL DOMAIN; EXPRESSION; ACTIVATION; SUBTYPE-1; REGION	Previously, we determined the crystal structures of the dimeric ligand binding region of the metabotropic glutamate receptor subtype 1. Each protomer binds L-glutamate within the crevice between the LB1 and LB2 domains. We proposed that the two different conformations of the dimer interface between the two LB1 domains define the activated and resting states of the receptor protein. In this study, the residues in the ligand-binding site and the dimer interface were mutated, and the effects were analyzed in the full-length and truncated soluble receptor forms. The variations in the ligand binding activities of the purified truncated receptors are comparable with those of the full-length form. The mutated full-length receptors were also analyzed by inositol phosphate production and Ca2+ response. The magnitude of the ligand binding capacities and the amplitude of the intracellular signaling were almost correlated. Alanine substitutions of four residues, Thr(188), Asp(208), Tyr(236), and Asp(318), which interact with the alpha-amino group of glutamate in the crystal, abolished their responses both to glutamate and quisqualate. The mutations of the Tyr(74), Arg(78), and Gly(293) residues, which interact with the gamma-carboxyl group of glutamate, lost their responsiveness to glutamate but not to quisqualate. Furthermore, a mutant receptor containing alanine instead of isoleucine at position 120 located within an a helix constituting the dimer interface showed no intracellular response to ligand stimulation. The results demonstrate the crucial role of the dimer interface in receptor activation.	Biomol Engn Res Inst, Dept Mol Biol, Suita, Osaka 5650874, Japan; Kyoto Univ, Fac Med, Dept Biol Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Jingami, H (corresponding author), Biomol Engn Res Inst, Dept Mol Biol, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan.							Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Brauner-Osborne H, 1999, J BIOL CHEM, V274, P18382, DOI 10.1074/jbc.274.26.18382; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jensen AA, 2000, EUR J PHARMACOL, V397, P247, DOI 10.1016/S0014-2999(00)00283-1; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Malherbe P, 2001, MOL PHARMACOL, V60, P944, DOI 10.1124/mol.60.5.944; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Miyazaki J, 1999, BIOCHEM J, V340, P687, DOI 10.1042/0264-6021:3400687; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Neki A, 1996, NEUROSCI LETT, V202, P197, DOI 10.1016/0304-3940(95)12248-6; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; PARIS S, 1986, EMBO J, V5, P55, DOI 10.1002/j.1460-2075.1986.tb04177.x; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Rosemond E, 2002, J BIOL CHEM, V277, P7333, DOI 10.1074/jbc.M110476200; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144	22	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4314	4321		10.1074/jbc.M210278200	http://dx.doi.org/10.1074/jbc.M210278200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12444084	hybrid			2022-12-27	WOS:000180869700099
J	Chen, JC; Zhuang, SH; Nguyen, TH; Boss, GR; Pilz, RB				Chen, JC; Zhuang, SH; Nguyen, TH; Boss, GR; Pilz, RB			Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; CELL-ADHESION; TRANSCRIPTIONAL ACTIVATION; TRANSFORMED FIBROBLASTS; NUCLEOTIDE EXCHANGE; SIGNALING PATHWAYS; GENE-EXPRESSION; FAMILY GTPASES; STRESS FIBERS; SH3 DOMAIN	Transformation by oncogenic Ras requires signaling through Rho family proteins including RhoA, but the mechanism(s) whereby oncogenic Ras regulates the activity of RhoA is (are) unknown. We examined the effect of Ras on RhoA activity in NIH 3T3 cells either stably transfected with H-Ras(V12) under control of an inducible promoter or transiently expressing the activated H-Ras. Using a novel method to quantitate enzymatically the GTP bound to Rho, we found that expression of the oncogenic Ras increased Rho activity similar to2-fold. Increased Rho activity was associated with increased plasma membrane binding,of RhoA and decreased activity of the Rho/Ras-regulated p21(WAF1/CIP1) promoter. RhoA activation by oncogenic Ras could be explained by a decrease in cytosolic p190 Rho-GAP activity and translocation of p190 Rho-GAP from the cytosol to a detergent-insoluble cytoskeletal fraction. Pharmacologic inhibition of the Ras/Raf/MEK/ERK pathway prevented Ras-induced activation of RhoA and translocation of p190 Rho-GAP; expression of constitutively active Raf-1 kinase or MEK was sufficient to induce p190 Rho-GAP translocation. We conclude that in NIH 3T3 cells oncogenic Ras activates RhoA through the Raf/MEK/ERK pathway by decreasing the cytosolic activity and changing the subcellular localization of p190 Rho-GAP.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Basic Sci Bldg 5080, La Jolla, CA 92093 USA.			Boss, Gerry/0000-0002-9758-8714	NATIONAL CANCER INSTITUTE [R33CA089828, R01CA090932] Funding Source: NIH RePORTER; NCI NIH HHS [CA90932, CA89828] Funding Source: Medline; NIGMS NIH HHS [GM55586] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fincham VJ, 1999, J CELL SCI, V112, P947; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; GRAZIANI A, 1993, J BIOL CHEM, V268, P9165; Gudi T, 2002, J BIOL CHEM, V277, P37382, DOI 10.1074/jbc.M204491200; Gudi T, 1996, J BIOL CHEM, V271, P4597; Guha A, 1996, ONCOGENE, V12, P507; Gupta S, 2000, MOL CELL BIOL, V20, P9294, DOI 10.1128/MCB.20.24.9294-9306.2000; Hart MJ, 1996, J BIOL CHEM, V271, P25452, DOI 10.1074/jbc.271.41.25452; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Izawa I, 1998, ONCOGENE, V17, P2863, DOI 10.1038/sj.onc.1202213; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; Karaguni IM, 2002, CANCER RES, V62, P1718; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Li S, 1999, J CLIN INVEST, V103, P1141, DOI 10.1172/JCI5367; Mayer T, 1999, ONCOGENE, V18, P2117, DOI 10.1038/sj.onc.1202537; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Moustakas A, 1999, J CELL SCI, V112, P1169; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Pawlak G, 2002, MOL BIOL CELL, V13, P336, DOI 10.1091/mbc.01-02-0302; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; Pilz RB, 1997, CELL GROWTH DIFFER, V8, P53; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; SCHEELE JS, 1995, P NATL ACAD SCI USA, V92, P1097, DOI 10.1073/pnas.92.4.1097; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Suhasini M, 1998, MOL CELL BIOL, V18, P6983, DOI 10.1128/MCB.18.12.6983; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Vincent S, 1999, EUR J CELL BIOL, V78, P539, DOI 10.1016/S0171-9335(99)80019-3; von Lintig FC, 2000, CLIN CANCER RES, V6, P1804; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; von Lintig FC, 2000, ONCOGENE, V19, P4029, DOI 10.1038/sj.onc.1203741; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; Zhong CL, 1997, MOL BIOL CELL, V8, P2329, DOI 10.1091/mbc.8.11.2329; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	70	61	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2807	2818		10.1074/jbc.M207943200	http://dx.doi.org/10.1074/jbc.M207943200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12429740	hybrid			2022-12-27	WOS:000180915000007
J	Li, AK; Sadasivam, M; Ding, JL				Li, AK; Sadasivam, M; Ding, JL			Receptor-ligand interaction between vitellogenin receptor (VtgR) and vitellogenin (Vtg), implications on low density lipoprotein receptor and apolipoprotein B/E - The first three ligand-binding repeats of VtgR interact with the amino-terminal region on Vtg	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED SUGAR DOMAIN; LDL RECEPTOR; CELLS EXPRESS; NMR STRUCTURE; PROTEIN; FAMILY; SEQUENCE; MODULES; CHICKEN; IDENTIFICATION	The vitellogenin receptor (VtgR) belongs to the low density lipoprotein receptor (LDLR) gene family. It mediates the uptake of vitellogenin (Vtg) in oocyte development of oviparous animals. In this study, we cloned and characterized two forms of Oreochromis aureus VtgR. Northern analysis showed that VtgR was specifically expressed in ovarian tissues. However, reverse transcription-PCR indicates that either there are trace levels of expression of VtgR or a homolog of LDLR exists in nonovarian tissues. The VtgR is highly homologous to the very low density lipoprotein receptor. To better understand the mechanism by which similar structural modules in the ligand-binding domain bind different ligands, we used the yeast two-hybrid system to screen for the minimal interaction motifs in Vtg and VtgR. The amino-terminal region of the lipovitellin I domain of Vtg interacts with the ligand-binding domain of VtgR. The first three ligand-binding repeats of the receptor were found to be essential for ligand binding. Computational analysis of the binding sequence indicates that Vtg has a similar receptor-binding region to apolipoprotein (apo) E and apoB. Site-directed mutagenesis of this region indicates electrostatic interaction between Vtg and its receptor. Sequence analysis suggests the coevolution of receptor-ligand pairs for the LDLR/apo superfamily and suggests that the mode of binding of LDLR/very low density lipoprotein receptor to apoB and apoE is inherited from the electrostatic attraction of VtgR and Vtg.	Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore	National University of Singapore	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Ding, Jeak/H-8057-2012					Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; Babin PJ, 1999, J MOL EVOL, V49, P150, DOI 10.1007/PL00006528; BAERT JL, 1991, EUR J BIOCHEM, V201, P191, DOI 10.1111/j.1432-1033.1991.tb16273.x; Bajari TM, 1998, BIOL CHEM, V379, P1053, DOI 10.1515/bchm.1998.379.8-9.1053; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; BUJO H, 1995, J BIOL CHEM, V270, P23546, DOI 10.1074/jbc.270.40.23546; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Chen JS, 1997, J MOL EVOL, V44, P440, DOI 10.1007/PL00006164; Clayton D, 2000, FEBS LETT, V479, P118, DOI 10.1016/S0014-5793(00)01842-1; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DEELEY RG, 1975, J BIOL CHEM, V250, P9060; Herz J, 2001, NAT STRUCT BIOL, V8, P476, DOI 10.1038/88519; HOSPATTANKAR AV, 1986, BIOCHEM BIOPH RES CO, V139, P1078, DOI 10.1016/S0006-291X(86)80287-X; Iijima H, 1998, J BIOCHEM-TOKYO, V124, P747, DOI 10.1093/oxfordjournals.jbchem.a022175; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Kurniawan ND, 2000, PROTEIN SCI, V9, P1282, DOI 10.1110/ps.9.7.1282; Li YH, 2001, MOL NEUROBIOL, V23, P53; Lim EH, 2001, GENE, V277, P175, DOI 10.1016/S0378-1119(01)00688-6; Magrane J, 1998, J LIPID RES, V39, P2172; Magrane J, 1999, FEBS LETT, V451, P56, DOI 10.1016/S0014-5793(99)00494-9; Mikhailenko I, 1999, J CELL SCI, V112, P3269; Nakamura Y, 1998, BRAIN RES, V793, P47, DOI 10.1016/S0006-8993(98)00112-7; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; OPRESKO LK, 1987, J BIOL CHEM, V262, P4109; PEREZ LE, 1991, COMP BIOCHEM PHYS B, V100, P821, DOI 10.1016/0305-0491(91)90297-Q; ROEHRKASTEN A, 1992, BIOCHIM BIOPHYS ACTA, V1133, P160, DOI 10.1016/0167-4889(92)90064-I; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; Schneider WJ, 1996, INT REV CYTOL, V166, P103, DOI 10.1016/S0074-7696(08)62507-3; Segrest JP, 2001, J LIPID RES, V42, P1346; SHARROCK WJ, 1992, J MOL BIOL, V226, P903, DOI 10.1016/0022-2836(92)90642-W; STEYRER E, 1995, ANAL BIOCHEM, V226, P44, DOI 10.1006/abio.1995.1189; STIFANI S, 1990, J BIOL CHEM, V265, P882; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; VANDERWESTHUYZEN DR, 1991, BIOCHEM J, V277, P677, DOI 10.1042/bj2770677; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827	44	98	104	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2799	2806		10.1074/jbc.M205067200	http://dx.doi.org/10.1074/jbc.M205067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12429745	hybrid			2022-12-27	WOS:000180915000006
J	Thathiah, A; Blobel, CP; Carson, DD				Thathiah, A; Blobel, CP; Carson, DD			Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN SECRETASES; ADAM-12 MELTRIN-ALPHA; TNF-ALPHA; MATRIX-METALLOPROTEINASE; INTRACELLULAR MATURATION; TISSUE INHIBITORS; IN-VIVO; DISINTEGRIN-METALLOPROTEASE; INTERLEUKIN-6 RECEPTOR; EXTRACELLULAR-MATRIX	MUC1 clearance from the uterine epithelial cell surface is a prerequisite for the creation of an environment conducive to embryo implantation. In some species, reduced mRNA levels along with metabolic turnover account for loss of MUC1 during the receptive phase throughout the uterine epithelium. In other species, MUC1 is rapidly lost solely at the site of blastocyst attachment, suggesting the action of a protease. Correlative studies also indicate the presence of soluble forms of MUC1 in cell culture supernatants in vitro and in bodily fluids in vivo. To characterize the proteolytic activity mediating MUC1 release, shedding of MUC1 was analyzed in a human uterine epithelial cell line (HES) that abundantly expresses and readily sheds MUC1 MUC1 release was stimulated by phorbol 12-myristate 13-acetate and was markedly inhibited by the synthetic peptide hydroxamate metalloprotease inhibitor, tumor necrosis factor-alpha protease inhibitor (TA-PI), as well as by an endogenous inhibitor of matrix metalloproteases, tissue inhibitor of metalloproteases (TIMP)-3. These characteristics along with studies conducted with cell lines genetically deficient in various ADAMs (for a disintegrin and metalloprotease) identified tumor necrosis factor-a converting enzyme (TACE)/ADAM 17 as a MUC1 sheddase. Furthermore, both TACE and MUC1 were expressed in human uterine epithelia during the receptive phase, and co-immunoprecipitation experiments revealed a physical interaction between TACE and MUC1 in HES cells. These studies establish a proteolytic mechanism for MUC1 clearance from a human uterine epithelial cell line and identify TACE as a MUC1 sheddase.	Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, Sloan Kettering Inst, New York, NY 10021 USA	University of Delaware; Memorial Sloan Kettering Cancer Center	Carson, DD (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD029963, R01HD029963] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 29963] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1996, BIOCHEM BIOPH RES CO, V225, P400, DOI 10.1006/bbrc.1996.1186; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; Blobel CP, 2000, CURR OPIN CELL BIOL, V12, P606, DOI 10.1016/S0955-0674(00)00139-3; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Borland G, 1999, J BIOL CHEM, V274, P2810, DOI 10.1074/jbc.274.5.2810; BOSHELL M, 1992, BIOCHEM BIOPH RES CO, V185, P1, DOI 10.1016/S0006-291X(05)80946-5; Bowen JA, 1996, BIOL REPROD, V55, P1098, DOI 10.1095/biolreprod55.5.1098; BRAMWELL ME, 1986, J CELL SCI, V86, P249; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Butler GS, 1997, EUR J BIOCHEM, V244, P653, DOI 10.1111/j.1432-1033.1997.t01-1-00653.x; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Codony-Servat J, 1999, CANCER RES, V59, P1196; DeSouza MM, 1998, BIOL REPROD, V58, P1503, DOI 10.1095/biolreprod58.6.1503; DeSouza MM, 1999, J REPROD IMMUNOL, V45, P127, DOI 10.1016/S0165-0378(99)00046-7; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Garton KJ, 2001, J BIOL CHEM, V276, P37993; GENDLER SJ, 1991, AM REV RESPIR DIS, V144, P42; Gilpin BJ, 1998, J BIOL CHEM, V273, P157, DOI 10.1074/jbc.273.1.157; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Guddo F, 1998, ANTICANCER RES, V18, P1915; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Hargreaves PG, 1998, BRIT J HAEMATOL, V101, P694, DOI 10.1046/j.1365-2141.1998.00754.x; HEY NA, 1994, J CLIN ENDOCR METAB, V78, P337, DOI 10.1210/jc.78.2.337; HildPetito S, 1996, BIOL REPROD, V54, P939, DOI 10.1095/biolreprod54.5.939; Hoffman LH, 1998, ENDOCRINOLOGY, V139, P266, DOI 10.1210/en.139.1.266; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Irwin JC, 2001, J CLIN ENDOCR METAB, V86, P2060, DOI 10.1210/jc.86.5.2060; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Julian J, 2002, BIOCHEM BIOPH RES CO, V293, P1183, DOI 10.1016/S0006-291X(02)00352-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; Li L, 2000, Zhonghua Fu Chan Ke Za Zhi, V35, P544; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; LITVINOV SV, 1993, J BIOL CHEM, V268, P21364; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; McCulloch DR, 2000, MOL CELL ENDOCRINOL, V167, P11, DOI 10.1016/S0303-7207(00)00305-1; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; MCGUCKIN MA, 1995, HUM PATHOL, V26, P432, DOI 10.1016/0046-8177(95)90146-9; Meseguer M, 2001, BIOL REPROD, V64, P590, DOI 10.1095/biolreprod64.2.590; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; MURPHY CR, 1993, PROGR HISTOCHEM CYTO, V27, P1; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Nikas G, 1999, HUM REPROD, V14, P787, DOI 10.1093/humrep/14.3.787; Ohta S, 2001, J RHEUMATOL, V28, P1756; Olson GE, 1998, CELL TISSUE RES, V293, P489, DOI 10.1007/s004410051141; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pimental RA, 1996, J BIOL CHEM, V271, P28128, DOI 10.1074/jbc.271.45.28128; PORZIO MA, 1977, BIOCHIM BIOPHYS ACTA, V490, P27, DOI 10.1016/0005-2795(77)90102-7; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639; Treon SP, 2000, BLOOD, V96, P3147, DOI 10.1182/blood.V96.9.3147.h8003147_3147_3153; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Turner AJ, 1999, BIOCHEM SOC T, V27, P255, DOI 10.1042/bst0270255; Vincent B, 2001, J BIOL CHEM, V276, P37743; Werb Z, 1998, SCIENCE, V282, P1279, DOI 10.1126/science.282.5392.1279; WESSELING J, 1995, J CELL BIOL, V129, P255, DOI 10.1083/jcb.129.1.255; Wesseling J, 1996, MOL BIOL CELL, V7, P565, DOI 10.1091/mbc.7.4.565; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; WOESSNER JF, 2000, MATRIX METALLOPROTEA; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502; Wu E, 1997, BIOCHEM BIOPH RES CO, V235, P437, DOI 10.1006/bbrc.1997.6714; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zhang K, 1996, J CELL BIOCHEM, V60, P538, DOI 10.1002/(SICI)1097-4644(19960315)60:4<538::AID-JCB10>3.3.CO;2-A; Zhang Y, 2000, ENDOCRINOLOGY, V141, P4342, DOI 10.1210/en.141.12.4342; Zhao LC, 2001, J BIOL CHEM, V276, P30631, DOI 10.1074/jbc.M103748200	85	150	161	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3386	3394		10.1074/jbc.M208326200	http://dx.doi.org/10.1074/jbc.M208326200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441351	hybrid			2022-12-27	WOS:000180915000079
J	Charbonneau, NL; Dzamba, BJ; Ono, RN; Keene, DR; Corson, GM; Reinhardt, DP; Sakai, LY				Charbonneau, NL; Dzamba, BJ; Ono, RN; Keene, DR; Corson, GM; Reinhardt, DP; Sakai, LY			Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR MICROFIBRILS; DEVELOPMENTAL EXPRESSION; TERMINAL DOMAINS; MARFAN-SYNDROME; HETEROGENEITY; ORGANIZATION; COMPONENT; SUGGESTS; TISSUES; BINDING	Fibrillins are microfibril-forming extracellular matrix macromolecules that modulate skeletal development. In humans, mutations in fibrillins result in long bone overgrowth as well as other distinct phenotypes. Whether fibrillins form independent microfibrillar networks or can co-polymerize, forming a single microfibril, is not known. However, this knowledge is required to determine whether phenotypes arise because of loss of singular or composite functions of fibrillins. Immunolocalization experiments using tissues and de novo matrices elaborated by cultured cells demonstrated that both fibrillins can be present in the same individual microfibril in certain tissues and that both fibrillins can copolymerize in fibroblast cultures. These studies suggest that the molecular information directing fibrillin fibril formation may be similar in both fibrillins. Furthermore, these studies provide a molecular basis for compensation of one fibrillin by the other during fetal life. In postnatal tissues, fibrillin-2 antibodies demonstrated exuberant staining in only one location: peripheral nerves. This surprising finding implicates distinct functions for fibrillin-2 in peripheral nerves, because a unique feature in humans and in mice mutant for fibrillin-2 is joint contractures that resolve over time.	Oregon Hlth Sci Univ, Shriners Hosp Children, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University	Sakai, LY (corresponding author), Oregon Hlth Sci Univ, Shriners Hosp Children, Dept Biochem & Mol Biol, 3101 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046811] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR46811] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashworth JL, 1999, J CELL SCI, V112, P3549; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dzamba BJ, 2001, J INVEST DERMATOL, V117, P1612, DOI 10.1046/j.0022-202x.2001.01588.x; GALLAGHER BC, 1993, DEV DYNAM, V196, P70, DOI 10.1002/aja.1001960109; Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002; Handford PA, 2000, MATRIX BIOL, V19, P457, DOI 10.1016/S0945-053X(00)00100-1; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MARIENCHECK MC, 1995, CONNECT TISSUE RES, V31, P87, DOI 10.3109/03008209509028396; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; QUANDAMATTEO F, 2003, IN PRESS MATRIX BIOL; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rongish BJ, 1998, DEV DYNAM, V212, P461; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200; Trask TM, 1999, BIOCHEM J, V340, P693, DOI 10.1042/0264-6021:3400693; WUNSCH AM, 1994, DEV BIOL, V165, P585, DOI 10.1006/dbio.1994.1278; Yang QW, 1999, DEV BIOL, V212, P229, DOI 10.1006/dbio.1999.9331; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	29	103	106	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2740	2749		10.1074/jbc.M209201200	http://dx.doi.org/10.1074/jbc.M209201200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12429739	Green Published, hybrid			2022-12-27	WOS:000180562000087
J	Isogai, Z; Ono, RN; Ushiro, S; Keene, DR; Chen, Y; Mazzieri, R; Charbonneau, NL; Reinhardt, DP; Rifkin, DB; Sakai, LY				Isogai, Z; Ono, RN; Ushiro, S; Keene, DR; Chen, Y; Mazzieri, R; Charbonneau, NL; Reinhardt, DP; Rifkin, DB; Sakai, LY			Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX MICROFIBRILS; MARFAN-SYNDROME; TGF-BETA; DEVELOPMENTAL EXPRESSION; 8-CYSTEINE REPEAT; IDENTIFICATION; SEQUENCE; GENE; COMPONENT; ORGANIZATION	Latent transforming growth factor 6-binding protein 1 (LTBP-1) targets latent complexes of transforming growth factor beta to the extracellular matrix, where the latent cytokine is subsequently activated by several different mechanisms. Fibrillins are extracellular matrix macromolecules whose primary function is architectural: fibrillins assemble into ultrastructurally distinct microfibrils that are ubiquitous in the connective tissue space. LTBPs and fibrillins are highly homologous molecules, and colocalization in the matrix of cultured cells has been reported. To address whether LTBP-1 functions architecturally like fibrillins, microfibrils were extracted from tissues and analyzed immunochemically. In addition, binding studies were conducted to determine whether LTBP-1 interacts with fibrillins. LTBP-1 was not detected in extracted beaded-string microfibrils, suggesting that LTBP-I is not an integral structural component of microfibrils. However, binding studies demonstrated interactions between LTBP-1 and fibrillins. The binding site was within three domains of the LTBP-1 C terminus, and in fibrillin-1 the site was defined within four domains near the N terminus. Immunolocalization data were consistent with the hypothesis that LTBP-1 is a fibrillin-associated protein present in certain tissues but not in others. In tissues where LTBP-1 is not expressed, LTBP-4 may substitute for LTBP-1, because the C-terminal end of LTBP-4 binds equally well to fibrillin. A model depicting the relationship between LTBP-1 and fibrillin microfibrils is proposed.	Oregon Hlth Sci Univ, Shriners Hosp Children, Dept Biochem & Mol Biol, Portland, OR 97239 USA; NYU, Dept Cell Biol & Mol, New York, NY 10016 USA; Med Univ Lubeck, Dept Med Mol Biol, D-23538 Lubeck, Germany	Oregon Health & Science University; New York University; University of Lubeck	Sakai, LY (corresponding author), Oregon Hlth Sci Univ, Shriners Hosp Children, Dept Biochem & Mol Biol, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	LYS@SHCC.org	Mazzieri, Roberta/C-9773-2015; Reinhardt, Dieter P/A-3102-2008; Isogai, Zenzo/AAD-3690-2022	Mazzieri, Roberta/0000-0002-5172-0927; Reinhardt, Dieter P/0000-0001-6535-9872; 	NCI NIH HHS [CA 23753, CA 34282] Funding Source: Medline; NIDCR NIH HHS [DE13742] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013742] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045; CHARBONNEASU NL, 2002, J BIOL CHEM; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; GIBSON MA, 1995, MOL CELL BIOL, V15, P6932; Giltay R, 1997, FEBS LETT, V411, P164, DOI 10.1016/S0014-5793(97)00685-6; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Hyytiainen M, 1998, J BIOL CHEM, V273, P20669, DOI 10.1074/jbc.273.32.20669; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P441, DOI 10.1177/39.4.2005373; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; KIELTY CM, 1991, J CELL SCI, V99, P797; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MASLEN CL, 1991, NATURE, V352, P334, DOI 10.1038/352334a0; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; MOREN A, 1994, J BIOL CHEM, V269, P32469; Nakajima Y, 1997, J CELL BIOL, V136, P193, DOI 10.1083/jcb.136.1.193; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; PUTNAM EA, 1995, NAT GENET, V11, P456, DOI 10.1038/ng1295-456; Raghunath M, 1998, J INVEST DERMATOL, V111, P559, DOI 10.1046/j.1523-1747.1998.00339.x; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Saharinen J, 1996, EMBO J, V15, P245, DOI 10.1002/j.1460-2075.1996.tb00355.x; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; SAKAI LY, 1994, METHOD ENZYMOL, V245, P29; SAKAI LY, 1982, AM J PATHOL, V108, P310; SAKAI LY, 1991, J BIOL CHEM, V266, P14763; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; TAIPALE J, 1995, J BIOL CHEM, V270, P4689, DOI 10.1074/jbc.270.9.4689; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Unsold C, 2001, J CELL SCI, V114, P187; YIN WS, 1995, J BIOL CHEM, V270, P10147, DOI 10.1074/jbc.270.17.10147; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	48	410	424	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2750	2757		10.1074/jbc.M209256200	http://dx.doi.org/10.1074/jbc.M209256200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12429738	hybrid, Green Published			2022-12-27	WOS:000180562000088
J	Sun, P; Loh, HH				Sun, P; Loh, HH			Transcriptional regulation of mouse delta-opioid receptor gene - Ikaros-2 and upstream stimulatory factor synergize in trans-activating mouse delta-opioid receptor gene in T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS MAJOR LATE; FACTOR USF; TATA BOX; ACTIVATION; EXPRESSION; PROMOTER; SPLENOCYTES; COMPLEXES	Considerable evidence indicates that transcription of the delta-opioid receptor (dor) gene is correlated with both the expression of DOR on T cells and the capacity of DOR agonists to modulate the immunological functions of the T cell. We previously reported that increased Ikaros (Ik) binding activity over an Ik-binding site at -378 to -374 (with the translation start site designated as + 1) in the mouse dor promoter was required for the enhanced transcription of dor gene in phytohemagglutinin-activated EL-4 cells, a mouse T cell line that constitutively expresses DOR. In the present study, we have analyzed further the mouse dor promoter in EL-4 cells and have demonstrated that Ik-2 homodimers bind to the -378/-374 Ik-binding site and exerts a position-dependent trans-activation effect on the dor promoter. Moreover, an E box (-185 to -180) that binds upstream stimulatory factor is essential for the dor promoter activity in both resting and phytohemagglutinin-activated T cells. Furthermore, we have demonstrated that Ik-2 and upstream stimulatory factor synergize in trans-activating the dor promoter via the putative Ik-binding site and the E box, respectively.	Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Sun, P (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	sunx0078@tc.umn.edu			NIDA NIH HHS [K05-DA-70554, DA-01583, DA-11806, DA-00546] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA011806, R01DA001583, K05DA070554, R37DA001583] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AUGUSTIN LB, 1995, BIOCHEM BIOPH RES CO, V207, P111, DOI 10.1006/bbrc.1995.1160; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; BLALOCK JE, 1988, PNEI, V1, P9; BUNGERT J, 1992, J MOL BIOL, V223, P885, DOI 10.1016/0022-2836(92)90250-N; CARCAMO J, 1989, J BIOL CHEM, V264, P7704; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; DU H, 1993, EMBO J, V12, P501, DOI 10.1002/j.1460-2075.1993.tb05682.x; GAVERIAUX C, 1995, FEBS LETT, V369, P272, DOI 10.1016/0014-5793(95)00766-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; HALLE JP, 1995, J BIOL CHEM, V270, P21307, DOI 10.1074/jbc.270.36.21307; Hedin KE, 1997, J IMMUNOL, V159, P5431; JOHNSON DR, 1995, BIOTECHNIQUES, V19, P190; LEWIN B, 1997, GENES, V6, P811; Li MD, 1999, J LEUKOCYTE BIOL, V65, P707, DOI 10.1002/jlb.65.5.707; Li N, 1998, J BIOL CHEM, V273, P28170, DOI 10.1074/jbc.273.43.28170; LINNER KM, 1995, J IMMUNOL, V154, P5049; Liu HC, 1999, J BIOL CHEM, V274, P23617, DOI 10.1074/jbc.274.33.23617; Miller BC, 1998, ADV EXP MED BIOL, V437, P159; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Nichogiannopoulou A, 1998, SEMIN IMMUNOL, V10, P119, DOI 10.1006/smim.1998.0113; POGNONEC P, 1991, NUCLEIC ACIDS RES, V19, P6650, DOI 10.1093/nar/19.23.6650; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; ROY AL, 1991, NATURE, V354, P245, DOI 10.1038/354245a0; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Shahabi NA, 2000, CELL IMMUNOL, V205, P84, DOI 10.1006/cimm.2000.1717; Sharp BM, 1996, P NATL ACAD SCI USA, V93, P8294, DOI 10.1073/pnas.93.16.8294; Sharp BM, 1998, BIOCHEM PHARMACOL, V56, P289, DOI 10.1016/S0006-2952(98)00155-5; Sharp BM, 1998, ANN NY ACAD SCI, V840, P420, DOI 10.1111/j.1749-6632.1998.tb09580.x; Singh VK, 1999, NEUROIMMUNOMODULAT, V6, P355, DOI 10.1159/000026395; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun P, 2002, J BIOL CHEM, V277, P12854, DOI 10.1074/jbc.M112268200; Sun P, 2001, J BIOL CHEM, V276, P45462, DOI 10.1074/jbc.M104793200; TWYMAN RM, 1998, ADV MOL BIOL CONCISE, P443; WESLEY HJ, 1986, J EXP MED, V163, P1589	36	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2304	2308		10.1074/jbc.M208162200	http://dx.doi.org/10.1074/jbc.M208162200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431989	hybrid			2022-12-27	WOS:000180562000032
J	Yoon, HS; Chen, XM; Yang, VW				Yoon, HS; Chen, XM; Yang, VW			Kruppel-like factor 4 mediates p53-dependent G(1)/S cell cycle arrest in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH SUPPRESSION; P53; GENE; P21; TRANSCRIPTION; CHECKPOINTS; CDC2; OVEREXPRESSION; PROGRESSION; DETERMINANT	The tumor suppressor p53 is required for the maintenance of genomic integrity following DNA damage. One mechanism by which p53 functions is to induce a block in the transition between the G, and S phase of the cell cycle. Previous studies indicate that the Kruppel-like factor 4 (KLF4) gene is activated following DNA damage and that such activation depends on p53. In addition, enforced expression of KLF4 causes G(1)/S arrest. The present study examines the requirement of KLF4 in mediating the p53-dependent cell cycle arrest process in response to DNA damage. We show that the G, population of a colon cancer cell line, HCT116, that is null for the p53 alleles (-/-) was abolished following gamma irradiation compared with cells with wild-type p53 (+/+). Conditional expression of KLF4 in irradiated HCT116 p53-/- cells restored the G, cell population to a level similar to that seen in irradiated HCT116 p53 +/+ cells. Conversely, treatment of HCT116 p53+/+ cells with small interfering RNA (siRNA) specific for KLF4 significantly reduced the number of cells in the G, phase following gamma irradiation compared with the untreated control or those treated with a nonspecific siRNA. In each case the increase or decrease in KLF4 level because of conditional induction or siRNA inhibition, respectively, was accompanied by an increase or decrease in the level of p21(WAF1/CIP1). Results of our study indicate that KLF4 is an essential mediator of p53 in controlling G(1)/S progression of the cell cycle following DNA damage.	Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), Emory Univ, Sch Med, Div Digest Dis, Dept Med, 201 Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.				NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052230] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084197-03, R01 CA084197, CA84197] Funding Source: Medline; NIDDK NIH HHS [DK52230, R01 DK052230-05, R01 DK052230] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; CHEN X, 2003, IN PRESS J MOL BIOL; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; COX LS, 1995, BIOESSAYS, V17, P501, DOI 10.1002/bies.950170606; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; GUILLOUF C, 1995, ONCOGENE, V10, P2263; HARPER JW, 1993, CELL, V75, P805; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Johns DC, 1999, ANN NY ACAD SCI, V868, P418, DOI 10.1111/j.1749-6632.1999.tb11304.x; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Nurse P, 1998, NAT MED, V4, P1103, DOI 10.1038/2594; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WALDMAN T, 1995, CANCER RES, V55, P5187; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; Yin XY, 2001, CANCER RES, V61, P6487; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200	47	204	216	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2101	2105		10.1074/jbc.M211027200	http://dx.doi.org/10.1074/jbc.M211027200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427745	Green Accepted, hybrid			2022-12-27	WOS:000180562000005
J	Santos, JH; Hunakova, L; Chen, YM; Bortner, C; Van Houten, B				Santos, JH; Hunakova, L; Chen, YM; Bortner, C; Van Houten, B			Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN FIBROBLASTS; BASE EXCISION-REPAIR; OXIDATIVE STRESS; GROWTH ARREST; HYDROGEN-PEROXIDE; OXYGEN-TOXICITY; SENESCENCE; ENZYME; H2O2; P53	In order to understand the molecular events following oxidative stress, which lead to persistence of lesions in the mtDNA, experiments were performed on normal human fibroblast (NHF) expressing human telomerase reverse transcriptase (hTERT). The formation and repair of H2O2-induced DNA lesions were examined using quantitative PCR. It was found that NHF hTERTs show extensive mtDNA damage (similar to4 lesions/10 kb) after exposure to 200 muM H2O2, which is partially repaired during a recovery period of 6 h. At the same time, the nDNA seemed to be completely resistant to damage. Cell sorting experiments revealed persistent mtDNA damage at 24 h only in the fraction of cells with low mitochondrial membrane potential (DeltaPsim). Further analysis also showed increased production of H2O2 by these cells, which subsequently undergo apoptosis. This work supports a hypothesis for a feed-forward cascade of reactive oxygen species generation and mtDNA damage and also suggested a possible mechanism for persistence of lesions in the mtDNA involving a drop in DeltaPsim, compromised protein import, secondary reactive oxygen species generation, and loss of repair capacity.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; Canc Res Inst, Bratislava 83391, Slovakia	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Slovak Academy of Sciences	Van Houten, B (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 Alexander Dr,POB 12233, Res Triangle Pk, NC 27709 USA.		Van Houten, Bennett/K-2284-2019; Hunakova, Luba/E-4523-2015	Hunakova, Luba/0000-0003-2159-0807	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES061062] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054; Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Bohr VA, 1999, J BIOENERG BIOMEMBR, V31, P391, DOI 10.1023/A:1005484004167; Bortner CD, 1999, J BIOL CHEM, V274, P21953, DOI 10.1074/jbc.274.31.21953; Bowman KK, 2000, MOL CARCINOGEN, V29, P17, DOI 10.1002/1098-2744(200009)29:1<17::AID-MC3>3.3.CO;2-5; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Chen KH, 1998, NUCLEIC ACIDS RES, V26, P2001, DOI 10.1093/nar/26.8.2001; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chen QM, 2000, ANN NY ACAD SCI, V908, P111; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Crawford DR, 1996, ARCH BIOCHEM BIOPHYS, V329, P137, DOI 10.1006/abbi.1996.0202; Crawford DR, 1997, FREE RADICAL BIO MED, V22, P1295, DOI 10.1016/S0891-5849(96)00544-8; Crawford DR, 1998, FREE RADICAL BIO MED, V25, P1106, DOI 10.1016/S0891-5849(98)00143-9; Crawford DR, 1997, FREE RADICAL BIO MED, V22, P551, DOI 10.1016/S0891-5849(96)00380-2; Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Deng GM, 1999, EXP NEUROL, V159, P309, DOI 10.1006/exnr.1999.7145; Dobson AW, 2000, J BIOL CHEM, V275, P37518, DOI 10.1074/jbc.M000831200; Doetsch PW, 2001, PROG NUCLEIC ACID RE, V68, P29; FLINT DH, 1993, J BIOL CHEM, V268, P25547; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Fridovich I, 1998, J EXP BIOL, V201, P1203; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Garbe J, 1999, ONCOGENE, V18, P2169, DOI 10.1038/sj.onc.1202523; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; HALLIWELL B, 1994, ENV HLTH PERSPECT, V10, P5; Haugland R.P., 1996, HDB FLUORESCENT PROB, P269; Herrmann JM, 2000, BBA-BIOENERGETICS, V1459, P331, DOI 10.1016/S0005-2728(00)00169-9; Hilbert TP, 1997, J BIOL CHEM, V272, P6733, DOI 10.1074/jbc.272.10.6733; HOFFSCHIR F, 1993, CARCINOGENESIS, V14, P1569, DOI 10.1093/carcin/14.8.1569; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; KEHRER JP, 1989, FREE RADICAL RES COM, V6, P305; LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9; Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Sawyer DE, 1999, MUTAT RES-DNA REPAIR, V434, P161, DOI 10.1016/S0921-8777(99)00027-0; Waterhouse NJ, 2002, BIOCHIMIE, V84, P113, DOI 10.1016/S0300-9084(02)01379-2; WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	50	152	162	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1728	1734		10.1074/jbc.M208752200	http://dx.doi.org/10.1074/jbc.M208752200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424245	hybrid			2022-12-27	WOS:000180462200049
J	Hosoda, H; Kojima, M; Mizushima, T; Shimizu, S; Kangawa, K				Hosoda, H; Kojima, M; Mizushima, T; Shimizu, S; Kangawa, K			Structural divergence of human ghrelin - Identification of multiple ghrelin-derived molecules produced by post-translational processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE SECRETION; BETA-NEO-ENDORPHIN; AMINO-ACID-SEQUENCE; SECRETAGOGUE RECEPTOR; ACYLATED PEPTIDE; GH SECRETION; RELEASE; CLONING; CDNA; PURIFICATION	Ghrelin, a novel 28-amino acid peptide with an n-octanoyl modification at Ser(3), was isolated from rat stomach and found to be an endogenous ligand for the growth-hormone secretagogue receptor (GHS-R). This octanoyl modification is essential for ghrelin-induced GH release. We report here the purification and identification of human ghrelin from the stomach, as well as structural analysis of the human ghrelin gene and quantitation of changes in plasma ghrelin concentration before and after gastrectomy. Human ghrelin was purified from the stomach by gel filtration and high performance liquid chromatography, using a ghrelin-specific radioimmunoassay and an intracellular calcium influx assay on a stable cell line expressing GHS-R to test the fractions. In the course of purification, we isolated human ghrelin of the expected size, as well as several other ghrelin-derived molecules. Classified into four groups by the type of acylation observed at Ser3; these peptides were found to be non-acylated, octanoylated (C8:0), decanoylated (C10:0), and possibly decenoylated (C10:1). All peptides found were either 27 or 28 amino acids in length, the former lacking the C-terminal Arg(28), and are derived from the same ghrelin precursor through two alternative pathways. The major active form of human ghrelin is a 28-amino acid peptide octanoylated at Ser(3), as was found for rat ghrelin. Synthetic octanoylated and decanoylated ghrelins produce intracellular calcium increases in GHS-R-expressing cells and stimulate GH release in rats to a similar degree. Both ghrelin and the ghrelin-derived molecules were found to be present in plasma as well as stomach tissue. Plasma levels of immunoreactive ghrelin after total gastrectomy in three patients were reduced to approximately half of their pre-gastrectomy values, after which they gradually increased. This suggests that the stomach is the major source of circulating ghrelin and that other tissues compensate for the loss of ghrelin production after gastrectomy.	Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; Kurume Univ, Inst Life Sci, Kurume, Fukuoka 8390861, Japan; Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Postgenom & Dis, Suita, Osaka 5650871, Japan; Kyoto Univ Hosp, Translat Res Ctr, Kyoto 6068507, Japan	National Cerebral & Cardiovascular Center - Japan; Kurume University; Osaka University; Osaka University; Kyoto University	Kangawa, K (corresponding author), Natl Cardiovasc Ctr, Res Inst, Dept Biochem, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.							Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Bowers CY, 1998, CELL MOL LIFE SCI, V54, P1316, DOI 10.1007/s000180050257; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Hosoda H, 2000, J BIOL CHEM, V275, P21995, DOI 10.1074/jbc.M002784200; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Kaiya H, 2001, J BIOL CHEM, V276, P40441, DOI 10.1074/jbc.M105212200; KAKIDANI H, 1982, NATURE, V298, P245, DOI 10.1038/298245a0; KANGAWA K, 1981, BIOCHEM BIOPH RES CO, V99, P871, DOI 10.1016/0006-291X(81)91244-4; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; MAINS RE, 1983, TRENDS NEUROSCI, V6, P229, DOI 10.1016/0166-2236(83)90100-5; Matsumoto M, 2001, BIOCHEM BIOPH RES CO, V287, P142, DOI 10.1006/bbrc.2001.5553; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; MINAMINO N, 1981, BIOCHEM BIOPH RES CO, V99, P864, DOI 10.1016/0006-291X(81)91243-2; Muller EE, 1999, PHYSIOL REV, V79, P511, DOI 10.1152/physrev.1999.79.2.511; Nagaya N, 2001, AM J PHYSIOL-REG I, V280, pR1483, DOI 10.1152/ajpregu.2001.280.5.R1483; NAKANISHI S, 1979, NATURE, V278, P423, DOI 10.1038/278423a0; NODA M, 1982, NATURE, V295, P202, DOI 10.1038/295202a0; Peino R, 2000, EUR J ENDOCRINOL, V143, pR11, DOI 10.1530/eje.0.143R011; Seoane LM, 2000, EUR J ENDOCRINOL, V143, pR7, DOI 10.1530/eje.0.143R007; Smith RG, 1999, TRENDS ENDOCRIN MET, V10, P128, DOI 10.1016/S1043-2760(98)00132-5; Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621; TAKAHASHI Y, 1985, P NATL ACAD SCI USA, V82, P1931, DOI 10.1073/pnas.82.7.1931; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Tanaka M, 2001, ENDOCRINOLOGY, V142, P3697, DOI 10.1210/en.142.8.3697; TANNENBAUM GS, 1984, ENDOCRINOLOGY, V115, P1952, DOI 10.1210/endo-115-5-1952; WEBER E, 1982, BIOCHEM BIOPH RES CO, V108, P81, DOI 10.1016/0006-291X(82)91834-4	30	245	257	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					64	70		10.1074/jbc.M205366200	http://dx.doi.org/10.1074/jbc.M205366200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414809	hybrid			2022-12-27	WOS:000180255700008
J	MacFarlane, AJ; Burghardt, KM; Kelly, J; Simell, T; Simell, O; Altosaar, I; Scott, FW				MacFarlane, AJ; Burghardt, KM; Kelly, J; Simell, T; Simell, O; Altosaar, I; Scott, FW			A type 1 diabetes-related protein from wheat (Triticum aestivum) - cDNA clone of a wheat storage globulin, Glb1, linked to islet damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROVIRUS INFECTION; CELIAC-DISEASE; IGE-BINDING; INSULIN; CHILDREN; GLUTEN; ONSET; DIET; IDENTIFICATION; PERMEABILITY	The development of autoimmune type 1 diabetes involves complex interactions among several genes and environmental agents. Human patients with type 1 diabetes show an unusually high frequency of wheat gluten-sensitive enteropathy; T-cell response to wheat proteins is increased in some patients, and high concentrations of wheat antibodies in blood have been reported. In both major models of spontaneous type 1 diabetes, the BioBreeding (BB) rat and non-obese diabetic mouse, at least half of the cases are diet-related. In studies of BB rats fed defined semipurified diets, wheat gluten was the most potent diabetes-inducing protein source. A major limitation in understanding how wheat or other dietary antigens affect type 1 diabetes has been the difficulty in identifying specific diabetes-related dietary proteins. To address this issue, we probed a wheat cDNA expression library with polyclonal IgG antibodies from diabetic BB rats. Three clones were identified, and the intensity of antibody binding to one of them, WP5212, was strongly associated with pancreatic islet inflammation and damage. The WP5212 putative protein has high amino acid sequence homology with a wheat storage globulin, G1b1. Serum IgG antibodies from diabetic rats and humans recognized low molecular mass (33-46 kDa) wheat proteins. Furthermore, antibodies to G1b1 protein were found in serum from diabetic patients but not in age-, sex-, and HILA-DQ-matched controls. This study raises the possibility that in some individuals, type 1 diabetes may be induced by wheat proteins. Also, it provides a first candidate wheat protein that is not only antigenic in diabetic rats and human patients but is also closely linked with the autoimmune attack in the pancreas.	Ottawa Hlth Res Inst, Autoimmune Dis Grp Diabet, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; Univ Turku, Dept Pediat, FIN-20520 Turku, Finland; Hlth Canada, Nutr Res Div, Ottawa, ON K1A 0L2, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; National Research Council Canada; University of Turku; Health Canada	Scott, FW (corresponding author), Ottawa Hlth Res Inst, Autoimmune Dis Grp Diabet, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	fscott@ohri.ca	ALTOSAAR, ILLIMAR/A-4668-2008	ALTOSAAR, ILLIMAR/0000-0001-5018-036X; Burghardt, Karolina/0000-0002-5942-5308				Akerblom HK, 1998, DIABETES METAB REV, V14, P31, DOI 10.1002/(SICI)1099-0895(199803)14:1&lt;31::AID-; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAEKKESKOV S, 1984, SCIENCE, V224, P1348, DOI 10.1126/science.6374896; BAEKKESKOV S, 1987, J CLIN INVEST, V79, P926, DOI 10.1172/JCI112903; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Bao F, 1999, J AUTOIMMUN, V13, P143, DOI 10.1006/jaut.1999.0303; Beales PE, 2002, DIABETOLOGIA, V45, P1240, DOI 10.1007/s00125-002-0898-2; BUESAGOMEZ J, 1994, J MED VIROL, V42, P193, DOI 10.1002/jmv.1890420217; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Carratu R, 1999, J PEDIATR GASTR NUTR, V28, P264, DOI 10.1097/00005176-199903000-00010; COLEMAN DL, 1990, DIABETES, V39, P432, DOI 10.2337/diabetes.39.4.432; FABIJANSKI S, 1985, FEBS LETT, V182, P465, DOI 10.1016/0014-5793(85)80355-0; Field LL, 2002, DIABETOLOGIA, V45, P21, DOI 10.1007/s125-002-8241-7; Foulis AK, 1997, DIABETOLOGIA, V40, P53, DOI 10.1007/s001250050642; Funda DP, 1999, DIABETES-METAB RES, V15, P323; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gianibelli MC, 2001, CEREAL CHEM, V78, P635, DOI 10.1094/CCHEM.2001.78.6.635; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; GRAVELAND A, 1979, J SCI FOOD AGR, V30, P71, DOI 10.1002/jsfa.2740300112; HOORFAR J, 1993, BRIT J NUTR, V69, P597, DOI 10.1079/BJN19930059; HOORFAR J, 1991, J NUTR, V121, P908, DOI 10.1093/jn/121.6.908; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; Juhela S, 2000, DIABETES, V49, P1308, DOI 10.2337/diabetes.49.8.1308; Karges W, 1997, DIABETES, V46, P557, DOI 10.2337/diabetes.46.4.557; Klemetti P, 1998, SCAND J IMMUNOL, V47, P48; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lampasona V, 1999, DIABETOLOGIA, V42, P1195, DOI 10.1007/s001250051291; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Marcone MF, 1998, FOOD CHEM, V62, P27, DOI 10.1016/S0308-8146(97)00158-1; MARCONE MF, 1995, J FOOD BIOCHEM, V18, P123, DOI 10.1111/j.1745-4514.1994.tb00493.x; Meddings JB, 1999, AM J PHYSIOL-GASTR L, V276, pG951, DOI 10.1152/ajpgi.1999.276.4.G951; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Patterson CC, 2000, DIABETOLOGIA, V43, P684; Rao GN, 1996, FUND APPL TOXICOL, V32, P102, DOI 10.1006/faat.1996.0112; ROBERT LS, 1985, PLANT PHYSIOL, V78, P812, DOI 10.1104/pp.78.4.812; ROSSINI AA, 1979, DIABETES, V28, P1031, DOI 10.2337/diabetes.28.11.1031; Scott F W, 1988, Adv Exp Med Biol, V246, P277; Scott FW, 1996, DIABETES METAB REV, V12, P341, DOI 10.1002/(SICI)1099-0895(199612)12:4&lt;341::AID-DMR173&gt;3.0.CO;2-O; SHEWRY PR, 1995, BIOL REV, V70, P375, DOI 10.1111/j.1469-185X.1995.tb01195.x; Singh J, 2001, J CEREAL SCI, V34, P85, DOI 10.1006/jcrs.2001.0380; Vaarala O, 2002, DIABETOLOGIA, V45, P531, DOI 10.1007/s00125-002-0787-8; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Viskari HR, 2002, DIABETES, V51, P2568, DOI 10.2337/diabetes.51.8.2568	47	64	71	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					54	63		10.1074/jbc.M210636200	http://dx.doi.org/10.1074/jbc.M210636200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409286	hybrid			2022-12-27	WOS:000180255700007
J	Dunaeva, M; Michelson, P; Kogerman, P; Toftgard, R				Dunaeva, M; Michelson, P; Kogerman, P; Toftgard, R			Characterization of the physical interaction of Gli proteins with SUFU proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC ORGANIZATION; CUBITUS INTERRUPTUS; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; MOUSE SUPPRESSOR; HEDGEHOG; GENE; DROSOPHILA; FAMILY; TRANSCRIPTION	The Hedgehog signaling pathway is involved in both development and cancer induction in a wide range of organisms. The end point of the Hedgehog signal-transduction cascade is the Gli/Ci, zinc-finger transcription factors. Proteins such as Fused, Suppressor of fused (SUFU), Costal-2, and protein kinase A are essential for regulation of Gli/Ci processing, activity, and localization. Coimmunoprecipitation and Far Western assays, coupled with truncation analysis and mutagenesis have been used to define the region of interaction between Gli proteins and SUFU. We identify a novel motif SYGH in Gli/Ci family proteins, which is required for the interaction with SUFU. Mutational studies revealed that Gly(122) and His(123) are crucial for binding to SUFU, suggesting the importance of hydrophobicity for the correct binding conformation. Functional analysis revealed that the activity of GLI transcription factors with mutations in this motif is no longer suppressed by coexpression of SUFU. Moreover, we have found that a C-terminal 19-amino acid deletion in SUFU (Delta465) is sufficient to abrogate interaction with GLI1. Interestingly, this SUFU mutant localizes in the nucleus, most probably because it is not efficiently sequestered in the cytoplasm. Taken together, we identified a novel motif in the Gli/Ci family of proteins that is essential both for protein-protein interaction with SUFU and for functional repression of GLI1 by SUFU.	Karolinska Inst, NOVUM, Ctr Nutr & Toxicol, Dept Biosci, SE-14157 Huddinge, Sweden; Tallinn Univ Technol, Lab Mol Genet, NICPB, EE-12618 Tallinn, Estonia; Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	Karolinska Institutet; National Institute of Chemical Physics & Biophysics (NICPB); Tallinn University of Technology; Tallinn University of Technology	Toftgard, R (corresponding author), Karolinska Inst, NOVUM, Ctr Nutr & Toxicol, Dept Biosci, SE-14157 Huddinge, Sweden.	Rune.Toftgard@cnt.ki.se	Kogerman, Priit/B-6333-2008		NIAMS NIH HHS [P01 AR47898-02] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Grimm T, 2001, FEBS LETT, V505, P13, DOI 10.1016/S0014-5793(01)02682-5; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Matise MP, 1999, ONCOGENE, V18, P7852, DOI 10.1038/sj.onc.1203243; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Methot N, 2000, DEVELOPMENT, V127, P4001; Mo R, 1997, DEVELOPMENT, V124, P113; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Monnier Veronique, 2002, BMC Developmental Biology, V2, P1; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; PHAM A, 1995, GENETICS, V140, P587; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; ROBERTS WM, 1989, CANCER RES, V49, P5407; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; SALGALLER M, 1991, CANCER LETT, V57, P243, DOI 10.1016/0304-3835(91)90164-D; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Simon-Chazottes D, 2000, MAMM GENOME, V11, P614, DOI 10.1007/s003350010144; Stone DM, 1999, J CELL SCI, V112, P4437; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828	36	141	147	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5116	5122		10.1074/jbc.M209492200	http://dx.doi.org/10.1074/jbc.M209492200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12426310	hybrid			2022-12-27	WOS:000180968900098
J	Pilloff, D; Dabovic, K; Romanowski, MJ; Bonanno, JB; Doherty, M; Burley, SK; Leyh, TS				Pilloff, D; Dabovic, K; Romanowski, MJ; Bonanno, JB; Doherty, M; Burley, SK; Leyh, TS			The kinetic mechanism of phosphomevalonate kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEVALONATE KINASE; NUCLEOSIDE PHOSPHOROTHIOATES; HOMOSERINE KINASE; BIOSYNTHESIS; CATALYSIS; SITE; PURIFICATION; HEXOKINASE; ENZYMES; DISEASE	Phosphomevalonate kinase catalyzes an essential step in the so-called mevalonate pathway, which appears to be the sole pathway for the biosynthesis of sterols and other isoprenoids in mammals and archea. Despite the well documented importance of this pathway in the cause and prevention of human disease and that it is the biosynthetic root of an enormous diverse class of metabolites, the mechanism of phosphomevalonate kinase from any organism is not yet well characterized. The first structure of a phosphomevalonate kinase from Streptococcus pneumoniae was solved recently. The enzyme exhibits an atypical P-loop that is a conserved defining feature of the GHMP kinase superfamily. In this study, the kinetic mechanism of the S. pneumoniae enzyme is characterized in the forward and reverse directions using a combination of classical initial-rate methods including alternate substrate inhibition using ADPbetaS. The inhibition patterns strongly support that in either direction the substrates bind randomly to the enzyme prior to chemistry, a random sequential bi-bi mechanism. The kinetic constants are as follows: k(cat(forward)) = 3.4 s(-1), K-i(ATP) = 137 muM, K-m(ATP) = 74 muM, K-i(pmev) = 7-7 muM, K-m(pmev) = 4.2 muM; k(cat(reverse)) 3.9 s(-1), K-i(ADP) = 410 muM, K-m(ADP) = 350 muM, K-i(ppmev) = 14 muM, K-m(ppmev) = 12 muM, where pmev and ppmev represent phosphomevalonate and diphosphomevalonate, respectively.	Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; Rockefeller Univ, Howard Hughes Med Inst, Labs Mol Biophys, New York, NY 10021 USA	Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; Rockefeller University	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Doherty, Mary/AAA-7764-2019	Burley, Stephen K./0000-0002-2487-9713; Doherty, Mary/0000-0002-3480-4088	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062529, R01GM054469] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54469, P50-GM62529] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; BAZAES S, 1980, BIOCHEMISTRY-US, V19, P2300, DOI 10.1021/bi00552a003; Bonanno JB, 2001, P NATL ACAD SCI USA, V98, P12896, DOI 10.1073/pnas.181466998; BORK P, 1993, PROTEIN SCI, V2, P31; Bruckert E, 2002, CARDIOLOGY, V97, P59, DOI 10.1159/000057673; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W. W, 1970, ENZYMES, V2, P1; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P176; CORNISHBOWDEN A, 1976, PRINCIPLES ENZYME KI; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; EYZAGUIRRE J, 1985, METHOD ENZYMOL, V110, P78; Fersht A., 1999, STRUCTURE MECH PROTE; FREY PA, 1985, SCIENCE, V228, P541, DOI 10.1126/science.2984773; Fromm H J, 1979, Methods Enzymol, V63, P467; Fu ZJ, 2002, J BIOL CHEM, V277, P18134, DOI 10.1074/jbc.M200912200; Haldane J. B. S., 1965, ENZYMES; JAFFE EK, 1979, J BIOL CHEM, V254, P839; Krell T, 2001, PROTEIN SCI, V10, P1137, DOI 10.1110/ps.52501; Krishna SS, 2001, BIOCHEMISTRY-US, V40, P10810, DOI 10.1021/bi010851z; LEE CS, 1985, J BIOL CHEM, V260, P3909; LEE CS, 1985, BIOCHIM BIOPHYS ACTA, V839, P83, DOI 10.1016/0304-4165(85)90184-9; LERMAN CL, 1980, J BIOL CHEM, V255, P8756; LIU CX, 1994, BIOCHEMISTRY-US, V33, P2042, DOI 10.1021/bi00174a009; MCCLURE WR, 1969, BIOCHEMISTRY-US, V8, P2782, DOI 10.1021/bi00835a014; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; Rios SE, 2001, BBA-MOL CELL BIOL L, V1531, P165, DOI 10.1016/S1388-1981(01)00105-6; Romanowski MJ, 2002, PROTEINS, V47, P568, DOI 10.1002/prot.10118; SAMSON R, 1978, J CHEM PHYS, V68, P285, DOI 10.1063/1.435494; SCHAFER BL, 1992, J BIOL CHEM, V267, P13229; Schulte AE, 2000, ARCH BIOCHEM BIOPHYS, V378, P287, DOI 10.1006/abbi.2000.1779; Smit A, 2000, GENOME RES, V10, P1468, DOI 10.1101/gr.145600; Tabernero L, 1999, P NATL ACAD SCI USA, V96, P7167, DOI 10.1073/pnas.96.13.7167; Tolman KG, 2002, AM J CARDIOL, V89, P1374, DOI 10.1016/S0002-9149(02)02355-X; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yang D, 2002, J BIOL CHEM, V277, P9462, DOI 10.1074/jbc.M110787200; Zhou T, 2000, STRUCTURE, V8, P1247, DOI 10.1016/S0969-2126(00)00533-5	39	44	56	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4510	4515		10.1074/jbc.M210551200	http://dx.doi.org/10.1074/jbc.M210551200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12424232	hybrid			2022-12-27	WOS:000180968900021
J	Luke, MR; Kjer-Nielsen, L; Brown, DL; Stow, JL; Gleeson, PA				Luke, MR; Kjer-Nielsen, L; Brown, DL; Stow, JL; Gleeson, PA			GRIP domain-mediated targeting of two new coiled-coil proteins, GCC88 and GCC185, to subcompartments of the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; APPARATUS; SEQUENCE; INSIGHTS; P230; YPT6	The GRIP domain is a targeting sequence found in a family of coiled-coil peripheral Golgi proteins. Previously we demonstrated that the GRIP domain of p230/golgin245 is specifically recruited to tubulovesicular structures of the traps-Golgi network (TGN). Here we have characterized two novel Golgi proteins with functional GRIP domains, designated GCC88 and GCC185. GCC88 cDNA encodes a protein of 88 kDa, and GCC185 cDNA encodes a protein of 185 kDa. Both molecules are brefeldin A-sensitive peripheral membrane proteins and are predicted to have extensive coiled-coil regions with the GRIP domain at the C terminus. By immunofluorescence and immunoelectron microscopy GCC88 and GCC185, and the GRIP protein golgin97, are all localized to the TGN of Hela cells. Overexpression of full-length GCC88 leads to the formation of large electron dense structures that extend from the traps-Golgi. These de novo structures contain GCC88 and co-stain for the TGN markers syntaxin 6 and TGN38 but not for alpha2,6-sialyltransferase, beta-COP, or cis-Golgi GM130. The formation of these abnormal structures requires the N-terminal domain of GCC88. TGN38, which recycles between the TGN and plasma membrane, was transported into and out of the GCC88 decorated structures. These data introduce two new GRIP domain proteins and implicate a role for GCC88 in the organization of a specific TGN subcompartment involved with membrane transport.	Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia	University of Melbourne; University of Queensland; University of Queensland	Gleeson, PA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.		Stow, Jennifer L/I-4723-2013	Stow, Jennifer L/0000-0002-5409-9101; Gleeson, Paul/0000-0002-5336-6503; Brown, Darren/0000-0003-2174-7691				Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Black MW, 2001, CURR BIOL, V11, pR460, DOI 10.1016/S0960-9822(01)00281-0; BOS K, 1993, EMBO J, V12, P2219, DOI 10.1002/j.1460-2075.1993.tb05870.x; Brown DL, 2001, TRAFFIC, V2, P336, DOI 10.1034/j.1600-0854.2001.002005336.x; CHAN EKL, 1998, ELECTRON J BIOTECHN, V1, P1; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Gleeson PA, 1996, J CELL SCI, V109, P2811; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Keller P, 1997, J CELL SCI, V110, P3001; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; KOOY J, 1992, J BIOL CHEM, V267, P20255; KRIES TE, 1986, EMBO J, V5, P931; LADINSKY MS, 1994, J CELL BIOL, V127, P29, DOI 10.1083/jcb.127.1.29; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McConville MJ, 2002, EUR J CELL BIOL, V81, P485, DOI 10.1078/0171-9335-00268; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Perez F, 2002, J CELL BIOL, V156, P631, DOI 10.1083/jcb.200111003; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rojo M, 2000, J CELL SCI, V113, P1043; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Tsukada M, 1999, MOL BIOL CELL, V10, P63, DOI 10.1091/mbc.10.1.63	32	101	106	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4216	4226		10.1074/jbc.M210387200	http://dx.doi.org/10.1074/jbc.M210387200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446665	hybrid			2022-12-27	WOS:000180869700089
J	Nunziante, M; Gilch, S; Schatzl, HM				Nunziante, M; Gilch, S; Schatzl, HM			Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-CELLS; SCRAPIE ISOFORM; EPITHELIAL-CELLS; MDCK CELLS; MEMBRANE; GLYCOSYLATION; ENDOCYTOSIS; ACQUISITION; CONVERSION; INSERTION	Aberrant metabolism and conformational alterations of the cellular prion protein (PrPc) are the underlying causes of transmissible spongiform encephalopathies in humans and animals. In cells, PrPc is modified post-translationally and transported along the secretory pathway to the plasma membrane, where it is attached to the cell surface by a glycosylphosphatidylinositol anchor. In surface biotinylation assays we observed that deletions within the unstructured N terminus of murine PrPc led to a significant reduction of internalization of PrP after transfection of murine neuroblastoma cells. Truncation of the entire N terminus most significantly inhibited internalization of PrPc. The same deletions caused a significant prolongation of cellular half-life of PrPc and a delay in the transport through the secretory pathway to the cell surface. There was no difference in the glycosylation kinetics, indicating that all PrP constructs equally passed endoplasmic reticulum-based cellular quality control. Addition of the N terminus of the Xenopus laevis PrP, which does not encode a copper-binding repeat element, to N-terminally truncated mouse PrP restored the wild type phenotype. These results provide deeper insight into the life cycle of the PrPc, raising the novel possibility of a targeting function of its N-proximal part by interacting with the secretory and the endocytic machinery. They also indicate the conservation of this targeting property in evolution.	Univ Munich, Gene Ctr Munich, Dept Virol, Max Von Pettenkofer Inst,Fac Med, D-81377 Munich, Germany	University of Munich	Schatzl, HM (corresponding author), Univ Munich, Gene Ctr Munich, Dept Virol, Max Von Pettenkofer Inst,Fac Med, Feodor Lynen Str 25, D-81377 Munich, Germany.		Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740				BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Davis S, 1993, CURR OPIN CELL BIOL, V5, P281, DOI 10.1016/0955-0674(93)90117-9; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; HARRIS DA, 1991, P NATL ACAD SCI USA, V88, P7664, DOI 10.1073/pnas.88.17.7664; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P2333, DOI 10.1073/pnas.94.6.2333; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Lecat S, 2000, J CELL SCI, V113, P2607; Lehmann S, 1996, P NATL ACAD SCI USA, V93, P5610, DOI 10.1073/pnas.93.11.5610; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Liemann S, 1998, BIOCHEM BIOPH RES CO, V250, P187, DOI 10.1006/bbrc.1998.9169; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Marella M, 2002, J BIOL CHEM, V277, P25457, DOI 10.1074/jbc.M203248200; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; OWEN F, 1990, MOL BRAIN RES, V7, P273, DOI 10.1016/0169-328X(90)90038-F; OWEN F, 1992, MOL BRAIN RES, V13, P155, DOI 10.1016/0169-328X(92)90056-H; Parizek P, 2001, J BIOL CHEM, V276, P44627, DOI 10.1074/jbc.M107458200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; SHYNG SL, 1995, J BIOL CHEM, V270, P14793, DOI 10.1074/jbc.270.24.14793; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Strumbo B, 2001, FEBS LETT, V508, P170, DOI 10.1016/S0014-5793(01)03027-7; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Vorberg I, 2002, J BIOL CHEM, V277, P36775, DOI 10.1074/jbc.M206865200; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Weissmann C, 2001, PHILOS T R SOC B, V356, P177, DOI 10.1098/rstb.2000.0763; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zhao Y, 2000, MOL BIOL CELL, V11, P721, DOI 10.1091/mbc.11.2.721; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	48	88	91	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3726	3734		10.1074/jbc.M206313200	http://dx.doi.org/10.1074/jbc.M206313200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12431994	hybrid			2022-12-27	WOS:000180869700028
J	Dumon, N; Bakin, AV; Arteaga, CL				Dumon, N; Bakin, AV; Arteaga, CL			Autocrine transforming growth factor-beta signaling mediates smad-independent motility in human cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; I RECEPTORS; MESENCHYMAL TRANSDIFFERENTIATION; PHOSPHATIDYLINOSITOL 3-KINASE; PLASMINOGEN-ACTIVATOR; C-JUN; TUMOR; SURVIVAL; ACTIVIN; EXPRESSION	Transforming growth factor-beta (TGF-beta) is a pleiotropic growth factor that plays a critical role in modulating cell growth, differentiation, and plasticity. There is increasing evidence that after cells lose their sensitivity to TGF-beta-mediated growth inhibition, autocrine TGF-beta signaling may potentially promote tumor cell motility and invasiveness. To understand the molecular mechanisms by which autocrine TGF-beta may selectively contribute to tumor cell motility, we have generated MDA-AM-231 breast cancer cells stably expressing a kinase-inactive type II TGF-beta receptor (TbetaRII-K277R). Our data indicate that T13RII-K277R is expressed, can associate with the type I TGF-beta receptor, and block both Smad-dependent and -independent signaling pathways activated by TGF-beta. In addition, wound closure and transwell migration assays indicated that the basal migratory potential of T13RII-K277R expressing cells was impaired. The impaired motility of TbetaRII-K277R cells could be restored by reconstituting TGF-beta signaling with a constitutively active TGF-beta type I receptor (ALK5(TD)) but not by reconstituting Smad signaling with Smad2/4 or Smad3/4 expression. In addition, the levels of ALK5TD expression sufficient to restore motility in the cells expressing TbetaRII-K277R were associated with an increase in phosphorylation of Akt and extracellular signal-regulated kinase 1/2 but not Smad2. These data indicate that different signaling pathways require different thresholds of TGF-beta activation and suggest that TGF-beta promotes motility through mechanisms independent of Smad signaling, possibly involving activation of the phosphatidylinositol 3-kinase/Akt and/or mitogen-activated protein kinase pathways.	Vanderbilt Univ, Sch Med, Div Oncol, Dept Canc Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Arteaga, CL (corresponding author), Vanderbilt Univ, Sch Med, Div Oncol, Dept Canc Biol, 2220 Pierce Ave,777 Preston Res Bldg, Nashville, TN 37232 USA.			Bakin, Andrei/0000-0002-7728-1969	NATIONAL CANCER INSTITUTE [P30CA068485, R01CA095263, R01CA062212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593] Funding Source: NIH RePORTER; NCI NIH HHS [CA62212, CA68485, CA95263] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; ARNOLETTI JP, 1995, CANCER, V76, P998, DOI 10.1002/1097-0142(19950915)76:6<998::AID-CNCR2820760613>3.0.CO;2-0; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Berking C, 2001, CANCER RES, V61, P8306; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Calonge MJ, 1999, J BIOL CHEM, V274, P33637, DOI 10.1074/jbc.274.47.33637; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; Datto MB, 1999, MOL CELL BIOL, V19, P2495; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; DUMONT N, 1995, MOL CELL ENDOCRINOL, V111, P57, DOI 10.1016/0303-7207(95)03548-L; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Farina AR, 1998, INT J CANCER, V75, P721; Frey RS, 1997, CANCER RES, V57, P628; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hata A, 1998, MOL MED TODAY, V4, P257, DOI 10.1016/S1357-4310(98)01247-7; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Higaki M, 1999, ARTERIOSCL THROM VAS, V19, P2127, DOI 10.1161/01.ATV.19.9.2127; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Huang Y, 2000, J BIOL CHEM, V275, P18234, DOI 10.1074/jbc.M909431199; Hudson JB, 1998, DEVELOPMENT, V125, P1407; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; KALKHOVEN E, 1995, CELL GROWTH DIFFER, V6, P1151; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Lallemand F, 2001, ONCOGENE, V20, P879, DOI 10.1038/sj.onc.1204167; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Martinez-Carpio PA, 1999, CANCER LETT, V147, P25, DOI 10.1016/S0304-3835(99)00261-X; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McDonnell MA, 2001, EXP CELL RES, V263, P265, DOI 10.1006/excr.2000.5117; McEarchern JA, 2001, INT J CANCER, V91, P76, DOI 10.1002/1097-0215(20010101)91:1<76::AID-IJC1012>3.0.CO;2-8; MORTON DM, 1995, CANCER RES, V55, P2596; MOSES HL, 1981, CANCER RES, V41, P2842; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Piek E, 1999, J CELL SCI, V112, P4557; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; POULSEN KT, 1994, NEURON, V13, P1245, DOI 10.1016/0896-6273(94)90062-0; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Schutte M, 1996, CANCER RES, V56, P2527; Schwarte-Waldhoff I, 1999, ONCOGENE, V18, P3152, DOI 10.1038/sj.onc.1202641; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Souchelnytskyi S, 1998, J BIOL CHEM, V273, P25364, DOI 10.1074/jbc.273.39.25364; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang YA, 2002, CELL GROWTH DIFFER, V13, P123; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523	66	133	142	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3275	3285		10.1074/jbc.M204623200	http://dx.doi.org/10.1074/jbc.M204623200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12421823	hybrid			2022-12-27	WOS:000180915000065
J	Laybutt, DR; Glandt, M; Xu, G; Ahn, YB; Trivedi, N; Bonner-Weir, S; Weir, GC				Laybutt, DR; Glandt, M; Xu, G; Ahn, YB; Trivedi, N; Bonner-Weir, S; Weir, GC			Critical reduction in beta-cell mass results in two distinct outcomes over time - Adaptation with impaired glucose tolerance or decompensated diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; LACTATE-DEHYDROGENASE; C-MYC; CHRONIC HYPERGLYCEMIA; TRANSCRIPTION FACTORS; PANCREATIC-ISLETS; GENE-EXPRESSION; FATTY-ACIDS; RAT; APOPTOSIS	We have proposed that hyperglycemia-induced dedifferentiation of beta-cells is a critical factor for the loss of insulin secretory function in diabetes. Here we examined the effects of the duration of hyperglycemia on gene expression in islets of partially pancreatectomized (Px) rats. Islets were isolated, and mRNA was extracted from rats 4 and 14 weeks after Px or sham Px surgery. Px rats developed different degrees of hyperglycemia; low hyperglycemia was assigned to Px rats with fed blood glucose levels less than 150 mg/dl, and high hyperglycemia was assigned above 150 mg/dl. beta-Cell hypertrophy was present at both 4 and 14 weeks. At the same time points, high hyperglycemia rats showed a global alteration in gene expression with decreased mRNA for insulin, IAPP, islet-associated transcription factors (pancreatic and duodenal homeobox-1, BETA2/NeuroD, Nkx6.1, and hepatocyte nuclear factor 1alpha), beta-cell metabolic enzymes (glucose transporter 2, glucokinase, mitochondrial glycerol phosphate dehydrogenase, and pyruvate carboxylase), and ion channels/pumps (Kir6.2, VDCCbeta, and sarcoplasmic reticulum. Ca2+-ATPase 3). Conversely, genes normally suppressed in beta-cells, such as lactate dehydrogenase-A, hexokinase 1, glucose-6-phosphatase, stress genes (heme oxygenase-1, A20, and Fas), and the transcription factor c-Myc, were markedly increased. In contrast, gene expression in low hyperglycemia rats was only minimally changed at 4 weeks but significantly changed at 14 weeks, indicating that even low levels of hyperglycemia induce beta-cell dedifferentiation over time. In addition, whereas 2 weeks of correction of hyperglycemia completely reverses the changes in gene expression of Px rats at 4 weeks, the changes at 14 weeks were only partially reversed, indicating that the phenotype becomes resistant to reversal in the long term. In conclusion, chronic hyperglycemia induces a progressive loss of beta-cell phenotype with decreased expression of beta-cell-associated genes and increased expression of normally suppressed genes, these changes being present with even minimal levels of hyperglycemia. Thus, both the severity and duration of hyperglycemia appear to contribute to the deterioration of the beta-cell phenotype found in diabetes.	Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.	Weir, GC (corresponding author), Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, 1 Joslin Pl, Boston, MA 02215 USA.	Gordon.Weir@joslin.harvard.edu		Bonner-Weir, Susan/0000-0003-4682-0656	NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035449] Funding Source: NIH RePORTER; NCRR NIH HHS [2U42 RR16606-02] Funding Source: Medline; NIDDK NIH HHS [DK-35449] Funding Source: Medline; PHS HHS [36836] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ainscow EK, 2000, DIABETES, V49, P1149, DOI 10.2337/diabetes.49.7.1149; Alcazar O, 2000, BIOCHEM J, V352, P373, DOI 10.1042/0264-6021:3520373; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; Harmon JS, 2001, DIABETES, V50, P2481, DOI 10.2337/diabetes.50.11.2481; Huang HP, 2000, J BIOMED SCI, V7, P27, DOI 10.1159/000025426; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Jonas JC, 2001, J BIOL CHEM, V276, P35375, DOI 10.1074/jbc.M105020200; Katic M, 1999, CARCINOGENESIS, V20, P1521; KOSAKA K, 1980, DIABETOLOGIA, V18, P23, DOI 10.1007/BF01228297; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Leibowitz G, 2001, DIABETES, V50, P1799, DOI 10.2337/diabetes.50.8.1799; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; NEWGARD CB, 2000, HDB PHYSL 7, V11, P125; OGAWA Y, 1995, DIABETES, V44, P75, DOI 10.2337/diabetes.44.1.75; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; PORTHA B, 1994, DIABETES METAB, V20, P108; Sander M, 1997, J MOL MED, V75, P327, DOI 10.1007/s001090050118; Sander M, 2000, DEVELOPMENT, V127, P5533; SCAGLIA L, 1995, ENDOCRINOLOGY, V136, P5461, DOI 10.1210/en.136.12.5461; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; SRIKANTA S, 1984, DIABETES, V33, P717, DOI 10.2337/diabetes.33.8.717; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Suzuki K, 1998, TRANSPLANTATION, V66, P21, DOI 10.1097/00007890-199807150-00004; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; TOKUYAMA Y, 1995, DIABETES, V44, P1447, DOI 10.2337/diabetes.44.12.1447; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yoshikawa H, 2001, METABOLISM, V50, P613, DOI 10.1053/meta.2001.22565; ZAMBON A, 1993, J LIPID RES, V34, P1021	51	135	141	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2997	3005		10.1074/jbc.M210581200	http://dx.doi.org/10.1074/jbc.M210581200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12438314	hybrid			2022-12-27	WOS:000180915000031
J	Legendre, F; Dudhia, J; Pujol, JP; Bogdanowicz, P				Legendre, F; Dudhia, J; Pujol, JP; Bogdanowicz, P			JAK/STAT but not ERK1/ERK2 pathway mediates interleukin (IL)-6/soluble IL-6R down-regulation of type II collagen, aggrecan core, and link protein transcription in articular chondrocytes - Association with a down-regulation of SOX9 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; AMELIORATES JOINT DISEASE; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; SIGNAL-TRANSDUCTION; GROWTH-FACTOR; PROTEOGLYCAN SYNTHESIS; SOLUBLE RECEPTOR; TRANSGENIC MICE; IN-VIVO	Signal transducers and activators of transcription (STAT) factors are cytoplasmic proteins that can be activated by Janus kinases (JAK) and that modulate gene expression in response to cytokine receptor stimulation. STAT proteins dimerize, translocate into the nucleus, and activate specific target genes. In the present study, we show for the first time that interleukin-6 (IL), in the presence of its soluble receptor (sIL-6R), induces activation of JAK1, JAK2, and STAT1/STAT3 proteins in bovine articular chondrocytes. Western blotting and mobility shift assays demonstrated that this effect is accompanied by the DNA binding of the STAT proteins. The mitogen-activated protein kinase pathway was also activated in response to IL-6/sIL-6R association, as reflected by phosphorylation of ERK1 and ERK2 proteins. In these conditions, the expression of cartilage-specific matrix genes, type 11 collagen, aggrecan core, and link proteins was found to be markedly down-regulated. This negative effect was abolished by addition of parthenolide, an inhibitor of the STAT activation, whereas blockade of the MAP kinases with PD098059 was without significant effect. Thus, activation of the STAT signaling pathways, but not ERK-dependent pathways, is essential for down-regulation of the major cartilage-specific matrix genes by IL-6. In addition, a parallel reduction of Sox9 expression, a key factor of chondrocyte phenotype, was found in these experimental conditions. These IL-6 effects might contribute to the phenotype loss of chondrocytes in joint diseases and the alteration of articular cartilage associated with this pathology.	Fac Med, Lab Biochim Tissu Conjonct, F-14032 Caen, France; Univ London Royal Vet Coll, Dept Vet Basic Sci, London NW1 0TU, England	Universite de Caen Normandie; University of London; University of London Royal Veterinary College	Bogdanowicz, P (corresponding author), Fac Med, Lab Biochim Tissu Conjonct, Niveau 3, F-14032 Caen, France.	pbogdanowicz@hotmail.com		Dudhia, Jayesh/0000-0002-2503-697X; legendre, florence/0000-0002-9951-1585				AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Bellido T, 1997, ENDOCRINOLOGY, V138, P3666, DOI 10.1210/en.138.9.3666; BENDER S, 1990, FEBS LETT, V263, P321, DOI 10.1016/0014-5793(90)81404-C; BENYA PD, 1977, BIOCHEMISTRY-US, V16, P865, DOI 10.1021/bi00624a009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DACIPOUR M, 1993, J IMMUNOL, V150, P4743; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Desgeorges A, 1997, J RHEUMATOL, V24, P1510; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Flannery CR, 2000, MATRIX BIOL, V19, P549, DOI 10.1016/S0945-053X(00)00111-6; FRIELING JTM, 1995, J INFECT DIS, V171, P469, DOI 10.1093/infdis/171.2.469; GUERNE PA, 1990, J IMMUNOL, V144, P499; Guerne PA, 1999, MATRIX BIOL, V18, P253, DOI 10.1016/S0945-053X(99)00021-9; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; Hehner SP, 1999, J IMMUNOL, V163, P5617; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hirano T, 1998, Int Rev Immunol, V16, P249; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; ISHIMI Y, 1990, J IMMUNOL, V145, P3297; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Krebsbach PH, 1996, J BIOL CHEM, V271, P4298, DOI 10.1074/jbc.271.8.4298; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARUS DD, 1993, LYMPHOKINE CYTOK RES, V12, P219; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lewis AJ, 1999, CURR OPIN CHEM BIOL, V3, P489, DOI 10.1016/S1367-5931(99)80071-4; MADHOK R, 1993, ANN RHEUM DIS, V52, P232, DOI 10.1136/ard.52.3.232; MALFAIT AM, 1994, J RHEUMATOL, V21, P314; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; NIETFELD JJ, 1990, ARTHRITIS RHEUM, V33, P1695, DOI 10.1002/art.1780331113; Nishimoto N, 2000, ANN RHEUM DIS, V59, P21, DOI 10.1136/ard.59.suppl_1.i21; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; O'Shea JJ, 2000, ANN RHEUM DIS, V59, P115; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; POOLE AR, 1994, ANN RHEUM DIS, V53, P3, DOI 10.1136/ard.53.1.3; RHODES C, 1995, NUCLEIC ACIDS RES, V23, P2305, DOI 10.1093/nar/23.12.2305; SACK U, 1993, RHEUMATOL INT, V13, P45, DOI 10.1007/BF00307733; SADOWSKI HB, 1993, NATURE, V362, P79, DOI 10.1038/362079a0; Sasai M, 1999, ARTHRITIS RHEUM, V42, P1635, DOI 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Seidel HM, 2000, ONCOGENE, V19, P2645, DOI 10.1038/sj.onc.1203550; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Sobota R, 2000, BIOCHEM BIOPH RES CO, V267, P329, DOI 10.1006/bbrc.1999.1948; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Valhmu WB, 1998, J BIOL CHEM, V273, P6196, DOI 10.1074/jbc.273.11.6196; VANDENBERG WB, 1994, CLIN EXP IMMUNOL, V95, P237; WANG F, 1995, J EXP MED, V182, P1825, DOI 10.1084/jem.182.6.1825; Weidler M, 2000, BIOCHEM BIOPH RES CO, V276, P447, DOI 10.1006/bbrc.2000.3499; WENDLING D, 1993, J RHEUMATOL, V20, P259; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; YAN ZF, 1994, J BIOL CHEM, V269, P13231; Yokota Akira, 1997, Arthritis and Rheumatism, V40, pS274; Yoshizaki K, 1998, SPRINGER SEMIN IMMUN, V20, P247, DOI 10.1007/s002810050033; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; ZHOU G, 1995, J CELL SCI, V108, P3677	69	161	174	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2903	2912		10.1074/jbc.M110773200	http://dx.doi.org/10.1074/jbc.M110773200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12419823	hybrid			2022-12-27	WOS:000180915000019
J	Wigneshweraraj, SR; Kuznedelov, K; Severinov, K; Buck, M				Wigneshweraraj, SR; Kuznedelov, K; Severinov, K; Buck, M			Multiple roles of the RNA polymerase beta subunit flap domain in sigma(54)-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL SEQUENCES; SIGMA-FACTOR; DNA COMPLEX; BINDING; ISOMERIZATION; REQUIREMENT; ACTIVATORS; MECHANISM; BYPASS; START	Recent determinations of the structures of the bacterial RNA polymerase (RNAP) and promoter complex thereof establish that RNAP functions as a complex molecular machine that contains distinct structural modules that undergo major conformational changes during transcription. However, the contribution of the RNAP structural modules to transcription remains poorly understood. The bacterial core RNAP (alpha(2)betabeta' omegaa, E) associates with a sigma (sigma) subunit to form the holoenzyme (Esigma). A mutation removing the beta subunit flap domain renders the Escherichia coli or sigma(70) RNAP holoenzyme unable to recognize promoters. sigma(54) is the major variant sigma subunit that utilizes enhancer-dependent promoters. Here, we determined the effects of beta flap removal on sigma(54)-dependent transcription. Our analysis shows that the role of the beta flap in sigma(54)-dependent and sigma(54)-dependent transcription is different. Removal of the beta flap does not prevent the recognition of sigma(54)-dependent promoters, but causes multiple defects in sigma(54) -dependent transcription. Most importantly, the beta flap appears to orchestrate the proper formation of the Esigma(54) regulatory center at the start site proximal promoter element where activator binds and DNA melting originates.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08904 USA; Rutgers State Univ, Dept Genet, Piscataway, NJ 08904 USA	Imperial College London; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Buck, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Sir Alexander Fleming Bldg,Imperial Coll Rd, London SW7 2AZ, England.		Severinov, Konstantin/C-8545-2016	Wigneshweraraj, Sivaramesh/0000-0002-1418-4029	NIGMS NIH HHS [R01 GM64530] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Cannon W, 2002, NUCLEIC ACIDS RES, V30, P886, DOI 10.1093/nar/30.4.886; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Cannon W, 2001, J BIOL CHEM, V276, P386, DOI 10.1074/jbc.M007779200; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Casaz P, 1999, J MOL BIOL, V292, P229, DOI 10.1006/jmbi.1999.3076; Chaney M, 1999, MOL MICROBIOL, V33, P1200, DOI 10.1046/j.1365-2958.1999.01566.x; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Datwyler SA, 2000, TRENDS BIOCHEM SCI, V25, P408, DOI 10.1016/S0968-0004(00)01652-2; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; Gallegos MT, 2000, J MOL BIOL, V297, P849, DOI 10.1006/jmbi.2000.3608; Gallegos MT, 1999, J MOL BIOL, V288, P539, DOI 10.1006/jmbi.1999.2704; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Guo YL, 2000, GENE DEV, V14, P2242, DOI 10.1101/gad.794800; Guo YL, 1999, EMBO J, V18, P3736, DOI 10.1093/emboj/18.13.3736; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; LEE JH, 1995, P NATL ACAD SCI USA, V92, P9702, DOI 10.1073/pnas.92.21.9702; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MERRICK MJ, 1992, MOL MICROBIOL, V10, P903; MORRIS L, 1994, J BIOL CHEM, V269, P11563; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nechaev S, 2000, J BIOL CHEM, V275, P25516, DOI 10.1074/jbc.M002511200; Neuwald AF, 1999, GENOME RES, V9, P27; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wang JT, 1996, J BIOL CHEM, V271, P32707, DOI 10.1074/jbc.271.51.32707; Wang JT, 1997, P NATL ACAD SCI USA, V94, P9538, DOI 10.1073/pnas.94.18.9538; Wang L, 1999, J BACTERIOL, V181, P7558, DOI 10.1128/JB.181.24.7558-7565.1999; Wang L, 1998, J BACTERIOL, V180, P5626, DOI 10.1128/JB.180.21.5626-5631.1998; WEDEL A, 1995, GENE DEV, V9, P2042, DOI 10.1101/gad.9.16.2042; Wigneshweraraj SR, 2000, EMBO J, V19, P3038, DOI 10.1093/emboj/19.12.3038; Wigneshweraraj SR, 2002, J MOL BIOL, V319, P1067, DOI 10.1016/S0022-2836(02)00330-3; Wigneshweraraj SR, 2001, J MOL BIOL, V306, P681, DOI 10.1006/jmbi.2000.4393; WIGNESHWERARAJ SR, NUCL ACIDS RES, V30, P1016; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	40	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3455	3465		10.1074/jbc.M209442200	http://dx.doi.org/10.1074/jbc.M209442200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12424241	hybrid			2022-12-27	WOS:000180915000087
J	Yabal, M; Brambillasca, S; Soffientini, P; Pedrazzini, E; Borgese, N; Makarow, M				Yabal, M; Brambillasca, S; Soffientini, P; Pedrazzini, E; Borgese, N; Makarow, M			Translocation of the C terminus of a tail-anchored protein across the endoplasmic reticulum membrane in yeast mutants defective in signal peptide-driven translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; CYTOCHROME B(5); SECRETORY PROTEINS; BETA-LACTAMASE; SEC PROTEINS; TRANSPORT; COMPLEX; INSERTION; GENES; RETENTION	C-tail-anchored proteins are defined by an N-terminal cytosolic domain followed by a transmembrane anchor close to the C terminus. Their extreme C-terminal polar residues are translocated across membranes by poorly understood post-translational mechanism(s). Here we have used the yeast system to study translocation of the C terminus of a tagged form of mammalian cytochrome b(5), carrying an N-glycosylation site in its C-terminal domain (b(5)-Nglyc). Utilization of this site was adopted as a rigorous criterion for translocation across the ER membrane of yeast wild-type and mutant cells. The C terminus of b(5)-Nglyc was rapidly glycosylated in mutants where Sec61p was defective and incapable of translocating carboxypeptidase Y, a well known substrate for post-translational translocation. Likewise, inactivation of several other components of the translocon machinery had no effect on b(5)-Nglyc translocation. The kinetics of translocation were faster for b(5)-Nglyc than for a signal peptide-containing reporter. Depletion of the cellular ATP pool to a level that retarded Sec61p-dependent post-translational translocation still allowed translocation of b(5)-Nglyc. Similarly, only low ATP concentrations (below I pm), in addition to cytosolic protein(s), were required for in vitro translocation of b(5)-Nglyc into mammalian microsomes. Thus, translocation of tail-anchored b(5)-Nglyc proceeds by a mechanism different from that of signal peptide-driven post-translational translocation.	CNR, Inst Neurosci, Cellular & Mol Pharmacol Sect, I-20129 Milan, Italy; Univ Catanzaro Magna Graecia, Fac Pharm, I-8021 Roccelletta di Borgia, Catanzaro, Italy	Consiglio Nazionale delle Ricerche (CNR); Magna Graecia University of Catanzaro	Borgese, N (corresponding author), CNR, Inst Neurosci, Cellular & Mol Pharmacol Sect, Via Vanvitelli 32, I-20129 Milan, Italy.	nica@csfic.mi.cnr.it	Pedrazzini, Emanuela/ABB-9410-2020; Borgese, Nica/GWZ-8895-2022	Borgese, Nica/0000-0002-7537-3974; Soffientini, Paolo/0000-0002-1730-5615; PEDRAZZINI, EMANUELA/0000-0002-9238-3840				ADAMUS G, 1991, J NEUROIMMUNOL, V34, P89, DOI 10.1016/0165-5728(91)90118-Q; ARINC E, 1987, J BIOL CHEM, V262, P15563; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 1993, Subcell Biochem, V21, P313; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bulbarelli A, 2002, J CELL SCI, V115, P1689; DAILEY HA, 1981, J BIOL CHEM, V256, P3951; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; JANTTI J, 1994, J CELL SCI, V107, P3623; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lan L, 2000, BIOCHEM J, V349, P611, DOI 10.1042/0264-6021:3490611; LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102; Masaki R, 1996, J BIOL CHEM, V271, P16939, DOI 10.1074/jbc.271.28.16939; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Paunola E, 2001, J BIOL CHEM, V276, P34553, DOI 10.1074/jbc.M102056200; Paunola E, 1998, MOL BIOL CELL, V9, P817, DOI 10.1091/mbc.9.4.817; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Romisch K, 1999, J CELL SCI, V112, P4185; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Saris N, 1997, J CELL BIOL, V137, P813, DOI 10.1083/jcb.137.4.813; Simola M, 2000, MOL MICROBIOL, V37, P42, DOI 10.1046/j.1365-2958.2000.01970.x; Simonen M, 1996, YEAST, V12, P457, DOI 10.1002/(SICI)1097-0061(199604)12:5<457::AID-YEA930>3.0.CO;2-D; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Suntio T, 1999, J CELL SCI, V112, P3889; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; VERGERES G, 1993, J CELL SCI, V106, P249; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0	54	53	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3489	3496		10.1074/jbc.M210253200	http://dx.doi.org/10.1074/jbc.M210253200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12446686	hybrid			2022-12-27	WOS:000180915000091
J	Buitrago, CG; Pardo, VG; de Boland, AR; Boland, R				Buitrago, CG; Pardo, VG; de Boland, AR; Boland, R			Activation of RAF-1 through Ras and protein kinase C alpha mediates 1 alpha,25(OH)(2)-vitamin D-3 regulation of the mitogen-activated protein kinase pathway in muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MAP KINASE; PLASMA-MEMBRANE; VITAMIN-D; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CULTURED MYOBLASTS; CALCIUM; PROLIFERATION	We have previously shown that stimulation of proliferation of avian embryonic muscle cells (myoblasts) by lalpha,25(OH)(2)-vitamin D-3 (1alpha,,25(OH)(2)D-3) is mediated by activation of the mitogen-activated protein kinase (MAPK; ERK1/2). To understand how lalpha,25(OH)(2)D-3 up-regulates the MAPK cascade, we have investigated whether the hormone acts upstream through stimulation of Raf-1 and the signaling mechanism by which this effect might take place. Treatment of chick myoblasts with lalpha,25(OH)(2)D-3 (1 nM) caused a fast increase of Raf-1 serine phosphorylation (1- and 3-fold over basal at 1 and 2 min, respectively), indicating activation of Raf-1 by the hormone. These effects were abolished by preincubation of cells with a specific Ras inhibitor peptide that involves Ras in 1alpha,25(OH)(2)D-3 stimulation of Raf-1. 1alpha,25(OH)(2)D-3 rapidly induced tyrosine de-phosphorylation of Ras-GTPase-activating protein, suggesting that inhibition of Ras-GTP hydrolysis is part of the mechanism by which 1alpha,25(OH)(2)D-3 activates Ras in myoblasts. The protein kinase CPKC inhibitors calphostin C, bisindolylmaleimide I, and Ro 318220 blocked lalpha,25(OH)(2)D-3-induced Raf-1 serine phosphorylation, revealing that hormone stimulation of Raf-1 also involves PKC. In addition, transfection of muscle cells with an antisense oligodeoxynucleotide against PKCalpha mRNA suppressed serine phosphorylation by lalpha,25(OH)(2)D-3. The increase in MAPK activity and tyrosine phosphorylation caused by lalpha,25(OH)(2)D-3 could be abolished by Ras inhibitor peptide, compound PD 98059, which prevents the activation of MEK by Raf-1, or incubation of cell lysates before 1alpha,25(OH)(2)D-3 exposure with an anti-Raf-1 antibody. In conclusion, these results demonstrate for the first time in a la,25(011)2% target cell that activation of Raf-1 via Ras and PKCalpha-dependent serine phosphorylation plays a central role in hormone stimulation of the MAPK-signaling pathway leading to muscle cell proliferation.	Univ Nacl Sur, Dept Biol Bioquim & Farm, RA-8000 Bahia Blanca, Buenos Aires, Argentina	National University of the South	Boland, R (corresponding author), Univ Nacl Sur, Dept Biol Bioquim & Farm, San Juan 670, RA-8000 Bahia Blanca, Buenos Aires, Argentina.							ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Baran DT, 2000, J CELL BIOCHEM, V78, P34, DOI 10.1002/(SICI)1097-4644(20000701)78:1<34::AID-JCB4>3.3.CO;2-Q; BOLAND R, 1995, MOL CELL ENDOCRINOL, V114, P1, DOI 10.1016/0303-7207(95)03650-V; Borowski P, 1996, BIOCHEM MOL BIOL INT, V39, P635; Buitrago C, 2000, J CELL BIOCHEM, V79, P274, DOI 10.1002/1097-4644(20001101)79:2<274::AID-JCB100>3.0.CO;2-R; Capiati DA, 2000, CELL PROLIFERAT, V33, P307, DOI 10.1046/j.1365-2184.2000.00182.x; Capiati DA, 1999, MOL CELL ENDOCRINOL, V153, P39, DOI 10.1016/S0303-7207(99)00093-3; Capiati DA, 1999, J CELL BIOCHEM, V74, P292, DOI 10.1002/(SICI)1097-4644(19990801)74:2<292::AID-JCB13>3.0.CO;2-M; Capiati DA, 2000, J CELL BIOCHEM, V77, P200, DOI 10.1002/(SICI)1097-4644(20000501)77:2<200::AID-JCB4>3.0.CO;2-5; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DEBOLAND AR, 1994, CELL SIGNAL, V6, P717, DOI 10.1016/0898-6568(94)00042-5; DEBOLAND AR, 1987, ENDOCRINOLOGY, V120, P1858, DOI 10.1210/endo-120-5-1858; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Gniadecki R, 1996, J INVEST DERMATOL, V106, P1212, DOI 10.1111/1523-1747.ep12348498; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; JOHANNES FJ, 1994, P NATL ACAD SCI USA, V91, P8572; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LEMMON MA, 1994, J BIOL CHEM, V269, P31653; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lin CC, 2001, CELL SIGNAL, V13, P257, DOI 10.1016/S0898-6568(01)00134-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORELLI S, 1993, BIOCHEM J, V289, P675, DOI 10.1042/bj2890675; Morelli S, 2001, MOL CELL ENDOCRINOL, V173, P41, DOI 10.1016/S0303-7207(00)00435-4; Morelli S, 2000, J BIOL CHEM, V275, P36021, DOI 10.1074/jbc.M002025200; Nemere I, 1998, J BONE MINER RES, V13, P1353, DOI 10.1359/jbmr.1998.13.9.1353; NEMERE I, 1994, J BIOL CHEM, V269, P23750; Pizon V, 2000, ONCOGENE, V19, P6074, DOI 10.1038/sj.onc.1203984; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Sasa H, 1998, JPN J PHARMACOL, V76, P121, DOI 10.1254/jjp.76.121; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SLUPSKY JR, 1998, CELL GROWTH ONCOGENE; Snedecor G.W., 1967, STAT METHODS; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TROPPMAIR J, 1992, ONCOGENE, V7, P1867; VAZQUEZ G, 1993, BIOCHEM MOL BIOL INT, V31, P677; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O	48	70	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2199	2205		10.1074/jbc.M205732200	http://dx.doi.org/10.1074/jbc.M205732200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12417593	hybrid, Green Published			2022-12-27	WOS:000180562000018
J	Torres, GE; Carneiro, A; Seamans, K; Fiorentini, C; Sweeney, A; Yao, WD; Caron, MG				Torres, GE; Carneiro, A; Seamans, K; Fiorentini, C; Sweeney, A; Yao, WD; Caron, MG			Oligomerization and trafficking of the human dopamine transporter - Mutational analysis identifies critical domains important for the functional expression of the transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER; TRANSMEMBRANE GLYCOPROTEIN; SUBCELLULAR-LOCALIZATION; ACETYLCHOLINE-RECEPTOR; SEROTONIN TRANSPORTER; PLASMA-MEMBRANE; PHORBOL ESTERS; PROTEIN; INTERNALIZATION; GLYCOSYLATION	The dopamine transporter (DAT) is a presynaptic plasma membrane protein responsible for the termination of dopaminergic neurotransmission in the central nervous system. While most studies have focused on structure/function analysis, much less information is available regarding the assembly and the trafficking of this protein. To address this problem, we performed a mutational analysis of the DAT protein, combined with biochemical, immunological, and functional approaches. In mammalian cells co-expressing differentially tagged DAT molecules, HA-tagged DAT co-purified with 6His-tagged DAT demonstrating a physical interaction between transporter proteins. Evidence for the functional oligomerization of DAT was obtained using dominant-negative mutants of DAT. Two loss-of-function mutant transporters (Y335A and D79G) that were targeted to the cell surface inhibited wild-type DAT uptake activity without affecting the membrane targeting of the wildtype transporter. Moreover, non-functional amino and carboxyl termini-truncated mutants of DAT inhibited wild-type DAT function by interfering with the normal processing of the wild-type transporter to the cell membrane. Mutations in the leucine repeat of the second transmembrane domain of the transporter could eliminate the dominant-negative effect of all these mutants. In addition, a small fragment comprising the first two transmembrane domains of DAT inhibited wild-type transporter function but not when the leucine repeat motif was mutated. Taken together, our results suggest that the assembly of DAT monomers plays a critical role in the expression and function of the transporter.	Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Howard Hughes Med Inst, Rm 489,CARL Bldg,Res Dr, Durham, NC 27710 USA.			MD Carneiro, Ana/0000-0002-7470-7047; Marin Dias Carneiro, Ana/0000-0002-1204-9202	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA014150] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-14150] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P733; ARKIN IT, 1994, EMBO J, V13, P4757, DOI 10.1002/j.1460-2075.1994.tb06801.x; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Chen NH, 2000, EUR J PHARMACOL, V405, P329, DOI 10.1016/S0014-2999(00)00563-X; CHEN SSL, 1993, J VIROL, V67, P3615, DOI 10.1128/JVI.67.6.3615-3619.1993; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Deslauriers B, 1999, BIOCHEM J, V339, P397, DOI 10.1042/0264-6021:3390397; DUBAY JW, 1992, J VIROL, V66, P4748, DOI 10.1128/JVI.66.8.4748-4756.1992; Eskandari S, 2000, P NATL ACAD SCI USA, V97, P8641, DOI 10.1073/pnas.97.15.8641; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1992, MOL PHARMACOL, V42, P383; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hersch SM, 1997, J COMP NEUROL, V388, P211; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Huff RA, 1997, J NEUROCHEM, V68, P225; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Luo ZL, 1999, J VIROL, V73, P8152, DOI 10.1128/JVI.73.10.8152-8159.1999; Melikian HE, 1999, J NEUROSCI, V19, P7699; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Shah H, 2001, J MOL BIOL, V309, P641, DOI 10.1006/jmbi.2001.4706; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; SUMIKAWA K, 1992, MOL BRAIN RES, V13, P349, DOI 10.1016/0169-328X(92)90218-Z; TATE CG, 1994, J BIOL CHEM, V269, P26303; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	39	196	197	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2731	2739		10.1074/jbc.M201926200	http://dx.doi.org/10.1074/jbc.M201926200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12429746	hybrid			2022-12-27	WOS:000180562000086
J	Lopez, P; Yaman, R; Lopez-Fernandez, LA; Vidal, F; Puel, D; Clertant, P; Cuzin, F; Rassoulzadegan, M				Lopez, P; Yaman, R; Lopez-Fernandez, LA; Vidal, F; Puel, D; Clertant, P; Cuzin, F; Rassoulzadegan, M			A novel germ line-specific gene of the phosducin-like protein (PhLP) family - A meiotic function conserved from yeast to mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5'-FLANKING REGION; MOUSE; SEQUENCE; BINDING	We identified a new member of the phosducin-like (PhLP) protein family that is predominantly, if not exclusively, expressed in mate and female germ cells. In situ analysis on testis sections and analysis of purified spermatogenic cell fractions evidenced a stage-specific expression with high levels of RNA and protein in pachytene spermatocytes and round spermatids. Three mRNA species were detected, which correspond to different polyadenylation sites and vary in abundance during germ cell maturation. Only low levels of RNA were detected in whole ovary extracts, but expression of the protein became detectable within hours after hormonal induction of superovulation. The gene (Mgcphlp) is located on mouse chromosome 5 in the immediate vicinity of the Clock locus. The predicted amino acid sequence shows extensive similarities not only with the known mammalian PhLP proteins but also with the yeast phosducin-like protein Plp2, required for the production and growth of haploid cells. Expression of the murine protein was found to complement the defect of a yeast plp2Delta mutant. We propose that MgcPhLP/Plp2 proteins exert a function in germ cell maturation that is conserved from yeast to mammals.	Univ Nice, INSERM, U470, F-06108 Nice 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Cuzin, F (corresponding author), Univ Nice, INSERM, U470, F-06108 Nice 2, France.		Lopez-Fernandez, Luis/AAV-2580-2021; Lopez-Fernandez, Luis A/B-7330-2011; Lopez-Fernandez, Luis A/I-9679-2019; Rassoulzadegan, Minoo/O-7939-2016	Lopez-Fernandez, Luis/0000-0003-3964-5837; Lopez-Fernandez, Luis A/0000-0003-3964-5837; Lopez-Fernandez, Luis A/0000-0003-3964-5837; Lopez, Pascal/0000-0002-3936-3058				ABE T, 1993, GENE, V133, P179; ABE T, 1994, GENOMICS, V19, P369, DOI 10.1006/geno.1994.1072; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; CRAFT CM, 1991, GENOMICS, V10, P400, DOI 10.1016/0888-7543(91)90325-9; Craft CM, 1998, BIOCHEMISTRY-US, V37, P15758, DOI 10.1021/bi980921a; Danner S, 1996, P NATL ACAD SCI USA, V93, P10145, DOI 10.1073/pnas.93.19.10145; de Luis O, 1999, EXP CELL RES, V249, P320, DOI 10.1006/excr.1999.4482; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Garzon J, 2002, NEUROPHARMACOLOGY, V42, P813, DOI 10.1016/S0028-3908(02)00027-8; Harlow E., 1988, ANTIBODIES LAB MANUA; HOGAN B, 1994, MANIPULATING MOUSE E, P130; LEE RH, 1988, EXP EYE RES, V46, P829, DOI 10.1016/S0014-4835(88)80035-6; Lopez P, 2002, MOL CELL BIOL, V22, P3488, DOI 10.1128/MCB.22.10.3488-3496.2002; Nakano K, 2001, P NATL ACAD SCI USA, V98, P4693, DOI 10.1073/pnas.071067198; Oh B, 2000, DEVELOPMENT, V127, P3795; Perego L, 1997, MOL REPROD DEV, V47, P370, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;370::AID-MRD3&gt;3.0.CO;2-H; Schroder S, 1996, P NATL ACAD SCI USA, V93, P2100, DOI 10.1073/pnas.93.5.2100; SIKORSKI RS, 1989, GENETICS, V122, P19; Stutz A, 1998, GENE DEV, V12, P2535, DOI 10.1101/gad.12.16.2535; Thibault C, 1997, J BIOL CHEM, V272, P12253, DOI 10.1074/jbc.272.19.12253	20	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1751	1757		10.1074/jbc.M207434200	http://dx.doi.org/10.1074/jbc.M207434200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424248	hybrid			2022-12-27	WOS:000180462200052
J	Peterson, G; Reznikoff, W				Peterson, G; Reznikoff, W			Tn5 transposase active site mutations suggest position of donor backbone DNA in synaptic complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA VIRUS INTEGRASE; 3-DIMENSIONAL STRUCTURE; DIVALENT-CATIONS; BINDING; RESIDUES; DOMAIN	Tn5 transposase (Tnp), a 53.3-kDa protein, enables the movement of transposon Tn5 by a conservative mechanism. Within the context of a protein and DNA synaptic complex, a single Tnp molecule catalyzes four sequential DNA breaking and joining reactions at the end of a single transposon. The three amino acids of the DDE motif (Asp-97, Asp-188, and Glu-326), which are conserved among transposases and retroviral integrases, have been shown previously to be absolutely required for all catalytic steps. To probe the effect of active site geometry on the ability to form synaptic complexes and perform catalysis, single mutations at each position of the DDE motif were constructed. The aspartates were changed to glutamates, and the glutamate was changed to an aspartate. These mutants were studied by performing in vitro binding assays using short oligonucleotide substrates simulating the natural substrates for the synaptic complex formation and subsequent transposition steps. The results indicate that the aspartate to glutamate mutations restrict synaptic complex formation with substrates resembling the natural transposon prior to transferred strand nicking. This suggests a structural model in which the donor backbone DNA, prior to nicking, occupies the same space that is invaded by the longer side chains present in the aspartate to glutamate mutants. Additionally, catalytic assays support the previous proposal that the active site coordinates two divalent metal ions.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Reznikoff, W (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.				NIGMS NIH HHS [GM 50692] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bhasin A, 2000, J MOL BIOL, V302, P49, DOI 10.1006/jmbi.2000.4048; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davies DR, 1999, J BIOL CHEM, V274, P11904, DOI 10.1074/jbc.274.17.11904; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Naumann TA, 2000, P NATL ACAD SCI USA, V97, P8944, DOI 10.1073/pnas.160107997; Naumann TA, 2002, J BIOL CHEM, V277, P17623, DOI 10.1074/jbc.M200742200; Reznikoff WS, 1999, BIOCHEM BIOPH RES CO, V266, P729, DOI 10.1006/bbrc.1999.1891; Sambrook J., 2002, MOL CLONING LAB MANU; Zhou M, 1998, J MOL BIOL, V276, P913, DOI 10.1006/jmbi.1997.1579	18	16	20	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1904	1909		10.1074/jbc.M208968200	http://dx.doi.org/10.1074/jbc.M208968200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424243	hybrid			2022-12-27	WOS:000180462200072
J	Kwon, JH; Keates, S; Simeonidis, S; Grall, F; Libermann, TA; Keates, AC				Kwon, JH; Keates, S; Simeonidis, S; Grall, F; Libermann, TA; Keates, AC			ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3 alpha gene expression in Caco-2 human colonic epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CHEMOATTRACTANT PROTEIN-1 GENE; INFLAMMATORY-BOWEL-DISEASE; MOLECULAR-CLONING; BINDING PROTEIN; DNA-BINDING; T-CELLS; INTESTINAL EPITHELIUM; HUMAN CHEMOKINES; DENDRITIC CELLS	We have previously shown that colonic epithelial cells are a major site of MIP-3alpha production in human colon and that enterocyte MIP-3alpha protein levels are elevated in inflammatory bowel disease. The aim of this study was to determine the molecular mechanisms regulating MIP-3alpha gene transcription in Caco-2 intestinal epithelial cells. We show that a kappaB element at nucleotides -82 to -93 of the MIP-3alpha promoter binds p50/p65 NF-kappaB heterodimers and is a major regulator of basal and interleukin-1beta (IL-1beta)-mediated gene activation. Scanning mutagenesis of the MIP-3alpha 5'-flanking region also identified two additional binding elements: Site X (nucleotides -63 to -69) and Site Y (nucleotides -143 to -154). Site X (CGCCTTC) bound Sp1 and regulated basal MIP-3alpha gene transcription. Overexpression of Sp1 increased basal luciferase activity, whereas, substitutions in the Sp1 element significantly reduced reporter activity. In contrast, Site Y (AAGCAGGAAGTT) regulated both basal and cytokine-induced gene activation and bound the Ets nuclear factor ESE-1. Substitutions in the Site Y element markedly reduced inducible MIP-3alpha reporter activity. Conversely, overexpression of ESE-1 significantly up-regulated MIP-3alpha luciferase levels. Taken together, our findings demonstrate that co-ordinate activation and binding of ESE-1, Sp1, and NF-kappaB to the MIP-3alpha promoter is required for maximal gene expression by cytokine-stimulated Caco-2 human intestinal epithelial cells.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, New England Baptist Bone & Joint Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; New England Baptist Hospital	Keates, AC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, 330 Brookline Ave,Dana 501, Boston, MA 02215 USA.		Libermann, Towia/F-9866-2010	Libermann, Towia/0000-0002-4006-8179	NATIONAL CANCER INSTITUTE [R01CA076323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054920] Funding Source: NIH RePORTER; NCI NIH HHS [CA-76323] Funding Source: Medline; NIDDK NIH HHS [DK-54920, DK-43551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; ASHAR HR, 1995, CELL, V82, P57; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; Brembeck FH, 2000, ONCOGENE, V19, P1941, DOI 10.1038/sj.onc.1203441; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Choi SG, 1998, J BIOL CHEM, V273, P110, DOI 10.1074/jbc.273.1.110; Cominelli F, 1996, ALIMENT PHARM THERAP, V10, P49, DOI 10.1046/j.1365-2036.1996.22164020.x; Davidson NJ, 1996, J EXP MED, V184, P241, DOI 10.1084/jem.184.1.241; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hiura TS, 1999, CLIN IMMUNOL, V90, P287, DOI 10.1006/clim.1998.4659; Imaizumi Y, 2002, INT IMMUNOL, V14, P147, DOI 10.1093/intimm/14.2.147; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; JAMES SP, 1986, GASTROENTEROLOGY, V91, P1483, DOI 10.1016/0016-5085(86)90205-2; Jobin C, 1997, J IMMUNOL, V158, P226; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Keates AC, 1997, BIOCHEM J, V324, P295, DOI 10.1042/bj3240295; Keates AC, 2001, J BIOL CHEM, V276, P43713, DOI 10.1074/jbc.M107838200; Keates S, 1997, AM J PHYSIOL-GASTR L, V273, pG75, DOI 10.1152/ajpgi.1997.273.1.G75; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Kwon JH, 2002, GUT, V51, P818, DOI 10.1136/gut.51.6.818; Liao F, 1999, J IMMUNOL, V162, P186; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Minami T, 1998, EUR J BIOCHEM, V258, P879, DOI 10.1046/j.1432-1327.1998.2580879.x; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Murakami K, 1997, DNA CELL BIOL, V16, P173, DOI 10.1089/dna.1997.16.173; Neurath MF, 1998, GUT, V43, P856, DOI 10.1136/gut.43.6.856; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Peng HM, 2000, ARCH BIOCHEM BIOPHYS, V382, P129, DOI 10.1006/abbi.2000.2001; Perrella MA, 1999, J BIOL CHEM, V274, P9045, DOI 10.1074/jbc.274.13.9045; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Power CA, 1997, J EXP MED, V186, P825, DOI 10.1084/jem.186.6.825; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rossi DL, 1997, J IMMUNOL, V158, P1033; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Scheerens H, 2001, EUR J IMMUNOL, V31, P1465, DOI 10.1002/1521-4141(200105)31:5<1465::AID-IMMU1465>3.0.CO;2-E; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Taub Dennis D., 1996, Cytokine and Growth Factor Reviews, V7, P355, DOI 10.1016/S1359-6101(97)89237-4; UEDA A, 1994, J IMMUNOL, V153, P2052; Wang DY, 1997, J BIOL CHEM, V272, P14244, DOI 10.1074/jbc.272.22.14244; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Wu GD, 1997, J BIOL CHEM, V272, P2396; Ye JP, 1997, FASEB J, V11, P825, DOI 10.1096/fasebj.11.11.9285480; Zhang CY, 1997, J BIOL CHEM, V272, P26236, DOI 10.1074/jbc.272.42.26236	65	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					875	884		10.1074/jbc.M208241200	http://dx.doi.org/10.1074/jbc.M208241200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414801	hybrid			2022-12-27	WOS:000180321900025
J	Hallmann, D; Trumper, K; Trusheim, H; Ueki, K; Kahn, R; Cantley, LC; Fruman, DA; Horsch, D				Hallmann, D; Trumper, K; Trusheim, H; Ueki, K; Kahn, R; Cantley, LC; Fruman, DA; Horsch, D			Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTE DIFFERENTIATION; MUSCLE; MICE; PHOSPHORYLATION; PROLIFERATION; EXPRESSION; ACTIVATION; ISOFORMS	The p85alpha regulatory subunit of class I(A) phosphoinositide 3-kinases (PI3K) is derived from the Pik3r1 gene, which also yields alternatively spliced variants p50alpha and p55alpha. It has been proposed that excess monomeric p85 competes with functional PI3K p85-p110 heterodimers. We examined embryonic stem (ES) cells with heterozygous and homozygous disruptions in the Pik3r gene and found that wild type ES cells express virtually no monomeric p85alpha. Although, IGF-1-stimulated PI3K activity associated with insulin receptor substrates was unaltered in all cell lines, p85alpha-null ES cells showed diminished protein kinase B activation despite increased PI3K activity associated with the p85beta subunit. Furthermore, p85alpha-null cells demonstrated growth retardation, increased frequency of apoptosis, and altered cell cycle regulation with a G(0)/G(1) cell cycle arrest and up-regulation of p27(KIP), whereas signaling through CREB and MAPK was enhanced. These phenotypes were reversed by re-expression of p85alpha via adenoviral gene transfer. Surprisingly, all ES cell lines could be differentiated into adipocytes. In these differentiated ES cells, however, compensatory p85beta signaling was lost in p85alpha-null cells while increased signaling by CREB and MAPK was still observed. Thus, loss of p85alpha in ES cells induced alterations in IGF-1 signaling and regulation of apoptosis and cell cycle but no defects in differentiation. However, differentiated ES cells partially lost their ability for compensatory signaling at the level of PI3K, which may explain some of the defects observed in mice with homozygous deletion of the Pik3r1 gene.	Univ Marburg, Div Gastroenterol & Metab, Dept Internal Med, D-35033 Marburg, Germany; Harvard Univ, Sch Med, Div Res, Joslin Diabet Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Signal Transduct, Boston, MA 02215 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Philipps University Marburg; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Irvine	Horsch, D (corresponding author), Univ Marburg, Div Gastroenterol & Metab, Dept Internal Med, Baldingerstr, D-35033 Marburg, Germany.	hoerschd@post.med.uni-marburg.de	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033201, R01DK055545, P30DK036836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK036836, R01 DK055545, R01 DK033201] Funding Source: Medline; NIGMS NIH HHS [R37 GM041890, R01 GM041890, GM41890] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Dani C, 1997, J CELL SCI, V110, P1279; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Horsch D, 1999, J COMP NEUROL, V415, P105; HUONG PLT, 1991, J IMMUNOL METHODS, V140, P243, DOI 10.1016/0022-1759(91)90377-R; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Inukai K, 1996, J BIOL CHEM, V271, P5317, DOI 10.1074/jbc.271.10.5317; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; PONS S, 1995, MOL CELL BIOL, V15, P4453; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamir Y, 2000, J BIOL CHEM, V275, P34424, DOI 10.1074/jbc.M005815200; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; UEHARA T, 1995, BIOCHEM BIOPH RES CO, V210, P574, DOI 10.1006/bbrc.1995.1698; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; UKEI K, 2002, P NATL ACAD SCI USA, V99, P419; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	36	34	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5099	5108		10.1074/jbc.M208451200	http://dx.doi.org/10.1074/jbc.M208451200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435753	Green Accepted, hybrid			2022-12-27	WOS:000180968900096
J	Reggiori, F; Wang, CW; Stromhaug, PE; Shintani, T; Klionsky, DJ				Reggiori, F; Wang, CW; Stromhaug, PE; Shintani, T; Klionsky, DJ			Vps51 is part of the yeast Vps fifty-three tethering complex essential for retrograde traffic from the early endosome and Cvt vesicle completion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TARGETING PATHWAY; LATE SECRETORY PATHWAY; SACCHAROMYCES-CEREVISIAE; AMINOPEPTIDASE-I; LATE GOLGI; CARBOXYPEPTIDASE-Y; AUTOPHAGIC PROCESS; SYNTAXIN HOMOLOG; SORTING RECEPTOR; VACUOLAR PROTEIN	Autophagy, pexophagy, and the Cvt pathway are processes that deliver hydrolytic enzymes and substrates to the yeast vacuole/lysosome via double-membrane cytosolic vesicles. Whereas these pathways operate under different nutritional conditions, they all employ common machinery with only a few specific factors assisting in the choice of the delivery program and the membrane source for the sequestering vesicle. We found that the YKR020w gene product is essential for Cvt vesicle formation but not for pexophagy or induction of autophagy. Autophagosomes in the ykr020wDelta mutant, however, have a reduced size. We demonstrate that Ykr020 is a subunit of the Vps fifty-three tethering complex, composed of Vps52, Vps53, and Vps54, which is required for retrograde traffic from the early endosome back to the late Golgi, and for this reason we named it Vps51. This complex participates in a fusion event together with Tlg1 and Tlg2, two SNAREs also shown to be necessary for Cvt vesicle assembly. In particular, those factors are essential to correctly target the prApe1-Cvt19-Cvt9 complex to the preautophagosomal structure, the site of Cvt vesicle formation.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Life Sci Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Reggiori, Fulvio/U-8327-2019; SHINTANI, Takahiro/ABE-1267-2020; Klionsky, Daniel J./ABD-5189-2021; WANG, CHAO-WEN/HIR-2326-2022	Reggiori, Fulvio/0000-0003-2652-2686; Klionsky, Daniel J./0000-0002-7828-8118; WANG, CHAO-WEN/0000-0002-4073-299X; Shintani, Takahiro/0000-0001-6630-5892	NIGMS NIH HHS [GM53396, R01 GM053396] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; ABELIOVICH H, 2003, IN PRESS MOL BIOL CE; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Baba M, 1995, CELL STRUCT FUNCT, V20, P465, DOI 10.1247/csf.20.465; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; BANFIELD DK, 1994, J CELL BIOL, V127, P357, DOI 10.1083/jcb.127.2.357; BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Chiang HL, 1996, J BIOL CHEM, V271, P9934, DOI 10.1074/jbc.271.17.9934; Conboy MJ, 2000, MOL BIOL CELL, V11, P2429, DOI 10.1091/mbc.11.7.2429; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; EVERS ME, 1991, FEMS MICROBIOL LETT, V90, P73, DOI 10.1016/0378-1097(91)90649-U; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Hutchins MU, 1999, J CELL SCI, V112, P4079; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Meiling-Wesse K, 2002, FEBS LETT, V526, P71, DOI 10.1016/S0014-5793(02)03119-8; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 2002, TRENDS CELL BIOL, V12, P231, DOI 10.1016/S0962-8924(02)02278-X; Panek HR, 2000, J CELL SCI, V113, P4545; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Reggiori F, 2000, MOL BIOL CELL, V11, P3737, DOI 10.1091/mbc.11.11.3737; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Scott SV, 2000, J BIOL CHEM, V275, P25840, DOI 10.1074/jbc.M002813200; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Siniossoglou S, 2002, J BIOL CHEM, V277, P48318, DOI 10.1074/jbc.M209428200; Siniossoglou S, 2001, EMBO J, V20, P5991, DOI 10.1093/emboj/20.21.5991; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; TEICHERT U, 1989, J BIOL CHEM, V264, P16037; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wang CW, 2001, J BIOL CHEM, V276, P30442, DOI 10.1074/jbc.M102342200; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Whyte JRC, 2002, J CELL SCI, V115, P2627; Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050	78	83	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5009	5020		10.1074/jbc.M210436200	http://dx.doi.org/10.1074/jbc.M210436200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12446664	Green Accepted, hybrid			2022-12-27	WOS:000180968900086
J	Kosolapov, A; Deutsch, C				Kosolapov, A; Deutsch, C			Folding of the voltage-gated K+ channel T1 recognition domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER POTASSIUM CHANNEL; ENDOPLASMIC-RETICULUM; TETRAMERIZATION DOMAIN; PROTEIN TRANSLOCATION; IN-VITRO; SUBUNIT; KV1.3; BIOGENESIS; MEMBRANE; CELLS	Voltage-gated K+ channels (Kv) are tetramers whose assembly is coordinated in part by a conserved T1 recognition domain. Although T1 achieves its quaternary structure in the ER, nothing is known about its acquisition of tertiary structure. We developed a new folding assay that relies on intramolecular cross-linking of pairs of cysteines engineered at the folded T1 monomer interface. Using this assay, we show directly that the T1 domain is largely folded while the Kv protein is still attached to membrane-bound ribosomes. The ER membrane facilitates both folding and oligomerization of Kv proteins. We show that folding and oligomerization assays can be used to study coupling between these two biogenic events and diagnose defects in assembly of Kv channels.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Deutsch, C (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.				NHLBI NIH HHS [HL-07027] Funding Source: Medline; NIGMS NIH HHS [GM 52302] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052302] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Hebert DN, 1998, BIOCHEM CELL BIOL, V76, P867, DOI 10.1139/bcb-76-5-867; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MARQUARDT T, 1993, J BIOL CHEM, V268, P19618; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Panyi G, 1996, J GEN PHYSIOL, V107, P409, DOI 10.1085/jgp.107.3.409; Prabakaran D, 1996, EUR J CELL BIOL, V70, P134; ROSENBERG RL, 1992, NATURE, V360, P166, DOI 10.1038/360166a0; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; SHEN NV, 1993, NEURON, V11, P67; Tu L, 2000, BIOCHEMISTRY-US, V39, P824, DOI 10.1021/bi991740r; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	31	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4305	4313		10.1074/jbc.M209422200	http://dx.doi.org/10.1074/jbc.M209422200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12431984	hybrid			2022-12-27	WOS:000180869700098
J	Crociani, O; Guasti, L; Balzi, M; Becchetti, A; Wanke, E; Olivotto, M; Wymore, RS; Arcangeli, A				Crociani, O; Guasti, L; Balzi, M; Becchetti, A; Wanke, E; Olivotto, M; Wymore, RS; Arcangeli, A			Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERG K+ CHANNEL; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; TERMINAL DOMAIN; UP-REGULATION; HUMAN HEART; PROLIFERATION; CANCER; SYSTEM; MOUSE	The role of K+ channel activity during cell cycle progression has become a research topic of considerable interest. Blocking of K+ channels inhibits the proliferation of many cell types, although the mechanism of this inhibition is unclear. There is speculation that K+ channels differentially regulate the electrical potential of the plasma membrane (V-m) during proliferation. We have demonstrated that in tumor cells the value of V-m is clamped to rather depolarized values by K+ channels belonging to the HERG family. We report here that tumor cell lines preferentially express the herg1 gene and a truncated, N-deleted form that corresponds to herg1b. This alternative transcript is also expressed in human primary acute myeloid leukemias. Both HERG1 and HERG1B proteins are expressed on the plasma membrane of tumor cells and can form heterotetramers. The expression of HERG protein isoforms is strongly cell cycle-dependent, accounting for variations in HERG currents along the mitotic cycle. Moreover, the blocking of HERG channels dramatically impairs cell growth of HERG-bearing tumor cells. These results suggest that modulated expression of different K+ channels is the molecular basis of a novel mechanism regulating neoplastic cell proliferation.	Univ Florence, Dept Expt Pathol & Oncol, I-50134 Florence, Italy; Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; Univ Florence, Dept Clin Physiopathol, I-50134 Florence, Italy; Univ Milan, Dept Biosci & Biotechnol, I-20126 Milan, Italy	University of Florence; University of Tulsa; University of Florence; University of Milan	Arcangeli, A (corresponding author), Univ Florence, Dept Expt Pathol & Oncol, Viale GB Morgagni 50, I-50134 Florence, Italy.	annarosa.arcangeli@unifi.it	Becchetti, Andrea/AAF-7821-2020	Becchetti, Andrea/0000-0002-9297-0527; Balzi, Manuela/0000-0002-9510-021X; Crociani, Olivia/0000-0003-3485-2132; Guasti, Leonardo/0000-0002-4616-6044; GUASTI, LUIGINA/0000-0002-4524-4864				Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Arcangeli A, 1997, EUR J NEUROSCI, V9, P2596, DOI 10.1111/j.1460-9568.1997.tb01689.x; Arcangeli A, 1995, J PHYSIOL-LONDON, V489, P455, DOI 10.1113/jphysiol.1995.sp021065; Bianchi L, 1998, CANCER RES, V58, P815; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Cherubini A, 2000, BRIT J CANCER, V83, P1722, DOI 10.1054/bjoc.2000.1497; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; COLEMAN CN, 1988, J NATL CANCER I, V80, P310, DOI 10.1093/jnci/80.5.310; Crociani O, 2000, MECH DEVELOP, V95, P239, DOI 10.1016/S0925-4773(00)00335-X; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dixon JE, 1996, EUR J NEUROSCI, V8, P183, DOI 10.1111/j.1460-9568.1996.tb01179.x; Faravelli L, 1996, J PHYSIOL-LONDON, V496, P13, DOI 10.1113/jphysiol.1996.sp021661; Fontana L, 2001, BIOCHEM BIOPH RES CO, V286, P857, DOI 10.1006/bbrc.2001.5464; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Itoh T, 1998, HUM GENET, V102, P435, DOI 10.1007/s004390050717; Kupershmidt S, 1998, J BIOL CHEM, V273, P27231, DOI 10.1074/jbc.273.42.27231; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Macfarlane SN, 2000, GLIA, V30, P39, DOI 10.1002/(SICI)1098-1136(200003)30:1<39::AID-GLIA5>3.0.CO;2-S; MANIATIS T, 1989, MOL CLONING LAB MANU, P194; Mercatante D, 2000, PHARMACOL THERAPEUT, V85, P237, DOI 10.1016/S0163-7258(99)00067-4; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; NILIUS B, 1992, J PHYSIOL-LONDON, V445, P537, DOI 10.1113/jphysiol.1992.sp018938; Occhiodoro T, 1998, FEBS LETT, V434, P177, DOI 10.1016/S0014-5793(98)00973-9; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Pillozzi S, 2002, LEUKEMIA, V16, P1791, DOI 10.1038/sj.leu.2402572; Pond AL, 2000, J BIOL CHEM, V275, P5997, DOI 10.1074/jbc.275.8.5997; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schonherr R, 1999, EUR J NEUROSCI, V11, P753, DOI 10.1046/j.1460-9568.1999.00493.x; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Shi WM, 1997, J NEUROSCI, V17, P9423; Shirihai O, 1996, PFLUG ARCH EUR J PHY, V431, P632, DOI 10.1007/s004240050045; Skryma RN, 1997, PROSTATE, V33, P112, DOI 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Vaur S, 1998, J CELL PHYSIOL, V177, P402, DOI 10.1002/(SICI)1097-4652(199812)177:3<402::AID-JCP4>3.0.CO;2-Z; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; VINDELOV LL, 1990, CYTOMETRY, V11, P753, DOI 10.1002/cyto.990110702; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang SY, 1998, J CELL PHYSIOL, V176, P456, DOI 10.1002/(SICI)1097-4652(199809)176:3<456::AID-JCP2>3.0.CO;2-N; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Xu B, 1996, AM J PHYSIOL-CELL PH, V271, pC2037, DOI 10.1152/ajpcell.1996.271.6.C2037; Yao XQ, 1999, LIFE SCI, V65, P55, DOI 10.1016/S0024-3205(99)00218-0; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	51	166	182	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2947	2955		10.1074/jbc.M210789200	http://dx.doi.org/10.1074/jbc.M210789200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431979	hybrid, Green Published			2022-12-27	WOS:000180915000024
J	Curtain, CC; Ali, FE; Smith, DG; Bush, AI; Masters, CL; Barnham, KJ				Curtain, CC; Ali, FE; Smith, DG; Bush, AI; Masters, CL; Barnham, KJ			Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; PROTEIN; ZINC; PHOSPHOLIPIDS; AGGREGATION; VESICLES; NEUROTOXICITY; PRESENILIN-1; COMPLEXES; CHANNELS	The interaction of Abeta peptides with the lipid matrix of neuronal cell membranes plays an important role in the pathogenesis of Alzheimer's disease. By using EPR and CD spectroscopy, we found that in the presence of Cu2+ or Zn2+, pH, cholesterol, and the length of the peptide chain influenced the interaction of these peptides with lipid bilayers. In the presence of Zn2+, Abeta40 and Abeta42 both inserted into the bilayer over the pH range 5.5-7.5, as did Abeta42 in the presence of Cu2+. However, Abeta40 only penetrated the lipid bilayer in the presence of Cu2+ at pH 5.5-6.5; at higher pH there was a change in the Cu2+ coordination sphere that inhibited membrane insertion. In the absence of the metals, insertion of both peptides only occurred at pH < 5.5. Raising cholesterol to 0.2 mol fraction of the total lipid inhibited insertion of both peptides under all conditions investigated. Membrane insertion was accompanied by the formation of alpha-helical structures. The nature of these structures was the same irrespective of the conditions used, indicating a single low energy structure for Abeta in membranes. Peptides that did not insert into the membrane formed beta-sheet structures on the surface of the lipid.	Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Mental Hlth Res Int Victoria, Parkville, Vic 3052, Australia; Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia; Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Lab Oxidat Biol, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Dept Psychiat, Charlestown, MA 02129 USA	University of Melbourne; Monash University; University of Melbourne; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Barnham, KJ (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.		Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Curtain, Cyril/0000-0001-6955-320X	NIA NIH HHS [2R01AG12686] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG012686] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Boas J.F., 1978, BIOL MAGN RESON, P277; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; CORNELL BA, 1988, BIOPHYS J, V53, P67, DOI 10.1016/S0006-3495(88)83066-2; Curtain C, 1999, EUR BIOPHYS J BIOPHY, V28, P427, DOI 10.1007/s002490050225; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; DAVOUST J, 1982, J MAGN RESON, V48, P475, DOI 10.1016/0022-2364(82)90079-8; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; DURELL SR, 1994, BIOPHYS J, V67, P2137, DOI 10.1016/S0006-3495(94)80717-9; GORDON LM, 1985, J MEMBRANE BIOL, V84, P81, DOI 10.1007/BF01871650; GORDON LM, 1988, ADV MEMBRANE FLUIDIT, V1, P25; HARTMANN H, 1994, BIOCHEM BIOPH RES CO, V200, P1185, DOI 10.1006/bbrc.1994.1576; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; HORVATH LI, 1988, BIOCHEMISTRY-US, V27, P5296, DOI 10.1021/bi00414a052; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; HUBBELL WL, 1971, J AM CHEM SOC, V93, P314; HYDE JS, 1979, SPIN LABELING, V2, P71; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; MARSH D, 1998, BIOCHIM BIOPHYS ACTA, V1376, P767; MARSH D, 1989, BIOL MAGN RESON, V8, P255; Martinez-Senac MD, 1999, EUR J BIOCHEM, V265, P744, DOI 10.1046/j.1432-1327.1999.00775.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCINTYRE JO, 1982, BIOPHYS J, V37, P53, DOI 10.1016/S0006-3495(82)84595-5; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Muller WE, 2001, BIOCHEM SOC T, V29, P617, DOI 10.1042/BST0290617; Muller WE, 1998, AMYLOID, V5, P10, DOI 10.3109/13506129809007284; MULLER WE, 1995, BRAIN RES, V674, P133, DOI 10.1016/0006-8993(94)01463-R; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Suzuki K, 2001, BIOCHEM BIOPH RES CO, V285, P991, DOI 10.1006/bbrc.2001.5263; TERZI E, 1994, BIOCHEMISTRY-US, V33, P1346; TOMBS MP, 1959, BIOCHEM J, V73, P167, DOI 10.1042/bj0730167; WOLFS C J A M, 1989, Biochemistry, V28, P9995, DOI 10.1021/bi00452a018; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; YOEHIIKE Y, 2001, J BIOL CHEM, V276, P32293	44	181	187	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2977	2982		10.1074/jbc.M205455200	http://dx.doi.org/10.1074/jbc.M205455200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12435742	hybrid			2022-12-27	WOS:000180915000028
J	Castro, A; Mandart, E; Lorca, T; Galas, S				Castro, A; Mandart, E; Lorca, T; Galas, S			Involvement of aurora A kinase during meiosis I-II transition in xenopus oocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN INTERMEDIATE CHAIN; SMALL-MOLECULE INHIBITOR; SPINDLE ORIENTATION; DYNACTIN COMPLEX; PHOSPHORYLATION; ACTIN; MICROTUBULES; CENTROSOME; MECHANISMS; MATURATION	The Aurora kinase family has been involved both in vivo and in vitro in the stability of the metaphase plate and chromosome segregation. However, to date only one member of this family, the protein kinase Aurora B, has been implicated in the regulation of meiotic division in Caenorhabditis elegans. In this species, disruption of Aurora B results in the failure of polar body extrusion. To investigate whether Aurora A is also required in meiosis, we microinjected highly specific a-Aurora A antibodies in Xenopus oocytes. We demonstrated that microinjected oocytes fail to extrude the first polar body and are arrested with condensed chromosomes on a typical metaphase I plate, which has not performed its normal 90degrees rotation. We additionally found that, although the failure of first polar body extrusion observed in a-Aurora A-microinjected oocytes is likely mediated by Eg5, the impairment of the metaphase plate rotation does not involve this kinesin-like protein. Surprisingly, although chromosomes remain condensed at a metaphase I stage in a-Aurora A-microinjected oocytes, the cytoplasmic cell cycle events progress normally through meiosis until metaphase II arrest. Moreover, these oocytes are able to undergo parthenogenetic activation. We conclude that Aurora A and Eg5 are involved in meiosis I to meiosis II transition in Xenopus oocytes.	CRBM, UPR 1086 CNRS, F-34293 Montpellier 5, France	Universite de Montpellier	Galas, S (corresponding author), CRBM, UPR 1086 CNRS, 1919 Route Mende, F-34293 Montpellier 5, France.	galas@crbm.cnrs-mop.fr	CASTRO, ANNA/F-4350-2010; Galas, Simon/X-1312-2019	CASTRO, ANNA/0000-0002-3655-1352; Galas, Simon/0000-0002-1717-1266; Lorca, Thierry/0000-0003-2007-8924				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Castro A, 2002, EMBO REP, V3, P457, DOI 10.1093/embo-reports/kvf095; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Fisher N, 2000, SOUTH CULT, V6, P90, DOI 10.1353/scu.2000.0025; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giet R, 1999, J CELL SCI, V112, P3591; Giet R, 2000, EXP CELL RES, V258, P145, DOI 10.1006/excr.2000.4903; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Gonczy P, 1996, TRENDS CELL BIOL, V6, P382, DOI 10.1016/0962-8924(96)10035-0; Huang CYF, 1999, J BIOL CHEM, V274, P14262, DOI 10.1074/jbc.274.20.14262; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MUHUA L, 1994, CELL, V78, P669, DOI 10.1016/0092-8674(94)90531-2; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; OHSUMI K, 1994, J CELL SCI, V107, P3005; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Roghi C, 1998, J CELL SCI, V111, P557; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Thibier C, 1997, DEV BIOL, V185, P55, DOI 10.1006/dbio.1997.8543; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200	30	39	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2236	2241		10.1074/jbc.M207894200	http://dx.doi.org/10.1074/jbc.M207894200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12426316	hybrid			2022-12-27	WOS:000180562000023
J	Ge, BX; Xiong, XS; Jing, Q; Mosley, JL; Filose, A; Bian, DF; Huang, S; Han, JH				Ge, BX; Xiong, XS; Jing, Q; Mosley, JL; Filose, A; Bian, DF; Huang, S; Han, JH			TAB1 beta (transforming growth Factor-beta-activated protein kinase 1-binding protein 1 beta), a novel splicing variant of TAB1 that interacts with p38 alpha but not TAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; I-KAPPA-B; MAP KINASES; CELL-SURFACE; DUAL PHOSPHORYLATION; GENE-EXPRESSION; P38 GROUP; MITOGEN; AUTOPHOSPHORYLATION; TYROSINE	The mitogen-activated protein kinases (MAPKs) play an important role in a variety of biological processes. Activation of MAPKs is mediated by phosphorylation on specific regulatory tyrosine and threonine sites. We have recently found that activation of p38alpha MAPK can be carried out not only by its upstream MAPK kinases (MKKs) but also by p38alpha autophosphorylation. p38alpha autoactivation requires an interaction of p38alpha with TAB1 (transforming growth factor-beta-activated protein kinase 1-binding protein 1). The autoactivation mechanism of p38alpha has been found to be important in cellular responses to a number of physiologically relevant stimuli. Here, we report the characterization of a splicing variant of TAB1, TAB1beta. TAB1 and TAB1beta share the first 10 exons. The 11th and 12th exons of TAB1 were spliced out in TAB1beta, and an extra exon, termed exon beta, downstream of exons 11 and 12 in the genome was used as the last exon in TAB1beta. The mRNA of TAB1beta was expressed in all cell lines examined. The TAB1beta mRNA encodes a protein with an identical sequence to TAB1 except the C-terminal 69 amino acids were replaced with an unrelated 27-amino acid sequence. Similar to TAB1, TAB1beta interacts with p38alpha but not other MAPKs and stimulates p38alpha autoactivation. Different from TAB1, TAB1beta does not bind or activate TAK1. Inhibition of TAB1beta expression with RNA interference in MDA231 breast cancer cells resulted in the reduction of basal activity of p38alpha and invasiveness of MDA231 cells, suggesting that TAB1beta is involved in regulating p38alpha activity in physiological conditions.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Han, J/G-4671-2010		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41637] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CHOA HHJ, 1995, MOL BIOL CELL, V6, P736; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Deak JC, 1997, BIOCHEM J, V322, P185, DOI 10.1042/bj3220185; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Emrick MA, 2001, J BIOL CHEM, V276, P46469, DOI 10.1074/jbc.M107708200; Fanger GR, 1997, CURR OPIN GENET DEV, V7, P67, DOI 10.1016/S0959-437X(97)80111-6; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; GUAN KL, 1994, CELL SIGNAL, V6, P581, DOI 10.1016/0898-6568(94)90041-8; Gutkind J.S, 2000, SCI STKE; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HAN JH, 1993, J BIOL CHEM, V268, P25009; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Huang S, 2000, J BIOL CHEM, V275, P12266, DOI 10.1074/jbc.275.16.12266; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jiang Y, 1997, J BIOL CHEM, V272, P11096; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; ROSSOMANDO AJ, 1992, P NATL ACAD SCI USA, V89, P5779, DOI 10.1073/pnas.89.13.5779; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; Wu XY, 1996, J BIOL CHEM, V271, P3265, DOI 10.1074/jbc.271.6.3265; Zhang BH, 2001, EXP LUNG RES, V27, P269, DOI 10.1080/019021401300054046; Zhao M, 1999, MOL CELL BIOL, V19, P21	60	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2286	2293		10.1074/jbc.M210918200	http://dx.doi.org/10.1074/jbc.M210918200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12429732	hybrid			2022-12-27	WOS:000180562000030
J	De Moliner, E; Moro, S; Sarno, S; Zagotto, G; Zanotti, G; Pinna, LA; Battistutta, R				De Moliner, E; Moro, S; Sarno, S; Zagotto, G; Zanotti, G; Pinna, LA; Battistutta, R			Inhibition of protein kinase CK2 by anthraquinone-related compounds - A structural insight	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-FORCE FIELD; CONFORMATIONAL ENERGIES; II-ALPHA; MMFF94; SITE; ATP; GEOMETRIES; DESIGN; CRYSTALLOGRAPHY; LIBRARIES	Protein kinases play key roles in signal transduction and therefore are among the most attractive targets for drug design. The pharmacological aptitude of protein kinase inhibitors is highlighted by the observation that various diseases with special reference to cancer are because of the abnormal expression/activity of individual kinases. The resolution of the three-dimensional structure of the target kinase in complex with inhibitors is often the starting point for the rational design of this kind of drugs, some of which are already in advanced clinical trial or even in clinical practice. Here we present and discuss three new crystal structures of ATP site-directed inhibitors in complex with "casein kinase-2" (CK2), a constitutively active protein kinase implicated in a variety of cellular functions and misfunctions. With the help of theoretical calculations, we disclose some key features underlying the inhibitory efficiency of anthraquinone derivatives, outlining three different binding modes into the active site. In particular, we show that a nitro group in a hydroxyanthraquinone scaffold decreases the inhibitory constants K-i because of electron-withdrawing and resonance effects that enhance the polarization of hydroxylic substituents in paraposition.	Univ Padua, Dept Organ Chem, I-35131 Padua, Italy; Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy; Univ Padua, Dept Biol Chem, I-35121 Padua, Italy; Venetian Inst Mol Med, I-35131 Padua, Italy	University of Padua; University of Padua; University of Padua; Veneto Institute Molecular Medicine	Battistutta, R (corresponding author), Univ Padua, Dept Organ Chem, Via Marzolo 1, I-35131 Padua, Italy.		Moro, Stefano/A-2979-2012	Moro, Stefano/0000-0002-7514-3802; Zanotti, Giuseppe/0000-0002-0945-6501				*ACC INC, 1986, QUANTA MOL MOD PACK; Advanced Chemistry Development Inc., 2001, ACD PKA DB VERS 6 0; Ali AM, 2000, PHARM BIOL, V38, P298, DOI 10.1076/1388-0209(200009)38:4;1-A;FT298; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Baxter CA, 1998, PROTEINS, V33, P367, DOI 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.3.CO;2-N; Bohacova V, 1998, J CHROMATOGR B, V715, P273, DOI 10.1016/S0378-4347(98)00088-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CHEM COMP GROUP I, 2002, MOL OP ENV MOE 20020; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Davis ST, 2001, SCIENCE, V291, P134, DOI 10.1126/science.291.5501.134; Fabbro D, 2002, CURR OPIN PHARMACOL, V2, P374, DOI 10.1016/S1471-4892(02)00179-0; Garcia-Echeverria C, 2000, MED RES REV, V20, P28, DOI 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.3.CO;2-U; Goel Sanjay, 2002, Curr Oncol Rep, V4, P9, DOI 10.1007/s11912-002-0043-x; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P553, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<553::AID-JCC3>3.0.CO;2-T; Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO;2-Q; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Sarno S, 2002, PHARMACOL THERAPEUT, V93, P159, DOI 10.1016/S0163-7258(02)00185-7; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Stahura FL, 1999, J MOL GRAPH MODEL, V17, P1, DOI 10.1016/S1093-3263(99)00015-7; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Toledo LM, 1999, CURR MED CHEM, V6, P775; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Wang DX, 2001, ELECTROPHORESIS, V22, P464, DOI 10.1002/1522-2683(200102)22:3<464::AID-ELPS464>3.0.CO;2-4; *WAV INC, 2002, WAV FUNC SPART 02	41	65	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1831	1836		10.1074/jbc.M209367200	http://dx.doi.org/10.1074/jbc.M209367200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419810	hybrid			2022-12-27	WOS:000180462200062
J	Hayashi, M; Yamada, H; Uehara, S; Morimoto, R; Muroyama, A; Yatsushiro, S; Takeda, J; Yamamoto, A; Moriyama, Y				Hayashi, M; Yamada, H; Uehara, S; Morimoto, R; Muroyama, A; Yatsushiro, S; Takeda, J; Yamamoto, A; Moriyama, Y			Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in Islets of Langerhans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-AMINOBUTYRIC-ACID; INORGANIC-PHOSPHATE COTRANSPORTER; SYNAPTIC-LIKE MICROVESICLES; PANCREATIC ALPHA-CELLS; BETA-CELLS; INHIBITS EXOCYTOSIS; INSULIN-SECRETION; SYNAPTOTAGMIN-III; AMPA SUBTYPE; RAT PANCREAS	L-Glutamate is believed to function as an intercellular transmitter in the islets of Langerhans. However, critical issues, i.e. where, when and how L-glutamate appears, and what happens upon stimulation of glutamate receptors in the islets, remain unresolved. Vesicular glutamate transporter 2 (VGLUT2), an isoform of the vesicular glutamate transporter essential for neuronal storage of L-glutamate, is expressed in a cells (Hayashi, M., Otsuka, M., Morimoto, R., Hirota, S., Yatsushiro, S., Takeda, J., Yamamoto, A., and Moriyama, Y. (2001) J. Biol. Chem. 276, 43400-43406). Here we show that VGLUT2 is specifically localized in glucagon-containing secretory granules but not in synaptic-like microvesicles in alphaTC6 cells, clonal a cells, and islet a cells. VGLUT1, another VGLUT isoform, is also expressed and localized in secretory granules in a cells. Low glucose conditions triggered co-secretion of stoichiometric amounts of L-glutamate and glucagon from aTC6 cells and isolated islets, which is dependent on temperature and Ca2+ and inhibited by phentolamine. Similar co-secretion of L-glutamate and glucagon from islets was observed upon stimulation of beta-adrenergic receptors with isoproterenol. Under low glucose conditions, stimulation of glutamate receptors facilitates secretion of gamma-aminobutyric acid from MIN6 m9, clonal beta cells, and isolated islets. These results indicate that co-secretion of L-glutamate and glucagon from a cells under low glucose conditions triggers GABA secretion from 13 cells and defines the mode of action of L-glutamate as a regulatory molecule for the endocrine function. To our knowledge, this is the first example of secretory granule-mediated glutamatergic signal transmission.	Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Okayama 7008530, Japan; Gunma Univ, Inst Mol & Cellular Regulat, Dept Cell Biol, Maebashi, Gumma 3718512, Japan; Kansai Med Univ, Dept Physiol, Moriguchi, Osaka 5708506, Japan	Okayama University; Gunma University; Kansai Medical University	Moriyama, Y (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Biochem, Okayama 7008530, Japan.		Yamada, Hiroshi/AGZ-4497-2022; YAMADA, Hiroshi/B-2251-2011	Yamada, Hiroshi/0000-0002-9328-3446; YAMADA, Hiroshi/0000-0002-9328-3446				AHNERHILGER G, 1987, FEBS LETT, V314, P41; AhnertHilger G, 1996, GASTROENTEROLOGY, V110, P1595, DOI 10.1053/gast.1996.v110.pm8613067; Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Bai LQ, 2001, J BIOL CHEM, V276, P36764, DOI 10.1074/jbc.M104578200; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; BERTRAND G, 1992, BRIT J PHARMACOL, V106, P354, DOI 10.1111/j.1476-5381.1992.tb14340.x; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; Easom RA, 2000, SEMIN CELL DEV BIOL, V11, P253, DOI 10.1006/scdb.2000.0174; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; FUKUI Y, 1992, J HISTOCHEM CYTOCHEM, V40, P73, DOI 10.1177/40.1.1729355; Gaskins HR, 1995, J BIOL CHEM, V270, P30286, DOI 10.1074/jbc.270.51.30286; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; GONOI T, 1994, J BIOL CHEM, V269, P16989; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Gromada J, 2001, J PHYSIOL-LONDON, V535, P519, DOI 10.1111/j.1469-7793.2001.00519.x; Gut A, 2001, J CELL SCI, V114, P1709; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; Hayashi M, 2001, J BIOL CHEM, V276, P43400, DOI 10.1074/jbc.M106244200; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hoy M, 2001, J BIOL CHEM, V276, P924, DOI 10.1074/jbc.M007562200; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Mizuta M, 1997, DIABETES, V46, P2002, DOI 10.2337/diabetes.46.12.2002; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; Moriyama Y, 2000, J EXP BIOL, V203, P117; Nakatsuka S, 2001, J BIOL CHEM, V276, P26589, DOI 10.1074/jbc.M011754200; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Okada Y., 1986, GABAERGIC MECHANISMS, P223; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; ROBBINS MS, 1981, DIABETES, V30, P168, DOI 10.2337/diabetes.30.2.168; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SCHUIT FC, 1986, SCIENCE, V232, P875, DOI 10.1126/science.2871625; Smismans A, 1997, DIABETOLOGIA, V40, P1411, DOI 10.1007/s001250050843; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; THOMASREETZ A, 1993, P NATL ACAD SCI USA, V90, P5317, DOI 10.1073/pnas.90.11.5317; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Weaver CD, 1998, J BIOL CHEM, V273, P1647, DOI 10.1074/jbc.273.3.1647; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Winnock F, 2002, AM J PHYSIOL-ENDOC M, V282, pE937, DOI 10.1152/ajpendo.00071.2001; Yamada H, 2001, DIABETES, V50, P1012, DOI 10.2337/diabetes.50.5.1012	47	107	112	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1966	1974		10.1074/jbc.M206758200	http://dx.doi.org/10.1074/jbc.M206758200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12414805	hybrid			2022-12-27	WOS:000180462200080
J	Newport, G; Kuo, A; Flattery, A; Gill, C; Blake, JJ; Kurtz, MB; Abruzzo, GK; Agabian, N				Newport, G; Kuo, A; Flattery, A; Gill, C; Blake, JJ; Kurtz, MB; Abruzzo, GK; Agabian, N			Inactivation of Kex2p diminishes the virulence of Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST YARROWIA-LIPOLYTICA; SACCHAROMYCES-CEREVISIAE; HYPHAL FORMATION; IN-VIVO; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCE; MAJOR EXOGLUCANASE; MURINE MACROPHAGES; FILAMENTOUS GROWTH; SECRETORY PROTEINS	Deletion of the kexin gene (KEX2) in Candida albicans has a pleiotropic effect on phenotype and virulence due partly to a defect in the expression of two major virulence factors: the secretion of active aspartyl proteinases and the formation of hyphae. kex2/kex2 mutants are highly attenuated in a mouse systemic infection model and persist within cultured macrophages for at least 24 h without causing damage. Pathology is modest, with little disruption of kidney matrix. The infecting mutant cells are largely confined to glomeruli, and are aberrant in morphology. The complex phenotype of the deletion mutants reflects a role for kexin in a wide range of cellular processes. Taking advantage of the specificity of Kex2p cleavage, an algorithm we developed to scan the 9168 open reading frames in Assembly 6 of the C. albicans genome identified 147 potential substrates of Kex2p. These include all previously identified substrates, including eight secreted aspartyl proteinases, the exoglucanase Xog1p, the immunodominant antigen Mp65, and the adhesin Hwp1p. Other putative Kex2p substrates identified include several adhesins, cell wall proteins, and hydrolases previously not implicated in pathogenesis. Kexins also process fungal mating pheromones; a modification of the algorithm identified a putative mating pheromone with structural similarities to Saccharomyces cerevisiae alpha-factor.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94243 USA; Merck Res Labs, Rahway, NJ 07065 USA	University of California System; University of California San Francisco; Merck & Company	Agabian, N (corresponding author), Univ Calif San Francisco, Dept Stomatol, 521 Parnassus Ave,Box 0422, San Francisco, CA 94243 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE007946, R01DE012940] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33317] Funding Source: Medline; NIDCR NIH HHS [R01DE12940, P01 DE07946-15S2, P01 DE07946] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABRUZZO GK, 1995, ANTIMICROB AGENTS CH, V39, P1077, DOI 10.1128/AAC.39.5.1077; Ashman RB, 1997, FEMS IMMUNOL MED MIC, V19, P183, DOI 10.1111/j.1574-695X.1997.tb01087.x; Bader O, 2001, MOL MICROBIOL, V41, P1431, DOI 10.1046/j.1365-2958.2001.02614.x; Basco RD, 1996, BBA-MOL CELL RES, V1310, P110, DOI 10.1016/0167-4889(95)00156-5; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Borg-von Zepelin M, 1998, MOL MICROBIOL, V28, P543, DOI 10.1046/j.1365-2958.1998.00815.x; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; DANLEY DL, 1986, INFECT IMMUN, V51, P307, DOI 10.1128/IAI.51.1.307-313.1986; DAVEY J, 1994, EMBO J, V13, P5910, DOI 10.1002/j.1460-2075.1994.tb06936.x; ENDERLIN CS, 1994, YEAST, V10, P67, DOI 10.1002/yea.320100107; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; Ghosh S, 2001, MOL CELL BIOCHEM, V223, P47, DOI 10.1023/A:1017996609928; Goller SP, 1998, APPL ENVIRON MICROB, V64, P3202; Gonzalez MD, 1997, MICROBIOL-UK, V143, P3023, DOI 10.1099/00221287-143-9-3023; Gonzalez-Zorn B, 1999, MOL MICROBIOL, V33, P510, DOI 10.1046/j.1365-2958.1999.01486.x; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Heidenreich S, 1996, J LEUKOCYTE BIOL, V60, P737, DOI 10.1002/jlb.60.6.737; Hube B, 2001, MICROBIOL-SGM, V147, P1997, DOI 10.1099/00221287-147-8-1997; Hull CM, 2000, SCIENCE, V289, P307, DOI 10.1126/science.289.5477.307; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Iguchi K, 1997, MICROBIOL-SGM, V143, P1657, DOI 10.1099/00221287-143-5-1657; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; KNUDSEN LF, 1947, J AM STAT ASSOC, V42, P282, DOI 10.2307/2280657; Kobayashi SD, 1998, TRENDS MICROBIOL, V6, P92, DOI 10.1016/S0966-842X(98)01218-9; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P10752, DOI 10.1073/pnas.92.23.10752; La Valle R, 2000, INFECT IMMUN, V68, P6777, DOI 10.1128/IAI.68.12.6777-6784.2000; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; LARRIBA G, 1995, FEMS MICROBIOL LETT, V125, P121; LEHRER RI, 1971, CANCER, V27, P1211, DOI 10.1002/1097-0142(197105)27:5&lt;1211::AID-CNCR2820270528&gt;3.0.CO;2-3; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Magee BB, 2000, SCIENCE, V289, P310, DOI 10.1126/science.289.5477.310; Marshall MJ, 2000, J NAT TOXINS, V9, P125; MARTIN C, 1989, MOL CELL BIOL, V9, P2341, DOI 10.1128/MCB.9.6.2341; Miller MG, 2002, CELL, V110, P293, DOI 10.1016/S0092-8674(02)00837-1; MIZUNO K, 1988, BIOCHEM BIOPH RES CO, V156, P246, DOI 10.1016/S0006-291X(88)80832-5; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Newport G, 1997, J BIOL CHEM, V272, P28954, DOI 10.1074/jbc.272.46.28954; Odds FC, 2000, MICROBIOL-SGM, V146, P1881, DOI 10.1099/00221287-146-8-1881; ODDS FC, 1988, CANDIDA CANDIDOSIS, P42; Oluwatosin YE, 1998, MOL CELL BIOL, V18, P1534, DOI 10.1128/MCB.18.3.1534; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Pignede G, 2000, J BACTERIOL, V182, P2802, DOI 10.1128/JB.182.10.2802-2810.2000; PROJAN SJ, 1989, NUCLEIC ACIDS RES, V17, P3305, DOI 10.1093/nar/17.8.3305; REICHART PA, 1995, J ORAL PATHOL MED, V24, P276, DOI 10.1111/j.1600-0714.1995.tb01182.x; Richard M, 2001, J BACTERIOL, V183, P3098, DOI 10.1128/JB.183.10.3098-3107.2001; Riggle FJ, 1999, INFECT IMMUN, V67, P3649, DOI 10.1128/IAI.67.7.3649-3652.1999; Rockwell NC, 1998, BIOCHEMISTRY-US, V37, P3386, DOI 10.1021/bi972534r; ROGERS DT, 1979, BIOCHEM BIOPH RES CO, V90, P187, DOI 10.1016/0006-291X(79)91607-3; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Schroppel K, 2001, INT J MED MICROBIOL, V290, P659, DOI 10.1016/S1438-4221(01)80003-5; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SINGH A, 1983, NUCLEIC ACIDS RES, V11, P4049, DOI 10.1093/nar/11.12.4049; Suzuki Y, 2000, BIOTECHNOL APPL BIOC, V32, P53, DOI 10.1042/BA20000012; Togni G, 1996, MICROBIOL-SGM, V142, P493, DOI 10.1099/13500872-142-3-493; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Tsuchimori N, 2000, INFECT IMMUN, V68, P1997, DOI 10.1128/IAI.68.4.1997-2002.2000; Tzung KW, 2001, P NATL ACAD SCI USA, V98, P3249, DOI 10.1073/pnas.061628798; Watts HJ, 1998, FEMS MICROBIOL LETT, V159, P129, DOI 10.1111/j.1574-6968.1998.tb12851.x; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Wosten HAB, 1996, EMBO J, V15, P4274, DOI 10.1002/j.1460-2075.1996.tb00802.x; Zink S, 1996, INFECT IMMUN, V64, P5085, DOI 10.1128/IAI.64.12.5085-5091.1996	69	64	89	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1713	1720		10.1074/jbc.M209713200	http://dx.doi.org/10.1074/jbc.M209713200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419804	hybrid			2022-12-27	WOS:000180462200047
J	Piotrowski, M; Janowitz, T; Kneifel, H				Piotrowski, M; Janowitz, T; Kneifel, H			Plant C-N hydrolases and the identification of a plant N-carbamoylputrescine amidohydrolase involved in polyamine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; ARGININE DECARBOXYLASE; BETA-UREIDOPROPIONASE; OSMOTIC-STRESS; LIVER	A nitrilase-like protein from Arabidopsis thaliana (NLP1) was expressed in Escherichia coli as a His(6)-tagged protein and purified to apparent homogeneity by Ni(2+)-chelate affinity chromatography. The purified enzyme showed N-carbamoylputrescine amidohydrolase activity, an enzyme involved in the biosynthesis of polyamines in plants and bacteria. N-carbamoylputrescine amidohydrolase activity was confirmed by identification of two of the three occurring products, namely putrescine and ammonia. In contrast, no enzymatic activity could be detected when applying various compounds including nitriles, amines, and amides as well as other N-carbamoyl compounds, indicating the specificity of the enzyme for N-carbamoylputrescine. Like the homologous beta-alanine synthases, NLP1 showed positive cooperativity toward its substrate. The native enzyme had a molecular mass of 279 kDa as shown by blue-native polyacrylamide gel electrophoresis, indicating a complex of eight monomers. Expression of the NLP1 gene was found in all organs investigated, but it was not induced upon osmotic stress, which is known to induce biosynthesis of putrescine. This is the first report of cloning and expression of a plant N-carbamoylputrescine amidohydrolase and the first time that N-carbamoylputrescine amidohydrolase activity of a recombinant protein could be shown in vitro. NLP1 is one of the two missing links in the arginine decarboxylase pathway of putrescine biosynthesis in higher plants.	Ruhr Univ Bochum, Dept Plant Physiol, D-44801 Bochum, Germany; Forschungszentrum Julich, Inst Chem & Dynam Geosphere, D-52425 Julich, Germany	Ruhr University Bochum; Helmholtz Association; Research Center Julich	Piotrowski, M (corresponding author), Ruhr Univ Bochum, Dept Plant Physiol, Univ Str 150, D-44801 Bochum, Germany.	Markus.Piotrowski@ruhr-uni-bochum.de	Piotrowski, Markus/F-5419-2010	Piotrowski, Markus/0000-0002-6347-3337				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bagni N, 2001, AMINO ACIDS, V20, P301, DOI 10.1007/s007260170046; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Brenner C, 2002, CURR OPIN STRUC BIOL, V12, P775, DOI 10.1016/S0959-440X(02)00387-1; Feirer RP, 1998, J PLANT PHYSIOL, V153, P733, DOI 10.1016/S0176-1617(98)80228-9; Hanfrey C, 2001, PLANT J, V27, P551, DOI 10.1046/j.1365-313X.2001.01100.x; Kumar A, 1997, TRENDS PLANT SCI, V2, P124, DOI 10.1016/S1360-1385(97)01013-3; Nakada Y, 2001, J BACTERIOL, V183, P6517, DOI 10.1128/JB.183.22.6517-6524.2001; NAKAI T, 2000, STRUCTURE FOLD DES, V15, P729; PACE HC, 2001, GENOME BIOL, V12, P775; Piotrowski M, 2001, J BIOL CHEM, V276, P2616, DOI 10.1074/jbc.M007890200; Sakamoto T, 2001, J NUTR SCI VITAMINOL, V47, P132; Sambrook J., 2002, MOL CLONING LAB MANU; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SMITH TA, 1964, PHYTOCHEMISTRY, V3, P23, DOI 10.1016/S0031-9422(00)83990-4; Soyka S, 1999, FEBS LETT, V458, P219, DOI 10.1016/S0014-5793(99)01125-4; TAMAKI N, 1987, EUR J BIOCHEM, V169, P21, DOI 10.1111/j.1432-1033.1987.tb13575.x; Vorwerk S, 2001, PLANTA, V212, P508, DOI 10.1007/s004250000420; Walsh TA, 2001, PLANT PHYSIOL, V125, P1001, DOI 10.1104/pp.125.2.1001; Watson MB, 1998, PLANT J, V13, P231, DOI 10.1046/j.1365-313X.1998.00027.x	20	65	72	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1708	1712		10.1074/jbc.M205699200	http://dx.doi.org/10.1074/jbc.M205699200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12435743	Green Published, hybrid			2022-12-27	WOS:000180462200046
J	Sanz, MA; Madan, V; Carrasco, L; Nieva, JL				Sanz, MA; Madan, V; Carrasco, L; Nieva, JL			Interfacial domains in Sindbis virus 6K protein - Detection and functional characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEMLIKI-FOREST-VIRUS; ESCHERICHIA-COLI-CELLS; MODIFIES MEMBRANE-PERMEABILITY; SITE-DIRECTED MUTATIONS; VIRAL FUSION; GLYCOPROTEIN; EXPRESSION; GENE; ALPHAVIRUSES; MUTAGENESIS	Alphavirus 6K is a short, constitutive membrane protein involved in virus glycoprotein processing, membrane permeabilization, and the budding of virus particles. The amino-terminal region that immediately precedes the transmembrane anchor contains a conserved sequence motif consisting of two interfacial domains separated by Asn and Gln residues. The presence of this motif confers on the 6K pretransmembrane region the tendency to partition into the membrane interface. To study the functional importance of the interfacial sequences, three different Sindbis virus 6K variants were obtained with the following modifications: 9YLW11xAAA, 18FWV20xAAA, and 9YLW11xAAA/18FWV20xAAA. Reconstituted mutant viruses were infectious and showed no defects in glycoprotein processing, although virus budding was hampered. Single 6K expression in Escherichia coli cells showed interfacial mutants to have a diminished capacity to modify membrane permeability and to have lower toxicity. In particular, the 9YLW11xAAA/18FWV20xAAA variant was expressed at high levels and did not enhance membrane permeability significantly, although it retained its integral membrane protein condition. Parallel analyses of membrane permeabilization in baby hamster kidney cells were carried out using a Sindbis virus replicon that synthesized both capsid protein and 6K. Transfection of the construct with wild-type 6K strongly increased permeability to the antibiotic hygromycin B. Replicons encoding 6K interfacial mutants induced lower membrane permeabilization. Again, the greatest impairment was observed for the 9YLW11xAAA/18FWV20xAAA variant, permeabilization activity of which was similar to 10% that of wild-type 6K. These findings show the importance of the interfacial 6K sequence for virus budding and modification of membrane permeability.	Univ Autonoma Madrid Canto Blanco, Fac Ciencias, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid 28049, Spain; Univ Basque Country, Dept Bioquim, Unidad Biofis CSIC UPV EHU, Bilbao 48080, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Sanz, MA (corresponding author), Univ Autonoma Madrid Canto Blanco, Fac Ciencias, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid 28049, Spain.	masanz@cbm.uam.es	Nieva, Jose L/Q-2063-2019; sanz-gomez, miguel/Y-6244-2019; Carrasco, Luis/E-2435-2012; Sanz, Miguel A/H-1914-2015; Carrasco, Luis/H-3001-2017	Nieva, Jose L/0000-0001-6446-5649; sanz-gomez, miguel/0000-0002-5761-9010; Sanz, Miguel A/0000-0001-6573-883X; Carrasco, Luis/0000-0003-3833-8835				ARROYO J, 1995, J VIROL, V69, P4095, DOI 10.1128/JVI.69.7.4095-4102.1995; Bodelon G, 2002, J BIOL CHEM, V277, P17789, DOI 10.1074/jbc.M202018200; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; CARRASCO L, 1995, ADV VIRUS RES, V45, P61, DOI 10.1016/S0065-3527(08)60058-5; Ciccaglione AR, 2001, J GEN VIROL, V82, P2243, DOI 10.1099/0022-1317-82-9-2243; Deber CM, 1996, NAT STRUCT BIOL, V3, P815, DOI 10.1038/nsb1096-815; GAEDIGKNITSCHKO K, 1990, VIROLOGY, V175, P282, DOI 10.1016/0042-6822(90)90210-I; GAEDIGKNITSCHKO K, 1991, VIROLOGY, V183, P206, DOI 10.1016/0042-6822(91)90133-V; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; Gonzalez ME, 1998, BIOCHEMISTRY-US, V37, P13710, DOI 10.1021/bi981527f; GUINEA R, 1994, FEBS LETT, V343, P242, DOI 10.1016/0014-5793(94)80564-4; Ivanova L, 1995, VIRUS RES, V39, P165, DOI 10.1016/0168-1702(95)00083-6; IVANOVA L, 1995, VIROLOGY, V206, P1027, DOI 10.1006/viro.1995.1025; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lama J, 1996, J GEN VIROL, V77, P2109, DOI 10.1099/0022-1317-77-9-2109; LAMA J, 1992, J BIOL CHEM, V267, P15932; LILJESTROM P, 1991, J VIROL, V65, P4107; LILJESTROM P, 1991, J VIROL, V65, P147; LOEWY A, 1995, J VIROL, V69, P469, DOI 10.1128/JVI.69.1.469-475.1995; LUSA S, 1991, VIROLOGY, V185, P843, DOI 10.1016/0042-6822(91)90556-Q; Perez M, 1997, VIROLOGY, V235, P342, DOI 10.1006/viro.1997.8696; ROST B, 1995, PROTEIN SCI, V4, P521; Sambrook J., 2002, MOL CLONING LAB MANU; SANZ MA, 1994, J BIOL CHEM, V269, P12106; Sanz MA, 2001, J VIROL, V75, P7778, DOI 10.1128/JVI.75.16.7778-7784.2001; SCHLESINGER MJ, 1993, VIROLOGY, V193, P424, DOI 10.1006/viro.1993.1139; Schlesinger S., 1996, FIELDS VIROLOGY, P825; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Suarez T, 2000, FEBS LETT, V477, P145, DOI 10.1016/S0014-5793(00)01785-3; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yao JS, 1996, J VIROL, V70, P7910, DOI 10.1128/JVI.70.11.7910-7920.1996	37	47	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2051	2057		10.1074/jbc.M206611200	http://dx.doi.org/10.1074/jbc.M206611200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424249	hybrid			2022-12-27	WOS:000180462200091
J	Cho, JH; Johnson, GVW				Cho, JH; Johnson, GVW			Glycogen synthase kinase 3 beta phosphorylates tau at both primed and unprimed sites - Differential impact on microtubule binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; DISEASE-LIKE PHOSPHORYLATION; INTACT MAMMALIAN-CELLS; PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; TRANSGENIC MICE; BETA-CATENIN; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; LIVING CELLS	Glycogen synthase kinase 3beta (GSK3beta) phosphorylates substrates, including the microtubule-associated protein tau, at both primed and unprimed epitopes. GSK3beta phosphorylation of tau negatively regulates tau-microtubule interactions; however the differential effects of phosphorylation at primed and unprimed epitopes on tau is unknown. To examine the phosphorylation of tau at primed and unprimed epitopes and how this impacts tau function, the R96A mutant of GSK3beta was used, a mutation that prevents phosphorylation of substrates at primed sites. Both GSK3beta and GSK3beta-R96A phosphorylated tau efficiently in situ. However, expression of GSK3beta-R96A resulted in significantly less phosphorylation of tau at primed sites compared with GSK3beta. Conversely, GSK3beta-R96A phosphorylated unprimed tau sites to a significantly greater extent than GSK3beta. Pre-phosphorylating tau with cdk5/p25 impaired the ability of GSK3beta-1196A to phosphorylate tau, whereas GSK3beta-R96A phosphorylated recombinant tau to a significantly greater extent than GSK3beta. Moreover, the amount of tau associated with microtubules was reduced by overexpression of GSK3beta but only when tau was phosphorylated at primed sites, as phosphorylation of tau by GSK3beta-R96A did not negatively regulate the association of tau with microtubules. These results demonstrate that GSK3beta-mediated phosphorylation of tau at primed sites plays a more significant role in regulating the interaction of tau with microtubules than phosphorylation at unprimed epitopes.	Univ Alabama, Sch Med, Dept Psychiat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Johnson, GVW (corresponding author), Univ Alabama, Sch Med, Dept Psychiat, 1720 7th Ave S,SC1061, Birmingham, AL 35294 USA.		Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	NINDS NIH HHS [NS35060] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035060] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; BRANDT R, 1994, J BIOL CHEM, V269, P11776; Brownlees J, 1997, NEUROREPORT, V8, P3251, DOI 10.1097/00001756-199710200-00013; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Davis PK, 1999, J BIOL CHEM, V274, P35686, DOI 10.1074/jbc.274.50.35686; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hong M, 1997, J BIOL CHEM, V272, P19547, DOI 10.1074/jbc.272.31.19547; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Imahori K, 1997, J BIOCHEM, V121, P179; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; JAMESON L, 1980, BIOCHEMISTRY-US, V19, P2472, DOI 10.1021/bi00552a027; Johnson GVW, 1997, J NEUROCHEM, V68, P430; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Lee G, 1998, J CELL SCI, V111, P3167; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sang HC, 2001, NEUROSCI LETT, V312, P141, DOI 10.1016/S0304-3940(01)02206-6; Sengupta A, 1997, MOL CELL BIOCHEM, V167, P99, DOI 10.1023/A:1006883924775; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Trinczek B, 1999, J CELL SCI, V112, P2355; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Wagner U, 1996, J CELL SCI, V109, P1537; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zhang JW, 2002, PROTEINS, V48, P447, DOI 10.1002/prot.10173	62	195	206	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					187	193		10.1074/jbc.M206236200	http://dx.doi.org/10.1074/jbc.M206236200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409305	hybrid, Green Submitted			2022-12-27	WOS:000180255700025
J	Singh, B; Schwartz, NB				Singh, B; Schwartz, NB			Identification and functional characterization of the novel BM-motif in the murine phosphoadenosine phosphosulfate (PAPS) synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE 5'-PHOSPHOSULFATE KINASE; SITE-DIRECTED MUTAGENESIS; SULFATE-ACTIVATING ENZYMES; PENICILLIUM-CHRYSOGENUM; CRYSTAL-STRUCTURE; ATP SULFURYLASE; P-LOOP	PAPS synthetase (SK) catalyzes the two sequential reactions of phosphoadenosine phosphosulfate (PAPS) synthesis. A functional motif in the kinase domain of mouse SK, designated the BM-motif ((86)LDGDNhRxhh(N/S)(K/R)(97)), was defined in the course of identifying the brachymorphic (bm) defect. Sequence comparison and the secondary structure predicted for APS kinase suggest that the BM-motif consists of a DGD-turn sequence flanked by other conserved residues. Mutational analysis of the DGD-turn revealed that a flexible and neutral amino acid is preferred at residue 88, that negatively charged residues are strictly required at positions 87 and 89, and that the active site is rigid. The reduction in kinase activity for all DGD-turn mutants, except G88A, was much less severe than the reduction in overall activity, indicating that the BM-motif may also be playing a role in adenosine phosphosulfate (APS) channeling. Two switch mutations, LD86DL and DN89ND, designed to test the positional constraints of Asp 17 and Asp(89), exhibited complete loss of both kinase and overall activities, while LD86DL also exhibited a significant (60%) loss of reverse sulfurylase activity, suggesting that this peptide region is interacting with the sulfurylase domain as well as functioning in the kinase reaction. Other residues targeted for mutational analysis were the highly conserved flanking Asn(90), Arg(92), and Lys(97). N90A resulted in a partial (30%) loss in kinase and overall activities, R92A exhibited total loss of kinase and overall activities, and K97A had no effect on any of the three activities. The complexity of the bifunctional SK in catalyzing the kinase reaction and channeling APS is illustrated by the strict requirements of this novel structural motif in the kinase active site.	Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Chem Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Schwartz, NB (corresponding author), Univ Chicago, Dept Pediat, 5841 S Maryland Ave,MC 5058, Chicago, IL 60637 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD017332] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-17332] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Deyrup AT, 1999, J BIOL CHEM, V274, P28929, DOI 10.1074/jbc.274.41.28929; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; DEYRUP AT, 1997, PATHOLOGY; Hasemann CA, 1996, STRUCTURE, V4, P1017, DOI 10.1016/S0969-2126(96)00109-8; Kurima K, 1998, P NATL ACAD SCI USA, V95, P8681, DOI 10.1073/pnas.95.15.8681; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; LYLE S, 1994, BIOCHEMISTRY-US, V33, P6822, DOI 10.1021/bi00188a010; LYLE S, 1995, BIOCHEMISTRY-US, V34, P940, DOI 10.1021/bi00003a028; MacRae IJ, 1998, J BIOL CHEM, V273, P28583, DOI 10.1074/jbc.273.44.28583; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Rusiniak ME, 1996, MAMM GENOME, V7, P98, DOI 10.1007/s003359900027; Schwartz NB, 1998, CHEM-BIOL INTERACT, V109, P143, DOI 10.1016/S0009-2797(97)00129-4; SCHWARTZ NB, 1983, LIMB DEV REGENERATIO, VB, P97; STEHLE T, 1992, J MOL BIOL, V224, P1127, DOI 10.1016/0022-2836(92)90474-X; Sugahara K.., 1982, P 6 INT S GLYC, P493	16	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					71	75		10.1074/jbc.M206688200	http://dx.doi.org/10.1074/jbc.M206688200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414806	hybrid			2022-12-27	WOS:000180255700009
J	Teruel, T; Hernandez, R; Benito, M; Lorenzo, M				Teruel, T; Hernandez, R; Benito, M; Lorenzo, M			Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; SKELETAL-MUSCLE; RECEPTOR-GAMMA; PPAR-GAMMA; COACTIVATOR PGC-1; ENERGY-EXPENDITURE; MAP KINASE; IGF-I; ALPHA; DIFFERENTIATION	Brown adipose tissue expresses the thermogenic uncoupling protein-1 (UCP-1), which is positively regulated by peroxisome proliferator-activated receptor (PPAR) agonists and retinoids through the activation of the heterodimers PPAR/retinoid X receptor (RXR) and retinoic acid receptor (RAR)/RXR and binding to specific elements in the ucp-1 enhancer. In this study we show that in fetal rat brown adipocyte primary cultures the PPARgamma agonist rosiglitazone (Rosi), as well as retinoic acids 9-cis-retinoic acid and all-trans-retinoic acid also have "extragenic" effects and induce p44/p42 and p38 mitogen-activated protein kinase (p38MAPK) activation. The latter is involved in UCP-1 gene expression, because inhibition of p38MAPK activity with PD169316 impairs the ability of Rosi and retinoids for UCP-1 induction. The inhibitory effects of PD169316 are mimicked by the antioxidant GSH, suggesting a role for reactive oxygenated species (ROS) generation in the increase of UCP-1 expression in response either to Rosi or 9-cis-retinoic acid. Thus, we propose that Rosi and retinoids act as PPAR/RXR and RAR/RXR agonists and also activate p38MAPK. These two coordinated actions could result in a high increase of transcriptional activity on the ucp-1 enhancer and hence on thermogenesis. PPARalpha and gamma agonists but not retinoids also increase UCP-3 expression in fetal brown adipocytes. However, the regulation of UCP-3, which is not involved in thermogenesis, seems to differ from UCP-1 given the fact that is not affected by p38MAPK inhibition.	Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain	Complutense University of Madrid	Lorenzo, M (corresponding author), Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain.		Benito, Manuel/J-5637-2014	Benito, Manuel/0000-0002-7218-406X				Acin A, 1999, BIOCHEM BIOPH RES CO, V258, P278, DOI 10.1006/bbrc.1999.0530; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; AMY CM, 1989, P NATL ACAD SCI USA, V86, P3114, DOI 10.1073/pnas.86.9.3114; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; BOUILLAUD F, 1985, P NATL ACAD SCI USA, V82, P445, DOI 10.1073/pnas.82.2.445; Brun S, 1999, DIABETES, V48, P1217, DOI 10.2337/diabetes.48.6.1217; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; CASSARDDOULCIER AM, 1993, MOL ENDOCRINOL, V7, P497, DOI 10.1210/me.7.4.497; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Conejo R, 2002, ONCOGENE, V21, P3739, DOI 10.1038/sj.onc.1205469; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Lennon AM, 2002, J BIOL CHEM, V277, P29681, DOI 10.1074/jbc.M201517200; LORENZO M, 1993, J CELL BIOL, V123, P1567, DOI 10.1083/jcb.123.6.1567; Lorenzo M, 1996, CELL GROWTH DIFFER, V7, P1251; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Oberkofler H, 2002, J BIOL CHEM, V277, P16750, DOI 10.1074/jbc.M200475200; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Pedraza N, 2000, DIABETES, V49, P1224, DOI 10.2337/diabetes.49.7.1224; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; Silva JE, 1997, EUR J ENDOCRINOL, V136, P251, DOI 10.1530/eje.0.1360251; Takeda K, 2001, J BIOL CHEM, V276, P48950, DOI 10.1074/jbc.M108722200; Teruel T, 1998, J CELL PHYSIOL, V176, P99, DOI 10.1002/(SICI)1097-4652(199807)176:1<99::AID-JCP12>3.3.CO;2-6; Teruel T, 1999, BIOCHEM BIOPH RES CO, V264, P311, DOI 10.1006/bbrc.1999.1526; Teruel T, 2000, BIOCHEM BIOPH RES CO, V273, P560, DOI 10.1006/bbrc.2000.2982; TERUEL T, 1995, BIOCHEM J, V310, P771, DOI 10.1042/bj3100771; Tu N, 2000, LIFE SCI, V67, P2267, DOI 10.1016/S0024-3205(00)00802-X; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wilmer WA, 2001, BIOCHEM BIOPH RES CO, V281, P57, DOI 10.1006/bbrc.2001.4301; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	40	84	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					263	269		10.1074/jbc.M207200200	http://dx.doi.org/10.1074/jbc.M207200200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414803	hybrid			2022-12-27	WOS:000180255700035
J	Holtz, KM; Rockwell, S; Tomasz, M; Sartorelli, AC				Holtz, KM; Rockwell, S; Tomasz, M; Sartorelli, AC			Nuclear overexpression of NADH : cytochrome b(5) reductase activity increases the cytotoxicity of mitomycin C (MC) and the total number of MC-DNA adducts in Chinese hamster ovary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DT-DIAPHORASE ACTIVITY; NITRIC-OXIDE SYNTHASE; CROSS-LINK ADDUCT; P-450 REDUCTASE; CANCER-CELLS; EMT6 CELLS; ACTIVATION; CARCINOMA; ADJUNCT; METABOLISM	NADH:cytochrome b(5) reductase (FpD) is an enzyme capable of converting the prodrug mitomycin C (MC) into a DNA alkylating agent via reduction of its quininone moiety. In this study, Chinese hamster ovary (CHO) cells were transfected with a cDNA encoding rat FpD. Despite the demonstrated ability of this enzyme to reduce MC in vitro, a modest 5-fold level of overexpression of FpD activity in CHO cells did not increase the cytotoxicity of the drug over that seen with the parental cell line under either aerobic or hypoxic conditions. When the enzyme, which is predominantly localized in the mitochondria, was instead directed to the nucleus of cells by the fusion of the SV40 large T antigen nuclear localization signal sequence to the amino terminus of an FpD gene that lacked the membrane anchor domain, drug sensitivity was significantly enhanced at all concentrations of MC examined (2-10 muM) under both aerobic and hypoxic conditions, with greater cell kill occurring under hypoxia. The marked increase in drug sensitivity under hypoxia at 10 muM MC corresponded to a measurable increase in total MC-DNA adducts at the same concentration. The results indicate that the cytotoxicity of MC is modulated by the subcellular location of FpD, with greater cell kill occurring when bioactivation occurs in the proximity of its target, nuclear DNA.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dev Therapeut Program, New Haven, CT 06520 USA; CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA	Yale University; Yale University; Yale University; City University of New York (CUNY) System; Hunter College (CUNY)	Sartorelli, AC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.		Rockwell, Sara/B-8458-2009		NATIONAL CANCER INSTITUTE [R01CA080845] Funding Source: NIH RePORTER; NCI NIH HHS [CA-80845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BACHUR NR, 1979, P NATL ACAD SCI USA, V76, P954, DOI 10.1073/pnas.76.2.954; BEGLEITER A, 1992, MOL PHARMACOL, V41, P677; Belcourt MF, 1996, BIOCHEM PHARMACOL, V51, P1669, DOI 10.1016/0006-2952(96)00143-8; Belcourt MF, 1998, J BIOL CHEM, V273, P8875, DOI 10.1074/jbc.273.15.8875; Belcourt MF, 1996, P NATL ACAD SCI USA, V93, P456, DOI 10.1073/pnas.93.1.456; Belcourt MF, 1998, ADV ENZYME REGUL, V38, P111, DOI 10.1016/S0065-2571(97)00009-5; BIZANEK R, 1992, BIOCHEMISTRY-US, V31, P3084, DOI 10.1021/bi00127a008; CRESTEIL T, 1991, BIOCHEM PHARMACOL, V42, P1021, DOI 10.1016/0006-2952(91)90284-C; Fisher J., 1982, DEV BIOCHEM, V21, P240; Fitzsimmons SA, 1996, J NATL CANCER I, V88, P259, DOI 10.1093/jnci/88.5.259; GUSTAFSON DL, 1992, CANCER RES, V52, P6936; Haffty BG, 1997, J CLIN ONCOL, V15, P268, DOI 10.1200/JCO.1997.15.1.268; HAFFTY BG, 1993, INT J RADIAT ONCOL, V27, P241, DOI 10.1016/0360-3016(93)90234-M; HODNICK WF, 1993, CANCER RES, V53, P4907; Jiang HB, 2000, BIOCHEM PHARMACOL, V60, P571, DOI 10.1016/S0006-2952(00)00346-4; KEYES SR, 1991, CANCER COMMUN-US, V3, P351, DOI 10.3727/095535491820873812; KEYES SR, 1984, CANCER RES, V44, P5638; Kumar GS, 1997, BIOCHEMISTRY-US, V36, P14128, DOI 10.1021/bi971394i; MALKINSON AM, 1992, CANCER RES, V52, P4752; Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485; Matsuda H, 2000, BBA-BIOENERGETICS, V1459, P106, DOI 10.1016/S0005-2728(00)00117-1; NISHIYAMA M, 1993, INT J CANCER, V53, P1013; Palom Y, 1998, ONCOL RES, V10, P509; PAN SS, 1984, J BIOL CHEM, V259, P959; PAN SS, 1993, MOL PHARMACOL, V43, P870; Phillips RM, 2000, CANCER RES, V60, P6384; PRISTOS CA, 1994, ONCOL RES, V6, P477; Roberts KB, 2000, INT J CANCER, V90, P206, DOI 10.1002/1097-0215(20000820)90:4<206::AID-IJC4>3.0.CO;2-O; SARTORELLI AC, 1993, ADV ENZYME REGUL, V33, P3; SIEGEL D, 1990, CANCER RES, V50, P7483; SYZBALSKI W, 1964, FED PROC, V23, P946; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Tomasz M, 1997, PHARMACOL THERAPEUT, V76, P73, DOI 10.1016/S0163-7258(97)00088-0; TOMASZ M, 1988, BIOCHEMISTRY-US, V27, P3182, DOI 10.1021/bi00409a009; TOMASZ M, 1987, SCIENCE, V235, P1204, DOI 10.1126/science.3103215; TOMASZ M, 1986, P NATL ACAD SCI USA, V83, P6702, DOI 10.1073/pnas.83.18.6702; WEISSBERG JB, 1989, INT J RADIAT ONCOL, V17, P3, DOI 10.1016/0360-3016(89)90362-3	37	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5029	5034		10.1074/jbc.M209722200	http://dx.doi.org/10.1074/jbc.M209722200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12424239	hybrid			2022-12-27	WOS:000180968900088
J	Tavankar, GR; Mossialos, D; Williams, HD				Tavankar, GR; Mossialos, D; Williams, HD			Mutation or overexpression of a terminal oxidase leads to a cell division defect and multiple antibiotic sensitivity in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CYTOCHROME BD; INTRINSIC RESISTANCE; RESPIRATORY CHAINS; EFFLUX SYSTEM; CATALASE; CLONING; MUTANTS; OPERON; INVOLVEMENT	Mutation of the cyanide-insensitive terminal oxidase of Pseudomonas aeruginosa leads to pleiotropic effects. A cio mutant and strains, including the wild-type, carrying the cioAB genes on a multicopy plasmid were temperature-sensitive and had a cell division defect, leading to the formation of non-septate, multinucleated filaments. Such strains of this intrinsically antibiotic-resistant bacterium were more sensitive to a range of antibiotics including chloramphenicol, beta-lactams, quinolones, aminoglycosides, and macrolides. The effect of cio mutation on Deltap-dependent accumulation of chloramphenicol suggested that antibiotic sensitivity resulted from loss of or damage to a multidrug efflux pump. The ability of reducing agents and catalase to suppress the temperature-sensitive phenotype and of catalase to partially suppress antibiotic sensitivity suggested that increased levels of reactive oxygen species might be the cause of the observed phenotypes. Consistent with this was the increased sensitivity of strains to H2O2 and their increased protein carbonyl content, an indicator of oxidative protein modification. The temperature-dependent synthesis of a specific catalase was absent in the cio mutant and in strains carrying multiple plasmid-borne copies of cioAB. We propose that reduced catalase levels result in oxidative modification and consequent loss of function of proteins involved in a range of cellular functions. How mutation or overexpression of the cyanide-insensitive terminal oxidase leads to a loss of catalase activity is unknown at present.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England	Imperial College London	Williams, HD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England.			Williams, Huw/0000-0003-2225-6413				Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; Cunningham L, 1997, MOL MICROBIOL, V24, P579, DOI 10.1046/j.1365-2958.1997.3561728.x; CUNNINGHAM L, 1995, J BACTERIOL, V177, P432, DOI 10.1128/jb.177.2.432-438.1995; DARZINS A, 1989, J BACTERIOL, V171, P3917, DOI 10.1128/jb.171.7.3917-3925.1989; DAVIES KJP, 1989, J GEN MICROBIOL, V135, P2445; DELANEY JM, 1993, J BACTERIOL, V175, P166, DOI 10.1128/JB.175.1.166-175.1993; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; GOLDFARB WB, 1967, ANN SURG, V165, P104, DOI 10.1097/00000658-196701000-00014; Goldman BS, 1996, J BACTERIOL, V178, P6348, DOI 10.1128/jb.178.21.6348-6351.1996; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; HIRAGA S, 1989, J BACTERIOL, V171, P1496, DOI 10.1128/jb.171.3.1496-1505.1989; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; LI XZ, 1994, ANTIMICROB AGENTS CH, V38, P1732, DOI 10.1128/AAC.38.8.1732; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; MASUDA N, 1995, ANTIMICROB AGENTS CH, V39, P645, DOI 10.1128/AAC.39.3.645; Mine T, 1999, ANTIMICROB AGENTS CH, V43, P415, DOI 10.1128/AAC.43.2.415; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Palleroni N., 1984, BERGEYS MANUAL SYSTE, VVolume 1, P141; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; RORTH M, 1967, BIOCHIM BIOPHYS ACTA, V139, P171, DOI 10.1016/0005-2744(67)90124-6; Rothfield L, 1999, ANNU REV GENET, V33, P423, DOI 10.1146/annurev.genet.33.1.423; Sambrook J., 2002, MOL CLONING LAB MANU; Siegele DA, 1996, J BACTERIOL, V178, P6091, DOI 10.1128/jb.178.21.6091-6096.1996; SIEGELE DA, 1993, GENE DEV, V7, P2629, DOI 10.1101/gad.7.12b.2629; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; WALL D, 1992, J BACTERIOL, V174, P6554, DOI 10.1128/JB.174.20.6554-6562.1992; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; ZANNONI D, 1989, BIOCHIM BIOPHYS ACTA, V975, P299, DOI 10.1016/S0005-2728(89)80337-8	37	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4524	4530		10.1074/jbc.M210355200	http://dx.doi.org/10.1074/jbc.M210355200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435732	hybrid			2022-12-27	WOS:000180968900023
J	Li, ZG; Sacks, DB				Li, ZG; Sacks, DB			Elucidation of the interaction of calmodulin with the IQ motifs of IQGAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C PHOSPHORYLATION SITE; RASGAP-RELATED PROTEIN; BINDING-PROTEIN; REGULATORY DOMAIN; SCALLOP MYOSIN; IDENTIFICATION; CALCIUM; TARGET; CDC42; NEUROMODULIN	Calmodulin regulates the function of numerous proteins by binding to short regions on the target molecule. IQ motifs, which are found in over 100 human proteins, appear in tandem repeats and bind calmodulin in the absence of Ca2+. One of these IQ-containing proteins, IQGAP1, interacts with several targets, including Cdc42, beta-catenin, E-cadherin, and actin, in a calmodulin-regulated manner. To elucidate the molecular mechanism by which apocalmodulin and Ca2+/calmodulin- differentially regulate IQGAP1, a series of constructs of IQGAP1 with selected point mutations of the four tandem IQ motifs were generated. Mutating the basic charged arginine residues in all four IQ motifs abrogated binding of IQGAP1 to apocalmodulin, but had no effect on its interaction with Ca2+/calmodulin. Analysis of IQGAP1 constructs with point mutations in single, double, or triple IQ motifs revealed that apocalmodulin bound only to IQ3 and IQ4. By contrast to the arginine mutant constructs, mutation of selected hydrophobic residues in the IQ motifs produced an IQGAP1 protein incapable of binding either apocalmodulin or Ca2+/calmodulin. These results, which differ from the conventional model of Ca2+-independent binding of calmodulin to IQ motifs, provide insight into the complexity of the molecular interactions between calmodulin and IQ motifs.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sacks, DB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St,Thorn 530, Boston, MA 02115 USA.			Sacks, David/0000-0003-3100-0735				ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; BROCKERHOFF SE, 1994, J CELL BIOL, V124, P315, DOI 10.1083/jcb.124.3.315; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chun KY, 2000, CALCIUM: THE MOLECULAR BASIS OF CALCIUM ACTION IN BIOLOGY AND MEDICINE, P541; Cohen P, 1988, CALMODULIN; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; McCallum SJ, 1996, J BIOL CHEM, V271, P21732, DOI 10.1074/jbc.271.36.21732; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; SACKS DB, 1991, ANAL BIOCHEM, V194, P369, DOI 10.1016/0003-2697(91)90243-M; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; URBAUER JL, 1995, BIOCHEMISTRY-US, V34, P8099, DOI 10.1021/bi00025a016; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; WOLENSKI JS, 1993, J CELL BIOL, V122, P613, DOI 10.1083/jcb.122.3.613; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	37	74	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4347	4352		10.1074/jbc.M208579200	http://dx.doi.org/10.1074/jbc.M208579200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446675	hybrid			2022-12-27	WOS:000180869700103
J	Mongiat, M; Sweeney, SM; San Antonio, JD; Fu, J; Iozzo, RV				Mongiat, M; Sweeney, SM; San Antonio, JD; Fu, J; Iozzo, RV			Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FIBROBLAST GROWTH-FACTOR; DENSITY-LIPOPROTEIN-RECEPTOR; CELL-ADHESION MOLECULES; SMOOTH-MUSCLE CELLS; COLLAGEN TYPE-IV; BASEMENT-MEMBRANE; TUMOR-GROWTH; DOMAIN-V; ENDOTHELIAL-CELLS	Perlecan, a ubiquitous basement membrane heparan sulfate proteoglycan, plays key roles in blood vessel growth and structural integrity. We discovered that the C terminus of perlecan potently inhibited four aspects of angiogenesis: endothelial cell migration, collagen-induced endothelial tube morphogenesis, and blood vessel growth in the chorioallantoic membrane and in Matrigel plug assays. The C terminus of perlecan was active at nanomolar concentrations and blocked endothelial cell adhesion to fibronectin and type I collagen, without directly binding to either protein; henceforth we have named it "endorepellin." We also found that endothelial cells possess a significant number of high affinity (K-d of 11 nm) binding sites for endorepellin and that endorepellin binds endostatin and counteracts its anti-angiogenic effects. Thus, endorepellin represents a novel anti-angiogenic product, which may retard tumor neovascularization and hence tumor growth in vivo.	Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Dept Med, Cardeza Fdn, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Cellular Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 249 Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.		Mongiat, Maurizio/H-8297-2018; Iozzo, Renato/AAS-1980-2020	Mongiat, Maurizio/0000-0001-6509-0068; Iozzo, Renato/0000-0002-5908-5112	NCI NIH HHS [CA47282, CA39481] Funding Source: Medline; NHLBI NIH HHS [HL53590] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053590, R29HL053590] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Auerbach R, 2000, CANCER METAST REV, V19, P167, DOI 10.1023/A:1026574416001; Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Chang Z, 1999, AM J PATHOL, V155, P71, DOI 10.1016/S0002-9440(10)65101-2; COHEN IR, 1994, CANCER RES, V54, P5771; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; DUNLEVY JR, 2000, PROTEOGLYCANS STRUCT, P275; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FOLKMAN J, 1979, P NATL ACAD SCI USA, V76, P5217, DOI 10.1073/pnas.76.10.5217; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; French MM, 1999, J CELL BIOL, V145, P1103, DOI 10.1083/jcb.145.5.1103; Friedrich MVK, 1999, J MOL BIOL, V294, P259, DOI 10.1006/jmbi.1999.3259; Friedrich MVK, 2000, EUR J BIOCHEM, V267, P3149, DOI 10.1046/j.1432-1327.2000.01337.x; Gauer S, 1996, EUR J CELL BIOL, V70, P233; Ghiselli G, 2001, BIOCHEM J, V359, P153, DOI 10.1042/0264-6021:3590153; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; Henry MD, 2001, J CELL SCI, V114, P1137; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9; Knox S, 2002, J BIOL CHEM, V277, P14657, DOI 10.1074/jbc.M111826200; Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233; Lundmark K, 2001, J CELL PHYSIOL, V188, P67, DOI 10.1002/jcp.1094; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; Mathiak M, 1997, CANCER RES, V57, P2130; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; NUGENT MA, 1993, CIRC RES, V73, P1051, DOI 10.1161/01.RES.73.6.1051; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROGHANI M, 1992, J BIOL CHEM, V267, P22156; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Sage EH, 1997, TRENDS CELL BIOL, V7, P182; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; SUNDARRAJ N, 1995, J CELL SCI, V108, P2663; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tapanadechopone P, 2001, BIOCHEM J, V355, P517, DOI 10.1042/0264-6021:3550517; Tapanadechopone P, 1999, BIOCHEM BIOPH RES CO, V265, P680, DOI 10.1006/bbrc.1999.1714; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Villar MJ, 1999, J CELL BIOCHEM, V75, P665, DOI 10.1002/(SICI)1097-4644(19991215)75:4<665::AID-JCB12>3.0.CO;2-S; Weiser MCM, 1997, MOL BIOL CELL, V8, P999, DOI 10.1091/mbc.8.6.999; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0; YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668	78	258	275	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4238	4249		10.1074/jbc.M210445200	http://dx.doi.org/10.1074/jbc.M210445200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12435733	hybrid			2022-12-27	WOS:000180869700091
J	Franken, S; Junghans, U; Rosslenbroich, V; Baader, SL; Hoffmann, R; Gieselmann, V; Viebahn, C; Kappler, J				Franken, S; Junghans, U; Rosslenbroich, V; Baader, SL; Hoffmann, R; Gieselmann, V; Viebahn, C; Kappler, J			Collapsin response mediator proteins of neonatal rat brain interact with chondroitin sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING CEREBRAL-CORTEX; OCCURRING CELL-DEATH; MOLECULAR CHARACTERIZATION; NERVOUS-TISSUE; GENE; IDENTIFICATION; PROTEOGLYCANS; NEUROCAN; UNC-33; FAMILY	Chondroitin sulfate proteoglycans are structurally and functionally important components of the extracellular matrix of the central nervous system. Their expression in the developing mammalian brain is precisely regulated, and cell culture experiments implicate these proteoglycans in the control of cell adhesion, neuron migration, neurite formation, neuronal polarization, and neuron survival. Here, we report that a monoclonal antibody against chondroitin sulfate-binding proteins from neonatal rat brain recognizes collapsin response mediator protein-4 (CRMP-4), which belongs to a family of proteins involved in collapsin/semaphorin 3A signaling. Soluble CRMPs from neonatal rat brain bound to chondroitin sulfate affinity columns, and CRMP-specific antisera co-precipitated chondroitin sulfate. Moreover, chondroitin sulfate and CRMP-4 were found to be localized immunohistochemically in overlapping distributions in the marginal zone and the subplate of the cerebral cortex. CRMPs are released to culture supernatants of NTera-2 precursor cells and of neocortical neurons after cell death, and CRMP-4 is strongly expressed in the upper cortical plate of neonatal rat where cell death is abundant. Therefore, naturally occurring cell death is a plausible mechanism that targets CRMPs to the extracellular matrix at certain stages of development. In summary, our data indicate that CRMPs, in addition to their role as cytosolic signal transduction molecules, may subserve as yet unknown functions in the developing brain as ligands of the extracellular matrix.	Univ Bonn, Inst Physiol Chem, D-53115 Bonn, Germany; Univ Klinikum Dusseldorf, Neurol Klin, D-40225 Dusseldorf, Germany; Inst Anat, D-53115 Bonn, Germany; Univ Dusseldorf, Forschungszentrum Biol Med, D-40225 Dusseldorf, Germany	University of Bonn; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Bonn; Heinrich Heine University Dusseldorf	Kappler, J (corresponding author), Univ Bonn, Inst Physiol Chem, Nussallee 11, D-53115 Bonn, Germany.	kappler@institut.physiochem.uni-bonn.de	Hoffmann, Ralf/ABD-8779-2020	Franken, Sebastian/0000-0003-4844-6389				Aggarwal S, 1998, INT J ONCOL, V13, P1331; ANSORGE W, 1985, J BIOCHEM BIOPH METH, V11, P13, DOI 10.1016/0165-022X(85)90037-5; AQUINO DA, 1984, J CELL BIOL, V99, P1117, DOI 10.1083/jcb.99.3.1117; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bulliard C, 1997, BIOCHEM J, V324, P555, DOI 10.1042/bj3240555; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; Byk T, 1996, J NEUROSCI, V16, P688; Emerling DE, 1996, NEURON, V17, P1089, DOI 10.1016/S0896-6273(00)80242-1; FERNANDEZPATRON C, 1995, ANAL BIOCHEM, V224, P203, DOI 10.1006/abio.1995.1031; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; Forsberg E, 1996, P NATL ACAD SCI USA, V93, P6594, DOI 10.1073/pnas.93.13.6594; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Fukamauchi F, 1996, BIOCHEM BIOPH RES CO, V221, P151, DOI 10.1006/bbrc.1996.0561; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gevaert K, 1996, ELECTROPHORESIS, V17, P918, DOI 10.1002/elps.1150170513; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; Harlow E., 1988, ANTIBODIES LAB MANUA, P59; Horiuchi M, 2000, FEBS LETT, V480, P283, DOI 10.1016/S0014-5793(00)01952-9; Immler D, 1998, ELECTROPHORESIS, V19, P1015, DOI 10.1002/elps.1150190617; Inatome R, 2000, J BIOL CHEM, V275, P27291; JUNGHANS U, 1995, EUR J NEUROSCI, V7, P2341, DOI 10.1111/j.1460-9568.1995.tb00655.x; Junghans U, 2002, HISTOCHEM CELL BIOL, V117, P317, DOI 10.1007/s00418-002-0394-2; Kappler J, 2000, BIOCHEM BIOPH RES CO, V271, P287, DOI 10.1006/bbrc.2000.2583; Kappler J, 1997, EUR J NEUROSCI, V9, P306, DOI 10.1111/j.1460-9568.1997.tb01401.x; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee S, 2002, J BIOL CHEM, V277, P6542, DOI 10.1074/jbc.M108047200; Liu Y, 1996, J BIOCHEM-TOKYO, V119, P1004, DOI 10.1093/oxfordjournals.jbchem.a021315; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Margolis RK, 1996, PERSPECT DEV NEUROBI, V3, P273; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; MILLER B, 1995, J COMP NEUROL, V355, P615, DOI 10.1002/cne.903550410; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Rauch U, 1997, CELL TISSUE RES, V290, P349, DOI 10.1007/s004410050940; Rauch U, 2001, CELL MOL LIFE SCI, V58, P1842, DOI 10.1007/PL00000822; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; VALVERDE F, 1995, J NEUROSCI, V15, P5014; Wang LH, 1996, J NEUROSCI, V16, P6197; Wang LH, 1997, J NEUROCHEM, V69, P2261; Zhou XH, 2001, MOL CELL BIOL, V21, P5970, DOI 10.1128/MCB.21.17.5970-5978.2001	54	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3241	3250		10.1074/jbc.M210181200	http://dx.doi.org/10.1074/jbc.M210181200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12444086	hybrid			2022-12-27	WOS:000180915000061
J	Kueltzo, LA; Osiecki, J; Barker, J; Picking, WL; Ersoy, B; Picking, WD; Middaugh, CR				Kueltzo, LA; Osiecki, J; Barker, J; Picking, WL; Ersoy, B; Picking, WD; Middaugh, CR			Structure-function analysis of invasion plasmid antigen C (IpaC) from Shigella flexneri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; SECRETED EFFECTOR PROTEINS; HOST ACTIN CYTOSKELETON; EPITHELIAL-CELLS; CIRCULAR-DICHROISM; COLLECTIVE EFFORTS; PROMOTES ENTRY; HELA-CELLS; SALMONELLA; MEMBRANES	Shigella flexneri causes a self-limiting gastroenteritis in humans, characterized by severe localized inflammation and ulceration of the colonic mucosa. Shigellosis most often targets young children in underdeveloped countries. Invasion plasmid antigen C (IpaC) has been identified as the primary effector protein for Shigella invasion of epithelial cells. Although an initial model of IpaC function has been developed, no detailed structural information is available that could assist in a better understanding of the molecular basis for its interactions with the host cytoskeleton and phospholipid membrane. We have therefore initiated structural studies of IpaC, IpaC I', (residues 101-363 deleted), and IpaC DeltaH (residues 63-170 deleted). The secondary and tertiary structure of the protein was examined as a function of temperature, employing circular dichroism and high resolution derivative absorbance techniques. ANS (8-anilino-1-napthalene sulfonic acid) was used to probe the exposure of the hydrophobic surfaces under different conditions. The interaction of IpaC and these mutants with a liposome model (liposomes with entrapped fluorescein) was also examined. Domain III (residues 261-363) was studied using linker-scanning mutagenesis. It was shown that domain III contains periodic, sequence-dependent activity, suggesting helical structure in this section of the protein. In addition to these structural studies, investigation into the actin nucleation properties of IpaC was conducted, and actin nucleation by IpaC and some of the mutants was exhibited. Structure-function relationships of IpaC are discussed.	Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Picking, WD (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.		Ersoy, Baran/F-8192-2012	Kueltzo, Lisa/0000-0001-7157-320X	NIAID NIH HHS [AI34428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034428, R01AI034428] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Avanti Polar Lipids, DET TOT PHOSPH; Barzu S, 1997, INFECT IMMUN, V65, P1599; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; *CDCP, 2000, SHIGELLOSIS; Davis R, 1998, BBA-PROTEIN STRUCT M, V1429, P45, DOI 10.1016/S0167-4838(98)00213-1; De Geyter C, 2000, EUR J BIOCHEM, V267, P5769, DOI 10.1046/j.1432-1327.2000.01649.x; DeGeyter C, 1997, FEBS LETT, V400, P149, DOI 10.1016/S0014-5793(96)01379-8; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kuwae A, 2001, J BIOL CHEM, V276, P32230, DOI 10.1074/jbc.M103831200; MACH H, 1995, BIOCHEMISTRY-US, V34, P9913, DOI 10.1021/bi00031a013; MACH H, 1993, BIOTECHNIQUES, V15, P240; MACH H, 1994, ANAL BIOCHEM, V222, P323, DOI 10.1006/abio.1994.1499; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Marquart ME, 1996, INFECT IMMUN, V64, P4182, DOI 10.1128/IAI.64.10.4182-4187.1996; McGhie EJ, 2001, TRENDS MICROBIOL, V9, P569, DOI 10.1016/S0966-842X(01)02229-6; Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254; Osiecki JC, 2001, MOL MICROBIOL, V42, P469, DOI 10.1046/j.1365-2958.2001.02654.x; Page AL, 2001, MOL MICROBIOL, V42, P1133, DOI 10.1046/j.1365-2958.2001.02715.x; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Picking WL, 1996, PROTEIN EXPRES PURIF, V8, P401, DOI 10.1006/prep.1996.0117; Picking WL, 2001, MOL MICROBIOL, V39, P100, DOI 10.1046/j.1365-2958.2001.02210.x; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x; Shibata T, 2002, CURR BIOL, V12, P341, DOI 10.1016/S0960-9822(02)00689-9; SILVIUS JR, 1982, LIPID PROTEIN INTERA, P515; SREERAMA N, CDPRO SOFTWARE PACKA; SREERAMA N, 1990, ANAL BIOCHEM, V289, P32; Terajima J, 1999, MICROB PATHOGENESIS, V27, P223, DOI 10.1006/mpat.1999.0300; Tran N, 2000, INFECT IMMUN, V68, P3710, DOI 10.1128/IAI.68.6.3710-3715.2000; Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249; Zhou DG, 2001, TRENDS MICROBIOL, V9, P567, DOI 10.1016/S0966-842X(01)02227-2	36	54	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2792	2798		10.1074/jbc.M208383200	http://dx.doi.org/10.1074/jbc.M208383200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427760	Green Published, hybrid			2022-12-27	WOS:000180915000005
J	Lindermayr, C; Fliegmann, J; Ebel, J				Lindermayr, C; Fliegmann, J; Ebel, J			Deletion of a single amino acid residue from different 4-coumarate : CoA Ligases from soybean results in the generation of new substrate specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-FORMING ENZYMES; MOLECULAR-CLONING; GLYCINE-MAX; COA LIGASE; EXPRESSION; BIOSYNTHESIS; GENES; IDENTIFICATION; PHENYLALANINE; ANGIOSPERMS	Plant 4-coumarate:coenzyme A ligases, acyl-CoA ligases, peptide synthetases, and firefly luciferases are grouped in one family of AMP-binding proteins. These enzymes do not only use a common reaction mechanism for the activation of carboxylate substrates but are also very likely marked by a similar functional architecture. In soybean, four 4-coumarate:CoA ligases have been described that display different substrate utilization profiles. One of these (Gm4CL1) represented an isoform that was able to convert highly ring-substituted cinnamic acids. Using computer-based predictions of the conformation of Gm4CL1, a peptide motif was identified and experimentally verified to exert a critical influence on the selectivity toward differently ring-substituted cinnamate substrates. Furthermore, one unique amino acid residue present in the other isoenzymes of soybean was shown to be responsible for the incapability to accommodate highly substituted substrates. The deletion of this residue conferred the ability to activate sinapate and, in one case, also 3,4-dimethoxy cinnamate and was accompanied by a significantly better affinity for ferulate. The engineering of the substrate specificity of the critical enzymes that activate the common precursors of a variety of phenylpropanoid-derived secondary metabolites may offer a convenient tool for the generation of transgenic plants with desirably modified metabolite profiles.	Univ Munich, Dept Biol Bot I, D-80638 Munich, Germany	University of Munich	Ebel, J (corresponding author), Univ Munich, Dept Biol Bot I, Menzinger Str 67, D-80638 Munich, Germany.		Lindermayr, Christian/M-7338-2014	Lindermayr, Christian/0000-0002-9343-4996; Fliegmann, Judith/0000-0003-1021-8006				Allina SM, 1998, PLANT PHYSIOL, V116, P743, DOI 10.1104/pp.116.2.743; BABBITT PC, 1992, BIOCHEMISTRY-US, V31, P5594, DOI 10.1021/bi00139a024; BECKERANDRE M, 1991, J BIOL CHEM, V266, P8551; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DOUGLAS C, 1987, EMBO J, V6, P1189, DOI 10.1002/j.1460-2075.1987.tb02353.x; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Ehlting J, 2001, PLANT J, V27, P455, DOI 10.1046/j.1365-313X.2001.01122.x; FULDA M, 1994, MOL GEN GENET, V242, P241, DOI 10.1007/BF00280412; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Humphreys JM, 1999, P NATL ACAD SCI USA, V96, P10045, DOI 10.1073/pnas.96.18.10045; KNOBLOCH KH, 1975, EUR J BIOCHEM, V52, P311, DOI 10.1111/j.1432-1033.1975.tb03999.x; Lee D, 1996, PLANT PHYSIOL, V112, P193, DOI 10.1104/pp.112.1.193; Li LG, 2000, J BIOL CHEM, V275, P6537, DOI 10.1074/jbc.275.9.6537; Lindermayr C, 2002, EUR J BIOCHEM, V269, P1304, DOI 10.1046/j.1432-1033.2002.02775.x; NELSON M, 1992, METHOD ENZYMOL, V216, P279; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; RAGG H, 1981, J BIOL CHEM, V256, P61; Stuible HP, 2000, FEBS LETT, V467, P117, DOI 10.1016/S0014-5793(00)01133-9; Stuible HP, 2001, J BIOL CHEM, V276, P26893, DOI 10.1074/jbc.M100355200; UHLMANN A, 1993, PLANT PHYSIOL, V102, P1147, DOI 10.1104/pp.102.4.1147; Zhang XH, 1997, PLANT PHYSIOL, V113, P65, DOI 10.1104/pp.113.1.65	24	30	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2781	2786		10.1074/jbc.M202632200	http://dx.doi.org/10.1074/jbc.M202632200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12421821	hybrid			2022-12-27	WOS:000180915000003
J	Ortega, A; Niksic, M; Bachi, A; Wilm, M; Sanchez, L; Hastie, N; Valcarcel, J				Ortega, A; Niksic, M; Bachi, A; Wilm, M; Sanchez, L; Hastie, N; Valcarcel, J			Biochemical function of female-lethal (2)D/Wilms' tumor suppressor-1-associated proteins in alternative pre-mRNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; WILMS-TUMOR; SEX-LETHAL; GENE-PRODUCT; MOLECULAR ANALYSIS; TRANSFORMER GENE; BINDING-PROTEINS; NUCLEAR-PROTEIN; MESSENGER-RNA; FL(2)D GENE	Genetic and molecular data have implicated the Drosophila gene female-lethal (2)d (fl (2)d) in alternative splicing regulation of genes involved in sexual determination. Sex-specific splicing is under the control of the female-specific regulatory protein sex-lethal (SXL). Co-immunoprecipitation and mass spectrometry results indicate that SXL and FL (2)D form a complex and that the protein VIRILIZER and a Ran-binding protein implicated in protein nuclear import are also present in complexes containing FL (2)D. A human homolog of FL (2)D was identified and cloned. Interestingly, this gene encodes a protein (WTAP) that was previously found to interact with the Wilms' tumor suppressor-1 (WT1), an isoform of which binds to and co-localizes with splicing factors. Alternative splicing of transformer pre-mRNA, a target of SXL regulation, was affected by immunodepletion of hFL (2)D/WTAP from HeLa nuclear extracts, thus arguing for a biochemical function of FL (2)D/WTAP proteins in splicing regulation.	European Mol Biol Lab, Gene Express Programme, Heidelberg, Germany; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; EMBL, Biochem Instrumentat Programme, Heidelberg, Germany; CSIC, Ctr Invest Biol, E-28006 Madrid, Spain	European Molecular Biology Laboratory (EMBL); University of Edinburgh; European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Valcarcel, J (corresponding author), Ctr Regulacio Genom, Passeig Maritim 37-39, E-08003 Barcelona, Spain.		Ortega, Angeles/ABA-8118-2020; Valcarcel, Juan/O-9814-2014; Sánchez, Lucas/K-4238-2015; bachi, angela/B-3527-2015	Ortega, Angeles/0000-0002-0503-5793; Valcarcel, Juan/0000-0001-5398-3571; Sánchez, Lucas/0000-0002-7725-8961; bachi, angela/0000-0003-4842-6556; Wilm, Matthias/0000-0002-5461-6834				BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562; Davies RC, 1998, GENE DEV, V12, P3217, DOI 10.1101/gad.12.20.3217; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; FLICKINGER TW, 1994, GENE DEV, V8, P914, DOI 10.1101/gad.8.8.914; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Granadino B, 1996, MOL GEN GENET, V253, P26, DOI 10.1007/s004380050292; GRANADINO B, 1992, GENETICS, V130, P597; GRANADINO B, 1991, GENETICS, V129, P371; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hastie ND, 2001, CELL, V106, P391, DOI 10.1016/S0092-8674(01)00469-X; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; Kennedy D, 1996, NAT GENET, V12, P329, DOI 10.1038/ng0396-329; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Lorenzen JA, 2001, DEVELOPMENT, V128, P1403; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MCKEOWN M, 1987, CELL, V48, P489, DOI 10.1016/0092-8674(87)90199-1; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Niessen M, 2001, GENETICS, V157, P679; Penalva LOF, 2000, GENETICS, V155, P129; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; PolycarpouSchwarz M, 1996, RNA, V2, P11; Schutt C, 2000, DEVELOPMENT, V127, P667; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; VORM O, 1994, BIOL MASS SPECTROM, V23, P734, DOI 10.1002/bms.1200231204; WANG ZY, 1993, J BIOL CHEM, V268, P9172; Zhai G, 2001, BIOCHEMISTRY-US, V40, P2032, DOI 10.1021/bi001941r; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	43	72	84	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3040	3047		10.1074/jbc.M210737200	http://dx.doi.org/10.1074/jbc.M210737200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12444081	hybrid, Green Published			2022-12-27	WOS:000180915000036
J	Cimino-Reale, G; Pascale, E; Alvino, E; Starace, G; D'Ambrosio, E				Cimino-Reale, G; Pascale, E; Alvino, E; Starace, G; D'Ambrosio, E			Long telomeric C-rich 5 '-tails in human replicating cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-CHROMOSOMES; IN-VITRO; END; LENGTH; TAILS; RNA	Telomeres protect the ends of linear chromosomes from abnormal recombination events and buffer them against terminal DNA loss. Models of telomere replication predict that two daughter molecules have one end that is blunt, the product of leading-strand synthesis, and one end with a short G-rich 3'-overhang. However, experimental data from proliferating cells are not completely consistent with this model. For example, telomeres of human chromosomes have long G-rich 3'-overhangs, and the persistence of blunt ends is uncertain. Here we show that the product of leadingstrand synthesis is not always blunt but can contain a long C-rich 5'-tail, the incompletely replicated template of the leading strand. We examined the presence of Grich and Grich single-strand DNA in fibroblasts and HeLa cells. Although there were no significant changes in the length distribution of the 3'-overhang, the 5'-overhangs were mostly present in S phase. Similar results were obtained using telomerase-negative fibroblasts. The amount and the length distribution of the 5' C-rich tails strongly correlate with the proliferative rate of the cell cultures. Our results suggest that, contrary to what has commonly been supposed, completion of leadingstrand synthesis is inefficient and could well drive telomere shortening.	CNR, Ist Neurobiol & Med Mol, I-00137 Rome, Italy; Univ Roma La Sapienza, Dipartimento Med Sperimentale & Patol, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome	D'Ambrosio, E (corresponding author), Viale Marx,43, I-00137 Rome, Italy.	ettore.dambrosio@ims.rm.cnr.it	Alvino, Ester/J-8148-2012	Alvino, Ester/0000-0001-9467-7634				Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; Fan XQ, 1997, MOL BIOL CELL, V8, P2145, DOI 10.1091/mbc.8.11.2145; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gruber M, 2000, MOL CELL BIOL, V20, P5777, DOI 10.1128/MCB.20.15.5777-5787.2000; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Jacob NK, 2001, EMBO J, V20, P4299, DOI 10.1093/emboj/20.15.4299; LEE MS, 1993, COLD SPRING HARB SYM, V58, P707, DOI 10.1101/SQB.1993.058.01.078; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Reveal PM, 1997, J BIOL CHEM, V272, P11678, DOI 10.1074/jbc.272.18.11678; Riha K, 2000, PLANT J, V23, P633, DOI 10.1046/j.1365-313x.2000.00831.x; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Stansel RM, 2001, EMBO J, V20, P5532; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; ZAKIAN VA, 1995, SCIENCE, V270, P1601, DOI 10.1126/science.270.5242.1601	32	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2136	2140		10.1074/jbc.M208939200	http://dx.doi.org/10.1074/jbc.M208939200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435754	hybrid			2022-12-27	WOS:000180562000010
J	Marquordt, C; Fang, QH; Will, E; Peng, JH; von Figura, K; Dierks, T				Marquordt, C; Fang, QH; Will, E; Peng, JH; von Figura, K; Dierks, T			Posttranslational modification of serine to formylglycine in bacterial sulfatases - Recognition of the modification motif by the iron-sulfur protein AtsB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARYLSULFATASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CYSTEINE; CONVERSION; GENE; PURIFICATION; MECHANISM; TRANSPORT; ENZYMES	Calpha-formylglycine is the catalytic residue of sulfatases. Formylglycine is generated by posttranslational modification of a cysteine (pro- and eukaryotes) or serine (pro-karyotes) located in a conserved (C/S)XPXR motif. The modifying enzymes are unknown. AtsB, an iron-sulfur protein, is strictly required for modification of Se-72 in the periplasmic sulfatase AtsA of Klebsiella pneumoniae. Here we show W that AtsB is a cytosolic protein acting on newly synthesized serine-type sulfatases, (ii) that AtsB-mediated FGly formation is dependent on AtsA's signal peptide, and (iii) that the cytosolic cysteine-type sulfatase of Pseudomonas aeruginosa can be converted into a substrate of AtsB if the cysteine is substituted by serine and a signal peptide is added. Thus, formylglycine formation in serine-type sulfatases depends both on AtsB and on the presence of a signal peptide, and AtsB can act on sulfatases of other species. AtsB physically interacts with AtsA in a Ser(72)-dependent manner, as shown in yeast two-hybrid and GST pulldown experiments. This strongly suggests that AtsB is the serine-modifying enzyme and that AtsB relies on a cytosolic function of the sulfatase's signal peptide.	Univ Gottingen, Inst Biochem & Mol Zellbiol, Biochem Abt 2, D-37073 Gottingen, Germany; Max Planck Inst Biophys Chem, Abt Mol Genet, D-37070 Gottingen, Germany	University of Gottingen; Max Planck Society	Dierks, T (corresponding author), Univ Gottingen, Inst Biochem & Mol Zellbiol, Biochem Abt 2, Henrich Duker Weg 12, D-37073 Gottingen, Germany.	tdierks@gwdg.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339				BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Cheek J, 2001, J BIOL INORG CHEM, V6, P209, DOI 10.1007/s007750100210; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dierks T, 1998, FEBS LETT, V423, P61, DOI 10.1016/S0014-5793(98)00065-9; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 1996, EMBO J, V15, P6931, DOI 10.1002/j.1460-2075.1996.tb01085.x; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; DIERKS T, 2001, ENCY MOL MED, P974; DODGSON KS, 1982, SULFATASES MICROBIAL, P133; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hopwood JJ, 2001, METABOLIC MOL BASES, P3725; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Knaust A, 1998, BIOCHEMISTRY-US, V37, P13941, DOI 10.1021/bi9810205; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Miech C, 1998, J BIOL CHEM, V273, P4835, DOI 10.1074/jbc.273.9.4835; Miller J. H, 1972, EXPT MOL GENETICS; MUROOKA Y, 1990, J BACTERIOL, V172, P2131, DOI 10.1128/jb.172.4.2131-2140.1990; Ollagnier S, 1997, J BIOL CHEM, V272, P24216, DOI 10.1074/jbc.272.39.24216; Recksiek R, 1998, J BIOL CHEM, V273, P6096, DOI 10.1074/jbc.273.11.6096; Schirmer A, 1998, CHEM BIOL, V5, pR181, DOI 10.1016/S1074-5521(98)90154-5; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Selmer T, 1996, EUR J BIOCHEM, V238, P341, DOI 10.1111/j.1432-1033.1996.0341z.x; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Szameit C, 1999, J BIOL CHEM, V274, P15375, DOI 10.1074/jbc.274.22.15375; Tsukada M, 1999, MOL BIOL CELL, V10, P63, DOI 10.1091/mbc.10.1.63; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K	34	40	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2212	2218		10.1074/jbc.M209435200	http://dx.doi.org/10.1074/jbc.M209435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12419807	hybrid			2022-12-27	WOS:000180562000020
J	Wang, SX; Ikeda, M; Guggino, WB				Wang, SX; Ikeda, M; Guggino, WB			The cytoplasmic tail of large conductance, voltage- and Ca2+-activated K+ (MaxiK) channel is necessary for its cell surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; DARBY CANINE KIDNEY; RAT DISTAL COLON; EPITHELIAL-CELLS; APICAL MEMBRANE; BK CHANNELS; BETA-SUBUNIT; MOLECULAR-BASIS; ALPHA-SUBUNIT; SMOOTH-MUSCLE	The large conductance, voltage- and Ca2+-activated K+ channel (MaxiK) is expressed in several renal segments and functions in cell volume regulation and flow-mediated K+ secretion. Previously, we cloned two MaxiK channel isoforms, named rbslo1 and rbslo2, from rabbit renal cells. rbslo1 has a 58-amino acid insertion after the S8 hydrophobic domain, whereas rbslo2 is truncated and cannot be activated. Here we use the sequence differences between the two variants to examine their plasma membrane processing. Plasma membrane localization of rbslo1 and 2 expressed in HEK293 cells was assayed by electrophysiology, immunocytochemistry, and biochemistry studies. Consistent with its functional silence, rbslo2 localized primarily within the cytoplasm, presumably in the endoplasmic reticulum and Golgi region. Coexpression with MaxiK beta subunits did not alter the cellular localization of either rbslo1 or rbslo2. When rbslo1 and 2 are cotransfected in non-polarized cells, they colocalized primarily within the cell with only rbslo1 detected at the plasma membrane. When transfected into polarized, medullary-thick ascending limb (mTAL) cells, rbslo1 is expressed at the apical membrane whereas the majority of rbslo2 localized throughout the cytoplasm. Given the high degree of similarity between the two isoforms, we conclude that the cytoplasmic tail of rbslo1 is important for the cell surface expression of MaxiK channels.	Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, Wood Basic Sci Bldg,214 A,725 N Wolfe St, Baltimore, MD 21205 USA.			Ikeda, Masahiro/0000-0003-2539-8812	NIDDK NIH HHS [DK32753] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032753, R01DK032753] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Bian S, 2001, P NATL ACAD SCI USA, V98, P4776, DOI 10.1073/pnas.081072398; BOLIVAR JJ, 1987, J MEMBRANE BIOL, V97, P43, DOI 10.1007/BF01869613; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P54, DOI 10.1007/BF00378641; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Butterfield I, 1997, J PHYSIOL-LONDON, V501, P537, DOI 10.1111/j.1469-7793.1997.537bm.x; Caplan MJ, 2001, KIDNEY INT, V60, P427, DOI 10.1046/j.1523-1755.2001.060002427.x; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; CPALAN MJ, 1997, AM J PHYSIOL, V272, pF425; Dunbar LA, 2001, J BIOL CHEM, V276, P29617, DOI 10.1074/jbc.R100023200; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; GUGGINO SE, 1987, AM J PHYSIOL, V252, pC121, DOI 10.1152/ajpcell.1987.252.2.C121; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 1999, J MEMBRANE BIOL, V172, P193, DOI 10.1007/s002329900596; HIRSCH J, 1993, PFLUG ARCH EUR J PHY, V422, P492, DOI 10.1007/BF00375077; Huang Y, 1999, BIOL REPROD, V60, P1509, DOI 10.1095/biolreprod60.6.1509; JAMES AF, 1994, J MEMBRANE BIOL, V137, P109; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Lai GJ, 2002, P NATL ACAD SCI USA, V99, P7722, DOI 10.1073/pnas.112619799; LANCASTER B, 1991, J NEUROSCI, V11, P23; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; LING BN, 1991, KIDNEY INT, V40, P441, DOI 10.1038/ki.1991.231; MCCOBB DP, 1995, AM J PHYSIOL, V269, P767; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MEROT J, 1989, BIOCHIM BIOPHYS ACTA, V978, P134, DOI 10.1016/0005-2736(89)90508-7; Meyer E, 1999, EUR J NEUROSCI, V11, P1105, DOI 10.1046/j.1460-9568.1999.00548.x; Morita T, 1997, AM J PHYSIOL-RENAL, V273, pF615, DOI 10.1152/ajprenal.1997.273.4.F615; Moss BL, 2001, J GEN PHYSIOL, V118, P711, DOI 10.1085/jgp.118.6.711; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; NELSON MT, 1995, AM J PHYSIOL, V268, P799; Quirk JC, 2001, NEURON, V32, P13, DOI 10.1016/S0896-6273(01)00444-5; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; RANGANATHAN R, 1997, CURR BIOL, V7, P770; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Rosenblatt KP, 1997, NEURON, V19, P1061, DOI 10.1016/S0896-6273(00)80397-9; Roush DL, 1998, J BIOL CHEM, V273, P26862, DOI 10.1074/jbc.273.41.26862; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; SOHMA Y, 1994, J MEMBRANE BIOL, V141, P69; Sorensen JB, 2001, PFLUG ARCH EUR J PHY, V442, P1, DOI 10.1007/s004240000493; TAKEUCHI S, 1992, AM J PHYSIOL, V262, pC1430, DOI 10.1152/ajpcell.1992.262.6.C1430; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; TORO L, 1990, P NATL ACAD SCI USA, V87, P2892, DOI 10.1073/pnas.87.8.2892; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200	63	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2713	2722		10.1074/jbc.M208411200	http://dx.doi.org/10.1074/jbc.M208411200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12438308	hybrid			2022-12-27	WOS:000180562000084
J	Ayyagari, R; Gomes, XV; Gordenin, DA; Burgers, PMJ				Ayyagari, R; Gomes, XV; Gordenin, DA; Burgers, PMJ			Okazaki fragment maturation in yeast - I. Distribution of functions between FEN1 AND DNA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION PROTEIN-A; BASE-EXCISION-REPAIR; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; LIGASE-I; FLAP ENDONUCLEASE-1; MUTATION AVOIDANCE; PURIFIED PROTEINS	In the presence of proliferating cell nuclear antigen, yeast DNA polymerase delta (Pol delta) replicated DNA at a rate of 40-60 nt/s. When downstream double-stranded DNA was encountered, Pol 8 paused, but most replication complexes proceeded to carry out strand-displacement synthesis at a rate of 1.5 nt/s. In the presence of the flap endonuclease FEN1 (Rad27), the complex carried out nick translation (1.7 nt/s). The Dna2 nuclease/helicase alone did not efficiently promote nick translation, nor did it affect nick translation with FEN1. Maturation in the presence of DNA ligase was studied with various downstream primers. Downstream DNA primers, RNA primers, and small 5'-flaps were efficiently matured by Pol 5 and FEN1, and Dna2 did not stimulate maturation. However, maturation of long 5'-flaps to which replication protein A can bind required both DNA2 and FEN1. The maturation kinetics were optimal with a slight molar excess over DNA of Pol delta, FEN1, and proliferating cell nuclear antigen. A large molar excess of DNA ligase substantially enhanced the rate of maturation and shortened the nick-translation patch (nucleotides excised past the RNA/DNA junction before ligation) to 4-6 nt from 8-12 nt with equimolar ligase. These results suggest that FEN1, but not DNA ligase, is a stable component of the maturation complex.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; Lindenwood Univ, St Charles, MO 63301 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021; Dmitry, Gordenin/C-3907-2018	Dmitry, Gordenin/0000-0002-8399-1836	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065073, ZIAES065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058534, R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032431, GM58534] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bhagwat M, 2001, J BIOL CHEM, V276, P28516, DOI 10.1074/jbc.M103914200; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Formosa T, 1999, GENETICS, V151, P1459; Gary R, 1999, MOL CELL BIOL, V19, P5373; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Johnson RE, 1998, CURR GENET, V34, P21, DOI 10.1007/s002940050362; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; KABOORD BF, 1993, P NATL ACAD SCI USA, V90, P10881, DOI 10.1073/pnas.90.22.10881; Kang HY, 2000, GENETICS, V155, P1055; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Ma WP, 2000, J BIOL CHEM, V275, P24693, DOI 10.1074/jbc.M002268200; MACNEILL SA, 2000, YEAST NUCL, P19; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Mossi R, 1998, J BIOL CHEM, V273, P14322, DOI 10.1074/jbc.273.23.14322; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Negritto MC, 2001, MOL CELL BIOL, V21, P2349, DOI 10.1128/MCB.21.7.2349-2358.2001; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; PODUST LM, 1994, NUCLEIC ACIDS RES, V22, P2970, DOI 10.1093/nar/22.15.2970; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Tom S, 2001, J BIOL CHEM, V276, P24817, DOI 10.1074/jbc.M101673200; TOMKINSON AE, 1992, BIOCHEMISTRY-US, V31, P11762, DOI 10.1021/bi00162a013; TURCHI JJ, 1993, J BIOL CHEM, V268, P15136; WAGA S, 1994, J BIOL CHEM, V269, P10923; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; YODER BL, 1991, J BIOL CHEM, V266, P22689	62	194	198	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1618	1625		10.1074/jbc.M209801200	http://dx.doi.org/10.1074/jbc.M209801200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424238	hybrid			2022-12-27	WOS:000180462200034
J	Dong, SC; Cole, GJ; Halfter, W				Dong, SC; Cole, GJ; Halfter, W			Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; ENDOGENOUS INHIBITOR; BASAL LAMINA; CELL-SURFACE; PROTEOGLYCAN; ANGIOGENESIS; DOMAIN; FORMS; ENDOSTATIN; VARIANTS	Collagen XVIII is the only currently known collagen that carries heparan sulfate glycosaminoglycan side chains. The number and location of the glycosaminoglycan attachment sites in the core protein were determined by eukaryotic expression of full-length chick collagen XVIII and site-directed mutagenesis. Three Ser-Gly consensus sequences carrying glycosaminoglycan side chains were detected in the middle and N-terminal part of the core protein. One of the Ser-Gly consensus sequences carried a heparan sulfate side chain, and the remaining two had mixed chondroitin and heparan sulfate side chains; thus, recombinant collagen XVIII was a hybrid of heparan sulfate and chondroitin proteoglycan. In contrast, collagen XVIII from all chick tissues so far assayed have exclusively heparan sulfate side chains, indicating that the posttranslational modification of proteins expressed in vitro is not entirely identical to the processing that occurs in a living embryo. Incubating the various mutated collagen XVIIIs with retinal basement membranes showed that the heparan sulfate glycosaminoglycan side chains mediate the binding of collagen XVIII to basement membranes.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; North Carolina State University	Halfter, W (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, E1402 BST, Pittsburgh, PA 15261 USA.	whalfter@pitt.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033981] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33981-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Dolan M, 1997, J BIOL CHEM, V272, P4316, DOI 10.1074/jbc.272.7.4316; Dong SC, 2002, J COMP NEUROL, V447, P261, DOI 10.1002/cne.10245; Elamaa H, 2002, MECH DEVELOP, V114, P109, DOI 10.1016/S0925-4773(02)00014-X; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; HALFTER W, 1987, J NEUROSCI, V7, P3712; HALFTER W, 1994, EXP CELL RES, V214, P285, DOI 10.1006/excr.1994.1260; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; OH SP, 1994, P NATL ACAD SCI USA, V91, P4229, DOI 10.1073/pnas.91.10.4229; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	27	56	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1700	1707		10.1074/jbc.M209276200	http://dx.doi.org/10.1074/jbc.M209276200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12433925	hybrid			2022-12-27	WOS:000180462200045
J	Fu, DX; Kuo, YL; Liu, BY; Jeang, KT; Giam, CZ				Fu, DX; Kuo, YL; Liu, BY; Jeang, KT; Giam, CZ			Human T-lymphotropic virus type I Tax activates I-kappa B kinase by inhibiting I-kappa B kinase-associated serine/threonine protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; PERSISTENT ACTIVATION; TRANSCRIPTION FACTORS; TRANSFORMING PROTEIN; MEDIATED ACTIVATION; CATALYTIC SUBUNIT; IKK-ALPHA; S6 KINASE; PHOSPHORYLATION	I-kappaB kinase (IKK) is a serine/threonine kinase that phosphorylates I-kappaBalpha and I-kappaBbeta and targets them for polyubiquitination and proteasome-mediated degradation. IKK consists of two highly related catalytic subunits, alpha and beta, and a regulatory gamma subunit, which becomes activated after serine phosphorylation of the activation loops of the catalytic domains. The human T-lymphotropic retrovirus type-I trans-activator, Tax, has been shown to interact directly with IKKgamma and activates IKK via a mechanism not fully understood. Here we demonstrate that IKK binds serine/threonine protein phosphatase 2A (PP2A), and via a tripartite protein-protein interaction, Tax, IKKgamma, and PP2A form a stable ternary complex. In vitro, PP2A down-regulates active IKK prepared from Tax-producing MT4 cells. In the presence of Tax, however, the ability of PP2A to inactivate IKK is diminished. Despite their interaction with IKKgamma, PP2A-interaction-defective Tax mutants failed to activate NF-kappaB. Our data support the notion that IKKgamma-associated PP2A is responsible for the rapid deactivation of IKK, and inhibition of PP2A by Tax in the context of IKK.PP2A.Tax ternary complex leads to constitutive IKK and NF-kappaB activation.	Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; NIAID, Mol Virol Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Giam, CZ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.		Jeang, Kuan-Teh/A-2424-2008		NCI NIH HHS [R01 CA/GM 75688, R01 CA48709] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA048709, R01CA075688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000547] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; ADYA N, 1995, J VIROL, V69, P1834, DOI 10.1128/JVI.69.3.1834-1841.1995; Andjelkovic N, 1996, EMBO J, V15, P7156, DOI 10.1002/j.1460-2075.1996.tb01107.x; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; Chu ZL, 1998, J BIOL CHEM, V273, P15891, DOI 10.1074/jbc.273.26.15891; DE BI, 1999, BIOCHEMISTRY-US, V38, P16539; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Evans DRH, 2000, MOL GEN GENET, V264, P425; Evans DRH, 1998, NATURE, V394, P23, DOI 10.1038/27782; GILMORE TD, 1992, CANCER SURV, V15, P69; Good LF, 1996, J VIROL, V70, P2730, DOI 10.1128/JVI.70.5.2730-2735.1996; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harrod R, 2000, J BIOL CHEM, V275, P11852, DOI 10.1074/jbc.275.16.11852; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YL, 2000, AIDS RES HUM RETROV, V16, P1607, DOI 10.1089/08892220050193038; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; MUMBY MC, 1991, CELL REGUL, V2, P589, DOI 10.1091/mbc.2.8.589; NERI A, 1991, CELL, V67, P1075, DOI 10.1016/0092-8674(91)90285-7; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; SEMMES OJ, 1992, J VIROL, V66, P7183, DOI 10.1128/JVI.66.12.7183-7192.1992; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; SUN SC, 1995, J BIOL CHEM, V270, P18347, DOI 10.1074/jbc.270.31.18347; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Tie F, 1996, J VIROL, V70, P8368, DOI 10.1128/JVI.70.12.8368-8374.1996; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Xiao GT, 2000, ONCOGENE, V19, P5198, DOI 10.1038/sj.onc.1203894; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	45	87	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1487	1493		10.1074/jbc.M210631200	http://dx.doi.org/10.1074/jbc.M210631200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419799	hybrid			2022-12-27	WOS:000180462200017
J	Johnson, EN; Lee, YM; Sander, TL; Rabkin, E; Schoen, FJ; Kaushal, S; Bischoff, J				Johnson, EN; Lee, YM; Sander, TL; Rabkin, E; Schoen, FJ; Kaushal, S; Bischoff, J			NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCARDIAL CUSHION FORMATION; CONGENITAL HEART-DISEASE; FACTOR GENE-EXPRESSION; ACTIVATED T-CELLS; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; CYCLOSPORINE-A; NUCLEAR FACTOR; NF-ATC; CALCINEURIN	Mice deficient for the transcription factor NFATc1 fail to form pulmonary and aortic valves, a defect reminiscent of some types of congenital human heart disease. We examined the mechanisms by which NFATc1 is activated and translocated to the nucleus in human pulmonary valve endothelial cells to gain a better understanding of its potential role(s) in post-natal valvular repair as well as valve development. Herein we demonstrate that activation of NFATc1 in human pulmonary valve endothelial cells is specific to vascular endothelial growth factor (VEGF) signaling through VEGF receptor 2. VEGF-induced NFATc1 nuclear translocation was inhibited by either cyclosporin A or a calcineurin-specific peptide inhibitor; these findings suggest that VEGF stimulates NFATc1 nuclear import in human pulmonary valve endothelial cells by a calcineurin-dependent mechanism. Importantly, both cyclosporin A and the calcineurin-specific peptide inhibitor reduced VEGF-induced human pulmonary valve endothelial cell proliferation, indicating a functional role for NFATc1 in endothelial growth. In contrast, VEGF-induced proliferation of human dermal microvascular and human umbilical vein endothelial cells was not sensitive to cyclosporin A. Finally, NFATc1 was detected in the endothelium of human pulmonary valve leaflets by immunohistochemistry. These results suggest VEGF-induced NFATc1 activation may be an important mechanism in cardiac valve maintenance and function by enhancing endothelial proliferation.	Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bischoff, J (corresponding author), Childrens Hosp, Dept Surg, 300 Longwood Ave, Boston, MA 02115 USA.	joyce.bischoff@tch.harvard.edu	BISCHOFF, JOYCE/K-3354-2019	BISCHOFF, JOYCE/0000-0002-6367-1974; Aikawa, Elena/0000-0001-7835-2135	NHLBI NIH HHS [R01 HL060490-05, R01 HL060490, R01-HL60490] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060490] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alvarez-Arroyo MV, 2002, CIRC RES, V91, P202, DOI 10.1161/01.RES.0000027562.91075.56; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; CHANG HY, 1995, NATURE, V376, P686, DOI 10.1038/376686a0; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dor Y, 2001, DEVELOPMENT, V128, P1531; FERENCZ C, 1985, AM J EPIDEMIOL, V121, P31, DOI 10.1093/oxfordjournals.aje.a113979; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; HOFFMAN JIE, 1995, PEDIATR CARDIOL, V16, P155; JACKSON CJ, 1990, J CELL SCI, V96, P257; Kraling BM, 1998, IN VITRO CELL DEV-AN, V34, P308; Kroll J, 1997, J BIOL CHEM, V272, P32521, DOI 10.1074/jbc.272.51.32521; Li B, 2000, J BIOL CHEM, V275, P29823, DOI 10.1074/jbc.M002015200; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; McKinsey TA, 1999, CURR OPIN GENET DEV, V9, P267, DOI 10.1016/S0959-437X(99)80040-9; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5; Ramsdell AF, 1997, DEV BIOL, V188, P64, DOI 10.1006/dbio.1997.8637; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; YUEN S, 1987, METHOD ENZYMOL, V146, P42; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zoeteweij JP, 2001, BLOOD, V97, P2374, DOI 10.1182/blood.V97.8.2374	36	87	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1686	1692		10.1074/jbc.M210250200	http://dx.doi.org/10.1074/jbc.M210250200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427739	Green Accepted, hybrid			2022-12-27	WOS:000180462200043
J	Liu, MJ; Li, XL; Hassel, BA				Liu, MJ; Li, XL; Hassel, BA			Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; DOUBLE-STRANDED-RNA; ACTIVATING ENZYME; GENE-EXPRESSION; INTERFERON; DEGRADATION; INHIBITORS; VIRUS; CYTOSKELETAL; TRANSPORT	ISG15 is a ubiquitin-like protein that is induced by interferon and microbial challenge. Ubiquitin-like proteins are covalently conjugated to cellular proteins and may intersect the ubiquitin-proteasome system via common substrates or reciprocal regulation. To investigate the relationship between ISG15 conjugation and proteasome function, we treated interferon-induced cells with proteasome inhibitors. Surprisingly, inhibition of proteasomal, but not lysosomal, proteases dramatically enhanced the level of ISG15 conjugates. The stimulation of ISG15 conjugates occurred rapidly in the absence of protein synthesis and was most dramatic in the cytoskeletal protein fraction. Inhibition of ISG15 conjugation by ATP depletion abrogated the proteasome inhibitor-dependent increase in ISG15 conjugates, suggesting that the effect was mediated by de novo conjugation, rather than protection from proteasomal degradation or inhibition of ISG15 deconjugating activity. The increase in ISG15 conjugates did not occur through a stabilization of the ISG15 El enzyme, UBE1L. Furthermore, simultaneous modification of proteins by both ISG15 and ubiquitin did not account for the proteasome inhibitor-dependent increase in ISG15 conjugates. These findings provide the first evidence for a link between ISG15 conjugation and proteasome function and support a model in which proteins destined for ISG15 conjugation are proteasome-regulated.	Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Mol & Cell Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Hassel, BA (corresponding author), Univ Maryland, Sch Med, Greenebaum Canc Ctr, 655 W Baltimore St,9th Floor BRB, Baltimore, MD 21210 USA.	bhassel@som.umaryland.edu						Alberts B, 1994, MOL BIOL CELL, P787; Avalos RT, 1997, J VIROL, V71, P2947, DOI 10.1128/JVI.71.4.2947-2958.1997; BLOMSTROM DC, 1986, J BIOL CHEM, V261, P8811; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; DALY C, 1995, J BIOL CHEM, V270, P23739, DOI 10.1074/jbc.270.40.23739; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; De Wit R, 2000, FREE RADICAL BIO MED, V28, P28, DOI 10.1016/S0891-5849(99)00199-9; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DICK LR, 1992, BIOCHEMISTRY-US, V31, P7347, DOI 10.1021/bi00147a020; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Gupta S, 1998, J VIROL, V72, P2655, DOI 10.1128/JVI.72.4.2655-2662.1998; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hamerman JA, 2002, J IMMUNOL, V168, P2415, DOI 10.4049/jimmunol.168.5.2415; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; IIZUKA K, 1993, J MOL CELL CARDIOL, V25, P1101, DOI 10.1006/jmcc.1993.1122; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li XL, 2000, J BIOL CHEM, V275, P8880, DOI 10.1074/jbc.275.12.8880; Li XL, 2001, CYTOKINE, V14, P247, DOI 10.1006/cyto.2001.0887; LIBBY P, 1978, SCIENCE, V199, P534, DOI 10.1126/science.622552; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; LOEB KR, 1992, J BIOL CHEM, V267, P7806; LOEB KR, 1994, MOL CELL BIOL, V14, P8408, DOI 10.1128/MCB.14.12.8408; MA CP, 1994, J BIOL CHEM, V269, P3539; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; PARK EA, 1984, AM J PHYSIOL, V247, pC390, DOI 10.1152/ajpcell.1984.247.5.C390; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Potter JL, 1999, J BIOL CHEM, V274, P25061, DOI 10.1074/jbc.274.35.25061; Pru JK, 2001, BIOL REPROD, V65, P1471, DOI 10.1095/biolreprod65.5.1471; RAMSBY ML, 1994, ELECTROPHORESIS, V15, P265, DOI 10.1002/elps.1150150146; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Tang Y, 1999, J VIROL, V73, P10508, DOI 10.1128/JVI.73.12.10508-10513.1999; TOPP KS, 1994, J NEUROSCI, V14, P318; VALLEE BL, 1971, COLD SPRING HARB SYM, V36, P517, DOI 10.1101/SQB.1972.036.01.066; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362	58	66	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1594	1602		10.1074/jbc.M208123200	http://dx.doi.org/10.1074/jbc.M208123200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426315	hybrid			2022-12-27	WOS:000180462200031
J	Mai, HQ; May, WS; Gao, FQ; Jin, ZH; Deng, XM				Mai, HQ; May, WS; Gao, FQ; Jin, ZH; Deng, XM			A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C ISOZYMES; LUNG-CANCER CELLS; PROTEIN-KINASE; IN-VIVO; CIGARETTE-SMOKING; NECK-CANCER; CALCIUM; DEATH; ASSOCIATION; INVOLVEMENT	Nicotine is not only a major component in tobacco but is also a survival agonist that inhibits apoptosis induced by diverse stimuli including chemotherapeutic drugs. However, the intracellular mechanism(s) involved in nicotine suppression of apoptosis is unclear. Bcl2 is a potent antiapoptotic protein and tumor promotor that is expressed in both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) cells. It is possible that nicotine may regulate Bcl2 to stimulate cell survival. Here we report that nicotine can induce Bcl2 phosphorylation exclusively at the serine 70 site in association with prolonged survival of SCLC H82 cells expressing wild-type but not the phosphorylation-deficient S70A mutant Bcl2 after treatment with chemotherapeutic agents (i.e. cisplatin or VIP-16). Nicotine induces activation of PKCalpha and the MAPKs ERK1 and ERK2, which are physiological Bcl2 kinases. Furthermore, ET-18-OCH3, a specific phospholipase C (PLC) inhibitor, blocks nicotine-stimulated Bcl2 phosphorylation and promotes apoptosis, suggesting that PLC may be involved in nicotine activation of Bcl2 kinases. Using a genetic approach, the gain-of-function S70E mutant, which mimics Ser(70) site phosphorylation in the flexible loop domain, potently enhances chemoresistance in SCLC cells. Thus, nicotine-induced cell survival results, at least in part, from a mechanism that involves Bcl2 phosphorylation. Therefore, novel therapeutic strategies for lung cancer in which Bcl2 is expressed may be used to abrogate the anti-apoptotic activity of Bcl2 by inhibiting multiple upstream nicotine-activated pathways.	Univ Florida, Shands Canc Ctr, Gainesville, FL 32610 USA; Univ Florida, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Deng, XM (corresponding author), Univ Florida, Shands Canc Ctr, 1600 SW Archer Rd,Acad Res Bldg,R4-216,POB 100232, Gainesville, FL 32610 USA.		Jin, Zhaohui/AAI-5562-2020	Jin, Zhaohui/0000-0001-7844-5833				ABOOD LG, 1980, LIFE SCI, V27, P1307, DOI 10.1016/0024-3205(80)90224-6; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Alberts B., 1994, MOL BIOL CELL; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brain KL, 2001, NEUROSCIENCE, V106, P395, DOI 10.1016/S0306-4522(01)00280-9; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; Chen CY, 1996, J BIOL CHEM, V271, P2376, DOI 10.1074/jbc.271.5.2376; COCKCROFT S, 1992, BIOCHEM J, V288, P1; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Deng XM, 2001, BLOOD, V98, p796A; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Gajewski TF, 1996, CELL, V87, P589, DOI 10.1016/S0092-8674(00)81377-X; GALLO O, 1995, J NATL CANCER I, V87, P1024, DOI 10.1093/jnci/87.13.1024; GARNIER M, 1994, P NATL ACAD SCI USA, V91, P11743, DOI 10.1073/pnas.91.24.11743; Gibson S, 1999, J BIOL CHEM, V274, P10916, DOI 10.1074/jbc.274.16.10916; GIOVANELLI A, 1991, P NATL ACAD SCI USA, V88, P10069, DOI 10.1073/pnas.88.22.10069; Heusch WL, 1998, CARCINOGENESIS, V19, P551, DOI 10.1093/carcin/19.4.551; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; IKGAKI N, 1994, CANCER RES, V54, P6; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; LINETTE GP, 1995, BLOOD, V86, P1255, DOI 10.1182/blood.V86.4.1255.bloodjournal8641255; MANECKJEE R, 1994, CELL GROWTH DIFFER, V5, P1033; MAY WS, 1994, J BIOL CHEM, V269, P26865; Niell H B, 2001, Curr Treat Options Oncol, V2, P71, DOI 10.1007/s11864-001-0018-4; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; ROCHER C, 1992, CLIN ONCOL, V4, P214; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; Strassheim D, 2000, CANCER RES, V60, P2730; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WRIGHT SC, 1993, FASEB J, V7, P1045, DOI 10.1096/fasebj.7.11.8370474; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Zhang SL, 2001, PHYSIOL GENOMICS, V5, P187, DOI 10.1152/physiolgenomics.2001.5.4.187	44	115	126	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1886	1891		10.1074/jbc.M209044200	http://dx.doi.org/10.1074/jbc.M209044200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421819	hybrid			2022-12-27	WOS:000180462200070
J	Williams, RAM; Kelly, SM; Mottram, JC; Coombs, GH				Williams, RAM; Kelly, SM; Mottram, JC; Coombs, GH			3-mercaptopyruvate sulfurtransferase of Leishmania contains an unusual C-terminal extension and is involved in thioredoxin and antioxidant metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MITOCHONDRIAL RHODANESE; CRYSTAL-STRUCTURE; BIOTIN SYNTHASE; ACTIVE-SITE; CYSTEINE; SULFUR; 4-THIOURIDINE; MEXICANA; IDENTIFICATION	Cytosolic 3-mercaptopyruvate sulfurtransferases (EC 2.8.1.2) of Leishmania major and Leishmania mexicana have been cloned, expressed as active enzymes in Escherichia coli, and characterized. The leishmanial single-copy genes predict a sulfurtransferase that is structurally peculiar in possessing a C-terminal domain of some 70 amino acids. Homologous genes of Trypanosoma cruzi and Trypanosoma brucei encode enzymes with a similar C-terminal domain, suggesting that this feature, not known in any other sulfurtransferase, is a characteristic of trypanosomatid parasites. Short truncations of the C-terminal domain resulted in misfolded inactive proteins, demonstrating that the domain plays some key role in facilitating correct folding of the enzymes. The leishmanial recombinant enzymes exhibited high activity toward 3-mercaptopyruvate and catalyzed the transfer of sulfane sulfur to cyanide to form thiocyanate. They also used thiosulfate as a substrate and reduced thioredoxin as the accepting nucleophile, the latter being oxidized. The enzymes were expressed in all life cycle stages, and the expression level was increased under peroxide or hypo-sulfur stress. The results are consistent with the enzymes having an involvement in the synthesis of sulfur amino acids per se or iron-sulfur centers of proteins and the parasite's management of oxidative stress.	Univ Glasgow, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Anderson Coll, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow	Coombs, GH (corresponding author), Univ Glasgow, Div Infect & Immun, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.coombs@bio.gla.ac.uk	Kelly, Sharon/K-4611-2013; Williams, Roderick/V-4317-2019	Williams, Roderick/0000-0001-5065-9768; Kelly, Sharon/0000-0002-3516-1387; Mottram, Jeremy/0000-0001-5574-3766				BATES PA, 1992, PARASITOLOGY, V105, P193, DOI 10.1017/S0031182000074102; Bhattacharyya AM, 2002, BIOCHEMISTRY-US, V41, P422, DOI 10.1021/bi011726q; Bhattacharyya AM, 2001, J BIOL CHEM, V276, P28739, DOI 10.1074/jbc.M102500200; Bordo D, 2000, J MOL BIOL, V298, P691, DOI 10.1006/jmbi.2000.3651; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Brooks DR, 2001, J BIOL CHEM, V276, P47061, DOI 10.1074/jbc.M108498200; BRUN R, 1979, ACTA TROP, V36, P387; Bui BTS, 2000, EUR J BIOCHEM, V267, P2688; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; Duin EC, 1997, BIOCHEMISTRY-US, V36, P11811, DOI 10.1021/bi9706430; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Krauth-Siegel RL, 1999, PARASITOL TODAY, V15, P404, DOI 10.1016/S0169-4758(99)01516-1; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; LAUDENBACH DE, 1991, J BACTERIOL, V173, P2751, DOI 10.1128/JB.173.9.2751-2760.1991; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Leimkuhler S, 2001, J BIOL CHEM, V276, P22024, DOI 10.1074/jbc.M102072200; LUO GX, 1993, J BIOL CHEM, V268, P10246; LUO GX, 1994, J BIOL CHEM, V269, P8220; Marquet A, 2001, CURR OPIN CHEM BIOL, V5, P541, DOI 10.1016/S1367-5931(00)00249-0; McHugh CP, 1996, AM J TROP MED HYG, V55, P547, DOI 10.4269/ajtmh.1996.55.547; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; MENDOZA JA, 1991, J BIOL CHEM, V266, P13044; MENDOZA JA, 1991, J BIOL CHEM, V266, P16973; Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200; MOTTRAM JC, 1993, J BIOL CHEM, V268, P21044; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; Nagahara N, 1996, J BIOL CHEM, V271, P27395, DOI 10.1074/jbc.271.44.27395; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; OGATA K, 1990, J BIOL CHEM, V265, P8087; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Panda M, 2000, J PROTEIN CHEM, V19, P399, DOI 10.1023/A:1026491615076; Papenbrock J, 2000, EUR J BIOCHEM, V267, P145, DOI 10.1046/j.1432-1327.2000.00980.x; Picton R, 2002, GUT, V50, P201, DOI 10.1136/gut.50.2.201; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Reckenfelderbaumer N, 2000, J BIOL CHEM, V275, P7547, DOI 10.1074/jbc.275.11.7547; SACKS DL, 1985, J IMMUNOL, V135, P564; Sanderson SJ, 2000, BIOCHEM J, V347, P383, DOI 10.1042/0264-6021:3470383; SCHMIDT A, 1992, ANNU REV PLANT PHYS, V43, P325, DOI 10.1146/annurev.pp.43.060192.001545; SNEERAMA N, 1993, ANAL BIOCHEM, V209, P32; THONG KW, 1987, EXP PARASITOL, V63, P143, DOI 10.1016/0014-4894(87)90155-X; Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938; WATANABE F, 1985, AGR BIOL CHEM TOKYO, V49, P2203, DOI 10.1080/00021369.1985.10867051; WHITE ZW, 1995, J BIOL CHEM, V270, P20404, DOI 10.1074/jbc.270.35.20404	46	67	69	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1480	1486		10.1074/jbc.M209395200	http://dx.doi.org/10.1074/jbc.M209395200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419809	hybrid			2022-12-27	WOS:000180462200016
J	Jiang, X; Takahashi, N; Matsui, N; Tetsuka, T; Okamoto, T				Jiang, X; Takahashi, N; Matsui, N; Tetsuka, T; Okamoto, T			The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; NECROSIS-FACTOR-ALPHA; IKK-ALPHA; KINASE-ALPHA; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; BINDING PROTEIN; REL PROTEINS; MICE LACKING; SUBUNIT	NF-kappaB-inducing kinase (NIK) has been shown to play an essential role in the NF-kappaB activation cascade elicited by lymphotoxin beta receptor (LTbetaR) signaling. However, the molecular mechanism of this pathway remains unclear. In this report we demonstrate that both NIK and IkappaB kinase alpha (IKKalpha) are involved in LTbetaR signaling and that the phosphorylation of the p65 subunit at serine 536 in its transactivation domain 1 (TA1) plays an essential role. We also found that NF-kappaB could be activated in the LTbetaR pathway without altering the level of the phosphorylation of IkappaB and nuclear localization of p65. By using a heterologous transactivation system in which Gal4-dependent reporter gene is activated by the Gal4 DNA-binding domain in fusion with various portions of p65, we found that TA1 serves as a direct target in the NIK-IKKalpha pathway. In addition, mutation studies have revealed. the essential role of Ser-536 within TA1 of p65 in transcriptional control mediated by NIK-IKKalpha. Furthermore, we found that Ser-536 was phosphorylated following the stimulation of LTbetaR, and this phosphorylation was inhibited by the kinase-dead dominant-negative mutant of either NIK or IKKalpha. These observations provide evidence for a crucial role of the NIK-IKKalpha cascade for NF-kappaB activation in LTbetaR signaling.	Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Dept Orthopaed Surg, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya City University; Nagoya City University	Okamoto, T (corresponding author), Nagoya City Univ, Sch Med, Dept Mol Genet, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	tokamoto@med.nagoya-cu.ac.jp						Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bird TA, 1997, J BIOL CHEM, V272, P32606, DOI 10.1074/jbc.272.51.32606; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Browning JL, 1997, J IMMUNOL, V159, P3288; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Garceau N, 2000, J EXP MED, V191, P381, DOI 10.1084/jem.191.2.381; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HAYASHI T, 1993, J BIOL CHEM, V268, P26790; Hjelmstrom P, 2000, AM J PATHOL, V156, P1133, DOI 10.1016/S0002-9440(10)64981-4; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kajino S, 2000, ONCOGENE, V19, P2233, DOI 10.1038/sj.onc.1203560; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay F, 1996, J BIOL CHEM, V271, P24934, DOI 10.1074/jbc.271.40.24934; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Matsumoto M, 1997, IMMUNOL REV, V156, P137, DOI 10.1111/j.1600-065X.1997.tb00965.x; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; MOORE PA, 1993, MOL CELL BIOL, V13, P1666, DOI 10.1128/MCB.13.3.1666; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; NEUMANN M, 1995, EMBO J, V14, P1991, DOI 10.1002/j.1460-2075.1995.tb07191.x; Okamoto T, 1997, CURR TOP CELL REGUL, V35, P149, DOI 10.1016/S0070-2137(97)80006-4; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; TAKAHASHI N, 2002, EUR J BIOCHEM, V269, P1; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2000, J BIOL CHEM, V275, P21081, DOI 10.1074/jbc.M002552200; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	76	146	149	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					919	926		10.1074/jbc.M208696200	http://dx.doi.org/10.1074/jbc.M208696200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12419817	hybrid			2022-12-27	WOS:000180321900030
J	Ogata, K; Jaramillo, A; Cohen, W; Briand, JP; Connan, F; Choppin, J; Muller, S; Wodak, SJ				Ogata, K; Jaramillo, A; Cohen, W; Briand, JP; Connan, F; Choppin, J; Muller, S; Wodak, SJ			Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8(+) T cell recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN; PREDICTING PEPTIDES; PROTEIN; IMMUNOGENICITY; FLEXIBILITY; DYNAMICS; EPITOPES; RECEPTOR; DATABASE; LIGANDS	An automatic protein design procedure was used to compute amino acid sequences of peptides likely to bind the HLA-A2 major histocompatibility complex (MHC) class I allele. The only information used by the procedure are a structural template, a rotamer library, and a well established classical empirical force field. The calculations are performed on six different templates from x-ray structures of HLA-A0201-peptide complexes. Each template consists of the bound peptide backbone and the full atomic coordinates of the MHC protein. Sequences within 2 kcal/mol of the minimum energy sequence are computed for each template, and the sequences from all the templates are combined and ranked by their energies. The five lowest energy peptide sequences and five other low energy sequences reranked on the basis of their similarity to peptides known to bind the same MHC allele are chemically synthesized and tested for their ability to bind and form stable complexes with the HILA-A2 molecule. The most efficient binders are also tested for inhibition of the T cell receptor recognition of two known CD8(+) T effectors. Results show that all 10 peptides bind the expected MHC protein. The six strongest binders also form stable HLA-A2-peptide complexes, albeit to varying degrees, and three peptides display significant inhibition of CD8(+) T cell recognition. These results are rationalized in light of our knowledge of the three-dimensional structures of the HLA-A2-peptide and HLA-A2-peptide-T cell receptor complexes.	Free Univ Brussels, Ctr Biol Struct & Bioinformat, Serv Conformat Macromol Biol & Bioinformat, B-1050 Brussels, Belgium; Univ Paris 05, CNRS, UMR 8104, INSERM,U567,Dept Immunol,Inst Cochin, F-75014 Paris, France; CNRS, UPR 9021, F-67084 Strasbourg, France	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wodak, SJ (corresponding author), Free Univ Brussels, Ctr Biol Struct & Bioinformat, Serv Conformat Macromol Biol & Bioinformat, CP263,Blvd Triomphe, B-1050 Brussels, Belgium.	shosh@ucmb.ulb.ac.be	Muller, Sylviane/J-5319-2014; Jaramillo, Alfonso/G-4257-2013; Ogata, Koji/H-4925-2019	Jaramillo, Alfonso/0000-0002-6313-9689; Ogata, Koji/0000-0001-9002-9621; wodak, shoshana/0000-0002-0701-6545				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brusic V, 1998, NUCLEIC ACIDS RES, V26, P368, DOI 10.1093/nar/26.1.368; Busch DH, 1998, J IMMUNOL, V160, P4441; Choppin J, 2001, J IMMUNOL, V166, P6164, DOI 10.4049/jimmunol.166.10.6164; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; EISENMENGER F, 1993, J MOL BIOL, V231, P849, DOI 10.1006/jmbi.1993.1331; ENGELHARD VH, 1994, CURR OPIN IMMUNOL, V6, P13, DOI 10.1016/0952-7915(94)90028-0; ENGLAND RD, 1995, J IMMUNOL, V155, P4295; Fairchild PJ, 1997, EUR J IMMUNOGENET, V24, P157, DOI 10.1046/j.1365-2370.1997.00263.x; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Gordon DB, 1999, CURR OPIN STRUC BIOL, V9, P509, DOI 10.1016/S0959-440X(99)80072-4; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; Jaramillo A, 2001, COMB CHEM HIGH T SCR, V4, P643; Kersh GJ, 1996, NATURE, V380, P495, DOI 10.1038/380495a0; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; Mamitsuka H, 1998, PROTEINS, V33, P460, DOI 10.1002/(SICI)1097-0134(19981201)33:4<460::AID-PROT2>3.0.CO;2-M; Meziere C, 1997, J IMMUNOL, V159, P3230; NEIMARK J, 1993, PEPTIDE RES, V6, P219; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; Ostankovitch M, 1998, J IMMUNOL, V161, P200; Rabinowitz JD, 1996, IMMUNITY, V5, P125, DOI 10.1016/S1074-7613(00)80489-6; Raha K, 2000, PROTEIN SCI, V9, P1106, DOI 10.1110/ps.9.6.1106; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Roberts CGP, 1996, AIDS RES HUM RETROV, V12, P593, DOI 10.1089/aid.1996.12.593; Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9; SETTE A, 1994, J IMMUNOL, V153, P5586; Singh RR, 2000, CURR OPIN RHEUMATOL, V12, P399, DOI 10.1097/00002281-200009000-00008; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; TANIMURA R, 1994, PROTEIN SCI, V3, P2358, DOI 10.1002/pro.5560031220; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Weng ZP, 1998, IMMUNOL REV, V163, P251, DOI 10.1111/j.1600-065X.1998.tb01201.x; Wernisch L, 2000, J MOL BIOL, V301, P713, DOI 10.1006/jmbi.2000.3984	41	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1281	1290		10.1074/jbc.M206853200	http://dx.doi.org/10.1074/jbc.M206853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411444	hybrid			2022-12-27	WOS:000180321900076
J	Gutierrez-Lopez, MD; Ovalle, S; Yanez-Mo, M; Sanchez-Sanchez, N; Rubinstein, E; Olmo, N; Lizarbe, MA; Sanchez-Madrid, F; Cabanas, C				Gutierrez-Lopez, MD; Ovalle, S; Yanez-Mo, M; Sanchez-Sanchez, N; Rubinstein, E; Olmo, N; Lizarbe, MA; Sanchez-Madrid, F; Cabanas, C			A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated beta(1) integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOTYPIC CELL-AGGREGATION; IN-VITRO; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; POOR-PROGNOSIS; BREAST-CANCER; LUNG-CANCER; MOTILITY; ADHESION; PROTEIN	Tetraspanins associate on the cell membrane with several transmembrane proteins, including members of the integrin superfamily. The tetraspanin CD9 has been implicated in cell motility, metastasis, and sperm-egg fusion. In this study we characterize the first CD9 conformation-dependent epitope (detected by monoclonal antibody (mAb) PAINS-13) whose expression depends on changes in the activation state of associated beta(1), integrins. MAb PAINS-13 precipitates CD9 under conditions that preserve the association of this tetraspanin with integrins, but not under conditions that disrupt these interactions. Induction of activation of 13, integrins by temperature, divalent cation Mn2+, or mAb TS2/16 correlated with enhanced expression of the PAINS-13 epitope on a variety of cells. Through the use of different K562 myeloid leukemia transfectant cells expressing specific members of the beta(1) integrin subfamily we show that the expression of the PAINS-13 epitope depends on CD9 association with alpha(6)beta(1) integrin. The mAb PAINS-13 reactivity has been mapped to the CD9 region comprising residues 112-154 in the NH2 half of the large extracellular loop. Also, we show that the CD9 conformation recognized by mAb PAINS-13 is functionally relevant in beta(1) integrin-mediated cellular processes including wound healing migration, tubular morphogenesis, cell adhesion and spreading and in, signal transduction involving phosphatidylinositol 3-kinase activation.	UCM, Fac Med, CSIC, Inst Farmacol & Toxicol, Madrid 28040, Spain; Hosp Princesa, Serv Immunol, Madrid 28006, Spain; Hop Paul Brousse, INSERM, U268, F-94807 Villejuif, France; Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol, Madrid 28040, Spain; Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid 28029, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Hospital de La Princesa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Complutense University of Madrid; Autonomous University of Madrid	Cabanas, C (corresponding author), UCM, Fac Med, CSIC, Inst Farmacol & Toxicol, Pabellon 3, Madrid 28040, Spain.		Sanchez-Madrid, Francisco/M-7889-2016; YÃÃez-MÃ, Maria/AAI-4544-2020; LÓPEZ, NIEVES OLMO/K-5266-2014; Lizarbe, M Antonia/K-5219-2014; CABAÑAS, CARLOS/J-4595-2012; Yáñez-Mó, María/K-8577-2014; MD, Gutierrez-Lopez/P-2965-2014; Rubinstein, Eric/B-4650-2019; Ovalle Andreu, Susana/M-1011-2014	Sanchez-Madrid, Francisco/0000-0001-5303-0762; YÃÃez-MÃ, Maria/0000-0001-7484-2866; LÓPEZ, NIEVES OLMO/0000-0002-8013-5313; Lizarbe, M Antonia/0000-0003-1722-1240; CABAÑAS, CARLOS/0000-0002-8767-060X; Yáñez-Mó, María/0000-0001-7484-2866; Rubinstein, Eric/0000-0001-7623-9665; Ovalle Andreu, Susana/0000-0003-1466-6797; Gutierrez Lopez, Maria Dolores/0000-0002-9979-5573				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aplin AE, 1998, PHARMACOL REV, V50, P197; ARROYO AG, 1992, J CELL BIOL, V117, P659, DOI 10.1083/jcb.117.3.659; Berditchevski F, 2001, J CELL SCI, V114, P4143; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; BOUCHEIX C, 1985, LEUKEMIA RES, V9, P597, DOI 10.1016/0145-2126(85)90139-0; BOUCHEIX C, 1988, NOUV REV FR HEMATOL, V30, P201; BOUCHEIX C, 2001, EXPERT REV MOL MED; CAMPANERO MR, 1992, EUR J IMMUNOL, V22, P3111, DOI 10.1002/eji.1830221213; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; DRANSFIELD I, 1992, J CELL BIOL, V116, P1527, DOI 10.1083/jcb.116.6.1527; FRIDMAN R, 1990, P NATL ACAD SCI USA, V87, P6698, DOI 10.1073/pnas.87.17.6698; Geary SM, 2001, TISSUE ANTIGENS, V58, P141, DOI 10.1034/j.1399-0039.2001.580301.x; Gomez M, 1997, EUR J IMMUNOL, V27, P8, DOI 10.1002/eji.1830270103; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HIGASHIYAMA M, 1995, CANCER RES, V55, P6040; HOGG N, 1992, KIDNEY INT, V41, P613, DOI 10.1038/ki.1992.93; HOGG N, 1993, AM REV RESPIR DIS, V148, P55; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; Klein-Soyer C, 2000, ARTERIOSCL THROM VAS, V20, P360, DOI 10.1161/01.ATV.20.2.360; Kraling BM, 1999, J CELL SCI, V112, P1599; Longo N, 2001, BLOOD, V98, P3717, DOI 10.1182/blood.V98.13.3717; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; LUQUE A, 1994, FEBS LETT, V346, P278, DOI 10.1016/0014-5793(94)00490-0; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Miro X, 2000, BIOCHEM BIOPH RES CO, V274, P415, DOI 10.1006/bbrc.2000.3146; Miyake M, 2000, ONCOGENE, V19, P5221, DOI 10.1038/sj.onc.1203919; MIYAKE M, 1995, CANCER RES, V55, P4127; MIYAKE M, 1991, J EXP MED, V174, P1347, DOI 10.1084/jem.174.6.1347; Miyake M, 1996, CANCER RES, V56, P1244; Mori M, 1998, CLIN CANCER RES, V4, P1507; Munoz M, 1996, J BIOL CHEM, V271, P2696, DOI 10.1074/jbc.271.5.2696; PuzonMcLaughlin W, 1996, J BIOL CHEM, V271, P16580, DOI 10.1074/jbc.271.28.16580; SanchezMateos P, 1996, SEMIN CANCER BIOL, V7, P99, DOI 10.1006/scbi.1996.0015; Schmidt C, 1996, J NEUROSCI RES, V43, P12, DOI 10.1002/jnr.490430103; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; SHAW ARE, 1995, J BIOL CHEM, V270, P24092, DOI 10.1074/jbc.270.41.24092; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Sincock PM, 1999, J CELL SCI, V112, P833; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Tachibana I, 1997, J BIOL CHEM, V272, P29181, DOI 10.1074/jbc.272.46.29181; Tang KQ, 1999, BIOCHEM BIOPH RES CO, V264, P127, DOI 10.1006/bbrc.1999.1496; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; TIMPL R, 1979, J BIOL CHEM, V254, P9933; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Yanez-Mo M, 2001, MICROCIRCULATION, V8, P153; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yashiro-Ohtani Y, 2000, J IMMUNOL, V164, P1251, DOI 10.4049/jimmunol.164.3.1251; Zhang XA, 2002, MOL BIOL CELL, V13, P1, DOI 10.1091/mbc.01-10-0481	56	59	62	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					208	218		10.1074/jbc.M207805200	http://dx.doi.org/10.1074/jbc.M207805200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12411441	hybrid			2022-12-27	WOS:000180255700028
J	Mizuide, M; Hara, T; Furuya, T; Takeda, M; Kusanagi, K; Inada, Y; Mori, M; Imamura, T; Miyazawa, K; Miyazono, K				Mizuide, M; Hara, T; Furuya, T; Takeda, M; Kusanagi, K; Inada, Y; Mori, M; Imamura, T; Miyazawa, K; Miyazono, K			Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; TGF-BETA; TRANSCRIPTIONAL REPRESSION; L3 LOOP; PROTEINS; ONCOPROTEIN; COACTIVATORS; ACTIVATION; RECEPTORS; CBP/P300	c-Ski and SnoN are transcriptional co-repressors that inhibit transforming growth factor-beta signaling through interaction with Smad proteins. Among receptor-regulated Smads, c-Ski and SnoN bind more strongly to Smad2 and Smad3 than to Smad1. Here, we show that c-Ski and SnoN bind to the "SE" sequence in the C-terminal MH2 domain of Smad3, which is exposed on the N-terminal upper side of the toroidal structure of the MH2 oligomer. The "QPSMT" sequence, located in the vicinity of SE, supports the interaction with c-Ski and SnoN. Sequences similar to SE and QPSMT are found in Smad2, but not in Smad1. The N-terminal MH1 domain and linker region of Smad3 protrude from the N-terminal upper side of the MH2 oligomer toroid. Smurf2 induces ubiquitin-dependent degradation of SnoN, since it appears to be located close to SnoN through binding to the linker region of Smad2. In contrast, transcription factors Mixer and FoxH3 (FAST1) bind to the bottom side of the Smad3 MH2 toroid; therefore, c-Ski does not affect the interaction of Smads with these transcription factors. Our findings thus demonstrate the stoichiometry of how multiple molecules can associate with the Smad oligomers and how the Smad-interacting proteins functionally interact with each other.	Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan; Gunma Univ, Sch Med, Dept Internal Med 1, Maebashi, Gumma 3718511, Japan; PharmaDesign Inc, Tokyo 1040032, Japan; Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan	Japanese Foundation for Cancer Research; Gunma University; University of Tokyo	Miyazono, K (corresponding author), Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, 1-37-1 Kami Ikebukuro, Tokyo 1708455, Japan.		MIYAZAWA, KEIJI/I-9713-2014					Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Germain S, 2000, GENE DEV, V14, P435; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Kusanagi K, 2001, J BIOL CHEM, V276, P28155, DOI 10.1074/jbc.M103371200; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Qin BY, 2002, GENE DEV, V16, P1950, DOI 10.1101/gad.1002002; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Randall RA, 2002, EMBO J, V21, P145, DOI 10.1093/emboj/21.1.145; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; Wang W, 2000, P NATL ACAD SCI USA, V97, P14394, DOI 10.1073/pnas.97.26.14394; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797	31	43	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					531	536		10.1074/jbc.C200596200	http://dx.doi.org/10.1074/jbc.C200596200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12426322	hybrid			2022-12-27	WOS:000180255700070
J	Stadtman, TC				Stadtman, TC			A gold mine of fascinating enzymes: Those remarkable, strictly anaerobic bacteria, Methanococcus vannielii and Clostridium sticklandii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATE DEHYDROGENASE-H; AMINO-ACID-SEQUENCE; HUMAN THIOREDOXIN REDUCTASE; LUNG ADENOCARCINOMA CELLS; ESCHERICHIA-COLI; GLYCINE REDUCTASE; SELENOPHOSPHATE SYNTHETASE; GLUTATHIONE-PEROXIDASE; SELENOPROTEIN-A; TRANSFER-RNAS		NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Stadtman, TC (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 3, Bethesda, MD 20892 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000205] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARKOWITZ RA, 1989, BIOCHEMISTRY-US, V28, P4639, DOI 10.1021/bi00437a019; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; AXLEY MJ, 1991, P NATL ACAD SCI USA, V88, P8450, DOI 10.1073/pnas.88.19.8450; AXLEY MJ, 1991, J BIOL CHEM, V266, P13731; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Bordo' D, 2001, BIOL CHEM, V382, P1245, DOI 10.1515/BC.2001.155; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; CHOCAT P, 1985, J BACTERIOL, V163, P669, DOI 10.1128/JB.163.2.669-676.1985; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; DILWORTH GL, 1982, ARCH BIOCHEM BIOPHYS, V219, P30, DOI 10.1016/0003-9861(82)90130-8; ESAKI N, 1982, J BIOL CHEM, V257, P4386; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; FORSTROM JW, 1978, BIOCHEMISTRY-US, V17, P2639, DOI 10.1021/bi00606a028; GARCIA GE, 1991, J BACTERIOL, V173, P2093, DOI 10.1128/jb.173.6.2093-2098.1991; GARCIA GE, 1992, J BACTERIOL, V174, P7080, DOI 10.1128/jb.174.22.7080-7089.1992; GASDASKA PY, 1995, FEBS LETT, V373, P5, DOI 10.1016/0014-5793(95)01003-W; George GN, 1998, J AM CHEM SOC, V120, P1267, DOI 10.1021/ja973004l; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P232, DOI 10.1073/pnas.91.1.232; GLADYSHEV VN, 1994, P NATL ACAD SCI USA, V91, P7708, DOI 10.1073/pnas.91.16.7708; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; GLASS RS, 1993, BIOCHEMISTRY-US, V32, P12555, DOI 10.1021/bi00210a001; Gorlatov SN, 1998, P NATL ACAD SCI USA, V95, P8520, DOI 10.1073/pnas.95.15.8520; Gorlatov SN, 1999, ARCH BIOCHEM BIOPHYS, V369, P133, DOI 10.1006/abbi.1999.1356; GUNZLER WA, 1984, H-S Z PHYSIOL CHEM, V365, P195, DOI 10.1515/bchm2.1984.365.1.195; HADDOCK BA, 1982, BIOCHEM SOC T, V10, P478, DOI 10.1042/bst0100478; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; KIM IY, 1993, J BIOL CHEM, V268, P27020; Lacourciere GM, 1998, J BIOL CHEM, V273, P30921, DOI 10.1074/jbc.273.47.30921; Lacourciere GM, 2002, J BACTERIOL, V184, P1940, DOI 10.1128/JB.184.7.1940-1946.2002; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; LEINFELDER W, 1988, J BACTERIOL, V170, P540, DOI 10.1128/jb.170.2.540-546.1988; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Liu SY, 1997, P NATL ACAD SCI USA, V94, P6138, DOI 10.1073/pnas.94.12.6138; Liu SY, 1997, ARCH BIOCHEM BIOPHYS, V341, P353, DOI 10.1006/abbi.1997.9990; Mullins LS, 1997, J AM CHEM SOC, V119, P6684, DOI 10.1021/ja971074m; Ogasawara Y, 2001, P NATL ACAD SCI USA, V98, P9494, DOI 10.1073/pnas.171320998; PATTERSON EL, 1957, P SOC EXP BIOL MED, V95, P617, DOI 10.3181/00379727-95-23307; SCHWARZ K, 1957, J AM CHEM SOC, V79, P3292, DOI 10.1021/ja01569a087; Self WT, 2000, P NATL ACAD SCI USA, V97, P7208, DOI 10.1073/pnas.97.13.7208; SLIWKOWSKI MX, 1988, P NATL ACAD SCI USA, V85, P368, DOI 10.1073/pnas.85.2.368; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; STADTMAN TC, 1958, J BIOL CHEM, V231, P961; STADTMAN TC, 1966, ARCH BIOCHEM BIOPHYS, V113, P9, DOI 10.1016/0003-9861(66)90151-2; STADTMAN TC, 1951, J BACTERIOL, V61, P81, DOI 10.1128/JB.61.1.81-86.1951; STADTMAN TC, 1949, ARCH BIOCHEM, V21, P256; STADTMAN TC, 1990, ANNU REV BIOCHEM, V59, P111, DOI 10.1146/annurev.bi.59.070190.000551; STADTMAN TC, 1962, J BIOL CHEM, V237, P2409; STADTMAN TC, 1954, J BACTERIOL, V67, P314, DOI 10.1128/JB.67.3.314-320.1954; STADTMAN TC, 1991, BIOFACTORS, V3, P21; STADTMAN TC, 1951, J BACTERIOL, V62, P269, DOI 10.1128/JB.62.3.269-280.1951; STADTMAN TC, 1979, P 3 INT S ORG SEL TE, P115; STADTMAN TC, 1972, ENZYMES, V6, P539; STADTMAN TC, 1983, ANN NY ACAD SCI, V41, P233; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; TURNER DC, 1973, ARCH BIOCHEM BIOPHYS, V154, P366, DOI 10.1016/0003-9861(73)90069-6; VERES Z, 1994, J BIOL CHEM, V269, P10597; VERES Z, 1992, P NATL ACAD SCI USA, V89, P2975, DOI 10.1073/pnas.89.7.2975; VERES Z, 1994, P NATL ACAD SCI USA, V91, P8092, DOI 10.1073/pnas.91.17.8092; Walker H, 1998, P NATL ACAD SCI USA, V95, P2180, DOI 10.1073/pnas.95.5.2180; WITTWER AJ, 1984, BIOCHEMISTRY-US, V23, P4650, DOI 10.1021/bi00315a021; YAMAZAKI S, 1982, J BIOL CHEM, V257, P7926; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	65	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 20	2002	277	51					49091	49100		10.1074/jbc.X200005200	http://dx.doi.org/10.1074/jbc.X200005200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	629AU	12403767	hybrid			2022-12-27	WOS:000180028900001
J	Yao, Y; Berg, EA; Costello, CE; Troxler, RF; Oppenheim, FG				Yao, Y; Berg, EA; Costello, CE; Troxler, RF; Oppenheim, FG			Identification of protein components in human acquired enamel pellicle and whole saliva using novel proteomics approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE-RICH PROTEINS; HUMAN PAROTID-SALIVA; FLIGHT MASS-SPECTROMETRY; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; 2-DIMENSIONAL ELECTROPHORESIS; IN-VITRO; ACIDIC PEPTIDE; ALPHA-AMYLASE; CROSS-LINKING; CYSTATIN-S	Precursor proteins of the acquired enamel pellicle derive from glandular and non-glandular secretions, which are components of whole saliva. The purpose of this investigation was to gain further insights into the characteristics of proteins in whole saliva and in vivo formed pellicle components. To maximize separation and resolution using only micro-amounts of protein, a two-dimensional gel electrophoresis system was employed. Protein samples from parotid secretion, submandibular/sublingual secretion, whole saliva, and pellicle were subjected to isoelectric focusing followed by SDS-PAGE. Selected protein spots were excised, subjected to "in-gel" trypsin digestion, and examined by mass spectrometry (MS). The data generated, including peptide maps and tandem MS spectra, were analyzed using protein data base searches. Components identified in whole saliva include cystatins (SA-III, SA, and SN), statherin, albumin, amylase, and calgranulin A. Components identified in pellicle included histatins, lysozyme, statherin, cytokeratins, and calgranulin B. The results showed that whole saliva and pellicle have more complex protein patterns than those of glandular secretions. There are, some similarities and also distinct differences between the patterns of proteins present in whole saliva and pellicle. MS approaches allowed identification of not only well characterized salivary proteins but also novel proteins not previously identified in pellicle.	Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Boston University	Oppenheim, FG (corresponding author), 700 Albany St,CABR Bldg,W-201, Boston, MA 02118 USA.			Costello, Catherine/0000-0003-1594-5122	NCRR NIH HHS [P41-RR10888] Funding Source: Medline; NIDCR NIH HHS [DE07652, DE11691, DE05672] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR010888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011691, R37DE005672, R01DE005672] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ALHASHIMI I, 1989, ARCH ORAL BIOL, V34, P289, DOI 10.1016/0003-9969(89)90070-8; Anders T., 1985, TXB CARIOLOGY; AZEN EA, 1973, SCIENCE, V180, P1067, DOI 10.1126/science.180.4090.1067; BEELEY JA, 1991, ELECTROPHORESIS, V12, P1032, DOI 10.1002/elps.1150121207; BEELEY JA, 1991, ELECTROPHORESIS, V12, P493, DOI 10.1002/elps.1150120707; Beeley JA, 1999, ELECTROPHORESIS, V20, P1652, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1652::AID-ELPS1652>3.0.CO;2-R; BENNICK A, 1971, BIOCHEM J, V123, P455, DOI 10.1042/bj1230455; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; BOBEK LA, 1992, CRIT REV ORAL BIOL M, V3, P307, DOI 10.1177/10454411920030040101; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; Carlen A, 1998, CARIES RES, V32, P447, DOI 10.1159/000016486; Carlson AJ, 1910, AM J PHYSIOL, V26, P169, DOI 10.1152/ajplegacy.1910.26.1.169; Chambers G, 2000, J PATHOL, V192, P280, DOI 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L; Chaurand P, 1999, J AM SOC MASS SPECTR, V10, P91, DOI 10.1016/S1044-0305(98)00145-7; ECKERSALL PD, 1981, BIOCHEM GENET, V19, P1055, DOI 10.1007/BF00484564; GIBBONS RJ, 1991, INFECT IMMUN, V59, P2948, DOI 10.1128/IAI.59.9.2948-2954.1991; Guilhaus M, 2000, MASS SPECTROM REV, V19, P65, DOI 10.1002/(SICI)1098-2787(2000)19:2<65::AID-MAS1>3.0.CO;2-E; HAY, 1983, HDB EXPT ASPECTS ORA, P44; HAY DI, 1973, ARCH ORAL BIOL, V18, P1531, DOI 10.1016/0003-9969(73)90128-3; HAY DI, 1974, ARCH ORAL BIOL, V19, P627, DOI 10.1016/0003-9969(74)90130-7; ISEMURA S, 1987, J BIOCHEM-TOKYO, V102, P693, DOI 10.1093/oxfordjournals.jbchem.a122107; ISEMURA S, 1986, FEBS LETT, V198, P145, DOI 10.1016/0014-5793(86)81201-7; Jensen ON, 1999, METH MOL B, V112, P571; Jensen ON, 1999, METH MOL B, V112, P513; Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.3.CO;2-F; Jonsson AP, 2001, CELL MOL LIFE SCI, V58, P868, DOI 10.1007/PL00000907; Jungblut P, 1996, ELECTROPHORESIS, V17, P839, DOI 10.1002/elps.1150170505; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; KAUFFMAN DL, 1991, BIOCHEMISTRY-US, V30, P3351, DOI 10.1021/bi00228a001; KELLER PJ, 1971, BIOCHEMISTRY-US, V10, P4867, DOI 10.1021/bi00802a006; Kojima T, 2000, J DENT RES, V79, P740, DOI 10.1177/00220345000790020701; Kuster B, 2001, PROTEOMICS, V1, P350; Lamkin MS, 2001, J DENT RES, V80, P385, DOI 10.1177/00220345010800011501; LEVINE MJ, 1987, J DENT RES, V66, P436, DOI 10.1177/00220345870660020901; Liu B, 1999, ARCH BIOCHEM BIOPHYS, V364, P286, DOI 10.1006/abbi.1999.1141; MARSHALL T, 1991, ELECTROPHORESIS, V12, P461, DOI 10.1002/elps.1150120703; MISCHKE D, 1989, NUCLEIC ACIDS RES, V17, P7984, DOI 10.1093/nar/17.19.7984; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Morris HR, 1996, RAPID COMMUN MASS SP, V10, P889, DOI 10.1002/(SICI)1097-0231(19960610)10:8<889::AID-RCM615>3.0.CO;2-F; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1971, BIOCHEMISTRY-US, V10, P4233, DOI 10.1021/bi00799a013; ORSTAVIK D, 1974, SCAND J DENT RES, V82, P202; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; SCHLESINGER DH, 1977, J BIOL CHEM, V252, P1689; Schupbach P, 2001, EUR J ORAL SCI, V109, P60, DOI 10.1034/j.1600-0722.2001.00925.x; Shevchenko A, 2000, ANAL CHEM, V72, P2132, DOI 10.1021/ac9913659; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Smith AMV, 2000, ARCH ORAL BIOL, V45, P277, DOI 10.1016/S0003-9969(99)00141-7; SPENGLER B, 1987, J PHYS CHEM-US, V91, P6502, DOI 10.1021/j100310a016; Steen H, 2002, J BIOL CHEM, V277, P1031, DOI 10.1074/jbc.M109992200; Thiede B, 2000, RAPID COMMUN MASS SP, V14, P496, DOI 10.1002/(SICI)1097-0231(20000331)14:6<496::AID-RCM899>3.0.CO;2-1; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Wilkins MR, 1997, J THEOR BIOL, V186, P7, DOI 10.1006/jtbi.1996.0346; Yao Y, 1999, J DENT RES, V78, P1696, DOI 10.1177/00220345990780110601; Yao Y, 2000, J DENT RES, V79, P930, DOI 10.1177/00220345000790040801; Yao Y, 2001, ARCH ORAL BIOL, V46, P293, DOI 10.1016/S0003-9969(00)00134-5	57	175	181	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5300	5308		10.1074/jbc.M206333200	http://dx.doi.org/10.1074/jbc.M206333200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12444093	hybrid			2022-12-27	WOS:000180968900121
J	Benach, J; Chou, YT; Fak, JJ; Itkin, A; Nicolae, DD; Smith, PC; Wittrock, G; Floyd, DL; Golsaz, CM; Gierasch, LM; Hunt, JF				Benach, J; Chou, YT; Fak, JJ; Itkin, A; Nicolae, DD; Smith, PC; Wittrock, G; Floyd, DL; Golsaz, CM; Gierasch, LM; Hunt, JF			Phospholipid-induced monomerization and signal-peptide-induced oligomerization of SecA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRECURSOR PROTEIN TRANSLOCATION; ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; ATPASE ACTIVITY; MICELLE FORMATION; MODEL MEMBRANES; CRYSTAL-STRUCTURES; CATALYTIC CYCLE; MOLAL VOLUMES; HELICASE	The SecA ATPase drives the processive translocation of the N terminus of secreted proteins through the cytoplasmic membrane in eubacteria via cycles of binding and release from the SecYEG translocon coupled to ATP turnover. SecA forms a physiological dimer with a dissociation constant that has previously been shown to vary with temperature and ionic strength. We now present data showing that the oligomeric state of SecA in solution is altered by ligands that it interacts with during protein translocation. Analytical ultracentrifugation, chemical cross-linking, and fluorescence anisotropy measurements show that the physiological dimer of SecA is monomerized by long-chain phospholipid analogues. Addition of wild-type but not mutant signal sequence peptide to these SecA monomers redimerizes the protein. Physiological dimers of SecA do not change their oligomeric state when they bind signal sequence peptide in the compact, low temperature conformational state but polymerize when they bind the peptide in the domain-dissociated, high-temperature conformational state that interacts with SecYEG. This last result shows that, at least under some conditions, signal peptide interactions drive formation of new intermolecular contacts distinct from those stabilizing the physiological dimer. The observations that signal peptides promote conformationally specific oligomerization of SecA while phospholipids promote subunit dissociation suggest that the oligomeric state of SecA could change dynamically during the protein translocation reaction. Cycles of SecA subunit recruitment and dissociation could potentially be employed to achieve processivity in polypeptide transport.	Columbia Univ, Dept Sci Biol, New York, NY 10027 USA; Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Columbia University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hunt, JF (corresponding author), Columbia Univ, Dept Sci Biol, New York, NY 10027 USA.	hunt@sid.bio.columbia.edu	Gierasch, Lila M/D-1494-2009	Smith, Paul/0000-0003-4098-4588	NCRR NIH HHS [S10RR12848] Funding Source: Medline; NIGMS NIH HHS [GM58549, GM34962] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058549, R01GM034962] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn T, 1998, J BIOL CHEM, V273, P21692, DOI 10.1074/jbc.273.34.21692; Ahn T, 2001, ARCH BIOCHEM BIOPHYS, V395, P14, DOI 10.1006/abbi.2001.2565; AKITA M, 1990, J BIOL CHEM, V265, P8164; ALUE TM, 1992, ANAL ULTRACENTRIFUGA, P90; BAUD C, 2002, J BIOL CHEM; Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; BROWN GM, 1970, CAN J CHEMISTRY, V48, P2525, DOI 10.1139/v70-427; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P849; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; CHUN SY, 1994, J BACTERIOL, V176, P4197, DOI 10.1128/jb.176.14.4197-4203.1994; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; denBlaauwen T, 1996, BIOCHEMISTRY-US, V35, P11994, DOI 10.1021/bi9605088; DEVRIJE T, 1988, NATURE, V334, P173, DOI 10.1038/334173a0; Ding HY, 2001, BIOCHEMISTRY-US, V40, P1835, DOI 10.1021/bi002058w; Doyle SM, 2000, BIOCHEMISTRY-US, V39, P11667, DOI 10.1021/bi000299y; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Eastoe J, 1998, LANGMUIR, V14, P5719, DOI 10.1021/la980053i; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Economou A, 1998, MOL MICROBIOL, V27, P511, DOI 10.1046/j.1365-2958.1998.00713.x; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; Eichler J, 1997, EMBO J, V16, P2188, DOI 10.1093/emboj/16.9.2188; EMR SD, 1983, P NATL ACAD SCI-BIOL, V80, P4599, DOI 10.1073/pnas.80.15.4599; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; FIKES JD, 1989, J BACTERIOL, V171, P402, DOI 10.1128/jb.171.1.402-409.1989; Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2; HUIE JL, 1995, J BACTERIOL, V177, P3518, DOI 10.1128/jb.177.12.3518-3526.1995; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KIM YJ, 1994, CELL, V78, P845; KIMURA E, 1991, J BIOL CHEM, V266, P6600; KOONIN EV, 1992, FEBS LETT, V298, P6, DOI 10.1016/0014-5793(92)80009-6; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kresheck GC, 1998, J AM CHEM SOC, V120, P10964, DOI 10.1021/ja982156t; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Levin MK, 1999, J BIOL CHEM, V274, P31839, DOI 10.1074/jbc.274.45.31839; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Manting EH, 1999, J BIOL CHEM, V274, P23868, DOI 10.1074/jbc.274.34.23868; Miller A, 1998, J BIOL CHEM, V273, P11409, DOI 10.1074/jbc.273.19.11409; OLOFSSON G, 1985, J PHYS CHEM-US, V89, P1473, DOI 10.1021/j100254a034; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019; Ramamurthy V, 1998, J BACTERIOL, V180, P6419; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Schmidt M, 2000, J BIOL CHEM, V275, P15440, DOI 10.1074/jbc.M000605200; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shilton B, 1998, FEBS LETT, V436, P277, DOI 10.1016/S0014-5793(98)01141-7; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; van Voorst F, 2000, FEBS LETT, V486, P57, DOI 10.1016/S0014-5793(00)02209-2; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; VIKINGSTAD E, 1980, J COLLOID INTERF SCI, V74, P16, DOI 10.1016/0021-9797(80)90166-6; Wang LG, 2000, J BIOL CHEM, V275, P10154, DOI 10.1074/jbc.275.14.10154; WANG ZL, 1993, BIOCHEMISTRY-US, V32, P13991, DOI 10.1021/bi00213a032; Weinkauf S, 2001, ACTA CRYSTALLOGR D, V57, P559, DOI 10.1107/S0907444901001202; WENNERSTROM H, 1979, PHYS REP, V52, P1, DOI 10.1016/0370-1573(79)90087-5; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393	70	85	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3628	3638		10.1074/jbc.M205992200	http://dx.doi.org/10.1074/jbc.M205992200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12403785	hybrid			2022-12-27	WOS:000180869700016
J	Lee, YH; Giraud, J; Davis, RJ; White, MF				Lee, YH; Giraud, J; Davis, RJ; White, MF			c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; RECEPTOR SUBSTRATE-1 IRS-1; NH2-TERMINAL KINASE; TYROSINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; MICE LACKING; FACTOR-ALPHA; RESISTANCE; OBESITY	Activation of the c-Jun N-terminal kinase (JNK) by proinflammatory cytokines inhibits insulin signaling, at least in part, by stimulating phosphorylation of rat/mouse insulin receptor substrate 1 (Irs1) at Ser(307) (Ser(312) in human IRS1). Here we show that JNK mediated feedback inhibition of the insulin signal in mouse embryo fibroblasts, 3T3-L1 adipocytes, and 32D(IR) Cells. Insulin stimulation of JNK activity required phosphatidylinositol 3-kinase and Grb2 signaling. Moreover, activation of JNK by insulin was inhibited by a cell-permeable peptide that disrupted the interaction of JNK with cellular proteins. However, the direct binding of JNK to Irs1 was not required for its activation by insulin, whereas direct binding was required for Ser(307) phosphorylation of Irs1. Insulin-stimulated Ser(307) phosphorylation was reduced 80% in cells lacking JNK1 and JNK2 or in cells expressing a mutant Irs1 protein lacking the JNK binding site. Reduced Ser(307) phosphorylation was directly related to increased insulin-stimulated tyrosine phosphorylation, Akt phosphorylation, and glucose uptake. These results support the hypothesis that JNK is a negative feedback regulator of insulin action by phosphorylating Ser(307) in Irs1.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, Boston, MA 02215 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Howard Hughes Med Inst,Program Mol Med, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	White, MF (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.	morris.white@joslin.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R01DK063368, R29DK038712, R55DK038712, P30DK032520] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32520, DK38712, DK63368] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; BARON SH, 1982, DIABETES CARE, V5, P64, DOI 10.2337/diacare.5.1.64; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Carter EA, 1998, NUTR REV, V56, pS170; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Coso OA, 1996, J BIOL CHEM, V271, P3963; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; DeFronzo RA, 1997, DIABETES REV, V5, P177; Desbois-Mouthon C, 1998, BIOCHEM BIOPH RES CO, V243, P765, DOI 10.1006/bbrc.1998.8181; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Facchini FS, 2000, FREE RADICAL BIO MED, V29, P1302, DOI 10.1016/S0891-5849(00)00438-X; Fukunaga K, 2000, J BIOL CHEM, V275, P5208, DOI 10.1074/jbc.275.7.5208; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jakobsen SN, 2001, J BIOL CHEM, V276, P46912, DOI 10.1074/jbc.C100483200; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Krause D, 2001, J BIOL CHEM, V276, P19244, DOI 10.1074/jbc.M008186200; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Liu YF, 2001, J BIOL CHEM, V276, P14459, DOI 10.1074/jbc.M007281200; LopezIlasaca M, 1997, BIOCHEM BIOPH RES CO, V232, P273, DOI 10.1006/bbrc.1997.6289; Miller BS, 1996, BIOCHEMISTRY-US, V35, P8769, DOI 10.1021/bi952651r; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MIZOCK BA, 1995, AM J MED, V98, P75, DOI 10.1016/S0002-9343(99)80083-7; Myers MG, 1996, MOL CELL BIOL, V16, P4147; MYERS MG, 1994, MOL CELL BIOL, V14, P3577, DOI 10.1128/MCB.14.6.3577; Nelms K, 1999, MAMM GENOME, V10, P1160, DOI 10.1007/s003359901183; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Schwertfeger KL, 2000, MOL ENDOCRINOL, V14, P1592, DOI 10.1210/me.14.10.1592; Shapiro PS, 1996, J BIOL CHEM, V271, P5750, DOI 10.1074/jbc.271.10.5750; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Standaert ML, 1999, ENDOCRINOLOGY, V140, P2145, DOI 10.1210/en.140.5.2145; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Uchida T, 2000, MOL CELL BIOL, V20, P126, DOI 10.1128/MCB.20.1.126-138.2000; Uysal KT, 1998, ENDOCRINOLOGY, V139, P4832, DOI 10.1210/en.139.12.4832; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; WHITE MF, 2001, ENDOCRINOLOGY, V3, P712; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Withers DJ, 1999, CURR OPIN ENDOCRINOL, V6, P141; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yenush L, 1997, BIOESSAYS, V19, P491, DOI 10.1002/bies.950190608; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	65	321	347	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2896	2902		10.1074/jbc.M208359200	http://dx.doi.org/10.1074/jbc.M208359200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12417588	hybrid			2022-12-27	WOS:000180915000018
J	Li, CH; Najafi, H; Daikhin, Y; Nissim, IB; Collins, HW; Yudkoff, M; Matschinsky, FM; Stanley, CA				Li, CH; Najafi, H; Daikhin, Y; Nissim, IB; Collins, HW; Yudkoff, M; Matschinsky, FM; Stanley, CA			Regulation of leucine-stimulated insulin secretion and glutamine metabolism in isolated rat islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERINSULINISM/HYPERAMMONEMIA SYNDROME; DEHYDROGENASE GENE; PANCREATIC-ISLETS; GLUCOSE; MUTATIONS; SYNAPTOSOMES; MESSENGER; CHILDREN; LIVER; BRAIN	Glutamate dehydrogenase (GDH) is regulated by both positive (leucine and ADP) and negative (GTP and ATP) allosteric factors. We hypothesized that the phosphate potential of beta-cells regulates the sensitivity of leucine stimulation. These predictions were tested by measuring leucine-stimulated insulin secretion in perifused rat islets following glucose depletion and by tracing the nitrogen flux of [2-N-15]glutamine using stable isotope techniques. The sensitivity of leucine stimulation was enhanced by long time (120-min) energy depletion and inhibited by glucose pretreatment. After limited 50-min glucose depletion, leucine, not alpha-ketoisocaproate, failed to stimulate insulin release. beta-Cells sensitivity to leucine is therefore proposed to be a function of GDH activation. Leucine increased the flux through GDH 3-fold compared with controls while causing insulin release. High glucose inhibited flux through both glutaminase and GDH, and leucine was unable to override this inhibition. These results clearly show that leucine induced the secretion of insulin by augmenting glutaminolysis through activating glutaminase and GDH. Glucose regulates beta-cell sensitivity to leucine by elevating the ratio of ATP and GTP to ADP and Pi and thereby decreasing the flux through GDH and glutaminase. These mechanisms provide an explanation for hypoglycemia caused by mutations of GDH in children.	Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Child Dev & Pediat Rehabil, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Stanley, CA (corresponding author), Childrens Hosp Philadelphia, Div Endocrinol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.			STANLEY, CHARLES/0000-0003-4881-9392	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056268, R01DK053012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037915] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 26979] Funding Source: Medline; NIDDK NIH HHS [R01 DK 56268, R01 DK 53012] Funding Source: Medline; NINDS NIH HHS [NS 37915] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; Brosnan JT, 2001, J BIOL CHEM, V276, P31876, DOI 10.1074/jbc.M103890200; COOPER AJL, 1979, J BIOL CHEM, V254, P4982; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; Fajans S S, 1967, Recent Prog Horm Res, V23, P617; Gao Z, 1999, DIABETES, V48, P1535, DOI 10.2337/diabetes.48.8.1535; GROSS M, 1976, BIOCHEM BIOPH RES CO, V70, P373, DOI 10.1016/0006-291X(76)91056-1; Hsu BYL, 2001, J PEDIATR-US, V138, P383, DOI 10.1067/mpd.2001.111818; MacDonald MJ, 2000, J BIOL CHEM, V275, P34025, DOI 10.1074/jbc.C000411200; MacMullen C, 2001, J CLIN ENDOCR METAB, V86, P1782, DOI 10.1210/jc.86.4.1782; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 2002, DIABETES, V51, pS99, DOI 10.2337/diabetes.51.2007.S99; MATSCHINSKY FM, 1972, P 8 MIDW C END MET O, P63; MICHALIK M, 1992, METABOLISM, V41, P1319, DOI 10.1016/0026-0495(92)90102-G; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Stanley CA, 2000, DIABETES, V49, P667, DOI 10.2337/diabetes.49.4.667; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; TRUS M, 1980, DIABETES, V29, P1, DOI 10.2337/diabetes.29.1.1; WRZESZCZYNSKI KO, 1994, BIOCHEMISTRY-US, V33, P11544, DOI 10.1021/bi00204a017; Yamada S, 2001, ENDOCR J, V48, P391, DOI 10.1507/endocrj.48.391; YUDKOFF M, 1991, J NEUROCHEM, V57, P153, DOI 10.1111/j.1471-4159.1991.tb02110.x; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414	22	124	129	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2853	2858		10.1074/jbc.M210577200	http://dx.doi.org/10.1074/jbc.M210577200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12444083	hybrid			2022-12-27	WOS:000180915000013
J	Li, S; Takasu, T; Perlman, DM; Peterson, MS; Burrichter, D; Avdulov, S; Bitterman, PB; Polunovsky, VA				Li, S; Takasu, T; Perlman, DM; Peterson, MS; Burrichter, D; Avdulov, S; Bitterman, PB; Polunovsky, VA			Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; MALIGNANT-TRANSFORMATION; INITIATION FACTOR-4E; GENE-EXPRESSION; GROWTH-FACTOR; ACTIVATION; PHOSPHORYLATION; FIBROBLASTS; BINDING; MATTER	Eukaryotic translation initiation factor 4E (eIF4E) markedly reduces cellular susceptibility to apoptosis. However, the mechanism by which the translation apparatus operates on the cellular apoptotic machinery remains uncertain. Here we show that eIF4E-mediated rescue from Myc-dependent apoptosis is accompanied by inhibition of mitochondrial cytochrome c release. Experiments achieving gain and loss of function demonstrate that eIF4E-mediated rescue is governed by pre-translational and translational activation of bcl-x as well as by additional intermediates acting directly on, or upstream of, the mitochondria. Thus, our data trace a pathway controlling apoptotic susceptibility that begins with the activity state of the protein synthesis machinery and leads to interdiction of the apoptotic program at the mitochondrial checkpoint.	Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan	University of Minnesota System; University of Minnesota Twin Cities; Osaka Medical College	Bitterman, PB (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.	bitte001@umn.edu		Perlman, David/0000-0001-7055-0970; BITTERMAN, PETER/0000-0002-7995-7117	NHLBI NIH HHS [2P50-HL50152, HL 07741-07] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL050152] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; De Benedetti A, 1999, INT J BIOCHEM CELL B, V31, P59, DOI 10.1016/S1357-2725(98)00132-0; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; DEBENEDETTI A, 1991, MOL CELL BIOL, V11, P5435, DOI 10.1128/MCB.11.11.5435; Eischen CM, 2001, ONCOGENE, V20, P6983, DOI 10.1038/sj.onc.1204892; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; Geballe AP, 2000, COLD SPRING HARBOR M, V39, P595; GRAFF JR, 1995, INT J CANCER, V60, P255; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Grillot DAM, 1997, J IMMUNOL, V158, P4750; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; Harigai M, 1996, ONCOGENE, V12, P1369; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kirito K, 2002, J BIOL CHEM, V277, P8329, DOI 10.1074/jbc.M109824200; KLEIN PS, 1994, SCIENCE, V265, P803, DOI 10.1126/science.8047887; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LevyStrumpf N, 1997, MOL CELL BIOL, V17, P1615, DOI 10.1128/MCB.17.3.1615; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Marchetti P, 1996, CANCER RES, V56, P2033; Margue CM, 2000, ONCOGENE, V19, P2921, DOI 10.1038/sj.onc.1203607; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; PALMITER RD, 1974, J BIOL CHEM, V249, P6779; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Polunovsky VA, 2000, J BIOL CHEM, V275, P24776, DOI 10.1074/jbc.M001938200; Pyronnet S, 2000, BIOCHEM PHARMACOL, V60, P1237, DOI 10.1016/S0006-2952(00)00429-9; Raught B, 2000, COLD SPRING HARBOR M, V39, P245; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; RINKERSCHAEFFER CW, 1993, INT J CANCER, V55, P841, DOI 10.1002/ijc.2910550525; Rousseau D, 1996, ONCOGENE, V13, P2415; Rudin CM, 1997, ANNU REV MED, V48, P267; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Sevilla L, 1999, MOL CELL BIOL, V19, P2624; SMITH M R, 1990, New Biologist, V2, P648; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Strudwick S, 2002, DIFFERENTIATION, V70, P10, DOI 10.1046/j.1432-0436.2002.700102.x; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tan A, 2000, ONCOGENE, V19, P1437, DOI 10.1038/sj.onc.1203446; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wang XD, 2001, GENE DEV, V15, P2922; Wendt CH, 1998, AM J PHYSIOL-CELL PH, V274, pC356, DOI 10.1152/ajpcell.1998.274.2.C356; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; Zamzami N, 1996, FEBS LETT, V384, P53, DOI 10.1016/0014-5793(96)00280-3	58	98	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3015	3022		10.1074/jbc.M208821200	http://dx.doi.org/10.1074/jbc.M208821200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441348	hybrid			2022-12-27	WOS:000180915000033
J	Manciu, L; Chang, XB; Buyse, F; Hou, YX; Gustot, A; Riordan, JR; Ruysschaert, JM				Manciu, L; Chang, XB; Buyse, F; Hou, YX; Gustot, A; Riordan, JR; Ruysschaert, JM			Intermediate structural states involved in MRP1-mediated drug transport - Role of glutathione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; TRANSFORM INFRARED-SPECTROSCOPY; TERTIARY STRUCTURE CHANGES; CONJUGATE EXPORT PUMP; AMINO-ACID RESIDUE; TUMOR-CELL-LINES; P-GLYCOPROTEIN; ATPASE ACTIVITY; CONFORMATIONAL-CHANGES; SECONDARY STRUCTURE	Human multidrug resistance protein 1 (MRP1) is a member of the ATP-binding cassette transporter family and transports chemotherapeutic drugs as well as diverse organic anions such as leukotriene LTC4. The transport of chemotherapeutic drugs requires the presence of reduced GSH. By using hydrogen/deuterium exchange kinetics and limited trypsin digestion, the structural changes associated with each step of the drug transport process are analyzed. Purified MRP1 is reconstituted into lipid vesicles with an inside-out orientation, exposing its cytoplasmic region to the external medium. The resulting proteoliposomes have been shown previously to exhibit both ATP-dependent drug transport and drug-stimulated ATPase activity. Our results show that during GSH-dependent drug transport, MRP1 does not undergo secondary structure changes but only modifications in its accessibility toward the external environment. Drug binding induces a restructuring of MRP1 membrane-embedded domains that does not affect the cytosolic domains, including the nucleotide binding domains, responsible for ATP hydrolysis. This demonstrates that drug binding to MRP1 is not sufficient to propagate an allosteric signal between the membrane and the cytosolic domains. On the other hand, GSH binding induces a conformational change that affects the structural organization of the cytosolic domains and enhances ATP binding and/or hydrolysis suggesting that GSH-mediated conformational changes are required for the coupling between drug transport and ATP hydrolysis. Following ATP binding, the protein adopts a conformation characterized by a decreased stability and/or an increased accessibility toward the aqueous medium. No additional change in the accessibility toward the solvent and/or the stability of this specific conformational state and no change of the transmembrane helices orientation are observed upon ATP hydrolysis. Binding of a non-transported drug affects the dynamic changes occurring during ATP binding and hydrolysis and restricts the movement of the drug and its release.	Free Univ Brussels, Lab Struct & Fonct Membranes Biol, Ctr Struct Biol & Bioinformat, B-1050 Brussels, Belgium; Mayo Clin, SC Johnson Med Res Ctr, Scottsdale, AZ 85259 USA	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Mayo Clinic; Mayo Clinic Phoenix; SC Johnson & Son	Ruysschaert, JM (corresponding author), Free Univ Brussels, Lab Struct & Fonct Membranes Biol, Ctr Struct Biol & Bioinformat, CP 206-2,Bd Triomphe, B-1050 Brussels, Belgium.							Bakker M, 1997, INT J CANCER, V73, P362, DOI 10.1002/(SICI)1097-0215(19971104)73:3<362::AID-IJC10>3.0.CO;2-F; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Bechinger B, 1999, BIOPHYS J, V76, P552, DOI 10.1016/S0006-3495(99)77223-1; Blackmore CG, 2001, MOL MEMBR BIOL, V18, P97, DOI 10.1080/09687680010030200; BREUNINGER LM, 1995, CANCER RES, V55, P5342; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang XB, 1997, J BIOL CHEM, V272, P30962, DOI 10.1074/jbc.272.49.30962; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574; Daoud R, 2001, J BIOL CHEM, V276, P12324, DOI 10.1074/jbc.M009782200; Daoud R, 2000, BIOCHEMISTRY-US, V39, P6094, DOI 10.1021/bi9922188; Ding GY, 1999, ANTICANCER RES, V19, P3243; Evers R, 1996, J CLIN INVEST, V97, P1211, DOI 10.1172/JCI118535; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1996, APPL SPECTROSC, V50, P1519, DOI 10.1366/0003702963904610; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; GOORMAGHTIGH E, 1990, MOL DESCRIPTION BIOL, P285; Grimard V, 2001, BIOCHEMISTRY-US, V40, P11876, DOI 10.1021/bi010017+; HELMICHDEJONG ML, 1987, BIOCHIM BIOPHYS ACTA, V905, P358, DOI 10.1016/0005-2736(87)90464-0; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1999, BBA-BIOMEMBRANES, V1461, P359, DOI 10.1016/S0005-2736(99)00168-6; Hooijberg JH, 2000, FEBS LETT, V469, P47, DOI 10.1016/S0014-5793(00)01238-2; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Jedlitschky G, 1996, CANCER RES, V56, P988; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; Kashiwayama Y, 2002, BIOCHEM BIOPH RES CO, V291, P1245, DOI 10.1006/bbrc.2002.6588; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; Kast C, 1998, BIOCHEMISTRY-US, V37, P2305, DOI 10.1021/bi972332v; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; Loe DW, 1996, J BIOL CHEM, V271, P9683, DOI 10.1074/jbc.271.16.9683; Loe DW, 1998, CANCER RES, V58, P5130; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; Loo TW, 1997, J BIOL CHEM, V272, P20986, DOI 10.1074/jbc.272.34.20986; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; Manciu L, 2000, BIOCHEMISTRY-US, V39, P13026, DOI 10.1021/bi001043v; Mao QC, 2002, J BIOL CHEM, V277, P28690, DOI 10.1074/jbc.M202182200; Marsh D, 2000, BIOPHYS J, V78, P2499, DOI 10.1016/S0006-3495(00)76795-6; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Qian YM, 2001, J BIOL CHEM, V276, P38636, DOI 10.1074/jbc.M107025200; Qian YM, 2001, J BIOL CHEM, V276, P6404, DOI 10.1074/jbc.M008251200; Rappa G, 1997, CANCER RES, V57, P5232; Renes J, 1999, BRIT J PHARMACOL, V126, P681, DOI 10.1038/sj.bjp.0702360; Rhee KH, 2002, EMBO J, V21, P3582, DOI 10.1093/emboj/cdf385; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; Vanhoefer U, 1996, CLIN CANCER RES, V2, P1961; VERSANTVOORT CHM, 1995, BRIT J CANCER, V72, P82, DOI 10.1038/bjc.1995.281; Vigano C, 2002, J BIOL CHEM, V277, P5008, DOI 10.1074/jbc.M107928200; Wang GC, 1997, BIOCHEM J, V328, P897, DOI 10.1042/bj3280897; Wang GC, 1998, EUR J BIOCHEM, V255, P383, DOI 10.1046/j.1432-1327.1998.2550383.x; ZAMAN GJR, 1995, P NATL ACAD SCI USA, V92, P7690, DOI 10.1073/pnas.92.17.7690; ZAMAN GJR, 1994, P NATL ACAD SCI USA, V91, P8822, DOI 10.1073/pnas.91.19.8822; Zhang DW, 2002, J BIOL CHEM, V277, P20934, DOI 10.1074/jbc.M201311200; Zhang DW, 2001, J BIOL CHEM, V276, P34966, DOI 10.1074/jbc.M105063200; Zhang DW, 2001, J BIOL CHEM, V276, P13231, DOI 10.1074/jbc.M010008200	67	53	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3347	3356		10.1074/jbc.M207963200	http://dx.doi.org/10.1074/jbc.M207963200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12424247	hybrid			2022-12-27	WOS:000180915000074
J	Shinkawa, T; Nakamura, K; Yamane, N; Shoji-Hosaka, E; Kanda, Y; Sakurada, M; Uchida, K; Anazawa, H; Satoh, M; Yamasaki, M; Hanai, N; Shitara, K				Shinkawa, T; Nakamura, K; Yamane, N; Shoji-Hosaka, E; Kanda, Y; Sakurada, M; Uchida, K; Anazawa, H; Satoh, M; Yamasaki, M; Hanai, N; Shitara, K			The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; EXPRESSION; CLONING; GLYCOSYLATION; CARBOHYDRATE; GLYCOFORMS; RECEPTORS; AFFINITY; BINDING	An anti-human interleukin 5 receptor (hIL-5R) humanized immunoglobulin G1 (IgG1) and an anti-CD20 chimeric IgG1 produced by rat hybridoma YB2/0 cell lines showed more than 50-fold higher antibody-dependent cellular cytotoxicity (ADCC) using purified human peripheral blood mononuclear cells as effector than those produced by Chinese hamster ovary (CHO) cell lines. Monosaccharide composition and oligosaccharide profiling analysis showed that low fucose (Fue) content of complex-type oligosaccharides was characteristic in YB2/0-produced IgG1s compared with high Fuc content of CHO-produced IgG1s. YB2/0-produced anti-hIL-5R IgG1 was subjected to Lens culinaris aggulutin affinity column and fractionated based on the contents of Fuc. The lower Fuc IgG1 had higher ADCC than the IgG1 before separation. In contrast, the content of bisecting GlcNAc of the IgG1 affected ADCC much less than that of Fuc. In addition, the correlation between Gal and ADCC was not observed. When the combined effect of Fuc and bisecting GlcNAc was examined in anti-CD20 IgG1, only a severalfold increase of ADCC was observed by the addition of GlcNAc to highly fucosylated IgG1. Quantitative PCR analysis indicated that YB2/0 cells had lower expression level of FUT8 mRNA, which codes alpha1,6-fucosyltransferase, than CHO cells. Overexpression of FUT8 mRNA in YB2/0 cells led to an increase of fucosylated oligosaccharides and decrease of ADCC of the IgG1. These results indicate that the lack of fucosylation of IgG1 has the most critical role in enhancement of ADCC, although several reports have suggested the importance of Gal or bisecting GlcNAc and provide important information to produce the effective therapeutic antibody.	Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, Machida, Tokyo 1948533, Japan	Kyowa Kirin Ltd	Shitara, K (corresponding author), Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, 3-6-6 Asahi Machi, Machida, Tokyo 1948533, Japan.	kshitara@kyowa.co.jp						Boyd PN, 1995, MOL IMMUNOL, V32, P1311, DOI 10.1016/0161-5890(95)00118-2; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Hayashi H, 2000, DNA SEQUENCE, V11, P91, DOI 10.3109/10425170009033974; JEFFERIS R, 1990, BIOCHEM J, V268, P529, DOI 10.1042/bj2680529; Kumpel Belinda M., 1994, Human Antibodies and Hybridomas, V5, P143; Kumpel Belinda M., 1995, Human Antibodies and Hybridomas, V6, P82; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; Lifely MR, 1995, GLYCOBIOLOGY, V5, P813, DOI 10.1093/glycob/5.8.813; Masuda K, 2000, FEBS LETT, V473, P349, DOI 10.1016/S0014-5793(00)01557-X; McGuire JM, 1996, CARBOHYD RES, V292, P1; Mukhopadhyay C, 1998, BIOPOLYMERS, V45, P177, DOI 10.1002/(SICI)1097-0282(199803)45:3<177::AID-BIP1>3.0.CO;2-O; Nakamura K, 2000, MOL IMMUNOL, V37, P1035, DOI 10.1016/S0161-5890(01)00021-9; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; OHTA S, 1993, CANCER IMMUNOL IMMUN, V36, P260, DOI 10.1007/BF01740908; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; RADEMACHER TW, 1986, BIOCHEM SOC SYMP, P131; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Stubbs HJ, 1996, BIOCHEMISTRY-US, V35, P937, DOI 10.1021/bi9513719; TAKAHASHI N, 1987, BIOCHEMISTRY-US, V26, P1137, DOI 10.1021/bi00378a023; TAKAHASHI N, 1986, BIOCHEMISTRY-US, V25, P388, DOI 10.1021/bi00350a018; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; URLAUB G, 1986, SOMAT CELL MOLEC GEN, V12, P555, DOI 10.1007/BF01671941; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626	33	1036	1581	4	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3466	3473		10.1074/jbc.M210665200	http://dx.doi.org/10.1074/jbc.M210665200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427744	hybrid			2022-12-27	WOS:000180915000088
J	Tan, MQ; Xu, XM; Ohba, M; Ogawa, W; Cui, MZ				Tan, MQ; Xu, XM; Ohba, M; Ogawa, W; Cui, MZ			Thrombin rapidly induces protein kinase D phosphorylation, and protein kinase C delta mediates the activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; GENE-EXPRESSION; DIFFERENTIATION; DIACYLGLYCEROL; INHIBITION; PLATELETS; INDUCTION; ISOFORMS; EPSILON; TARGET	Thrombin plays a critical role in hemostasis, thrombosis, and inflammation. However, the responsible intracellular signaling pathways triggered by thrombin are still not well defined. We report here that thrombin rapidly and transiently induces activation of protein kinase D (PYD) in aortic smooth muscle cells. Our data demonstrate that protein kinase C (PKC) inhibitors completely block thrombin-induced PKD activation, suggesting that thrombin induces PKD activation via a PKC-dependent pathway. Furthermore, our results show that thrombin rapidly induces PKCdelta phosphorylation and that the PKCS-specific inhibitor rottlerin blocks thrombin-induced PKD activation, suggesting that PKCS mediates the thrombin-induced PKD activation. Using dominant negative approaches, we demonstrated that expression of a dominant negative PKCdelta inhibits the phosphorylation and activation of PKD induced by thrombin, whereas neither PKCEepsilon nor PKCzeta affects thrombin-induced PKD activation. In addition, our results of co-immunoprecipitation assays showed that PKD forms a complex with PKCdelta in smooth muscle cells. Taken together, the findings of the present study demonstrate that thrombin induces activation of PKD and reveal a novel role of PKCdelta in mediating thrombin-induced PKD activation in vascular smooth muscle cells.	Univ Tennessee, Coll Vet Med, Dept Pathol, Knoxville, TN 37996 USA; Showa Univ, Inst Mol Oncol, Shinagawa Ku, Tokyo 1428555, Japan; Kobe Univ, Dept Clin Mol Med, Kobe, Hyogo 6500017, Japan	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Showa University; Kobe University	Cui, MZ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Pathol, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	OGAWA, Wataru/AAQ-9586-2020	Cui, Mei-Zhen/0000-0003-4745-6999; xu, xuemin/0000-0002-7426-272X	NINDS NIH HHS [NS42314] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASSENDER JW, 1994, FEBS LETT, V342, P76, DOI 10.1016/0014-5793(94)80588-1; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bregoli L, 2001, J BIOL CHEM, V276, P23288, DOI 10.1074/jbc.M101501200; Chung SH, 2000, J BIOL CHEM, V275, P25286, DOI 10.1074/jbc.M004204200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cui MZ, 1999, J BIOL CHEM, V274, P32795, DOI 10.1074/jbc.274.46.32795; DIXON BS, 1994, AM J PHYSIOL, V266, pC1406, DOI 10.1152/ajpcell.1994.266.5.C1406; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Li QJ, 2000, BLOOD, V96, P3696, DOI 10.1182/blood.V96.12.3696.h8003696_3696_3706; Li WQ, 1996, ONCOGENE, V13, P731; MARI B, 1994, J BIOL CHEM, V269, P8517; Matsumoto M, 2001, J BIOL CHEM, V276, P14400, DOI 10.1074/jbc.M011093200; Maulon L, 2001, ONCOGENE, V20, P1964, DOI 10.1038/sj.onc.1204266; Morgan KG, 1998, ACTA PHYSIOL SCAND, V164, P495; Moussazadeh M, 1998, FEBS LETT, V438, P225, DOI 10.1016/S0014-5793(98)01302-7; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Osterud B, 2001, SEMIN THROMB HEMOST, V27, P605, DOI 10.1055/s-2001-18866; Pang LH, 2002, FASEB J, V16, P1435, DOI 10.1096/fj.02-0169fje; Patterson C, 2001, CIRC RES, V88, P987, DOI 10.1161/hh1001.091447; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; STAFFORD MJ, 2003, IN PRESS BLOOD; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 2002, INT J BIOCHEM CELL B, V34, P577, DOI 10.1016/S1357-2725(01)00163-7; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 1999, ELECTROPHORESIS, V20, P382, DOI 10.1002/(SICI)1522-2683(19990201)20:2<382::AID-ELPS382>3.0.CO;2-N; XU YP, 1995, J BIOL CHEM, V270, P23887, DOI 10.1074/jbc.270.41.23887; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	30	49	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2824	2828		10.1074/jbc.M211523200	http://dx.doi.org/10.1074/jbc.M211523200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431976	hybrid			2022-12-27	WOS:000180915000009
J	Matsuzawa, S; Li, CL; Ni, CZ; Takayama, S; Reed, JC; Ely, KR				Matsuzawa, S; Li, CL; Ni, CZ; Takayama, S; Reed, JC; Ely, KR			Structural analysis of Siah1 and its interactions with Siah-interacting protein (SIP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; TRANSCRIPTIONAL REPRESSOR; REGULATED PROTEOLYSIS; PROTEASOME PATHWAY; CRYSTAL-STRUCTURE; ABSENTIA; ACTIVATION; RNA; P53; MUTATIONS	Seven in absentia homologue (Siah) family proteins bind ubiquitin-conjugating enzymes and target proteins for proteasome-mediated degradation. Recently we identified a novel Siah-interacting protein (SIP) that is a Sgt1-related molecule that provides a physical link between Siah family proteins and the Skp1-Cullin-F-box ubiquitin ligase component Skp1. In the present study, a structure-based approach was used to identify interacting residues in Siah that are required for association with SIP. In Siah1 a large concave surface is formed across the dimer interface. Analysis of the electrostatic surface potential of the Siah1 dimer reveals that the beta-sheet concavity is predominately electronegative, suggesting that the protein-protein interactions between Siah1 and SIP are mediated by ionic contacts. The structural prediction was confirmed by site-directed mutagenesis of these electronegative residues, resulting in loss of binding of Siah1 to SIP in vitro and in cells. The results also provide a structural basis for understanding the mechanism by which Siah family proteins interact with partner proteins such as SIP.	Burnham Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Matsuzawa, S (corresponding author), Burnham Inst, La Jolla, CA 92037 USA.		Li, Chenglong/E-7182-2010	Li, Chenglong/0000-0003-3174-8719				Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 2002, J BIOL CHEM, V277, P21103, DOI 10.1074/jbc.M111010200; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Germani A, 1999, MOL CELL BIOL, V19, P3798; Germani A, 2000, ONCOGENE, V19, P5997, DOI 10.1038/sj.onc.1204002; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li SH, 2002, MOL CELL BIOL, V22, P6854, DOI 10.1128/MCB.22.19.6854-6865.2002; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NI CZ, 1995, STRUCTURE, V3, P255, DOI 10.1016/S0969-2126(01)00156-3; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; VALEGARD K, 1994, NATURE, V371, P623, DOI 10.1038/371623a0; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775	36	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1837	1840		10.1074/jbc.M210263200	http://dx.doi.org/10.1074/jbc.M210263200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421809	hybrid			2022-12-27	WOS:000180462200063
J	Ou, YJ; Strege, P; Miller, SM; Makielski, J; Ackerman, M; Gibbons, SJ; Farrugia, G				Ou, YJ; Strege, P; Miller, SM; Makielski, J; Ackerman, M; Gibbons, SJ; Farrugia, G			Syntrophin gamma 2 regulates SCN5A Gating by a PDZ domain-mediated interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MECHANOSENSITIVE CALCIUM-CHANNEL; LONG-QT SYNDROME; SODIUM-CHANNELS; DYSTROPHIN; CELLS; MUSCLE; ALPHA-1-SYNTROPHIN; LOCALIZATION; PROTEINS	SCN5A encodes the a subunit of the cardiac muscle and intestinal smooth muscle mechanosensitive Na+ channel. Mechanosensitivity in the intestine requires an intact cytoskeleton. We report, using laser capture microdissection, single cell PCR, and immunohistochemistry, that syntrophins, scaffolding proteins, were expressed in human intestinal smooth muscle cells. The distribution of syntrophin gamma2 was similar to that of SCN5A. Yeast two-hybrid and glutathione S-transferase pull-down experiments show that SCN5A and syntrophin gamma2 co-express and that the PDZ domain of syntrophin gamma2 directly interacts with the C terminus of SCN5A. In native cells, disruption of the C terminus-syntrophin gamma2 PDZ domain interaction using peptides directed against either region result in loss of mechanosensitivity. Co-transfection of syntrophin gamma2 with SCN5A in HEK293 cells markedly shifts the activation kinetics of SCN5A and reduces the availability of Na+ current. We propose that syntrophin gamma2 is an essential Na+ channel-interacting protein required for the full expression of the Na+ current and that the SCN5A-syntrophin gamma2 interaction determines mechanosensitivity and current availability.	Mayo Clin & Mayo Fdn, Enter Neurosci Program, Dept Physiol & Biophys, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Internal Med Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pediat Pediat Cardiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Expt Therapeut, Rochester, MN 55905 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison	Farrugia, G (corresponding author), Mayo Clin & Mayo Fdn, Enter Neurosci Program, Dept Physiol & Biophys, 200 1st St SW,Guggenheim 8, Rochester, MN 55905 USA.			Strege, Peter/0000-0003-4571-2207; Gibbons, Simon/0000-0001-5311-5993	NATIONAL EYE INSTITUTE [R01EY006005, R01EY003282, R37EY003282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017238, R01DK057061, R37DK017238, R01DK052766] Funding Source: NIH RePORTER; NEI NIH HHS [EY03282, EY06005] Funding Source: Medline; NIDDK NIH HHS [DK52766, DK57061, DK17238] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackerman MJ, 2001, JAMA-J AM MED ASSOC, V286, P2264, DOI 10.1001/jama.286.18.2264; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; ATTWELL D, 1979, PFLUG ARCH EUR J PHY, V379, P137, DOI 10.1007/BF00586939; Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CANTIELLO HF, 1995, KIDNEY INT, V48, P970, DOI 10.1038/ki.1995.379; Farrugia G, 1999, ANNU REV PHYSIOL, V61, P45, DOI 10.1146/annurev.physiol.61.1.45; Farrugia G, 1999, GASTROENTEROLOGY, V117, P900, DOI 10.1016/S0016-5085(99)70349-5; Franco-Obregon A, 2002, J PHYSIOL-LONDON, V539, P391, DOI 10.1113/jphysiol.2001.013043; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gee SH, 1998, J NEUROSCI, V18, P128; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Gu CX, 2001, BIOPHYS J, V80, P2678, DOI 10.1016/S0006-3495(01)76237-6; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hogan A, 2001, J BIOL CHEM, V276, P26526, DOI 10.1074/jbc.M104156200; Holm AN, 2002, GASTROENTEROLOGY, V122, P178, DOI 10.1053/gast.2002.30346; Holm AN, 2000, AM J PHYSIOL-GASTR L, V279, pG1155, DOI 10.1152/ajpgi.2000.279.6.G1155; Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193; Lyford GL, 2002, AM J PHYSIOL-CELL PH, V283, pC1001, DOI 10.1152/ajpcell.00140.2002; Maltsev VA, 1997, AM J PHYSIOL-HEART C, V273, pH1832, DOI 10.1152/ajpheart.1997.273.4.H1832; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Martinac B, 2001, CELL PHYSIOL BIOCHEM, V11, P61, DOI 10.1159/000047793; Miyagoe-Suzuki Y, 2001, MICROSC RES TECHNIQ, V55, P164, DOI 10.1002/jemt.1167; Morris CE, 2001, CELL MOL BIOL LETT, V6, P703; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Negulyaev YA, 2000, J BIOL CHEM, V275, P40933, DOI 10.1074/jbc.M008219200; OPSAHL LR, 1994, BIOPHYS J, V66, P71, DOI 10.1016/S0006-3495(94)80751-9; Ou Y, 2002, NEUROGASTROENT MOTIL, V14, P477, DOI 10.1046/j.1365-2982.2002.00348.x; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; Ribaux P, 2001, PFLUG ARCH EUR J PHY, V441, P746, DOI 10.1007/s004240000483; Roden DM, 2002, ANNU REV PHYSIOL, V64, P431, DOI 10.1146/annurev.physiol.64.083101.145105; Sachs F, 1998, REV PHYSIOL BIOCH P, V132, P1, DOI 10.1007/BFb0004985; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; STREGE P, 2002, IN PRESS AM J PHYSL; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; Tabarean IV, 2002, BIOPHYS J, V82, P2982, DOI 10.1016/S0006-3495(02)75639-7; UNDROVINAS AI, 1995, AM J PHYSIOL-HEART C, V269, pH203, DOI 10.1152/ajpheart.1995.269.1.H203; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3	46	83	87	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1915	1923		10.1074/jbc.M209938200	http://dx.doi.org/10.1074/jbc.M209938200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12429735	hybrid			2022-12-27	WOS:000180462200074
J	Rohde, J; Dietrich, L; Langosch, D; Ungermann, C				Rohde, J; Dietrich, L; Langosch, D; Ungermann, C			The transmembrane domain of Vam3 affects the composition of cis- and trans-SNARE complexes to promote homotypic vacuole fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION; T-SNARE; YEAST VACUOLE; SACCHAROMYCES-CEREVISIAE; PEPTIDE MIMICS; DOCKING STAGE; GTPASE YPT7P; SYNTAXIN 1A; IN-VITRO; V-SNARES	It is presently not clear how the function of SNARE proteins is affected by their transmembrane domains. Here, we analyzed the role of the transmembrane domain of the vacuolar SNARE Vam3 by replacing it by a lipid anchor. Vacuoles with mutant Vam3 fuse poorly and have increased amounts of cis-SNARE complexes, indicating that they are more stable. As a consequence efficient cis-SNARE complex disassembly that occurs at priming as a prerequisite of fusion requires addition of exogenous Sec18. trans-SNARE complexes in this mutant accumulate up to 4-fold over wild type, suggesting that the transmembrane domain of Vam3 is required to transit through this step. Finally, palmitoylation of Vac8, a reaction that also occurs early during priming is reduced by almost one-half. Since palmitoylated Vac8 is required beyond trans-SNARE complex formation, this may partially explain the fusion deficiency.	Tech Univ Munich, Lehrstuhl Chem Biopolymere, D-85345 Freising Weihenstephan, Germany; Univ Heidelberg, Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Univ Heidelberg, Interdiszliplinares Zentrum Neurowissensch IZN, D-69120 Heidelberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Langosch, D (corresponding author), Tech Univ Munich, Lehrstuhl Chem Biopolymere, Weihenstepaner Berg 3, D-85345 Freising Weihenstephan, Germany.			Dietrich, Lars/0000-0003-2049-1137				Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fleckenstein D, 1998, J CELL SCI, V111, P3109; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Grote E, 2000, J CELL BIOL, V151, P453, DOI 10.1083/jcb.151.2.453; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; IBARAKI K, 1995, BIOCHEM BIOPH RES CO, V211, P997, DOI 10.1006/bbrc.1995.1910; Katz L, 1998, EMBO J, V17, P6200, DOI 10.1093/emboj/17.21.6200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Laage R, 1997, EUR J BIOCHEM, V249, P540, DOI 10.1111/j.1432-1033.1997.00540.x; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Langosch D, 2001, J BIOL CHEM, V276, P32016, DOI 10.1074/jbc.M102579200; Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889; Lewis JL, 2001, J BIOL CHEM, V276, P15458, DOI 10.1074/jbc.M011687200; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Margittai M, 1999, FEBS LETT, V446, P40, DOI 10.1016/S0014-5793(99)00028-9; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Nonet ML, 1998, J NEUROSCI, V18, P70; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Pan XZ, 1998, J CELL SCI, V111, P2137; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Schneiter R, 2000, MOL CELL BIOL, V20, P2984, DOI 10.1128/MCB.20.9.2984-2995.2000; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wang Y, 2001, J BIOL CHEM, V276, P28598, DOI 10.1074/jbc.M101644200; Wang YX, 1996, MOL BIOL CELL, V7, P1375, DOI 10.1091/mbc.7.9.1375; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu ZY, 1996, J CELL BIOL, V132, P787, DOI 10.1083/jcb.132.5.787	64	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1656	1662		10.1074/jbc.M209522200	http://dx.doi.org/10.1074/jbc.M209522200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427733	hybrid			2022-12-27	WOS:000180462200039
J	Schuettengruber, B; Doetzlhofer, A; Kroboth, K; Wintersberger, E; Seiser, C				Schuettengruber, B; Doetzlhofer, A; Kroboth, K; Wintersberger, E; Seiser, C			Alternate activation of two divergently transcribed mouse genes from a bidirectional promoter is linked to changes in histone modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIDINE KINASE GENE; CELL-CYCLE; BINDING; SP1; DEACETYLASE-1; SPECIFICITY; COMPLEXES; SEQUENCES; ANTIGEN; TARGET	Thymidine kinase (TK) is a growth factor-inducible enzyme that is highly expressed in proliferating mammalian cells. Expression of mouse TK mRNA is controlled by transcriptional and posttranscriptional mechanisms including antisense transcription. Here we report the identification of a novel gene that is divergently transcribed from the bidirectional TK promoter. This gene encodes kynurenine formamidase (KF), an enzyme of the tryptophan metabolism. Whereas the TK gene is induced upon interleukin-2-mediated activation of resting T cells, the KF gene becomes simultaneously repressed. The TK promoter is regulated by E2F, SP1, histone acetyltransferases, and deacetylases. The binding site for the growth-regulated transcription factor E2F is beneficial for TK promoter activity but not required for KF expression. In contrast, the SP1 binding site is crucial for transcription in both directions. Inhibition of histone deacetylases by trichostatin A leads to increased histone acetylation at the TK/KF promoter and thereby to selective activation of the TK promoter and simultaneous shut-off of KF expression. Similarly, TK gene activation by interleukin-2 is linked to histone hyperacetylation, whereas KF expression correlates with reduced histone acetylation. The KF gene is the rare example of a mammalian gene whose expression is linked to histone hypoacetylation at its promoter.	Univ Vienna, Vienna Bioctr, Inst Med Biochem, Div Mol Biol, A-1030 Vienna, Austria	University of Vienna; Vienna Biocenter (VBC)	Seiser, C (corresponding author), Univ Vienna, Vienna Bioctr, Inst Med Biochem, Div Mol Biol, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.			Seiser, Christian/0000-0002-7046-9352; Schuettengruber, Bernd/0000-0001-7338-4648				Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Bartl S, 1997, MOL CELL BIOL, V17, P5033, DOI 10.1128/MCB.17.9.5033; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Dobrovolsky VN, 1999, MUTAT RES-FUND MOL M, V423, P125, DOI 10.1016/S0027-5107(98)00234-6; Dobrovolsky VN, 1996, ENVIRON MOL MUTAGEN, V28, P483, DOI 10.1002/(SICI)1098-2280(1996)28:4<483::AID-EM26>3.0.CO;2-A; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; DOU QP, 1991, P NATL ACAD SCI USA, V88, P1157, DOI 10.1073/pnas.88.4.1157; DOU QP, 1994, J BIOL CHEM, V269, P1306; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; FRIDOVICHKEIL JL, 1991, CELL GROWTH DIFFER, V2, P67; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Huhtinen K, 2002, J BIOL CHEM, V277, P3424, DOI 10.1074/jbc.M109040200; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; OGRIS E, 1993, J VIROL, V67, P1765, DOI 10.1128/JVI.67.4.1765-1771.1993; Pabarcus MK, 2002, BBA-PROTEIN STRUCT M, V1596, P201, DOI 10.1016/S0167-4838(02)00232-7; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; ROTHENEDER H, 1991, NUCLEIC ACIDS RES, V19, P6805, DOI 10.1093/nar/19.24.6805; SEISER C, 1993, J BIOL CHEM, V268, P13074; SEISER C, 1989, NUCLEIC ACIDS RES, V17, P185, DOI 10.1093/nar/17.1.185; Sorensen P, 1999, J BIOL CHEM, V274, P30943, DOI 10.1074/jbc.274.43.30943; Sutterluety H, 1998, NUCLEIC ACIDS RES, V26, P4989, DOI 10.1093/nar/26.21.4989; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; VONBOEHMER H, 1979, EUR J IMMUNOL, V9, P592, DOI 10.1002/eji.1830090804; WEICHSELBRAUN I, 1990, FEBS LETT, V275, P49, DOI 10.1016/0014-5793(90)81436-R; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wintersberger E, 1997, BIOCHEM SOC T, V25, P303, DOI 10.1042/bst0250303; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	29	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1784	1793		10.1074/jbc.M204843200	http://dx.doi.org/10.1074/jbc.M204843200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12411446	hybrid			2022-12-27	WOS:000180462200056
J	Ybarra, J; Bhattacharyya, AM; Panda, M; Horowitz, PM				Ybarra, J; Bhattacharyya, AM; Panda, M; Horowitz, PM			Active rhodanese lacking nonessential sulfhydryl groups contains an unstable C-terminal domain and can be bound, inactivated, and reactivated by GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LIVER RHODANESE; CHAPERONIN GROEL; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; DENATURED RHODANESE; CIRCULAR-DICHROISM; PROTEINS; RESOLUTION; STABILITY; BINDS	Mutation of all nonessential cysteine residues in rhodanese turns the enzyme into a form (C3S) that is fully active but less stable than wild type (WT). This less stable mutant allowed testing of two hypotheses; (a) the two domains of rhodanese are differentially stable, and (b) the chaperonin GroEL can bind better to less stable proteins. Reduced temperatures during expression and purification were required to limit inclusion bodies and obtain usable quantities of soluble C3S. C3S and WT have the same secondary structures by circular dichroism. C3S, in the absence of the substrate thiosulfate, is cleaved by trypsin to give a stable 21-kDa species. With thiosulfate, C3S is resistant to proteolysis. In contrast, wild type rhodanese is not proteolyzed significantly under any of the experimental conditions used here. Mass spectrometric analysis of bands from SDS gels of digested C3S indicated that the C-terminal domain of C3S was preferentially digested. Active C3S can exist in a state(s) recognized by GroEL, and it displays additional accessibility of tryptophans to acrylamide quenching. Unlike WT, the sulfur-loaded mutant form (C3S-ES) shows slow inactivation in the presence of GroEL. Both WT and C3S lacking transferred sulfur (WT-E and C3S-E) become inactivated. Inactivation is not due to irreversible covalent modification, since GroEL can reactivate both C3S-E and WT-E in the presence of GroES and ATP. C3S-E can be reactivated to 100%, the highest reactivation observed for any form of rhodanese. These results suggest that inactivation of C3S-E or WT-E is due to formation of an altered, labile conformation accessible from the native state. This conformation cannot as easily be achieved in the presence of the substrate, thiosulfate.	Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Horowitz, PM (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Biochem, 7703 Floyd Curl Dr,MSC 7760, San Antonio, TX 78229 USA.							BERNI R, 1986, BIOCHEM INT, V12, P733; Bhattacharyya AM, 2002, BIOCHEMISTRY-US, V41, P2421, DOI 10.1021/bi0115378; Bhattacharyya AM, 2002, BIOCHEMISTRY-US, V41, P422, DOI 10.1021/bi011726q; Bhattacharyya AM, 2001, J BIOL CHEM, V276, P28739, DOI 10.1074/jbc.M102500200; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; Clark AC, 1999, J MOL BIOL, V285, P1777, DOI 10.1006/jmbi.1998.2403; Gliubich F, 1996, J BIOL CHEM, V271, P21054, DOI 10.1074/jbc.271.35.21054; Gliubich F, 1998, ACTA CRYSTALLOGR D, V54, P481, DOI 10.1107/S090744499701216X; Hartmann WK, 2000, METH MOL B, V140, P97; HOL WGJ, 1983, FUND APPL TOXICOL, V3, P370, DOI 10.1016/S0272-0590(83)80007-4; HOROWITZ PM, 1995, BBA-PROTEIN STRUCT M, V1249, P161, DOI 10.1016/0167-4838(95)00037-U; JOHNSON WC, 1985, METHOD BIOCHEM ANAL, V31, P61, DOI 10.1002/9780470110522.ch2; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; Lawton JM, 1998, BIOCHEM J, V334, P219, DOI 10.1042/bj3340219; MILLER DM, 1991, J BIOL CHEM, V266, P4686; MILLERMARTINI DM, 1994, J BIOL CHEM, V269, P12414; MILLERMARTINI DM, 1994, J BIOL CHEM, V269, P3423; Panda M, 2000, J BIOL CHEM, V275, P63, DOI 10.1074/jbc.275.1.63; Panda M, 2000, J PROTEIN CHEM, V19, P399, DOI 10.1023/A:1026491615076; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Smith KE, 1998, J BIOL CHEM, V273, P28677, DOI 10.1074/jbc.273.44.28677; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; Westley J, 1981, Methods Enzymol, V77, P285; WOODY RW, 1995, METHOD ENZYMOL, V246, P34	31	4	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1693	1699		10.1074/jbc.M207574200	http://dx.doi.org/10.1074/jbc.M207574200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12433928	hybrid			2022-12-27	WOS:000180462200044
J	Dang, ZC; Audinot, V; Papapoulos, SE; Boutin, JA; Lowik, CWGM				Dang, ZC; Audinot, V; Papapoulos, SE; Boutin, JA; Lowik, CWGM			Peroxisome proliferator-activated receptor gamma (PPAR gamma) as a molecular target for the soy phytoestrogen genistein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEALTH BENEFITS; CELL-LINES; ESTROGEN; DIFFERENTIATION; BETA; ISOFLAVONES; KINASE; GROWTH; ADIPOGENESIS; MECHANISMS	The principal soy phytoestrogen genistein has an array of biological actions. It binds to estrogen receptor (ER) alpha and beta and has ER-mediated estrogenic effects. In addition, it has antiestrogenic effects as well as non-ER-mediated effects such as inhibition of tyrosine kinase. Because of its complex biological actions, the molecular mechanisms of action of genistein are poorly understood. Here we show that genistein dose-dependently increases estrogenic transcriptional activity in mesenchymal progenitor cells, but its biological effects on osteogenesis and adipogenesis are different. At low concentrations (less than or equal to1 muM), genistein acts as estrogen, stimulating osteogenesis and inhibiting adipogenesis. At high concentrations (> 1 muM), however, genistein acts as a ligand of PPARgamma, leading to up-regulation of adipogenesis and down-regulation of osteogenesis. Transfection experiments show that activation of PPARgamma by genistein at the micromolar concentrations down-regulates its estrogenic transcriptional activity, while activation of ERalpha or ERbeta by genistein downregulates PPARgamma transcriptional activity. Genistein concurrently activates two different transcriptional factors, ERs and PPARgamma, which have opposite effects on osteogenesis or adipogenesis. As a result, the balance between activated ERs and PPARgamma determines the biological effects of genistein on osteogenesis and adipogenesis. Our findings may explain distinct effects of genistein in different tissues.	Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis C4 R, NL-2300 RC Leiden, Netherlands; Inst Rech Int Servier, Div Pharmacol Mol & Cellulaire, F-78290 Croissy Sur Seine, France; Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Servier; Institut de Recherches Internationales Servier; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lowik, CWGM (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis C4 R, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.		Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204				Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Anderson JJB, 2001, J CLIN ENDOCR METAB, V86, P39; Barnes S, 2000, BIOFACTORS, V12, P209, DOI 10.1002/biof.5520120133; Barnes S, 1998, P SOC EXP BIOL MED, V217, P386; Barnes S, 2000, J NUTR, V130, p656S, DOI 10.1093/jn/130.3.656S; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bouker KB, 2000, ENVIRON HEALTH PERSP, V108, P701, DOI 10.2307/3434722; Calabrese EJ, 2001, CRIT REV TOXICOL, V31, P503, DOI 10.1080/20014091111785; Camp HS, 1997, J BIOL CHEM, V272, P10811; Chan GK, 2001, ENDOCRINOLOGY, V142, P4900, DOI 10.1210/en.142.11.4900; Dang ZC, 2002, J BONE MINER RES, V17, P394, DOI 10.1359/jbmr.2002.17.3.394; De Boever P, 2001, ENVIRON HEALTH PERSP, V109, P691, DOI 10.2307/3454785; Ferry G, 2001, EUR J PHARMACOL, V417, P77, DOI 10.1016/S0014-2999(01)00907-4; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; Kim H, 1998, AM J CLIN NUTR, V68, p1418S, DOI 10.1093/ajcn/68.6.1418S; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lazar MA, 2002, GENE DEV, V16, P1, DOI 10.1101/gad.964002; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; MARKOVITS J, 1989, CANCER RES, V49, P5111; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; OKURA A, 1988, BIOCHEM BIOPH RES CO, V157, P183, DOI 10.1016/S0006-291X(88)80030-5; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rumi MAK, 2002, J LAB CLIN MED, V140, P17, DOI 10.1067/mlc.2002.125055; Sasaki T, 2001, PATHOBIOLOGY, V69, P258, DOI 10.1159/000064336; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Shao ZM, 2000, ANTICANCER RES, V20, P2409; Shimada T, 2002, J LAB CLIN MED, V140, P4, DOI 10.1067/mlc.2002.125054; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223; Willson TM, 1997, CURR OPIN CHEM BIOL, V1, P235, DOI 10.1016/S1367-5931(97)80015-4; YAMASHITA T, 1990, J CELL PHYSIOL, V145, P587, DOI 10.1002/jcp.1041450327; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4	41	268	292	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					962	967		10.1074/jbc.M209483200	http://dx.doi.org/10.1074/jbc.M209483200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12421816	hybrid			2022-12-27	WOS:000180321900036
J	Demasi, M; Silva, GM; Netto, LES				Demasi, M; Silva, GM; Netto, LES			20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICATALYTIC PROTEINASE COMPLEX; CYSTEINE-SULFENIC ACID; HYDROGEN-PEROXIDE; SUBCELLULAR-LOCALIZATION; OXIDATIVE STRESS; IDENTIFICATION; MITOCHONDRIAL; DEGRADATION; CATALYSIS; SULFHYDRYLS	The 20 S proteasome core purified from Saccharomyces cerevisiae is inhibited by reduced glutathione (GSH), cysteine (Cys), or the GSH precursor gamma-glutamylcysteine. Chymotrypsin-like activity was more affected by GSH than trypsin-like activity, whereas the peptidylglutamyl-hydrolyzing activity (caspase-like) was not inhibited by GSH. Cys-sulfenic acid formation in the 20 S core was demonstrated by spectral characterization of the Cys-S(O)-4-nitrobenzo-2-oxa-1,3-diazole adduct, indicating that 20 S proteasome Cys residues might react with reduced sulfhydryls (GSH, Cys, and gamma-glutamylcysteine) through the oxidized Cys-sulfenic acid form. S-Glutahionylation of the 20 S core was demonstrated in vitro by GSH-biotin incorporation and by decreased alkylation with monobromobimane. Compounds such as N-ethyl-maleimide (-S-sulfhydril H alkylating), dimedone (-SO sulfenic acid H reactant), or 7-chloro-4-nitrobenzo-2oxa-1,3-diazole (either -SH or -SOH reactant) highly inhibited proteasomal chymotrypsin-like activity. In vivo experiments revealed that 20 S proteasome extracted from H2O2-treated cells showed decreased chymotrypsin-like activity accompanied by S-glutathionylation as demonstrated by GSH release from the 20 S core after reduction with NaBH,. Moreover, cells pretreated with H2O2 showed decreased reductive capacity assessed by determination of the GSH/oxidized glutathione ratio and increased protein carbonyl levels. The present results indicate that at the physiological level the yeast 20 S proteasome is regulated by its sulfhydryl content, thereby coupling intracellular redox signaling to proteasome-mediated proteolysis.	Univ Sao Paulo, Dept Biol, Inst Biociencias, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo	Demasi, M (corresponding author), Univ Sao Paulo, Dept Biol, Inst Biociencias, Rua Matao 277 Sao Paulo, BR-05508900 Sao Paulo, Brazil.	mari_mais@hotmail.com	Netto, Luis/A-3783-2008; Demasi, Marilene/E-5873-2012	Netto, Luis/0000-0002-4250-9177; Demasi, Marilene/0000-0002-3749-1160				Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; Bandyopadhyay S, 1998, J BIOL CHEM, V273, P392, DOI 10.1074/jbc.273.1.392; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Bellomo G, 1997, MICROSC RES TECHNIQ, V36, P243, DOI 10.1002/(SICI)1097-0029(19970215)36:4<243::AID-JEMT3>3.0.CO;2-N; BENITEZ LV, 1973, ARCH BIOCHEM BIOPHYS, V159, P89, DOI 10.1016/0003-9861(73)90432-3; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Demasi M, 2001, ARCH BIOCHEM BIOPHYS, V389, P254, DOI 10.1006/abbi.2001.2332; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5; GIULIVI C, 1994, ARCH BIOCHEM BIOPHYS, V311, P329, DOI 10.1006/abbi.1994.1245; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; HOUGH R, 1987, J BIOL CHEM, V262, P8303; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Netto LES, 1996, ARCH BIOCHEM BIOPHYS, V333, P233, DOI 10.1006/abbi.1996.0386; Nulton-Persson AC, 2002, FREE RADICAL BIO MED, V33, pS90; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; RADI R, 1991, J BIOL CHEM, V266, P4244; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Ullrich O, 1999, P NATL ACAD SCI USA, V96, P6223, DOI 10.1073/pnas.96.11.6223; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	38	99	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					679	685		10.1074/jbc.M209282200	http://dx.doi.org/10.1074/jbc.M209282200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409293	hybrid			2022-12-27	WOS:000180255700086
J	Nakayama, A; Murakami, H; Maeyama, N; Yamashiro, N; Sakakibara, A; Mori, N; Takahashi, M				Nakayama, A; Murakami, H; Maeyama, N; Yamashiro, N; Sakakibara, A; Mori, N; Takahashi, M			Role for RFX transcription factors in non-neuronal cell-specific inactivation of the microtubule-associated protein MAP1A promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARE LYMPHOCYTE SYNDROME; CLASS-II DEFICIENCY; B VIRUS ENHANCER; DNA-BINDING PROTEINS; REGULATORY FACTOR; REPRESSION DOMAINS; NUCLEAR FACTOR; GENE; TRANSACTIVATOR; EXPRESSION	Microtubule-associated protein MAP1A is expressed abundantly in mature neurons and is necessary for maintenance of neuronal morphology and localization of some molecules in association with the microtubule-based cytoskeleton. Previous studies indicated that its complementary expression together with MAP1B during nervous system development is regulated at the transcriptional level and that the mouse Map1A gene is transcribed under the control of 5' and intronic promoters. In this study, we investigated the regulatory mechanisms that govern the neuronal cell-specific activation of the MAP1A 5' promoter. We found that two regulatory factor for X box (RFX) binding sites in exon1 of both the mouse and human genes are important for effective transcriptional repression observed only in non-neuronal cells by reporter assays. Among RFX transcription factor family members, RFX1 and 3 mainly interact with repressive elements in vitro. Cotransfection studies indicated that RFX1, which is expressed ubiquitously, down-regulated the MAP1A 5' promoter activity in non-neuronal cells. Unexpectedly, RFX3, which is abundantly expressed in neuronal cells, down-regulated the transactivity as well, when it was expressed in non-neuronal cells. Both RFX1 and 3 did not down-regulate the transactivity in neuronal cells. These results suggest that RFX1 and 3 are pivotal factors in down-regulation of the MAP1A 5' promoter in non-neuronal cells. The cell type-specific down-regulation, however, does not depend simply on which RFX interacts with the elements, but seems to depend on underlying profound mechanisms.	Nagoya Univ, Sch Med, Dept Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University	Nakayama, A (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi 4800392, Japan.		Takahashi, Masahide/AAN-4770-2020	Takahashi, Masahide/0000-0002-2803-2683				Brenman JE, 1998, J NEUROSCI, V18, P8805; DATTA PK, 1995, MOL CELL BIOL, V15, P5444; DeFranco C, 1998, MOL BIOL CELL, V9, P1695, DOI 10.1091/mbc.9.7.1695; Durand B, 2000, GENE, V246, P285, DOI 10.1016/S0378-1119(00)00093-7; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Fink JK, 1996, GENOMICS, V35, P577, DOI 10.1006/geno.1996.0400; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; GARNER CC, 1990, J NEUROCHEM, V55, P146, DOI 10.1111/j.1471-4159.1990.tb08832.x; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Iwama A, 1999, MOL CELL BIOL, V19, P3940; Katan Y, 1997, NUCLEIC ACIDS RES, V25, P3621, DOI 10.1093/nar/25.18.3621; Lee BH, 1998, J VIROL, V72, P1138, DOI 10.1128/JVI.72.2.1138-1145.1998; Liu D, 1997, J NEUROCHEM, V69, P910; Liu D, 1996, J NEUROSCI, V16, P5026; Liu MS, 1999, J BIOL CHEM, V274, P15433, DOI 10.1074/jbc.274.22.15433; Masternak K, 1998, NAT GENET, V20, P273, DOI 10.1038/3081; MATUS A, 1994, TRENDS NEUROSCI, V17, P19, DOI 10.1016/0166-2236(94)90030-2; Montesinos ML, 2001, J NEUROSCI, V21, P3350, DOI 10.1523/JNEUROSCI.21-10-03350.2001; Nakayama A, 2001, BBA-GENE STRUCT EXPR, V1518, P260, DOI 10.1016/S0167-4781(01)00173-7; Nunez J, 1997, J MOL NEUROSCI, V8, P207, DOI 10.1007/BF02736834; OBLINGER MM, 1994, DEV BRAIN RES, V77, P45, DOI 10.1016/0165-3806(94)90212-7; OSTAPCHUK P, 1989, MOL CELL BIOL, V9, P2787, DOI 10.1128/MCB.9.7.2787; OSTAPCHUK P, 1986, P NATL ACAD SCI USA, V83, P8550, DOI 10.1073/pnas.83.22.8550; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; REIDERER B, 1985, P NATL ACAD SCI USA, V82, P6006; REITH W, 1994, MOL CELL BIOL, V14, P1230, DOI 10.1128/MCB.14.2.1230; REITH W, 1990, GENE DEV, V4, P1528, DOI 10.1101/gad.4.9.1528; REITH W, 1989, P NATL ACAD SCI USA, V86, P4200, DOI 10.1073/pnas.86.11.4200; SAFAEI R, 1989, J NEUROCHEM, V52, P1871, DOI 10.1111/j.1471-4159.1989.tb07270.x; SAFRANY G, 1993, GENE, V132, P279, DOI 10.1016/0378-1119(93)90208-K; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Sengupta PK, 1999, J BIOL CHEM, V274, P36649, DOI 10.1074/jbc.274.51.36649; SIEGRIST CA, 1993, MOL CELL BIOL, V13, P6375, DOI 10.1128/MCB.13.10.6375; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tierney R, 2000, J VIROL, V74, P10458, DOI 10.1128/JVI.74.22.10458-10467.2000; Vandaele C, 2001, MECH DEVELOP, V103, P159, DOI 10.1016/S0925-4773(01)00340-9; WU SY, 1995, MOL CELL BIOL, V15, P1479; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510; ZHANG XY, 1991, VIROLOGY, V182, P865, DOI 10.1016/0042-6822(91)90631-K	45	26	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					233	240		10.1074/jbc.M209574200	http://dx.doi.org/10.1074/jbc.M209574200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12411430	hybrid			2022-12-27	WOS:000180255700031
J	Milkereit, P; Strauss, D; Bassler, J; Gadal, O; Kuhn, H; Schutz, S; Gas, N; Lechner, J; Hurt, E; Tschochner, H				Milkereit, P; Strauss, D; Bassler, J; Gadal, O; Kuhn, H; Schutz, S; Gas, N; Lechner, J; Hurt, E; Tschochner, H			A noc complex specifically involved in the formation and nuclear export of ribosomal 40 S subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; POLYMERASE-I; YEAST; BIOGENESIS; MATURATION; REQUIRES; TRANSPORT; TRANSCRIPTION	Formation and nuclear export of 60 S pre-ribosomes requires many factors including the heterodimeric Noc1-Noc2 and Noc2-Noc3 complexes. Here, we report another Noc complex with a specific role in 40 S subunit biogenesis. This complex consists of Noc4p, which exhibits the conserved Noc domain and is homologous to Noc1p, and Nop14p, a nucleolar protein with a role in 40 S subunit formation. Moreover, noc4 thermosensitive mutants are defective in 40 S biogenesis, and rRNA processing is inhibited at early cleavage sites A(0), A(1), and A(2). Using a fluorescence-based visual assay for 40 S subunit export, we observe a strong nucleolar accumulation of the Rps2p-green fluorescent protein reporter in noc4 is mutants, but 60 S subunit export was normal. Thus, Noc4p and Nop14p form a novel Noc complex with a specific role in nucleolar 40 S subunit formation and subsequent export to the cytoplasm.	Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Lab Biol Mol Eucaryote, F-32062 Toulouse, France	Ruprecht Karls University Heidelberg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Tschochner, H (corresponding author), Biochem Zentrum Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de; IM4@ix.urz.uni-heidelberg.de	Melnikov, Leonid A/F-8699-2010; Baßler, Jochen/AAC-5336-2021; Ed Hurt, Dr./AAE-8874-2019; Gadal, Olivier/A-4731-2008	Melnikov, Leonid A/0000-0002-0423-3982; Baßler, Jochen/0000-0002-7441-7867; Ed Hurt, Dr./0000-0002-4535-8255; Gadal, Olivier/0000-0001-9421-0831				ALLROBYN JA, 1990, MOL CELL BIOL, V10, P6544, DOI 10.1128/MCB.10.12.6544; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; FLANAGAN PM, 1992, P NATL ACAD SCI USA, V89, P7659, DOI 10.1073/pnas.89.16.7659; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hadjiolov A.A., 1985, Cell Biology Monographs, V12, P1; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; KRUISWIJK T, 1978, BIOCHIM BIOPHYS ACTA, V517, P378, DOI 10.1016/0005-2787(78)90204-6; Liang WQ, 1997, P NATL ACAD SCI USA, V94, P2864, DOI 10.1073/pnas.94.7.2864; Liu PCC, 2001, MOL BIOL CELL, V12, P3644, DOI 10.1091/mbc.12.11.3644; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; MILKEREIT P, 2003, IN PRESS NUCL ACIDS; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; STEVENS A, 1991, J BACTERIOL, V173, P7024, DOI 10.1128/jb.173.21.7024-7028.1991; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; TRAPMAN J, 1976, BIOCHIM BIOPHYS ACTA, V442, P265, DOI 10.1016/0005-2787(76)90301-4; UDEM SA, 1973, J BIOL CHEM, V248, P1412; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; WOOLFORD JL, 1991, ADV GENET, V29, P63, DOI 10.1016/S0065-2660(08)60107-8; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	42	99	103	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4072	4081		10.1074/jbc.M208898200	http://dx.doi.org/10.1074/jbc.M208898200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446671	hybrid			2022-12-27	WOS:000180869700072
J	Macris, MA; Glazer, PM				Macris, MA; Glazer, PM			Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOINDUCED CROSS-LINKING; DOUBLE-HELICAL DNA; MAMMALIAN-CELLS; INHIBITS TRANSCRIPTION; PSORALEN PHOTOADDUCTS; COVALENT MODIFICATION; HELA-CELLS; SEQUENCE; MUTAGENESIS; RECOMBINATION	Triplex-forming oligonucleotides (TFOs) recognize and bind to specific DNA sequences and have been used to modify gene function in cells. To study factors that might influence triplex formation at chromosomal sites in mammalian cells, we developed a restriction protection assay to detect triplex-directed psoralen crosslinks in genomic DNA prepared from TFO-transfected cells. Using this assay, we detected binding of a G-rich TFO to a chromosomal site even in the absence of transcription when high concentrations of the TFO were used for transfection. However, experimental induction of transcription at the target site, via an ecdysone-responsive promoter, resulted in substantial increases (3-fold or more) in target site crosslinking, especially at low TFO concentrations. When RNA polymerase activity was inhibited, even in the ecdysone-induced cells, the level of TFO binding was significantly decreased, indicating that transcription through the target region, and not just transcription factor binding, is necessary for the enhanced chromosomal targeting by TFOs. These findings provide evidence that physiologic activity at a chromosomal target site can influence its accessibility to TFOs and suggest that gene targeting by small molecules may be most effective at highly expressed chromosomal loci.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University	Glazer, PM (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.		Glazer, Peter/S-7651-2019	Glazer, Peter/0000-0003-4525-5560	NCI NIH HHS [CA64186] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA064186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGRAWAL S, 1991, P NATL ACAD SCI USA, V88, P7595, DOI 10.1073/pnas.88.17.7595; Bailey C, 2000, NUCLEIC ACIDS RES, V28, P1154, DOI 10.1093/nar/28.5.1154; Barre FX, 2000, P NATL ACAD SCI USA, V97, P3084, DOI 10.1073/pnas.050368997; BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; Becker NA, 1999, ANTISENSE NUCLEIC A, V9, P313, DOI 10.1089/oli.1.1999.9.313; Belousov ES, 1998, NUCLEIC ACIDS RES, V26, P1324, DOI 10.1093/nar/26.5.1324; Brown PM, 1998, BIOCHEMISTRY-US, V37, P16139, DOI 10.1021/bi981768n; Chan PP, 1999, J BIOL CHEM, V274, P11541, DOI 10.1074/jbc.274.17.11541; CHENG AJ, 1993, NUCLEIC ACIDS RES, V21, P5630, DOI 10.1093/nar/21.24.5630; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; DUVALVALENTIN G, 1992, P NATL ACAD SCI USA, V89, P504, DOI 10.1073/pnas.89.2.504; Ebbinghaus SW, 1999, BIOCHEMISTRY-US, V38, P619, DOI 10.1021/bi980981g; Espinas ML, 1996, J BIOL CHEM, V271, P31807, DOI 10.1074/jbc.271.50.31807; Faruqi AF, 2000, MOL CELL BIOL, V20, P990, DOI 10.1128/MCB.20.3.990-1000.2000; Faruqi AF, 1996, MOL CELL BIOL, V16, P6820; FRANCOIS JC, 1988, NUCLEIC ACIDS RES, V16, P11431, DOI 10.1093/nar/16.24.11431; Gewirtz AM, 1996, P NATL ACAD SCI USA, V93, P3161, DOI 10.1073/pnas.93.8.3161; GIOVANNANGELI C, 1992, NUCLEIC ACIDS RES, V20, P4275, DOI 10.1093/nar/20.16.4275; Giovannangeli C, 1997, P NATL ACAD SCI USA, V94, P79, DOI 10.1073/pnas.94.1.79; GRIGORIEV M, 1992, J BIOL CHEM, V267, P3389; Guieysse AL, 1996, NUCLEIC ACIDS RES, V24, P4210, DOI 10.1093/nar/24.21.4210; Gunther EJ, 1996, PHOTOCHEM PHOTOBIOL, V63, P207, DOI 10.1111/j.1751-1097.1996.tb03015.x; HAVRE PA, 1993, P NATL ACAD SCI USA, V90, P7879, DOI 10.1073/pnas.90.16.7879; HAVRE PA, 1993, J VIROL, V67, P7324, DOI 10.1128/JVI.67.12.7324-7331.1993; ING NH, 1993, NUCLEIC ACIDS RES, V21, P2789, DOI 10.1093/nar/21.12.2789; Kim HG, 1998, BIOCHEMISTRY-US, V37, P2666, DOI 10.1021/bi972399i; LETAI AG, 1988, BIOCHEMISTRY-US, V27, P9108, DOI 10.1021/bi00426a007; Luo ZJ, 2000, P NATL ACAD SCI USA, V97, P9003, DOI 10.1073/pnas.160004997; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; MAYFIELD C, 1994, J BIOL CHEM, V269, P18232; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; Oh DH, 1999, NUCLEIC ACIDS RES, V27, P4734, DOI 10.1093/nar/27.24.4734; OLIVAS WM, 1995, NUCLEIC ACIDS RES, V23, P1936, DOI 10.1093/nar/23.11.1936; POSTEL EH, 1991, P NATL ACAD SCI USA, V88, P8227, DOI 10.1073/pnas.88.18.8227; SANDOR Z, 1995, BBA-GENE STRUCT EXPR, V1263, P235, DOI 10.1016/0167-4781(95)00109-T; SINGLETON SF, 1992, BIOCHEMISTRY-US, V31, P10995, DOI 10.1021/bi00160a008; STROBEL SA, 1991, SCIENCE, V254, P1639, DOI 10.1126/science.1836279; TAKASUGI M, 1991, P NATL ACAD SCI USA, V88, P5602, DOI 10.1073/pnas.88.13.5602; TU GC, 1995, J BIOL CHEM, V270, P28402; VASQUEZ KM, 1995, BIOCHEMISTRY-US, V34, P7243, DOI 10.1021/bi00021a040; Vasquez KM, 1999, NUCLEIC ACIDS RES, V27, P1176, DOI 10.1093/nar/27.4.1176; Vasquez KM, 2000, SCIENCE, V290, P530, DOI 10.1126/science.290.5491.530; WANG G, 1995, J BIOL CHEM, V270, P22595, DOI 10.1074/jbc.270.38.22595; WANG G, 1995, MOL CELL BIOL, V15, P1759; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; WESTIN L, 1995, NUCLEIC ACIDS RES, V23, P2184, DOI 10.1093/nar/23.12.2184; YOUNG SL, 1991, P NATL ACAD SCI USA, V88, P10023, DOI 10.1073/pnas.88.22.10023; ZENDEGUI JG, 1992, NUCLEIC ACIDS RES, V20, P307, DOI 10.1093/nar/20.2.307	48	34	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3357	3362		10.1074/jbc.M206542200	http://dx.doi.org/10.1074/jbc.M206542200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431993	hybrid			2022-12-27	WOS:000180915000075
J	Petit, MMR; Meulemans, SMP; Van de Ven, WJM				Petit, MMR; Meulemans, SMP; Van de Ven, WJM			The focal Adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; ALPHA-ACTININ; EXPORT SIGNAL; STIMULATED PHOSPHOPROTEIN; ENA/VASP PROTEINS; DOMAIN PROTEIN; CELL-ADHESION; HMGI-C; ZYXIN; LOCALIZATION	Targeting of proteins to a particular cellular compartment is a critical determinant for proper functioning. LPP (LIM-containing lipoma-preferred partner) is a LIM domain protein that is localized at sites of cell adhesion and transiently in the nucleus. In various benign and malignant tumors, LPP is present in a mutant form, which permanently localizes the LIM domains in the nucleus. Here, we have investigated which regions in LPP target the protein to its sub,cellular locations. We found that the LIM domains are the main focal adhesion targeting elements and that the proline-rich region of LPP, which harbors binding sites for a-actinin and vasodilator-stimulated phosphoprotein (VASP), has a weak targeting capacity. All of the LIM domains of LPP cooperate in order to provide robust targeting to focal adhesions, and the linker between LIM domains 1 and 2 plays a pivotal role in this targeting. When overexpressed in the cytoplasm of cells, the LIM domains of LPP can deplete endogenous LPP and vinculin from focal adhesions. The proline-rich region of LPP contains targeting sites for focal adhesions and stress fibers that are distinct from the a-actinin and VASP binding sites, and the LPP LIM domains are dispensable for targeting LPP to the nucleus. Our studies have defined novel functional domains in the LPP protein.	Katholieke Univ Leuven, Dept Human Genet, Mol Oncol Lab, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol VIB, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Petit, MMR (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Mol Oncol Lab, Herestr 49, B-3000 Louvain, Belgium.	marleen.petit@med.kuleuven.ac.be						Aplin AE, 2001, J CELL BIOL, V155, P187, DOI 10.1083/jcb.200107116; ASHAR HR, 1995, CELL, V82, P57; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BECKERLE MC, 1986, J CELL BIOL, V103, P1679, DOI 10.1083/jcb.103.5.1679; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown S, 2001, IUBMB LIFE, V51, P359; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Daheron L, 2001, GENE CHROMOSOME CANC, V31, P382, DOI 10.1002/gcc.1157; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Edlund M, 2001, CELL MOTIL CYTOSKEL, V48, P190, DOI 10.1002/1097-0169(200103)48:3<190::AID-CM1008>3.0.CO;2-C; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kiss H, 1999, HUM GENET, V105, P552, DOI 10.1007/s004390051144; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Petit MMR, 1998, CANCER GENET CYTOGEN, V106, P18, DOI 10.1016/S0165-4608(98)00038-7; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Petit MMR, 1996, GENOMICS, V36, P118, DOI 10.1006/geno.1996.0432; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; Rogalla P, 1998, GENE CHROMOSOME CANC, V22, P100, DOI 10.1002/(SICI)1098-2264(199806)22:2<100::AID-GCC3>3.0.CO;2-0; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Thomas SM, 1999, J CELL SCI, V112, P181; Wang Y, 1999, GENE, V234, P403, DOI 10.1016/S0378-1119(99)00168-7; Wang Y, 2001, BBA-MOL CELL RES, V1538, P260, DOI 10.1016/S0167-4889(01)00077-5; Woods AJ, 2002, J BIOL CHEM, V277, P6428, DOI 10.1074/jbc.M109446200; Yi JS, 1998, GENOMICS, V49, P314, DOI 10.1006/geno.1998.5248	41	64	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2157	2168		10.1074/jbc.M206106200	http://dx.doi.org/10.1074/jbc.M206106200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441356	hybrid			2022-12-27	WOS:000180562000013
J	Stewart, D; Killeen, E; Naquin, R; Alam, S; Alam, J				Stewart, D; Killeen, E; Naquin, R; Alam, S; Alam, J			Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; HEME OXYGENASE-1 GENE; KAPPA-B-ALPHA; MEDIATED EXPRESSION; OXIDATIVE STRESS; SUBUNIT GENE; NF-E2-RELATED FACTOR-2; IN-VIVO; ACTIVATION; INDUCTION	Nrf2 mediates inducer-dependent activation of the heme oxygenase-1 (HO-1) gene (Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M., and Cook, J. L. (1999) J. Biol. Chem. 274, 26071-26078), but the mechanism by which HO-1 inducers regulate Nrf2 function is not known. Treatment of mouse hepatoma (Hepa) cells with 50 muM CdCl2 increased the amount of Nrf2 protein in a time-dependent manner; induction was observed within 30 min, prior to the accumulation of HO-1 mRNA. Cadmium did not significantly affect the steady-state level of Nrf2 mRNA or the initial rate of Nrf2 protein synthesis but increased the half-life of Nrf2 from similar to13 to 100 min. Proteasome inhibitors, but not other protease inhibitors, enhanced the expression of Nrf2, and ubiquitinylated Nrf2 was detected after proteasome inhibition. Cycloheximide inhibited cadmium-stimulated Nrf2 expression and DNA binding activity and attenuated HO-1 mRNA accumulation. Conversely, proteasome inhibitors enhanced HO-1 mRNA and protein accumulation by a Nrf2-dependent mechanism. Together, these results indicate that Nrf2 is targeted for rapid degradation by the ubiquitin-proteasome pathway and that cadmium delays the rate of Nrf2 degradation leading to ho-1 gene activation.	Alton Ochsner Med Fdn & Ochsner Clin, Dept Mol Genet, New Orleans, LA 70121 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Dept Environm Hlth Sci, New Orleans, LA 70112 USA	Ochsner Health System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University	Alam, J (corresponding author), Alton Ochsner Med Fdn & Ochsner Clin, Dept Mol Genet, 1516 Jefferson Highway, New Orleans, LA 70121 USA.		Alam, Jawed/F-2596-2010	Alam, Jawed/0000-0001-6520-482X				Alam J, 2000, J BIOL CHEM, V275, P27694; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALAM J, 1989, J BIOL CHEM, V264, P6371; ALAM J, 2000, FUNCTIONAL ANAL HUMA, V1; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Gong PF, 2002, ANTIOXID REDOX SIGN, V4, P249, DOI 10.1089/152308602753666307; Gong PF, 2001, J BIOL CHEM, V276, P27018, DOI 10.1074/jbc.M103658200; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang HC, 2000, P NATL ACAD SCI USA, V97, P12475, DOI 10.1073/pnas.220418997; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kim YC, 2001, J BIOL CHEM, V276, P18399, DOI 10.1074/jbc.M100103200; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Morano KA, 1999, GENE EXPRESSION, V7, P271; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Sekhar KR, 2002, FREE RADICAL BIO MED, V32, P650, DOI 10.1016/S0891-5849(02)00755-4; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; TAKEDA K, 1994, J BIOL CHEM, V269, P22858; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	48	366	383	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2396	2402		10.1074/jbc.M209195200	http://dx.doi.org/10.1074/jbc.M209195200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441344	hybrid			2022-12-27	WOS:000180562000045
J	Traweger, A; Fuchs, R; Krizbai, IA; Weiger, TM; Bauer, HC; Bauer, H				Traweger, A; Fuchs, R; Krizbai, IA; Weiger, TM; Bauer, HC; Bauer, H			The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONULA OCCLUDENS-1; BINDING PARTNERS; SAF-B; DOMAINS; ACTIN; IDENTIFICATION; COMPONENT; TRANSCRIPTION; POLYPEPTIDE; EXPRESSION	Zonula occludens proteins (ZOPs), currently comprising ZO-1, ZO-2, and ZO-3, belong to the family of membrane-associated guanylate kinase homologue (MAGUK) proteins that are involved in the organization of epithelial and endothelial intercellular junctions. ZOPs bind to the cytoplasmic C termini of junctional transmembrane proteins linking them to the actin cytoskeleton. They are characterized by several conserved modules, including three PDZ domains, one SH3 domain, and a guanylate kinase-like domain, elements indicating that ZOPs may serve multiple purposes. Interestingly, ZOPs contain some unique motifs not shared by other MAGUK family members, including nuclear localization and nuclear export signals and a leucine zipper-like sequence. Their potential involvement in cell growth and proliferation has been suggested earlier based on the observation that the N-terminal half of ZOPs displays significant similarity to the product of the Drosophila tumor suppressor gene lethal(l)discs-large (dlg). The nuclear targeting of ZOPs in subconfluent epithelial cell cultures is well documented, although the action of the junctional MAGUKs in the nucleus has remained elusive. Here we show for the first time that nuclear ZO-2 directly interacts with the DNA-binding protein scaffold attachment factor-B (SAF-B). Our results from two-hybrid assays and in vivo co-immunoprecipitation studies provide evidence to suggest that ZO-2 associates with the C-terminal portion of SAF-B via its PDZ-1 domain. We further demonstrate that enhanced green fluorescent protein (EGFP)- and DsRed-tagged ZO-2 and SAF-B fusion proteins partially co-localize in nuclei of transfected epithelial cells. As shown by laser confocal microscopy and epifluorescent analysis, nuclear ZO-2 is present in epithelial and endothelial cells, particularly in response to environmental stress conditions. Interestingly, no association of SAF-B with ZO-1 was found, which supports the notion that junctional MAGUKs serve nonredundant functions.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Inst Biophys, Biol Res Ctr, H-6723 Szeged, Hungary; Salzburg Univ, Inst Zool, A-5020 Salzburg, Austria	Austrian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Salzburg University	Bauer, HC (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.	hcbauer@imb.oeaw.ac.at	Weiger, Thomas M/D-8133-2017; Traweger, Andreas/M-1460-2015	Weiger, Thomas M/0000-0002-5231-930X; Traweger, Andreas/0000-0002-0220-4766; Krizbai, Istvan/0000-0002-0764-1527				ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Balda MS, 2000, SEMIN CELL DEV BIOL, V11, P281, DOI 10.1006/scdb.2000.0177; Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024; BAUER H, 2001, ENDOTHELIUM, V8, P294; Beatch M, 1996, J BIOL CHEM, V271, P25723, DOI 10.1074/jbc.271.42.25723; Chlenski A, 2000, BBA-GENE STRUCT EXPR, V1493, P319, DOI 10.1016/S0167-4781(00)00185-8; Citi S, 1998, BBA-MOL CELL RES, V1448, P1, DOI 10.1016/S0167-4889(98)00125-6; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gonzalez-Mariscal L, 1999, MOL BIOL CELL, V10, p407A; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; HOWARTH AG, 1995, CELL MOTIL CYTOSKEL, V31, P323, DOI 10.1002/cm.970310408; Islas S, 2002, EXP CELL RES, V274, P138, DOI 10.1006/excr.2001.5457; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; IZAURRALDE E, 1989, J MOL BIOL, V210, P573, DOI 10.1016/0022-2836(89)90133-2; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Nayler O, 1998, NUCLEIC ACIDS RES, V26, P3542, DOI 10.1093/nar/26.15.3542; OBERLEITHNER H, 1994, P NATL ACAD SCI USA, V91, P9784, DOI 10.1073/pnas.91.21.9784; Oesterreich S, 1997, J CELL BIOCHEM, V67, P275, DOI 10.1002/(SICI)1097-4644(19971101)67:2<275::AID-JCB13>3.0.CO;2-E; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Takahisa M, 1996, GENE DEV, V10, P1783, DOI 10.1101/gad.10.14.1783; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Weighardt F, 1999, J CELL SCI, V112, P1465; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Woodhouse E, 1998, DEV GENES EVOL, V207, P542, DOI 10.1007/s004270050145; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yamamoto T, 1997, J CELL BIOL, V139, P785, DOI 10.1083/jcb.139.3.785	44	124	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2692	2700		10.1074/jbc.M206821200	http://dx.doi.org/10.1074/jbc.M206821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12403786	hybrid			2022-12-27	WOS:000180562000082
J	Zou, PJ; Gautel, M; Geerlof, A; Wilmanns, M; Koch, MHJ; Svergun, DI				Zou, PJ; Gautel, M; Geerlof, A; Wilmanns, M; Koch, MHJ; Svergun, DI			Solution scattering suggests cross-linking function of telethonin in the complex with titin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMERIC PROTEIN TELETHONIN; RAY SOLUTION SCATTERING; ALPHA-ACTININ BINDING; Z-DISC; BIOLOGICAL MACROMOLECULES; SKELETAL-MUSCLE; I-BAND; EXPRESSION; ELASTICITY; RESOLUTION	Telethonin interacts specifically with the two Z-disk IG-like domains (Z1Z2) at the N terminus of titin, the largest presently known protein. Analytical ultracentrifugation and synchrotron radiation x-ray scattering were employed to study the solution structures of Z1Z2 and its complexes with telethonin, and low resolution models were constructed ab initio from the scattering data. A seven residues-long polyhistidine tag was localized at the tip of the Z1 domain by comparison of independent models of native and His-tagged versions of Z1Z2. The stoichiometry and shape of the complex between the telethonin construct lacking the C terminus and Z1Z2 indicate antiparallel association of two Z1Z2 molecules with telethonin acting as a central linker. The complex of full-length telethonin with Z1Z2 appears to also have a 1:2 stoichiometry at concentrations below 1 mg/ml but dimerizes at higher concentrations. These results suggest a possible role of telethonin in linking titin filaments at the Z-disk periphery.	EMBL, DESY, Hamburg Outstn, D-22603 Hamburg, Germany; Kings Coll London, Randall Ctr, London SE1 1UL, England; EMBL, D-69117 Heidelberg, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of London; King's College London; European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Wilmanns, M (corresponding author), EMBL, DESY, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	wilmanns@embl-hamburg.de; svergun@embl-hamburg.de	Gautel, Mathias/AAB-9860-2019	Gautel, Mathias/0000-0003-4027-9803; Wilmanns, Matthias/0000-0002-4643-5435; Svergun, Dmitri/0000-0003-0830-5696				Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Fraternali F, 1999, J MOL BIOL, V290, P581, DOI 10.1006/jmbi.1999.2876; GABRIEL A, 1982, NUCL INSTRUM METHODS, V201, P223, DOI 10.1016/0167-5087(82)90031-X; Gautel M, 1996, J CELL SCI, V109, P2747; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krueger JK, 1998, BIOCHEMISTRY-US, V37, P17810, DOI 10.1021/bi981656w; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Luther PK, 2000, J STRUCT BIOL, V129, P1, DOI 10.1006/jsbi.1999.4207; Mason P, 1999, BIOCHEM BIOPH RES CO, V257, P699, DOI 10.1006/bbrc.1999.0531; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Ralston G., 1993, INTRO ANAL ULTRACENT; Sambrook J., 2002, MOL CLONING LAB MANU; Sanger JW, 2001, J CELL BIOL, V154, P21, DOI 10.1083/jcb.200106072; Schroder R, 2001, J MUSCLE RES CELL M, V22, P259, DOI 10.1023/A:1012242011109; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Valle G, 1997, FEBS LETT, V415, P163, DOI 10.1016/S0014-5793(97)01108-3; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331	38	42	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2636	2644		10.1074/jbc.M210217200	http://dx.doi.org/10.1074/jbc.M210217200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12446666	hybrid			2022-12-27	WOS:000180562000075
J	Padilla, A; Noiva, R; Lee, N; Mohan, KVK; Nakhasi, HL; Debrabant, A				Padilla, A; Noiva, R; Lee, N; Mohan, KVK; Nakhasi, HL; Debrabant, A			An atypical protein disulfide isomerase from the protozoan parasite Leishmania containing a single thioredoxin-like domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; ACID-PHOSPHATASE; ENDOPLASMIC-RETICULUM; BOND FORMATION; GRP94 HOMOLOG; GENE; DONOVANI; ENCODES; OVEREXPRESSION; EXPRESSION	In higher eukaryotes, secretory proteins are under the quality control of the endoplasmic reticulum for their proper folding and release into the secretory pathway. One of the proteins involved in the quality control is protein disulfide isomerase, which catalyzes the formation of protein disulfide bonds. As a first step toward understanding the endoplasmic reticulum quality control of secretory proteins in lower eukaryotes, we have isolated a protein disulfide isomerase gene from the protozoan parasite Leishmania donovani. The parasite enzyme shows high sequence homology with homologs from other organisms. However, unlike the four thioredoxin-like domains found in most protein disulfide isomerases, of which two contain an active site, the leishmanial enzyme possesses only one active site present in a single thioredoxin-like domain. When expressed in Escherichia coli, the recombinant parasite enzyme shows both oxidase and isomerase activities. Replacement of the two cysteins with alanines in its active site results in loss of both enzymatic activities. Further, overexpression of the mutated/inactive form of the parasite enzyme in L. donovani significantly reduced their release of secretory acid phosphatases, suggesting that this single thioredoxin-like domain protein disulfide isomerase could play a critical role in the Leishmania secretory pathway.	US FDA, Ctr Biol Evaluat & Res, OBRR, DETTD,LBPUA, Bethesda, MD 20892 USA; US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD 20892 USA; Univ S Dakota, Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); University of South Dakota	Debrabant, A (corresponding author), US FDA, Ctr Biol Evaluat & Res, OBRR, DETTD,LBPUA, Bldg 29,Rm 425,HFM-310,29 Lincoln Dr, Bethesda, MD 20892 USA.	debrabanta@cber.fda.gov						BANGS JD, 1993, J CELL SCI, V105, P1101; BATES PA, 1987, MOL BIOCHEM PARASIT, V26, P289, DOI 10.1016/0166-6851(87)90081-8; BATES PA, 1990, MOL BIOCHEM PARASIT, V39, P247, DOI 10.1016/0166-6851(90)90063-R; Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CAI H, 1994, J BIOL CHEM, V269, P24550; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; CREIGHTON TE, 1995, TRENDS BIOTECHNOL, V13, P18, DOI 10.1016/S0167-7799(00)88896-4; CREIGHTON TE, 1993, J MOL BIOL, V232, P1176, DOI 10.1006/jmbi.1993.1470; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; DEBRABANT A, 1995, MOL BIOCHEM PARASIT, V71, P51, DOI 10.1016/0166-6851(95)00035-Y; Debrabant A, 2000, J BIOL CHEM, V275, P16366, DOI 10.1074/jbc.M908725199; Debrabant A, 2002, INT J PARASITOL, V32, P1423, DOI 10.1016/S0020-7519(02)00134-0; Descoteaux A, 2002, EMBO J, V21, P4458, DOI 10.1093/emboj/cdf447; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Furuya T, 2001, J BIOL CHEM, V276, P32437, DOI 10.1074/jbc.M104000200; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GOTTLIEB M, 1982, MOL CELL BIOL, V2, P76, DOI 10.1128/MCB.2.1.76; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; HSU MP, 1989, BIOCHEMISTRY-US, V28, P6440, DOI 10.1021/bi00441a042; Jensen ATR, 2001, BBA-PROTEIN STRUCT M, V1549, P73, DOI 10.1016/S0167-4838(01)00240-0; Joshi M, 1996, MOL BIOCHEM PARASIT, V81, P53, DOI 10.1016/0166-6851(96)02676-X; JOSHI M, 1993, MOL BIOCHEM PARASIT, V58, P345, DOI 10.1016/0166-6851(93)90057-5; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; Landfear SM, 2001, MOL BIOCHEM PARASIT, V115, P1, DOI 10.1016/S0166-6851(01)00262-6; Larreta R, 2000, EXP PARASITOL, V96, P108, DOI 10.1006/expr.2000.4553; McArthur AG, 2001, MOL BIOL EVOL, V18, P1455, DOI 10.1093/oxfordjournals.molbev.a003931; Monnat J, 1997, FEBS LETT, V418, P357, DOI 10.1016/S0014-5793(97)01415-4; NEIVA R, 1994, PROTEIN EXPRES PURIF, V5, P1; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; PUIG A, 1994, J BIOL CHEM, V269, P7764; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rodriguez NM, 2002, CELL MICROBIOL, V4, P117, DOI 10.1046/j.1462-5822.2002.00175.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shakarian AM, 1998, GENE, V208, P315, DOI 10.1016/S0378-1119(98)00011-0; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; SORENSEN AL, 1994, APMIS, V102, P265, DOI 10.1111/j.1699-0463.1994.tb04874.x; Stiles JK, 1999, ANN TROP MED PARASIT, V93, P781, DOI 10.1080/00034989957781; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Tatu U, 1997, J CELL BIOL, V136, P555, DOI 10.1083/jcb.136.3.555; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; VUORI K, 1992, J BIOL CHEM, V267, P7211; Wang HM, 2000, CURR GENET, V37, P57, DOI 10.1007/s002940050009; WILSON K, 1991, NUCLEIC ACIDS RES, V19, P5787, DOI 10.1093/nar/19.20.5787; Yao Y, 1997, EMBO J, V16, P651, DOI 10.1093/emboj/16.3.651; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	53	29	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1872	1878		10.1074/jbc.M210322200	http://dx.doi.org/10.1074/jbc.M210322200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427741	hybrid			2022-12-27	WOS:000180462200068
J	Corchnoy, SB; Swartz, TE; Lewis, JW; Szundi, I; Briggs, WR; Bogomolni, RA				Corchnoy, SB; Swartz, TE; Lewis, JW; Szundi, I; Briggs, WR; Bogomolni, RA			Intramolecular proton transfers and structural changes during the photocycle of the LOV2 domain of phototropin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTOR; ARABIDOPSIS NPH1; CIRCULAR-DICHROISM; BINDING DOMAINS; FLAVIN; RECEPTOR; PROTEIN; STATE; CHROMOPHORE; TRANSDUCER	The phototropins are a family of membrane-associated flavoproteins that function as the primary blue light receptors regulating phototropism, chloroplast movements, stomatal opening, and leaf expansion in plants. Phot1, a member of this family, contains two FMN-binding domains, LOV1 and LOV2, within the N-terminal region and a C-terminal serine-threonine protein kinase domain. Light irradiation of oat phot1 LOV2 produces a cysteinyl adduct (Cys-39) at the flavin C(4a) position, which decays thermally back to the dark state. We measured pH and isotope effects on the photocycle. Between pH 3.7 and 9.5, adduct formation showed minimal pH dependence, and adduct decay showed only slight pH dependence, indicating that the pK values of mechanistically relevant groups are outside this range. LOV2 showed a nearly 5-fold slowing of adduct formation in D2O relative to H2O, indicating that the rate-limiting step involves proton transfer(s). Light-induced changes in the far UV CD spectrum of LOV2 revealed putative protein structural perturbations. The light minus dark CD difference spectrum resembles an inverted alpha-helix spectrum, suggesting that alpha-helicity is reversibly lost upon light irradiation. Decay kinetics for CD spectral changes in the far UV region occur at the same rate as those in the visible region, indicating synchronous relaxation of protein and chromophore structures.	Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Carnegie Institution for Science	Bogomolni, RA (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St, Santa Cruz, CA 95064 USA.	bogo@chemistry.ucsc.edu						Bell R. P., 1973, PROTON CHEM, P226; BERNASCONI CF, 1986, INVESTIGATION RATES, V6, P565; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Briggs WR, 2001, ANTIOXID REDOX SIGN, V3, P775, DOI 10.1089/15230860152664975; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; FASMAN GD, 1996, CIRCULAR DICHROISM C, P47; GANDOUR RD, 1978, T STATES BIOCH PROCE, P165; HARDERS H, 1974, BIOCHEMISTRY-US, V13, P3360, DOI 10.1021/bi00713a028; Heberle J, 2002, BIOPHYS J, V82, p517A; HOFRICHTER J, 1989, BIOPHYS J, V56, P693, DOI 10.1016/S0006-3495(89)82716-X; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Huang KY, 2002, PHYSIOL PLANTARUM, V115, P613, DOI 10.1034/j.1399-3054.2002.1150416.x; HUG SJ, 1990, BIOCHEMISTRY-US, V29, P1475, DOI 10.1021/bi00458a019; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Kliger DS, 1990, POLARIZED LIGHT OPTI; Lee BC, 2001, J BIOL CHEM, V276, P20821, DOI 10.1074/jbc.C100106200; LEWIS JW, 1993, REV SCI INSTRUM, V64, P2828, DOI 10.1063/1.1144369; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; MILLER SM, 1990, BIOCHEMISTRY-US, V29, P2831, DOI 10.1021/bi00463a028; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Salomon M, 2001, P NATL ACAD SCI USA, V98, P12357, DOI 10.1073/pnas.221455298; SONG PS, 1968, PHOTOCHEM PHOTOBIOL, V7, P311, DOI 10.1111/j.1751-1097.1968.tb08018.x; Swartz TE, 2002, BIOCHEMISTRY-US, V41, P7183, DOI 10.1021/bi025861u; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Szundi I, 2001, BIOPHYS J, V80, P469, DOI 10.1016/S0006-3495(01)76029-8; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; TOLLIN G, 1968, BIOCHEMISTRY-US, V7, P1720, DOI 10.1021/bi00845a015	35	109	115	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					724	731		10.1074/jbc.M209119200	http://dx.doi.org/10.1074/jbc.M209119200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411437	hybrid			2022-12-27	WOS:000180321900006
J	Kong, GKW; Polekhina, G; McKinstry, WJ; Parker, MT; Dragani, B; Aceto, A; Paludi, D; Principe, DR; Mannervik, B; Stenberg, G				Kong, GKW; Polekhina, G; McKinstry, WJ; Parker, MT; Dragani, B; Aceto, A; Paludi, D; Principe, DR; Mannervik, B; Stenberg, G			Contribution of glycine 146 to a conserved folding module affecting stability and refolding of human glutathione transferase P1-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC-STAPLE MOTIF; N-CAPPING BOX; S-TRANSFERASE; 3-DIMENSIONAL STRUCTURE; ALPHA-HELICES; IDENTIFICATION; ISOENZYMES; RESOLUTION; PROTEINS; RESIDUES	In human glutathione transferase P1-1 (hGSTP1-1) position 146 is occupied by a glycine residue, which is located in a bend of a long loop that together with the alpha6-helix forms a substructure (GST motif 11) maintained in all soluble GSTs. In the present study G146A and G146V mutants were generated by site-directed mutagenesis in order to investigate the function played by this conserved residue in folding and stability of hG-STP1-1. Crystallographic analysis of the G146V variant, expressed at the permissive temperature of 25degreesC, indicates that the mutation causes a substantial change of the backbone conformation because of steric hindrance. Stability measurements indicate that this mutant is inactivated at a temperature as low as 32degreesC. The structure of the G146A mutant is identical to that of the wild type with the mutated residue having main-chain bond angles in a high energy region of the Ramachandran plot. However even this Gly --> Ala substitution inactivates the enzyme at 37degreesC. Thermodynamic analysis of all variants confirms, together with previous findings, the critical role played by GST motif II for overall protein stability. Analysis of reactivation in vitro indicates that any mutation of Gly-146 alters the folding pathway by favoring aggregation at 37degreesC. It is hypothesized that the GST motif 11 is involved in the nucleation mechanism of the protein and that the substitution of Gly-146 alters this transient substructure. Gly-146 is part of the buried local sequence GXXh(T/S)XXDh (X is any residue and h is a hydrophobic residue), conserved in all GSTs and related proteins that seems to behave as a characteristic structural module important for protein folding and stability.	Uppsala Univ, Biomed Ctr, Dept Biochem, SE-75123 Uppsala, Sweden; St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; Univ Melbourne, Russel Grimwade Sch Biochem & Mol Biol, Parkville, Vic 3010, Australia; Univ G DAnnunzio, Dipartimento Sci Biomed, I-66100 Chieti, Italy; Univ G DAnnunzio, Dipartimento Sci Farmaco, I-66100 Chieti, Italy	Uppsala University; St. Vincent's Institute of Medical Research; University of Melbourne; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Stenberg, G (corresponding author), Uppsala Univ, Biomed Ctr, Dept Biochem, Box 576, SE-75123 Uppsala, Sweden.		McKinstry, William J/D-2612-2013	McKinstry, William J/0000-0001-9668-9364				ACETO A, 1990, CARCINOGENESIS, V11, P2267, DOI 10.1093/carcin/11.12.2267; Aceto A, 1997, BIOCHEM J, V322, P229, DOI 10.1042/bj3220229; ACETO A, 1992, BIOCHEM J, V285, P241, DOI 10.1042/bj2850241; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P750; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; DANIELSON UH, 1985, BIOCHEM J, V231, P263, DOI 10.1042/bj2310263; Dragani B, 1997, J BIOL CHEM, V272, P25518, DOI 10.1074/jbc.272.41.25518; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; Gustafsson A, 1999, J MOL BIOL, V288, P787, DOI 10.1006/jmbi.1999.2712; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; ITZHAKI LS, 1995, J MOL BIOL, V254, P289, DOI 10.1006/jmbi.1995.0617; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Johnson F. H., 1954, KINETIC BASIS MOL BI; KOLM RH, 1995, PROTEIN EXPRES PURIF, V6, P265, DOI 10.1006/prep.1995.1034; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1982, J BIOL CHEM, V257, P9909; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; MUNOZ V, 1995, BIOCHEMISTRY-US, V34, P15301, DOI 10.1021/bi00046a039; MUNOZ V, 1995, NAT STRUCT BIOL, V2, P380, DOI 10.1038/nsb0595-380; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Ptitsyn OB, 1999, J MOL BIOL, V291, P671, DOI 10.1006/jmbi.1999.2920; Ptitsyn OB, 1996, FASEB J, V10, P3, DOI 10.1096/fasebj.10.1.8566544; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; REINEMER P, 1991, EMBO J, V10, P1997, DOI 10.1002/j.1460-2075.1991.tb07729.x; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Rossjohn J, 2000, J MOL BIOL, V302, P295, DOI 10.1006/jmbi.2000.4054; SEALE JW, 1994, PROTEIN SCI, V3, P1741, DOI 10.1002/pro.5560031014; Shakhnovich E, 1996, NATURE, V379, P96, DOI 10.1038/379096a0; SINNING I, 1993, J MOL BIOL, V232, P192, DOI 10.1006/jmbi.1993.1376; Snyder MJ, 1997, DNA CELL BIOL, V16, P1373, DOI 10.1089/dna.1997.16.1373; Stenberg G, 2000, J BIOL CHEM, V275, P10421, DOI 10.1074/jbc.275.14.10421; TAHIR MK, 1986, J BIOL CHEM, V261, P1048; WILCE MCJ, 1995, EMBO J, V14, P2133, DOI 10.1002/j.1460-2075.1995.tb07207.x; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986	41	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1291	1302		10.1074/jbc.M209581200	http://dx.doi.org/10.1074/jbc.M209581200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414796	hybrid			2022-12-27	WOS:000180321900077
J	Sprules, T; Green, N; Featherstone, M; Gehring, K				Sprules, T; Green, N; Featherstone, M; Gehring, K			Lock and key binding of the HOX YPWM peptide to the PBX homeodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOPERATIVE DNA-BINDING; NUCLEIC-ACIDS; PROTEINS; COMPLEX; DOMAIN; HEXAPEPTIDE; EXPRESSION; MOTIF; EXTRADENTICLE; RECOGNITION	HOX homeodomain proteins bind short core DNA sequences to control very specific developmental processes. DNA binding affinity and sequence selectivity are increased by the formation of cooperative complexes with the PBX homeodomain protein. A conserved YPWM motif in the HOX protein is necessary for cooperative binding with PBX. We have determined the structure of a PBX homeodomain bound to a 14-mer DNA duplex. A relaxation-optimized procedure was developed to measure DNA residual dipolar couplings at natural abundance in the 20-kDa binary complex. When the PBX homeodomain binds to DNA, a fourth a-helix is formed in the homeodomain. This helix rigidifies the DNA recognition helix of PBX and forms a hydrophobic binding site for the HOX YPWM peptide. The HOX peptide itself shows some structure in solution and suggests that the interaction between PBX and HOX is an example of "lock and key" binding. The NAIR structure explains the requirement of DNA for the PBX-HOX interaction and the increased affinity of DNA binding.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Chem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Montreal Joint Ctr Struct Biol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.		Featherstone, Mark/E-8057-2010; Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Featherstone, Mark/0000-0003-1576-046X; Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184				*AM BIOSC, 1998, GLUT SEPH 4B; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Billeter M, 1995, J BIOMOL NMR, V5, P1; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chang CP, 1997, MOL CELL BIOL, V17, P5679, DOI 10.1128/MCB.17.10.5679; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Ferretti E, 2000, DEVELOPMENT, V127, P155; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Fiala R, 2000, J BIOMOL NMR, V16, P291, DOI 10.1023/A:1008388400601; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Green NC, 1998, J BIOL CHEM, V273, P13273, DOI 10.1074/jbc.273.21.13273; Jabet C, 1999, J MOL BIOL, V291, P521, DOI 10.1006/jmbi.1999.2983; Jacobs Y, 1999, MOL CELL BIOL, V19, P5134, DOI 10.1128/mcb.19.7.5134; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; Lu Q, 1996, MOL CELL BIOL, V16, P1632; LU QA, 1995, MOL CELL BIOL, V15, P3786; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Marino JP, 1997, J AM CHEM SOC, V119, P7361, DOI 10.1021/ja964379u; NEUTEBOOM STC, 1995, P NATL ACAD SCI USA, V92, P9166, DOI 10.1073/pnas.92.20.9166; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; Pan L, 2001, J BIOL CHEM, V276, P32489, DOI 10.1074/jbc.M011541200; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Peltenburg LTC, 1997, DEVELOPMENT, V124, P1089; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Phelan ML, 1997, J BIOL CHEM, V272, P8635, DOI 10.1074/jbc.272.13.8635; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; Riek R, 2001, J AM CHEM SOC, V123, P658, DOI 10.1021/ja9938276; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shanmugam K, 1997, J BIOL CHEM, V272, P19081, DOI 10.1074/jbc.272.30.19081; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Slupsky CM, 2001, PROTEIN SCI, V10, P1244, DOI 10.1110/ps.50901; Sprules T, 2000, BIOCHEMISTRY-US, V39, P9943, DOI 10.1021/bi0001067	46	24	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1053	1058		10.1074/jbc.M207504200	http://dx.doi.org/10.1074/jbc.M207504200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409300	hybrid			2022-12-27	WOS:000180321900048
J	Hiroi, M; Ohmori, Y				Hiroi, M; Ohmori, Y			The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR COACTIVATORS; MOUSE PERITONEAL-MACROPHAGES; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; HISTONE ACETYLTRANSFERASE; TNF-ALPHA; P300/CBP-ASSOCIATED FACTOR; SIGNALING PATHWAYS; MEDIATE INDUCTION; CBP	Signal transducers and activators of transcription 1 (STAT1) and NF-kappaB cooperatively regulate the expression of many inflammatory genes. In the present study, we demonstrate that the transcriptional coactivator CREB-binding protein (CBP) mediated the STAT1/ NF-kappaB synergy for transcription of the gene for CXC ligand 9 (CXCL9), an interferon-gamma (IFN-gamma)-inducible chemokine. Reporter gene analysis showed that expression of CBP potentiated IFN-gamma and tumor necrosis factor (TNFalpha)-induced promoter activity and that the CBP-mediated synergy depended upon STAT1- and NF-kappaB-binding sites in the promoter. Experiments with CBP mutants indicated that the N-terminal and C-terminal regions were necessary for the transcriptional synergy, although the histone acetyltransferase activity of CBP was dispensable. A co-immunoprecipitation assay demonstrated that STAT1 and NF-kappaB RelA (p65) simultaneously associated with CBP in vivo. Furthermore, chromatin immunoprecipitation revealed that, although costimulation with IFN-gamma and TNFa did not cooperatively enhance the levels of acetylated histones, it did result in increased recruitment of STAT1, CBP, and RNA polymerase II at the promoter region of the CXCL 9 gene. Together, these results demonstrate that the STAT1/NF-kappaB-dependent transcriptional synergy could result from the enhanced recruitment of RNA polymerase II complex to the promoter via simultaneous interaction of CBP with STAT1 and NF-kappaB.	Meikai Univ, Sch Dent, Ctr Biol Mol, Dept Basic Dent Sci, Sakado, Saitama 3500283, Japan	Meikai University	Ohmori, Y (corresponding author), Meikai Univ, Sch Dent, Ctr Biol Mol, Dept Basic Dent Sci, 1-1 Keyakidai, Sakado, Saitama 3500283, Japan.			Ohmori, Yoshihiro/0000-0002-6069-357X				Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harton JA, 2001, J BIOL CHEM, V276, P38715, DOI 10.1074/jbc.M106652200; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; JAHNKE A, 1994, FEBS LETT, V354, P220, DOI 10.1016/0014-5793(94)01130-3; JOHNSON DR, 1994, MOL CELL BIOL, V14, P1322, DOI 10.1128/MCB.14.2.1322; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; Moreno CS, 1999, IMMUNITY, V10, P143, DOI 10.1016/S1074-7613(00)80015-1; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ohmori Y, 2000, J BIOL CHEM, V275, P38095, DOI 10.1074/jbc.M006227200; OHMORI Y, 1995, J IMMUNOL, V154, P5235; OHMORI Y, 1994, J IMMUNOL, V153, P2204; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; OHMORI Y, 1994, J BIOL CHEM, V269, P17684; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHMITZ ML, 1995, J BIOL CHEM, V270, P7219, DOI 10.1074/jbc.270.13.7219; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Westin S, 2000, ADV PHARMACOL, V47, P89; WONG P, 1994, MOL CELL BIOL, V14, P914, DOI 10.1128/MCB.14.2.914; WRIGHT TM, 1991, J EXP MED, V173, P417, DOI 10.1084/jem.173.2.417; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	54	79	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					651	660		10.1074/jbc.M204544200	http://dx.doi.org/10.1074/jbc.M204544200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403783	hybrid			2022-12-27	WOS:000180255700083
J	Ni, AG; Agata, J; Yang, Z; Chao, R; Chao, J				Ni, AG; Agata, J; Yang, Z; Chao, R; Chao, J			Overexpression of kinin B-1 receptors induces hypertensive response to Des-Arg(9)-bradykinin and susceptibility to inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SMOOTH-MUSCLE CELLS; CONSTITUTIVE ACTIVATION; BRADYKININ RECEPTOR; SIGNAL-TRANSDUCTION; HUMAN B1; ALPHA(1B)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; ADENYLATE-CYCLASE; TRANSGENIC MICE	We demonstrated that rat kinin B-1 receptors displayed a ligand-independent constitutive activity, assessed through inositol phosphate production in transiently or stably transfected human embryonic kidney 293A cells. Substitution of Ala for Asn(130) in the third transmembrane domain resulted in additional constitutive activation of the B-1 receptor. The constitutively active mutant N130A receptor could be further activated by the B, receptor agonist des-Arg(9)-bradykinin. To gain insights into the physiological function of the B-1 receptor, we have generated transgenic mice overexpressing wild-type and constitutively active mutant receptors under the control of human cytomegalovirus immediately early gene enhancer/promoter. The rat B-1 receptor transgene expression was detected in the aorta, brain, heart, lung, liver, kidney, uterus, and prostate of transgenic mice by reverse transcription-polymerase chain reaction/Southern blot analysis. Transgenic mice were fertile and normotensive. Overexpression of B-1 receptors exacerbated paw edema induced by carrageenan and rendered transgenic mice more susceptible to lipopolysaccharide-induced endotoxic shock. Interestingly, the hemodynamic response to kinins was altered in transgenic mice, with des-Arg(9)-bradykinin inducing blood pressure increase when intravenously administered. Our study supports an important role for B-1 receptors in modulating inflammatory responses and for the first time demonstrates that B-1 receptors mediate a hypertensive response to des-Arg(9)-bradykinin.	Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Chao, J (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 171 Ashley Ave, Charleston, SC 29425 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052196, R01HL029397] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 29397, HL52196] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALVAREZ AL, 1992, CLIN SCI, V82, P513, DOI 10.1042/cs0820513; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; Campos MM, 1996, BRIT J PHARMACOL, V117, P793, DOI 10.1111/j.1476-5381.1996.tb15262.x; Chai KX, 1996, GENOMICS, V31, P51, DOI 10.1006/geno.1996.0008; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; Decarie A, 1996, AM J PHYSIOL-HEART C, V271, pH1340, DOI 10.1152/ajpheart.1996.271.4.H1340; Decarie A, 1996, PEPTIDES, V17, P1009; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Emanueli C, 1999, BRIT J PHARMACOL, V126, P1769, DOI 10.1038/sj.bjp.0702527; Faussner A, 1998, J BIOL CHEM, V273, P2617, DOI 10.1074/jbc.273.5.2617; FRASER CM, 1988, P NATL ACAD SCI USA, V85, P5478, DOI 10.1073/pnas.85.15.5478; Gobeil F, 1997, CAN J PHYSIOL PHARM, V75, P591, DOI 10.1139/cjpp-75-6-591; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; KARPINSKI BA, 1989, MOL CELL BIOL, V9, P2588, DOI 10.1128/MCB.9.6.2588; Kenakin T, 1996, PHARMACOL REV, V48, P413; Leeb-Lundberg LMF, 2001, J BIOL CHEM, V276, P8785, DOI 10.1074/jbc.M007396200; Madeddu P, 1997, CIRCULATION, V96, P3570; Marceau F, 1998, PHARMACOL REV, V50, P357; Marie J, 1999, MOL PHARMACOL, V55, P92, DOI 10.1124/mol.55.1.92; McLean PG, 2000, CARDIOVASC RES, V48, P194, DOI 10.1016/S0008-6363(00)00184-X; Meini S, 1996, BRIT J PHARMACOL, V117, P1619, DOI 10.1111/j.1476-5381.1996.tb15331.x; MENKE JG, 1994, J BIOL CHEM, V269, P21583; Morin D, 1998, FEBS LETT, V441, P470, DOI 10.1016/S0014-5793(98)01585-3; Ni A, 1998, BBA-GENE STRUCT EXPR, V1442, P177, DOI 10.1016/S0167-4781(98)00163-8; Ni AG, 1998, J BIOL CHEM, V273, P2784, DOI 10.1074/jbc.273.5.2784; NWATOR IAA, 1989, EUR J PHARMACOL, V160, P125, DOI 10.1016/0014-2999(89)90661-4; OLIVEIRA L, 1994, TRENDS PHARMACOL SCI, V15, P170, DOI 10.1016/0165-6147(94)90137-6; PAIVA ACM, 1989, BRIT J PHARMACOL, V98, P206, DOI 10.1111/j.1476-5381.1989.tb16883.x; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Perez DM, 1996, MOL PHARMACOL, V49, P112; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; REGOLI D, 1980, PHARMACOL REV, V32, P1; Rupniak NMJ, 1997, PAIN, V71, P89, DOI 10.1016/S0304-3959(97)03343-5; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Scheer A, 1996, EMBO J, V15, P3566, DOI 10.1002/j.1460-2075.1996.tb00726.x; SCHNECK KA, 1994, EUR J PHARM-MOLEC PH, V266, P277, DOI 10.1016/0922-4106(94)90137-6; SMITH JAM, 1995, MOL PHARMACOL, V47, P525; TROPEA MM, 1993, J PHARMACOL EXP THER, V264, P930; Wang DZ, 1997, HYPERTENSION, V29, P488, DOI 10.1161/01.HYP.29.1.488; Wang DZ, 2000, AM J PHYSIOL-RENAL, V278, pF484, DOI 10.1152/ajprenal.2000.278.3.F484; WHALLEY ET, 1984, N-S ARCH PHARMACOL, V328, P202, DOI 10.1007/BF00512073; Zuscik MJ, 1998, J BIOL CHEM, V273, P3401, DOI 10.1074/jbc.273.6.3401	49	57	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					219	225		10.1074/jbc.M209490200	http://dx.doi.org/10.1074/jbc.M209490200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12411434	hybrid			2022-12-27	WOS:000180255700029
J	Sheu, TJ; Schwarz, EM; Martinez, DA; O'Keefe, RJ; Rosier, RN; Zuscik, MJ; Puzas, JE				Sheu, TJ; Schwarz, EM; Martinez, DA; O'Keefe, RJ; Rosier, RN; Zuscik, MJ; Puzas, JE			A phage display technique identifies a novel regulator of cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-INTERACTING PROTEIN; BONE MORPHOGENETIC PROTEIN-2; TITANIUM SURFACE-ROUGHNESS; ACID-PHOSPHATASE ACP-5; TGF-BETA; ALKALINE-PHOSPHATASE; TRANSFORMING GROWTH-FACTOR-BETA-1; MANNOSE-6-PHOSPHATE RECEPTORS; OSTEOBLAST RESPONSE	The formation of new bone during the process of bone remodeling occurs almost exclusively at sites of prior bone resorption. In an attempt to discover what regulatory pathways are utilized by osteoblasts to effect this site-specific formation event we probed components of an active bone resorption surface with an osteoblast phage expression library. In these experiments primary cultures of rat osteoblasts were used to construct a phage display library in T7 phage. Tartrate-resistant acid phosphatase (type V) (TRAP) was used as the bait in a biopanning procedure. 40 phage clones with very high affinity for TRAP were sequenced, and of the clones with multiple consensus sequences we identified a regulatory protein that modulates osteoblast differentiation. This protein is the TGFbeta receptor-interacting protein (TRIP-1). Our data demonstrate that TRAP activation of TRIP-1 evokes a TGFbeta-like differentiation process. Specifically, TRIP-1 activation increases the activity and expression of osteoblast alkaline phosphatase, osteoprotegerin, collagen, and Runx2. Moreover, we show that TRAP interacts with TRIP intracellularly, that activation of the TGFbeta type II receptor by TRIP-1 occurs in the presence of TRAP and that the differentiation process is mediated through the Smad2/3 pathway. A final experiment demonstrates that osteoblasts, when cultured in osteoclast lacunae containing TRAP, rapidly and specifically differentiate into a mature bone-forming phenotype. We hypothesize that binding to TRAP may be one mechanism by which the full osteoblast phenotype is expressed during the process of bone remodeling.	Univ Rochester, Sch Med & Dent, Dept Orthopaed, Mcclure Musculoskeletal Res Ctr, Rochester, NY 14642 USA; Univ Houston, Dept Biol & Biochem, Connect Tissue Physiol Lab, Houston, TX 77204 USA	University of Rochester; University of Houston System; University of Houston	Puzas, JE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Orthopaed, Mcclure Musculoskeletal Res Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.		Martinez, Daniel/A-5825-2008	Zuscik, Michael/0000-0003-0461-8708	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008121] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE 12011] Funding Source: Medline; NIEHS NIH HHS [R01 ES 08121] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARON R, 1988, J CELL BIOL, V106, P1863, DOI 10.1083/jcb.106.6.1863; Bikle DD, 1999, J BONE MINER METAB, V17, P233, DOI 10.1007/s007740050090; BONEWALD LF, 1992, BONE MINER, V17, P139, DOI 10.1016/0169-6009(92)90725-S; Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M; Cheifetz S, 1996, CONNECT TISSUE RES, V35, P71, DOI 10.3109/03008209609029176; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Choy L, 1998, J BIOL CHEM, V273, P31455, DOI 10.1074/jbc.273.47.31455; Chung CY, 1999, BIOCHEM BIOPH RES CO, V265, P246, DOI 10.1006/bbrc.1999.1639; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; FROST HM, 1966, J BONE JOINT SURG AM, VA 48, P1192, DOI 10.2106/00004623-196648060-00018; Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4; HARRIS SE, 1994, J BONE MINER RES, V9, P855; HARRIS WH, 1969, NEW ENGL J MED, V280, P303, DOI 10.1056/NEJM196902062800605; HARRIS WH, 1969, NEW ENGL J MED, V280, P253, DOI 10.1056/NEJM196901302800507; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hayman AR, 2000, J ANAT, V196, P433, DOI 10.1046/j.1469-7580.2000.19630433.x; Hirano T, 2000, BONE, V27, P13, DOI 10.1016/S8756-3282(00)00284-2; Ionescu AM, 2001, J BIOL CHEM, V276, P11639, DOI 10.1074/jbc.M006564200; Jiang JR, 2001, PLANT J, V26, P35, DOI 10.1046/j.1365-313x.2001.01007.x; JONES SJ, 1994, ANAT EMBRYOL, V190, P339; Kassem M, 2000, EUR J CLIN INVEST, V30, P429; LING P, 1993, J BIOL CHEM, V268, P6896; MARTINEZ DA, 1995, J CELL BIOCHEM, V59, P246, DOI 10.1002/jcb.240590213; Parfitt AM., 1983, BONE HISTOMORPHOMETR, V1983, P143; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; Romano PR, 1997, J PERIODONTAL RES, V32, P143, DOI 10.1111/j.1600-0765.1997.tb01396.x; Schwartz Z, 1999, Adv Dent Res, V13, P38; Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K; Seeman E, 2001, TRENDS ENDOCRIN MET, V12, P281, DOI 10.1016/S1043-2760(01)00460-X; Sheu TJ, 2002, J BONE MINER RES, V17, P915, DOI 10.1359/jbmr.2002.17.5.915; Tiffee JC, 1997, J ORAL MAXIL SURG, V55, P1108, DOI 10.1016/S0278-2391(97)90291-3; WERGEDAL JE, 1969, J HISTOCHEM CYTOCHEM, V17, P799, DOI 10.1177/17.12.799; Yamada T, 1999, HISTOCHEM J, V31, P687, DOI 10.1023/A:1003855922395; YAMAMOTO T, 1992, J BONE MINER RES, V7, P1267	34	63	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					438	443		10.1074/jbc.M208292200	http://dx.doi.org/10.1074/jbc.M208292200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403789	hybrid			2022-12-27	WOS:000180255700058
J	Cohen, GN				Cohen, GN			The early influence of the Institut Pasteur on the emergence of molecular biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BETA-GALACTOSIDASE		Inst Pasteur, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cohen, GN (corresponding author), Inst Pasteur, 28 Rue Docteur Roux, F-75724 Paris, France.	gncohen@pasteur.fr						BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; BUCHEL DE, 1980, NATURE, V283, P541, DOI 10.1038/283541a0; COHEN G, 1959, CR HEBD ACAD SCI, V248, P3490; COHEN GN, 1955, CR HEBD ACAD SCI, V240, P466; COHEN GN, 1957, BACTERIOL REV, V21, P169, DOI 10.1128/MMBR.21.3.169-194.1957; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; GROS F, 1961, COLD SPRING HARB SYM, V26, P111, DOI 10.1101/SQB.1961.026.01.016; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Monod J, 1941, CR HEBD ACAD SCI, V212, P934; MONOD J, 1942, THESIS ACTUALITES SC; PERLMAN R, 1968, BIOCHEM BIOPH RES CO, V30, P656, DOI 10.1016/0006-291X(68)90563-9; RICKENBERG HV, 1956, ANN I PASTEUR PARIS, V91, P829; STADTMAN ER, 1961, J BIOL CHEM, V236, P2033; ULLMANN A, 1992, BIOESSAYS, V14, P201, DOI 10.1002/bies.950140311; ULLMANN A, 1968, Febs Letters, V2, P57, DOI 10.1016/0014-5793(68)80100-0; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0; ZABIN I, 1959, BIOCHEM BIOPH RES CO, V1, P289, DOI 10.1016/0006-291X(59)90040-3	18	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50215	50218		10.1074/jbc.X200006200	http://dx.doi.org/10.1074/jbc.X200006200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12403766	hybrid			2022-12-27	WOS:000180177700001
J	D'Orso, I; Frasch, ACC				D'Orso, I; Frasch, ACC			TcUBP-1, an mRNA destabilizing factor from trypanosomes, homodimerizes and interacts with novel AU-rich element- and poly(A)-binding proteins forming a ribonucleoprotein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; PRE-MESSENGER-RNA; U1A PROTEIN; 3'-UNTRANSLATED REGION; RECOGNITION MOTIFS; GENE-EXPRESSION; SEX-LETHAL; CRUZI; DOMAIN; BRUCEI	Trypanosomes, protozoan parasites causing worldwide infections in human and animals, mostly regulate protein expression through post-transcriptional mechanisms and not at the transcription initiation level. We have previously identified a Trypanosoma cruzi RNA-binding protein named TcUBP-1. This protein is involved in mRNA destabilization in vivo through binding to AU-rich elements in the W-untranslated region of SMUG mucin mRNAs (D'Orso, I., and Frasch, A. C. (2001) J. Biol. Chem. 276, 34801-34809). In this work we show that TcUBP-1 is part of an similar to450-kDa ribonucleoprotein complex with a poly(A)-binding protein and a novel 18-kDa RNA-binding protein, named TcUBP-2. Recombinant TcUBP-1 and TcUBP-2 proteins recognize U-rich RNAs with similar specificity and affinity through the similar to92-amino acid RNA recognition motif. TcUBPs can homo- and heterodimerize in vitro through the glycine-rich C-terminal region. This interaction was also detected in vivo by co-immunoprecipitation of the ribonucleoprotein complex and using yeast two-hybrid assay. The poly(A)-binding protein identified was shown to disrupt the formation of TcUBP-1, but not TcUBP-2, homodimers in vitro. The possible role of TcUBP-1 ligands in the pathways that govern mRNA-stability and stage-specific expression in trypanosomes is discussed.	UNSAM, IIB, INTI, CONICET, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Industrial (INTI)	Frasch, ACC (corresponding author), UNSAM, IIB, INTI, CONICET, Av Gral Paz S-N,Edificio 24,Casilla Correo 30, RA-1650 San Martin, Buenos Aires, Argentina.			Frasch, Alberto Carlos/0000-0001-7532-653X				Avis JM, 1996, J MOL BIOL, V257, P398, DOI 10.1006/jmbi.1996.0171; BATISTA JAN, 1994, MOL BIOCHEM PARASIT, V67, P301, DOI 10.1016/0166-6851(94)00133-2; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Crowder SM, 1999, P NATL ACAD SCI USA, V96, P4892, DOI 10.1073/pnas.96.9.4892; D'Orso I, 2001, J BIOL CHEM, V276, P15783, DOI 10.1074/jbc.M010959200; D'Orso I, 2001, J BIOL CHEM, V276, P34801, DOI 10.1074/jbc.M102120200; DeMaria CT, 1997, NUCL ACIDS S SER, V36, P12; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Di Noia JM, 2000, J BIOL CHEM, V275, P10218, DOI 10.1074/jbc.275.14.10218; Di Noia JM, 1998, J BIOL CHEM, V273, P10843, DOI 10.1074/jbc.273.18.10843; DiNitto JP, 2001, BIOCHEMISTRY-US, V40, P12645, DOI 10.1021/bi011439m; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gilinger G, 2001, NUCLEIC ACIDS RES, V29, P1556, DOI 10.1093/nar/29.7.1556; Gunnewiek JMTK, 2000, MOL CELL BIOL, V20, P2209, DOI 10.1128/MCB.20.6.2209-2217.2000; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HEHL A, 1994, P NATL ACAD SCI USA, V91, P370, DOI 10.1073/pnas.91.1.370; Irmer H, 2001, NUCLEIC ACIDS RES, V29, P4707, DOI 10.1093/nar/29.22.4707; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; LU JR, 1995, J MOL BIOL, V247, P739, DOI 10.1016/S0022-2836(05)80152-4; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Nozaki T, 1995, MOL BIOCHEM PARASIT, V75, P55, DOI 10.1016/0166-6851(95)02512-X; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; Wan LL, 2001, J BIOL CHEM, V276, P7681, DOI 10.1074/jbc.M010207200; Weston D, 1999, MOL BIOCHEM PARASIT, V102, P53, DOI 10.1016/S0166-6851(99)00079-1; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016	37	62	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50520	50528		10.1074/jbc.M209092200	http://dx.doi.org/10.1074/jbc.M209092200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12403777	hybrid			2022-12-27	WOS:000180177700044
J	Tcherpakov, M; Bronfman, FC; Conticello, SG; Vaskovsky, A; Levy, Z; Niinobe, M; Yoshikawa, K; Arenas, E; Fainzilber, M				Tcherpakov, M; Bronfman, FC; Conticello, SG; Vaskovsky, A; Levy, Z; Niinobe, M; Yoshikawa, K; Arenas, E; Fainzilber, M			The p75 neurotrophin receptor interacts with multiple MAGE proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; NUCLEAR-PROTEIN; MOUSE-BRAIN; NECDIN; SYSTEM; CELLS	The p75 neurotrophin receptor has been implicated in diverse aspects of neurotrophin signaling, but the mechanisms by which its effects are mediated are not well understood. Here we identify two MAGE proteins, necdin and MAGE-H1, as interactors for the intracellular domain of p75 and show that the interaction is enhanced by ligand stimulation. PC12 cells transfected with necdin or MAGE-H1 exhibit accelerated differentiation in response to nerve growth factor. Expression of these two MAGE proteins is predominantly cytoplasmic in PC12 cells, and necdin was found to be capable of homodimerization, suggesting that it may act as a cytoplasmic adaptor to recruit a signaling complex to p75. These findings indicate that diverse MAGE family members can interact with the p75 receptor and highlight type II MAGE proteins as a potential family of interactors for signaling proteins containing type II death domains.	Weizmann Inst Sci, Dept Biol Chem, Mol Neurobiol Grp, IL-76100 Rehovot, Israel; Osaka Univ, Inst Prot Res, Div Regulat Macromol Funct, Suita, Osaka 5650871, Japan; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Weizmann Institute of Science; Osaka University; Karolinska Institutet	Fainzilber, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, Mol Neurobiol Grp, POB 26, IL-76100 Rehovot, Israel.		Conticello, Silvestro/G-9113-2011; Arenas, Ernest/AAO-5231-2020	Conticello, Silvestro/0000-0002-4244-1846; Arenas, Ernest/0000-0003-0197-6577; Fainzilber, Mike/0000-0001-8173-8557				AIZAWA T, 1992, DEV BRAIN RES, V68, P265, DOI 10.1016/0165-3806(92)90069-9; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bentley CA, 2000, J NEUROSCI, V20, P7706; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; Dobashi Y, 2000, J BIOL CHEM, V275, P12572, DOI 10.1074/jbc.275.17.12572; Fan G, 1999, NEUROSCIENCE, V90, P259, DOI 10.1016/S0306-4522(98)00432-1; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Takazaki R, 2002, EXP CELL RES, V277, P220, DOI 10.1006/excr.2002.5558; Taniura H, 2002, J CELL BIOCHEM, V84, P545, DOI 10.1002/jcb.10047.abs; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; WESKAMP G, 1991, NEURON, V6, P649, DOI 10.1016/0896-6273(91)90067-A; Zhu F, 2000, BIOTECHNIQUES, V29, P310, DOI 10.2144/00292st06	18	75	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 20	2002	277	51					49101	49104		10.1074/jbc.C200533200	http://dx.doi.org/10.1074/jbc.C200533200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	629AU	12414813	hybrid			2022-12-27	WOS:000180028900002
J	Corbalan-Garcia, S; Garcia-Garcia, J; Rodriguez-Alfaro, JA; Gomez-Fernandez, JC				Corbalan-Garcia, S; Garcia-Garcia, J; Rodriguez-Alfaro, JA; Gomez-Fernandez, JC			A new phosphatidylinositol 4,5-bisphosphate-binding site located in the C2 domain of protein kinase C alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BINDING-SITES; IN-VITRO; ACTIVATION; CALCIUM; DIACYLGLYCEROL; ROLES; CA2+; POLYPHOSPHOINOSITIDES; PHOSPHOLIPIDS	In view of the interest shown in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) as a second messenger, we studied the activation of protein kinase Calpha by this phosphoinositide. By using two double mutants from two different sites located in the C2 domain of protein kinase Calpha we have determined and characterized the PtdIns(4,5)P-2-binding site in the protein, which was found to be important for its activation. Thus, there are two distinct sites in the C2 domain: the first, the lysine-rich cluster located in the beta3- and beta4-sheets and which activates the enzyme through direct binding of PtdIns(4,5)p2; and the second, the already well described site formed by the Ca2+-binding region, which also binds phosphatidylserine and a result of which the enzyme is activated. The results obtained in this work point to a sequential activation model, in which protein kinase Ca needs Ca2+ before the PtdIns(4,5)P-2-dependent activation of the enzyme can occur.	Univ Murcia, Dept Bioquim & Biol Mol A, Fac Vet, E-30100 Murcia, Spain	University of Murcia	Gomez-Fernandez, JC (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Fac Vet, Apdo 4021, E-30100 Murcia, Spain.	jcgomez@um.es	Corbalan-Garcia, Senena/C-6477-2009; Gomez-Fernandez, Juan C/K-6758-2014	Corbalan-Garcia, Senena/0000-0003-1840-5578; Gomez-Fernandez, Juan C/0000-0002-5331-9029				Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; BACIU PC, 1995, MOL BIOL CELL, V6, P1503, DOI 10.1091/mbc.6.11.1503; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; CHAUHAN VPS, 1988, BIOCHEM BIOPH RES CO, V155, P18, DOI 10.1016/S0006-291X(88)81043-X; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; COCCO L, 1987, BIOCHEM J, V248, P765, DOI 10.1042/bj2480765; Conesa-Zamora P, 2000, BBA-MOL CELL BIOL L, V1487, P246, DOI 10.1016/S1388-1981(00)00099-8; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; EOKSOO O, 1997, J BIOL CHEM, V272, P8133; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P12020, DOI 10.1021/bi981107q; KHAN WA, 1995, CELL SIGNAL, V7, P171, DOI 10.1016/0898-6568(94)00089-T; KOCHS G, 1993, BIOCHEM J, V291, P627, DOI 10.1042/bj2910627; LEACH KL, 1989, J CELL BIOL, V109, P685, DOI 10.1083/jcb.109.2.685; LEE MH, 1991, BIOCHEMISTRY-US, V30, P1041, DOI 10.1021/bi00218a023; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; NEWTON AC, 1994, BIOCHEMISTRY-US, V33, P6651, DOI 10.1021/bi00187a035; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; PALMER RH, 1995, J BIOL CHEM, V270, P22412, DOI 10.1074/jbc.270.38.22412; Prevostel C, 2000, J CELL SCI, V113, P2575; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SINGH SS, 1993, BIOCHEM BIOPH RES CO, V195, P104, DOI 10.1006/bbrc.1993.2016; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; TOKER A, 1994, J BIOL CHEM, V269, P32358; Toker Alex, 1998, Frontiers in Bioscience, V3, pD1134; TRAN D, 1993, CELL SIGNAL, V5, P565, DOI 10.1016/0898-6568(93)90052-N; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512; Zheng L, 2002, BIOCHEMISTRY-US, V41, P4546, DOI 10.1021/bi0158775	57	87	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4972	4980		10.1074/jbc.M209385200	http://dx.doi.org/10.1074/jbc.M209385200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12426311	hybrid			2022-12-27	WOS:000180968900082
J	Bandhakavi, S; McCann, RO; Hanna, DE; Glover, CVC				Bandhakavi, S; McCann, RO; Hanna, DE; Glover, CVC			A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; HSP90 MOLECULAR CHAPERONE; CELL-CYCLE PROGRESSION; POLE BODY DUPLICATION; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; IN-VIVO; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION	We report here the identification of CDC37, which encodes a putative Hsp90 co-chaperone, as a multicopy suppressor of a temperature-sensitive allele (cka2-13(ts)) of the CKA2 gene encoding the alpha' catalytic subunit of protein kinase CKII. Unlike wild-type cells, cka2-13 cells were sensitive to the Hsp90-specific inhibitor geldanamycin, and this sensitivity was suppressed by overexpression of either Hsp90 or Cdc37. However, only CDC37 was capable of suppressing the temperature sensitivity of a cka2-13 strain, implying that Cdc37 is the limiting component. Immunoprecipitation of metabolically labeled Cdc37 from wild-type versus cka2-13 strains revealed that Cdc37 is a physiological substrate of CKII, and Ser-14 and/or Ser-17 were identified as the most likely sites of CKH phosphorylation in vivo. A cdc37-S14,17A strain lacking these phosphorylation sites exhibited severe growth and morphological defects that were partially reversed in a cdc37-S14,17E strain. Reduced CKH activity was observed in both cdc37-S14A and cdc37-S17A mutants at 37 degreesC, and cdc37-S14A or cdc37-S14,17A overexpression was incapable of protecting cka2-13 mutants on media containing geldanamycin. Additionally, CKH activity was elevated in cells arrested at the G(1) and G(2)/M phases of the cell cycle, the same phases during which Cdc37 function is essential. Collectively, these data define a positive feedback loop between CKH and Cdc37. Additional genetic assays demonstrate that this CKII/Cdc37 interaction positively regulates the activity of multiple protein kinases in addition to CKH.	Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Glover, CVC (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Life Sci Bldg, Athens, GA 30602 USA.	glover@arches.uga.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054626] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54626] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas-Terki T, 2000, FEBS LETT, V467, P111, DOI 10.1016/S0014-5793(00)01134-0; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dey B, 1996, MOL BIOL CELL, V7, P1405, DOI 10.1091/mbc.7.9.1405; Farrell A, 2000, MOL CELL BIOL, V20, P749, DOI 10.1128/MCB.20.3.749-754.2000; FERGUSON J, 1986, NUCLEIC ACIDS RES, V14, P6681, DOI 10.1093/nar/14.16.6681; Fliss AE, 1997, MOL BIOL CELL, V8, P2501, DOI 10.1091/mbc.8.12.2501; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; MARSHAK DR, 1994, CELL MOL BIOL RES, V40, P513; Morano KA, 1999, EMBO J, V18, P5953, DOI 10.1093/emboj/18.21.5953; Morano KA, 1999, MOL CELL BIOL, V19, P402; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REED SI, 1980, GENETICS, V95, P561; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schutz AR, 1997, J CELL BIOL, V136, P969, DOI 10.1083/jcb.136.5.969; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SIKORSKI RS, 1989, GENETICS, V122, P19; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Stepanova L, 2000, MOL CELL BIOL, V20, P4462, DOI 10.1128/MCB.20.12.4462-4473.2000; STRATHERN JN, 1991, METHOD ENZYMOL, V194, P319; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961; Zarzov P, 1997, J CELL SCI, V110, P1879	46	81	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2829	2836		10.1074/jbc.M206662200	http://dx.doi.org/10.1074/jbc.M206662200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12435747	hybrid			2022-12-27	WOS:000180915000010
J	Ishmael, FT; Trakselis, MA; Benkovic, SJ				Ishmael, FT; Trakselis, MA; Benkovic, SJ			Protein-protein interactions in the bacteriophage T4 replisome - The leading strand holoenzyme is physically linked to the lagging strand holoenzyme and the primosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE HOLOENZYME; REPLICATION HELICASE GP41; RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; CROSS-LINKING; SLIDING CLAMP; SWISS-MODEL; FORK; COMPLEX; GENE-41	The bacteriophage T4 replication complex is composed of eight proteins that function together to replicate DNA. This replisome can be broken down into four basic units: a primosome composed of gp41, gp61, and gp59; a leading strand holoenzyme composed of gp43, gp44/62, and gp45; a lagging strand holoenzyme; and a single strand binding protein polymer. These units interact further to form the complete replisome. The leading and lagging strand polymerases are physically linked in the presence of DNA or an active replisome. The region of interaction was mapped to an extension of the finger domain, such that Cys-507 of one subunit is in close proximity to Cys-507 of a second subunit. The leading strand polymerase and the primosome also associate, such that gp59 mediates the contact between the two complexes. Binding of gp43 to the primosome complex causes displacement of gp32 from the gp59-gp61-gp41 primosome complex. The resultant species is a complex of proteins that may allow coordinated leading and lagging strand synthesis, helicase DNA unwinding activity, and polymerase nucleotide incorporation.	Penn State Univ, Dept Chem, State Coll, PA 16827 USA; Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, State Coll, PA 16827 USA.		Trakselis, Michael/V-3806-2019	Trakselis, Michael/0000-0001-7054-8475	NIGMS NIH HHS [GM13306-37] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Alley SC, 2000, J AM CHEM SOC, V122, P6126, DOI 10.1021/ja000591t; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Berdis AJ, 1996, BIOCHEMISTRY-US, V35, P9253, DOI 10.1021/bi952569w; CHA TA, 1989, J BIOL CHEM, V264, P12220; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Dong F, 1996, J BIOL CHEM, V271, P19625, DOI 10.1074/jbc.271.32.19625; Dong F, 1996, P NATL ACAD SCI USA, V93, P14456, DOI 10.1073/pnas.93.25.14456; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HINTON DM, 1985, J BIOL CHEM, V260, P2858; HUANG CC, 1981, J BIOL CHEM, V256, P4087; HUBERMAN JA, 1971, J MOL BIOL, V62, P39, DOI 10.1016/0022-2836(71)90129-X; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; KABOORD BF, 1993, P NATL ACAD SCI USA, V90, P10881, DOI 10.1073/pnas.90.22.10881; Kadyrov FA, 2001, J BIOL CHEM, V276, P29559, DOI 10.1074/jbc.M101310200; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; ROTH AC, 1982, J BIOL CHEM, V257, P1267; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; TARUMI K, 1995, J BIOL CHEM, V270, P2614, DOI 10.1074/jbc.270.6.2614; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; WANG CC, 1995, J BIOL CHEM, V270, P26558, DOI 10.1074/jbc.270.44.26558; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2	37	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3145	3152		10.1074/jbc.M209858200	http://dx.doi.org/10.1074/jbc.M209858200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427736	hybrid			2022-12-27	WOS:000180915000049
J	Tse, SML; Furuya, W; Gold, E; Schreiber, AD; Sandvig, K; Inman, RD; Grinstein, S				Tse, SML; Furuya, W; Gold, E; Schreiber, AD; Sandvig, K; Inman, RD; Grinstein, S			Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLE FORMATION; TRANS-GOLGI NETWORK; MAMMALIAN-CELLS; MACROPHAGE PHAGOCYTOSIS; MEMBRANE DOMAINS; MUTANT DYNAMIN; INTERNALIZATION; DEGRADATION; MECHANISMS; 3-KINASE	Clustering of macrophage Fcy receptors by multimeric immunoglobulin complexes leads to their internalization. Formation of small aggregates leads to endocytosis, whereas large particulate complexes induce phagocytosis. In RAW-264.7 macrophages, Fey receptor endocytosis was found to be dependent on clathrin and dynamin and insensitive to cytochalasin. Clathrin also associates with nascent phagosomes, and earlier observations suggested that it plays an essential role in phagosome formation. However, we find that phagocytosis of IgG-coated large (greater than or equal to3 mum) particles was unaffected by inhibition of dynamin or by reducing the expression of clathrin using antisense mRNA but was eliminated by cytochalasin, implying a distinct mechanism dependent on actin assembly. The uptake of smaller particles (:51 mum) was only partially blocked by cytochalasin. Remarkably, the cytochalasin-resistant component was also insensitive to dominant-negative dynamin I and to clathrin antisense mRNA, implying the existence of a third internalization mechanism, independent of actin, dynamin, and clathrin. The uptake of small particles occurred by a process distinct from fluid phase pinocytosis, because it was not inhibited by dominant-negative Rab5. The insensitivity of phagocytosis to dominant-negative dynamin I enabled us to test the role of dynamin in phagosomal maturation. Although internalization of receptors from the plasma membrane was virtually eliminated by the K44A and S45N mutants of dynamin 1, clearance of transferrin receptors and of CD18 from maturing phagosomes was unaffected by these mutants. This implies that removal of receptors from the phagosomal membrane occurs by a mechanism that is different from the one mediating internalization of the same receptors at the plasma membrane. These results imply that, contrary to prevailing notions, normal dynamin and clathrin function is not required for phagocytosis and reveal the existence of a component of phagocytosis that is independent of actin and Rab5.	Hosp Sick Children, Dept Cell Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5G 1X8, Canada; Univ Toronto, Univ Hlth Network, Toronto, ON M5G 1X8, Canada; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Norwegian Radium Hosp, Inst Canc Res, N-0310 Oslo, Norway	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Oslo	Grinstein, S (corresponding author), Hosp Sick Children, Dept Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.			Inman, Robert/0000-0002-4750-1422				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; AGGELER J, 1982, J CELL BIOL, V94, P613, DOI 10.1083/jcb.94.3.613; Amigorena S, 1999, IMMUNOL REV, V172, P279, DOI 10.1111/j.1600-065X.1999.tb01372.x; Amigorena S, 1999, SEMIN IMMUNOL, V11, P385, DOI 10.1006/smim.1999.0196; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Botelho RJ, 2000, J BIOL CHEM, V275, P15717, DOI 10.1074/jbc.M910068199; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8; HEDIN U, 1984, EUR J CELL BIOL, V35, P41; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Iversen TG, 2001, MOL BIOL CELL, V12, P2099, DOI 10.1091/mbc.12.7.2099; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Llorente A, 2001, J CELL SCI, V114, P335; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MELLMAN I, 1984, J CELL BIOL, V98, P1170, DOI 10.1083/jcb.98.4.1170; MELLMAN IS, 1983, J CELL BIOL, V96, P887, DOI 10.1083/jcb.96.3.887; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Perry DG, 1999, J IMMUNOL, V162, P380; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Torgersen ML, 2001, J CELL SCI, V114, P3737; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097	45	94	94	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3331	3338		10.1074/jbc.M207966200	http://dx.doi.org/10.1074/jbc.M207966200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12424246	hybrid			2022-12-27	WOS:000180915000072
J	Banerjee, SS; Feinberg, MW; Watanabe, M; Gray, S; Haspel, RL; Denkinger, DJ; Kawahara, R; Hauner, H; Jain, MK				Banerjee, SS; Feinberg, MW; Watanabe, M; Gray, S; Haspel, RL; Denkinger, DJ; Kawahara, R; Hauner, H; Jain, MK			The Kruppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; TRANSCRIPTION FACTOR; ADIPOCYTE DIFFERENTIATION; C/EBP-ALPHA; GENE; PROTEIN; OBESITY; LKLF	Obesity is an important public health problem associated with a number of disease states such as diabetes and arteriosclerosis. As such, an understanding of the mechanisms governing adipose tissue differentiation and function is of considerable importance. We recently reported that the Kruppel-like zinc finger transcription factor KLF15 can induce adipocyte maturation and GLUT4 expression. In this study, we identify that a second family member, KLF2/Lung Kruppel-like factor (LKLF), as a negative regulator of adipocyte differentiation. KLF2 is highly expressed in adipose tissue, and studies in cell lines and primary cells demonstrate that KLF2 is expressed in preadipocytes but not mature adipocytes. Constitutive overexpression of KLF2 but not KLF15 potently inhibits peroxisome proliferator-activated receptor-gamma (PPARgamma) expression with no effect on the upstream regulators C/EBPbeta and C/EBPdelta. However, the expression of C/EBPalpha and SREBP1c/ADD1 (adipocyte determination and differentiation factor-1/sterol regulatory element-binding protein-1), two factors that feedback in a positive manner to enhance PPARgamma function, was also markedly reduced. In addition, transient transfection studies show that KLF2 directly inhibits PPARgamma2 promoter activity (70% inhibition; p < 0.001). Using a combination of promoter mutational analysis and gel mobility shift assays, we have identified a binding site within the PPARgamma2 promoter, which mediates this inhibitory effect. These data identify a novel role for KLF2 as a negative regulator of adipogenesis.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA; Deutsch Diabet Forsch Inst, D-40255 Dusseldorf, Germany	Harvard University; Brigham & Women's Hospital; University of Nebraska System; University of Nebraska Medical Center	Jain, MK (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, Thorn Bldg Room 1123,20 Shattuck St, Boston, MA 02115 USA.	mjain@rics.bwh.harvard.edu		Feinberg, Mark/0000-0001-9523-3859	NHLBI NIH HHS [K08HL03747, HL69477] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069477, K08HL003747] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Denkinger DJ, 2001, GENE, V281, P133, DOI 10.1016/S0378-1119(01)00792-2; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hauner H, 2000, METH MOL B, V155, P239; Hube F, 2000, ENDOCRINOLOGY, V141, P2582, DOI 10.1210/en.141.7.2582; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Ranganath S, 1998, J IMMUNOL, V161, P3822; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	32	220	250	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2581	2584		10.1074/jbc.M210859200	http://dx.doi.org/10.1074/jbc.M210859200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12426306	hybrid			2022-12-27	WOS:000180562000068
J	Baulard, AR; Gurcha, SS; Engohang-Ndong, J; Gouffi, K; Locht, C; Besra, GS				Baulard, AR; Gurcha, SS; Engohang-Ndong, J; Gouffi, K; Locht, C; Besra, GS			In vivo interaction between the polyprenol phosphate mannose synthase Ppm1 and the integral membrane protein Ppm2 from Mycobacterium smegmatis revealed by a bacterial two-hybrid system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOLICHOL-PHOSPHATE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; BIOSYNTHESIS; TRANSFORMATION; TOPOLOGY; ENZYME; DPM2; BCG	Dolichol phosphate-mannose (Dol-P-Man) is a mannose donor in various eukaryotic glycosylation processes. So far, two groups of Dol-P-Man synthases have been characterized based on the way they are stabilized in the endoplasmic reticulum membrane. Enzymes belonging to the first group, such as the yeast Dpm1, are typical integral membrane proteins harboring a transmembrane segment (TMS) at their C terminus. In contrast, mammalian Dpm1, enzymes of the second group, lack the typical TMS and require the association with the small hydrophobic proteins Dpm3 to be properly stabilized in the endoplasmic reticulum membrane. In Mycobacterium tuberculosis, the Polyprenol-P-Man synthase MtPpm1 is involved in the biosynthesis of the cell wall-associated glycolipid lipoarabinomannan. MtPpm1 is composed of two domains. The C-terminal catalytic domain is homologous to eukaryotic Dol-P-Man synthases. The N-terminal domain of MtPpm1 contains six TMS that anchor the enzyme in the cytoplasmic membrane. In contrast, in Mycobacterium smegmatis, orthologs of the two domains of MtPpm1 are encoded by two distinct open reading frames, Msppm1 and Msppm2, organized as an operon. No TMS are predicted in MsPpm1, and subcellular fractionation experiments indicate that this enzyme is cytosolic when produced in Escherichia coli. Computer-assisted topology predictions and alkaline phosphatase insertions showed that MsPpm2 is an integral membrane protein. Using a recently developed bacterial two-hybrid system, it was found that MsPpm2 interacts with MsPpm1 to stabilize the synthase MsPpm1 in the bacterial membrane. This interaction is reminiscent of that of mammalian Dpm1 with Dpm3 and mimics the structure of MtPpm1 as demonstrated by the capacity of the two domains of MtPpm1 to spontaneously interact when co-expressed in E. coli.	Inst Pasteur, Inst Biol Lille, INSERM U447, F-59019 Lille, France; Inst Biol Struct & Microbiol, UPR9043 CNRS, Chim Bacterienne Lab, F-13402 Marseille, France; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Birmingham	Baulard, AR (corresponding author), Inst Pasteur, Inst Biol Lille, INSERM U447, F-59019 Lille, France.	alain.baulard@pasteur-lille.fr	Locht, Camille/L-3516-2018; Baulard, Alain R/E-6830-2017	Baulard, Alain R/0000-0002-0150-5241; Besra, Gurdyal/0000-0002-5605-0395				Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Beverley SM, 1998, TRENDS MICROBIOL, V6, P35, DOI 10.1016/S0966-842X(97)01180-3; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; Colussi PA, 1997, P NATL ACAD SCI USA, V94, P7873, DOI 10.1073/pnas.94.15.7873; Ehrmann M, 1997, P NATL ACAD SCI USA, V94, P13111, DOI 10.1073/pnas.94.24.13111; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KREMER L, 1995, J BACTERIOL, V177, P642, DOI 10.1128/jb.177.3.642-653.1995; Kruszewska JS, 2000, GLYCOBIOLOGY, V10, P983, DOI 10.1093/glycob/10.10.983; LUGOSI L, 1989, TUBERCLE, V70, P159, DOI 10.1016/0041-3879(89)90046-9; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MANOIL C, 1991, METHOD CELL BIOL, V34, P61; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mengeling BJ, 1998, CURR OPIN STRUC BIOL, V8, P572, DOI 10.1016/S0959-440X(98)80146-2; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; Nilsson J, 2000, FEBS LETT, V486, P267, DOI 10.1016/S0014-5793(00)02321-8; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; SCHULTZ J, 1974, ARCH BIOCHEM BIOPHYS, V160, P311, DOI 10.1016/S0003-9861(74)80039-1; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0	25	36	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2242	2248		10.1074/jbc.M207922200	http://dx.doi.org/10.1074/jbc.M207922200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427759	hybrid			2022-12-27	WOS:000180562000024
J	Herms, J; Schneider, I; Dewachter, I; Caluwaerts, N; Kretzschmar, H; Van Leuven, F				Herms, J; Schneider, I; Dewachter, I; Caluwaerts, N; Kretzschmar, H; Van Leuven, F			Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; SYNAPTIC PLASTICITY; CELLS; NEURONS; APP; GENERATION; RECEPTOR; CURRENTS; BRAIN	Mutant presenilin-1 (PSI) increases amyloid peptide production, attenuates capacitative calcium entry (CCE), and augments calcium release from the endoplasmatic reticulum (ER). Here we measured the intracellular free Ca2+ concentration in hippocampal neurons from six different combinations of transgenic and gene-ablated mice to demonstrate that mutant PSI attenuated CCE directly, independent of the expression of the amyloid precursor protein (APP). On the other hand, increased Ca2+ release from the ER in mutant PS1 neurons, as induced by thapsigargin, was clearly dependent on the presence of APP and its processing by PS1, i.e. on the generation of the amyloid peptides and the APP C99 fragments. This observation was corroborated by the thapsigargin-induced increase in cytosolic [Ca2+](i) in PS1 deficient neurons, which accumulate C99 fragments due to deficient gamma-secretase activity. Moreover, co-expression of mutant APP[V717I] in PS1-deficient neurons further increased the apparent size of the ER calcium stores in parallel with increasing levels of the APP processing products. We conclude that mutant PSI deregulates neuronal calcium homeostasis by two different actions: (i) direct attenuation of CCE at the cell-surface independent of APP; and (ii) indirect increase of ER-calcium stores via processing of APP and generation of amyloid peptides and C99 fragments.	Katholieke Univ Leuven, Expt Genet Grp, Dept Human Genet, B-3000 Louvain, Belgium; Univ Munich, Dept Neuropathol, D-81377 Munich, Germany	KU Leuven; University of Munich	Van Leuven, F (corresponding author), Katholieke Univ Leuven, Expt Genet Grp, Dept Human Genet, Campus Gasthuisberg ON-06, B-3000 Louvain, Belgium.		Herms, Jochen/D-3518-2011	, Ilse Dewachter/0000-0001-7202-515X				Alkon DL, 1998, TRENDS NEUROSCI, V21, P529, DOI 10.1016/S0166-2236(98)01277-6; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Dewji NN, 1997, P NATL ACAD SCI USA, V94, P9926, DOI 10.1073/pnas.94.18.9926; Eckert A, 1997, NEUROBIOL AGING, V18, P281, DOI 10.1016/S0197-4580(97)80308-9; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Eilers Jens, 1995, P213; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Gibson GE, 1997, NEUROBIOL AGING, V18, P573, DOI 10.1016/S0197-4580(97)00149-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Herms JW, 2001, NEUROBIOL DIS, V8, P324, DOI 10.1006/nbdi.2000.0369; Johnston AR, 1998, EXP NEUROL, V151, P326, DOI 10.1006/exnr.1998.6817; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim HS, 2000, FASEB J, V14, P1508, DOI 10.1096/fj.14.11.1508; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li ZW, 1996, P NATL ACAD SCI USA, V93, P6158, DOI 10.1073/pnas.93.12.6158; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; NEHER E, 1989, NEUROMUSCULAR JUNCTI, P65; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Schellenberg G D, 2000, Curr Psychiatry Rep, V2, P158, DOI 10.1007/s11920-000-0061-z; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Thibault O, 2001, J NEUROSCI, V21, P9744, DOI 10.1523/JNEUROSCI.21-24-09744.2001; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	37	98	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2484	2489		10.1074/jbc.M206769200	http://dx.doi.org/10.1074/jbc.M206769200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431992	hybrid			2022-12-27	WOS:000180562000057
J	Fan, CG; Li, Q; Ross, D; Engelhardt, JF				Fan, CG; Li, Q; Ross, D; Engelhardt, JF			Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; ISCHEMIA/REPERFUSION INJURY; TRANSCRIPTION FACTOR; DEGRADATION; KINASE; STRESS; INVOLVEMENT; REQUIREMENT; SUBUNITS; HYPOXIA	NFkappaB is a critical transcription factor involved in modulating cellular responses to environmental injuries. Tyrosine 42 phosphorylation of IkappaBalpha has been shown to mediate NFkappaB activation following hypoxia/reoxygenation (HR) or pervanadate treatment. This pathway differs from the canonical proinflammatory pathways, which mediate NFkappaB activation through serine phosphorylation of IkappaBalpha by the IKK complex. In the present study, we investigated the involvement of c-Src in the redox activation of NFkappaB following H/R or pervanadate treatment. Our results demonstrate that pervanadate or H/R treatment leads to tyrosine phosphorylation of IkappaBalpha and NFkappaB transcriptional activation independent of the IKK pathway. In contrast, inhibition of c-Sre by pp2 treatment or in c-Sre (-/-) knockout cell lines, demonstrated a significant reduction in IkappaBalpha tyrosine phosphorylation and NFkappaB activation following pervanadate or H/R treatment. Overexpression of glutathione peroxidase-1 or catalase, but not Mn-SOD or Cu,Zn-SOD, significantly reduced both NFkappaB activation and tyrosine phosphorylation of IkappaBalpha. In vitro kinase assays further demonstrated that immunoprecipitated c-Src has the capacity to directly phosphorylate GST-IkappaBalpha and that this IkappaBalpha kinase activity is significantly reduced by Gpx-1 overexpression. These results suggest that c-Sre-dependent tyrosine phosphorylation of IkappaBalpha and subsequent activation of NFkappaB is controlled by intracellular H2O2 and defines an important redox-regulated pathway for NFkappaB activation following H/R injury that is independent of the IKK complex.	Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Mol Biol Grad Program, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Engelhardt, JF (corresponding author), Univ Iowa, Dept Anat & Cell Biol, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu		Engelhardt, John/0000-0003-2389-9277	NHLBI NIH HHS [P50 HL60316] Funding Source: Medline; NIDDK NIH HHS [DK51315, P30 DK54759] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051315, P30DK054759] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; Abu-Amer Y, 1998, J BIOL CHEM, V273, P29417, DOI 10.1074/jbc.273.45.29417; Beraud C, 1999, P NATL ACAD SCI USA, V96, P429, DOI 10.1073/pnas.96.2.429; Bolli R, 2000, CIRC RES, V87, P972, DOI 10.1161/01.RES.87.11.972; DAVIS AR, 1996, CURRENT PROTOCOLS HU, V3; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Duan DS, 2000, NAT MED, V6, P595, DOI 10.1038/75080; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; Engelhardt JF, 1999, ANTIOXID REDOX SIGN, V1, P5, DOI 10.1089/ars.1999.1.1-5; Fan CG, 1999, J MOL MED, V77, P577, DOI 10.1007/s001099900029; Fan CG, 2002, J CELL SCI, V115, P4843, DOI 10.1242/jcs.00151; Grey A, 2000, ENDOCRINOLOGY, V141, P2129, DOI 10.1210/en.141.6.2129; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KOONG AC, 1994, CANCER RES, V54, P5273; Li Q, 2001, ANTIOXID REDOX SIGN, V3, P415, DOI 10.1089/15230860152409068; Livolsi A, 2001, EUR J BIOCHEM, V268, P1508, DOI 10.1046/j.1432-1327.2001.02028.x; Qin SF, 2000, P NATL ACAD SCI USA, V97, P7118, DOI 10.1073/pnas.130198197; Raju U, 1998, INT J RADIAT BIOL, V74, P617, DOI 10.1080/095530098141195; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Saugstad OD, 1996, PEDIATRICS, V98, P103; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Seko Y, 1996, BIOCHEM BIOPH RES CO, V226, P530, DOI 10.1006/bbrc.1996.1389; Shi S, 2000, AM J PHYSIOL-LUNG C, V279, pL441, DOI 10.1152/ajplung.2000.279.3.L441; Singh S, 1996, J BIOL CHEM, V271, P31049, DOI 10.1074/jbc.271.49.31049; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Ushio-Fukai M, 2001, ARTERIOSCL THROM VAS, V21, P489, DOI 10.1161/01.ATV.21.4.489; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zwacka RM, 1998, HEPATOLOGY, V28, P1022, DOI 10.1002/hep.510280417	33	148	154	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2072	2080		10.1074/jbc.M206718200	http://dx.doi.org/10.1074/jbc.M206718200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12429743	hybrid			2022-12-27	WOS:000180462200094
J	McCornack, MA; Cassidy, CK; LiWang, PJ				McCornack, MA; Cassidy, CK; LiWang, PJ			The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRIPLE-RESONANCE NMR; RECEPTOR-BINDING; PEPTIDE BINDING; HEPARIN-BINDING; RANTES; MIP-1-BETA; SITE; IDENTIFICATION; RESIDUES	Chemokines comprise a family of proteins that function in the immune response to recruit leukocytes to sites of infection. This recruitment is believed to be carried out by the establishment of a chemokine gradient by the binding of chemokines to sulfated polysaccharides known as glycosaminoglycans (GAGs) located on the extracellular surface of endothelial cells. In the present studies, multidimensional NAIR spectroscopy was used to study the interaction of monomeric and dimeric chemokine macrophage inflammatory protein (MIP)-1beta variants with a series of differentially sulfated disaccharides. The data define a GAG binding surface, including both basic and uncharged residues such as Arg(18), Asn(23), Val(25), Thr (44), Lys(45), Arg(46), and Ser(41). Dissociation constants determined from these NMR studies consistently show for each disaccharide that dimeric wild type MIP-1beta binds more tightly than monomeric MIP(9). Furthermore, analysis of the binding surface suggests that participation in the dimer of residues Met(3), Gly(4), and Ser(5) may be responsible for this higher affinity. These studies also indicate that the specificity of MIP-1beta for particular GAG disaccharides is directly related not only to the degree of disaccharide sulfation but also to the position of the sulfate moiety, with O-sulfation at position 2 of the hexuronic acid unit and position 6 of the D-glucosamine being major determinants for binding.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	LiWang, PJ (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, TAMU 2128, College Stn, TX 77843 USA.				NIAID NIH HHS [1R01AI/HL47832] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047832] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali S, 2000, J BIOL CHEM, V275, P11721, DOI 10.1074/jbc.275.16.11721; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Bondue A, 2002, BIOCHEMISTRY-US, V41, P13548, DOI 10.1021/bi026087d; Burns JM, 1999, P NATL ACAD SCI USA, V96, P14499, DOI 10.1073/pnas.96.25.14499; Chakravarty L, 1998, J BIOL CHEM, V273, P29641, DOI 10.1074/jbc.273.45.29641; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Graham GJ, 1996, EMBO J, V15, P6506, DOI 10.1002/j.1460-2075.1996.tb01041.x; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kim S, 2001, BIOCHEMISTRY-US, V40, P10782, DOI 10.1021/bi011065x; Koopmann W, 1997, J BIOL CHEM, V272, P10103; Koopmann W, 1999, J IMMUNOL, V163, P2120; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; Laurence JS, 1998, BIOCHEMISTRY-US, V37, P9346, DOI 10.1021/bi980329l; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Laurence JS, 2001, BIOCHEMISTRY-US, V40, P4990, DOI 10.1021/bi002593w; Liwang AC, 1999, PROTEIN SCI, V8, P2270; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357; McKay RT, 2000, BIOCHEMISTRY-US, V39, P12731, DOI 10.1021/bi001240u; Mellado M, 2001, ANNU REV IMMUNOL, V19, P397, DOI 10.1146/annurev.immunol.19.1.397; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TANAKA Y, 1993, NATURE, V361, P79, DOI 10.1038/361079a0; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Ylisastigui L, 2000, VIROLOGY, V278, P412, DOI 10.1006/viro.2000.0670	43	24	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1946	1956		10.1074/jbc.M207440200	http://dx.doi.org/10.1074/jbc.M207440200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12411442	hybrid			2022-12-27	WOS:000180462200078
J	Naik, RS; Krishnegowda, G; Gowda, DC				Naik, RS; Krishnegowda, G; Gowda, DC			Glucosamine inhibits inositol acylation of the glycosylphosphatidylinositol anchors in intraerythrocytic Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTIC STAGES; STRUCTURAL-ANALYSIS; MEMBRANE ANCHOR; MANNOSAMINE; PROTEINS; BIOSYNTHESIS; INTERMEDIATE; PRECURSORS; CELLS	Glycosylphosphatidylinositol (GPI) anchors are crucial for the survival of the intraerythrocytic stage Plasmodium falciparum because of their role in membrane anchoring of merozoite surface proteins involved in parasite invasion of erythrocytes. Recently, we showed that mannosamine can prevent the growth of P. falciparum by inhibiting the GPI biosynthesis. Here, we investigated the effect of isomeric amino sugars glucosamine, galactosamine, and their N-acetyl derivatives on parasite growth and GPI biosynthesis. Glucosamine, but not galactosamine, N-acetylglucosamine, and N-acetylgalactosamine inhibited the growth of the parasite in a dose-dependent manner. Glucosamine specifically arrested the maturation of trophozoites, a stage at which the parasite synthesizes all of its GPI anchor pool and had no effect during the parasite growth from rings to early trophozoites and from late trophozoites to schizonts and merozoites. An analysis of GPI intermediates formed when parasites incubated with glucosamine indicated that the sugar interferes with the inositol acylation of glucosamine-phosphatidylinositol (GlcN-PI) to form GlcN-(acyl)PI. Consistent with the non-inhibitory effect on parasite growth, galactosamine, N-acetylglucosamine, and N-acetylgalactosamine had no significant effect on the parasite GPI biosynthesis. The results indicate that the enzyme that transfers the fatty acyl moiety to inositol residue of GlcN-PI discriminates the configuration at C-4 of hexosamines. An analysis of GPIs formed in a cell-free system in the presence and absence of glucosamine suggests that the effect of the sugar is because of direct inhibition of the enzyme activity and not gene repression. Because the fatty acid acylation of inositol is an obligatory step for the addition of the first mannosyl residue during the biosynthesis of GPIs, our results offer a strategy for the development of novel anti-malarial drugs. Furthermore, this is the first study to report the specific inhibition of GPI inositol acylation by glucosamine in eukaryotes.	Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; Georgetown Univ, Ctr Med, Dept Biochem & Mol Biol, Washington, DC 20007 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Georgetown University	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu		GOWDA, KRISHNE/0000-0002-6042-0520; Gowda, Channe/0000-0002-6860-5108	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER; NIAID NIH HHS [AI41139] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Breman JG, 2001, AM J TROP MED HYG, V64, P1; BRETON CB, 1990, RES IMMUNOL, V141, P743, DOI 10.1016/0923-2494(90)90005-J; Delorenzi M, 2002, INFECT IMMUN, V70, P4510, DOI 10.1128/IAI.70.8.4510-4522.2002; Ferguson M. A. J., 1992, LIPID MODIFICATION P, P191; Ferguson MAJ, 1999, BBA-MOL BASIS DIS, V1455, P327, DOI 10.1016/S0925-4439(99)00058-7; FIELD MC, 1993, J BIOL CHEM, V268, P9570; Gerold P, 1999, BIOCHEM J, V344, P731, DOI 10.1042/0264-6021:3440731; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LISANTI MP, 1991, EMBO J, V10, P1969, DOI 10.1002/j.1460-2075.1991.tb07726.x; Marshall VM, 1997, INFECT IMMUN, V65, P4460, DOI 10.1128/IAI.65.11.4460-4467.1997; MENON AK, 1994, METHOD ENZYMOL, V230, P418; Milne KG, 1999, J BIOL CHEM, V274, P1465, DOI 10.1074/jbc.274.3.1465; Naik RS, 2000, J BIOL CHEM, V275, P24506, DOI 10.1074/jbc.M002151200; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; PAN YT, 1992, J BIOL CHEM, V267, P21250; Ropert C, 2000, CURR OPIN MICROBIOL, V3, P395, DOI 10.1016/S1369-5274(00)00111-9; SEVLEVER D, 1993, J BIOL CHEM, V268, P10938; Surolia N, 2002, BIOESSAYS, V24, P192, DOI 10.1002/bies.10042; Trigg P. I., 1998, MALARIA PARASITE BIO, P11; VARKI A, 1994, METHOD ENZYMOL, V230, P16; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	26	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2036	2042		10.1074/jbc.M208976200	http://dx.doi.org/10.1074/jbc.M208976200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419814	hybrid			2022-12-27	WOS:000180462200089
J	Quirk, CC; Seachrist, DD; Nilson, JH				Quirk, CC; Seachrist, DD; Nilson, JH			Embryonic expression of the luteinizing hormone beta gene appears to be coupled to the transient appearance of p8, a high mobility group-related transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROIDOGENIC FACTOR-I; GROWTH-RESPONSE PROTEIN-1; ALPHA-SUBUNIT GENE; PITUITARY-GLAND; TRANSGENIC MICE; MESSENGER-RNA; BINDING-SITE; ANTERIOR-PITUITARY; MOLECULAR-BIOLOGY; TUMOR PROGRESSION	A comparison between two pituitary-derived cell lines (alphaT3-1 and LbetaT2) that represent gonadotropes at early and late stages of development, respectively, was performed to further elucidate the genomic repertoire required for gonadotrope specification and luteinizing hormone beta (LHbeta) gene expression. One isolated clone that displayed higher expression levels in LbetaT2 cells encodes p8, a high mobility group-like protein with mitogenic potential that is up-regulated in response to proapoptotic stimuli and in some developing tissues. To test the functional significance of this factor in developing gonadotropes, a knockdown of p8 in LbetaT2 cells was generated. The loss of p8 mRNA correlated with loss of endogenous LHbeta mRNA and the loss of activity of a transfected LHbeta promoter-driven reporter, even upon treatment with gonadotropin-releasing hormone. In addition, expression of p8 mRNA in developing mouse pituitary glands mirrored its expression in the gonadotrope-derived cell lines and coincided with the first detectable appearance of LHbeta mRNA. In contrast, p8 mRNA was undetectable in the pituitary glands of normal adults. Taken together, our data indicate that p8 is a stage-specific component of the gonadotrope transcriptome that may play a functional role in the initiation of LHbeta gene expression during embryonic cellular differentiation.	Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Nilson, JH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.				NIDDK NIH HHS [DK-09843, DK-28559] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009843, R01DK028559] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSEN B, 1990, MOL ENDOCRINOL, V4, P573, DOI 10.1210/mend-4-4-573; BAUER D, 1993, NUCLEIC ACIDS RES, V21, P4272, DOI 10.1093/nar/21.18.4272; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Currie RA, 1997, J BIOL CHEM, V272, P30880, DOI 10.1074/jbc.272.49.30880; Cushman LJ, 2000, GENESIS, V28, P167, DOI 10.1002/1526-968X(200011/12)28:3/4<167::AID-GENE120>3.3.CO;2-E; Dasen JS, 1999, CURR OPIN CELL BIOL, V11, P669, DOI 10.1016/S0955-0674(99)00034-4; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Dasen JS, 2001, ANNU REV NEUROSCI, V24, P327, DOI 10.1146/annurev.neuro.24.1.327; Dorn C, 1999, J BIOL CHEM, V274, P13870, DOI 10.1074/jbc.274.20.13870; Drouin J, 1998, MOL CELL ENDOCRINOL, V140, P31, DOI 10.1016/S0303-7207(98)00026-4; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Encinar JA, 2001, J BIOL CHEM, V276, P2742, DOI 10.1074/jbc.M008594200; FIDDES J C, 1981, Journal of Molecular and Applied Genetics, V1, P3; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Garcia-Montero AC, 2001, BIOCHEM J, V357, P249, DOI 10.1042/0264-6021:3570249; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; Halvorson LM, 1999, MOL ENDOCRINOL, V13, P106, DOI 10.1210/me.13.1.106; Halvorson LM, 1998, J BIOL CHEM, V273, P14712, DOI 10.1074/jbc.273.24.14712; HECKERT LL, 1995, J BIOL CHEM, V270, P26497, DOI 10.1074/jbc.270.44.26497; Hoffmeister A, 2002, J BIOL CHEM, V277, P22314, DOI 10.1074/jbc.M201657200; HORN F, 1992, MOL CELL BIOL, V12, P2143, DOI 10.1128/MCB.12.5.2143; JACKSON SM, 1993, MOL CELL ENDOCRINOL, V96, P167, DOI 10.1016/0303-7207(93)90107-U; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; JOHN S, 1995, MOL CELL BIOL, V15, P1786; Kaiser UB, 1998, J BIOL CHEM, V273, P12943, DOI 10.1074/jbc.273.21.12943; Kaiser UB, 2000, MOL ENDOCRINOL, V14, P1235, DOI 10.1210/me.14.8.1235; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Keri RA, 2000, J BIOL CHEM, V275, P13082, DOI 10.1074/jbc.275.17.13082; Kumar TR, 1995, GENE, V166, P335, DOI 10.1016/0378-1119(96)81753-7; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Mallo GV, 1997, J BIOL CHEM, V272, P32360, DOI 10.1074/jbc.272.51.32360; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Quirk CC, 2001, MOL ENDOCRINOL, V15, P734, DOI 10.1210/me.15.5.734; Ree AH, 1999, CANCER RES, V59, P4675; Ree AH, 2000, CLIN CANCER RES, V6, P1778; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Rosenberg SB, 2002, MOL ENDOCRINOL, V16, P1280, DOI 10.1210/me.16.6.1280; ROSENBERG SB, 2002, 84 ANN M END SOC JUN, P1; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; Su SB, 2001, CLIN CANCER RES, V7, P1320; Su SB, 2001, CLIN CANCER RES, V7, P309; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829; Tremblay JJ, 1999, EMBO J, V18, P3431, DOI 10.1093/emboj/18.12.3431; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; TSUTSUMI M, 1992, MOL ENDOCRINOL, V6, P1163, DOI 10.1210/me.6.7.1163; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasseur S, 1999, EUR J BIOCHEM, V259, P670, DOI 10.1046/j.1432-1327.1999.00092.x; Vasseur S, 2002, ONCOGENE, V21, P1685, DOI 10.1038/sj.onc.1205222; Vasseur S, 2002, EMBO REP, V3, P165, DOI 10.1093/embo-reports/kvf023; Vasseur S, 1999, BIOCHEM J, V343, P377, DOI 10.1042/0264-6021:3430377; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Weck J, 2000, MOL ENDOCRINOL, V14, P472, DOI 10.1210/me.14.4.472; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; Wolfe MW, 1999, MOL ENDOCRINOL, V13, P1497, DOI 10.1210/me.13.9.1497; Wolfe MW, 1999, MOL ENDOCRINOL, V13, P752, DOI 10.1210/me.13.5.752; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746	66	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1680	1685		10.1074/jbc.M209906200	http://dx.doi.org/10.1074/jbc.M209906200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12429736	hybrid			2022-12-27	WOS:000180462200042
J	Drozdowicz, YM; Shaw, M; Nishi, M; Striepen, B; Liwinski, HA; Roos, DS; Rea, PA				Drozdowicz, YM; Shaw, M; Nishi, M; Striepen, B; Liwinski, HA; Roos, DS; Rea, PA			Isolation and characterization of TgVP1, a type I vacuolar H+-translocating pyrophosphatase from Toxoplasma gondii - The dynamics of its subcellular localization and the cellular effects of a diphosphonate inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-PUMPING PYROPHOSPHATASE; PROTEIN; PLANT; ACIDOCALCISOMES; CALCIUM; EXPRESSION; SEQUENCE; SENSITIVITY; RESIDUES	Here we report the isolation and characterization of a type I vacuolar-type H+-pyrophosphatase (V-PPase), TgVP1, from an apicomplexan, Toxoplasma gondii, a parasitic protist that is particularly amenable to molecular and genetic manipulation. The 816-amino acid TgVP1 polypeptide is 50% sequence-identical (65% similar) to the prototypical type I V-PPase from Arabidopsis thaliana, AVP1, and contains all the sequence motifs characteristic of this pump category. Unlike AVP1 and other known type I enzymes, however, TgVP1 contains a 74-residue N-terminal extension encompassing a 42-residue N-terminal signal peptide sequence, sufficient for targeting proteins to the secretory pathway of T. gondii. Providing that the coding sequence for the entire N-terminal extension is omitted from the plasmid, transformation of Saccharomyces cerevisiae with plasmid-borne TgVP1 yields a stable and functional translation product that is competent in aminomethylenediphosphonate (AMDP)-inhibitable K+-activated pyrophosphate (PPi) hydrolysis and PPi-energized H+ translocation. Immunofluorescence microscopy of both free and intracellular T. gondii tachyzoites using purified universal V-PPase polyclonal antibodies reveals a punctate apical distribution for the enzyme. Equivalent studies of the tachyzoites during host cell invasion, by contrast, disclose a transverse radial distribution in which the V-PPase is associated with a collar-like structure that migrates along the length of the parasite in synchrony with and in close apposition to the penetration furrow. Although treatment of T. gondii with AMDP concentrations as high as 100 mum had no discernible effect on the efficiency of host cell invasion and integration, concentrations commensurate with the I-50 for the inhibition of TgVP1 activity in vitro (0.9 mum) do inhibit cell division and elicit nuclear enlargement concomitant with the inflation and eventual disintegration of acidocalcisome-like vesicular structures. A dynamic association of TgVP1 with the host cell invasion apparatus is invoked, one in which the effects of inhibitory V-PPase substrate analogs are exerted after rather than during host cell invasion.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Rea, PA (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	parea@sas.upenn.edu		Roos, David Siker/0000-0001-6725-4089; Striepen, Boris/0000-0002-7426-432X				BAYKOV AA, 1993, FEBS LETT, V327, P199, DOI 10.1016/0014-5793(93)80169-U; BONHOMME A, 1993, MICROSC RES TECHNIQ, V25, P276, DOI 10.1002/jemt.1070250403; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURG JL, 1988, J IMMUNOL, V141, P3584; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Drozdowicz YM, 1999, FEBS LETT, V460, P505, DOI 10.1016/S0014-5793(99)01404-0; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; KIM EJ, 1995, J BIOL CHEM, V270, P2630, DOI 10.1074/jbc.270.6.2630; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lu HG, 1998, MOL CELL BIOL, V18, P2309, DOI 10.1128/MCB.18.4.2309; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; Luo SH, 2001, EMBO J, V20, P55, DOI 10.1093/emboj/20.1.55; Marchesini N, 2000, BIOCHEM J, V347, P243, DOI 10.1042/0264-6021:3470243; Marchesini N, 2002, J BIOL CHEM, V277, P8146, DOI 10.1074/jbc.M111130200; Martell A.E., 1976, CRITICAL STABILITY C, V4; Martinez R, 2002, MOL BIOCHEM PARASIT, V120, P205, DOI 10.1016/S0166-6851(01)00456-X; MCGEOCH DJ, 1985, VIRUS RES, V3, P271, DOI 10.1016/0168-1702(85)90051-6; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Pezzella-D'Alessandro N, 2001, J HISTOCHEM CYTOCHEM, V49, P445, DOI 10.1177/002215540104900404; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; REA PA, 1992, PLANT PHYSIOL, V100, P1706, DOI 10.1104/pp.100.4.1706; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Rodrigues CO, 2000, BIOCHEM J, V349, P737, DOI 10.1042/bj3490737; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Scott DA, 1998, J BIOL CHEM, V273, P22151, DOI 10.1074/jbc.273.34.22151; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; Striepen B, 2001, MOL BIOCHEM PARASIT, V113, P45, DOI 10.1016/S0166-6851(00)00379-0; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Urbina JA, 1999, J BIOL CHEM, V274, P33609, DOI 10.1074/jbc.274.47.33609; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; ZHEN RG, 1994, J BIOL CHEM, V269, P23342; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340; Zhen RG, 1997, ADV BOT RES, V25, P297, DOI 10.1016/S0065-2296(08)60156-1	49	39	41	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1075	1085		10.1074/jbc.M209436200	http://dx.doi.org/10.1074/jbc.M209436200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411435	hybrid			2022-12-27	WOS:000180321900051
J	Frohloff, F; Jablonowski, D; Fichtner, L; Schaffrath, R				Frohloff, F; Jablonowski, D; Fichtner, L; Schaffrath, R			Subunit communications crucial for the functional integrity of the yeast RNA polymerase II elongator (gamma-toxin target (TOT)) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLUYVEROMYCES-LACTIS TOXIN; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; PROTEIN; GENES; EXPRESSION; HOLOENZYME; ZYMOCIN; IDENTIFICATION; MUTATIONS	In response to the Kluyveromyces lactis zymocin, the gamma-toxin target (TOT) function of the Saccharomyces cerevisiae RNA polymerase II (pol II) Elongator complex prevents sensitive strains from cell cycle progression. Studying Elongator subunit communications, Tot1p (Elp1p), the yeast homologue of human IKK-associated protein, was found to be essentially involved in maintaining the structural integrity of Elongator. Thus, the ability of Tot2p (Elp2p) to interact with the HAT subunit Tot3p (Elp3p) of Elongator and with subunit Tot5p (Elp5p) is dependent on Tot1p (Elp1p). Also, the association of core-Elongator (Tot1-3p/Elp1-3p) with HAP (Elp4-6p/Tot5-7p), the second three-subunit subcomplex of Elongator, was found to be sensitive to loss of TOT1 (ELP1) gene function. Structural integrity of the HAP complex itself requires the ELP4/TOT7, ELP5/TOT5, and ELP6/TOT6 genes, and elp6Delta/tot6Delta as well as elp4Delta/tot7Delta cells can no longer promote interaction between Tot5p (Elp5p) and Tot2p (Elp2p). The association between Elongator and Tot4p (Kti12p), a factor that may modulate the TOT activity of Elongator, requires Tot1-3p (Elp1-3p) and Tot5p (Elp5p), indicating that this contact requires a preassembled holo-Elongator complex. Tot4p also binds pol II hyperphosphorylated at its C-terminal domain Ser(5) raising the possibility that Tot4p bridges the contact between Elongator and pol II.			Schaffrath, R (corresponding author), Univ Halle Wittenberg, Genet Inst, Biologicum, Weinbergweg 10, D-06120 Halle An Der Saale, Germany.	schaffrath@genetik.uni-halle.de						BUTLER AR, 1994, MOL CELL BIOL, V14, P6306, DOI 10.1128/MCB.14.9.6306; BUTLER AR, 1991, EUR J BIOCHEM, V199, P483, DOI 10.1111/j.1432-1033.1991.tb16147.x; BUTLER AR, 1991, YEAST, V7, P617, DOI 10.1002/yea.320070610; BUTLER AR, 1991, J GEN MICROBIOL, V137, P1749, DOI 10.1099/00221287-137-7-1749; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Collum RG, 2000, P NATL ACAD SCI USA, V97, P10120, DOI 10.1073/pnas.170192197; Fellows J, 2000, J BIOL CHEM, V275, P12896, DOI 10.1074/jbc.275.17.12896; Fichtner L, 2002, MOL MICROBIOL, V45, P817, DOI 10.1046/j.1365-2958.2002.03055.x; Fichtner L, 2002, MOL MICROBIOL, V44, P865, DOI 10.1046/j.1365-2958.2002.02928.x; Fichtner L, 2002, MOL MICROBIOL, V43, P783, DOI 10.1046/j.1365-2958.2002.02794.x; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hendzel MJ, 2001, J STEROID BIOCHEM, V76, P9, DOI 10.1016/S0960-0760(00)00153-9; Jablonowski D, 2002, J BIOL CHEM, V277, P26276, DOI 10.1074/jbc.M203354200; Jablonowski D, 2001, GENETICS, V159, P1479; Jablonowski D, 2001, MOL MICROBIOL, V42, P1095, DOI 10.1046/j.1365-2958.2001.02705.x; Jablonowski D, 2001, YEAST, V18, P1285, DOI 10.1002/yea.776; KAWKES NA, 2002, J BIOL CHEM, V277, P3047; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; KIRKPATRICK D, 1994, GENETICS, V137, P381; Kishida M, 1996, BIOSCI BIOTECH BIOCH, V60, P798, DOI 10.1271/bbb.60.798; Kitamoto HK, 2002, MOL GENET GENOMICS, V268, P49, DOI 10.1007/s00438-002-0720-3; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krappmann D, 2000, J BIOL CHEM, V275, P29779, DOI 10.1074/jbc.M003902200; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Li Y, 2001, J BIOL CHEM, V276, P29628, DOI 10.1074/jbc.C100274200; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Schaffrath R, 2000, FUNGAL GENET BIOL, V30, P173, DOI 10.1006/fgbi.2000.1221; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; STARK MJR, 1990, YEAST, V6, P1, DOI 10.1002/yea.320060102; TOKUNAGA M, 1989, NUCLEIC ACIDS RES, V17, P3435, DOI 10.1093/nar/17.9.3435; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 2000, EMBO J, V19, P3060, DOI 10.1093/emboj/19.12.3060; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	45	32	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					956	961		10.1074/jbc.M210060200	http://dx.doi.org/10.1074/jbc.M210060200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12424236	hybrid			2022-12-27	WOS:000180321900035
J	Takeshima, K; Chikushi, A; Lee, KK; Yonehara, S; Matsuzaki, K				Takeshima, K; Chikushi, A; Lee, KK; Yonehara, S; Matsuzaki, K			Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYERS; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PORE FORMATION; CYTOTOXICITY; KINETICS	Cationic antimicrobial peptides play important roles in innate immunity. Compared with extensive studies on peptide-bacteria interactions, little is known about peptide-human cell interactions. Using human cervical carcinoma HeLa and fibroblastic TM12 cells, we investigated the cellular uptake of fluorescent analogues of the two representative antimicrobial peptides magainin 2 and buforin 2 in comparison with the representative Arg-rich cell-penetrating Tat-(47-57) peptide (YGRKKRRQRRR). The dose, time, temperature, and energy dependence of translocation suggested that the three peptides cross cell membranes through different mechanisms. The magainin peptide was internalized within a time scale of tens of minutes. The cooperative concentration dependence of uptake suggested that the peptide forms a pore as an intermediate similar to the observations in model membranes. Furthermore, the translocation was coupled with cytotoxicity, which was larger for tumor HeLa cells. In contrast, the buforin peptide translocated within 10 min by a temperature-independent, less concentration-dependent passive mechanism without showing any significant cytotoxicity at the highest concentration investigated (100 muM). The uptake of the Tat peptide was proportional to the peptide concentration, and the concentration dependence was lost upon ATP depletion. The peptide exhibited a moderate cytotoxicity at higher concentrations. The time course did not show saturation even after 120 min. The buforin peptide, covalently attached to the 28-kDa green fluorescent protein, also entered cells, suggesting a potency of the peptide as a vector for macromolecular delivery into cells. However, the mechanism appeared to be different from that of the parent peptide.	Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Matsuzaki, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan.	katsumim@pharm.kyoto-u.ac.jp						Alberts B, 1995, MOL BIOL CELL; BAKER MA, 1993, CANCER RES, V53, P3052; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Chan YR, 1998, J BIOL CHEM, V273, P28978, DOI 10.1074/jbc.273.44.28978; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Drin G, 2002, BBA-BIOMEMBRANES, V1559, P160, DOI 10.1016/S0005-2736(01)00447-3; Drin G, 2001, BIOCHEMISTRY-US, V40, P1824, DOI 10.1021/bi002019k; Feder R, 2001, PEPTIDES, V22, P1683, DOI 10.1016/S0196-9781(01)00504-6; Ganz Tomas, 2001, P139; Ghosh JK, 1997, J BIOL CHEM, V272, P31609, DOI 10.1074/jbc.272.50.31609; Haimovich B, 1995, BBA-BIOMEMBRANES, V1240, P149, DOI 10.1016/0005-2736(95)00204-9; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Haukland HH, 2001, FEBS LETT, V508, P389, DOI 10.1016/S0014-5793(01)03100-3; Iwahana H, 1999, EUR J BIOCHEM, V264, P397, DOI 10.1046/j.1432-1327.1999.00615.x; Kobayashi S, 2000, BIOCHEMISTRY-US, V39, P8648, DOI 10.1021/bi0004549; Krugliak M, 2000, ANTIMICROB AGENTS CH, V44, P2442, DOI 10.1128/AAC.44.9.2442-2451.2000; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P12553, DOI 10.1021/bi00039a009; MATSUZAKI K, 1994, BIOCHEMISTRY-US, V33, P3342, DOI 10.1021/bi00177a027; Matsuzaki K, 1997, BBA-BIOMEMBRANES, V1327, P119, DOI 10.1016/S0005-2736(97)00051-5; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P2104, DOI 10.1021/bi961870p; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Oehlke J, 1998, BBA-BIOMEMBRANES, V1414, P127, DOI 10.1016/S0005-2736(98)00161-8; OHSAKI Y, 1992, CANCER RES, V52, P3534; Park CB, 1996, BIOCHEM BIOPH RES CO, V218, P408, DOI 10.1006/bbrc.1996.0071; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Polyakov V, 2000, BIOCONJUGATE CHEM, V11, P762, DOI 10.1021/bc000008y; Sai Y, 1998, AM J PHYSIOL-GASTR L, V275, pG514, DOI 10.1152/ajpgi.1998.275.3.G514; SCHMID SL, 1990, J CELL BIOL, V111, P2307, DOI 10.1083/jcb.111.6.2307; SOBALLE PW, 1995, INT J CANCER, V60, P280; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Tossi A, 2000, BIOPOLYMERS, V55, P4; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; WESTERHOFF HV, 1989, BIOCHIM BIOPHYS ACTA, V975, P361, DOI 10.1016/S0005-2728(89)80344-5; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	45	164	175	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1310	1315		10.1074/jbc.M208762200	http://dx.doi.org/10.1074/jbc.M208762200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417587	hybrid			2022-12-27	WOS:000180321900079
J	Cuadrado, A; Garcia-Fernandez, LF; Gonzalez, L; Suarez, Y; Losada, A; Alcaide, V; Martinez, T; Fernandez-Sousa, JM; Sanchez-Puelles, JM; Munoz, A				Cuadrado, A; Garcia-Fernandez, LF; Gonzalez, L; Suarez, Y; Losada, A; Alcaide, V; Martinez, T; Fernandez-Sousa, JM; Sanchez-Puelles, JM; Munoz, A			Aplidin (TM) induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; DEHYDRODIDEMNIN-B; PROTEIN-KINASE; C-SRC; SIGNAL-TRANSDUCTION; FAMILY KINASES; SURVIVAL; PHOSPHORYLATION; MECHANISMS; PATHWAYS	We report that Aplidin(TM), a novel antitumor agent of marine origin presently undergoing Phase 11 clinical trials, induced growth arrest and apoptosis in human MDA-MB-231 breast cancer cells at nanomolar concentrations. Aplidin(TM) induced a specific cellular stress response program, including sustained activation of the epidermal growth factor receptor (EGFR), the non-receptor protein-tyrosine kinase Src, and the serine/threonine kinases JNK and p38 MAPK Aplidin(TM)-induced apoptosis was only partially blocked by the general caspase inhibitor benzyloxycarbonyl-VAD-fluoromethyl ketone and was also sensitive to AG1478 (an EGFR inhibitor), PP2 (an Src inhibitor), and SB203580 (an inhibitor of JNK and p38 MAPK) in MDA-MB-231 cells. Supporting a role for EGFR in Aplidin(TM) action, EGFR-deficient mouse embryo fibroblasts underwent apoptosis upon treatment more slowly than wild-type-EGFR fibroblasts and also showed delayed JNK and reduced p38 MAPK activation. N-Acetylcysteine and ebselen (but not other antioxidants such as diphenyleneiodonium, Tiron, catalase, ascorbic acid, and vitamin E) reduced EGFR activation by Aplidin(TM). N-Acetylcysteine and PP2 also partially inhibited JNK and p38 MAPK activation. The intracellular level of GSH affected Aplidin(TM) action; pretreatment of cells with GSH or N-acetylcysteine inhibited, whereas GSH depletion caused, hyperinduction of EGFR, Src, JNK, and p38 MAPK. Remarkably, Aplidin(TM) also induced apoptosis and activated EGFR, JNK, and p38 MAPK in two cell lines (A-498 and ACHN) derived from human renal cancer, a neoplasia that is highly refractory to chemotherapy. These data provide a molecular basis for the anticancer activity of Aplidin(TM).	Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; PharmaMar SA, Drug Discovery Dept, E-28760 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); PharmaMar	Munoz, A (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, E-28029 Madrid, Spain.	amunoz@iib.uam.es	Losada, Alejandro/AAW-8589-2021; Munoz, Alberto/O-6393-2014; Cuadrado, Ana/AAA-9277-2019; Sanchez-Puelles, Jose Maria/E-4159-2018	Munoz, Alberto/0000-0003-3890-4251; Cuadrado, Ana/0000-0002-9752-5932; Suarez, Yajaira/0000-0003-4549-2953; Sanchez-Puelles, Jose Maria/0000-0002-4283-4885				ABELLA B, 2002, EUR J CANCER, V38, P1395; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; BROGGINI M, 2000, P 11 NAT CANC I EUR, P86; CHANG JH, 1993, ONCOGENE, V8, P959; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Depenbrock H, 1998, BRIT J CANCER, V78, P739, DOI 10.1038/bjc.1998.570; DEVRIES N, 1993, J CELL BIOCHEM, P270; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; EINCHHORST ST, 2000, MOL CELL BIOL, V20, P7826; Faircloth G., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P103; Fan MY, 2001, CANCER RES, V61, P4450; FERNANDES RS, 1994, BIOCHEM PHARMACOL, V48, P675, DOI 10.1016/0006-2952(94)90044-2; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Gilhooly EM, 1999, INT J ONCOL, V15, P267; GomezFabre PM, 1997, CANCER LETT, V113, P141, DOI 10.1016/S0304-3835(96)04591-0; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hayakawa J, 1999, J BIOL CHEM, V274, P31648, DOI 10.1074/jbc.274.44.31648; Herr I, 1999, INT J CANCER, V80, P417, DOI 10.1002/(SICI)1097-0215(19990129)80:3<417::AID-IJC14>3.3.CO;2-2; Kamata H, 2000, EUR J BIOCHEM, V267, P1933, DOI 10.1046/j.1432-1327.2000.01194.x; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; Lo YYC, 1996, J BIOL CHEM, V271, P15703, DOI 10.1074/jbc.271.26.15703; Lobo C, 1997, ANTICANCER RES, V17, P333; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Mandlekar S, 2000, CANCER RES, V60, P5995; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; OSHEROV N, 1994, EUR J BIOCHEM, V225, P1047, DOI 10.1111/j.1432-1033.1994.1047b.x; Palmer HJ, 1997, NUTR REV, V55, P353, DOI 10.1111/j.1753-4887.1997.tb01561.x; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; RAYMOND E, 2001, P 11 EUR CANC C LISB, pS32; Sakai R, 1996, J MED CHEM, V39, P2819, DOI 10.1021/jm960048g; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanchez-Perez I, 1999, FEBS LETT, V453, P151, DOI 10.1016/S0014-5793(99)00690-0; Seimiya H, 1997, J BIOL CHEM, V272, P4631, DOI 10.1074/jbc.272.7.4631; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shtil AA, 1999, ONCOGENE, V18, P377, DOI 10.1038/sj.onc.1202305; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Urdiales JL, 1996, CANCER LETT, V102, P31, DOI 10.1016/0304-3835(96)04151-1; WALTON GM, 1990, J BIOL CHEM, V265, P1750; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Wilmer WA, 1997, J BIOL CHEM, V272, P10877; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yoshizumi M, 2000, J BIOL CHEM, V275, P11706, DOI 10.1074/jbc.275.16.11706; Yu R, 1996, CANCER LETT, V107, P73, DOI 10.1016/0304-3835(96)04345-5; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	61	134	141	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					241	250		10.1074/jbc.M201010200	http://dx.doi.org/10.1074/jbc.M201010200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414812	hybrid			2022-12-27	WOS:000180255700032
J	Fleming, JV; Wang, TC				Fleming, JV; Wang, TC			The production of 53-55-kDa isoforms is not required for rat L-histidine decarboxylase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCHROMAFFIN-LIKE CELLS; MASTOCYTOMA P-815 CELLS; ORNITHINE DECARBOXYLASE; PURIFICATION; STOMACH; ACTIVATION; EXPRESSION; GASTRIN; FORM; LOCALIZATION	Post-translational processing of the histamine-producing enzyme, L-histidine decarboxylase (HDC), leads to the formation of multiple carboxyl-truncated isoforms. Nevertheless, it has been widely reported that the mature catalytically active dimer is dependent specifically on the production of carboxyl-truncated 53-55-kDa monomers. Here we use transiently transfected COS-7 cells to study the properties of carboxyl-truncated rat HDC isoforms in the 52-58-kDa size range. Amino acid sequences important for the production of a 55-kDa HDC isoform were identified by successive truncations through amino acids 502, 503, and 504. Mutating this sequence in the full-length protein prevented the production of 55-kDa HDC but did not affect enzymatic activity. Further truncations to amino acid 472 generated an inactive 53-kDa HDC isoform that was degraded by the proteasome pathway. These results suggested that processed isoforms, apart from 53-55-kDa ones, contribute toward histamine biosynthesis in vivo. This was confirmed in physiological studies where regulated increases in HDC activity were associated with the expression of isoforms that were greater than 55 kDa in size. We provide evidence to show that regulation of HDC expression can be achieved by the differential production or differential stabilization of multiple enzyme isoforms.	Univ Massachusetts, Sch Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Wang, TC (corresponding author), Dept Med, Div Digest Dis & Nutr, 364 Plantat St, Worcester, MA 01605 USA.				NIDDK NIH HHS [DK48077] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048077] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHEN D, 1994, GASTROENTEROLOGY, V107, P18, DOI 10.1016/0016-5085(94)90056-6; Chen D, 1998, REGUL PEPTIDES, V77, P169, DOI 10.1016/S0167-0115(98)00111-6; Cui GL, 2002, ACTA PHYSIOL SCAND, V174, P125, DOI 10.1046/j.1365-201X.2002.00933.x; Dartsch C, 1998, REGUL PEPTIDES, V77, P33, DOI 10.1016/S0167-0115(98)00045-7; Ding XQ, 1996, AM J PHYSIOL-GASTR L, V270, pG476, DOI 10.1152/ajpgi.1996.270.3.G476; Engel N, 1996, BIOCHEM J, V320, P365, DOI 10.1042/bj3200365; Fajardo I, 2001, BIOCHEM PHARMACOL, V61, P1101, DOI 10.1016/S0006-2952(01)00567-6; Fleming JV, 2000, MOL CELL BIOL, V20, P4932, DOI 10.1128/MCB.20.13.4932-4947.2000; GRZANNA R, 1984, NEUROCHEM RES, V9, P993, DOI 10.1007/BF00964529; HAMMAR L, 1980, AGENTS ACTIONS, V10, P93, DOI 10.1007/BF02024185; HAMMAR L, 1980, AGENTS ACTIONS, V10, P92, DOI 10.1007/BF02024184; HUSZTI Z, 1991, EUR J BIOCHEM, V197, P191, DOI 10.1111/j.1432-1033.1991.tb15898.x; JOSEPH DR, 1990, P NATL ACAD SCI USA, V87, P733, DOI 10.1073/pnas.87.2.733; MARTIN SAM, 1986, BIOCHEM J, V234, P349, DOI 10.1042/bj2340349; OHMORI E, 1990, J BIOCHEM, V107, P834, DOI 10.1093/oxfordjournals.jbchem.a123134; Prinz C, 1999, AM J PHYSIOL-CELL PH, V277, pC845, DOI 10.1152/ajpcell.1999.277.5.C845; Safina F, 2002, J BIOL CHEM, V277, P14211, DOI 10.1074/jbc.M200702200; SAVANY A, 1982, EUR J BIOCHEM, V123, P593; Suzuki S, 1998, FEBS LETT, V437, P44, DOI 10.1016/S0014-5793(98)01195-8; TAGUCHI Y, 1984, J BIOL CHEM, V259, P5214; Tanaka S, 1998, J BIOL CHEM, V273, P8177, DOI 10.1074/jbc.273.14.8177; Tanaka S, 1997, FEBS LETT, V417, P203, DOI 10.1016/S0014-5793(97)01281-7; TANAKA S, 1995, BBA-PROTEIN STRUCT M, V1253, P9, DOI 10.1016/0167-4838(95)00185-W; TRAN VT, 1981, J BIOL CHEM, V256, P680; WATABE A, 1992, BIOCHEM PHARMACOL, V43, P587, DOI 10.1016/0006-2952(92)90582-4; YAMAMOTO J, 1993, BIOCHIM BIOPHYS ACTA, V1216, P431, DOI 10.1016/0167-4781(93)90011-2; YAMAMOTO J, 1990, FEBS LETT, V276, P214, DOI 10.1016/0014-5793(90)80545-T; Yatsunami K, 1995, METHOD FIND EXP CLIN, V17, P10; ZHOU XY, 1991, EMBO J, V10, P4041, DOI 10.1002/j.1460-2075.1991.tb04980.x	29	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					686	694		10.1074/jbc.M210718200	http://dx.doi.org/10.1074/jbc.M210718200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414789	hybrid			2022-12-27	WOS:000180255700087
J	Kanda, S; Mochizuki, Y; Kanetake, H				Kanda, S; Mochizuki, Y; Kanetake, H			Stromal cell-derived factor-1 alpha induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CXC-CHEMOKINE RECEPTOR-4; GROWTH-FACTOR RECEPTOR-1; IN-VITRO; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; TUMOR ANGIOGENESIS; KINASE ACTIVATION; C-FES; PROTEIN; DIFFERENTIATION	Stromal cell-derived factor-1alpha (SDF-1alpha) is a CXC chemokine, which induces tube formation of endothelial cells. Although SDF-1alpha transduces signals via CXC receptor 4 (CXCR4), resulting in activating a panel of downstream signaling molecules, such as phosphoinositide 3-kinase (PI3-kinase), little is known about the SDF-1alpha-mediated signaling pathways leading to tube formation. Here we examined the signal transduction pathway involved in SDF-1alpha-mediated tube formation by primary human umbilical endothelial cells and murine brain capillary endothelial cell line (IBE (immortalized murine brain capillary endothelial) cells). SDF-1alpha stimulated tube formation by IBE cells, which was blocked by LY294002 and pertussis toxin, suggesting that PI3-kinase and G(i) protein were involved in this process. SDF-1 also stimulated tube formation of human umbilical endothelial cells, and the response was LY294002-sensitive. SDF-1alpha activated PI3-kinase in IBE cells. In stable IBE cell lines expressing either the mutant p85 subunit of PI3-kinase (denoted DeltaP85-8 cells), which lacks association with the p110 subunit, or kinase-inactive c-Fes (denoted KEFes 5-15 cells), SDF-1alpha failed to activate PI3-kinase and to stimulate tube formation. SDF-1alpha-induced tube formation was inhibited by an antibody against murine vascular endothelial cadherin. The antibody as well as LY294002 attenuated SDF-1alpha-mediated compact cell-cell contact, which proceeded to tube formation. Taken together, SDF-1alpha induces compact cell-cell contact through PI3-kinase, resulting in tube formation of endothelial cells.	Nagasaki Univ, Grad Sch Med Sci, Dept Mol Microbiol & Immunol, Div Endothelial Cell Biol, Nagasaki 8528501, Japan; Nagasaki Univ, Grad Sch Med Sci, Dept Urol, Nagasaki 8528501, Japan	Nagasaki University; Nagasaki University	Kanda, S (corresponding author), Nagasaki Univ, Grad Sch Med Sci, Dept Mol Microbiol & Immunol, Div Endothelial Cell Biol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.							Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; CHEMOCK RD, 2001, BLOOD, V97, P608; Chen WJ, 1998, MOL PHARMACOL, V53, P177, DOI 10.1124/mol.53.2.177; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Dias S, 2001, CANCER INVEST, V19, P732, DOI 10.1081/CNV-100106148; Feil C, 1998, BIOCHEM BIOPH RES CO, V247, P38, DOI 10.1006/bbrc.1998.8499; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317; Kanda S, 1999, EXP CELL RES, V248, P203, DOI 10.1006/excr.1999.4400; Kanda S, 1996, CELL GROWTH DIFFER, V7, P383; Kanda S, 2000, J BIOL CHEM, V275, P10105, DOI 10.1074/jbc.275.14.10105; Kanda S, 1997, J BIOL CHEM, V272, P23347, DOI 10.1074/jbc.272.37.23347; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; MATSUBARA S, J CELL BIOL, V154, P573; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Mochizuki Y, 2002, ONCOGENE, V21, P7027, DOI 10.1038/sj.onc.1205736; Mochizuki Y, 2002, J CELL SCI, V115, P175; Molino M, 2000, BBA-MOL BASIS DIS, V1500, P227, DOI 10.1016/S0925-4439(99)00110-6; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Moore BB, 1998, J LAB CLIN MED, V132, P97, DOI 10.1016/S0022-2143(98)90004-X; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Rahmanian M, 1997, EXP CELL RES, V237, P223, DOI 10.1006/excr.1997.3792; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Smithgall TE, 1998, CRIT REV ONCOGENESIS, V9, P43, DOI 10.1615/CritRevOncog.v9.i1.40; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tsuda S, 2002, BIOCHEM BIOPH RES CO, V290, P1354, DOI 10.1006/bbrc.2002.6345; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Volin MV, 1998, BIOCHEM BIOPH RES CO, V242, P46, DOI 10.1006/bbrc.1997.7890; Weber KSC, 2001, MOL BIOL CELL, V12, P3074, DOI 10.1091/mbc.12.10.3074	37	55	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					257	262		10.1074/jbc.M204771200	http://dx.doi.org/10.1074/jbc.M204771200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414810	hybrid			2022-12-27	WOS:000180255700034
J	Chamero, P; Villalobos, C; Alonso, MT; Garcia-Sancho, J				Chamero, P; Villalobos, C; Alonso, MT; Garcia-Sancho, J			Dampening of cytosolic Ca2+ oscillations on propagation to nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM DYNAMICS; PITUITARY-CELLS; STIMULATION; RELEASE; SIGNALS; ATP	Ca2+ signals may regulate gene expression. The increase of the cytosolic Ca2+ concentration ([Ca2+](c)) promotes activation and/or nuclear import of some transcription factors, but others require the increase of the nuclear Ca2+ concentration ([Ca2+](N)) for activation. Whether the nuclear envelope may act as a diffusion barrier for propagation of [Ca2+](c) signals remains controversial. We have studied the spreading of Ca2+ from the cytosol to the nucleus by comparing the cytosolic and the nuclear Ca2+ signals reported by targeted aequorins in adrenal chromaffin, PC12, and GH(3) pituitary cells. Strong stimulation of either Ca2+ entry (by depolarization. with high K+ or acethyleholine) or Ca2+ release from the intracellular Ca2+ stores (by stimulation with caffeine, UTP, bradykinin, or thyrotropin-releasing hormone (TRH)) produced similar Ca2+ signals in cytosol and nucleus. In contrast, both spontaneous and TRH-stimulated. oscillations of cytosolic Ca2+ in single GH3 cells were considerably dampened during propagation to the nucleus. These results are consistent with the existence of a kinetic barrier that filters high frequency physiological [Ca2+](c) oscillations without disturbing sustained [Ca2+](c) increases. Thus, encoding of the Ca2+ signal may allow differential control of Ca2+-dependent mechanisms located at either the cytosol or the nucleus.	Univ Valladolid, IBGM, Fac Med, Dept Fisiol, E-47005 Valladolid, Spain; Fac Med, Dept Bioquim & Fisiol, CSIC, E-47005 Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Garcia-Sancho, J (corresponding author), Univ Valladolid, IBGM, Fac Med, Dept Fisiol, E-47005 Valladolid, Spain.	jgsancho@ibgm.uva.es	Alonso Alonso, Maria Teresa/K-5003-2014; Villalobos, Carlos/M-9839-2017; Garcia-Sancho, Javier/K-2975-2014	Villalobos, Carlos/0000-0002-0429-3846; Garcia-Sancho, Javier/0000-0003-4573-7930; Chamero, Pablo/0000-0002-4305-1073				Alonso MT, 1998, CELL CALCIUM, V24, P87, DOI 10.1016/S0143-4160(98)90076-8; Alonso MT, 1999, J CELL BIOL, V144, P241, DOI 10.1083/jcb.144.2.241; Alvarez Javier, 2001, P147; Badminton MN, 1996, J BIOL CHEM, V271, P31210, DOI 10.1074/jbc.271.49.31210; Badminton MN, 1998, CELL CALCIUM, V23, P79, DOI 10.1016/S0143-4160(98)90105-1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bootman MD, 2000, CELL MOL LIFE SCI, V57, P371, DOI 10.1007/PL00000699; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Bustamante JO, 2000, PFLUG ARCH EUR J PHY, V439, P433, DOI 10.1007/s004240050960; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Gerasimenko OV, 1996, PFLUG ARCH EUR J PHY, V432, P1, DOI 10.1007/s004240050098; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Lui PPY, 1998, PFLUG ARCH EUR J PHY, V436, P371, DOI 10.1007/s004240050645; Mollard P, 1996, TRENDS ENDOCRIN MET, V7, P361, DOI 10.1016/S1043-2760(96)00186-5; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Nakazawa H, 1999, J NEUROCHEM, V73, P1075, DOI 10.1046/j.1471-4159.1999.0731075.x; Petersen OH, 1998, CELL CALCIUM, V23, P87, DOI 10.1016/S0143-4160(98)90106-3; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; SHIMOMURA O, 1993, CELL CALCIUM, V14, P373, DOI 10.1016/0143-4160(93)90041-4; Shirakawa H, 1996, J PHYSIOL-LONDON, V494, P29, DOI 10.1113/jphysiol.1996.sp021473; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Teruel MN, 2000, CURR BIOL, V10, P86, DOI 10.1016/S0960-9822(00)00295-5; Villalobos C, 1996, PFLUG ARCH EUR J PHY, V431, P371, DOI 10.1007/BF02207274; Villalobos C, 2002, ENDOCRINOLOGY, V143, P3548, DOI 10.1210/en.2002-220266; Villalobos C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0630com; Villalobos C, 1996, FASEB J, V10, P654, DOI 10.1096/fasebj.10.5.8621065; Villalobos C, 2001, J BIOL CHEM, V276, P40293, DOI 10.1074/jbc.C100465200; WINIGER BP, 1988, BIOCHEM J, V255, P161, DOI 10.1042/bj2550161	32	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50226	50229		10.1074/jbc.C200522200	http://dx.doi.org/10.1074/jbc.C200522200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12427748	Green Published, hybrid			2022-12-27	WOS:000180177700004
J	Gupta, P; Prywes, R				Gupta, P; Prywes, R			ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAY; TRANSCRIPTION FACTOR MEF2C; RECEPTOR TYROSINE KINASES; DNA-BINDING SPECIFICITY; CELL-PROLIFERATION; GENE-EXPRESSION; CREB KINASE; FOS GENE; SERUM	Epidermal growth factor induction of c-jun expression requires ATF1 and MEF2 sites in the c-jun promoter. We find that activation of the c-jun promoter through the ATF1 site requires phosphorylation of ATF1 at serine 63. A serine 63 to alanine mutation of ATF1 acts to block epidermal growth factor (EGF) induction of a transfected c-jun gene. ATF1 can be phosphorylated by mitogen- and stress-activated protein kinase 1 (MSK1), which is activated by EGF and ERK1/2. Kinase-dead MSK1 mutants blocked EGF induction of a transfected c-jun gene suggesting that MSK1 or a similar family member is required for induced c-jun expression. Use of the MEK1 inhibitor U0126 and dominant negative MEK1 further showed that MSK1 activation and c-jun induction require the ERK pathway. In contrast, a JNK inhibitor blocked EGF induction of c-jun expression but not ATF1 phosphorylation. These results show that the two MAPK pathways, ERK and JNK, are required for EGF-induced c-jun expression and that the ERK pathway acts through downstream phosphorylation of ATF1.	Columbia Univ, Dept Sci Biol, New York, NY 10027 USA	Columbia University	Prywes, R (corresponding author), Columbia Univ, Dept Sci Biol, Fairchild 813B,MC 2420,1212 Amsterdam Ave, New York, NY 10027 USA.				NCI NIH HHS [CA50329] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050329] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Chen X, 1999, MOL CELL BIOL, V19, P4695; Clarke N, 1998, MOL CELL BIOL, V18, P1065, DOI 10.1128/MCB.18.2.1065; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeSilva DR, 1998, J IMMUNOL, V160, P4175; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; English JM, 1999, J BIOL CHEM, V274, P31588, DOI 10.1074/jbc.274.44.31588; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; HAN TH, 1992, MOL CELL BIOL, V12, P4472, DOI 10.1128/MCB.12.10.4472; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Ornatsky OI, 1996, J BIOL CHEM, V271, P24927, DOI 10.1074/jbc.271.40.24927; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Pawson T, 2000, GENE DEV, V14, P1027; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Rolli M, 1999, J BIOL CHEM, V274, P19559, DOI 10.1074/jbc.274.28.19559; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; Sambrook J., 2002, MOL CLONING LAB MANU; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sun WY, 2001, J BIOL CHEM, V276, P5093, DOI 10.1074/jbc.M003719200; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang Y, 2000, J BIOL CHEM, V275, P27013; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; WU BY, 1989, J BIOL CHEM, V264, P9000; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Xu SC, 1996, P NATL ACAD SCI USA, V93, P5291, DOI 10.1073/pnas.93.11.5291; YAN MH, 1994, NATURE, V372, P798; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	63	65	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50550	50556		10.1074/jbc.M209799200	http://dx.doi.org/10.1074/jbc.M209799200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12414794	hybrid			2022-12-27	WOS:000180177700048
J	Qi, HY; Hyndman, JB; Bernstein, HD				Qi, HY; Hyndman, JB; Bernstein, HD			DnaK promotes the selective export of outer membrane protein precursors in SecA-deficient Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; MALTOSE-BINDING PROTEIN; HEAT-SHOCK PROTEINS; TRIGGER FACTOR; SUBSTRATE-SPECIFICITY; TARGETING PATHWAY; IN-VIVO; TRANSLOCATION; INSERTION; SECRETION	Consistent with many other results indicating that SecA plays an essential role in the translocation of presecretory proteins across the Escherichia coli inner membrane, we previously found that a similar to95% depletion of SecA completely blocks the export of periplasmic proteins in vivo. Surprisingly, we found that about 25% of the outer membrane protein (OMP) OmpA synthesized after SecA depletion was gradually translocated across the inner membrane. In this study we analyzed the export of several other OMPs after SecA depletion. We found that 25-50% of each OMP as well as an OmpA-alkaline phosphatase fusion protein was exported from SecA-deficient cells. This partial export was completely abolished by the SecA inhibitor sodium azide and therefore still required the participation of SecA. Examination of a variety of OmpA derivatives, however, ruled out the possibility that OMPs are selectively translocated in SecA-deficient cells because SecA binds to their N termini with unusually high affinity. Export after SecA depletion was observed in cells that lack SecB, the primary targeting factor for OMPs, but was abolished by partial inactivation of DnaK. Furthermore, OmpA could be isolated in a stable complex with DnaK. The data strongly suggest that OMPs require only a relatively low level of translocase activity to cross the inner membrane because they can be preserved in a prolonged export-competent state by DnaK.	NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bernstein, HD (corresponding author), NIDDK, Genet & Biochem Branch, NIH, Bldg 5,Rm 201, Bethesda, MD 20892 USA.	harris_bernstein@nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052022, ZIADK052022] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACALLAO R, 1986, J BIOL CHEM, V261, P2907; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Economou A, 1998, MOL MICROBIOL, V27, P511, DOI 10.1046/j.1365-2958.1998.00713.x; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; GUTHRIE B, 1990, J BACTERIOL, V172, P5555, DOI 10.1128/jb.172.10.5555-5562.1990; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; INOUYE H, 1981, J BACTERIOL, V146, P668, DOI 10.1128/JB.146.2.668-675.1981; KADOKURA H, 1995, J BACTERIOL, V177, P3596, DOI 10.1128/jb.177.12.3596-3600.1995; KAMATHLOEB AS, 1995, J BIOL CHEM, V270, P30051; KHISTY VJ, 1995, J BACTERIOL, V177, P3277, DOI 10.1128/jb.177.11.3277-3282.1995; KLOSE M, 1988, J BIOL CHEM, V263, P13297; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; LEE C, 1986, ANNU REV CELL BIOL, V2, P315, DOI 10.1146/annurev.cellbio.2.1.315; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Meyer TH, 1999, J MOL BIOL, V285, P1789, DOI 10.1006/jmbi.1998.2413; MILLER JH, 1992, SHORT COURS BACT GEN; Newitt JA, 1998, J BIOL CHEM, V273, P12451, DOI 10.1074/jbc.273.20.12451; NILSSON B, 1991, J BIOL CHEM, V266, P2970; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Randall LL, 1998, PROTEIN SCI, V7, P2384, DOI 10.1002/pro.5560071115; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; TOPPING TB, 1994, PROTEIN SCI, V3, P730; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Wild J, 1996, J BACTERIOL, V178, P3608, DOI 10.1128/jb.178.12.3608-3613.1996; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; WILD J, 1992, P NATL ACAD SCI USA, V89, P7139, DOI 10.1073/pnas.89.15.7139; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Yang YB, 1997, J BIOL CHEM, V272, P13660, DOI 10.1074/jbc.272.21.13660; Yang YB, 1997, J BACTERIOL, V179, P7386, DOI 10.1128/jb.179.23.7386-7393.1997; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	47	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					51077	51083		10.1074/jbc.M209238200	http://dx.doi.org/10.1074/jbc.M209238200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12403776	hybrid			2022-12-27	WOS:000180177700115
J	Bjornstrom, L; Sjoberg, M				Bjornstrom, L; Sjoberg, M			Mutations in the estrogen receptor DNA-binding domain discriminate between the classical mechanism of action and cross-talk with Stat5b and activating protein 1 (AP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; ER-ALPHA; BETA; CELLS; REPRESSION; PHOSPHORYLATION; EXPRESSION; PROMOTER; PATHWAY	Estrogen receptors (ERs) efficiently potentiate the transcriptional activity of prolactin-activated Stat5b through a mechanism that involves the ER DNA-binding domain (DBD) and the hinge domain. We have identified residues within the DBD of ER that are critical for the functional interaction of ER with Stat5b. We show that disruption of the second zinc finger structure abrogated cross-talk between ER and Stat5b, while the structure of the first zinc finger was not important. Furthermore, we confirm that intact DNA binding activity was not required for potentiation of Stat5b activity and that the dimerization of ER did not seem to be involved. Ligand-bound ERs also modulated activating protein 1-dependent transcription, and our data demonstrate that both zinc finger structures of the ER DBD are important for an intact response. We show that introduction of various point mutations within the DBD altered the response of the receptor to 17beta-estradiol and to the estrogen antagonists 4-hydroxytamoxifen and ICI 182,870 on the collagenase promoter. These findings provide new insights into the mechanisms by which ERs act in cross-talk with non-related transcription factors.	Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Sjoberg, M (corresponding author), Karo Bio AB, Novum, SE-14157 Huddinge, Sweden.							BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bevan C, 1999, EXP CELL RES, V253, P349, DOI 10.1006/excr.1999.4719; Bjornstrom L, 2001, J MOL ENDOCRINOL, V27, P93, DOI 10.1677/jme.0.0270093; BLOBEL GA, 1995, MOL CELL BIOL, V15, P3147; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Cowley SM, 1999, J STEROID BIOCHEM, V69, P165, DOI 10.1016/S0960-0760(99)00055-2; Glass CK, 2000, GENE DEV, V14, P121; Gottlicher M, 1998, J MOL MED-JMM, V76, P480, DOI 10.1007/s001090050242; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; LAHOOTI H, 1994, MOL ENDOCRINOL, V8, P182, DOI 10.1210/me.8.2.182; LESUEUR L, 1990, MOL CELL ENDOCRINOL, V71, pR7, DOI 10.1016/0303-7207(90)90079-N; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Philips A, 1998, MOL ENDOCRINOL, V12, P973, DOI 10.1210/me.12.7.973; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Price RH, 2001, ENDOCRINOLOGY, V142, P2039, DOI 10.1210/en.142.5.2039; RAY A, 1994, J BIOL CHEM, V269, P12940; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WHITE R, 1994, ENDOCRINOLOGY, V135, P175, DOI 10.1210/en.135.1.175	26	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 13	2002	277	50					48479	48483		10.1074/jbc.C200570200	http://dx.doi.org/10.1074/jbc.C200570200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	624YK	12411447	hybrid			2022-12-27	WOS:000179789600068
J	Yokota, A; Tsumoto, K; Shiroishi, M; Kondo, H; Kumagai, I				Yokota, A; Tsumoto, K; Shiroishi, M; Kondo, H; Kumagai, I			The role of hydrogen bonding via interfacial water molecules in antigen-antibody complexation - The HyHEL-10-HEL interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTILYSOZYME MONOCLONAL-ANTIBODY; SALT BRIDGE FORMATION; EGG-WHITE LYSOZYME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; ENTROPIC CONTRIBUTION; PROTEIN ANTIGEN; RECOGNITION; THERMODYNAMICS	To study the role of hydrogen bonding via interfacial water molecules in protein-protein interactions, we examined the interaction between hen egg white lysozyme (HEL) and its HyHEL-10 variable domain fragment (Fv) antibody. We constructed three antibody mutants (L-Y50F, L-S91A, and L-S93A) and investigated the interactions between the mutant Fvs and HEL. Isothermal titration calorimetry indicated that the mutations significantly decreased the negative enthalpy change (8-25 kJ mol(-1)), despite some offset by a favorable entropy change. X-ray crystallography demonstrated that the complexes had nearly identical structures, including the positions of the interfacial water molecules. Taken together, the isothermal titration calorimetric and x-ray crystallographic results indicate that hydrogen bonding via interfacial water enthalpically contributes to the Fv-HEL interaction despite the partial offset because of entropy loss, suggesting that hydrogen bonding stiffens the antigen-antibody complex.	Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; Natl Inst Adv Ind Sci & Technol, AIST, Hokkaido Ctr, Toyohira Ku, Sapporo, Hokkaido 0118511, Japan	Tohoku University; National Institute of Advanced Industrial Science & Technology (AIST)	Tsumoto, K (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Aoba Ku, Aoba Yama 07, Sendai, Miyagi 9808579, Japan.	tsumoto@mail.cc.tohoku.ac.jp; kmiz@mail.cc.tohoku.ac.jp	Kondo, Hidemasa/M-7465-2018	Kondo, Hidemasa/0000-0003-2799-1775; Shiroishi, Mitsunori/0000-0002-3133-157X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Borea PA, 2000, BIOCHEM PHARMACOL, V60, P1549, DOI 10.1016/S0006-2952(00)00368-3; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x; Braden BC, 1995, J MOL RECOGNIT, V8, P317, DOI 10.1002/jmr.300080505; BRUNGER A, 1992, X PLOR MANUAL; Calderone CT, 2001, J AM CHEM SOC, V123, P6262, DOI 10.1021/ja003016y; CHACKO S, 1995, J MOL BIOL, V245, P261, DOI 10.1006/jmbi.1994.0022; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; DUNITZ JD, 1994, SCIENCE, V264, P670, DOI 10.1126/science.264.5159.670; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Goldbaum FA, 1996, J MOL RECOGNIT, V9, P6, DOI 10.1002/(SICI)1099-1352(199601)9:1<6::AID-JMR240>3.3.CO;2-M; GUILLET V, 1993, STRUCTURE, V1, P165, DOI 10.1016/0969-2126(93)90018-C; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Imoto T., 1972, ENZYMES, V7, P665; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jen-Jacobson L, 2000, STRUCTURE, V8, P1015, DOI 10.1016/S0969-2126(00)00501-3; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kabat E. A., 1991, SEQUENCES PROTEINS I; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; Kondo H, 1999, J BIOL CHEM, V274, P27623, DOI 10.1074/jbc.274.39.27623; KORNBLATT JA, 1993, BIOPHYS J, V65, P1059, DOI 10.1016/S0006-3495(93)81168-8; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LADBURY JE, 1994, J MOL BIOL, V238, P669, DOI 10.1006/jmbi.1994.1328; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; LEE LLY, 1987, BIOCHEMISTRY-US, V26, P7813, DOI 10.1021/bi00398a042; LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5; Li YL, 2000, BIOCHEMISTRY-US, V39, P6296, DOI 10.1021/bi000054l; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Merk H, 1999, J BIOCHEM, V125, P328, DOI 10.1093/oxfordjournals.jbchem.a022290; Morton CJ, 1996, PROTEIN SCI, V5, P2115, DOI 10.1002/pro.5560051018; MURPHY KP, 1995, PROTEINS, V21, P83, DOI 10.1002/prot.340210202; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; NATARAJAN K, 2000, ANNU REV IMMUNOL, V20, P853; NAVAZA J, 1994, ACTA CRYSTALLOGR D, V50, P805; Nishimiya Y, 2000, J BIOL CHEM, V275, P12813, DOI 10.1074/jbc.275.17.12813; NOVOTNY J, 1989, BIOCHEMISTRY-US, V28, P4735, DOI 10.1021/bi00437a034; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Padlan EA, 1996, ADV PROTEIN CHEM, V49, P57, DOI 10.1016/S0065-3233(08)60488-X; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; SAKABE N, 1991, NUCL INSTRUM METH A, V303, P448, DOI 10.1016/0168-9002(91)90282-U; SCHWARZ FP, 1995, EUR J BIOCHEM, V228, P388; SHAKKED Z, 1994, NATURE, V368, P469, DOI 10.1038/368469a0; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shiroishi M, 2001, J BIOL CHEM, V276, P23042, DOI 10.1074/jbc.M100480200; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; SMITHGILL SJ, 1984, J IMMUNOL, V133, P384; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STURTEVANT JM, 1994, CURR OPIN STRUC BIOL, V4, P69, DOI 10.1016/S0959-440X(94)90062-0; Tame JRH, 1996, NAT STRUCT BIOL, V3, P998, DOI 10.1038/nsb1296-998; Trinh CH, 1997, STRUCTURE, V5, P937, DOI 10.1016/S0969-2126(97)00247-5; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; TSUMOTO K, 1994, J BIOL CHEM, V269, P28777; TSUMOTO K, 1994, BIOCHEM BIOPH RES CO, V201, P546, DOI 10.1006/bbrc.1994.1736; Tsumoto K, 1996, J BIOL CHEM, V271, P32612, DOI 10.1074/jbc.271.51.32612; Ueda H, 1996, NAT BIOTECHNOL, V14, P1714, DOI 10.1038/nbt1296-1714; UEDA Y, 1993, GENE, V129, P129; Vajda S, 1997, CURR OPIN STRUC BIOL, V7, P222, DOI 10.1016/S0959-440X(97)80029-2; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; WESTHOL E, 1993, WATER BIOL MACROMOLE; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xavier KA, 1997, BIOPHYS J, V73, P2116, DOI 10.1016/S0006-3495(97)78242-0; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412	75	59	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5410	5418		10.1074/jbc.M210182200	http://dx.doi.org/10.1074/jbc.M210182200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12444085	hybrid			2022-12-27	WOS:000180968900133
J	Nicolas, FJ; Lehmann, K; Warne, PH; Hill, CS; Downward, J				Nicolas, FJ; Lehmann, K; Warne, PH; Hill, CS; Downward, J			Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; GENE; PROMOTER; SUPPRESSION; ELEMENTS	In normal epithelial cells, transforming growth factor-beta (TGF-beta) typically causes growth arrest in the G(1) phase of the cell cycle and may eventually lead to apoptosis. However, transformed cells lose these inhibitory responses and often instead show an increase in malignant character following TGF-beta treatment. In the canine kidney-derived epithelial cell line, MDCK, synergism between activation of the RaVNLAPK pathway and the resulting autocrine production of TGF-beta triggers transition from an epithelial to a mesenchymal phenotype. During this process, these cells become refractive to TGF-beta-induced cell cycle arrest and apoptosis. TGF-beta signals are primarily transduced to the nucleus through complexes of receptor-regulated Smads, Smad2 and Smad3 with the common mediator Smad, Smad4. Here we show that the transition from an epithelial to mesenchymal phenotype is accompanied by gradual down-regulation of expression of Smad3. Restoration of Smad3 to previous levels of expression restores the cell cycle arrest induced by TGF-beta without reverting the cells to an epithelial phenotype or impacting on the MAPK pathway. Regulation of apoptosis is not affected by Smad3 levels. These data attribute to Smad3 a critical role in the control of cell proliferation by TGF-beta which is lost following an epithelial to mesenchymal transition.	Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Dev Signalling Lab, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.		Downward, Julian/A-3251-2012; Nicolás, Francisco José/H-9422-2019	Nicolás, Francisco José/0000-0002-3969-1430; Hill, Caroline/0000-0002-8632-0480; Downward, Julian/0000-0002-2331-4729				Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Datto MB, 1999, MOL CELL BIOL, V19, P2495; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; GENG Y, 1993, P NATL ACAD SCI USA, V90, P10315, DOI 10.1073/pnas.90.21.10315; Hay ED, 1995, ACTA ANAT, V154, P8; Howell M, 1997, EMBO J, V16, P7411, DOI 10.1093/emboj/16.24.7411; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Khwaja A, 1996, ONCOGENE, V12, P2491; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wong C, 1999, MOL CELL BIOL, V19, P1821; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416	25	67	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3251	3256		10.1074/jbc.M209019200	http://dx.doi.org/10.1074/jbc.M209019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12435725	hybrid			2022-12-27	WOS:000180915000062
J	Xu, GM; Gonzalez-Perrett, S; Essafi, M; Timpanaro, GA; Montalbetti, N; Arnaout, MA; Cantiello, HF				Xu, GM; Gonzalez-Perrett, S; Essafi, M; Timpanaro, GA; Montalbetti, N; Arnaout, MA; Cantiello, HF			Polycystin-1 activates and stabilizes the polycystin-2 channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; CATION CHANNEL; PROTEIN; PKD2; GENE; INTERACTS	Autosomal dominant polycystic kidney disease (AD-PKD) is a prevalent genetic disorder largely caused by mutations in the PKD1 and PKD2 genes that encode the transmembrane proteins polycystin-1 and -2, respectively. Both proteins appear to be involved in the regulation of cell growth and maturation, but the precise mechanisms are not yet well defined. Polycystin-2 has recently been shown to function as a Ca2+-permeable, non-selective cation channel. Polycystin-2 interacts through its cytoplasmic carboxyl-terminal region with a coiled-coil motif in the cytoplasmic tail of polycystin-1 (P1CC). The functional consequences of this interaction on its channel activity, however, are unknown. In this report, we show that P1CC enhanced the channel activity of polycystin-2. R742X, a disease-causing polycystin-2 mutant lacking the polycystin-1 interacting region, fails to respond to P1CC. Also, P1CC containing a disease-causing mutation in its coiled-coil motif loses its stimulatory effect on wild-type polycystin-2 channel activity. The modulation of polycystin-2 channel activity by polycystin-1 may be important for the various biological processes mediated by this molecular complex.	Massachusetts Gen Hosp, Renal Unit, Dept Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Fac Farm & Bioquim, Fac Fisioquim & Quim Anal, RA-1113 Buenos Aires, DF, Argentina; Fac Med, Dept Fisiol, RA-1121 Buenos Aires, DF, Argentina	Harvard University; Massachusetts General Hospital; Harvard University; University of Buenos Aires	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Renal Unit, Dept Med, 149 13th St, Charlestown, MA 02129 USA.		Montalbetti, Nicolas/T-4212-2019; Essafi, Makram/V-8411-2019	Montalbetti, Nicolas/0000-0003-2897-9540; 	NIDDK NIH HHS [DK54711] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054711] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Badenas C, 1999, KIDNEY INT, V55, P1225, DOI 10.1046/j.1523-1755.1999.00368.x; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Gonzalez-Perrett S, 2002, J BIOL CHEM, V277, P24959, DOI 10.1074/jbc.M105084200; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Scheffers MS, 2000, HUM MOL GENET, V9, P2743, DOI 10.1093/hmg/9.18.2743; SNEDECOR MM, 1973, STAT METHODS, P104; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Xu GM, 2001, J BIOL CHEM, V276, P46544, DOI 10.1074/jbc.M107828200	19	83	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1457	1462		10.1074/jbc.M209996200	http://dx.doi.org/10.1074/jbc.M209996200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12407099	hybrid			2022-12-27	WOS:000180462200013
J	Hinkovska-Galcheva, V; Boxer, L; Mansfield, PJ; Schreiber, AD; Shayman, JA				Hinkovska-Galcheva, V; Boxer, L; Mansfield, PJ; Schreiber, AD; Shayman, JA			Enhanced phagocytosis through inhibition of de novo ceramide synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA RECEPTOR; PROTEIN-KINASE-C; IGG-DEPENDENT PHAGOCYTOSIS; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; ADHERENT HUMAN NEUTROPHILS; PHOSPHOLIPASE-D; TYROSINE KINASE; MEDIATED PHAGOCYTOSIS; HUMAN-PLATELETS; SPHINGOLIPID BIOSYNTHESIS	Fcgamma receptors are important mediators of the binding of IgG to and induction of phagocytosis in neutrophils. COS-1 cells provide a potentially useful model for studying these receptors because transfection with the FcgammaRIIA renders these cells phagocytic. During FcgammaRIIA-mediated phagocytosis in COS-1 cells, endogenous ceramide levels increased 52% by 20 min (p < 0.01). Phospholipase D activity increased by 62% (p < 0.01). Correspondingly, the phagocytic index increased by 3.7 fold by 20 min. Two inhibitors of ceramide formation were used to assess the consequences of reduced ceramide generation. L-Cycloserine, an inhibitor that blocks serine palmitoyltransferase activity, lowered both sphingosine and ceramide levels. Under these conditions, the phagocytic index increased 100% in the presence of 2 mM L-cycloserine. The formation of ceramide resulting from the N-acylation of dihydrosphingosine or sphingosine by ceramide synthase is inhibited by the fungal toxin fumonisin B-1. When cells were treated with 5-50 mum fumonisin B-1, the cellular level of ceramide decreased in a concentration-dependent manner, while simultaneously the phagocytic index increased by 52%. Concomitantly, three indirect measures of FcgammaRIIA activity were altered with the fall in ceramide levels. Syk phosphorylation, phospholipase D activity, and mitogen-activated protein (MAP) kinase phosphorylation were increased at 30 min. When Syk phosphorylation was blocked with piceatannol and cells were similarly challenged, phosphatidylinositol 3-kinase activation was blocked, but no changes in either ceramide accumulation or MAP kinase activation were observed. Ceramide formation and MAP kinase activation are therefore not dependent on Syk kinase activity in this system. These results indicate that COS-1 cells provide a useful model for the recapitulation of sphingolipid signaling in the study of phagocytosis. Ceramide formed by de novo synthesis may represent an important mechanism in the regulation of phagocytosis.	Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; Univ Michigan, Div Pediat, Div Hematol Oncol, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania	Shayman, JA (corresponding author), Univ Michigan, Dept Internal Med, Div Nephrol, Box 0676,Rm 1560,MSRB II,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020065] Funding Source: NIH RePORTER; NIAID NIH HHS [AI20065] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE A, 1992, EUR J BIOCHEM, V210, P765, DOI 10.1111/j.1432-1033.1992.tb17479.x; Abe A, 1996, J BIOL CHEM, V271, P14383, DOI 10.1074/jbc.271.24.14383; AGARWAL A, 1993, J BIOL CHEM, V268, P15900; ANDERSON CL, 1995, SEMIN THROMB HEMOST, V21, P1, DOI 10.1055/s-2007-1000374; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; COMBER PG, 1989, CELL IMMUNOL, V124, P292, DOI 10.1016/0008-8749(89)90132-9; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; DELLABIANCA V, 1991, BIOCHEM BIOPH RES CO, V177, P948, DOI 10.1016/0006-291X(91)90630-P; DESAI NN, 1992, J BIOL CHEM, V267, P23122; FALLMAN M, 1993, J IMMUNOL, V151, P330; FALLMAN M, 1992, J BIOL CHEM, V267, P2656; GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; Greenberg S, 2001, J CELL SCI, V114, P1039; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; Hinkovska-Galcheva V, 1998, BLOOD, V91, P4761, DOI 10.1182/blood.V91.12.4761.412k24_4761_4769; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; Indik Z K, 1995, Semin Immunol, V7, P45, DOI 10.1016/1044-5323(95)90007-1; INDIK ZK, 1994, EXP HEMATOL, V22, P599; INDIK ZK, 1995, BLOOD, V85, P1175, DOI 10.1182/blood.V85.5.1175.bloodjournal8551175; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; KIENER PA, 1993, J BIOL CHEM, V268, P24442; KING M, 1990, CELL IMMUNOL, V128, P462, DOI 10.1016/0008-8749(90)90041-O; LAVIE Y, 1990, FEBS LETT, V277, P7, DOI 10.1016/0014-5793(90)80796-L; Matsuda M, 1996, MOL BIOL CELL, V7, P1095, DOI 10.1091/mbc.7.7.1095; MEDLOCK KA, 1988, BIOCHEMISTRY-US, V27, P7079, DOI 10.1021/bi00418a061; Merrill AH, 1996, ADV EXP MED BIOL, V392, P297; MERRILL AH, 1993, ADV LIPID RES, V26, P215; NAKAMURA T, 1994, J BIOL CHEM, V269, P18384; PARK JG, 1995, P NATL ACAD SCI USA, V92, P7381, DOI 10.1073/pnas.92.16.7381; PERRY DK, 1992, J IMMUNOL, V149, P2749; PREISS J, 1986, J BIOL CHEM, V261, P8597; ROSSMAN MD, 1993, EXP HEMATOL, V21, P177; Schreiber A D, 1989, Transfus Med Rev, V3, P282, DOI 10.1016/S0887-7963(89)70088-2; Spiegel S, 1996, FASEB J, V10, P1388, DOI 10.1096/fasebj.10.12.8903509; Suchard SJ, 1997, BLOOD, V89, P2139, DOI 10.1182/blood.V89.6.2139; Suchard SJ, 1997, J IMMUNOL, V158, P4961; SUCHARD SJ, 1994, J BIOL CHEM, V269, P8063; SUNDARAM KS, 1984, J NEUROCHEM, V42, P577, DOI 10.1111/j.1471-4159.1984.tb02716.x; UNKELESS JC, 1989, J CLIN INVEST, V83, P355, DOI 10.1172/JCI113891; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480; ZHANG H, 1990, J BIOL CHEM, V265, P76	43	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					974	982		10.1074/jbc.M206199200	http://dx.doi.org/10.1074/jbc.M206199200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12424251	hybrid			2022-12-27	WOS:000180321900038
J	Ni, ZY; Anini, Y; Fang, XJ; Mills, G; Brubakers, PL; Jin, TR				Ni, ZY; Anini, Y; Fang, XJ; Mills, G; Brubakers, PL; Jin, TR			Transcriptional activation of the proglucagon gene by lithium and beta-catenin in intestinal endocrine L cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLYCOGEN-SYNTHASE KINASE-3; TRANSGENIC MICE; IN-VIVO; DIFFERENTIAL REGULATION; INTEROCEPTIVE STRESS; DEPENDENT PATHWAY; RESPONSE ELEMENT; PROMOTER ELEMENT; T-ANTIGEN	The proglucagon gene encodes several peptide hormones that regulate blood glucose homeostasis, growth of the small intestine, and satiety. Among them, glucagon-like peptide 1 (GLP-1) lowers blood glucose levels in patients with diabetes and inhibits eating and drinking in fasted rats. Although proglucagon transcription and GLP-1 synthesis were shown to be activated by forskolin and other protein kinase A (PKA) activators, deleting or mutating the cAMP-response element (CRE) only moderately attenuates the proglucagon gene promoter in response to PKA activation. Therefore, PKA may activate proglucagon transcription via a mechanism independent of the CRE motif. Recently, PKA was shown to phosphorylate and inactivate GSK-3beta, a key mediator in the Wnt signaling pathway. We show here that lithium, an inhibitor of GSK-3beta, activates proglucagon gene transcription and stimulates GLP-1 synthesis in an intestinal endocrine L cell line, GLUTag. The activation was also observed in primary fetal rat intestinal cell (FRIC) cultures, but not in a pancreatic A cell line. Co-transfection of beta-catenin, a downstream effector of GSK-3beta activities, activated the proglucagon gene promoter without a CRE. Furthermore, forskolin and 8-Br-cAMP phosphorylated GSK-3beta at serine 9 in intestinal proglucagon-producing cells, and both lithium and forskolin induced the accumulation of free beta-catenin in these cell lines. These observations indicate that the proglucagon gene is among the targets of the Wnt signaling pathway.	Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 2M1, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Texas System; UTMD Anderson Cancer Center	Jin, TR (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Rm 421,67 Coll St, Toronto, ON M5G 2M1, Canada.			Anini, Younes/0000-0002-0115-658X				Anini Y, 2002, ENDOCRINOLOGY, V143, P2420, DOI 10.1210/en.143.6.2420; ANINI Y, 2003, IN PRESS DIABETES, V52; Beimesche S, 1999, MOL ENDOCRINOL, V13, P718, DOI 10.1210/me.13.5.718; Brubaker PL, 1998, ENDOCRINOLOGY, V139, P4108, DOI 10.1210/en.139.10.4108; BRUBAKER PL, 1992, J BIOL CHEM, V267, P20728; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Cordier-Bussat M, 1998, DIABETES, V47, P1038, DOI 10.2337/diabetes.47.7.1038; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dhanvantari S, 2001, ENDOCRINOLOGY, V142, P37, DOI 10.1210/en.142.1.37; Diedrich T, 1997, BIOL CHEM, V378, P89, DOI 10.1515/bchm.1997.378.2.89; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DRUCKER DJ, 1989, P NATL ACAD SCI USA, V86, P3953, DOI 10.1073/pnas.86.11.3953; DRUCKER DJ, 1988, J BIOL CHEM, V263, P13475; DRUCKER DJ, 1992, MOL ENDOCRINOL, V6, P2175, DOI 10.1210/me.6.12.2175; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; DRUCKER DJ, 1991, ENDOCRINOLOGY, V128, P394, DOI 10.1210/endo-128-1-394; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fang XJ, 2002, MOL CELL BIOL, V22, P2099, DOI 10.1128/MCB.22.7.2099-2110.2002; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Furstenau U, 1999, J BIOL CHEM, V274, P5851, DOI 10.1074/jbc.274.9.5851; GAJIC D, 1993, ENDOCRINOLOGY, V132, P1055, DOI 10.1210/en.132.3.1055; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; GOODE N, 1992, J BIOL CHEM, V267, P16878; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Herzig S, 2000, J BIOL CHEM, V275, P27989; HUANG THJ, 1995, ENDOCRINE, V3, P499, DOI 10.1007/BF02738824; Hussain MA, 1997, MOL CELL BIOL, V17, P7186, DOI 10.1128/MCB.17.12.7186; JIN T, 1995, MOL ENDOCRINOL, V9, P1306, DOI 10.1210/me.9.10.1306; Jin TR, 1996, MOL CELL BIOL, V16, P19; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kao KR, 1998, BIOL CELL, V90, P585, DOI 10.1016/S0248-4900(99)80016-1; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; LEE YC, 1992, J BIOL CHEM, V267, P10705; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu YF, 2002, BIOCHEM J, V366, P633, DOI 10.1042/BJ20020095; Lovshin J, 2001, J BIOL CHEM, V276, P21489, DOI 10.1074/jbc.M009382200; Lu F, 1996, ENDOCRINOLOGY, V137, P3710, DOI 10.1210/en.137.9.3710; MCCANN MJ, 1989, AM J PHYSIOL, V256, pR463, DOI 10.1152/ajpregu.1989.256.2.R463; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; Meigs TE, 2001, P NATL ACAD SCI USA, V98, P519, DOI 10.1073/pnas.021350998; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nian M, 1999, AM J PHYSIOL-GASTR L, V277, pG829, DOI 10.1152/ajpgi.1999.277.4.G829; Peters CT, 2001, J NUTR, V131, P2164, DOI 10.1093/jn/131.8.2164; PHILIPPE J, 1988, MOL CELL BIOL, V8, P4877, DOI 10.1128/MCB.8.11.4877; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR582, DOI 10.1152/ajpregu.1999.277.2.R582; Rinaman L, 1999, AM J PHYSIOL-REG I, V277, pR1537, DOI 10.1152/ajpregu.1999.277.5.R1537; RITTER S, 1980, BRAIN RES, V201, P501, DOI 10.1016/0006-8993(80)91061-6; Ritz-Laser B, 2000, J BIOL CHEM, V275, P32708, DOI 10.1074/jbc.M005704200; Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687; Seeley RJ, 2000, J NEUROSCI, V20, P1616; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Siemann G, 1999, MOL PHARMACOL, V55, P1094, DOI 10.1124/mol.55.6.1094; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Thiele TE, 1998, BRAIN RES, V801, P164, DOI 10.1016/S0006-8993(98)00584-8; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; van Dijk G, 1999, NEUROPEPTIDES, V33, P406; van Es JH, 2001, EXP CELL RES, V264, P126, DOI 10.1006/excr.2000.5142; WANG M, 1995, J BIOL CHEM, V270, P12646, DOI 10.1074/jbc.270.21.12584; Wojdemann M, 1998, SCAND J GASTROENTERO, V33, P828; Xiao Q, 2000, AM J PHYSIOL-REG I, V278, pR1057, DOI 10.1152/ajpregu.2000.278.4.R1057; Xu FH, 1999, J BIOL CHEM, V274, P34310, DOI 10.1074/jbc.274.48.34310; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200	71	67	68	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1380	1387		10.1074/jbc.M206006200	http://dx.doi.org/10.1074/jbc.M206006200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12421827	hybrid			2022-12-27	WOS:000180321900088
J	Moore, RK; Otsuka, F; Shimasaki, S				Moore, RK; Otsuka, F; Shimasaki, S			Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; OSTEOGENIC PROTEIN-1; BETA SUPERFAMILY; I RECEPTORS; KINASE; IDENTIFICATION; EXPRESSION; PATHWAYS; ACTIVIN; OOCYTES	Bone morphogenetic protein-15 (BMP-15), an oocyte growth factor belonging to the transforming growth factor-beta superfamily, has recently been shown to be necessary for normal female fertility in mammals. We have previously demonstrated that BMP-15 regulates granulosa cell (GC) proliferation and differentiation; namely, BMP-15 promotes GC mitosis, suppresses follicle-stimulating hormone (FSH) receptor expression, and stimulates kit ligand expression. Although the role of BMP-15 in female reproduction has progressively deserved much attention, there is nothing known to date about the signaling pathway and receptors for BMP-15. Using rat primary GCs and a human GC cell line, COV434, we have now found that administration of BMP-15 causes a rapid and transient phosphorylation, thus activation, of the Smad1/5/8 pathway. BMP-15 also stimulated promoter activity of a selective BMP-responsive reporter construct, further demonstrating the stimulation of Smad1/5/8 signaling by BMP-15. In contrast, BMP-15 stimulation of Smad2 phosphorylation was very weak. To identify the receptors for BMP-15, we utilized recombinant extracellular domains of individual transforming growth factor-beta superfamily receptors and found that activin receptor-like kinase-6 extracellular domain most effectively co-immunoprecipitates with BMP-15, whereas BMP receptor type II extracellular domain was most effective in inhibiting BMP-15 bioactivity on FSH-induced progesterone production and GC thymidine incorporation. We also investigated whether activation of the MAPK pathway is necessary for BMP-15 biological activity and found that the addition of U0126, an inhibitor of ERK1/2 phosphorylation, suppresses BMP-15 activity on GC mitotsis but not on FSH-induced progesterone production, suggesting a selective signaling cascade in GC proliferation and differentiation.	Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Shimasaki, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Reprod Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NICHD NIH HHS [R01 HD41494, U54HD12303, F32 HD41320] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041494, U54HD012303] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD041320] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoki H, 2001, J CELL SCI, V114, P1483; CAMERON VA, 1994, ENDOCRINOLOGY, V134, P799, DOI 10.1210/en.134.2.799; Candia AF, 1997, DEVELOPMENT, V124, P4467; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; Drummond AE, 2002, ENDOCRINOLOGY, V143, P1423, DOI 10.1210/en.143.4.1423; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Ebisawa T, 1999, J CELL SCI, V112, P3519; Faure S, 2000, DEVELOPMENT, V127, P2917; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Gouedard L, 2000, J BIOL CHEM, V275, P27973; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jaatinen R, 2002, J CLIN ENDOCR METAB, V87, P1254, DOI 10.1210/jc.87.3.1254; Kang SK, 2000, MOL CELL ENDOCRINOL, V170, P143; Kano K, 1999, J VET MED SCI, V61, P213, DOI 10.1292/jvms.61.213; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Laitinen M, 1998, MECH DEVELOP, V78, P135, DOI 10.1016/S0925-4773(98)00161-0; LIU F, 1995, MOL CELL BIOL, V15, P3479; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Moore RK, 2001, BIOCHEM BIOPH RES CO, V289, P796, DOI 10.1006/bbrc.2001.6052; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Otsuka F, 2001, J BIOL CHEM, V276, P11387, DOI 10.1074/jbc.M010043200; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Otsuka F, 2001, BIOCHEM BIOPH RES CO, V289, P961, DOI 10.1006/bbrc.2001.6103; Pangas SA, 2002, J CLIN ENDOCR METAB, V87, P2644, DOI 10.1210/jc.87.6.2644; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; SHIMASAKI S, 1989, MOL ENDOCRINOL, V3, P651, DOI 10.1210/mend-3-4-651; SHIMASAKI S, 2002, IN PRESS REPRODUCTIO; Souza CJH, 2002, REPRODUCTION, V123, P363, DOI 10.1530/rep.0.1230363; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; Tai CJ, 2001, ENDOCRINOLOGY, V142, P1554, DOI 10.1210/en.142.4.1554; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Visser JA, 2001, MOL ENDOCRINOL, V15, P936, DOI 10.1210/me.15.6.936; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Wood Jennifer R, 2002, Rev Endocr Metab Disord, V3, P33, DOI 10.1023/A:1012748718150; Wrana JL, 2000, CYTOKINE GROWTH F R, V11, P5, DOI 10.1016/S1359-6101(99)00024-6; Xu J, 2002, BIOL REPROD, V66, P1571, DOI 10.1095/biolreprod66.6.1571; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146; Zhao J, 2001, BIOL REPROD, V65, P967, DOI 10.1095/biolreprod65.3.967	52	245	286	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					304	310		10.1074/jbc.M207362200	http://dx.doi.org/10.1074/jbc.M207362200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12419820	hybrid			2022-12-27	WOS:000180255700041
J	Swaminath, G; Lee, TW; Kobilka, B				Swaminath, G; Lee, TW; Kobilka, B			Identification of an allosteric binding site for ZN(2+) on the beta(2) adrenergic receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; EXTRACELLULAR CA2+-SENSING RECEPTOR; PROTEIN-COUPLED RECEPTOR; MODULATION; SODIUM; AMINO; PD-81,723; GALLAMINE; ENHANCER; LIGANDS	The activity of G protein-coupled receptors (GPCRs) can be modulated by a diverse spectrum of drugs ranging from full agonists to partial agonists, antagonists, and inverse agonists. The vast majority of these ligands compete with native ligands for binding to orthosteric binding sites. Allosteric ligands have also been described for a number of GPCRs. However, little is known about the mechanism by which these ligands modulate the affinity of receptors for orthosteric ligands. We have previously reported that Zn(H) acts as a positive allosteric modulator of the beta(2)-adrenergic receptor (beta(2)AR). To identify the Zn2+ binding site responsible for the enhancement of agonist affinity in the beta(2)AR, we mutated histidines located in hydrophilic sequences bridging the seven transmembrane domains. Mutation of His-269 abolished the effect of Zn2+ on agonist affinity. Mutations of other histidines had no effect on agonist affinity. Further mutagenesis of residues adjacent to His-269 demonstrated that Cys-265 and Glu-225 are also required to achieve the full allosteric effect of Zn2+ on agonist binding. Our results suggest that bridging of the cytoplasmic extensions of TM5 and TM6 by Zn2+ facilitates agonist binding. These, results are in agreement with recent biophysical studies demonstrating that agonist binding leads to movement of TM6 relative to TM5.	Stanford Univ, Med Ctr, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Kobilka, B (corresponding author), Stanford Univ, Sch Med, 157 Beckman Ctr,279 Campus Dr, Stanford, CA 94305 USA.			Kobilka, Brian/0000-0001-5958-3990	NINDS NIH HHS [5-R01-NS28471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BHATTACHARYA S, 1995, BBA-MOL CELL RES, V1265, P15, DOI 10.1016/0167-4889(94)00204-R; Conigrave AD, 2000, TRENDS PHARMACOL SCI, V21, P401, DOI 10.1016/S0165-6147(00)01546-7; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Ellis J, 2000, MOL PHARMACOL, V58, P1451, DOI 10.1124/mol.58.6.1451; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Jakubik J, 1997, MOL PHARMACOL, V52, P172, DOI 10.1124/mol.52.1.172; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Maret W, 2001, P NATL ACAD SCI USA, V98, P12325, DOI 10.1073/pnas.231481398; MOTULSKY HJ, 1983, J BIOL CHEM, V258, P3913; Musser B, 1999, J PHARMACOL EXP THER, V288, P446; NEVE KA, 1991, MOL PHARMACOL, V39, P570; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; REGAN L, 1995, TRENDS BIOCHEM SCI, V20, P280, DOI 10.1016/S0968-0004(00)89044-1; Schetz JA, 2001, J PHARMACOL EXP THER, V296, P359; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Swaminath G, 2002, MOL PHARMACOL, V61, P65, DOI 10.1124/mol.61.1.65; TUCEK S, 1995, TRENDS PHARMACOL SCI, V16, P205, DOI 10.1016/S0165-6147(00)89023-9; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200	23	68	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					352	356		10.1074/jbc.M206424200	http://dx.doi.org/10.1074/jbc.M206424200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409304	hybrid			2022-12-27	WOS:000180255700047
J	Boraston, AB; Kwan, E; Chiu, P; Warren, RAJ; Kilburn, DG				Boraston, AB; Kwan, E; Chiu, P; Warren, RAJ; Kilburn, DG			Recognition and hydrolysis of noncrystalline cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; GLUCAN-BINDING; LARGE LIGANDS; FIMI; SPECIFICITY; DOMAIN; IDENTIFICATION; AFFINITY; MCGHEE	Cellulase Ce15A from alkalophilic Bacillus sp. 1139 contains a family 17 carbohydrate-binding module (BspCBM17) and a family 28 CBM (BspCBM28) in tandem. The two modules have significantly similar amino acid sequences, but amino acid residues essential for binding are not conserved. BspCBM28 was obtained as a discrete polypeptide by engineering the cel5A gene. BspCBM17 could not be obtained as a discrete polypeptide, so a family 17 CBM from endoglucanase Cel5A of Clostridium cellulovorans, CcCBM17, was used to compare the binding characteristics of the two families of CBM. Both CcCBM17 and BspCBM28 recognized two classes of binding sites on amorphous cellulose: a high affinity site (K-a similar to1 x 10(6) m(-1)) and a low affinity site ( similar to2 X 10(4) m(-1)). They did not compete for binding to the high affinity sites, suggesting that they bound at different sites on the cellulose. A polypeptide, BspCBM17/ CBM28, comprising the tandem CBMs from Ce15A, bound to amorphous cellulose with a significantly higher affinity than the sum of the affinities of CcCBM17 and BspCBM28, indicating cooperativity between the linked CBMs. Ce15A mutants were constructed that were defective in one or both of the CBMs. The mutants differed from the wild-type enzyme in the amounts and sizes of the soluble products produced from amorphous cellulose. This suggests that either the CBMs can modify the action of the catalytic module of Ce15A or that they target the enzyme to areas of the cellulose that differ in susceptibility to hydrolysis.	PENCE Inc, Prot Engn Network Ctr Excellenc, Natl Business Ctr, Edmonton, AB T6G 2S2, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, CSC, POB 3055 Stn, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Boraston, Alisdair/0000-0001-6417-0592				Ali MK, 2001, BIOSCI BIOTECH BIOCH, V65, P41, DOI 10.1271/bbb.65.41; ATALLA RH, 1993, TRICHODERMA REESEI C, P25; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2002, BIOCHEM J, V361, P35, DOI 10.1042/0264-6021:3610035; Boraston AB, 2002, MOL MICROBIOL, V43, P187, DOI 10.1046/j.1365-2958.2002.02730.x; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; Boraston AB, 2000, BIOCHEM J, V350, P933, DOI 10.1042/0264-6021:3500933; Boraston AB, 2000, BIOCHEMISTRY-US, V39, P11129, DOI 10.1021/bi0007728; Boraston AB, 1999, ROY SOC CH, P202; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; GILKES NR, 1992, J BIOL CHEM, V267, P6743; GILKES NR, 1988, J BIOL CHEM, V263, P10401; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Ichi-Ishi A, 1998, APPL ENVIRON MICROB, V64, P1086; Kong Y, 2002, BIOPHYS CHEM, V95, P1, DOI 10.1016/S0301-4622(01)00234-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kormos J, 2000, BIOCHEMISTRY-US, V39, P8844, DOI 10.1021/bi000607s; Kristiansen A, 1998, BBA-GEN SUBJECTS, V1425, P137, DOI 10.1016/S0304-4165(98)00063-4; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MAGLIONE G, 1992, APPL ENVIRON MICROB, V58, P3593, DOI 10.1128/AEM.58.11.3593-3597.1992; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Sugiyama H, 2000, J MOL STRUCT, V556, P173, DOI 10.1016/S0022-2860(00)00630-X; Sundari CS, 1997, PROG BIOPHYS MOL BIO, V67, P183, DOI 10.1016/S0079-6107(97)00016-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; Tomme P, 1995, ACS SYM SER, V618, P142; Zverlov VV, 2001, MICROBIOL-SGM, V147, P621, DOI 10.1099/00221287-147-3-621	40	81	82	0	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					6120	6127		10.1074/jbc.M209554200	http://dx.doi.org/10.1074/jbc.M209554200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12427734	hybrid			2022-12-27	WOS:000181129400079
J	Bhagwandin, VJ; Han, LWT; Mallen-St Clair, J; Wolters, PJ; Caughey, GH				Bhagwandin, VJ; Han, LWT; Mallen-St Clair, J; Wolters, PJ; Caughey, GH			Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL TRYPTASE; TISSUE DISTRIBUTION; PROTEASE; PROSTASIN; LOCALIZATION; PURIFICATION; ACTIVATION; TRYPSIN; CLONING; GENES	In a search for genes encoding the serine peptidases prostasin and testisin, which are expressed mainly in prostate and testis, respectively, we identified a related, novel gene. Sequencing of cDNA allowed us to deduce the full amino acid sequence of the human gene product, which we term "pancreasin" because it is transcribed strongly in the pancreas. The idiosyncratic 6-exon organization of the gene is shared by a small group of tryptic proteases, including prostasin, testisin, and gamma-tryptase. Like the other genes, the pancreasin gene resides on chromosome 16p. Pancreasin cDNA predicts a 290-residue, N-glycosylated, serine peptidase with a typical signal peptide, a 12-residue activation peptide cleaved by tryptic hydrolysis, and a 256-amino acid catalytic domain. Unlike prostasin and other close relatives, human pancreasin and a nearly identical chimpanzee homologue lack a carboxyl-terminal membrane anchor, although this is present in 328-residue mouse pancreasin, the cDNA of which we also cloned and sequenced. In marked contrast to prostasin, which is 43% identical in the catalytic domain, human pancreasin is transcribed strongly in pancreas (and in the pancreatic ductal adenocarcinoma line, HPAC) but weakly or not at all in kidney and prostate. Antibodies raised against pancreasin detect cytoplasmic expression in HPAC cells. Recombinant, epitope-tagged pancreasin expressed in Chinese hamster ovary cells is glycosylated and secreted as an active tryptic peptidase. Pancreasin's preferences for hydrolysis of extended peptide substrates feature a strong preference for P1 Arg and differ from those of trypsin. Pancreasin is inhibited by benzamidine and leupeptin but resists several classic inhibitors of trypsin. Thus, pancreasin is a secreted, tryptic serine protease of the pancreas with novel physical and enzymatic properties. These studies provide a rationale for exploring the natural targets and roles of this enzyme.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Caughey, GH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	ghc@itsa.ucsf.edu	Wolters, Paul/A-7181-2009		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-24136] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRETT AJ, 1998, HDB PROTEOLYTIC ENZY, P3; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; CAUGHEY GH, 1987, ARCH BIOCHEM BIOPHYS, V258, P555, DOI 10.1016/0003-9861(87)90377-8; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Caughey GH, 1997, AM J RESP CELL MOL, V16, P621, DOI 10.1165/ajrcmb.16.6.9191463; Davies BJ, 1998, J BIOL CHEM, V273, P23004, DOI 10.1074/jbc.273.36.23004; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Inoue M, 1998, BIOCHEM BIOPH RES CO, V252, P307, DOI 10.1006/bbrc.1998.9645; Inoue M, 1999, BIOCHEM BIOPH RES CO, V266, P564, DOI 10.1006/bbrc.1999.1870; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; NORMAN J, 1994, J SURG RES, V57, P33, DOI 10.1006/jsre.1994.1105; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; RAYMOND WW, 1995, J BIOL CHEM, V270, P13164, DOI 10.1074/jbc.270.22.13164; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shaw-Smith CJ, 2000, BBA-GENE STRUCT EXPR, V1490, P131, DOI 10.1016/S0167-4781(99)00226-2; Soto D, 2002, CLIN EXP ALLERGY, V32, P1000, DOI 10.1046/j.1365-2222.2002.01416.x; TANAKA T, 1983, J BIOL CHEM, V258, P3552; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Yamada K, 2000, GENE, V252, P209, DOI 10.1016/S0378-1119(00)00225-0; Yamada K, 1999, DEV BIOL, V214, P318, DOI 10.1006/dbio.1999.9412; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; Yu JX, 1996, GENOMICS, V32, P334, DOI 10.1006/geno.1996.0127; YU JX, 1994, J BIOL CHEM, V269, P18843	34	23	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3363	3371		10.1074/jbc.M209353200	http://dx.doi.org/10.1074/jbc.M209353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441343	hybrid			2022-12-27	WOS:000180915000076
J	Hamel, PP; Dreyfuss, BW; Xie, ZY; Gabilly, ST; Merchant, S				Hamel, PP; Dreyfuss, BW; Xie, ZY; Gabilly, ST; Merchant, S			Essential histidine and tryptophan residues in CcsA, a system II polytopic cytochrome c biogenesis protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME CHAPERONE CCME; PARACOCCUS-DENITRIFICANS; MEMBRANE-PROTEIN; CHLAMYDOMONAS-REINHARDTII; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; LYASE ACTIVITY; GENE; CHLOROPLAST	Three distinct systems (I, II, and III) for catalysis of heme attachment to c-type apocytochromes are known. The CcsA and Ccs1 proteins are required in system II for the assembly of bacterial and plastid cytochromes c. A tryptophan-rich signature motif (WWD), also occurring in CcmC and CcmF found in system I, and three histidinyl residues, all strictly conserved in CcsA suggest a function in heme handling. Topological analysis of plastid CcsA in bacteria using the PhoA and LacZa reporters placed the WWD motif, the conserved residues His(212) and His(347) on the lumen side of the membrane, whereas His(309) was assigned a location on the stromal side. Functional analysis of CcsA through site-directed mutagenesis enabled the designation of the initiation codon of the ccsA gene and established the functional importance of the WIND signature motif and the absolute requirement of all three histidines for the assembly of plastid c-type cytochromes. In a ccsA mutant, a 200-kDa Ccs1-containing complex is absent from solubilized thylakoid membranes, suggesting that CcsA operates together with Ccs1. We propose a model where the WWD motif and histidine residues function in relaying heme from stroma to lumen and we postulate the existence of a cytochrome c assembly machinery containing CcsA, Ccs1 and additional components.	Univ Calif Los Angeles, Dept Biochem & Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Merchant, S (corresponding author), Univ Calif Los Angeles, Dept Biochem & Chem, Box 951569, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu			NIGMS NIH HHS [GM48350] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beckett CS, 2000, MOL MICROBIOL, V38, P465, DOI 10.1046/j.1365-2958.2000.02174.x; BECKMAN DL, 1992, GENE DEV, V6, P268, DOI 10.1101/gad.6.2.268; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Cervera AM, 1998, MOL MICROBIOL, V30, P67, DOI 10.1046/j.1365-2958.1998.01039.x; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; CRAMER WA, 1994, J BIOENERG BIOMEMBR, V26, P31, DOI 10.1007/BF00763218; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Dreyfuss BW, 2003, J BIOL CHEM, V278, P2604, DOI 10.1074/jbc.M208652200; DREYFUSS BW, 1999, CCS5 NEW LOCUS REQUI, V4, P3139; DRYGAS ME, 1989, J BIOL CHEM, V264, P17897; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Fabianek RA, 1997, J BIOL CHEM, V272, P4467, DOI 10.1074/jbc.272.7.4467; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Gaballa A, 1998, MOL MICROBIOL, V30, P547, DOI 10.1046/j.1365-2958.1998.01085.x; Goldman BS, 1997, J MOL BIOL, V268, P724, DOI 10.1006/jmbi.1997.0992; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Goldman BS, 2001, RES MICROBIOL, V152, P323, DOI 10.1016/S0923-2508(01)01203-7; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HOWE G, 1995, MOL GEN GENET, V246, P156, DOI 10.1007/BF00294678; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; Hubschmann T, 1997, FEBS LETT, V408, P201, DOI 10.1016/S0014-5793(97)00421-3; Inoue K, 1997, J BIOL CHEM, V272, P31747, DOI 10.1074/jbc.272.50.31747; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; KRANZ RG, 1989, J BACTERIOL, V171, P456, DOI 10.1128/jb.171.1.456-464.1989; KRANZ RG, 1985, GENE, V40, P203, DOI 10.1016/0378-1119(85)90043-5; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; Le Brun NE, 2000, MOL MICROBIOL, V36, P638, DOI 10.1046/j.1365-2958.2000.01883.x; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MAYER A, 1995, J BIOL CHEM, V270, P12390, DOI 10.1074/jbc.270.21.12390; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Nakamoto SS, 2000, BIOCHIMIE, V82, P603, DOI 10.1016/S0300-9084(00)00605-2; NARGANG FE, 1988, J BIOL CHEM, V263, P9388; NEWMAN SM, 1990, GENETICS, V126, P875; Page MD, 1997, MICROBIOL-SGM, V143, P563, DOI 10.1099/00221287-143-2-563; PAGE MD, 1995, MOL MICROBIOL, V15, P307, DOI 10.1111/j.1365-2958.1995.tb02245.x; Page MD, 1997, MICROBIOL-SGM, V143, P3111, DOI 10.1099/00221287-143-10-3111; Page MD, 1997, MOL MICROBIOL, V24, P977, DOI 10.1046/j.1365-2958.1997.4061775.x; Page MD, 1998, TRENDS BIOCHEM SCI, V23, P103, DOI 10.1016/S0968-0004(98)01173-6; Page MD, 1999, MICROBIOL-UK, V145, P3047, DOI 10.1099/00221287-145-11-3047; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Pisa R, 2002, MOL MICROBIOL, V43, P763, DOI 10.1046/j.1365-2958.2002.02784.x; Pollock WBR, 1998, BIOCHEMISTRY-US, V37, P6124, DOI 10.1021/bi972188d; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; RAMSEIER TM, 1991, J BIOL CHEM, V266, P7793; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Ren Q, 2001, J BIOL CHEM, V276, P32591, DOI 10.1074/jbc.M103058200; Ridder ANJA, 2000, BIOCHEMISTRY-US, V39, P6521, DOI 10.1021/bi000073v; RITZ D, 1995, MOL GEN GENET, V247, P27, DOI 10.1007/BF00425818; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; SAMBONGI Y, 1994, FEBS LETT, V353, P235, DOI 10.1016/0014-5793(94)01053-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sawant SV, 2000, BIOTECHNIQUES, V29, P246, DOI 10.2144/00292bm09; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schiott T, 1997, J BACTERIOL, V179, P4523, DOI 10.1128/jb.179.14.4523-4529.1997; Schiott T, 1997, J BACTERIOL, V179, P1962, DOI 10.1128/jb.179.6.1962-1973.1997; Schulz H, 1998, SCIENCE, V281, P1197, DOI 10.1126/science.281.5380.1197; Schulz H, 1999, P NATL ACAD SCI USA, V96, P6462, DOI 10.1073/pnas.96.11.6462; Schulz H, 2000, MOL MICROBIOL, V37, P1379, DOI 10.1046/j.1365-2958.2000.02083.x; Simon J, 2001, EUR J BIOCHEM, V268, P5776, DOI 10.1046/j.0014-2956.2001.02520.x; STEINER H, 1995, J BIOL CHEM, V270, P22842, DOI 10.1074/jbc.270.39.22842; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Sun GF, 1996, J BACTERIOL, V178, P1374, DOI 10.1128/jb.178.5.1374-1385.1996; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; THONYMEYER L, 1995, J BACTERIOL, V177, P4321; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tichy M, 1999, J BIOL CHEM, V274, P32396, DOI 10.1074/jbc.274.45.32396; Tong JC, 1998, J BIOL CHEM, V273, P25695, DOI 10.1074/jbc.273.40.25695; Xie ZY, 1998, BBA-BIOENERGETICS, V1365, P309, DOI 10.1016/S0005-2728(98)00085-1; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Xie ZY, 1998, GENETICS, V148, P681; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x	78	58	63	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2593	2603		10.1074/jbc.M208651200	http://dx.doi.org/10.1074/jbc.M208651200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427766	hybrid			2022-12-27	WOS:000180562000070
J	Hu, TH; Exton, JH				Hu, TH; Exton, JH			Mechanisms of regulation of phospholipase D1 by protein kinase Ca	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; RAT-BRAIN; PLASMA-MEMBRANE; C2 DOMAINS; ALPHA; ACTIVATION; CLONING; PHOSPHORYLATION; EXPRESSION; CELLS	It has been suggested that protein-protein interaction is important for protein kinase C (PKC) alpha to activate phospholipase D1 (PLD1). To determine the one or more sites on PKCalpha that are involved in binding to PLD1, fragments containing the regulatory domain, catalytic domain, and C1-C3 domain of PKCalpha were constructed and shown to be functional, but they all failed to bind and activate PLD1 in vivo and in vitro. A C-terminal 23-amino acid (aa) deletion mutant of PKCalpha was also found to be inactive. To define the binding/activation site(s) in the C terminus of PKCalpha, 1- to 11-aa deletion mutants were made in this terminus. Deletion of up to 9 aa did not alter the ability of PKCalpha to bind and activate PLD1, whereas a 10-aa deletion was inactive. The residue at position 10 was Phe(663). Mutations of this residue (F663D and F663A) caused loss of binding, activation, and phosphorylation of PLD1, indicating that Phe(663) is essential for these activities. Time course experiments showed that the activation of PLD1 by PMA was much faster than its phosphorylation, and its activity decreased as phosphorylation increased with time. Staurosporine, a PKC inhibitor, completely inhibited PLD1 phosphorylation in response to 4beta-phorbol 12-myristate 13-acetate PMA and blocked the later decrease in PLD activity. The same results were found with the D481E mutant of PKCalpha, which is unable to phosphorylate PLD1 These results indicate that neither the regulatory nor catalytic domains of PKCalpha alone can bind to or activate PLD1 and that a residue in the C terminus of PKCalpha(Phe(663).) is required for these effects. The initial activation of PLD1 by PMA is highly correlated with the binding of PKCalpha. Although PKCalpha can phosphorylate PLD1, this is a relatively slow process and is associated with inactivation of the enzyme.	Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA	Howard Hughes Medical Institute; Vanderbilt University; Vanderbilt University	Exton, JH (corresponding author), Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA.		Hu, T/G-3381-2010					Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; Czarny M, 1999, J BIOL CHEM, V274, P2717, DOI 10.1074/jbc.274.5.2717; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Exton JH, 1998, BBA-MOL CELL BIOL L, V1436, P105, DOI 10.1016/S0005-2760(98)00124-6; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Kim JH, 1999, BIOCHEMISTRY-US, V38, P3763, DOI 10.1021/bi982478+; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kim Y, 1999, BIOCHEMISTRY-US, V38, P10344, DOI 10.1021/bi990579h; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Lee TG, 1997, BBA-LIPID LIPID MET, V1347, P199, DOI 10.1016/S0005-2760(97)00083-0; LOPEZ I, 1995, J BIOL CHEM, V270, P19465, DOI 10.1074/jbc.270.33.19465; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Malcolm KC, 1996, J BIOL CHEM, V271, P13135, DOI 10.1074/jbc.271.22.13135; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Min D, 1998, BIOCHEM BIOPH RES CO, V248, P533, DOI 10.1006/bbrc.1998.8990; Min DS, 1998, J BIOL CHEM, V273, P7044, DOI 10.1074/jbc.273.12.7044; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Park SK, 1998, BIOCHEM BIOPH RES CO, V244, P364, DOI 10.1006/bbrc.1998.8275; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; Sciorra VA, 2001, BIOCHEMISTRY-US, V40, P2640, DOI 10.1021/bi002528m; Singer WD, 1996, J BIOL CHEM, V271, P4504; SU LH, 1993, RECEPTOR CHANNEL, V1, P1; Sung TC, 1999, J BIOL CHEM, V274, P3659, DOI 10.1074/jbc.274.6.3659; Xie Z, 2000, J BIOL CHEM, V275, P24962, DOI 10.1074/jbc.M909745199; Zhang Y, 1999, EMBO J, V18, P6339, DOI 10.1093/emboj/18.22.6339	33	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2348	2355		10.1074/jbc.M210093200	http://dx.doi.org/10.1074/jbc.M210093200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431982	hybrid			2022-12-27	WOS:000180562000038
J	Yokoyama, H; Kurumizaka, H; Ikawa, S; Yokoyama, S; Shibata, T				Yokoyama, H; Kurumizaka, H; Ikawa, S; Yokoyama, S; Shibata, T			Holliday junctilon binding activity of the human Rad51B protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RUVA; MIGRATION MOTOR PROTEIN; DNA-REPAIR PROTEINS; STRAND BREAK REPAIR; BRANCH MIGRATION; CRYSTAL-STRUCTURE; RECA PROTEIN; RECOMBINATION; COMPLEX; IDENTIFICATION	The human Rad51B protein is involved in the recombinational repair of damaged DNA. Chromosomal rearrangements of the Rad51B gene have been found in uterine leiomyoma patients, suggesting that the Rad51B gene suppresses tumorigenesis. In the present study, we found that the purified Rad51B protein bound to single-stranded DNA and double-stranded DNA in the presence of ATP and either Mg2+ or Mn2+ and hydrolyzed ATP in a DNA-dependent manner. When the synthetic Holliday junction was present along with the half-cruciform and double-stranded oligonucleotides, the Rad51B protein only bound to the synthetic Holliday junction, which mimics a key intermediate in homologous recombination. In contrast, the human Rad51 protein bound to all three DNA substrates with no obvious preference. Therefore, the Rad51B protein may have a specific function in Holliday junction processing in the homologous recombinational repair pathway in humans.	RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; RIKEN, Harima Inst, Cellular Signaling Lab, Hyogo 6795148, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; RIKEN, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, CREST, Chiba 2920812, Japan	RIKEN; RIKEN; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Shibata, T (corresponding author), RIKEN, Genom Sci Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp; tshibata@postman.riken.go.jp	Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kurumizaka, Hitoshi/0000-0001-7412-3722				Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Blank C, 2001, CYTOGENET CELL GENET, V95, P17, DOI 10.1159/000057011; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Chen YJ, 2002, J MOL BIOL, V319, P587, DOI 10.1016/S0022-2836(02)00353-4; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; Constantinou A, 2002, EMBO J, V21, P5577, DOI 10.1093/emboj/cdf554; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; CUNNINGHAM RP, 1980, CELL, V20, P223, DOI 10.1016/0092-8674(80)90250-0; Dosanjh MK, 1998, NUCLEIC ACIDS RES, V26, P1179, DOI 10.1093/nar/26.5.1179; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; French CA, 2002, J BIOL CHEM, V277, P19322, DOI 10.1074/jbc.M201402200; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Holzmann K, 1998, BIOCHEM BIOPH RES CO, V252, P39, DOI 10.1006/bbrc.1998.9604; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; IWASAKI H, 1992, GENE DEV, V6, P2214, DOI 10.1101/gad.6.11.2214; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; Kurumizaka H, 2002, J BIOL CHEM, V277, P14315, DOI 10.1074/jbc.M105719200; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Liu N, 2002, NUCLEIC ACIDS RES, V30, P1009, DOI 10.1093/nar/30.4.1009; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Miller KA, 2002, J BIOL CHEM, V277, P8406, DOI 10.1074/jbc.M108306200; Miyata T, 2000, J STRUCT BIOL, V131, P83, DOI 10.1006/jsbi.2000.4290; Noirot P, 1998, J BIOL CHEM, V273, P12274, DOI 10.1074/jbc.273.20.12274; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Schoenmakers EFPM, 1999, CANCER RES, V59, P19; SHIBA T, 1991, P NATL ACAD SCI USA, V88, P8445, DOI 10.1073/pnas.88.19.8445; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Shu ZG, 1999, MOL CELL BIOL, V19, P8686; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; STASIAK A, 1994, P NATL ACAD SCI USA, V91, P7618, DOI 10.1073/pnas.91.16.7618; Takahashi T, 2001, GENE CHROMOSOME CANC, V30, P196, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1078>3.0.CO;2-8; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Thacker J, 1999, BIOCHIMIE, V81, P77, DOI 10.1016/S0300-9084(99)80041-8; Thacker J, 1999, TRENDS GENET, V15, P166, DOI 10.1016/S0168-9525(99)01733-3; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; TSANEVA IR, 1993, P NATL ACAD SCI USA, V90, P1315, DOI 10.1073/pnas.90.4.1315; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; van Gool AJ, 1999, GENE DEV, V13, P1861, DOI 10.1101/gad.13.14.1861; Wiese C, 2002, NUCLEIC ACIDS RES, V30, P1001, DOI 10.1093/nar/30.4.1001; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yamada K, 2002, MOL CELL, V10, P671, DOI 10.1016/S1097-2765(02)00641-X; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yu X, 1997, J MOL BIOL, V266, P217, DOI 10.1006/jmbi.1996.0799	67	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2767	2772		10.1074/jbc.M210899200	http://dx.doi.org/10.1074/jbc.M210899200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441335	hybrid			2022-12-27	WOS:000180562000090
J	Zhu, GY; Liu, J; Terzyan, S; Zhai, P; Li, GP; Zhang, XC				Zhu, GY; Liu, J; Terzyan, S; Zhai, P; Li, GP; Zhang, XC			High resolution crystal structures of human Rab5a and five mutants with substitutions in the catalytically important phosphate-binding loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; GUANINE-NUCLEOTIDE EXCHANGE; H-RAS P21; TRANSITION-STATE; 3-DIMENSIONAL STRUCTURES; SIGNAL-TRANSDUCTION; ENDOSOME FUSION; MECHANISM; HYDROLYSIS; DOMAIN	GTPase domain crystal structures of Rab5a wild type and five variants with mutations in the phosphate-binding loop are reported here at resolutions up to 1.5 Angstrom. Of particular interest, the A30P mutant was crystallized in complexes with GDP, GDP+AlF3, and authentic GTP, respectively. The other variant crystals were obtained in complexes with a non-hydrolyzable GTP analog, GppNHp. All structures were solved in the same crystal form, providing an unusual opportunity to compare structures of small GTPases with different catalytic rates. The A30P mutant exhibits dramatically reduced GTPase activity and forms a GTP-bound complex stable enough for crystallographic analysis. Importantly, the A30P structure with bound GDP plus AlF3 has been solved in the absence of a GTPase-activating protein, and it may resemble that of a transition state intermediate. Conformational changes are observed between the GTP-bound form and the transition state intermediate, mainly in the switch II region containing the catalytic Gln(79) residue and independent of A30P mutation-induced local alterations in the P-loop. The structures suggest an important catalytic role for a P-loop backbone amide group, which is eliminated in the A30P mutant, and support the notion that the transition state of GTPase-mediated GTP hydrolysis is of considerable dissociative character.	Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhang, XC (corresponding author), Oklahoma Med Res Fdn, Crystallog Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.		Liu, Jay/D-4711-2011; Li, Guangpu/GRS-5397-2022; Zhu, Guangyu/F-6279-2011	Zhu, Guangyu/0000-0003-4228-135X				ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Armstrong J, 2000, INT J BIOCHEM CELL B, V32, P303, DOI 10.1016/S1357-2725(99)00112-0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURTON JL, 1994, EMBO J, V13, P5547, DOI 10.1002/j.1460-2075.1994.tb06892.x; Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791; CHUNG HH, 1993, SCIENCE, V259, P806, DOI 10.1126/science.8430333; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Deacon SW, 2001, J CELL BIOL, V152, pF21, DOI 10.1083/jcb.152.4.F21; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492; Esters H, 2000, J MOL BIOL, V298, P111, DOI 10.1006/jmbi.2000.3645; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048, DOI 10.1074/jbc.270.10.5048; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LI GP, 1994, J BIOL CHEM, V269, P14631; LI GP, 1993, J BIOL CHEM, V268, P24475; Li GP, 2001, BIOCHEM J, V355, P681, DOI 10.1042/bj3550681; Liang ZM, 2000, BIOCHEM J, V346, P501, DOI 10.1042/0264-6021:3460501; Liu K, 1998, J BIOL CHEM, V273, P10087, DOI 10.1074/jbc.273.17.10087; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; MILLER AF, 1992, BIOCHEMISTRY-US, V31, P10208, DOI 10.1021/bi00157a007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; PRIVE GG, 1992, P NATL ACAD SCI USA, V89, P3649, DOI 10.1073/pnas.89.8.3649; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rodman JS, 2000, J CELL SCI, V113, P183; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1997, PROTEINS, V27, P315, DOI 10.1002/(SICI)1097-0134(199702)27:2<315::AID-PROT17>3.0.CO;2-P; Schlichting I, 1999, NAT STRUCT BIOL, V6, P721, DOI 10.1038/11485; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Shih T Y, 1986, Gene Amplif Anal, V4, P53; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	65	52	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2452	2460		10.1074/jbc.M211042200	http://dx.doi.org/10.1074/jbc.M211042200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433916	hybrid			2022-12-27	WOS:000180562000053
J	Zvonic, S; Cornelius, P; Stewart, WC; Mynatt, RL; Stephens, JM				Zvonic, S; Cornelius, P; Stewart, WC; Mynatt, RL; Stephens, JM			The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; 3T3-L1 PREADIPOCYTE DIFFERENTIATION; LOW-AFFINITY RECEPTORS; CNTF RECEPTOR; RNA ACCUMULATION; NEUROPEPTIDE-Y; ONCOSTATIN-M; BINDING; EXPRESSION; MICE	Ciliary neurotrophic factor (CNTF) is primarily known for its roles as a lesion factor released by the ruptured glial cells that prevent neuronal degeneration. However, CNTF has also been shown to cause weight loss in a variety of rodent models of obesity/ type II diabetes, whereas a modified form also causes weight loss in humans. CNTF administration can correct or improve hyperinsulinemia, hyperphagia, and hyperlipidemia associated with these models of obesity. In order to investigate the effects of CNTF on fat cells, we examined the expression of CNTF receptor complex proteins (LIFR, gp130, and CNTFRalpha) during adipocyte differentiation and the effects of CNTF on STAT, Akt, and MAPK activation. We also examined the ability of CNTF to regulate the expression of adipocyte transcription factors and other adipogenic proteins. Our studies clearly demonstrate that the expression of two of the three CNTF receptor complex components, CNTFRalpha and LIFR, decreases during adipocyte differentiation. In contrast, gp130 expression is relatively unaffected by differentiation. In addition, preadipocytes are more sensitive to CNTF treatment than adipocytes, as judged by both STAT 3 and Akt activation. Despite decreased levels of CNTFRalpha expression in fully differentiated 3T3-L1 adipocytes, CNTF treatment of these cells resulted in a time-dependent activation of STAT 3. Chronic treatment of adipocytes resulted in a substantial decrease in fatty-acid synthase and a notable decline in SREBP-1 levels but had no effect on the expression of peroxisome proliferator-activated receptor gamma, acrp30, adipocyte-expressed STAT proteins, or C/EBPalpha. However, CNTF resulted in a significant increase in IRS-1 expression. CNTFRalpha receptor expression was substantially induced in the fat pads of four rodent models of obesity/type 11 diabetes as compared with lean littermates. Moreover, we demonstrated that CNTF can activate STAT 3 in adipose tissue and skeletal muscle in vivo. In summary, CNTF affects adipocyte gene expression, and the specific receptor for this cytokine is induced in rodent models of obesity/type II diabetes.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; Pfizer Inc, Dept Cardiovasc & Metab Dis, Groton, CT 06340 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Middle Tennessee State University; Pfizer	Stephens, JM (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	jsteph1@lsu.edu	Mynatt, Randall L/N-1980-2017; Stephens, Jacqueline M/R-5217-2018	Mynatt, Randall L/0000-0003-4399-0019; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK52968-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; Aubert J, 1999, J BIOL CHEM, V274, P24965, DOI 10.1074/jbc.274.35.24965; Balhoff JP, 1998, BIOCHEM BIOPH RES CO, V247, P894, DOI 10.1006/bbrc.1998.8890; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; DESERIO A, 1995, J MOL BIOL, V254, P795, DOI 10.1006/jmbi.1995.0655; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; Henderson JT, 1996, CYTOKINE, V8, P784, DOI 10.1006/cyto.1996.0104; HUBER J, 1993, EUR J BIOCHEM, V218, P1031, DOI 10.1111/j.1432-1033.1993.tb18462.x; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; Lotz B, 1996, NEUROLOGY, V46, P1244; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; Monville C, 2001, MOL CELL NEUROSCI, V17, P373, DOI 10.1006/mcne.2000.0926; Pan WH, 1999, NEUROSCI LETT, V263, P69, DOI 10.1016/S0304-3940(99)00083-X; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Pu S, 2000, J NEUROENDOCRINOL, V12, P827, DOI 10.1046/j.1365-2826.2000.00526.x; SENDTNER M, 1991, J CELL SCI, P103; STAHL N, 1994, J NEUROBIOL, V25, P1454, DOI 10.1002/neu.480251111; STEPHENS JM, 1993, MOL CELL BIOCHEM, V123, P63, DOI 10.1007/BF01076476; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; STEPHENS JM, 1992, J MOL ENDOCRINOL, V9, P61, DOI 10.1677/jme.0.0090061; Tanaka T, 1999, DIABETOLOGIA, V42, P702, DOI 10.1007/s001250051218; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Xu B, 1998, ENDOCRINOLOGY, V139, P466, DOI 10.1210/en.139.2.466	37	59	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2228	2235		10.1074/jbc.M205871200	http://dx.doi.org/10.1074/jbc.M205871200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12424252	Green Published, hybrid			2022-12-27	WOS:000180562000022
J	Baqui, M; Botero, D; Gereben, B; Curcio, C; Harney, JW; Salvatore, D; Sorimachi, K; Larsen, PR; Bianco, AC				Baqui, M; Botero, D; Gereben, B; Curcio, C; Harney, JW; Salvatore, D; Sorimachi, K; Larsen, PR; Bianco, AC			Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONKEY HEPATOCARCINOMA CELLS; CENTRAL-NERVOUS-SYSTEM; THYROID-HORMONES; CHOLESTEROL; DEIODINASE; LOCALIZATION; EXPRESSION; METAMORPHOSIS; METABOLISM; RECEPTOR	The type 3 iodothyronine selenodeiodinase (D3) is an integral membrane protein that inactivates thyroid hormones. By using immunofluorescence cytochemistry confocal microscopy of live or fixed cells transiently expressing FLAG-tagged human D3 or monkey hepatocarcinoma cells expressing endogenous D3, we identified D3 in the plasma membrane. It co-localizes with Na,K-ATPase alpha, with the early endosomal marker EEA-1 and clathrin, but not with two endoplasmic reticulum resident proteins. Most of the D3 molecule is extracellular and can be biotinylated with a cell-impermeant probe. There is constant internalization of D3 that is blocked by sucrose or methyl-beta-cyclodextrin-containing medium. Exposing cells to a weak base such as primaquine increases the pool of internalized D3, suggesting that D3 is recycled between plasma membrane and early endosomes. Such recycling could account for the much longer half-life of D3 (12 h) than the thyroxine activating members of the selenodeiodinase family, type I (D1; 8 h) or type 2 (D2; 2 h) deiodinase. The extracellular location of D3 gives ready access to circulating thyroid hormones, explaining its capacity for rapid inactivation of circulating thyroxine and triiodothyronine in patients with hemangiomas and its blockade of the access of maternal thyroid hormones to the human fetus.	Brigham & Womens Hosp, Dept Med, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bianco, AC (corresponding author), 77 Ave Louis Pasteur,HIM Bldg,Rm 560, Boston, MA 02115 USA.	abianco@partners.org	Salvatore, Domenico/D-4881-2013; Baqui, Munira M. A/H-5243-2013; Bianco, Antonio C/A-4965-2008; Bianco, Antonio/AAK-6336-2020	Baqui, Munira M. A/0000-0002-7945-2899; Bianco, Antonio C/0000-0001-7737-6813; Bianco, Antonio/0000-0001-7737-6813; Sorimachi, Kenji/0000-0002-5259-9671; SALVATORE, DOMENICO/0000-0002-4556-7620	NIDDK NIH HHS [DK 44128, DK 36256] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044128, R01DK036256] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baqui MMA, 1996, EUR J CELL BIOL, V70, P243; Baqui MMA, 2000, ENDOCRINOLOGY, V141, P4309, DOI 10.1210/en.141.11.4309; Berry DL, 1998, DEV BIOL, V203, P24, DOI 10.1006/dbio.1998.8975; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BURKE B, 1984, EMBO J, V3, P551, DOI 10.1002/j.1460-2075.1984.tb01845.x; CamposBarros A, 1996, J CLIN ENDOCR METAB, V81, P2179, DOI 10.1210/jc.81.6.2179; Canfield VA, 1996, BIOCHEMISTRY-US, V35, P14165, DOI 10.1021/bi961851f; Ding W, 2001, J VIROL, V75, P7672, DOI 10.1128/JVI.75.16.7672-7682.2001; GALTON VA, 1988, ENDOCRINOLOGY, V122, P640; Gereben B, 2000, MOL ENDOCRINOL, V14, P1697, DOI 10.1210/me.14.11.1697; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; HUANG H, 2003, IN PRESS J CLIN ENDO; Huang HC, 1999, P NATL ACAD SCI USA, V96, P962, DOI 10.1073/pnas.96.3.962; Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305; Huang SA, 2002, J CLIN ENDOCR METAB, V87, P4457, DOI 10.1210/jc.2002-020627; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Peeters R, 2001, AM J PHYSIOL-ENDOC M, V281, pE54, DOI 10.1152/ajpendo.2001.281.1.E54; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; SCHWARTZ AL, 1984, J CELL BIOL, V98, P732, DOI 10.1083/jcb.98.2.732; SHEN WC, 1985, J BIOL CHEM, V260, P905; SORIMACHI K, 1978, BIOCHIM BIOPHYS ACTA, V542, P515, DOI 10.1016/0304-4165(78)90381-1; SORIMACHI K, 1977, J BIOL CHEM, V252, P4458; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; TOYODA N, 1995, J BIOL CHEM, V270, P12310, DOI 10.1074/jbc.270.20.12310; Tu HM, 1999, ENDOCRINOLOGY, V140, P784, DOI 10.1210/en.140.2.784; Turvy DN, 1998, J IMMUNOL METHODS, V212, P9, DOI 10.1016/S0022-1759(97)00206-8	31	95	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1206	1211		10.1074/jbc.M210266200	http://dx.doi.org/10.1074/jbc.M210266200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12419801	hybrid			2022-12-27	WOS:000180321900067
J	Sachpatzidis, A; Benton, BK; Manfredi, JP; Wang, H; Hamilton, A; Dohlman, HG; Lolis, E				Sachpatzidis, A; Benton, BK; Manfredi, JP; Wang, H; Hamilton, A; Dohlman, HG; Lolis, E			Identification of allosteric peptide agonists of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; PHEROMONE RESPONSE PATHWAY; PROTEIN-COUPLED RECEPTORS; CORECEPTOR CXCR4; CHARGED RESIDUES; LIGAND-BINDING; ALPHA-SUBUNIT; C5A RECEPTOR; HIV-1 ENTRY; FACTOR-I	The chemokine receptor CXCR4 is a co-receptor for T-tropic strains of HIV-1. A number of small molecule antagonists of CXCR4 are in development but all are likely to lead to adverse effects due to the physiological function of CXCR4. To prevent these complications, allosteric agonists may be therapeutically useful as adjuvant therapy in combination with small molecule antagonists. A synthetic cDNA library coding for 160,000 different SDF-based peptides was screened for CXCR4 agonist activity in a yeast strain expressing a functional receptor. Peptides that activated CXCR4 in an autocrine manner induced colony formation. Two peptides, designated RSVM and ASLW, were identified as novel agonists that are insensitive to the CXCR4 antagonist AMD3100. In chemotaxis assays using the acute lymphoblastic leukemia cell line CCRF-CEM, RSVM behaves as a partial agonist and ASLW as a superagonist. The superagonist activity of ASLW may be related to its inability to induce receptor internalization. In CCRF-CEM cells, the two peptides are also not inhibited by another CXCR4 antagonist, T140, or the neutralizing monoclonal antibodies 12G5 and 44717.111. These results suggest that alternative agonist-binding sites are present on CXCR4 that could be screened to develop molecules for therapeutic use.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Cadus Phrmaceut Corp, Tarrytown, NY 10591 USA	Yale University; Yale University	Lolis, E (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.			Dohlman, Henrik/0000-0003-2443-0729; Sachpatzidis, Aristidis/0000-0002-5237-0842; Lolis, Elias/0000-0002-7902-7868	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035208] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35208] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arakaki R, 1999, J VIROL, V73, P1719, DOI 10.1128/JVI.73.2.1719-1723.1999; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Baranski TJ, 1999, J BIOL CHEM, V274, P15757, DOI 10.1074/jbc.274.22.15757; Biard-Piechaczyk M, 2000, VIROLOGY, V268, P329, DOI 10.1006/viro.1999.0151; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Doranz BJ, 2001, AIDS RES HUM RETROV, V17, P475, DOI 10.1089/08892220151126508; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Ehrhard KN, 2000, NAT BIOTECHNOL, V18, P1075, DOI 10.1038/80274; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Erlenbach I, 2001, J BIOL CHEM, V276, P29382, DOI 10.1074/jbc.M103203200; Erlenbach I, 2001, J NEUROCHEM, V77, P1327, DOI 10.1046/j.1471-4159.2001.00344.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Geva A, 2000, J BIOL CHEM, V275, P35393, DOI 10.1074/jbc.M005602200; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hatse S, 2001, MOL PHARMACOL, V60, P164, DOI 10.1124/mol.60.1.164; Hesselgesser J, 1998, J IMMUNOL, V160, P877; Heveker N, 1998, CURR BIOL, V8, P369, DOI 10.1016/S0960-9822(98)70155-1; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Luo ZW, 1999, BIOCHEM BIOPH RES CO, V263, P691, DOI 10.1006/bbrc.1999.1441; Manfredi JP, 1996, MOL CELL BIOL, V16, P4700; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Price LA, 1996, MOL PHARMACOL, V50, P829; PRICE LA, 1995, MOL CELL BIOL, V15, P6188; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Tremblay CL, 2000, J ACQ IMMUN DEF SYND, V25, P99, DOI 10.1097/00126334-200010010-00001; Ueda H, 1997, J BIOL CHEM, V272, P24966, DOI 10.1074/jbc.272.40.24966; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	57	102	107	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					896	907		10.1074/jbc.M204667200	http://dx.doi.org/10.1074/jbc.M204667200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417595	hybrid			2022-12-27	WOS:000180321900028
J	Zhang, Y; Iwasaki, H; Wang, H; Kudo, T; Kalka, TB; Hennet, T; Kubota, T; Cheng, LM; Inaba, N; Gotoh, M; Togayachi, A; Guo, JM; Hisatomi, H; Nakajima, K; Nishihara, S; Nakamura, M; Marth, JD; Narimatsu, H				Zhang, Y; Iwasaki, H; Wang, H; Kudo, T; Kalka, TB; Hennet, T; Kubota, T; Cheng, LM; Inaba, N; Gotoh, M; Togayachi, A; Guo, JM; Hisatomi, H; Nakajima, K; Nishihara, S; Nakamura, M; Marth, JD; Narimatsu, H			Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine : polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-COLON-CANCER; MOLECULAR-CLONING; CDNA CLONING; O-GLYCOSYLATION; ANTIBODY MLS-128; TANDEM REPEAT; TN ANTIGEN; 3 MEMBERS; IN-VIVO; MUCIN	To date, 10 members of the UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase (pp-GaINAc-T) family have been cloned and analyzed in human. In this study, we cloned and analyzed a novel human pp-GaINAc-T from an NT2 cell cDNA library, and we named it pp-GaINAc-T13. In amino acid sequences, pp-GaINAc-T13 was highly homologous, showing 84.3% identity, to pp-GaINAc-T1. Real time PCR analysis revealed pp-GalNAc-T13 to be highly and restrictively expressed in the brain and present at very low or undetectable levels in other tissues, in contrast to the ubiquitous expression of pp-GalNAc-T1. pp-GakNAc-T13 was abundantly expressed in all neuroblastoma cells examined and primary cultured neurons but not in glioblastoma cells and primary cultured astrocytes. pp-GalNAc-T13 exhibited much stronger activity to transfer GalNAc to mucin peptides, such as Muc5Ac and MUC7, than did pp-GaINAc-T1. In addition, pp-GaINAc-T13 differed in substrate specificity to pp-GaINAc-T1. pp-Gal-NAc-T13 was able to form a triplet Tn epitope, three consecutive GalNAc-Ser/Thr structures, on peptides en- coded in syndecan-3, a proteoglycan expressed in neurons. pp-GalNAc-T13-deficient mice have been established in a previous work. Immunohistochemical study showed a remarkable decrease in Tn antigen expression in the cerebellum of the pp-GalNAc-T13knockout mouse. pp-GalNAc-T13 would be a major enzyme responsible for the synthesis of O-glycan and specifically the Tn antigen epitope in neurons.	Natl Inst Adv Ind Sci & Technol, Glycogene Funct Team, Res Ctr Glycosci, Open Space Lab, Tsukuba, Ibaraki 3058568, Japan; Natl Inst Adv Ind Sci & Technol, Cell Regulat Anal Team, Res Ctr Glycosci, Tsukuba, Ibaraki 3058568, Japan; Amersham Biosci KK, Shiku, Tokyo 1690073, Japan; JGS Japan Genome Solut Inc, Hachioji, Tokyo 1920031, Japan; SRL Inc, Ctr Mol Biol & Cytogenet, Hino, Tokyo 1910002, Japan; Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, San Diego, CA 92103 USA; Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Soka Univ, Inst Life Sci, Hachioji, Tokyo 1928577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); SRL Inc.; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of Zurich; Soka University	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Glycogene Funct Team, Res Ctr Glycosci, Open Space Lab, Cent-2,1-1-1 Umezomo, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp	Narimatsu, Hisashi/M-4757-2018; Togayachi, Akira/M-4144-2018; Kubota, Tomomi/J-1492-2018; Yang, Fang/AAF-3024-2019	Narimatsu, Hisashi/0000-0002-8402-133X; Togayachi, Akira/0000-0003-3600-9149; Kubota, Tomomi/0000-0002-0723-135X; Nishihara, Shoko/0000-0002-1668-2603				Akita K, 2001, CELL STRUCT FUNCT, V26, P271, DOI 10.1247/csf.26.271; Akita K, 2001, J NEUROSCI RES, V65, P595, DOI 10.1002/jnr.1190; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Berndt C, 2001, J CELL BIOCHEM, V82, P246, DOI 10.1002/jcb.1119; BOBEK LA, 1993, J BIOL CHEM, V268, P20563; Brockhausen I, 1998, GLYCOCONJUGATE J, V15, P595, DOI 10.1023/A:1006967910803; Carey DJ, 1997, J BIOL CHEM, V272, P2873, DOI 10.1074/jbc.272.5.2873; DAVID L, 1992, APMIS, V100, P162; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GUM JR, 1989, J BIOL CHEM, V264, P6480; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1995, GLYCOCONJUGATE J, V12, P901, DOI 10.1007/BF00731252; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; HIROHASHI S, 1985, P NATL ACAD SCI USA, V82, P7039, DOI 10.1073/pnas.82.20.7039; HOMA FL, 1993, J BIOL CHEM, V268, P12609; ITZKOWITZ SH, 1989, CANCER RES, V49, P197; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Kato K, 2001, GLYCOBIOLOGY, V11, P821, DOI 10.1093/glycob/11.10.821; Kato K, 2001, BIOCHEM BIOPH RES CO, V287, P110, DOI 10.1006/bbrc.2001.5562; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; KUBOTA T, 1992, J BIOCHEM-TOKYO, V111, P91, DOI 10.1093/oxfordjournals.jbchem.a123725; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; MANDEL U, 1991, J INVEST DERMATOL, V97, P713, DOI 10.1111/1523-1747.ep12484064; Marth JD, 1996, GLYCOBIOLOGY, V6, P701, DOI 10.1093/glycob/6.7.701; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; NAGATA K, 1993, J NEUROSCI RES, V34, P357, DOI 10.1002/jnr.490340313; NAKADA H, 1991, J BIOL CHEM, V266, P12402; NAKADA H, 1993, P NATL ACAD SCI USA, V90, P2495, DOI 10.1073/pnas.90.6.2495; Nakanishi T, 1997, OBSTET GYNECOL, V90, P285, DOI 10.1016/S0029-7844(97)00237-8; Nehrke K, 1998, GLYCOBIOLOGY, V8, P367, DOI 10.1093/glycob/8.4.367; OHASHI H, 1994, P NATL ACAD SCI USA, V91, P158, DOI 10.1073/pnas.91.1.158; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; Tetaert D, 2001, CARBOHYD RES, V333, P165, DOI 10.1016/S0008-6215(01)00135-5; Tetaert D, 2001, BIOCHEM J, V357, P313, DOI 10.1042/0264-6021:3570313; Toba S, 2000, BBA-GENE STRUCT EXPR, V1493, P264, DOI 10.1016/S0167-4781(00)00180-9; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; Zara J, 1996, BIOCHEM BIOPH RES CO, V228, P38, DOI 10.1006/bbrc.1996.1613	54	106	117	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					573	584		10.1074/jbc.M203094200	http://dx.doi.org/10.1074/jbc.M203094200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407114	hybrid			2022-12-27	WOS:000180255700075
J	Shi, JQ; Feng, YM; Goulet, AC; Vaillancourt, RR; Sachs, NA; Hershey, JW; Nelson, MA				Shi, JQ; Feng, YM; Goulet, AC; Vaillancourt, RR; Sachs, NA; Hershey, JW; Nelson, MA			The p34(cdc2)-related cyclin-dependent kinase 11 interacts with the p47 subunit of eukaryotic initiation factor 3 during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-LINES; FACTOR 4G; TRANSLATION; PHOSPHORYLATION; NUCLEAR; EXPRESSION; CLEAVAGE; ISOFORMS; BINDING	Cyclin-dependent kinase 11 (CDK11; also named PITSLRE) is part of the large family of p34(cdc2)-related kinases whose functions appear to be linked with cell cycle progression, tumorigenesis, and apoptotic signaling. However, substrates of CDK11 during apoptosis have not been identified. We used a yeast two-hybrid screening strategy and identified eukaryotic initiation factor 3 p47 protein (eIF3 p47) as an interacting partner of caspase-processed C-terminal kinase domain of CDK11 (CDK11(p46)). We demonstrate that the eIF3 p47 can interact with CDK11 in vitro and in vivo, and the interaction can be strengthened by stimulation of apoptosis. EIF3 p47 contains a Mov34/JAB domain and appears to interact with CDK11(p46), through this motif. We show in vitro that the caspase-processed CDK11(p46) can phosphorylate eIF3 p47 at a specific serine residue (Ser(46)) and that eIF3 p47 is phosphorylated in vivo during apoptosis. Purified recombinant CDK11(p46) inhibited translation of a reporter gene in vitro in a dose-dependent manner. In contrast, a kinase-defective mutant CDK11(p46M) did not inhibit translation of the reporter gene. Stable expression of CDK11(p46) in vivo inhibited the synthesis of a transfected luciferase reporter protein and overall cellular protein synthesis. These data provide insight into the cellular function of CDK1 I during apoptosis.	Univ Arizona, Arizona Canc Ctr, Dept Pathol, Tucson, AZ 85724 USA; Univ Arizona, Arizona Canc Ctr, Dept Pharmacol Toxicol, Tucson, AZ 85724 USA; Univ Calif Davis, Sch Med, Dept Biol Chem, Davis, CA 95616 USA	Arizona Center Cancer Care; University of Arizona; Arizona Center Cancer Care; University of Arizona; University of California System; University of California Davis	Nelson, MA (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Pathol, 1515 N Campbell Ave, Tucson, AZ 85724 USA.			Shi, Jiaqi/0000-0003-4893-1587	NATIONAL CANCER INSTITUTE [R29CA070145, R01CA070145, P30CA023074] Funding Source: NIH RePORTER; NCI NIH HHS [CA 23074, CA70145] Funding Source: Medline; NIEHS NIH HHS [ES066694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AFFOLTER M, 1994, ANAL BIOCHEM, V223, P74, DOI 10.1006/abio.1994.1549; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Ariza ME, 1999, J BIOL CHEM, V274, P28505, DOI 10.1074/jbc.274.40.28505; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Beretta L, 1998, J IMMUNOL, V160, P3269; Beyaert R, 1997, J BIOL CHEM, V272, P11694, DOI 10.1074/jbc.272.18.11694; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Clemens MJ, 1998, ONCOGENE, V17, P2921, DOI 10.1038/sj.onc.1202227; DICKINSON LA, 2002, J BIOL CHEM, V29, P29; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; Hershey J, 1996, BIOCHIMIE, V78, P903, DOI 10.1016/S0300-9084(97)86711-9; LAHTI JM, 1995, MOL CELL BIOL, V15, P1; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; LI HM, 1995, GENE, V153, P237, DOI 10.1016/0378-1119(94)00801-X; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Loyer P, 1998, J CELL SCI, V111, P1495; MALEK SN, 1994, J BIOL CHEM, V269, P33009; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; MEYER LJ, 1982, BIOCHEMISTRY-US, V21, P4206, DOI 10.1021/bi00261a003; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Miura Y, 2002, BLOOD, V100, P2650, DOI 10.1182/blood-2002-01-0176; Morley SJ, 1998, FEBS LETT, V438, P41, DOI 10.1016/S0014-5793(98)01269-1; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; Rosorius O, 1999, J CELL SCI, V112, P2369; Sauer K, 1996, MOL BIOL CELL, V7, P1759, DOI 10.1091/mbc.7.11.1759; Scott CE, 1999, J CELL PHYSIOL, V181, P147, DOI 10.1002/(SICI)1097-4652(199910)181:1<147::AID-JCP15>3.0.CO;2-M; Sheikh MS, 1999, ONCOGENE, V18, P6121, DOI 10.1038/sj.onc.1203131; SRIVASTAVA SP, 1995, J BIOL CHEM, V270, P16619, DOI 10.1074/jbc.270.28.16619; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Tang DM, 1998, J BIOL CHEM, V273, P16601, DOI 10.1074/jbc.273.26.16601; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Wallach D, 1997, TRENDS BIOCHEM SCI, V22, P107, DOI 10.1016/S0968-0004(97)01015-3; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wu XY, 1996, J BIOL CHEM, V271, P3265, DOI 10.1074/jbc.271.6.3265; XIANG JL, 1994, J BIOL CHEM, V269, P15786; Zhang SW, 2002, J BIOL CHEM, V277, P35314, DOI 10.1074/jbc.M202179200; Zhang XL, 1998, ANAL CHEM, V70, P2050, DOI 10.1021/ac971207m	40	79	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5062	5071		10.1074/jbc.M206427200	http://dx.doi.org/10.1074/jbc.M206427200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12446680	hybrid			2022-12-27	WOS:000180968900092
J	Kontrogianni-Konstantopoulos, A; Bloch, RJ				Kontrogianni-Konstantopoulos, A; Bloch, RJ			The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY SPLICED FORMS; SARCOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; STRUCTURAL BASIS; Z-DISC; Z-LINE; T-CAP; MUSCLE; SKELETAL; ISOFORM	Little is known about the mechanisms that organize the internal membrane systems in eukaryotic cells. We are addressing this question in striated muscle, which contains two novel systems of internal membranes, the transverse tubules and the sarcoplasmic reticulum (SR). Small ankyrin-1 (sAnk1) is an similar to17-kDa transmembrane protein of the SR that concentrates around the Z-disks and M-lines of each sarcomere. We used the yeast two-hybrid assay to determine whether sAnk1 interacts with titin, a giant myofibrillar protein that organizes the sarcomere. We found that the hydrophilic cytoplasmic domain of sAnk1 interacted with the two most N-terminal Ig domains of titin, ZIg1 and ZIg2, which are present at the Z-line in situ. Both ZIg1 and ZIg2 were required for binding activity. sAnk1 did not interact with other sequences of titin that span the Z-disk or with Ig domains of titin near the M-line. Titin ZIg1/2 also bound T-cap/telethonin, a 19-kDa protein of the Z-line. We show that titin ZIg1/2 could form a three-way complex with sAnk1 and T-cap. Our results indicate that titin ZIg1/2 can bind sAnk1 in muscle homogenates and suggest a role for these proteins in organizing the SR around the contractile apparatus at the Z-line.	Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kontrogianni-Konstantopoulos, A (corresponding author), Univ Maryland, Sch Med, Dept Physiol, 685 W Baltimore St, Baltimore, MD 21201 USA.	akons001@umaryland.edu			NHLBI NIH HHS [R01 HL64304] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064304] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; BENNETT V, 1992, J BIOL CHEM, V267, P8703; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; De Matteis MA, 1998, CURR OPIN CELL BIOL, V10, P542, DOI 10.1016/S0955-0674(98)80071-9; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; FLUCHER BE, 1992, DEV BIOL, V154, P245, DOI 10.1016/0012-1606(92)90065-O; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Franzini-Armstrong C, 1999, FASEB J, V13, pS266, DOI 10.1096/fasebj.13.9002.S266; Franzini-Armstrong C, 1994, MYOLOGY, V1, P176; FRANZINIARMSTRONG C, 1981, J CELL BIOL, V91, pS166, DOI 10.1083/jcb.91.3.166s; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Gallagher PG, 1997, J BIOL CHEM, V272, P19220, DOI 10.1074/jbc.272.31.19220; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; Granzier H, 1997, BIOPHYS J, V73, P2043, DOI 10.1016/S0006-3495(97)78234-1; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; HOUMEIDA A, 1995, J CELL BIOL, V131, P1471, DOI 10.1083/jcb.131.6.1471; Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; KONTROGIANNIKON.A, 2003, IN PRESS MOL BIOL CE; KORDELI E, 1991, J CELL BIOL, V114, P1243, DOI 10.1083/jcb.114.6.1243; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kunimoto M, 1995, J CELL BIOL, V131, P1821, DOI 10.1083/jcb.131.6.1821; LABEIT S, 1992, EMBO J, V11, P1711, DOI 10.1002/j.1460-2075.1992.tb05222.x; Labeit S, 1997, CIRC RES, V80, P290, DOI 10.1161/01.RES.80.2.290; Linke WA, 1997, BIOPHYS J, V73, P905, DOI 10.1016/S0006-3495(97)78123-2; Linke WA, 1998, J CELL SCI, V111, P1567; Linke WA, 1998, P NATL ACAD SCI USA, V95, P8052, DOI 10.1073/pnas.95.14.8052; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mohler PJ, 2002, J CELL SCI, V115, P1565; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; MUHLEGOLL C, 1998, STRUCTURE, V6, P1291; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Ohtsuka H, 1997, FEBS LETT, V401, P65, DOI 10.1016/S0014-5793(96)01432-9; OKANAGI T, 1993, J CELL BIOL, V123, P619; OTTO E, 1991, J CELL BIOL, V114, P241, DOI 10.1083/jcb.114.2.241; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Rubtsov AM, 2000, FEBS LETT, V482, P1, DOI 10.1016/S0014-5793(00)01924-4; Sanger JW, 2001, J CELL BIOL, V154, P21, DOI 10.1083/jcb.200106072; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Trinick J, 1999, TRENDS CELL BIOL, V9, P377, DOI 10.1016/S0962-8924(99)01641-4; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Wang K, 1996, ADV BIOPHYS, V33, P123; Williams MW, 2001, J CELL SCI, V114, P751; Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	58	55	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3985	3991		10.1074/jbc.M209012200	http://dx.doi.org/10.1074/jbc.M209012200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12444090	hybrid			2022-12-27	WOS:000180869700060
J	Di Palma, T; Nitsch, R; Mascia, A; Nitsch, L; Di Lauro, R; Zannini, M				Di Palma, T; Nitsch, R; Mascia, A; Nitsch, L; Di Lauro, R; Zannini, M			The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; B GENE PROMOTER; PROTEIN-C GENE; SP-A GENE; THYROID TRANSCRIPTION; FACTOR-I; CONGENITAL HYPOTHYROIDISM; LUNG; DIFFERENTIATION; HYPOPLASIA	Pax genes encode for transcription factors essential for tissue development in many species. Pax8, the only member of the family expressed in the thyroid tissue, is involved in the morphogenesis of the gland and in the transcriptional regulation of thyroid-specific genes. TTF-1, a homeodomain-containing factor, is also expressed in the thyroid tissue and has been demonstrated to play a role in thyroid-specific gene expression. Despite the presence of Pax8 and TTF-1 also in a few other tissues, the simultaneous expression of the two transcription factors occurs only in the thyroid, supporting the idea that Pax8 and TTF-1 might cooperate to influence thyroid-specific gene expression. In this report, we describe a physical and functional interaction between these two factors. The fusion protein GST-Pax8 is able to bind TTF-1 present in thyroid or in non-thyroid cell extracts, and by using bacterial purified TTF-1 we demonstrate that the interaction is direct. By co-immunoprecipitation, we also show that the interaction between the two proteins occurs in vivo in thyroid cells. Moreover, Pax8 and TTF-1 when co-expressed in HeLa cells synergistically activate Tg gene transcription. The synergism requires the N-terminal activation domain of TTF-1, and deletions of Pax8 indicate that the C-terminal domain of the protein is involved. Our results demonstrate a functional cooperation and a physical interaction between transcription factors of the homeodomain-containing and of the paired domain-containing gene families in the regulation of tissue-specific gene expression.	Univ Naples Federico II, IEOS, CNR, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy; Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, I-80121 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli	Zannini, M (corresponding author), Univ Naples Federico II, IEOS, CNR, Dipartimento Biol & Patol Cellulare & Mol, Via Pansini 5, I-80131 Naples, Italy.	stella@alpha.szn.it	Di+Palma, Tina/AAN-6853-2021; Di Lauro, Roberto/A-2746-2012; Nitsch, Roberto/AAT-3666-2020; Zannini, Mariastella/I-1735-2012	Di Lauro, Roberto/0000-0001-9493-3036; Nitsch, Roberto/0000-0001-8766-6267; 				Ambesi-Impiombato F S, 1979, Int Rev Cytol Suppl, P163; Aurisicchio L, 1998, J BIOL CHEM, V273, P1477, DOI 10.1074/jbc.273.3.1477; BERLINGIERI MT, 1988, MOL CELL BIOL, V8, P2261, DOI 10.1128/MCB.8.5.2261; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BRUNO MD, 1995, J BIOL CHEM, V270, P6531, DOI 10.1074/jbc.270.12.6531; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; Congdon T, 2001, J CLIN ENDOCR METAB, V86, P3962, DOI 10.1210/jc.86.8.3962; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; DAMANTE G, 1994, BIOCHIM BIOPHYS ACTA, V1218, P256; De Vita G, 1998, CELL GROWTH DIFFER, V9, P97; DEFELICE M, 1995, J BIOL CHEM, V270, P26649, DOI 10.1074/jbc.270.44.26649; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Dorfler P, 1996, EMBO J, V15, P1971, DOI 10.1002/j.1460-2075.1996.tb00548.x; Espinoza CR, 2001, J MOL ENDOCRINOL, V27, P59, DOI 10.1677/jme.0.0270059; Fabbro D, 1998, J MOL ENDOCRINOL, V21, P347, DOI 10.1677/jme.0.0210347; Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198; FRANCISLANG H, 1992, MOL CELL BIOL, V12, P576, DOI 10.1128/MCB.12.2.576; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; JAVAUX F, 1992, FEBS LETT, V300, P222, DOI 10.1016/0014-5793(92)80850-G; Kelly SE, 1996, J BIOL CHEM, V271, P6881, DOI 10.1074/jbc.271.12.6881; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Liu C, 2002, J BIOL CHEM, V277, P4519, DOI 10.1074/jbc.M107585200; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Mansouri A, 1999, CANCER RES, V59, p1707S; Mascia A, 2002, J ENDOCRINOL, V172, P163, DOI 10.1677/joe.0.1720163; Miccadei S, 2002, MOL ENDOCRINOL, V16, P837, DOI 10.1210/me.16.4.837; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; PLACHOV D, 1990, DEVELOPMENT, V110, P643; POLEEV A, 1995, EUR J BIOCHEM, V228, P899, DOI 10.1111/j.1432-1033.1995.tb20338.x; Sever-Chroneos Z, 1999, AM J PHYSIOL-LUNG C, V277, pL79, DOI 10.1152/ajplung.1999.277.1.L79; SINCLAIR AJ, 1990, EUR J BIOCHEM, V193, P311, DOI 10.1111/j.1432-1033.1990.tb19339.x; Stuart ET, 1996, CELL GROWTH DIFFER, V7, P405; Vilain C, 2001, J CLIN ENDOCR METAB, V86, P234, DOI 10.1210/jc.86.1.234; Wheat W, 1999, MOL CELL BIOL, V19, P2231; Yan C, 2001, J BIOL CHEM, V276, P21686, DOI 10.1074/jbc.M011378200; YAN C, 1995, J BIOL CHEM, V270, P24852, DOI 10.1074/jbc.270.42.24852; Yang YS, 2001, AM J RESP CELL MOL, V24, P30, DOI 10.1165/ajrcmb.24.1.4050; Yi M, 2002, J BIOL CHEM, V277, P2997, DOI 10.1074/jbc.M109793200; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230; Zhang LQ, 1997, BBA-GENE STRUCT EXPR, V1350, P359, DOI 10.1016/S0167-4781(96)00180-7	46	109	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3395	3402		10.1074/jbc.M205977200	http://dx.doi.org/10.1074/jbc.M205977200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441357	hybrid			2022-12-27	WOS:000180915000080
J	Giles, KM; Daly, JM; Beveridge, DJ; Thomson, AM; Voon, DC; Furneaux, HM; Jazayeri, JA; Leedman, PJ				Giles, KM; Daly, JM; Beveridge, DJ; Thomson, AM; Voon, DC; Furneaux, HM; Jazayeri, JA; Leedman, PJ			The 3 '-untranslated region of p21(WAF1) mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; AU-RICH ELEMENTS; ERYTHROPOIETIN MESSENGER-RNA; RECEPTOR GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; POSTTRANSCRIPTIONAL REGULATION; GROWTH-INHIBITION; CARCINOMA-CELLS; EGF RECEPTOR; TUMOR CELLS	Despite promoting growth in many cell types, epidermal growth factor (EGF) induces growth inhibition in a variety of cancer cells that overexpress its receptor. The cyclin-dependent kinase inhibitor p21(WAF1) is a central component of this pathway. We found in human MDA-468 breast cancer cells that EGF up-regulates p21(WAF1) mRNA and protein, through a combination of increased mRNA stability and transcription. The decay rate of a hybrid luciferase reporter full-length p21(WAF1) 3'-untranslated region (UTR) mRNA was significantly faster than that of a control mRNA. Transfections with a variety of p21(WAF1) 3'-UTR constructs identified multiple cis-acting elements capable of reducing basal reporter activity. Short wavelength ultraviolet light induced reporter activity in constructs containing the 5' region of the p21(WAF1) 3'-UTR, whereas EGF induced reporter activity in constructs containing sequences 3' of the UVC-responsive region. These cis-elements bound multiple proteins from MDA-468 cells, including HuR and poly(C)-binding protein 1 (CP1). Immunoprecipitation studies confirmed that HuR and CP1 associate with p21(WAF1) mRNA in MDA-468 cells. Over- and underexpression of HuR in MDA-468 cells did not affect EGF-induced p21(WAF1) protein expression or growth inhibition. However, binding of HuR to its target 3'-UTR cis-element was regulated by UVC but not by EGF, suggesting that these stimuli modulate the stability of p21(WAF1) mRNA via different mechanisms. We conclude that EGF-induced p21(WAF1) protein expression is mediated largely by stabilization of p21(WAF1) mRNA elicited via multiple 3'-UTR cis-elements. Although HuR binds at least one of these elements, it does not appear to be a major modulator of p21(WAF1) expression or growth inhibition in this system. CP1 is a novel p21(WAF1) mRNA-binding protein that may function cooperatively with other mRNA-binding proteins to regulate p21(WAF1) mRNA stability.	Univ Western Australia, Lab Canc Med, Perth, WA 6001, Australia; Univ Western Australia, Dept Med, Western Australian Inst Med Res, Perth, WA 6001, Australia; Univ Western Australia, Med Res Ctr, Perth, WA 6001, Australia; Royal Perth Hosp, Dept Endocrinol & Diabet, Perth, WA 6001, Australia; Univ Connecticut, Ctr Hlth, Dept Physiol, Vasc Biol Program, Farmington, CT 06030 USA	University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Connecticut	Leedman, PJ (corresponding author), Univ Western Australia, Dept Med, Royal Perth Hosp, GPO Box X2213, Perth, WA 6001, Australia.		Leedman, Peter J/O-4044-2014	furneaux, henry/0000-0003-2212-1017; Voon, Dominic Chih-Cheng/0000-0002-2963-9305				Afonina E, 1997, J BIOL CHEM, V272, P2307, DOI 10.1074/jbc.272.4.2307; Akashi M, 1999, BIOCHEM J, V337, P607, DOI 10.1042/0264-6021:3370607; BJORGE JD, 1989, J BIOL CHEM, V264, P4021; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CHEN CYA, 1994, MOL CELL BIOL, V14, P8471, DOI 10.1128/MCB.14.12.8471; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; Daly JM, 1997, CANCER RES, V57, P3804; Daly JM, 1999, ONCOGENE, V18, P3440, DOI 10.1038/sj.onc.1202700; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; DelSal G, 1996, ONCOGENE, V12, P177; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; GILLIS P, 1991, J BIOL CHEM, V266, P3172; Gorospe M, 1998, MOL CELL BIOL, V18, P1400, DOI 10.1128/MCB.18.3.1400; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; Jakus J, 1996, ONCOGENE, V12, P2369; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; Joseph B, 1998, J BIOL CHEM, V273, P20511, DOI 10.1074/jbc.273.32.20511; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; Kiledjian M, 1999, METHODS, V17, P84, DOI 10.1006/meth.1998.0710; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li XS, 1996, CANCER RES, V56, P5055; Liu J, 2000, J BIOL CHEM, V275, P11846, DOI 10.1074/jbc.275.16.11846; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Maurer F, 1999, NUCLEIC ACIDS RES, V27, P1664, DOI 10.1093/nar/27.7.1664; McGary EC, 1997, J BIOL CHEM, V272, P8628, DOI 10.1074/jbc.272.13.8628; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHEIKH MS, 1995, ONCOGENE, V11, P1899; Shiohara M, 1996, J CELL PHYSIOL, V166, P568, DOI 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3; Sokolowski M, 1999, J VIROL, V73, P1080, DOI 10.1128/JVI.73.2.1080-1091.1999; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Xie W, 1997, ANTICANCER RES, V17, P2627; Yeap BB, 1999, ENDOCRINOLOGY, V140, P3282, DOI 10.1210/en.140.7.3282; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	60	99	105	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2937	2946		10.1074/jbc.M208439200	http://dx.doi.org/10.1074/jbc.M208439200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431987	hybrid			2022-12-27	WOS:000180915000023
J	Koegel, H; Kaesler, S; Burgstahler, R; Werner, S; Alzheimer, C				Koegel, H; Kaesler, S; Burgstahler, R; Werner, S; Alzheimer, C			Unexpected down-regulation of the hIK1 Ca2+-activated K+ channel by its opener 1-ethyl-2-benzimidazolinone in HaCaT Keratinocytes - Inverse effects on cell growth and proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN T-LYMPHOCYTES; ACTIVATED POTASSIUM CHANNELS; C6 GLIOMA-CELLS; INTERMEDIATE-CONDUCTANCE; CA CHANNEL; ION CHANNELS; TERMINAL DIFFERENTIATION; INTRACELLULAR CALCIUM; GENE-TRANSCRIPTION; PITUITARY-CELLS	We used a combination of electrophysiological and cell and molecular biological techniques to study the regulation and functional role of the intermediate conductance Ca2+-activated K+ channel, hIK1, in HaCaT keratinocytes. When we incubated cells with the hIK1 opener, 1-ethyl-2-benzimidazolinone (1-EBIO), to investigate the cellular consequences of prolonged channel activity, an unexpected down-regulation of channels occurred within a few hours. The same effect was produced by the hlK1 openers chlorzoxazone and zoxazolamine and was also observed in a different cell line (C6 glioma cells). After 3 days of treatment with 1-EBIO, mRNA levels of hlK1 were substantially diminished and no channel activity was detected. Down-regulation of hlK1 was accompanied by a loss of mitogenic activity and a strong increase in cell size. After withdrawal of 1-EBIO, hlK1 mRNA and channel activity fully recovered and the cells resumed mitogenic activity. Our data present evidence for a novel feedback mechanism of hlK1 expression that appears to result from the paradoxical action of its pharmacological activator during prolonged application. Because the down-regulation of hIK1 bears immediate significance on the biological fate of keratinocytes, 1-EBIO and related compounds might emerge as potent tools to influence the proliferation of various non-excitable cells endowed with IK channels.	Univ Munich, Inst Physiol, D-80336 Munich, Germany; ETH Honggerberg, Dept Biol, CH-8093 Zurich, Switzerland; Univ Kiel, Inst Physiol, D-24098 Kiel, Germany	University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kiel	Koegel, H (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-80336 Munich, Germany.	h.koegel@lrz.uni-muenchen.de		Werner, Sabine/0000-0001-7397-8710				Biro T, 1998, ARCH DERMATOL RES, V290, P270, DOI 10.1007/s004030050303; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bunemann M, 1999, ANNU REV PHYSIOL, V61, P169, DOI 10.1146/annurev.physiol.61.1.169; Cao YJ, 2001, J PHARMACOL EXP THER, V296, P683; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Ennion SJ, 2001, FEBS LETT, V489, P154, DOI 10.1016/S0014-5793(01)02102-0; Fuchs E, 1990, CURR OPIN CELL BIOL, V2, P1028, DOI 10.1016/0955-0674(90)90152-5; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I., 2002, Pfluegers Archiv European Journal of Physiology, V443, pS178; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Jorgensen NK, 1997, J MEMBRANE BIOL, V157, P281, DOI 10.1007/s002329900236; Khanna R, 1999, J BIOL CHEM, V274, P14838, DOI 10.1074/jbc.274.21.14838; Koegel H, 2001, FASEB J, V15, P145, DOI 10.1096/fj.00-0055com; LEVITAN ES, 1995, J BIOL CHEM, V270, P6036, DOI 10.1074/jbc.270.11.6036; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; MANOR D, 1994, J MEMBRANE BIOL, V140, P69; Mauro T, 1997, J INVEST DERMATOL, V108, P864, DOI 10.1111/1523-1747.ep12292585; MAURO TM, 1993, J MEMBRANE BIOL, V132, P201; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; PASSAFARO M, 1992, J NEUROSCI, V12, P3372; Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200; Pena TL, 2000, J BIOL CHEM, V275, P13677, DOI 10.1074/jbc.275.18.13677; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; PILLAI S, 1992, J CLIN INVEST, V90, P42, DOI 10.1172/JCI115854; Rouzaire-Dubois B, 2000, PFLUG ARCH EUR J PHY, V440, P881, DOI 10.1007/s004240000371; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Schwab A, 2001, AM J PHYSIOL-RENAL, V280, pF739, DOI 10.1152/ajprenal.2001.280.5.F739; Singh AK, 2000, J PHARMACOL EXP THER, V292, P778; Syme CA, 2000, AM J PHYSIOL-CELL PH, V278, pC570, DOI 10.1152/ajpcell.2000.278.3.C570; TAKIMOTO K, 1993, NEURON, V11, P359, DOI 10.1016/0896-6273(93)90191-S; THOMASYOUNG RJ, 1993, BIOCHIM BIOPHYS ACTA, V1146, P81, DOI 10.1016/0005-2736(93)90341-V; TUSCHIL A, 1992, J INVEST DERMATOL, V99, P294, DOI 10.1111/1523-1747.ep12616634; Wachtler J, 1996, NEUROREPORT, V7, P1289, DOI 10.1097/00001756-199605170-00014; WAECHTER CJ, 1983, J BIOL CHEM, V258, P5117; Wakita N, 1999, J BIOL CHEM, V274, P37285, DOI 10.1074/jbc.274.52.37285; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x; Wohlrab D, 1999, SKIN PHARMACOL APPL, V12, P257, DOI 10.1159/000066250; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151	45	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3323	3330		10.1074/jbc.M208914200	http://dx.doi.org/10.1074/jbc.M208914200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12421833	hybrid			2022-12-27	WOS:000180915000071
J	Setsukinai, K; Urano, Y; Kakinuma, K; Majima, HJ; Nagano, T				Setsukinai, K; Urano, Y; Kakinuma, K; Majima, HJ; Nagano, T			Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS MEASUREMENTS; FREE-RADICAL FORMATION; HYDROGEN-PEROXIDE; NITRIC-OXIDE; HORSERADISH-PEROXIDASE; SINGLET OXYGEN; NADPH OXIDASE; POLYMORPHONUCLEAR LEUKOCYTES; SUPEROXIDE-DISMUTASE; ACTIVATION	We designed and synthesized 2-[6-(4'-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (HPF) and 2[6-(4'-amino)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid (APF) as novel fluorescence probes to detect selectively highly reactive oxygen species (hROS) such as hydroxyl radical ((OH)-O-.) and reactive intermediates of peroxidase. Although HPF and APF themselves scarcely fluoresced, APF selectively and dose-dependently afforded a strongly fluorescent compound, fluorescein, upon reaction with hROS and hypochlorite (-OCl), but not other reactive oxygen species (ROS). HPF similarly afforded fluorescein upon reaction with hROS only. Therefore, not only can hROS be differentiated from hydrogen peroxide (H2O2), nitric oxide (NO), and superoxide (O-2(.-)) by using HPF or APF alone, but -OCl can also be specifically detected by using HPF and APF together. Furthermore, we applied HPF and APF to living cells and found that HPF and APF were resistant to light-induced autoxidation, unlike 2',7'-dichlorodihydrofluoreseein, and for the first time we could visualize -OCl generated in stimulated neutrophils. HPF and APF should be useful as tools to study the roles of hROS and -OCl in many biological and chemical applications.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Biophoton Res Project, MMBS, Miura, Kanagawa 2380225, Japan; Kagoshima Univ, Sch Dent, Kagoshima 8908544, Japan	University of Tokyo; University of Tokyo; Kagoshima University	Nagano, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Hongo, Tokyo 1130033, Japan.		Majima, Hideyuki J./K-3778-2019; Urano, Yasuteru/H-1380-2012					AUBRY JM, 1989, J ORG CHEM, V54, P726, DOI 10.1021/jo00264a046; Az-ma T, 1999, BRIT J PHARMACOL, V126, P1462, DOI 10.1038/sj.bjp.0702438; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Coudray C, 2000, FREE RADICAL BIO MED, V29, P1064, DOI 10.1016/S0891-5849(00)00403-2; Damiani E, 2000, FREE RADICAL BIO MED, V28, P1257, DOI 10.1016/S0891-5849(00)00242-2; Dobashi K, 2000, MOL CELL BIOCHEM, V205, P1, DOI 10.1023/A:1007047505107; Frohlich KU, 2000, FEBS LETT, V473, P6, DOI 10.1016/S0014-5793(00)01474-5; Grishko VI, 1999, NUCLEIC ACIDS RES, V27, P4510, DOI 10.1093/nar/27.22.4510; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALFPENNY E, 1952, J CHEM SOC, P939, DOI 10.1039/jr9520000939; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030; KAKINUMA K, 1974, BIOCHIM BIOPHYS ACTA, V348, P76; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; Klebanoff S.J., 1978, NEUTROPHIL FUNCTION; KUPPUSAMY P, 1994, P NATL ACAD SCI USA, V91, P3388, DOI 10.1073/pnas.91.8.3388; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529; MCHEDLOVPETROSSYAN NO, 1992, DYES PIGMENTS, V18, P179, DOI 10.1016/0143-7208(92)87002-I; MINTA A, 1989, J BIOL CHEM, V264, P8171; Motoori S, 2001, CANCER RES, V61, P5382; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; OHE T, 1995, TETRAHEDRON LETT, V36, P7681, DOI 10.1016/0040-4039(95)01611-K; Raible DG, 2000, FREE RADICAL BIO MED, V28, P1652, DOI 10.1016/S0891-5849(00)00279-3; Ren JG, 2001, FEBS LETT, V488, P123, DOI 10.1016/S0014-5793(00)02377-2; REPINE JE, 1974, J LAB CLIN MED, V83, P911; Rodriguez-Lopez JN, 2001, J AM CHEM SOC, V123, P11838, DOI 10.1021/ja011853+; ROSSI F, 1986, BIOCHIM BIOPHYS ACTA, V853, P65, DOI 10.1016/0304-4173(86)90005-4; Rota C, 1999, J BIOL CHEM, V274, P28161, DOI 10.1074/jbc.274.40.28161; Rota C, 1999, FREE RADICAL BIO MED, V27, P873, DOI 10.1016/S0891-5849(99)00137-9; SAMUNI A, 1991, FREE RADICAL BIO MED, V10, P305, DOI 10.1016/0891-5849(91)90037-4; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; SMITH JA, 1993, J IMMUNOL METHODS, V162, P261, DOI 10.1016/0022-1759(93)90391-J; SUEMATSU M, 1989, J BIOCHEM-TOKYO, V106, P355, DOI 10.1093/oxfordjournals.jbchem.a122857; TAMURA Z, 1994, BUNSEKI KAGAKU, V43, P339; Tatla S, 1999, FREE RADICAL BIO MED, V26, P14, DOI 10.1016/S0891-5849(98)00133-6; TUUMINEN T, 1991, J IMMUNOASSAY, V12, P29, DOI 10.1080/01971529108055055; Umezawa N, 1999, ANGEW CHEM INT EDIT, V38, P2899, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2899::AID-ANIE2899>3.0.CO;2-M; Urano Y, 1996, J CHEM SOC PERK T 2, P1169, DOI 10.1039/p29960001169; WAKEYAMA H, 1982, BIOCHEM J, V205, P593, DOI 10.1042/bj2050593; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Yasui H, 2000, BIOCHEM BIOPH RES CO, V269, P131, DOI 10.1006/bbrc.2000.2254; Yermolaieva O, 2000, P NATL ACAD SCI USA, V97, P448, DOI 10.1073/pnas.97.1.448; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	48	1007	1042	8	389	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3170	3175		10.1074/jbc.M209264200	http://dx.doi.org/10.1074/jbc.M209264200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12419811	hybrid			2022-12-27	WOS:000180915000052
J	Shields, DJ; Lehner, R; Agellon, LB; Vance, DE				Shields, DJ; Lehner, R; Agellon, LB; Vance, DE			Membrane topography of human phosphatidylethanolamine N-methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT HEPATOCYTES; TURN PROPENSITY SCALE; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; PHOSPHATIDYLCHOLINE SYNTHESIS; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE HELICES; LIVER; METHYLATION; SECRETION	In liver, phosphatidylethanolamine is converted to phosphatidylcholine through a series of three sequential methylation reactions. Phosphatidylethanolamine N-methyltransferase (PEMT) catalyzes each transmethylation reaction, and S-adenosylmethionine is the methyl group donor. Biochemical analysis of human liver revealed that the methyltransferase activity is primarily localized to the endoplasmic reticulum and mitochondria-associated membranes. Bioinformatic analysis of the predicted amino acid sequence suggested that the enzyme adopts a polytopic conformation in those membranes. To elucidate the precise membrane topography of PEMT and thereby provide the basis for in-depth functional characterization of the enzyme, we performed endoproteinase-protection analysis of epitope-tagged, recombinant protein. Our data suggest a topographical model of PEMT in which four transmembrane regions span the membrane such that both the N and C termini of the enzyme are localized external to the ER. Two hydrophilic connecting loops protrude into the luminal space of the microsomes whereas a corresponding loop on the cytosolic side remains proximate to the membrane. Further support for this model was obtained following endoproteinase-protection analysis of mutant recombinant PEMT derivatives in which specific protease cleavage sites had been genetically engineered or ablated.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Dept Pediat & Cell Biol, Edmonton, AB T6G 2S2, Canada; Univ Alberta, Canadian Inst Hlth Res, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; Institute for Work & Health; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, 328 HMRC, Edmonton, AB T6G 2S2, Canada.			Lehner, Richard/0000-0002-6008-1805				Agellon LB, 1999, HEPATOLOGY, V30, P725, DOI 10.1002/hep.510300305; Agellon LB., 2002, BIOCH LIPIDS LIPOPRO, P433; ALHABORI M, 1995, INT J BIOCHEM CELL B, V27, P123, DOI 10.1016/1357-2725(94)00079-Q; AUDUBERT F, 1984, BIOCHIM BIOPHYS ACTA, V792, P359, DOI 10.1016/0005-2760(84)90204-2; CROZE EM, 1984, J CELL PHYSIOL, V119, P46, DOI 10.1002/jcp.1041190109; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FAROOQUI JZ, 1983, BIOCHIM BIOPHYS ACTA, V757, P342; FAUMAN EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001; FINKELSTEIN JD, 1986, J BIOL CHEM, V261, P1582; GRAHAM JM, 1997, SUBCELLULAR FRACTION, P205; Hardt B, 2002, BIOCHEM BIOPH RES CO, V291, P751, DOI 10.1006/bbrc.2002.6515; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Mathur SN, 1996, BIOCHEM J, V314, P569, DOI 10.1042/bj3140569; Monne M, 1999, J MOL BIOL, V288, P141, DOI 10.1006/jmbi.1999.2657; Monne M, 1999, J MOL BIOL, V293, P807, DOI 10.1006/jmbi.1999.3183; NIETO A, 1983, ENDOCRINOLOGY, V113, P758, DOI 10.1210/endo-113-2-758; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; NishimakiMogami T, 1996, BBA-LIPID LIPID MET, V1304, P11, DOI 10.1016/S0005-2760(96)00101-4; NishimakiMogami T, 1996, BBA-LIPID LIPID MET, V1304, P21, DOI 10.1016/S0005-2760(96)00100-2; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; OLENDER EH, 1992, J BIOL CHEM, V267, P4223; PANAGIA V, 1984, BIOCHIM BIOPHYS ACTA, V792, P245, DOI 10.1016/0005-2760(84)90192-9; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; PRASAD C, 1981, J BIOL CHEM, V256, P1300; Reo NV, 2000, TOXICOL APPL PHARM, V164, P113, DOI 10.1006/taap.2000.8901; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; SARZALA MG, 1976, BIOCHIM BIOPHYS ACTA, V441, P81, DOI 10.1016/0005-2760(76)90283-6; Shields DJ, 2001, BBA-MOL CELL BIOL L, V1532, P105, DOI 10.1016/S1388-1981(01)00122-6; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Vance D.E., 2002, BIOCH LIPIDS LIPOPRO, P205; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Walkey CJ, 1999, BBA-MOL CELL BIOL L, V1436, P405, DOI 10.1016/S0005-2760(98)00147-7	44	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2956	2962		10.1074/jbc.M210904200	http://dx.doi.org/10.1074/jbc.M210904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431977	hybrid			2022-12-27	WOS:000180915000025
J	Pollok-Kopp, B; Schwarze, K; Baradari, VK; Oppermann, M				Pollok-Kopp, B; Schwarze, K; Baradari, VK; Oppermann, M			Analysis of ligand-stimulated CC chemokine receptor 5 (CCR5) phosphorylation in intact cells using phosphosite-specific antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BETA-ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; IN-VIVO; MOLECULAR MECHANISM; COUPLED RECEPTORS; HIV-1 CORECEPTOR; DESENSITIZATION; SITES; IDENTIFICATION	Human CC chemokine receptor 5 (CCR5), a member of the superfamily of G protein-coupled receptors, regulates the activation and directed migration of leukocytes and serves as the main coreceptor for the entry of R5 tropic strains of human immunodeficiency viruses. We have previously shown that RANTES/CCL5 binding to CCR5 induces GPCR kinase (GRK)- and protein kinase C (PKC)-mediated phosphorylation of four distinct C-terminal serine residues. To study these phosphorylation events in vivo, we have generated monoclonal antibodies, which specifically react only with either phosphorylated or nonphosphorylated CCR5. These phosphosite-specific antibodies reveal that following ligand stimulation of the receptor serine 337 is exclusively phosphorylated by a PKC-mediated mechanism, while GRKs phosphorylate serine 349. GRK-mediated receptor phosphorylation proceeds in a regular time-dependent manner (t(1/2),similar to2 min) with an apparent EC50 of 5 nm. In contrast, PKC phosphorylates serine 337 at 50-fold lower concentrations and in a very rapid, albeit transient manner. Protein phosphatases that are active at neutral pH and are inhibited by okadaic acid rapidly dephosphorylate phosphoserine 337, but less efficiently phosphoserine 349, in intact cells and in an in vitro assay. Immunofluorescence microscopy demonstrates that phosphorylated receptors accumulate in a perinuclear compartment, which resembles recycling endosomes. This study is the first to analyze in detail the spatial and temporal dynamics of GRK- versus PKC-mediated phosphorylation of a G protein-coupled receptor and its subsequent dephosphorylation on the level of individual phosphorylation sites.	Univ Gottingen, Dept Immunol, D-37075 Gottingen, Germany	University of Gottingen	Oppermann, M (corresponding author), Univ Gottingen, Dept Immunol, Kreuzbergring 57, D-37075 Gottingen, Germany.							ALI H, 1993, J BIOL CHEM, V268, P24247; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Blaukat A, 2001, J BIOL CHEM, V276, P40431, DOI 10.1074/jbc.M107024200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; Bohm SK, 1997, BIOCHEM J, V322, P1; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Fan GH, 2001, J BIOL CHEM, V276, P16960, DOI 10.1074/jbc.M009292200; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Innamorati G, 1998, P NATL ACAD SCI USA, V95, P2222, DOI 10.1073/pnas.95.5.2222; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Krueger KM, 1997, J BIOL CHEM, V272, P5; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; Olbrich H, 1999, J LEUKOCYTE BIOL, V65, P281, DOI 10.1002/jlb.65.3.281; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; Palmer TM, 2000, MOL PHARMACOL, V57, P539, DOI 10.1124/mol.57.3.539; Perry SJ, 2002, TRENDS CELL BIOL, V12, P130, DOI 10.1016/S0962-8924(01)02239-5; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; Rodriguez-Frade JM, 2001, TRENDS IMMUNOL, V22, P612, DOI 10.1016/S1471-4906(01)02036-1; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281	43	57	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2190	2198		10.1074/jbc.M209844200	http://dx.doi.org/10.1074/jbc.M209844200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12403770	hybrid			2022-12-27	WOS:000180562000017
J	Jo, M; Thomas, KS; O'Donnell, DM; Gonias, SL				Jo, M; Thomas, KS; O'Donnell, DM; Gonias, SL			Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; PROTEIN-COUPLED RECEPTORS; TYROSINE KINASE; BREAST-CANCER; ADHESION; RAC; INHIBITION; MIGRATION; BINDING; ERK	Urokinase-type plasminogen activator (uPA) and vitronectin activate cell-signaling pathways by binding to the uPA receptor (uPAR). Because uPAR is glyco-sylphosphatidylinositol-anchored, the signaling receptor is most likely a uPAR-containing multiprotein complex. This complex may be heterogeneous within a single cell and among different cell types. The goal of this study was to elucidate the role of the EGF receptor (EGFR) as a component of the uPAR-signaling machinery. uPA activated extracellular signal-regulated kinase (ERK) in COS-7 cells and in COS-7 cells that overexpress uPAR, and this response was blocked by the EGFR inhibitor, tyrphostin AG1478, implicating the EGFR in the pathway that links uPAR to ERK. By contrast, Rac1 activation, which occurred as a result of uPAR overexpression, was EGFR-independent. COS-7 cell migration was stimulated, in an additive manner, by uPAR-dependent pathways leading to ERK and Rac1. AG1478 inhibited only the ERK-dependent component of the response. CHO-K1 cells do not express EGFR; however, these cells demonstrated ERK activation in response to uPA, indicating the presence of an EGFR-independent alternative pathway. As anticipated, this response was insensitive to AG1478. When CHO-K1 cells were transfected to express EGFR or a kinase-inactive mutant of EGFR, ERK activation in response to uPA was unchanged; however, the EGFR-expressing cells acquired sensitivity to AG1478. We conclude that the EGFR may function as a transducer of the signal from uPAR to ERK, but not Rac1. In the absence of EGFR, an alternative pathway links uPAR to ERK; however, this pathway is apparently silenced by EGFR expression.	Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Biochem, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Mol Genet, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Gonias, SL (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Box 800214, Charlottesville, VA 22908 USA.	slg2t@virginia.edu		Ramirez, Denise/0000-0003-4090-033X	NATIONAL CANCER INSTITUTE [R01CA094900] Funding Source: NIH RePORTER; NCI NIH HHS [01 CA94900] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bialkowska K, 2000, J CELL BIOL, V151, P685, DOI 10.1083/jcb.151.3.685; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; Carmeliet P, 1997, CIRC RES, V81, P829; Carriero MV, 1999, CANCER RES, V59, P5307; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Degryse B, 1999, BLOOD, V94, P649, DOI 10.1182/blood.V94.2.649.414k34_649_662; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GYETKO MR, 1993, J LEUKOCYTE BIOL, V53, P598, DOI 10.1002/jlb.53.5.598; Gyetko MR, 2002, J IMMUNOL, V168, P801, DOI 10.4049/jimmunol.168.2.801; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kindzelskii AL, 1997, BIOPHYS J, V73, P1777, DOI 10.1016/S0006-3495(97)78208-0; Kjoller L, 2002, BIOL CHEM, V383, P5, DOI 10.1515/BC.2002.002; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; KOOK YH, 1994, EMBO J, V13, P3983, DOI 10.1002/j.1460-2075.1994.tb06714.x; Koshelnick Y, 1997, J BIOL CHEM, V272, P28563, DOI 10.1074/jbc.272.45.28563; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Ma Z, 2001, J CELL SCI, V114, P3387; Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Shapiro RL, 1996, CANCER RES, V56, P3597; Sitrin RG, 1996, J LEUKOCYTE BIOL, V59, P302, DOI 10.1002/jlb.59.2.302; Tang H, 1998, J BIOL CHEM, V273, P18268, DOI 10.1074/jbc.273.29.18268; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Xue W, 1997, CANCER RES, V57, P1682; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393	53	112	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1642	1646		10.1074/jbc.M210877200	http://dx.doi.org/10.1074/jbc.M210877200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426305	hybrid			2022-12-27	WOS:000180462200037
J	Hallows, KR; McCane, JE; Kemp, BE; Witters, LA; Foskett, JK				Hallows, KR; McCane, JE; Kemp, BE; Witters, LA; Foskett, JK			Regulation of channel gating by AMP-activated protein kinase modulates cystic fibrosis transmembrane conductance regulator activity in lung submucosal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; CFTR; SUBUNIT; STIMULATION; EXPRESSION; MUTATIONS; MECHANISM; DISEASE; DOMAIN	Cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel activity is important for fluid and electrolyte transport in many epithelia including the lung, the site of most cystic fibrosis-associated morbidity. CFTR is unique among ion channels in requiring ATP hydrolysis for its gating, suggesting that its activity is coupled to cellular metabolic status. The metabolic sensor AMP-activated kinase (AMPK) binds to and phosphorylates CFTR, co-localizes with it in various tissues, and inhibits CFTR currents in Xenopus oocytes (Hallows, K. R., Raghuram, V., Kemp, B. E.9 Witters, L. A. & Foskett, J. K. (2000) J. Clin. Invest. 105, 1711-1721). Here we demonstrate that this AMPKCFTR interaction has functional implications in human lung epithelial cells. Pharmacologic activation of AMPK inhibited forskolin-stimulated CFTR short circuit currents in polarized Calu-3 cell monolayers. In whole-cell patch clamp experiments, the activation of endogenous AMPK either pharmacologically or by the overexpression of an AMPK-activating non-catalytic subunit mutant (AMPK-gamma1-R70Q) dramatically inhibited forskolin-stimulated CFTR conductance in Calu-3 and CFTR-expressing Chinese hamster ovary cells. Plasma membrane expression of CFTR, assessed by surface biotinylation, was not affected by AMPK activation. In contrast, the single channel open probability of CFTR was strongly reduced in cell-attached patch clamp measurements of Calu-3 cells transfected with the AMPK-activating mutant, an effect due primarily to a substantial prolongation of the mean closed time of the channel. As a metabolic sensor in cells, AMPK may be important in tuning CFTR activity to cellular energy charge, thereby linking transepithelial transport and the maintenance of cellular ion gradients to cellular metabolism.	Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Dartmouth Coll Sch Med, Dept Med, Hanover, NH 03755 USA; Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St. Vincent's Institute of Medical Research; Dartmouth College; Dartmouth College; Dartmouth College	Foskett, JK (corresponding author), Univ Penn, Sch Med, Dept Physiol, B39 Anat Chem Bldg, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; Kemp, Bruce/G-9602-2019; Kemp, Bruce E/L-2633-2014	Kemp, Bruce/0000-0001-6735-5082; Kemp, Bruce E/0000-0001-6735-5082; Foskett, J. Kevin/0000-0002-8854-0268; Hallows, Kenneth/0000-0002-2964-2440	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK059477, F32DK009994, R01DK035712] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK35712, K08-DK59477, K08 DK059477-02, F32-DK09994, K08 DK059477, K08 DK059477-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbud W, 2000, ARCH BIOCHEM BIOPHYS, V380, P347, DOI 10.1006/abbi.2000.1935; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Caldwell RA, 2002, J GEN PHYSIOL, V119, P3, DOI 10.1085/jgp.119.1.3; Chang SY, 2002, J CELL SCI, V115, P783; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Devor DC, 1997, AM J PHYSIOL-CELL PH, V272, pC976, DOI 10.1152/ajpcell.1997.272.3.C976; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Hallows KR, 2000, J CLIN INVEST, V105, P1711, DOI 10.1172/JCI9622; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HORN R, 1983, BIOPHYS J, V43, P207, DOI 10.1016/S0006-3495(83)84341-0; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Huang P, 2000, AM J PHYSIOL-CELL PH, V278, pC417, DOI 10.1152/ajpcell.2000.278.2.C417; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; O'Sullivan DA, 1998, AM J KIDNEY DIS, V32, P976, DOI 10.1016/S0272-6386(98)70072-1; PASYK EA, 1995, J BIOL CHEM, V270, P12347, DOI 10.1074/jbc.270.21.12347; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	38	93	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					998	1004		10.1074/jbc.M210621200	http://dx.doi.org/10.1074/jbc.M210621200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12427743	hybrid			2022-12-27	WOS:000180321900041
J	Yao, EM; Tavis, JE				Yao, EM; Tavis, JE			Kinetics of synthesis and turnover of the duck hepatitis B virus reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GENE PRODUCT; CORE PROTEIN; ELECTRON CRYOMICROSCOPY; ENCAPSIDATION SIGNAL; POLYMERASE GENE; TRANSLATION; RNA; HEPADNAVIRUS; INITIATION; ANTIBODIES	Hepadnaviral reverse transcription occurs in subviral capsids in which the core protein surrounds the reverse transcriptase ("polymerase") and the pregenomic RNA, The pregenomic RNA is the template for reverse transcription and also the bicistronic mRNA for core and polymerase. The pregenomic RNA structure and the capsid stoichiometry imply that vastly more core would be translated than polymerase. Previously, we found that duck hepatitis B virus polymerase unexpectedly accumulates in the cytoplasm (Yao, E., Gong, Y., Chen, N., and Tavis, J. E. (2000) J. Virol 74,8648-8657). The production mechanism and function of the excess polymerase are unknown. Here, we determined the kinetics of expression and degradation of polymerase and core in cells producing virus. Polymerase was translated 10% as rapidly as core, the half-life of nonencapsidated polymerase was very short, core had a very long half-life, and very few polymerase molecules were encapsidated. The presence of excess polymerase indicates that the translation rate of the polymerase is not limiting for encapsidation. Therefore, encapsidation must be regulated by other events, most likely binding of the polymerase to the pregenomic RNA. These data support the hypothesis that polymerase may have functions beyond copying the viral genome by demonstrating that the polymerase is a cytoplasmic protein that is only rarely encapsidated.	St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; St Louis Univ, Sch Med, Ctr Liver, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University	Tavis, JE (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, 1402 S Grand Blvd, St Louis, MO 63104 USA.				NCI NIH HHS [CA91327] Funding Source: Medline; NIAID NIH HHS [AI38447] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA091327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI038447, R01AI038447] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARTENSCHLAGER R, 1992, NUCLEIC ACIDS RES, V20, P195, DOI 10.1093/nar/20.2.195; BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; CHANG LJ, 1990, P NATL ACAD SCI USA, V87, P5158, DOI 10.1073/pnas.87.13.5158; CHANG LJ, 1989, NATURE, V337, P364, DOI 10.1038/337364a0; CONDREAY LD, 1990, J VIROL, V64, P3249, DOI 10.1128/JVI.64.7.3249-3258.1990; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; FEITELSON MA, 1988, J MED VIROL, V24, P121, DOI 10.1002/jmv.1890240202; FOUILLOT N, 1993, J VIROL, V67, P4886, DOI 10.1128/JVI.67.8.4886-4895.1993; Fouillot N, 1996, J GEN VIROL, V77, P1123, DOI 10.1099/0022-1317-77-6-1123; GANEM D, 2001, FIELDS VIROLOGY, P2923; Howe AYM, 1996, J VIROL, V70, P5035, DOI 10.1128/JVI.70.8.5035-5042.1996; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Hu JM, 2002, J VIROL, V76, P269, DOI 10.1128/JVI.76.1.269-279.2002; Hwang WL, 1999, J GEN VIROL, V80, P1769, DOI 10.1099/0022-1317-80-7-1769; Hwang WL, 1998, J GEN VIROL, V79, P2181, DOI 10.1099/0022-1317-79-9-2181; JEANJEAN O, 1989, J VIROL, V63, P5451, DOI 10.1128/JVI.63.12.5451-5454.1989; JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x; KANN M, 1993, J MED VIROL, V40, P285, DOI 10.1002/jmv.1890400406; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lanford RE, 1998, P NATL ACAD SCI USA, V95, P5757, DOI 10.1073/pnas.95.10.5757; LIN CG, 1992, VIROLOGY, V188, P342, DOI 10.1016/0042-6822(92)90763-F; OU JH, 1990, J VIROL, V64, P4578, DOI 10.1128/JVI.64.9.4578-4581.1990; POLLACK JR, 1994, J VIROL, V68, P5579, DOI 10.1128/JVI.68.9.5579-5587.1994; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; SCHLICHT HJ, 1989, CELL, V56, P85, DOI 10.1016/0092-8674(89)90986-0; SCHODEL F, 1989, ADV VIRAL ONCOL, V8, P73; SEIFER M, 1993, J VIROL, V67, P249, DOI 10.1128/JVI.67.1.249-257.1993; SPRENGEL R, 1985, J MED VIROL, V15, P323, DOI 10.1002/jmv.1890150402; SPRENGEL R, 1988, J VIROL, V62, P3832, DOI 10.1128/JVI.62.10.3832-3839.1988; WEIMER T, 1990, J VIROL, V64, P5665, DOI 10.1128/JVI.64.11.5665-5668.1990; Yao EM, 2000, J VIROL, V74, P8648, DOI 10.1128/JVI.74.18.8648-8657.2000	34	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1201	1205		10.1074/jbc.M208895200	http://dx.doi.org/10.1074/jbc.M208895200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12444091	hybrid			2022-12-27	WOS:000180321900066
J	Chen, J; Jin, S; Tahir, SK; Zhang, HC; Liu, XS; Sarthy, AV; McGonigal, TP; Liu, ZH; Rosenberg, SH; Ng, SC				Chen, J; Jin, S; Tahir, SK; Zhang, HC; Liu, XS; Sarthy, AV; McGonigal, TP; Liu, ZH; Rosenberg, SH; Ng, SC			Survivin enhances Aurora-B kinase activity and localizes Aurora-B in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE PROTEIN INCENP; CHROMOSOME SEGREGATION; HISTONE H3; APOPTOSIS; CYTOKINESIS; DIVISION; SPINDLE; PHOSPHORYLATION; FAMILY; AIR-2	Survivin, one of the most tumor-specific gene products, has been implicated in both anti-apoptosis and cytokinesis. However, the mechanism by which survivin regulates these two different processes is still elusive. Here, we show that survivin binds to the catalytic domain of Aurora-B. We demonstrate that in the presence of survivin, Aurora-B phosphorylates histone H3 much more efficiently than in the absence of survivin in a cell-free system. Furthermore, we confirm that cells lacking survivin due to survivin antisense oligonucleotide-treatment have lower Aurora-B kinase activity, whereas cells overexpressing survivin have higher Aurora-B kinase activity. We also provide evidence that depletion of survivin by survivin antisense oligonucleotide treatment causes significant reduction of endogenous phosphorylated histone H3 and mislocalization of Aurora-B. These results indicate that survivin stimulates Aurora-B kinase activity and helps correctly target Aurora-B to its substrates during the cell cycle, thus providing a mechanism as to how survivin exerts its function in human cells.	Abbott Labs, Canc Res, Abbott Pk, IL 60064 USA	Abbott Laboratories	Chen, J (corresponding author), Abbott Labs, Canc Res, D-4N6,AP10-1,100 Abbott Pk Rd, Abbott Pk, IL 60064 USA.							Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Chen J, 2000, NEOPLASIA, V2, P235, DOI 10.1038/sj.neo.7900091; Cutts SM, 1999, HUM MOL GENET, V8, P1145, DOI 10.1093/hmg/8.7.1145; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Giet R, 1999, J CELL SCI, V112, P3591; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Giet R, 2001, J CELL SCI, V114, P2095; Giodini A, 2002, CANCER RES, V62, P2462; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Leverson JD, 2002, MOL BIOL CELL, V13, P1132, DOI 10.1091/mbc.01-07-0330; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Murata-Hori M, 2002, CURR BIOL, V12, P894, DOI 10.1016/S0960-9822(02)00848-5; Murata-Hori M, 2000, J BIOCHEM-TOKYO, V128, P903, DOI 10.1093/oxfordjournals.jbchem.a022840; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Speliotes EK, 2000, MOL CELL, V6, P211, DOI 10.1016/S1097-2765(00)00023-X; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Tamm I, 1998, CANCER RES, V58, P5315; Tatsuka M, 1998, CANCER RES, V58, P4811; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	37	109	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					486	490		10.1074/jbc.M211119200	http://dx.doi.org/10.1074/jbc.M211119200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12419797	hybrid			2022-12-27	WOS:000180255700064
J	Rizzo, VF; Coskun, U; Radermacher, M; Ruiz, T; Armbruster, A; Gruber, G				Rizzo, VF; Coskun, U; Radermacher, M; Ruiz, T; Armbruster, A; Gruber, G			Resolution of the V-1 ATPase from Manduca sexta into subcomplexes and visualization of an ATPase-active A(3)B(3)EG complex by electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED VESICLE; V-ATPASE; INDIVIDUAL SUBUNITS; STRUCTURAL-CHANGES; VACUOLAR; RECONSTITUTION; V-1-ATPASE; MECHANISM; FORMS; STALK	The effect of the ATPase activity of Manduca sexta V-1 ATPase by the amphipathic detergent lauryldimethylamine oxide (LDAO) and the relationship of these activities to the subunit composition of V, were studied. The V, was highly activated in the presence of 0.04-0.06% LDAO combined with release of the subunits H, C, and F from the enzyme. Increase of LDAO concentration to 0.1-0.2% caused the characterized subcomplexes A(3)B(3)HEGF and A(3)B(3)EG with a remaining ATPase activity of 52 and 65%, respectively. The hydrolytic-active A(3)B(3)EG subcomplex has been visualized by electron microscopy showing six major masses of density in a pseudo-hexagonal arrangement surrounding a seventh mass. The compositions of the various subcomplexes and fragments of V-1 provide an organization of the subunits in the enzyme in the framework of the known three-dimensional reconstruction of the V-1 ATPase from M. sexta.	Univ Saarland, Fachrichtung Biophys 2 5, D-66421 Homburg, Germany; Univ Vermont, Coll Med, Dept Physiol & Mol Biophys, Burlington, VT 05405 USA	Saarland University; University of Vermont	Gruber, G (corresponding author), Univ Saarland, Fachrichtung Biophys 2 5, Universitatsbau 76, D-66421 Homburg, Germany.	ggrueber@med-rz.uni-saarland.de	Feher, George/E-3050-2010; Coskun, Ünal/F-4683-2011	Coskun, Ünal/0000-0003-4375-3144; Rizzo, Vincenzo F/0000-0001-5810-3537				Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Boekema EJ, 1998, PHOTOSYNTH RES, V57, P267, DOI 10.1023/A:1006044931980; Bowman EJ, 2000, J EXP BIOL, V203, P97; Chaban Y, 2002, EMBO REP, V3, P982, DOI 10.1093/embo-reports/kvf196; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; DAMERVAL C, 1987, ELECTROPHORESIS, V8, P158, DOI 10.1002/elps.1150080308; Diday E., 1971, REV STAT APPL, V19, P19; DSCHIDA WJA, 1995, J BIOL CHEM, V270, P1557, DOI 10.1074/jbc.270.4.1557; Forgac M, 2000, J EXP BIOL, V203, P71; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOGOL EP, 1989, BIOCHEMISTRY-US, V28, P4717, DOI 10.1021/bi00437a031; GOGOL EP, 1994, MICROSC RES TECHNIQ, V27, P294, DOI 10.1002/jemt.1070270405; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; GRAF R, 1994, BBA-BIOMEMBRANES, V1190, P193, DOI 10.1016/0005-2736(94)90053-1; Graham LA, 2000, J EXP BIOL, V203, P61; Gruber G, 2001, J EXP BIOL, V204, P2597; Gruber G, 2000, J BIOL CHEM, V275, P30082, DOI 10.1074/jbc.M002976200; Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u; Helenius A, 1979, Methods Enzymol, V56, P734; HO MN, 1993, J BIOL CHEM, V268, P18286; HUSS M, 2001, THESIS U OSNABRUCK G; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; NELSON H, 1995, P NATL ACAD SCI USA, V92, P497, DOI 10.1073/pnas.92.2.497; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oluwatosin YE, 1997, J BIOL CHEM, V272, P28149, DOI 10.1074/jbc.272.44.28149; PENG SB, 1994, J BIOL CHEM, V269, P11356; Perzov N, 2001, FEBS LETT, V504, P223, DOI 10.1016/S0014-5793(01)02709-0; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; Radermacher M, 1999, FEBS LETT, V453, P383, DOI 10.1016/S0014-5793(99)00739-5; Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395; RADERMACHER M, 2002, IN PRESS SCANNING MI; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schafer HJ, 2001, BIOCHEM BIOPH RES CO, V286, P1218, DOI 10.1006/bbrc.2001.5502; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; Tomashek JJ, 1997, J BIOL CHEM, V272, P26787, DOI 10.1074/jbc.272.42.26787; Van Heel M., 1982, LIFE CHEM REPORTS S, V1, P69; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; WEBER K, 1969, J BIOL CHEM, V244, P4406; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Wieczorek H, 2000, J EXP BIOL, V203, P127; WILKENS S, 1994, BIOL CHEM H-S, V375, P43; WILKENS S, 1992, ARCH BIOCHEM BIOPHYS, V299, P105, DOI 10.1016/0003-9861(92)90250-Z; Xie XS, 1996, J BIOL CHEM, V271, P30980; XIE XS, 1988, J BIOL CHEM, V263, P9859; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200	52	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					270	275		10.1074/jbc.M208623200	http://dx.doi.org/10.1074/jbc.M208623200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414800	hybrid			2022-12-27	WOS:000180255700036
J	Sandusky, G; Berg, DT; Richardson, MA; Myers, L; Grinnell, BW				Sandusky, G; Berg, DT; Richardson, MA; Myers, L; Grinnell, BW			Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; ANTAGONIST; DYSFUNCTION; INHIBITION; MECHANISMS; PROMOTER; RECEPTOR; CELLS; RISK	Protein C is a plasma protease that in its active form plays a central role in the regulation of vascular function by modulating thrombosis, inflammation, and apoptosis. A central player in this pathway is the cytokine-regulated receptor thrombomodulin (TM), which functions as a co-factor for the thrombin-dependent generation of activated protein C. We have found that tumor necrosis factor-beta (TGF-beta)-dependent suppression of TM on endothelial cells is differentially regulated by endothelial Smad6s and Smad7. Overexpression of Smad6s resulted in activation of a TGF-beta reporter alone and enhanced TGF-beta response. Moreover, Smad6s overexpression suppressed TM and subsequently reduced activated protein C generation. Antisense inhibition of Smad6s expression enhanced the TM-dependent activation of protein C, whereas blocking the inhibitory Smad7 by antisense resulted in reduced TM-dependent activation of protein C. The effect of Smad6s appeared to be due, at least in part, to up-regulation of TGF-beta itself. Immunohistochemisty studies in normal versus atherosclerotic vessels showed that TM levels were suppressed in the endothelium over plaque. Consistent with the in vitro data, we found differential expression of Smad6s and Smad7 in normal versus atherosclerotic vessels, with Smad6s expression low in normal vessels but elevated in atherosclerotic vessels. In contrast, the opposite expression pattern was observed for Smad7. Overall, our results suggest that the relative balance of these intracellular Smads modulate the balance of endothelial function with regard to protein C activation.	Lilly Corp Ctr, Lilly Res Labs, Div Res Technol, Indianapolis, IN 46285 USA	Eli Lilly	Grinnell, BW (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Div Res Technol, Indianapolis, IN 46285 USA.	grinnell@lilly.com						ANTONOV AS, 1992, THROMB RES, V67, P135, DOI 10.1016/0049-3848(92)90133-U; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bobik A, 1999, CIRCULATION, V99, P2883, DOI 10.1161/01.CIR.99.22.2883; Calnek DS, 1998, EXP CELL RES, V238, P294, DOI 10.1006/excr.1997.3812; Esmon C, 2000, CRIT CARE MED, V28, pS44, DOI 10.1097/00003246-200009001-00010; ESMON CT, 1995, TRENDS CARDIOVAS MED, V5, P141, DOI 10.1016/1050-1738(95)00054-D; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Gimbrone M A Jr, 1989, J Card Surg, V4, P180, DOI 10.1111/j.1540-8191.1989.tb00275.x; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; Grinnell BW, 1998, CORONARY ARTERY DIS, V9, P89; Grinnell BW, 2001, CRIT CARE MED, V29, pS53, DOI 10.1097/00003246-200107001-00020; GRINNELL BW, 1987, BIO-TECHNOL, V5, P1189, DOI 10.1038/nbt1187-1189; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Ishisaki A, 1998, J BIOL CHEM, V273, P24293, DOI 10.1074/jbc.273.38.24293; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Joyce DE, 2002, CRIT CARE MED, V30, pS288, DOI 10.1097/00003246-200205001-00019; Keaney John F. Jr., 2000, Molecular Aspects of Medicine, V21, P99, DOI 10.1016/S0098-2997(00)00005-4; Kiechl S, 1999, CIRCULATION, V99, P614, DOI 10.1161/01.CIR.99.5.614; KIM SJ, 1989, J BIOL CHEM, V264, P402; Kleeff J, 1999, BIOCHEM BIOPH RES CO, V255, P268, DOI 10.1006/bbrc.1999.0171; Krishnan P, 2001, DEV GROWTH DIFFER, V43, P115; LAFYATIS R, 1990, J BIOL CHEM, V265, P19128; Landmesser U, 2000, SEMIN THROMB HEMOST, V26, P529, DOI 10.1055/s-2000-13209; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Lentz SR, 1999, ARTERIOSCL THROM VAS, V19, P1744, DOI 10.1161/01.ATV.19.7.1744; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCaffrey TA, 2000, CYTOKINE GROWTH F R, V11, P103, DOI 10.1016/S1359-6101(99)00034-9; Miyazono K, 2000, J CELL SCI, V113, P1101; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakayama T, 1998, GENES CELLS, V3, P387, DOI 10.1046/j.1365-2443.1998.00196.x; OHJI T, 1995, THROMB HAEMOSTASIS, V73, P812; Richardson MA, 2000, ENDOCRINOLOGY, V141, P3908, DOI 10.1210/en.141.10.3908; Richter KK, 1997, RADIOTHER ONCOL, V44, P65, DOI 10.1016/S0167-8140(97)00063-7; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Tran ND, 1999, STROKE, V30, P1671, DOI 10.1161/01.STR.30.8.1671; Verschueren K, 1999, CYTOKINE GROWTH F R, V10, P187, DOI 10.1016/S1359-6101(99)00012-X; Vervloet MG, 1998, SEMIN THROMB HEMOST, V24, P33, DOI 10.1055/s-2007-995821; WAGNER RW, 1993, SCIENCE, V260, P1510, DOI 10.1126/science.7684856; Yamada M, 1999, DEV BIOL, V215, P48, DOI 10.1006/dbio.1999.9419; Yan S. Betty, 1994, Perspectives in Drug Discovery and Design, V1, P503, DOI 10.1007/BF02171862; YAN SB, 1994, ANNU REP MED CHEM, V29, P103	48	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2002	277	51					49815	49819		10.1074/jbc.C200543200	http://dx.doi.org/10.1074/jbc.C200543200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	629AU	12407115	hybrid			2022-12-27	WOS:000180028900095
J	Donev, R; Horton, R; Beck, S; Doneva, T; Vatcheva, R; Bowen, WR; Sheer, D				Donev, R; Horton, R; Beck, S; Doneva, T; Vatcheva, R; Bowen, WR; Sheer, D			Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II REGION; CROSS-LINKED-CHROMATIN; HNRNP A1; GENE-EXPRESSION; RAPID IDENTIFICATION; ATTACHMENT REGIONS; INTERFERON-GAMMA; HUMAN MHC; MATRIX; PROTEINS	were identified adjacent to the LMP/TAP gene cluster in the human and mouse major histocompatibility complex class II region. These sequences were shown to function as nuclear matrix attachment regions (MARs). Three of the five human MARs and the single mouse MAR recruit heterogeneous nuclear ribonucleoprotein A1 (hnRNP-A1) in vivo during transcriptional up-regulation of the major histocompatibility complex class 11 genes. The timing of this recruitment correlates with a rise in mature TAP1 mRNA. Two of the human NLARs bind hnRNP-A1 in vitro directly within a 35-bp sequence that shows over 90% similarity to certain Alu repeat sequences. This study shows that MARs recruit and bind hnRNP-A1 upon transcriptional up-regulation.	Canc Res UK London Rs Inst, Lincolns Inn Fields Labs, Human Cytogenet Lab, London WC2A 3PX, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Coll Swansea, Dept Chem & Biol Proc Engn, Swansea SA2 8PP, W Glam, Wales	Cancer Research UK; Wellcome Trust Sanger Institute; Swansea University	Sheer, D (corresponding author), Canc Res UK London Rs Inst, Lincolns Inn Fields Labs, Human Cytogenet Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Denise.Sheer@cancer.org.uk	Sheer, Denise/C-6705-2011; Donev, Rossen/C-5105-2009	Sheer, Denise/0000-0001-9067-1796; Donev, Rossen/0000-0002-9345-6888	Cancer Research UK [A3585] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BECK S, 1992, J MOL BIOL, V228, P433, DOI 10.1016/0022-2836(92)90832-5; Beck S, 1996, J MOL BIOL, V255, P1, DOI 10.1006/jmbi.1996.0001; Berezney R, 1995, INT REV CYTOL, V162A, P1; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Bode J, 1995, INT REV CYTOL, V162A, P389; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boulikas T, 1995, INT REV CYTOL, V162A, P279; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Dickinson LA, 2002, J BIOL CHEM, V277, P25465, DOI 10.1074/jbc.M202266200; Donev RM, 2000, MOL CELL BIOCHEM, V214, P103; Donev RM, 2002, MOL CELL BIOCHEM, V233, P181, DOI 10.1023/A:1015504318726; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; Eils R, 2000, MOL BIOL CELL, V11, P413, DOI 10.1091/mbc.11.2.413; Fiset S, 2001, NUCLEIC ACIDS RES, V29, P2268, DOI 10.1093/nar/29.11.2268; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kramer JA, 1997, BIOTECHNIQUES, V22, P826, DOI 10.2144/97225bm07; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; Ma H, 1999, J CELL BIOL, V146, P531, DOI 10.1083/jcb.146.3.531; MARKOVA D, 1994, DNA CELL BIOL, V13, P941, DOI 10.1089/dna.1994.13.941; Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Namciu SJ, 1998, MOL CELL BIOL, V18, P2382, DOI 10.1128/MCB.18.4.2382; Nickerson JA, 2001, J CELL SCI, V114, P463; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Pederson T, 1998, J MOL BIOL, V277, P147, DOI 10.1006/jmbi.1997.1618; Peleraux A, 1996, IMMUNOGENETICS, V43, P204, DOI 10.1007/BF00587301; Pemov A, 1998, P NATL ACAD SCI USA, V95, P14757, DOI 10.1073/pnas.95.25.14757; Pinol-Roma Serafin, 1993, Trends in Cell Biology, V3, P151, DOI 10.1016/0962-8924(93)90135-N; Razin SV, 2001, CELL MOL BIOL LETT, V6, P59; ROPER RL, 1994, CELL IMMUNOL, V154, P296, DOI 10.1006/cimm.1994.1079; SAEGUSA Y, 1993, BIOCHIM BIOPHYS ACTA, V1172, P274, DOI 10.1016/0167-4781(93)90214-X; Sambrook J., 2002, MOL CLONING LAB MANU; Singh GB, 1997, NUCLEIC ACIDS RES, V25, P1419, DOI 10.1093/nar/25.7.1419; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; STADEN R, 1988, COMPUT APPL BIOSCI, V4, P53; Tan JH, 2000, MOL BIOL CELL, V11, P1547, DOI 10.1091/mbc.11.5.1547; TANAKA K, 1994, J LEUKOCYTE BIOL, V56, P571, DOI 10.1002/jlb.56.5.571; Urnov FD, 2001, ONCOGENE, V20, P2991, DOI 10.1038/sj.onc.1204323; van Drunen CM, 1999, NUCLEIC ACIDS RES, V27, P2924, DOI 10.1093/nar/27.14.2924; van Endert PM, 1999, CURR OPIN IMMUNOL, V11, P82, DOI 10.1016/S0952-7915(99)80015-6; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; Vautier D, 2001, J CELL SCI, V114, P1521; Volpi EV, 2000, J CELL SCI, V113, P1565; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	53	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5214	5226		10.1074/jbc.M206621200	http://dx.doi.org/10.1074/jbc.M206621200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12435746	hybrid			2022-12-27	WOS:000180968900110
J	Adams, DJ; Smith, AB; Schroeder, CI; Yasuda, T; Lewis, RJ				Adams, DJ; Smith, AB; Schroeder, CI; Yasuda, T; Lewis, RJ			omega-conotoxin CVID inhibits a pharmacologically distinct voltage sensitive calcium channel associated with transmitter release from preganglionic nerve terminals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING ACETYLCHOLINE-RELEASE; N-TYPE; CA2+ CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR-DYNAMICS; RAT; GANGLIA; GVIA; SUBTYPES; MVIIA	Neurotransmitter release from preganglionic parasympathetic neurons is resistant to inhibition by selective antagonists of L-, N-, P/Q-, R-, and T-type calcium channels. In this study, the effects of different omega-conotoxins from genus Conus were investigated on current flow-through cloned voltage-sensitive calcium channels expressed in Xenopus oocytes and nerve-evoked transmitter release from the intact preganglionic cholinergic nerves innervating the rat submandibular ganglia. Our results indicate that omega-conotoxin CVID from Conus catus inhibits a pharmacologically distinct voltage-sensitive calcium channel involved in neurotransmitter release, whereas w-conotoxin MVIIA had no effect. omega-Conotoxin CVID and MVIIA inhibited depolarization-activated Ba2+ currents recorded from oocytes expressing N-type but not L- or R-type calcium channels. High affinity inhibition of the CVID-sensitive calcium channel was enhanced when position 10 of the w-conotoxin was occupied by the smaller residue lysine as found in CVID instead of an arginine as found in MVIIA. Given that relatively small differences in the sequence of the N-type calcium channel alpha(1B) subunit can influence omega-conotoxin access (Feng, Z. P:, Hamid, J., Doering, C., Bosey, G. M., Snutch, T. P., and Zamponi, G. W. (2001) J. Biol. Chem. 276, 15728-15735), it is likely that the calcium channel in preganglionic nerve terminals targeted by CVID is a N-type (Ca(v)2.2) calcium channel variant.	Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Adams, DJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	dadams@mailbox.uq.edu.au	Lewis, Richard J/E-8674-2013; Adams, David/J-9125-2014; Schroeder, Cristina I./K-2042-2014; Lewis, Richard/T-8763-2019; Adams, David John/K-3578-2019	Lewis, Richard J/0000-0003-3470-923X; Adams, David/0000-0002-7030-2288; Schroeder, Cristina I./0000-0002-6737-6374; Lewis, Richard/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288				Adams DJ, 1999, DRUG DEVELOP RES, V46, P219; BLEAKMAN D, 1995, NEUROPHARMACOLOGY, V34, P753, DOI 10.1016/0028-3908(95)00078-K; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; BROCK JA, 1992, NEUROSCIENCE, V47, P185, DOI 10.1016/0306-4522(92)90131-K; Brose WG, 1997, CLIN J PAIN, V13, P256, DOI 10.1097/00002508-199709000-00012; Brunger A. T., 1992, SYSTEM XRAY CRYSTALL; BRUNGER AT, 1986, P NATL ACAD SCI USA, V83, P3801, DOI 10.1073/pnas.83.11.3801; BURGOS GRG, 1995, NEUROSCIENCE, V64, P117, DOI 10.1016/0306-4522(94)00368-F; Feng ZP, 2001, J BIOL CHEM, V276, P15728, DOI 10.1074/jbc.M100406200; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Ireland DR, 1999, J PHYSIOL-LONDON, V514, P59, DOI 10.1111/j.1469-7793.1999.059af.x; Kaneko S, 2002, J NEUROSCI, V22, P82, DOI 10.1523/JNEUROSCI.22-01-00082.2002; KAWA K, 1984, J PHYSIOL-LONDON, V346, P301, DOI 10.1113/jphysiol.1984.sp015023; KIM JI, 1994, J BIOL CHEM, V269, P23876; KIM JI, 1995, BIOCHEM BIOPH RES CO, V206, P449, DOI 10.1006/bbrc.1995.1063; Lew MJ, 1997, J BIOL CHEM, V272, P12014, DOI 10.1074/jbc.272.18.12014; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; McDonough SI, 2002, J GEN PHYSIOL, V119, P313, DOI 10.1085/jgp.20028560; MILJANICH GP, 1995, ANNU REV PHARMACOL, V35, P707, DOI 10.1146/annurev.pa.35.040195.003423; NADASDI L, 1995, BIOCHEMISTRY-US, V34, P8076, DOI 10.1021/bi00025a013; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nielsen KJ, 1999, J MOL BIOL, V289, P1405, DOI 10.1006/jmbi.1999.2817; Nielsen KJ, 1999, BIOCHEMISTRY-US, V38, P6741, DOI 10.1021/bi982980u; Nielsen KJ, 2000, J MOL RECOGNIT, V13, P55, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<55::AID-JMR488>3.0.CO;2-O; OLIVERA BM, 1991, J BIOL CHEM, V266, P22067; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; Smith AB, 1999, NEUROSCIENCE, V94, P891, DOI 10.1016/S0306-4522(99)00286-9; Smith AB, 2000, NEUROSCIENCE, V95, P1121; Smith MT, 2002, PAIN, V96, P119, DOI 10.1016/S0304-3959(01)00436-5; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Stephens GJ, 1997, PFLUG ARCH EUR J PHY, V433, P523, DOI 10.1007/s004240050308; TOMLINSON WJ, 1993, NEUROPHARMACOLOGY, V32, P1117, DOI 10.1016/0028-3908(93)90006-O; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yan LZ, 2000, J BIOL CHEM, V275, P21309, DOI 10.1074/jbc.M000212200	42	78	86	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4057	4062		10.1074/jbc.M209969200	http://dx.doi.org/10.1074/jbc.M209969200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12441339	hybrid, Green Published			2022-12-27	WOS:000180869700070
J	Bradshaw, NR; Chilcoat, ND; Verbsky, JW; Turkewitz, AP				Bradshaw, NR; Chilcoat, ND; Verbsky, JW; Turkewitz, AP			Proprotein processing within secretory dense core granules of Tetrahymena thermophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEIN; BIOCHEMICAL-CHARACTERIZATION; IMMUNOCYTOCHEMICAL ANALYSIS; PARAMECIUM-TETRAURELIA; TRICHOCYST PROTEINS; CLEAVAGE; FAMILY; POLYPEPTIDES; MATURATION; MUTANTS	In the ciliate Tetrahymena thermophila, the polypeptides stored in secretory dense core granules (DCGs) are generated by proteolytic processing of precursors, and the mature products assemble as a crystal. Previous observations suggested that this maturation involves precise cleavage at distinct motifs by a small number of enzymes. To test these inferences, we analyzed the determinants for site-specific processing of pro-Grl1p (Granule lattice protein 1) by complete gene replacement with modified alleles. Contrary to the predictions of previous models, none of the component amino acids in a putative processing motif was necessary for targeted cleavage. Indeed, cleavage at a range of alternative positions near the native site was consistent with normal DCG assembly. Furthermore, substitution of other classes of processing site motifs did not perturb DCG structure or function. These results suggest that processing can be catalyzed by multiple proteases, for which substrate accessibility may be the prime determinant of site specificity. Consistent with this, inhibition of either subtilisin or cathepsin family proteases resulted in delayed processing of pro-Grl1p.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago	Turkewitz, AP (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.		Chilcoat, Doane/AAG-1034-2019	Turkewitz, Aaron/0000-0003-3531-5806; Bradshaw, Niels/0000-0002-6845-4717	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077607] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-50946, R01 GM077607] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADOUTTE A, 1984, J MOL BIOL, V180, P1065, DOI 10.1016/0022-2836(84)90271-7; Allen SL, 1998, GENETICS, V149, P459; BAILYES EM, 1992, BIOCHEM J, V285, P391, DOI 10.1042/bj2850391; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CassidyHanley D, 1997, GENETICS, V146, P135; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Chilcoat ND, 1996, J CELL BIOL, V135, P1775, DOI 10.1083/jcb.135.6.1775; COLLINS T, 1981, J BIOL CHEM, V256, P475; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; GAERTIG J, 1992, P NATL ACAD SCI USA, V89, P9196, DOI 10.1073/pnas.89.19.9196; GAUTIER MC, 1994, J CELL BIOL, V124, P893, DOI 10.1083/jcb.124.6.893; Gautier MC, 1996, J BIOL CHEM, V271, P10247, DOI 10.1074/jbc.271.17.10247; HAUSMANN K, 1988, J ULTRA MOL STRUCT R, V99, P213, DOI 10.1016/0889-1605(88)90065-1; Hook VYH, 2002, J NEUROCHEM, V81, P237; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MADEDDU L, 1995, MOL BIOL CELL, V6, P649, DOI 10.1091/mbc.6.6.649; MADEDDU L, 1994, BIOCHIMIE, V76, P329, DOI 10.1016/0300-9084(94)90167-8; MAIHLE NJ, 1986, J BIOL CHEM, V261, P7566; Miller SA, 2001, J BIOL CHEM, V276, P45341, DOI 10.1074/jbc.M106665200; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; ORIAS E, 1983, J CELL SCI, V64, P49; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SATIR B, 1977, CELL BIOL INT REP, V1, P69, DOI 10.1016/0309-1651(77)90012-1; Shaw MK, 2002, MICROBES INFECT, V4, P119, DOI 10.1016/S1286-4579(01)01520-9; SHIH SJ, 1991, J CELL SCI, V100, P85; SHIH SJ, 1992, J CELL SCI, V103, P349; STEERS E, 1969, EXP CELL RES, V57, P392, DOI 10.1016/0014-4827(69)90165-7; STEINER DF, 1973, NATURE, V243, P528, DOI 10.1038/243528a0; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; TIEDTKE A, 1976, NATURWISSENSCHAFTEN, V63, P93, DOI 10.1007/BF00622415; TINDALL SH, 1989, J CELL SCI, V92, P441; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURKEWITZ AP, 1991, EMBO J, V10, P1979, DOI 10.1002/j.1460-2075.1991.tb07727.x; Turkewitz AP, 2000, METHOD CELL BIOL, V62, P347; TURKEWITZ AP, 1992, DEV GENET, V13, P151, DOI 10.1002/dvg.1020130209; Urbe S, 1997, BBA-MOL CELL RES, V1358, P6, DOI 10.1016/S0167-4889(97)00050-5; Vayssie L, 2001, J CELL SCI, V114, P875; Verbsky JW, 1998, MOL BIOL CELL, V9, P497, DOI 10.1091/mbc.9.2.497; Wuitschick JD, 1999, J EUKARYOT MICROBIOL, V46, P239, DOI 10.1111/j.1550-7408.1999.tb05120.x	40	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4087	4095		10.1074/jbc.M207236200	http://dx.doi.org/10.1074/jbc.M207236200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12435750	hybrid			2022-12-27	WOS:000180869700074
J	Masumiya, H; Wang, RW; Zhang, J; Xiao, BL; Chen, SRW				Masumiya, H; Wang, RW; Zhang, J; Xiao, BL; Chen, SRW			Localization of the 12.6-kDa FK506-binding protein (FKBP12.6) binding site to the NH2-terminal domain of the cardiac Ca2+ release channel (ryanodine receptor)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; MUTATIONS; STABILIZATION; COMPLEX; GENE; MICE	The 12.6-kDa FK506-binding protein (FKBP12.6) interacts with the cardiac ryanodine receptor (RyR2) and modulates its channel function. However, the molecular basis of FKBP12.6-RyR2 interaction is poorly understood. To investigate the significance of the isoleucine-proline (residues 2427-2428) dipeptide epitope, which is thought to form an essential part of the FKBP12.6 binding site in RyR2, we generated single and double mutants, P2428Q, I2427E/P2428A, and P2428A/L2429E, expressed them in HEK293 cells, and assessed their ability to bind GST-FKBP12.6. None of these mutations abolished GST-FKBP12.6 binding, indicating that this isoleucine-proline motif is unlikely to form the core of the FKBP12.6 binding site in RyR2. To systematically define the molecular determinants of FKBP12.6 binding, we constructed a series of internal and NH2- and COOH-terminal deletion mutants of RyR2 and examined the effect of these deletions on GST-FKBP12.6 binding. These deletion analyses revealed that the first 305 NH2-terminal residues and COOH-terminal residues 19374967 are not essential for GST-FKBP12.6 binding, whereas multiple sequences within a large region between residues 305 and 1937 are required for GST-FKBP12.6 interaction. Furthermore, an NH2-terminal fragment containing the first 1937 residues is sufficient for GST-FKBP12.6 binding. Co-expression of overlapping NH2 and COOH-terminal fragments covering the entire sequence of RyR2 produced functional channels but did not restore GST-FKBP12.6 binding. These data suggest that FKBP12.6 binding is likely to be conformation-dependent. Binding of FKBP12.6 to the NH2-terminal domain may play a role in stabilizing the conformation of this region.	Univ Calgary, Cardiovasc Res Grp, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Calgary, Cardiovasc Res Grp, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Chen, SRW (corresponding author), Univ Calgary, Cardiovasc Res Grp, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Xiao, Bailong/B-6187-2012					Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Bultynck G, 2001, J BIOL CHEM, V276, P47715, DOI 10.1074/jbc.M106573200; Bultynck G, 2001, BIOCHEM J, V354, P413, DOI 10.1042/0264-6021:3540413; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; Chen SRW, 1997, J BIOL CHEM, V272, P24234, DOI 10.1074/jbc.272.39.24234; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Doi M, 2002, CIRCULATION, V105, P1374, DOI 10.1161/hc1102.105270; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Marks AR, 2002, CIRCULATION, V106, P8, DOI 10.1161/01.CIR.0000021746.82888.83; Marks AR, 2002, FRONT BIOSCI-LANDMRK, V7, pD970, DOI 10.2741/marks; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Masumiya H, 2001, J BIOL CHEM, V276, P39727, DOI 10.1074/jbc.M106557200; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Priori SG, 2001, CIRCULATION, V103, P196; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sharma MR, 2002, BIOPHYS J, V82, p644A; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; TIMERMAN AP, 1994, BIOCHEM BIOPH RES CO, V198, P701, DOI 10.1006/bbrc.1994.1101; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Xiao BL, 2002, J BIOL CHEM, V277, P41778, DOI 10.1074/jbc.M208210200; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Zissimopoulos S, 2002, BIOPHYS J, V82, p59A; Zucchi R, 1997, PHARMACOL REV, V49, P1	34	80	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3786	3792		10.1074/jbc.M210962200	http://dx.doi.org/10.1074/jbc.M210962200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446682	hybrid			2022-12-27	WOS:000180869700035
J	Zhang, SB; Mizutani, A; Hisatsune, C; Higo, T; Bannai, H; Nakayama, T; Hattori, M; Mikoshiba, K				Zhang, SB; Mizutani, A; Hisatsune, C; Higo, T; Bannai, H; Nakayama, T; Hattori, M; Mikoshiba, K			Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; ACTIN-BINDING DOMAIN; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; CYTOSKELETAL PROTEIN-4.1; MONOCLONAL-ANTIBODIES; SKELETAL PROTEIN-4.1; 4.1-BINDING SITE; MOUSE CEREBELLUM; TERNARY COMPLEX	Protein 4.1N was identified as a binding molecule for the C-terminal cytoplasmic tail of inositol 1,4,5-trisphosphate receptor type 1 (IP(3)R1) using a yeast two-hybrid system. 4.1N and IP(3)R1 associate in both subconfluent and confluent Madin-Darby canine kidney (MDCK) cells, a well studied tight polarized epithelial cell line. In subconfluent MDCK cells, 4.1N is distributed in the cytoplasm and the nucleus; IP(3)R1 is localized in the cytoplasm. In confluent MDCK cells, both 4.1N and IP(3)R1 are predominantly translocated to the basolateral membrane domain, whereas 4.1R, the prototypical homologue of 4.1N, is localized at the tight junctions (Mattagajasingh, S. N., Huang, S. C., Hartenstein, J. S., and Benz, E. J., Jr. (2000) J. Biol. Chem. 275, 3057330585), and other endoplasmic reticulum marker proteins are still present in the cytoplasm. Moreover, the 4.1N-binding region of IP(3)R1 is necessary and sufficient for the localization of IP(3)R1 at the basolateral membrane domain. A fragment of the IP(3)R1-binding region of 4.1N blocks the localization of co-expressed IP3R1 at the basolateral membrane domain. These data indicate that 4.1N is required for IP3R1 translocation to the basolateral membrane domain in polarized MDCK cells.	Univ Tokyo, Inst Med Sci, Div Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; Tokyo Womens Med Univ, Dept Pediat, Tokyo 1628666, Japan; Japan Sci & Technol Corp, ICORP, Calcium Osciallat Project, Tokyo 1080071, Japan	University of Tokyo; RIKEN; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Zhang, SB (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Neurobiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Bannai, Hiroko/I-7130-2014; Mizutani, Akihiro/GPS-4809-2022; Hattori, Mitsuharu/F-3859-2010; Hisatsune, Chihiro/C-6661-2017; Mikoshiba, Katsuhiko/N-7943-2015	Bannai, Hiroko/0000-0002-0951-488X; Mizutani, Akihiro/0000-0003-4155-802X; Hattori, Mitsuharu/0000-0002-0503-4969; Hisatsune, Chihiro/0000-0001-7811-7784; Zhang, Songbai/0000-0002-2033-8389				Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Binda AV, 2002, MOL PHARMACOL, V62, P507, DOI 10.1124/mol.62.3.507; BUSH KT, 1994, J BIOL CHEM, V269, P23694; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; DeLisle S, 1996, AM J PHYSIOL-CELL PH, V270, pC1255; DISCHER D, 1993, J BIOL CHEM, V268, P7186; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUILLEMETTE G, 1988, J BIOL CHEM, V263, P4541; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; Holda JR, 1997, FEBS LETT, V403, P191, DOI 10.1016/S0014-5793(97)00051-3; HORNE WC, 1993, BLOOD, V82, P2558; KHAN AA, 1992, SCIENCE, V257, P815, DOI 10.1126/science.1323146; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; LIEVREMONT JP, 1994, BIOCHEM J, V300, P419, DOI 10.1042/bj3000419; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LUCKHOFF A, 1994, BIOPHYS J, V67, P177, DOI 10.1016/S0006-3495(94)80467-9; MAEDA N, 1988, J NEUROCHEM, V51, P1724, DOI 10.1111/j.1471-4159.1988.tb01151.x; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; Maes K, 1999, CELL CALCIUM, V25, P143, DOI 10.1054/ceca.1998.0011; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; MIGNERY GA, 1992, J BIOL CHEM, V267, P7450; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Mikoshiba K, 1997, CURR OPIN NEUROBIOL, V7, P339, DOI 10.1016/S0959-4388(97)80061-X; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL574, DOI 10.1152/ajplung.1998.275.3.L574; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Parra M, 2000, J BIOL CHEM, V275, P3247, DOI 10.1074/jbc.275.5.3247; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; Putney JW, 1997, CELL CALCIUM, V21, P257, DOI 10.1016/S0143-4160(97)90050-6; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Rosado JA, 2000, TRENDS CARDIOVAS MED, V10, P327, DOI 10.1016/S1050-1738(01)00073-1; ROSSIER MF, 1991, BIOCHEM J, V274, P643, DOI 10.1042/bj2740643; SATOH T, 1990, J CELL BIOL, V111, P615, DOI 10.1083/jcb.111.2.615; SHARP AH, 1992, J BIOL CHEM, V267, P7444; Shen L, 2000, J NEUROSCI, V20, P7932; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Tanimura A, 2000, J BIOL CHEM, V275, P27488; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC920, DOI 10.1152/ajpcell.1994.267.4.C920; Walensky LD, 1998, J CELL BIOL, V141, P143, DOI 10.1083/jcb.141.1.143; Walensky LD, 1999, J NEUROSCI, V19, P6457; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; YAMADA M, 1995, BIOCHEM J, V308, P83, DOI 10.1042/bj3080083; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613	58	65	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4048	4056		10.1074/jbc.M209960200	http://dx.doi.org/10.1074/jbc.M209960200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12444087	hybrid			2022-12-27	WOS:000180869700069
J	Strieder, V; Lutz, W				Strieder, V; Lutz, W			E2F proteins regulate MYCN expression in neuroblastomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; N-MYC; C-MYC; CELL-CYCLE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; RETINOIC ACID; NEGATIVE REGULATION; TGF-BETA; IN-VIVO	Amplification of the MYCN gene, resulting in overexpression. of MYCN, distinguishes a subset of neuroblastomas with poor prognosis. The transcription factors driving MYCN expression in neuroblastomas are unknown. In transient-transfection assays, E2F-1, E2F-2, and E2F-3 activate a MYCN reporter construct dependent on the presence of several putative E2F-binding sites. Using chromatin immunoprecipitation, we show that E2F-1, E2F-2, and E2F-3 bind to the proximal MYCN promoter in vivo, specifically in neuroblastoma cell lines expressing MYCN. Inhibition of E2F activity in MYCN-amplified cells by the overexpression of p16(INK4A) reduced MYCN expression. In addition, we provide evidence that E2F proteins are involved in the negative regulation of MYCN by TGF-beta and retinoic acid. These data suggest that E2F transcription factors are critical for both the full activation and the repression of MYCN in neuroblastomas.	Int Mol Biol & Tumor Res, IMT, D-35033 Marburg, Germany		Lutz, W (corresponding author), Int Mol Biol & Tumor Res, IMT, Emil Mannhopff Str 2, D-35033 Marburg, Germany.	lutz@imt.uni-marburg.de						Bouzahzah B, 2000, CANCER RES, V60, P4531; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Diccianni MB, 1999, INT J CANCER, V80, P145, DOI 10.1002/(SICI)1097-0215(19990105)80:1<145::AID-IJC26>3.3.CO;2-7; Easton J, 1998, CANCER RES, V58, P2624; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Ferreira R, 2001, ONCOGENE, V20, P3128, DOI 10.1038/sj.onc.1204337; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; HILLER S, 1991, ONCOGENE, V6, P969; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Iolascon A, 2000, BRIT J CANCER, V82, P1171; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; JOOSS K, 1995, ONCOGENE, V10, P1529; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Lutz W, 1997, ONCOGENE, V15, P303, DOI 10.1038/sj.onc.1201195; Lutz W, 2002, BBA-REV CANCER, V1602, P61, DOI 10.1016/S0304-419X(02)00036-7; MCCUNE BK, 1993, AM J PATHOL, V142, P49; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Peverali FA, 1996, ONCOGENE, V12, P457; Raschella G, 1997, J CELL BIOCHEM, V67, P297, DOI 10.1002/(SICI)1097-4644(19971201)67:3<297::AID-JCB2>3.0.CO;2-R; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Savelyeva L, 2001, CANCER LETT, V167, P115, DOI 10.1016/S0304-3835(01)00472-4; SCHULZE A, 1994, ONCOGENE, V9, P3475; SERRA R, 1995, DEVELOPMENT, V121, P3057; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Strieder V, 2002, CANCER LETT, V180, P107, DOI 10.1016/S0304-3835(02)00020-4; Takahashi Y, 2000, GENE DEV, V14, P804; Takita J, 1998, ONCOGENE, V17, P3137, DOI 10.1038/sj.onc.1202232; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; WADA RK, 1992, ONCOGENE, V7, P711; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; WONG KK, 1995, MOL CELL BIOL, V15, P6535; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X	54	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2983	2989		10.1074/jbc.M207596200	http://dx.doi.org/10.1074/jbc.M207596200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12438307	hybrid			2022-12-27	WOS:000180915000029
J	Uyama, T; Kitagawa, H; Tanaka, J; Tamura, J; Ogawa, T; Sugahara, K				Uyama, T; Kitagawa, H; Tanaka, J; Tamura, J; Ogawa, T; Sugahara, K			Molecular cloning and expression of a second chondroitin N-acetylgalactosaminyltransferase involved in the initiation and elongation of chondroitin/dermatan sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE-REGION; TUMOR SUPPRESSORS EXT1; HEPARAN-SULFATE; CAENORHABDITIS-ELEGANS; CHAIN INITIATION; DROSOPHILA-MELANOGASTER; GLUCURONIC-ACID; CORE PROTEIN; KEY ENZYME; BIOSYNTHESIS	We identified a novel human chondroitin N-acetyl-galactosaminyltransferase, designated chondroitin Gal-NAcT-2 after a BLAST analysis of the GenBank(TM) data base using the sequence of a previously described human chondroitin N-acetylgalactosaminyltransferase (chondroitin GaINAcT-1) as a probe. The new cDNA sequence contained an open reading frame encoding a protein of 542 amino acids with a type 11 transmembrane protein topology. The amino acid sequence displayed 60% identity to that of human chondroitin GaINAcT-1. Like chondroitin GaINAcT-1, the expression of a soluble form of the protein in COS-1 cells produced an active enzyme, which not only transferred 131,4-N-acetylgalactosamine (GaINAc) from UDP-[H-3]GaINAc to a polymer chondroitin representing growing chondroitin chains (beta-GaINAc transferase II activity) but also to GleUAbeta1-3Galbeta1-O-C(2)H(4)NHCbz, a synthetic substrate for beta-Gal-NAc transferase I that transfers the first GaINAc to the core tetrasaccharide in the protein-linkage region of chondroitin sulfate. In contrast, the tetrasaccharide serine (GIcUAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser) derived from the linkage region, which is an inert acceptor substrate for chondroitin GaINAcT-1, served as an acceptor substrate. The coding region of this enzyme was divided into seven discrete exons, which is similar to the genomic organization of the chondroitin GalNAcT-1 gene, and was localized to chromosome 10q11.22. Northern blot analysis revealed that the chondroitin GaIN-AcT-2 gene exhibited a ubiquitous but differing expression in human tissues, and the expression pattern differed from that of chondroitin GaINAcT-1. Thus, we demonstrated redundancy in the chondroitin GaINAc transferases involved in the biosynthetic initiation and elongation of chondroitin sulfate, which is important for understanding the biosynthetic mechanisms leading to the selective chain assembly of chondroitin/dermatan sulfate on the linkage region tetrasaccharide common to various proteoglyeans containing chondroitin/dermatan sulfate and heparin/heparan sulfate chains.	Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Tottori Univ, Fac Educ & Reg Sci, Dept Environm Sci, Tottori 6808551, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	Kobe Pharmaceutical University; Tottori University; RIKEN	Sugahara, K (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	k-sugar@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079				Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; Fritz TA, 1997, GLYCOBIOLOGY, V7, P587, DOI 10.1093/glycob/7.5.587-c; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Kim BT, 2002, J BIOL CHEM, V277, P13659, DOI 10.1074/jbc.M111630200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P905, DOI 10.1093/glycob/7.7.905; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; KITAGAWA H, 1995, J BIOCHEM-TOKYO, V117, P1083, DOI 10.1093/oxfordjournals.jbchem.a124810; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kitagawa H, 2001, J BIOL CHEM, V276, P4834, DOI 10.1074/jbc.C000835200; Kitagawa H, 1999, GLYCOBIOLOGY, V9, P697, DOI 10.1093/glycob/9.7.697; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lidholt K, 1997, GLYCOCONJUGATE J, V14, P737, DOI 10.1023/A:1018525602197; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Lindahl U., 1972, GLYCOPROTEINS THEIR, P491; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 1999, BIOCHEM J, V340, P353, DOI 10.1042/0264-6021:3400353; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; ROHRMANN K, 1985, EUR J BIOCHEM, V148, P463, DOI 10.1111/j.1432-1033.1985.tb08862.x; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Tamura J, 1996, LIEBIGS ANN, P1239; Tamura J, 2002, BIOORG MED CHEM LETT, V12, P1901, DOI 10.1016/S0960-894X(02)00327-X; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295	51	92	97	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3072	3078		10.1074/jbc.M209446200	http://dx.doi.org/10.1074/jbc.M209446200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12433924	hybrid			2022-12-27	WOS:000180915000040
J	Hosoda, A; Kimata, Y; Tsuru, A; Kohno, K				Hosoda, A; Kimata, Y; Tsuru, A; Kohno, K			JPDI, a novel endoplasmic reticulum-resident protein containing both a BiP-interacting J-domain and thioredoxin-like motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE ACTIVITY; DISULFIDE-ISOMERASE; DNAJ HOMOLOG; MOLECULAR CHAPERONES; ER MEMBRANE; YEAST; DEGRADATION; TRANSLOCON; BINDING; STRESS	Several endoplasmic reticulum. (ER)-resident luminal proteins have a characteristic ER retrieval signal, KDEL, or its variants at their C terminus. Our previous work searching EST databases for proteins containing the C-terminal KDEL motif predicted some novel murine proteins, one of which designated JPDI (J-domain-containing protein disulfide isomerase-like protein) is characterized in this study. The primary structure of JPDI is unique, because in addition to a J-domain motif adjacent to the N-terminal translocation signal sequence, four thioredoxin-like motifs were found in a single polypeptide. As examined by Northern blotting, the expression of JPDI was essentially ubiquitous in tissues and almost independent of ER stress. A computational prediction that JPDl is an ER-resident luminal protein was experimentally supported by immunofluorescent staining of epitope-tagged JPDI-expressing cells together with glycosylation and protease protection studies of this protein. JPDI probably acts as a DnaJ-like partner of BiP, because a recombinant protein carrying the J-domain of JPDI associated with BiP in an ATP-dependent manner and enhanced its ATPase activity. We speculate that for the folding of some proteins in the ER, chaperoning by BiP and formation of proper disulfide bonds may synchronously occur in a JPDI-dependent manner.	Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, Nara 6300101, Japan	Nara Institute of Science & Technology	Kohno, K (corresponding author), Nara Inst Sci & Technol, Res & Educ Ctr Genet Informat, 8916-5 Takayama, Nara 6300101, Japan.		Kohno, Kenji/AAZ-6573-2020	Kohno, Kenji/0000-0002-3503-6551				Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1997, MOL CHAPERONES PROTE, P108; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Dudek J, 2002, EMBO J, V21, P2958, DOI 10.1093/emboj/cdf315; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kimata Y, 2000, GENE, V261, P321, DOI 10.1016/S0378-1119(00)00499-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Silberstein S, 1998, J CELL BIOL, V143, P921, DOI 10.1083/jcb.143.4.921; Skowronek MH, 1999, BIOL CHEM, V380, P1133, DOI 10.1515/BC.1999.142; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; WALL D, 1994, J BIOL CHEM, V269, P5446; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300; WAWRZYNOW A, 1997, MOL CHAPERONES PROTE, P95; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200	42	82	88	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2669	2676		10.1074/jbc.M208346200	http://dx.doi.org/10.1074/jbc.M208346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12446677	hybrid			2022-12-27	WOS:000180562000079
J	Kukarin, A; Rong, MQ; McAllister, WT				Kukarin, A; Rong, MQ; McAllister, WT			Exposure of T7 RNA polymerase to the isolated binding region of the promoter allows transcription from a single-stranded template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START SITE; INITIATION; COMPLEX; SPECIFICITY; STABILITY; SEQUENCE; DEPENDS; PROTEIN; GAL4; DNA	While the binding region of the T7 promoter must be double-stranded (ds) to function, the non-template strand in the initiation region is dispensable, and a promoter that lacks this element allows efficient initiation. To determine whether the binding region serves merely to recruit the RNA polymerase (RNAP) to the vicinity of a melted initiation region or provides other functions, we utilized a GAL4-T7 RNAP fusion protein to provide an independent binding capacity to the RNAP. When the GAL4-T7 RNAP was recruited to a single-stranded (ss) promoter via a nearby Gal4 recognition sequence, no transcription was observed. However, transcription from the ss promoter could be activated by the addition, in trans, of a ds hairpin loop that contains only the binding region of the promoter. The same results were obtained in the absence of the GAL4 recognition sequence in the template and were also observed with wild type enzyme. Gel-shift experiments indicate that exposure of the RNAP to the isolated binding region facilitates recruitment of the ss template, but that the binding region is displaced from the complex prior to initiation. We conclude that exposure of the RNAP to the isolated binding region reorganizes the enzyme, allowing it to bind to the ss template. These findings have potential implications with regard to mechanisms of promoter binding and melting.	SUNY Hlth Sci Ctr, Dept Immunol & Microbiol, Downstate Med Ctr, Morse Inst Mol Genet, Brooklyn, NY 11203 USA; Russian Acad Sci, Inst Mol Genet, Lab Mol Genet Microorganisms, Moscow 123182, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Russian Academy of Sciences	McAllister, WT (corresponding author), SUNY Hlth Sci Ctr, Dept Immunol & Microbiol, Downstate Med Ctr, Morse Inst Mol Genet, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	wmcallister@downstate.edu			NIGMS NIH HHS [R01 GM038147-14S1, GM38147, R01 GM038147] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038147] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bandwar RP, 2001, J BIOL CHEM, V276, P14075, DOI 10.1074/jbc.M011289200; Brieba LG, 2001, BIOCHEMISTRY-US, V40, P3882, DOI 10.1021/bi002716c; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Diaz GA, 1996, BIOCHEMISTRY-US, V35, P10837, DOI 10.1021/bi960488+; DIAZ GA, 1993, J MOL BIOL, V229, P805, DOI 10.1006/jmbi.1993.1086; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; Imburgio D, 2002, J MOL BIOL, V319, P37, DOI 10.1016/S0022-2836(02)00261-9; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; KLEMENT JF, 1990, J MOL BIOL, V215, P21, DOI 10.1016/S0022-2836(05)80091-9; Liang SD, 1996, MOL CELL BIOL, V16, P3773; MASLAK M, 1993, BIOCHEMISTRY-US, V32, P4281, DOI 10.1021/bi00067a017; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; OSTRANDER EA, 1990, SCIENCE, V249, P1261, DOI 10.1126/science.2399463; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Rong MQ, 1998, P NATL ACAD SCI USA, V95, P515, DOI 10.1073/pnas.95.2.515; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Stano NM, 2002, J MOL BIOL, V315, P1009, DOI 10.1006/jmbi.2001.5313; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; TEMIAKOV D, 2002, IN PRESS ACTA CRYSTA; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Villemain J, 1997, J MOL BIOL, V273, P958, DOI 10.1006/jmbi.1997.1358; Weston BF, 1997, J MOL BIOL, V272, P21, DOI 10.1006/jmbi.1997.1199; Young BA, 2002, CELL, V109, P417, DOI 10.1016/S0092-8674(02)00752-3	31	7	7	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2419	2424		10.1074/jbc.M210058200	http://dx.doi.org/10.1074/jbc.M210058200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441338	hybrid			2022-12-27	WOS:000180562000048
J	Liu, B; Wu, D				Liu, B; Wu, D			The first inner loop of endothelin receptor type B is necessary for specific coupling to G alpha(13)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN ACTIVATION; MOLECULAR MECHANISMS; PHOSPHOLIPASE-C; ALPHA-SUBUNITS; SELECTIVITY; INVOLVEMENT; SEQUENCES; DEFECTS; MICE	Endothelin (EDN) receptor type B (EDNRB) activates serum response factor (SRF) via G(q/11) and G(12/13) G proteins. In this study, we investigated the involvement of intracellular loop sequences of EDNRB in coupling to these G proteins. EDNRB mutants were generated and tested for their abilities to activate SRF in NIH3T3 cells and in the mouse embryonic fibroblast cell line (F-q/11) lacking both Galpha(q) and Galpha(11). EDNRB can activate SRF in NIH 3T3 cells via G(q/11), although it can only activate SRF through G(12/13) in F-q/11 cells. Mutants with mutations in the second and third inner loops of EDNRB functioned in the same manner in both cell lines, either able or unable to activate SRF. This finding suggests that the second and third inner loops of EDNRB either participate or not in coupling to both G(q/11) and G(12/13) but are not specific for either one. However, in the first inner loop, a substitution of three Ala residues for Met(128)-Arg(129)-Asn(130) abolished the ability to activate SRF only in F-q/11 cells, suggesting that this mutation might specifically disrupt the coupling to G(12/13) rather than to G(q/11). Further characterization of this first inner loop mutant revealed that exogenous expression of Galpha(12) or Galpha(q) could restore SRF activation, whereas the expression of Galpha(13) did not. Therefore, we conclude that although the three intracellular loops of EDNRB may be involved in coupling to G proteins, residues Met(128)-Arg(129)-Asn(130) in the first intracellular loop are specifically required for activation of Galpha(13).	Univ Connecticut, Med Ctr, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Rochester, Dept Pharmacol, Rochester, NY 14620 USA	University of Connecticut; University of Rochester	Wu, D (corresponding author), Univ Connecticut, Med Ctr, Dept Genet & Dev Biol, Farmington, CT 06030 USA.							Aquilla E, 1996, J BIOL CHEM, V271, P31572, DOI 10.1074/jbc.271.49.31572; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Cramer H, 2001, EUR J BIOCHEM, V268, P5449, DOI 10.1046/j.0014-2956.2001.02486.x; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Kitamura K, 1999, AM J PHYSIOL-CELL PH, V276, pC930, DOI 10.1152/ajpcell.1999.276.4.C930; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; PIN JP, 1994, EMBO J, V13, P342, DOI 10.1002/j.1460-2075.1994.tb06267.x; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; TAKAGI Y, 1995, J BIOL CHEM, V270, P10072, DOI 10.1074/jbc.270.17.10072; TAKIGAWA M, 1995, EUR J BIOCHEM, V228, P102, DOI 10.1111/j.1432-1033.1995.0102o.x; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; WU DQ, 1995, J BIOL CHEM, V270, P9828, DOI 10.1074/jbc.270.17.9828; WU DQ, 1992, J BIOL CHEM, V267, P1811; Xie W, 1997, J BIOL CHEM, V272, P24948, DOI 10.1074/jbc.272.40.24948	21	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2384	2387		10.1074/jbc.M208683200	http://dx.doi.org/10.1074/jbc.M208683200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441350	hybrid			2022-12-27	WOS:000180562000043
J	Williams, RS; Glover, JNM				Williams, RS; Glover, JNM			Structural consequences of a cancer-causing BRCA1-BRCT missense mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER; TRANSCRIPTIONAL ACTIVATION; GERMLINE MUTATIONS; GENETIC-ANALYSIS; PROTEIN MODELS; BRCT DOMAINS; BREAST; SUSCEPTIBILITY; INTERACTS; BINDING	The integrity of the carboxyl-terminal BRCT repeat region is critical for BRCA1 tumor suppressor function; however, the molecular details of how a number of clinically derived BRCT missense mutations affect BRCA1 function remain largely unknown. Here we assess the structural response of the BRCT tandem repeat domain to a well characterized, cancer-associated single amino acid substitution, Met-1775 --> Arg-1775. The structure of BRCT-M1775R reveals that the mutated side chain is extruded from the protein hydrophobic core, thereby altering the protein surface. Charge-charge repulsion, rearrangement of the hydrophobic core, and disruption of the native hydrogen bonding network at the interface between the two BRCT repeats contribute to the conformational instability of BRCT-M1775R. Destabilization and global unfolding of the mutated BRCT domain at physiological temperatures explain the pleiotropic molecular and genetic defects associated with the BRCA1-M1775R protein.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Glover, JNM (corresponding author), Univ Alberta, Dept Biochem, 437 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Williams, R Scott/A-6059-2015	Williams, R Scott/0000-0002-4610-8397				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; Deng CX, 2000, BIOESSAYS, V22, P728; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Krishnan VV, 2001, BIOCHEMISTRY-US, V40, P13158, DOI 10.1021/bi010979g; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Matthews BW, 1996, FASEB J, V10, P35, DOI 10.1096/fasebj.10.1.8566545; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Shen DJ, 1999, ONCOL RES, V11, P63; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yarden RI, 1999, P NATL ACAD SCI USA, V96, P4983, DOI 10.1073/pnas.96.9.4983; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	38	84	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2630	2635		10.1074/jbc.M210019200	http://dx.doi.org/10.1074/jbc.M210019200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427738	hybrid			2022-12-27	WOS:000180562000074
J	Yoon, S; Liu, ZC; Eyobo, Y; Orth, K				Yoon, S; Liu, ZC; Eyobo, Y; Orth, K			Yersinia effector YopJ inhibits yeast MAPK signaling pathways by an evolutionarily conserved mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; FOCAL ADHESIONS; KINASE; DISRUPTION; EXPRESSION; ACTIVATION; P130(CAS); TARGETS; BINDING	Yersinia effector, YopJ, inhibits the innate immune response by blocking MAP kinase and NFkappaB signaling pathways in mammalian cells. Herein, YopJ is shown to disrupt the MAP kinase signaling pathways in Saccharomyces cerevisiae. Expression of YopJ in yeast blocks the ability of yeast to respond to a factor by disrupting activation of the pheromone signaling pathway upstream of the activation of the MAPK Fus3p. YopJ also blocks the high osmolarity growth (HOG) MAP kinase pathway in yeast upstream of the activation of the MAPK Hog1p. YopJ is proposed to block the MAP kinase pathways in yeast in a similar manner to the way it blocks mammalian signaling pathways, implicating that a novel, evolutionarily conserved mechanism of regulation is utilized for signal transduction by these pathways.	Univ Texas, Dept Mol Biol, SW Med Ctr, SW Med Sch, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas, Dept Mol Biol, SW Med Ctr, SW Med Sch, 5323 Harry Hines Blvd,Rm NA5-320, Dallas, TX 75390 USA.		Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620				Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; CHAN RK, 1982, MOL CELL BIOL, V2, P21, DOI 10.1128/MCB.2.1.21; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mangel WF, 1997, TRENDS BIOCHEM SCI, V22, P393, DOI 10.1016/S0968-0004(97)01123-7; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307; Rose MD., 1990, METHODS YEAST GENETI; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289	31	41	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2131	2135		10.1074/jbc.M209905200	http://dx.doi.org/10.1074/jbc.M209905200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433923	hybrid			2022-12-27	WOS:000180562000009
J	Blanc, V; Davidson, NO				Blanc, V; Davidson, NO			C-to-U RNA editing: Mechanisms leading to genetic diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							B MESSENGER-RNA; APOBEC-1 COMPLEMENTATION FACTOR; CYTIDINE DEAMINASE AID; BINDING PROTEIN; SECONDARY STRUCTURE; MOLECULAR-CLONING; CATALYTIC SUBUNIT; ENZYME-COMPLEX; GRY-RBP; SITE		Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Davidson, NO (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.				NHLBI NIH HHS [HL-38180] Funding Source: Medline; NIDDK NIH HHS [DK-56260] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180, R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anant S, 2002, BBA-GENE STRUCT EXPR, V1575, P54, DOI 10.1016/S0167-4781(02)00250-6; Anant S, 2001, J BIOL CHEM, V276, P47338, DOI 10.1074/jbc.M104911200; Anant S, 2000, MOL CELL BIOL, V20, P1982, DOI 10.1128/MCB.20.6.1982-1992.2000; Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Anant S, 2001, AM J PHYSIOL-CELL PH, V281, pC1904, DOI 10.1152/ajpcell.2001.281.6.C1904; BACKUS JW, 1991, NUCLEIC ACIDS RES, V19, P6781, DOI 10.1093/nar/19.24.6781; Blanc V, 2001, J BIOL CHEM, V276, P46386, DOI 10.1074/jbc.M107654200; Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200; Cappione AJ, 1997, AM J HUM GENET, V60, P305; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Dance GSC, 2002, J BIOL CHEM, V277, P12703, DOI 10.1074/jbc.M111337200; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Greeve J, 1999, ONCOGENE, V18, P6357, DOI 10.1038/sj.onc.1203039; Greeve J, 1998, BIOL CHEM, V379, P1063, DOI 10.1515/bchm.1998.379.8-9.1063; HARRIS SG, 1993, J BIOL CHEM, V268, P7382; Henderson JO, 2001, BBA-GENE STRUCT EXPR, V1522, P22, DOI 10.1016/S0167-4781(01)00295-0; Hersberger M, 1999, J BIOL CHEM, V274, P34590, DOI 10.1074/jbc.274.49.34590; Hersberger M, 1998, J BIOL CHEM, V273, P9435, DOI 10.1074/jbc.273.16.9435; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; LAU PP, 1991, J BIOL CHEM, V266, P20550; Lau PP, 1997, J BIOL CHEM, V272, P1452, DOI 10.1074/jbc.272.3.1452; Lau PP, 2001, BIOCHEM BIOPH RES CO, V282, P977, DOI 10.1006/bbrc.2001.4679; Lau PP, 2001, J BIOL CHEM, V276, P46445, DOI 10.1074/jbc.M109215200; Lee RM, 1998, GASTROENTEROLOGY, V115, P1096, DOI 10.1016/S0016-5085(98)70080-0; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Lellek H, 2002, J BIOL CHEM, V277, P23638, DOI 10.1074/jbc.M203517200; LI XX, 1994, J CELL BIOL, V124, P7, DOI 10.1083/jcb.124.1.7; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mehta A, 2002, RNA, V8, P69, DOI 10.1017/S1355838202015649; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Mukhopadhyay D, 2002, AM J HUM GENET, V70, P38, DOI 10.1086/337952; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Richardson N, 1998, J BIOL CHEM, V273, P31707, DOI 10.1074/jbc.273.48.31707; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; SHAH RR, 1991, J BIOL CHEM, V266, P16301; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Sowden MP, 2002, J CELL SCI, V115, P1027; Sowden MP, 2001, BIOCHEM J, V359, P697, DOI 10.1042/0264-6021:3590697; Yamanaka S, 2000, EMBO J, V19, P5533, DOI 10.1093/emboj/19.20.5533; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yang Y, 2001, EXP CELL RES, V267, P153, DOI 10.1006/excr.2001.5255	48	104	113	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1395	1398		10.1074/jbc.R200024200	http://dx.doi.org/10.1074/jbc.R200024200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12446660	hybrid			2022-12-27	WOS:000180462200003
J	Fiedler, U; Krissl, T; Koidl, S; Weiss, C; Koblizek, T; Deutsch, U; Martiny-Baron, G; Marme, D; Augustin, HG				Fiedler, U; Krissl, T; Koidl, S; Weiss, C; Koblizek, T; Deutsch, U; Martiny-Baron, G; Marme, D; Augustin, HG			Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-VESSEL MATURATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; EXPRESSION; SURVIVAL; MODEL; MICE	Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) have been identified as ligands with different effector functions of the vascular assembly and maturation-mediating receptor tyrosine kinase Tie-2. To understand the molecular interactions of the angiopoietins with their receptor, we have studied the binding of Ang-1 and Ang-2 to the Tie-2 receptor. Enzyme-linked immunosorbent assay-based competition assays and co-immunoprecipitation experiments analyzing the binding of Ang-1 and Ang-2 to truncation mutants of the extracellular domain of Tie-2 showed that the first Ig-like loop of Tie-2 in combination with the epidermal growth factor (EGF)-like repeats (amino acids 1-360) is required for angiopoietin binding. The first Ig-like domain or the EGF-like repeats alone are not capable of binding Ang-1 and Ang-2. Concomitantly, we made the surprising finding that Tie-2 exon-2 knockout mice do express a mutated Tie-2 protein that lacks 104 amino acids of the first Ig-like domain. This mutant Tie-2 receptor is functionally inactive as shown by the lack of ligand binding and receptor phosphorylation. Collectively, the data show that the first 104 amino acids of the Tie-2 receptor are essential but not sufficient for angiopoietin binding. Conversely, the first 360 amino acids (Ig-like domain plus EGF-like repeats) of the Tie-2 receptor are necessary and sufficient to bind both Ang-1 and Ang-2, which suggests that differential receptor binding is not likely to be responsible for the different functions of Ang-1 and Ang-2.	Tumor Biol Ctr, Dept Vasc Biol & Angiogenesis Res, D-79106 Freiburg, Germany; Max Planck Inst Physiol & Clin Res, D-61231 Bad Nauheim, Germany	Max Planck Society	Fiedler, U (corresponding author), Tumor Biol Ctr, Dept Vasc Biol & Angiogenesis Res, D-79106 Freiburg, Germany.	augustin@angiogenese.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242; Deutsch, Urban/0000-0003-4265-6262				Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Goede V, 1998, LAB INVEST, V78, P1385; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Huang YQ, 2002, BLOOD, V99, P1646, DOI 10.1182/blood.V99.5.1646; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mandriota SJ, 1998, CIRC RES, V83, P852, DOI 10.1161/01.RES.83.8.852; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Reiss Y, 1998, EUR J IMMUNOL, V28, P3086, DOI 10.1002/(SICI)1521-4141(199810)28:10<3086::AID-IMMU3086>3.3.CO;2-Q; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904	25	128	147	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1721	1727		10.1074/jbc.M208550200	http://dx.doi.org/10.1074/jbc.M208550200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427764	hybrid			2022-12-27	WOS:000180462200048
J	Govaerts, C; Bondue, A; Springael, JY; Olivella, M; Deupi, X; Le Poul, E; Wodak, SJ; Parmentier, M; Pardo, L; Blanpain, C				Govaerts, C; Bondue, A; Springael, JY; Olivella, M; Deupi, X; Le Poul, E; Wodak, SJ; Parmentier, M; Pardo, L; Blanpain, C			Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; CONFORMATIONAL-CHANGES; NEUROKININ-1 RECEPTOR; SIGNAL-TRANSDUCTION; ANTAGONIST BINDING; TYROSINE RESIDUES; HYDROGEN-BONDS; RHODOPSIN; 2ND	CCR5 is a G protein-coupled receptor responding to four natural agonists, the chemokines RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and monocyte chemotactic protein (MCP)-2, and is the main co-receptor for the macrophage-tropic human immunodeficiency virus strains. We have previously identified a structural motif in the second transmembrane helix of CCR5, which plays a crucial role in the mechanism of receptor activation. We now report the specific role of aromatic residues in helices 2 and 3 of CCR5 in this mechanism. Using site-directed mutagenesis and molecular modeling in a combined approach, we demonstrate that a cluster of aromatic residues at the extracellular border of these two helices are involved in chemokine-induced activation. These aromatic residues are involved in interhelical interactions that are key for the conformation of the helices and govern the functional response to chemokines in a ligand-specific manner. We therefore suggest that transmembrane helices 2 and 3 contain important structural elements for the activation mechanism of chemokine receptors, and possibly other related receptors as well.	Free Univ Brussels, IRIBHN, B-1070 Brussels, Belgium; Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, Lab Med Computac, Bellaterra 08193, Spain; Euroscreen SA, B-1070 Brussels, Belgium; Free Univ Brussels, Serv Conformat Macromol Biol, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Autonomous University of Barcelona; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Parmentier, M (corresponding author), Free Univ Brussels, IRIBHN, 808 Route Lennik,Campus Erasme, B-1070 Brussels, Belgium.		Deupi, Xavier/B-2424-2009; Blanpain, Cedric/ABD-8392-2021	Deupi, Xavier/0000-0003-4572-9316; Parmentier, Marc/0000-0001-8081-4685; Pardo, Leonardo/0000-0003-1778-7420; wodak, shoshana/0000-0002-0701-6545				Abdulaev NG, 1998, P NATL ACAD SCI USA, V95, P12854, DOI 10.1073/pnas.95.22.12854; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 1999, BLOOD, V94, P1899; Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CASE DA, 1997, AMBER5; CHO W, 1995, J NEUROCHEM, V65, P2105, DOI 10.1046/j.1471-4159.1995.65052105.x; Colson AO, 1998, MOL PHARMACOL, V54, P968, DOI 10.1124/mol.54.6.968; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dairaghi DJ, 1998, BLOOD, V91, P2905, DOI 10.1182/blood.V91.8.2905.2905_2905_2913; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FONG TM, 1994, J BIOL CHEM, V269, P2728; FONG TM, 1993, NATURE, V362, P350; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Granas C, 1998, J RECEPT SIGNAL TR R, V18, P225, DOI 10.3109/10799899809047745; Huang XP, 1999, BRIT J PHARMACOL, V126, P735, DOI 10.1038/sj.bjp.0702301; Javitch JA, 1998, BIOCHEMISTRY-US, V37, P998, DOI 10.1021/bi972241y; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Kask K, 1996, EMBO J, V15, P236, DOI 10.1002/j.1460-2075.1996.tb00354.x; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lee SY, 1996, RECEPT SIGNAL TRANS, V6, P43; Lopez-Rodriguez ML, 2002, MOL PHARMACOL, V62, P15, DOI 10.1124/mol.62.1.15; Marjamaki A, 1999, J BIOL CHEM, V274, P21867, DOI 10.1074/jbc.274.31.21867; Meng EC, 2001, TRENDS PHARMACOL SCI, V22, P587, DOI 10.1016/S0165-6147(00)01825-3; Misse D, 2001, BLOOD, V98, P541, DOI 10.1182/blood.V98.3.541; Olivella M, 2002, BIOPHYS J, V82, P3207, DOI 10.1016/S0006-3495(02)75663-4; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rhee MH, 2000, J NEUROCHEM, V75, P2485, DOI 10.1046/j.1471-4159.2000.0752485.x; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; SUZUKI S, 1992, SCIENCE, V257, P942, DOI 10.1126/science.257.5072.942; Tsuzuki S, 2000, J AM CHEM SOC, V122, P3746, DOI 10.1021/ja993972j; Turner CA, 1999, BIOCHEM BIOPH RES CO, V257, P704, DOI 10.1006/bbrc.1999.0207; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; ZOFFMANN S, 1993, FEBS LETT, V336, P506, DOI 10.1016/0014-5793(93)80865-R	54	79	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1892	1903		10.1074/jbc.M205685200	http://dx.doi.org/10.1074/jbc.M205685200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12411445	hybrid			2022-12-27	WOS:000180462200071
J	Wei, SJ; Trempus, CS; Cannon, RE; Bortner, CD; Tennant, RW				Wei, SJ; Trempus, CS; Cannon, RE; Bortner, CD; Tennant, RW			Identification of Dss1 as a 12-O-tetradecanoylphorbol-13-acetate-responsive gene expressed in keratinocyte progenitor cells, with possible involvement in early skin tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC TG.AC MICE; STEM-CELLS; MOUSE SKIN; P53 HOMOLOG; PAPILLOMA DEVELOPMENT; SURFACE PHENOTYPE; EPIDERMAL-CELLS; CANDIDATE GENE; BETA-CATENIN; HAIR CYCLE	This study identifies genes expressed early in 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin carcinogenesis in genetically initiated Tg.AC nu-Ha-ras transgenic mice. Keratinocyte progenitor cells from TPA-treated Tg.AC mice were isolated with fluorescence-activated cell sorting and expression was analyzed using cDNA microarray technology. Eleven genes were identified whose expression changed significantly in response to carcinogen treatment. Deleted in split hand/split foot 1 (Dss1) is a gene associated with a heterogeneous limb developmental disorder called split hand/split foot malformation. cDNA microarray expression analysis showed that the mouse homologue of Dss1 is induced by TPA. Dss1 overexpression was detected by Northern blot analysis in early TPA-treated hyperplastic skins and in JB6 Cl 41-5a epidermal cells. Interestingly, Dss1 expression was also shown to be elevated in skin papillomas relative to normal skins, and further increased in squamous cell malignancies. Functional studies by ectopically constitutive expression of Dss1 in JB6 Cl 41-5a preneoplastic cells strongly increased focus formation and proliferation of these cells and enhanced efficiency of neoplastic transformation of the cells in soft agar. These results strongly suggest that Dss1 is a TPA-inducible gene that may play an important role in the early stages of skin carcinogenesis.	NIEHS, Natl Ctr Toxicogenomics, NIH, Res Triangle Pk, NC 27709 USA; NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wei, SJ (corresponding author), NIEHS, Natl Ctr Toxicogenomics, NIH, Bldg 101,Rm F-149,MD F1-05,POB 12233, Res Triangle Pk, NC 27709 USA.			Wei, Sung Jen/0000-0002-9810-9041	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100610, Z01ES021235, Z01ES021175, ZIAES021175] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berenblum I, 1941, CANCER RES, V1, P807; BOWDEN GT, 1994, CANCER RES, V54, pS1882; Breitenbach U, 2001, J INVEST DERMATOL, V117, P634, DOI 10.1046/j.0022-202x.2001.01437.x; Cannon RE, 1997, MOL CARCINOGEN, V20, P108, DOI 10.1002/(SICI)1098-2744(199709)20:1<108::AID-MC12>3.0.CO;2-5; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; COX AD, 1994, METHOD ENZYMOL, V238, P277; Crackower MA, 1996, HUM MOL GENET, V5, P571, DOI 10.1093/hmg/5.5.571; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; HANSEN LA, 1994, MOL CARCINOGEN, V9, P143, DOI 10.1002/mc.2940090306; HERRLICH P, 1995, EUR J CANCER, V31A, P1110, DOI 10.1016/0959-8049(95)00252-E; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; KRIEG P, 1993, J BIOL CHEM, V268, P17362; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; LAVKER RM, 1993, J INVEST DERMATOL, V101, P16; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Marston NJ, 1999, MOL CELL BIOL, V19, P4633; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MILLER SJ, 1993, J INVEST DERMATOL, V101, P591, DOI 10.1111/1523-1747.ep12366045; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MORRIS RJ, 1990, CELL TISSUE KINET, V23, P587, DOI 10.1111/j.1365-2184.1990.tb01348.x; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 2000, J CLIN INVEST, V106, P3, DOI 10.1172/JCI10508; Parsa R, 1999, J INVEST DERMATOL, V113, P1099, DOI 10.1046/j.1523-1747.1999.00780.x; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; PRASHER DC, 1995, TRENDS GENET, V11, P320, DOI 10.1016/S0168-9525(00)89090-3; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SPALDING JW, 1993, CARCINOGENESIS, V14, P1335, DOI 10.1093/carcin/14.7.1335; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; TEMTAMY SA, 1978, GENETICS HAND MALFOR, P53; Trempus Carol, 2002, Proceedings of the American Association for Cancer Research Annual Meeting, V43, P1008; Trempus CS, 1998, J INVEST DERMATOL, V111, P445, DOI 10.1046/j.1523-1747.1998.00237.x; Wei SJ, 1999, GENE THER, V6, P420, DOI 10.1038/sj.gt.3300817; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; YUSPA SH, 1982, CANCER RES, V42, P2344; Yuspa SH, 1998, J DERMATOL SCI, V17, P1, DOI 10.1016/S0923-1811(97)00071-6; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	48	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1758	1768		10.1074/jbc.M206328200	http://dx.doi.org/10.1074/jbc.M206328200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419822	hybrid			2022-12-27	WOS:000180462200053
J	Filisetti, L; Fontecave, M; Niviere, V				Filisetti, L; Fontecave, M; Niviere, V			Mechanism and substrate specificity of the flavin reductase ActVB from Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEON ARCHAEOGLOBUS-FULGIDUS; ESCHERICHIA-COLI; NAD(P)H-FLAVIN OXIDOREDUCTASE; CRYSTAL-STRUCTURE; FERRIC REDUCTASE; VIBRIO-FISCHERI; IDENTIFICATION; PURIFICATION; NADPH; BIOSYNTHESIS	ActVB is the NADH:flavin oxidoreductase participating in the last step of actinorhodin synthesis in Streptomyces coelicolor. It is the prototype of a whole class of flavin reductases with both sequence and functional similarities. The mechanism of reduction of free flavins by ActVB has been studied. Although ActVB was isolated with FMN bound, we have demonstrated that it is not a flavoprotein. Instead, ActVB contains only one flavin binding site, suitable for the flavin reductase activity and with a high affinity for FMN. In addition, ActVB proceeds by an ordered sequential mechanism, where NADH is the first substrate. Whereas ActVB is highly specific for NADH, it is able to catalyze the reduction of a great variety of natural and synthetic flavins, but with K-m values ranging from I muM (FMN) to 69 muM (lumiflavin). We show that both the ribitol-phosphate chain and the isoalloxazine ring contribute to the protein-flavin interaction. Such properties are unique and set the ActVB family apart from the well characterized Fre flavin reductase family.	Univ Grenoble 1, CNRS, CEA, DRDC,Lab Chim & Biochim,Ctr Redox Biol, F-38054 Grenoble 9, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecave, M (corresponding author), Univ Grenoble 1, CNRS, CEA, DRDC,Lab Chim & Biochim,Ctr Redox Biol, 17 Ave Martyrs, F-38054 Grenoble 9, France.			Niviere, Vincent/0000-0002-5132-457X				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNS CM, 1995, J MOL BIOL, V247, P125, DOI 10.1006/jmbi.1994.0127; Chiu HJ, 2001, STRUCTURE, V9, P311, DOI 10.1016/S0969-2126(01)00589-5; COVES J, 1993, EUR J BIOCHEM, V211, P635, DOI 10.1111/j.1432-1033.1993.tb17591.x; DALZIEL K, 1973, ENZYMES, V11, P2; ESCHENBRENNER M, 1995, J BIOL CHEM, V270, P20550, DOI 10.1074/jbc.270.35.20550; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; FONTECAVE M, 1994, BIOMETALS, V7, P3; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; Ingelman M, 1999, BIOCHEMISTRY-US, V38, P7040, DOI 10.1021/bi982849m; Jeffers CE, 2001, BIOCHEMISTRY-US, V40, P1749, DOI 10.1021/bi0024310; KENDREW SG, 1995, J BIOL CHEM, V270, P17339, DOI 10.1074/jbc.270.29.17339; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Massey V., 1970, PYRIDINE NUCLEOTIDE, P393; Niviere V, 1999, J BIOL CHEM, V274, P18252, DOI 10.1074/jbc.274.26.18252; Niviere V, 1996, J BIOL CHEM, V271, P16656, DOI 10.1074/jbc.271.28.16656; Niviere V, 1998, BIOCHEMISTRY-US, V37, P11879, DOI 10.1021/bi980396f; Parry RJ, 1997, J BIOL CHEM, V272, P23303, DOI 10.1074/jbc.272.37.23303; RUDOLPH FB, 1979, METHOD ENZYMOL, V63, P139; Segel I.H., 1975, ENZYME KINETICS; SPECTOR T, 1981, BIOCHEM PHARMACOL, V30, P1, DOI 10.1016/0006-2952(81)90277-X; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; UETZ T, 1992, J BACTERIOL, V174, P1179, DOI 10.1128/jb.174.4.1179-1188.1992; Vadas A, 1999, J BIOL CHEM, V274, P36715, DOI 10.1074/jbc.274.51.36715; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; ZANETTI G, 1991, CHEM BIOCH FLAVOPROT, V2, P306; ZENNO S, 1994, J BACTERIOL, V176, P3536, DOI 10.1128/JB.176.12.3536-3543.1994; ZENNO S, 1994, J BACTERIOL, V176, P3544, DOI 10.1128/JB.176.12.3544-3551.1994	30	41	41	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					296	303		10.1074/jbc.M209689200	http://dx.doi.org/10.1074/jbc.M209689200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12417584	hybrid			2022-12-27	WOS:000180255700040
J	Higuchi, H; Yoon, JH; Grambihler, A; Werneburg, N; Bronk, SF; Gores, GJ				Higuchi, H; Yoon, JH; Grambihler, A; Werneburg, N; Bronk, SF; Gores, GJ			Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; HEPATOCYTE APOPTOSIS; CELL-DEATH; CASPASE HOMOLOG; RECEPTOR; ACTIVATION; EXPRESSION; FAS; INHIBITION; GENE	Bile acids induce hepatocyte injury by enhancing death receptor-mediated apoptosis. In this study, bile acid effects on TRAIL-mediated apoptosis were examined to gain insight into bile acid potentiation of death receptor signaling. TRAIL-induced apoptosis of HuH-7 cells, stably transfected with a bile acid transporter, was enhanced by bile acids. Caspase 8 and 10 activation, bid cleavage, cytosolic cytochrome c, and caspase 3 activation by TRAIL were all increased by the bile acid glycochenodeoxycholate (GCDCA). GCDCA (100 muM) did not alter expression of TRAIL-R1/DR4, TRAIL-R2/DR5, procaspase 8, cFLIP-L, cFLIP-s, Bax, Bcl-xL, or Bax. However, both caspase 8 and caspase 10 recruitment and processing within the TRAIL death-inducing signaling complex (DISC) were greater in GCDCA-treated cells whereas recruitment of cFLIP long and short was reduced. GCDCA stimulated phosphorylation of both cFLIP isoforms, which was associated with decreased binding to GST-FADD. The protein kinase C antagonist chelerythrine prevented bile acid-stimulated cFLIP-L and -s phosphorylation, restored cFLIP binding to GST-FADD, and attenuated bile acid potentiation of TRAIL-induced apoptosis. These results provide new insights into the mechanisms of bile acid cytotoxicity and the proapoptotic effects of cFLIP phosphorylation in TRAIL signaling.	Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu	Yoon, Jung Hwan/J-5563-2012	Yoon, Jung-Hwan/0000-0002-9128-3610	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041876, R37DK041876, R01DK041876] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK41876] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Burns TF, 2001, J BIOL CHEM, V276, P37879; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; de Almodovar CR, 2001, ONCOGENE, V20, P7128, DOI 10.1038/sj.onc.1204887; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Goltsev YV, 1997, J BIOL CHEM, V272, P19641, DOI 10.1074/jbc.272.32.19641; GREIM H, 1972, GASTROENTEROLOGY, V63, P846; Han DKM, 1997, P NATL ACAD SCI USA, V94, P11333, DOI 10.1073/pnas.94.21.11333; Higuchi H, 2002, J PHARMACOL EXP THER, V303, P461, DOI 10.1124/jpet.102.040030; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; HOFMANN AF, 1990, HEPATOLOGY, V12, P17; Hopkins-Donaldson S, 2000, CANCER RES, V60, P4315; Hu SM, 1997, J BIOL CHEM, V272, P17255, DOI 10.1074/jbc.272.28.17255; Im EO, 2001, CANCER LETT, V163, P83, DOI 10.1016/S0304-3835(00)00671-6; Inohara N, 1997, P NATL ACAD SCI USA, V94, P10717, DOI 10.1073/pnas.94.20.10717; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jones BA, 1997, AM J PHYSIOL-GASTR L, V272, pG1109, DOI 10.1152/ajpgi.1997.272.5.G1109; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Knight MJ, 2001, ONCOGENE, V20, P5789, DOI 10.1038/sj.onc.1204810; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Kullak-Ublick G A, 2000, Clin Liver Dis, V4, P357, DOI 10.1016/S1089-3261(05)70114-8; KWO P, 1995, AM J PHYSIOL-GASTR L, V268, pG613, DOI 10.1152/ajpgi.1995.268.4.G613; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Leist M, 1998, MOL PHARMACOL, V54, P789, DOI 10.1124/mol.54.5.789; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Meng RD, 2001, EXP CELL RES, V262, P154, DOI 10.1006/excr.2000.5073; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Ozoren N, 2000, INT J ONCOL, V16, P917; Popper H, 1970, Hum Pathol, V1, P1, DOI 10.1016/S0046-8177(70)80002-8; POPPER H, 1968, ANNU REV MED, V19, P39, DOI 10.1146/annurev.me.19.020168.000351; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Ravi R, 2002, CANCER RES, V62, P1583; Rust C, 2000, J BIOL CHEM, V275, P20210, DOI 10.1074/jbc.M909992199; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Sheikh MS, 1998, CANCER RES, V58, P1593; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Sodeman T, 2000, AM J PHYSIOL-GASTR L, V278, pG992, DOI 10.1152/ajpgi.2000.278.6.G992; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; SRINIVASULA SM, 1997, J BIOL CHEM, V272, P18452; Strasser A, 1999, INT J BIOCHEM CELL B, V31, P533, DOI 10.1016/S1357-2725(99)00003-5; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Takikawa Y, 2001, GASTROENTEROLOGY, V120, P1810, DOI 10.1053/gast.2001.24835; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3	53	94	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					454	461		10.1074/jbc.M209387200	http://dx.doi.org/10.1074/jbc.M209387200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407100	hybrid			2022-12-27	WOS:000180255700060
J	Lau, PJ; Kolodner, RD				Lau, PJ; Kolodner, RD			Transfer of the MSH2 center dot MSH6 complex from proliferating cell nuclear antigen to mispaired bases in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR PROTEIN MUTS; MISMATCH REPAIR; SACCHAROMYCES-CEREVISIAE; SLIDING CLAMP; REPLICATION COMPLEX; RECOGNITION COMPLEX; PCNA; BINDING; HYDROLYSIS; MSH2-MSH6	Proliferating cell nuclear antigen (PCNA) is thought to play a role in DNA mismatch repair at the DNA synthesis step as well as in an earlier step. Studies showing that PCNA interacts with mispair-binding protein complexes, MSH2-MSH3 and MSH2-MSH6, and that PCNA enhances MSH2-MSH6 mispair binding specificity suggest PCNA may be involved in mispair recognition. Here we show that PCNA and MSH2-MSH6 form a stable ternary complex with a homoduplex (G/C) DNA, but MSH2-MSH6 binding to a heteroduplex (G/T) DNA disrupts MSH2-MSH6 binding to PCNA. We also found that the addition of ATP or adenosine 5'-O-(thiotriphosphate) restores MSH2-MSH6 binding to PCNA, presumably by disrupting MSH2-MSH6 binding to the heteroduplex (G/T) DNA. These results support a model in which MSH2-MSH6 binds to PCNA loaded on newly replicated DNA and is transferred from PCNA to mispaired bases in DNA.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Ctr Canc, CMME 3058,9500 Gilman Dr, La Jolla, CA 92093 USA.				NIGMS NIH HHS [GM50006] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 1996, MOL CELL BIOL, V16, P5604; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Bowers J, 2001, J MOL BIOL, V306, P957, DOI 10.1006/jmbi.2001.4467; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Joshi A, 2000, NUCLEIC ACIDS RES, V28, P853, DOI 10.1093/nar/28.4.853; Kelman Z, 1998, TRENDS BIOCHEM SCI, V23, P236, DOI 10.1016/S0968-0004(98)01223-7; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lau PJ, 2002, MOL CELL BIOL, V22, P6669, DOI 10.1128/MCB.22.19.6669-6680.2002; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Schofield MJ, 2001, J BIOL CHEM, V276, P28291, DOI 10.1074/jbc.M103148200; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; SU SS, 1988, J BIOL CHEM, V263, P6829; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659	46	75	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					14	17		10.1074/jbc.C200627200	http://dx.doi.org/10.1074/jbc.C200627200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12435741	hybrid			2022-12-27	WOS:000180255700002
J	Li, YZ; Hansotia, T; Yusta, B; Ris, F; Halban, PA; Drucker, DJ				Li, YZ; Hansotia, T; Yusta, B; Ris, F; Halban, PA; Drucker, DJ			Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT INSULINOTROPIC POLYPEPTIDE; VASOACTIVE-INTESTINAL-PEPTIDE; IN-VITRO; ENDOCRINE PANCREAS; GLUCOSE-TOLERANCE; SECRETORY SYSTEM; GENE-EXPRESSION; DIABETIC RATS; GROWTH-FACTOR; ISLET CELLS	Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion and augments beta cell mass via activation of beta cell proliferation and islet neogenesis. We examined whether GLP-1 receptor signaling modifies the cellular susceptibility to apoptosis. Mice administered streptozotocin (STZ), an agent known to induce beta cell apoptosis, exhibit sustained improvement in glycemic control and increased levels of plasma insulin with concomitant administration of the GLP-1 agonist exendin-4 (Ex-4). Blood glucose remained significantly lower for weeks after cessation of exendin-4. STZ induced beta cell apoptosis, which was significantly reduced by co-administration of Ex-4. Conversely, mice with a targeted disruption of the GLP-1 receptor gene exhibited increased beta cell apoptosis after STZ administration. Exendin-4 directly reduced cytokine-induced apoptosis in purified rat beta cells exposed to interleukin 1beta, tumor necrosis fator alpha, and interferon gamma in vitro. Furthermore, Ex-4-treated BHK-GLP-1R cells exhibited significantly increased cell viability, reduced caspase activity, and decreased cleavage of beta-catenin after treatment with cycloheximide in vitro. These findings demonstrate that GLP-1 receptor signaling directly modifies the susceptibility to apoptotic injury, and provides a new potential mechanism linking GLP-1 receptor activation to preservation or enhancement of beta cell mass in vivo.	Univ Toronto, Toronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada; Univ Geneva, Med Ctr, Louis Jeantet Res Labs, CH-1211 Geneva 4, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Geneva	Drucker, DJ (corresponding author), Univ Toronto, Toronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, 200 Elizabeth St,MBRW4R-402, Toronto, ON M5G 2C4, Canada.		Ris, Frederic/H-7030-2019; Drucker, Daniel J/A-4092-2010; Tuluc, Petronel/C-2527-2011	Ris, Frederic/0000-0001-7421-6101; 				Baggio L, 2000, ENDOCRINOLOGY, V141, P3703, DOI 10.1210/en.141.10.3703; Barsig J, 1997, INFECT IMMUN, V65, P4075, DOI 10.1128/IAI.65.10.4075-4081.1997; Borboni P, 1999, ENDOCRINOLOGY, V140, P5530, DOI 10.1210/en.140.12.5530; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Boushey RP, 1999, AM J PHYSIOL-ENDOC M, V277, pE937, DOI 10.1152/ajpendo.1999.277.5.E937; Boushey RP, 2001, CANCER RES, V61, P687; BREGENHOLT S, 2001, 61 ANN M AM DIAB ASS, V50, pOR125; Brubaker PL, 1997, ENDOCRINOLOGY, V138, P4837, DOI 10.1210/en.138.11.4837; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; CAMPBELL IL, 1988, J IMMUNOL, V141, P2325; de la Tour DD, 2001, MOL ENDOCRINOL, V15, P476; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610; Delgado M, 2001, J IMMUNOL, V166, P1028, DOI 10.4049/jimmunol.166.2.1028; Delgado M, 1996, BLOOD, V87, P5152, DOI 10.1182/blood.V87.12.5152.bloodjournal87125152; Drucker DJ, 1999, TRENDS ENDOCRIN MET, V10, P153, DOI 10.1016/S1043-2760(98)00136-2; Drucker DJ, 1997, AM J PHYSIOL-GASTR L, V273, pG1252, DOI 10.1152/ajpgi.1997.273.6.G1252; Drucker DJ, 2001, J CLIN ENDOCR METAB, V86, P1759, DOI 10.1210/jc.86.4.1759; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Edvell A, 1999, ENDOCRINOLOGY, V140, P778, DOI 10.1210/en.140.2.778; Edwards CMB, 1999, DIABETES, V48, P86, DOI 10.2337/diabetes.48.1.86; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; Flamez D, 1999, DIABETES, V48, P1979, DOI 10.2337/diabetes.48.10.1979; Greig NH, 1999, DIABETOLOGIA, V42, P45, DOI 10.1007/s001250051111; Hansen L, 1999, ENDOCRINOLOGY, V140, P5356, DOI 10.1210/en.140.11.5356; Heller RS, 1997, DIABETES, V46, P785, DOI 10.2337/diabetes.46.5.785; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; KANETO H, 1995, DIABETES, V44, P733, DOI 10.2337/diabetes.44.7.733; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; KOLLIGS F, 1995, DIABETES, V44, P16, DOI 10.2337/diabetes.44.1.16; KOMATSU R, 1989, DIABETES, V38, P902, DOI 10.2337/diabetes.38.7.902; Kowluru A, 2002, BIOCHEM PHARMACOL, V63, P1027, DOI 10.1016/S0006-2952(02)00849-3; KREYMANN B, 1987, LANCET, V2, P1300; Ling Z, 2001, VIRCHOWS ARCH, V438, P382, DOI 10.1007/s004280000374; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; MORGAN NG, 1994, BIOSCIENCE REP, V14, P243, DOI 10.1007/BF01209729; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; OBrien BA, 1996, J PATHOL, V178, P176; ORSKOV C, 1988, FEBS LETT, V229, P175, DOI 10.1016/0014-5793(88)80821-4; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; ROSSINI AA, 1977, DIABETES, V26, P916, DOI 10.2337/diabetes.26.10.916; ROUILLER DG, 1990, EXP CELL RES, V191, P305, DOI 10.1016/0014-4827(90)90019-7; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Schuit F, 1999, J BIOL CHEM, V274, P32803, DOI 10.1074/jbc.274.46.32803; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Scrocchi LA, 2000, DIABETES, V49, P1552, DOI 10.2337/diabetes.49.9.1552; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Tourrel C, 2001, DIABETES, V50, P1562, DOI 10.2337/diabetes.50.7.1562; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Wang XL, 1999, ENDOCRINOLOGY, V140, P4904, DOI 10.1210/en.140.10.4904; WANG YH, 1995, ENDOCRINOLOGY, V136, P4910, DOI 10.1210/en.136.11.4910; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; WETTERGREN A, 1993, DIGEST DIS SCI, V38, P665, DOI 10.1007/BF01316798; Xiao QA, 1999, GASTROENTEROLOGY, V117, P99, DOI 10.1016/S0016-5085(99)70555-X; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yusta B, 2000, J BIOL CHEM, V275, P35345, DOI 10.1074/jbc.M005510200; Zhou J, 1999, DIABETES, V48, P2358, DOI 10.2337/diabetes.48.12.2358	65	481	534	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					471	478		10.1074/jbc.M209423200	http://dx.doi.org/10.1074/jbc.M209423200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409292	hybrid, Green Published			2022-12-27	WOS:000180255700062
J	Maier, O; Hoekstra, D				Maier, O; Hoekstra, D			Trans-golgi network and subapical compartment of HepG2 cells display different properties in sorting and exiting of sphingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; MULTIDRUG-RESISTANCE PROTEIN; PLASMA-MEMBRANE PROTEINS; GPI-ANCHORED PROTEINS; MDCK CELLS; ENDOCYTIC PATHWAY; MAMMALIAN-CELLS; HEPATOMA-CELLS; CACO-2 CELLS; HT29 CELLS	In HepG2 cells, the subapical compartment (SAC) is involved in the biogenesis of membrane polarity. By contrast, direct apical transport originating from the trans-Golgi network (TGN), which may contribute to polarity establishment, has been poorly defined in these cells. Thus, although newly synthesized sphingolipids can be directly transported from the TGN to the apical membrane, numerous apical resident proteins are traveling via the transcytotic route. Here, we developed an in vitro transport assay and compared the molecular sorting of 6-[N-(7-nitrobenz-2-oxa-1,3 diazol-4-yl)amino] hexanoyl-sphingomyelin (C6NBD-SM) and C6NBD-glucosylceramide (C6NBD-GlcCer) in TGN and SAC. SM is released from both TGN and SAC in the lumenal leaflet of transport vesicles. This holds also for GlcCer released from the SAC but not for a substantial fraction that departed from the Golgi. Distinct transport vesicles, enriched in either SM or GlcCer are released from SAC, consistent with their rigid sorting in this compartment. Different vesicle populations could not be recovered from TGN, although in situ experiments reveal that GlcCer is preferentially transported to the apical membrane, reflecting different transport mechanisms. The results indicate that in HepG2 cells sphingolipids are mainly sorted in the SAC membrane and that the release of SM from SAC and TGN is differentially regulated.	Univ Groningen, Dept Membrane Cell Biol, Fac Med Sci, NL-9713 AV Groningen, Netherlands	University of Groningen	Hoekstra, D (corresponding author), Univ Groningen, Dept Membrane Cell Biol, Fac Med Sci, A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.							BABIA T, 1994, EUR J CELL BIOL, V63, P172; BARTLES JR, 1990, METHOD ENZYMOL, V191, P825; Bastaki M, 2002, MOL BIOL CELL, V13, P225, DOI 10.1091/mbc.01-07-0376; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gibson A, 1998, J CELL BIOL, V143, P81, DOI 10.1083/jcb.143.1.81; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; KISHIMOTO Y, 1975, CHEM PHYS LIPIDS, V15, P33, DOI 10.1016/0009-3084(75)90029-8; KNIGHT A, 1995, MOL BIOL CELL, V6, P597, DOI 10.1091/mbc.6.5.597; KOBAYASHI T, 1992, FEBS LETT, V300, P227, DOI 10.1016/0014-5793(92)80851-7; KOK JW, 1991, J CELL BIOL, V114, P231, DOI 10.1083/jcb.114.2.231; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Lipardi C, 2000, MOL BIOL CELL, V11, P531, DOI 10.1091/mbc.11.2.531; Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; NICKEL W, 1994, J CELL BIOL, V125, P721, DOI 10.1083/jcb.125.4.721; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Raggers RJ, 1999, J CELL SCI, V112, P415; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Roelofsen H, 1997, GASTROENTEROLOGY, V112, P511, DOI 10.1053/gast.1997.v112.pm9024305; Rothman JE, 1996, PROTEIN SCI, V5, P185; SAUCAN L, 1994, J CELL BIOL, V125, P733, DOI 10.1083/jcb.125.4.733; Simon JP, 1996, J BIOL CHEM, V271, P16952, DOI 10.1074/jbc.271.28.16952; SLIMANE TA, 2003, IN PRESS MOL BIOL CE; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; VAN GENDEREN I, 1995, J CELL BIOL, V131, P645, DOI 10.1083/jcb.131.3.645; van Ijzendoorn SCD, 1999, TRENDS CELL BIOL, V9, P144, DOI 10.1016/S0962-8924(99)01512-3; van IJzendoorn SCD, 1998, J CELL BIOL, V142, P683, DOI 10.1083/jcb.142.3.683; van Ijzendoorn SCD, 1999, MOL BIOL CELL, V10, P3449, DOI 10.1091/mbc.10.10.3449; van Ijzendoorn SCD, 2000, MOL BIOL CELL, V11, P1093, DOI 10.1091/mbc.11.3.1093; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; vanIjzendoorn SCD, 1997, J CELL BIOL, V137, P347, DOI 10.1083/jcb.137.2.347; VANTHOF W, 1990, J CELL BIOL, V111, P977, DOI 10.1083/jcb.111.3.977; Verkade P, 1997, HISTOCHEM CELL BIOL, V108, P211, DOI 10.1007/s004180050161; WANDINGERNESS A, 1990, J CELL BIOL, V111, P987, DOI 10.1083/jcb.111.3.987; Wang TY, 2000, BIOPHYS J, V79, P1478, DOI 10.1016/S0006-3495(00)76399-5; WARNOCK DE, 1994, P NATL ACAD SCI USA, V91, P2708, DOI 10.1073/pnas.91.7.2708; Zegers MMP, 1997, BIOCHEM J, V328, P489, DOI 10.1042/bj3280489; Zegers MMP, 1997, J CELL BIOL, V138, P307, DOI 10.1083/jcb.138.2.307	50	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					164	173		10.1074/jbc.M208259200	http://dx.doi.org/10.1074/jbc.M208259200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407103	hybrid			2022-12-27	WOS:000180255700022
J	Prescott, M; Nowakowski, S; Gavin, P; Nagley, P; Whisstock, JC; Devenish, RJ				Prescott, M; Nowakowski, S; Gavin, P; Nagley, P; Whisstock, JC; Devenish, RJ			Subunit gamma-green fluorescent protein fusions are functionally incorporated into mitochondrial F1F0-ATP synthase, arguing against a rigid cap structure at the top of F-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVITY-CONFERRING PROTEIN; ATP SYNTHASE; OSCP SUBUNIT; YEAST; ROTATION; EXPRESSION; MOTOR; IDENTIFICATION; PURIFICATION; MANIPULATION	We have investigated the question of the presence of a cap structure located at the top of the F-1 alpha(3)beta(3) hexamer of the yeast mitochondrial F1F0-ATP synthase complex. Specifically, we sought to determine whether the putative cap has a rigid structure and occludes the central shaft space formed by the alpha(3)beta(3) hexamer or alternatively whether the cap is more flexible permitting access to the central shaft space under certain conditions. Thus, we sought to establish whether subunit gamma, an essential component of the F-1 central stalk housed within the central shaft space and whose N and C termini would both lie beneath a putative cap, could be fused at its C terminus to green fluorescent protein (GFP) without loss of enzyme function. The GFP moiety serves to report on the integrity and location of fusion proteins containing different length polypeptide linkers between GFP and subunit gamma, as well as being a potential occluding structure in itself. Functional incorporation of subunit gamma-GFP fusions into ATP synthase of yeast cells lacking native subunit gamma was demonstrated by the ability of intact complexes to hydrolyze ATP and retain sensitivity to oligomycin. Our conclusion is that the putative cap structure cannot be an inflexible structure, but must be of a more flexible nature consistent with the accommodation of subunit gamma-GFP fusions within functional ATP synthase complexes.	Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Monash University	Devenish, RJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, POB 13D,Clayton Campus, Clayton, Vic 3800, Australia.	Rodney.Devenish@med.monash.edu.au		Whisstock, James/0000-0003-4200-5611				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Bateson M, 1999, J BIOL CHEM, V274, P7462, DOI 10.1074/jbc.274.11.7462; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blum DJ, 2001, BIOCHEM BIOPH RES CO, V287, P801, DOI 10.1006/bbrc.2001.5634; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Boyle GM, 2000, J BIOENERG BIOMEMBR, V32, P595, DOI 10.1023/A:1005674628249; Boyle GM, 1999, EUR J BIOCHEM, V262, P315, DOI 10.1046/j.1432-1327.1999.00345.x; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Devenish RJ, 2000, BBA-BIOENERGETICS, V1458, P428, DOI 10.1016/S0005-2728(00)00092-X; Devenish RJ, 2000, J BIOENERG BIOMEMBR, V32, P507, DOI 10.1023/A:1005621125812; Engelbrecht S, 1998, EUR J BIOCHEM, V252, P277, DOI 10.1046/j.1432-1327.1998.2520277.x; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GRAY RE, 1995, METHOD ENZYMOL, V260, P133; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; HAMES BD, 1990, GEL ELECTROPHORESIS, P30; HUNDAL T, 1983, FEBS LETT, V162, P5, DOI 10.1016/0014-5793(83)81038-2; Karrasch S, 1999, J MOL BIOL, V290, P379, DOI 10.1006/jmbi.1999.2897; Ko YH, 2000, J BIOL CHEM, V275, P32931, DOI 10.1074/jbc.M004453200; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PAUL MF, 1994, J BIOL CHEM, V269, P26158; PRESCOTT M, 1995, BIOCHEM BIOPH RES CO, V207, P943, DOI 10.1006/bbrc.1995.1276; Prescott M, 1997, FEBS LETT, V411, P97, DOI 10.1016/S0014-5793(97)00670-4; PRESCOTT M, 1994, BIOCHEM MOL BIOL INT, V34, P789; Prescott M, 1999, ANAL BIOCHEM, V273, P305, DOI 10.1006/abio.1999.4235; ROTT R, 1981, J BIOL CHEM, V256, P9224; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1989, GENETICS, V122, P19; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Velours J, 2001, J BIOL CHEM, V276, P8602, DOI 10.1074/jbc.M008123200; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; Wilkens S, 2000, J MOL BIOL, V295, P387, DOI 10.1006/jmbi.1999.3381; Wilkens S, 1998, NATURE, V393, P29, DOI 10.1038/29908; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910	44	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					251	256		10.1074/jbc.M204556200	http://dx.doi.org/10.1074/jbc.M204556200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414811	hybrid			2022-12-27	WOS:000180255700033
J	Ribas, C; Takesono, A; Sato, M; Hildebrandt, JD; Lanier, SM				Ribas, C; Takesono, A; Sato, M; Hildebrandt, JD; Lanier, SM			Pertussis toxin-insensitive activation of the heterotrimeric G-proteins G(i)/G(o) by the NG108-15 G-protein activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL-DIVISION; ALPHA-SUBUNITS; DROSOPHILA; INTEGRATION; G(ALPHA-I2); G-ALPHA(O); EXCHANGE; PARTNER; SYSTEM; YEAST	A ligand-independent activator of heterotrimeric brain G-protein was partially purified from detergent-solubilized extracts of the neuroblastoma-glioma cell hybrid NG108-15. The G-protein activator (NG108-15 G-protein activator (NG-GPA)) increased [S-35]guanosine 5'-O-(thiotriphosphate) ([S-35]GTPgammaS) to purified brain G-protein in a magnesium-dependent manner and promoted GDP dissociation from Galpha(o). The NG-GPA also increased GTPgammaS binding to purified, recombinant Galpha(i2), Galpha(i3), and Galpha(o), but minimally altered nucleotide binding to purified transducin. The NG-GPA increased GTPgammaS binding to membrane-bound G-proteins and inhibited basal, forskolin- and hormone-stimulated adenylyl cyclase activity in DDT1-MF-2 cell membranes. In contrast to G-protein coupled receptor-mediated activation of heterotrimeric G-proteins in DDT1-MF-2 cell membrane preparations, the action of the NG-GPA was not altered by treatment of the cells with pertussis toxin. ADP-ribosylation of purified brain G-protein also failed to alter the increase in GTPgammaS binding elicited by the NG-GPA. Thus, the NG-GPA acts in a manner distinct from that of a G-protein coupled receptor and other recently described receptor-independent activators of G-protein signaling. These data indicate the presence of unexpected regulatory domains on G(i)/G(o) proteins and suggest the existence of pertussis toxin-insensitive modes of signal input to G(i)/G(o) signaling systems.	Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; NHGRI, Bethesda, MD 20892 USA; Univ Autonoma Madrid, Ctr Biol Mol, Severo Ochoa CSIC, E-28049 Madrid, Spain; Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Medical University of South Carolina	Lanier, SM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, 1901 Perdido St, New Orleans, LA 70112 USA.			Lanier, Stephen/0000-0002-2740-7607	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37219] Funding Source: Medline; NIMH NIH HHS [MH59931] Funding Source: Medline; NINDS NIH HHS [R01-NS24821] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; CARTY DJ, 1994, METHOD ENZYMOL, V237, P63; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kroslak T, 2001, J BIOL CHEM, V276, P39772, DOI 10.1074/jbc.M106991200; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Marjamaki A, 1997, J BIOL CHEM, V272, P16466, DOI 10.1074/jbc.272.26.16466; McLaughlin JN, 2002, J BIOL CHEM, V277, P34885, DOI 10.1074/jbc.M205583200; Meng JW, 1999, J BIOL CHEM, V274, P36663, DOI 10.1074/jbc.274.51.36663; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Yang Q, 1999, MOL PHARMACOL, V56, P651, DOI 10.1124/mol.56.3.651; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	27	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50223	50225		10.1074/jbc.C200567200	http://dx.doi.org/10.1074/jbc.C200567200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12426323	hybrid			2022-12-27	WOS:000180177700003
J	Lucerna, M; Mechtcheriakova, D; Kadl, A; Schabbauer, G; Schafer, R; Gruber, F; Koshelnick, Y; Muller, HD; Issbrucker, K; Clauss, M; Binder, BR; Hofer, E				Lucerna, M; Mechtcheriakova, D; Kadl, A; Schabbauer, G; Schafer, R; Gruber, F; Koshelnick, Y; Muller, HD; Issbrucker, K; Clauss, M; Binder, BR; Hofer, E			NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; TISSUE FACTOR EXPRESSION; NF-KAPPA-B; UP-REGULATION; SIGNALING PATHWAYS; FACTOR RECEPTOR; A EGR-1; ACTIVATION; BINDING; INJURY	In this study we have investigated the role of a specific corepressor of EGR-1, NAB2, to down-regulate vascular endothelial growth factor (VEGF)-induced gene expression in endothelial cells and to inhibit angiogenesis. Firstly, we show a reciprocal regulation of EGR-1 and NAB2 following VEGF treatment. During the initial phase EGR-1 is rapidly induced and NAB2 levels are down-regulated. This is followed by a reduction of EGR-1 and a concomitant increase of NAB2. Secondly, using the tissue factor gene as a readout for VEGF-induced and EGR-1-regulated gene expression we demonstrate that NAB2 can completely block VEGF-induced tissue factor reporter gene activity. Thirdly, by adenovirus-mediated expression we show that NAB2 inhibits up-regulation of tissue factor, VEGF receptor-1, and urokinase plasminogen activator mRNAs even when a combination of VEGF and bFGF is used for induction. In addition, NAB2 overexpression significantly reduced tubule and sprout formation in two different in vitro angiogenesis assays and largely prevented the invasion of cells and formation of vessel-like structures in the murine Matrigel model. These data suggest that NAB2 regulation represents a mechanism to guarantee transient EGR-1 activity following exposure of endothelial cells to VEGF and that NAB2 overexpression could be used to inhibit signals involved in the early phase of angiogenesis.	Univ Vienna, Int Res Cooperat Ctr, Dept Vasc Biol & Thrombosis Res, A-1235 Vienna, Austria; Max Planck Inst Physiol & Clin Res, Dept Mol Cell Biol, D-61231 Bad Nauheim, Germany	University of Vienna; Max Planck Society	Hofer, E (corresponding author), Univ Vienna, Int Res Cooperat Ctr, Dept Vasc Biol & Thrombosis Res, Brunnerstr 59, A-1235 Vienna, Austria.		Kadl, Alexandra/AAV-3395-2021; Bieber, Katja/K-8826-2014	Clauss, Matthias/0000-0001-5180-3899; Mechtcheriakova, Diana/0000-0002-8737-3592; Schabbauer, Gernot/0000-0002-7490-8009; Gruber, Florian/0000-0003-1094-5641				Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Blasi F, 1997, IMMUNOL TODAY, V18, P415, DOI 10.1016/S0167-5699(97)01121-3; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; deMartin R, 1997, GENE THER, V4, P493, DOI 10.1038/sj.gt.3300408; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; GOMEZFOIX AM, 1992, J BIOL CHEM, V267, P25129; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Houston P, 2001, BIOCHEM BIOPH RES CO, V283, P480, DOI 10.1006/bbrc.2001.4810; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kirsch KH, 1996, ONCOGENE, V12, P963; Korpelainen EI, 1998, CURR OPIN CELL BIOL, V10, P159, DOI 10.1016/S0955-0674(98)80137-3; LI VW, 1994, LANCET, V344, P82, DOI 10.1016/S0140-6736(94)91280-7; MACKMAN N, 1995, FASEB J, V9, P883, DOI 10.1096/fasebj.9.10.7615158; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; NEHLS V, 1994, MICROVASC RES, V48, P349, DOI 10.1006/mvre.1994.1061; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; PASSANITI A, 1992, LAB INVEST, V67, P519; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu ZC, 1998, J CELL BIOL, V142, P1075, DOI 10.1083/jcb.142.4.1075; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; SAKAMOTO KM, 1994, MOL CELL BIOL, V14, P5975, DOI 10.1128/MCB.14.9.5975; Santiago FS, 1999, AM J PATHOL, V154, P937, DOI 10.1016/S0002-9440(10)65341-2; Silverman ES, 1999, AM J PATHOL, V155, P1311, DOI 10.1016/S0002-9440(10)65233-9; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Takayama K, 2000, CANCER RES, V60, P2169; Tschugguel W, 1997, J VASC RES, V34, P281, DOI 10.1159/000159235; Vidal F, 2000, BLOOD, V95, P3387, DOI 10.1182/blood.V95.11.3387.011k09_3387_3395; Wang DF, 2000, J BIOL CHEM, V275, P15905, DOI 10.1074/jbc.M001847200; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	48	83	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 28	2003	278	13					11433	11440		10.1074/jbc.M204937200	http://dx.doi.org/10.1074/jbc.M204937200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660VU	12427750	hybrid			2022-12-27	WOS:000181855400073
J	Nualart, FJ; Rivas, CI; Montecinos, VP; Godoy, AS; Guaiquil, VH; Golde, DW; Vera, JC				Nualart, FJ; Rivas, CI; Montecinos, VP; Godoy, AS; Guaiquil, VH; Golde, DW; Vera, JC			Recycling of vitamin C by a bystander effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMMENDED DIETARY ALLOWANCE; ASCORBIC-ACID TRANSPORT; DEHYDROASCORBIC ACID; NADPH OXIDASE; FACILITATED TRANSPORT; HL-60 CELLS; ACCUMULATION; EXPRESSION; GLUCOSE; ANTIOXIDANT	Human cells transport dehydroascorbic acid through facilitative glucose transporters, in apparent contradiction with evidence indicating that vitamin C is present in human blood only as ascorbic acid. On the other hand, activated host defense cells undergoing the oxidative burst show increased vitamin C accumulation. We analyzed the role of the oxidative burst and the glucose transporters on vitamin C recycling in an in vitro system consisting of activated host-defense cells co-cultured with human cell lines and primary cells. We asked whether human cells can acquire vitamin C by a "bystander effect" by taking up dehydroascorbic acid generated from extracellular ascorbic acid by neighboring cells undergoing the oxidative burst. As activated cells, we used HL-60 neutrophils and normal human neutrophils activated with phorbol 12 myristate 13-acetate. As bystander cells, we used immortalized cell lines and primary cultures of human epithelial and endothelial cells. Activated cells produced superoxide anions that oxidized. extracellular ascorbic acid to dehydroascorbic acid. At the same time, there was a marked increase in vitamin C uptake by the bystander cells that was blocked by superoxide dismutase but not by catalase and was inhibited by the glucose transporter inhibitor cytochalasin B. Only ascorbic acid was accumulated intracellularly by the bystander cells. Glucose partially blocked vitamin C uptake by the bystander cells, although it increased superoxide production by the activated cells. We conclude that the local production of superoxide anions by activated cells causes the oxidation of extracellular ascorbic acid to dehydroascorbic acid, which is then transported by neighboring cells through the glucose transporters and immediately reduced to ascorbic acid intracellularly. In addition to causing increased intracellular concentrations of ascorbic acid with likely associated enhanced antioxidant defense mechanisms, the bystander effect may allow the recycling of vitamin C in vivo, which may contribute to the low daily requirements of the vitamin in humans.	Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Concepcion, Chile; Univ Concepcion, Fac Ciencias Biol, Dept Histol & Embriol, Concepcion, Chile; Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA	Universidad de Concepcion; Universidad de Concepcion; Memorial Sloan Kettering Cancer Center	Vera, JC (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Fisiopatol, Barrio Univ S-N, Concepcion, Chile.	juvera@udec.cl	Godoy, Alejandro/GPS-4942-2022; Nualart, Francisco/AAB-9342-2021		NCI NIH HHS [CA30388] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA030388, R37CA030388] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agus DB, 1999, CANCER RES, V59, P4555; Agus DB, 1997, J CLIN INVEST, V100, P2842, DOI 10.1172/JCI119832; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BODE AM, 1990, CLIN CHEM, V36, P1807; BOWERSKOMRO DM, 1991, J NUTR, V121, P57, DOI 10.1093/jn/121.1.57; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Carr AC, 1999, AM J CLIN NUTR, V69, P1086; Castro M, 2001, J NEUROCHEM, V78, P815, DOI 10.1046/j.1471-4159.2001.00461.x; DILIBERTO EJ, 1983, J BIOL CHEM, V258, P2886; DIMATTIO J, 1989, EXP EYE RES, V49, P873, DOI 10.1016/S0014-4835(89)80046-6; FRANCESCHI RT, 1995, AM J PHYSIOL-CELL PH, V268, pC1430, DOI 10.1152/ajpcell.1995.268.6.C1430; Guaiquil VH, 1997, J BIOL CHEM, V272, P9915; HELBIG H, 1989, AM J PHYSIOL, V256, pC44, DOI 10.1152/ajpcell.1989.256.1.C44; HODGES RE, 1971, AM J CLIN NUTR, V24, P432; Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626, DOI 10.1152/ajpheart.1996.271.4.H1626; KHATAMI M, 1986, INVEST OPHTH VIS SCI, V27, P1665; Koshiishi I, 1998, BBA-GEN SUBJECTS, V1379, P257, DOI 10.1016/S0304-4165(97)00106-2; Koshiishi I, 1998, BBA-GEN SUBJECTS, V1425, P209, DOI 10.1016/S0304-4165(98)00073-7; Koshiishi I, 1998, CLIN CHEM, V44, P863; Laggner T, 2000, BIOCHEM J, V345, P195; Marumo T, 1997, CIRCULATION, V96, P2361; MAY JM, 1995, BIOCHEMISTRY-US, V34, P12721, DOI 10.1021/bi00039a031; MCPHAIL LC, 1992, GRANULOCYTE RESPONSE, P47; Mendiratta S, 1998, FREE RADICAL BIO MED, V24, P789, DOI 10.1016/S0891-5849(97)00351-1; Montecinos VP, 2000, J PHYSIOL-LONDON, V529, P777, DOI 10.1111/j.1469-7793.2000.00777.x; Ness AR, 1996, J HYPERTENS, V14, P503; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Pagano PJ, 1997, P NATL ACAD SCI USA, V94, P14483, DOI 10.1073/pnas.94.26.14483; PATTERSON LT, 1982, LIFE SCI, V31, P2783, DOI 10.1016/0024-3205(82)90725-1; Qutob S, 1998, ENDOCRINOLOGY, V139, P51, DOI 10.1210/en.139.1.51; Rivas CI, 1997, J BIOL CHEM, V272, P5814, DOI 10.1074/jbc.272.9.5814; ROSE RC, 1988, BIOCHIM BIOPHYS ACTA, V947, P335, DOI 10.1016/0304-4157(88)90014-7; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Sargeant LA, 2000, DIABETES CARE, V23, P726, DOI 10.2337/diacare.23.6.726; Siushansian R, 1997, J NEUROCHEM, V68, P2378; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Spielholz C, 1997, CANCER RES, V57, P2529; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TOMONAGA M, 1986, BLOOD, V67, P1433; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; VERA JC, 1994, BLOOD, V84, P1628; Vera JC, 1998, BLOOD, V91, P2536, DOI 10.1182/blood.V91.7.2536.2536_2536_2546; VERA JC, 1995, J BIOL CHEM, V270, P23706, DOI 10.1074/jbc.270.40.23706; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Wang HP, 1999, BBA-BIOMEMBRANES, V1461, P1, DOI 10.1016/S0005-2736(99)00182-0; Wang YH, 1997, P NATL ACAD SCI USA, V94, P13816, DOI 10.1073/pnas.94.25.13816; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; WASHKO PW, 1993, J BIOL CHEM, V268, P15531; WILSON JX, 1989, J MEMBRANE BIOL, V111, P83, DOI 10.1007/BF01869211; WINKLER BS, 1987, BIOCHIM BIOPHYS ACTA, V925, P258, DOI 10.1016/0304-4165(87)90190-5; Young VR, 1996, P NATL ACAD SCI USA, V93, P14344, DOI 10.1073/pnas.93.25.14344; ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847	52	117	120	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2003	278	12					10128	10133		10.1074/jbc.M210686200	http://dx.doi.org/10.1074/jbc.M210686200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	659LE	12435736	hybrid			2022-12-27	WOS:000181777500020
J	Jullien, J; Guili, V; Derrington, EA; Darlix, JL; Reichardt, LF; Rudkin, BB				Jullien, J; Guili, V; Derrington, EA; Darlix, JL; Reichardt, LF; Rudkin, BB			Trafficking of TrkA-green fluorescent protein chimerae during nerve growth factor-induced differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROGRADE AXONAL-TRANSPORT; P75 NEUROTROPHIN RECEPTOR; ZINC-FINGER PROTEIN; TYROSINE KINASE; INTERNALIZED NEUROTROPHINS; PHEOCHROMOCYTOMA CELLS; SIGNALING ORGANELLE; PLASMA-MEMBRANE; ACTIVATION; ASSOCIATION	A chimera of the nerve growth factor (NGF) receptor, TrkA, and green fluorescent protein (GFP) was engineered by expressing GFP in phase with the carboxyl terminus of TrkA. TrkA-GFP becomes phosphorylated on tyrosine residues in response to NGF and is capable of initiating signaling cascades leading to prolonged MAPK activation and differentiation in PC12 nnr5 cells. TrkA constructs, progressively truncated in the carboxyl-terminal domain, were prepared as GFP chimerae in order to identify which part of the receptor intracellular domain is involved in its trafficking. Immunofluorescence observations show that TrkA-GFP is found mainly in cell surface membrane ruffles and in endosomes. Biochemical analysis indicated that the cytoplasmic domain of TrkA is not necessary for correct maturation and cell surface translocation of the receptor. An antibody against the extracellular domain of TrkA (RTA) was used as ligand to stimulate internalization and phosphorylation of TrkA. Co-localization studies with anti-phosphorylated TrkA antibodies support a role for such complexes in the propagation of signaling from the cell surface, resulting in the activation of TrkA in areas of the endosome devoid of receptor-ligand complexes. Confocal time-lapse analysis reveals that the TrkA-GFP chimera shows highly dynamic trafficking between the cell surface and internal locations. TrkA-positive vesicles were estimated to move 0.46 +/- 0.09 mum/s anterograde and 0.48 +/- 0.07 mum/s retrograde. This approach and the fidelity of the biochemical properties of the TrkA-GFP demonstrate that real-time visualization of trafficking of tyrosine kinase receptors in the presence or absence of the ligand is feasible.	Ecole Normale Super Lyon, UMR 5665 CNRS, Lab Biol Mol & Cellulaire, Differentiat & Cell Cycle Grp, F-69364 Lyon 07, France; Ecole Normale Super Lyon, INSERM U412, LaboRetro, F-69364 Lyon 07, France; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Howard Hughes Medical Institute; University of California System; University of California San Francisco	Rudkin, BB (corresponding author), Ecole Normale Super Lyon, UMR 5665 CNRS, Lab Biol Mol & Cellulaire, Differentiat & Cell Cycle Grp, F-69364 Lyon 07, France.	bbrudkin@ens-lyon.fr	LUC, DARLIX JEAN/AAE-9268-2020; Derrington, Ed/G-9478-2017; jerome, jullien/K-5565-2019; jullien, jerome/AAC-1887-2022	jerome, jullien/0000-0002-7868-0021; RUDKIN, Brian B./0000-0003-3700-1982	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016033, P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-19, NS 16033, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; CLARY DO, 1994, MOL BIOL CELL, V5, P549, DOI 10.1091/mbc.5.5.549; CLAUDE P, 1982, J NEUROSCI, V2, P431; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Diaz-Rodriguez E, 1999, EUR J NEUROSCI, V11, P1421, DOI 10.1046/j.1460-9568.1999.00552.x; DOWRICK P, 1993, EUR J CELL BIOL, V61, P44; EVELETH DD, 1992, J CELL BIOL, V117, P291, DOI 10.1083/jcb.117.2.291; Glass David J., 1993, Trends in Cell Biology, V3, P262, DOI 10.1016/0962-8924(93)90054-5; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; Gryz EA, 2000, ONCOGENE, V19, P417, DOI 10.1038/sj.onc.1203330; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LAMAZE C, 1995, CURR OPIN CELL BIOL, V7, P573, DOI 10.1016/0955-0674(95)80015-8; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LOEB DM, 1994, J BIOL CHEM, V269, P8901; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Oldenbourg R, 2000, BIOPHYS J, V78, P1176, DOI 10.1016/S0006-3495(00)76675-6; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; RABIN SJ, 1993, MOL CELL BIOL, V13, P2203, DOI 10.1128/MCB.13.4.2203; Reynolds AJ, 1999, J NEUROCHEM, V73, P87, DOI 10.1046/j.1471-4159.1999.0730087.x; Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rohn WM, 2000, J CELL SCI, V113, P2093; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Sandow SL, 2000, IMMUNOL CELL BIOL, V78, P430, DOI 10.1046/j.1440-1711.2000.00924.x; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; Urdiales JL, 1998, J NEUROSCI, V18, P6767; vanGrunsven LA, 1996, ONCOGENE, V12, P1347; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Weible MW, 2001, CYTOMETRY, V43, P182, DOI 10.1002/1097-0320(20010301)43:3<182::AID-CYTO1047>3.0.CO;2-J; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; ZANELLATO A, 1994, MOL BRAIN RES, V23, P299, DOI 10.1016/0169-328X(94)90239-9; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	55	54	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2003	278	10					8706	8716		10.1074/jbc.M202401200	http://dx.doi.org/10.1074/jbc.M202401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	653ZK	12438306	Green Accepted, hybrid			2022-12-27	WOS:000181466800123
J	Fuks, F; Hurd, PJ; Wolf, D; Nan, XS; Bird, AP; Kouzarides, T				Fuks, F; Hurd, PJ; Wolf, D; Nan, XS; Bird, AP; Kouzarides, T			The Methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PROTEIN; CHROMATIN STRUCTURE; LYSINE 9; H3; METHYLTRANSFERASE; DEACETYLASE; DOMAIN; HP1; SITE; GENE	DNA methylation plays an important role in mammalian development and correlates with chromatin-associated gene silencing. The recruitment of MeCP2 to methylated CpG dinucleotides represents a major mechanism by which DNA methylation can repress transcription. MeCP2 silences gene expression partly by recruiting histone deacetylase (HDAC) activity, resulting in chromatin remodeling. Here, we show that MeCP2 associates with histone methyltransferase activity in vivo and that this activity is directed against Lys(9) of histone H3. Two characterized repression domains of MeCP2 are involved in tethering the histone methyltransferase to MeCP2. We asked if MeCP2 can deliver Lys(9)H3 methylation to the H19 gene, whose activity it represses. We show that the presence of MeCP2 on nucleosomes within the repressor region of the H19 gene (the differentially methylated domain) coincides with an increase in H3 Lys(9) methylation. Our data provide evidence that MeCP2 reinforces a repressive chromatin state by acting as a bridge between two global epigenetic modifications, DNA methylation and histone methylation.	Univ Cambridge, Wellcome Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.			Kouzarides, Tony/0000-0002-8918-4162; Bird, Adrian/0000-0002-8600-0372; Nan, Xinsheng/0000-0002-0865-7934; Hurd, Paul/0000-0003-1112-9347				Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998	24	740	785	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4035	4040		10.1074/jbc.M210256200	http://dx.doi.org/10.1074/jbc.M210256200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12427740	hybrid			2022-12-27	WOS:000180869700067
J	Nelsen, CJ; Rickheim, DG; Tucker, MM; Hansen, LK; Albrecht, JH				Nelsen, CJ; Rickheim, DG; Tucker, MM; Hansen, LK; Albrecht, JH			Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE; LIVER-REGENERATION; TRANSGENIC MICE; S6 KINASE; IN-VIVO; PROGRESSION; HYPERPLASIA; EXPRESSION; RAPAMYCIN	Signaling through the target of rapamycin is required for increased protein synthesis, cell growth, and proliferation in response to growth factors. However, the downstream mediators of these responses, and the elements linking growth and proliferation, have not been fully elucidated. Rapamycin inhibits hepatocyte proliferation in culture and liver regeneration in vivo. In cultured rat hepatocytes, rapamycin prevented the up-regulation of cyclin D1 as well as proteins acting downstream in the cell cycle. Transfection with cyclin D1 or E2F2, but not cyclin E or activated Akt, overcame the rapamycin-mediated cell cycle arrest. Rapamycin also inhibited the induction of global protein synthesis after growth factor stimulation, and cyclin D1 overcame this inhibition. Rapamycin inhibited hepatocyte proliferation and cyclin D1 expression in the mouse liver after 70% partial hepatectomy. In rapamycin-treated mice, transfection with cyclin D1 induced hepatocyte proliferation, increased hepatocyte cell size, and promoted growth of the liver. These results suggest that cyclin D1 is a key mediator of increased protein synthesis, cell growth, and proliferation downstream of target of rapamycin in mitogen-stimulated hepatocytes.	Hennepin Cty Med Ctr, Dept Med 865B, Minneapolis, MN 55415 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA	Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Minneapolis Medical Research Foundation	Albrecht, JH (corresponding author), Hennepin Cty Med Ctr, Dept Med 865B, 701 Pk Ave, Minneapolis, MN 55415 USA.			Hansen, Linda/0000-0003-3651-0419	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054921] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK54921] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albrecht JH, 1999, AM J PHYSIOL-GASTR L, V277, pG1207, DOI 10.1152/ajpgi.1999.277.6.G1207; Albrecht JH, 1999, CELL GROWTH DIFFER, V10, P397; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Awad MM, 2000, CELL GROWTH DIFFER, V11, P325; Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Bernards R, 1999, BBA-REV CANCER, V1424, pM17, DOI 10.1016/S0304-419X(99)00024-4; Boylan JM, 2001, J BIOL CHEM, V276, P44457, DOI 10.1074/jbc.M103457200; Cockcroft CE, 2000, NATURE, V405, P575, DOI 10.1038/35014621; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fausto N, 2001, LIVER TRANSPLANT, V7, P835, DOI 10.1053/jlts.2001.27865; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; FRANCAVILLA A, 1992, HEPATOLOGY, V15, P871, DOI 10.1002/hep.1840150520; FRANCAVILLA A, 1992, TRANSPLANTATION, V53, P496; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Hansen LK, 1999, J CELL SCI, V112, P2971; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Ilan Y, 1999, SEMIN LIVER DIS, V19, P49, DOI 10.1055/s-2007-1007097; Imanishi Y, 2001, J CLIN INVEST, V107, P1093, DOI 10.1172/JCI10523; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; Jones SM, 2001, FEBS LETT, V490, P110, DOI 10.1016/S0014-5793(01)02113-5; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Kroll SL, 2001, J BIOL CHEM, V276, P49410, DOI 10.1074/jbc.M109577200; Larminie CGC, 1998, J MOL MED, V76, P94, DOI 10.1007/s001090050196; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; LU XP, 1992, J BIOL CHEM, V267, P2841; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nelsen CJ, 2001, CANCER RES, V61, P8564; Nelsen CJ, 2001, ONCOGENE, V20, P1825, DOI 10.1038/sj.onc.1204248; NEMENOFF RA, 1988, J BIOL CHEM, V263, P19455; Pomfret EA, 2001, J HEPATOL, V34, P613, DOI 10.1016/S0168-8278(01)00031-9; Prober DA, 2001, CURR OPIN GENET DEV, V11, P19, DOI 10.1016/S0959-437X(00)00151-9; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Robles AI, 1996, P NATL ACAD SCI USA, V93, P7634, DOI 10.1073/pnas.93.15.7634; Rodriguez-Puebla ML, 1999, CELL GROWTH DIFFER, V10, P467; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Scott PH, 2001, J BIOL CHEM, V276, P1005, DOI 10.1074/jbc.M005417200; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sherr CJ, 2000, CANCER RES, V60, P3689; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Volarevic S, 2001, PROG NUCLEIC ACID RE, V65, P101; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0	55	105	110	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3656	3663		10.1074/jbc.M209374200	http://dx.doi.org/10.1074/jbc.M209374200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446670	hybrid			2022-12-27	WOS:000180869700019
J	Neznanov, N; Neznanova, L; Kondratov, RV; Burdelya, L; Kandel, ES; O'Rourke, DM; Ullrich, A; Gudkov, AV				Neznanov, N; Neznanova, L; Kondratov, RV; Burdelya, L; Kandel, ES; O'Rourke, DM; Ullrich, A; Gudkov, AV			Dominant negative form of signal-regulatory protein-alpha (SIRP alpha/SHPS-1) inhibits tumor necrosis factor-mediated apoptosis by activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC SUPPRESSOR ELEMENTS; TYROSINE-PHOSPHATASE SHP-1; EXPRESSION; PHOSPHORYLATION; RESISTANCE; RECEPTORS; SHPS-1; ASSOCIATION; INDUCTION; DEATH	Genetic suppressor element (GSE) methodology was applied to identify new genes controlling cell response to tumor necrosis factor (TNF). A retroviral library of randomly fragmented normalized cDNA from mouse fibroblasts was screened for GSEs capable of protecting NIH3T3 cells from TNF-induced apoptosis. The most abundant among isolated GSEs represented a fragment of cDNA encoding the C-terminal cytoplasmic region of the immunoglobulin family inhibitory receptor, SHPS-1 (mouse homologue of human SIRPalpha). Ectopic expression of this fragment (both from human and mouse versions) increased the NF-kappaB-dependent transcription in three cell lines tested; this effect could be reduced by the expression of full-length SIRPa, suggesting that the isolated GSE acts through a dominant negative mechanism. GSE-mediated activation of NF-kappaB depended on the presence of serum, was abrogated by wortmannin, and was associated with phosphorylation of PKB/Akt, suggesting that Akt mediates it. These data indicate that SIRPalpha/SHPS-1 is involved in negative regulation of NF-kappaB signaling.	Cleveland Clin Fdn, Dept Virol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biol Mol, Lerner Res Inst, Cleveland, OH 44195 USA; Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Max Planck Inst Biochem, Dept Biol Mol, D-82152 Martinsried, Germany	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Pennsylvania; University of Pennsylvania; Max Planck Society	Neznanov, N (corresponding author), Cleveland Clin Fdn, Dept Virol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	neznann@ccf.org	O'Rourke, Donald/AAC-3376-2021	Gudkov, Andrei/0000-0003-2548-0154; O'Rourke, Donald/0000-0002-8479-7314; Kondratov, Roman/0000-0003-3449-745X	NATIONAL CANCER INSTITUTE [R01CA060730] Funding Source: NIH RePORTER; NCI NIH HHS [CA60730] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Cambier JC, 1997, P NATL ACAD SCI USA, V94, P5993, DOI 10.1073/pnas.94.12.5993; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Erez N, 2002, ONCOGENE, V21, P6713, DOI 10.1038/sj.onc.1205867; Foos G, 1998, J BIOL CHEM, V273, P18871, DOI 10.1074/jbc.273.30.18871; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Georganas C, 2000, J IMMUNOL, V165, P7199, DOI 10.4049/jimmunol.165.12.7199; Gudkov A V, 1997, Methods Mol Biol, V69, P221; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Hideshima T, 2001, ONCOGENE, V20, P5991, DOI 10.1038/sj.onc.1204833; Hsu HC, 2001, J IMMUNOL, V166, P772, DOI 10.4049/jimmunol.166.2.772; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Lawlor MA, 2001, J CELL SCI, V114, P2903; LIU ZG, 2001, CURR ISSUES MOL BIOL, V4, P79; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; Massa PT, 1998, J INTERF CYTOK RES, V18, P499, DOI 10.1089/jir.1998.18.499; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Migone TS, 1998, P NATL ACAD SCI USA, V95, P3845, DOI 10.1073/pnas.95.7.3845; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Ozes ON, 1999, NATURE, V401, P82; PAYA CV, 1992, P NATL ACAD SCI USA, V89, P7826, DOI 10.1073/pnas.89.16.7826; Petak Istvan, 2001, Pathology and Oncology Research, V7, P95; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sanz G, 2002, CANCER RES, V62, P4453; Scharenberg AM, 1996, CELL, V87, P961, DOI 10.1016/S0092-8674(00)81790-0; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Takada T, 1998, J BIOL CHEM, V273, P9234, DOI 10.1074/jbc.273.15.9234; Thangaraju M, 1999, J BIOL CHEM, V274, P29549, DOI 10.1074/jbc.274.41.29549; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	42	31	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3809	3815		10.1074/jbc.M210698200	http://dx.doi.org/10.1074/jbc.M210698200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446684	hybrid			2022-12-27	WOS:000180869700038
J	Kiernan, R; Bres, V; Ng, RWM; Coudart, MP; El Messaoudi, S; Sardet, C; Jin, DY; Emiliani, S; Benkirane, M				Kiernan, R; Bres, V; Ng, RWM; Coudart, MP; El Messaoudi, S; Sardet, C; Jin, DY; Emiliani, S; Benkirane, M			Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-INDUCED DEGRADATION; NUCLEAR EXPORT SIGNAL; HISTONE ACETYLTRANSFERASES; GENE-EXPRESSION; REL PROTEINS; DNA-BINDING; HIV-1 TAT; ALPHA; REQUIRES; P300	NF-kappaB represents a family of eukaryotic transcription factors participating in the regulation of various cellular genes involved in the immediate early processes of immune, acute-phase, and inflammatory responses. Cellular localization and consequently the transcriptional activity of NF-kappaB is tightly regulated by its partner IkappaBalpha. Here, we show that the p65 subunit of NF-kappaB is acetylated by both p300 and PCAF on lysines 122 and 123. Both HDAC2 and HDAC3 interact with p65, although only HDAC3 was able to deacetylate p65. Acetylation of p65 reduces its ability to bind kappaB-DNA. Finally, acetylation of p65 facilitated its removal from DNA and consequently its IkappaBalpha-mediated export from the nucleus. We propose that acetylation of p65 plays a key role in IkappaBalpha-mediated attenuation of NF-kappaB transcriptional activity which is an important process that restores the latent state in post-induced cells.	Inst Genet Humaine, Lab Virol Mol, F-34296 Montpellier, France; Inst Genet Mol, F-34296 Montpellier, France; Inst Cochin, Dept Maladies Infect, F-75014 Paris, France; Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Universite de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hong Kong	Benkirane, M (corresponding author), Inst Genet Humaine, Lab Virol Mol, 141 Rue Cardonille, F-34396 Montpellier, France.		Kiernan, Rosemary/GXV-8695-2022	Kiernan, Rosemary/0000-0001-6645-0686				ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bannister AJ, 2000, CURR BIOL, V10, P467, DOI 10.1016/S0960-9822(00)00445-0; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Benkirane M, 1998, J BIOL CHEM, V273, P24898, DOI 10.1074/jbc.273.38.24898; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fajas L, 2001, MOL CELL BIOL, V21, P2956, DOI 10.1128/MCB.21.8.2956-2966.2001; Furia B, 2002, J BIOL CHEM, V277, P4973, DOI 10.1074/jbc.M107848200; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Klement JF, 1996, MOL CELL BIOL, V16, P2341; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Phelps CB, 2000, J BIOL CHEM, V275, P29840, DOI 10.1074/jbc.M004899200; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; URBAN MB, 1990, GENE DEV, V4, P1975, DOI 10.1101/gad.4.11.1975; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	41	402	419	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2758	2766		10.1074/jbc.M209572200	http://dx.doi.org/10.1074/jbc.M209572200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12419806	Green Published, hybrid			2022-12-27	WOS:000180562000089
J	Nordlund, HR; Laitinen, OH; Uotila, STH; Nyholm, T; Hytonen, VP; Slotte, JP; Kulomaa, MS				Nordlund, HR; Laitinen, OH; Uotila, STH; Nyholm, T; Hytonen, VP; Slotte, JP; Kulomaa, MS			Enhancing the thermal stability of avidin - Introduction of disulfide bridges between subunit interfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; SEA-URCHIN; ESCHERICHIA-COLI; BIOTIN COMPLEX; CHICKEN AVIDIN; HIGH-AFFINITY; STREPTAVIDIN; GENE; EXPRESSION; PROTEINS	In this study we showed that tetrameric chicken avidin can be stabilized by introducing intermonomeric disulfide bridges between its subunits. These covalent bonds had no major effects on the biotin binding properties of the respective mutants. Moreover, one of the mutants (Avd-ccci) maintained its tetrameric integrity even in denaturing conditions. The new avidin forms Avd-ci and Avd-ccci, which have native --> denatured transition midpoints (T-m) of 98.6 and 94.7 degreesC, respectively, in the absence of biotin, will find use in applications where extreme stability or minimal leakage of subunits is required. Furthermore, we showed that the intramonomeric disulfide bridges found in the wild-type avidin affect its stability. The mutant Avd-nc, in which this bridge was removed, had a lower T-m in the absence of biotin than the wild-type avidin but showed comparable stability in the presence of biotin.	Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40014 Jyvaskyla, Finland; Abo Akad Univ, Dept Biochem & Pharm, FIN-20521 Turku, Finland	University of Jyvaskyla; Abo Akademi University	Kulomaa, MS (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35 YAB, FIN-40014 Jyvaskyla, Finland.		Laitinen, Olli H/A-6618-2016; Kulomaa, Markku S/C-9063-2014; Hytonen, Vesa P./E-8855-2013	Laitinen, Olli H/0000-0002-3751-9952; Hytonen, Vesa P./0000-0002-9357-1480				Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; BISGROVE BW, 1993, DEV BIOL, V157, P526, DOI 10.1006/dbio.1993.1155; BISGROVE BW, 1995, J MOL EVOL, V41, P34; CHILKOTI A, 1995, P NATL ACAD SCI USA, V92, P1754, DOI 10.1073/pnas.92.5.1754; CHILKOTI A, 1995, BIO-TECHNOL, V13, P1198, DOI 10.1038/nbt1195-1198; DELGADILLOREYNOSO MG, 1989, J MOL EVOL, V29, P314, DOI 10.1007/BF02103619; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Hood EE, 1999, ADV EXP MED BIOL, V464, P127; HUNT LT, 1989, FASEB J, V3, P1760, DOI 10.1096/fasebj.3.6.2784773; Kusnaki AR, 1998, BIOTECHNOL PROGR, V14, P149, DOI 10.1021/bp970138u; Laitinen OH, 1999, FEBS LETT, V461, P52, DOI 10.1016/S0014-5793(99)01423-4; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Laitinen OH, 2001, J BIOL CHEM, V276, P8219, DOI 10.1074/jbc.M007930200; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Marttila AT, 1998, FEBS LETT, V441, P313, DOI 10.1016/S0014-5793(98)01570-1; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Reznik GO, 1996, NAT BIOTECHNOL, V14, P1007, DOI 10.1038/nbt0896-1007; SANO T, 1990, P NATL ACAD SCI USA, V87, P142, DOI 10.1073/pnas.87.1.142; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; THOMPSON LD, 1993, GENE, V136, P243, DOI 10.1016/0378-1119(93)90472-F; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilchek M, 1999, BIOMOL ENG, V16, P1; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5	28	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2479	2483		10.1074/jbc.M210721200	http://dx.doi.org/10.1074/jbc.M210721200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12446662	hybrid			2022-12-27	WOS:000180562000056
J	Trembley, JH; Hu, DL; Slaughter, CA; Lahti, JM; Kidd, VJ				Trembley, JH; Hu, DL; Slaughter, CA; Lahti, JM; Kidd, VJ			Casein kinase 2 interacts with cyclin-dependent kinase 11 (CDK11) in vivo and phosphorylates both the RNA polymerase II carboxyl-terminal domain and CDK11 in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; CELL-CYCLE; TRANSCRIPTION; COMPLEXES; ISOFORMS; INHIBITION; ELONGATION; TRANSITION; EXPRESSION; INITIATION	The PITSLRE protein kinases, hereafter referred to as cyclin-dependent kinase 11 (CDK11) due to their association with cyclin L, are part of large molecular weight protein complexes that contain RNA polymerase II (RNAP II) as well as numerous transcription and RNA processing factors. Data presented here demonstrate that the influence of CDK11(p110) on transcription and splicing does not involve phosphorylation of the RNAP 11 carboxyl-terminal domain by CDK11(p110). We have isolated a DRB- and heparin-sensitive protein kinase activity that co-purifies with CDK11(p110) after ion exchange and affinity purification chromatography. This protein kinase was identified as casein kinase 2 (CK2) by immunoblot and mass spectrometry analyses. In addition to the RNAP II carboxyl-terminal domain, CK2 phosphorylates the CDK11(p110) amino-terminal domain. These data suggest that CDK11(p110) isoforms participate in signaling pathways that include CK2 and that its function may help to coordinate the regulation of RNA transcription and processing events. Future experiments will determine how phosphorylation of CDK11(p110) by CK2 specifically affects RNA transcription and/or processing events.	St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kidd, VJ (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	vincent.kidd@stjude.org		Trembley, Janeen/0000-0003-3597-2611	NCI NIH HHS [P30 CA21765] Funding Source: Medline; NIGMS NIH HHS [GM44088] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044088] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; DAHMUS ME, 1995, BBA-GENE STRUCT EXPR, V1261, P171, DOI 10.1016/0167-4781(94)00233-S; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dickinson LA, 2002, J BIOL CHEM, V277, P25465, DOI 10.1074/jbc.M202266200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egyhazi E, 1999, MOL CELL BIOCHEM, V191, P149; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Korn I, 1999, MOL CELL BIOCHEM, V191, P75, DOI 10.1023/A:1006818513560; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Loyer P, 1998, J CELL SCI, V111, P1495; MARSHAK DR, 1994, CELL MOL BIOL RES, V40, P513; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Tang DM, 1998, J BIOL CHEM, V273, P16601, DOI 10.1074/jbc.273.26.16601; TAYLOR SS, 1993, TRENDS BIOCHEM SCI, V18, P84, DOI 10.1016/0968-0004(93)80001-R; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; XIANG JL, 1994, J BIOL CHEM, V269, P15786; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414	30	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2265	2270		10.1074/jbc.M207518200	http://dx.doi.org/10.1074/jbc.M207518200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12429741	hybrid			2022-12-27	WOS:000180562000027
J	Nomura, M; Shimizu, S; Sugiyama, T; Narita, M; Ito, T; Matsuda, H; Tsujimoto, Y				Nomura, M; Shimizu, S; Sugiyama, T; Narita, M; Ito, T; Matsuda, H; Tsujimoto, Y			14-3-3 interacts directly with and negatively regulates pro-apoptotic bax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MULTIPLE SIGNALING PATHWAYS; MITOCHONDRIAL DYSFUNCTION; BCL-2 FAMILY; CASPASE ACTIVATION; CELL-SURVIVAL; MOTOR COMPLEX; PROTEIN; DEATH; CYTOSOL	The Bcl-2 family of proteins comprises well characterized regulators of apoptosis, consisting of anti-apoptotic members and pro-apoptotic members. Pro-apoptotic members possessing BH1, BH2, and BH3 domains (such as Bax and Bak) act as a gateway for a variety of apoptotic signals. Bax is normally localized to the cytoplasm in an inactive form. In response to apoptotic stimuli, Bax translocates to the mitochondria and undergoes oligomerization to induce the release of apoptogenic factors such as cytochrome c, but it is still largely unknown how the mitochondrial translocation and proapoptotic activity of Bax is regulated. Here we report that cytoplasmic protein 14-3-3theta binds to Bax and, upon apoptotic stimulation, releases Bax by a caspase-independent mechanism, as well as through direct cleavage of 14-3-3theta by caspases. Unlike Bad, the interaction with 14-3-3theta is not dependent on the phosphorylation of Bax. In isolated mitochondria, we found that 14-3-3theta inhibited the integration of Bax and Bax-induced cytochrome c release. Bax-induced apoptosis was inhibited by overexpression of either 14-3-3theta or its mutant (which lacked the ability to bind to various phosphorylated targets but still bound to Bax), whereas overexpression of 14-3-3theta was unable to inhibit apoptosis induced by a Bax mutant that did not bind to 14-3-3theta. These findings indicate that 14-3-3theta plays a crucial role in negatively regulating the activity of Bax.	Osaka Univ, Grad Sch Med, Dept Post Genom & Dis, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Tsujimoto, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Post Genom & Dis, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tsujimot@gene.med.osaka-u.ac.jp		Sugiyama, Tomoyasu/0000-0001-5704-6606; Narita, Masashi/0000-0001-7764-577X				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; ALAM R, 1994, J BIOCHEM-TOKYO, V116, P416, DOI 10.1093/oxfordjournals.jbchem.a124541; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Ichimura T, 1997, FEBS LETT, V413, P273, DOI 10.1016/S0014-5793(97)00910-1; ICHIMURA T, 1995, J BIOL CHEM, V270, P28515, DOI 10.1074/jbc.270.48.28515; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomura M, 1999, CANCER RES, V59, P5542; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolf BB, 2002, CURR BIOL, V12, pR177, DOI 10.1016/S0960-9822(02)00736-4; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	46	288	304	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2058	2065		10.1074/jbc.M207880200	http://dx.doi.org/10.1074/jbc.M207880200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426317	hybrid			2022-12-27	WOS:000180462200092
J	Okamoto, K; Eger, BT; Nishino, T; Kondo, S; Pai, EF; Nishino, T				Okamoto, K; Eger, BT; Nishino, T; Kondo, S; Pai, EF; Nishino, T			An extremely potent inhibitor of xanthine oxidoreductase - Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-DENSITY MAPS; DEHYDROGENASE TYPE D; X-RAY-DIFFRACTION; OXIDASE TYPE; PURIFICATION; CONVERSION; PROTEIN; INACTIVATION; REPERFUSION; REDUCTION	TEI-6720 (2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5thiazolecarboxylic acid) is an extremely potent inhibitor of xanthine oxidoreductase. Steady state kinetics measurements exhibit mixed type inhibition with K-i and K-i' values of 1.2 +/- 0.05 x 10(-10) m and 9 +/- 0.05 x 10(-10) m, respectively. Fluorescence-monitored titration experiments showed that TEI-6720 bound very tightly to both the active and the inactive desulfo-form of the enzyme. The dissociation constant determined for the desulfoform was 2 +/- 0.03 x 10(-9) m; for the active form, the corresponding number was too low to allow accurate measurements. The crystal structure of the active sulfoform of milk xanthine dehydrogepase complexed with TEI-6720 and determined at 2.8-Angstrom resolution revealed the inhibitor molecule bound in a long, narrow channel leading to the molybdenum-pterin active site of the enzyme. It filled up most of the channel and the immediate environment of the cofactor, very effectively inhibiting the activity of the enzyme through the prevention of substrate binding. Although the inhibitor did not directly coordinate to the molybdenum ion, numerous hydrogen bonds as well as hydrophobic interactions with the protein matrix were observed, most of which are also used in substrate recognition.	Nippon Med Coll, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130022, Japan; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Teijin Inst Biomed Res, Pharmaceut Dev Res Labs, Hino, Tokyo 191, Japan; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Princess Margaret Hosp, Hlth Network, Ontario Canc Inst,Div Mol & Struct Biol, Toronto, ON M5G 2M9, Canada	Nippon Medical School; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Nishino, T (corresponding author), Nippon Med Coll, Dept Biochem & Mol Biol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1130022, Japan.	pai@hera.med.utoronto.ca; nishino@nms.ac.jp	Pai, Emil/R-8908-2019; Pai, Emil F/D-2526-2013	Pai, Emil/0000-0002-1162-7242; 				Ball EG, 1939, J BIOL CHEM, V128, P51; Beedham C, 1987, Prog Med Chem, V24, P85, DOI 10.1016/S0079-6468(08)70420-X; Berglund L, 1996, J DAIRY SCI, V79, P198, DOI 10.3168/jds.S0022-0302(96)76351-8; Bray R. C., 1975, ENZYMES, P300; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Della Corte E, 1970, Biochem J, V117, P97; DELLACOR.E, 1972, BIOCHEM J, V126, P739, DOI 10.1042/bj1260739; Eger BT, 2000, ACTA CRYSTALLOGR D, V56, P1656, DOI 10.1107/S0907444900012890; ELION GB, 1963, BIOCHEM PHARMACOL, V12, P85, DOI 10.1016/0006-2952(63)90012-1; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R., 1985, Metal Ions in Biology, V7, P443; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; ICHIDA K, 1993, GENE, V133, P279; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KOMORIYA K, 1993, EUR J PHARMACOL, V250, P455, DOI 10.1016/0014-2999(93)90033-E; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MASSEY V, 1970, J BIOL CHEM, V245, P6595; Massey V, 1970, Vitam Horm, V28, P505; MASSEY V, 1970, J BIOL CHEM, V245, P2837; MASSEY V, 1969, J BIOL CHEM, V244, P1682; Matsumura F, 1998, HEPATOLOGY, V28, P1578, DOI 10.1002/hep.510280618; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; MOORHOUSE PC, 1987, FEBS LETT, V213, P23, DOI 10.1016/0014-5793(87)81458-8; Nishino T, 1997, J BIOL CHEM, V272, P29859, DOI 10.1074/jbc.272.47.29859; NISHINO T, 1981, FEBS LETT, V131, P369, DOI 10.1016/0014-5793(81)80406-1; NISHINO T, 1994, J BIOCHEM, V116, P1; NISHINO T, 1982, J BIOL CHEM, V257, P7348; OKAMOTO K, 1995, J BIOL CHEM, V270, P7816, DOI 10.1074/jbc.270.14.7816; OLSON JS, 1974, J BIOL CHEM, V249, P4350; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REGINATO AJ, 2001, HARRISONS PRINCIPLES, P1994; RYAN MG, 1995, J BIOL CHEM, V270, P19209, DOI 10.1074/jbc.270.33.19209; Sanders SA, 1997, EUR J BIOCHEM, V245, P541, DOI 10.1111/j.1432-1033.1997.00541.x; SPECTOR T, 1968, BIOCHEM BIOPH RES CO, V32, P1039, DOI 10.1016/0006-291X(68)90134-4; STIRPE F, 1969, J BIOL CHEM, V244, P3855; Suzuki H, 1998, P NATL ACAD SCI USA, V95, P4754, DOI 10.1073/pnas.95.8.4754; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Xia M, 1999, J BIOL CHEM, V274, P3323, DOI 10.1074/jbc.274.6.3323	46	316	353	2	38	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1848	1855		10.1074/jbc.M208307200	http://dx.doi.org/10.1074/jbc.M208307200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421831	hybrid			2022-12-27	WOS:000180462200065
J	Wei, M; Burenkova, O; Lippard, SJ				Wei, M; Burenkova, O; Lippard, SJ			Cisplatin sensitivity in Hmgb1(-/-) and Hmgb1 mouse cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP PROTEIN-1; DOMAIN PROTEIN; DNA-ADDUCTS; CHROMATIN PROTEIN; ANNEXIN-V; IN-VITRO; BINDING; RECOGNITION; ASSAY; APOPTOSIS	The study presented here investigates the effect of HMGB1 knockout on the sensitivity of mouse embryonic fibroblasts treated with the anticancer drug cisplatin. We evaluated both the growth inhibition by cisplatin and cisplatin-induced cell death in the Hmgb1(-/-) cells and its wild-type counterpart. No Significant differences were observed in the responses of these cells to cisplatin, indicating that HMGB1 does not play a significant role in modulating the cellular responses to cisplatin in this context. Since HMGB1 significantly enhances the cytotoxicity of cisplatin in other cells, these results illustrate the importance of cell type in determining the ability of this and probably other cisplatin-DNA-binding proteins to influence the efficacy of the drug.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lippard, SJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	lippard@lippard.mit.edu			NATIONAL CANCER INSTITUTE [R37CA034992, R01CA034992] Funding Source: NIH RePORTER; NCI NIH HHS [CA34992] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arioka H, 1999, JPN J CANCER RES, V90, P108, DOI 10.1111/j.1349-7006.1999.tb00673.x; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P1604, DOI 10.1093/nar/23.9.1604; Boersma AWM, 1996, CYTOMETRY, V24, P123, DOI 10.1002/(SICI)1097-0320(19960601)24:2<123::AID-CYTO4>3.0.CO;2-K; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bosl GJ, 1997, NEW ENGL J MED, V337, P242, DOI 10.1056/NEJM199707243370406; BROWN SJ, 1993, SCIENCE, V261, P603, DOI 10.1126/science.8342024; BUCCI LR, 1985, BIOCHEM J, V229, P233, DOI 10.1042/bj2290233; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; CHOW CS, 1995, BIOCHEMISTRY-US, V34, P2956, DOI 10.1021/bi00009a027; CHOW CS, 1994, BIOCHEMISTRY-US, V33, P15124, DOI 10.1021/bi00254a023; CHU G, 1994, J BIOL CHEM, V269, P787; Clarke RG, 2000, CYTOMETRY, V39, P141, DOI 10.1002/(SICI)1097-0320(20000201)39:2<141::AID-CYTO7>3.3.CO;2-F; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DONAHUE BA, 1990, BIOCHEMISTRY-US, V29, P5872, DOI 10.1021/bi00476a032; Dunham SU, 1997, BIOCHEMISTRY-US, V36, P11428, DOI 10.1021/bi9709452; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; Farid RS, 1996, TOXICOL APPL PHARM, V141, P532, DOI 10.1006/taap.1996.0319; He Q, 2000, P NATL ACAD SCI USA, V97, P5768, DOI 10.1073/pnas.100108697; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; HUGHES EN, 1992, J BIOL CHEM, V267, P13520; Jamieson ER, 2000, BIOCHEMISTRY-US, V39, P8426, DOI 10.1021/bi000342h; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P1, DOI 10.1016/s0027-5107(01)00142-7; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; LEPRE CA, 1990, NUCL ACIDS MOL BIOL, V4, P9, DOI [DOI 10.1007/978-3-642-84150-7-2, DOI 10.1007/978-3-642-84150-7]; LIPPARD SJ, 1993, R A WELCH FDN 37 C C, P49; McANulty MM, 1996, BIOCHEMISTRY-US, V35, P6089, DOI 10.1021/bi952877u; McANulty MM, 1996, MUTAT RES-DNA REPAIR, V362, P75, DOI 10.1016/0921-8777(95)00037-2; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; PEREZ RP, 1993, EUR J CANCER, V29A, P395, DOI 10.1016/0959-8049(93)90394-U; Perez RP, 1998, EUR J CANCER, V34, P1535, DOI 10.1016/S0959-8049(98)00227-5; Pestell KE, 2000, MOL PHARMACOL, V57, P503, DOI 10.1124/mol.57.3.503; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; READ CM, 1995, NUCL ACIDS MOL BIOL, P333; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sutrias-Grau M, 1999, J BIOL CHEM, V274, P1628, DOI 10.1074/jbc.274.3.1628; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wong B, 2002, BIOCHEMISTRY-US, V41, P5404, DOI 10.1021/bi012077l; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; Zlatanova J, 1998, FASEB J, V12, P791, DOI 10.1096/fasebj.12.10.791	47	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1769	1773		10.1074/jbc.M210562200	http://dx.doi.org/10.1074/jbc.M210562200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12429734				2022-12-27	WOS:000180462200054
J	Bauch, C; Forster, N; Loffing-Cueni, D; Summa, V; Verrey, F				Bauch, C; Forster, N; Loffing-Cueni, D; Summa, V; Verrey, F			Functional cooperation of epithelial heteromeric amino acid transporters expressed in madin-darby canine kidney cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINURIC PROTEIN INTOLERANCE; BROAD-SPECIFICITY; I CYSTINURIA; IDENTIFICATION; GLYCOPROTEIN; MUTATIONS; RBAT; GENE; Y(+)LAT-1; EXCHANGE	The heteromeric amino acid transporters b(0,+)AT-rBAT (apical), y(+)LAT1-4F2hc, and possibly LAT2-4F2hc (basolateral) participate to the (re)absorption of cationic and neutral amino acids in the small intestine and kidney proximal tubule. We show now by immunofluorescence that their expression levels follow the same axial gradient along the kidney proximal tubule (S1 > S2 much greater than S3). We reconstituted their co-expression in I MDCK cell epithelia and verified their polarized localization by immunofluorescence. Expression of b(0,+)AT-rBAT alone led to a net reabsorption Of L-Arg (given together with L-Leu). Coexpression of basolateral y(+)LAT1-4F2hc increased L-Arg reabsorption and reversed L-Leu transport from (re)absorption to secretion. Similarly, L-cystine was (re)absorbed when b(0,+)AT-rBAT was expressed alone. This net transport was further increased by the coexpression of 4F2hc, due to the mobilization of LAT2 (exogenous and/or endogenous) to the basolateral membrane. In summary, apical b(0,+)AT-rBAT cooperates with y(+)LAT1-4F2hc or LAT2-4F2hc for the transepithelial reabsorption of cationic amino acids and cystine, respectively. The fact that the reabsorption of L-Arg led to the secretion Of L-Leu demonstrates that the implicated heteromeric amino acid transporters function in epithelia as exchangers coupled in series and supports the notion that the parallel activity of unidirectional neutral amino acid transporters is required to drive net amino acid reabsorption.	Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich	Verrey, F (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Verrey, Francois/0000-0003-3250-9824				Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; BOERNER P, 1986, J BIOL CHEM, V261, P13957; Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815; BUSCH AE, 1994, J BIOL CHEM, V269, P25581; CALONGE MJ, 1995, P NATL ACAD SCI USA, V92, P9667, DOI 10.1073/pnas.92.21.9667; Chairoungdua A, 1999, J BIOL CHEM, V274, P28845, DOI 10.1074/jbc.274.41.28845; Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761; COADY MJ, 1994, FEBS LETT, V356, P174, DOI 10.1016/0014-5793(94)01262-8; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Feliubadalo L, 1999, NAT GENET, V23, P52, DOI 10.1038/12652; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Font M, 2001, HUM MOL GENET, V10, P305, DOI 10.1093/hmg/10.4.305; HAYNES BF, 1981, J IMMUNOL, V126, P1409; Kanai Y, 2000, J BIOL CHEM, V275, P20787, DOI 10.1074/jbc.M000634200; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Mizoguchi K, 2001, KIDNEY INT, V59, P1821, DOI 10.1046/j.1523-1755.2001.0590051821.x; Mykkanen J, 2000, HUM MOL GENET, V9, P431, DOI 10.1093/hmg/9.3.431; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Pear Warren S., 1997, P41; Pfeiffer R, 1999, MOL BIOL CELL, V10, P4135, DOI 10.1091/mbc.10.12.4135; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Toivonen M, 2002, BIOCHEM BIOPH RES CO, V291, P1173, DOI 10.1006/bbrc.2002.6564; Torrents D, 1999, NAT GENET, V21, P293, DOI 10.1038/6809; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001	28	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1316	1322		10.1074/jbc.M210449200	http://dx.doi.org/10.1074/jbc.M210449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417581	hybrid			2022-12-27	WOS:000180321900080
J	Messageot, F; Salhi, S; Eon, P; Rossignol, JM				Messageot, F; Salhi, S; Eon, P; Rossignol, JM			Proteolytic processing of the hepatitis B virus e antigen precursor - Cleavage at two furin consensus sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-C REGION; SECRETORY PATHWAY; HBE ANTIGEN; PROTEIN; BIOSYNTHESIS; ENDOPROTEASE; DEGRADATION; ACTIVATION; TERMINUS; MUTATION	The Hepatitis B virus P22 protein is a nonstructural protein that is the precursor of the 17-kDa secreted e antigen (HBeAg). The mature HBeAg is obtained after the removal of the C-terminal region of P22, a process which involves a proprotein convertase. Our studies show first that the protease could cleave P22 at the C-terminal side of Arg(167) or Arg(154) and second, that the maturation process can be either done in one step or in two steps with the generation of a processing intermediate (P20). Our data also demonstrate that the removal of the P22 C terminus, which occurs mainly in the trans-Golgi network, can also be achieved after exocytosis. Keeping in mind this characteristic and the amino acid sequence of the cleavage sites, we concluded that furin is involved in the maturation of the HBeAg. In addition, we show that in our experimental system, the HBeAg is a 164-amino acid protein and not a 159-amino acid protein as previously reported.	Univ Versailles, Lab Genet & Biol Cellulaire, ESA 8087 CNRS, F-78035 Versailles, France; Lab Genet Virus, F-91198 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay	Rossignol, JM (corresponding author), Univ Versailles, Lab Genet & Biol Cellulaire, ESA 8087 CNRS, Bat Buffon,45 Ave Etat Unis, F-78035 Versailles, France.							CARLIER D, 1994, J GEN VIROL, V75, P171, DOI 10.1099/0022-1317-75-1-171; CARLIER D, 1995, J GEN VIROL, V76, P1041, DOI 10.1099/0022-1317-76-4-1041; GARTEN W, 1989, VIROLOGY, V172, P25, DOI 10.1016/0042-6822(89)90103-7; Gil-Torregrosa BC, 1998, J EXP MED, V188, P1105, DOI 10.1084/jem.188.6.1105; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; JEANJEAN O, 1989, J VIROL, V63, P5497, DOI 10.1128/JVI.63.12.5497-5500.1989; JEANJEAN O, 1989, VIROLOGY, V170, P99, DOI 10.1016/0042-6822(89)90356-5; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Mains RE, 1997, BIOCHEM J, V321, P587, DOI 10.1042/bj3210587; Messageot F, 1998, J BIOL CHEM, V273, P18594, DOI 10.1074/jbc.273.29.18594; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Ou JH, 1997, J GASTROEN HEPATOL, V12, pS178, DOI 10.1111/j.1440-1746.1997.tb00499.x; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; Salhi S, 2001, J VIRAL HEPATITIS, V8, P169, DOI 10.1046/j.1365-2893.2001.00293.x; SCHLICHT HJ, 1987, J VIROL, V61, P3701, DOI 10.1128/JVI.61.12.3701-3709.1987; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; TAKAHASHI K, 1983, J IMMUNOL, V130, P2903; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; TONG S, 1991, VIROLOGY, V181, P733, DOI 10.1016/0042-6822(91)90908-T; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; WATANABE T, 1992, J BIOL CHEM, V267, P8270; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797	25	63	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					891	895		10.1074/jbc.M207634200	http://dx.doi.org/10.1074/jbc.M207634200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417589	hybrid			2022-12-27	WOS:000180321900027
J	Yi, CE; Bekker, JM; Miller, G; Hill, KL; Crosbie, RH				Yi, CE; Bekker, JM; Miller, G; Hill, KL; Crosbie, RH			Specific and potent RNA interference in terminally differentiated myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MEDIATED GENETIC INTERFERENCE; TARGETED DISRUPTION; MESSENGER-RNA; CELLS; EXPRESSION; DROSOPHILA; SARCOSPAN; IDENTIFICATION; DYSTROPHIN	Double-stranded RNA (dsRNA) interference is a potent mechanism for sequence-specific silencing of gene expression and represents an invaluable approach for investigating gene function in normal and diseased states as well as for drug target validation. Here, we report that skeletal muscle myoblasts and terminally differentiated myotubes are susceptible to RNA interference. We employed an approach in which dsRNA is generated by cellular transcription from plasmids containing long (1 kilobase) inverted DNA repeats of the target gene rather than using dsRNA synthesized in vitro. We show that gene silencing by this method is effective for endogenously expressed genes as well as for exogenous reporter genes. An analysis of the expression of several endogenous genes and exogenous reporters demonstrates that the silencing effect is specific for the target gene containing sequences within the inverted repeat. Our method eliminates the need to chemically synthesize dsRNA and is not accompanied by global repression of gene expression. Furthermore, we show for the first time that sequence-specific dsRNA-mediated gene silencing is possible in differentiated, multinucleated skeletal muscle myotubes. These findings provide an important molecular tool for the examination of protein function in terminally differentiated muscle cells and provide alternative approaches for generating disease models.	Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Crosbie, RH (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Life Sci Bldg 5804,621 Charles E Young Dr S, Los Angeles, CA 90025 USA.	rcrosbie@physci.ucla.edu	Miller, Gaynor/G-8917-2014	Miller, Gaynor/0000-0003-4527-3814	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048179] Funding Source: NIH RePORTER; NIAMS NIH HHS [1R01AR48179-01, R01 AR048179] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Bahramian MB, 1999, MOL CELL BIOL, V19, P274; BELKIN AM, 1995, J BIOL CHEM, V270, P6328, DOI 10.1074/jbc.270.11.6328; Bespalova IN, 2000, GENOMICS, V63, P69, DOI 10.1006/geno.1999.6049; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Bosher JM, 1999, GENETICS, V153, P1245; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Crosbie RH, 1999, J CELL BIOL, V145, P153, DOI 10.1083/jcb.145.1.153; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Harborth J, 2001, J CELL SCI, V114, P4557; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Jorgensen RA, 1996, PLANT MOL BIOL, V31, P957, DOI 10.1007/BF00040715; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Li WQ, 2000, DEV BIOL, V218, P172, DOI 10.1006/dbio.1999.9593; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Que QD, 1998, DEV GENET, V22, P100, DOI 10.1002/(SICI)1520-6408(1998)22:1&lt;100::AID-DVG10&gt;3.0.CO;2-D; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; Wargelius A, 1999, BIOCHEM BIOPH RES CO, V263, P156, DOI 10.1006/bbrc.1999.1343; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	41	27	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					934	939		10.1074/jbc.M205946200	http://dx.doi.org/10.1074/jbc.M205946200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12421826	hybrid			2022-12-27	WOS:000180321900032
J	Newton, DC; Bevan, SC; Choi, S; Robb, GB; Millar, A; Wang, Y; Marsden, PA				Newton, DC; Bevan, SC; Choi, S; Robb, GB; Millar, A; Wang, Y; Marsden, PA			Translational regulation of human neuronal nitric-oxide synthase by an alternatively spliced 5 '-untranslated region leader exon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; FERRITIN MESSENGER-RNA; 5' UNTRANSLATED REGION; BINDING-PROTEIN; SECONDARY STRUCTURE; OXIDATIVE STRESS; NO SYNTHASE; GENE; EXPRESSION; IDENTIFICATION	Expression of the neuronal nitric-oxide synthase (nNOS) mRNA is subject to complex cell-specific transcriptional regulation, which is mediated by alternative promoters. Unexpectedly, we identified a 89-nucleotide alternatively spliced exon located in the 5'-untranslated region between exon 1 variants and a common exon 2 that contains the translational initiation codon. Alternative splicing events that do not affect the open reading frame are distinctly uncommon in mammals; therefore, we assessed its functional relevance. Transient transfection of reporter RNAs performed in a variety of cell types revealed that this alternatively spliced exon acts as a potent translational repressor. Stably transfected cell lines confirmed that the alternatively spliced exon inhibited translation of the native nNOS open reading frame. Reverse transcription-PCR and RNase protection assays indicated that nNOS mRNAs containing this exon are common and expressed in both a promoter-specific and tissue-restricted fashion. Mutational analysis identified the functional cis-element within this novel exon, and a secondary structure prediction revealed that it forms a putative stem-loop. RNA electrophoretic mobility shift assay techniques revealed that a specific cytoplasmic RNA-binding complex interacts with this motif. Hence, a unique splicing event within a 5'-untranslated region is demonstrated to introduce a translational control element. This represents a newer model for the translational control of a mammalian mRNA.	Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; St Michaels Hosp, Div Renal, Toronto, ON M5S 1A8, Canada; St Michaels Hosp, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Marsden, PA (corresponding author), Univ Toronto, Dept Med, Med Sci Bldg,Rm 7358,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Choi, Stephen/AAS-5123-2021; Marsden, Philip A/B-1441-2012	Choi, Stephen/0000-0003-3662-9073; Robb, Gregory Brett/0000-0002-2382-2256				AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Boissel JP, 1998, NITRIC OXIDE-BIOL CH, V2, P337, DOI 10.1006/niox.1998.0189; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; Catania MV, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-11-j0002.2001; Christopherson KS, 1997, J CLIN INVEST, V100, P2424, DOI 10.1172/JCI119783; COX TC, 1991, EMBO J, V10, P1891, DOI 10.1002/j.1460-2075.1991.tb07715.x; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Duga S, 1999, EUR J BIOCHEM, V259, P188, DOI 10.1046/j.1432-1327.1999.00029.x; Ehresmann C, 1995, BIOCHEM CELL BIOL, V73, P1131, DOI 10.1139/o95-122; Eliasson MJL, 1997, P NATL ACAD SCI USA, V94, P3396, DOI 10.1073/pnas.94.7.3396; FU LN, 1991, SCIENCE, V251, P807, DOI 10.1126/science.1990443; FUJISAWA H, 1994, J NEUROCHEM, V63, P140; Galy B, 2001, ONCOGENE, V20, P1669, DOI 10.1038/sj.onc.1204271; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Gu W, 1996, MOL CELL BIOL, V16, P4535; HALL AV, 1994, J BIOL CHEM, V269, P33082; HENDERSON BR, 1993, J BIOL CHEM, V268, P27327; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Huo L, 1999, GENE, V233, P213, DOI 10.1016/S0378-1119(99)00135-3; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; JAFFREY SR, 1994, P NATL ACAD SCI USA, V91, P12994, DOI 10.1073/pnas.91.26.12994; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Kim KW, 2001, GENE, V273, P163, DOI 10.1016/S0378-1119(01)00595-9; KLAUSNER RD, 1993, MOL BIOL CELL, V4, P1; Kohler SA, 1995, J BIOL CHEM, V270, P30781, DOI 10.1074/jbc.270.51.30781; Kolesnikov YA, 1997, P NATL ACAD SCI USA, V94, P8220, DOI 10.1073/pnas.94.15.8220; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LEIBOLD EA, 1987, J BIOL CHEM, V262, P7335; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCPHEETERS DS, 1988, J MOL BIOL, V201, P517, DOI 10.1016/0022-2836(88)90634-1; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Morrisey K, 2001, AM J PATHOL, V159, P1905, DOI 10.1016/S0002-9440(10)63037-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; PANTOPOULOS K, 1995, P NATL ACAD SCI USA, V92, P1267, DOI 10.1073/pnas.92.5.1267; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Paraskeva E, 1999, MOL CELL BIOL, V19, P807; Ranganathan G, 2000, J BIOL CHEM, V275, P40986, DOI 10.1074/jbc.M008775200; RAO SM, 1993, J BIOL CHEM, V268, P22164; Roczniak A, 1998, AM J PHYSIOL-RENAL, V275, pF46, DOI 10.1152/ajprenal.1998.275.1.F46; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; Saur D, 2000, GASTROENTEROLOGY, V118, P849, DOI 10.1016/S0016-5085(00)70171-5; Saur D, 2002, J BIOL CHEM, V277, P25798, DOI 10.1074/jbc.M109802200; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; Sonenberg Nahum, 1993, Gene Expression, V3, P317; Sun XL, 1996, J BIOL CHEM, V271, P25539; TANG CK, 1989, CELL, V57, P531, DOI 10.1016/0092-8674(89)90123-2; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; THEIL EC, 1990, ENZYME, V44, P68, DOI 10.1159/000468748; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wang Y, 1997, J BIOL CHEM, V272, P11392; Wang Y, 2002, AM J PATHOL, V160, P369, DOI 10.1016/S0002-9440(10)64380-5; Wang Y, 1999, CRIT REV NEUROBIOL, V13, P21, DOI 10.1615/CritRevNeurobiol.v13.i1.20; Wang Y, 1999, P NATL ACAD SCI USA, V96, P12150, DOI 10.1073/pnas.96.21.12150; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Zhou B, 1997, J CLIN INVEST, V100, P3070, DOI 10.1172/JCI119862; Zhu WY, 2001, J CELL BIOCHEM, V81, P205, DOI 10.1002/1097-4644(20010501)81:2<205::AID-JCB1036>3.0.CO;2-S	67	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					636	644		10.1074/jbc.M209988200	http://dx.doi.org/10.1074/jbc.M209988200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403769	hybrid			2022-12-27	WOS:000180255700081
J	Ngo, HM; Yang, M; Paprotka, K; Pypaert, M; Hoppe, H; Joiner, KA				Ngo, HM; Yang, M; Paprotka, K; Pypaert, M; Hoppe, H; Joiner, KA			AP-1 in Toxoplasma gondii mediates biogenesis of the rhoptry secretory organelle from a post-Golgi compartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORTING SIGNALS; DOWN-REGULATION; PROTEIN; ANTISENSE; INVASION; BINDING; RECOGNITION; EXPRESSION; DISTINCT; REVEALS	We have previously demonstrated that Toxoplasma gondii has a tyrosine-based sorting system, which mediates protein targeting to the lysosome-like rhoptry secretory organelle. We now show that rhoptry protein targeting is also dependent on a dileucine motif and occurs from a post-Golgi endocytic organelle to mature rhoptries in an adaptin-dependent fashion. The T. gondii AP-1 adaptin complex is implicated in this transport because the mu1 chain of T. gondii AP-1 (a) was localized to multivesicular endosomes and the limiting and luminal membranes of the rhoptries; (b) bound to endocytic tyrosine motifs in rhoptry proteins, but not in proteins from dense granule secretory organelles; (c) when mutated in predicted tyrosine-binding motifs, led to accumulation of the rhoptry protein ROP2 in a post-Golgi multivesicular compartment; and (d) when depleted via antisense mRNA, resulted in accumulation of multivesicular endosomes and immature rhoptries. These are the first results to implicate AP-1 in transport from a post-Golgi compartment to a mature secretory organelle and substantially expand the role for AP-1 in anterograde protein transport.	Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Joiner, KA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, LCI 808,333 Cedar St, New Haven, CT 06520 USA.	keith.joiner@yale.edu	Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Hoppe, Heinrich/0000-0003-4409-1955	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404, F32AI010044, R01AI045806, R01AI030060, Z01AI005093] Funding Source: NIH RePORTER; NIAID NIH HHS [5T32AI07404, AI05093, R01 AI30060, 5F32AI10044, 1R01AI045806-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ajioka JW, 1998, GENOME RES, V8, P18, DOI 10.1101/gr.8.1.18; [Anonymous], 1979, STEREOLOGICAL METHOD; Austin C, 2002, BIOCHEMISTRY-US, V41, P4669, DOI 10.1021/bi016064j; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Boehm M, 2002, GENE, V286, P175, DOI 10.1016/S0378-1119(02)00422-5; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Bristol LA, 1998, METHOD ENZYMOL, V296, P514; Calvo PA, 1999, J BIOL CHEM, V274, P12780, DOI 10.1074/jbc.274.18.12780; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; FOUSSARD F, 1991, PARASITOLOGY, V102, P367, DOI 10.1017/S0031182000064313; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Hager KM, 1999, J CELL SCI, V112, P2631; Hoppe HC, 2000, NAT CELL BIOL, V2, P449, DOI 10.1038/35017090; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Liendo A, 2001, J BIOL CHEM, V276, P18272, DOI 10.1074/jbc.M008352200; Luzio JP, 2000, J CELL SCI, V113, P1515; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Nakaar V, 1999, J BIOL CHEM, V274, P5083, DOI 10.1074/jbc.274.8.5083; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Ngo HM, 2000, TRENDS CELL BIOL, V10, P67, DOI 10.1016/S0962-8924(99)01698-0; Ngo HM, 1998, J EUKARYOT MICROBIOL, V45, P323, DOI 10.1111/j.1550-7408.1998.tb04543.x; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; Pauloin A, 1999, J CELL SCI, V112, P4089; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Preiser P, 2000, MICROBES INFECT, V2, P1461, DOI 10.1016/S1286-4579(00)01301-0; Que XC, 2002, J BIOL CHEM, V277, P25791, DOI 10.1074/jbc.M202659200; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Robibaro B, 2002, CELL MICROBIOL, V4, P139, DOI 10.1046/j.1462-5822.2002.00178.x; Robibaro B, 2001, INT J PARASITOL, V31, P1343, DOI 10.1016/S0020-7519(01)00252-1; SamYellowe TY, 1996, PARASITOL TODAY, V12, P308, DOI 10.1016/0169-4758(96)10030-2; Shaw MK, 1998, PARASITOLOGY, V117, P435, DOI 10.1017/S0031182098003278; Sinai AP, 2001, J CELL BIOL, V154, P95, DOI 10.1083/jcb.200101073; Soldati D, 1998, MOL BIOCHEM PARASIT, V96, P37, DOI 10.1016/S0166-6851(98)00090-5; STEWART MJ, 1986, AM J TROP MED HYG, V35, P37, DOI 10.4269/ajtmh.1986.35.37; Zhang WW, 2000, MOL BIOCHEM PARASIT, V107, P315, DOI 10.1016/S0166-6851(99)00236-4	45	70	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5343	5352		10.1074/jbc.M208291200	http://dx.doi.org/10.1074/jbc.M208291200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12446678	hybrid			2022-12-27	WOS:000180968900126
J	Carlson, CG; Barrientos, A; Tzagoloff, A; Glerum, DM				Carlson, CG; Barrientos, A; Tzagoloff, A; Glerum, DM			COX16 encodes a novel protein required for the assembly of cytochrome oxidase in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COPPER RECRUITMENT; HEME A-FARNESYLTRANSFERASE; COLI SHUTTLE VECTORS; C-OXIDASE; RESTRICTION SITES; MEMBRANE SYSTEM; 2.8 ANGSTROM; YEAST; GENE; DEFICIENCY	We have characterized Cox16p, a new cytochrome oxidase (COX) assembly factor. This protein is encoded by COX16, corresponding to the previously uncharacterized open reading frame YJL003w of the yeast genome. COX16 was identified in studies of COX-deficient mutants previously assigned to complementation group G22 of a collection of yeast pet mutants. To determine its location, Cox16p was tagged with a Myc epitope at the C terminus. The fusion protein, when expressed from a low-copy plasmid, complements the mutant and is detected solely in mitochondria. Cox16p-myc is an integral component of the mitochondrial inner membrane, with its C terminus exposed to the intermembrane space. Cox16 homologues are found in both the human and murine genomes, although human COX16 does not complement the yeast mutant. Cox16p does not appear to be involved in maturation of subunit 2, copper recruitment, or heme A biosynthesis. Cox16p is thus a new protein in the growing family of eukaryotic COX assembly factors for which there are as yet no specific functions known. Like other recently described nuclear gene products involved in expression of cytochrome oxidase, COX16 is a candidate for screening in inherited human COX deficiencies.	Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Columbia Univ, Dept Sci Biol, New York, NY 10027 USA	University of Alberta; Columbia University	Glerum, DM (corresponding author), Univ Alberta, Dept Med Genet, 8-33 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.		Glerum, Moira/AHD-3271-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050187] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM050187, GM50187] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amaravadi R, 1997, HUM GENET, V99, P329, DOI 10.1007/s004390050367; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Beers J, 1997, J BIOL CHEM, V272, P33191, DOI 10.1074/jbc.272.52.33191; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Dickinson EK, 2000, J BIOL CHEM, V275, P26780; Forsha D, 2001, BIOCHEM SOC T, V29, P436, DOI 10.1042/BST0290436; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glerum DM, 1998, ANAL BIOCHEM, V260, P38, DOI 10.1006/abio.1998.2683; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; GLERUM DM, 1994, P NATL ACAD SCI USA, V91, P8452, DOI 10.1073/pnas.91.18.8452; Glerum DM, 1996, J BIOL CHEM, V271, P20531, DOI 10.1074/jbc.271.34.20531; GLERUM DM, 1995, J BIOL CHEM, V270, P15585, DOI 10.1074/jbc.270.26.15585; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Heaton DN, 2001, BIOCHEMISTRY-US, V40, P743, DOI 10.1021/bi002315x; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lode A, 2000, FEBS LETT, V485, P19, DOI 10.1016/S0014-5793(00)02176-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Papadopoulou LC, 1999, NAT GENET, V23, P333; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Saracco SA, 2002, MOL BIOL CELL, V13, P1122, DOI 10.1091/mbc.01-12-0580; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Souza RL, 2000, J BIOL CHEM, V275, P14898, DOI 10.1074/jbc.275.20.14898; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; TZAGOLOFF A, 1972, J BIOL CHEM, V247, P594; Valnot I, 2000, AM J HUM GENET, V67, P1104; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	47	28	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3770	3775		10.1074/jbc.M209893200	http://dx.doi.org/10.1074/jbc.M209893200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446688	hybrid			2022-12-27	WOS:000180869700033
J	Alphey, MS; Attrill, H; Crocker, PR; van Aalten, DMF				Alphey, MS; Attrill, H; Crocker, PR; van Aalten, DMF			High resolution crystal structures of Siglec-7 - Insights into ligand specificity in the Siglec family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHATASES SHP-1; NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR; MOLECULAR-CLONING; HUMAN CD33; PROTEIN; MEMBER; ACID; IDENTIFICATION; SIALOADHESIN	Sialic acid-binding immunoglobulin-like lectins (Siglecs) recognize sialylated glycoconjugates and play a role in cell-cell recognition. Siglec-7 is expressed on natural killer cells and displays unique ligand binding properties different from other members of the Siglec family. Here we describe the high resolution structures of the N-terminal V-set Ig-like domain of Siglec-7 in two crystal forms, at 1.75 and 1.9 Angstrom. The latter crystal form reveals the full structure of this domain and allows us to speculate on the differential ligand binding properties displayed by members of the Siglec family. A fully ordered N-linked glycan is observed, tethered by tight interactions with symmetry-related protein molecules in the crystal. Comparison of the structure with that of sialoadhesin and a model of Siglec-9 shows that the unique preference of Siglec-7 for alpha(2,8)-linked disialic acid is likely to reside in the C-C' loop, which is variable in the Siglec family. In the Siglec-7 structure, the ligand-binding pocket is occupied by a loop of a symmetry-related molecule, mimicking the interactions with sialic acid.	Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee, Scotland; Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee, Scotland	University of Dundee; University of Dundee	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Biol & Immunol, Dundee, Scotland.			Attrill, Helen/0000-0003-3212-6364; van Aalten, Daan/0000-0002-1499-6908; Crocker, Paul/0000-0001-6230-0293				Angata T, 2001, J BIOL CHEM, V276, P45128, DOI 10.1074/jbc.M108573200; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Houston DR, 2002, P NATL ACAD SCI USA, V99, P9127, DOI 10.1073/pnas.132060599; Jain D, 2000, J BIOL CHEM, V275, P16098, DOI 10.1074/jbc.275.21.16098; Jin L, 2002, J EXP MED, V195, P1199, DOI 10.1084/jem.20011796; Johnson MA, 2002, AUST J CHEM, V55, P13, DOI 10.1071/CH02047; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kelm S, 2002, J EXP MED, V195, P1207, DOI 10.1084/jem.20011783; Lanoue A, 2002, EUR J IMMUNOL, V32, P348, DOI 10.1002/1521-4141(200202)32:2<348::AID-IMMU348>3.0.CO;2-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul SP, 2000, BLOOD, V96, P483; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Puthalakath H, 1996, J BIOL CHEM, V271, P27818, DOI 10.1074/jbc.271.44.27818; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Whitney G, 2001, EUR J BIOCHEM, V268, P6083, DOI 10.1046/j.0014-2956.2001.02543.x; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Yu ZB, 2001, J BIOL CHEM, V276, P23816, DOI 10.1074/jbc.M102394200; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200	34	88	90	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3372	3377		10.1074/jbc.M210602200	http://dx.doi.org/10.1074/jbc.M210602200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12438315	hybrid			2022-12-27	WOS:000180915000077
J	Flemming, D; Hellwig, P; Friedrich, T				Flemming, D; Hellwig, P; Friedrich, T			Involvement of tyrosines 114 and 139 of subunit NuoB in the proton pathway around cluster N2 in Escherichia coli NADH : ubiquinone oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; INFRARED DIFFERENCE SPECTROSCOPY; SITE-DIRECTED MUTAGENESIS; RESPIRATORY COMPLEX-I; PARACOCCUS-DENITRIFICANS; DEHYDROGENASE FRAGMENT; MITOCHONDRIAL NADH; TRANSLOCATING NADH; REDOX; PROTEINS	The proton-pumping NADH:ubiquinone oxidoreductase (complex 1) couples the transfer of electrons from NADH to ubiquinone with the translocation of protons across the membrane. Electron transfer is accomplished by FMN and a series of iron-sulfur clusters. Its coupling with proton translocation is not yet understood. Here, we report that the redox reaction of the FeS cluster N2 located on subunit NuoB of the Escherichia coli complex I induces a protonation/deprotonation of tyrosine side chains. Electrochemically induced FT-IR difference spectra revealed characteristic tyrosine signals at 1,515 and 1,498 cm-L for the protonated and deprotonated form, respectively. Mutants of three conserved tyrosines on NuoB were generated by complementing a chromosomal in-frame deletion strain with nuoB on a plasmid. Though the single mutations did not alter the electron transport activity of complex I, the EPR signal of cluster N2 was slightly shifted. The tyrosine signals detected by FT-IR spectroscopy were roughly halved in the mutants Y114C and Y139C while only minor changes were detected in the Y154H mutant. The enzymatic activity of the Y114C/Y139F double mutant was 80% reduced, and FT-IR difference spectra of the double mutant revealed a complete loss the modes characteristic for protonation reactions of tyrosines. Therefore, we propose that tyrosines 114 and 139 on NuoB were protonated upon reduction of cluster N2 and were thus involved in the proton-transfer reaction coupled with its redox reaction.	Univ Freiburg, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany; Univ Frankfurt, Inst Biophys, D-60590 Frankfurt, Germany	University of Freiburg; Goethe University Frankfurt	Friedrich, T (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-79104 Freiburg, Germany.		Flemming, Dirk/AAP-3274-2021	hellwig, petra/0000-0001-6294-5163				Ahlers PM, 2000, J BIOL CHEM, V275, P23577, DOI 10.1074/jbc.M002074200; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Behr J, 2000, BIOCHEMISTRY-US, V39, P1356, DOI 10.1021/bi991504g; Bottcher B, 2002, J BIOL CHEM, V277, P17970, DOI 10.1074/jbc.M112357200; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Bungert S, 1999, FEBS LETT, V460, P207, DOI 10.1016/S0014-5793(99)01341-1; Duarte M, 2002, BIOCHEM J, V364, P833, DOI 10.1042/BJ20011750; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; Friedrich T, 1998, BBA-BIOENERGETICS, V1365, P215, DOI 10.1016/S0005-2728(98)00070-X; FRIEDRICH T, 1989, EUR J BIOCHEM, V180, P173, DOI 10.1111/j.1432-1033.1989.tb14629.x; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, BBA-BIOENERGETICS, V1459, P305, DOI 10.1016/S0005-2728(00)00165-1; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hellwig P, 1998, BIOCHEMISTRY-US, V37, P7390, DOI 10.1021/bi9725576; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P9116, DOI 10.1021/bi012056r; Hellwig P, 2000, BIOCHEMISTRY-US, V39, P10884, DOI 10.1021/bi000842a; Hienerwadel R, 1997, BIOCHEMISTRY-US, V36, P14712, DOI 10.1021/bi971521a; INGLEDEW WJ, 1980, BIOCHEM J, V186, P111, DOI 10.1042/bj1860111; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; MANTELE W, 1993, TRENDS BIOCHEM SCI, V18, P197, DOI 10.1016/0968-0004(93)90186-Q; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Pfitzner U, 2000, BIOCHEMISTRY-US, V39, P6756, DOI 10.1021/bi992235x; Puustinen A, 1999, P NATL ACAD SCI USA, V96, P35, DOI 10.1073/pnas.96.1.35; Rasmussen T, 2001, BIOCHEMISTRY-US, V40, P6124, DOI 10.1021/bi0026977; Schulte U, 1999, J MOL BIOL, V292, P569, DOI 10.1006/jmbi.1999.3096; Spehr V, 1999, BIOCHEMISTRY-US, V38, P16261, DOI 10.1021/bi9919605; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V1320, P217; VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1259, DOI 10.1002/bip.360301310; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; WEISS H, 1991, EUR J BIOCHEM, V197, P563, DOI 10.1111/j.1432-1033.1991.tb15945.x; YAGI T, 1998, BIOCHIM BIOPHYS ACTA, V1364, P112; Yano T, 2000, BBA-BIOENERGETICS, V1459, P299, DOI 10.1016/S0005-2728(00)00164-X	44	32	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3055	3062		10.1074/jbc.M208849200	http://dx.doi.org/10.1074/jbc.M208849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12446673	hybrid			2022-12-27	WOS:000180915000038
J	Kerins, SM; Collins, R; McCarthy, TV				Kerins, SM; Collins, R; McCarthy, TV			Characterization of an endonuclease IV 3 '-5 ' exonuclease activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; ESCHERICHIA-COLI K-12; DNA-REPAIR; APURINIC/APYRIMIDINIC ENDONUCLEASE; NUCLEOTIDE-SEQUENCE; OXIDATIVE DAMAGE; APURINIC SITES; GENE; APN1; ENZYMOLOGY	Previous characterization of Escherichia coli endonuclease IV has shown that the enzyme specifically cleaves the DNA backbone at apurinic/apyrimidinic sites and removes 3' DNA blocking groups. By contrast, and unlike the major apurinic/apyrimidinic endonuclease exonuclease III, negligible exonuclease activity has been associated with endonuclease IV. Here we report that endonuclease IV does possess an intrinsic 3'-5' exonuclease activity. The activity was detected in purified preparations of the endonuclease IV protein from E. coli and from the distantly related thermophile Thermotoga maritima; it co-eluted with both enzymes under different chromatographic conditions. Induction of either endonuclease IV in an E. coli overexpression system resulted in induction of the exonuclease activity, and the E. coli exonuclease activity had similar heat stability to the endonuclease IV A-P endonuclease activity. Characterization of the exonuclease activity showed that its progression on substrate is sensitive to ionic strength, metal ions, EDTA, and reducing conditions. Substrates with 3' recessed ends were preferred substrates for the 3'-5' exonuclease activity. Comparison of the relative apurinic/apyrimidinic endonuclease and exonuclease activity of endonuclease IV shows that the relative exonuclease activity is high and is likely to be significant in vivo.	Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland	University College Cork	McCarthy, TV (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland.			McCarthy, Tommie/0000-0003-4884-6972				BARZILAY G, 1995, BIOESSAYS, V17, P713, DOI 10.1002/bies.950170808; CHAN E, 1987, P NATL ACAD SCI USA, V84, P3189, DOI 10.1073/pnas.84.10.3189; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Friedberg E.C., 1995, DNA REPAIR MUTAGENES, P135; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; LEVIN JD, 1991, J BIOL CHEM, V266, P22893; LEVIN JD, 1988, J BIOL CHEM, V263, P8066; Ljungquist S, 1980, Methods Enzymol, V65, P212; LJUNGQUIST S, 1977, J BIOL CHEM, V252, P2808; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; LOEB LA, 1985, CELL, V40, P483, DOI 10.1016/0092-8674(85)90191-6; Masson JY, 1996, GENE, V179, P291, DOI 10.1016/S0378-1119(96)00375-7; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; Ramotar D, 1998, BBA-GENE STRUCT EXPR, V1396, P15, DOI 10.1016/S0167-4781(97)00160-7; SAPORITO SM, 1988, J BACTERIOL, V170, P4542, DOI 10.1128/jb.170.10.4542-4547.1988; SAPORITO SM, 1988, J BACTERIOL, V170, P5141, DOI 10.1128/jb.170.11.5141-5145.1988; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; WEISS B, 1976, J BIOL CHEM, V251, P1896	23	41	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3048	3054		10.1074/jbc.M210750200	http://dx.doi.org/10.1074/jbc.M210750200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12444080	hybrid			2022-12-27	WOS:000180915000037
J	Nicke, A; Loughnan, ML; Millard, EL; Alewood, PF; Adams, DJ; Daly, NL; Craik, DJ; Lewis, RJ				Nicke, A; Loughnan, ML; Millard, EL; Alewood, PF; Adams, DJ; Daly, NL; Craik, DJ; Lewis, RJ			Isolation, structure, and activity of GID, a novel alpha 4/7-conotoxin with an extended N-terminal sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; NMR STRUCTURE CALCULATION; ALPHA-CONOTOXIN PNIA; 3-DIMENSIONAL SOLUTION STRUCTURE; SPIN COUPLING-CONSTANTS; 1.1 ANGSTROM RESOLUTION; TORSION ANGLE DYNAMICS; CRYSTAL-STRUCTURE; PAIRWISE INTERACTIONS; CONUS-EPISCOPATUS	Using assay-directed fractionation of Conus geographus crude venom, we isolated a-conotoxin GID, which acts selectively at neuronal nicotinic acetylcholine receptors (nAChRs). Unlike other neuronally selective alpha-conotoxins, alpha-GID has a four amino acid N-terminal tail, gamma-carboxyglutamate (Gla), and hydroxyproline (0) residues, and lacks an amidated C terminus. GID inhibits alpha7 and alpha3beta2 nAChRs with IC50 values of 5 and 3 nm, respectively and is at least 1000-fold less potent at the alpha1beta1gammadelta, alpha3beta4, and alpha4beta4 combinations. GID also potently inhibits the alpha4beta2 subtype (IC50 of 150 nm). Deletion of the N-terminal sequence (GIDDelta1-4) significantly decreased activity at the alpha4beta2 nAChR but hardly affected potency at alpha3beta2 and alpha7 nAChRs, despite enhancing the off-rates at these receptors. In contrast, Arg(12) contributed to alpha4beta2 and alpha7 activity but not to alpha3beta2 activity. The three-dimensional structure of GID is well defined over residues 4-19 with a similar motif to other a-conotoxins. However, despite its influence on activity, the tail appears to be disordered in solution. Comparison of GID with other alpha4/7-conotoxins which possess an NN(P/O) motif in loop II, revealed a correlation between increasing length of the aliphatic side-chain in position 10 (equivalent to 13 in GID) and greater alpha7 versus alpha3beta2 selectivity.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.		Lewis, Richard J/E-8674-2013; Adams, David John/K-3578-2019; Loughnan, Marion/B-4508-2009; Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010; Adams, David/J-9125-2014; Lewis, Richard/T-8763-2019	Lewis, Richard J/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796; Adams, David/0000-0002-7030-2288; Lewis, Richard/0000-0003-3470-923X; Alewood, Paul/0000-0001-7454-6522; Nicke, Annette/0000-0001-6798-505X				BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; COLQUHOUN LM, 1997, J NEUROCHEM, V69, P2356; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; Dwoskin LP, 2001, J PHARMACOL EXP THER, V298, P395; ECCLES C, 1991, Journal of Biomolecular NMR, V1, P111, DOI 10.1007/BF01877224; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gehrmann J, 1999, J MED CHEM, V42, P2364, DOI 10.1021/jm990114p; GLOOR S, 1995, GENE, V160, P213, DOI 10.1016/0378-1119(95)00226-V; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Guddat LW, 1996, BIOCHEMISTRY-US, V35, P11329, DOI 10.1021/bi960820h; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hu SH, 1998, BIOCHEMISTRY-US, V37, P11425, DOI 10.1021/bi9806549; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lloyd GK, 2000, J PHARMACOL EXP THER, V292, P461; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MARTINEZ JS, 1995, BIOCHEMISTRY-US, V34, P14519, DOI 10.1021/bi00044a030; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Quiram PA, 1999, J BIOL CHEM, V274, P19517, DOI 10.1074/jbc.274.28.19517; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Rogers JP, 1999, BIOCHEMISTRY-US, V38, P3874, DOI 10.1021/bi9826254; Rogers JP, 2000, J MOL BIOL, V304, P911, DOI 10.1006/jmbi.2000.4247; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P15693, DOI 10.1021/bi971443r; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K., 1986, NMR PROTEINS NUCL AC	53	122	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3137	3144		10.1074/jbc.M210280200	http://dx.doi.org/10.1074/jbc.M210280200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12419800	hybrid, Green Published			2022-12-27	WOS:000180915000048
J	Ribeiro, C; Vignes, M; Brehelin, M				Ribeiro, C; Vignes, M; Brehelin, M			Xenorhabdus nematophila (Enterobacteriacea) secretes a cation-selective calcium-independent porin which causes vacuolation of the rough endoplasmic reticulum and cell lysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIUM PHOTORHABDUS-LUMINESCENS; ESCHERICHIA-COLI HEMOLYSIN; INSECTICIDAL TOXINS; HELICOBACTER-PYLORI; PLASMA-MEMBRANE; FORMING TOXIN; TARGET-CELLS; ALPHA-TOXIN; PROTEIN; MECHANISMS	Xenorhabdus nematophila and Photorhabdus luminescens are two related enterobacteriaceae studied for their use in biological control and for synthesis of original virulence factors and new kinds of antibiotics. X. nematophila broth growth exhibits different cytotoxic activities on insect (Spodoptera littoralis, lepidoptera) immunocytes (hemocytes). Here we report the purification of the flhDC-dependent cytotoxin, a 10,790-Da peptide we have called alpha-Xenorhabdolysin (alphaX). We show that plasma membrane of insect hemocytes and of mammal red blood cells is the first target of this toxin. Electrophysiological and pharmacological approaches indicate that the initial effect of alphaX on macrophage plasma membrane is an increase of monovalent cation permeability, sensitive to potassium channel blockers. As a consequence, several events can occur intracellularly, such as selective vacuolation of the endoplasmic reticulum, cell swelling, and cell death by colloid-osmotic lysis. These effects, inhibited by potassium channel blockers, are totally independent of Ca2+. However, the size of the pores created by alphaX on macrophage or red blood cell plasma membrane increases with toxin concentration, which leads to a rapid cell lysis.	Univ Montpellier 2, INRA, UMR 1133,EMIP, Dept Ecol Microbienne Insectes & Interact Insecte, F-34095 Montpellier, France; Univ Montpellier 2, CNRS, UMR 5102, Dept Plast & Synapse Glutamat, F-34095 Montpellier, France	INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Brehelin, M (corresponding author), Univ Montpellier 2, INRA, UMR 1133,EMIP, Dept Ecol Microbienne Insectes & Interact Insecte, Pl Eugene Bataillon, F-34095 Montpellier, France.		Vignes, Michel/AAA-7693-2019	Vignes, Michel/0000-0003-0969-2966				Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; BLOOM W, 1975, TXB HISTOLOGY, P1; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Bowen DJ, 1998, APPL ENVIRON MICROB, V64, P3029; Brehelin M., 1986, P36; Brillard J, 2001, APPL ENVIRON MICROB, V67, P2515, DOI 10.1128/AEM.67.6.2515-2525.2001; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo LN, 1999, J BIOL CHEM, V274, P9836, DOI 10.1074/jbc.274.14.9836; Hertle R, 1999, INFECT IMMUN, V67, P817, DOI 10.1128/IAI.67.2.817-825.1999; HILDEBRAND A, 1991, J BIOL CHEM, V266, P17195; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Krause KH, 1998, J BIOL CHEM, V273, P18122, DOI 10.1074/jbc.273.29.18122; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; LAUMOND C, 1979, ENTOMOPHAGA, V24, P13, DOI 10.1007/BF02377505; MEAD GP, 1986, J INSECT PHYSIOL, V32, P167, DOI 10.1016/0022-1910(86)90137-X; MENESTRINA G, 1994, MOL ASPECTS MED, V15, P79, DOI 10.1016/0098-2997(94)90043-4; Menestrina G, 1996, J MEMBRANE BIOL, V149, P113, DOI 10.1007/s002329900012; MOAYERI M, 1994, INFECT IMMUN, V62, P4124, DOI 10.1128/IAI.62.10.4124-4134.1994; Ogden D., 1994, MICROELECTRODE TECHN, P53; PAPINI E, 1994, P NATL ACAD SCI USA, V91, P9720, DOI 10.1073/pnas.91.21.9720; Peel MM, 1999, J CLIN MICROBIOL, V37, P3647, DOI 10.1128/JCM.37.11.3647-3653.1999; RAMM LE, 1980, J IMMUNOL, V124, P2281; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ribeiro C, 1999, J INSECT PHYSIOL, V45, P677, DOI 10.1016/S0022-1910(99)00043-8; ROWE GE, 1994, METHOD ENZYMOL, V235, P657; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; SCHWARTZ JL, 1991, BIOCHIM BIOPHYS ACTA, V1065, P250, DOI 10.1016/0005-2736(91)90237-3; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; YOUNG JDE, 1987, ADV IMMUNOL, V41, P269, DOI 10.1016/S0065-2776(08)60033-4	39	37	39	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3030	3039		10.1074/jbc.M210353200	http://dx.doi.org/10.1074/jbc.M210353200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441337	Green Published, hybrid			2022-12-27	WOS:000180915000035
J	Andreola, A; Bellotti, V; Giorgetti, S; Mangione, P; Obici, L; Stoppini, M; Torres, J; Monzani, E; Merlini, G; Sunde, M				Andreola, A; Bellotti, V; Giorgetti, S; Mangione, P; Obici, L; Stoppini, M; Torres, J; Monzani, E; Merlini, G; Sunde, M			Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVELY UNFOLDED PROTEINS; ALZHEIMERS-DISEASE; FIBRILS; MUTATION; VARIANT; TRANSTHYRETIN	The N-terminal portion of apolipoprotein A-I corresponding to the first 93 residues has been identified as the main component of apolipoprotein A-I fibrils in a form of systemic amyloidosis. We have been able to characterize the process of conformational switching and fibrillogenesis in this fragment of apolipoprotein A-I purified directly from ex vivo amyloid material. The peptide exists in an unstructured form in aqueous solution at neutral pH. The acidification of the solution provokes a collapse into a more compact, intermediate state and the transient appearance of a helical conformation that rapidly converts to a stable, mainly beta-structure in the fibrils. The transition from helical to sheet structure occurs concomitantly with peptide self-aggregation, and fibrils are detected after 72 h. The alpha-helical conformation is induced by the addition of trifluoroethanol and phospholipids. Interaction of the amyloidogenic polypeptide with phospholipids prevents the switching from helical to beta-sheet form and inhibits fibril formation. The secondary structure propensity of the apolipoprotein A-I fragment appears poised between helix and the beta-sheet. These findings reinforce the idea of a delicate balance between natively stabilizing interactions and fatally stabilizing interactions and stress the importance of cellular localization and environment in the maintenance of protein conformation.	Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; Univ Pavia, Ctr Interdipartimentale Biol Applicata, I-27100 Pavia, Italy; Univ Pavia, Dept Chem, I-27100 Pavia, Italy; Policlin San Matteo, Ist Rocovero & Cura Carrettere Sci, I-27100 Pavia, Italy; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Pavia; University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Cambridge	Bellotti, V (corresponding author), Univ Pavia, Dept Biochem, Via Taramelli 3B, I-27100 Pavia, Italy.	vbellot@unipv.it	Giorgetti, Sofia/AAD-4341-2019; Bellotti, Vittorio/A-6201-2014; Merlini, Giampaolo/A-3817-2008; Obici, Laura/AAC-3060-2019; Sunde, Margaret/A-5186-2016; Torres, Jaume/AAJ-4510-2020; Torres, Jaume/A-2179-2011; Sunde, Margaret/ABH-2584-2020	Giorgetti, Sofia/0000-0001-9438-6511; Bellotti, Vittorio/0000-0001-8678-662X; Merlini, Giampaolo/0000-0001-7680-3254; Obici, Laura/0000-0001-7468-700X; Sunde, Margaret/0000-0002-0150-3203; Torres, Jaume/0000-0002-1282-9727; Sunde, Margaret/0000-0002-0150-3203; Mangione, Palma/0000-0003-0260-1400; MONZANI, ENRICO/0000-0002-8791-6446	Telethon [GP0186Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Asl LH, 1999, AM J PATHOL, V154, P221, DOI 10.1016/S0002-9440(10)65268-6; Benson MD, 2001, GENOMICS, V72, P272, DOI 10.1006/geno.2000.6499; Bergstrom J, 2001, BIOCHEM BIOPH RES CO, V285, P903, DOI 10.1006/bbrc.2001.5260; BOOTH DR, 1995, QJM-INT J MED, V88, P695; Booth DR, 1996, J CLIN INVEST, V97, P2714, DOI 10.1172/JCI118725; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; CREIGHTON T. E., 1993, PROTEINS STRUCTURES, P193; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; de Sousa MM, 2000, AM J PATHOL, V156, P1911, DOI 10.1016/S0002-9440(10)65064-X; Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1; Fielding CJ, 2001, BBA-MOL CELL BIOL L, V1533, P175, DOI 10.1016/S1388-1981(01)00162-7; Frangione B, 1996, CIBA F SYMP, V199, P132; Hamidi Asl K, 1999, BIOCHEM BIOPH RES CO, V257, P584, DOI DOI 10.1006/BBRC.1999.0518; Hatters DM, 2001, FEBS LETT, V494, P220, DOI 10.1016/S0014-5793(01)02355-9; Hatters DM, 2000, BIOCHEMISTRY-US, V39, P8276, DOI 10.1021/bi000002w; JOHNSON KH, 1992, AM J PATHOL, V141, P1013; JOHNSON RE, 1981, BIOCHEMISTRY-US, V20, P4239, DOI 10.1021/bi00517a044; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; LEROY A, 1994, BBA-LIPID LIPID MET, V1212, P285, DOI 10.1016/0005-2760(94)90202-X; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Mangione P, 2001, PROTEIN SCI, V10, P187, DOI 10.1110/ps.29201; McManus DC, 2001, J BIOL CHEM, V276, P21292, DOI 10.1074/jbc.M100463200; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X; Persey MR, 1998, KIDNEY INT, V53, P276, DOI 10.1046/j.1523-1755.1998.00770.x; Perutz MF, 1997, NATURE, V385, P773, DOI 10.1038/385773a0; PRAS M, 1968, J CLIN INVEST, V47, P924; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P945, DOI 10.1021/bi9713512; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; SOUTAR AK, 1992, P NATL ACAD SCI USA, V89, P7389, DOI 10.1073/pnas.89.16.7389; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; YAKAR S, 1995, SEMIN ARTHRITIS RHEU, V24, P255, DOI 10.1016/S0049-0172(95)80035-2	40	75	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2444	2451		10.1074/jbc.M204801200	http://dx.doi.org/10.1074/jbc.M204801200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12421824	hybrid			2022-12-27	WOS:000180562000052
J	Guberman, AS; Scassa, ME; Giono, LE; Varone, CL; Canepa, ET				Guberman, AS; Scassa, ME; Giono, LE; Varone, CL; Canepa, ET			Inhibitory effect of AP-1 complex on 5-aminolevulinate synthase gene expression through sequestration of cAMP-response element protein (CRE)-binding protein (CBP) coactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING-PROTEIN; DELTA-AMINOLEVULINATE SYNTHASE; C-FOS TRANSCRIPTION; KINASE-C; RAT HEPATOCYTES; PHORBOL ESTER; DNA-BINDING; NUCLEAR RECEPTORS; CELL-GROWTH; CROSS-TALK	Activation protein-1 (AP-1) transcription factors are early response genes involved in a diverse set of transcriptional regulatory processes. The phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) is often used to induce AP-1 activity. The purpose of this work was to explore the molecular mechanisms involved in the TPA regulation of ubiquitous 5-aminolevulinate synthase (ALAS) gene expression, the first and rate-controlling step of the heme biosynthesis. Previous analysis of the 5'-flanking sequence of ALAS revealed the existence of two cAMP-response elements (CRE) required for basal and cAMP-stimulated expression. The fragment -833 to +42 in the 5'-flanking region of rat ALAS gene was subcloned into a chloramphenicol acetyltransferase (CAT) reporter vector. The expression vector pALAS/CAT produced a significant CAT activity in transiently transfected HepG2 human hepatoma cells, which was repressed by TPA. Sequence and deletion analysis delected a TPA response element (TRE), located between -261 and -255 (TRE-ALAS), that was critical for TPA regulation. We demonstrated that c-Fos, c-Jun, and JunD are involved in TPA inhibitory effect due to their ability to bind TRE-ALAS, evidenced by supershift analysis and their capacity to repress promoter activity in transfection assays. Repression of ALAS promoter activity by TPA treatment or Fos/Jun overexpression was largely relieved when CRE protein-binding protein or p300 was ectopically expressed. When the TRE site was placed in a different context with respect to CRE sites, it appeared to act as a transcriptional enhancer. We propose that the decrease in ALAS basal activity observed in the presence of TPA may reflect a lower ability of this promoter to assemble the productive pre-initiation complex due to CRE protein-binding protein sequestration. We also suggest that the transcriptional properties of this AP-1 site would depend on a spatial-disposition-dependent manner with respect to the CRE sites and to the transcription initiation site.	Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol, RA-1428 Buenos Aires, DF, Argentina	University of Buenos Aires	Canepa, ET (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Lab Biol Mol, Pabellon 2 Piso 4,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.			Giono, Luciana/0000-0001-6958-6044; Canepa, Eduardo T./0000-0002-4322-1650; Varone, Cecilia/0000-0001-5930-4082				Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34; Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BISHOP DF, 1990, NUCLEIC ACIDS RES, V18, P7187, DOI 10.1093/nar/18.23.7187; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAIDOTTI G, 1993, J BIOL CHEM, V268, P1109; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; Cheng XB, 1997, MOL CELL BIOL, V17, P1407, DOI 10.1128/MCB.17.3.1407; CHIN R, 1988, CELL, V54, P541; CHOMCZYNSKY P, 1987, ANAL BIOCHEM, V71, P341; Dajani OF, 1999, J CELL PHYSIOL, V180, P203, DOI 10.1002/(SICI)1097-4652(199908)180:2<203::AID-JCP8>3.3.CO;2-K; DiSepio D, 1999, Mol Cell Biol Res Commun, V1, P7, DOI 10.1006/mcbr.1999.0101; DONCHENKO V, 1994, BBA-MOL CELL RES, V1222, P492, DOI 10.1016/0167-4889(94)90059-0; Fronsdal K, 1998, J BIOL CHEM, V273, P31853, DOI 10.1074/jbc.273.48.31853; Gabbay RA, 1996, J BIOL CHEM, V271, P1890, DOI 10.1074/jbc.271.4.1890; Giono LE, 2001, BIOCHEM J, V353, P307, DOI 10.1042/0264-6021:3530307; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Holmes TJ, 2001, LIFE SCI, V69, P2975, DOI 10.1016/S0024-3205(01)01406-0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; ICARDLIEPKALNS C, 1992, J NEUROSCI RES, V32, P290, DOI 10.1002/jnr.490320219; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang KS, 2002, CANCER LETT, V178, P53, DOI 10.1016/S0304-3835(01)00821-7; Kappas A, 1995, METABOLIC MOL BASES, P2103; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2001, J ENDOCRINOL, V169, P447, DOI 10.1677/joe.0.1690447; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kimura M, 1999, J PHARMACOL EXP THER, V291, P171; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Lee SK, 2001, MOL ENDOCRINOL, V15, P241, DOI 10.1210/me.15.2.241; Liu SL, 2000, ONCOGENE, V19, P3352, DOI 10.1038/sj.onc.1203675; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; MESSINA JL, 1994, ENDOCRINOLOGY, V135, P2327, DOI 10.1210/en.135.6.2327; MESSINA JL, 1992, J BIOL CHEM, V267, P9223; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; Ogbourne S, 1998, BIOCHEM J, V331, P1; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Quattrochi LC, 1998, ARCH BIOCHEM BIOPHYS, V350, P41, DOI 10.1006/abbi.1997.0491; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Roesler WJ, 1998, MOL CELL BIOCHEM, V178, P1, DOI 10.1023/A:1006886421795; SAATCIOGLU F, 1994, SEMIN CANCER BIOL, V5, P347; Sakamoto S, 2001, J BIOL CHEM, V276, P37237, DOI 10.1074/jbc.M105543200; Sambrook J, 2001, MOL CLONING LAB MAN; Scassa ME, 2001, EXP CELL RES, V271, P201, DOI 10.1006/excr.2001.5386; Scassa ME, 1998, EXP CELL RES, V244, P460, DOI 10.1006/excr.1998.4206; Schuurmans MM, 2001, HEPATOLOGY, V33, P1217, DOI 10.1053/jhep.2001.24170; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374; Thunell S, 2000, SCAND J CLIN LAB INV, V60, P509, DOI 10.1080/003655100448310; TOURNIERTHURNEYSSEN I, 1993, TUMOR BIOL, V14, P201, DOI 10.1159/000217835; Varone CL, 1997, ARCH BIOCHEM BIOPHYS, V341, P259, DOI 10.1006/abbi.1997.9978; Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Watanabe A, 2000, SURG TODAY, V30, P622, DOI 10.1007/s005950070102; Wisdom R, 1999, EXP CELL RES, V253, P180, DOI 10.1006/excr.1999.4685; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	66	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2317	2326		10.1074/jbc.M205057200	http://dx.doi.org/10.1074/jbc.M205057200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433930	Green Published, hybrid			2022-12-27	WOS:000180562000034
J	Ladner, KJ; Caliguri, MA; Guttridge, DC				Ladner, KJ; Caliguri, MA; Guttridge, DC			Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; ZINC-FINGER PROTEIN; FACTOR-ALPHA; PERSISTENT ACTIVATION; TNF RECEPTOR; BETA; DIFFERENTIATION; GAMMA; A20; TRANSCRIPTION	NF-kappaB activation is classically defined as a transient response initiated by the degradation of IkappaB inhibitor proteins leading to nuclear import of NF-kappaB and culminating with the resynthesis of IkappaBalpha and subsequent inactivation of the transcription factor. Although this type of regulation is considered the paradigm for NF-kappaB activation, other regulatory profiles are known to exist. By far the most common of these is chronic or persistent activation of NF-kappaB. In comparison, regulation of NF-kappaB in a biphasic manner represents a profile that is scarcely documented and whose biological significance remains poorly understood. Here we show using differentiated skeletal muscle cells, that tumor necrosis factor (TNF) induces NF-kappaB activation in a biphasic manner, Unlike the first transient phase, which is terminated within 1 h of cytokine addition, the second phase persists for an additional 24-36 h. Biphasic activation is mediated at both the levels of NF-kappaB DNA binding and transactivation function, and both phases are dependent on the IKK/26 S proteasome pathway. We find that regulation of the first transient phase is mediated by the degradation and subsequent resynthesis of IkappaBalpha, as well as by a TNF-induced expression of A20. Second phase activity correlates with persistent down-regulation of both lkappaBalpha and IkappaBbeta proteins, derived from a continuous TNF signal. Finally, we demonstrate that inhibition of NF-kappaB prior to initiation of the second phase of activity inhibits cytokine-mediated loss of muscle proteins. We propose that the biphasic activation of NF-kappaB in response to TNF may play a key regulatory role in skeletal muscle wasting associated with cachexia.	Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Div Hematol & Oncol, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Guttridge, DC (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, 420 W 12Th Ave, Columbus, OH 43210 USA.	Guttridge-1@medctr.osu.edu		Guttridge, Denis/0000-0002-7276-6609	NCI NIH HHS [P30 CA16058, K01 CA97953] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA097953, P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Bourke E, 2000, J BIOL CHEM, V275, P39996, DOI 10.1074/jbc.M007693200; Carter RS, 2001, J BIOL CHEM, V276, P24445, DOI 10.1074/jbc.C000777200; Cheshire JL, 1997, MOL CELL BIOL, V17, P6746, DOI 10.1128/MCB.17.11.6746; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; DeLuca C, 1999, J BIOL CHEM, V274, P13010, DOI 10.1074/jbc.274.19.13010; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Fields ER, 2000, J IMMUNOL, V164, P4762, DOI 10.4049/jimmunol.164.9.4762; GELIN J, 1991, CANCER RES, V51, P415; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Han SJ, 2002, J BIOL CHEM, V277, P44715, DOI 10.1074/jbc.M202524200; Han YQ, 1997, J BIOL CHEM, V272, P9825; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kemler I, 1999, GLIA, V26, P212, DOI 10.1002/(SICI)1098-1136(199905)26:3<212::AID-GLIA3>3.0.CO;2-F; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lille ST, 2001, MUSCLE NERVE, V24, P534, DOI 10.1002/mus.1037; MATTHYS P, 1991, INT J CANCER, V49, P77, DOI 10.1002/ijc.2910490115; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pC766, DOI 10.1152/ajpcell.1987.253.6.C766; OHMORI Y, 1995, J IMMUNOL, V154, P5235; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Xiao GT, 2000, J BIOL CHEM, V275, P34060, DOI 10.1074/jbc.M002970200; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	50	175	176	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2294	2303		10.1074/jbc.M207129200	http://dx.doi.org/10.1074/jbc.M207129200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431991	hybrid			2022-12-27	WOS:000180562000031
J	Ogawa, C; Kihara, A; Gokoh, M; Igarashi, Y				Ogawa, C; Kihara, A; Gokoh, M; Igarashi, Y			Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; SPHINGOSINE 1-PHOSPHATE; IMPROVED SOFTWARE; SEQUENCE MOTIF; METABOLISM; PROTEIN; CLONING	Sphingosine 1-phosphate (SIP) is a bioactive lipid molecule that acts as both an extracellular signaling mediator and an intracellular second messenger. SIP is synthesized from sphingosine by sphingosine kinase and is degraded either by SIP lyase or by SIP phosphohydrolase. Recently, mammalian SIP phosphohydrolase (SPP1) was identified and shown to constitute a novel lipid phosphohydrolase family, the SPP family. In this study we have identified a second human SIP phosphohydrolase, SPP2, based on sequence homology to human SPP1. SPP2 exhibited high phosphohydrolase activity against SIP and dihydrosphingosine 1-phosphate. The dihydrosphingosine-l-phosphate phosphohydrolase activity was efficiently inhibited by excess SIP but not by lysophosphatidic acid, phosphatidic acid, or glycerol 3-phosphate, indicating that SPP2 is highly specific to sphingoid base 1-phosphates. Immunofluoresence microscopic analysis demonstrated that SPP2 is localized to the endoplasmic reticulum. Although the enzymatic properties and localization of SPP2 were similar to those of SPP1, the tissue-specific expression pattern of SPP2 was different from that of SPP1. Thus, SPP2 is another member of the SPP family that may play a role in attenuating intracellular SIP signaling.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Hokkaido University	Igarashi, Y (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biomembrane & Biofunct Chem, Kita Ku, Kita 12 Jo,Nishi 6 Choume, Sapporo, Hokkaido 0600812, Japan.		KIHARA, AKIO/A-3802-2012	KIHARA, AKIO/0000-0001-5889-0788; Fuse, Chie/0000-0002-8495-2580				CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; DECEUSTER P, 1995, BIOCHEM J, V311, P139, DOI 10.1042/bj3110139; Dillon DA, 1997, J BIOL CHEM, V272, P10361; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Igarashi Y, 1997, J BIOCHEM-TOKYO, V122, P1080; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Kai M, 1997, J BIOL CHEM, V272, P24572, DOI 10.1074/jbc.272.39.24572; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Stukey J, 1997, PROTEIN SCI, V6, P469; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; VANVELDHOVEN PP, 1994, BIOCHEM J, V299, P597, DOI 10.1042/bj2990597; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	23	144	149	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1268	1272		10.1074/jbc.M209514200	http://dx.doi.org/10.1074/jbc.M209514200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411432	hybrid			2022-12-27	WOS:000180321900074
J	Wu, DF; Cederbaum, AI				Wu, DF; Cederbaum, AI			Role of p38 MAPK in CYP2E1-dependent arachidonic acid toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; SIGNAL-REGULATED KINASE; SODIUM-SALICYLATE; RAT HEPATOCYTES; CYCLOSPORINE-A; CELL-LINE; FISH-OIL; INHIBITION; NECROSIS	Polyunsaturated fatty acids such as arachidonic acid (AA) play an important role in alcohol-induced liver injury. AA promotes toxicity in rat hepatocytes with high levels of cytochrome P4502E1 (CYP2E1) and in HepG2 E47 cells, which express CYP2E1. The possible role of mitogen-activated protein kinase (MAPK) members in this process was evaluated. SB203580, a p38 MAPK inhibitor, and PD98059, an ERK inhibitor, but not wortmannin a phosphatidylinositol 3-kinase (PI3K) inhibitor, prevented AA toxicity in pyrazole hepatocytes and E47 cells. SB203580 prevented the enhancement of AA toxicity by salicylate. SB203580 neither lowered the levels of CYP2E1 nor affected CYP2E1-dependent oxidative stress. The decrease in mitochondrial membrane potential produced by AA was prevented by SB203580. Treating CYP2E1-induced cells with AA activated p38 MAPK but not ERK or AKT. This activation was blocked by antioxidants. AA increased the translocation of NF-kappaB to the nucleus. Salicylate blocked this translocation, which may contribute to the enhancement of AA toxicity by salicylate. SB203580 restored AA-induced NF-kappaB translocation, which may contribute to protection against toxicity. In conclusion, AA toxicity was related to lipid peroxidation and oxidative stress, and to the activation of p38 MAPK, as a consequence of CYP2E1-dependent production of reactive oxygen species. Activation of p38 MAPK by AA coupled to AA-induced oxidative stress may synergize to cause cell toxicity by affecting mitochondrial membrane potential and by modulation of NF-kappaB activation.	CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Cederbaum, AI (corresponding author), CUNY Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, 1Gustave L Levy Pl,Box 1603, New York, NY 10029 USA.	arthur.cederbaum@mssm.edu			NIAAA NIH HHS [AA03312, AA 06610] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006610, R37AA006610, R01AA003312, R56AA003312] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alexander LD, 2001, KIDNEY INT, V59, P2039, DOI 10.1046/j.1523-1755.2001.00718.x; Alpert D, 2000, J BIOL CHEM, V275, P10925, DOI 10.1074/jbc.275.15.10925; Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; BIBAN C, 1995, BIOCHEM PHARMACOL, V50, P497, DOI 10.1016/0006-2952(95)00165-V; Bitko V, 1997, VIROLOGY, V232, P369, DOI 10.1006/viro.1997.8582; Caro AA, 2002, J BIOL CHEM, V277, P104, DOI 10.1074/jbc.M107864200; CASTILLO T, 1992, HEPATOLOGY, V16, P992, DOI 10.1002/hep.1840160423; Chang LC, 2000, J PHARM PHARMACOL, V52, P539, DOI 10.1211/0022357001774336; Chang LC, 2001, J LEUKOCYTE BIOL, V69, P659; Chen LC, 1999, BIOCHEM J, V342, P503, DOI 10.1042/0264-6021:3420503; Chen Q, 1997, J BIOL CHEM, V272, P14532, DOI 10.1074/jbc.272.23.14532; Chen RF, 2000, RARE METALS, V19, P231; CHOW SC, 1990, J BIOL CHEM, V265, P902; Cussac D, 2002, J BIOL CHEM, V277, P19882, DOI 10.1074/jbc.M110142200; FRENCH SW, 1992, CRIT REV CL LAB SCI, V29, P83, DOI 10.3109/10408369209114597; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOLUBIC M, 1991, EMBO J, V10, P2897, DOI 10.1002/j.1460-2075.1991.tb07839.x; Granet C, 2001, BIOCHEM BIOPH RES CO, V284, P622, DOI 10.1006/bbrc.2001.5023; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; HII CST, 1995, J BIOL CHEM, V270, P4201, DOI 10.1074/jbc.270.9.4201; Hii CST, 1998, J BIOL CHEM, V273, P19277, DOI 10.1074/jbc.273.30.19277; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HUANG JMC, 1992, P NATL ACAD SCI USA, V89, P6452, DOI 10.1073/pnas.89.14.6452; Jones BE, 2000, AM J PHYSIOL-GASTR L, V278, pG693, DOI 10.1152/ajpgi.2000.278.5.G693; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; KINOSHITA T, 1995, EMBO J, V14, P266, DOI 10.1002/j.1460-2075.1995.tb07000.x; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; McDade TP, 1999, J SURG RES, V83, P56, DOI 10.1006/jsre.1998.5560; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MORIMOTO M, 1994, P SOC EXP BIOL MED, V207, P197, DOI 10.3181/00379727-207-43807; NANJI AA, 1994, ALCOHOL CLIN EXP RES, V18, P1280, DOI 10.1111/j.1530-0277.1994.tb00119.x; Paine E, 2000, J BIOL CHEM, V275, P11284, DOI 10.1074/jbc.275.15.11284; RAO GN, 1994, J BIOL CHEM, V269, P32586; Rizzo MT, 2002, PROSTAG LEUKOTR ESS, V66, P31, DOI 10.1054/plef.2001.0330; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schwenger P, 1996, J BIOL CHEM, V271, P8089, DOI 10.1074/jbc.271.14.8089; Schwenger P, 1998, MOL CELL BIOL, V18, P78, DOI 10.1128/MCB.18.1.78; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Tournier C, 1997, EUR J BIOCHEM, V244, P587, DOI 10.1111/j.1432-1033.1997.00587.x; Trost LC, 1997, TOXICOL APPL PHARM, V147, P431, DOI 10.1006/taap.1997.8313; TSUKAMOTO H, 1990, HEPATOLOGY, V12, P599, DOI 10.1002/hep.1840120325; Wu DF, 2002, HEPATOLOGY, V35, P1420, DOI 10.1053/jhep.2002.33639; Wu DF, 1996, J BIOL CHEM, V271, P23914, DOI 10.1074/jbc.271.39.23914; Wu DF, 2001, MOL PHARMACOL, V59, P795, DOI 10.1124/mol.59.4.795; WU DF, 1990, HEPATOLOGY, V12, P1379, DOI 10.1002/hep.1840120620; Wu DF, 2000, MOL CELL BIOCHEM, V204, P157, DOI 10.1023/A:1007064706101; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	54	51	52	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1115	1124		10.1074/jbc.M207856200	http://dx.doi.org/10.1074/jbc.M207856200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12403788	hybrid			2022-12-27	WOS:000180321900056
J	Jiang, GQ; Dallas-Yang, Q; Liu, F; Moller, DE; Zhang, BB				Jiang, GQ; Dallas-Yang, Q; Liu, F; Moller, DE; Zhang, BB			Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor alpha (TNF alpha)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; MITOCHONDRIAL PERMEABILITY TRANSITION; INDUCED TYROSINE PHOSPHORYLATION; TNF-ALPHA; SERINE/THREONINE PHOSPHORYLATION; PHOSPHATIDYLINOSITOL 3-KINASE; TARGETED DISRUPTION; SODIUM-SALICYLATE; IL-2 PROMOTER	Salicylates, including aspirin, have been shown to improve insulin sensitivity both in human and animal models. Although it has been suggested that salicylates sensitize insulin action by inhibiting IkappaB kinase beta (IKKbeta), the detailed mechanisms remain unclear. Protein kinase C isoforms and tumor necrosis factor a (TNFalpha) signaling pathways are well described mediators of insulin resistance; they are implicated in the activation of IKKbeta and the subsequent inhibition of proximal insulin signaling via insulin receptor substrate 1 (IRS1) and Akt. This study investigated the effect of salicylic acid on phorbol 12-myristate 13-acetate (PMA)- and TNFalpha-induced insulin resistance in a human embryonic kidney 293 (HEK293) cell line stably expressing recombinant human IRS1. The results showed that both PMA and TNFa inhibited insulin-induced Akt phosphorylation and promoted IRS1 phosphorylation on Ser-307. Salicylic acid pretreatment completely reversed the effects of PMA and TNFa on both Akt and IRS1. Whereas PMA activated protein kinase C isoforms and IKKbeta, TNFa activated neither. On the other hand, both PMA and TNFalpha activated the c-Jun N-terminal kinase (JNK), which has been reported to directly phosphorylate IRS1 Ser-307. SP600125, a JNK inhibitor, prevented PMA and TNFalpha-induced IRS1 Ser-307 phosphorylation. Finally, salicylic acid inhibited JNK activation induced by both PMA and TNFalpha. Taken together, these observations suggest that salicylic acid can reverse the inhibitory effects of TNFalpha on insulin signaling via an IKKbeta-independent mechanism(s), potentially involving the inhibition of JNK activation. The role of JNK in salicylic acid-mediated insulin sensitization, however, requires further validation because the JNK inhibitor SP600125 appears to have other nonspecific activity in addition to inhibiting JNK activity.	Merck & Co Inc, Merck Sharp & Dohme Res Labs, Metab Disorders Diabet, Dept Mol Endocrinol Diabet, Rahway, NJ 07065 USA	Merck & Company	Jiang, GQ (corresponding author), Merck & Co Inc, Merck Sharp & Dohme Res Labs, Metab Disorders Diabet, Dept Mol Endocrinol Diabet, RY80N-C31,POB 2000, Rahway, NJ 07065 USA.	guoqiang_jiang@merck.com						Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; AGUIRRE V, 2001, J BIOL CHEM, V17, P17; Al-Nasser IA, 1999, TOXICOL LETT, V105, P1, DOI 10.1016/S0378-4274(98)00373-7; Alpert D, 2000, J BIOL CHEM, V275, P10925, DOI 10.1074/jbc.275.15.10925; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; Chan ED, 1997, P NATL ACAD SCI USA, V94, P13169, DOI 10.1073/pnas.94.24.13169; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; DeFea K, 1997, BIOCHEMISTRY-US, V36, P12939, DOI 10.1021/bi971157f; Delahaye L, 1998, ENDOCRINOLOGY, V139, P4911, DOI 10.1210/en.139.12.4911; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; FERRO TJ, 1993, AM J PHYSIOL, V264, pL7, DOI 10.1152/ajplung.1993.264.1.L7; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Kaneki M, 1999, MOL CELL BIOL, V19, P461; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LANG CH, 1992, ENDOCRINOLOGY, V130, P43, DOI 10.1210/en.130.1.43; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; MATSUBARA N, 1991, IMMUNOLOGY, V73, P457; MATSUBARA N, 1993, CELL SIGNAL, V5, P811, DOI 10.1016/0898-6568(93)90042-K; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Pierce JW, 1996, J IMMUNOL, V156, P3961; Prasanna G, 1998, J OCUL PHARMACOL TH, V14, P401, DOI 10.1089/jop.1998.14.401; Quest AFG, 1996, ENZYME PROTEIN, V49, P231, DOI 10.1159/000468635; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; REID J, 1957, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5053.1071; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Shepherd PR, 1998, BIOCHEM J, V333, P471, DOI 10.1042/bj3330471; Strack V, 2000, DIABETOLOGIA, V43, P443, DOI 10.1007/s001250051327; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TANTI JF, 1994, J BIOL CHEM, V269, P6051; Trost LC, 1997, TOXICOL APPL PHARM, V147, P431, DOI 10.1006/taap.1997.8313; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Wang ZY, 2002, BIOCHEM PHARMACOL, V63, P1197, DOI 10.1016/S0006-2952(02)00853-5; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Williamson RT, 1901, BRIT MED J, V1901, P760, DOI 10.1136/bmj.1.2100.760; Wyatt TA, 1997, AM J PHYSIOL-LUNG C, V273, pL1007, DOI 10.1152/ajplung.1997.273.5.L1007; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	52	77	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					180	186		10.1074/jbc.M205565200	http://dx.doi.org/10.1074/jbc.M205565200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409308	hybrid			2022-12-27	WOS:000180255700024
J	Guillaume, P; Legler, DF; Boucheron, N; Doucey, MA; Cerottini, JC; Luescher, IF				Guillaume, P; Legler, DF; Boucheron, N; Doucey, MA; Cerottini, JC; Luescher, IF			Soluble major histocompatibility complex-peptide Octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; MHC CLASS-I; LIGAND INTERACTIONS; MEDIATED CYTOTOXICITY; EFFECTOR FUNCTIONS; LYMPHOCYTES-T; ACTIVATION; ANTIGEN; TCR; CTL	Fluorescence-labeled soluble major histocompatibility complex class I-peptide "tetramers" constitute a powerful tool to detect and isolate antigen-specific CD8(+) T cells by flow cytometry. Conventional "tetramers" are prepared by refolding of heavy and light chains with a specific peptide, enzymatic biotinylation at an added C-terminal biotinylation sequence, and "tetramerization" by reaction with phycoerythrin- or allophycocyanin-labeled avidin derivatives. We show here that such preparations are heterogeneous and describe a new procedure that allows the preparation of homogeneous tetra- or octameric major histocompatibility complex-peptide complexes. These compounds were tested on T1 cytotoxic T lymphocytes (CTLs), which recognize the Plasmodium berghei circumsporzoite peptide 252-260 (SYIPSAEKI) containing photoreactive 4-azidobenzoic acid on Lys(259) in the context of H-2K(d). We report that mutation of the CD8 binding site of K-d greatly impairs the binding of tetrameric but not octameric or multimeric K-d-PbCS(ABA) complexes to CTLs. This mutation abolishes the ability of the octamer to elicit significant phosphorylation of CD3, intracellular calcium mobilization, and CTL degranulation. Remarkably, however, this octamer efficiently activates CTLs for Fas (CD95)-dependent apoptosis.	Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1015 Lausanne, Switzerland; Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne	Luescher, IF (corresponding author), Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1015 Lausanne, Switzerland.			Boucheron, Nicole/0000-0002-4979-8311; Legler, Daniel F./0000-0001-8610-4764				Bodinier M, 2000, NAT MED, V6, P707, DOI 10.1038/76292; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; CAO WX, 1995, NATURE, V378, P295, DOI 10.1038/378295a0; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Daniels MA, 2000, J EXP MED, V191, P335, DOI 10.1084/jem.191.2.335; Denkberg G, 2001, J IMMUNOL, V167, P270, DOI 10.4049/jimmunol.167.1.270; Doucey MA, 2001, EUR J IMMUNOL, V31, P1561, DOI 10.1002/1521-4141(200105)31:5&lt;1561::AID-IMMU1561&gt;3.0.CO;2-W; Esser MT, 1998, J EXP MED, V187, P1057, DOI 10.1084/jem.187.7.1057; Esser MT, 1996, J EXP MED, V183, P1697, DOI 10.1084/jem.183.4.1697; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fuller CL, 1999, J IMMUNOL, V162, P6337; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; GRAY LS, 1988, J IMMUNOL, V141, P2424; HOCHMAN JH, 1991, J IMMUNOL, V146, P1862; Hudrisier D, 1998, J IMMUNOL, V161, P553; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Kalergis AM, 2000, J IMMUNOL METHODS, V234, P61, DOI 10.1016/S0022-1759(99)00215-X; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kessler B, 1998, J IMMUNOL, V161, P6939; Konig R, 2002, CURR OPIN IMMUNOL, V14, P75, DOI 10.1016/S0952-7915(01)00300-4; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; LUESCHER IF, 1995, IMMUNITY, V3, P51, DOI 10.1016/1074-7613(95)90158-2; McMichael AJ, 1998, J EXP MED, V187, P1367, DOI 10.1084/jem.187.9.1367; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; OROURKE AM, 1991, J EXP MED, V173, P241, DOI 10.1084/jem.173.1.241; Pestano GA, 1999, SCIENCE, V284, P1187, DOI 10.1126/science.284.5417.1187; Purbhoo MA, 2001, J BIOL CHEM, V276, P32786, DOI 10.1074/jbc.M102498200; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SCHRAVEN B, 1995, FEBS LETT, V368, P491, DOI 10.1016/0014-5793(95)00720-T; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Sousa CRE, 1996, J EXP MED, V184, P149, DOI 10.1084/jem.184.1.149; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Walter JB, 1998, J IMMUNOL METHODS, V214, P41, DOI 10.1016/S0022-1759(98)00035-0; Wang JH, 2002, MOL IMMUNOL, V38, P1039, DOI 10.1016/S0161-5890(02)00033-0; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Xu XN, 2001, IMMUNITY, V14, P591, DOI 10.1016/S1074-7613(01)00133-9; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Ybarrondo B, 1997, IMMUNOLOGY, V91, P186, DOI 10.1046/j.1365-2567.1997.00237.x; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	40	39	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4500	4509		10.1074/jbc.M208863200	http://dx.doi.org/10.1074/jbc.M208863200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12407102	hybrid, Green Published			2022-12-27	WOS:000180968900020
J	Khaldoyanidi, SK; Glinsky, VV; Sikora, L; Glinskii, AB; Mossine, VV; Quinn, TP; Glinsky, GV; Sriramarao, P				Khaldoyanidi, SK; Glinsky, VV; Sikora, L; Glinskii, AB; Mossine, VV; Quinn, TP; Glinsky, GV; Sriramarao, P			MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC CANCER-CELLS; NUDE-MICE; VASCULAR ENDOTHELIUM; EXTRACELLULAR-MATRIX; LAMINAR-FLOW; TUMOR-CELLS; P-SELECTIN; IN-VIVO; APOPTOSIS; ANTIGEN	The importance of Thomsen-Friedenreich antigen (T antigen)-galectin-3 interactions in adhesion of human breast carcinoma cells to the endothelium under conditions of flow was studied. Highly metastatic cells (MDA-MB-435) expressing high levels of both galectin-3 and T antigen demonstrated significantly increased adhesion to monolayers of endothelial cells compared with their non-metastatic counterpart (MDA-MB-468) in vitro. Within minutes of adhesion, the highly metastatic cells acquire the ability of enhanced homotypic adhesion, leading to the formation of multicellular aggregates at sites of attachment to endothelial cells in vitro. Treatment of cells with lactulosyl-L-leucine, a synthetic T antigen antagonist that targets galectin-3 by mimicking T antigen, caused a 60-80% inhibition of both homo- and heterotypic adhesion of MDA-MB-435 cells. Confocal microscopy and fluorescence-activated cell sorter analysis revealed redistribution of endothelial galectin-3 to the site of heterotypic intercellular contacts, whereas galectin-3 in MDA-MB-435 cells accumulated at sites of homotypic interaction. MDA-MB-435 cells also exhibited increased adhesion and intravascular retention within the microvessels of transplanted lung allografts in nude mice. T antigen and galectin-3-mediated interactions of metastatic cancer cells with endothelium under conditions of flow are characterized by a unique adhesion mechanism that qualitatively distinguishes their homo-and heterotypic adhesive behavior from other cell types such as leukocytes.	La Jolla Inst Mol Med, Div Vasc Biol, San Diego, CA 92121 USA; Univ Missouri, Dept Biochem, Columbia, MO 65201 USA; Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Metastat Inc, San Diego, CA 92121 USA	University of Missouri System; University of Missouri Columbia	Sriramarao, P (corresponding author), La Jolla Inst Mol Med, Div Vasc Biol, 4570 Execut Dr, San Diego, CA 92121 USA.			Rao, Srirama/0000-0001-9082-1029; Glinsky, Vladislav/0000-0003-0893-4388	NCI NIH HHS [CA86290-01, 1R01CA89827-01, 1R43CA72284] Funding Source: Medline; NIAID NIH HHS [1R01AI35796] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R43CA072284, P20CA086290, R01CA089827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035796] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Borgstrom P, 1997, J CLIN INVEST, V99, P2246, DOI 10.1172/JCI119399; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cooper CR, 2000, PROSTATE CANCER P D, V3, P6, DOI 10.1038/sj.pcan.4500387; Fogel M, 1999, CANCER LETT, V143, P87, DOI 10.1016/S0304-3835(99)00195-0; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Glinsky GV, 1998, CANCER METAST REV, V17, P177, DOI 10.1023/A:1006050302406; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Glinsky GV, 1996, CANCER LETT, V101, P43, DOI 10.1016/0304-3835(96)04112-2; GLINSKY GV, 1993, CRIT REV ONCOL HEMAT, V14, P229, DOI 10.1016/1040-8428(93)90011-R; Glinsky GV, 1996, CANCER RES, V56, P5319; Glinsky GV, 1996, CLIN EXP METASTAS, V14, P253; Glinsky VV, 2001, CANCER RES, V61, P4851; Glinsky VV, 2000, CANCER RES, V60, P2584; Haier J, 1999, CLIN EXP METASTAS, V17, P377, DOI 10.1023/A:1006658414040; Haier J, 2001, DIS COLON RECTUM, V44, P876, DOI 10.1007/BF02234713; Haier J, 2000, J CANCER RES CLIN, V126, P699, DOI 10.1007/s004320000161; LEHR HA, 1993, AM J PATHOL, V143, P1055; Lehr JE, 1998, J NATL CANCER I, V90, P118, DOI 10.1093/jnci/90.2.118; PARKS DR, 1979, P NATL ACAD SCI USA, V76, P1962, DOI 10.1073/pnas.76.4.1962; PRICE JE, 1990, CANCER RES, V50, P717; SRIRAMARAO P, 1994, J IMMUNOL, V153, P4238; Sriramarao P, 2000, BLOOD, V95, P592, DOI 10.1182/blood.V95.2.592; SRIRAMARAO P, 1998, AM J RESP CRIT CARE, V157, P205; Thorlacius H, 1997, CLIN IMMUNOL IMMUNOP, V83, P68, DOI 10.1006/clin.1996.4325; Wallach-Dayan SB, 2001, J CELL SCI, V114, P3463; Wong CW, 2001, CANCER RES, V61, P333; ZHANG RD, 1991, INVAS METAST, V11, P204	29	157	167	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4127	4134		10.1074/jbc.M209590200	http://dx.doi.org/10.1074/jbc.M209590200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12438311	hybrid			2022-12-27	WOS:000180869700079
J	Ogawa, H; Murayama, A; Nagata, S; Fukunaga, R				Ogawa, H; Murayama, A; Nagata, S; Fukunaga, R			Regulation of myeloid zinc finger protein 2A transactivation activity through phosphorylation by mitogen-activated protein kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; STIMULATING FACTOR-RECEPTOR; TRANSCRIPTION FACTOR; C-JUN; SCAN BOX; HEMATOPOIETIC DEVELOPMENT; CELLULAR STRESSES; STEM-CELLS; GENE; DOMAIN	The myeloid zinc finger protein (MZF)-2 is a C2H2 zinc finger transcription factor that is expressed in myeloid cells and involved in the growth, differentiation, and tumorigenesis of myeloid progenitors. Here we describe a novel isoform of MZF-2, designated MZF-2A, and show that it is phosphorylated by the mitogen-activated protein (MAP) kinases. An in vitro phosphorylation experiment revealed that the transactivation domain (TAD) of MZF-2A was phosphorylated strongly by extracellular signal-regulated kinase (ERK) and phosphorylated weakly by p38 MAP kinase but not by Jun N-terininal kinase. Experiments using "add-back" mutants showed that three serine residues (Ser(257), Ser(271), and Ser(295)) in the TAD were phosphorylated in vitro by ERK. In myeloid LGM-1 cells, various extracellular stimuli induced the phosphorylation of these serine residues, which was differentially inhibited by the protein kinase inhibitors U0126 and SB203580. Substitution of these phosphorylation sites with alanines resulted in a strong enhancement of the ability of MZF-2A to activate transcription in a luciferase reporter assay. Taken together, these results indicate that MZF-2A is a novel target for the ERK and p38 MAP kinase signaling pathways, and its transactivation activity is negatively regulated by MAP kinase-mediated phosphorylation of the TAD.	Osaka Univ, Dept Genet B3, Grad Sch Med, Suita, Osaka 5650871, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Fukunaga, R (corresponding author), Osaka Univ, Dept Genet B3, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Fukunaga, Rikiro/CAG-2891-2022; Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426				Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fujimoto K, 2000, NUCLEIC ACIDS RES, V28, P2557, DOI 10.1093/nar/28.13.2557; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HROMAS R, 1991, J BIOL CHEM, V266, P14183; HROMAS R, 1995, CANCER RES, V55, P3610; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KIM M, 2000, BIOCHEM BIOPH RES CO, V294, P1151; KINASHI T, 1991, J EXP MED, V173, P1267, DOI 10.1084/jem.173.5.1267; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LEE KH, 1991, J EXP MED, V173, P1257, DOI 10.1084/jem.173.5.1257; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; MORRIS JF, 1995, BLOOD, V86, P3640; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Murai K, 1997, GENES CELLS, V2, P581, DOI 10.1046/j.1365-2443.1997.1430341.x; Murai K, 1998, P NATL ACAD SCI USA, V95, P3461, DOI 10.1073/pnas.95.7.3461; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; ORKIN SH, 1995, J BIOL CHEM, V270, P4955, DOI 10.1074/jbc.270.10.4955; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Peterson MJ, 2000, GENE, V254, P105, DOI 10.1016/S0378-1119(00)00281-X; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Sander TL, 2000, J BIOL CHEM, V275, P12857, DOI 10.1074/jbc.275.17.12857; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Williams AJ, 1999, MOL CELL BIOL, V19, P8526; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	57	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2921	2927		10.1074/jbc.M207615200	http://dx.doi.org/10.1074/jbc.M207615200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427756	hybrid			2022-12-27	WOS:000180915000021
J	Petrulis, JR; Kusnadi, A; Ramadoss, P; Hollingshead, B; Perdew, GH				Petrulis, JR; Kusnadi, A; Ramadoss, P; Hollingshead, B; Perdew, GH			The hsp90 co-chaperone XAP2 alters importin beta recognition of the bipartite nuclear localization signal of the Ah receptor and represses transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; HEAT-SHOCK-PROTEIN; NF-KAPPA-B; X-ASSOCIATED PROTEIN-2; SUBCELLULAR-LOCALIZATION; GLUCOCORTICOID RECEPTOR; DIOXIN RECEPTOR; COMPLEX; CYTOPLASM; SUBUNIT	The mouse aryl hydrocarbon receptor (mAhR) is ligand-activated transcription factor that exists in a tetrameric, core complex with a dimer of the 90-kDa heat shock protein, and the hepatitis B virus X-associate protein 2 (XAP2). Transiently expressed mAhR-YFP (yellow fluorescent protein fused with the mAhR) localize throughout cells, with a majority occupying nuclei. Co-expression of XAP2 with mAhR-YFP results in a distinct redistribution to the cytoplasm. We have utilized several approaches to attempt to identify the mechanism by which XAP2 modulates the sub-cellular localization of the mAhR. The nuclear export inhibitor, leptomycin B was used to demonstrate that XAP2 inhibits ligand-in dependent nucleocytoplasmic shuttling of the receptor Results from cytoskeletal disruption and the addition of an alternate nuclear localization sequence (NLS) to mAhR-YFP suggest that XAP2 does not physically tether the complex in the cytoplasm. The use of a rabbit poly clonal antibody raised against a portion of the bipartite NLS of the mAhR revealed that XAP2 does not appear to block access to the NLS. However, XAP2 hinders importin, beta binding to the mAhR complex, suggesting that XAP2 alters the conformation of the bipartite NLS of mAhR. XAP2 also represses the transactivation potential of the AhR, in contrast to previously published reports, perhaps by stabilizing the receptor complex and/or blocking nucleocytoplasmic shuttling of the AhR complex.	Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA; Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Perdew, GH (corresponding author), Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA.	ghp2@psu.edu			NIEHS NIH HHS [ES04869] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004869, R01ES004869] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Carver LA, 1997, J BIOL CHEM, V272, P11452; CHEN HS, 1994, J BIOL CHEM, V269, P27554; Czar MJ, 1997, BIOCHEMISTRY-US, V36, P7776, DOI 10.1021/bi970648x; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; Heid SE, 2000, MOL PHARMACOL, V57, P82; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Ikuta T, 2000, J BIOCHEM, V127, P503, DOI 10.1093/oxfordjournals.jbchem.a022633; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; LaPres JJ, 2000, J BIOL CHEM, V275, P6153, DOI 10.1074/jbc.275.9.6153; Lu YF, 1996, BIOCHEM PHARMACOL, V51, P1077, DOI 10.1016/0006-2952(96)00063-9; Ma Q, 1997, J BIOL CHEM, V272, P8878; MCGUIRE J, 1994, MOL CELL BIOL, V14, P2438, DOI 10.1128/MCB.14.4.2438; Meyer BK, 2000, CELL STRESS CHAPERON, V5, P243, DOI 10.1379/1466-1268(2000)005<0243:AHARLA>2.0.CO;2; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Moroianu J, 1999, J CELL BIOCHEM, P76; PERDEW GH, 1995, HYBRIDOMA, V14, P279, DOI 10.1089/hyb.1995.14.279; PERDEW GH, 1992, BIOCHEM BIOPH RES CO, V182, P55, DOI 10.1016/S0006-291X(05)80111-1; Petrulis JR, 2000, J BIOL CHEM, V275, P37448, DOI 10.1074/jbc.M006873200; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Richter CA, 2001, ARCH BIOCHEM BIOPHYS, V389, P207, DOI 10.1006/abbi.2001.2339; SCHOLLER A, 1994, MOL PHARMACOL, V45, P944; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wilson CL, 1998, TOXICOL PATHOL, V26, P657, DOI 10.1177/019262339802600510; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	34	73	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2677	2685		10.1074/jbc.M209331200	http://dx.doi.org/10.1074/jbc.M209331200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431985	hybrid			2022-12-27	WOS:000180562000080
J	Wang, JL; Lu, S; Moenne-Loccoz, P; de Montellano, PRO				Wang, JL; Lu, S; Moenne-Loccoz, P; de Montellano, PRO			Interaction of nitric oxide with human heme oxygenase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN; CARBON-MONOXIDE; ENDOTHELIAL-CELLS; REVERSIBLE BINDING; EXPRESSION; INDUCTION; COMPLEXES; SYNTHASE; RELEASE; DONORS	NO and CO may complement each other as signaling molecules in some physiological situations. We have examined the binding of NO to human heme oxygenase-1 (hHO-1), an enzyme that oxidizes heme to biliverdin, CO, and free iron, to determine whether inhibition of hHO-1 by NO can contribute to the signaling interplay of NO and CO. An Fe3+-NO hHO-1-heme complex is formed with NO or the NO donors NOC9 or 2-(N,N-diethyl-amino)-diazenolate-2-oxide-sodium salt. Resonance Raman spectroscopy shows that ferric hHO-1-heme forms a 6-coordinated, low spin complex with NO. The nu(N-O) vibration of this complex detected by Fourier transform IR is only 4 cm(-1) lower than that of the corresponding metmyoglobin (met-Mb) complex but is broader, suggesting a greater degree of ligand conformational freedom. The Fe3+-NO complex of hHO-1 is much more stable than that of met-Mb. Stopped-flow studies indicate that k(on) for formation of the hHO-1-heme Fe3+-NO complex is similar to50-times faster, and k(off) 10 times slower, than for met-Mb, resulting in K-d = 1.4 muM for NO. NO thus binds 500-fold more tightly to ferric hHO-1-heme than to met-Mb. The hHO-1 mutations E29A, G139A, D140A, S142A, G143A, G143F, and K179A/R183A do not significantly diminish the tight binding of NO, indicating that NO binding is not highly sensitive to mutations of residues that normally stabilize the distal water ligand. As expected from the Kd value, the enzyme is reversibly inhibited upon exposure to pathologically, and possibly physiologically, relevant concentrations of NO. Inhibition of hHO-1 by NO may contribute to the pleiotropic responses to NO and CO.	Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Oregon Hlth & Sci Univ, Sch Sci & Engn, Dept Biochem & Mol Biol, Oregon Grad Inst, Beaverton, OR 97006 USA	University of California System; University of California San Francisco; Oregon Health & Science University	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ortiz@cgl.ucsf.edu		MOENNE-LOCCOZ, PIERRE/0000-0002-7684-7617	NIDDK NIH HHS [DK30297] Funding Source: Medline; NIGMS NIH HHS [GM18865] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018865] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADDISON AW, 1986, BIOCHEMISTRY-US, V25, P4104, DOI 10.1021/bi00362a018; Alcaraz MJ, 2000, BRIT J PHARMACOL, V130, P57, DOI 10.1038/sj.bjp.0703281; ASHER SA, 1979, BIOCHEMISTRY-US, V18, P5377, DOI 10.1021/bi00591a019; BENKO B, 1983, P NATL ACAD SCI USA, V80, P7042, DOI 10.1073/pnas.80.22.7042; BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x; Cavicchi M, 2000, GUT, V47, P771, DOI 10.1136/gut.47.6.771; Chen K, 2000, CELL MOL BIOL, V46, P609; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Datta PK, 1999, KIDNEY INT, V55, P1734, DOI 10.1046/j.1523-1755.1999.00429.x; Datta PK, 1999, J AM SOC NEPHROL, V10, P2540; Ding Y, 1999, EUR J BIOCHEM, V264, P854, DOI 10.1046/j.1432-1327.1999.00677.x; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Hartsfield CL, 1997, AM J PHYSIOL-LUNG C, V273, pL980; Hoshino M, 1999, COORDIN CHEM REV, V187, P75, DOI 10.1016/S0010-8545(98)00228-8; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; Kitamura Y, 1998, GLIA, V22, P138; Laverman LE, 2001, J AM CHEM SOC, V123, P285, DOI 10.1021/ja001696z; Laverman LE, 2001, J AM CHEM SOC, V123, P11614, DOI 10.1021/ja0113910; Liang MY, 2000, AM J PHYSIOL-RENAL, V279, pF728, DOI 10.1152/ajprenal.2000.279.4.F728; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Liu Y, 2000, J BIOL CHEM, V275, P5297, DOI 10.1074/jbc.275.8.5297; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; LOEHR TM, 1993, METHOD ENZYMOL, V226, P431; MAINES MD, 1986, J BIOL CHEM, V261, P411; MAINES MD, 1992, HEME OXGENASE CLIN A; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V194, P960, DOI 10.1006/bbrc.1993.1914; MALINSKI T, 1992, NATURE, V358, P676, DOI 10.1038/358676a0; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Miller LM, 1997, BIOCHEMISTRY-US, V36, P12199, DOI 10.1021/bi962744o; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Murad F, 1999, ANGEW CHEM INT EDIT, V38, P1857, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1856::AID-ANIE1856>3.0.CO;2-D; Nath KA, 2001, KIDNEY INT, V59, P106, DOI 10.1046/j.1523-1755.2001.00471.x; Otterbein LE, 2000, AM J PHYSIOL-LUNG C, V279, pL1029, DOI 10.1152/ajplung.2000.279.6.L1029; Polte T, 2000, ARTERIOSCL THROM VAS, V20, P1209, DOI 10.1161/01.ATV.20.5.1209; Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257; ROTENBERG MO, 1990, J BIOL CHEM, V265, P7501; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scheidt WR, 1999, ACCOUNTS CHEM RES, V32, P350, DOI 10.1021/ar9700116; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; SHEN AL, 1991, J BIOL CHEM, V266, P19976; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; SHIBUKI K, 1990, NEUROSCI RES, V9, P69, DOI 10.1016/0168-0102(90)90048-J; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Shimizu H, 2000, J BIOL CHEM, V275, P4816, DOI 10.1074/jbc.275.7.4816; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; SPINGER BA, 1994, CHEM REV, V94, P699; SUN J, 1993, BIOCHEMISTRY-US, V32, P14151, DOI 10.1021/bi00214a012; Takahashi K, 1997, J BIOCHEM-TOKYO, V121, P1162; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; TSUKAHARA H, 1993, BIOCHEM BIOPH RES CO, V193, P722, DOI 10.1006/bbrc.1993.1685; Turcanu V, 1998, RES IMMUNOL, V149, P741, DOI 10.1016/S0923-2494(99)80050-9; Weichsel A, 2000, NAT STRUCT BIOL, V7, P551, DOI 10.1038/76769; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; WILKS A, 1993, J BIOL CHEM, V268, P22357; WILLIS D, 1995, BIOCHEM BIOPH RES CO, V214, P1152, DOI 10.1006/bbrc.1995.2406; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Zakhary R, 1997, P NATL ACAD SCI USA, V94, P14848, DOI 10.1073/pnas.94.26.14848; ZHANG J, 1995, ANNU REV PHARMACOL, V35, P213; Zhou H, 2000, J AM CHEM SOC, V122, P8311, DOI 10.1021/ja0002868	65	58	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2341	2347		10.1074/jbc.M211131200	http://dx.doi.org/10.1074/jbc.M211131200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433915	hybrid			2022-12-27	WOS:000180562000037
J	Francin, M; Mirande, M				Francin, M; Mirande, M			Functional dissection of the eukaryotic-specific tRNA-interacting factor of lysyl-tRNA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; IMMUNODEFICIENCY-VIRUS TYPE-1; N-TERMINAL EXTENSION; ESCHERICHIA-COLI; BINDING DOMAIN; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; REVERSE TRANSCRIPTION; SECONDARY STRUCTURE	In the cytoplasm of higher eukaryotic cells, aminoacyl-tRNA synthetases (aaRSs) have polypeptide chain extensions appended to conventional prokaryotic-like synthetase domains. The supplementary domains, refered to as tRNA-interacting factors (tIFs), provide the core synthetases with potent tRNA-binding capacities, a functional requirement related to the low concentration of free tRNA prevailing in the cytoplasm of eukaryotic cells. Lysyl-tRNA synthetase is a component of the multi-tRNA synthetase complex. It exhibits a lysine-rich N-terminal polypeptide extension that increases its catalytic efficiency. The functional characterization of this new type of tRNA-interacting factor has been conducted. Here we describe the systematic substitution of the 13 lysine or arginine residues located within the general RNA-binding domain of hamster LysRS made of 70 residues. Our data show that three lysine and one arginine residues are major building blocks of the tRNA-binding site. Their mutation into alanine led to a reduced affinity for tRNA(3)(Lys) or minimalized tRNA mimicking the acceptor-TPsiC stem-loop of tRNA(3)(Lys) and a decrease in catalytic efficiency similar to that observed after a complete deletion of the N-terminal domain. Moreover, covalent continuity between the tRNA-binding and core domain is a prerequisite for providing LysRS with a tRNA binding capacity. Thus, our results suggest that the ability of LysRS to promote tRNA(Lys) networking during translation or to convey tRNA(3)(Lys) into the human immunodeficiency virus type 1 viral particles rests on the addition in evolution of this tRNA-interacting factor.	CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Mirande, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	mirande@lebs.cnrs-gif.fr						Agou F, 1996, BIOCHEMISTRY-US, V35, P15322, DOI 10.1021/bi9617926; AGOU F, 1995, BIOCHEMISTRY-US, V34, P569, DOI 10.1021/bi00002a023; Beaulande M, 2001, FEBS LETT, V494, P170, DOI 10.1016/S0014-5793(01)02340-7; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Beuning PJ, 1999, BIOPOLYMERS, V52, P1; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; CIRAKOGLU B, 1985, EUR J BIOCHEM, V151, P101, DOI 10.1111/j.1432-1033.1985.tb09074.x; COMMANS S, 1995, J MOL BIOL, V253, P100, DOI 10.1006/jmbi.1995.0539; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; ERIANI G, 1991, EUR J BIOCHEM, V200, P337, DOI 10.1111/j.1432-1033.1991.tb16190.x; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Hammamieh R, 2001, J BIOL CHEM, V276, P428, DOI 10.1074/jbc.M007570200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Javanbakht H, 2002, J BIOL CHEM, V277, P17389, DOI 10.1074/jbc.M112479200; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; JIANG M, 1993, J VIROL, V67, P3246, DOI 10.1128/JVI.67.6.3246-3253.1993; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2000, EMBO J, V19, P6908, DOI 10.1093/emboj/19.24.6908; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Lazard M, 2000, J MOL BIOL, V302, P991, DOI 10.1006/jmbi.2000.4102; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; MARTINEZ R, 1992, EUR J BIOCHEM, V207, P1, DOI 10.1111/j.1432-1033.1992.tb17012.x; MCCLAIN WH, 1993, J MOL BIOL, V234, P257, DOI 10.1006/jmbi.1993.1582; MEINNEL T, 1992, NUCLEIC ACIDS RES, V20, P4741, DOI 10.1093/nar/20.18.4741; MIRANDE M, 1991, PROG NUCLEIC ACID RE, V40, P95; Onesti S, 2000, BIOCHEMISTRY-US, V39, P12853, DOI 10.1021/bi001487r; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shimada A, 2001, P NATL ACAD SCI USA, V98, P13537, DOI 10.1073/pnas.231267998; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Smith J.A., 2000, CURRENT PROTOCOLS MO; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stello T, 1999, NUCLEIC ACIDS RES, V27, P4823, DOI 10.1093/nar/27.24.4823; Tisne C, 2000, RNA, V6, P1403, DOI 10.1017/S1355838200000947; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	48	41	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1472	1479		10.1074/jbc.M208802200	http://dx.doi.org/10.1074/jbc.M208802200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12417586	hybrid			2022-12-27	WOS:000180462200015
J	Miyazaki, J; Kobashi, N; Nishiyama, M; Yamane, H				Miyazaki, J; Kobashi, N; Nishiyama, M; Yamane, H			Characterization of homoisocitrate dehydrogenase involved in lysine biosynthesis of an extremely thermophilic bacterium, Thermus thermophilus HB27, and evolutionary implication of beta-decarboxylating dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-ISOPROPYLMALATE DEHYDROGENASE; ISOPROPYLMALATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE; SUBSTRATE-SPECIFICITY; COENZYME SPECIFICITY; THERMOSTABLE ENZYME; GENOME SEQUENCE; GENE; CLONING; ACID	Although the presence of an enzyme that catalyzes beta-decarboxylating dehydrogenation of homoisocitrate to synthesize 2-oxoadipate has been postulated in the lysine biosynthesis pathway through a-aminoadipate (AAA), the enzyme has not yet been analyzed at all, because no gene encoding the enzyme has been identified until recently. A gene encoding a protein with a significant amino acid sequence identity to both isocitrate dehydrogenase and 3-isopropylmalate dehydrogenase was cloned from Thermus thermophilus HB27. The gene product produced in recombinant Escherichia coli cells demonstrated homoisocitrate dehydrogenase (HICDH) activity. A knockout mutant of the gene showed an AAA-auxotrophic phenotype, indicating that the gene product is involved in lysine biosynthesis through AAA. We therefore named this gene hicdh. HICDH, the gene product, did not catalyze the conversion of 3-isopropylmalate to 2-oxoisocaproate, a leucine biosynthetic reaction, but it did recognize isocitrate, a related compound in the tricarboxylic acid cycle, as well as homoisocitrate as a substrate. It is of interest that HICDH catalyzes the reaction with isocitrate about 20 times more efficiently than the reaction with the putative native substrate, homoisocitrate. The broad specificity and possible dual function suggest that this enzyme represents a key link in the evolution of the pathways utilizing citrate derivatives. Site-directed mutagenesis study reveals that replacement of Arg(85) with Val in HICDH causes complete loss of activity with isocitrate but significant activity with 3-isopropylmalate and retains activity with homoisocitrate. These results indicate that Arg(85) is a key residue for both substrate specificity and evolution of beta-decarboxylating dehydrogenases.	Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp		Miyazaki, Junichi/0000-0001-5394-5129; Nishiyama, Makoto/0000-0001-8143-8052				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkman AB, 2002, J BIOL CHEM, V277, P29537, DOI 10.1074/jbc.M203528200; Broquist HP., 1971, METHODS ENZYMOL, V17B, P112; Chen RD, 1996, P NATL ACAD SCI USA, V93, P12171, DOI 10.1073/pnas.93.22.12171; Chen RD, 2000, PROTEIN SCI, V9, P2344, DOI 10.1110/ps.9.12.2344; Cleland W W, 1979, Methods Enzymol, V63, P103; Doyle SA, 2000, BIOCHEMISTRY-US, V39, P14348, DOI 10.1021/bi001458g; GAILLARDIN CM, 1982, EUR J BIOCHEM, V128, P489; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; IDA HT, 2001, J BIOL CHEM, V276, P43924; IMADA K, 1991, J MOL BIOL, V222, P725, DOI 10.1016/0022-2836(91)90508-4; Imada K, 1998, STRUCTURE, V6, P971, DOI 10.1016/S0969-2126(98)00099-9; Irvin SD, 1998, J MOL EVOL, V46, P401, DOI 10.1007/PL00006319; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; KAGAWA Y, 1984, J BIOL CHEM, V259, P2956; Kawarabayasi Y, 2001, DNA RES, V8, P123, DOI 10.1093/dnares/8.4.123; KIRINO H, 1994, EUR J BIOCHEM, V220, P275, DOI 10.1111/j.1432-1033.1994.tb18623.x; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; LIAO H, 1986, P NATL ACAD SCI USA, V83, P576, DOI 10.1073/pnas.83.3.576; Maseda H, 1998, J FERMENT BIOENG, V86, P121, DOI 10.1016/S0922-338X(98)80044-5; Miyazaki J, 2002, FEBS LETT, V512, P269, DOI 10.1016/S0014-5793(02)02290-1; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; MIYAZAKI K, 1994, EUR J BIOCHEM, V221, P899, DOI 10.1111/j.1432-1033.1994.tb18805.x; MIYAZAKI K, 1992, APPL ENVIRON MICROB, V58, P93, DOI 10.1128/AEM.58.1.93-98.1992; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; Nishida H, 2001, BIOINFORMATICS, V17, P189, DOI 10.1093/bioinformatics/17.2.189; NUMATA K, 1995, PROTEIN ENG, V8, P39, DOI 10.1093/protein/8.1.39; OSHIMA T, 1994, CURR OPIN STRUC BIOL, V4, P623, DOI 10.1016/S0959-440X(94)90228-3; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Suzuki T, 1997, J BACTERIOL, V179, P1174, DOI 10.1128/jb.179.4.1174-1179.1997; TANAKA T, 1981, J BIOCHEM-TOKYO, V89, P677, DOI 10.1093/oxfordjournals.jbchem.a133245; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Yaoi T, 1996, J BIOCHEM-TOKYO, V119, P1014	42	38	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1864	1871		10.1074/jbc.M205133200	http://dx.doi.org/10.1074/jbc.M205133200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427751	hybrid			2022-12-27	WOS:000180462200067
J	Payet, MD; Bilodeau, L; Breault, L; Fournier, A; Yon, L; Vaudry, H; Gallo-Payet, N				Payet, MD; Bilodeau, L; Breault, L; Fournier, A; Yon, L; Vaudry, H; Gallo-Payet, N			PAC(1) receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; SENSITIVE CALCIUM STORES; ADENYLATE-CYCLASE; SIGNAL-TRANSDUCTION; POLYPEPTIDE PACAP; FLUORESCENCE PROPERTIES; FUNCTIONAL EXPRESSION; RYANODINE RECEPTOR; MOLECULAR-CLONING; SPLICE VARIANTS	Previous studies have shown that human fetal adrenal gland from 17- to 20-week-old fetuses expressed pituitary adenylate cyclase-activating polypeptide (PACA-P) receptors, which were localized on chromaffin cells. The aim of the present study was to identify PACAP receptor isoforms and to determine whether PACAP can affect intracellular calcium concentration ([Ca2+](i)) and catecholamine secretion. Using primary cultures and specific stimulation of chromaffin cells, we demonstrate that PACAP-38 induced an increase in [Ca2+](i) that was blocked by PACAP (6-38), was independent of external Ca2+, and originated from thapsigargin-insensitive internal stores. The PACAP-triggered Ca2+ increase was not affected by inhibition of PLC beta (preincubation with U-73122) or by pretreatment of cells with Xestospongin C, indicating that the inositol 1,4,5-triphosphate-sensitive stores were not mobilized. However, forskolin (FSK), which raises cytosolic cAMP, induced an increase in Ca2+ similar to that recorded with PACAP-38. Blockage of PKA by H-89 or (R-p)-cAMPS suppressed both PACAP-38 and FSK calcium responses. The effect of PACAP-38 was also abolished by emptying the caffeine/ryanodine-sensitive Ca2+ stores. Furthermore, treatment of cells with orthovanadate (100 pm) impaired Ca2+ reloading of PACAP-sensitive stores indicating that PACAP-38 can mobilize Ca2+ from secretory vesicles. Moreover, PACAP induced catecholamine secretion by chromaffin cells. It is concluded that PACAP-38, through the PAC(1) receptor, acts as a neurotransmitter in human fetal chromaffin cells inducing catecholamine secretion, through nonclassical, recently described, ryanodine/caffeine-sensitive pools, involving a cAMP- and PKA-dependent phosphorylation mechanism.	Univ Sherbrooke, Fac Med, Dept Phys & Biophys, Sherbrooke, PQ J1H 5N4, Canada; Univ Sherbrooke, Fac Med, Dept Med, Serv Endocrinol, Sherbrooke, PQ J1H 5N4, Canada; Univ Quebec, Inst Natl Rech Sci Sante, Pointe Claire, PQ H9R 1G6, Canada; Univ Rouen, UA CNRS, INSERM U413, European Inst Peptide Res,IFRMP 23,Lab Cellular &, F-76821 Mont St Aignan, France	University of Sherbrooke; University of Sherbrooke; University of Quebec; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Payet, MD (corresponding author), Univ Sherbrooke, Fac Med, Dept Phys & Biophys, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.		Yon, Laurent/E-1981-2016	Yon, Laurent/0000-0002-5420-5779				[Anonymous], 1920, CONTRIBUTIONS EMBRYO; Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Basille M, 2000, J COMP NEUROL, V425, P495; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Breault L, 2000, ANN NY ACAD SCI, V921, P429; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Chamoux E, 2002, J CLIN ENDOCR METAB, V87, P1819, DOI 10.1210/jc.87.4.1819; Chamoux E, 1999, J CLIN ENDOCR METAB, V84, P4722, DOI 10.1210/jc.84.12.4722; CHARTREL N, 1991, P NATL ACAD SCI USA, V88, P3862, DOI 10.1073/pnas.88.9.3862; CHOWDHURY PS, 1994, NEUROSCIENCE, V59, P1, DOI 10.1016/0306-4522(94)90092-2; COUVINEAU A, 1994, BIOCHEM BIOPH RES CO, V200, P769, DOI 10.1006/bbrc.1994.1517; EhrhartBornstein M, 1997, HORM METAB RES, V29, P30, DOI 10.1055/s-2007-978976; FRODIN M, 1995, NEUROSCIENCE, V65, P599, DOI 10.1016/0306-4522(94)00522-7; Gandia L, 1998, PFLUG ARCH EUR J PHY, V436, P696, DOI 10.1007/s004240050691; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUO X, 1994, J PHYSIOL-LONDON, V475, P539, DOI 10.1113/jphysiol.1994.sp020092; Guse AH, 1997, EUR J BIOCHEM, V245, P411, DOI 10.1111/j.1432-1033.1997.t01-1-00411.x; Hahm SH, 1998, J MOL NEUROSCI, V11, P43, DOI 10.1385/JMN:11:1:43; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Harmar AJ, 1998, PHARMACOL REV, V50, P265; HOHENEGGER M, 1993, BIOCHEM J, V296, P303, DOI 10.1042/bj2960303; Kopp MDA, 1999, J NEUROSCI, V19, P206, DOI 10.1523/JNEUROSCI.19-01-00206.1999; KRAMER RH, 1994, PFLUG ARCH EUR J PHY, V426, P12, DOI 10.1007/BF00374665; LIU PS, 1991, J NEUROCHEM, V56, P172, DOI 10.1111/j.1471-4159.1991.tb02577.x; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Moller K, 1996, REGUL PEPTIDES, V63, P129; MURTHY KS, 1994, J BIOL CHEM, V269, P15977; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OGI K, 1993, BIOCHEM BIOPH RES CO, V196, P1511, DOI 10.1006/bbrc.1993.2423; Ohta T, 1996, CELL CALCIUM, V20, P303, DOI 10.1016/S0143-4160(96)90036-6; Olianas MC, 1997, J NEUROCHEM, V69, P1213; Osipenko ON, 2000, J BIOL CHEM, V275, P16626, DOI 10.1074/jbc.M909636199; PerezTerzic C, 1997, CELL CALCIUM, V21, P275, DOI 10.1016/S0143-4160(97)90115-9; Pisegna JR, 1996, J BIOL CHEM, V271, P17267, DOI 10.1074/jbc.271.29.17267; Przywara DA, 1996, J BIOL CHEM, V271, P10545, DOI 10.1074/jbc.271.18.10545; ROBBERECHT P, 1992, MOL PHARMACOL, V42, P347; ROBINSON IM, 1991, J NEUROCHEM, V56, P1587, DOI 10.1111/j.1471-4159.1991.tb02055.x; SALARI H, 1993, AM J RESP CELL MOL, V9, P405, DOI 10.1165/ajrcmb/9.4.405; Solano RM, 1996, ENDOCRINOLOGY, V137, P2815, DOI 10.1210/en.137.7.2815; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; STAUDERMAN KA, 1991, BIOCHEM J, V278, P643, DOI 10.1042/bj2780643; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; SVOBODA M, 1994, BIOCHEM BIOPH RES CO, V205, P1617, DOI 10.1006/bbrc.1994.2852; TABARIN A, 1994, NEUROENDOCRINOLOGY, V59, P113, DOI 10.1159/000126647; Tanaka K, 1998, J NEUROCHEM, V70, P1652; TATSUNO I, 1992, ENDOCRINOLOGY, V131, P73, DOI 10.1210/en.131.1.73; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Yon L, 1998, J CLIN ENDOCR METAB, V83, P1299, DOI 10.1210/jc.83.4.1299; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938	58	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1663	1670		10.1074/jbc.M206470200	http://dx.doi.org/10.1074/jbc.M206470200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12429744	Green Published, hybrid			2022-12-27	WOS:000180462200040
J	Hanson, CL; Fucini, P; Ilag, LL; Nierhaus, KH; Robinson, CV				Hanson, CL; Fucini, P; Ilag, LL; Nierhaus, KH; Robinson, CV			Dissociation of intact Escherichia coli ribosomes in a mass spectrometer - Evidence for conformational change in a ribosome elongation factor g complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN L7/L12; CROSS-LINKING; 70S RIBOSOME; EF-G; RNA; BINDING; TRANSLOCATION; THIOSTREPTON; SUBUNIT; HYDROLYSIS	We used mass spectrometry to identify proteins that are released in the gas phase from Escherichia coli ribosomes in response to a range of different solution conditions and cofactor binding. From solution at neutral pH the spectra are dominated by just 4 of the 54 ribosomal proteins (L7/L12, L11, and L10). Lowering the pH of the solution leads to the gas phase dissociation of four additional proteins as well as the 5 S RNA. Replacement of Mg2+ by Li+ ions in solutions of ribosomes induced the dissociation of 17 ribosomal proteins. Correlation of these results with available structural information for ribosomes revealed that a relatively high interaction surface area of the protein with RNA was the major force in preventing dissociation. By using the proteins that dissociate to probe their interactions with RNA, we examined different complexes of the ribosome formed with the elongation factor G and inhibited by fusidic acid or thiostrepton. Mass spectra recorded for the fusidic acid-inhibited complex reveal subtle changes in peak intensity of the proteins that dissociate. By contrast gas phase dissociation from the thiostrepton-inhibited complex is markedly different and demonstrates the presence of L5 and LIS, two proteins that interact exclusively with the 5 S RNA. These results allow us to propose that the ribosome elongation factor-G complex inhibited by thiostrepton, but not fusidic acid, involves destabilization of 5 S RNA-protein interactions.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Max Planck Inst Mol Genet, AG Ribosomen, D-14195 Berlin, Germany	University of Cambridge; Max Planck Society	Robinson, CV (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk	Fucini, Paola/M-1118-2014	Fucini, Paola/0000-0003-1724-8507; robinson, carol/0000-0001-7829-5505; Ilag, Leopold/0000-0003-3678-7100				Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Benjamin DR, 1998, P NATL ACAD SCI USA, V95, P7391, DOI 10.1073/pnas.95.13.7391; BODLEY JW, 1970, J BIOL CHEM, V245, P5662; BODLEY JW, 1970, J BIOL CHEM, V245, P5656; Cameron DM, 2002, J MOL BIOL, V319, P27, DOI 10.1016/S0022-2836(02)00235-8; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Dey D, 1998, J BIOL CHEM, V273, P1670, DOI 10.1074/jbc.273.3.1670; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; GUDKOV AT, 1984, FEBS LETT, V176, P32, DOI 10.1016/0014-5793(84)80906-0; GUDKOV AT, 1989, BIOCHIMIE, V71, P779, DOI 10.1016/0300-9084(89)90040-0; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HUBBARD SJ, 1992, THESIS U LONDON LOND; Huppler A, 2002, NAT STRUCT BIOL, V9, P431, DOI 10.1038/nsb800; KALTSCHMIDT E, 1971, ANAL BIOCHEM, V43, P25, DOI 10.1016/0003-2697(71)90103-5; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200; Moore PB, 2001, BIOCHEMISTRY-US, V40, P3243, DOI 10.1021/bi0029402; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Nierhaus K., 1990, RIBOSOMES PROTEIN SY, P161; Ramakrishnan V, 2001, CURR OPIN STRUC BIOL, V11, P144, DOI 10.1016/S0959-440X(00)00184-6; Rodnina MV, 1999, P NATL ACAD SCI USA, V96, P9586, DOI 10.1073/pnas.96.17.9586; Rostom AA, 2000, P NATL ACAD SCI USA, V97, P5185, DOI 10.1073/pnas.97.10.5185; ROSTOM AA, 1999, THESIS U OXFORD OXFO; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Shiman R, 2000, J MOL BIOL, V302, P79, DOI 10.1006/jmbi.2000.4031; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; SPEDDING G, 1990, RIBOSOMES PROTEIN SY, P1; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; THOMPSON J, 1991, BIOCHIMIE, V73, P1131, DOI 10.1016/0300-9084(91)90156-U; Traut RR, 1995, BIOCHEM CELL BIOL, V73, P949, DOI 10.1139/o95-102; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	41	48	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1259	1267		10.1074/jbc.M208966200	http://dx.doi.org/10.1074/jbc.M208966200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409297	hybrid			2022-12-27	WOS:000180321900073
J	Hommers, LG; Lohse, MJ; Bunemann, M				Hommers, LG; Lohse, MJ; Bunemann, M			Regulation of the inward rectifying properties of G-protein-activated inwardly rectifying K+ (GIRK) channels by G beta gamma subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFIER POTASSIUM CHANNELS; I-KACH; ATRIAL MYOCYTES; RECTIFICATION; BINDING; CELLS; BLOCK; IDENTIFICATION; MECHANISM; KIR2.1	Gbetagamma subunits are known to bind to and activate G-protein-activated inwardly rectifying K+ channels (GIRK) by regulating their open probability and bursting behavior. Studying G-protein regulation of either native GIRK (I-KACh) channels in feline atrial myocytes or heterologously expressed GIRK1/4 channels in Chinese hamster ovary cells and HEK 293 cells uncovered a novel Gbetagamma subunit mediated regulation of the inwardly rectifying properties of these channels. I-KACh activated by submaximal concentrations of acetylcholine exhibited a similar to2.5-fold stronger inward rectification than I-KACh activated by saturating concentrations of acetylcholine. Similarly, the inward rectification of currents through GIRK1/4 channels expressed in HEK cells was substantially weakened upon maximal stimulation with co-expressed Gbetagamma subunits. Analysis of the outward current block underlying inward rectification demonstrated that the fraction of instantaneously blocked channels was reduced when Gbetagamma was over-expressed. The Gbetagamma induced weakening of inward rectification was associated with reduced potencies for Ba2+ and Cs+ to block channels from the extracellular side. Based on these results we propose that saturation of the channel with Gbetagamma leads to a conformational change within the pore of the channel that reduced the potency of extracellular cations to block the pore and increased the fraction of channels inert to a pore block in outward direction.	Univ Wurzburg, Dept Pharmacol & Toxicol, D-97078 Wurzburg, Germany	University of Wurzburg	Bunemann, M (corresponding author), Univ Wurzburg, Dept Pharmacol & Toxicol, Versbacherstr 9, D-97078 Wurzburg, Germany.		Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510				Becker D, 1996, P NATL ACAD SCI USA, V93, P8123, DOI 10.1073/pnas.93.15.8123; Bunemann M, 2000, J BIOL CHEM, V275, P12537, DOI 10.1074/jbc.275.17.12537; Bunemann M, 1995, J PHYSIOL-LONDON, V489, P701; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Bunemann M, 1998, J BIOL CHEM, V273, P31186, DOI 10.1074/jbc.273.47.31186; Burt AR, 1998, J BIOL CHEM, V273, P10367, DOI 10.1074/jbc.273.17.10367; CAMPBELL GD, 1989, J PHYSIOL-LONDON, V415, P57, DOI 10.1113/jphysiol.1989.sp017711; Corey S, 2001, J BIOL CHEM, V276, P11409, DOI 10.1074/jbc.M100058200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FORSAYETH JR, 1994, BIOTECHNIQUES, V17, P354; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARVEY RD, 1988, J GEN PHYSIOL, V91, P593, DOI 10.1085/jgp.91.4.593; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Lancaster MK, 2000, J BIOL CHEM, V275, P35831, DOI 10.1074/jbc.M006565200; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lee JK, 1999, J GEN PHYSIOL, V113, P555, DOI 10.1085/jgp.113.4.555; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Nichols CG, 1996, CIRC RES, V78, P1, DOI 10.1161/01.RES.78.1.1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Shieh RC, 1998, BIOPHYS J, V75, P2313, DOI 10.1016/S0006-3495(98)77675-1; Shyng SL, 1996, P NATL ACAD SCI USA, V93, P12014, DOI 10.1073/pnas.93.21.12014; Thompson GA, 2000, J PHYSIOL-LONDON, V526, P231, DOI 10.1111/j.1469-7793.2000.00231.x; Wickman K, 1999, ANN NY ACAD SCI, V868, P386, DOI 10.1111/j.1749-6632.1999.tb11300.x; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YAMADA M, 1995, J BIOL CHEM, V270, P9289, DOI 10.1074/jbc.270.16.9289; Yamada M, 1998, PHARMACOL REV, V50, P723; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhou H, 1996, AM J PHYSIOL-CELL PH, V271, pC1949, DOI 10.1152/ajpcell.1996.271.6.C1949	41	37	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1037	1043		10.1074/jbc.M205325200	http://dx.doi.org/10.1074/jbc.M205325200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12403784	hybrid			2022-12-27	WOS:000180321900046
J	Tischkau, SA; Mitchell, JW; Tyan, SH; Buchanan, GF; Gillette, MU				Tischkau, SA; Mitchell, JW; Tyan, SH; Buchanan, GF; Gillette, MU			Ca2+/cAMP response element-binding protein (CREB)-dependent activation of Per1 is required for light-induced signaling in the Suprachiasmatic nucleus circadian clock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PHASE ADVANCES; IMMEDIATE-EARLY GENES; CREB PHOSPHORYLATION; BIOLOGICAL CLOCK; PERIOD HOMOLOGS; KINASE-II; EXPRESSION; RHYTHMS; SHIFTS; MPER1	Light is a prominent stimulus that synchronizes endogenous circadian rhythmicity to environmental light/dark cycles. Nocturnal light elevates mRNA of the Period1 (Per1) gene and induces long term state changes, expressed as phase shifts of circadian rhythms. The cellular mechanism for Per1 elevation and light-induced phase advance in the suprachiasmatic nucleus (SCN), a process initiated primarily by glutamatergic neuro-transmission from the retinohypothalamic tract, was examined. Glutamate (GLU)-induced phase advances in the rat SCN were blocked by antisense oligodeoxynucleotide (ODN) against Perl and Ca2+/cAMP response element (CRE)-decoy ODN. CRE-decoy ODN also blocked light-induced phase advances in vivo. Furthermore, the CRE-decoy blocked GLU-induced accumulation of Perl mRNA. Thus, Ca2+/cAMP response element-binding protein (CREB) and Perl are integral components of the pathway transducing light-stimulated GLU neurotransmission into phase advance of the circadian clock.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gillette, MU (corresponding author), Univ Illinois, Dept Cell & Struct Biol, B107 CLSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	mgillett@uiuc.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Buchanan, Gordon/0000-0003-2371-4455	NHLBI NIH HHS [HL67007, R01 HL067007] Funding Source: Medline; NIMH NIH HHS [MH12351] Funding Source: Medline; NINDS NIH HHS [R01 NS022155, NS22155, NS10170, NS11158] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH012351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022155, F32NS010170, F32NS011158] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE H, 1992, BRAIN RES BULL, V28, P831, DOI 10.1016/0361-9230(92)90269-4; Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Beaule C, 1999, BRAIN RES, V821, P95, DOI 10.1016/S0006-8993(99)01073-2; Best JD, 1999, J NEUROSCI, V19, P828; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Chen D, 1999, P NATL ACAD SCI USA, V96, P13468, DOI 10.1073/pnas.96.23.13468; COLWELL CS, 1992, J BIOL RHYTHM, V7, P125, DOI 10.1177/074873049200700204; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Ding JM, 1997, J NEUROSCI, V17, P667; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Edelstein K, 2000, BRAIN RES, V870, P54, DOI 10.1016/S0006-8993(00)02401-X; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fukushima T, 1997, NEUROSCI LETT, V227, P45, DOI 10.1016/S0304-3940(97)00297-8; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOLOMBEK DA, 1994, NEUROREPORT, V5, P1638, DOI 10.1097/00001756-199408150-00024; Guido ME, 1999, J BIOL RHYTHM, V14, P275, DOI 10.1177/074873099129000687; Hurst WJ, 2002, BIOCHEM BIOPH RES CO, V298, P133, DOI 10.1016/S0006-291X(02)02346-X; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; KORNHAUSER JM, 1992, SCIENCE, V255, P1581, DOI 10.1126/science.1549784; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kornhauser JM, 1996, BEHAV GENET, V26, P221, DOI 10.1007/BF02359382; Mathur A, 1996, AM J PHYSIOL-REG I, V270, pR1031, DOI 10.1152/ajpregu.1996.270.5.R1031; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mintz EM, 1999, J NEUROSCI, V19, P5124; Miyake S, 2000, NEUROSCI LETT, V294, P41, DOI 10.1016/S0304-3940(00)01545-7; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Park YG, 1999, J BIOL CHEM, V274, P1573, DOI 10.1074/jbc.274.3.1573; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360, DOI 10.1152/ajpregu.1994.267.2.R360; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; SHIRAKAWA T, 1994, NEUROSCI LETT, V178, P47, DOI 10.1016/0304-3940(94)90286-0; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tischkau SA, 2000, J NEUROSCI, V20, P7830; TISCHKAU SA, 1999, J NEUROSCI, V15, P1; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WEBER ET, 1995, NEUROSCI LETT, V197, P227, DOI 10.1016/0304-3940(95)11961-U; Yamaguchi S, 2000, CURR BIOL, V10, P873, DOI 10.1016/S0960-9822(00)00602-3; Yokota S, 2001, J NEUROCHEM, V77, P618, DOI 10.1046/j.1471-4159.2001.00270.x; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	55	209	212	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					718	723		10.1074/jbc.M209241200	http://dx.doi.org/10.1074/jbc.M209241200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409294	hybrid			2022-12-27	WOS:000180321900005
J	Kast, C; Wang, ML; Whiteway, M				Kast, C; Wang, ML; Whiteway, M			The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CELLS IN-VITRO; PHORBOL ESTER; HUMAN GLIOMAS; CANCER-CELLS; CDNA CLONING; ACTIVATION; EXPRESSION; RAS; MITOGEN	Human tissue factor pathway inhibitor-2 (hTFPI-2) is a 32-kDa serine protease inhibitor that is associated with the extracellular matrix. hTFPI-2 inhibits several extracellular matrix-degrading serine proteases and may play a role in tumor invasion and metastasis. To study the signal transduction pathway that leads to the activation of the hTFPI-2, we cloned the potential promoter region of this gene adjacent to a heterologous luciferase reporter gene. Phorbol 12-myristate 13-acetate (PMA) induced the luciferase reporter gene in HEK293 cells and other epithelial cell lines, such as the human lung carcinoma A549 cells, the breast carcinoma MCF7 cells, and the cervical HeLa cells. This PMA induction was blocked with the MEK inhibitor UO126, suggesting that the PMA-induced activation of the hTFPI-2 promoter is mediated through MEK. Furthermore, epidermal growth factor induced the luciferase reporter gene in HeLa cells. Cotransfection of the luciferase construct with constitutively active components of the Ras/Raf/MEK/ERK pathway in EcR-293 cells lead to a 7- to 92-fold induction of the luciferase reporter gene, indicating that regulation of hTFPI-2 is mediated through this pathway. A series of luciferase reporter gene constructs with progressive deletions of the 5'-flanking region suggested that the minimal basal promoter activity is located between nucleotide positions -89 and -384, whereas the minimal inducible promoter activity is between -89 and -222. We have used the computer program TFSEARCH and mutagenesis to analyze potential transcription factor binding sites. We identified an AP-1 binding site at nucleotide position -156 (inducible activity) and a Sp1 site at position -134 (basal activity) as potential cis-acting elements in the promoter region of the hTFPI-2.	Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	National Research Council Canada	Kast, C (corresponding author), Natl Res Council Canada, Biotechnol Res Inst, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada.							ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Chen NY, 2001, J BIOL CHEM, V276, P46722, DOI 10.1074/jbc.M107156200; Chiloeches A, 1999, J BIOL CHEM, V274, P19762, DOI 10.1074/jbc.274.28.19762; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Iochmann S, 2002, THROMB RES, V105, P217, DOI 10.1016/S0049-3848(02)00018-X; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; Jin MS, 2001, GYNECOL ONCOL, V83, P325, DOI 10.1006/gyno.2001.6394; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kamei S, 2001, BBA-GENE STRUCT EXPR, V1517, P430, DOI 10.1016/S0167-4781(00)00298-0; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Konduri SD, 2002, ONCOGENE, V21, P921, DOI 10.1038/sj.onc.1204983; Konduri SD, 2001, INT J ONCOL, V18, P127; Konduri SD, 2000, CLIN EXP METASTAS, V18, P303, DOI 10.1023/A:1011085820250; Konduri SD, 2001, ONCOGENE, V20, P6938, DOI 10.1038/sj.onc.1204847; LINO M, 1998, ARTERIOSCLER THROMB, V18, P40; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; MIYAGI Y, 1994, J BIOCHEM-TOKYO, V116, P939, DOI 10.1093/oxfordjournals.jbchem.a124648; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Nantel A, 1998, J BIOL CHEM, V273, P10475, DOI 10.1074/jbc.273.17.10475; Neaud V, 2000, J BIOL CHEM, V275, P35565, DOI 10.1074/jbc.M006101200; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OKA H, 1995, CANCER RES, V55, P4182; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Petersen LC, 1996, BIOCHEMISTRY-US, V35, P266, DOI 10.1021/bi951501d; Rao CN, 1996, ARCH BIOCHEM BIOPHYS, V335, P82, DOI 10.1006/abbi.1996.0484; RAO CN, 1995, ARCH BIOCHEM BIOPHYS, V317, P311, DOI 10.1006/abbi.1995.1168; Rao CN, 1999, BIOCHEM BIOPH RES CO, V255, P94, DOI 10.1006/bbrc.1999.0153; Rao CN, 2001, CLIN CANCER RES, V7, P570; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shinoda E, 1999, J BIOL CHEM, V274, P5379, DOI 10.1074/jbc.274.9.5379; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; SPRECHER CA, 1994, P NATL ACAD SCI USA, V91, P3353, DOI 10.1073/pnas.91.8.3353; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Zhou H, 2000, J BIOL CHEM, V275, P22868, DOI 10.1074/jbc.M909273199	44	39	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 28	2003	278	9					6787	6794		10.1074/jbc.M210935200	http://dx.doi.org/10.1074/jbc.M210935200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649EZ	12446683	hybrid			2022-12-27	WOS:000181195100021
J	Higashi, K; Inagaki, Y; Suzuki, N; Mitsui, S; Mauviel, A; Kaneko, H; Nakatsuka, I				Higashi, K; Inagaki, Y; Suzuki, N; Mitsui, S; Mauviel, A; Kaneko, H; Nakatsuka, I			Y-box-binding protein YB-1 mediates transcriptional repression of human alpha 2(I) collagen gene expression by interferon-gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-BETA; HUMAN DERMAL FIBROBLASTS; MESSENGER-RNA; FUNCTIONAL INTERACTION; NUCLEAR TRANSLOCATION; INSITU HYBRIDIZATION; COL1A2 PROMOTER; ACTIVATION; MECHANISM	We have demonstrated previously that a proximal element within the human alpha2(l) collagen gene (COL1A2) promoter mediates transcriptional repression by interferon-gamma (IFN-gamma), and designated this region the IFN-gamma response element (IgRE). Screening of a human fibroblast cDNA expression library with a radiolabeled IgRE probe exclusively yielded clones with a sequence identical to that of the transcription factor YB-1. Electrophoretic mobility shift assays (EMSA) using various IgRE-derived oligonucleotide probes containing serial two-base mutations showed that YB-1 protein was preferentially bound to the pyrimidine-rich sequence within the IgRE. This region is located immediately downstream of and partly overlaps the previously reported Sp1/Sp3 binding site. Overexpression of YB-1 in human dermal fibroblasts decreased steady state levels of COL1A2 mRNA and repressed COLlA2 promoter activity in a dose-dependent manner. This inhibitory effect of YB-1 on COLlA2 expression was abolished by mutations of the IgRE shown to prevent YB-1 binding in EMSA. In addition, these mutations also abolished the inhibitory effect of IFN-gamma, suggesting that YB-1 mediates the inhibitory action of IFN-gamma on COL1A2 promoter through its binding to the IgRE. Also, overexpression of a deletion mutant YB-1, which lacks the carboxyl-terminal domain, abrogated the repression of COL1A2 transcription by IFN-gamma. A functional correlation between IFN-gamma and YB-1 was further supported by luciferase assays using four tandem repeats of the Y-box consensus oligonucleotide linked to a minimal promoter. EMSA and Western blot analysis using cytoplasmic and nuclear proteins implied that IFN-gamma promotes the nuclear translocation of YB-1. Direct evidence for the nuclear translocation of YB-1 by IFN-gamma was further provided by using a YB-1-green fluorescent protein expression plasmid transfected into human fibroblasts. Altogether, this study represents the definitive identification of the transcription factor responsible for IFN-gamma-elicited inhibition of COL1A2 expression, namely YB-1.	Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, Osaka 5548558, Japan; Tokai Univ, Sch Med, Dept Community Hlth, Kanagawa 2591193, Japan; Kyoto Prefectural Univ Med, Res Inst Neuronal Dis & Geriatr, Dept Cell Biol, Kamigyo Ku, Kyoto 6028566, Japan; Hop St Louis, INSERM U532, F-75010 Paris, France	Sumitomo Chem Co Ltd; Tokai University; Kyoto Prefectural University of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Higashi, K (corresponding author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, Osaka 5548558, Japan.		MAUVIEL, Alain/F-6251-2013	HIGASHI, KIYOSHI/0000-0003-3577-0526; Mauviel, Alain/0000-0002-0438-2793				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bitzer M, 2000, GENE DEV, V14, P187; BOAST S, 1990, J BIOL CHEM, V265, P13351; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Dhalla AK, 1998, BIOCHEM J, V336, P373, DOI 10.1042/bj3360373; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; GRANT CE, 1993, MOL CELL BIOL, V13, P4186, DOI 10.1128/MCB.13.7.4186; Greenwel P, 2000, MOL CELL BIOL, V20, P912, DOI 10.1128/MCB.20.3.912-918.2000; Higashi K, 1998, MATRIX BIOL, V16, P447, DOI 10.1016/S0945-053X(98)90016-6; Ihn H, 1996, J BIOL CHEM, V271, P26717, DOI 10.1074/jbc.271.43.26717; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; Ihn H, 2000, J INVEST DERMATOL, V114, P1011, DOI 10.1046/j.1523-1747.2000.00956.x; INAGAKI Y, 1995, J BIOL CHEM, V270, P3353, DOI 10.1074/jbc.270.7.3353; JACOB G, 1999, P NATL ACAD SCI USA, V96, P12719; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; KOLLURI R, 1992, NUCLEIC ACIDS RES, V20, P111, DOI 10.1093/nar/20.1.111; Kouba DJ, 1999, J IMMUNOL, V162, P4226; KULOZIK M, 1990, J CLIN INVEST, V86, P917, DOI 10.1172/JCI114793; Lin HY, 1998, J IMMUNOL, V161, P843; MAUVIEL A, 1993, WOUNDS, V5, P137; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Norman JT, 2001, J BIOL CHEM, V276, P29880, DOI 10.1074/jbc.M103145200; Ogawa H, 1998, ACTA HISTOCHEM CYTOC, V31, P303, DOI 10.1267/ahc.31.303; Ohga T, 1996, CANCER RES, V56, P4224; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; PELTONEN J, 1990, J INVEST DERMATOL, V94, P365, DOI 10.1111/1523-1747.ep12874491; Reano A, 1997, ARCH DERMATOL RES, V289, P617, DOI 10.1007/s004030050250; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; Sawaya BE, 1998, J GEN VIROL, V79, P239, DOI 10.1099/0022-1317-79-2-239; SCHARFFETTER K, 1988, EUR J CLIN INVEST, V18, P9, DOI 10.1111/j.1365-2362.1988.tb01158.x; Stein U, 2001, J BIOL CHEM, V276, P28562, DOI 10.1074/jbc.M100311200; Stenina OI, 2001, P NATL ACAD SCI USA, V98, P7277, DOI 10.1073/pnas.121592298; TAKAI T, 1994, NUCLEIC ACIDS RES, V22, P5576, DOI 10.1093/nar/22.25.5576; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Yuan WH, 1999, J CELL PHYSIOL, V179, P97, DOI 10.1002/(SICI)1097-4652(199904)179:1<97::AID-JCP12>3.3.CO;2-5	40	61	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5156	5162		10.1074/jbc.M208724200	http://dx.doi.org/10.1074/jbc.M208724200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12446674	hybrid			2022-12-27	WOS:000180968900103
J	Vinals, M; Xu, SZ; Vasile, E; Krieger, M				Vinals, M; Xu, SZ; Vasile, E; Krieger, M			Identification of the N-linked glycosylation sites on the high density lipoprotein (HDL) receptor SR-BI and assessment of their effects on HDL binding and selective lipid uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR; MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; MEDIATED ENDOCYTOSIS; CHOLESTERYL ESTER; TARGETED MUTATION; APOPTOTIC CELLS; TRANSGENIC MICE; DEFICIENT MICE; LIMP-II	The murine class B, type I scavenger receptor mSR-BI, a high density lipoprotein (HDL) receptor that mediates selective uptake of HDL lipids, contains 11 potential N-linked glycosylation sites and unknown numbers of both endoglycosidase, H-sensitive and -resistant oligosaccharides. We have examined the consequences of mutating each of these sites (Asn --> Gln or Thr --> Ala) on post-translational processing of mSR-BI, cell surface expression, and HDL binding and lipid transport activities. All 11 sites were glycosylated; however, disruption of only two (Asn-108 and Asn-173) substantially altered expression and function. There was very little detectable post-translational processing of these two mutants to endoglycosidase H resistance and very low cell sur-face expression, suggesting that oligosaccharide modification at these sites apparently plays an important role in endoplasmic reticulum. folding and/or intracellular transport. Strikingly, although the low levels of the 108 and 173 mutants that were expressed on the cell surface exhibited a marked reduction in their ability to transfer lipids from HDL to cells, they nevertheless bound nearly normal amounts of HDL. Indeed, the affinity of I-125-HDL binding to the 173 mutant was similar to that of the wild-type receptor. Thus, N-linked glycosylation can influence both the intracellular transport and lipid-transporter activity of SR-BI. The ability to uncouple the HDL binding and lipid transport activities of mSR-BI by in vitro mutagenesis should provide a powerful tool for further analysis of the mechanism of SR-BI-mediated selective lipid uptake.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483, Cambridge, MA 02139 USA.		Krieger, Marco/AAE-8611-2020; Eckhardt, Erik/G-1567-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52212] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; BABBITT J, 1997, J BIOL CHEM, V272, P13242; Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CALVO D, 1995, GENOMICS, V25, P100, DOI 10.1016/0888-7543(95)80114-2; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Gu XJ, 2000, J BIOL CHEM, V275, P9120, DOI 10.1074/jbc.275.13.9120; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; HART K, 1993, J MOL BIOL, V234, P249, DOI 10.1006/jmbi.1993.1580; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Liu B, 2002, J BIOL CHEM, V277, P34125, DOI 10.1074/jbc.M204265200; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; Mardones P, 2001, J LIPID RES, V42, P170; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; OPDENAKKER G, 1993, FASEB J, V7, P1330, DOI 10.1096/fasebj.7.14.8224606; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Ray K, 1997, J BIOL CHEM, V272, P31355, DOI 10.1074/jbc.272.50.31355; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; STEIN Y, 1983, BIOCHIM BIOPHYS ACTA, V752, P98, DOI 10.1016/0005-2760(83)90237-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; VEGA MA, 1991, J BIOL CHEM, V266, P16818; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920	46	60	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5325	5332		10.1074/jbc.M211073200	http://dx.doi.org/10.1074/jbc.M211073200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12429731	hybrid			2022-12-27	WOS:000180968900124
J	Lakshminarayanan, R; Valiyaveettil, S; Rao, VS; Kini, RM				Lakshminarayanan, R; Valiyaveettil, S; Rao, VS; Kini, RM			Purification, characterization, and in vitro mineralization studies of a novel goose eggshell matrix protein, ansocalcin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; ORGANIC MATRIX; CALCITE CRYSTALS; AVIAN EGGSHELL; BINDING PROTEIN; MACROMOLECULES; LOCALIZATION; DESIGN; BIOMINERALIZATION; LITHOSTATHINE	Biomineralization is an important process in which hard tissues are generated through mineral deposition, often assisted by biomacromolecules. Eggshells, because of their rapid formation via mineralization, are chosen as a model for understanding the fundamentals of biomineralization. This report discusses purification and characterization of various proteins and peptides from goose eggshell matrix. A novel 15-kDa protein (ansocalcin) was extracted from the eggshell matrix, purified, and identified and its role in mineralization evaluated using in vitro crystal growth experiments. The complete amino acid sequence of ansocalcin showed high homology to ovocleidin-17, a chicken eggshell protein, and to C-type lectins from snake venom. The amino acid sequence of ansocalcin was characterized by the presence of acidic and basic amino acid multiplets. In vitro crystallization experiments showed that ansocalcin induced pits on the rhombohedral faces at lower concentrations (<50 mug/ml). At higher concentrations, the nucleation of calcite crystal aggregates was observed. Molecular weight determinations by size exclusion chromatography and sodium dodecyl sulfate -polyacrylamide gel electrophoresis showed reversible concentration-dependent aggregation of ansocalcin in solution. We propose that such aggregated structures may act as a template for the nucleation of calcite crystal aggregates. Similar aggregation of calcite crystals was also observed when crystallizations were performed in the presence of whole goose eggshell extract. These results show that ansocalcin plays a significant role in goose eggshell calcification.	Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore; National University of Singapore	Valiyaveettil, S (corresponding author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore.	chmsv@nus.edu.sg	Rajamani, Lakshminarayanan/AAG-5541-2019; Kini, Manjunatha/H-8029-2012; Valiyaveettill, Suresh/D-4848-2009	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Valiyaveettill, Suresh/0000-0001-6990-660X; Kini, Manjunatha/0000-0002-6100-3251				ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005; Arias JL, 2001, WORLD POULTRY SCI J, V57, P349, DOI 10.1079/WPS20010024; ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3; BAKER JR, 1962, BIOCHEM J, V82, P352, DOI 10.1042/bj0820352; BERMAN A, 1988, NATURE, V331, P546, DOI 10.1038/331546a0; Bertrand JA, 1996, EMBO J, V15, P2678, DOI 10.1002/j.1460-2075.1996.tb00628.x; Carrino DA, 1997, CONNECT TISSUE RES, V36, P175, DOI 10.3109/03008209709160219; Collier AP, 2000, J CRYST GROWTH, V208, P513, DOI 10.1016/S0022-0248(99)00507-2; DEMCHENKO AP, 1994, TOPICS FLUORESCENCE, P77; Dominguez-Vera JM, 2000, POULTRY SCI, V79, P901, DOI 10.1093/ps/79.6.901; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; Gautron J, 2001, J BIOL CHEM, V276, P39243, DOI 10.1074/jbc.M104543200; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; GEORGE D, 1985, ADV PROTEIN CHEM, V37, P1; Gower LA, 1998, J CRYST GROWTH, V191, P153, DOI 10.1016/S0022-0248(98)00002-5; GREENFIELD EM, 1984, AM ZOOL, V24, P925; Gregoire C, 2001, EMBO J, V20, P3313, DOI 10.1093/emboj/20.13.3313; HALLORAN BA, 1995, COMP BIOCHEM PHYS B, V111, P221, DOI 10.1016/0305-0491(94)00245-P; Hattan SJ, 2001, J BIOL CHEM, V276, P4461, DOI 10.1074/jbc.M006803200; HEANEY RK, 1976, BIOCHIM BIOPHYS ACTA, V451, P133, DOI 10.1016/0304-4165(76)90265-8; HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311; HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593; Hincke MT, 1999, J BIOL CHEM, V274, P32915, DOI 10.1074/jbc.274.46.32915; Hincke MT, 1995, CONNECT TISSUE RES, V31, P227, DOI 10.3109/03008209509010814; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; Killian CE, 1996, J BIOL CHEM, V271, P9150, DOI 10.1074/jbc.271.15.9150; KRAMPITZ G, 1988, ANGEW CHEM INT EDIT, V27, P1145, DOI 10.1002/anie.198811451; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavelin I, 2000, POULTRY SCI, V79, P1014, DOI 10.1093/ps/79.7.1014; LEACH RM, 1982, POULTRY SCI, V61, P2040, DOI 10.3382/ps.0612040; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; Lowenstam H.A., 1989, ON BIOMINERALIZATION; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann K, 1999, BIOCHEM MOL BIOL INT, V47, P997; Mann K, 1999, FEBS LETT, V463, P12, DOI 10.1016/S0014-5793(99)01586-0; MANN S, 1989, BIOMINERALIZATION CH, P35; Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029; PAIN HR, 1995, CURRENT PROTOCOLS PR; Panheleux M, 1999, BRIT POULTRY SCI, V40, P240, DOI 10.1080/00071669987665; Pikul, 1997, P 7 EUR S POZH POL, P66; ROBINSON AB, 1991, P NATL ACAD SCI USA, V88, P8880, DOI 10.1073/pnas.88.20.8880; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sarashina I, 2001, MAR BIOTECHNOL, V3, P362, DOI 10.1007/s10126-001-0013-6; SIMKISS K, 1961, BIOL REV, V36, P321, DOI 10.1111/j.1469-185X.1961.tb01292.x; Testeniere O, 2002, BIOCHEM J, V361, P327, DOI 10.1042/0264-6021:3610327; WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G; WEINER S, 1983, BIOCHEMISTRY-US, V22, P4139, DOI 10.1021/bi00286a023; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Weiner S, 2000, MAT SCI ENG C-BIO S, V11, P1, DOI 10.1016/S0928-4931(00)00141-7; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WOODY RW, 1996, CIRCULAR DICHROISM C, P123; WU TM, 1995, MATRIX BIOL, V14, P507, DOI 10.1016/0945-053X(95)90008-X	55	46	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2928	2936		10.1074/jbc.M201518200	http://dx.doi.org/10.1074/jbc.M201518200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12431998	Green Published, hybrid			2022-12-27	WOS:000180915000022
J	Xiong, HB; Zhu, C; Li, HX; Chen, F; Mayer, L; Ozato, K; Unkeless, JC; Plevy, SE				Xiong, HB; Zhu, C; Li, HX; Chen, F; Mayer, L; Ozato, K; Unkeless, JC; Plevy, SE			Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MOUSE PERITONEAL-MACROPHAGES; REGULATORY FACTOR FAMILY; TRANSCRIPTION FACTOR; ANTIMICROBIAL ACTIVITY; REACTIVE OXYGEN; FACTOR PU.1; KAPPA-B; ACTIVATION; INDUCTION	This study describes the role of the interferon (IFN) consensus sequence-binding protein (ICSBP or IRF-8) in iNOS gene expression by murine macrophages. An ICSBP binding site in the iNOS promoter region (-923 to -913) was identified using an electrophoretic mobility shift assay and chromatin co-immunoprecipitation. Overexpression of ICSBP greatly enhanced IFN-gamma-induced iNOS promoter activation in RAW264.7 cells, and IFN-gamma-induced iNOS promoter activation was abolished in ICSBP-/- macrophages. Furthermore, transduction of retrovirus-ICSBP in ICSBP-/- macrophages rescued IFN-gamma-induced iNOS gene expression. However, transduction of retrovirus-ICSBP in the absence of IFN-/- activation did not induce iNOS expression in either RAW264.7 cells or ICSBP-/- macrophages. Interestingly, ICSBP alone transduced into ICSBP-/- macrophages did not bind to IFN-stimulated response element site (-923 to -913) of the iNOS promoter region, although following activation with IFN-gamma, a DNA(.)protein complex was formed that contains ICSBP and IRF-1. Co-transduction of ICSBP with IRF-1 clearly induces nitric oxide production. In addition, interleukin-4 inhibits IFN-gamma-induced iNOS gene expression by attenuating the physical interaction of ICSBP with IRF-1. Complex formation of ICSBP with IRF-1 is essential for iNOS expression, and interleulkin-4 attenuates the physical interaction of ICSBP with IRF-1 resulting in the inhibition of INOS gene expression.	Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15261 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiong, HB (corresponding author), Mt Sinai Sch Med, Immunobiol Ctr, Box 1630,1 Gustave L Levy Pl, New York, NY 10029 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001310] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Contursi C, 2000, P NATL ACAD SCI USA, V97, P91, DOI 10.1073/pnas.97.1.91; DENG WL, 1994, J IMMUNOL, V153, P2130; DING AH, 1988, J IMMUNOL, V141, P2407; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Fehr T, 1997, J EXP MED, V185, P921, DOI 10.1084/jem.185.5.921; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; Gao JJ, 1997, J BIOL CHEM, V272, P1226, DOI 10.1074/jbc.272.2.1226; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim YM, 2000, J IMMUNOL, V165, P3198, DOI 10.4049/jimmunol.165.6.3198; LARNER AC, 1993, J IMMUNOL, V150, P1944; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; LOWENSTEIN CJ, 1993, P NATL ACAD SCI USA, V90, P9730, DOI 10.1073/pnas.90.20.9730; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Marietta M. A., 1994, CELL, V78, P927; MARTIN E, 1994, J EXP MED, V180, P977, DOI 10.1084/jem.180.3.977; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Nelson N, 1996, J IMMUNOL, V156, P3711; NELSON N, 1993, MOL CELL BIOL, V13, P588, DOI 10.1128/MCB.13.1.588; NUSSLER AK, 1993, J LEUKOCYTE BIOL, V54, P171, DOI 10.1002/jlb.54.2.171; Ohmori Y, 1997, J IMMUNOL, V159, P5474; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; POLITIS AD, 1994, J IMMUNOL, V152, P2270; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Salkowski CA, 1999, J IMMUNOL, V163, P1529; Saura M, 1999, J MOL BIOL, V289, P459, DOI 10.1006/jmbi.1999.2752; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wu CY, 1999, J IMMUNOL, V162, P807; XIE QW, 1994, J BIOL CHEM, V269, P28500; XIE QW, 1994, J BIOL CHEM, V269, P4705; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Xiong HB, 1996, CELL IMMUNOL, V172, P118, DOI 10.1006/cimm.1996.0222; Yamamoto H, 1999, ONCOGENE, V18, P1495, DOI 10.1038/sj.onc.1202427; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	53	57	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2271	2277		10.1074/jbc.M209583200	http://dx.doi.org/10.1074/jbc.M209583200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12429737	hybrid			2022-12-27	WOS:000180562000028
J	Yan, CH; Wang, H; Toh, Y; Boyd, DD				Yan, CH; Wang, H; Toh, Y; Boyd, DD			Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTASIS-ASSOCIATED GENE; MATRIX-METALLOPROTEINASE-9 GENE; TRANSCRIPTIONAL ACTIVATION; MESSENGER-RNA; SNF COMPLEX; GELATINASE; CELLS; CHROMATIN; PROTEIN; MMP-9	Although the expression of the metastases-associated gene MTA1 correlates with tumor metastases, its role in regulating type IV collagenase expression is unknown. Enforced MTA1 expression in HT1080 cells reduced basal and 12-myristate 13-acetate-induced 92-kDa type IV collagenase (MMP-9) protein/mRNA levels. DNase I hypersensitivity and PstI accessibility assays revealed multiple regions of the MMP-9 promoter (-650/-450 and -120/+1), showing reduced hypersensitivity in the MTA1-expressing cells. Chromatin immunoprecipitation assays demonstrated MTA1 binding to the distal region, which spans several regulatory cis elements. Coimmunoprecipitation and chromatin immunoprecipitation assay experiments revealed histone deacetylase 2 (HDAC2)-MTA1 protein-protein interactions and the MTA1-dependent recruitment of HDAC2 to the distal MMP-9 promoter region, yielding diminished histone H3/H4 acetylation. However, HDAC2 binding and H3/H4 acetylation at the proximal MMP-9 region were unaffected by MTA1 expression. Furthermore, trichostatin treatment only partially relieved MTA1-repressed MMP-9 expression, indicating a HDAC-insensitive component possibly involving the nucleosome-remodeling Mi2 activity, which was recruited to the promoter by MTA1. In summary, (a) MMP-9 adds to a short list of MTA1-regulated genes, which so far only includes c-myc and pS2, and (b) MTA1 binds to the MMP-9 promoter, thereby repressing expression of this type IV collagenase via histone-dependent and independent mechanisms.	Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Boyd, DD (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd,Box 179, Houston, TX 77030 USA.	dboyd@mdanderson.org		Yan, Chunhong/0000-0002-3974-7991	NATIONAL CANCER INSTITUTE [R01CA058311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010845] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA58311] Funding Source: Medline; NIDCR NIH HHS [R01 DE10845] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Anderson IC, 1996, CANCER RES, V56, P715; Armstrong JA, 1998, CURR OPIN GENET DEV, V8, P165, DOI 10.1016/S0959-437X(98)80137-8; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BERNHARD EJ, 1990, CANCER RES, V50, P3872; BERNHARD EJ, 1994, P NATL ACAD SCI USA, V91, P4293, DOI 10.1073/pnas.91.10.4293; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; COLLIER IE, 1991, GENOMICS, V9, P429, DOI 10.1016/0888-7543(91)90408-7; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cui Q, 2001, CYTOGENET CELL GENET, V93, P139, DOI 10.1159/000056969; DAVIS GE, 1990, CANCER RES, V50, P1113; De la Serna IL, 2000, MOL CELL BIOL, V20, P2839, DOI 10.1128/MCB.20.8.2839-2851.2000; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Futamura M, 1999, J HUM GENET, V44, P52, DOI 10.1007/s100380050107; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Himelstein BP, 1998, CLIN EXP METASTAS, V16, P169; Hua J, 1996, CANCER RES, V56, P5279; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; HUHTALA P, 1991, J BIOL CHEM, V266, P16485; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jiang Y, 2002, CANCER RES, V62, P1910; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lee JH, 1997, CANCER RES, V57, P2384; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Linn R, 1996, CYTOGENET CELL GENET, V72, P159, DOI 10.1159/000134175; Mahoney MG, 2002, ONCOGENE, V21, P2161, DOI 10.1038/sj.onc.1205277; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mohan R, 1998, J BIOL CHEM, V273, P25903, DOI 10.1074/jbc.273.40.25903; Munaut C, 1999, J BIOL CHEM, V274, P5588, DOI 10.1074/jbc.274.9.5588; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Naglich JG, 2001, CANCER RES, V61, P8480; NAKAJIMA M, 1993, CANCER RES, V53, P5802; NEAD MA, 1995, J INVEST DERMATOL, V105, P668, DOI 10.1111/1523-1747.ep12324367; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Nielsen BS, 1997, LAB INVEST, V77, P345; Nielsen BS, 1996, INT J CANCER, V65, P57, DOI 10.1002/(SICI)1097-0215(19960103)65:1<57::AID-IJC10>3.0.CO;2-F; PYKE C, 1993, AM J PATHOL, V142, P359; PYKE C, 1992, CANCER RES, V52, P1336; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sehgal I, 1999, MOL BIOL CELL, V10, P407, DOI 10.1091/mbc.10.2.407; STAHLEBACKDAHL M, 1993, AM J PATHOL, V142, P995; Toh Y, 2000, J EXP CLIN CANC RES, V19, P105; TOH Y, 1994, J BIOL CHEM, V269, P22958; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; WANG H, 1994, INT J CANCER, V58, P650, DOI 10.1002/ijc.2910580506; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; White A, 1998, ONCOGENE, V16, P3143, DOI 10.1038/sj.onc.1201852; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yu Q, 2000, GENE DEV, V14, P163	56	62	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2309	2316		10.1074/jbc.M210369200	http://dx.doi.org/10.1074/jbc.M210369200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12431981	hybrid			2022-12-27	WOS:000180562000033
J	Freiberg, A; Morona, R; Van den Bosch, L; Jung, C; Behlke, J; Carlin, N; Seckler, R; Baxa, U				Freiberg, A; Morona, R; Van den Bosch, L; Jung, C; Behlke, J; Carlin, N; Seckler, R; Baxa, U			The tailspike protein of Shigella phage Sf6 - A structural homolog of Salmonella phage p22 tailspike protein without sequence similarity in the beta-helix domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAD-BINDING DOMAIN; CRYSTAL-STRUCTURE; MODULAR ORGANIZATION; EVOLUTION; RECOGNITION; ENDORHAMNOSIDASE; POLYSACCHARIDE; DEGRADATION; NEWINGTON; ENZYMES	Bacteriophage Sf6 tailspike protein is functionally equivalent to the well characterized tailspike of Salmonella phage P22, mediating attachment of the viral particle to host cell-surface polysaccharide. However, there is significant sequence similarity between the two 70-kDa polypeptides only in the N-terminal putative capsid-binding domains. The major, central part of P22 tailspike protein, which forms a parallel beta-helix and is responsible for saccharide binding and hydrolysis, lacks detectable sequence homology to the Sf6 protein. After recombinant expression in Escherichia coli as a soluble protein, the Sf6 protein was purified to homogeneity. As shown by circular dichroism and Fourier transform infrared spectroscopy, the secondary structure contents of Sf6 and P22 tailspike proteins are very similar. Both tailspikes are thermostable homotrimers and resist denaturation by SDS at room temperature. The specific endorhamnosidase activities of Sf6 tailspike protein toward fluorescence-labeled dodeca-, deca-, and octasaccharide fragments of Shigella O-antigen suggest a similar active site topology of both proteins. Upon deletion of the N-terminal putative capsid-binding domain, the protein still forms a thermostable, SDS-resistant trimer that has been crystallized. The observations strongly suggest that the tailspike of phage Sf6 is a trimeric parallel beta-helix protein with high structural similarity to its functional homolog from phage P22.	Univ Potsdam, D-14476 Golm, Germany; Univ Adelaide, Dept Mol Biosci, Adelaide, SA 5005, Australia; Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; SBL Vaccin AB, Dept Mol Biol, S-10521 Stockholm, Sweden	University of Potsdam; University of Adelaide; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Seckler, R (corresponding author), Univ Potsdam, Karl Liebknecht Str 24-25, D-14476 Golm, Germany.	seckler@rz.uni-potsdam.de	Morona, Renato/B-7746-2013	Morona, Renato/0000-0001-7009-7440; Baxa, Ulrich/0000-0002-7263-5078; Freiberg, Alexander N/0000-0001-8413-8960				ACKERMANN HW, 1995, ARCH VIROL, V140, P1871, DOI 10.1007/BF01384350; ACKERMANN HW, 1974, INTERVIROLOGY, V3, P201, DOI 10.1159/000149758; Barbeyron T, 2000, J BIOL CHEM, V275, P35499, DOI 10.1074/jbc.M003404200; Baxa U, 1996, BIOPHYS J, V71, P2040, DOI 10.1016/S0006-3495(96)79402-X; Baxa U, 2001, BIOCHEMISTRY-US, V40, P5144, DOI 10.1021/bi0020426; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; Bhandari P, 1997, J BACTERIOL, V179, P4403, DOI 10.1128/jb.179.13.4403-4406.1997; Botstein D, 1980, Ann N Y Acad Sci, V354, P484, DOI 10.1111/j.1749-6632.1980.tb27987.x; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; CARLIN NIA, 1984, EUR J BIOCHEM, V139, P189, DOI 10.1111/j.1432-1033.1984.tb07993.x; CHEN BL, 1991, BIOCHEMISTRY-US, V30, P6260, DOI 10.1021/bi00239a026; Chua JEH, 1999, MICROBIOL-UK, V145, P1649, DOI 10.1099/13500872-145-7-1649; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; DANNER M, 1993, PROTEIN SCI, V2, P1869, DOI 10.1002/pro.5560021109; DANNER M, 1993, EUR J BIOCHEM, V215, P653, DOI 10.1111/j.1432-1033.1993.tb18076.x; DIAZ E, 1990, P NATL ACAD SCI USA, V87, P8125, DOI 10.1073/pnas.87.20.8125; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; GARCIA P, 1990, GENE, V86, P81, DOI 10.1016/0378-1119(90)90116-9; Greenberg M, 1995, J STRUCT BIOL, V115, P283, DOI 10.1006/jsbi.1995.1053; Heffron S, 1998, J STRUCT BIOL, V122, P223, DOI 10.1006/jsbi.1998.3978; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; ISRAEL V, 1972, J VIROL, V10, P1152, DOI 10.1128/JVI.10.6.1152-1158.1972; IWASHITA S, 1975, VIROLOGY, V68, P27, DOI 10.1016/0042-6822(75)90144-0; IWASHITA S, 1976, EUR J BIOCHEM, V65, P87, DOI 10.1111/j.1432-1033.1976.tb10392.x; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C; JUNG C, 1992, BIOCHEMISTRY-US, V31, P12855, DOI 10.1021/bi00166a021; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khurana R, 2000, BIOPHYS J, V78, P994, DOI 10.1016/S0006-3495(00)76657-4; LINDBERG AA, 1978, J VIROL, V27, P38, DOI 10.1128/JVI.27.1.38-44.1978; Michel G, 2001, J BIOL CHEM, V276, P40202, DOI 10.1074/jbc.M100670200; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; Pace C N, 1986, Methods Enzymol, V131, P266; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; RESKE K, 1973, EUR J BIOCHEM, V36, P167, DOI 10.1111/j.1432-1033.1973.tb02897.x; Scholl D, 2002, J BACTERIOL, V184, P2833, DOI 10.1128/JB.184.10.2833-2836.2002; Seckler R, 1998, J STRUCT BIOL, V122, P216, DOI 10.1006/jsbi.1998.3974; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; SUSSKIND MM, 1978, MICROBIOL REV, V42, P385, DOI 10.1128/MMBR.42.2.385-413.1978; SVENSON SB, 1979, J VIROL, V32, P583, DOI 10.1128/JVI.32.2.583-592.1979; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WANG CC, 1995, J BIOL CHEM, V270, P26558, DOI 10.1074/jbc.270.44.26558; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7	49	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1542	1548		10.1074/jbc.M205294200	http://dx.doi.org/10.1074/jbc.M205294200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424253	hybrid			2022-12-27	WOS:000180462200024
J	Laurie, AD; Bernardo, LMD; Sze, CC; Skarfstad, E; Szalewska-Palasz, A; Nystrom, T; Shingler, V				Laurie, AD; Bernardo, LMD; Sze, CC; Skarfstad, E; Szalewska-Palasz, A; Nystrom, T; Shingler, V			The role of the alarmone (p)ppGpp in sigma(N) competition for core RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR DMPR; ESCHERICHIA-COLI; IN-VIVO; GUANOSINE TETRAPHOSPHATE; STRINGENT RESPONSE; PROMOTER; PPGPP; INITIATION; EXPRESSION; REGULATOR	Some promoters, including the DmpR-controlled sigma(N)-dependent Po promoter, are effectively rendered silent in cells lacking the nutritional alarmone (p)ppGpp. Here we demonstrate that four mutations within the housekeeping sigma(D)-factor can restore sigma(N)-dependent Po transcription in the absence of (p)ppGpp. Using both in vitro and in vivo transcription competition assays, we show that all the four sigma(D) mutant proteins are defective in their ability to compete with sigma(N) for available core RNA polymerase and that the magnitude of the defect reflects the hierarchy of restoration of transcription from Po in (p)ppGpp-deficient cells. Consistently, underproduction of sigma(D) or overproduction of the anti-sigma(D) protein Rsd were also found to allow (p)ppGpp-independent transcription from the sigma(N)-Po promoter. Together with data from the direct effects of (p)ppGpp on sigma(N)-dependent Po transcription and sigma-factor competition, the results support a model in which (p)ppGpp serves as a master global regulator of transcription by differentially modulating alternative sigma-factor competition to adapt to changing cellular nutritional demands.	Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden	Umea University; University of Gothenburg	Shingler, V (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	victoria.shingler@molbiol.umu.se	Sze, Chun Chau/A-2200-2011; Szalewska-Palasz, Agnieszka/AAI-4826-2020	Sze, Chun Chau/0000-0003-2245-9050; Szalewska-Palasz, Agnieszka/0000-0001-8013-4057; Shingler, Victoria/0000-0002-7349-1678				Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Carmona M, 2000, J BACTERIOL, V182, P4711, DOI 10.1128/JB.182.17.4711-4718.2000; CASHEL M, 1974, ANAL BIOCHEM, V57, P100, DOI 10.1016/0003-2697(74)90056-6; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Chatterji D, 1998, GENES CELLS, V3, P279, DOI 10.1046/j.1365-2443.1998.00190.x; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Gallegos MT, 1999, J MOL BIOL, V288, P539, DOI 10.1006/jmbi.1999.2704; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Gourse RL, 1998, COLD SPRING HARB SYM, V63, P131, DOI 10.1101/sqb.1998.63.131; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; GROSSMAN AD, 1985, J MOL BIOL, V186, P357, DOI 10.1016/0022-2836(85)90110-X; HERNANDEZ VJ, 1995, J MOL BIOL, V252, P536; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; Kvint K, 2000, MOL MICROBIOL, V35, P435, DOI 10.1046/j.1365-2958.2000.01714.x; Kvint K, 2000, J BIOL CHEM, V275, P14795, DOI 10.1074/jbc.C000128200; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; LANGE R, 1991, J BACTERIOL, V173, P4474, DOI 10.1128/JB.173.14.4474-4481.1991; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Ng LC, 1996, J BIOL CHEM, V271, P17281, DOI 10.1074/jbc.271.29.17281; Nichols BP, 1998, J BACTERIOL, V180, P6408; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; RIGGS DL, 1986, P NATL ACAD SCI USA, V83, P9333, DOI 10.1073/pnas.83.24.9333; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAUDER B, 1987, GENE, V52, P279, DOI 10.1016/0378-1119(87)90054-0; Scott DJ, 2000, BIOCHEM J, V352, P539, DOI 10.1042/0264-6021:3520539; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; SHINGLER V, 1995, MOL MICROBIOL, V17, P505, DOI 10.1111/j.1365-2958.1995.mmi_17030505.x; SIHAVY TJ, 1984, EXPT GENE FUSIONS; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Sze CC, 2002, J BACTERIOL, V184, P760, DOI 10.1128/JB.184.3.760-770.2002; Sze CC, 1999, MOL MICROBIOL, V31, P1217, DOI 10.1046/j.1365-2958.1999.01264.x; Sze CC, 2001, J BACTERIOL, V183, P2842, DOI 10.1128/JB.183.9.2842-2851.2001; Sze CC, 1996, J BACTERIOL, V178, P3727, DOI 10.1128/jb.178.13.3727-3735.1996; Toulokhonov II, 2001, J BIOL CHEM, V276, P1220, DOI 10.1074/jbc.M007184200; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wikstrom P, 2001, J MOL BIOL, V314, P971, DOI 10.1006/jmbi.2000.5212; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; ZUKOWSKI MM, 1983, P NATL ACAD SCI-BIOL, V80, P1101, DOI 10.1073/pnas.80.4.1101	65	87	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1494	1503		10.1074/jbc.M209268200	http://dx.doi.org/10.1074/jbc.M209268200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421818	hybrid			2022-12-27	WOS:000180462200018
J	Okada, S; Ouchi, T				Okada, S; Ouchi, T			Cell cycle differences in DNA damage-induced BRCA1 phosphorylation affect its subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROSOME AMPLIFICATION; NUCLEAR PHOSPHOPROTEIN; OVARIAN-CANCER; IN-VIVO; KINASE; ATM; CHECKPOINT; BREAST; IDENTIFICATION; PROTEIN	Phosphorylation of BRCA1 tumor suppressor protein is regulated during the cell cycle and in response to DNA damage. Several Ser/Thr kinases have been implicated in BRCA1 phosphorylation, including ATM/ATR, cdk2, and hChk2 kinases. In this study, phospho-Ser-specific antibodies recognizing Ser-988, -1423, -1497, and -1524 residues of BRCA1 were employed to study BRCA1 phosphorylation during the S and G2/M phases under conditions of DNA damage. We observed that IR (ionizing radiation) treatment induced phosphorylation of Ser-988/Ser-1524 during the S phase and of Ser-988/Ser-1423 during the G2/M phase. UV treatment induced phosphorylation of Ser-988 during the S phase and of Ser-1423 during the G2/M phase. Phosphorylation of serines 1423 and -1524 was not induced in HCC1937 breast cancer cells, which contain mutant BRCA1 protein. Confocal microscopy revealed that unphosphorylated BRCA1 localizes on chromosomes from metaphase through telophase, whereas Ser-988-phosphorylated BRCA1 resides in the inner chromosomal structure, centrosome, and the cleavage furrow during prophase through telophase. We also found that Ser-988-phosphorylated BRCA1 relocalizes to the perinuclear region when cells are subjected to IR or UV radiation in the S phase. These results reinforce a model wherein phosphorylation of specific residues of BRCA1 after DNA damage affects its localization and function.	CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Ouchi, T (corresponding author), CUNY Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, Box 1130,1 Gustave L Levy Pl, New York, NY 10029 USA.				NCI NIH HHS [CA90631, CA79892] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090631, R01CA079892] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen JJ, 2000, CANCER RES, V60, P5037; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen YM, 1996, CANCER RES, V56, P3168; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Deng CX, 2000, BIOESSAYS, V22, P728; Futamura M, 2000, CANCER RES, V60, P1531; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Hsu LC, 2001, CANCER RES, V61, P7713; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Tomlinson GE, 1998, CANCER RES, V58, P3237; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	33	67	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2015	2020		10.1074/jbc.M208685200	http://dx.doi.org/10.1074/jbc.M208685200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427729	hybrid			2022-12-27	WOS:000180462200086
J	Siddhanta, A; Radulescu, A; Stankewich, MC; Morrow, JS; Shields, D				Siddhanta, A; Radulescu, A; Stankewich, MC; Morrow, JS; Shields, D			Fragmentation of the golgi apparatus - A role for beta III spectrin and synthesis of phosphatidylinositol 4,5-bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASCENT SECRETORY VESICLES; CASEIN KINASE-I; PHOSPHATIDIC-ACID; ENDOPLASMIC-RETICULUM; MEMBRANE SKELETON; ENDOCRINE-CELLS; PHOSPHOLIPASE-D; EXCHANGE FACTOR; MATRIX PROTEIN; COMPLEX	Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) synthesis has been implicated in maintaining the function of the Golgi apparatus. Here we demonstrate that the inhibition of PtdIns(4,5)P-2 synthesis in vitro in response to primary alcohol treatment and the kinetics of Golgi fragmentation in vivo were very rapid and tightly coupled. Preloading Golgi membranes with short chain phosphatidic acid abrogated the alcohol-mediated inhibition of PtdIns(4,5)P-2 synthesis in vitro. We also show that fragmentation of the Golgi apparatus in response to diminished Ptdlns(4,5)P-2 synthesis correlated with both the phosphorylation of a Golgi form of betaIII spectrin, a Ptdlns(4,5)P-2-interacting protein, and changes in its intracellular redistribution. The data are consistent with a model suggesting that the decreased Ptdlns(4,5)P-2 synthesis and the phosphorylation state of betaIII spectrin modulate the structural integrity of the Golgi apparatus.	Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Biol Struct, Bronx, NY 10461 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yale University	Shields, D (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NCI NIH HHS [P30CA13330] Funding Source: Medline; NIDDK NIH HHS [DK21860, DK38979, DK43812] Funding Source: Medline; NIGMS NIH HHS [T32 GM07491] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038979, R01DK043812, R01DK021860, R37DK021860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Austin CD, 1996, J CELL BIOL, V135, P1471, DOI 10.1083/jcb.135.6.1471; BAZENET CE, 1990, J BIOL CHEM, V265, P7369; Beck KA, 1998, BBA-MOL CELL RES, V1404, P153, DOI 10.1016/S0167-4889(98)00054-8; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Beck KA, 1997, J CELL SCI, V110, P1239; BROCKMAN JL, 1991, J BIOL CHEM, V266, P2508; Chen YG, 1997, J CELL BIOL, V138, P495, DOI 10.1083/jcb.138.3.495; Choukroun GJ, 2000, J CLIN INVEST, V106, P983, DOI 10.1172/JCI8914; DASCHER C, 1994, J BIOL CHEM, V269, P1437; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; FOWLER VM, 1992, J CELL BIOL, V119, P1559, DOI 10.1083/jcb.119.6.1559; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; GROSS SD, 1995, J CELL BIOL, V130, P711, DOI 10.1083/jcb.130.3.711; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; LUCOCQ J, 1991, J CELL SCI, V100, P753; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Monier S, 1998, J CELL SCI, V111, P3427; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Shields D, 1999, CURR OPIN CELL BIOL, V11, P489, DOI 10.1016/S0955-0674(99)80070-2; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Sohda M, 1998, J BIOL CHEM, V273, P5385, DOI 10.1074/jbc.273.9.5385; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Sweeney DA, 2002, J BIOL CHEM, V277, P3030, DOI 10.1074/jbc.M104639200; TOCKER A, 1997, NATURE, V387, P673; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557	45	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1957	1965		10.1074/jbc.M209137200	http://dx.doi.org/10.1074/jbc.M209137200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12411436	hybrid			2022-12-27	WOS:000180462200079
J	Moos, PJ; Edes, K; Cassidy, P; Massuda, E; Fitzpatrick, FA				Moos, PJ; Edes, K; Cassidy, P; Massuda, E; Fitzpatrick, FA			Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; KAPPA-B KINASE; CYCLOPENTENONE PROSTAGLANDINS; COLORECTAL-CANCER; GROWTH-INHIBITION; NUCLEAR EXCLUSION; BINDING-SITES; BREAST-CANCER; DNA-BINDING; MECHANISMS	Tumor suppressor p53 exhibits an enigmatic phenotype in cells exposed to electrophilic, cyclopentenone prostaglandins of the A and J series. Namely, cells harboring a wild-type p53 gene accumulate p53 protein that is conformationally and functionally impaired. This occurs via an unknown molecular mechanism. We report that electrophilic cyclopentenone prostaglandins covalently modify and inhibit thioredoxin reductase, a selenoprotein that governs p53 and other redox-sensitive transcription factors. This mechanism accounts fully for the unusual p53 phenotype in cells exposed to electrophilic prostaglandins. Based on this mechanism we derived, tested, and affirmed several predictions regarding the kinetics of p53 inactivation; the protective effects of selenium; the structure-activity relationships for inhibition of thioredoxin reductase and impairment of p53 by electrophilic lipids; the susceptibility of hypoxia-inducible factor to inactivation by electrophilic lipids; and the equivalence of chemical inactivation of p53 to deletion of a p53 allele. Chemical precepts dictate that other electrophilic agents should also inhibit thioredoxin reductase and impair its governance of redox-sensitive proteins. Our results provide a novel framework to understand how endogenous and exogenous electrophiles might participate in carcinogenesis; how selenoproteins and selenium might confer protection against cancer; how certain tumors might acquire their paradoxical p53 phenotype; and how chronic inflammation might heighten the risk for cancer.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fitzpatrick, FA (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.			Moos, Philip/0000-0002-8223-442X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026730] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI26730] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BASU AK, 1988, CHEM RES TOXICOL, V1, P53, DOI 10.1021/tx00001a010; BASU AK, 1983, CARCINOGENESIS, V4, P331, DOI 10.1093/carcin/4.3.331; BASU AK, 1984, CANCER RES, V44, P2848; Berggren M, 1997, ANTICANCER RES, V17, P3377; Borresen-Dale AL, 1998, CLIN CANCER RES, V4, P203; BOSARI S, 1995, AM J PATHOL, V147, P790; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Casso D, 1996, MOL GEN GENET, V252, P518, DOI 10.1007/BF02172398; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; FITZPATRICK FA, 1981, BIOCHEMISTRY-US, V20, P6129, DOI 10.1021/bi00524a033; Fitzpatrick FA, 2001, INT IMMUNOPHARMACOL, V1, P1651, DOI 10.1016/S1567-5769(01)00102-3; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gallegos A, 1997, CANCER RES, V57, P4965; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GOH HS, 1995, CANCER RES, V55, P5217; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; HONN KV, 1985, BIOCHEM BIOPH RES CO, V129, P34, DOI 10.1016/0006-291X(85)91398-1; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Khan QA, 1997, CARCINOGENESIS, V18, P2313, DOI 10.1093/carcin/18.12.2313; Kubbutat MHG, 1998, MOL MED TODAY, V4, P250, DOI 10.1016/S1357-4310(98)01260-X; LEGROS Y, 1994, ONCOGENE, V9, P3689; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lou MA, 1997, BRIT J CANCER, V75, P746, DOI 10.1038/bjc.1997.132; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Moos PJ, 1998, CELL GROWTH DIFFER, V9, P687; Moos PJ, 2000, P NATL ACAD SCI USA, V97, P9215, DOI 10.1073/pnas.160241897; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; Parker J, 1995, PROSTAGLANDINS, V50, P359, DOI 10.1016/0090-6980(95)00136-0; PARKER J, 1992, BIOCHEM PHARMACOL, V43, P1053, DOI 10.1016/0006-2952(92)90612-M; Pearson GD, 1998, J BIOL CHEM, V273, P5431, DOI 10.1074/jbc.273.10.5431; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; STENMARKASKMALM M, 1994, EUR J CANCER, V30A, P175, DOI 10.1016/0959-8049(94)90082-5; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sun XF, 1996, EUR J CANCER, V32A, P1963, DOI 10.1016/0959-8049(96)00205-5; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; Webley KM, 2000, J PATHOL, V191, P361	49	135	137	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					745	750		10.1074/jbc.M211134200	http://dx.doi.org/10.1074/jbc.M211134200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12424231	hybrid			2022-12-27	WOS:000180321900009
J	Wolfe, MD; Lipscomb, JD				Wolfe, MD; Lipscomb, JD			Hydrogen peroxide-coupled cis-diol formation catalyzed by naphthalene 1,2-dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; DIOXYGENASE; DIHYDROXYLATION; INTERMEDIATE; ACTIVATION; COMPONENT; SITE	Naphthalene 1,2-dioxygenase (NDOS) catalyzes the NAD(P)H and O-2-dependent oxidation of naphthalene to (+)-cis-(1R,2S)-dihydroxy-1,2-dihydronaphthalene. NDOS consists of three protein components: a flavo-[2Fe-2S] reductase (NDR), a ferredoxin electron transfer protein (NDF), and an (alphabeta)(3) oxygenase (NDO) containing a mononuclear iron site and a Rieske-type [2Fe-2S] cluster in each a-subunit. The active site is built across a subunit-subunit boundary, and each subunit contributes one type of metal center. Our previous studies have shown that NDO with both metal centers reduced is capable of an O-2-coupled single turnover to yield the correct cis-diol product in the absence of the NDR and NDF components (Wolfe, M. D., Parales, J. V., Gibson, D. T., and Lipscomb, J. D. (2001) J. Biol. Chem. 276, 1945-1953). It is shown here that addition of H2O2 to NDO allows reaction with naphthalene to rapidly yield the correct product in a "peroxide shunt" reaction that does not require a reduced Rieske cluster. The mononuclear Fe2+ center is oxidized during turnover, while the Rieske cluster remains in the oxidized state. Peroxide shunt turnover in the presence of O-18-labeled H2O2, H2O, or O-2 shows that both oxygen atoms in the product derive primarily from H2O2. The peroxide shunt halts after one turnover despite the presence of excess H2O2 and naphthalene, but this is not the result of enzyme inactivation. Rather, it appears that the product cannot be released when the mononuclear iron is in the Fe3+ state, blocking a second turnover. This work supports the hypotheses that the cis-dihydroxylation activity of NDOS requires only the NDO component, that a peroxo intermediate is formed during normal catalysis, and that product release requires an additional reducing equivalent beyond those necessary for the first turnover.	Univ Minnesota, Dept Biochem Mol Biol & Cellular, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lipscomb, JD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Cellular, 6-155 Jackson Hall,321 Church St, Minneapolis, MN 55455 USA.	lipsc001@tc.umn.edu		Lipscomb, John/0000-0002-8158-5594	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008277, R37GM024689, R01GM024689] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM024689, R01 GM024689, GM24689, GM08277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON KK, 1991, NEW J CHEM, V15, P411; Bassan A, 2002, J AM CHEM SOC, V124, P11056, DOI 10.1021/ja026488g; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Chen K, 1999, ANGEW CHEM INT EDIT, V38, P2227, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2227::AID-ANIE2227>3.0.CO;2-B; Chen K, 1999, CHEM COMMUN, P1375, DOI 10.1039/a901678c; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Costas M, 2001, J AM CHEM SOC, V123, P6722, DOI 10.1021/ja015601k; FROLAND WA, 1992, J BIOL CHEM, V267, P17588; HRYCAY EG, 1976, EUR J BIOCHEM, V61, P43, DOI 10.1111/j.1432-1033.1976.tb09995.x; JEFFREY AM, 1975, BIOCHEMISTRY-US, V14, P575, DOI 10.1021/bi00674a018; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Lee K, 1999, J BACTERIOL, V181, P2719, DOI 10.1128/JB.181.9.2719-2725.1999; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; McMurry T. J., 1986, CYTOCHROME P450 STRU, P1; Parales RE, 2000, J BACTERIOL, V182, P1641, DOI 10.1128/JB.182.6.1641-1649.2000; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Tierney DL, 1999, BIOCHEMISTRY-US, V38, P11051, DOI 10.1021/bi990431y; Twilfer H, 2000, EUR J BIOCHEM, V267, P5926, DOI 10.1046/j.1432-1327.2000.01662.x; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; WHITTAKER JW, 1990, METHOD ENZYMOL, V188, P82; Wolfe MD, 2002, BIOCHEMISTRY-US, V41, P9611, DOI 10.1021/bi025912n; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	24	98	98	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					829	835		10.1074/jbc.M209604200	http://dx.doi.org/10.1074/jbc.M209604200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12403773	hybrid			2022-12-27	WOS:000180321900020
J	Gouveia, AM; Guimaraes, CP; Oliveira, ME; Reguenga, C; Sa-Miranda, C; Azevedo, JE				Gouveia, AM; Guimaraes, CP; Oliveira, ME; Reguenga, C; Sa-Miranda, C; Azevedo, JE			Characterization of the peroxisomal cycling receptor, Pex5p, using a cell-free in vitro import system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL RECEPTOR; HUMAN PTS1 RECEPTOR; MEMBRANE-PROTEIN; FUNCTIONAL COMPLEMENTATION; SACCHAROMYCES-CEREVISIAE; DOCKING SITE; RAT-LIVER; BIOGENESIS; MATRIX; YEAST	According to current models of peroxisomal biogenesis, Pex5p cycles between the cytosol and the peroxisome transporting newly synthesized proteins to the organelle matrix. However, little is known regarding the mechanism of this pathway. Here, we show that Pex5p enters and exits the peroxisomal compartment in a process that requires ATP. Insertion of Pex5p into the peroxisomal membrane is blocked by anti-Pex14p IgGs. At the peroxisomal level, two Pex14p-associated populations of Pex5p could be resolved, stage 2 and stage 3 Pex5p, both exposing the majority of their masses into the organelle lumen. Stage 3 Pex5p can be easily detected only under ATP-limiting conditions; in the presence of ATP it leaves the peroxisomal compartment rapidly. Our data suggest that translocation of PTS1-containing proteins across the peroxisomal membrane occurs concomitantly with formation of the Pex5p-Pex14p membrane complex and that this is probably the site from which Pex5p leaves the peroxisomal compartment.	Inst Biol Mol & Celular, P-4150180 Oporto, Portugal; Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal; Inst Genet Med Jacinto Magalhaes, P-4050466 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Azevedo, JE (corresponding author), Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Gouveia, Alexandra/P-3525-2016; sá Miranda, Maria Clara/K-3920-2013; Azevedo, Jorge E/A-4113-2008	Gouveia, Alexandra/0000-0001-8784-4246; sá Miranda, Maria Clara/0000-0003-0123-5525; Azevedo, Jorge E/0000-0001-7714-5302; Oliveira, Marcia/0000-0003-2437-2004; Reguenga, Carlos/0000-0003-1219-9961				Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Albertini M, 2001, EUR J CELL BIOL, V80, P257, DOI 10.1078/0171-9335-00164; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; LUERS G, 1993, J CELL BIOL, V121, P1271, DOI 10.1083/jcb.121.6.1271; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Sacksteder KA, 2000, ANNU REV GENET, V34, P623, DOI 10.1146/annurev.genet.34.1.623; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Titorenko VI, 2000, CELL BIOCHEM BIOPHYS, V32, P21, DOI 10.1385/CBB:32:1-3:21; TSUKAMOTO T, 1995, NAT GENET, V11, P395, DOI 10.1038/ng1295-395; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; Will GK, 1999, MOL CELL BIOL, V19, P2265; ZUURENDONK PF, 1974, BIOCHIM BIOPHYS ACTA, V333, P393, DOI 10.1016/0005-2728(74)90022-X	33	73	73	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					226	232		10.1074/jbc.M209498200	http://dx.doi.org/10.1074/jbc.M209498200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12411433	hybrid			2022-12-27	WOS:000180255700030
J	Paoli, P; Pazzagli, L; Giannoni, E; Caselli, A; Manao, G; Camici, G; Ramponi, G				Paoli, P; Pazzagli, L; Giannoni, E; Caselli, A; Manao, G; Camici, G; Ramponi, G			A nucleophilic catalysis step is involved in the hydrolysis of aryl phosphate monoesters by human CT acylphosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; MUSCLE ACYLPHOSPHATASE; STEADY-STATE; EXPRESSION; DIFFERENTIATION; ISOENZYMES; MECHANISM; RESIDUES; NUCLEUS; CELLS	Acylphosphatase, one of the smallest enzymes, is expressed in all organisms. It displays hydrolytic activity on acyl phosphates, nucleoside di- and triphosphates, aryl phosphate monoesters, and polynucleotides, with acyl phosphates being the most specific substrates in vitro. The mechanism of catalysis for human acylphosphatase (the organ-common type isoenzyme) was investigated using both aryl phosphate monoesters and acyl phosphates as substrates. The enzyme is able to catalyze phosphotransfer from p-nitrophenyl phosphate to glycerol (but not from benzoyl phosphate to glycerol), as well as the inorganic phosphate-(H2O)-O-18 oxygen exchange reaction in the absence of carboxylic acids or phenols. In short, our findings point to two different catalytic pathways for aryl phosphate monoesters and acyl phosphates. In particular, in the aryl phosphate monoester hydrolysis pathway, an enzyme-phosphate covalent intermediate is formed, whereas the hydrolysis of acyl phosphates seems a more simple process in which the Michaelis complex is attacked directly by a water molecule generating the reaction products. The formation of an enzyme-phosphate covalent complex is consistent with the experiments of isotope exchange and transphosphorylation from substrates to glycerol, as well as with the measurements of the Bronsted free energy relationships using a panel of aryl phosphates with different structures. His-25 involvement in the formation of the enzyme-phosphate covalent complex during the hydrolysis of aryl phosphate monoesters finds significant confirmation in experiments performed with the H25Q mutated enzyme.	Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy	University of Florence	Camici, G (corresponding author), Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.		Paoli, Paolo/A-2040-2014; Caselli, Anna/O-7512-2014; Giannoni, Elisa/AAE-2092-2020; Camici, Giovanni/H-1631-2018	Paoli, Paolo/0000-0001-6448-7266; Caselli, Anna/0000-0001-8140-3415; Giannoni, Elisa/0000-0001-7136-1098; Camici, Giovanni/0000-0002-0523-0695				BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; BERTI A, 1992, ARCH BIOCHEM BIOPHYS, V294, P261, DOI 10.1016/0003-9861(92)90166-T; CAMICI G, 1976, EXPERIENTIA, V32, P535, DOI 10.1007/BF01920843; Cecchi C, 2000, MOL CELL BIOCHEM, V211, P95, DOI 10.1023/A:1007162717292; Chiarugi P, 1997, CELL DEATH DIFFER, V4, P334, DOI 10.1038/sj.cdd.4400230; CHIARUGI P, 1995, BIOCHEM J, V311, P567, DOI 10.1042/bj3110567; Chiarugi P, 1997, BIOCHEM BIOPH RES CO, V231, P717, DOI 10.1006/bbrc.1997.6176; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; FERSHT A, 1999, STRUCTURE MECH PROTE, P216; FIASCHI T, 1995, FEBS LETT, V367, P145, DOI 10.1016/0014-5793(95)00553-L; Giannoni E., 2000, Molecular Cell Biology Research Communications, V3, P264, DOI 10.1006/mcbr.2000.0228; NASSI P, 1991, J BIOL CHEM, V266, P10867; NEDIANI C, 1991, BIOCHEM INT, V24, P959; Paoli P, 1997, BIOCHEM J, V327, P177, DOI 10.1042/bj3270177; Paoli P, 1997, BIOCHEM J, V328, P855, DOI 10.1042/bj3280855; RAMPONI G, 1966, EXPERIENTIA, V22, P705, DOI 10.1007/BF01901326; Raugei G, 1999, BIOCHEM MOL BIOL INT, V47, P127; Raugei G, 1996, BIOTECHNOL APPL BIOC, V23, P273; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Taddei N, 1996, BIOCHEMISTRY-US, V35, P7077, DOI 10.1021/bi952900b; TADDEI N, 1994, BBA-PROTEIN STRUCT M, V1208, P75, DOI 10.1016/0167-4838(94)90161-9; Thunnissen MMGM, 1997, STRUCTURE, V5, P69, DOI 10.1016/S0969-2126(97)00167-6; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6; ZHANG ZY, 1994, J BIOL CHEM, V269, P8140; ZHANG ZY, 1991, J BIOL CHEM, V266, P1516; Zhao Y, 1998, J BIOL CHEM, V273, P5484, DOI 10.1074/jbc.273.10.5484	26	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					194	199		10.1074/jbc.M206918200	http://dx.doi.org/10.1074/jbc.M206918200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409302	hybrid, Green Published			2022-12-27	WOS:000180255700026
J	Mangani, S; Meyer-Klaucke, W; Moir, AJG; Ranieri-Raggi, M; Martini, D; Raggi, A				Mangani, S; Meyer-Klaucke, W; Moir, AJG; Ranieri-Raggi, M; Martini, D; Raggi, A			Characterization of the zinc-binding site of the histidine-proline-rich glycoprotein associated with rabbit skeletal muscle AMP deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY-CHROMATOGRAPHY; SUBSTRATE-SPECIFICITY; MECHANISM; DOMAIN; SERUM; PH; AMINOHYDROLASE; PURIFICATION; INHIBITION; CATALYSIS	The AMP deaminase-associated variant of histidine-proline-rich glycoprotein (HPRG) is isolated from rabbit skeletal muscle by a modification of the protocol previously used for the purification of AMP deaminase. This procedure yields highly pure HPRG suitable for investigation by x-ray absorption spectroscopy of the zinc-binding behavior of the protein. X-ray absorption spectroscopy analysis of a 2:1 zinc-HPRG complex shows that zinc is bound to the protein, most probably in a dinuclear cluster where each Zn2+ ion is coordinated, on average, by three histidine ligands and one heavier ligand, likely a sulfur from a cysteine. 11 cysteines of HPRG from different species are totally conserved, suggesting that five disulfide bridges are essential for the proper folding of the protein. At least another cysteine is present at different positions in the histidine-proline-rich domain of HPRG in all species, suggesting that this cysteine is the candidate for zinc ligation in the muscle variant of HPRG. The same conclusion is likely to be true for the six histidines used by the protein as zinc ligands. The presence in muscle HPRG of a specific zinc-binding site permits us to envisage the addition of HPRG into the family of metallochaperones. In this view, HPRG may enhance the in vivo stability of metalloenzymes such as AMP deaminase.	Univ Pisa, Dipartimento Sci Uomo & Ambiente, I-56126 Pisa, Italy; Univ Siena, Dipartimento Chim, I-53100 Siena, Italy; European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; Univ Sheffield, Dept Mol Biol & Biotechnol, Krebs Inst, Sheffield S10 2UH, S Yorkshire, England	University of Pisa; University of Siena; European Molecular Biology Laboratory (EMBL); University of Sheffield	Raggi, A (corresponding author), Univ Pisa, Dipartimento Sci Uomo & Ambiente, Via Roma 55, I-56126 Pisa, Italy.	araggi@bm.med.unipi.it	Meyer-Klaucke, Wolfram/G-1148-2010	Raggi, Antonio/0000-0002-8727-8106				Benini S, 1998, J BIOL INORG CHEM, V3, P268, DOI 10.1007/s007750050231; Benini S, 1996, EUR J BIOCHEM, V239, P61, DOI 10.1111/j.1432-1033.1996.0061u.x; Benning MM, 2000, J BIOL CHEM, V275, P30556, DOI 10.1074/jbc.M003852200; Binsted N, 1996, J SYNCHROTRON RADIAT, V3, P185, DOI 10.1107/S0909049596005651; Borza DB, 1996, BIOCHEMISTRY-US, V35, P1925, DOI 10.1021/bi952061t; Clark-Baldwin K, 1998, J AM CHEM SOC, V120, P8401, DOI 10.1021/ja980580o; GUTHANS SL, 1982, ARCH BIOCHEM BIOPHYS, V218, P320, DOI 10.1016/0003-9861(82)90350-2; Hulett MD, 2000, IMMUNOL CELL BIOL, V78, P280, DOI 10.1046/j.1440-1711.2000.00940.x; KOIDE T, 1987, FEBS LETT, V216, P17, DOI 10.1016/0014-5793(87)80748-2; KOIDE T, 1986, BIOCHEMISTRY-US, V25, P2220, DOI 10.1021/bi00356a055; LEGENDRE N, 1989, PRACTICAL GUIDE TO PROTEIN AND PEPTIDE PURIFICATION FOR MICROSEQUENCING, P49; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martini D, 2001, BBA-PROTEIN STRUCT M, V1544, P123, DOI 10.1016/S0167-4838(00)00211-9; MERKLER DJ, 1993, BIOCHEMISTRY-US, V32, P5792, DOI 10.1021/bi00073a011; MORGAN WT, 1981, BIOCHEMISTRY-US, V20, P1054, DOI 10.1021/bi00508a002; MORGAN WT, 1985, BIOCHEMISTRY-US, V24, P1496, DOI 10.1021/bi00327a031; Mori S, 2000, ARCH BIOCHEM BIOPHYS, V383, P191, DOI 10.1006/abbi.2000.2032; NOLTING HF, 1993, EXPROG EMBL EXAFS DA; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; PETERSON CB, 1987, J BIOL CHEM, V262, P7567; PETTIFER RF, 1985, J APPL CRYSTALLOGR, V18, P404, DOI 10.1107/S0021889885010627; RAGGI A, 1970, FEBS LETT, V10, P101, DOI 10.1016/0014-5793(70)80426-4; Ralle M, 1999, BIOCHEMISTRY-US, V38, P7185, DOI 10.1021/bi982885l; Ranieri-Raggi M, 2003, BBA-PROTEINS PROTEOM, V1645, P81, DOI 10.1016/S1570-9639(02)00527-7; RANIERIRAGGI M, 1990, BIOCHEM J, V272, P755, DOI 10.1042/bj2720755; RANIERIRAGGI M, 1980, BIOCHEM J, V189, P367, DOI 10.1042/bj1890367; RanieriRaggi M, 1997, BIOCHEM J, V326, P641, DOI 10.1042/bj3260641; RANIERIRAGGI M, 1979, FEBS LETT, V102, P59, DOI 10.1016/0014-5793(79)80928-X; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; RONCA F, 1994, BBA-PROTEIN STRUCT M, V1209, P123, DOI 10.1016/0167-4838(94)90147-3; SMILEY KL, 1967, J BIOL CHEM, V242, P2502; SORENSEN CB, 1993, FEBS LETT, V328, P285, DOI 10.1016/0014-5793(93)80945-Q; Tepper AWJW, 2002, J BIOL CHEM, V277, P30436, DOI 10.1074/jbc.M202461200; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; WANG S, 1994, INORG CHEM, V33, P1589, DOI 10.1021/ic00086a006; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b; ZIELKE CL, 1971, J BIOL CHEM, V246, P1313; ZIELKE CL, 1971, J BIOL CHEM, V246, P2179	40	17	17	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3176	3184		10.1074/jbc.M208794200	http://dx.doi.org/10.1074/jbc.M208794200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441349	hybrid			2022-12-27	WOS:000180915000053
J	Shin, DW; Pan, Z; Kim, EK; Lee, JM; Bhat, MB; Parness, J; Kim, DH; Ma, JJ				Shin, DW; Pan, Z; Kim, EK; Lee, JM; Bhat, MB; Parness, J; Kim, DH; Ma, JJ			A retrograde signal from calsequestrin for the regulation of store-operated Ca2+ entry in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CALCIUM-ENTRY; JUNCTIONAL SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR CA2+; PULMONARY-ARTERY; CHANNELS; CELLS; INFLUX; TRIADIN	Calsequestrin (CSQ) is a high capacity Ca2+-binding protein present in the lumen of sarcoplasmic reticulum (SR) in striated muscle cells and has been shown to regulate the ryanodine receptor Ca2+ release channel activity through interaction with other proteins present in the SR. Here we show that overexpression of wildtype CSQ or a CSQ mutant lacking the junction binding region (amino acids 86-191; Deltajunc-CSQ) in mouse skeletal C2Cl2 myotube enhanced caffeine- and voltage-induced Ca2+ release by increasing the Ca2+ load in SR, whereas overexpression of a mutant CSQ lacking a Ca2+ binding, aspartate-rich domain (amino acids 352-367; Deltaasp-CSQ) showed the opposite effects. Depletion of SR Ca2+ by thapsigargin initiated store-operated Ca2+ entry (SOCE) in C2Cl2 myotubes. A large component of SOCE was inhibited by overexpression of wild-type CSQ or Deltajunc-CSQ, whereas myotubes transfected with Deltaasp-CSQ exhibited normal function of SOCE. These results indicate that the aspartate-rich segment of CSQ, under conditions of overexpression, can sustain structural interactions that interfere with the SOCE mechanism. Such retrograde activation mechanisms are possibly taking place at the junctional site of the SR.	Kwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Anesthesia, Piscataway, NJ 08854 USA; Cleveland Clin Fdn, Ctr Anesthesiol Res, Cleveland, OH 44195 USA	Gwangju Institute of Science & Technology (GIST); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cleveland Clinic Foundation	Kim, DH (corresponding author), Kwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea.	dhkim@kjist.ac.kr		Pan, Zui/0000-0003-4105-901X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015556] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA95379] Funding Source: Medline; NHLBI NIH HHS [R01-HL69000] Funding Source: Medline; NIAMS NIH HHS [R01-AR045593] Funding Source: Medline; NIA NIH HHS [R01-AG15556] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bennett DL, 1998, BIOCHEM J, V329, P349; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; COLLINS JH, 1990, BIOCHEM BIOPH RES CO, V167, P189, DOI 10.1016/0006-291X(90)91749-I; Donoso P, 1996, BIOCHEMISTRY-US, V35, P13419, DOI 10.1021/bi9616209; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; Kim HY, 1999, MOL CELLS, V9, P326; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kiselyov KI, 2000, MOL CELL, V6, P421, DOI 10.1016/S1097-2765(00)00041-1; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Madge L, 1997, J PHYSIOL-LONDON, V498, P351, DOI 10.1113/jphysiol.1997.sp021863; Maguire PB, 1997, BIOCHEM BIOPH RES CO, V240, P721, DOI 10.1006/bbrc.1997.7729; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Pizzo P, 1997, J CELL BIOL, V136, P355, DOI 10.1083/jcb.136.2.355; Putney JW, 2001, J CELL SCI, V114, P2223; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Shin DW, 2002, BIOPHYS J, V83, P2539, DOI 10.1016/S0006-3495(02)75265-X; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Szegedi C, 1999, BIOCHEM J, V337, P19, DOI 10.1042/0264-6021:3370019; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	33	67	67	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3286	3292		10.1074/jbc.M209045200	http://dx.doi.org/10.1074/jbc.M209045200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12419813	hybrid			2022-12-27	WOS:000180915000066
J	Maas, S; Rich, A; Nishikura, K				Maas, S; Rich, A; Nishikura, K			A-to-I RNA editing: Recent news and residual mysteries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DNA BINDING DOMAIN; SUBUNIT GLUR-B; ADENOSINE-DEAMINASE; MESSENGER-RNA; UNWINDING ACTIVITY; RECEPTOR; BRAIN; GENE; ENZYME; DROSOPHILA		MIT, Dept Biol, Cambridge, MA 02139 USA; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); The Wistar Institute	Nishikura, K (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beghini A, 2000, HUM MOL GENET, V9, P2297, DOI 10.1093/oxfordjournals.hmg.a018921; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Filipowicz W, 2000, P NATL ACAD SCI USA, V97, P14035, DOI 10.1073/pnas.97.26.14035; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Grauso M, 2002, GENETICS, V160, P1519; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 1999, P NATL ACAD SCI USA, V96, P8895, DOI 10.1073/pnas.96.16.8895; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; OCONNELL MA, 1995, MOL CELL BIOL, V15, P1389; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Polson AG, 1996, NATURE, V380, P454; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Scadden ADJ, 2001, EMBO J, V20, P4243, DOI 10.1093/emboj/20.15.4243; Scadden ADJ, 2001, EMBO REP, V2, P1107, DOI 10.1093/embo-reports/kve244; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Slavov D, 2000, GENE, V250, P53, DOI 10.1016/S0378-1119(00)00175-X; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	50	144	155	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1391	1394		10.1074/jbc.R200025200	http://dx.doi.org/10.1074/jbc.R200025200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12446659	hybrid			2022-12-27	WOS:000180462200002
J	Pai, TG; Oxendine, I; Sugahara, T; Suiko, M; Sakakibara, Y; Liu, MC				Pai, TG; Oxendine, I; Sugahara, T; Suiko, M; Sakakibara, Y; Liu, MC			Structure-function relationships in the stereospecific and manganese-dependent 3,4-dihydroxyphenylalanine/tyrosine-sulfating activity of human monoamine-form phenol sulfotransferase, SULT1A3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEREOSELECTIVE SULFATE CONJUGATION; HUMAN DOPAMINE SULFOTRANSFERASE; HUMAN HEPATOMA-CELLS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; PHENOLSULFOTRANSFERASES; PROTEINS; BIOLOGY; DOMAINS; ENZYME	The human monoamine-form phenol sulfotransferase (PST), SULT1A3, has a unique 3,4-dihydroxyphenylalanine (Dopa)/tyrosine-sulfating activity that is stereospecific for their D-form enantiomers and can be stimulated dramatically by Mn2+. This activity is not present in the simple phenol-form PST, SULT1A1, which is otherwise >93% identical to SULT1A3 in amino acid sequence. The majority of the differences between these two proteins reside in two variable regions of their sequences. Through the characterization of chimeric PSTs where these two regions were exchanged between them, it was demonstrated that variable Region II of SULT1A3 is required for the stereospecificity of its Dopa/tyrosine-sulfating activity, whereas variable Region I of SULT1A3 is required for the stimulation by Mn2+ of this activity. Further studies using point-mutated SULT1A3s mutated at amino acid residues in these two regions and deletional mutants missing residues 84-86 and 84-90 implicate residue Glu-146 (in variable Region II of SULT1A3), as well as the presence of residues 84-90 of variable Region I, in the stereospecificity in the absence of Mn2+. Residue Asp-86 (in variable Region I of SULT1A3), on the other hand, is critical in the Mn2+ stimulation of the Dopa/tyrosine-sulfating activity of SULT1A3. A model is proposed, with reference to the reported x-ray crystal structure of SULT1A3, to explain how the normal role of SULT1A3 in dopamine regulation may be subverted in the presence of Mn2+. These studies could be relevant in understanding the stereoselective action of SULT1A3 on chiral drugs.	Univ Texas Hlth Ctr, Ctr Biomed Res, Tyler, TX 75708 USA		Liu, MC (corresponding author), Univ Texas Hlth Ctr, Ctr Biomed Res, 11937 US Highway 271, Tyler, TX 75708 USA.			Sugahara, Takuya/0000-0002-0335-8273				Bidwell LM, 1999, J MOL BIOL, V293, P521, DOI 10.1006/jmbi.1999.3153; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brix LA, 1999, BIOCHEMISTRY-US, V38, P10474, DOI 10.1021/bi990795q; Brix LA, 1999, BIOCHEM J, V337, P337, DOI 10.1042/0264-6021:3370337; BUTLER PR, 1983, J NEUROCHEM, V41, P630, DOI 10.1111/j.1471-4159.1983.tb04788.x; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; Dajani R, 1999, J BIOL CHEM, V274, P37862, DOI 10.1074/jbc.274.53.37862; Duffel MW, 1997, COMPREHENSIVE TOXICO, V3, P365; Falany C., 1993, HUMAN DRUG METABOLIS, P101; FERNANDO PHP, 1993, BIOSCI BIOTECH BIOCH, V5, P1974; GERGELY A, 1971, ACTA CHIM HUNG, V68, P285; HEROUX JA, 1988, MOL PHARMACOL, V34, P194; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPMANN F, 1958, SCIENCE, V128, P575, DOI 10.1126/science.128.3324.575; LIU MC, 1984, P NATL ACAD SCI-BIOL, V81, P3695, DOI 10.1073/pnas.81.12.3695; Liu MC, 2000, J BIOL CHEM, V275, P13460, DOI 10.1074/jbc.275.18.13460; Mulder G.J., 1990, CONJUGATION REACTION, P107; Pai TG, 2002, J BIOL CHEM, V277, P43813, DOI 10.1074/jbc.M200785200; Pedersen LC, 2000, FEBS LETT, V475, P61, DOI 10.1016/S0014-5793(00)01479-4; PERSOLA GR, 1993, CHIRALITY, V5, P602; Petrotchenko EV, 2001, FEBS LETT, V490, P39, DOI 10.1016/S0014-5793(01)02129-9; Rubin GL, 1996, XENOBIOTICA, V26, P1113, DOI 10.3109/00498259609050256; Sakakibara Y, 1998, J BIOL CHEM, V273, P6242, DOI 10.1074/jbc.273.11.6242; Sakakibara Y, 1997, BBA-MOL CELL RES, V1355, P102, DOI 10.1016/S0167-4889(96)00166-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Smith RM, 1974, CRITICAL STABILITY C, V1-6; Suiko M, 1998, J BIOCHEM-TOKYO, V124, P707, DOI 10.1093/oxfordjournals.jbchem.a022170; Suiko M, 1996, BIOCHEM J, V314, P151, DOI 10.1042/bj3140151; WALLE T, 1992, DRUG METAB DISPOS, V20, P333; WALLE UK, 1993, BRIT J CLIN PHARMACO, V35, P413, DOI 10.1111/j.1365-2125.1993.tb04159.x; Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160; Wilson AA, 1997, XENOBIOTICA, V27, P1147, DOI 10.1080/004982597239903; Yanagisawa K, 1998, BIOSCI BIOTECH BIOCH, V62, P1037, DOI 10.1271/bbb.62.1037	34	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1525	1532		10.1074/jbc.M203108200	http://dx.doi.org/10.1074/jbc.M203108200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424257	hybrid			2022-12-27	WOS:000180462200022
J	Wang, CG; Chen, JD				Wang, CG; Chen, JD			Phosphorylation and hsp90 binding mediate heat shock stabilization of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; MUTANT P53; CELL-LINE; WILD-TYPE; MDM2; PROTEIN; ASSOCIATION; ACTIVATION; STABILITY; APOPTOSIS	The p53 tumor suppressor is stabilized and activated by diverse stress signals. In this study, we investigated the mechanism of p53 activation by heat shock. We found that heat shock inhibited p53 ubiquitination and caused accumulation of p53 at the post-transcriptional level. Heat shock induced phosphorylation of p53 at serine 15 in an ATM kinase-dependent fashion, which may contribute partially to heat-induced p53 accumulation. However, p53 accumulation also occurred after heat shock in ATM-deficient cells. Heat shock induced conformational change of wild type p53 and binding to hsp90. Inhibition of hsp90-p53 interaction by geldanamycin prevented p53 accumulation partially in ATM-wild type cells and completely in ATM-deficient cells. Therefore, phosphorylation and interaction with hsp90 both contribute to stabilization of p53 after heat shock.	H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; Res Inst, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, MRC3057A,12902 Magnolia Dr, Tampa, FL 33612 USA.	jchen@moffitt.usf.edu			NATIONAL CANCER INSTITUTE [R01CA088406] Funding Source: NIH RePORTER; NCI NIH HHS [CA88406] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Balint E, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Chehab NH, 2000, GENE DEV, V14, P278; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Friedlander P, 1996, J BIOL CHEM, V271, P25468, DOI 10.1074/jbc.271.41.25468; Fuse T, 1998, NEUROSURGERY, V42, P843, DOI 10.1097/00006123-199804000-00092; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lu H, 1998, P NATL ACAD SCI USA, V95, P6399, DOI 10.1073/pnas.95.11.6399; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; MCCORMICK W, 1969, J MOL BIOL, V39, P315, DOI 10.1016/0022-2836(69)90320-9; MINISINI MP, 1994, MUTAT RES-DNA REPAIR, V315, P169, DOI 10.1016/0921-8777(94)90016-7; Miyakoda M, 2002, ONCOGENE, V21, P1090, DOI 10.1038/sj.onc.1205196; Miyakoda M, 1999, BIOCHEM BIOPH RES CO, V266, P377, DOI 10.1006/bbrc.1999.1829; Nagata Y, 1999, ONCOGENE, V18, P6037, DOI 10.1038/sj.onc.1202978; Nitta M, 1997, ONCOGENE, V15, P561, DOI 10.1038/sj.onc.1201210; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohnishi K, 2001, INT J HYPERTHER, V17, P415, DOI 10.1080/02656730110063604; Ohnishi T, 1996, J BIOL CHEM, V271, P14510, DOI 10.1074/jbc.271.24.14510; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Peng YH, 2001, J BIOL CHEM, V276, P6874, DOI 10.1074/jbc.C000781200; Pochampally R, 1999, J BIOL CHEM, V274, P15271, DOI 10.1074/jbc.274.21.15271; Prives C, 1999, J PATHOL, V187, P112; Selkirk James K., 1994, Applied and Theoretical Electrophoresis, V4, P11; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Takahashi I, 2002, SURGERY, V131, pS78, DOI 10.1067/msy.2002.119308; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Witkamp AJ, 2001, CANCER TREAT REV, V27, P365, DOI 10.1053/ctrv.2001.0232; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; ZHANG W, 1992, ONCOGENE, V7, P1645; Zhang YP, 2001, CELL GROWTH DIFFER, V12, P175	43	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2066	2071		10.1074/jbc.M206697200	http://dx.doi.org/10.1074/jbc.M206697200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427754	hybrid			2022-12-27	WOS:000180462200093
J	Aghajanian, S; Hovsepyan, M; Geoghegan, KF; Chirunyk, BA; Engel, PC				Aghajanian, S; Hovsepyan, M; Geoghegan, KF; Chirunyk, BA; Engel, PC			A thermally sensitive loop in clostridial glutamate dehydrogenase detected by limited proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY; CIRCULAR-DICHROISM; TERTIARY STRUCTURE; SYMBIOSUM; PROTEIN; INACTIVATION; ORGANIZATION; MECHANISM; PH	The structural flexibility and thermostability of glutamate dehydrogenase (GDH) from Clostridium symbiosum were examined by limited proteolysis using three proteinases with different specificities, trypsin, chymotrypsin, and endoproteinase Glu-C. Clostridial GDH resisted proteolysis by any of these enzymes at 25 degreesC. Above 30 degreesC, however, GDH became cleavable by chymotrypsin, apparently at a single site. SDS-PAGE indicated the formation of one large fragment with a molecular mass of similar to44 kDa and one small one of <10 kDa. Proteolysis was accompanied by the loss of enzyme activity, which outran peptide cleavage, suggesting a cooperative conformational change. Proteolysis was prevented by either of the substrates 2-oxoglutarate or L-glutamate but not by the coenzymes NAD(+) or NADH. Circular dichroism spectroscopy indicated that the protective effects of these ligands resulted from fixation of flexible regions of the native structure of the enzyme. Size-exclusion chromatography and SDS-PAGE studies of chymotrypsin-treated GDH showed that the enzyme retained its hexameric structure and all of its proteolytic fragments. However, circular dichroism spectroscopy and analytical ultracentrifugation showed global conformational changes affecting the overall compactness of the protein structure. Chymotrypsin-catalyzed cleavage also diminished the thermostability of GDH and the cooperativity of the transition between its native and denatured states. N-terminal amino acid sequencing and mass spectrometry showed that heat-induced sensitivity to chymotrypsin emerged in the loop formed by residues 390-393 that lies between helices alpha(15) and alpha(16) in the folded structure of the enzyme.	Univ Coll Dublin, Dept Biochem, Dublin 4, Ireland; Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; Pfizer Global Res & Dev, Groton, CT 06340 USA	University College Dublin; University College Dublin; Pfizer	Engel, PC (corresponding author), Univ Coll Dublin, Dept Biochem, Dublin 4, Ireland.							Aghajanian S, 1998, PROTEIN ENG, V11, P569, DOI 10.1093/protein/11.7.569; Aghajanian S, 1998, BIOCHEM SOC T, V26, pS26, DOI 10.1042/bst026s026; AGHAJANIAN SA, 1995, BIOCHEM J, V311, P905, DOI 10.1042/bj3110905; Aitchison MJ, 1980, BIOCHEM SOC T, V8, P649, DOI 10.1042/bst0080649; AITCHISON MJ, 1983, INT J BIOCHEM, V15, P79, DOI 10.1016/0020-711X(83)90014-9; Arnold U, 1996, EUR J BIOCHEM, V237, P862, DOI 10.1111/j.1432-1033.1996.0862p.x; ARNONE MI, 1992, EUR J BIOCHEM, V204, P1183, DOI 10.1111/j.1432-1033.1992.tb16745.x; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; BEYNON RJ, 1976, INT J BIOCHEM, V7, P449, DOI 10.1016/0020-711X(76)90044-6; BROCKERHOFF SE, 1992, PROTEIN SCI, V1, P504; COHEN SL, 1995, PROTEIN SCI, V4, P1088, DOI 10.1002/pro.5560040607; Creighton T.E., 1984, PROTEINS STRUCTURE M; EISENBERG H, 1970, BIOPOLYMERS, V9, P113, DOI 10.1002/bip.1970.360090110; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; HUCHO F, 1975, EUR J BIOCHEM, V52, P221, DOI 10.1111/j.1432-1033.1975.tb03990.x; LOOMES K, 1991, BIOCHEMISTRY-US, V30, P8865, DOI 10.1021/bi00100a020; MALCOLM A D B, 1974, Biochemical Society Transactions, V2, P140; Nakagawa N, 1997, J BIOL CHEM, V272, P22703, DOI 10.1074/jbc.272.36.22703; Parrado J, 1996, PROTEIN SCI, V5, P693; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; PLACE GA, 1982, BIOCHEM J, V205, P75, DOI 10.1042/bj2050075; RICE DW, 1987, BIOCHEM J, V242, P789, DOI 10.1042/bj2420789; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; SUND H, 1969, EUR J BIOCHEM, V7, P517; SYED SEH, 1990, FEBS LETT, V262, P176, DOI 10.1016/0014-5793(90)80183-J; SYED SEH, 1991, BIOCHIM BIOPHYS ACTA, V1115, P123, DOI 10.1016/0304-4165(91)90020-H; TELLER JK, 1992, EUR J BIOCHEM, V206, P151, DOI 10.1111/j.1432-1033.1992.tb16912.x; WANG XG, 1995, BIOCHEMISTRY-US, V34, P11417, DOI 10.1021/bi00036a014; Zappacosta F, 1996, PROTEIN SCI, V5, P802, DOI 10.1002/pro.5560050502	30	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1067	1074		10.1074/jbc.M206099200	http://dx.doi.org/10.1074/jbc.M206099200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12414808	hybrid			2022-12-27	WOS:000180321900050
J	Arikkath, J; Chen, CC; Ahern, C; Allamand, V; Flanagan, JD; Coronado, R; Gregg, RG; Campbell, KP				Arikkath, J; Chen, CC; Ahern, C; Allamand, V; Flanagan, JD; Coronado, R; Gregg, RG; Campbell, KP			gamma(1) subunit interactions within the skeletal muscle L-type voltage-gated calcium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOGLYCAN-DEFICIENT MICE; DIHYDROPYRIDINE RECEPTOR; BETA-SUBUNIT; CA2+ CHANNELS; 1,4-DIHYDROPYRIDINE RECEPTOR; ALPHA(2)DELTA SUBUNIT; MUSCULAR DYSGENESIS; EXPRESSION; ABSENCE; MOUSE	Voltage-gated calcium channels mediate excitation-contraction coupling in the skeletal muscle. Their molecular composition, similar to neuronal channels, includes the pore-forming alpha(1) and auxiliary alpha(2)delta beta, and gamma subunits. The gamma subunits are the least characterized, and their subunit interactions are unclear. The physiological importance of the neuronal gamma is emphasized by epileptic stargazer mice that lack gamma(2). In this study, we examined the molecular basis of interaction between skeletal gamma(1) and the calcium channel. Our data show that the alpha(1)1.1, beta(1a), and alpha(2)delta subunits are still associated in gamma(1), null mice. Reexpression of gamma(1) and gamma(2) showed that gamma(1), but not gamma(2), incorporates into gamma null channels. By using chimeric constructs, we demonstrate that the first half of the gamma(1) subunit, including the first two transmembrane domains, is important for subunit interaction. Interestingly, this chimera also restores calcium conductance in gamma(1) null myotubes, indicating that the domain mediates both subunit interaction and current modulation. To determine the subunit of the channel that interacts with gamma(1), we examined the channel in muscular dysgenesis mice. Cosedimentation experiments showed that gamma(1) and alpha(2)delta are not associated. Moreover, alpha(1)1.1 and gamma(1) subunits form a complex in transiently transfected cells, indicating direct interaction between the gamma(1) and alpha(1)1.1 subunits. Our data demonstrate that the first half of gamma(1) subunit is required for association with the channel through alpha(1)1.1. Because subunit interactions are conserved, these studies have broad implications for gamma heterogeneity, function and subunit association with voltage-gated calcium channels.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Neurol, Iowa City, IA 52242 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Louisville, Sch Med, Dept Biochem, Louisville, KY 40202 USA; Univ Louisville, Sch Med, Dept Mol Biol, Louisville, KY 40202 USA; Univ Louisville, Sch Med, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Wisconsin System; University of Wisconsin Madison; University of Louisville; University of Louisville; University of Louisville	Campbell, KP (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, 400 EMRB, Iowa City, IA 52242 USA.		Allamand, Valerie/M-4333-2017; Chen, Chien-Chang/D-2023-2015; Tuluc, Petronel/C-2527-2011; Allamand, Valérie/AAH-6272-2021	Chen, Chien-Chang/0000-0001-8850-4278; Allamand, Valérie/0000-0001-8997-9742; Ahern, Christopher/0000-0002-7975-2744; Campbell, Kevin/0000-0003-2066-5889; Gregg, Ronald/0000-0001-5805-224X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046448] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 47053] Funding Source: Medline; NIAMS NIH HHS [R01 AR 46448] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2001, BIOPHYS J, V81, P3294, DOI 10.1016/S0006-3495(01)75963-2; AHERN CA, 2001, BMC PHYSL; Allamand V, 2000, GENE THER, V7, P1385, DOI 10.1038/sj.gt.3301247; BOSSE E, 1990, FEBS LETT, V267, P153, DOI 10.1016/0014-5793(90)80312-7; Burgess DL, 2001, GENOMICS, V71, P339, DOI 10.1006/geno.2000.6440; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CHAUDHARI N, 1992, J BIOL CHEM, V267, P25636; CHU P, 2002, BIOPH SOC 46 ANN M F; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Crosbie RH, 1997, J BIOL CHEM, V272, P31221, DOI 10.1074/jbc.272.50.31221; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; FLUCHER BE, 1991, J CELL BIOL, V115, P1345, DOI 10.1083/jcb.115.5.1345; Flucher BE, 2000, J CELL BIOL, V151, P467, DOI 10.1083/jcb.151.2.467; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Freise D, 2000, J BIOL CHEM, V275, P14476, DOI 10.1074/jbc.275.19.14476; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; JORGENSEN AO, 1989, J CELL BIOL, V109, P135, DOI 10.1083/jcb.109.1.135; Kang MG, 2001, J BIOL CHEM, V276, P32917, DOI 10.1074/jbc.M100787200; Klugbauer N, 1999, J NEUROSCI, V19, P684; Klugbauer N, 2000, FEBS LETT, V470, P189, DOI 10.1016/S0014-5793(00)01306-5; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; Rahkila P, 2001, EXP CELL RES, V267, P61, DOI 10.1006/excr.2001.5101; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sipos I, 2000, PFLUG ARCH EUR J PHY, V439, P691, DOI 10.1007/s004240050994; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Ursu D, 2001, J PHYSIOL-LONDON, V533, P367, DOI 10.1111/j.1469-7793.2001.0367a.x	40	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1212	1219		10.1074/jbc.M208689200	http://dx.doi.org/10.1074/jbc.M208689200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409298	hybrid, Green Submitted			2022-12-27	WOS:000180321900068
J	Haj, FG; Markova, B; Klaman, LD; Bohmer, FD; Neel, BG				Haj, FG; Markova, B; Klaman, LD; Bohmer, FD; Neel, BG			Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INSULIN SENSITIVITY; NEGATIVE REGULATION; 1B INTERACTS; PTP1B; PHOSPHORYLATION; IDENTIFICATION; ENDOCYTOSIS; FIBROBLASTS; ATTENUATION	Receptor tyrosine kinases (RTKs) are key regulators of cellular homeostasis. Based on in vitro and ex vivo studies, protein tyrosine phosphatase-1B (PTP1B) was implicated in the regulation of several RTKs, yet mice lacking PTP1B show defects mainly in insulin and leptin receptor signaling. To address this apparent paradox, we studied RTK signaling in primary and immortalized fibroblasts from PTP1B(-/-) mice. After growth factor treatment, cells lacking PTP1B exhibit increased and sustained phosphorylation of the epidermal growth factor receptor (EGFR) and the platelet-derived growth factor receptor (PDGFR). However, Erk activation is enhanced only slightly, and there is no increase in Akt activation in PTP1B-deficient cells. Our results show that PTP1B does play a role in regulating EGFR and PDGFR phosphorylation but that other signaling mechanisms can largely compensate for PTPlB deficiency. In-gel phosphatase experiments suggest that other PTPs may help to regulate the EGFR and PDGFR in PTP1B-fibroblasts. This and other compensatory mechanisms prevent widespread, uncontrolled activation of RTKs in the absence of PTP1B and probably explain the relatively mild effects of PTP1B deletion in mice.	Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Hematol Oncol,Canc Biol Program, Boston, MA 02215 USA; Jean Univ Hosp, Res Unit Mol Cell Biol, D-07747 Jena, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Friedrich Schiller University of Jena	Neel, BG (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Hematol Oncol,Canc Biol Program, HIM-1043,330 Brookline Ave, Boston, MA 02215 USA.	bneel@caregroup.harvard.edu			NCI NIH HHS [CA49152] Funding Source: Medline; NIDDK NIH HHS [DK60838] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA049152, R01CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060838] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; Balsamo J, 1998, J CELL BIOL, V143, P523, DOI 10.1083/jcb.143.2.523; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; BURRIDGE K, 1995, ANAL BIOCHEM, V232, P56, DOI 10.1006/abio.1995.9961; CARPENTIER JL, 1985, BIOCHIMIE, V67, P1143, DOI 10.1016/S0300-9084(85)80112-7; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Dadke S, 2000, J BIOL CHEM, V275, P23642, DOI 10.1074/jbc.M001063200; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FLINT AJ, 1993, EMBO J, V12, P1937, DOI 10.1002/j.1460-2075.1993.tb05843.x; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hunter T, 1997, CELL, V88, P333, DOI 10.1016/S0092-8674(00)81872-3; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Keilhack H, 2001, J CELL BIOL, V152, P325, DOI 10.1083/jcb.152.2.325; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kulas DT, 1996, J BIOL CHEM, V271, P748, DOI 10.1074/jbc.271.2.748; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139; Liu F, 1998, CURR BIOL, V8, P173, DOI 10.1016/S0960-9822(98)70066-1; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pierce KL, 2000, P NATL ACAD SCI USA, V97, P1489, DOI 10.1073/pnas.97.4.1489; Rhee J, 2001, J BIOL CHEM, V276, P6640, DOI 10.1074/jbc.M007656200; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; Roche S, 1996, EMBO J, V15, P4940, DOI 10.1002/j.1460-2075.1996.tb00874.x; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; SCHIEVELLA AR, 1993, CELL GROWTH DIFFER, V4, P239; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Shifrin VI, 1997, J BIOL CHEM, V272, P2957, DOI 10.1074/jbc.272.5.2957; SHIFRIN VI, 1993, J BIOL CHEM, V268, P25376; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002; Zhao RX, 1999, BIOCHEM J, V338, P35, DOI 10.1042/0264-6021:3380035	61	213	222	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					739	744		10.1074/jbc.M210194200	http://dx.doi.org/10.1074/jbc.M210194200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12424235	hybrid			2022-12-27	WOS:000180321900008
J	Axelrod, J				Axelrod, J			Journey of a late blooming biochemical neuroscientist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; TRITIATED-NORADRENALINE; CIRCADIAN RHYTHM; O-METHYLATION; RAT-BRAIN; PINEAL; NOREPINEPHRINE; SEROTONIN; DEMETHYLATION; EPINEPHRINE		NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Axelrod, J (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							Abel JJ., 1897, J HOPKINS HOSP B, V8, P151; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ARIENSKAPPERS J, 1960, ANAT REC, V136, P220; ARMSTRONG MD, 1957, FED PROC, V16, P146; AXELROD J, 1953, J PHARMACOL EXP THER, V109, P62; AXELROD J, 1953, J PHARMACOL EXP THER, V107, P519; AXELROD J, 1959, SCIENCE, V130, P800, DOI 10.1126/science.130.3378.800; AXELROD J, 1954, J PHARMACOL EXP THER, V110, P315; AXELROD J, 1955, J PHARMACOL EXP THER, V114, P430; AXELROD J, 1959, J PHARMACOL EXP THER, V127, P251; AXELROD J, 1971, SCIENCE, V173, P598, DOI 10.1126/science.173.3997.598; AXELROD J, 1958, J BIOL CHEM, V233, P702; AXELROD J, 1961, SCIENCE, V133, P383, DOI 10.1126/science.133.3450.383; AXELROD J, 1957, NATURE, V180, P1426, DOI 10.1038/1801426a0; AXELROD J, 1956, J PHARMACOL EXP THER, V117, P322; AXELROD J, 1961, J BIOL CHEM, V236, P211; AXELROD JULIUS, 1955, JOUR BIOL CHEM, V214, P753; Barger G, 1910, J PHYSIOL-LONDON, V41, P19; BRODIE BB, 1948, J PHARMACOL EXP THER, V94, P29; BROWN DD, 1959, J BIOL CHEM, V234, P2948; BROWNSTEIN M, 1974, SCIENCE, V184, P163, DOI 10.1126/science.184.4133.163; BROWNSTEIN MJ, 1974, P NATL ACAD SCI USA, V71, P4662, DOI 10.1073/pnas.71.12.4662; Chen KK, 1930, MEDICINE, V9, P1, DOI 10.1097/00005792-193002000-00001; COYLE JT, 1969, J PHARMACOL EXP THER, V170, P221; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598; DUTTON GJ, 1954, BIOCHEM J, V57, P275, DOI 10.1042/bj0570275; ELIOTT TR, 1904, J PHYSIOL-LONDON, V31, pR20; Elliott TR, 1905, J PHYSIOL-LONDON, V32, P401; FISKE VM, 1960, ENDOCRINOLOGY, V66, P489; GLOWINSKI J, 1964, NATURE, V204, P1318, DOI 10.1038/2041318a0; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; HERTTING G, 1961, NATURE, V189, P66, DOI 10.1038/189066a0; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; HOFFMAN BJ, 1991, SCIENCE, V154, P79; HOKFELT T, 1980, NATURE, V284, P515, DOI 10.1038/284515a0; Iversen L, 2000, MOL PSYCHIATR, V5, P357, DOI 10.1038/sj.mp.4000728; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; KUHN R, 1957, Schweiz Med Wochenschr, V87, P1135; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; LOEWI O., 1960, PERSPECTIVES IN BIOL AND MED, V4, P3; Loewi O, 1921, PFLUG ARCH GES PHYS, V189, P239, DOI 10.1007/BF01738910; LU AYH, 1979, PHARMACOL REV, V31, P277; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Oliver G, 1895, J Physiol, V18, P230; OMURA T., 1965, FEDERATION PROC, V24, P1181; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; QUAY WB, 1963, GEN COMP ENDOCR, V3, P473, DOI 10.1016/0016-6480(63)90079-0; Reith MEA, 1997, NEUROTRANSMITTER TRA; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RYAN KJ, 1957, J BIOL CHEM, V225, P103; SAAVEDRA JM, 1974, J PSYCHIAT RES, V11, P289, DOI 10.1016/0022-3956(74)90108-3; SCHNEIDER WC, 1948, J BIOL CHEM, V176, P259; SNYDER SH, 1965, P NATL ACAD SCI USA, V53, P301, DOI 10.1073/pnas.53.2.301; SOBERMAN R, 1949, J BIOL CHEM, V179, P31; STROMINGER JL, 1954, J AM CHEM SOC, V76, P6411, DOI 10.1021/ja01653a051; WEILMALHERBE H, 1959, SCIENCE, V129, P1226, DOI 10.1126/science.129.3357.1226; WEISSBACH H, 1961, BIOCHIM BIOPHYS ACTA, V54, P190, DOI 10.1016/0006-3002(61)90954-4; WHITBY LG, 1960, NATURE, V187, P604, DOI 10.1038/187604a0; WOLFE DE, 1962, SCIENCE, V138, P440, DOI 10.1126/science.138.3538.440; ZATZ M, 1978, NEURONAL INFORMATION, P47	61	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					1	13		10.1074/jbc.X200004200	http://dx.doi.org/10.1074/jbc.X200004200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12414788	hybrid			2022-12-27	WOS:000180255700001
J	Tan, YSH; Morcos, PA; Cannon, JF				Tan, YSH; Morcos, PA; Cannon, JF			Pho85 phosphorylates the Glc7 protein phosphatase regulator Glc8 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; BACTERIOPHAGE-T7 RNA-POLYMERASE; SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEIN PHOSPHATASE; CHROMOSOME SEGREGATION; CATALYTIC SUBUNIT; SYNTHETIC LETHAL; SHUTTLE VECTORS; BUDDING YEAST; INHIBITOR-2	The budding yeast Glc7 serine/threonine protein phosphatase-1 is regulated by Glc8, the yeast ortholog of mammalian phosphatase inhibitor-2. In this work, we demonstrated that similarly to inhibitor-2, Glc8 function is regulated by phosphorylation. The cyclin-dependent protein kinase, Pho85, in conjunction with the related cyclins Pcl6 and Pcl7 comprise the major Glc8 kinase in vivo and in vitro. Several glc7 mutations are dependent on the presence of Glc8 for viability. For example, glc7 alleles R121K, R142H, and R198D are lethal in combination with a glc8 deletion. We found that glc7-R121K is lethal in combination with a pho85 deletion. This finding indicates that Pho85 is the sole Glc8 kinase in vivo. Furthermore, glc7-R121K is also lethal when combined with deletions of pcl6, plc7, pcl8, and pcl10, indicating that these related cyclins redundantly activate Pho85 for Glc8 phosphorylation in vivo. In vitro kinase assays and genetic results indicate that Pho85 cyclins Pcl6 and Pcl7 comprise the predominant Glc8 kinase.	Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Cannon, JF (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, 1 Hosp Dr, Columbia, MO 65212 USA.	CannonJ@missouri.edu		Cannon, John/0000-0001-6698-176X				Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Akada R, 2000, BIOTECHNIQUES, V28, P668, DOI 10.2144/00284st02; ALESSI DR, 1993, EUR J BIOCHEM, V213, P1055, DOI 10.1111/j.1432-1033.1993.tb17853.x; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNON JF, 1994, GENETICS, V136, P485; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; ESPINOZA FH, 1994, SCIENCE, V266, P1388, DOI 10.1126/science.7973730; Eto M, 2002, J BIOL CHEM, V277, P44013, DOI 10.1074/jbc.M208035200; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Haut DD, 1998, J VIROL, V72, P1834, DOI 10.1128/JVI.72.3.1834-1843.1998; HEMMINGS BA, 1982, FEBS LETT, V150, P319, DOI 10.1016/0014-5793(82)80760-6; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOLMES CFB, 1986, BIOCHIM BIOPHYS ACTA, V870, P408, DOI 10.1016/0167-4838(86)90248-7; Hong G, 2000, ARCH BIOCHEM BIOPHYS, V376, P288, DOI 10.1006/abbi.2000.1715; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; INNIS MA, 1990, PCR PROTOCOLS GUIDE, P177; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; JURGENSEN S, 1984, J BIOL CHEM, V259, P5864; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CW, 1991, METHOD ENZYMOL, V194, P273; LEE EYC, 1999, FRONT BIOSCI, V4, P270; Lee M, 2000, MOL MICROBIOL, V38, P411, DOI 10.1046/j.1365-2958.2000.02140.x; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282; MEASDAY V, 1994, SCIENCE, V266, P1391, DOI 10.1126/science.7973731; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; Nigavekar SS, 2002, ARCH BIOCHEM BIOPHYS, V404, P71, DOI 10.1016/S0003-9861(02)00231-X; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Phizicky EM, 2002, METHOD ENZYMOL, V350, P546; Ramaswamy NT, 1998, GENETICS, V149, P57; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sherman F, 1986, LAB COURSE MANUAL ME; SIKORSKI RS, 1989, GENETICS, V122, P19; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VILLAMORUZZI E, 1984, J BIOL CHEM, V259, P5857; Walsh EP, 2002, BIOCHEMISTRY-US, V41, P2409, DOI 10.1021/bi015815e; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; WANG QM, 1995, J BIOL CHEM, V270, P18352, DOI 10.1074/jbc.270.31.18352; Wang Z, 2001, FEBS LETT, V506, P277, DOI 10.1016/S0014-5793(01)02914-3; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang J, 2000, J BIOL CHEM, V275, P22635, DOI 10.1074/jbc.M003082200; Zheng JH, 2000, J BIOL CHEM, V275, P18070, DOI 10.1074/jbc.M000918200; Zheng JH, 1998, METH MOL B, V93, P293	60	31	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					147	153		10.1074/jbc.M208058200	http://dx.doi.org/10.1074/jbc.M208058200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12407105	hybrid			2022-12-27	WOS:000180255700020
J	Shu, D; Guo, PX				Shu, D; Guo, PX			A viral RNA that binds ATP and contains a motif similar to an ATP-binding aptamer from SELEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PACKAGING MOTOR; BACTERIOPHAGE-LAMBDA TERMINASE; BACILLUS-SUBTILIS; PHAGE PHI-29; IN-VITRO; STRUCTURAL BASIS; HEXAMERIC RNA; COMPLEX; MOLECULES; SYSTEM	The intriguing process of free energy conversion, ubiquitous in all living organisms, is manifested in ATP binding and hydrolysis. ATPase activity has long been recognized to be a capability limited to proteins. However, the presence of an astonishing variety of unknown RNA species in cells and the finding that RNA has catalytic activity have bred the notion that RNA might not be excluded from the group of ATPases. All DNA-packaging motors of double-stranded DNA phages involve two nonstructural components with certain characteristics typical of ATPases. In bacterial virus phi29, one of these two components is an RNA (pRNA). Here we report that this pRNA is able to bind ATP. A comparison between the chemically selected ATP-binding RNA aptamer and the central region of pRNA reveals similarity in sequence and structure. The replacement of the central region of pRNA with the sequence from ATP-binding RNA aptamer produced chimeric aptRNA that is able to both bind ATP and assemble infectious viruses in the presence of ATP. RNA mutation studies revealed that changing only one base essential for ATP binding caused both ATP binding and viral assembly to cease, suggesting that the ATP binding motif is the vital part of the pRNA that forms a hexamer to drive the phi29 DNA-packaging motor. This is the first demonstration of a natural RNA molecule that binds ATP and the first case to report the presence of a SELEX-derived RNA aptamer in living organisms.	Purdue Univ, Purdue Canc Ctr, W Lafayette, IN 47907 USA; Purdue Univ, Dept Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Guo, PX (corresponding author), Purdue Univ, Purdue Canc Ctr, B-36 Hansen Life Sci Res Bldg, W Lafayette, IN 47907 USA.	guop@purdue.edu	Guo, Peixuan/AAE-2573-2022; Guo, Peixuan/I-7184-2015	Guo, Peixuan/0000-0001-5706-2833; Shu, Dan/0000-0002-0267-1102	NIGMS NIH HHS [GM59944] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059944] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON DL, 1966, J BACTERIOL, V91, P2081, DOI 10.1128/JB.91.5.2081-2089.1966; ARNOLD FH, 1986, J CHROMATOGR, V355, P1, DOI 10.1016/S0021-9673(01)97299-1; BAILEY S, 1990, J BIOL CHEM, V265, P22365; BAZINET C, 1985, ANNU REV MICROBIOL, V39, P109; BLACK LW, 1988, BACTERIOPHAGES; Burke DH, 1998, RNA, V4, P1165, DOI 10.1017/S1355838298980542; Cech TR, 1996, RNA, V2, P625; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; Chen CP, 1997, J VIROL, V71, P3864, DOI 10.1128/JVI.71.5.3864-3871.1997; Chen CP, 2000, J BIOL CHEM, V275, P17510, DOI 10.1074/jbc.M909662199; Chen CP, 1999, RNA, V5, P805, DOI 10.1017/S1355838299990350; Chen CP, 1997, J VIROL, V71, P495, DOI 10.1128/JVI.71.1.495-500.1997; Chen T, 1997, J BIOMED MATER RES, V36, P190, DOI 10.1002/(SICI)1097-4636(199708)36:2<190::AID-JBM7>3.3.CO;2-7; CIESIOLKA J, 1995, RNA, V1, P538; Davenport RJ, 2001, SCIENCE, V291, P807, DOI 10.1126/science.291.5511.2071; Dieckmann T, 1997, J MOL BIOL, V273, P467, DOI 10.1006/jmbi.1997.1329; Dieckmann T, 1996, RNA, V2, P628; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GRIMES S, 1990, J MOL BIOL, V215, P559, DOI 10.1016/S0022-2836(05)80168-8; Guasch A, 2002, J MOL BIOL, V315, P663, DOI 10.1006/jmbi.2001.5278; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GUO PX, 1994, SEMIN VIROL, V5, P1, DOI 10.1006/smvy.1994.1001; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1991, VIROLOGY, V185, P395, DOI 10.1016/0042-6822(91)90787-C; GUO PX, 1987, SCIENCE, V236, P690, DOI 10.1126/science.3107124; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Guo PX, 2002, PROG NUCLEIC ACID RE, V72, P415, DOI 10.1016/S0079-6603(02)72076-X; Hang JQ, 2000, J MOL BIOL, V302, P777, DOI 10.1006/jmbi.2000.4086; Hendrix RW, 1998, CELL, V94, P147, DOI 10.1016/S0092-8674(00)81413-0; Hoeprich S, 2002, J BIOL CHEM, V277, P20794, DOI 10.1074/jbc.M112061200; Ibarra B, 2001, NUCLEIC ACIDS RES, V29, P4264, DOI 10.1093/nar/29.21.4264; Jiang F, 1997, J BIOMOL NMR, V9, P55, DOI 10.1023/A:1018623601946; Jiang F, 1996, NATURE, V382, P183, DOI 10.1038/382183a0; JIMENEZ J, 1986, SCIENCE, V232, P1113, DOI 10.1126/science.3754654; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; LEE CS, 1995, J VIROL, V69, P5018, DOI 10.1128/JVI.69.8.5018-5023.1995; LEE CS, 1994, VIROLOGY, V202, P1039, DOI 10.1006/viro.1994.1434; MELLADO RP, 1980, VIROLOGY, V104, P84, DOI 10.1016/0042-6822(80)90367-0; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nonin S, 1997, J MOL BIOL, V268, P359, DOI 10.1006/jmbi.1997.0986; PARRIS W, 1988, J BIOL CHEM, V263, P8413; RAO VB, 1988, J MOL BIOL, V200, P475, DOI 10.1016/0022-2836(88)90537-2; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Szkaradkiewicz K, 2002, FEBS LETT, V514, P90, DOI 10.1016/S0014-5793(02)02308-6; Trottier M, 2000, RNA, V6, P1257, DOI 10.1017/S1355838200992501; Trottier M, 1997, J VIROL, V71, P487, DOI 10.1128/JVI.71.1.487-494.1997; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang C, 1999, ACTA BIOCH BIOPH SIN, V31, P504; ZHANG CL, 1994, VIROLOGY, V201, P77, DOI 10.1006/viro.1994.1267; Zhang F, 1998, MOL CELL, V2, P141, DOI 10.1016/S1097-2765(00)80123-9	54	43	53	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2003	278	9					7119	7125		10.1074/jbc.M209895200	http://dx.doi.org/10.1074/jbc.M209895200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	649EZ	12444088	hybrid			2022-12-27	WOS:000181195100063
J	Niebisch, A; Bott, M				Niebisch, A; Bott, M			Purification of a cytochrome bc(1)-aa(3) supercomplex with quinol oxidase activity from Corynebacterium glutamicum - Identification of a fourth subunit of cytochrome aa(3) oxidase and mutational analysis of diheme cytochrome c(1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-OXIDASE; BRADYRHIZOBIUM-JAPONICUM; UBIQUINOL OXIDASE; RESPIRATORY-CHAIN; PARACOCCUS-DENITRIFICANS; MOLECULAR ANALYSIS; PROTEIN COMPLEXES; ESCHERICHIA-COLI; TERMINAL OXIDASE; GENE	The aerobic respiratory chain of the Gram-positive Corynebacterium glutamicum involves a be, complex with a diheme cytochrome c(1) and a cytochrome aa(3) oxidase but no additional c-type cytochromes. Here we show that the two enzymes form a supercomplex, because affinity chromatography of either strep-tagged cytochrome b (QcrB) or strep-tagged subunit I (CtaD) of cytochrome aa(3) always resulted in the copurification of the subunits of the bc(1) complex (QcrA, QcrB, QcrC) and the aa(3) complex (CtaD, CtaC, CtaE). The isolated bc(1)-aa(3) supercomplexes had quinol oxidase activity, indicating functional electron transfer between cytochrome c(1) and the Cu-A center of cytochrome aa(3). Besides the known bc(1) and aa(3) subunits, few additional proteins were copurified, one of which (CtaF) was identified as a fourth subunit of cytochrome aa(3). If either of the two CXXCH motifs for covalent heme attachment in cytochrome c(1) was changed to SXXSH, the resulting mutants showed severe growth defects, had no detectable c-type cytochrome, and their cytochrome b level was strongly reduced. This indicates that the attachment of both heme groups to apo-cytochrome c(1) is not only required for the activity but also for the assembly and/or stability of the bc(1) complex.	Forschungszentrum Julich, Inst Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Bott, M (corresponding author), Forschungszentrum Julich, Inst Biotechnol 1, Postfach 1913, D-52425 Julich, Germany.	m.bott@fz-juelich.de	Bott, Michael/E-8004-2011	Bott, Michael/0000-0002-4701-8254				ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Abramson J, 2000, NAT STRUCT BIOL, V7, P910; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Castiglioni E, 1997, REV SCI INSTRUM, V68, P4288, DOI 10.1063/1.1148344; CHANCE B, 1957, METHOD ENZYMOL, V4, P273, DOI 10.1016/0076-6879(57)04060-4; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; CREMER J, 1990, MOL GEN GENET, V220, P478, DOI 10.1007/BF00391757; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Eggeling L, 1999, APPL MICROBIOL BIOT, V52, P146, DOI 10.1007/s002530051501; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GERHUS E, 1990, J BACTERIOL, V172, P2392, DOI 10.1128/jb.172.5.2392-2400.1990; GRAY KA, 1992, BIOCHEMISTRY-US, V31, P11864, DOI 10.1021/bi00162a027; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Iwasaki T, 1995, J BIOL CHEM, V270, P30881, DOI 10.1074/jbc.270.52.30881; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jager W, 1996, ARCH MICROBIOL, V166, P76, DOI 10.1007/s002030050359; KEEFE RG, 1993, BIOCHIM BIOPHYS ACTA, V1183, P91, DOI 10.1016/0005-2728(93)90008-4; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; KRUBER O, 1929, CHEM BER, V62, P3046; Kusumoto K, 2000, ARCH MICROBIOL, V173, P390, DOI 10.1007/s002030000161; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsushita K, 2001, FEMS MICROBIOL LETT, V204, P271, DOI 10.1016/S0378-1097(01)00417-7; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Molenaar D, 1998, EUR J BIOCHEM, V254, P395, DOI 10.1046/j.1432-1327.1998.2540395.x; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Nolden L, 2002, FEMS MICROBIOL LETT, V208, P287, DOI 10.1016/S0378-1097(02)00474-3; PetersWendisch PG, 1997, MICROBIOL-SGM, V143, P1095, DOI 10.1099/00221287-143-4-1095; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; REINSCHEID DJ, 1994, APPL ENVIRON MICROB, V60, P126, DOI 10.1128/AEM.60.1.126-132.1994; Saiki K, 1996, J BIOL CHEM, V271, P15336, DOI 10.1074/jbc.271.26.15336; Sakamoto J, 2001, MICROBIOL-SGM, V147, P2865, DOI 10.1099/00221287-147-10-2865; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schaffer S, 2001, ELECTROPHORESIS, V22, P4404, DOI 10.1002/1522-2683(200112)22:20<4404::AID-ELPS4404>3.0.CO;2-2; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schirawski J, 1998, EUR J BIOCHEM, V257, P210, DOI 10.1046/j.1432-1327.1998.2570210.x; Skerra A, 2000, METHOD ENZYMOL, V326, P271; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONE N, 1987, J BIOL CHEM, V262, P15386; Sone N, 2001, BBA-BIOENERGETICS, V1503, P279, DOI 10.1016/S0005-2728(00)00205-X; SONE N, 1982, BIOCHIM BIOPHYS ACTA, V682, P216, DOI 10.1016/0005-2728(82)90101-3; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; THONYMEYER L, 1989, CELL, V57, P683, DOI 10.1016/0092-8674(89)90137-2; THONYMEYER L, 1991, P NATL ACAD SCI USA, V88, P5001, DOI 10.1073/pnas.88.11.5001; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; van Montfort BA, 2002, J MASS SPECTROM, V37, P322, DOI 10.1002/jms.288; VILLANI G, 1995, BBA-BIOENERGETICS, V1232, P67, DOI 10.1016/0005-2728(95)00112-5; Witt H, 1997, J BIOL CHEM, V272, P5514, DOI 10.1074/jbc.272.9.5514; Zufferey R, 1997, FEBS LETT, V412, P75, DOI 10.1016/S0014-5793(97)00746-1	54	97	110	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4339	4346		10.1074/jbc.M210499200	http://dx.doi.org/10.1074/jbc.M210499200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446663	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000180869700102
J	Illenberger, D; Walliser, C; Nurnberg, B; Lorente, MD; Gierschik, P				Illenberger, D; Walliser, C; Nurnberg, B; Lorente, MD; Gierschik, P			Specificity and structural requirements of phospholipase C-beta stimulation by Rho GTPases versus G protein beta gamma dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HUMAN NEUTROPHILS; HUMAN PLATELETS; SMOOTH-MUSCLE; ALPHA-SUBUNIT; BOVINE BRAIN; ACTIVATION; C-BETA(2); EXPRESSION; IDENTIFICATION	Phospholipase C-beta(2) (PLCbeta(2)) is activated both by heterotrimeric G protein alpha- and betagamma- subunits and by Rho GTPases. In this study, activated Rho GTPases are shown to stimulate PLCbeta isozymes with the rank order of PLCbeta(2) > PLCbeta(3) greater than or equal to PLCbeta(1). The sensitivity of PLCbeta isozymes to Rho GTPases was clearly different from that observed for G protein betagamma dimers, which decreased in the following order: PLCbeta(3) > PLCbeta(2) > PLCbeta(1), for beta(1)gamma(1/2) and PLCbeta(2) > PLCbeta(1) >>> PLCbeta(3) for beta(5)gamma(2). Rac1 and Rac2 were found to be more potent and efficacious activators of PLCbeta(2) than was Cdc42Hs. The stimulation of PLCbeta(2) by Rho GTPases and G protein betagamma dimers was additive, suggesting that PLCbeta(2) activation can be augmented by independent regulation of the enzyme by the two stimuli. Using chimeric PLCbeta(1)-PLCbeta(2) enzymes, betagamma dimers, and Rho GTPases are shown to require different regions of PLCbeta(2) to mediate efficient stimulation of the enzyme. Although the catalytic subdomains X and Y of PLCbeta(2) were sufficient for efficient stimulation by betagamma, the presence of the putative pleckstrin homology domain of PLCbeta(2) was absolutely required for the stimulation of the enzyme by Rho GTPases. Taken together, these results identify Rho GTPases as novel PLCbeta regulators, which mediate PLCbeta isozyme-specific stimulation and are potentially involved in coordinating the activation of PLCbeta(2) by extracellular mediators in intact cells.	Univ Ulm, Dept Pharmacol & Toxicol, D-89081 Ulm, Germany	Ulm University	Illenberger, D (corresponding author), Univ Ulm, Dept Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.			Nurnberg, Bernd/0000-0002-5995-6555				Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; BANNO Y, 1994, FEBS LETT, V340, P185, DOI 10.1016/0014-5793(94)80134-7; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BLANK JL, 1993, J BIOL CHEM, V268, P25184; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CAROZZI AJ, 1992, EUR J BIOCHEM, V210, P521, DOI 10.1111/j.1432-1033.1992.tb17450.x; Chan JSC, 2000, MOL PHARMACOL, V57, P700, DOI 10.1124/mol.57.4.700; Coburn RF, 1997, J CELL PHYSIOL, V171, P271, DOI 10.1002/(SICI)1097-4652(199706)171:3<271::AID-JCP5>3.0.CO;2-L; Di Pietro R, 1998, HUM IMMUNOL, V59, P25, DOI 10.1016/S0198-8859(97)00228-0; DIETRICH A, 1994, EUR J BIOCHEM, V219, P171, DOI 10.1111/j.1432-1033.1994.tb19927.x; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; GIERSCHIK P, 1994, METHOD ENZYMOL, V238, P181; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; JHON DY, 1993, J BIOL CHEM, V268, P6654; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; Jiang HP, 1996, J BIOL CHEM, V271, P13430, DOI 10.1074/jbc.271.23.13430; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kuang YN, 1996, P NATL ACAD SCI USA, V93, P2964, DOI 10.1073/pnas.93.7.2964; Labelle EF, 1996, J CELL PHYSIOL, V169, P358, DOI 10.1002/(SICI)1097-4652(199611)169:2<358::AID-JCP15>3.0.CO;2-5; Lee SB, 1996, BLOOD, V88, P1684; LeMellay V, 1997, J BIOL CHEM, V272, P11902, DOI 10.1074/jbc.272.18.11902; MA HW, 1994, METHOD ENZYMOL, V238, P244; Maier U, 2000, J BIOL CHEM, V275, P13746, DOI 10.1074/jbc.275.18.13746; Min DS, 2000, NEUROSCI LETT, V292, P9, DOI 10.1016/S0304-3940(00)01419-1; PARK D, 1992, J BIOL CHEM, V267, P16048; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; Rabiet MJ, 2002, BLOOD, V100, P1835, DOI 10.1182/blood-2001-12-0193; Razzini G, 2000, J BIOL CHEM, V275, P14873, DOI 10.1074/jbc.275.20.14873; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; RYU SH, 1986, BIOCHEM BIOPH RES CO, V141, P137, DOI 10.1016/S0006-291X(86)80345-X; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; SCHNABEL P, 1993, EUR J BIOCHEM, V217, P1109, DOI 10.1111/j.1432-1033.1993.tb18343.x; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; SINKE RJ, 1995, GENOMICS, V25, P568, DOI 10.1016/0888-7543(95)80060-Y; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; SUH PG, 1988, J BIOL CHEM, V263, P14497; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; VAN AL, 1997, GENE DEV, V11, P2295; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Wang TL, 1999, BIOCHEMISTRY-US, V38, P1517, DOI 10.1021/bi982008f; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Zhang W, 2001, J BIOL CHEM, V276, P2503, DOI 10.1074/jbc.M003562200	56	59	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3006	3014		10.1074/jbc.M208282200	http://dx.doi.org/10.1074/jbc.M208282200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12441352	hybrid			2022-12-27	WOS:000180915000032
J	Pillai, B; Verma, J; Abraham, A; Francis, P; Kumar, Y; Tatu, U; Brahmachari, SK; Sadhale, PP				Pillai, B; Verma, J; Abraham, A; Francis, P; Kumar, Y; Tatu, U; Brahmachari, SK; Sadhale, PP			Whole genome expression profiles of yeast RNA polymerase II core subunit, Rpb4, in stress and nonstress conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; TEMPERATURE EXTREMES; TRANSCRIPTION; PROTEIN; GROWTH; INFORMATION; DELETION; MUTANT; GENE	Organisms respond to environmental stress by adopting changes in gene expression at the transcriptional level. Rpb4, a nonessential subunit of the core RNA polymerase 11 has been proposed to play a role in non-stress-specific transcription and in the regulation of stress response in yeast. We find that in addition to the temperature sensitivity of the null mutant of Rpb4, diploid null mutants are also compromised in sporulation and show morphological changes associated with nitrogen starvation. Using whole genome expression analysis, we report here the effects of Rpb4 on expression of genes during normal growth and following heat shock and nutritional starvation. Our analysis shows that Rpb4 affects expression of a small yet significant fraction of the genome in both stress and normal conditions. We found that genes involved in galactose metabolism were dependent on the presence of Rpb4 irrespective of the environmental condition. Rpb4 was also found to affect the expression of several other genes specifically in conditions of nutritional starvation. The general defect in the absence of Rpb4 is in the expression of metabolic genes, especially those involved in carbon metabolism and energy generation. We report that various stresses are affected by RPB4 and that on overexpression the stress-specific activators can partially rescue the corresponding defects.	Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; Inst Genom & Integrat Biol, New Delhi 110007, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sadhale, PP (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.		Sadhale, PArag/A-7799-2009	Pillai, Beena/0000-0002-9302-9878; Tatu, Utpal/0000-0003-0404-8872; budigi, yadunanda/0000-0003-3784-2431				Ausubel FM, 1994, CURRENT PROTOCOLS MO; BAILEY TL, 1994, P 2 INT C INT SYST M, V26, P28; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chan TF, 2000, P NATL ACAD SCI USA, V97, P13227, DOI 10.1073/pnas.240444197; CHERRY JM, 2001, SACCHAROMYES GENOME; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kimura M, 2002, MOL CELL BIOL, V22, P1577, DOI 10.1128/MCB.22.5.1577-1588.2002; Maillet I, 1999, J BIOL CHEM, V274, P22586, DOI 10.1074/jbc.274.32.22586; Marc P, 2001, Nucleic Acids Res, V29, pE63, DOI 10.1093/nar/29.13.e63; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Miyao T, 1998, P NATL ACAD SCI USA, V95, P15281, DOI 10.1073/pnas.95.26.15281; Miyao T, 2001, J BIOL CHEM, V276, P46408, DOI 10.1074/jbc.M107012200; Moskvina E, 1999, MOL MICROBIOL, V32, P1263, DOI 10.1046/j.1365-2958.1999.01438.x; Palecek SP, 2000, GENETICS, V156, P1005; Pillai B, 2001, J BIOL CHEM, V276, P30641, DOI 10.1074/jbc.M010952200; Pillai B, 2001, CURR SCI INDIA, V81, P574; Rosenheck S, 1998, J BACTERIOL, V180, P6187; SHAH JC, 1992, MOL CELL BIOL, V12, P1078, DOI 10.1128/MCB.12.3.1078; Tan Q, 2000, MOL CELL BIOL, V20, P8124, DOI 10.1128/MCB.20.21.8124-8133.2000; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; WOYCHIK NA, 1991, J BIOL CHEM, V266, P19053; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854	33	41	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3339	3346		10.1074/jbc.M112180200	http://dx.doi.org/10.1074/jbc.M112180200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12429747	hybrid			2022-12-27	WOS:000180915000073
J	Borchert, A; Savaskan, NE; Kuhn, H				Borchert, A; Savaskan, NE; Kuhn, H			Regulation of expression of the phospholipid hydroperoxide/sperm nucleus glutathione peroxidase gene - Tissue-specific expression pattern and identification of functional cis- and trans-regulatory elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICING ENHANCER; RAT TESTIS; PROTEIN; EXON; MEMBRANE; BINDING; SITE	A sperm nucleus glutathione peroxidase (snGPx), which is closely related to the phospholipid hydroperoxide glutathione peroxidase (phGPx), was recently discovered in late spermatids. Both GPx isoforms originate from a joint ph/snGPx gene, but their N-terminal peptides are encoded by alternative first exons. The expression of the two enzymes is differentially regulated in various cells, but little is known about the regulatory mechanisms. To explore the tissue-specific regulation of expression of the two isoenzymes, we first investigated their tissue distribution. Whereas phGPx is expressed at low levels in many organs, snGPx was only detected in testis, kidney, and in the human embryonic kidney cell line HEK293. Subcellular fractionation studies and immunoelectron microscopy revealed a cytosolic localization. To explore the mechanistic reasons for the differential expression pattern, we first tested the activity of the putative phGPx and snGPx promoters. The 5'-flanking region of the joint ph/snGPx gene exhibits strong promoter activity. In contrast, the putative snGPx promoter, which comprises 334 bp of intronic sequences, lacks major promoter activity. However, it strongly suppresses the activity of the ph/snGPx promoter. These data suggest negative regulatory elements in the first intron of the ph/snGPx gene, and DNase protection assays revealed the existence of several protein-binding sites. The corresponding trans-regulatory proteins (SP1, ERG1, GATA1, SREBP1, USF1, and CREBP1) were identified, and in vivo binding of EGR1 and SREBP1 was shown by chromatin immunoprecipitation. These data indicate for the first time somatic expression of the snGPx and provide evidence for the existence of intronic negative cis-regulatory elements in the ph/snGPx gene. Our failure to detect an alternative snGPx promoter suggests that transcription of the ph/snGPx gene may be regulated by a joint basic promoter. The decision, which GPx isoform is expressed in a given cell, appears to be made by alternative splicing of a joint primary transcript.	Humboldt Univ, Inst Biochem, Univ Klinikum, Charite,Med Sch, D-10117 Berlin, Germany; Humboldt Univ, Inst Anat & Cell Biol, Sch Med, Charite, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhn, H (corresponding author), Humboldt Univ, Inst Biochem, Univ Klinikum, Charite,Med Sch, Monbijoustr 2, D-10117 Berlin, Germany.	hartmut.kuehn@charite.de	; Savaskan, Nicolai/D-2923-2018	Borchert, Astrid/0000-0003-3551-5592; Savaskan, Nicolai/0000-0003-1348-094X				Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Ashiya M, 1997, RNA, V3, P996; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Cheng WH, 1997, J NUTR, V127, P1445, DOI 10.1093/jn/127.8.1445; CONZ PA, 1993, EXP NEPHROL, V1, P376; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Dreher I, 1997, J TRACE ELEM MED BIO, V11, P83, DOI 10.1016/S0946-672X(97)80031-4; Flohe L., 1989, GLUTATHIONE CHEM BIO, P643; Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9; Gee SL, 2000, BLOOD, V95, P692, DOI 10.1182/blood.V95.2.692; Gille L, 2001, FREE RADICAL BIO MED, V30, P865, DOI 10.1016/S0891-5849(01)00475-0; HELFMAN DM, 1988, GENE DEV, V2, P1627, DOI 10.1101/gad.2.12a.1627; Jaiswal AS, 2001, J CELL BIOCHEM, V81, P262, DOI 10.1002/1097-4644(20010501)81:2<262::AID-JCB1041>3.0.CO;2-R; Knopp EA, 1999, MAMM GENOME, V10, P601, DOI 10.1007/s003359901053; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; MAIORINO M, 1991, FREE RADICAL RES COM, V12-3, P131, DOI 10.3109/10715769109145777; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; NASIM FH, 1990, GENE DEV, V4, P1172, DOI 10.1101/gad.4.7.1172; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; ROVERI A, 1994, BBA-PROTEIN STRUCT M, V1208, P211, DOI 10.1016/0167-4838(94)90106-6; ROVERI A, 1992, J BIOL CHEM, V267, P6142; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Schoonjans K, 2000, BBA-MOL CELL BIOL L, V1529, P114, DOI 10.1016/S1388-1981(00)00141-4; Standiford DM, 2001, GENETICS, V157, P259; TSUKAHARA T, 1994, NUCLEIC ACIDS RES, V22, P2318, DOI 10.1093/nar/22.12.2318; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; YAMAMOTO Y, 1987, ANAL BIOCHEM, V160, P7, DOI 10.1016/0003-2697(87)90606-3; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Zabel MD, 2000, J IMMUNOL, V165, P4437, DOI 10.4049/jimmunol.165.8.4437; Zhai G, 2001, BIOCHEMISTRY-US, V40, P2032, DOI 10.1021/bi001941r	34	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2571	2580		10.1074/jbc.M209064200	http://dx.doi.org/10.1074/jbc.M209064200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427732	hybrid			2022-12-27	WOS:000180562000067
J	Freebern, WJ; Smith, JL; Chaudhry, SS; Haggerty, CM; Gardner, K				Freebern, WJ; Smith, JL; Chaudhry, SS; Haggerty, CM; Gardner, K			Novel cell-specific and dominant negative anti-apoptotic roles of p73 in transformed leukemia cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-RELATED PROTEIN; MUTATION ANALYSIS; SPLICE VARIANTS; GENE; P53; EXPRESSION; VIRUS; OVEREXPRESSION; PROMOTER; CANCER	Although extensive homology exists between related genes p53 and p 73, recent data suggest that the family members have divergent roles. We demonstrate that the differential regulatory roles of p53 family member p73 are highly cell-context and promoter-specific. Full-length p73 expressed in the transformed leukemia cell line Jurkat behaves as a specific dominant negative transcriptional repressor of the cell cycle inhibitor gene p21 and blocks p53-mediated apoptosis. These findings provide evidence for a new mechanism in oncogenesis through which the functional properties of p73 can be altered in an inheritable and cell-specific fashion independent of transcriptional coding.	NCI, Lab Receptor Biol & Gene Express, Adv Technol Ctr, NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; Howard Univ, Dept Microbiol, Washington, DC 20001 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University	Gardner, K (corresponding author), NCI, Lab Receptor Biol & Gene Express, Adv Technol Ctr, NIH, Rm 134C,8717 Grovemont Circle, Bethesda, MD 20892 USA.	gardnerk@mail.nih.gov		Haggerty, Cynthia/0000-0002-6019-2724				Banelli B, 2000, ONCOGENE, V19, P4553, DOI 10.1038/sj.onc.1203807; Butscher WG, 1998, J BIOL CHEM, V273, P552, DOI 10.1074/jbc.273.1.552; Butscher WG, 2001, J BIOL CHEM, V276, P27647, DOI 10.1074/jbc.M009614200; CESARMAN E, 1992, BLOOD, V80, P3205; Chaudhry S, 2002, J IMMUNOL, V169, P6767, DOI 10.4049/jimmunol.169.12.6767; CHENG J, 1990, MOL CELL BIOL, V21, P5520; Chi SG, 1999, CANCER RES, V59, P2791; Chi SW, 1999, EMBO J, V18, P4438, DOI 10.1093/emboj/18.16.4438; Corn PG, 1999, CANCER RES, V59, P3352; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Davis PK, 2001, INT J BIOCHEM CELL B, V33, P935, DOI 10.1016/S1357-2725(01)00073-5; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Han S, 1999, EUR J SURG ONCOL, V25, P194, DOI 10.1053/ejso.1998.0626; Hingorani R, 2000, J IMMUNOL, V164, P4032, DOI 10.4049/jimmunol.164.8.4032; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; JUVEN T, 1993, ONCOGENE, V8, P3411; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kawano S, 1999, BLOOD, V94, P1113; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Lemasson I, 2001, J BIOL CHEM, V276, P15720, DOI 10.1074/jbc.M100131200; Levrero M, 2000, J CELL SCI, V113, P1661; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Loiseau H, 1999, NEUROSCI LETT, V263, P173, DOI 10.1016/S0304-3940(99)00130-5; Mai M, 1998, CANCER RES, V58, P2347; Mai M, 1998, GENOMICS, V51, P359, DOI 10.1006/geno.1998.5387; Mulloy JC, 1998, J VIROL, V72, P8852, DOI 10.1128/JVI.72.11.8852-8860.1998; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nomoto S, 1998, CANCER RES, V58, P1380; Novak U, 2001, ANN ONCOL, V12, P981, DOI 10.1023/A:1011153206003; Pise-Masison CA, 1998, J VIROL, V72, P6348, DOI 10.1128/JVI.72.8.6348-6355.1998; Pise-Masison CA, 2001, J BIOL CHEM, V276, P200, DOI 10.1074/jbc.M005601200; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; STANO S, 2000, J BIOL CHEM, V275, P29503; Sunahara M, 1998, INT J ONCOL, V13, P319; Takahashi H, 1998, CANCER RES, V58, P2076; Tokuchi Y, 1999, BRIT J CANCER, V80, P1623, DOI 10.1038/sj.bjc.6690572; Van Orden K, 1999, J BIOL CHEM, V274, P26321, DOI 10.1074/jbc.274.37.26321; Vikhanskaya F, 2000, NUCLEIC ACIDS RES, V28, P513, DOI 10.1093/nar/28.2.513; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; YEARGIN J, 1992, LEUKEMIA, V6, pS85; Yokomizo A, 1999, ONCOGENE, V18, P1629, DOI 10.1038/sj.onc.1202474; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zaika AI, 1999, CANCER RES, V59, P3257; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhu JH, 1998, CANCER RES, V58, P5061; Zwahlen D, 2000, INT J CANCER, V88, P66	52	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2249	2255		10.1074/jbc.M208517200	http://dx.doi.org/10.1074/jbc.M208517200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427762	hybrid			2022-12-27	WOS:000180562000025
J	Lambert, G; Amar, MJA; Guo, G; Brewer, HB; Gonzalez, FJ; Sinal, CJ				Lambert, G; Amar, MJA; Guo, G; Brewer, HB; Gonzalez, FJ; Sinal, CJ			The farnesoid X-receptor is an essential regulator of cholesterol homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; BILE-ACID; NUCLEAR RECEPTOR; TRANSGENIC MICE; TARGETED DISRUPTION; SELECTIVE UPTAKE; UP-REGULATION; PROTEIN GENE; LXR-ALPHA; IN-VIVO	To address the importance of the farnesoid X-receptor (FXR; NR1H4) for normall. cholesterol homeostasis, we evaluated the major pathways of cholesterol metabolism in the FXR-deficient (-/-) mouse model. Compared with wild-type, FXR(-/-) mice have increased plasma high density lipoprotein (HDL cholesterol and a markedly reduced rate of plasma HDL cholesterol ester clearance. Concomitantly, FXR(-/-) mice exhibit reduced expression of hepatic genes involved in reverse cholesterol transport, most notably, that for scavenger receptor BI. FXR(-/-) mice also have increased: W plasma non-HDL cholesterol and triglyceride levels, (ii) apolipoprotein B-containing lipoprotein synthesis, and (iii) intestinal cholesterol absorption. Surprisingly, biliary cholesterol elimination was increased in FXR(-/-) mice, despite decreased expression of hepatic genes thought to be involved in this process. These data demonstrate that FXR is a critical regulator, of normal cholesterol metabolism and that genetic changes affecting FXR function have the potential to be pro-atherogenic.	Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada; NHLBI, Mol Dis Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	Dalhousie University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sinal, CJ (corresponding author), Dalhousie Univ, Dept Pharmacol, Sir Charles Tupper Med Bldg,5859 Univ Ave, Halifax, NS B3H 4H7, Canada.		Amar, Marcelo/AAD-5599-2019	Lambert, Gilles/0000-0001-5632-0685; Sinal, Christopher/0000-0001-8301-3349				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bjorkhem I, 2001, CURR OPIN LIPIDOL, V12, P97, DOI 10.1097/00041433-200104000-00002; Boisfer E, 1999, J BIOL CHEM, V274, P11564, DOI 10.1074/jbc.274.17.11564; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; CHEN CH, 1982, J LIPID RES, V23, P680; Claudel T, 2002, J CLIN INVEST, V109, P961; Costet P, 2000, J BIOL CHEM, V275, P28240; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; Edwards PA, 2002, J LIPID RES, V43, P2; Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200; Fuchs M, 2001, HEPATOLOGY, V33, P1451, DOI 10.1053/jhep.2001.24373; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Lambert G, 2001, J BIOL CHEM, V276, P15090, DOI 10.1074/jbc.M008466200; Lambert G, 2000, J LIPID RES, V41, P667; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300; Miyake JH, 2001, J BIOL CHEM, V276, P23304, DOI 10.1074/jbc.M101853200; Natarajan R, 1998, BIOCHEM BIOPH RES CO, V243, P349, DOI 10.1006/bbrc.1997.8030; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72; Shamburek RD, 1997, J LIPID RES, V38, P2422; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Tall AR, 2001, J CLIN INVEST, V108, P1273; Tso P, 2001, ANNU REV NUTR, V21, P231, DOI 10.1146/annurev.nutr.21.1.231; TURLEY SD, 1994, J LIPID RES, V35, P328; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wu J, 2002, MOL ENDOCRINOL, V16, P1590, DOI 10.1210/me.16.7.1590; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Zanlungo S, 2000, GASTROENTEROLOGY, V119, P1708, DOI 10.1053/gast.2000.20198; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200	54	287	314	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2563	2570		10.1074/jbc.M209525200	http://dx.doi.org/10.1074/jbc.M209525200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12421815	hybrid			2022-12-27	WOS:000180562000066
J	Kloth, MT; Laughlin, KK; Biscardi, JS; Boerner, JL; Parsons, SJ; Silva, CM				Kloth, MT; Laughlin, KK; Biscardi, JS; Boerner, JL; Parsons, SJ; Silva, CM			STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; PROTEIN-TYROSINE KINASES; MITOGENIC RESPONSIVENESS; CONSTITUTIVE ACTIVATION; TRANSCRIPTION FACTORS; CYTOKINE RECEPTORS; CARCINOMA CELLS; DNA-BINDING; IM-9 CELLS; V-SRC	Overexpression of the epidermal growth factor receptor (EGFR) and its association with the tyrosine kinase, c-Src, is correlated with increased cellular proliferation and tumorigenesis. Previous studies have shown that EGFR and c-Src co-overexpression and association leads to the c-Src-mediated phosphorylation of tyrosine 845 of the EGFR and that mutation of Tyr(845) ablates epidermal growth factor (EGF)-induced DNA synthesis. Here, we investigate the contribution of the signal transducers and activators of transcription (STAT5b) in the signaling pathways regulated by EGFR and c-Src overexpression in human breast tumor cell lines as well as in a mouse fibroblast model (C3H10T1/2). We demonstrate that 1) activation of STAT5b by EGF requires overexpression of the EGFR, 2) co-overexpression of c-Src alone does not result in EGF-induced activation of STAT5b but enhances that seen in EGFR-overexpressing cells, and 3) EGF-induced tyrosine phosphorylation of STAT5b requires Tyr845 of the EGFR. Furthermore, the stable overexpression of a kinase-defective c-Src in the context of EGFR overexpression results in a decrease in the tyrosine phosphorylation of STAT5b in response to EGF and a more dramatic decrease in EGF-induced transcriptional activation of STAT5b, suggesting an integral role for c-Src in the physiological actions of STAT5b. Using a dominant negative STAT5b, we provide evidence that one such physiological action is to mediate EGF-induced DNA-synthesis. Finally, the use of site-specific tyrosine mutants demonstrates that EGF-induced phosphorylation of STAT5b involves not only tyrosine 699 of STAT5b, which is required for its transcriptional activation, but also three previously identified tyrosines in the C terminus of STAT5b (Tyr(725)/Tyr(740)/Tyr(743)).	Univ Virginia, Hth Syst, Dept Internal Med, Charlottesville, VA 22908 USA; Univ Virginia, Hth Syst, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Hth Syst, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Silva, CM (corresponding author), Univ Virginia, Hth Syst, Dept Internal Med, Box 800578, Charlottesville, VA 22908 USA.				NCI NIH HHS [CA71449, CA39438] Funding Source: Medline; NICHD NIH HHS [P30-HD28934] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028934] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA071449, R01CA039438] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BATTAGLIA F, 1988, EUR J CANCER CLIN ON, V24, P1685, DOI 10.1016/0277-5379(88)90068-5; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; HARRIS JR, 1992, NEW ENGL J MED, V327, P473, DOI 10.1056/NEJM199208133270706; Humphreys RC, 1999, CELL GROWTH DIFFER, V10, P685; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Kazansky AV, 1999, J BIOL CHEM, V274, P22484, DOI 10.1074/jbc.274.32.22484; Kazansky AV, 2001, CELL GROWTH DIFFER, V12, P1; Kloth MT, 2002, J BIOL CHEM, V277, P8693, DOI 10.1074/jbc.M111884200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; LUTTRELL DK, 1988, MOL CELL BIOL, V8, P497, DOI 10.1128/MCB.8.1.497; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; MUTHUSWAMY SK, 1995, ONCOGENE, V11, P271; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Ren SX, 2002, ONCOGENE, V21, P4335, DOI 10.1038/sj.onc.1205484; ROCHE S, 1995, MOL CELL BIOL, V15, P1102; SAINSBURY J, 1987, J CLIN PATHOL, V38, P1225; Sartor CI, 1997, CANCER RES, V57, P978; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SILVA CM, 1994, J BIOL CHEM, V269, P27532; Silva CM, 1996, MOL ENDOCRINOL, V10, P508, DOI 10.1210/me.10.5.508; Silverberg D, 1998, NEPHRON, V80, P1, DOI 10.1159/000045118; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; TOI M, 1991, EUR J CANCER, V27, P977, DOI 10.1016/0277-5379(91)90262-C; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536	42	118	123	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1671	1679		10.1074/jbc.M207289200	http://dx.doi.org/10.1074/jbc.M207289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12429742	hybrid			2022-12-27	WOS:000180462200041
J	Nogami, K; Wakabayashi, H; Schmidt, K; Fay, PJ				Nogami, K; Wakabayashi, H; Schmidt, K; Fay, PJ			Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FACTOR-VIII; ACTIVATED PROTEIN-C; LENGTH CROSS-LINKING; FACTOR-IXA; COFACTOR ACTIVITY; CATALYZED PROTEOLYSIS; PROCOAGULANT ACTIVITY; ANTIHEMOPHILIC-FACTOR; A1/A3-C1-C2 DIMER; HEAVY-CHAIN	Factor VIIIa consists of subunits designated A1, A2, and A3-C1-C2. The limited cofactor activity observed with the isolated A2 subunit is markedly enhanced by the Al subunit. A truncated Al (A1(336)) was previously shown to possess similar affinity for A2 and retain similar to60% of its A2 stimulatory activity. We now identify a second site in A1 at Lys(36) that is cleaved by factor Xa. A1 truncated at both cleavage sites (A1(37-336)) showed little if any affinity for A2 (K-d > 2 mum), whereas factor VIIIa reconstituted with A2 plus A1(37-336)/A3-C1-C2 dimer demonstrated significant cofactor activity (similar to30% that of factor VIIIa reconstituted with native A1) in a factor Xa generation assay. These affinity values were consistent with values obtained by fluorescence energy transfer using acrylodan-labeled A2 and fluorescein-labeled A1. In contrast, factor VIIIa reconstituted with A137-336 showed little activity in a one-stage clotting assay. This resulted in part from a 5-fold increase in K-m for factor X when A1 was cleaved at Arg(336). These findings suggest that both A1 termini are necessary for functional interaction of A1 with A2. Furthermore, the C terminus of A1 contributes to the K-m for factor X binding to factor Xase, and this parameter is critical for activity assessed in plasma-based assays.	Univ Rochester, Dept Biochem & Biophys, Med Ctr, Sch Med & Dent, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Fay, PJ (corresponding author), Univ Rochester, Dept Biochem & Biophys, Med Ctr, Sch Med & Dent, 601 Elmwood Ave,POB 610, Rochester, NY 14642 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030616, R01HL038199] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30616, HL 38199] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cameron C, 1998, THROMB HAEMOSTASIS, V79, P317, DOI 10.1055/s-0037-1614984; CASILLAS G, 1971, COAGULATION, V4, P107; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; ELDER B, 1993, GENOMICS, V16, P374, DOI 10.1006/geno.1993.1200; FAY PJ, 1993, J BIOL CHEM, V268, P17861; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 2001, BBA-PROTEIN STRUCT M, V1548, P159, DOI 10.1016/S0167-4838(01)00225-4; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Fay PJ, 1999, J BIOL CHEM, V274, P15401, DOI 10.1074/jbc.274.22.15401; FOSTER PA, 1988, J CLIN INVEST, V82, P123, DOI 10.1172/JCI113559; Healey JF, 1996, BLOOD, V88, P4209; Koszelak ME, 2000, J BIOL CHEM, V275, P27137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Lapan KA, 1998, THROMB HAEMOSTASIS, V80, P418, DOI 10.1055/s-0037-1615223; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LOLLAR P, 1993, METHOD ENZYMOL, V222, P128; LOLLAR P, 1985, BIOCHEMISTRY-US, V24, P8056, DOI 10.1021/bi00348a033; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; MCMULLEN BA, 1995, PROTEIN SCI, V4, P740; Medzihradszky KF, 1997, ANAL CHEM, V69, P3986, DOI 10.1021/ac970372z; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; OBrien LM, 1997, BLOOD, V90, P3943, DOI 10.1182/blood.V90.10.3943; Parker ET, 1997, BIOCHEMISTRY-US, V36, P9365, DOI 10.1021/bi970599o; Pemberton S, 1997, BLOOD, V89, P2413, DOI 10.1182/blood.V89.7.2413; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Regan LM, 1996, J BIOL CHEM, V271, P3982; Rosenblum MEK, 2002, J BIOL CHEM, V277, P11664, DOI 10.1074/jbc.M200037200; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Wakabayashi H, 2001, BIOCHEMISTRY-US, V40, P10293, DOI 10.1021/bi010353q; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	45	48	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1634	1641		10.1074/jbc.M209811200	http://dx.doi.org/10.1074/jbc.M209811200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426309	hybrid			2022-12-27	WOS:000180462200036
J	Lee, SJ; Engelmann, A; Horlacher, R; Qu, QH; Vierke, G; Hebbeln, C; Thomm, M; Boos, W				Lee, SJ; Engelmann, A; Horlacher, R; Qu, QH; Vierke, G; Hebbeln, C; Thomm, M; Boos, W			TrmB, a sugar-specific transcriptional regulator of the trehalose/maltose ABC transporter from the hyperthermophilic archaeon Thermococcus litoralis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE TRANSCRIPTION; BINDING-PROTEIN; ESCHERICHIA-COLI; PYROCOCCUS-FURIOSUS; BIOCHEMICAL-ANALYSIS; MALTOSE TRANSPORT; CRYSTAL-STRUCTURE; SYSTEM; INITIATION; COMPLEX	We report the characterization of TrmB, a protein of 38,800 apparent molecular weight, that is involved in the maltose-specific regulation of a gene cluster in Thermococcus litoralis, malE malF malG orf trmB malK, encoding a binding protein-dependent ABC transporter for trehalose and maltose. TrmB binds maltose and trehalose half-maximally at 20 muM and 0.5 mM sugar concentration, respectively. Binding of maltose but not of trehalose showed indications of sigmoidality and quenched the intrinsic tryptophan fluorescence by 15%, indicating a conformational change on maltose binding. TrmB causes a shift in electrophoretic mobility of DNA fragments harboring the promoter and upstream regulatory motif identified by footprinting. Band shifting by TrmB can be prevented by maltose. In vitro transcription assays with purified components from Pyrococcus furiosus have been established to show pmalE promoter-dependent transcription at 80 degreesC. TrmB specifically inhibits transcription, and this inhibition is counteracted by maltose and trehalose. These data characterize TrmB as a maltose-specific repressor for the trehalose/maltose transport operon of Thermococcus litoralis.	Univ Konstanz, Dept Biol, D-78457 Constance, Germany; Univ Kiel, Inst Allgemeine Mikrobiol, D-24118 Kiel, Germany	University of Konstanz; University of Kiel	Boos, W (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.		Lee, Sungjae/AAI-8586-2020	Lee, Sungjae/0000-0002-3997-9020				Ausubel FM, 1987, CURRENTS PROTOCOLS M; BANEYX F, 1991, J BACTERIOL, V173, P2696, DOI 10.1128/jb.173.8.2696-2703.1991; Bell SD, 2000, J BIOL CHEM, V275, P31624, DOI 10.1074/jbc.M005422200; Bell SD, 1999, MOL CELL, V4, P971, DOI 10.1016/S1097-2765(00)80226-9; Bell SD, 1998, COLD SPRING HARB SYM, V63, P41, DOI 10.1101/sqb.1998.63.41; Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200; Boos W, 2000, TRENDS GENET, V16, P404, DOI 10.1016/S0168-9525(00)02086-2; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Brinkman AB, 2000, J BIOL CHEM, V275, P38160, DOI 10.1074/jbc.M005916200; Dahlke I, 2002, NUCLEIC ACIDS RES, V30, P701, DOI 10.1093/nar/30.3.701; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; DiRuggiero J, 2000, MOL MICROBIOL, V38, P684, DOI 10.1046/j.1365-2958.2000.02161.x; DIRUGGIERO J, 1995, ARCHAEA LAB MANUAL; Enoru-Eta J, 2000, J BACTERIOL, V182, P3661, DOI 10.1128/JB.182.13.3661-3672.2000; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; Greller G, 1999, J BIOL CHEM, V274, P20259, DOI 10.1074/jbc.274.29.20259; Greller G, 2001, EUR J BIOCHEM, V268, P4011, DOI 10.1046/j.1432-1327.2001.02313.x; HAUSNER W, 1991, J MOL BIOL, V222, P495, DOI 10.1016/0022-2836(91)90492-O; Hausner W, 2001, J BACTERIOL, V183, P3025, DOI 10.1128/JB.183.10.3025-3031.2001; Hethke C, 1996, NUCLEIC ACIDS RES, V24, P2369, DOI 10.1093/nar/24.12.2369; Horlacher R, 1998, J BACTERIOL, V180, P680, DOI 10.1128/JB.180.3.680-689.1998; Koning Sonja M., 2002, Archaea, V1, P19, DOI 10.1155/2002/529610; Lamosa P, 1998, APPL ENVIRON MICROB, V64, P3591; Napoli A, 1999, J BACTERIOL, V181, P1474, DOI 10.1128/JB.181.5.1474-1480.1999; NEUNER A, 1990, ARCH MICROBIOL, V153, P205, DOI 10.1007/BF00247822; Pajatsch M, 1998, J BACTERIOL, V180, P2630, DOI 10.1128/JB.180.10.2630-2635.1998; RAIBAUD O, 1989, J MOL BIOL, V205, P471, DOI 10.1016/0022-2836(89)90218-0; RAIBAUD O, 1987, J BACTERIOL, V169, P3059, DOI 10.1128/jb.169.7.3059-3061.1987; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; RICHET E, 1991, CELL, V66, P1185, DOI 10.1016/0092-8674(91)90041-V; Rinker KD, 1996, APPL ENVIRON MICROB, V62, P4478, DOI 10.1128/AEM.62.12.4478-4485.1996; Soppa J, 1999, MOL MICROBIOL, V31, P1295, DOI 10.1046/j.1365-2958.1999.01273.x; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; SZMELCMAN S, 1976, EUR J BIOCHEM, V65, P13, DOI 10.1111/j.1432-1033.1976.tb10383.x; Thomm M, 1996, FEMS MICROBIOL REV, V18, P159; Voorhorst WGB, 1999, J BACTERIOL, V181, P3777, DOI 10.1128/JB.181.12.3777-3783.1999; Xavier KB, 1999, J BACTERIOL, V181, P3358, DOI 10.1128/JB.181.11.3358-3367.1999; Xavier KB, 1996, J BACTERIOL, V178, P4773, DOI 10.1128/jb.178.16.4773-4777.1996	40	68	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					983	990		10.1074/jbc.M210236200	http://dx.doi.org/10.1074/jbc.M210236200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12426307	hybrid			2022-12-27	WOS:000180321900039
J	Magnusson, LU; Nystrom, T; Farewell, A				Magnusson, LU; Nystrom, T; Farewell, A			Underproduction of sigma(70) mimics a stringent response - A proteome approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; COLI RNA-POLYMERASE; ESCHERICHIA-COLI; GUANOSINE TETRAPHOSPHATE; RIBOSOMAL-RNA; TRANSCRIPTION INITIATION; GENE-EXPRESSION; PROMOTERS RPLJ; IN-VITRO; RPSA P1	When Escherichia coli cells enter stationary phase due to carbon starvation the synthesis of ribosomal proteins is rapidly repressed. In a DeltarelA DeltaspoT mutant, defective in the production of the alarmone guanosine tetraphosphate (ppGpp), this regulation of the levels of the protein synthesizing system is abolished. Using a proteomic approach we demonstrate that the production of the vast majority of detected E. coli proteins are decontrolled during carbon starvation in the DeltarelA DeltaspoT strain and that the starved cells behave as if they were growing exponentially. In addition we show that the inhibition of ribosome synthesis by the stringent response can be qualitatively mimicked by artificially lowering the levels of the housekeeping sigma factor, sigma(70). In other words, genes encoding the protein-synthesizing system are especially sensitive to reduced availability of sigma(70) programmed RNA polymerase. This effect is not dependent on ppGpp since lowering the levels of sigma(70) gives a similar but less pronounced effect in a ppGpp(0) strain. The data is discussed in view of the models advocating for a passive control of gene expression during stringency based on alterations in RNA polymerase availability.	Univ Gothenburg, Dept Cell & Mol Biol Microbiol, S-40530 Gothenburg, Sweden	University of Gothenburg	Farewell, A (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Box 462, S-40530 Gothenburg, Sweden.	anne.farewell@gmm.gu.se	Farewell, Anne/M-2618-2016; Farewell, Anne/O-4167-2019	Farewell, Anne/0000-0002-0841-4908; Farewell, Anne/0000-0002-0841-4908				Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; BARACCHINI E, 1988, J BIOL CHEM, V263, P2597; BARACCHINI E, 1987, ANAL BIOCHEM, V167, P245, DOI 10.1016/0003-2697(87)90160-6; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; Daniels Lacy, 1994, P512; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; GENTRY DR, 1995, J BACTERIOL, V177, P3890, DOI 10.1128/jb.177.13.3890-3893.1995; Gourse Richard L., 1996, P521; HERNANDEZ VJ, 1991, J BIOL CHEM, V266, P5991; Hicks KA, 1996, MOL MICROBIOL, V20, P201, DOI 10.1111/j.1365-2958.1996.tb02501.x; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; KAJITANI M, 1984, J BIOL CHEM, V259, P1951; Krohn M, 1996, J BIOL CHEM, V271, P23884, DOI 10.1074/jbc.271.39.23884; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kvint K, 2000, MOL MICROBIOL, V35, P435, DOI 10.1046/j.1365-2958.2000.01714.x; Kvint K, 2000, J BIOL CHEM, V275, P14795, DOI 10.1074/jbc.C000128200; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; Neubauer P, 1995, J BIOTECHNOL, V43, P195, DOI 10.1016/0168-1656(95)00130-1; NYSTROM T, 1994, MOL GEN GENET, V245, P355, DOI 10.1007/BF00290116; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PHILLIPS T, 1987, ESCHERICHIA COLI SAL, V2; Raghavan A, 1998, BIOPHYS CHEM, V75, P21, DOI 10.1016/S0301-4622(98)00186-0; Raghavan A, 1998, BIOPHYS CHEM, V75, P7, DOI 10.1016/S0301-4622(98)00185-9; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHREIBER G, 1991, J BIOL CHEM, V266, P3760; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; VANBOGELEN RA, 1992, ELECTROPHORESIS, V13, P1014, DOI 10.1002/elps.11501301203; Vogel U, 1997, J BIOL CHEM, V272, P12265, DOI 10.1074/jbc.272.19.12265; WANNER BL, 1977, J BACTERIOL, V130, P212, DOI 10.1128/JB.130.1.212-222.1977; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; Zou YN, 1997, J BACTERIOL, V179, P4292, DOI 10.1128/jb.179.13.4292-4298.1997	40	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					968	973		10.1074/jbc.M209881200	http://dx.doi.org/10.1074/jbc.M209881200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12421813	hybrid			2022-12-27	WOS:000180321900037
J	Shibusawa, N; Hollenberg, AN; Wondisford, FE				Shibusawa, N; Hollenberg, AN; Wondisford, FE			Thyroid hormone receptor DNA binding is required for both positive and negative gene regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT GENE; RESPONSE ELEMENTS; GLUCOCORTICOID RECEPTOR; PARAVENTRICULAR NUCLEUS; TRANSCRIPTIONAL ACTIVITY; STIMULATING HORMONE; HISTONE DEACETYLASE; INHIBITORY ELEMENT; RAT HYPOTHALAMUS; CO-REPRESSOR	The 13 isoform of thyroid hormone receptor (TR-beta) has a key role in the feedback regulation of the hypothalamic-pituitary-thyroid (H-P-T) axis. The mechanism of trans-repression of the hypothalamic thyrotropin-releasing hormone (TRH) and pituitary thyroid-stimulating hormone (TSH) subunit genes, however, remains poorly understood. A number of distinct mechanisms for TR-beta-mediated negative regulation by thyroid hormone have been proposed, including those that require and do not require DNA binding. To clarify the importance of DNA binding in negative regulation, we constructed a DNA-binding mutant of TR-beta in which two amino acids within the P box were altered (GSG for EGG) to resemble that found in the glucocorticoid receptor (GR). We termed this mutant GS125, and as expected, it displayed low binding affinities for positive and negative thyroid hormone-response element (pTRE and nTRE, respectively) in gel-mobility shift assays. In transient transfection assays, the GS125 mutant abolished transactivation on three classic pTREs (DR+4, LAP, and PAL) and all negatively regulated promoters in the H-P-T axis (TRH, TSH-beta, and TSH-alpha). However, GS125 TR-beta bound to a composite TR/GR-response element and was fully functional on this hybrid TR/GR-response element. Moreover, the GS125 TR-beta mutant displayed normal interactions with transcriptional cofactors in mammalian two-hybrid assays. These data do not support a DNA-binding independent mechanism for thyroid hormone negative regulation in the H-P-T axis.	Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA	University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wondisford, FE (corresponding author), Univ Chicago, Dept Med, Endocrinol Sect, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.							Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; Bishop TC, 1997, BIOPHYS J, V72, P2056, DOI 10.1016/S0006-3495(97)78849-0; BODENNER DL, 1991, J BIOL CHEM, V266, P21666; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Breen JJ, 1997, MOL CELL ENDOCRINOL, V131, P137, DOI 10.1016/S0303-7207(97)00099-3; BRENT GA, 1991, MOL ENDOCRINOL, V5, P542, DOI 10.1210/mend-5-4-542; BRENT GA, 1989, J BIOL CHEM, V264, P178; CARR FE, 1992, J BIOL CHEM, V267, P18689; CARR FE, 1994, J BIOL CHEM, V269, P4175; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; COHEN O, 1995, J BIOL CHEM, V270, P13899, DOI 10.1074/jbc.270.23.13899; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; COOK CB, 1992, ENDOCRINOLOGY, V130, P1077, DOI 10.1210/en.130.2.1077; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; HODIN RA, 1989, SCIENCE, V244, P76, DOI 10.1126/science.2539642; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; Hollenberg AN, 1996, J BIOL CHEM, V271, P28516, DOI 10.1074/jbc.271.45.28516; HOLLENBERG AN, 1995, J BIOL CHEM, V270, P14274, DOI 10.1074/jbc.270.24.14274; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Ikeda M, 1996, J BIOL CHEM, V271, P23096, DOI 10.1074/jbc.271.38.23096; KOLLER KJ, 1987, P NATL ACAD SCI USA, V84, P7329, DOI 10.1073/pnas.84.20.7329; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; LECHAN RM, 1994, ENDOCRINOLOGY, V135, P92, DOI 10.1210/en.135.1.92; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MADISON LD, 1993, MOL CELL ENDOCRINOL, V94, P129, DOI 10.1016/0303-7207(93)90060-W; Monden T, 1997, J BIOL CHEM, V272, P29834, DOI 10.1074/jbc.272.47.29834; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; Nagaya T, 1996, BIOCHEM BIOPH RES CO, V222, P524, DOI 10.1006/bbrc.1996.0777; Nelson CC, 1996, J BIOL CHEM, V271, P19464, DOI 10.1074/jbc.271.32.19464; NELSON CC, 1994, MOL ENDOCRINOL, V8, P829, DOI 10.1210/me.8.7.829; Oberste-Berghaus C, 2000, J BIOL CHEM, V275, P1787, DOI 10.1074/jbc.275.3.1787; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; SCHWARTZ HL, 1994, J BIOL CHEM, V269, P24777; SEGERSON TP, 1987, SCIENCE, V238, P78, DOI 10.1126/science.3116669; SHUPNIK MA, 1989, ENDOCR REV, V10, P459, DOI 10.1210/edrv-10-4-459; SHUPNIK MA, 1989, ENDOCR RES, V15, P579, DOI 10.3109/07435808909036353; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3130, DOI 10.1073/pnas.88.8.3130; STEINFELDER HJ, 1992, P NATL ACAD SCI USA, V89, P5942, DOI 10.1073/pnas.89.13.5942; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Tagami T, 1999, J BIOL CHEM, V274, P22345, DOI 10.1074/jbc.274.32.22345; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; Williams Graham R., 1995, P217; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; YEN PM, 1994, J BIOL CHEM, V269, P12704; Zanger K, 2001, MOL CELL, V7, P551, DOI 10.1016/S1097-2765(01)00202-7	60	92	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					732	738		10.1074/jbc.M207264200	http://dx.doi.org/10.1074/jbc.M207264200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12419821	hybrid			2022-12-27	WOS:000180321900007
J	Tuttle, MS; Radisky, D; Li, LT; Kaplan, J				Tuttle, MS; Radisky, D; Li, LT; Kaplan, J			A dominant allele of PDR1 alters transition metal resistance in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-EFFICIENCY TRANSFORMATION; PLEIOTROPIC DRUG-RESISTANCE; MULTICOPPER OXIDASE FET3P; AFFINITY IRON TRANSPORT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL CONTROL; GENE; COPPER; ELECTROPORATION; DISEASE	A yeast mutant was found to have defective growth on low iron medium despite a normal high affinity iron transport system. The phenotype results from a gain of function mutation in PDR1, which encodes a transcription factor that acts as a regulator of pleiotropic drug resistance in Saccharomyces cerevisiae. The mutant allele, PDR1(R821H), was found to result in increased expression of at least 19 genes, three of which are ATP-binding cassette (ABC) transporters. Expression of at least six genes was required to show the low iron growth defect. Wild type cells transformed with the PDR1(R821H) allele or a PDR1 dominant allele (PDR1-3) showed the low iron growth defect as well as increased resistance to drugs such as cycloheximide and oligomycin. Transformation of PDR1(R821H) into Deltaccc1 cells, which were previously shown to have increased sensitivity to high iron medium because of defective vacuolar iron storage (Li, L., Chen, O.S., Ward, D. M., and Kaplan, J. (2001) J. Biol. Chem. 276, 29515-29519), conferred resistance to high iron medium. Cells expressing PDR1(R821H) also showed increased resistance to copper and manganese because of increased metal export. These results suggest that expression of PDR1-regulated genes affects both efflux and storage of transition metals.	Univ Utah, Dept Pathol, Sch Med, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Dept Pathol, Sch Med, 50 N Med Dr, Salt Lake City, UT 84132 USA.		Radisky, Derek/B-6569-2018	Radisky, Derek/0000-0002-1962-8784; Tuttle, Marie/0000-0003-1198-2727	NCI NIH HHS [P30CA 42014] Funding Source: Medline; NIDDK NIH HHS [DK-30534] Funding Source: Medline; NIGMS NIH HHS [GM 07464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Askwith CC, 1998, J BIOL CHEM, V273, P22415, DOI 10.1074/jbc.273.35.22415; BALZI E, 1987, J BIOL CHEM, V262, P16871; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; CALVIN NM, 1988, J BACTERIOL, V170, P2796, DOI 10.1128/jb.170.6.2796-2801.1988; Carvajal E, 1997, MOL GEN GENET, V256, P406, DOI 10.1007/s004380050584; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EIDE D, 1992, J GEN MICROBIOL, V138, P347, DOI 10.1099/00221287-138-2-347; EIDE D, 1992, J BIOL CHEM, V267, P20774; Eide DJ, 2000, ADV MICROB PHYSIOL, V43, P1, DOI 10.1016/S0065-2911(00)43001-8; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kolaczkowska A, 2002, MOL GENET GENOMICS, V267, P96, DOI 10.1007/s00438-002-0642-0; LEPPERT G, 1990, GENETICS, V125, P13; Li LT, 1998, J BIOL CHEM, V273, P22181, DOI 10.1074/jbc.273.35.22181; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Mahe Y, 1996, MOL MICROBIOL, V20, P109, DOI 10.1111/j.1365-2958.1996.tb02493.x; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Miller J.H., 1972, EXPT MOL GENETICS; Miyahara K, 1996, FEBS LETT, V399, P317, DOI 10.1016/S0014-5793(96)01353-1; Moore DD, 1995, GLOB MOB SURV; Nourani A, 1997, MOL GEN GENET, V256, P397, DOI 10.1007/s004380050583; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; Sambrook J., 2002, MOL CLONING LAB MANU; SHERMAN F, 1989, METHODS YEAST GENETI; Stadler JA, 2002, J BIOL CHEM, V277, P39649, DOI 10.1074/jbc.M203924200; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; SUBIK J, 1986, CURR GENET, V10, P665, DOI 10.1007/BF00410914; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	34	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1273	1280		10.1074/jbc.M209631200	http://dx.doi.org/10.1074/jbc.M209631200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12411429	hybrid			2022-12-27	WOS:000180321900075
J	Hayes, GM; Chiu, R; Carpenito, C; Dougherty, ST; Dougherty, GJ				Hayes, GM; Chiu, R; Carpenito, C; Dougherty, ST; Dougherty, GJ			Identification of sequence motifs responsible for the adhesive interaction between exon v10-containing CD44 isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE HOMING RECEPTOR; SULFATE PROTEOGLYCAN; HYALURONAN-BINDING; SPLICED EXONS; CELLS; RECOGNITION; DISTINCT; GLYCOSYLATION; INVOLVEMENT; STIMULATION	Previous studies have demonstrated that CD44 isoforms containing the alternatively spliced exon v10 promote cell-cell adhesion via a mechanism that involves the recognition of chondroitin sulfate side chains presented on the surface of interacting cells in association with other CD44 molecules. Sequence analysis revealed the presence within exon v10 of two motifs that may be relevant to this interaction, a B[X-7]B motif that may contribute to the recognition and binding of chondroitin sulfate and a serine-glycine motif that may serve as a site of chondroitin sulfate attachment. To determine whether either of these two motifs explain the unique adhesive activity of exon v10-containing CD44 isoforms, each was targeted by site-directed mutagenesis, and the adhesive activity of the resultant mutants was determined using a quantitative cell-cell binding assay. The data obtained demonstrate conclusively that it is the exon v10-encoded B[X-7]B motif that is solely responsible for the enhanced adhesive activity of exon v10-containing CD44 isoforms.	Univ Calif Los Angeles, Dept Radiat Oncol, David Geffen Sch Med, Ctr Hlth Sci, Los Angeles, CA 90095 USA; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; Univ Maastricht, Dept Radiat Oncol, NL-6200 MD Maastricht, Netherlands	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of British Columbia; Maastricht University	Dougherty, GJ (corresponding author), Univ Calif Los Angeles, Dept Radiat Oncol, David Geffen Sch Med, Ctr Hlth Sci, Rm B3-109,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	graeme@radonc.ucla.edu			NCI NIH HHS [1-R01-CA-82296] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082296] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Bartolazzi A, 1996, J CELL BIOL, V132, P1199, DOI 10.1083/jcb.132.6.1199; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; Chiu RK, 1999, EXP CELL RES, V248, P314, DOI 10.1006/excr.1999.4391; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DOUGHERTY GJ, 1991, J EXP MED, V174, P1, DOI 10.1084/jem.174.1.1; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; DROLL A, 1995, J BIOL CHEM, V270, P11567, DOI 10.1074/jbc.270.19.11567; FINN L, 1994, BIOCHEM BIOPH RES CO, V200, P1015, DOI 10.1006/bbrc.1994.1551; Fujimoto T, 2001, INT IMMUNOL, V13, P359, DOI 10.1093/intimm/13.3.359; GALLUZZO E, 1995, EUR J IMMUNOL, V25, P2932, DOI 10.1002/eji.1830251033; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; HE Q, 1992, J CELL BIOL, V119, P1711, DOI 10.1083/jcb.119.6.1711; Kawashima H, 2000, J BIOL CHEM, V275, P35448, DOI 10.1074/jbc.M003387200; LAKER C, 1987, P NATL ACAD SCI USA, V84, P8458, DOI 10.1073/pnas.84.23.8458; MANN DM, 1990, J BIOL CHEM, V265, P5317; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; NAOT D, 1997, ADV CANCER RES, V71, P241; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Rudzki Z, 1997, J CLIN PATHOL-MOL PA, V50, P57, DOI 10.1136/mp.50.2.57; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; SY MS, 1991, J EXP MED, V174, P859, DOI 10.1084/jem.174.4.859; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; Weg-Remers S, 1998, ANN NY ACAD SCI, V859, P304, DOI 10.1111/j.1749-6632.1998.tb11151.x; YANG BH, 1993, J BIOL CHEM, V268, P8617	28	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50529	50534		10.1074/jbc.M206719200	http://dx.doi.org/10.1074/jbc.M206719200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12407110	Green Published, hybrid			2022-12-27	WOS:000180177700045
J	Saliba, KJ; Allen, RJW; Zissis, S; Bray, PG; Ward, SA; Kirk, K				Saliba, KJ; Allen, RJW; Zissis, S; Bray, PG; Ward, SA; Kirk, K			Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATING INORGANIC PYROPHOSPHATASE; ACRIDINE-ORANGE FLUORESCENCE; PLASMODIUM-FALCIPARUM; TONOPLAST VESICLES; PH; ACIDOCALCISOMES; MEMBRANE; ANTIMALARIALS; REVERSIBILITY; ERYTHROCYTES	As it grows within the human erythrocyte, the malaria parasite, Plasmodium falciparum, ingests the erythrocyte cytosol, depositing it via an endocytotic feeding mechanism in the "digestive vacuole," a specialized acidic organelle. The digestive vacuole is the site of hemoglobin degradation, the storage site for hemozoin (an inert biocrystal of toxic heme), the site of action of many antimalarial drugs, and the site of proteins known to be involved in antimalarial drug resistance. The acidic pH of this organelle is thought to play a critical role in its various functions; however, the mechanisms by which the pH within the vacuole is maintained are not well understood. In this study, we have used a combination of techniques to demonstrate the presence on the P. falciparum digestive vacuole membrane of two discrete H+ pumping mechanisms, both capable of acidifying the vacuole interior. One is a V-type H+-ATPase, sensitive to concanamycin A and bafilomycin A, The other is a H+-pyrophosphatase, which was inhibited by NaF and showed a partial dependence on K+. The operation of the H+-pyrophosphatase was dependent on the presence of a Mg2+-pyrophosphate complex, and kinetic experiments gave results consistent with free pyrophosphate acting as an inhibitor of the protein. The presence of the combination of a H+-ATPase and a H+-pyrophosphatase on the P. falciparum digestive vacuole is similar to the situation in the acidic tonoplasts (vacuoles) of plant cells.	Australian Natl Univ, Fac Sci, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Univ Liverpool Liverpool Sch Trop Med, Mol & Biochem Parasitol Grp, Liverpool L5 3QA, Merseyside, England	Australian National University; Liverpool School of Tropical Medicine	Saliba, KJ (corresponding author), Australian Natl Univ, Fac Sci, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia.	kevin.saliba@anu.edu.au	Saliba, Kevin J/C-9166-2009; Ward, Steve/G-6003-2015; Allen, Richard/B-4752-2008; Kirk, Kiaran/C-8299-2009	Saliba, Kevin J/0000-0003-3345-8440; Ward, Steve/0000-0003-2331-3192; Kirk, Kiaran/0000-0002-5613-2622				Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Bray PG, 2002, MOL BIOCHEM PARASIT, V119, P311, DOI 10.1016/S0166-6851(01)00405-4; Bray PG, 2002, MOL BIOCHEM PARASIT, V119, P301, DOI 10.1016/S0166-6851(01)00403-0; CHOI I, 1990, EXP PARASITOL, V71, P452, DOI 10.1016/0014-4894(90)90071-J; CHOI I, 1988, MOL BIOCHEM PARASIT, V31, P71, DOI 10.1016/0166-6851(88)90146-6; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DESLAURIERS R, 1982, BIOCHIM BIOPHYS ACTA, V721, P449, DOI 10.1016/0167-4889(82)90101-X; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Facanha AR, 1998, PLANT PHYSIOL, V116, P1487, DOI 10.1104/pp.116.4.1487; FENG Y, 1992, J BIOL CHEM, V267, P19769; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; GOLDBERG DE, 1990, P NATL ACAD SCI USA, V87, P2931, DOI 10.1073/pnas.87.8.2931; Hayashi M, 2000, J BIOL CHEM, V275, P34353, DOI 10.1074/jbc.M003323200; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; KANAANI J, 1988, BIOCHEM INT, V17, P451; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; KARCZ SR, 1994, MOL BIOCHEM PARASIT, V65, P123, DOI 10.1016/0166-6851(94)90121-X; KARCZ SR, 1993, MOL BIOCHEM PARASIT, V58, P333, DOI 10.1016/0166-6851(93)90056-4; Kirk K, 2001, DRUG RESIST UPDATE, V4, P335, DOI 10.1054/drup.2002.0234; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; LEIGH RA, 1992, PLANT PHYSIOL, V100, P1698, DOI 10.1104/pp.100.4.1698; Luo SH, 1999, FEBS LETT, V460, P217, DOI 10.1016/S0014-5793(99)01353-8; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; Marchesini N, 2000, BIOCHEM J, V347, P243, DOI 10.1042/0264-6021:3470243; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Moreno B, 2001, BIOCHEM BIOPH RES CO, V284, P632, DOI 10.1006/bbrc.2001.5009; Parker D. R., 1995, Chemical equilibrium and reaction models. Proceedings San Antonio, Texas, USA, 23 and 24 October, 1990., P253; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Sherman Irwin W., 1998, P135; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Takasu A, 1997, J BIOCHEM-TOKYO, V122, P883, DOI 10.1093/oxfordjournals.jbchem.a021837; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WALKER RR, 1981, PLANTA, V153, P150, DOI 10.1007/BF00384096; WANG YZ, 1986, PLANT PHYSIOL, V81, P497, DOI 10.1104/pp.81.2.497; WHITE PJ, 1990, PLANT PHYSIOL, V93, P1063, DOI 10.1104/pp.93.3.1063	49	92	95	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					5605	5612		10.1074/jbc.M208648200	http://dx.doi.org/10.1074/jbc.M208648200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12427765	Green Accepted, hybrid			2022-12-27	WOS:000181129400017
J	Olson, MR; Holley, CL; Yoo, SJ; Huh, JR; Hay, BA; Kornbluth, S				Olson, MR; Holley, CL; Yoo, SJ; Huh, JR; Hay, BA; Kornbluth, S			Reaper is regulated by UP-mediated ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STRUCTURAL BASIS; DROSOPHILA REAPER; MAMMALIAN-CELLS; PROTEIN LIGASE; APOPTOSIS; GRIM; XIAP; INHIBITION; SYSTEM	In most cases, apoptotic cell death culminates in the activation of the caspase family of cysteine proteases, leading to the orderly dismantling and elimination of the cell. The IAPs (inhibitors of apoptosis) comprise a family of proteins that oppose caspases and thus act to raise the apoptotic threshold. Disruption of IAP-mediated caspase inhibition has been shown to be an important activity for pro-apoptotic proteins in Drosophila (Reaper, HID, and Grim) and in mammalian cells (Smac/DIABLO and Omi/HtrA2). In addition, in the case of the fly, these proteins are able to stimulate the ubiquitination and degradation of IAPs by a mechanism involving the ubiquitin ligase activity of the LAP itself. In this report, we show that the Drosophila RHG proteins (Reaper, HID, and Grim) are themselves substrates for LAP-mediated ubiquitination. This ubiquitination of Reaper requires LAP ubiquitin-ligase activity and a stable interaction between Reaper and the LAP. Additionally, degradation of Reaper can be blocked by mutating its potential ubiquitination sites. Most importantly, we also show that regulation of Reaper by ubiquitination is a significant factor in determining its biological activity. These data demonstrate a novel function for IAPs and suggest that IAPs and Reaper-like proteins mutually control each other's abundance.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Duke University; California Institute of Technology	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813,Rm C370 LSRC, Durham, NC 27710 USA.		Holley, Christopher/T-1312-2019; Holley, Christopher/ABB-6677-2020	Holley, Christopher/0000-0002-2870-3352; 	NIGMS NIH HHS [R01 GM61919, R01 GM57422] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061919, R01GM057422] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Claveria C, 1998, EMBO J, V17, P7199, DOI 10.1093/emboj/17.24.7199; Evans EK, 1997, EMBO J, V16, P7372, DOI 10.1093/emboj/16.24.7372; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Hays R, 2002, NAT CELL BIOL, V4, P425, DOI 10.1038/ncb794; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2001, CELL, V104, P781, DOI 10.1016/S0092-8674(01)00273-2; Jiang CA, 2000, MOL CELL, V5, P445, DOI 10.1016/S1097-2765(00)80439-6; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; McCarthy JV, 1998, J BIOL CHEM, V273, P24009, DOI 10.1074/jbc.273.37.24009; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; Olson AL, 2001, AMBUL PEDIATR, V1, P91, DOI 10.1367/1539-4409(2001)001<0091:PCPRAP>2.0.CO;2; Peterson C, 2002, DEVELOPMENT, V129, P1467; Pronk GJ, 1996, SCIENCE, V271, P808, DOI 10.1126/science.271.5250.808; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Robinow S, 1997, DEV BIOL, V190, P206, DOI 10.1006/dbio.1997.8696; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Wing JP, 1998, CELL DEATH DIFFER, V5, P930, DOI 10.1038/sj.cdd.4400423; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Wu JW, 2001, MOL CELL, V8, P95, DOI 10.1016/S1097-2765(01)00282-9; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	43	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4028	4034		10.1074/jbc.M209734200	http://dx.doi.org/10.1074/jbc.M209734200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12446669	hybrid, Green Accepted			2022-12-27	WOS:000180869700066
J	Boer, VM; de Winde, JH; Pronk, JT; Piper, MDW				Boer, VM; de Winde, JH; Pronk, JT; Piper, MDW			The genome-wide transcriptional responses of Saccharomyces cerevisiae grown on glucose in aerobic chemostat cultures limited for carbon, nitrogen, phosphorus, or sulfur	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; CATABOLITE REPRESSION; STRESS TOLERANCE; GENE-EXPRESSION; YEAST; METABOLISM; ACTIVATION; ELEMENT; EVOLUTION; SEQUENCES	Profiles of genome-wide transcriptional events for a given environmental condition can be of importance in the diagnosis of poorly defined environments. To identify clusters of genes constituting such diagnostic profiles, we characterized the specific transcriptional responses of Saccharomyces cerevisiae to growth limitation by carbon, nitrogen, phosphorus, or sulfur. Microarray experiments were performed using cells growing in steady-state conditions in chemostat cultures at the same dilution rate. This enabled us to study the effects of one particular limitation while other growth parameters (pH, temperature, dissolved oxygen tension) remained constant. Furthermore, the composition of the media fed to the cultures was altered so that the concentrations of excess nutrients were comparable between experimental conditions. In total, 1881 transcripts (31% of the annotated genome) were significantly changed between at least two growth conditions. Of those, 484 were significantly higher or lower in one limitation only. The functional annotations of these genes indicated cellular metabolism was altered to meet the growth requirements for nutrient-limited growth. Furthermore, we identified responses for several active transcription factors with a role in nutrient assimilation. Finally, 51 genes were identified that showed 10-fold higher or lower expression in a single condition only. The transcription of these genes can be used as indicators for the characterization of nutrient-limited growth conditions and provide information for metabolic engineering strategies.	Delft Univ Technol, Biotechnol Lab, NL-2628 BC Delft, Netherlands; Technol Cluster, Div Bakery Ingredients, DSM Life Sci, NL-2600 MA Delft, Netherlands	Delft University of Technology; DSM NV	Piper, MDW (corresponding author), Delft Univ Technol, Biotechnol Lab, Julianalaan 67, NL-2628 BC Delft, Netherlands.		Piper, Matthew/C-1714-2008; de Winde, J.H./AAC-5520-2021	Piper, Matthew/0000-0003-3245-7219; de Winde, J.H./0000-0002-7999-9317; Pronk, Jack/0000-0002-5617-4611				Attfield PV, 1997, NAT BIOTECHNOL, V15, P1351, DOI 10.1038/nbt1297-1351; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; BYSANI N, 1991, J BACTERIOL, V173, P4977, DOI 10.1128/jb.173.16.4977-4982.1991; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Coffman JA, 1997, J BACTERIOL, V179, P5609, DOI 10.1128/jb.179.17.5609-5613.1997; Cooper T. G., 1996, P139; Crowther DJ, 1996, BIOCHEM SOC T, V24, P354, DOI 10.1042/bst0240354; CUHEL RL, 1981, ARCH MICROBIOL, V130, P1, DOI 10.1007/BF00527063; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Diderich JA, 2002, FEMS YEAST RES, V2, P165, DOI 10.1111/j.1567-1364.2002.tb00081.x; Diderich JA, 2001, YEAST, V18, P1515, DOI 10.1002/yea.779; ELSKENS MT, 1991, J GEN MICROBIOL, V137, P637, DOI 10.1099/00221287-137-3-637; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; GRIGGS DW, 1993, MOL CELL BIOL, V13, P4999, DOI 10.1128/MCB.13.8.4999; HARDER W, 1977, J APPL BACTERIOL, V43, P1, DOI 10.1111/j.1365-2672.1977.tb00717.x; Hayes A, 2002, METHODS, V26, P281, DOI 10.1016/S1046-2023(02)00032-4; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; LARSSON C, 1993, J BACTERIOL, V175, P4809, DOI 10.1128/JB.175.15.4809-4816.1993; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MAZEL D, 1989, NATURE, V341, P245, DOI 10.1038/341245a0; Ogawa N, 1995, MOL GEN GENET, V249, P406, DOI 10.1007/BF00287102; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Ozsarac N, 1997, MOL CELL BIOL, V17, P1152, DOI 10.1128/MCB.17.3.1152; PARDEE AB, 1966, J BIOL CHEM, V241, P5886; PATTON JL, 1995, J BACTERIOL, V177, P3379, DOI 10.1128/jb.177.12.3379-3385.1995; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; SCHOLER A, 1994, MOL CELL BIOL, V14, P3613, DOI 10.1128/MCB.14.6.3613; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; TEMPEST DW, 1970, BIOCHEM J, V117, P405, DOI 10.1042/bj1170405; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Merwe GK, 2001, CURR GENET, V39, P156; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1	55	251	280	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3265	3274		10.1074/jbc.M209759200	http://dx.doi.org/10.1074/jbc.M209759200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12414795	hybrid, Green Published			2022-12-27	WOS:000180915000064
J	Feng, CJ; Wilson, HL; Hurley, JK; Hazzard, JT; Tollin, G; Rajagopalan, KV; Enemark, JH				Feng, CJ; Wilson, HL; Hurley, JK; Hazzard, JT; Tollin, G; Rajagopalan, KV; Enemark, JH			Role of conserved tyrosine 343 in intramolecular electron transfer in human sulfite oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN LIVER; MOLYBDENUM ENZYMES; ESEEM SPECTROSCOPY; MOLECULAR-CLONING; CYTOCHROME-C; PH FORM; PROTON; IDENTIFICATION; EXPRESSION; INTERPROTEIN	Tyrosine 343 in human sulfite oxidase (SO) is conserved in all SOs sequenced to date. Intramolecular electron transfer (IET) rates between reduced heme (Fell) and oxidized molybdenum (Mo-VI) in the recombinant wild-type and Y343F human SO were measured for the first time by flash photolysis. The IET rate in wild-type human SO at pH 7.4 is about 37% of that in chicken SO with a similar decrease in k(cat). Steady-state kinetic analysis of the Y343F mutant showed an increase in K-m(sulfite) and a decrease in k(cat) resulting in a 23-fold attenuation in the specificity constant k(cat)/K-m(sulfite) at the optimum pH value of 8.25. This indicates that Tyr-343 is involved in the binding of the substrate and catalysis within the molybdenum active site. Furthermore, the IET rate constant in the mutant at pH 6.0 is only about one-tenth that of the wild-type enzyme, suggesting that the OH group of Tyr-343 is vital for efficient IET in SO. The pH dependences of IET rate constants in the wild-type and mutant SO are consistent with the previously proposed coupled electron-proton transfer mechanism.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Arizona; University of Arizona; Duke University	Tollin, G (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	gtollin@u.arizano.edu; raj@biochem.duke.edu; jenemark@u.arizona.edu	Enemark, John/AAQ-4395-2020	Feng, Changjian/0000-0003-4542-6497	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037773] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 15057] Funding Source: Medline; NIGMS NIH HHS [GM 37773, GM 44283] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1993, ADV INORGANIC CHEM, DOI DOI 10.1016/S0898-8838(08)60181-6; Astashkin AV, 2000, J AM CHEM SOC, V122, P5294, DOI 10.1021/ja9916761; Astashkin AV, 2002, J AM CHEM SOC, V124, P6109, DOI 10.1021/ja0115417; Astashkin AV, 2002, APPL MAGN RESON, V22, P421, DOI 10.1007/BF03166122; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; Conry RR, 2001, J BIOL INORG CHEM, V6, P359, DOI 10.1007/s007750100207; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Elliott SJ, 2002, J AM CHEM SOC, V124, P11612, DOI 10.1021/ja027776f; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; Feng CJ, 2002, BIOCHEMISTRY-US, V41, P5816, DOI 10.1021/bi016059f; GARRETT RM, 1994, J BIOL CHEM, V269, P272; GARRETT RM, 1995, BBA-GENE STRUCT EXPR, V1262, P147, DOI 10.1016/0167-4781(95)00068-R; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2000, Subcell Biochem, V35, P445; Hille R, 2002, MET IONS BIOL SYST, V39, P187; Hille R, 2001, J BIOL CHEM, V276, P31193, DOI 10.1074/jbc.M100673200; HUANG J, 1994, J AM CHEM SOC, V116, P6769, DOI 10.1021/ja00094a036; HUANG JO, 1995, INORG CHEM, V34, P1090, DOI 10.1021/ic00109a015; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P11100, DOI 10.1021/bi9709001; JOHNSON JL, 1988, METHOD ENZYMOL, V158, P371, DOI 10.1016/0076-6879(88)58069-2; Kappler U, 2000, J BIOL CHEM, V275, P13202, DOI 10.1074/jbc.275.18.13202; KESSLER DL, 1974, BIOCHIM BIOPHYS ACTA, V370, P389, DOI 10.1016/0005-2744(74)90100-4; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; KISKER C, 2001, HDB METALLOPROTEINS, V2, P1121; Laughlin LJ, 1996, INORG CHEM, V35, P1050, DOI 10.1021/ic950815m; Leimkuhler S, 2001, J BIOL CHEM, V276, P1837, DOI 10.1074/jbc.M007304200; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Murgida DH, 2001, J AM CHEM SOC, V123, P4062, DOI 10.1021/ja004165j; NEAME PJ, 1989, J BIOL CHEM, V264, P20894; Pacheco A, 1996, INORG CHEM, V35, P7001, DOI 10.1021/ic9607806; Pacheco A, 1999, J BIOL INORG CHEM, V4, P390, DOI 10.1007/s007750050325; Raitsimring AM, 1998, J AM CHEM SOC, V120, P11263, DOI 10.1021/ja981903j; Rajagopalan K.V., 1980, MOLYBDENUM MOLYBDENU, P241; ROTELLO VM, 2001, ELECT TRANSFER CHEM, V41, P69; Schindelin H, 2001, ADV PROTEIN CHEM, V58, P47; SPECK SH, 1981, J BIOL CHEM, V256, P7394; STIEFEL EI, 1973, P NATL ACAD SCI USA, V70, P988, DOI 10.1073/pnas.70.4.988; SULLIVAN EP, 1992, J AM CHEM SOC, V114, P9662, DOI 10.1021/ja00050a058; SULLIVAN EP, 1993, BIOCHEMISTRY-US, V32, P12465, DOI 10.1021/bi00097a026; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; TOLLIN G, 1995, J BIOENERG BIOMEMBR, V27, P303, DOI 10.1007/BF02110100; TOLLIN G, 1993, BIOPHYS CHEM, V48, P259, DOI 10.1016/0301-4622(93)85014-9; TOLLIN G, 2001, ELECT TRANSFER CHEM, V4, P202; UEYAMA N, 1992, J AM CHEM SOC, V114, P8129, DOI 10.1021/ja00047a022	48	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2913	2920		10.1074/jbc.M210374200	http://dx.doi.org/10.1074/jbc.M210374200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12424234	hybrid			2022-12-27	WOS:000180915000020
J	Harris, TJC; Ravandi, A; Awrey, DE; Siu, CH				Harris, TJC; Ravandi, A; Awrey, DE; Siu, CH			Cytoskeleton interactions involved in the assembly and function of glycoprotein-80 adhesion complexes in Dictyostelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; SITE-A GLYCOPROTEIN; LIPID RAFTS; PLASMA-MEMBRANE; NERVOUS-SYSTEM; MOLECULE GP80; DISCOIDEUM; PROTEIN; MORPHOGENESIS; PONTICULIN	Adhesion complexes typically assemble from clustered receptors that link to the cytoskeleton via cytoplasmic adapter proteins. However, it is unclear how phospholipid-anchored adhesion molecules, such as the Dictyostelium receptor gp80, interact with the cytoskeleton. gp80 has been found to form adhesion complexes from raftlike membrane domains, which can be isolated as a Triton X-100-insoluble floating fraction (TIFF). We report here that the actin-binding protein ponticulin mediates TIFF-cytoskeleton interactions. Analysis of gp80-null cells revealed that these interactions were minimal in the absence of gp80. During development, gp80 was required to enhance these interactions as its adhesion complexes assembled. Whereas ponticulin and gp80 could partition independently into TIFF, gp80 was shown to recruit ponticulin to cell-cell contacts and to increase its partitioning into TIFF. However, these proteins did not co-immunoprecipitate. Furthermore, sterol sequestration abrogated the association of ponticulin with TIFF without affecting gp80, suggesting that sterols may mediate the interactions between ponticulin and gp80. In ponticulin-null cells, large gp80 adhesion complexes assembled in the absence of ponticulin despite the lack of cytoskeleton association. We propose that such nascent gp80 adhesion complexes produce expanded raftlike domains that recruit ponticulin and thereby establish stable cytoskeleton interactions to complete the assembly process.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5G 1L6, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada	University of Toronto; University of Toronto	Siu, CH (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.		Ravandi, Amir/O-7552-2019					Alattia JR, 1999, CELL MOL LIFE SCI, V55, P359, DOI 10.1007/s000180050297; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; BRAR SK, 1993, J BIOL CHEM, V268, P24902; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CHIA CP, 1993, J CELL BIOL, V120, P909, DOI 10.1083/jcb.120.4.909; CHOI AHC, 1987, J CELL BIOL, V104, P1375, DOI 10.1083/jcb.104.5.1375; DESBARATS L, 1992, J BIOL CHEM, V267, P19655; FONTANA DR, 1993, DIFFERENTIATION, V53, P139, DOI 10.1111/j.1432-0436.1993.tb00702.x; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Harris TJC, 2001, J BIOL CHEM, V276, P48764, DOI 10.1074/jbc.M108030200; Harris TJC, 2001, J BIOL CHEM, V276, P18640, DOI 10.1074/jbc.M010016200; HITT AL, 1994, J CELL BIOL, V126, P1433, DOI 10.1083/jcb.126.6.1433; HITT AL, 1994, J CELL BIOL, V126, P1421, DOI 10.1083/jcb.126.6.1421; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; INGALLS HM, 1986, P NATL ACAD SCI USA, V83, P4779, DOI 10.1073/pnas.83.13.4779; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; Jung E, 1996, EMBO J, V15, P1238, DOI 10.1002/j.1460-2075.1996.tb00465.x; KAMBOJ RK, 1989, CELL, V59, P615, DOI 10.1016/0092-8674(89)90007-X; Kloboucek A, 1999, BIOPHYS J, V77, P2311, DOI 10.1016/S0006-3495(99)77070-0; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM TY, 1981, DIFFERENTIATION, V20, P22, DOI 10.1111/j.1432-0436.1981.tb01151.x; Locascio A, 2001, CURR OPIN GENET DEV, V11, P464, DOI 10.1016/S0959-437X(00)00218-5; Loomis WF., 1975, DICTYOSTELIUM DISCOI; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; OCHIAI H, 1982, CELL DIFFER DEV, V11, P1, DOI 10.1016/0045-6039(82)90011-2; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; SADEGHI H, 1988, P NATL ACAD SCI USA, V85, P5512, DOI 10.1073/pnas.85.15.5512; Sesaki H, 1996, DEV BIOL, V177, P504, DOI 10.1006/dbio.1996.0181; Sheetz MP, 1998, TRENDS CELL BIOL, V8, P51, DOI 10.1016/S0962-8924(98)80005-6; SHELDEN E, 1995, J CELL SCI, V108, P1105; Shin JS, 2000, SCIENCE, V289, P785, DOI 10.1126/science.289.5480.785; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIU CH, 1990, DEV GENET, V11, P377, DOI 10.1002/dvg.1020110509; SIU CH, 1987, J CELL BIOL, V105, P2523, DOI 10.1083/jcb.105.6.2523; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; STADLER J, 1989, EMBO J, V8, P371, DOI 10.1002/j.1460-2075.1989.tb03387.x; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WALSH FS, 1991, CELL BIOL INT REP, V15, P1151, DOI 10.1016/0309-1651(91)90061-M; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881; Wong E, 2002, DEVELOPMENT, V129, P3839; Wong EFS, 1996, J BIOL CHEM, V271, P16399, DOI 10.1074/jbc.271.27.16399; WUESTEHUBE LJ, 1989, CELL MOTIL CYTOSKEL, V13, P245, DOI 10.1002/cm.970130404; Zobiack N, 2002, J CELL SCI, V115, P91	56	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2614	2623		10.1074/jbc.M206241200	http://dx.doi.org/10.1074/jbc.M206241200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12421828	hybrid			2022-12-27	WOS:000180562000072
J	Klutts, S; Pastuszak, I; Edavana, VK; Thampi, P; Pan, YT; Abraham, EC; Carroll, JD; Elbein, AD				Klutts, S; Pastuszak, I; Edavana, VK; Thampi, P; Pan, YT; Abraham, EC; Carroll, JD; Elbein, AD			Purification, cloning, expression, and properties of mycobacterial trehalose-phosphate phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SYNTHASE; THERMOTOLERANCE; TUBERCULOSIS; YEAST; GENES	The trehalose-phosphate phosphatase (TPP) was purified from the cytosol of Mycobacterium smegmatis to near homogeneity using a variety of conventional steps to achieve a purification of about 1600-fold with a yield of active enzyme of about 1%. Based on gel filtration, the active enzyme had a molecular weight of about 27,000, and the most purified fraction also gave a major band on SDS-PAGE corresponding to a molecular weight of about 27,000. A number of peptides from the 27-kDa protein were sequenced and these sequences showed considerable homology to the trehalose-P phosphatase (otsB) of Escherichia coli. Based on these peptides, the M. smegmatis gene for TPP was cloned and expressed in E. coli. The recombinant protein was synthesized with a (His)(6) tag at the amino terminus. Most of the TPP activity in the crude E. coli sonicate was initially found in the membrane fraction, but it became solubilized in the presence of 0.2% Sarkosyl. The solubilized protein was purified to apparent homogeneity on a metal ion column and this fraction had high phosphatase activity that was completely specific for trehalose-P. The purified enzyme, either isolated from M. smegmatis, or expressed in E. coli, rapidly dephosphorylated trehalose-6-P, but had essentially no activity on any other sugar phosphates, or on p-nitrophenyl phosphate. The K-M for trehalose-6-P was about 1.6 mm, and the pH optimum was about 7.5. The native enzyme showed an almost absolute requirement for Mg2+ and was not very active with Mn2+, whereas both of these cations were equally effective with the recombinant TPP. The enzyme activity was inhibited by the antibiotics, diumycin and moenomycin, but not by a number of other antibiotics or trehalose analogs. TPP activity was strongly inhibited by the detergents, Sarkosyl and deoxycholate, even at 0.025%, but it was not inhibited by Nonidet P-40, Triton X-100, or octyl glucoside, even at concentrations up to 0.3%. The purified enzyme was stable to heating at 60 degreesC for up to 6 min, but was slowly inactivated at 70 degreesC. Circular dichroism studies on recombinant TPP indicate that the secondary structure of this protein has considerable beta-pleated sheet and is very compact. TPP may play a key role in the biosynthesis of trehalose compounds, such as trehalose mycolates, and therefore may represent an excellent target site for chemotherapy against tuberculosis and other mycobacterial diseases.	Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Elbein, AD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.				NIAID NIH HHS [R03 AI-43292] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI043292] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALUGUPALLI S, 1995, J BACTERIOL, V177, P4566, DOI 10.1128/jb.177.15.4566-4570.1995; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; BERSA GS, 1992, BIOCHEMISTRY-US, V31, P9832; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CABIB E, 1958, J BIOL CHEM, V231, P259; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; ELBEIN AD, 1968, J BACTERIOL, V96, P1623, DOI 10.1128/JB.96.5.1623-1631.1968; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; HENGGEARONIS R, 1991, J BACTERIOL, V173, P7918, DOI 10.1128/jb.173.24.7918-7924.1991; KAASEN I, 1992, J BACTERIOL, V174, P889, DOI 10.1128/jb.174.3.889-898.1992; LAPP D, 1971, J BIOL CHEM, V246, P4567; LORNITZO FA, 1964, J BIOL CHEM, V239, P2730; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; Pan YT, 1996, GLYCOBIOLOGY, V6, P453, DOI 10.1093/glycob/6.4.453; PAN YT, 1996, ARCH BIOCHEM BIOPHYS, V355, P258; PASCHOALIN VMF, 1989, CURR GENET, V16, P81, DOI 10.1007/BF00393399; TAKAYAMA K, 1976, BIOCHEMISTRY-US, V15, P441, DOI 10.1021/bi00647a032; YANG JT, 1986, METHOD ENZYMOL, V130, P208	21	40	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2093	2100		10.1074/jbc.M209937200	http://dx.doi.org/10.1074/jbc.M209937200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12417583	hybrid			2022-12-27	WOS:000180562000004
J	Zhao, YG; Wang, ZB; Xu, JX				Zhao, YG; Wang, ZB; Xu, JX			Effect of cytochrome c on the generation and elimination of O-2(center dot-) and H2O2 in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIS-N-METHYLACRIDINIUM; BOVINE HEART-MITOCHONDRIA; ANION-RADICAL PRODUCTION; SUPEROXIDE ANION; HYDROGEN-PEROXIDE; LUCIGENIN; REDUCTASE; UBIQUINONE; METABOLISM; COMPLEX	The primary recognized function of cytochrome c is to act as an electron carrier transferring electrons from complex III to complex IV in the respiratory chain of mitochondria. Recent studies on cell apoptosis reveal that cytochrome c is responsible for the programmed cell death when it is released from mitochondria to cytoplasm. In this study we present evidence showing that cytochrome c plays an antioxidative role by acting on the generation and elimination of O-2(.-) and H2O2 in mito chondria. The O-2(-.) and H2O2 generation in cytochrome c-depleted Keilin-Hartree heart muscle preparation (HMP) is 7-8 times higher than that in normal HMP. The reconstitution of cytochrome c to the cytochrome c-depleted HMP causes the O-2(-.) and H2O2 generation to exponentially decrease. An alternative electron-leak pathway of the respiratory chain is suggested to explain how cytochrome c affects on the generation and elimination of O-2(-.) and H2O2 in mitochondria. Enough cytochrome c in the respiratory chain is needed for keeping O-2(-.) and H2O2 at a lower physiological level. A dramatic increase of 072 and H2O2 generation occurs when cytochrome c is released from the respiratory chain. The burst of O-2(-.) and H2O2 H2O2 which happens at the same time as cytochrome c release from the respiratory chain, should have some role in the early stage of cell apoptosis.	Chinese Acad Sci, Inst Biophys, Ctr Mol Biol, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS	Xu, JX (corresponding author), Chinese Acad Sci, Inst Biophys, Ctr Mol Biol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	xujx@sun5.ibp.ac.cn	Wang, Zhibo/GSD-3371-2022; Wang, Zhibo/B-3945-2010					BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CROSS AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P281, DOI 10.1016/S0005-2728(05)80140-9; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; KEILIN D, 1947, BIOCHEM J, V41, P500, DOI 10.1042/bj0410500; Li YB, 1999, BIOCHEM BIOPH RES CO, V262, P80, DOI 10.1006/bbrc.1999.1174; Li YB, 1998, J BIOL CHEM, V273, P2015, DOI 10.1074/jbc.273.4.2015; Liochev SI, 1997, ARCH BIOCHEM BIOPHYS, V337, P115, DOI 10.1006/abbi.1997.9766; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LOSCHEN G, 1973, FEBS LETT, V33, P84, DOI 10.1016/0014-5793(73)80165-6; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; TSOU CL, 1952, BIOCHEM J, V50, P493, DOI 10.1042/bj0500493; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VasquezVivar J, 1997, FEBS LETT, V403, P127, DOI 10.1016/S0014-5793(97)00036-7; XU JX, 1995, PROG BIOCHEM BIOPHYS, V22, P179; XU JX, 1988, 2 JAP CHIN BIL S BIO, P79; XU JX, 1996, P INT S NAT ANT MOL, P530; YONETANI T, 1967, METHOD ENZYMOL, V10, P336; YU CA, 1974, J BIOL CHEM, V249, P4905; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	28	110	123	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2356	2360		10.1074/jbc.M209681200	http://dx.doi.org/10.1074/jbc.M209681200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435729	hybrid			2022-12-27	WOS:000180562000039
J	Birkeli, KA; Llorente, A; Torgersen, ML; Keryer, G; Tasken, R; Sandvig, K				Birkeli, KA; Llorente, A; Torgersen, ML; Keryer, G; Tasken, R; Sandvig, K			Endosome-to-golgi transport is regulated by protein kinase a type II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE KIDNEY-CELLS; MDCK CELLS; INTRACELLULAR-TRANSPORT; BINDING-SITES; SHIGA TOXIN; CYCLIC-AMP; RII-ALPHA; RICIN; ENDOCYTOSIS; CAMP	Studies of RIIalpha-deficient B lymphoid cells and stable transfectants expressing the type IIalpha regulatory subunit (RIIalpha) of cAMP-dependent protein kinase (PKA), which is targeted to the Golgi-centrosomal area, reveal that the presence of a Golgi-associated pool of PKA type IIalpha mediates a change in intracellular transport of the plant toxin ricin. The transport of ricin from endosomes to the Golgi apparatus, measured as sulfation of a modified ricin (ricin sulf-1), increased in RIIalpha-expressing cells when PKA was activated. However, not only endosome-to-Golgi transport, but also retrograde ricin transport to the endoplasmic reticulum (ER), measured as sulfation and N-glycosylation of another modified ricin (ricin sulf-2), seemed to be increased in cells expressing RIIalpha in the presence of a cAMP analog, 8-(4-chlorophenylthio)-cAMP. Thus, PKA type IIalpha seems to be involved in both endosome-to-Golgi and Golgi-to-ER transport. Because ricin, after being retrogradely transported to the ER, is translocated to the cytosol, where it inhibits protein synthesis, we also investigated the influence of RIM expression on ricin toxicity. In agreement with the other data obtained, 8-(4-chlorophenylthio)-cAMP and RIM were found to sensitize cells to ricin, indicating an increased transport of ricin to the cytosol. In conclusion, our results demonstrate that transport of ricin from endosomes to the Golgi apparatus and further to the ER is regulated by PKA type IIalpha isozyme.	Norwegian Radium Hosp, Canc Res Inst, N-0310 Oslo, Norway; Inst Curie, F-75248 Paris 05, France; Univ Oslo, Inst Med Biochem, N-0317 Oslo, Norway	University of Oslo; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Oslo	Sandvig, K (corresponding author), Norwegian Radium Hosp, Canc Res Inst, N-0310 Oslo, Norway.		Llorente, Alicia/AAP-7349-2021; Torgersen, Maria Lyngaas L/F-3492-2017; Torgersen, Maria Lyngaas/O-6240-2019	Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Torgersen, Maria Lyngaas/0000-0003-2616-7194; Llorente, Alicia/0000-0002-0045-071X; Tasken, Kjetil/0000-0003-2841-4697				BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; Carlson CR, 2001, J CELL SCI, V114, P3243; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; EKER P, 1994, J BIOL CHEM, V269, P18607; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; HANSEN SH, 1994, J CELL BIOL, V126, P677, DOI 10.1083/jcb.126.3.677; HUANG WM, 1983, HISTOCHEMISTRY, V77, P275, DOI 10.1007/BF00506570; Keryer G, 1999, EXP CELL RES, V249, P131, DOI 10.1006/excr.1999.4447; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lauvrak SU, 2002, J CELL SCI, V115, P3449; LEITINGER B, 1994, J BIOL CHEM, V269, P8115; Llorente A, 1996, EXP CELL RES, V227, P298, DOI 10.1006/excr.1996.0279; Llorente A, 1998, FEBS LETT, V431, P200, DOI 10.1016/S0014-5793(98)00754-6; Martin ME, 1999, J CELL SCI, V112, P3869; Martin ME, 2000, J BIOL CHEM, V275, P19050, DOI 10.1074/jbc.275.25.19050; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; OGREID D, 1981, FEBS LETT, V129, P287, DOI 10.1016/0014-5793(81)80185-8; OGREID D, 1989, EUR J BIOCHEM, V181, P19; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; PIMPLIKAR SW, 1994, J BIOL CHEM, V269, P19054; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; SANDVIG K, 1979, EXP CELL RES, V121, P15, DOI 10.1016/0014-4827(79)90439-7; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Skretting G, 1999, J CELL SCI, V112, P3899; SMYTHE E, 1992, METHOD ENZYMOL, V219, P223; TASKEN K, 1993, J BIOL CHEM, V268, P21276	29	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1991	1997		10.1074/jbc.M209982200	http://dx.doi.org/10.1074/jbc.M209982200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419802	hybrid			2022-12-27	WOS:000180462200083
J	Budagian, V; Bulanova, E; Brovko, L; Orinska, Z; Fayad, R; Paus, R; Bulfone-Paus, S				Budagian, V; Bulanova, E; Brovko, L; Orinska, Z; Fayad, R; Paus, R; Bulfone-Paus, S			RETRACTED: Signaling through P2X7 receptor in human T cells involves p56(lck), kinases, and transcription factors AP-1 and NF-kappa B (Retracted Article. See vol 286, pg 9894, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ACTIVATED PROTEIN-KINASE; EXTRACELLULAR ATP; TYROSINE KINASE; PURINERGIC RECEPTORS; TERMINAL KINASE; P-2Z RECEPTOR; P2X(7); LCK; EXPRESSION; PATHWAY	ATP-gated ion channel P2X receptors are expressed on the surface of most immune cells and can trigger multiple cellular responses, such as membrane permeabilization, cytokine production, and cell proliferation or apoptosis. Despite broad distribution and pleiotropic activities, signaling pathways downstream of these ionotropic receptors are still poorly understood. Here, we describe intracellular signaling events in Jurkat cells treated with millimolar concentrations of extracellular ATP. Within minutes, ATP treatment resulted in the phosphorylation and activation of p56(lck) kinase, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase but not p38 kinase. These effects were wholly dependent upon the presence of extracellular Ca2+ ions in the culture medium. Nevertheless, calmodulin antagonist calmidazolium and CaM kinase inhibitor KN-93 both had no effect on the activation of p56(lck) and ERK, whereas a pretreatment of Jurkat cells with MAP kinase kinase inhibitor P098059 was able to abrogate phosphorylation of ERK Further, expression of c-Jun and e-Fos proteins and activator protein (AP-1) DNA binding activity were enhanced in a time-dependent manner. In contrast, DNA binding activity of NF-kappaB was reduced. ATP failed to stimulate the phosphorylation of ERK and c-Jun N-terminal kinase and activation of AP-1 in the p56(lck)-deficient isogenic T cell line JCaM1, suggesting a critical role for p56(lck) kinase in downstream signaling. Regarding the biological significance of the ATP-induced signaling events we show that although extracellular ATP was able to stimulate proliferation of both Jurkat and JCaM1 cells, an increase in interleukin-2 transcription was observed only in Jurkat cells. The nucleotide selectivity and pharmacological profile data supported the evidence that the ATP-induced effects in Jurkat cells were mediated through the P2X7 receptor. Taken together, these results demonstrate the ability of extracellular ATP to activate multiple downstream signaling events in a human T-lymphoblastoid cell line.	Res Ctr Borstel, Dept Immunol & Cellular Biol, D-23845 Borstel, Germany; Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada; Loyola Univ, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; Univ Hamburg, Hosp Eppendorf, Dept Dermatol, D-20246 Hamburg, Germany	Forschungszentrum Borstel; University of Guelph; Loyola University Chicago; University of Hamburg	Bulanova, E (corresponding author), Res Ctr Borstel, Dept Immunol & Cellular Biol, Pk Allee 22, D-23845 Borstel, Germany.	ebulanova@fz-borstel.de	Paus, Ralf/F-6243-2011					ALBERTINI M, 1998, BIOCHEM BIOPH RES CO, V248, P822; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDERSON SJ, 1994, ADV IMMUNOL, V56, P151, DOI 10.1016/S0065-2776(08)60451-4; APASOV S, 1995, IMMUNOL REV, V146, P5, DOI 10.1111/j.1600-065X.1995.tb00680.x; Apasov SG, 1997, J IMMUNOL, V158, P5095; Baird AM, 1999, CURR OPIN IMMUNOL, V11, P157, DOI 10.1016/S0952-7915(99)80027-2; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Brake AJ, 1996, ANNU REV CELL DEV BI, V12, P519, DOI 10.1146/annurev.cellbio.12.1.519; Bulanova EG, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1021; Burnstock G, 1996, CIBA F SYMP, V198, P1; BURNSTOCK G, 1998, P2 NUCLEOTIDE RECEPT, P3; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; Denny MF, 1999, J BIOL CHEM, V274, P5146, DOI 10.1074/jbc.274.8.5146; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DIVIRGILIO F, 1995, IMMUNOL TODAY, V16, P524, DOI 10.1016/0167-5699(95)80045-X; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Fernando KC, 1999, ARCH BIOCHEM BIOPHYS, V362, P197, DOI 10.1006/abbi.1998.1045; Ferrari D, 1999, J BIOL CHEM, V274, P13205, DOI 10.1074/jbc.274.19.13205; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J CELL BIOL, V139, P1635, DOI 10.1083/jcb.139.7.1635; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Franklin RA, 2000, MOL IMMUNOL, V37, P675, DOI 10.1016/S0161-5890(00)00087-0; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUPTA S, 1994, J BIOL CHEM, V269, P17349; Hardwick JS, 1997, J BIOL CHEM, V272, P25429, DOI 10.1074/jbc.272.41.25429; Henning RH, 1996, EUR J PHARMACOL, V301, P91, DOI 10.1016/0014-2999(96)00065-9; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Isakov N, 2000, EUR J BIOCHEM, V267, P3413, DOI 10.1046/j.1432-1327.2000.01412.x; Jung S, 1995, ANN NY ACAD SCI, V766, P245, DOI 10.1111/j.1749-6632.1995.tb26672.x; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kim HS, 2002, J MED CHEM, V45, P208, DOI 10.1021/jm010369e; King BF, 1998, TRENDS PHARMACOL SCI, V19, P506, DOI 10.1016/S0165-6147(98)01271-1; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee ZH, 2000, MOL PHARMACOL, V58, P1536, DOI 10.1124/mol.58.6.1536; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; MAJID MA, 1992, BIOCHIM BIOPHYS ACTA, V1136, P283, DOI 10.1016/0167-4889(92)90118-U; Manna SK, 2000, J BIOL CHEM, V275, P13297, DOI 10.1074/jbc.275.18.13297; Manna SK, 2000, J IMMUNOL, V164, P5156, DOI 10.4049/jimmunol.164.10.5156; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Moller A, 2001, J BIOL CHEM, V276, P20022, DOI 10.1074/jbc.M011139200; Morse DM, 2001, AM J PHYSIOL-CELL PH, V280, pC1485, DOI 10.1152/ajpcell.2001.280.6.C1485; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Naemsch LN, 2001, J BIOL CHEM, V276, P39107, DOI 10.1074/jbc.M105881200; Neary JT, 1998, NEUROSCI LETT, V242, P159, DOI 10.1016/S0304-3940(98)00067-6; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; Rincon M, 2001, ONCOGENE, V20, P2490, DOI 10.1038/sj.onc.1204382; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; ROZENGURT E, 1977, J BIOL CHEM, V252, P4584; Santana MA, 2000, J BIOL CHEM, V275, P31460, DOI 10.1074/jbc.M005231200; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Swanson KD, 1998, J BIOL CHEM, V273, P19965, DOI 10.1074/jbc.273.32.19965; TOKUMITSU Y, 1991, FEBS LETT, V288, P81, DOI 10.1016/0014-5793(91)81007-U; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Vigne P, 1999, BIOCHEM BIOPH RES CO, V256, P94, DOI 10.1006/bbrc.1999.9558; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; WILEY JS, 1989, BLOOD, V73, P1316; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Zhang FL, 2002, J PHARMACOL EXP THER, V301, P705, DOI 10.1124/jpet.301.2.705; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	76	94	104	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1549	1560		10.1074/jbc.M206383200	http://dx.doi.org/10.1074/jbc.M206383200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424250	hybrid			2022-12-27	WOS:000180462200025
J	Kamao, M; Tatematsu, S; Hatakeyama, S; Ozono, K; Kubodera, N; Reddy, GS; Okano, T				Kamao, M; Tatematsu, S; Hatakeyama, S; Ozono, K; Kubodera, N; Reddy, GS; Okano, T			Two novel metabolic pathways of 22-oxacalcitriol (OCT) - C-25 dehydration and C-3 epimerization and biological activities of novel OCT metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D ANALOG; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; CELL-LINES; 1-ALPHA,25-DIHYDROXY-3-EPI-VITAMIN D-3; OXIDATION PATHWAY; SYNTHETIC ANALOG; DIFFERENTIATION; 1,25-DIHYDROXYVITAMIN-D3; PROLIFERATION; OSTEOSARCOMA	22-Oxacalcitriol (OCT) is an analog of calcitriol, characterized by potent differentiation-inducing activity and low calcemic liability. The metabolism of OCT has been studied and its polar metabolites, such as 24/26-hydroxylated-OCT and hexanor-1alpha,20-dihydroxyvitamin D-3 (1alpha,20(OH)(2)D-3), have been identified. In contrast, little is known about the less polar metabolites of OCT, which have been found in relatively large amounts. In this study, the in vitro metabolism of OCT was studied in UMR 106, Caco-2, and LLC-PK1 cells to identify the less polar metabolites and to assess their biological activity. OCT was initially metabolized to three less polar metabolites, 3-epi-OCT and two dehydrates, 25-dehydroxy-25-ene-22-oxa-1alpha(OH)D-3 (25-ene-22-oxa-1alpha(OH)D-3) and 25-dehydroxy-24-ene-22-oxa-1alpha(OH)D-3 (24-ene-22-oxa-1alpha(OH)D-3). We also observed further metabolites, the two C-3 epimers of the C-25 dehydrates, 25-ene-3-epi-22-oxa-1alpha(OH)D-3 and 24-ene-3-epi-22-oxa-1alpha(OH)D-3. The structures of these metabolites were successfully assigned by H-1 NMR and LC-MS analyses. The three cell lines differ in their ability to metabolize OCT through the C-3 epimerization or the C-25 dehydration pathway. The biological activity of the OCT metabolites assessed by a luciferase reporter gene transcriptional activation system, binding assays for the vitamin D receptor (VDR) and vitamin D-binding protein (DBP), and assays for regulatory activities of cell differentiation and proliferation was found to be lower than that of OCT. Thus, both the C-3 epimerization and C-25 dehydration may work to reduce the biological activity of OCT.	Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan; Nagasaki Univ, Fac Pharmaceut Sci, Nagasaki 8528521, Japan; Osaka Med Ctr Maternal & Child Hlth, Dept Environm Med, Res Inst, Osaka 5941101, Japan; Chugai Pharmaceut Co Ltd, Tokyo 1718301, Japan; Brown Univ, Women & Infants Hosp, Providence, RI 02905 USA	Kobe Pharmaceutical University; Nagasaki University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Brown University; Women & Infants Hospital Rhode Island	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.							ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; ABE J, 1989, ENDOCRINOLOGY, V124, P2645, DOI 10.1210/endo-124-5-2645; BIKLE DD, 1995, J INVEST DERMATOL, V105, P693, DOI 10.1111/1523-1747.ep12324474; Bischof MG, 1998, EXP CELL RES, V241, P194, DOI 10.1006/excr.1998.4044; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN AJ, 1992, BIOCHEM BIOPH RES CO, V189, P759, DOI 10.1016/0006-291X(92)92266-Z; Brown AJ, 1999, J CELL BIOCHEM, V73, P106, DOI 10.1002/(SICI)1097-4644(19990401)73:1&lt;106::AID-JCB12&gt;3.0.CO;2-Q; COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083, DOI 10.1210/endo-108-3-1083; COLSTON KW, 1989, LANCET, V1, P188; EISMAN JA, 1989, P SOC EXP BIOL MED, V191, P221; EISMAN JA, 1987, CANCER RES, V47, P21; FINCH JL, 1993, KIDNEY INT, V43, P561, DOI 10.1038/ki.1993.83; Higashi T, 2000, ANAL SCI, V16, P477, DOI 10.2116/analsci.16.477; Higashi T, 1999, BIOL PHARM BULL, V22, P767; IINO Y, 1992, BREAST CANCER RES TR, V22, P133, DOI 10.1007/BF01833343; Kamao M, 2001, J NUTR SCI VITAMINOL, V47, P108, DOI 10.3177/jnsv.47.108; KOBAYASHI T, 1991, CONTRIB NEPHROL, V91, P129; KOBAYASHI T, 1994, J BIOCHEM-TOKYO, V115, P373, DOI 10.1093/oxfordjournals.jbchem.a124346; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Masuda S, 1996, J BIOL CHEM, V271, P8700, DOI 10.1074/jbc.271.15.8700; Masuda S, 2000, BIOL PHARM BULL, V23, P133, DOI 10.1248/bpb.23.133; MORIMOTO S, 1989, BIOCHEM INT, V19, P1143; Nakagawa K, 2001, STEROIDS, V66, P327, DOI 10.1016/S0039-128X(00)00142-2; NORMAN AW, 1993, J BIOL CHEM, V268, P20022; Ohyama Y, 1996, J BIOL CHEM, V271, P30381, DOI 10.1074/jbc.271.48.30381; OKANO T, 1989, J NUTR SCI VITAMINOL, V35, P529, DOI 10.3177/jnsv.35.529; OZONO K, 1990, J BIOL CHEM, V265, P21881; PEEHL DM, 1994, CANCER RES, V54, P805; Rao DS, 2001, STEROIDS, V66, P423; Reddy GS, 2000, ARCH BIOCHEM BIOPHYS, V383, P197, DOI 10.1006/abbi.2000.2074; Reddy GS, 2001, STEROIDS, V66, P441, DOI 10.1016/S0039-128X(00)00228-2; Schuster I, 1997, VITAMIN D CHEM BIOL, P551; Sekimoto H, 1999, FEBS LETT, V448, P278, DOI 10.1016/S0014-5793(99)00377-4; Siu-Caldera ML, 1999, BONE, V24, P457, DOI 10.1016/S8756-3282(99)00019-8; SUDA T, 1995, ENDOCRINE REV MONOGR, V4, P266; Takeyama KI, 1999, MOL CELL BIOL, V19, P1049; Tsugawa N., 1994, J BONE MINER METAB, V12, pS13	38	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1463	1471		10.1074/jbc.M203773200	http://dx.doi.org/10.1074/jbc.M203773200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12417596	hybrid			2022-12-27	WOS:000180462200014
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, TW; Bartlett, MC; Clarke, DM			Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; STIMULATED ATPASE ACTIVITY; TRANSMEMBRANE DOMAIN; CROSS-LINKING; CYSTEINE; MDR1; HYDROLYSIS; MUTATIONS; MUTANTS; SITES	The human multidrug resistance P-glycoprotein (P-gp, ABCB1) uses ATP to transport many structurally diverse compounds out of the cell. It is an ABC transporter with two nucleotide-binding domains (NBDs) and two transmembrane domains (TMDs). Recently, we showed that the "LSGGQ" motif in one NBD ((LS)-L-531-GGQ(535) in NBD1; (1176)SGGQ(1180) in NBD2) is adjacent to the "Walker A" sequence ((1070)GSSGCGKS(1077) in NBD2; (427)GNSGCGKS(434) in NBD1) in the other NBD (Loo, T. W., Bartlett, M. C., and Clarke, D. M. (2002) J. Biol. Chem. 277, 41303-41306). Drug substrates can stimulate or inhibit the ATPase activity of P-gp. Here, we report the effect of drug binding on cross-linking between the LSGGQ signature and Walker A sites (Cys(431) (NBD1)/C1176C(NBD2) and Cys(1074) (NBD2)/L531C(NBD1), respectively). Seven drug substrates (calcein-AM, demecolcine, cis(Z)-flupentixol, verapamil, cyclosporin A, Hoechst 33342, and trans(E)-flupentixol) were tested for their effect on oxidative cross-linking. Substrates that stimulated the ATPase activity of P-gp (calcein-AM, demecolcine, cis(Z)-flupentixol, and verapamil) increased the rate of cross-linking between Cys(431) (NBD1-Walker A)/C1176C(NBD2-LSGGQ) and between CyS1074(NBD2-Walker A)/L531C(NBD1-LSGGQ) when compared with cross-linking in the absence of drug substrate. By contrast, substrates that inhibited ATPase activity (cyclosporin A, Hoechst 33342, and trans(E)-flupentixol) decreased the rate of cross-linking. These results indicate that interaction between the LSGGQ motifs and Walker A sites must be essential for coupling drug binding to ATP hydrolysis. Drug binding in the transmembrane domains can induce long range conformational changes in the NBDs, such that compounds that stimulate or inhibit ATPase activity must decrease and increase, respectively, the distance between the Walker A and LSGGQ sequences.	Univ Toronto, Dept Med, Canadian Inst Hlth Res Grp Membrane Biol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, Canadian Inst Hlth Res Grp Membrane Biol, Rm 7342,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	NCI NIH HHS [CA80900] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080900] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Bakos E, 1997, BIOCHEM J, V323, P777, DOI 10.1042/bj3230777; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P149, DOI 10.1016/0005-2736(92)90078-Z; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Kast C, 1996, J BIOL CHEM, V271, P9240, DOI 10.1074/jbc.271.16.9240; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 1996, J BIOL CHEM, V271, P27488, DOI 10.1074/jbc.271.44.27488; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P7750; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Loo TW, 2000, J BIOL CHEM, V275, P39272, DOI 10.1074/jbc.M007741200; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; LOO TW, 1993, J BIOL CHEM, V268, P19965; Loo TW, 2000, JNCI-J NATL CANCER I, V92, P898, DOI 10.1093/jnci/92.11.898; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; SMITHPC, 2002, MOL CELL, V10, P139; Szakacs G, 2001, BIOCHEM J, V356, P71, DOI 10.1042/0264-6021:3560071; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020	38	111	114	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1575	1578		10.1074/jbc.M211307200	http://dx.doi.org/10.1074/jbc.M211307200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421806	hybrid			2022-12-27	WOS:000180462200028
J	Schmidt, M; Giessl, A; Laufs, T; Hankeln, T; Wolfrum, U; Burmester, T				Schmidt, M; Giessl, A; Laufs, T; Hankeln, T; Wolfrum, U; Burmester, T			How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; MYOGLOBIN; CONSUMPTION; HEMOGLOBIN; GLOBIN; CELLS; TRAFFICKING; NEURONS; LIGHT; CONES	Visual performance of the vertebrate eye requires large amounts of oxygen, and thus the retina is one of the highest oxygen-consuming tissues of the body. Here we show that neuroglobin, a neuron-specific respiratory protein distantly related to hemoglobin and myoglobin, is present at high amounts in the mouse retina (similar to100 muM). The estimated concentration of neuroglobin in the retina is thus about 100-fold higher than in the brain and is in the same range as that of myoglobin in the muscle. Neuroglobin is expressed in all neurons of the retina but not in the retinal pigment epithelium. Neuroglobin mRNA was detected in the perikarya of the nuclear and ganglion layers of the neuronal retina, whereas the protein was present mainly in the plexiform layers and in the ellipsoid region of photoreceptor inner segment. The distribution of neuroglobin correlates with the subcellular localization of mitochondria and with the relative oxygen demands, as the plexiform layers and the inner segment consume most of the retinal oxygen. These findings suggest that neuroglobin supplies oxygen to the retina, similar to myoglobin in the myocardium and the skeletal muscle.	Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Genet Mol, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Burmester, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, D-55099 Mainz, Germany.	burmeste@mail.uni-mainz.de	Burmester, Thorsten/I-7225-2013	Burmester, Thorsten/0000-0002-5772-7863; Giessl, Andreas/0000-0002-9768-2049				AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; ANDERSON B, 1964, ARCH OPHTHALMOL-CHIC, V72, P792; Anderson B Jr, 1968, Trans Am Ophthalmol Soc, V66, P423; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Cringle SJ, 2002, INVEST OPHTH VIS SCI, V43, P1922; Cringle SJ, 2002, COMP BIOCHEM PHYS A, V132, P61, DOI 10.1016/S1095-6433(01)00530-X; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 1996, J BIOL CHEM, V271, P19865, DOI 10.1074/jbc.271.33.19865; Germer A, 1998, J NEUROCYTOL, V27, P347, DOI 10.1023/A:1006938825474; Karakucuk S, 2000, OPHTHALMIC RES, V32, P30, DOI 10.1159/000055584; McGinnis JF, 2002, J NEUROSCI RES, V67, P290, DOI 10.1002/jnr.10120; Merx Marc W., 2001, FASEB Journal, V15, P1077; Moens L, 2000, NATURE, V407, P461, DOI 10.1038/35035181; NORK TM, 1993, INVEST OPHTH VIS SCI, V34, P2918; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pulvermuller A, 2002, MOL CELL BIOL, V22, P2194, DOI 10.1128/MCB.22.7.2194-2203.2002; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; Reuss S, 2002, NEUROSCIENCE, V115, P645, DOI 10.1016/S0306-4522(02)00536-5; Richardson RS, 2001, J APPL PHYSIOL, V91, P2679, DOI 10.1152/jappl.2001.91.6.2679; SCHUDER S, 1979, ANAL BIOCHEM, V92, P473, DOI 10.1016/0003-2697(79)90687-0; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Tsacopoulos M, 1998, PROG RETIN EYE RES, V17, P429, DOI 10.1016/S1350-9462(98)00010-X; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wiedman M, 1999, OPHTHALMOLOGY, V106, P1924, DOI 10.1016/S0161-6420(99)90402-5; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; WITTENBERG JB, 1990, ANNU REV BIOPHYS BIO, V19, P217; WITTENBERG JB, 1975, COMP BIOCHEM PHYS A, V51, P425, DOI 10.1016/0300-9629(75)90390-4; WOLFRUM U, 1991, CELL TISSUE RES, V263, P399, DOI 10.1007/BF00318782; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; [No title captured]	36	272	305	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1932	1935		10.1074/jbc.M209909200	http://dx.doi.org/10.1074/jbc.M209909200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12409290	hybrid			2022-12-27	WOS:000180462200076
J	Stefanovic, B; Brenner, DA				Stefanovic, B; Brenner, DA			5 ' stem-loop of collagen alpha 1(I) mRNA inhibits translation in vitro but is required for triple helical collagen synthesis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAMES; I COLLAGEN; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; PROCOLLAGEN; GENE; INITIATION; PRO-ALPHA-1(I); BIOSYNTHESIS	The 5' stem-loop is a conserved sequence element found around the translation initiation site of three collagen mRNAs, alpha1(I), alpha2(I), and alpha1(III). We show here that the 5' stem-loop of collagen alpha1(l) mRNA is inhibitory to translation in vitro. The sequence 5' to the translation initiation codon, as a part of the 5' stem-loop, is also not efficient in initiating translation under competitive conditions. This suggests that collagen alpha1(I) mRNA may not be a good substrate for translation. Since the 5' stem-loop binds protein factors in collagen-producing cells, this binding may regulate its translation in vivo. We studied in vivo translation of collagen alpha1(I) mRNA after transfecting collagen alpha1(I) genes with and without the 5' stem-loop into Mov 13 fibroblasts. The mRNA with the alpha1(I) 5' stem-loop wag translated into pepsin-resistant collagen, which was secreted into the cellular medium. This mRNA also produced more disulfide-bonded high molecular weight collagen found intracellularly. The mRNA in which the 5' stem-loop was mutated, but without affecting the coding region of the gene, was translated into pepsin-sensitive collagen and produced only trace amounts of disulfide-bonded collagen. This suggests that the 5' stem-loop is required for proper folding or stabilization of the collagen triple helix. To our knowledge this is the first example that an RNA element located in the 5'-untranslated region is involved in synthesis of a secreted multisubunit protein. We suggest that 5' stem-loop, with its cognate binding proteins, targets collagen mRNAs for coordinate translation and couples translation apparatus to the rest of the collagen biosynthetic pathway.	Florida State Univ, Dept Biol Sci, Coll Med, Tallahassee, FL 32306 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biophys, Chapel Hill, NC 27599 USA	State University System of Florida; Florida State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stefanovic, B (corresponding author), Florida State Univ, Dept Biol Sci, Coll Med, Tallahassee, FL 32306 USA.	branko.stefanovic@med.fsu.edu		Brenner, David/0000-0003-2573-525X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059466] Funding Source: NIH RePORTER; NIDDK NIH HHS [1R01DK59466-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BATEMAN JF, 1994, MATRIX BIOL, V14, P251, DOI 10.1016/0945-053X(94)90189-9; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; DALESSIO M, 1990, J BIOL CHEM, V265, P7050; DEGNIN CR, 1993, J VIROL, V67, P5514, DOI 10.1128/JVI.67.9.5514-5521.1993; ECKES B, 1993, FEBS LETT, V318, P129, DOI 10.1016/0014-5793(93)80006-G; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Friedman S L, 1996, Prog Liver Dis, V14, P101; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; HARTUNG S, 1986, NATURE, V320, P365, DOI 10.1038/320365a0; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; HORLEIN D, 1981, P NATL ACAD SCI-BIOL, V78, P6163, DOI 10.1073/pnas.78.10.6163; KIRK TZ, 1987, J BIOL CHEM, V262, P5540; Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5; Kos M, 2002, J BIOL CHEM, V277, P37131, DOI 10.1074/jbc.M206325200; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; MILANI S, 1990, AM J PATHOL, V137, P59; Niederreither K, 1995, MATRIX BIOL, V14, P705, DOI 10.1016/S0945-053X(05)80013-7; PAGLIA L, 1979, BIOCHEMISTRY-US, V18, P5030, DOI 10.1021/bi00589a034; PHILLIPS CL, 1992, ARCH BIOCHEM BIOPHYS, V295, P397, DOI 10.1016/0003-9861(92)90533-3; Rocnik EF, 2002, J BIOL CHEM, V277, P38571, DOI 10.1074/jbc.M206689200; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; SCHNIEKE A, 1987, P NATL ACAD SCI USA, V84, P764, DOI 10.1073/pnas.84.3.764; STACEY A, 1987, J VIROL, V61, P2549, DOI 10.1128/JVI.61.8.2549-2554.1987; Stefanovic A, 2000, NUCLEIC ACIDS RES, V28, P641, DOI 10.1093/nar/28.2.641; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; STEFANOVIC B, 1995, NUCL ACIDS S SER, V33, P212; SU MW, 1991, J CELL BIOL, V115, P565, DOI 10.1083/jcb.115.2.565; Suokas M, 2000, J BIOL CHEM, V275, P17863, DOI 10.1074/jbc.M908025199; Tajima Shingo, 1994, Journal of Dermatology (Tokyo), V21, P219; VEIS A, 1989, J BIOL CHEM, V264, P3884; VEIS A, 1977, P NATL ACAD SCI USA, V74, P902, DOI 10.1073/pnas.74.3.902; WILLING MC, 1995, J MED GENET, V32, P697, DOI 10.1136/jmg.32.9.697; YAMADA Y, 1983, J BIOL CHEM, V258, P4914	44	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					927	933		10.1074/jbc.M209175200	http://dx.doi.org/10.1074/jbc.M209175200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12419812	hybrid			2022-12-27	WOS:000180321900031
J	Cronin, NB; O'Reilly, A; Duclohier, H; Wallace, BA				Cronin, NB; O'Reilly, A; Duclohier, H; Wallace, BA			Binding of the anticonvulsant drug lamotrigine and the neurotoxin batrachotoxin to voltage-gated sodium channels induces conformational changes associated with block and steady-state activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; DIFFERENTIAL LIGHT-SCATTERING; NA+-CHANNEL; K+-CHANNEL; ELECTROPHORUS-ELECTRICUS; POINT MUTATIONS; SEGMENT; PORE; INACTIVATION	Voltage-gated sodium channels are dynamic membrane proteins characterized by rapid conformational changes that switch the molecule between closed resting, activated, and inactivated states. Sodium channels are specifically blocked by the anticonvulsant drug lamotrigine, which preferentially binds to the channel pore in the inactivated open state. Batrachotoxin is a lipid-soluble alkaloid that causes steady-state activation and binds in the inner pore of the sodium channel with overlapping but distinct molecular determinants from those of lamotrigine. Using circular dichroism spectroscopy on purified voltage-gated sodium channels from Electrophorus electricus, the secondary structures associated with the mixture of states present at equilibrium in the absence of these ligands were compared with specific stabilized states in their presence. As the channel shifts to open states, there appears to be a significant change in secondary structure to a more alpha-helical conformation. The observed changes are consistent with increased order involving the S6 segments that form the pore, the domain III-IV linker, and the P-loops that form the outer pore and selectivity filter. A molecular model has been constructed for the sodium channel based on its homology with the pore-forming regions of bacterial potassium channels, and automated docking of the crystal structure of lamotrigine with this model produces a structure in which the close contacts of the drug are with the residues previously identified by mutational studies as forming the binding site for this drug.	Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Univ Rennes 1, UMR 6026 CNRS, Lab Interact Cellulaires & Mol, F-35042 Rennes, France	University of London; Birkbeck University London; Universite de Rennes	Wallace, BA (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.	ubcg25a@mail.cryst.bbk.ac.uk	O'Reilly, Andrias/AAC-7628-2022; Wallace, B A/C-3753-2008	O'Reilly, Andrias/0000-0003-3449-2368; Wallace, B A/0000-0001-9649-5092				ALLEN PZ, 1982, J CLIN MICROBIOL, V15, P324, DOI 10.1128/JCM.15.2.324-329.1982; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Anger T, 2001, J MED CHEM, V44, P115, DOI 10.1021/jm000155h; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balser JR, 2001, J MOL CELL CARDIOL, V33, P599, DOI 10.1006/jmcc.2000.1346; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BENDAHHOU S, 1991, CR ACAD SCI III-VIE, V312, P277; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; Chen Y, 1997, BIOPHYS CHEM, V65, P65, DOI 10.1016/S0301-4622(96)02225-9; Chen ZH, 2002, J BIOL CHEM, V277, P24653, DOI 10.1074/jbc.M111862200; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; HANKE W, 1984, BIOELECTROCH BIOENER, V12, P329, DOI 10.1016/0302-4598(84)87013-0; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; HEINEMANN SH, 1994, BRAZ J MED BIOL RES, V27, P2781; Hille B., 2001, IONIC CHANNELS EXCIT, P814; JAMES WM, 1989, BIOCHEMISTRY-US, V28, P6001, DOI 10.1021/bi00440a042; JANES RW, 1989, ACTA CRYSTALLOGR C, V45, P129, DOI 10.1107/S0108270188010224; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Keynes R.D., 2001, NOVART FDN SYMP, V241, P5; Korsgaard MPG, 2001, PFLUG ARCH EUR J PHY, V443, P18, DOI 10.1007/s004240100625; Kuroda Y, 1999, BIOPHYS J, V77, P1363, DOI 10.1016/S0006-3495(99)76985-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Levinson S R, 1990, Ion Channels, V2, P33; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MILLER JA, 1983, BIOCHEMISTRY-US, V22, P462, DOI 10.1021/bi00271a032; NARAHASHI T, 1986, ANN NY ACAD SCI, V479, P133, DOI 10.1111/j.1749-6632.1986.tb15566.x; Narahashi T, 1999, Adv Neurol, V79, P457; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otoom SA, 2001, CYTOBIOS, V106, P75; Patten CD, 1999, FEBS LETT, V463, P375, DOI 10.1016/S0014-5793(99)01659-2; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ptacek LJBS, 2001, DISORDERS VOLUNTARY, P604; RECIOPINTO E, 1987, J GEN PHYSIOL, V90, P375, DOI 10.1085/jgp.90.3.375; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Smith G., 1985, Parasitology Today, V1, P76, DOI 10.1016/0169-4758(85)90047-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; WALLACE BA, 1987, BIOCHEMISTRY-US, V26, P65, DOI 10.1021/bi00375a010; WALLACE BA, 1984, ANAL BIOCHEM, V142, P317, DOI 10.1016/0003-2697(84)90471-8; Wang SY, 1999, BIOPHYS J, V76, P3141, DOI 10.1016/S0006-3495(99)77465-5; Wang SY, 1998, P NATL ACAD SCI USA, V95, P2653, DOI 10.1073/pnas.95.5.2653; Wang SY, 2001, MOL PHARMACOL, V59, P1100, DOI 10.1124/mol.59.5.1100; Wang SY, 2000, BIOPHYS J, V79, P1379, DOI 10.1016/S0006-3495(00)76390-9; Wartenberg HC, 2001, BASIC RES CARDIOL, V96, P645, DOI 10.1007/s003950170017; XIE XM, 1995, PFLUG ARCH EUR J PHY, V430, P437, DOI 10.1007/BF00373920; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; Zhang H, 2000, BBA-BIOMEMBRANES, V1467, P406, DOI 10.1016/S0005-2736(00)00238-8; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	71	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2003	278	12					10675	10682		10.1074/jbc.M208356200	http://dx.doi.org/10.1074/jbc.M208356200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	659LE	12431988	hybrid			2022-12-27	WOS:000181777500089
J	Iwasaki, H; Zhang, Y; Tachibana, K; Gotoh, M; Kikuchi, N; Kwon, YD; Togayachi, A; Kudo, T; Kubota, T; Narimatsu, H				Iwasaki, H; Zhang, Y; Tachibana, K; Gotoh, M; Kikuchi, N; Kwon, YD; Togayachi, A; Kudo, T; Kubota, T; Narimatsu, H			Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM IGA1; CONSECUTIVE THREONINE RESIDUES; MOLECULAR-CLONING; LINKED OLIGOSACCHARIDE; MASS-SPECTROMETRY; TANDEM REPEAT; CDNA CLONING; NEPHROPATHY; GLYCOSYLATION; EXPRESSION	The hinge region of human immunoglobulin A1 (*IgA1) possesses multiple O-glycans, of which synthesis is initiated by the addition of GaINAc to serine or threonine through the activity of UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases (pp-GaINAc-Ts). We found that six pp-GaINAc-Ts, ppGaINAc-T1, -T2, -T3, -T4, -T6, and -T9, were expressed in B cells, IgA-bearing B cells, and NCI-H929 IgA myeloma cells. pp-GaINAc-T activities of these six enzymes for a synthetic IgA hinge peptide, which has nine possible O-glycosylation sites, were examined using a reversed phase-high performance liquid chromatography, a matrix-assisted laser desorption ionization time of flight mass spectrometry, and peptide sequencing analysis. pp-GaINAc-T2 showed the strongest activity transferring GaINAe to a maximum of eight positions. Other pp-GaINAc-Ts exhibited different substrate specificities from pp-GaINAc-T2; however, their activities were extremely weak. It was reported that the IgA1 hinge region possesses a maximum of five O-glycans, and their amino acid positions have been determined. We found that pp-GaINAc-T2 selectively transferred GaINAc residues to the same five positions. These results strongly suggested that pp-GaINAc-T2 is an essential enzyme for initiation of O-linked glycosylation of the IgA1 hinge region.	Natl Inst Adv Ind Sci & Technol, AIST, Res Ctr Glycosci, Open Space Lab,Glycogene Funct Team, Tsukuba, Ibaraki 3058568, Japan; Amersham Biosci KK, Shinjuku Ku, Tokyo, Japan; Mitsui Knowledge Ind Co Ltd, Nakano Ku, Tokyo 1648721, Japan; New Energy & Ind Technol Dev Org, Toshima Ku, Tokyo 1706028, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, AIST, Res Ctr Glycosci, Open Space Lab,Glycogene Funct Team, C-2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp	Narimatsu, Hisashi/M-4757-2018; Togayachi, Akira/M-4144-2018; Yang, Fang/AAF-3024-2019; Kubota, Tomomi/J-1492-2018	Narimatsu, Hisashi/0000-0002-8402-133X; Togayachi, Akira/0000-0003-3600-9149; Kubota, Tomomi/0000-0002-0723-135X				Allen AC, 1997, NEPHROL DIAL TRANSPL, V12, P701, DOI 10.1093/ndt/12.4.701; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; ALLEN AC, 1995, CLIN EXP IMMUNOL, V100, P470; BAENZIGER J, 1974, J BIOL CHEM, V249, P7270; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; BERGER J, 1968, J UROL NEPHROL, V74, P694; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; CASANUEVA B, 1986, NEPHRON, V43, P33, DOI 10.1159/000183714; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; Fukuda M, 1996, CANCER RES, V56, P2237; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; HIKI Y, 1995, CONTRIB NEPHROL, V111, P73; HOMA FL, 1993, J BIOL CHEM, V268, P12609; Iida S, 1999, FEBS LETT, V449, P230, DOI 10.1016/S0014-5793(99)00445-7; Ikehara Y, 1999, GLYCOBIOLOGY, V9, P1213, DOI 10.1093/glycob/9.11.1213; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Iwase H, 1999, TRENDS GLYCOSCI GLYC, V11, P113, DOI 10.4052/tigg.11.113; Iwase H, 1999, BIOCHEM BIOPH RES CO, V261, P472, DOI 10.1006/bbrc.1999.1006; Iwase H, 1999, J CHROMATOGR B, V724, P1, DOI 10.1016/S0378-4347(98)00552-0; Iwase H, 2001, ANAL BIOCHEM, V288, P22, DOI 10.1006/abio.2000.4870; IWASE H, 1992, ANAL BIOCHEM, V206, P202, DOI 10.1016/S0003-2697(05)80034-X; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kato K, 2001, GLYCOBIOLOGY, V11, P821, DOI 10.1093/glycob/11.10.821; Kato K, 2001, BIOCHEM BIOPH RES CO, V287, P110, DOI 10.1006/bbrc.2001.5562; Kim YJ, 1996, BIOCHEM BIOPH RES CO, V228, P324, DOI 10.1006/bbrc.1996.1660; Kirnarsky L, 1998, BIOCHEMISTRY-US, V37, P12811, DOI 10.1021/bi981034a; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kokubo T, 1999, NEPHROL DIAL TRANSPL, V14, P81, DOI 10.1093/ndt/14.1.81; Kudo T, 2002, J BIOL CHEM, V277, P47724, DOI 10.1074/jbc.M205839200; Mattu TS, 1998, J BIOL CHEM, V273, P2260, DOI 10.1074/jbc.273.4.2260; MESTECKY J, 1986, MONOGR ALLERGY, V19, P277; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; NOMOTO Y, 1979, AM J CLIN PATHOL, V71, P158; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Novak J, 2000, MOL IMMUNOL, V37, P1047, DOI 10.1016/S0161-5890(01)00019-0; Odani H, 2000, BIOCHEM BIOPH RES CO, V271, P268, DOI 10.1006/bbrc.2000.2613; PILLER F, 1988, J BIOL CHEM, V263, P15146; Samyn-Petit B, 2000, BBA-GEN SUBJECTS, V1474, P201, DOI 10.1016/S0304-4165(00)00020-9; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Tetaert D, 2001, BIOCHEM J, V357, P313, DOI 10.1042/0264-6021:3570313; Toba S, 2000, BBA-GENE STRUCT EXPR, V1493, P264, DOI 10.1016/S0167-4781(00)00180-9; Tomana M, 1997, KIDNEY INT, V52, P509, DOI 10.1038/ki.1997.361; TORANO A, 1977, P NATL ACAD SCI USA, V74, P2301, DOI 10.1073/pnas.74.6.2301; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; YANG JM, 1994, GLYCOBIOLOGY, V4, P873, DOI 10.1093/glycob/4.6.873; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; ZHANG Y, 2002, IN PRESS J BIOL CHEM, V277	58	77	87	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2003	278	8					5613	5621		10.1074/jbc.M211097200	http://dx.doi.org/10.1074/jbc.M211097200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	648BF	12438318	hybrid			2022-12-27	WOS:000181129400018
J	Jijakli, H; Courtois, P; Zhang, HX; Sener, A; Malaisse, WJ				Jijakli, H; Courtois, P; Zhang, HX; Sener, A; Malaisse, WJ			Anomeric specificity of the stimulatory effect of D-glucose on D-fructose phosphorylation by human liver glucokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL GLUCOKINASE; PANCREATIC-ISLETS; HEXOSE METABOLISM; INSULINOTROPIC ACTION; RATS; COOPERATIVITY; CALCIUM; RELEASE	D-Glucose was recently reported to stimulate D-fructose phosphorylation by human B-cell glucokinase. The present study aims at investigating the anomeric specificity of such a positive cooperativity. The a-anomer of D-glucose was found to increase much more markedly than beta-D-glucose the phosphorylation of D-fructose by human liver glucokinase. Such an anomeric preference diminished at high concentrations of the D-glucose anomers, i.e. when the effect of the aldohexose upon D-fructose phosphorylation became progressively less marked. A comparison between the effects of the two anomers of D-glucose and those of equilibrated D-glucose upon D-fructose phosphorylation by human liver glucokinase indicated that the results obtained with the equilibrated aldohexose were not significantly different from those expected from the combined effects of each anomers of D-glucose. In isolated rat islets incubated for 60 min at 4 degreesC, alpha-D-glucose (5.6 mM), but not beta-D-glucose (also 5.6 mm), augmented significantly the conversion of D-[U-C-14]fructose (5.0 mM) to acidic radioactive metabolites. Likewise, in islets prelabeled with Ca-45 and perifused at 37 degreesC, D-fructose (20.0 mM) augmented Ca-45 efflux and provoked a biphasic stimulation of insulin release from islets exposed to alpha-D-glucose (5.6 mm), while inhibiting Ca-45 efflux and causing only a sluggish and modest increase in insulin output from islets exposed to beta-D-glucose (also 5.6 mm). The enhancing action of D-glucose upon D-fructose phosphorylation by glucokinase thus displays an obvious anomeric preference for alpha-D-glucose, and such an anomeric specificity remains operative in intact pancreatic islets.	Free Univ Brussels, Expt Med Lab, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Malaisse, WJ (corresponding author), Free Univ Brussels, Expt Med Lab, 808 Route Lennik, B-1070 Brussels, Belgium.		SENER, Abdullah/A-1769-2008	SENER, Abdullah/0000-0003-2718-5423; Courtois, Philippe/0000-0002-1135-3157				Courtois P, 2000, ARCH BIOCHEM BIOPHYS, V373, P126, DOI 10.1006/abbi.1999.1546; GIROIX MH, 1984, BIOCHEM J, V223, P447, DOI 10.1042/bj2230447; Giroix MH, 1999, ENDOCRINOLOGY, V140, P5556, DOI 10.1210/en.140.12.5556; GYLFE E, 1988, J BIOL CHEM, V263, P13750; HERCHUELZ A, 1980, J MEMBRANE BIOL, V57, P1, DOI 10.1007/BF01868981; Jijakli H, 2000, ACTA DIABETOL, V37, P27, DOI 10.1007/s005920070032; Jijakli H, 1996, PHARMACOL RES, V34, P105, DOI 10.1006/phrs.1996.0072; MALAISSE WJ, 1990, AM J PHYSIOL, V259, pE117, DOI 10.1152/ajpendo.1990.259.1.E117; MALAISSE WJ, 1993, J CLIN INVEST, V91, P432, DOI 10.1172/JCI116219; MALAISSE WJ, 1986, AM J PHYSIOL, V251, pC841, DOI 10.1152/ajpcell.1986.251.6.C841; MALAISSE WJ, 1988, BIOCHIM BIOPHYS ACTA, V971, P246, DOI 10.1016/S0005-2728(88)80038-0; Malaisse WJ, 1984, METHODS DIABETES RES, V1, P147; Moukil MA, 2001, J BIOL CHEM, V276, P3872, DOI 10.1074/jbc.M008722200; Scruel O, 1997, MOL CELL BIOCHEM, V175, P263, DOI 10.1023/A:1006834010660; Scruel O, 1999, MOL GENET METAB, V68, P86, DOI 10.1006/mgme.1999.2888; Scruel O, 1999, MOL CELL BIOCHEM, V197, P209, DOI 10.1023/A:1006910201767; Scruel O, 1999, J CHROMATOGR A, V847, P53, DOI 10.1016/S0021-9673(99)00010-2; Sener A, 1996, BBA-MOL CELL RES, V1312, P73, DOI 10.1016/0167-4889(96)00010-9	18	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					4531	4535		10.1074/jbc.M206730200	http://dx.doi.org/10.1074/jbc.M206730200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12444092	hybrid			2022-12-27	WOS:000180968900024
J	Barre, B; Avril, S; Coqueret, O				Barre, B; Avril, S; Coqueret, O			Opposite regulation of Myc and p21(waf1) transcription by STAT3 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE INHIBITOR P21(WAF1/CIP1); INTERFERON-BETA ENHANCEOSOME; RNA-POLYMERASE-II; C-MYC; IN-VITRO; ACTIVATION; GENE; CELLS; RECRUITMENT; PROGRESSION	Activated forms of STAT3 transcription factors are often found in various cancers and tumor cell lines, indicating that this signaling pathway is involved in tumorogenesis. At the molecular level, STAT3 proteins function as transcriptional activators and up-regulate several growth-promoting genes such as myc, pim-1, or cyclin D1. However, these transcription factors have also proapoptotic functions and can activate the expression of the cell-cycle inhibitor p21(waf1), suggesting that STAT3 can also block cell-cycle progression and prevent abnormal cell proliferation. To reconcile these observations, one would predict that the STAT3-mediated activation of p21(waf1) is lost during cell transformation. In this study, we show that upon IL-6 stimulation of glioblastoma cells, STAT3 does not activate the expression of the p21(waf1) gene, whereas the expression of the myc gene remains unaltered. Chromatin immunoprecipitation experiments show that STAT3 and its cofactor NcoA/SRC1a are effectively recruited to the p21(waf1) promoter but that this is not followed by the association of the CREB-binding protein (CBP) histone acetylase and the type II RNA polymerase as normally seen on the myc promoter. Whereas the PI-3K/Akt pathway is constitutively activated in these cells, inactivation of this pathway restores the loading of CBP and the RNA polymerase and the expression of the p21(waf1) gene without having any effect on myc regulation. Moreover, this effect was recapitulated in HepG2 cells expressing an activated form of the Akt kinase. In these cells, the kinase blocked the STAT3-mediated expression of the p21(waf1) gene by inhibiting the recruitment of CREB-binding protein and the type II RNA polymerase, without having any effects on the loading of STAT3 and its cofactor NcoA/SRC1a. Together, these findings suggest that the phosphatidylinositol 3-kinase/Akt pathway inhibits the transcriptional activation of the p21(waf1) gene by STAT3 proteins without altering the regulation of the myc promoter.	CHU Angers, INSERM, U564, F-49033 Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Coqueret, O (corresponding author), CHU Angers, INSERM, U564, 4 Rue Larrey, F-49033 Angers, France.		Coqueret, Olivier/K-9660-2015; AVRIL, sylvie/K-6024-2015	Coqueret, Olivier/0000-0002-2843-7867; Avril, Sylvie/0000-0003-0574-6752				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Allan LA, 2000, MOL CELL BIOL, V20, P1291, DOI 10.1128/MCB.20.4.1291-1298.2000; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Florenes VA, 1999, ONCOGENE, V18, P1023, DOI 10.1038/sj.onc.1202382; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Ivanov VN, 2002, J BIOL CHEM, V277, P4932, DOI 10.1074/jbc.M108233200; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Kim TK, 1998, P NATL ACAD SCI USA, V95, P12191, DOI 10.1073/pnas.95.21.12191; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Roman-Gomez J, 2002, BLOOD, V99, P2291, DOI 10.1182/blood.V99.7.2291; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	36	94	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2990	2996		10.1074/jbc.M210422200	http://dx.doi.org/10.1074/jbc.M210422200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12438313	hybrid			2022-12-27	WOS:000180915000030
J	Hantgan, RR; Lyles, DS; Mallett, TC; Rocco, M; Nagaswami, C; Weisel, JW				Hantgan, RR; Lyles, DS; Mallett, TC; Rocco, M; Nagaswami, C; Weisel, JW			Ligand binding promotes the entropy-driven oligomerization of integrin alpha(IIb)beta(3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARG-GLY-ASP; MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN SECONDARY STRUCTURE; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; INSIDE-OUT; EXTRACELLULAR SEGMENT; DETERGENT STRUCTURE; THERMAL-STABILITY; PLATELET-ADHESION	Integrin alpha(IIb)beta(3) clusters on the platelet surface after binding adhesive proteins in a process that regulates signal transduction. However, the intermolecular forces driving integrin self-association are poorly understood. This work provides new insights into integrin clustering mechanisms by demonstrating how temperature and ligand binding interact to affect the oligomeric state of alpha(IIb)beta(3). The ligand-free receptor, solubilized in thermostable octyl glucoside micelles, exhibited a cooperative transition at similar to43 degreesC, monitored by changes in intrinsic fluorescence and circular dichroism. Both signals changed in a direction opposite to that for global unfolding, and both were diminished upon binding the fibrinogen gamma-chain ligand-mimetic peptide cHArGD. Free and bound receptors also exhibited differential sensitivity to temperature-enhanced oligomerization, as measured by dynamic light scattering, sedimentation velocity, and sedimentation equilibrium. Van't Hoff analyses of dimerization constants for alpha(IIb)beta(3) complexed with cHArGD, cRGD, or eptifibatide yielded large, favorable entropy changes partly offset by unfavorable enthalpy changes. Transmission electron microscopy showed that ligand binding and 37 degreesC incubation enhanced assembly of integrin dimers and larger oligomers linked by tail-to-tail contacts. Interpretation of these images was aided by threading models for alpha(IIb)beta(3) protomers and dimers based on the ectodomain structure of alpha(v)beta(3). We propose that entropy-favorable nonpolar interactions drive ligand-induced integrin clustering and outside-in signaling.	Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; CBA, Unita Operat Biol Strutturale, Ist Nazl Ric Canc, IST, I-16132 Genoa, Italy; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Wake Forest University; Wake Forest University; University of Genoa; IRCCS AOU San Martino IST; University of Pennsylvania	Hantgan, RR (corresponding author), Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	rhantgan@wfubmc.edu	Rocco, Mattia/AAN-7942-2021	Rocco, Mattia/0000-0002-0456-7528; Lyles, Douglas/0000-0002-8401-3073	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015892, R55AI015892] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 30954] Funding Source: Medline; NIAID NIH HHS [AI15892] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aerts T, 1997, EUR BIOPHYS J BIOPHY, V25, P445, DOI 10.1007/s002490050059; Amzel LM, 2000, METHOD ENZYMOL, V323, P167; Aoudia M, 1998, J COLLOID INTERF SCI, V206, P158, DOI 10.1006/jcis.1998.5627; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Berne B, 1990, DYNAMIC LIGHT SCATTE; Bogusz S, 2000, J PHYS CHEM B, V104, P5462, DOI 10.1021/jp000159y; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Calderone CT, 2001, J AM CHEM SOC, V123, P6262, DOI 10.1021/ja003016y; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cantor, 1980, BIOPHYS CHEM; Cierniewski CS, 1999, J BIOL CHEM, V274, P16923, DOI 10.1074/jbc.274.24.16923; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Faull RJ, 1996, J AM SOC NEPHROL, V7, P1091; Fieber W, 2001, J MOL BIOL, V307, P1395, DOI 10.1006/jmbi.2001.4537; FOWLER WE, 1979, J MOL BIOL, V134, P241, DOI 10.1016/0022-2836(79)90034-2; Gall A, 2001, BIOPOLYMERS, V58, P231, DOI 10.1002/1097-0282(200103)58:3<231::AID-BIP1000>3.0.CO;2-#; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GINSBERG MH, 1992, COLD SPRING HARB SYM, V57, P221, DOI 10.1101/SQB.1992.057.01.027; Gottschalk M, 2001, J MOL BIOL, V311, P605, DOI 10.1006/jmbi.2001.4895; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANTGAN RR, 1984, BLOOD, V64, P896; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hantgan RR, 2002, THROMB HAEMOSTASIS, V87, P910; Hantgan RR, 2001, PROTEIN SCI, V10, P1614, DOI 10.1110/ps.3001; Hantgan RR, 2001, BBA-MOL CELL RES, V1540, P82, DOI 10.1016/S0167-4889(01)00120-3; HANTGAN RR, 1993, BIOCHEMISTRY-US, V32, P3935, DOI 10.1021/bi00066a013; HANTGAN RR, 1992, THROMB HAEMOSTASIS, V68, P694; Hartwig JH, 1999, THROMB HAEMOSTASIS, V82, P392; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KEGELES G, 1967, P NATL ACAD SCI USA, V58, P45, DOI 10.1073/pnas.58.1.45; Klein-Seetharaman J, 2002, P NATL ACAD SCI USA, V99, P3452, DOI 10.1073/pnas.052713999; Klotz IM, 1975, PROTEINS, V1, P293; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Liddington RC, 2000, EXP CELL RES, V261, P37, DOI 10.1006/excr.2000.5058; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Liu SC, 2000, J CELL SCI, V113, P3563; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Makogonenko EM, 1996, EUR J BIOCHEM, V237, P205, DOI 10.1111/j.1432-1033.1996.0205n.x; MARCUM JM, 1978, J BIOL CHEM, V253, P2852; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moore JMR, 1999, BIOCHEMISTRY-US, V38, P13960, DOI 10.1021/bi9905516; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pandit A, 2001, BIOCHEMISTRY-US, V40, P12913, DOI 10.1021/bi010163f; Payrastre B, 2000, BIOCHEM PHARMACOL, V60, P1069, DOI 10.1016/S0006-2952(00)00417-2; PEBAYPEYROULA E, 1995, STRUCTURE, V3, P1051, DOI 10.1016/S0969-2126(01)00241-6; PECORA R, 1983, MEASUREMENT SUSPENDE; Phillips DR, 1997, AM J CARDIOL, V80, pB11, DOI 10.1016/S0002-9149(97)00572-9; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Quinn M, 1999, CIRCULATION, V99, P2231, DOI 10.1161/01.CIR.99.17.2231; ROTH M, 1989, NATURE, V340, P659, DOI 10.1038/340659a0; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STAFFORD WF, 1994, MODERN ANAL ULTRACEN; TRANQUI L, 1989, J CELL BIOL, V108, P2519, DOI 10.1083/jcb.108.6.2519; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; VANHOLDE KE, 1998, MACROMOLECULES SOLUT; Vanhoudt J, 2000, BIOCHEMISTRY-US, V39, P4483, DOI 10.1021/bi990386u; VEKLICH YI, 1993, J BIOL CHEM, V268, P13577; VENABLE RM, 1993, SCIENCE, V262, P223, DOI 10.1126/science.8211140; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	82	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3417	3426		10.1074/jbc.M208869200	http://dx.doi.org/10.1074/jbc.M208869200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12426312	hybrid			2022-12-27	WOS:000180915000083
J	Sponne, I; Fifre, A; Drouet, A; Klein, C; Koziel, V; Pingon-Raymond, M; Olivier, JL; Chambaz, J; Pillot, T				Sponne, I; Fifre, A; Drouet, A; Klein, C; Koziel, V; Pingon-Raymond, M; Olivier, JL; Chambaz, J; Pillot, T			Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION PRODUCT; SYNAPTIC PLASMA-MEMBRANES; C-TERMINAL DOMAIN; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSGENIC MICE; A-BETA; PLAQUE-FORMATION; BRAIN; NEUROTOXICITY	In the present study, we have determined the nature and the kinetics of the cellular events triggered by the exposure of cells to non-fibrillar amyloid-beta peptide (Abeta). When cortical neurons were treated with low concentrations of soluble Abeta (1-40), an early reactive oxygen species (ROS)-dependent cytoskeleton disruption precedes caspase activation. Indeed, caspase activation and neuronal cell death were prevented by the microtubule-stabilizing drug taxol. A perturbation of the microtubule network was noticeable after being exposed to Abeta for 1 h, as revealed by electron microscopy and immunocytochemistry. Microtubule disruption and neuronal cell death induced by Abeta were inhibited in the presence of antioxidant molecules, such as probucol. These data highlight the critical role of ROS production in Abeta-mediated cytoskeleton disruption and neuronal cell death. Finally, using FRAP (fluorescence recovery after photo bleaching) analysis, we observed a time-dependent bi-phasic modification of plasma membrane fluidity, as early as microtubule disorganization. Interestingly, molecules that inhibited neurotubule perturbation and cell death did not affect the membrane destabilizing properties of Abeta, suggesting that the lipid phase of the plasma membrane might represent the earliest target for Abeta. Altogether our results convey the idea that upon interaction with the plasma membrane, the non-fibrillar Abeta induces a rapid ROS-dependent disorganization of the cytoskeleton, which results in apoptosis.	Univ Nancy 1, INSERM, EMI 0014, F-54505 Vandoeuvre Les Nancy, France; Univ Paris 06, INSERM, U505, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pillot, T (corresponding author), Univ Nancy 1, INSERM, EMI 0014, 9 Ave Foret de Haye,BP 184, F-54505 Vandoeuvre Les Nancy, France.	Thierry.Pillot@bcmn.facmed.u-nancy.fr	Olivier, Jean luc/AAQ-2721-2021	klein, christophe/0000-0001-8015-287X				Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Avdulov NA, 1997, J NEUROCHEM, V68, P2086; Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; Blitzer RD, 2000, MOL BRAIN RES, V76, P115, DOI 10.1016/S0169-328X(99)00340-X; BLONK CG, 1992, J MICROSCOPY, V169, P363; Brasseur R, 1997, TRENDS BIOCHEM SCI, V22, P167, DOI 10.1016/S0968-0004(97)01047-5; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Cribbs DH, 1997, J BIOL CHEM, V272, P7431, DOI 10.1074/jbc.272.11.7431; Drouet B, 2000, CELL MOL LIFE SCI, V57, P705, DOI 10.1007/s000180050035; Drouet B, 1999, J NEUROCHEM, V73, P742, DOI 10.1046/j.1471-4159.1999.0730742.x; Drouet B, 2001, J NEUROCHEM, V76, P117, DOI 10.1046/j.1471-4159.2001.00047.x; Estus S, 1997, J NEUROSCI, V17, P7736; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; HARTMANN H, 1994, BIOCHEM BIOPH RES CO, V200, P1185, DOI 10.1006/bbrc.1994.1576; Hertel C, 1997, P NATL ACAD SCI USA, V94, P9412, DOI 10.1073/pnas.94.17.9412; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Inoue S, 1999, BRAIN RES REV, V29, P218, DOI 10.1016/S0165-0173(98)00055-1; Ivins KJ, 1999, NEUROBIOL DIS, V6, P440, DOI 10.1006/nbdi.1999.0268; Ivins KJ, 2000, J NEUROL, V247, P155, DOI 10.1007/PL00007801; Keller JN, 1997, J NEUROCHEM, V69, P273; Koistinaho M, 2002, P NATL ACAD SCI USA, V99, P1610, DOI 10.1073/pnas.032670899; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; KUBITSCHECK U, 1994, BIOPHYS J, V67, P948, DOI 10.1016/S0006-3495(94)80596-X; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Malecki A, 2000, J NEUROCHEM, V74, P2278, DOI 10.1046/j.1471-4159.2000.0742278.x; Mason RP, 1999, J BIOL CHEM, V274, P18801, DOI 10.1074/jbc.274.26.18801; Michaelis ML, 1998, J NEUROCHEM, V70, P1623; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Miranda S, 2000, PROG NEUROBIOL, V62, P633, DOI 10.1016/S0301-0082(00)00015-0; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2; Muller WE, 1998, AMYLOID, V5, P10, DOI 10.3109/13506129809007284; Neely MD, 1999, J NEUROCHEM, V72, P2323, DOI 10.1046/j.1471-4159.1999.0722323.x; OYAMA Y, 1995, JPN J PHARMACOL, V68, P77, DOI 10.1254/jjp.68.77; Paris D, 2000, NEUROBIOL AGING, V21, P183, DOI 10.1016/S0197-4580(99)00111-6; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Rhee SK, 1998, J BIOL CHEM, V273, P13379, DOI 10.1074/jbc.273.22.13379; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; Suo ZM, 1998, NEUROSCI LETT, V257, P77, DOI 10.1016/S0304-3940(98)00814-3; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Vickers JC, 2000, PROG NEUROBIOL, V60, P139, DOI 10.1016/S0301-0082(99)00023-4; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; Zhang L, 2001, NEUROREPORT, V12, P1919, DOI 10.1097/00001756-200107030-00030	57	92	95	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3437	3445		10.1074/jbc.M206745200	http://dx.doi.org/10.1074/jbc.M206745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12435748	hybrid			2022-12-27	WOS:000180915000085
J	Bradney, C; Hjelmeland, M; Komatsu, Y; Yoshida, M; Yao, TP; Zhuang, Y				Bradney, C; Hjelmeland, M; Komatsu, Y; Yoshida, M; Yao, TP; Zhuang, Y			Regulation of E2A activities by histone acetyltransferases in B lymphocyte development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; DNA-BINDING; CELL DIFFERENTIATION; HLH PROTEINS; TRANSCRIPTION; ACETYLATION; GENE; ACTIVATION; MOTIF; COMMITMENT	Genetic studies have demonstrated that the basic helix-loop-helix protein E2A is an essential transcription factor in B lymphocyte lineage commitment and differentiation. However, the mechanism underlying E2A-mediated transcription regulation is not fully understood. Here, we investigated the physical and genetic interactions between E2A and co-activators histone acetyl-transferases (HATs) in B cells. Gel filtration analysis of human pre-B cell nuclear extract showed that E2A co-elutes with the HATs p300, CBP, and PCAF. A co-immunoprecipitation assay further demonstrated that a fraction of endogenous E2A proteins is associated with each of the three HATs. We show that these HATs acetylate E2A in vitro, enhance E2A-mediated transcription activity, and promote nuclear retention of E2A proteins. A catalytic mutation of p300 completely abrogates the ability of p300 to acetylate E2A and to promote E2A nuclear retention in 293T cells. A breeding test between E2A heterozygous mice and p300 heterozygous mice demonstrated that these two genes interact for proper B cell development. Collectively, these results suggest that E2A and HATs collaboratively regulate B cell development.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Adv Life Sci Inst Inc, Wako, Saitama 3510112, Japan; RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan	Duke University; Duke University; RIKEN	Zhuang, Y (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.		Yoshida, Minoru/C-8049-2014	Yoshida, Minoru/0000-0002-4376-5674; zhuang, yuan/0000-0002-2964-3654; Komatsu, Yasuhiko/0000-0003-1739-8222				ARONHEIM A, 1993, P NATL ACAD SCI USA, V90, P8063, DOI 10.1073/pnas.90.17.8063; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; BAIN G, 1993, MOL CELL BIOL, V13, P3522, DOI 10.1128/MCB.13.6.3522; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barndt RJ, 2000, MOL CELL BIOL, V20, P6677, DOI 10.1128/MCB.20.18.6677-6685.2000; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Goodman RH, 2000, GENE DEV, V14, P1553; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Herblot S, 2002, MOL CELL BIOL, V22, P886, DOI 10.1128/MCB.22.3.886-900.2002; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Kee BL, 2001, CURR OPIN IMMUNOL, V13, P180, DOI 10.1016/S0952-7915(00)00202-8; KOMATSU Y, IN PRESS J IMMUNOL M; Kung AL, 2000, GENE DEV, V14, P272; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; O'Riordan M, 1999, IMMUNITY, V11, P21, DOI 10.1016/S1074-7613(00)80078-3; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; Quong MW, 1999, EMBO J, V18, P6307, DOI 10.1093/emboj/18.22.6307; ROLINK A, 1993, BLOOD, V81, P2290; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0	34	57	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2370	2376		10.1074/jbc.M211464200	http://dx.doi.org/10.1074/jbc.M211464200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12435739	hybrid			2022-12-27	WOS:000180562000041
J	Kloss, S; Furneaux, H; Mulsch, A				Kloss, S; Furneaux, H; Mulsch, A			Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHASE; RNA-BINDING PROTEIN; MESSENGER-RNA; GENE-EXPRESSION; HUR; STABILITY; RECEPTOR; CELLS; INOS	We investigated the molecular mechanism of cyclic GMP-induced down-regulation of soluble guanylyl cyclase expression in rat aorta. 3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1), an allosteric activator of this enzyme, decreased the expression of soluble guanylyl cyclase alpha(1) subunit mRNA and protein. This effect was blocked by the enzyme inhibitor 4H-8-bromo-1,2,4-oxadiazolo(3,4-d)benz(b-1,,4)oxazin-1-one (NS2028) and by actinomycin D. Guanylyl cyclase alpha(1) mRNA-degrading activity was increased in protein extracts from YC-1-exposed aorta and was attenuated by pretreatment with actinomycin D and NS2028. Gelshift and supershift analyses using an adenylate-uridylate-rich ribonucleotide from the 3'-untranslated region of the alpha(1) mRNA and a monoclonal antibody directed against the mRNA-stabilizing protein HuR revealed HuR mRNA binding activity in aortic extracts, which was absent in extracts from YC-1-stimulated aortas. YC-1 decreased the expression of HuR, and this decrease was prevented by NS2028. Similarly, down-regulation of HuR by RNA interference in cultured it-at aortic smooth muscle cells decreased alpha(1) mRNA and protein expression. We conclude that HuR protects the guanylyl cyclase alpha(1) mRNA by binding to the W-untranslated region. Activation of guanylyl cyclase decreases HuR expression, inducing a rapid degradation of guanylyl cyclase alpha(1) mRNA and lowering alpha(1) subunit expression as a negative feedback response.	Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60590 Frankfurt, Germany; Univ Connecticut, Sch Med, Dept Biochem, Farmington, CT 06030 USA	Goethe University Frankfurt; University of Connecticut	Mulsch, A (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	muelsch@em.uni-frankfurt.de		furneaux, henry/0000-0003-2212-1017				Bauersachs J, 1999, CIRCULATION, V100, P292, DOI 10.1161/01.CIR.100.3.292; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Filippov G, 1997, J CLIN INVEST, V100, P942, DOI 10.1172/JCI119610; Hartsfield CL, 1997, AM J PHYSIOL-LUNG C, V273, pL980; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; King PH, 2000, GENE, V242, P125, DOI 10.1016/S0378-1119(99)00537-5; Kloss S, 2000, HYPERTENSION, V35, P43; LEVINE TD, 1993, MOL CELL BIOL, V13, P3494, DOI 10.1128/MCB.13.6.3494; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Liu HL, 1997, J BIOL CHEM, V272, P6038, DOI 10.1074/jbc.272.9.6038; Mulsch A, 1997, BRIT J PHARMACOL, V120, P681, DOI 10.1038/sj.bjp.0700982; Mulsch A, 2001, CIRCULATION, V103, P2188; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; PAPAPETROPOULOS A, 1995, HYPERTENSION, V26, P696, DOI 10.1161/01.HYP.26.4.696; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; SchiniKerth VB, 1997, ARTERIOSCL THROM VAS, V17, P672, DOI 10.1161/01.ATV.17.4.672; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; SHIMOUCHI A, 1993, AM J PHYSIOL, V265, pL456, DOI 10.1152/ajplung.1993.265.5.L456; UJIIE K, 1994, J PHARMACOL EXP THER, V270, P761; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; WEDEL B, 1995, J BIOL CHEM, V270, P24871, DOI 10.1074/jbc.270.42.24871; Zhao ZQ, 2000, NUCLEIC ACIDS RES, V28, P2695, DOI 10.1093/nar/28.14.2695	27	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2377	2383		10.1074/jbc.M206453200	http://dx.doi.org/10.1074/jbc.M206453200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441354	hybrid			2022-12-27	WOS:000180562000042
J	Verrecchia, F; Tacheau, C; Wagner, EF; Mauviel, A				Verrecchia, F; Tacheau, C; Wagner, EF; Mauviel, A			A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; TGF-BETA; COLLAGEN GENE; TRANSCRIPTIONAL ACTIVATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; DERMAL FIBROBLASTS; COL7A1 PROMOTER; DNA-BINDING; APOPTOSIS	We have focused our attention on the molecular events underlying the antagonistic activities of pro-inflammatory cytokines against transforming growth factor-beta (TGF-beta)/SMAD signaling. Using jnk1/2-knockout (jnk(-/-)) and IkappaB kinase-gamma/nemo(-/-) fibroblasts, we have determined the specific roles played by the JNK/AP-1 and NF-kappaB/Rel pathways in this phenomenon. We demonstrate that, in a cellular context devoid of JNK activity (ie. jnk(-/-) fibroblasts), interleukin-1 and tumor necrosis factor-alpha (TNF-alpha) did not inhibit the formation of SMAD-DNA complexes and the resulting SMAD-driven transcription in response to TGF-beta. On the other hand, lack of NF-kappaB activity in nemo(-/-) fibroblasts did not affect the antagonistic effect of pro-inflammatory cytokines against TGF-beta. In the latter cell type, overexpression of antisense c-jun mRNA or of a dominant-negative form of MKK4 blocked the inhibitory activity of TNF-alpha, similar to what was observed in normal human dermal fibroblasts. Among JNK substrates, c-Jun and JunB (but not activating transcription factor-2) antagonized TGFbeta/SMAD signaling in a JNK-dependent manner. Overexpression of JNK1 in jnk(-/-) fibroblasts restored the ability of cytokines and Jun proteins to interfere with SMAD signaling. In junAA mouse embryo fibroblasts, in which c-Jun can no longer be phosphorylated by JNK, JunB substituted for c-Jun in mediating the cytokine effect against SMAD-driven transcription in a JNK-dependent manner. These results suggest a critical role for JNK-mediated c-Jun and JunB phosphorylation in transmitting the inhibitory effect of pro-inflammatory cytokines against TGF-beta-induced SMAD signaling. In addition, we demonstrate that such a JNK-dependent regulatory mechanism underlies the antagonistic activity of TNF-alpha against TGF-beta-induced up-regulation of type I and III collagens in fibroblasts.	Hop St Louis, INSERM, U532, Inst Rech Peau, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mauviel, A (corresponding author), Hop St Louis, INSERM, U532, Inst Rech Peau, Pavillon Bazin,1 Ave Claude Vellefaux, F-75475 Paris 10, France.		MAUVIEL, Alain/F-6251-2013; Verrecchia, Franck/G-5535-2018	Verrecchia, Franck/0000-0003-4920-2554; Mauviel, Alain/0000-0002-0438-2793; Wagner, Erwin F/0000-0001-7872-0196				Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bitzer M, 2000, GENE DEV, V14, P187; CHU ML, 1985, J BIOL CHEM, V260, P4357; CHU ML, 1985, J BIOL CHEM, V260, P2315; Chung KY, 1996, J BIOL CHEM, V271, P3272, DOI 10.1074/jbc.271.6.3272; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; MAUVIEL A, 1993, CURR BIOL, V3, P822, DOI 10.1016/0960-9822(93)90216-B; Mauviel A, 1996, J BIOL CHEM, V271, P10917, DOI 10.1074/jbc.271.18.10917; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Mendelson KG, 1996, P NATL ACAD SCI USA, V93, P12908, DOI 10.1073/pnas.93.23.12908; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schreiber M, 2000, DEVELOPMENT, V127, P4937; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Topper JN, 1997, P NATL ACAD SCI USA, V94, P9314, DOI 10.1073/pnas.94.17.9314; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Verrecchia F, 2002, EMBO REP, V3, P1069, DOI 10.1093/embo-reports/kvf219; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; Watson A, 1998, J NEUROSCI, V18, P751; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	46	78	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1585	1593		10.1074/jbc.M206927200	http://dx.doi.org/10.1074/jbc.M206927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426318				2022-12-27	WOS:000180462200030
J	Yu, Q; Cok, SJ; Zeng, CB; Morrison, AR				Yu, Q; Cok, SJ; Zeng, CB; Morrison, AR			Translational repression of human matrix metalloproteinases-13 by an alternatively spliced form of T-cell-restricted intracellular antigen-related protein (TIAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; POSTTRANSCRIPTIONAL MECHANISMS; COLLAGENASE-3 EXPRESSION; TUMOR PROGRESSION; OSTEOBLASTS; ACTIVATION; HUR	Human matrix metalloproteinases-13 (HMMP13) shows a wide substrate specificity, and its expression is limited to pathological situations such as chronic inflammation and cancer. The coding sequence for HMMP13 is 86% identical to rat matrix metalloproteinases-13 (RMMP13); however, the regulation of HMMP13 and RMMP13 protein synthesis in renal mesangial cells is strikingly different. In human cells there is a discordance between HMMP13 mRNA levels and protein expression. Following IL-1beta or TGF-beta(1) stimulation, HMMP13 mRNA levels increase significantly, whereas the protein expression is absent. This discordance is because of a species-dependent translational repression. In addition to the W-untranslated region of the matrix metalloproteinases-13 (MMP13) gene, the differential expression of an alternatively spliced transcript of the RNA-binding protein TLAR in human cell cultures is also critical for this post-transcriptional regulation. Transient expression of the 17-amino acid insert of the alternatively spliced form of TIAR reverses the HMMP13 mRNA silencing observed in human and primate species. In addition, co-transfection of the alternatively spliced form of TIAR and HMMP13 into Rat2 cells suppresses HMMP13 protein expression. Thus, we report for the first time that a species-dependent TIAR isoform plays a major role in the post-transcriptional silencing for HMMP13.	Washington Univ, Sch Med, Dept Med & Mol Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Morrison, AR (corresponding author), Barnes Jewish Hosp, 822 Yalem Res Bldg,216 S Kings Hwy, St Louis, MO 63110 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK009976] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 09976] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ala-aho R, 2000, ONCOGENE, V19, P248, DOI 10.1038/sj.onc.1203306; Beck ARP, 1996, NUCLEIC ACIDS RES, V24, P3829, DOI 10.1093/nar/24.19.3829; Brewer G, 2001, J EXP MED, V193, pF1, DOI 10.1084/jem.193.2.F1; Brinckerhoff CE, 2000, CLIN CANCER RES, V6, P4823; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; DaphnaIken D, 1995, AM J PHYSIOL-RENAL, V269, pF831, DOI 10.1152/ajprenal.1995.269.6.F831; DELANY AM, 1995, J BIOL CHEM, V270, P26607, DOI 10.1074/jbc.270.44.26607; Dember LM, 1996, J BIOL CHEM, V271, P2783, DOI 10.1074/jbc.271.5.2783; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Guan ZH, 1996, AM J PHYSIOL-RENAL, V270, pF634, DOI 10.1152/ajprenal.1996.270.4.F634; KAWAKAMI A, 1992, P NATL ACAD SCI USA, V89, P8681, DOI 10.1073/pnas.89.18.8681; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Le Guienr C, 2001, J BIOL CHEM, V276, P40638, DOI 10.1074/jbc.M105642200; Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Ravanti L, 1999, J BIOL CHEM, V274, P37292, DOI 10.1074/jbc.274.52.37292; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Varghese S, 2000, J BONE MINER RES, V15, P2345, DOI 10.1359/jbmr.2000.15.12.2345; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8	29	52	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1579	1584		10.1074/jbc.M203526200	http://dx.doi.org/10.1074/jbc.M203526200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12426321	hybrid			2022-12-27	WOS:000180462200029
J	Ishisaki, A; Hiyashi, H; Li, AJ; Imamura, T				Ishisaki, A; Hiyashi, H; Li, AJ; Imamura, T			Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; FIBROBLAST GROWTH FACTOR-2; ACTIVIN-BINDING PROTEIN; BETA FAMILY MEMBERS; TGF-BETA; SMAD PROTEINS; MESENCHYMAL CELLS; VESSEL FORMATION; I RECEPTORS; EXPRESSION	Mouse embryonic stem-derived cells were recently shown to differentiate into endothelial and smooth muscle cells. In the present study, we investigated whether human umbilical vein endothelium-derived cells retain the potential to differentiate into smooth muscle cells. Examination of biochemical markers, including basic calponin, SM22alpha, prostaglandin E synthase, von Willebrand factor, and PECAM-1, as well as cell contractility, showed that whereas endothelium-derived cells cultured with fibroblast growth factor can be characterized as endothelial cells, when deprived of fibroblast growth factor, a significant fraction differentiates into smooth muscle-like cells. Reapplication of fibroblast growth factor reversed this differentiation. Activin A was up-regulated in fibroblast growth factor-deprived, endothelium-derived cells; moreover, the inhibitory effects of exogenous follistatin and overexpressed Smad7 on smooth muscle-like differentiation confirmed that the differentiation was driven by activin A signaling. These findings indicate that when deprived of fibroblast growth factor, human umbilical vein endothelium-derived cells are capable of differentiating into smooth muscle-like cells through activin A-induced, Smad-dependent signaling, and that maintenance of the endothelial cell phenotype and differentiation into smooth muscle-like cells are reciprocally controlled by fibroblast growth factor-1 and activin A.	Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Imamura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	imamura-toru@aist.go.jp		Ishisaki, Akira/0000-0001-6704-4436				ARAKI S, 1990, BIOCHEM BIOPH RES CO, V168, P1194, DOI 10.1016/0006-291X(90)91155-L; ARCINIEGAS E, 1992, J CELL SCI, V103, P521; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Carballada R, 2001, DEVELOPMENT, V128, P35; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cox CM, 2000, DEV DYNAM, V218, P371, DOI 10.1002/(SICI)1097-0177(200006)218:2<371::AID-DVDY10>3.3.CO;2-Q; Debiais F, 2001, J CELL BIOCHEM, V81, P68, DOI 10.1002/1097-4644(20010401)81:1<68::AID-JCB1024>3.0.CO;2-S; DeRuiter MC, 1997, CIRC RES, V80, P444, DOI 10.1161/01.RES.80.4.444; DUBAND JL, 1993, DIFFERENTIATION, V55, P1, DOI 10.1111/j.1432-0436.1993.tb00027.x; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; FRIESEL RE, 1995, FASEB J, V9, P919, DOI 10.1096/fasebj.9.10.7542215; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Garfinkel S, 1996, J CELL BIOL, V134, P783, DOI 10.1083/jcb.134.3.783; Giuliani R, 1999, J CELL SCI, V112, P2597; Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; IMAMURA T, 1987, EXP CELL RES, V172, P92, DOI 10.1016/0014-4827(87)90096-6; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jinga VV, 2000, PLACENTA, V21, P325, DOI 10.1053/plac.1999.0492; Kawabata M, 1999, J BIOCHEM, V125, P9, DOI 10.1093/oxfordjournals.jbchem.a022273; Kozian DH, 1997, LAB INVEST, V76, P267; LAZARD D, 1993, P NATL ACAD SCI USA, V90, P999, DOI 10.1073/pnas.90.3.999; LITTLE D, 1986, J PATHOL, V149, P89, DOI 10.1002/path.1711490203; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCCOMB RD, 1982, ACTA NEUROPATHOL, V56, P207, DOI 10.1007/BF00690637; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; Nakajima Y, 1997, DEV DYNAM, V209, P296, DOI 10.1002/(SICI)1097-0177(199707)209:3<296::AID-AJA5>3.3.CO;2-4; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Ozawa K, 1997, BRAIN RES PROTOC, V1, P211, DOI 10.1016/S1385-299X(96)00030-X; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Poole TJ, 2001, DEV DYNAM, V220, P1, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1087>3.0.CO;2-2; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Rood PML, 2000, EUR J CLIN INVEST, V30, P618; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Soler M, 2000, CIRC RES, V87, P504; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; Taddei S, 2001, Heart Fail Rev, V6, P277; TAKAHASHI K, 1991, J BIOL CHEM, V266, P13284; Tokuda H, 2000, J BONE MINER RES, V15, P2371, DOI 10.1359/jbmr.2000.15.12.2371; Weissberg P L, 1995, Blood Press Suppl, V2, P68; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	49	75	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1303	1309		10.1074/jbc.M207329200	http://dx.doi.org/10.1074/jbc.M207329200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12417591	hybrid			2022-12-27	WOS:000180321900078
J	Thore, S; Mayer, C; Sauter, C; Weeks, S; Suck, D				Thore, S; Mayer, C; Sauter, C; Weeks, S; Suck, D			Crystal structures of the Pyrococcus abyssi Sm core and its complex with RNA - Common features of RNA binding in Archaea and Eukarya	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; PROTEINS ASSEMBLE; DIFFRACTION DATA; U1 SNRNA; SITE; HFQ; HOMOLOG; U6; IDENTIFICATION; ASSOCIATION	The Sm proteins are conserved in all three domains of life and are always associated with U-rich RNA sequences. Their proposed function is to mediate RNA-RNA interactions. We present here the crystal structures of Pyrococcus abyssi Sm protein (PA-Sm1) and its complex with a uridine heptamer. The overall structure of the protein complex, a heptameric ring with a central cavity, is similar to that proposed for the eukaryotic Sm core complex and found for other archaeal Sm proteins. RNA molecules bind to the protein at two different sites. They interact specifically inside the ring with three highly conserved residues, defining the uridine-binding pocket. In addition, nucleotides also interact on the surface formed by the N-terminal alpha-helix as well as a conserved aromatic residue in beta-strand 2 of the PA-Sm1 protein. The mutation of this conserved aromatic residue shows the importance of this second site for the discrimination between RNA sequences. Given the high structural homology between archaeal and eukaryotic Sm proteins, the PA-Sm1-RNA complex provides a model for how the small nuclear RNA contacts the Sm proteins in the Sm core. In addition, it suggests how Sm proteins might exert their function as modulators of RNA-RNA interactions.	European Mol Biol Lab, Struct Biol Program, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Suck, D (corresponding author), European Mol Biol Lab, Struct Biol Program, Meyerhofstr 1, D-69117 Heidelberg, Germany.	suck@embl-heidelberg.de	Weeks, Stephen/N-4813-2019; Weeks, Stephen D/G-6150-2017; Thore, Stephane/AAW-6482-2020; Thore, stéphane/M-7759-2014	Weeks, Stephen/0000-0002-1360-0852; Weeks, Stephen D/0000-0002-1360-0852; Thore, Stephane/0000-0001-7058-3887; Thore, stéphane/0000-0001-7058-3887				Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; Achsel T, 2001, P NATL ACAD SCI USA, V98, P3685, DOI 10.1073/pnas.071033998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer CB, 2000, J BIOL CHEM, V275, P38494, DOI 10.1074/jbc.M005585200; Bordonne R, 1996, GENE, V176, P111, DOI 10.1016/0378-1119(96)00230-2; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Collins BM, 2001, J MOL BIOL, V309, P915, DOI 10.1006/jmbi.2001.4693; EVANS SV, 1993, J MOL GRAPHICS, V11, P127; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; GILMARTIN GM, 1988, MOL CELL BIOL, V8, P1076, DOI 10.1128/MCB.8.3.1076; Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hartmuth K, 1999, J MOL BIOL, V285, P133, DOI 10.1006/jmbi.1998.2300; He WH, 2000, CURR OPIN CELL BIOL, V12, P346, DOI 10.1016/S0955-0674(00)00098-3; HEINRICHS V, 1992, J MOL BIOL, V227, P15, DOI 10.1016/0022-2836(92)90678-D; JARMOLOWSKI A, 1993, EMBO J, V12, P223, DOI 10.1002/j.1460-2075.1993.tb05648.x; JONES MH, 1990, EMBO J, V9, P2555, DOI 10.1002/j.1460-2075.1990.tb07436.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KROL A, 1990, NUCLEIC ACIDS RES, V18, P3803, DOI 10.1093/nar/18.13.3803; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAGRUM LJ, 1978, J MOL EVOL, V11, P1, DOI 10.1007/BF01768019; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mattaj IW, 1998, CURR BIOL, V8, pR93, DOI 10.1016/S0960-9822(98)70055-7; Mayer C, 2001, TRENDS BIOCHEM SCI, V26, P143, DOI 10.1016/S0968-0004(00)01779-5; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Mura C, 2001, P NATL ACAD SCI USA, V98, P5532, DOI 10.1073/pnas.091102298; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; STRUB K, 1986, EMBO J, V5, P1675, DOI 10.1002/j.1460-2075.1986.tb04411.x; Toro I, 2002, J MOL BIOL, V320, P129, DOI 10.1016/S0022-2836(02)00406-0; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zhang D, 2001, MOL CELL, V7, P319, DOI 10.1016/S1097-2765(01)00180-0	55	83	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					1239	1247		10.1074/jbc.M207685200	http://dx.doi.org/10.1074/jbc.M207685200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12409299	hybrid			2022-12-27	WOS:000180321900071
J	Chandra, D; Liu, JW; Tang, DG				Chandra, D; Liu, JW; Tang, DG			Early mitochondrial activation and cytochrome c up-regulation during apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; SERINE-PROTEASE; CELL-DEATH; BCL-2 FAMILY; RELEASE; BAX; IDENTIFICATION; INDUCTION; PRECURSOR; REQUIRES	Apoptosis induced by many stimuli requires the mitochondrial respiratory chain (MRC) function. While studying the molecular mechanisms underlying this AIRC-dependent apoptotic pathway, we find that apoptosis in multiple cell types induced by a variety of stimuli is preceded by an early induction of MRC proteins such as cytochrome c (which is encoded by a nuclear gene) and cytochrome c oxidase subunit II (COX II) (which is encoded by the mitochondrial genome). Several non-MRC proteins localized in the mitochondria, e.g. Smac, Bim, Bak, and Bcl-2, are also rapidly up-regulated. The up-regulation of many of these proteins (e.g. cytochrome c, COX II, and Bim) results from transcriptional activation of the respective genes. The up-regulated cytosolic cytochrome c rapidly translocates to the mitochondria, resulting in an accumulation of holocytochrome c in the mitochondria accompanied by increasing holocytochrome c release into the cytosol. The increased cytochrome c transport from cytosol to the mitochondria does not depend on the mitochondrial protein synthesis or MRC per se. In contrast, cytochrome c release from the mitochondria involves dynamic changes in Bcl-2 family proteins (e.g. up-regulation of Bak, Bcl-2, and Bcl-x(L)), opening of permeability transition pore, and loss of mitochondrial membrane potential. Overexpression of cytochrome c enhances caspase activation and promotes cell death in response to apoptotic stimulation, but simple up-regulation of cytochrome c using an ecdysone-inducible system is, by itself, insufficient to induce apoptosis. Taken together, these results suggest that apoptosis induced by many stimuli involves an early mitochondrial activation, which may be responsible for the subsequent disruption of MRC functions, loss of Deltapsi(m), cytochrome c release, and ultimately cell death.	Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Tang, DG (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Sci Pk Res Div, Pk Rd 1C, Smithville, TX 78957 USA.	dtang@sprd1.mdacc.tmc.edu	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Chandra, Dhyan/0000-0001-7272-9384	NATIONAL CANCER INSTITUTE [R01CA090297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NCI NIH HHS [CA90297] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Banki K, 1999, J IMMUNOL, V162, P1466; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Degterev A, 2001, J CELL BIOL, V155, P695, DOI 10.1083/jcb.200110147; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Deshpande SS, 2000, FASEB J, V14, P1705, DOI 10.1096/fj.99-0910com; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Eguchi Y, 1997, CANCER RES, V57, P1835; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; Hail N, 2001, CANCER RES, V61, P6698; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Heerdt BG, 1997, CELL GROWTH DIFFER, V8, P523; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Joshi B, 1999, CANCER RES, V59, P4343; Kataoka A, 1997, CANCER RES, V57, P5243; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu JW, 2002, CANCER RES, V62, P2976; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lotem J, 1996, P NATL ACAD SCI USA, V93, P9166, DOI 10.1073/pnas.93.17.9166; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; Oubrahim H, 2001, P NATL ACAD SCI USA, V98, P9505, DOI 10.1073/pnas.181319898; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; RICHTER C, 1993, FEBS LETT, V325, P104, DOI 10.1016/0014-5793(93)81423-W; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Sanchez-Alcazar JA, 2001, CANCER RES, V61, P1038; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; Sestili P, 1999, FEBS LETT, V457, P139, DOI 10.1016/S0014-5793(99)01027-3; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; STUART RA, 1990, BIOCHIMIE, V72, P115, DOI 10.1016/0300-9084(90)90136-5; Sugiyama T, 2002, ONCOGENE, V21, P4944, DOI 10.1038/sj.onc.1205621; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1999, J EXP MED, V189, P381, DOI 10.1084/jem.189.2.381; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Tang DG, 2000, J CELL BIOL, V148, P971, DOI 10.1083/jcb.148.5.971; Tang DG, 1998, CANCER RES, V58, P3466; Tang DG, 1998, BIOCHEM BIOPH RES CO, V242, P380, DOI 10.1006/bbrc.1997.7969; Tang DG, 1997, J CELL PHYSIOL, V172, P155, DOI 10.1002/(SICI)1097-4652(199708)172:2<155::AID-JCP3>3.0.CO;2-N; Um HD, 1996, J IMMUNOL, V156, P3469; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang GQ, 2001, J BIOL CHEM, V276, P34307, DOI 10.1074/jbc.M103526200; Wang XD, 2001, GENE DEV, V15, P2922; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zarotti M., 1995, BIOCHIM BIOPHYS ACTA, V1241, P139	69	160	170	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50842	50854		10.1074/jbc.M207622200	http://dx.doi.org/10.1074/jbc.M207622200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12407106	hybrid			2022-12-27	WOS:000180177700085
J	Hirano, M; Kaneko, S; Yamashita, T; Luo, H; Qin, WP; Shirota, Y; Nomura, T; Kobayashi, K; Murakami, S				Hirano, M; Kaneko, S; Yamashita, T; Luo, H; Qin, WP; Shirota, Y; Nomura, T; Kobayashi, K; Murakami, S			Direct interaction between nucleolin and hepatitis C virus NS5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; X-PROTEIN; IDENTIFICATION; TRANSACTIVATION; INITIATION; TRANSCRIPTION; REPLICATION; REGIONS; COMPLEX	Hepatitis C virus (HCV) NS5B is an RNA-dependent RNA polymerase (RdRP), a central catalytic enzyme in HCV replication. While studying the subcellular localization of a NS513 mutant lacking the C-terminal membrane-anchoring domain, NS5Bt, we found that expression of the green fluorescent protein (GFP)-fused form was exclusively nucleolar. Interestingly, the distribution of endogenous nucleolin changed greatly in the cells expressing GFP-NS5B, with nucleolin colocalized with GFP-NS5B in perinuclear regions in addition to the nucleolus, suggesting that NS513 retains the ability to bind nucleolin. The interaction between nucleolin and NS513 was. demonstrated by GST pull-down assay. GST pull-down assay results indicated that C-terminal region of nucleolin was important for its binding to NS513. Scanning clustered alanine substitution mutants library of NS513 revealed two sites on NS513 that binds nucleolin. NS513 amino acids 208-214 and 500-506 were both found to be indispensable for the nucleolin binding. We reported that the latter sequence is essential for oligomerization of NS513, which is a prerequisite for the RdRP activity. C-terminal nucleolin inhibited the NS513 RdRP activity in a dose-dependent manner. Taken together, this indicates the binding ability of nucleolin may be involved in NS513 functions.	Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, Kanazawa, Ishikawa 9200934, Japan; Kanazawa Univ, Dept Internal Med 1, Kanazawa, Ishikawa 9200934, Japan	Kanazawa University; Kanazawa University	Murakami, S (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Mol Oncol, 13-1 Takaramachi, Kanazawa, Ishikawa 9200934, Japan.	semuraka@kenroku.ipc.kanazawa-u.ac.jp		Shirota, Yukihiro/0000-0001-6561-4626				Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Ferrari E, 1999, J VIROL, V73, P1649, DOI 10.1128/JVI.73.2.1649-1654.1999; Ginisty H, 1999, J CELL SCI, V112, P761; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; Harms G, 2001, BIOCHEM J, V360, P531, DOI 10.1042/0264-6021:3600531; HONDA M, 1993, ARCH VIROL, V128, P163, DOI 10.1007/BF01309797; Hwang SB, 1997, VIROLOGY, V227, P439, DOI 10.1006/viro.1996.8357; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Ishii K, 1999, HEPATOLOGY, V29, P1227, DOI 10.1002/hep.510290448; Izumi RE, 2001, VIRUS RES, V76, P17, DOI 10.1016/S0168-1702(01)00240-4; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Kyono K, 2002, BIOCHEM BIOPH RES CO, V292, P659, DOI 10.1006/bbrc.2002.6702; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Lee CH, 1998, J BIOL CHEM, V273, P7650, DOI 10.1074/jbc.273.13.7650; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Lin Y, 1998, J BIOL CHEM, V273, P27097, DOI 10.1074/jbc.273.42.27097; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Luo GX, 2000, J VIROL, V74, P851, DOI 10.1128/JVI.74.2.851-863.2000; Major ME, 1997, HEPATOLOGY, V25, P1527, DOI 10.1002/hep.510250637; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; MIYAZAKI Y, 1995, EXP CELL RES, V219, P93, DOI 10.1006/excr.1995.1209; MURAKAMI S, 1994, J BIOL CHEM, V269, P15118; MURAKAMI S, 1994, VIROLOGY, V199, P243, DOI 10.1006/viro.1994.1119; Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Qin WP, 2001, HEPATOLOGY, V33, P728, DOI 10.1053/jhep.2001.22765; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Valdez BC, 1995, MOL IMMUNOL, V32, P1207, DOI 10.1016/0161-5890(95)00093-3; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; Waggoner S, 1998, J VIROL, V72, P6699, DOI 10.1128/JVI.72.8.6699-6709.1998; Wang QM, 2002, J VIROL, V76, P3865, DOI 10.1128/JVI.76.8.3865-3872.2002; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yi MK, 1997, VIROLOGY, V231, P119, DOI 10.1006/viro.1997.8516	46	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2003	278	7					5109	5115		10.1074/jbc.M207629200	http://dx.doi.org/10.1074/jbc.M207629200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	645GY	12427757	hybrid			2022-12-27	WOS:000180968900097
J	Affaitati, A; Cardone, L; de Cristofaro, T; Carlucci, A; Ginsberg, MD; Varrone, S; Gottesman, ME; Avvedimento, EV; Feliciello, A				Affaitati, A; Cardone, L; de Cristofaro, T; Carlucci, A; Ginsberg, MD; Varrone, S; Gottesman, ME; Avvedimento, EV; Feliciello, A			Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; PC12 CELLS; REGULATORY SUBUNITS; SERUM DEPRIVATION; GERM-CELLS; CYCLIC-AMP; PHOSPHORYLATION; APOPTOSIS; DEATH; PKA	A-Kinase anchor proteins (AKAPs) immobilize and concentrate protein kinase A (PKA) isoforms at specific subcellular compartments. Intracellular targeting of PKA holoenzyme elicits rapid and efficient phosphorylation of target proteins, thereby increasing sensitivity of downstream effectors to cAMP action. AKAP121 targets PKA to the cytoplasmic surface of mitochondria. Here we show that conditional expression of AKAP121 in PC12 cells selectively enhances cAMP.PKA signaling to mitochondria. AKAP121 induction stimulates PKA-dependent phosphorylation of the proapoptotic protein BAD at Ser(155), inhibits release of cytochrome c from mitochondria, and protects cells from apoptosis. An AKAP121 derivative mutant that localizes on mitochondria but does not bind PKA down-regulates PKA signaling to the mitochondria and promotes apoptosis. These findings indicate that PKA anchored by AKAP121 transduces cAMP signals to the mitochondria, and it may play an important role in mitochondrial physiology.	Univ Naples Federico II, Fac Med,CNR, Dipartimento Biol & Patol Mol & Cellulare, Ist Endocrinol & Oncol Sperimentale,BioGeM Consort, I-80131 Naples, Italy; Columbia Univ, Inst Canc Res, New York, NY 10032 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Columbia University	Feliciello, A (corresponding author), Univ Naples Federico II, Fac Med,CNR, Dipartimento Biol & Patol Mol & Cellulare, Ist Endocrinol & Oncol Sperimentale,BioGeM Consort, Via S Pansini 5, I-80131 Naples, Italy.		De+Cristofaro, Tiziana/AAX-4405-2020	DECRISTOFARO, TIZIANA/0000-0003-0121-0002; Cardone, Luca/0000-0001-8184-2856; Feliciello, Antonio/0000-0002-7932-2170				Angelo RG, 2000, J BIOL CHEM, V275, P4351, DOI 10.1074/jbc.275.6.4351; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Cardone L, 2002, J MOL BIOL, V320, P663, DOI 10.1016/S0022-2836(02)00479-5; CARR DW, 1991, J BIOL CHEM, V266, P14188; Cassano S, 1999, J BIOL CHEM, V274, P32574, DOI 10.1074/jbc.274.46.32574; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Diviani D, 2001, J CELL SCI, V114, P1431; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Feliciello A, 1997, CURR BIOL, V7, P1011, DOI 10.1016/S0960-9822(06)00424-6; Feliciello A, 2000, J BIOL CHEM, V275, P303, DOI 10.1074/jbc.275.1.303; Feliciello A, 1998, J BIOL CHEM, V273, P23361, DOI 10.1074/jbc.273.36.23361; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Gu CH, 2000, J BIOL CHEM, V275, P20726, DOI 10.1074/jbc.M000152200; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim YM, 1999, J NEUROSCI, V19, P6740, DOI 10.1523/JNEUROSCI.19-16-06740.1999; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Ma YL, 2002, J BIOL CHEM, V277, P27328, DOI 10.1074/jbc.M201421200; McKnight GS, 1998, RECENT PROG HORM RES, V53, P139; Miki K, 1999, J BIOL CHEM, V274, P29057, DOI 10.1074/jbc.274.41.29057; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; Nunez G, 1998, CURR OPIN NEUROBIOL, V8, P613, DOI 10.1016/S0959-4388(98)80089-5; Paolillo M, 1999, J BIOL CHEM, V274, P6546, DOI 10.1074/jbc.274.10.6546; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Rakowicz WP, 2002, J NEUROSCI, V22, P3953, DOI 10.1523/JNEUROSCI.22-10-03953.2002; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; SAMBROOK J, 1989, MOL CLONING LABORATO, V2, P16; Sandal T, 2002, J BIOL CHEM, V277, P20783, DOI 10.1074/jbc.M112248200; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; TAYLOR SS, 1992, ANNU REV CELL BIOL, V8, P429, DOI 10.1146/annurev.cb.08.110192.002241; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Trendelenburg G, 1996, BIOCHEM BIOPH RES CO, V225, P313, DOI 10.1006/bbrc.1996.1172; Troy CM, 1997, J NEUROSCI, V17, P1911; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhou XM, 2000, J BIOL CHEM, V275, P25046, DOI 10.1074/jbc.M002526200	62	85	86	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					4286	4294		10.1074/jbc.M209941200	http://dx.doi.org/10.1074/jbc.M209941200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12427737	hybrid			2022-12-27	WOS:000180869700096
J	Kurkela, M; Garcia-Horsman, JA; Luukkanen, L; Morsky, S; Taskinen, J; Baumann, M; Kostiainen, R; Hirvonen, J; Finel, M				Kurkela, M; Garcia-Horsman, JA; Luukkanen, L; Morsky, S; Taskinen, J; Baumann, M; Kostiainen, R; Hirvonen, J; Finel, M			Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; GLUCURONIC ACID; CRIGLER-NAJJAR; 1A6; IDENTIFICATION; SPECIFICITY; SUBSTRATE; CLEAVAGE; PROTEINS; UGT1A1	Eight human liver UDP-glucuronosyltransferases (UGTs) were expressed in baculovirus-infected insect cells as fusion proteins carrying a short C-terminal extension that ends with 6 histidine residues (His tag). The activity of recombinant UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT2B4, UGT2B7, and UGT2B15 was almost fully inhibited by 0.2% Triton X-100. In the case of UGT1A9, however, glucuronidation of a-naphthol and scopoletin was resistant to such inhibition, whereas glucuronidation of entacapone and several other aglycones was sensitive. His-tagged UGT1A9 was purified by immobilized metal-chelating chromatography (IMAC). Purified UGT1A9 glucuronidated scopoletin at a high rate, whereas its glucuronidation activity toward entacapone was low and largely dependent on phospholipid addition. Recombinant UGT1A9 in which the His tag was replaced by hemagglutinin antigenic peptide (HA tag) was also prepared. Insect cells were co-infected with baculoviruses encoding both HA-tagged and His-tagged UGT1A9. Membranes from the co-infected cells, or a mixture of membranes from separately infected cells, were subjected to detergent extraction and IMAC, and the resulting fractions were analyzed for the presence of each type of UGT1A9 using tag-specific antibodies. In the case of separate infection, the HA-tagged UGT1A9 did not bind to the column. When co-infected with His-tagged UGT1A9, however, part of the HA-tagged enzyme was bound to the column and was eluted by imidazole concentration gradient together with the His-tagged UGT1A9, suggesting the formation of stable dimers that contain one His-tagged and one HA-tagged UGT1A9 monomers.	Univ Helsinki, Viikki DDTC, Dept Pharm, FIN-00014 Helsinki, Finland; Univ Helsinki, Inst Biomed, Prot Chem Unit, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Finel, M (corresponding author), Univ Helsinki, Viikki DDTC, Dept Pharm, POB 56,Viikinkaari 5E, FIN-00014 Helsinki, Finland.		García-Horsman, J. Arturo/ABF-3658-2022; Kostiainen, Risto K/B-5491-2008; García-Horsman, J. Arturo/AAN-8147-2021	García-Horsman, J. Arturo/0000-0002-9680-717X; Baumann, Marc/0000-0002-2991-889X; Hirvonen, Jouni Tapio/0000-0002-5029-1657; Kostiainen, Risto/0000-0003-2454-4574				Battaglia E, 1998, DRUG METAB DISPOS, V26, P812; BAUMANN M, 1990, ANAL BIOCHEM, V190, P198, DOI 10.1016/0003-2697(90)90181-8; Burchell B, 2000, TOXICOL LETT, V112, P333, DOI 10.1016/S0378-4274(99)00209-X; BURCHELL B, 1995, LIFE SCI, V57, P1819, DOI 10.1016/0024-3205(95)02073-R; Ethell BT, 2001, DRUG METAB DISPOS, V29, P48; Forsman T, 2000, LIFE SCI, V67, P2473, DOI 10.1016/S0024-3205(00)00831-6; Ghosh SS, 2001, J BIOL CHEM, V276, P42108, DOI 10.1074/jbc.M106742200; Guengerich FP, 1997, DRUG METAB DISPOS, V25, P1234; Gueraud F, 1998, GEN PHARMACOL, V31, P683, DOI 10.1016/S0306-3623(98)00114-1; Ikushiro S, 1997, BIOCHEMISTRY-US, V36, P7154, DOI 10.1021/bi9702344; Ishii Y, 2001, MOL PHARMACOL, V60, P1040, DOI 10.1124/mol.60.5.1040; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kaivosaari S, 2001, ANAL BIOCHEM, V292, P178, DOI 10.1006/abio.2001.5092; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Koiwai O, 1996, HUM MOL GENET, V5, P645, DOI 10.1093/hmg/5.5.645; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lautala P, 2000, DRUG METAB DISPOS, V28, P1385; Luukkanen L, 1999, BIOCONJUGATE CHEM, V10, P150, DOI 10.1021/bc980064n; Luukkanen L, 1997, PHARMACOL TOXICOL, V80, P152, DOI 10.1111/j.1600-0773.1997.tb00389.x; MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432; Meech R, 1998, ARCH BIOCHEM BIOPHYS, V356, P77, DOI 10.1006/abbi.1998.0750; Meech R, 1997, CLIN EXP PHARMACOL P, V24, P907, DOI 10.1111/j.1440-1681.1997.tb02718.x; Meech R, 1997, J BIOL CHEM, V272, P26913, DOI 10.1074/jbc.272.43.26913; Nguyen N, 1997, DRUG METAB DISPOS, V25, P745; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; PILLOT T, 1993, BIOCHEM BIOPH RES CO, V197, P785, DOI 10.1006/bbrc.1993.2547; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; Strassburg CP, 2002, GUT, V50, P851, DOI 10.1136/gut.50.6.851; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Yueh MF, 2001, CARCINOGENESIS, V22, P943, DOI 10.1093/carcin/22.6.943	31	133	143	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 7	2003	278	6					3536	3544		10.1074/jbc.M206136200	http://dx.doi.org/10.1074/jbc.M206136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	643PM	12435745	hybrid			2022-12-27	WOS:000180869700006
J	Kuzmine I; Gottlieb, PA; Martin, CT				Kuzmine, I; Gottlieb, PA; Martin, CT			Binding of the priming nucleotide in the initiation of transcription by T7 RNA polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							START SITE SELECTION; I KLENOW FRAGMENT; DNA-POLYMERASE; BACTERIOPHAGE-T7 DNA; PROMOTER; SEQUENCE; RECOGNITION; IDENTIFICATION; MODEL	Unlike DNA polymerases, an RNA polymerase must initiate transcription de novo, that is binding of the initiating (+1) nucleoside triphosphate must be achieved without benefit of the cooperative binding energetics of an associated primer. Since a single Watson-Crick base pair is not stable in solution, RNA polymerases might be expected to provide additional stabilizing interactions to facilitate binding and positioning of the initiating (priming) nucleoside triphosphate at position +1. Consistent with base-specific stabilizing interactions, of the 17 T7 RNA polymerase promoters in the phage genome, 15 begin with guanine. In this work, we demonstrate that the purine N-7 is important in the utilization of the initial substrate GTP. The fact that on a template encoding AG as the first two bases in the transcript (as in the remaining two of the T7 genome) transcription starts predominantly (but not exclusively) at the G at position +2 additionally implicates the purine O-6 as an important recognition element in the major groove. Finally, results suggest that these interactions serve primarily to position the initiating base in the active site. It is proposed that T7 RNA polymerase interacts directly with the Hoogsteen side of the initial priming GTP (most likely via an interaction with an arginine side chain in the protein) to provide the extra stability required at this unique step in transcription.	Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	University of Massachusetts System; University of Massachusetts Amherst; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	CMartin@chem.umass.edu	Gottlieb, Philip/C-3113-2019; Martin, Craig T/L-3596-2013	Gottlieb, Philip/0000-0003-3764-9885; Martin, Craig T/0000-0003-1029-5239	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055002] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM55002] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD E, 1995, CURR OPIN STRUC BIOL, V5, P27, DOI 10.1016/0959-440X(95)80006-M; ASTATKE M, 1995, J BIOL CHEM, V270, P1945, DOI 10.1074/jbc.270.4.1945; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Brieba LG, 2002, BIOCHEMISTRY-US, V41, P5144, DOI 10.1021/bi016057v; CARTER AD, 1981, J MOL BIOL, V153, P825, DOI 10.1016/0022-2836(81)90421-6; CHAMBERL.M, 1973, J BIOL CHEM, V248, P2235; DORONIN SV, 1989, FEBS LETT, V259, P83, DOI 10.1016/0014-5793(89)81500-5; DUNN JJ, 1981, J MOL BIOL, V148, P303, DOI 10.1016/0022-2836(81)90178-9; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Helm M, 1999, RNA, V5, P618, DOI 10.1017/S1355838299982328; Imburgio D, 2002, J MOL BIOL, V319, P37, DOI 10.1016/S0022-2836(02)00261-9; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Jamieson AC, 1996, P NATL ACAD SCI USA, V93, P12834, DOI 10.1073/pnas.93.23.12834; Jiang ML, 2001, J MOL BIOL, V310, P509, DOI 10.1006/jmbi.2001.4793; KING GC, 1986, BIOCHEMISTRY-US, V25, P36, DOI 10.1021/bi00349a006; Kuzmine I, 2001, J MOL BIOL, V305, P559, DOI 10.1006/jmbi.2000.4316; MARTIN CT, 1989, BIOCHEMISTRY-US, V28, P2760, DOI 10.1021/bi00433a002; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; NAM SC, 1988, J BIOL CHEM, V263, P18123; OAKLEY JL, 1977, P NATL ACAD SCI USA, V74, P4266, DOI 10.1073/pnas.74.10.4266; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PORTER KW, 1995, BIOCHEMISTRY-US, V34, P11963, DOI 10.1021/bi00037a038; REDDY PS, 1994, EUR J BIOCHEM, V225, P737, DOI 10.1111/j.1432-1033.1994.00737.x; SCHICK C, 1993, BIOCHEMISTRY-US, V32, P4275, DOI 10.1021/bi00067a016; SEELA F, 1982, BIOCHEMISTRY-US, V21, P4338, DOI 10.1021/bi00261a024; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Segel IH, 1975, ENZYME KINETICS BEHA; SOUSA R, 1992, J MOL BIOL, V224, P319, DOI 10.1016/0022-2836(92)90997-X; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Weston BF, 1997, J MOL BIOL, V272, P21, DOI 10.1006/jmbi.1997.1199; Xirasagar S, 1998, J BIOL CHEM, V273, P27146, DOI 10.1074/jbc.273.42.27146	32	33	42	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					2819	2823		10.1074/jbc.M208405200	http://dx.doi.org/10.1074/jbc.M208405200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12427761	hybrid			2022-12-27	WOS:000180915000008
J	Makino, A; Baba, T; Fujimoto, K; Iwamoto, K; Yano, Y; Terada, N; Ohno, S; Sato, SB; Ohta, A; Umeda, M; Matsuzaki, K; Kobayashi, T				Makino, A; Baba, T; Fujimoto, K; Iwamoto, K; Yano, Y; Terada, N; Ohno, S; Sato, SB; Ohta, A; Umeda, M; Matsuzaki, K; Kobayashi, T			Cinnamycin (Ro 09-0198) promotes cell binding and toxicity by inducing transbilayer lipid movement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID FLIP-FLOP; INFRARED-SPECTROSCOPY; CYCLIC PEPTIDE; MEMBRANES; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS; TRANSPORT; ANTICOAGULANT; PROTEIN; SURFACE	Cinnamycin is a unique toxin in that its receptor, phosphatidylethanolamine (PE), resides in the inner layer of the plasma membrane. Little is known about how the toxin recognizes PE and causes cytotoxicity. We showed that cinnamycin induced transbilayer phospholipid movement in target cells that leads to the exposure of inner leaflet PE to the toxin. Model membrane studies revealed that cinnamycin induced transbilayer lipid movement in a PE concentration-dependent manner. Re-orientation of phospholipids was accompanied by an increase in the incidence of beta-sheet structure in cinnamycin. When the surface concentration of PE was high, cinnamycin induced membrane re-organization such as membrane fusion and the alteration of membrane gross morphology. These results suggest that cinnamycin promotes its own binding to the cell and causes toxicity by inducing transbilayer lipid movement.	RIKEN, Inst Phys & Chem Res, Suprabiomol Syst Res Grp, Wako, Saitama 3510198, Japan; Univ Yamanashi, Fac Med, Dept Anat, Tamaho, Yamanashi 4093898, Japan; Fukui Prefectural Univ, Sect Physiol Anat, Fukui 9101195, Japan; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Biodynam, Bunkyo Ku, Tokyo 1138613, Japan; Inst Natl Sci Appl, INSERM, U352, F-69621 Villeurbanne, France	RIKEN; University of Yamanashi; Fukui Prefectural University; University of Tokyo; Kyoto University; Kyoto University; Tokyo Metropolitan Institute of Medical Science; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Kobayashi, T (corresponding author), RIKEN, Inst Phys & Chem Res, Suprabiomol Syst Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270				ANDREE HAM, 1992, J BIOL CHEM, V267, P17907; AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; BITBOL M, 1988, P NATL ACAD SCI USA, V85, P6783, DOI 10.1073/pnas.85.18.6783; CASAL HL, 1984, BIOCHIM BIOPHYS ACTA, V779, P381, DOI 10.1016/0304-4157(84)90017-0; CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P171, DOI 10.1016/0005-2736(88)90192-7; CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P180, DOI 10.1016/0005-2736(88)90193-9; CONNOR J, 1992, J BIOL CHEM, V267, P19412; Dekkers DWC, 1998, BIOCHEMISTRY-US, V37, P14833, DOI 10.1021/bi981011w; ElJastimi R, 1997, BBA-BIOMEMBRANES, V1324, P151, DOI 10.1016/S0005-2736(96)00221-0; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; Emoto K, 1999, P NATL ACAD SCI USA, V96, P12400, DOI 10.1073/pnas.96.22.12400; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; FATTAL E, 1994, BIOCHEMISTRY-US, V33, P6721, DOI 10.1021/bi00187a044; Hosoda K, 1996, J BIOCHEM-TOKYO, V119, P226; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; KESSLER H, 1992, BIOPOLYMERS, V32, P427, DOI 10.1002/bip.360320420; KOBAYASHI T, 1989, J BIOL CHEM, V264, P5966; KOBAYASHI T, 1988, CELL, V55, P797, DOI 10.1016/0092-8674(88)90135-3; KOBAYASHI T, 1992, FEBS LETT, V300, P227, DOI 10.1016/0014-5793(92)80851-7; Lencer WI, 1999, BBA-MOL CELL RES, V1450, P177, DOI 10.1016/S0167-4889(99)00070-1; Lingwood CA, 1999, BBA-MOL BASIS DIS, V1455, P375, DOI 10.1016/S0925-4439(99)00062-9; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Machaidze G, 2002, BIOCHEMISTRY-US, V41, P1965, DOI 10.1021/bi015841c; Marx U, 2000, BIOPHYS J, V78, P2628, DOI 10.1016/S0006-3495(00)76807-X; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; MATSUZAKI K, 1991, BIOCHIM BIOPHYS ACTA, V1070, P419, DOI 10.1016/0005-2736(91)90082-J; McAuliffe O, 2001, FEMS MICROBIOL REV, V25, P285, DOI 10.1016/S0168-6445(00)00065-6; Moll GN, 1998, J BACTERIOL, V180, P6565, DOI 10.1128/JB.180.24.6565-6570.1998; OKAMURA E, 1986, BIOCHIM BIOPHYS ACTA, V856, P68, DOI 10.1016/0005-2736(86)90011-8; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; REUTELINGSPERGER CPM, 1985, EUR J BIOCHEM, V151, P625, DOI 10.1111/j.1432-1033.1985.tb09150.x; REUTELINGSPERGER CPM, 1988, EUR J BIOCHEM, V173, P171, DOI 10.1111/j.1432-1033.1988.tb13981.x; SLEIGHT RG, 1983, J BIOL CHEM, V258, P9050; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; TAIT JF, 1989, J BIOL CHEM, V264, P7944; UMEDA M, 1989, J IMMUNOL, V143, P2273; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; WAKAMATSU K, 1990, BIOCHEMISTRY-US, V29, P113, DOI 10.1021/bi00453a013; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yano Y, 2002, BIOCHEMISTRY-US, V41, P3073, DOI 10.1021/bi011161y; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	43	66	69	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 31	2003	278	5					3204	3209		10.1074/jbc.M210347200	http://dx.doi.org/10.1074/jbc.M210347200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	644JW	12446685	hybrid			2022-12-27	WOS:000180915000056
J	Grewer, C; Watzke, N; Rauen, T; Bicho, A				Grewer, C; Watzke, N; Rauen, T; Bicho, A			Is the glutamate residue Glu-373 the proton acceptor of the excitatory amino acid carrier 1?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; RAT-BRAIN; TRANSPORTER GLT-1; FUNCTIONAL-CHARACTERIZATION; ANION CONDUCTANCE; SUBSTRATE-BINDING; CHLORIDE CHANNEL; ESCHERICHIA-COLI; MECHANISM; BACTERIORHODOPSIN	Glutamate transport by the neuronal excitatory amino acid carrier (EAAC1) is accompanied by the coupled movement of one proton across the membrane. We have demonstrated previously that the cotransported proton binds to the carrier in the absence of glutamate and, thus, modulates the EAAC1 affinity for glutamate. Here, we used site-directed mutagenesis together with a rapid kinetic technique that allows one to generate sub-millisecond glutamate concentration jumps to locate possible binding sites of the glutamate transporter for the cotransported proton. One candidate for this binding site, the highly conserved glutamic acid residue Glu-373 of EAAC1, was mutated to glutamine. Our results demonstrate that the mutant transporter does not catalyze net transport of glutamate, whereas Na+/glutamate homoexchange is unimpaired. Furthermore, the voltage dependence of the rates of Na+ binding and glutamate translocation are unchanged compared with the wild-type. In contrast to the wild-type, however, homoexchange of the E373Q transporter is completely pH-independent. In line with these findings the transport kinetics of the mutant EAAC1 show no deuterium isotope effect. Thus, we suggest a new transport mechanism, in which Glu-373 forms part of the binding site of EAAC1 for the cotransported proton. In this model, protonation of Glu-373 is required for Na+/glutamate trans-location, whereas the relocation of the carrier is only possible when Glu-373 is negatively charged. Interestingly, the Glu-373-homologous amino acid residue is glutamine in the related neutral amino acid transporter alanine-serine-cysteine transporter. The function of alanine-serine-cysteine transporter is neither potassiumnor proton-dependent. Consequently, our results emphasize the general importance of glutamate and aspartate residues for proton transport across membranes.	Max Planck Inst Biophys, D-60596 Frankfurt, Germany; Univ Munster, Inst Biochem, D-48149 Munster, Germany	Max Planck Society; University of Munster	Grewer, C (corresponding author), Max Planck Inst Biophys, Kennedyallee 70, D-60596 Frankfurt, Germany.			Rauen, Thomas/0000-0001-9699-182X				AssadiPorter FM, 1995, BIOCHEMISTRY-US, V34, P16186, DOI 10.1021/bi00049a034; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; Broer A, 2000, BIOCHEM J, V346, P705, DOI 10.1042/0264-6021:3460705; Broer A, 1999, J NEUROCHEM, V73, P2184; BUTT HJ, 1989, EMBO J, V8, P1657, DOI 10.1002/j.1460-2075.1989.tb03556.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; ERECINSKA M, 1983, J BIOL CHEM, V258, P9069; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 1999, BIOPHYS J, V77, P727, DOI 10.1016/S0006-3495(99)76927-4; Grewer C, 2001, BIOCHEMISTRY-US, V40, P232, DOI 10.1021/bi0015919; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KANAI Y, 1994, J BIOL CHEM, V269, P20599; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kanner BI, 2001, BIOCHEM SOC T, V29, P707, DOI 10.1042/0300-5127:0290707; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Mulkidjanian AY, 1999, FEBS LETT, V463, P199, DOI 10.1016/S0014-5793(99)01536-7; Ondrechen MJ, 2001, P NATL ACAD SCI USA, V98, P12473, DOI 10.1073/pnas.211436698; Otis TS, 2000, J NEUROSCI, V20, P2749; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; Rauen T, 2000, NEUROCHEM INT, V37, P179, DOI 10.1016/S0197-0186(00)00021-8; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Sahin-Toth M, 2001, P NATL ACAD SCI USA, V98, P6068, DOI 10.1073/pnas.111139698; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; SZARAZ S, 1994, BIOPHYS J, V67, P1706, DOI 10.1016/S0006-3495(94)80644-7; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Watzke N, 2000, J GEN PHYSIOL, V116, P609, DOI 10.1085/jgp.116.5.609; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; WIEBOLDT R, 1994, P NATL ACAD SCI USA, V91, P8752, DOI 10.1073/pnas.91.19.8752; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YU X, 1994, J BIOL CHEM, V269, P16656; Zarbiv R, 1998, J BIOL CHEM, V273, P14231, DOI 10.1074/jbc.273.23.14231; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; ZHANG YM, 1994, J BIOL CHEM, V269, P19573; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	48	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2585	2592		10.1074/jbc.M207956200	http://dx.doi.org/10.1074/jbc.M207956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12419818	hybrid			2022-12-27	WOS:000180562000069
J	Liu, GM; Ma, WY; Bode, AM; Zhang, YG; Dong, ZG				Liu, GM; Ma, WY; Bode, AM; Zhang, YG; Dong, ZG			NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; INDUCED AP-1 ACTIVITY; HUMAN COLON-CANCER; N-TERMINAL KINASE; CELL-TRANSFORMATION; EPITHELIAL-CELLS; BINDING-ACTIVITY; MESANGIAL CELLS; JB6 CELLS; P38 MAPK	Cyclooxygenases (COX) are rate-limiting enzymes that catalyze the conversion of arachidonic acid to prostaglandins, which are involved in many physiological and pathophysiological responses. COX-2, one of two isoforms of COX, was recently found to play an important role in carcinogenesis in many cell and tissue types. COX-2 inhibitors, which belong to the family of nonsteroidal anti-inflammatory drugs, are believed to be effective in many biological activities such as tumor chemoprevention because of their inhibition of COX-2. However, in the present study we found that both piroxicam, a general COX inhibitor, and NS-398, a COX-2 selective inhibitor, effectively suppressed the activation of transcription factor activator protein 1 (AP-1) induced by ultraviolet B (UVB) or 12-O-tetradecanoyl-phorbol-13-acetate in mouse epidermal JB6 cells. These COX-2 inhibitors could also inhibit 12-0-tetradecanoyl-phorbol-13-acetate-induced cell transformation. UVB significantly increased AP-1 activity in Cox-2(-/-) fibroblasts transfected with an AP-1 luciferase reporter gene, and this increase was blocked by NS-389 or piroxicam. In JB6, Cox-2(-/-), or wild-type Cox-2(+/+) cells, both NS-398 and piroxicam inhibited UVB-induced phosphorylation of c-Jun NH2-terminal kinases, the kinases that activate the AP-1/c-Jun complex. Based on our results, we propose that the inhibition of AP-1 activity by COX-2 inhibitors NS-398 or piroxicam may occur by a mechanism that is independent of COX-2.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.			Zhang, Yiguo/0000-0003-3910-2779	NCI NIH HHS [CA74916, CA77646] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077646, R29CA074916] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blumenthal RD, 2001, CLIN CANCER RES, V7, P3178; CARTY TJ, 1980, PROSTAGLANDINS, V19, P51, DOI 10.1016/0090-6980(80)90153-7; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; Ding M, 1999, J BIOL CHEM, V274, P30611, DOI 10.1074/jbc.274.43.30611; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dong ZG, 1997, CANCER RES, V57, P4414; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Guan ZH, 1998, J BIOL CHEM, V273, P28670, DOI 10.1074/jbc.273.44.28670; Hsu AL, 2000, J BIOL CHEM, V275, P11397, DOI 10.1074/jbc.275.15.11397; Huang CS, 1997, J BIOL CHEM, V272, P4187, DOI 10.1074/jbc.272.7.4187; Huang CS, 1997, J BIOL CHEM, V272, P26325, DOI 10.1074/jbc.272.42.26325; KARGMAN SL, 1995, CANCER RES, V55, P2556; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Liu GM, 2001, P NATL ACAD SCI USA, V98, P5786, DOI 10.1073/pnas.101116298; Liu GM, 2001, CANCER RES, V61, P5749; MARNETT LJ, 1992, CANCER RES, V52, P5575; Masferrer JL, 2000, CANCER RES, V60, P1306; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Monick MM, 1999, J BIOL CHEM, V274, P18075, DOI 10.1074/jbc.274.25.18075; Monno S, 2000, ENDOCRINOLOGY, V141, P544, DOI 10.1210/en.141.2.544; OUELLET M, 1995, BIOCHEM J, V306, P247, DOI 10.1042/bj3060247; Reese J, 2000, P NATL ACAD SCI USA, V97, P9759, DOI 10.1073/pnas.97.17.9759; Ristimaki A, 1997, CANCER RES, V57, P1276; Rosenberger SF, 1996, ONCOGENE, V12, P2301; Sheng GG, 1997, GASTROENTEROLOGY, V113, P1883, DOI 10.1016/S0016-5085(97)70007-6; SIMONSON MS, 1994, EXP CELL RES, V215, P137, DOI 10.1006/excr.1994.1325; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; STRICKLAND PT, 1986, J INVEST DERMATOL, V87, P272, DOI 10.1111/1523-1747.ep12696669; Subbaramaiah K, 1996, CANCER RES, V56, P4424; Tchou WW, 1999, ONCOGENE, V18, P6974, DOI 10.1038/sj.onc.1203195; THUN MJ, 1994, CANCER METAST REV, V13, P269, DOI 10.1007/BF00666097; Tremblay C, 1999, JNCI-J NATL CANCER I, V91, P1398, DOI 10.1093/jnci/91.16.1398; Vartiainen N, 2001, J NEUROCHEM, V76, P480, DOI 10.1046/j.1471-4159.2001.00065.x; Waskewich C, 2002, CANCER RES, V62, P2029; Williams CS, 2000, CANCER RES, V60, P6045; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Williams CS, 1996, AM J PHYSIOL, V270, P393; Won JS, 1998, MOL BRAIN RES, V60, P203, DOI 10.1016/S0169-328X(98)00182-X	48	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2124	2130		10.1074/jbc.M202443200	http://dx.doi.org/10.1074/jbc.M202443200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12433932	hybrid			2022-12-27	WOS:000180562000008
J	Liu, HF; Di Cunto, F; Imarisio, S; Reid, LM				Liu, HF; Di Cunto, F; Imarisio, S; Reid, LM			Citron kinase is a cell cycle-dependent, nuclear protein required for G(2)/M transition of hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED RAT HEPATOCYTES; RHO-ASSOCIATED KINASE; PARTIAL-HEPATECTOMY; CLEAVAGE FURROW; GLUTAMATERGIC SYNAPSES; CYTOPLASMIC DIVISION; LIVER GROWTH; CYTOKINESIS; PHOSPHORYLATION; APOPTOSIS	Citron Kinase (Citron-K) is a cell cycle-dependent protein regulating the G(2)/M transition in hepatocytes. Synchronization studies demonstrated that expression of the Citron-K protein starts at the late S and/or the early G(2) phase after that of cyclin B1. Expression of Citron-K is developmentally regulated. Levels of Citron-K mRNA and protein are highest in embryonic liver and gradually decrease after birth. Citron-K exists in interphase nuclei and begins to disperse into the cytoplasm at prophase. It concentrates at the cleavage furrow and midbody during anaphase, telophase, and cytokinesis, implicating a role in the control of cytokinesis. However, studies with knockouts show that Citron-K is not essential for cytokinesis in hepatocytes. Instead, loss of Citron-K causes a significant increase of G(2) tetraploid nuclei in one-week-old rat and mouse liver. In addition, Citron-K deficiency triggers apoptosis in a small subset of embryonic liver cells. In summary, our data demonstrate that Citron-K has a distinct cell cycle-dependent expression pattern and cellular localization as a down-stream target of Rho-GTPase and functions in the control of G(2)/M transition in the hepatocyte cell cycle.	Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Turin	Reid, LM (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, CB 7038, Chapel Hill, NC 27599 USA.		Di Cunto, Ferdinando/K-5575-2016	di cunto, ferdinando/0000-0001-9367-6357	NIDDK NIH HHS [1 R01 DK52851] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052851] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AEPFELBACHER M, 1995, BIOCHEM J, V308, P853, DOI 10.1042/bj3080853; Assy N, 1998, J LAB CLIN MED, V131, P251, DOI 10.1016/S0022-2143(98)90097-X; CELIS JE, 1988, ARCH BIOL MED EXP, V21, P417; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cogswell CA, 1998, NEUROSCI LETT, V251, P5, DOI 10.1016/S0304-3940(98)00478-9; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706; DICUNTO F, 2002, IN PRESS J CELL SCI; Drechsel DN, 1997, CURR BIOL, V7, P12, DOI 10.1016/S0960-9822(06)00023-6; Eda M, 2001, J CELL SCI, V114, P3273; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; FREDERIKS WM, 1990, HISTOCHEMISTRY, V93, P627, DOI 10.1007/BF00272205; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x; HUTCHISON C, 1989, J CELL SCI, V93, P605; KISHI K, 1993, J CELL BIOL, V120, P1187, DOI 10.1083/jcb.120.5.1187; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kosako H, 1999, ONCOGENE, V18, P2783, DOI 10.1038/sj.onc.1202633; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; MELCHIORRI C, 1993, CARCINOGENESIS, V14, P1825, DOI 10.1093/carcin/14.9.1825; Moorman JP, 1996, J IMMUNOL, V156, P4146; MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; O'Keefe L, 2001, CELL STRUCT FUNCT, V26, P619, DOI 10.1247/csf.26.619; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Roberts MR, 2000, J NEUROSCI, V20, P2295; Sakata H, 2000, HEPATOLOGY, V32, P193, DOI 10.1053/jhep.2000.8271; Sarkisian MR, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-08-j0001.2002; SATTLER CA, 1988, HEPATOLOGY, V8, P1540, DOI 10.1002/hep.1840080612; SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x; TAKAISHI K, 1995, ONCOGENE, V11, P39; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Weglarz TC, 2000, P NATL ACAD SCI USA, V97, P12595, DOI 10.1073/pnas.220430497; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; ZARNEGAR R, 1991, BIOCHEM BIOPH RES CO, V177, P559, DOI 10.1016/0006-291X(91)92020-K; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	38	37	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2541	2548		10.1074/jbc.M210391200	http://dx.doi.org/10.1074/jbc.M210391200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12411428	hybrid			2022-12-27	WOS:000180562000063
J	Luque, CM; Perez-Ferreiro, CM; Perez-Gonzalez, A; Englmeier, L; Koffa, MD; Correas, I				Luque, CM; Perez-Ferreiro, CM; Perez-Gonzalez, A; Englmeier, L; Koffa, MD; Correas, I			An alternative domain containing a leucine-rich sequence regulates nuclear cytoplasmic localization of protein 4.1R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; SPECTRIN-ACTIN BINDING; EXPORT SIGNAL; STRUCTURAL PROTEIN-4.1; CYTOSKELETAL PROTEIN; NONERYTHROID ISOFORM; CONSTITUTIVE REGION; MULTIPLE ISOFORMS; ERYTHROID-CELLS; TIGHT JUNCTION	In red blood cells, protein 4.1 (4.1R) is an 80-kDa protein that stabilizes the spectrin-actin network and anchors it to the plasma membrane. The picture is more complex in nucleated cells, in which many 4.1R iso-forms, varying in size and intracellular location, have been identified. To contribute to the characterization of signals involved in differential intracellular localization of 4.1R, we have analyzed the role the exon 5-encoded sequence plays in 4.1R distribution. We show that exon 5 encodes a leucine-rich sequence that shares key features with nuclear export signals (NESs). This sequence adopts the topology employed for NESs of other proteins and conserves two hydrophobic residues that are shown to be critical for NES function. A 4.1R isoform expressing the leucine-rich sequence binds to the export receptor CRM1 in a RanGTP-dependent fashion, whereas this does not occur in a mutant whose two conserved hydrophobic residues are substituted. These two residues are also essential for 4.1R intracellular distribution, because the 4.1R protein containing the leucine-rich sequence localizes in the cytoplasm, whereas the mutant protein predominantly accumulates in the nucleus. We hypothesize that the leucine-rich sequence in 4.1R controls distribution and concomitantly function of a specific set of 4.1R isoforms.	Univ Autonoma Madrid, Dept Biol Mol, Ctr Mol Biol Severo Ochoa, CSIC, E-28049 Madrid, Spain; European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); European Molecular Biology Laboratory (EMBL)	Correas, I (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Mol Biol Severo Ochoa, CSIC, E-28049 Madrid, Spain.		Englmeier, Ludwig/AAU-8430-2020; Koffa, Maria/AAP-3999-2020; Luque, Carlos M./Q-6043-2019; Luque, Carlos/H-6810-2015; Correas, Isabel/O-4061-2018	Luque, Carlos M./0000-0002-2993-4152; Luque, Carlos/0000-0002-2993-4152; Correas, Isabel/0000-0002-2286-186X; Koffa, Maria (Margy)/0000-0003-2255-3426				Baklouti F, 1997, GENOMICS, V39, P289, DOI 10.1006/geno.1996.4512; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Bredt DS, 2000, NATURE, V404, P241, DOI 10.1038/35005208; CHASIS JA, 1993, J CLIN INVEST, V91, P329, DOI 10.1172/JCI116189; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; COHEN CM, 1982, NATURE, V299, P648, DOI 10.1038/299648a0; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; CORREAS I, 1986, J BIOL CHEM, V261, P3362; CORREAS I, 1991, BIOCHEM J, V279, P581, DOI 10.1042/bj2790581; CORREAS I, 1986, J BIOL CHEM, V261, P3310; DeCarcer G, 1995, BIOCHEM J, V312, P871, DOI 10.1042/bj3120871; DELAUNAY J, 1995, CRIT REV ONCOL HEMAT, V19, P79, DOI 10.1016/1040-8428(94)00139-K; Englmeier L, 1999, CURR BIOL, V9, P30, DOI 10.1016/S0960-9822(99)80044-X; Englmeier L, 2001, EMBO REP, V2, P926, DOI 10.1093/embo-reports/kve200; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Gama-Carvalho M, 2001, J BIOL CHEM, V276, P13104, DOI 10.1074/jbc.M008759200; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; Gascard P, 1999, MOL BIOL CELL, V10, P1783, DOI 10.1091/mbc.10.6.1783; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GURLICH D, 1996, SCIENCE, V271, P1513; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HORNE WC, 1993, BLOOD, V82, P2558; Hou CL, 2000, BLOOD, V96, P747; HUANG JP, 1993, J BIOL CHEM, V268, P3758; Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Koffa MD, 2001, EMBO J, V20, P5769, DOI 10.1093/emboj/20.20.5769; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; Kontrogianni-Konstantopoulos A, 2001, J BIOL CHEM, V276, P20679, DOI 10.1074/jbc.M010581200; Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275; Krauss SW, 1997, P NATL ACAD SCI USA, V94, P7297, DOI 10.1073/pnas.94.14.7297; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lallena MJ, 1997, J CELL SCI, V110, P239; Lallena MJ, 1998, J CELL SCI, V111, P1963; LETO TL, 1986, J CELL PHYSIOL, V127, P423, DOI 10.1002/jcp.1041270311; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Luque CM, 1998, J BIOL CHEM, V273, P11643, DOI 10.1074/jbc.273.19.11643; Luque CM, 1999, P NATL ACAD SCI USA, V96, P14925, DOI 10.1073/pnas.96.26.14925; Luque CM, 2000, J CELL SCI, V113, P2485; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2000, J BIOL CHEM, V275, P30573, DOI 10.1074/jbc.M004578200; Mittl PRE, 1998, ACTA CRYSTALLOGR D, V54, P86, DOI 10.1107/S0907444997006550; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Nunomura W, 1997, J BIOL CHEM, V272, P30322, DOI 10.1074/jbc.272.48.30322; Perez-Ferreiro CM, 2001, J BIOL CHEM, V276, P44785, DOI 10.1074/jbc.M107369200; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Schischmanoff PO, 1997, J BIOL CHEM, V272, P10254, DOI 10.1074/jbc.272.15.10254; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Tang CJC, 1998, BLOOD, V92, P1442, DOI 10.1182/blood.V92.4.1442.416k14_1442_1447; TANG TK, 1988, P NATL ACAD SCI USA, V85, P3713, DOI 10.1073/pnas.85.11.3713; TANG TK, 1990, J CELL BIOL, V110, P617, DOI 10.1083/jcb.110.3.617; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x	67	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2686	2691		10.1074/jbc.M201521200	http://dx.doi.org/10.1074/jbc.M201521200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12427749	hybrid			2022-12-27	WOS:000180562000081
J	Thomas, J; Bramlett, KS; Montrose, C; Foxworthy, P; Eacho, PI; McCann, D; Cao, GQ; Kiefer, A; McCowan, J; Yu, KL; Grese, T; Chin, WW; Burris, TP; Michael, LF				Thomas, J; Bramlett, KS; Montrose, C; Foxworthy, P; Eacho, PI; McCann, D; Cao, GQ; Kiefer, A; McCowan, J; Yu, KL; Grese, T; Chin, WW; Burris, TP; Michael, LF			A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPAR alpha) versus liver X receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TANGIER-DISEASE; FATTY-ACID; LXR-ALPHA; BINDING; CHOLESTEROL; TRANSCRIPTION; METABOLISM; ABCA1; MICE	Fenofibrate is clinically successful in treating hyper-triglyceridemia and mixed hyperlipidemia presumably through peroxisome proliferator-activated receptor a (PPARalpha)-dependent induction of genes that control fatty acid beta-oxidation. Lipid homeostasis and cholesterol metabolism also are regulated by the nuclear oxysterol receptors, liver X receptors alpha and beta (LXRalpha and L-XRbeta). Here we show that fenofibrate ester, but not fenofibric acid, functions as an LXR antagonist by directly binding to LXRs. Likewise, ester forms, but not carboxylic acid forms, of other members of the fibrate class of molecules antagonize the LXRs. The fibrate esters display greater affinity for LXRs than the corresponding fibric acids have for PPARalpha. Thus, these two nuclear receptors display a degree of conservation in their recognition of ligands; yet, the acid/ester moiety acts as a chemical switch that determines PPARalpha versus LXR specificity. Consistent with its LXR antagonistic activity, fenofibrate potently represses LXR agonist-induced transcription of hepatic lipogenic genes. Surprisingly, fenofibrate does not repress LXR-induced transcription of various ATP-hinding cassette transporters either in liver or in macrophages, suggesting that fenofibrate manifests variable biocharacter in the context of differing gene promoters. These findings provide not only an unexpected mechanism by which fenofibrate inhibits lipogenesis but also the basis for examination of the pharmacology of an LXR ligand in humans.	Eli Lilly & Co, Dept Cardiovasc Res, Indianapolis, IN 46285 USA; Eli Lilly & Co, Dept Gene Regulat, Indianapolis, IN 46285 USA; Eli Lilly & Co, Dept Lead Optimizat Biol, Indianapolis, IN 46285 USA; Eli Lilly & Co, Dept Drug Disposit, Indianapolis, IN 46285 USA; Eli Lilly & Co, Dept Med Chem, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Michael, LF (corresponding author), Eli Lilly & Co, Dept Cardiovasc Res, DC 0520, Indianapolis, IN 46285 USA.	laura_michael@lilly.com	Burris, Thomas P/B-3886-2016; Burris, Thomas/H-5078-2011	Burris, Thomas P/0000-0003-2922-4449; 				Bramlett KS, 2002, MOL GENET METAB, V76, P225, DOI 10.1016/S1096-7192(02)00043-4; Brooks DA, 2001, J MED CHEM, V44, P2061, DOI 10.1021/jm0155188; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; CALDWELL J, 1989, CARDIOLOGY, V76, P33, DOI 10.1159/000174545; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Costet P, 2000, J BIOL CHEM, V275, P28240; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Fruchart J C, 2001, Curr Atheroscler Rep, V3, P83, DOI 10.1007/s11883-001-0015-x; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Jones PS, 1999, J BIOL CHEM, V274, P32008, DOI 10.1074/jbc.274.45.32008; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; KRITCHEVSKY D, 1979, PHARMACOL RES COMMUN, V11, P635, DOI 10.1016/S0031-6989(79)80053-3; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Latruffe N, 2000, BIOCHEM PHARMACOL, V60, P1027, DOI 10.1016/S0006-2952(00)00416-0; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liu Z, 2002, P NATL ACAD SCI USA, V99, P7940, DOI 10.1073/pnas.122225699; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Mak PA, 2002, J BIOL CHEM, V277, P31900, DOI 10.1074/jbc.M202993200; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Oram JF, 2001, J LIPID RES, V42, P1173; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pawar A, 2002, J BIOL CHEM, V277, P39243, DOI 10.1074/jbc.M206170200; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; SMITH GD, 1992, JAMA-J AM MED ASSOC, V267, P70, DOI 10.1001/jama.267.1.70; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Tobin KAR, 2000, MOL ENDOCRINOL, V14, P741, DOI 10.1210/me.14.5.741; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200	44	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2003	278	4					2403	2410		10.1074/jbc.M209629200	http://dx.doi.org/10.1074/jbc.M209629200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	638FY	12441342	hybrid			2022-12-27	WOS:000180562000046
J	Gronow, S; Noah, C; Blumenthal, A; Lindner, B; Brade, H				Gronow, S; Noah, C; Blumenthal, A; Lindner, B; Brade, H			Construction of a deep-rough mutant of Burkholderia cepacia ATCC 25416 and characterization of its chemical and biological properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID KDO TRANSFERASE; LIPID-A COMPONENT; PSEUDOMONAS-CEPACIA; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CYSTIC-FIBROSIS; CORE REGION; FUNCTIONAL-CHARACTERIZATION; INTRACELLULAR SURVIVAL; EPITOPE SPECIFICITIES	Burkholderia cepacia is a bacterium with increasing importance as a pathogen in patients with cystic fibrosis. The deep-rough mutant Ko2b was generated from R cepacia type strain ATCC 25416 by insertion of a kanamycin resistance cassette into the gene waaC encoding heptosyltransferase I. Mass spectrometric analysis of the de-O-acylated lipopolysaccharide (LPS) of the mutant showed that it consisted of a bisphosphorylated glucosamine backbone with two 3-hydroxyhexade-canoic acids in amide-linkage, 4-amino-4-deoxyarabinose (Ara4N) residues on both phosphates, and a core oligosaccharide of the sequence Ara4N-(1 --> 8) D-glycero-D-talo-oct-2-ulosonic acid (Ko)-(2 --> 4)3-deoxy-D-manno-oct-2-ulosonic acid (Kdo). The mutant allowed investigations on the biosynthesis of the LPS as well as on its role in human infection. Mutant Ko2b showed no difference in its ability to invade human macrophages as compared with the wild type. Furthermore, isolated LPS of both strains induced the production of tumor necrosis factor a from macrophages to the same extent. Thus, the truncation of the LPS did not decrease the biological activity of the mutant or its LPS in these aspects.	Ctr Med & Biosci, Res Ctr Borstel, Div Med & Biochem Microbiol, D-23845 Borstel, Germany; Ctr Med & Biosci, Res Ctr Borstel, Div Mol Infect Biol, D-23845 Borstel, Germany; Ctr Med & Biosci, Res Ctr Borstel, Div Biophys, D-23845 Borstel, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel	Gronow, S (corresponding author), Ctr Med & Biosci, Res Ctr Borstel, Div Med & Biochem Microbiol, Parkallee 22, D-23845 Borstel, Germany.	sgronow@fz-borstel.de	Blumenthal, Antje/A-3608-2011; Lindner, Buko/G-9731-2014	Blumenthal, Antje/0000-0003-3673-7015; 				AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BECKMAN W, 1979, J BACTERIOL, V140, P1126, DOI 10.1128/JB.140.3.1126-1128.1979; BELUNIS CJ, 1995, J BIOL CHEM, V270, P27646, DOI 10.1074/jbc.270.46.27646; Bode CE, 1998, EUR J BIOCHEM, V254, P404, DOI 10.1046/j.1432-1327.1998.2540404.x; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Brabetz N, 2000, J BACTERIOL, V182, P4654, DOI 10.1128/JB.182.16.4654-4657.2000; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; BRADE L, 1987, INFECT IMMUN, V55, P462, DOI 10.1128/IAI.55.2.462-466.1987; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; CHATTERJEE AK, 1976, CAN J MICROBIOL, V22, P1540, DOI 10.1139/m76-226; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; COX AD, 1991, MOL MICROBIOL, V5, P641, DOI 10.1111/j.1365-2958.1991.tb00735.x; deKievit TR, 1997, J BACTERIOL, V179, P3451, DOI 10.1128/jb.179.11.3451-3457.1997; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; FARRAR WE, 1980, GENUS SERRATIA, P121; FOLSOM BR, 1990, APPL ENVIRON MICROB, V56, P1279, DOI 10.1128/AEM.56.5.1279-1285.1990; GALLATI H, 1985, J CLIN CHEM CLIN BIO, V23, P453; GAY P, 1983, J BACTERIOL, V153, P1424, DOI 10.1128/JB.153.3.1424-1431.1983; Govan JRW, 1998, MICROBIOL-SGM, V144, P2373, DOI 10.1099/00221287-144-9-2373; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GRAGEGRIEBENOW E, 1993, EUR J IMMUNOL, V23, P3126, DOI 10.1002/eji.1830231213; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; HASE S, 1977, EUR J BIOCHEM, V75, P23, DOI 10.1111/j.1432-1033.1977.tb11500.x; Helander IM, 1996, EUR J BIOCHEM, V237, P272, DOI 10.1111/j.1432-1033.1996.0272n.x; HELANDER IM, 1994, MOL MICROBIOL, V11, P481, DOI 10.1111/j.1365-2958.1994.tb00329.x; Holmes A, 1998, EMERG INFECT DIS, V4, P221, DOI 10.3201/eid0402.980209; Holst O, 2002, TRENDS GLYCOSCI GLYC, V14, P87, DOI 10.4052/tigg.14.87; Holst O, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P115; HOLST O, 1994, EUR J BIOCHEM, V222, P183, DOI 10.1111/j.1432-1033.1994.tb18856.x; Hughes JE, 1997, INFECT IMMUN, V65, P4281, DOI 10.1128/IAI.65.10.4281-4287.1997; Hutchison ML, 2000, FEMS IMMUNOL MED MIC, V27, P73, DOI 10.1111/j.1574-695X.2000.tb01414.x; IMOTO M, 1984, TETRAHEDRON LETT, V25, P2667, DOI 10.1016/S0040-4039(01)81258-2; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Isobe T, 1999, J BACTERIOL, V181, P2648, DOI 10.1128/JB.181.8.2648-2651.1999; Isshiki Y, 1998, CARBOHYD RES, V313, P21, DOI 10.1016/S0008-6215(98)00179-7; Jones AM, 2001, EUR RESPIR J, V17, P295, DOI 10.1183/09031936.01.17202950; KACA W, 1988, CARBOHYD RES, V179, P289, DOI 10.1016/0008-6215(88)84125-9; Kadrmas JL, 1998, J BIOL CHEM, V273, P2799, DOI 10.1074/jbc.273.5.2799; Kawahara K, 1998, FEMS MICROBIOL LETT, V169, P283; KAWAHARA K, 1987, EUR J BIOCHEM, V163, P489, DOI 10.1111/j.1432-1033.1987.tb10895.x; Klena JD, 1998, GENE, V222, P177, DOI 10.1016/S0378-1119(98)00501-0; Lessie TG, 1996, FEMS MICROBIOL LETT, V144, P117, DOI 10.1016/0378-1097(96)00343-6; LIEBL W, 1990, ISOLATION RESTRICTIO, P323; LiPuma JJ, 1998, CLIN CHEST MED, V19, P473, DOI 10.1016/S0272-5231(05)70094-0; LiPuma JJ, 1999, EMERG INFECT DIS, V5, P305, DOI 10.3201/eid0502.990226; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Mohr CD, 2001, MICROBES INFECT, V3, P425, DOI 10.1016/S1286-4579(01)01389-2; Molinaro A, 2002, J BIOL CHEM, V277, P10058, DOI 10.1074/jbc.M110283200; Noah C, 2001, J ENDOTOXIN RES, V7, P25, DOI 10.1179/096805101101532495; ONEIL KM, 1986, J PEDIATR-US, V108, P940, DOI 10.1016/S0022-3476(86)80934-9; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Rick PD, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P283; ROANTREE RJ, 1977, J GEN MICROBIOL, V103, P223, DOI 10.1099/00221287-103-2-223; ROZALSKI A, 1989, INFECT IMMUN, V57, P2645, DOI 10.1128/IAI.57.9.2645-2652.1989; Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819; Saini LS, 1999, MICROBIOL-UK, V145, P3465, DOI 10.1099/00221287-145-12-3465; SHAW D, 1995, FEMS IMMUNOL MED MIC, V11, P99, DOI 10.1016/0928-8244(95)00012-V; Shimomura H, 2001, INFECT IMMUN, V69, P3663, DOI 10.1128/IAI.69.6.3663-3669.2001; SIDORCZYK Z, 1983, EUR J BIOCHEM, V137, P15, DOI 10.1111/j.1432-1033.1983.tb07789.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SIRISENA DM, 1992, J BIOL CHEM, V267, P18874; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; SONESSON A, 1994, MICROBIOL-SGM, V140, P1261, DOI 10.1099/00221287-140-6-1261; Stojiljkovic I, 1997, FEMS MICROBIOL LETT, V151, P41, DOI 10.1016/S0378-1097(97)00135-3; SUN L, 1995, NAT MED, V1, P661, DOI 10.1038/nm0795-661; SWIERZKO A, 1994, J ENDOTOXIN RES, V1, P38; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tipper J. L., 1998, Clinical Microbiology and Infection, V4, P450, DOI 10.1111/j.1469-0691.1998.tb00394.x; TRENT MS, 2001, J BIOL CHEM; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov EV, 2002, CARBOHYD RES, V337, P775, DOI 10.1016/S0008-6215(02)00074-5; Vinogradov EV, 1997, EUR J BIOCHEM, V243, P122, DOI 10.1111/j.1432-1033.1997.0122a.x; Vinogradov EV, 1997, EUR J BIOCHEM, V247, P82, DOI 10.1111/j.1432-1033.1997.00082.x; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; White KA, 1998, FASEB J, V12, pA1285; Wigley P, 2000, J APPL MICROBIOL, V88, P914, DOI 10.1046/j.1365-2672.2000.01033.x; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; WOLLENWEBER HW, 1990, J MICROBIOL METH, V11, P195, DOI 10.1016/0167-7012(90)90056-C; Zughaier SM, 1999, INFECT IMMUN, V67, P1505, DOI 10.1128/IAI.67.3.1505-1507.1999	81	35	36	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1647	1655		10.1074/jbc.M206942200	http://dx.doi.org/10.1074/jbc.M206942200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427755	hybrid			2022-12-27	WOS:000180462200038
J	Hahn, PY; Evans, SE; Kottom, TJ; Standing, JE; Pagano, RE; Limper, AH				Hahn, PY; Evans, SE; Kottom, TJ; Standing, JE; Pagano, RE; Limper, AH			Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; COMPLEMENT RECEPTOR-TYPE-3 CD11B/CD18; N-BUTYLDEOXYNOJIRIMYCIN; GENE-EXPRESSION; LECTIN SITE; PGG-GLUCAN; CYST WALL; LUNG; CHEMOATTRACTANT; INHIBITOR	Infiltration of the lungs with neutrophils promotes respiratory failure during severe Pneumocystis carinii (PC) pneumonia. Recent studies have shown that alveolar epithelial cells (AECs), in addition to promoting PC attachment, also participate in lung inflammation by the release of cytokines and chemokines. Herein, we demonstrate that a PC beta-glucan rich cell wall isolate (PCBG) stimulates the release of macrophage inflammatory protein-2 (MIP-2) from isolated AECs through a lactosylceramide-dependent mechanism. The results demonstrate that MIP-2 mRNA and protein production is significantly increased at both early and late time points after PCBG challenge. Although CD11b/CD18 (Mac-1, CR3) is the most widely studied P-glucan receptor, we demonstrate that CD11b/CD18 is not present on AECs. This study instead demonstrates that preincubation of AECs with an antibody directed against the membrane glycosphingolipid lactosylceramide (CDw17) results in a significant decrease in MIP-2 secretion. Preincubation of the anti-CDw17 antibody with solubilized lactosylceramide reverses this effect. Furthermore, incubation of AECs with inhibitors of glycosphingolipid biosynthesis, including N-butyldeoxyno jirimycin and D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanot-HCI, also results in a significant decrease in AEC MIP-2 production following challenge with PCBG. These data demonstrate that PC beta-glucan induces significant production of MIP-2 from AECs and that CDw17 participates in the glucan-induced inflammatory signaling in lung epithelial cells during PC infection.	Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Limper, AH (corresponding author), Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, 8-24 Stabile Bldg, Rochester, MN 55905 USA.			Hahn, Peter/0000-0003-2410-6152; Evans, Scott/0000-0003-4503-0644	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062150, R01HL057125, R01HL055934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM022942, R01GM022942] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62150, R01 HL062150, HL57125, HL55934] Funding Source: Medline; NIGMS NIH HHS [GM22942] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABEL G, 1992, INT J IMMUNOPHARMACO, V14, P1363, DOI 10.1016/0192-0561(92)90007-8; Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Benfield TL, 1999, EUR J CLIN INVEST, V29, P717, DOI 10.1046/j.1365-2362.1999.00517.x; BOZZETTE SA, 1990, NEW ENGL J MED, V323, P1451, DOI 10.1056/NEJM199011223232104; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; CASTRO M, 1993, AM J RESP CELL MOL, V9, P73, DOI 10.1165/ajrcmb/9.1.73; CHEN WX, 1992, INFECT IMMUN, V60, P1279, DOI 10.1128/IAI.60.4.1279-1284.1992; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; EDMAN JC, 1988, NATURE, V334, P519, DOI 10.1038/334519a0; HOFFMAN OA, 1993, J IMMUNOL, V150, P3932; JIMENEZLUCHO V, 1990, INFECT IMMUN, V58, P2085, DOI 10.1128/IAI.58.7.2085-2090.1990; KALLENBERG CGM, 1987, CLIN EXP IMMUNOL, V67, P182; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kolls JK, 1997, AM J RESP CELL MOL, V16, P112, DOI 10.1165/ajrcmb.16.2.9032117; Kovacs P, 2000, CELL BIOCHEM FUNCT, V18, P269; LIMPER AH, 1989, AM REV RESPIR DIS, V140, P1204, DOI 10.1164/ajrccm/140.5.1204; Limper AH, 1998, J CLIN INVEST, V101, P1148, DOI 10.1172/JCI659; LUO Y, 1993, J IMMUNOL, V150, P971; LUO Y, 1994, J IMMUNOL, V153, P4616; MATSUMOTO Y, 1989, J PROTOZOOL, V36, pS21, DOI 10.1111/j.1550-7408.1989.tb05814.x; NOLLSTADT KH, 1994, ANTIMICROB AGENTS CH, V38, P2258, DOI 10.1128/AAC.38.10.2258; Olson EJ, 1996, INFECT IMMUN, V64, P3548, DOI 10.1128/IAI.64.9.3548-3554.1996; Platt FM, 1997, J BIOL CHEM, V272, P19365, DOI 10.1074/jbc.272.31.19365; Ross GD, 2000, CRIT REV IMMUNOL, V20, P197; Rudmann DG, 1998, J IMMUNOL, V161, P360; Schmal H, 1996, J IMMUNOL, V156, P1963; SCHNEEBERGER EE, 1986, LAB INVEST, V55, P138; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; STANDIFORD TJ, 1990, J CLIN INVEST, V86, P1945, DOI 10.1172/JCI114928; Thomas C F Jr, 1998, Semin Respir Infect, V13, P289; Thornton BP, 1996, J IMMUNOL, V156, P1235; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Vassallo R, 2000, J IMMUNOL, V164, P3755, DOI 10.4049/jimmunol.164.7.3755; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; Wakshull E, 1999, IMMUNOPHARMACOLOGY, V41, P89, DOI 10.1016/S0162-3109(98)00059-9; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; Wright TW, 1999, INFECT IMMUN, V67, P3452, DOI 10.1128/IAI.67.7.3452-3460.1999; Xavier AM, 1999, AM J RESP CELL MOL, V21, P510, DOI 10.1165/ajrcmb.21.4.3602; Yan J, 1999, J IMMUNOL, V163, P3045; Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014	44	117	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					2043	2050		10.1074/jbc.M209715200	http://dx.doi.org/10.1074/jbc.M209715200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12419803	hybrid			2022-12-27	WOS:000180462200090
J	Jin, YH; Ayyagari, R; Resnick, MA; Gordenin, DA; Burgers, PMJ				Jin, YH; Ayyagari, R; Resnick, MA; Gordenin, DA; Burgers, PMJ			Okazaki fragment maturation in yeast - II. Cooperation between the polymerase and 3 '-5 '-exonuclease activities of Pol delta in the creation of a ligatable nick	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE; SACCHAROMYCES-CEREVISIAE; DEOXYRIBONUCLEIC-ACID; 2 FORMS; REPLICATION; REPAIR; PCNA; HELICASE; BINDING; EXONUCLEASE	To address the different functions of Pol delta and FEN1 (Rad27) in Okazaki fragment maturation, exonuclease-deficient polymerase Pol delta-01 and Pol delta-5DV (corresponding to alleles pol3-01-(D321A, E323A) and pol3-5DV-(D520V), respectively) were purified and characterized in this process. In the presence of the replication clamp PCNA, both wild-type and exo(-) Poldelta carried out strand displacement synthesis with similar rates; however, initiation of strand displacement synthesis was much more efficient with Pol delta-exo(-). When Pol delta-exo(-) encountered a downstream primer, it paused with 3-5 nucleotides of the primer displaced, whereas the wild type carried out precise gap filling. Consequently, in the absence of FEN1, Pol 5 exonuclease activity was essential for closure of simple gaps by DNA ligase. Compared with wild type, Okazaki fragment maturation with Pol delta-exo(-) proceeded with an increased duration of nick translation prior to ligation. Maturation was efficient in the absence of Dna2 and required Dna2 only when FEN1 activity was compromised. In agreement with these results, the proposed generation of double strand breaks in pol3-exo(-) rad27 mutants was suppressed by the overexpression of DNA2. Further genetic studies showed that pol3-exo- rad27 double mutants were sensitive to alkylation damage consistent with an in vivo defect in gap filling by exonuclease-deficient Pol delta.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; Lindenwood Univ, St Charles, MO 63301 USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Burgers, PMJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	resnick, Michael/F-1668-2019; Dmitry, Gordenin/C-3907-2018; Burgers, Peter M/AAW-6621-2021	resnick, Michael/0000-0002-8473-7506; Dmitry, Gordenin/0000-0002-8399-1836; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065073, ZIAES065073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM032431] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bhagwat M, 2001, J BIOL CHEM, V276, P28516, DOI 10.1074/jbc.M103914200; BLANK A, 1994, P NATL ACAD SCI USA, V91, P9047, DOI 10.1073/pnas.91.19.9047; BUDD ME, 1995, MOL CELL BIOL, V15, P2173; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; BURGERS PMJ, 1993, J BIOL CHEM, V268, P19923; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; ENGLER MJ, 1983, J BIOL CHEM, V258, P1165; Formosa T, 1999, GENETICS, V151, P1459; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Gary R, 1999, MOL CELL BIOL, V19, P5373; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; KABOORD BF, 1993, P NATL ACAD SCI USA, V90, P10881, DOI 10.1073/pnas.90.22.10881; Kang HY, 2000, GENETICS, V155, P1055; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; MORRISON A, 1993, EMBO J, V12, P1467, DOI 10.1002/j.1460-2075.1993.tb05790.x; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; PODUST LM, 1994, NUCLEIC ACIDS RES, V22, P2970, DOI 10.1093/nar/22.15.2970; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; RESNICK MA, 1978, J THEOR BIOL, V71, P339, DOI 10.1016/0022-5193(78)90164-9; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487	33	124	126	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1626	1633		10.1074/jbc.M209803200	http://dx.doi.org/10.1074/jbc.M209803200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424237	hybrid			2022-12-27	WOS:000180462200035
J	Marshall-Batty, KR; Nakai, H				Marshall-Batty, KR; Nakai, H			trans-Targeting of the phage Mu repressor is promoted by conformational changes that expose its ClpX recognition determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTATIONS; ATP-DEPENDENT PROTEASES; BACTERIOPHAGE-MU; ESCHERICHIA-COLI; DEGRADATION; PROTEINS; SEQUENCE; TRANSPOSASE; OPERATOR; SUBUNIT	Dominant negative forms of the phage Mu repressor, including the mutant Vir repressors, are not only rapidly degraded by the ClpXP protease but also promote degradation of the unmodified, wild-type repressor. This trans-targeting of the wild-type repressor depends upon a determinant within its C-terminal domain, which is needed for recognition by ClpX. An environmentally sensitive fluorescent probe (2-(4'-maleimidylanilino)naphthalene-6-sulfonic acid (MIANS)) attached to the C terminus of the full-length repressor indicated that Vir induces the movement of this domain into a more exposed configuration. Vir also promoted attachment of MIANS to the C terminus of the repressor at an accelerated rate, and it greatly increased the rate of phosphorylation of a cAMP-dependent protein kinase motif attached to the repressor C terminus. While an excess of Vir was needed to promote repressor phosphorylation at maximal rates, the presence of ClpX could increase phosphorylation rates at lower Vir levels. trans-Targeting of the Mu repressor is therefore promoted by exposing its ClpX recognition determinant, and the action of ClpX can assist Vir in exposing these determinants.	Georgetown Univ, Dept Biochem & Mol Biol, Sch Med, Ctr Med, Washington, DC 20057 USA	Georgetown University	Nakai, H (corresponding author), Georgetown Univ, Dept Biochem & Mol Biol, Sch Med, Ctr Med, Box 571455, Washington, DC 20057 USA.	nakai@bc.georgetown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058265] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM58265] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alazard R, 1998, EUR J BIOCHEM, V252, P408, DOI 10.1046/j.1432-1327.1998.2520408.x; Atkins JF, 1996, NATURE, V379, P769, DOI 10.1038/379769a0; Bearson SMD, 1996, J BACTERIOL, V178, P2572, DOI 10.1128/jb.178.9.2572-2579.1996; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x; GEUSKENS V, 1991, J BACTERIOL, V173, P6578, DOI 10.1128/jb.173.20.6578-6585.1991; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476; HIRATSUKA T, 1992, J BIOL CHEM, V267, P14941; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Ilangovan U, 1999, BIOCHEMISTRY-US, V38, P8367, DOI 10.1021/bi990530b; Jentsch S, 1996, SCIENCE, V271, P955, DOI 10.1126/science.271.5251.955; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; KRAUSE HM, 1986, J BIOL CHEM, V261, P3744; Lamrani S, 1999, MOL MICROBIOL, V32, P327, DOI 10.1046/j.1365-2958.1999.01352.x; LEUNG PC, 1989, NATURE, V338, P656, DOI 10.1038/338656a0; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; MAENHAUTMICHEL G, 1994, EMBO J, V13, P5229, DOI 10.1002/j.1460-2075.1994.tb06854.x; MHAMMEDIALAOUI A, 1994, MOL MICROBIOL, V11, P1109, DOI 10.1111/j.1365-2958.1994.tb00387.x; MIZUUCHI M, 1989, CELL, V58, P399, DOI 10.1016/0092-8674(89)90854-4; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; MUKHOPADYAY B, 2002, IN PRESS MOL MICROBI; O'Handley D, 2002, J MOL BIOL, V322, P311, DOI 10.1016/S0022-2836(02)00755-6; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rai SS, 2001, J MOL BIOL, V312, P311, DOI 10.1006/jmbi.2001.4957; Ranquet C, 2001, P NATL ACAD SCI USA, V98, P10220, DOI 10.1073/pnas.171620598; Rousseau P, 2002, RES MICROBIOL, V153, P511, DOI 10.1016/S0923-2508(02)01363-3; Rousseau P, 1996, J BIOL CHEM, V271, P9739, DOI 10.1074/jbc.271.16.9739; SHAPIRO JA, 1984, MOL GEN GENET, V194, P79, DOI 10.1007/BF00383501; SHAPIRO JA, 1990, GENETICS, V126, P293; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Symonds N., 1987, PHAGE MU; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; VOGEL JL, 1991, J BACTERIOL, V173, P6568, DOI 10.1128/jb.173.20.6568-6577.1991; Vogel JL, 1996, GENETICS, V142, P661; Welty DJ, 1997, J MOL BIOL, V272, P31, DOI 10.1006/jmbi.1997.1193; Wickner RB, 2000, J STRUCT BIOL, V130, P310, DOI 10.1006/jsbi.2000.4250; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	48	10	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1612	1617		10.1074/jbc.M209352200	http://dx.doi.org/10.1074/jbc.M209352200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12424242	hybrid			2022-12-27	WOS:000180462200033
J	Perraud, AL; Shen, B; Dunn, CA; Rippe, K; Smith, MK; Bessman, MJ; Stoddard, BL; Scharenberg, AM				Perraud, AL; Shen, B; Dunn, CA; Rippe, K; Smith, MK; Bessman, MJ; Stoddard, BL; Scharenberg, AM			NUDT9, a member of the nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER; MUTT MOTIF; IDENTIFICATION; NUCLEOTIDES; CLONING; CALCIUM	We have recently characterized the protein product of the human NUDT9 gene as a highly specific ADP-ribose (ADPR) pyrophosphatase (1). We now report an analysis of the human NUDT9 gene and its potential alternative transcripts along with detailed studies of the enzymatic properties and cell biological behavior of human NUDT9 protein. Our analysis of the human NUDT9 gene and twenty-two distinct cloned NUDT9 transcripts indicates that the full-length NUDT9alpha transcript is the dominant form, and suggests that an alternative NUDT9beta transcript (2) occurs as the result of a potentially aberrant splice from a cryptic donor site within the first exon to the splice acceptor site of exon 2. Computer analysis of the predicted protein of the NUDT9alpha transcript identified an N-terminal signal peptide or subcellular targeting sequence. Using green fluorescence protein tagging, we demonstrate that the predicted human NUDT9alpha protein is targeted highly specifically to mitochondria, whereas the predicted protein of the NUDT9beta transcript, which is missing this sequence, exhibits no clear subcellular localization. Investigation of the physical and enzymatic properties of NUDT9 indicates that it is functional as a monomer, optimally active at near neutral pH, and that it requires divalent metal ions and an intact Nudix motif for enzymatic activity. Furthermore, partial proteolysis of NUDT9 suggests that NUDT9 enzymes consist of two distinct domains: a proteolytically resistant C-terminal domain retaining essentially full specific ADPR pyrophosphatase activity and a proteolytically labile N-terminal portion that functions to enhance the affinity of the C-terminal domain for ADPR.	Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA 98195 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Johns Hopkins University; Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ)	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat, 1959 NE Pacific Ave, Seattle, WA 98195 USA.		Rippe, Karsten/A-3562-2012	Rippe, Karsten/0000-0001-9951-9395; Dunn, Christopher/0000-0001-7899-0110	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064091] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64091, GM18649] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERNET D, 1994, BIOCHEM J, V299, P679, DOI 10.1042/bj2990679; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; CANALES J, 1995, BBA-PROTEIN STRUCT M, V1246, P167, DOI 10.1016/0167-4838(94)00191-I; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; FRICK DN, 1995, BIOCHEMISTRY-US, V34, P5577, DOI 10.1021/bi00016a032; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gasmi L, 1999, BIOCHEM J, V344, P331, DOI 10.1042/0264-6021:3440331; Harris TK, 2000, BIOCHEMISTRY-US, V39, P1655, DOI 10.1021/bi9918745; Jacobson EL, 1997, ADV EXP MED BIOL, V419, P371; Lin SR, 2002, BBA-PROTEIN STRUCT M, V1594, P127, DOI 10.1016/S0167-4838(01)00296-5; LOTSCHER HR, 1980, J BIOL CHEM, V255, P9325; McLennan AG, 1999, INT J MOL MED, V4, P79; MIRO A, 1989, FEBS LETT, V244, P123, DOI 10.1016/0014-5793(89)81176-7; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Ribeiro JM, 2001, BBA-GEN SUBJECTS, V1526, P86, DOI 10.1016/S0304-4165(01)00113-1; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Rippe K, 1998, J MOL BIOL, V278, P915, DOI 10.1006/jmbi.1998.1746; Sheikh S, 1998, J BIOL CHEM, V273, P20924, DOI 10.1074/jbc.273.33.20924; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 1997, CURR OPIN BIOTECH, V8, P14, DOI 10.1016/S0958-1669(97)80152-8; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844	22	89	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1794	1801		10.1074/jbc.M205601200	http://dx.doi.org/10.1074/jbc.M205601200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12427752	hybrid			2022-12-27	WOS:000180462200057
J	Samuel, CE				Samuel, CE			RNA editing minireview series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review									Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.							Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J	10	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1389	1390		10.1074/jbc.R200032200	http://dx.doi.org/10.1074/jbc.R200032200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12446658	hybrid			2022-12-27	WOS:000180462200001
J	Whittingham, JL; Turkenburg, JP; Verma, CS; Walsh, MA; Grogan, G				Whittingham, JL; Turkenburg, JP; Verma, CS; Walsh, MA; Grogan, G			The 2-A crystal structure of 6-oxo camphor hydrolase - New structural diversity in the crotonase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; COA HYDRATASE; PROTEIN; COENZYME; DEGRADATION; MECHANISM; MOLSCRIPT; CATALYZE; DYNAMICS; REVEALS	6-Oxo camphor hydrolase (OCH) is an enzyme of the crotonase superfamily that catalyzes carbon-carbon bond cleavage in bicyclic beta-diketones via a retro-Claisen reaction (Grogan, G., Roberts, G. A., Bougioukou, D., Turner, N. J., and Flitsch, S. L. (2001) J. Biol. Chem. 276, 12565-12572). The native structure of OCH has been solved at 2.0-Angstrom resolution with selenomethionine multiple wave anomalous dispersion and refined to a final R-free of 19.0. The structure of OCH consists of a dimer of trimers that resembles the "parent" enzyme of the superfamily, enoyl-CoA hydratase. In contrast to enoyl-CoA hydratase, however, two octahedrally coordinated sodium atoms are found at the 3-fold axis of the hexamer of OCH, and the C-terminal helix of OCH does not form a discrete domain. Models of the substrate, 6-oxo camphor, and a proposed enolate intermediate in the putative active site suggest possible mechanistic roles for Glu-244, Asp-154, His-122, His-45, and His-145.	Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of York - UK; European Synchrotron Radiation Facility (ESRF)	Grogan, G (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England.	gg12@york.ac.uk	Walsh, Martin A/I-1566-2013	Walsh, Martin A/0000-0001-5683-1151; Turkenburg, Johan/0000-0001-6992-6838				Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; BRADSHAW WH, 1959, J AM CHEM SOC, V81, P5507, DOI 10.1021/ja01529a060; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; CHAPMAN PJ, 1966, J AM CHEM SOC, V88, P618, DOI 10.1021/ja00955a049; CROOKS GP, 1994, BIOCHEMISTRY-US, V33, P11645, DOI 10.1021/bi00204a028; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FOWLER SM, 1994, J CHEM SOC CHEM COMM, P2761, DOI 10.1039/c39940002761; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Grogan G, 2001, ANGEW CHEM INT EDIT, V40, P1111, DOI 10.1002/1521-3773(20010316)40:6<1111::AID-ANIE11110>3.0.CO;2-2; Grogan G, 2001, J BIOL CHEM, V276, P12565, DOI 10.1074/jbc.M011538200; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hofstein HA, 1999, BIOCHEMISTRY-US, V38, P9508, DOI 10.1021/bi990506y; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurimoto K, 2001, STRUCTURE, V9, P1253, DOI 10.1016/S0969-2126(01)00686-4; Lewis D.F.V., 1996, CYTOCHROME P450 STRU; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier DA, 1998, J BACTERIOL, V180, P2330, DOI 10.1128/JB.180.9.2330-2336.1998; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wu WJ, 2000, J AM CHEM SOC, V122, P3987, DOI 10.1021/ja992286h	30	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2003	278	3					1744	1750		10.1074/jbc.M211188200	http://dx.doi.org/10.1074/jbc.M211188200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	636NK	12421807	hybrid			2022-12-27	WOS:000180462200051
J	Huang, TY; Markley, NA; Young, D				Huang, TY; Markley, NA; Young, D			Nak1, an essential germinal center (GC) kinase regulates cell morphology and growth in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P21-ACTIVATED PROTEIN-KINASE; MITOGEN-ACTIVATED PROTEIN; FISSION YEAST-CELL; SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; GENETIC-ANALYSIS; XENOPUS OOCYTES; STRESS-RESPONSE; SID1P KINASE; MORPHOGENESIS	We have identified and characterized Nak1, a 652-amino acid NH2-terminal kinase belonging to the group II germinal center kinase (GCK) family, in Schizosaccharomyces pombe. We found that nak1 is essential for cell proliferation. Furthermore, partial repression of nak1, under regulation of an integrated nmt1 promoter, resulted in an aberrant round cellular morphology, actin and microtubule mislocalization, slow growth, and cell division defects. Overexpression of either a kinase-inactive mutant (Nak1(K39R)) or the non-catalytic domain resulted in similar phenotypes, suggesting dominant-negative effects. By deletion analysis, we mapped the region responsible for this dominant-negative effect to the COOH-terminal 99 residues. Furthermore, we found that deletion of the COOH-terminal 99 residues inhibited Nakl autophosphorylation, and expression of a partially inactive (Nak1(T171A)) or truncated (Nak(1-562)) protein only weakly suppressed morphological and growth phenotypes, indicating that both kinase and COOH-terminal regions are important for Nakl function. GFPNak1 localized uniformly throughout the cytoplasm, unlike many other proteins which influence cell polarity that preferentially localize to cell ends. Together, our results implicate Nakl in the regulation of cell polarity, growth, and division and suggest that the COOH-terminal end plays an important role in the regulation of this kinase.	Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary	Young, D (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	young@ucalgary.ca						Alfa C, 1993, EXPT FISSION YEAST L; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Balasubramanian MK, 1998, GENETICS, V149, P1265; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Colussi PA, 1997, YEAST, V13, P139, DOI 10.1002/(SICI)1097-0061(199702)13:2<139::AID-YEA69>3.3.CO;2-J; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Faure S, 1997, EMBO J, V16, P5550, DOI 10.1093/emboj/16.18.5550; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gilbreth M, 1996, P NATL ACAD SCI USA, V93, P13802, DOI 10.1073/pnas.93.24.13802; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Guertin DA, 2000, EMBO J, V19, P1803, DOI 10.1093/emboj/19.8.1803; Guertin DA, 2001, J BIOL CHEM, V276, P28185, DOI 10.1074/jbc.M103802200; Kyriakis JM, 1999, J BIOL CHEM, V274, P5259, DOI 10.1074/jbc.274.9.5259; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; LEHMANN R, 1995, CELL, V83, P353, DOI 10.1016/0092-8674(95)90111-6; Loewith R, 2000, J CELL SCI, V113, P153; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARCUS S, 1995, P NATL ACAD SCI USA, V92, P6180, DOI 10.1073/pnas.92.13.6180; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Meijer M, 2002, J BIOL CHEM, V277, P4050, DOI 10.1074/jbc.M109383200; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrell JL, 1999, MOL BIOL CELL, V10, P4201, DOI 10.1091/mbc.10.12.4201; NOVAK B, 1989, J CELL SCI, V94, P657; NURSE P, 1977, EXP CELL RES, V107, P365, DOI 10.1016/0014-4827(77)90358-5; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; POLVERINO A, 1995, J BIOL CHEM, V270, P26067, DOI 10.1074/jbc.270.44.26067; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sells MA, 1998, J BIOL CHEM, V273, P18490, DOI 10.1074/jbc.273.29.18490; Sengar AS, 1997, MOL CELL BIOL, V17, P3508, DOI 10.1128/MCB.17.7.3508; Shulman JM, 1999, TRENDS BIOCHEM SCI, V24, pM60, DOI 10.1016/S0968-0004(99)01490-5; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; STROME S, 1993, CELL, V72, P3, DOI 10.1016/0092-8674(93)90041-N; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Verde F, 2001, CURR BIOL, V11, pR600, DOI 10.1016/S0960-9822(01)00362-1; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; XU HP, 1990, CELL REGUL, V1, P763, DOI 10.1091/mbc.1.10.763; Yang PR, 1998, J BIOL CHEM, V273, P18481, DOI 10.1074/jbc.273.29.18481; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	55	20	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2003	278	2					991	997		10.1074/jbc.M208993200	http://dx.doi.org/10.1074/jbc.M208993200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	634CF	12427731	hybrid			2022-12-27	WOS:000180321900040
J	Clark-Lewis, I; Mattioli, I; Gong, JH; Loetscher, P				Clark-Lewis, I; Mattioli, I; Gong, JH; Loetscher, P			Structure-function relationship between the human chemokine receptor CXCR3 and its ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ALPHA-CHEMOATTRACTANT; PROTEIN-COUPLED RECEPTORS; ACUTE ALLOGRAFT-REJECTION; T-CELLS; DIFFERENTIAL EXPRESSION; ENDOTHELIAL-CELLS; CHEMOTACTIC RESPONSIVENESS; NH2-TERMINAL RESIDUES; MULTIPLE-SCLEROSIS; NATURAL ANTAGONIST	I-TAC, IP10, and Mig are interferon-gamma inducible CXC chemokines that share the same G-protein-coupled receptor CXCR3, which is preferentially expressed on Th1 lymphocytes. We have explored the structure-function relationship of the CXCR3 ligands, in particular of I-TAC, which has highest affinity for CXCR3 and is the most potent agonist. A potent antagonist for CXCR3 was obtained by NH2-terminal truncation of I-TAC. I-TAC (4-73), which lacks the first three residues, has no agonistic activity but competes for the binding of I-TAC to CXCR3-bearing cells and inhibits migration and Ca2+ changes in such cells in response to stimulation with I-TAC, IP10, and Mig. It does also not induce internalization of CXCR3, which is in support of the lack of agonistic effects. Hybrid chemokines between I-TAC and IP10 were used to identify regions responsible for the higher activity of I-TAC. I-TAC-like IP10 analogs are obtained by substituting the NH2 terminus (residues 1-8) or N-loop region (residues 12-17) of IP10 with those of I-TAC, suggesting that the differences in function of the CXCR3 ligands can be assigned to distinct regions and that these regions are interchangeable. Structure-activity studies with Mig showed that the extended basic COOH-terminal region, which is not present in I-TAC and IP10, is important for binding and activity.	Univ British Columbia, Ctr Biomed Res, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Bern, Theodor Kocher Inst, CH-3000 Bern, Switzerland	University of British Columbia; University of British Columbia; University of Bern	Loetscher, P (corresponding author), Univ British Columbia, Ctr Biomed Res, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.							Agostini C, 1998, J IMMUNOL, V161, P6413; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Blanpain C, 1999, BLOOD, V94, P1899; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Booth V, 2002, BIOCHEMISTRY-US, V41, P10418, DOI 10.1021/bi026020q; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cox MA, 2001, MOL PHARMACOL, V59, P707, DOI 10.1124/mol.59.4.707; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Flier J, 2001, J PATHOL, V194, P398, DOI 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S; Garcia-Lopez MA, 2001, LAB INVEST, V81, P409, DOI 10.1038/labinvest.3780248; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; GOTTLIEB AB, 1988, J EXP MED, V168, P941, DOI 10.1084/jem.168.3.941; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Hensbergen PJ, 2001, EUR J BIOCHEM, V268, P4992, DOI 10.1046/j.0014-2956.2001.02433.x; Jones D, 2000, BLOOD, V95, P627, DOI 10.1182/blood.V95.2.627; Jones SA, 1997, J BIOL CHEM, V272, P16166, DOI 10.1074/jbc.272.26.16166; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; Loetscher P, 2001, J LEUKOCYTE BIOL, V69, P881; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Ludwig A, 2002, J LEUKOCYTE BIOL, V72, P183; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; MOSER B, 1993, J BIOL CHEM, V268, P7125; Murphy PM, 2000, PHARMACOL REV, V52, P145; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Ogilvie P, 2001, BLOOD, V97, P1920, DOI 10.1182/blood.V97.7.1920; Patel DD, 2001, CLIN IMMUNOL, V98, P39, DOI 10.1006/clim.2000.4957; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rabin RL, 1999, J IMMUNOL, V162, P3840; Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601; Romagnani P, 2001, J CLIN INVEST, V107, P53, DOI 10.1172/JCI9775; Sabroe I, 2000, J BIOL CHEM, V275, P25985, DOI 10.1074/jbc.M908864199; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Struyf S, 1999, J IMMUNOL, V162, P4903; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Trentin L, 1999, J CLIN INVEST, V104, P115, DOI 10.1172/JCI7335; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	67	143	158	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					289	295		10.1074/jbc.M209470200	http://dx.doi.org/10.1074/jbc.M209470200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12417585	hybrid			2022-12-27	WOS:000180255700039
J	Hisano, T; Tsuge, T; Fukui, T; Iwata, T; Miki, K; Doi, Y				Hisano, T; Tsuge, T; Fukui, T; Iwata, T; Miki, K; Doi, Y			Crystal structure of the (R)-specific enoyl-CoA hydratase from Aeromonas caviae involved in polyhydroxyalkanoate biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIFUNCTIONAL PROTEIN-DEFICIENCY; PEROXISOMAL BETA-OXIDATION; MOLECULAR-CLONING; ENZYME; COENZYME; BINDING; GENES; THIOESTERASE; RESOLUTION; EXPRESSION	The (R)-specific enoyl coenzyme A hydratase ((R)-hydratase) from Aeromonas caviae catalyzes the addition of a water molecule to trans-2-enoyl coenzyme A (CoA), with a chain-length of 4-6 carbons, to produce the corresponding (R)-3-hydroxyacyl-CoA. It forms a dimer of identical subunits with a molecular weight of about 14,000 and is involved in polyhydroxyalkanoate (PHA) biosynthesis. The crystal structure of the enzyme has been determined at 1.5-Angstrom resolution. The structure of the monomer consists of a five-stranded antiparallel beta-sheet and a central alpha-helix, folded into a so-called "hot dog" fold, with an overhanging segment. This overhang contains the conserved residues including the hydratase 2 motif residues. In dimeric form, two beta-sheets are associated to form an extended 10-stranded beta-sheet, and the overhangs obscure the putative active sites at the subunit interface. The active site is located deep within the substrate-binding tunnel, where Asp(31) and HiS(36) form a catalytic dyad. These residues are catalytically important as confirmed by site-directed mutagenesis and are possibly responsible for the activation of a water molecule and the protonation of a substrate molecule, respectively. Residues such as Leu(65) and Val(130) are situated at the bottom of the substrate-binding tunnel, defining the preference of the enzyme for the chain length of the substrate. These results provide target residues for protein engineering, which will enhance the significance of this enzyme in the production of novel PHA polymers. In addition, this study provides the first structural information of the (R)-hydratase family and may facilitate further functional studies for members of the family.	RIKEN, Harima Inst, Hyogo 6795148, Japan; Riken Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	RIKEN; RIKEN; Kyoto University	Hisano, T (corresponding author), RIKEN, Harima Inst, SPring 8,1-1-1 Koto, Hyogo 6795148, Japan.	hisano@postman.riken.go.jp	福居, 俊昭/K-5056-2012; Doi, Yoshiharu/C-3824-2009; Fukui, Toshiaki/S-6882-2019; Tsuge, Takeharu/F-6618-2011	福居, 俊昭/0000-0003-4557-6284; Fukui, Toshiaki/0000-0003-4557-6284; Tsuge, Takeharu/0000-0002-6296-6500				ADACHI S, 1996, SPRING 8 ANN REPORT, P239; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR MANUAL VERSION; DieuaideNoubhani M, 1997, BIOCHEM J, V325, P367, DOI 10.1042/bj3250367; DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007; DOI Y, 1990, MICROBIOL POLYESTERS; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fukui T, 1999, FEMS MICROBIOL LETT, V170, P69, DOI 10.1111/j.1574-6968.1999.tb13356.x; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Fukui T, 1997, J BACTERIOL, V179, P4821, DOI 10.1128/jb.179.15.4821-4830.1997; Fukui T, 2001, BIOMACROMOLECULES, V2, P148, DOI 10.1021/bm0056052; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Hiltunen JK, 2000, BBA-MOL CELL BIOL L, V1484, P117, DOI 10.1016/S1388-1981(00)00013-5; HILTUNEN JK, 1992, J BIOL CHEM, V267, P6646; Hisano T, 2001, ACTA CRYSTALLOGR D, V57, P145, DOI 10.1107/S0907444900014062; Hofstein HA, 1999, BIOCHEMISTRY-US, V38, P9508, DOI 10.1021/bi990506y; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Itoh M, 2000, BRAIN RES, V858, P40, DOI 10.1016/S0006-8993(99)02423-3; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; JONES TA, 1985, METHOD ENZYMOL, V115, P157; Kichise T, 1999, INT J BIOL MACROMOL, V25, P69, DOI 10.1016/S0141-8130(99)00017-3; Kiema TR, 1999, BIOCHEMISTRY-US, V38, P2991, DOI 10.1021/bi981646v; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurosawa T, 2001, STEROIDS, V66, P107, DOI 10.1016/S0039-128X(00)00217-8; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li J, 2000, NAT STRUCT BIOL, V7, P555; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Mcree D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MINAMIISHII N, 1989, EUR J BIOCHEM, V185, P73, DOI 10.1111/j.1432-1033.1989.tb15083.x; MOTHES G, 1995, CAN J MICROBIOL, V41, P68, DOI 10.1139/m95-170; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; Qin YM, 1997, BIOCHEM J, V328, P377, DOI 10.1042/bj3280377; Reiser SE, 2000, APPL MICROBIOL BIOT, V53, P209, DOI 10.1007/s002530050010; Slater S, 1999, NAT BIOTECHNOL, V17, P1011, DOI 10.1038/13711; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; Tsuge T, 2000, FEMS MICROBIOL LETT, V184, P193, DOI 10.1111/j.1574-6968.2000.tb09013.x; van Grunsven EG, 1999, HUM MOL GENET, V8, P1509, DOI 10.1093/hmg/8.8.1509; van Grunsven EG, 1999, AM J HUM GENET, V64, P99, DOI 10.1086/302180; WATERSON RM, 1972, J BIOL CHEM, V247, P5258; Wu WJ, 1997, BIOCHEMISTRY-US, V36, P2211, DOI 10.1021/bi962549+	49	60	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					617	624		10.1074/jbc.M205484200	http://dx.doi.org/10.1074/jbc.M205484200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12409309	hybrid			2022-12-27	WOS:000180255700079
J	Lehmann, U; Schmitz, J; Weissenbach, M; Sobota, RM; Hortner, M; Friederichs, K; Behrmann, I; Tsiaris, W; Sasaki, A; Schneider-Mergener, J; Yoshimura, A; Neel, BG; Heinrich, PC; Schaper, F				Lehmann, U; Schmitz, J; Weissenbach, M; Sobota, RM; Hortner, M; Friederichs, K; Behrmann, I; Tsiaris, W; Sasaki, A; Schneider-Mergener, J; Yoshimura, A; Neel, BG; Heinrich, PC; Schaper, F			SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; LEUKEMIA-INHIBITORY FACTOR; TRANSDUCER GP130; ONCOSTATIN-M; SH2 DOMAIN; TRANSCRIPTION FACTOR; LEPTIN RECEPTOR; GROWTH-FACTOR; KINASE JAK1; BOX MOTIF	Interleukin-6 (IL-6) activates the Jak/STAT pathway as well as the mitogen-activated protein kinase cascade. Tyrosine 759 of the IL-6 signal-transducing receptor subunit gp130 has been identified as being involved in negative regulation of IL-6-induced gene induction and activation of the Jak/STAT pathway. Because this site is known to be a recruitment motif for the protein-tyrosine phosphatase SHP2, it has been suggested that SHP2 is the mediator of tyrosine 759-dependent signal attenuation. We recently observed that the suppressor of cytokine-signaling SOCS3 also acts through the tyrosine motif 759 of gp130. However, the relative contributions of SHP2 and SOCS3 to the repression of IL-6 signaling are not understood. Therefore, we designed experiments allowing the independent recruitment of each of these proteins to the IL-6-receptor complex. We show that receptor- and membrane-targeted SHP2 counteracts IL-6 signaling independent of SOCS3 binding to gp130. On the other hand, SOCS3 inhibits signaling in cells expressing a truncated SHP2 protein, which is not recruited to gp130. These data suggest, that there are two, largely distinct modes of negative regulation of gp130 activity, despite the fact that both SOCS3 and SHP2 are recruited to the same site within gp130.	Rhein Westfal TH Aachen, Dept Biochem, D-52074 Aachen, Germany; Bayer Pharma Res Ctr, D-42096 Wuppertal, Germany; Beth Israel Deaconess Med Ctr, Canc Biol Program, Boston, MA 02215 USA; Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; Univ Klinikum Charite, Dept Med Immunol, D-10117 Berlin, Germany	RWTH Aachen University; Bayer AG; Bayer Healthcare Pharmaceuticals; Harvard University; Beth Israel Deaconess Medical Center; Kyushu University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Heinrich, PC (corresponding author), Rhein Westfal TH Aachen, Dept Biochem, Pauwelsstr 30, D-52074 Aachen, Germany.		Schaper, Fred/F-1403-2013; Yoshimura, Akihiko/K-5515-2013	Schaper, Fred/0000-0002-8899-5414; Sasaki, Atsuo/0000-0003-2963-4501; Behrmann, Iris/0000-0003-3688-3645; Tsiaras, William/0000-0002-4080-4762				Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513; Anhuf D, 2000, J IMMUNOL, V165, P2535, DOI 10.4049/jimmunol.165.5.2535; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjorbaek C, 2001, J BIOL CHEM, V276, P4747, DOI 10.1074/jbc.M007439200; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; DECHERT U, 1994, J BIOL CHEM, V269, P5602; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Gerhartz C, 1996, J BIOL CHEM, V271, P12991, DOI 10.1074/jbc.271.22.12991; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Haan C, 2002, BIOCHEM J, V361, P105, DOI 10.1042/0264-6021:3610105; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hermanns HM, 2000, J BIOL CHEM, V275, P40742, DOI 10.1074/jbc.M005408200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Horsten U, 1997, J BIOL CHEM, V272, P23748, DOI 10.1074/jbc.272.38.23748; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Oh ES, 1999, MOL CELL BIOL, V19, P3205; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; PAYNE G, 1993, P NATL ACAD SCI USA, V90, P4902, DOI 10.1073/pnas.90.11.4902; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Sasaki A, 2000, J BIOL CHEM, V275, P29338, DOI 10.1074/jbc.M003456200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; Schiemann WP, 1997, J BIOL CHEM, V272, P16631, DOI 10.1074/jbc.272.26.16631; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Siewert E, 1999, EUR J BIOCHEM, V265, P251, DOI 10.1046/j.1432-1327.1999.00719.x; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Symes A, 1997, CURR BIOL, V7, P697, DOI 10.1016/S0960-9822(06)00298-3; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WEIERGRABER O, 1995, EUR J BIOCHEM, V234, P661, DOI 10.1111/j.1432-1033.1995.661_b.x; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; YUAN JP, 1994, MOL CELL BIOL, V14, P1657, DOI 10.1128/MCB.14.3.1657; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	62	185	189	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					661	671		10.1074/jbc.M210552200	http://dx.doi.org/10.1074/jbc.M210552200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403768	hybrid			2022-12-27	WOS:000180255700084
J	Zhou, YL; Mehta, KR; Choi, AP; Scolavino, S; Zhang, X				Zhou, YL; Mehta, KR; Choi, AP; Scolavino, S; Zhang, X			DNA damage-induced inhibition of securin expression is mediated by p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-TRANSFORMING GENE; SISTER-CHROMATID SEPARATION; DEPENDENT PROTEIN-KINASE; NF-Y; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL STABILITY; ANAPHASE INHIBITOR; HSP70 PROMOTER; FISSION YEAST	Tumor suppressor p53 induces the cellular response to DNA damage mainly by regulating expression of its downstream target genes. The human securin is an anaphase inhibitor, preventing premature chromosome separation through inhibition of separase activity. It is also known as the product of the human pituitary tumor-transforming gene, pttg, a proto-oncogene. Here we report that the expression of human securin is suppressed in cells treated with the DNA-damaging drugs doxorubicin and bleomycin. This suppression requires functional p53. Analysis of the human securin promoter reveals that DNA-binding sites for Sp1 and NF-Y are both required for activation of securin expression; however, only the NF-Y site is essential for the suppression by p53. Our study indicates that securin is a p53 target gene and may play a role in p53-mediated cellular response to DNA damage.	Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, X (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, 55 Fruit St,Bulfinch 457, Boston, MA 02114 USA.				NATIONAL CANCER INSTITUTE [F32CA088519] Funding Source: NIH RePORTER; NCI NIH HHS [5 F32 CA88519-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Bolognese F, 1999, ONCOGENE, V18, P1845, DOI 10.1038/sj.onc.1202494; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; CHEN JL, 1994, CELL, V79, P93, DOI 10.1016/0092-8674(94)90403-0; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Facchinetti V, 2000, ONCOGENE, V19, P3931, DOI 10.1038/sj.onc.1203730; Faniello MC, 1999, J BIOL CHEM, V274, P7623, DOI 10.1074/jbc.274.12.7623; Frontini M, 2002, J BIOL CHEM, V277, P5841, DOI 10.1074/jbc.M103651200; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Ge YB, 2001, BIOCHEM J, V357, P97, DOI 10.1042/0264-6021:3570097; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Huet X, 1996, MOL CELL BIOL, V16, P3789; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Ishikawa H, 2001, J CLIN ENDOCR METAB, V86, P867, DOI 10.1210/jc.86.2.867; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Liang FQ, 2001, J BIOL CHEM, V276, P1516, DOI 10.1074/jbc.M006350200; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Mei JJ, 2001, CURR BIOL, V11, P1197, DOI 10.1016/S0960-9822(01)00325-6; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2001, J BIOL CHEM, V276, P8484, DOI 10.1074/jbc.M009654200; PERREM K, 1995, ONCOGENE, V11, P1299; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Roder K, 1997, J BIOL CHEM, V272, P21616, DOI 10.1074/jbc.272.34.21616; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; WRIGHT KL, 1995, J BIOL CHEM, V270, P20978, DOI 10.1074/jbc.270.36.20978; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yun J, 1999, J BIOL CHEM, V274, P29677, DOI 10.1074/jbc.274.42.29677; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhao RB, 2000, GENE DEV, V14, P981; Zhong ZD, 2000, J BIOL CHEM, V275, P18602, DOI 10.1074/jbc.M001389200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou YL, 2000, MOL ENDOCRINOL, V14, P2066, DOI 10.1210/me.14.12.2066; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	65	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 3	2003	278	1					462	470		10.1074/jbc.M203793200	http://dx.doi.org/10.1074/jbc.M203793200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	632ZX	12403781	hybrid			2022-12-27	WOS:000180255700061
J	Li, MY; Luo, JY; Brooks, CL; Gu, W				Li, MY; Luo, JY; Brooks, CL; Gu, W			Acetylation of p53 inhibits its ubiquitination by Mdm2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DNA-DAMAGE; NUCLEAR EXPORT; PHOSPHORYLATION; DEGRADATION; STABILITY; ACTIVATION; PROMOTES; STRESS; LIGASE	In response to DNA damage, the activity of the p53 tumor suppressor is modulated by protein stabilization and post-translational modifications including acetylation. Interestingly, both acetylation and ubiquitination can modify the same lysine residues at the C terminus of p53, implicating a role of acetylation in the regulation of p53 stability. However, the direct effect of acetylation on Mdm2-mediated ubiquitination of p53 is still lacking because of technical difficulties. Here, we have developed a method to obtain pure acetylated p53 proteins from cells, and by using an in vitro purified system, we provide the direct evidence that acetylation of the C-terminal domain is sufficient to abrogate its ubiquitination by Mdm2. Importantly, even in the absence of DNA damage, acetylation of the p53 protein is capable of reducing the ubiquitination levels and extending its half-life in vivo. Moreover, we also show that acetylation of p53 can affect its ubiquitination through other mechanisms in addition to the site competition. This study has significant implications regarding a general mechanism by which protein acetylation modulates ubiquitination-dependent proteasome proteolysis.	Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, Berrie Res Pavil,Rm 412C,1150 St Nicholas Ave, New York, NY 10032 USA.		Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NCI NIH HHS [5-T32-CAO9503-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2000, PATHOL BIOL, V48, P227; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu Y, 2000, MOL CELL BIOL, V20, P5540, DOI 10.1128/MCB.20.15.5540-5553.2000; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	35	373	381	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 27	2002	277	52					50607	50611		10.1074/jbc.C200578200	http://dx.doi.org/10.1074/jbc.C200578200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	631QD	12421820	hybrid			2022-12-27	WOS:000180177700055
